PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Saffarian, S; Collier, IE; Marmer, BL; Elson, EL; Goldberg, G				Saffarian, S; Collier, IE; Marmer, BL; Elson, EL; Goldberg, G			Interstitial collagenase is a Brownian ratchet driven by proteolysis of collagen	SCIENCE			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; SKIN FIBROBLAST COLLAGENASE; MATRIX METALLOPROTEINASES; MOLECULAR MOTORS; ACTIVE-SITE; I COLLAGEN; KINETICS; PROTEIN	We show that activated collagenase (MMP-1) moves processively on the collagen fibril. The mechanism of movement is a biased diffusion with the bias component dependent on the proteolysis of its substrate, not adenosine triphosphate (ATP) hydrolysis. inactivation of the enzyme by a single amino acid residue substitution in the active center eliminates the bias without noticeable effect on rate of diffusion. Monte Carlo simulations using a model similar to a "burnt bridge" Brownian ratchet accurately describe our experimental results and previous observations on kinetics of collagen digestion. The biological implications of MMP-1 acting as a molecular ratchet tethered to the cell surface suggest new mechanisms for its role in tissue remodeling and cell-matrix interaction.	Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; Washington Univ, Sch Med, Div Dermatol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Goldberg, G (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.	goldberg@medicine.wustl.edu			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040618, R01AR039472] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038838] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR39472, AR40618] Funding Source: Medline; NIGMS NIH HHS [GM-38838] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Astumian RD, 1997, SCIENCE, V276, P917, DOI 10.1126/science.276.5314.917; Collier IE, 2001, BIOPHYS J, V81, P2370, DOI 10.1016/S0006-3495(01)75883-3; Derenyi I, 1999, PHYS REV LETT, V83, P903, DOI 10.1103/PhysRevLett.83.903; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Feynman R. P., 1966, FEYNMAN LECT PHYS, VI; FIELDS GB, 1987, J BIOL CHEM, V262, P6221; Fox RF, 1998, PHYS REV E, V57, P2177, DOI 10.1103/PhysRevE.57.2177; GOLDBERG GI, 1986, J BIOL CHEM, V261, P6600; JEFFREY JJ, 1983, J BIOL CHEM, V258, P1123; Julicher F, 1997, REV MOD PHYS, V69, P1269, DOI 10.1103/RevModPhys.69.1269; Kadler KE, 1996, BIOCHEM J, V316, P1; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; MAGDE D, 1978, BIOPOLYMERS, V17, P361, DOI 10.1002/bip.1978.360170208; Mai J, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.011102; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; PESKIN CS, 1993, BIOPHYS J, V65, P316, DOI 10.1016/S0006-3495(93)81035-X; Pilcher BK, 1997, J CELL BIOL, V137, P1445, DOI 10.1083/jcb.137.6.1445; PROST J, 1994, PHYS REV LETT, V72, P2652, DOI 10.1103/PhysRevLett.72.2652; Qian H, 2000, BIOPHYS CHEM, V83, P35, DOI 10.1016/S0301-4622(99)00121-0; Saffarian S, 2003, BIOPHYS J, V84, P2030, DOI 10.1016/S0006-3495(03)75011-5; SAFFARIAN S, UNPUB; Schliwa M, 2003, NATURE, V422, P759, DOI 10.1038/nature01601; Shimada T, 1999, EUR J BIOCHEM, V262, P907, DOI 10.1046/j.1432-1327.1999.00459.x; Steele DL, 2000, PROTEIN ENG, V13, P397, DOI 10.1093/protein/13.6.397; TORBET J, 1984, BIOCHEM J, V219, P1057, DOI 10.1042/bj2191057; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; WELGUS HG, 1980, J BIOL CHEM, V255, P6806; WINDSOR LJ, 1994, J BIOL CHEM, V269, P26201	30	144	147	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2004	306	5693					108	111		10.1126/science.1099179	http://dx.doi.org/10.1126/science.1099179			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459390	Green Submitted			2022-12-24	WOS:000224304000047
J	Holzelova, E; Vonarbourg, C; Stolzenberg, MC; Arkwright, PD; Selz, F; Prieur, AM; Blanche, S; Bartunkova, J; Vilmer, E; Fischer, A; Le Deist, F; Rieux-Laucat, F				Holzelova, E; Vonarbourg, C; Stolzenberg, MC; Arkwright, PD; Selz, F; Prieur, AM; Blanche, S; Bartunkova, J; Vilmer, E; Fischer, A; Le Deist, F; Rieux-Laucat, F			Autoimmune lymphoproliferative syndrome with somatic Fas mutations	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; IN-VIVO REVERSION; GENE-MUTATIONS; CELL APOPTOSIS; HUMAN-DISEASE; T-CELLS; EXPRESSION; DOMINANT; PATIENT; LYMPHOCYTE	BACKGROUND: Impaired Fas-induced apoptosis of lymphocytes in vitro is a principal feature of the autoimmune lymphoproliferative syndrome (ALPS). We studied six children with ALPS whose lymphocytes had normal sensitivity to Fas-induced apoptosis in vitro. METHODS: Susceptibility to Fas-mediated apoptosis and the Fas gene were analyzed in purified subgroups of T cells and other mononuclear cells from six patients with ALPS type III. RESULTS: Heterozygous dominant Fas mutations were detected in the polyclonal double-negative T cells from all six patients. In two patients, these mutations were found in a fraction of CD4+ and CD8+ T cells, monocytes, and CD34+ hematopoietic precursors, but not in hair or mucosal epithelial cells. CONCLUSIONS: Somatic heterozygous mutations of Fas can cause a sporadic form of ALPS by allowing lymphoid precursors to resist the normal process of cell death.	Hop Necker Enfants Malad, INSERM, U429, Paris, France; Hop Necker Enfants Malad, Unite Immunol Hematol Pediat, Paris, France; Univ Manchester, Booth Hall Childrens Hosp, Acad Unit Child Hlth, Manchester, Lancs, England; Charles Univ, Sch Med 2, Inst Immunol, Prague, Czech Republic; Hop Robert Debre, Unite Immunohematol, F-75019 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Royal Manchester Children's Hospital; University of Manchester; Charles University Prague; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Holzelova, E (corresponding author), Hop Necker Enfants Malad, INSERM, U429, Paris, France.		Rieux-Laucat, Frédéric/A-7916-2017; Arkwright, Peter/C-5149-2012; Stolzenberg, Marie-Claude/I-6281-2017	Rieux-Laucat, Frédéric/0000-0001-7858-7866; Stolzenberg, Marie-Claude/0000-0001-8026-0360; Arkwright, Peter/0000-0002-7411-5375				Bensoussan D, 2002, BRIT J HAEMATOL, V117, P899, DOI 10.1046/j.1365-2141.2002.03496.x; Bettinardi A, 1997, BLOOD, V89, P902, DOI 10.1182/blood.V89.3.902; Bleesing JJH, 2001, CLIN IMMUNOL, V100, P314, DOI 10.1006/clim.2001.5069; CANALE VC, 1967, J PEDIATR-US, V70, P891, DOI 10.1016/S0022-3476(67)80262-2; Drappa J, 1996, NEW ENGL J MED, V335, P1643, DOI 10.1056/NEJM199611283352204; Erickson RP, 2003, MUTAT RES-REV MUTAT, V543, P125, DOI 10.1016/S1383-5742(03)00010-3; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; Fuss IJ, 1997, J IMMUNOL, V158, P1912; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616; Hezard N, 1998, THROMB HAEMOSTASIS, V79, P1054; Hirschhorn R, 1996, NAT GENET, V13, P290, DOI 10.1038/ng0796-290; ILLUM N, 1991, SCAND J IMMUNOL, V34, P635, DOI 10.1111/j.1365-3083.1991.tb01587.x; Jackson CE, 1999, AM J HUM GENET, V64, P1002, DOI 10.1086/302333; Kasahara Y, 1998, INT IMMUNOL, V10, P195, DOI 10.1093/intimm/10.2.195; Krueger A, 2003, IMMUNOL REV, V193, P58, DOI 10.1034/j.1600-065X.2003.00047.x; LeDeist F, 1996, LANCET, V348, P719, DOI 10.1016/S0140-6736(96)02293-3; Leuer M, 2001, AM J HUM GENET, V69, P75, DOI 10.1086/321285; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; NAGATA S, 1995, IMMUNOL TODAY, V16, P39, DOI 10.1016/0167-5699(95)80069-7; Ramenghi U, 2000, BLOOD, V95, P3176; Renno T, 1998, EUR J IMMUNOL, V28, P540, DOI 10.1002/(SICI)1521-4141(199802)28:02<540::AID-IMMU540>3.3.CO;2-P; Rieux-Laucat F, 1999, BLOOD, V94, P2575; Rieux-Laucat F, 2003, CURR OPIN IMMUNOL, V15, P325, DOI 10.1016/S0952-7915(03)00042-6; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; Schneider E, 1999, BLOOD, V94, P2613, DOI 10.1182/blood.V94.8.2613.420k33_2613_2621; Senju S, 1996, INT IMMUNOL, V8, P423, DOI 10.1093/intimm/8.3.423; Simon HU, 1996, J EXP MED, V183, P1071, DOI 10.1084/jem.183.3.1071; Sneller MC, 1997, BLOOD, V89, P1341, DOI 10.1182/blood.V89.4.1341; Stephan V, 1996, NEW ENGL J MED, V335, P1563, DOI 10.1056/NEJM199611213352104; Strain L, 1998, NEW ENGL J MED, V338, P166, DOI 10.1056/NEJM199801153380305; Vaishnaw AK, 1999, J CLIN INVEST, V103, P1099, DOI 10.1172/JCI5121C1; Vaishnaw AK, 1999, J CLIN INVEST, V103, P355, DOI 10.1172/JCI5121; van der Burg M, 2000, PEDIATR RES, V47, P336, DOI 10.1203/00006450-200003000-00009; vanDijk BA, 1996, AM J MED GENET, V61, P264, DOI 10.1002/(SICI)1096-8628(19960122)61:3<264::AID-AJMG11>3.0.CO;2-R; Wada T, 2001, P NATL ACAD SCI USA, V98, P8697, DOI 10.1073/pnas.151260498; Wang J, 1999, CELL, V98, P47, DOI 10.1016/S0092-8674(00)80605-4; Wu JG, 1996, J CLIN INVEST, V98, P1107, DOI 10.1172/JCI118892	37	212	237	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 30	2004	351	14					1409	1418		10.1056/NEJMoa040036	http://dx.doi.org/10.1056/NEJMoa040036			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857XT	15459302				2022-12-24	WOS:000224153900009
J	Go, AS; Chertow, GM; Fan, DJ; McCulloch, CE; Hsu, CY				Go, AS; Chertow, GM; Fan, DJ; McCulloch, CE; Hsu, CY			Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	36th Annual Meeting of the American-Society-of-Nephrology	NOV 12-17, 2003	SAN DIEGO, CA	Amer Soc Nephrol			CHRONIC RENAL-INSUFFICIENCY; 3RD NATIONAL-HEALTH; SERUM CREATININE; ALL-CAUSE; MORTALITY; OUTCOMES; CARE; HYPERTENSION; IMPACT; COHORT	Background: End-stage renal disease substantially increases the risks of death, cardiovascular disease, and use of specialized health care, but the effects of less severe kidney dysfunction on these outcomes are less well defined. Methods: We estimated the longitudinal glomerular filtration rate (GFR) among 1,120,295 adults within a large, integrated system of health care delivery in whom serum creatinine had been measured between 1996 and 2000 and who had not undergone dialysis or kidney transplantation. We examined the multivariable association between the estimated GFR and the risks of death, cardiovascular events, and hospitalization. Results: The median follow-up was 2.84 years, the mean age was 52 years, and 55 percent of the group were women. After adjustment, the risk of death increased as the GFR decreased below 60 ml per minute per 1.73 m(2) of body-surface area: the adjusted hazard ratio for death was 1.2 with an estimated GFR of 45 to 59 ml per minute per 1.73 m(2) (95 percent confidence interval, 1.1 to 1.2), 1.8 with an estimated GFR of 30 to 44 ml per minute per 1.73 m(2) (95 percent confidence interval, 1.7 to 1.9), 3.2 with an estimated GFR of 15 to 29 ml per minute per 1.73 m(2) (95 percent confidence interval, 3.1 to 3.4), and 5.9 with an estimated GFR of less than 15 ml per minute per 1.73 m(2) (95 percent confidence interval, 5.4 to 6.5). The adjusted hazard ratio for cardiovascular events also increased inversely with the estimated GFR: 1.4 (95 percent confidence interval, 1.4 to 1.5), 2.0 (95 percent confidence interval, 1.9 to 2.1), 2.8 (95 percent confidence interval, 2.6 to 2.9), and 3.4 (95 percent confidence interval, 3.1 to 3.8), respectively. The adjusted risk of hospitalization with a reduced estimated GFR followed a similar pattern. Conclusions: An independent, graded association was observed between a reduced estimated GFR and the risk of death, cardiovascular events, and hospitalization in a large, community-based population. These findings highlight the clinical and public health importance of chronic renal insufficiency.	Kaiser Permanente No Calif, Div Res, Oakland, CA 94612 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA	Kaiser Permanente; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Go, AS (corresponding author), Kaiser Permanente No Calif, Div Res, 2000 Broadway,3rd Fl, Oakland, CA 94612 USA.	alan.s.go@kp.org	Go, Alan S./AAE-7745-2019	Hsu, Chi-yuan/0000-0001-8182-1238; Chertow, Glenn/0000-0002-7599-0534	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058411] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK58411] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alexander M, 1999, ARCH INTERN MED, V159, P2673, DOI 10.1001/archinte.159.22.2673; [Anonymous], 2003, USRDS 2003 ANN DAT R; ARELLANO MG, 1984, AM J PUBLIC HEALTH, V74, P1324, DOI 10.2105/AJPH.74.12.1324; Blacher J, 2003, KIDNEY INT, V63, P1852, DOI 10.1046/j.1523-1755.2003.00932.x; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Culleton BF, 1999, KIDNEY INT, V56, P2214, DOI 10.1046/j.1523-1755.1999.00773.x; DAMSGAARD EM, 1990, BRIT MED J, V300, P297, DOI 10.1136/bmj.300.6720.297; Drey N, 2003, AM J KIDNEY DIS, V42, P677, DOI 10.1016/S0272-6386(03)00916-8; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Feldman HI, 2003, J AM SOC NEPHROL, V14, pS148, DOI 10.1097/01.ASN.0000070149.78399.CE; Fireman BH, 2000, J NATL CANCER I, V92, P136, DOI 10.1093/jnci/92.2.136; Garg AX, 2002, KIDNEY INT, V61, P1486, DOI 10.1046/j.1523-1755.2002.00270.x; Go AS, 1999, ANN INTERN MED, V131, P927, DOI 10.7326/0003-4819-131-12-199912210-00004; Hsu CY, 2002, J AM SOC NEPHROL, V13, P504, DOI 10.1681/ASN.V132504; Karter AJ, 2002, JAMA-J AM MED ASSOC, V287, P2519, DOI 10.1001/jama.287.19.2519; Karter AJ, 2002, JAMA-J AM MED ASSOC, V288, P46; Khan SS, 2002, KIDNEY INT, V62, P229, DOI 10.1046/j.1523-1755.2002.00432.x; Landis JR, 2003, J AM SOC NEPHROL, V14, p294A; LANGFORD HG, 1986, PROG CARDIOVASC DIS, V29, P29, DOI 10.1016/0033-0620(86)90033-2; Levey Andrew S., 2000, Journal of the American Society of Nephrology, V11, p155A; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levin A, 1999, AM J KIDNEY DIS, V34, P125, DOI 10.1016/S0272-6386(99)70118-6; London GM, 2003, NEPHROL DIAL TRANSPL, V18, P1731, DOI 10.1093/ndt/gfg414; Manjunath G, 2003, KIDNEY INT, V63, P1121, DOI 10.1046/j.1523-1755.2003.00838.x; Manjunath G, 2003, J AM COLL CARDIOL, V41, P47, DOI 10.1016/S0735-1097(02)02663-3; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; Muntner P, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133745; Muntner P, 2004, ANN INTERN MED, V140, P9, DOI 10.7326/0003-4819-140-1-200401060-00006; Raggi P, 2002, J AM COLL CARDIOL, V39, P695, DOI 10.1016/S0735-1097(01)01781-8; Ruilope LM, 2001, J AM SOC NEPHROL, V12, P218, DOI 10.1681/ASN.V122218; Selby JV, 1997, DIABETES CARE, V20, P1396, DOI 10.2337/diacare.20.9.1396; SHEMESH O, 1985, KIDNEY INT, V28, P830, DOI 10.1038/ki.1985.205; Shlipak MG, 2002, ANN INTERN MED, V137, P555, DOI 10.7326/0003-4819-137-7-200210010-00006; Shlipak MG, 2001, J AM COLL CARDIOL, V38, P705, DOI 10.1016/S0735-1097(01)01450-4; Shlipak MG, 2003, CIRCULATION, V107, P87, DOI 10.1161/01.CIR.0000042700.48769.59; SHULMAN N B, 1989, Hypertension (Dallas), V13, pI80; Therneau T. M., 2000, STAT BIOL HEALTH; *US BUR CENS, 2001, 2000 CENS POP HOUS S; Wang JG, 2001, HYPERTENSION, V37, P1069, DOI 10.1161/01.HYP.37.4.1069; Wannamethee SG, 1997, STROKE, V28, P557, DOI 10.1161/01.STR.28.3.557	42	8354	8668	13	600	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 23	2004	351	13					1296	1305		10.1056/NEJMoa041031	http://dx.doi.org/10.1056/NEJMoa041031			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	855TP	15385656	Bronze			2022-12-24	WOS:000223997700007
J	Lappe, JM; Muhlestein, JB; Lappe, DL; Badger, RS; Bair, TL; Brockman, R; French, TK; Hofmann, LC; Horne, BD; Kralick-Goldberg, S; Nicponski, N; Orton, JA; Pearson, RR; Renlund, DG; Rimmasch, H; Roberts, C; Anderson, JL				Lappe, JM; Muhlestein, JB; Lappe, DL; Badger, RS; Bair, TL; Brockman, R; French, TK; Hofmann, LC; Horne, BD; Kralick-Goldberg, S; Nicponski, N; Orton, JA; Pearson, RR; Renlund, DG; Rimmasch, H; Roberts, C; Anderson, JL			Improvements in 1-year cardiovascular clinical outcomes associated with a hospital-based discharge medication program	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CORONARY-ARTERY-DISEASE; STATIN THERAPY; UNITED-STATES; ASPIRIN; MORTALITY; PREVENTION; ANGINA; TRIAL	Background: Despite recent advances in the treatment and prevention of cardiovascular disease, a treatment gap for secondary prevention medications still exists. Objective: To develop and implement a program ensuring appropriate prescription of aspirin, statins, beta-blockers, angiotensin-converting enzyme inhibitors, and warfarin at hospital discharge. Design: A nonrandomized before-after study comparing patients hospitalized before (1996-1998) and after (1999-2002) implementation of a discharge medication program (DMP). Patients were followed for up to 1 year. Setting: The 10 largest hospitals in the Utah-based Intermountain Health Care system. Patients: In the pre-DMP and DMP time periods, 26 000 and 31465 patients, respectively, were admitted to cardiovascular services (n = 57 465). Measurements: Prescription of indicated medications at hospital discharge; postdischarge death or readmission. Results: By 1 year, the rate of prescription of each medication increased significantly to more than 90% (P < 0.001); this rate was sustained. At 1 year, unadjusted absolute event rates for readmission and death, respectively, were 210 per 1000 years and 96 per 1000 person-years before DMP implementation and 191 per 1000 person-years and 70 per 1000 person-years afterward. Relative risk for death and readmission at 30 days decreased after DMP implementation; hazard ratios (HRs) for death and readmission were 0.81 (95% Cl, 0.73 to 0.89) and 0.92 (Cl, 0.87 to 0.99) (P < 0.001 and P = 0.017, respectively). At 1 year, risk for death continued to decrease (hazard ratio, 0.79 [Cl, 0.75 to 0.84]; P < 0.001) while risk for readmission stabilized (hazard ratio, 0.94 [Cl, 0.90 to 0.98]; P = 0.002), probably because survivors had more opportunities to be readmitted. Limitations: The study design was observational and nonrandomized, and the authors could not control for potential confounders or determine the extent to which secular trends accounted for the observed improvements. Conclusions: A relatively simple quality improvement program aimed at enhancing the prescription of appropriate discharge medications among cardiovascular patients is feasible and can be sustained within an integrated multihospital system. Such a program may be associated with improvements in cardiovascular readmission rates and mortality.	LDS Hosp, Intermt Hlth Care, Salt Lake City, UT USA	Intermountain Healthcare	Muhlestein, JB (corresponding author), Hosp Cardiovasc Dept, 8th Ave & C St, Salt Lake City, UT 84143 USA.		Horne, Benjamin/GQP-7851-2022					*AM HEART ASS, 2001, HEART DIS STROK STAT; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; ELLERBECK EF, 1995, JAMA-J AM MED ASSOC, V273, P1509, DOI 10.1001/jama.273.19.1509; Fonarow GC, 2001, AM J CARDIOL, V87, P819, DOI 10.1016/S0002-9149(00)01519-8; Frolkis JP, 1998, CIRCULATION, V98, P851, DOI 10.1161/01.CIR.98.9.851; Gottlieb SS, 1998, NEW ENGL J MED, V339, P489, DOI 10.1056/NEJM199808203390801; Horne BD, 2000, J AM COLL CARDIOL, V36, P1774, DOI 10.1016/S0735-1097(00)00950-5; JUULMOLLER S, 1992, LANCET, V340, P1421, DOI 10.1016/0140-6736(92)92619-Q; LEWIS HD, 1983, NEW ENGL J MED, V309, P396, DOI 10.1056/NEJM198308183090703; Maycock CAA, 2002, J AM COLL CARDIOL, V40, P1777, DOI 10.1016/S0735-1097(02)02477-4; Miller M, 2000, ARCH INTERN MED, V160, P343, DOI 10.1001/archinte.160.3.343; Muhlestein JB, 2001, AM J CARDIOL, V87, P257, DOI 10.1016/S0002-9149(00)01354-0; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; PEDERSEN TR, 1994, LANCET, V344, P1383; PETERSEN P, 1989, LANCET, V1, P175; Stafford RS, 2000, CIRCULATION, V101, P1097, DOI 10.1161/01.CIR.101.10.1097; Sueta CA, 1999, AM J CARDIOL, V83, P1303, DOI 10.1016/S0002-9149(99)00117-4; *UT DEP HLTH CTR H, 2001, UT VIT STAT 2001; *UT DEP HTLH CTR H, 1998, VIT STAT 1998; 1929, N ENGL J MED, V328, P293	20	104	103	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 21	2004	141	6					446	453		10.7326/0003-4819-141-6-200409210-00010	http://dx.doi.org/10.7326/0003-4819-141-6-200409210-00010			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856TM	15381518				2022-12-24	WOS:000224067900005
J	Balaban, NQ; Merrin, J; Chait, R; Kowalik, L; Leibler, S				Balaban, NQ; Merrin, J; Chait, R; Kowalik, L; Leibler, S			Bacterial persistence as a phenotypic switch	SCIENCE			English	Article							ESCHERICHIA-COLI K-12; ANTIBIOTIC-RESISTANCE; SOFT LITHOGRAPHY; LETHALITY; MUTANTS; DEATH; HIPA	A fraction of a genetically homogeneous microbial population may survive exposure to stress such as antibiotic treatment. Unlike resistant mutants, cells regrown from such persistent bacteria remain sensitive to the antibiotic. We investigated the persistence of single cells of Escherichia coli with the use of microfluidic devices. Persistence was linked to preexisting heterogeneity in bacterial populations because phenotypic switching occurred between normally growing cells and persister cells having reduced growth rates. Quantitative measurements led to a simple mathematical description of the persistence switch. Inherent heterogeneity of bacterial populations may be important in adaptation to fluctuating environments and in the persistence of bacterial infections.	Rockefeller Univ, Lab Living Matter, New York, NY 10021 USA; Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10021 USA; Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel	Rockefeller University; Rockefeller University; Hebrew University of Jerusalem	Balaban, NQ (corresponding author), Rockefeller Univ, Lab Living Matter, 1230 York Ave, New York, NY 10021 USA.	nathalieqb@phys.huji.ac.il	Sandstedt, Sara A/A-3001-2010; Balaban, Nathalie/AGI-1487-2022; Balaban, Nathalie/AAH-1004-2019	Balaban, Nathalie/0000-0001-8018-0766; Balaban, Nathalie/0000-0001-8018-0766; Chait, Remy/0000-0003-0876-3187				Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Bigger JW, 1944, LANCET, V2, P497; BRADFORD MJ, 1993, ECOLOGY, V74, P1129, DOI 10.2307/1940482; COZENS RM, 1986, ANTIMICROB AGENTS CH, V29, P797, DOI 10.1128/AAC.29.5.797; Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; Korch SB, 2003, MOL MICROBIOL, V50, P1199, DOI 10.1046/j.1365-2958.2003.03779.x; Lewis K, 2000, MICROBIOL MOL BIOL R, V64, P503, DOI 10.1128/MMBR.64.3.503-514.2000; Massey RC, 2001, CURR BIOL, V11, P1810, DOI 10.1016/S0960-9822(01)00507-3; McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C; MOYED HS, 1983, J BACTERIOL, V155, P768, DOI 10.1128/JB.155.2.768-775.1983; Mukamolova GV, 1999, ARCH MICROBIOL, V172, P9, DOI 10.1007/s002030050733; Sat B, 2001, J BACTERIOL, V183, P2041, DOI 10.1128/JB.183.6.2041-2045.2001; SCHERRER R, 1988, J BACTERIOL, V170, P3321, DOI 10.1128/jb.170.8.3321-3326.1988; Stewart GR, 2003, NAT REV MICROBIOL, V1, P97, DOI 10.1038/nrmicro749; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335; WOLFSON JS, 1990, ANTIMICROB AGENTS CH, V34, P1938, DOI 10.1128/AAC.34.10.1938	18	1886	1969	15	493	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2004	305	5690					1622	1625		10.1126/science.1099390	http://dx.doi.org/10.1126/science.1099390			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	854GV	15308767				2022-12-24	WOS:000223891200044
J	Fortin, NJ; Wright, SP; Eichenbaum, H				Fortin, NJ; Wright, SP; Eichenbaum, H			Recollection-like memory retrieval in rats is dependent on the hippocampus	NATURE			English	Article							HUMAN RECOGNITION MEMORY; OBJECT-RECOGNITION; EPISODIC MEMORY; FAMILIARITY; DAMAGE; LESIONS; MONKEYS; INFORMATION; COMPONENTS; INSIGHTS	Recognition memory may be supported by two independent types of retrieval, conscious recollection of a specific experience and a sense of familiarity gained from previous exposure to particular stimuli(1,2). In humans, signal detection techniques have been used to distinguish recollection and familiarity, respectively, in asymmetrical and curvilinear components of their receiver operating characteristic (ROC) curves, standard curves that represent item recognition across different levels of confidence or bias. To determine whether animals also employ multiple processes in recognition memory and to explore the anatomical basis of this distinction, we adapted these techniques to examine odour recognition memory in rats. Their ROC curve had asymmetrical and curvilinear components, indicating the existence of both recollection and familiarity in rats. Furthermore, following selective damage to the hippocampus the ROC curve became entirely symmetrical and remained curvilinear, supporting the view that the hippocampus specifically mediates the capacity for recollection.	Boston Univ, Ctr Memory & Brain, Boston, MA 02215 USA	Boston University	Eichenbaum, H (corresponding author), Boston Univ, Ctr Memory & Brain, 2 Cummington St, Boston, MA 02215 USA.	hbe@bu.edu		Fortin, Norbert/0000-0002-6793-6984	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009973] Funding Source: NIH RePORTER; NIA NIH HHS [P01 AG009973, P01 AG009973-070005] Funding Source: Medline; NIMH NIH HHS [R01 MH052090-05, R01 MH052090] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Beason-Held LL, 1999, HIPPOCAMPUS, V9, P562, DOI 10.1002/(SICI)1098-1063(1999)9:5<562::AID-HIPO10>3.0.CO;2-X; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Bunsey M, 1996, NATURE, V379, P255, DOI 10.1038/379255a0; Clark RE, 1998, SCIENCE, V280, P77, DOI 10.1126/science.280.5360.77; Davachi L, 2002, J NEUROPHYSIOL, V88, P982, DOI 10.1152/jn.2002.88.2.982; Day M, 2003, NATURE, V424, P205, DOI 10.1038/nature01769; Dudchenko PA, 2000, J NEUROSCI, V20, P2964; Eacott MJ, 2004, J NEUROSCI, V24, P1948, DOI 10.1523/JNEUROSCI.2975-03.2004; EICHENBAUM H, 1994, BEHAV BRAIN SCI, V17, P449, DOI 10.1017/S0140525X00035391; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; HOCKLEY WE, 1992, J EXP PSYCHOL LEARN, V18, P1321, DOI 10.1037/0278-7393.18.6.1321; Kesner RP, 1990, NEUROBIOLOGY COMP CO, P179; Macmillan N. A., 1991, DETECTION THEORY USE; Manns JR, 2003, NEURON, V37, P171, DOI 10.1016/S0896-6273(02)01147-9; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; Mumby DG, 2001, BEHAV BRAIN RES, V127, P159, DOI 10.1016/S0166-4328(01)00367-9; Murray EA, 1998, J NEUROSCI, V18, P6568; Nemanic S, 2004, J NEUROSCI, V24, P2013, DOI 10.1523/JNEUROSCI.3763-03.2004; Ranganath C, 2003, NEUROPSYCHOLOGIA, V41, P378, DOI 10.1016/S0028-3932(02)00169-0; Sherman SJ, 2003, BEHAV NEUROSCI, V117, P526, DOI 10.1037/0735-7044.117.3.526; Stark CEL, 2000, J NEUROSCI, V20, P7776; Steckler T, 1998, PROG NEUROBIOL, V54, P313, DOI 10.1016/S0301-0082(97)00061-0; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; Yonelinas AP, 1998, NEUROPSYCHOLOGY, V12, P323, DOI 10.1037/0894-4105.12.3.323; Yonelinas AP, 2002, PSYCHON B REV, V9, P575, DOI 10.3758/BF03196315; Yonelinas AP, 2002, NAT NEUROSCI, V5, P1236, DOI 10.1038/nn961; Yonelinas AP, 2001, PHILOS T R SOC B, V356, P1363, DOI 10.1098/rstb.2001.0939; Zola SM, 2000, J NEUROSCI, V20, P451, DOI 10.1523/JNEUROSCI.20-01-00451.2000	30	329	336	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 9	2004	431	7005					188	191		10.1038/nature02853	http://dx.doi.org/10.1038/nature02853			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HI	15356631	Green Accepted			2022-12-24	WOS:000223746000045
J	Baumiller, TK; Gahn, FJ				Baumiller, TK; Gahn, FJ			Testing predator-driven evolution with paleozoic crinoid arm regeneration	SCIENCE			English	Article							FLOROMETRA-SERRATISSIMA ECHINODERMATA; ADAPTATIONS; AUTOTOMY; TIME	Regenerating arms of crinoids represent direct evidence of nonlethal attacks by predators and provide an opportunity for exploring the importance of predation through geologic time. Analysis of 11 Paleozoic crinoid Lagerstatten revealed a significant increase in arm regeneration during the Siluro-Devonian. During this interval, referred to as the Middle Pateozoic Marine Revolution, the diversity of shell-crushing predators increased, and antipredatory morphologies among invertebrate prey, such as crinoids, became more common. Crinoid arm-regeneration data suggest an increase in nonlethal attacks at this time and represent a causal link between those patterns, which implies an important role for predator-driven evolution.	Univ Michigan, Museum Paleontol, Ann Arbor, MI 48105 USA; Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20013 USA	University of Michigan System; University of Michigan; Smithsonian Institution; Smithsonian National Museum of Natural History	Baumiller, TK (corresponding author), Univ Michigan, Museum Paleontol, Ann Arbor, MI 48105 USA.	tomaszb@umich.edu; gahn.forest@nmnh.si.edu	Baumiller, Tomasz K/C-3596-2012	Baumiller, Tomasz K/0000-0002-4506-9330				ALLMON WD, 1990, PALAEONTOLOGY, V33, P595; Baumiller T.K., 2003, P243; Baumiller TK, 2001, ECHINODERMS 2000, P3; BAUMILLER TK, 1994, ECHINODERMS THROUGH TIME, P193; Brett CE, 2003, T GEOBIOL, V20, P401; EFRON B, 1981, BIOMETRIKA, V68, P589, DOI 10.1093/biomet/68.3.589; FISHELSON L, 1974, MAR BIOL, V26, P183, DOI 10.1007/BF00388888; FOOTE M, 1995, PALEOBIOLOGY, V21, P273, DOI 10.1017/S0094837300013300; HOLLAND ND, 1981, ZOOMORPHOLOGY, V98, P169, DOI 10.1007/BF00310434; MEYER DL, 1985, PALEOBIOLOGY, V11, P154, DOI 10.1017/S0094837300011477; MEYER DL, 1984, MAR BIOL, V78, P179, DOI 10.1007/BF00394698; MEYER DL, 1993, J PALEONTOL, V67, P250, DOI 10.1017/S0022336000032170; MLADENOV PV, 1983, CAN J ZOOL, V61, P2873, DOI 10.1139/z83-375; NEUMANN C, 1998, FOSSILIEN, P175; OJI T, 1994, PALEOBIOLOGY, V20, P27, DOI 10.1017/S0094837300011118; Oji T, 1996, PALEOBIOLOGY, V22, P339, DOI 10.1017/S0094837300016328; Schneider J.A., 1988, P531; SCOTESE CR, 1990, GEO SOC MEM, V12, P1, DOI 10.1144/GSL.MEM.1990.012.01.01; SIGNOR PW, 1984, PALEOBIOLOGY, V10, P229, DOI 10.1017/S0094837300008174; SIMMS MJ, 1993, PALAEONTOLOGY, V36, P91; VERMEIJ G J, 1977, Paleobiology, V3, P245; Vermeij G.J., 1987, EVOLUTION ESCALATION; VERMEIJ GJ, 1994, ANNU REV ECOL SYST, V25, P219, DOI 10.1146/annurev.es.25.110194.001251; VERMEIJ GJ, 1981, SCIENCE, V214, P1024, DOI 10.1126/science.214.4524.1024; VERMEIJ GJ, 1985, AM NAT, V125, P470, DOI 10.1086/284354; WATERS JA, 1991, PALEOBIOLOGY, V17, P400, DOI 10.1017/S0094837300010733	26	72	80	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2004	305	5689					1453	1455		10.1126/science.1101009	http://dx.doi.org/10.1126/science.1101009			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852NK	15353799				2022-12-24	WOS:000223761900045
J	Song, JJ; Smith, SK; Hannon, GJ; Joshua-Tor, L				Song, JJ; Smith, SK; Hannon, GJ; Joshua-Tor, L			Crystal structure of argonaute and its implications for RISC slicer activity	SCIENCE			English	Article							PAZ DOMAIN; RNA; DROSOPHILA; COMPLEX; INTEGRASE; SIRNAS; CORE; TRANSPOSITION; INTERFERENCE; RECOGNITION	Argonaute proteins and small interfering RNAs (siRNAs) are the known signature components of the RNA interference effector complex RNA-induced silencing complex (RISC). However, the identity of "Slicer," the enzyme that cleaves the messenger RNA (mRNA) as directed by the siRNA, has not been resolved. Here, we report the crystal structure of the Argonaute protein from Pyrococcus furiosus at 2.25 angstrom resolution. The structure reveals a crescent-shaped base made up of the amino-terminal, middle, and PIWI domains. The Piwi Argonaute Zwille (PAZ) domain is held above the base by a "stalk"-like region. The PIWI domain (named for the protein piwi) is similar to ribonuclease H, With a conserved active site aspartate-aspartate-glutamate motif, strongly implicating Argonaute as "Slicer." The architecture of the molecule and the placement of the PAZ and PIWI domains define a groove for substrate binding and suggest a mechanism for siRNA-guided mRNA cleavage.	Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; Cold Spring Harbor Lab, Keck Struct Biol Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory	Joshua-Tor, L (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	leemor@cshl.edu	Hannon, Gregory/AAB-3568-2019; Song, Ji-Joon/C-1721-2011	Goldsmith, Stephanie/0000-0002-5010-1657; Joshua-Tor, Leemor/0000-0001-8185-8049				ARIYOSHI M, 1994, CELL, V78, P1063, DOI 10.1016/0092-8674(94)90280-1; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Cerutti L, 2000, TRENDS BIOCHEM SCI, V25, P481, DOI 10.1016/S0968-0004(00)01641-8; Davies DR, 2000, SCIENCE, V289, P77, DOI 10.1126/science.289.5476.77; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; FRIEDMAN AM, 1995, SCIENCE, V268, P1721, DOI 10.1126/science.7792597; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; KATAYANAGI K, 1993, PROTEINS, V17, P337, DOI 10.1002/prot.340170402; Lai LH, 2000, STRUCTURE, V8, P897, DOI 10.1016/S0969-2126(00)00179-9; Lingel A, 2004, NAT STRUCT MOL BIOL, V11, P576, DOI 10.1038/nsmb777; Lingel A, 2003, NATURE, V426, P465, DOI 10.1038/nature02123; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lubkowski J, 1999, BIOCHEMISTRY-US, V38, P13512, DOI 10.1021/bi991362q; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Martinez J, 2004, GENE DEV, V18, P975, DOI 10.1101/gad.1187904; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; RICE P, 1995, CELL, V82, P209, DOI 10.1016/0092-8674(95)90308-9; Schwarz DS, 2004, CURR BIOL, V14, P787, DOI 10.1016/j.cub.2004.03.008; Schwarz DS, 2002, MOL CELL, V10, P537, DOI 10.1016/S1097-2765(02)00651-2; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; WINTERSBERGER U, 1990, PHARMACOL THERAPEUT, V48, P259, DOI 10.1016/0163-7258(90)90083-E; Yan KS, 2003, NATURE, V426, P469, DOI 10.1038/nature02129; YANG W, 1995, STRUCTURE, V3, P131, DOI 10.1016/S0969-2126(01)00142-3	29	1036	1143	5	162	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2004	305	5689					1434	1437		10.1126/science.1102514	http://dx.doi.org/10.1126/science.1102514			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852NK	15284453				2022-12-24	WOS:000223761900039
J	Kiso, M; Mitamura, K; Sakai-Tagawa, Y; Shiraishi, K; Kawakami, C; Kimura, K; Hayden, FG; Sugaya, N; Kawaoka, Y				Kiso, M; Mitamura, K; Sakai-Tagawa, Y; Shiraishi, K; Kawakami, C; Kimura, K; Hayden, FG; Sugaya, N; Kawaoka, Y			Resistant influenza A viruses in children treated with oseltarnivir: descriptive study	LANCET			English	Article							INHIBITOR SUSCEPTIBILITY NETWORK; NEURAMINIDASE INHIBITORS; SIALIC-ACID; IN-VITRO; ACTIVE-SITE; OSELTAMIVIR; SELECTION; CELLS; 4-GUANIDINO-NEU5AC2EN; SENSITIVITY	Background Oseltamivir is an effective inhibitor of influenza virus neuraminidase. Although viruses resistant to oseltamivir emerge less frequently than those resistant to amantadine or rimantadine, information on oseltamivir-resistant viruses arising during clinical use of the drug in children is limited. Our aim was to investigate oseltamivir resistance in a group of children treated for influenza. Methods We analysed influenza A viruses (H3N2) collected from 50 children before and during treatment with oseltamivir. We sequenced the genes for neuraminidase and haemagglutinin and studied the mutant neuraminidases for their sensitivity to oseltamivir carboxylate. Findings We found neuraminidase mutations in viruses from nine patients (18%), six of whom had mutations at position 292 (Arg292Lys) and two at position 119 (Glu119Val), which are known to confer resistance to neuraminidase inhibitors. We also identified another mutation (Asn294Ser) in one patient. Sensitivity testing to oseltamivir carboxylate revealed that the neuraminidases of viruses that have an Arg292Lys, Glu119Val, or Asn294Ser mutation were about 10(4)-10(5)-fold, 500-fold, or 300-fold more resistant than their pretreatment neuraminidases, respectively. Oseltamivir-resistant viruses were first detected at day 4 of treatment and on each successive day of the study. More than 10(3) infectious units per mL of virus were detected in some of the patients who did not shed drug-resistant viruses, even after 5 days of treatment. Interpretation Oseltamivir-resistant mutants in children being treated for influenza with oseltamivir arise more frequently than previously reported. Furthermore, children can be a source of viral transmission, even after 5 days of treatment with oseltamivir.	Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol,Minato Ku, Tokyo 1088639, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Kawaguchi, Saitama, Japan; Kawasaki Municipal Hosp, Dept Paediat, Kawasaki, Kanagawa, Japan; Yokohama City Inst Hlth, Yokohama, Kanagawa, Japan; Isehara Kyodo Hosp, Dept Paediat, Isehara, Kanagawa, Japan; Univ Virginia, Sch Med, Charlottesville, VA 22908 USA; Keiyu Hosp, Dept Paediat, Yokohama, Kanagawa, Japan; Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA	University of Tokyo; Japan Science & Technology Agency (JST); University of Virginia; University of Wisconsin System; University of Wisconsin Madison	Kawaoka, Y (corresponding author), Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	kawaoka@ims.u-tokyo.ac.jp						Barnett JM, 1999, VIROLOGY, V265, P286, DOI 10.1006/viro.1999.0058; BURMEISTER WP, 1992, EMBO J, V11, P49, DOI 10.1002/j.1460-2075.1992.tb05026.x; Carr J, 2002, ANTIVIR RES, V54, P79, DOI 10.1016/S0166-3542(01)00215-7; Gubareva LV, 2004, VIRUS RES, V103, P199, DOI 10.1016/j.virusres.2004.02.034; Gubareva LV, 1998, J INFECT DIS, V178, P1257, DOI 10.1086/314440; Gubareva LV, 1997, J VIROL, V71, P3385, DOI 10.1128/JVI.71.5.3385-3390.1997; Gubareva LV, 1996, J VIROL, V70, P1818, DOI 10.1128/JVI.70.3.1818-1827.1996; Gubareva LV, 2001, J INFECT DIS, V183, P523, DOI 10.1086/318537; Gubareva LV, 2000, LANCET, V355, P827, DOI 10.1016/S0140-6736(99)11433-8; Hayden FG, 2001, PHILOS T R SOC B, V356, P1877, DOI 10.1098/rstb.2001.1007; Herlocher ML, 2003, J INFECT DIS, V188, P1355, DOI 10.1086/379049; Herlocher ML, 2002, ANTIVIR RES, V54, P99, DOI 10.1016/S0166-3542(01)00214-5; Jackson HC, 2000, CLIN DRUG INVEST, V20, P447, DOI 10.2165/00044011-200020060-00007; Kim CU, 1997, J AM CHEM SOC, V119, P681, DOI 10.1021/ja963036t; Matrosovich M, 2003, J VIROL, V77, P8418, DOI 10.1128/JVI.77.15.8418-8425.2003; McKimm-Breschkin JL, 2000, ANTIVIR RES, V47, P1, DOI 10.1016/S0166-3542(00)00103-0; OXFORD JS, 1970, NATURE, V226, P82, DOI 10.1038/226082a0; Ozaki H, 2004, J VIROL, V78, P1851, DOI 10.1128/JVI.78.4.1851-1857.2004; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; Shiraishi K, 2003, J INFECT DIS, V188, P57, DOI 10.1086/375799; Tai CY, 1998, ANTIMICROB AGENTS CH, V42, P3234, DOI 10.1128/AAC.42.12.3234; Tisdale M, 2000, REV MED VIROL, V10, P45, DOI 10.1002/(SICI)1099-1654(200001/02)10:1&lt;45::AID-RMV265&gt;3.0.CO;2-R; TOBITA K, 1975, MED MICROBIOL IMMUN, V162, P9, DOI 10.1007/BF02123572; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; VARGHESE JN, 1992, PROTEINS, V14, P327, DOI 10.1002/prot.340140302; VARGHESE JN, 1983, NATURE, V303, P35, DOI 10.1038/303035a0; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0; Wetherall NT, 2003, J CLIN MICROBIOL, V41, P742, DOI 10.1128/JCM.41.2.742-750.2003; Whitley RJ, 2001, PEDIATR INFECT DIS J, V20, P127, DOI 10.1097/00006454-200102000-00002; Zambon M, 2001, ANTIVIR RES, V49, P147, DOI 10.1016/S0166-3542(01)00124-3	30	595	671	3	39	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 28	2004	364	9436					759	765		10.1016/S0140-6736(04)16934-1	http://dx.doi.org/10.1016/S0140-6736(04)16934-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	849VO	15337401				2022-12-24	WOS:000223569600026
J	Benvenuti, F; Hugues, S; Walmsley, M; Ruf, S; Fetler, L; Popoff, M; Tybulewicz, VLJ; Amigorena, S				Benvenuti, F; Hugues, S; Walmsley, M; Ruf, S; Fetler, L; Popoff, M; Tybulewicz, VLJ; Amigorena, S			Requirement of Rac1 and Rac2 expression by mature dendritic cells for T cell priming	SCIENCE			English	Article							IMMUNOLOGICAL SYNAPSE; CUTTING EDGE; CYTOSKELETON; RHO; GTPASE	Upon maturation, dendritic cells (DCs) acquire the unique ability to activate naive T cells. We used time-lapse video microscopy and two-photon imaging of intact lymph nodes to show that after establishing initial contact between their dendrites and naive T lymphocytes, mature DCs migrate toward the contacted lymphocytes. Subsequently, the DCs; tightly entrap the T cells within a complex net of membrane extensions. The Rho family guanosine triphosphatases Rac1 and Rac2 but not Rho itself control the formation of dendrites in mature DCs, their polarized short-range migration toward T cells, and T cell priming.	Inst Curie, INSERM, U365, F-75005 Paris, France; Natl Inst Med Res, Div Immune Cell Biol, London NW7 1AA, England; Inst Curie, CNRS, UMR 168, F-75005 Paris, France; Inst Pasteur, Unite Toxines Microbiennes, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; MRC National Institute for Medical Research; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Amigorena, S (corresponding author), Inst Curie, INSERM, U365, 26 Rue Ulm, F-75005 Paris, France.	sebastian.amigorena@curie.fr	Benvenuti, Federica/O-1100-2013; Fetler, luc/M-9034-2018	hugues, stephanie/0000-0002-1031-5909; Amigorena, Sebastian/0000-0001-8583-8416; Tybulewicz, Victor/0000-0003-2439-0798; Benvenuti, Federica/0000-0002-1908-8052				Al-Alwan MM, 2003, J IMMUNOL, V171, P4479, DOI 10.4049/jimmunol.171.9.4479; Al-Alwan MM, 2001, J IMMUNOL, V166, P1452, DOI 10.4049/jimmunol.166.3.1452; Benvenuti F, 2004, J IMMUNOL, V172, P292, DOI 10.4049/jimmunol.172.1.292; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Dustin ML, 2000, NAT IMMUNOL, V1, P23, DOI 10.1038/76877; Granucci F, 2003, BLOOD, V102, P2940, DOI 10.1182/blood-2002-12-3651; Kobayashi M, 2001, J IMMUNOL, V167, P3585, DOI 10.4049/jimmunol.167.7.3585; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lantz O, 2000, NAT IMMUNOL, V1, P54, DOI 10.1038/76917; Lanzavecchia A, 2001, CURR OPIN IMMUNOL, V13, P291, DOI 10.1016/S0952-7915(00)00218-1; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, P NATL ACAD SCI USA, V101, P998, DOI 10.1073/pnas.0306407101; Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; Walmsley MJ, 2003, SCIENCE, V302, P459, DOI 10.1126/science.1089709; Wells CM, 2004, J CELL SCI, V117, P1259, DOI 10.1242/jcs.00997	16	188	197	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 20	2004	305	5687					1150	1153		10.1126/science.1099159	http://dx.doi.org/10.1126/science.1099159			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849RD	15326354				2022-12-24	WOS:000223557400047
J	Lane, R				Lane, R			On reflection - The perils of myopia	LANCET			English	Article									Lancet, London NW1 7BY, England		Lane, R (corresponding author), Lancet, London NW1 7BY, England.								0	0	0	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 14	2004	364	9434					575	575		10.1016/S0140-6736(04)16834-7	http://dx.doi.org/10.1016/S0140-6736(04)16834-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845WD	15329944				2022-12-24	WOS:000223275100014
J	Chang, S; Johnston, RJ; Frokjaer-Jensen, C; Lockery, S; Hobert, O				Chang, S; Johnston, RJ; Frokjaer-Jensen, C; Lockery, S; Hobert, O			MicroRNAs act sequentially and asymmetrically to control chemosensory laterality in the nematode	NATURE			English	Article							NEURONS; EXPRESSION; PATTERN; SYSTEM	Animal microRNAs ( miRNAs) are gene regulatory factors that prevent the expression of specific messenger RNA targets by binding to their 3' untranslated region(1-3). The Caenorhabditis elegans lsy-6 miRNA ( for lateral symmetry defective) is required for the left/right asymmetric expression of guanyl cyclase (gcy) genes in two chemosensory neurons termed ASE left (ASEL) and ASE right (ASER)(4,5). The asymmetric expression of these putative chemoreceptors in turn correlates with the functional lateralization of the ASE neurons(6). Here we find that a mutation in the die-1 zinc-finger transcription factor disrupts both the chemosensory laterality and left/right asymmetric expression of chemoreceptor genes in the ASE neurons. die-1 controls chemosensory laterality by activating the expression of lsy-6 specifically in ASEL, but not in ASER, where die-1 expression is downregulated through two sites in its 30 untranslated region. These two sites are complementary to mir-273, a previously uncharacterized miRNA, whose expression is strongly biased towards ASER. Forced bilateral expression of mir-273 in ASEL and ASER causes a loss of asymmetric die-1 expression and ASE laterality. Thus, an inverse distribution of two sequentially acting miRNAs in two bilaterally symmetric neurons controls laterality of the nematode chemosensory system.	Columbia Univ, Med Ctr, Ctr Neurobiol & Behav, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	Columbia University; University of Oregon	Hobert, O (corresponding author), Columbia Univ, Med Ctr, Ctr Neurobiol & Behav, Dept Biochem & Mol Biophys, 701 W 168th St, New York, NY 10032 USA.	or38@columbia.edu	Frøkjær-Jensen, Christian/ABB-4637-2020	Frokjaer-Jensen, Christian/0000-0002-3178-0906; Hobert, Oliver/0000-0002-7634-2854	NINDS NIH HHS [R01 NS050266, R01 NS050266-05] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050266] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bulyk ML, 2004, GENOME BIOL, V5; Chang S, 2003, GENE DEV, V17, P2123, DOI 10.1101/gad.1117903; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Grad Y, 2003, MOL CELL, V11, P1253, DOI 10.1016/S1097-2765(03)00153-9; Heid PJ, 2001, DEV BIOL, V236, P165, DOI 10.1006/dbio.2001.0315; Hobert O, 2002, NAT REV NEUROSCI, V3, P629, DOI 10.1038/nrn897; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; Palmer RE, 2002, DEV BIOL, V252, P202, DOI 10.1006/dbio.2002.0850; Pierce-Shimomura JT, 2001, NATURE, V410, P694, DOI 10.1038/35070575; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384	17	269	315	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2004	430	7001					785	789		10.1038/nature02752	http://dx.doi.org/10.1038/nature02752			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306811				2022-12-24	WOS:000223233600043
J	Jamieson, CHM; Ailles, LE; Dylla, SJ; Muijtjens, M; Jones, C; Zehnder, JL; Gotlib, J; Li, K; Manz, MG; Keating, A; Sawyers, CL; Weissman, IL				Jamieson, CHM; Ailles, LE; Dylla, SJ; Muijtjens, M; Jones, C; Zehnder, JL; Gotlib, J; Li, K; Manz, MG; Keating, A; Sawyers, CL; Weissman, IL			Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC MYELOID-LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; BCR-ABL; BETA-CATENIN; GENE-TRANSFER; CHRONIC-PHASE; BONE-MARROW; IN-VITRO; ACTIVATION; EXPRESSION	Background: The progression of chronic myelogenous leukemia (CML) to blast crisis is supported by self-renewing leukemic stem cells. In normal mouse hematopoietic stem cells, the process of self-renewal involves the (beta)-catenin-signaling pathway. We investigated whether leukemic stem cells in CML also use the (beta)-catenin pathway for self-renewal. Methods: We used fluorescence-activated cell sorting to isolate hematopoietic stem cells, common myeloid progenitors, granulocyte-macrophage progenitors, and megakaryocyte-erythroid progenitors from marrow during several phases of CML and from normal marrow. BCR-ABL, (beta)-catenin, and LEF-1 transcripts were compared by means of a quantitative reverse-transcriptase-polymerase-chain-reaction assay in normal and CML hematopoietic stem cells and granulocyte-macrophage progenitors. Confocal fluorescence microscopy and a lymphoid enhancer factor/T-cell factor reporter assay were used to detect nuclear (beta)-catenin in these cells. In vitro replating assays were used to identify self-renewing cells as candidate leukemic stem cells, and the dependence of self-renewal on (beta)-catenin activation was tested by lentiviral transduction of hematopoietic progenitors with axin, an inhibitor of the (beta)-catenin pathway. Results: The granulocyte-macrophage progenitor pool from patients with CML in blast crisis and imatinib-resistant CML was expanded, expressed BCR-ABL, and had elevated levels of nuclear (beta)-catenin as compared with the levels in progenitors from normal marrow. Unlike normal granulocyte-macrophage progenitors, CML granulocyte-macrophage progenitors formed self-renewing, replatable myeloid colonies, and in vitro self-renewal capacity was reduced by enforced expression of axin. Conclusions: Activation of (beta)-catenin in CML granulocyte-macrophage progenitors appears to enhance the self-renewal activity and leukemic potential of these cells.	Stanford Univ, Sch Med, Dept Pathol,Inst Canc & Stem Cell Biol & Med, Beckman Ctr B257, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Dev Biol, Inst Canc & Stem Cell Biol & Med, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Div Hematol, Stanford, CA 94305 USA; Univ Toronto, Princess Margaret Hosp, Toronto, ON, Canada; Univ Calif Los Angeles, Los Angeles, CA USA	Stanford University; Stanford University; Stanford University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of California System; University of California Los Angeles	Weissman, IL (corresponding author), Stanford Univ, Sch Med, Dept Pathol,Inst Canc & Stem Cell Biol & Med, Beckman Ctr B257, 279 Campus Dr, Stanford, CA 94305 USA.	ljquinn@stanford.edu	Manz, Markus G/C-7588-2011; Sawyers, Charles/G-5327-2016	Manz, Markus/0000-0002-4676-7931	NATIONAL CANCER INSTITUTE [R01CA086017, P01CA049605] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL004409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER; NCI NIH HHS [2PO1CA49605, CA55209, CA86017] Funding Source: Medline; NHLBI NIH HHS [K23 HL04409] Funding Source: Medline; NIAID NIH HHS [5T32AI07290] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AFAR DEH, 1995, P NATL ACAD SCI USA, V92, P9540, DOI 10.1073/pnas.92.21.9540; AFAR DEH, 1994, SCIENCE, V264, P424, DOI 10.1126/science.8153630; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; BAUM CM, 1992, P NATL ACAD SCI USA, V89, P2804, DOI 10.1073/pnas.89.7.2804; BEN-NERIAH Y, 1986, SCIENCE, V233, P212, DOI 10.1126/science.3460176; Bose S, 1998, BLOOD, V92, P3362, DOI 10.1182/blood.V92.9.3362; Chomel JC, 2000, BLOOD, V95, P404, DOI 10.1182/blood.V95.2.404; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Domen J, 2000, J EXP MED, V192, P1707, DOI 10.1084/jem.192.12.1707; Era T, 2000, P NATL ACAD SCI USA, V97, P1737, DOI 10.1073/pnas.97.4.1737; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; GISHIZKY ML, 1993, P NATL ACAD SCI USA, V90, P3755, DOI 10.1073/pnas.90.8.3755; Goldman JM, 2003, NEW ENGL J MED, V349, P1451, DOI 10.1056/NEJMra020777; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Haraguchi K, 2004, BIOCHEM BIOPH RES CO, V313, P841, DOI 10.1016/j.bbrc.2003.12.021; Huettner CS, 2003, BLOOD, V102, P3363, DOI 10.1182/blood-2003-03-0768; Huettner CS, 2000, NAT GENET, V24, P57, DOI 10.1038/71691; Hughes TP, 2003, NEW ENGL J MED, V349, P1423, DOI 10.1056/NEJMoa030513; Jaiswal S, 2003, P NATL ACAD SCI USA, V100, P10002, DOI 10.1073/pnas.1633833100; Jamieson CHM, 2004, RES PER NEUROSCI, P157; Jones CD, 2003, AM J CLIN PATHOL, V120, P42, DOI 10.1309/60A9C8WGEGHRNXEE; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; LUGO TG, 1990, SCIENCE, V247, P1079, DOI 10.1126/science.2408149; Manz MG, 2002, P NATL ACAD SCI USA, V99, P11872, DOI 10.1073/pnas.172384399; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; Miyamoto T, 2000, P NATL ACAD SCI USA, V97, P7521, DOI 10.1073/pnas.97.13.7521; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; NOWELL PC, 1960, SCIENCE, V132, P1497; Nusse R, 2003, DEVELOPMENT, V130, P5297, DOI 10.1242/dev.00821; NUSSE R, 1984, NATURE, V307, P131, DOI 10.1038/307131a0; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; Orkin SH, 2002, NAT IMMUNOL, V3, P323, DOI 10.1038/ni0402-323; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100; Raaijmakers MHGP, 2002, EXP HEMATOL, V30, P481, DOI 10.1016/S0301-472X(02)00787-7; Rask K, 2003, BRIT J CANCER, V89, P1298, DOI 10.1038/sj.bjc.6601265; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; Schmelz EM, 2001, CANCER RES, V61, P6723; Schroeder JA, 2003, ONCOGENE, V22, P1324, DOI 10.1038/sj.onc.1206291; SHTIVELMAN E, 1985, NATURE, V315, P550, DOI 10.1038/315550a0; Sirard C, 1996, BLOOD, V87, P1539, DOI 10.1182/blood.V87.4.1539.bloodjournal8741539; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Traver D, 1998, IMMUNITY, V9, P47, DOI 10.1016/S1074-7613(00)80587-7; Uchida N, 1998, P NATL ACAD SCI USA, V95, P11939, DOI 10.1073/pnas.95.20.11939; UDOMSAKDI C, 1992, P NATL ACAD SCI USA, V89, P6192, DOI 10.1073/pnas.89.13.6192; Uematsu K, 2003, ONCOGENE, V22, P7218, DOI 10.1038/sj.onc.1206817; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Varnum-Finney B, 2000, NAT MED, V6, P1278, DOI 10.1038/81390; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611	58	1154	1262	1	41	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 12	2004	351	7					657	667		10.1056/NEJMoa040258	http://dx.doi.org/10.1056/NEJMoa040258			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845FZ	15306667	Bronze			2022-12-24	WOS:000223225500008
J	Rietjens, JAC; van der Heide, A; Vrakking, AM; Onwuteaka-Philipsen, BD; van der Maas, PJ; van der Wal, G				Rietjens, JAC; van der Heide, A; Vrakking, AM; Onwuteaka-Philipsen, BD; van der Maas, PJ; van der Wal, G			Physician reports of terminal sedation without hydration or nutrition for patients nearing death in the Netherlands	ANNALS OF INTERNAL MEDICINE			English	Article							LAST RESORT; UNCONTROLLED SYMPTOMS; CAREFUL CONVERSATION; PALLIATIVE OPTIONS; ASSISTED SUICIDE; END; CANCER; LIFE	Background: Terminal sedation in patients nearing death is an important issue related to end-of-life care. Objective: To describe the practice of terminal sedation in the Netherlands. Design: Face-to-face interviews. Setting: The Netherlands. Participants: Nationwide stratified sample of 482 physicians; 410 responded and 211 of these reported characteristics of their most recent terminal sedation case. Measurements: Physician reports of frequency of terminal sedation (defined as the administration of drugs to keep the patient in deep sedation or coma until death, without giving artificial nutrition or hydration), characteristics of the decision-making process, drugs used, the estimated life-shortening effect, and frequency of euthanasia discussions. Results: Of respondents, 52% (95% CI, 48% to 57%) had ever used terminal sedation. Of the 211 most recent cases, physicians used terminal sedation to alleviate severe pain in 51% of patients (CI, 44% to 58%), agitation in 38% (CI, 32% to 45%), and dyspnea in 38% (CI, 32% to 45%). Physicians reported discussing with patients the decision to use deep sedation in 59% of the 211 most recent cases (CI, 52% to 66%) and the decision to forgo artificial nutrition or hydration in 34% (CI, 28% to 41%). Hastening death was partly the intention of the physician in 47% (CI, 41% to 54%) of cases and the explicit intention in 17% (CI, 13% to 22%) of cases. Limitations: The generalizability of physician reports about their most recent cases to all terminal sedation cases is uncertain. In addition, the findings are subject to recall bias and may not apply to other geographic settings. Conclusions: Terminal sedation precedes a substantial number of deaths in the Netherlands. In about two thirds of most recently reported cases, physicians indicated that in addition to alleviating symptoms, they intended to hasten death.	Erasmus MC, Dept Publ Hlth, NL-3000 DR Rotterdam, Netherlands; Vrije Univ Amsterdam, Med Ctr, NL-1081 HV Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam	Rietjens, JAC (corresponding author), Erasmus MC, Dept Publ Hlth, POB 1738, NL-3000 DR Rotterdam, Netherlands.	j.rietjens@erasmusmc.nl						Billings JA, 1996, J PALLIAT CARE, V12, P21, DOI 10.1177/082585979601200404; Chater S, 1998, PALLIATIVE MED, V12, P255, DOI 10.1191/026921698671831786; Cherny N I, 1994, J Palliat Care, V10, P31; Chiu TY, 2001, J PAIN SYMPTOM MANAG, V21, P467, DOI 10.1016/S0885-3924(01)00286-X; Coyle N, 1990, J Pain Symptom Manage, V5, P83; Emanuel LL, 1998, JAMA-J AM MED ASSOC, V280, P643, DOI 10.1001/jama.280.7.643; Fainsinger RL, 2000, PALLIATIVE MED, V14, P257, DOI 10.1191/026921600666097479; Fainsinger RL, 1998, J PAIN SYMPTOM MANAG, V16, P145, DOI 10.1016/S0885-3924(98)00066-9; Jansen LA, 2002, ANN INTERN MED, V136, P845, DOI 10.7326/0003-4819-136-11-200206040-00014; Kvasnicka John H, 2002, Ann Intern Med, V137, pW2; Letvak R, 1998, JAMA-J AM MED ASSOC, V279, P1065, DOI 10.1001/jama.279.14.1065; LETVAK R, 1998, JAMA-J AM MED ASSOC, V279, P1066; Loewy EH, 2001, ARCH INTERN MED, V161, P329, DOI 10.1001/archinte.161.3.329; Morita T, 2003, J PAIN SYMPTOM MANAG, V25, P357, DOI 10.1016/S0885-3924(02)00684-X; Morita T, 2002, J CLIN ONCOL, V20, P758, DOI 10.1200/JCO.2002.20.3.758; Morita T, 2001, LANCET, V358, P335, DOI 10.1016/S0140-6736(01)05515-5; Morita Tatsuya, 2002, Ann Intern Med, V137, pW1; Muller-Busch H Christof, 2003, BMC Palliat Care, V2, P2, DOI 10.1186/1472-684X-2-2; Quill TE, 2000, ANN INTERN MED, V132, P488, DOI 10.7326/0003-4819-132-6-200003210-00011; Quill TE, 2000, ANN INTERN MED, V132, P408, DOI 10.7326/0003-4819-132-5-200003070-00012; Quill TE, 1997, JAMA-J AM MED ASSOC, V278, P2099, DOI 10.1001/jama.278.23.2099; Quill TE, 2002, ANN INTERN MED, V137, P1009, DOI 10.7326/0003-4819-137-12-200212170-00026; Rousseau P, 2002, ANN INTERN MED, V137, P1009, DOI 10.7326/0003-4819-137-12-200212170-00027; Sasser CG, 2002, ANN INTERN MED, V137, P1008, DOI 10.7326/0003-4819-137-12-200212170-00025; Sepulveda C, 2002, J PAIN SYMPTOM MANAG, V24, P91, DOI 10.1016/S0885-3924(02)00440-2; Stone P, 1997, PALLIATIVE MED, V11, P140, DOI 10.1177/026921639701100208; Sulmasy DP, 2000, ANN INTERN MED, V133, P562, DOI 10.7326/0003-4819-133-7-200010030-00023; Sulmasy DP, 2000, ANN INTERN MED, V133, P560, DOI 10.7326/0003-4819-133-7-200010030-00021; Sykes N, 2003, LANCET ONCOL, V4, P312, DOI 10.1016/S1470-2045(03)01079-9; Sykes N, 2003, ARCH INTERN MED, V163, P341, DOI 10.1001/archinte.163.3.341; Vainio A, 1996, J PAIN SYMPTOM MANAG, V12, P3, DOI 10.1016/0885-3924(96)00042-5; van der Heide A, 2003, LANCET, V362, P345, DOI 10.1016/S0140-6736(03)14019-6; VANDERWAL G, 2003, MED BESLUITVORMING L; Ventafridda V, 1990, J Palliat Care, V6, P7; 2004, STAT NETHERLANDS CEN	35	133	134	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 3	2004	141	3					178	185		10.7326/0003-4819-141-3-200408030-00006	http://dx.doi.org/10.7326/0003-4819-141-3-200408030-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843HG	15289214	Green Published			2022-12-24	WOS:000223068600002
J	Greenstein, RJ; Collins, MT				Greenstein, RJ; Collins, MT			Emerging pathogens: is Mycobacterium avium subspecies paratuberculosis zoonotic?	LANCET			English	Editorial Material							CROHNS-DISEASE; BIOPSY SPECIMENS; NOD2		Vet Adm Med Ctr, Dept Surg, Bronx, NY 10468 USA; Univ Wisconsin, Sch Vet Med, Madison, WI 53706 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Wisconsin System; University of Wisconsin Madison	Greenstein, RJ (corresponding author), Vet Adm Med Ctr, Dept Surg, Bronx, NY 10468 USA.	BGAxis@aol.com						Behr MA, 2004, LANCET INFECT DIS, V4, P136, DOI 10.1016/S1473-3099(04)00935-1; Bull TJ, 2003, J CLIN MICROBIOL, V41, P2915, DOI 10.1128/JCM.41.7.2915-2923.2003; Collins MT, 2000, J CLIN MICROBIOL, V38, P4373, DOI 10.1128/JCM.38.12.4373-4381.2000; Girardin SE, 2003, TRENDS IMMUNOL, V24, P652, DOI 10.1016/j.it.2003.10.007; GREEN JP, 2002, DRAFT GUIDANCE CONTR; Greenstein RJ, 2003, LANCET INFECT DIS, V3, P507, DOI 10.1016/S1473-3099(03)00724-2; Hermon-Taylor J, 2004, PATHOGENIC MYCOBACTE, P74; Mishina D, 1996, P NATL ACAD SCI USA, V93, P9816, DOI 10.1073/pnas.93.18.9816; Mortensen H, 2004, J DAIRY SCI, V87, P2108, DOI 10.3168/jds.S0022-0302(04)70029-6; Naser SA, 2000, AM J GASTROENTEROL, V95, P1094, DOI 10.1111/j.1572-0241.2000.01954.x; Sechi LA, 2001, J CLIN MICROBIOL, V39, P4514, DOI 10.1128/JCM.39.12.4514-4517.2001	11	62	63	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 31	2004	364	9432					396	397		10.1016/S0140-6736(04)16781-0	http://dx.doi.org/10.1016/S0140-6736(04)16781-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	842IX	15288721				2022-12-24	WOS:000222998600007
J	Bruggemann, H; Henne, A; Hoster, F; Liesegang, H; Wiezer, A; Strittmatter, A; Hujer, S; Durre, P; Gottschalk, G				Bruggemann, H; Henne, A; Hoster, F; Liesegang, H; Wiezer, A; Strittmatter, A; Hujer, S; Durre, P; Gottschalk, G			The complete genome sequence of Propionibacterium acnes, a commensal of human skin	SCIENCE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; HYALURONATE LYASE; ANTIGENS; PROTEINS; CLONING; LEPRAE	Propionibacterium acnes is a major inhabitant of adult human skin, where it resides within sebaceous follicles, usually as a harmless commensal although it has been implicated in acne vulgaris formation. The entire genome sequence of this Gram-positive bacterium encodes 2333 putative genes and revealed numerous gene products involved in degrading host molecules, including sialidases, neuraminidases, endoglycoceramidases, lipases, and pore-forming factors. Surface-associated and other immunogenic factors have been identified, which might be involved in triggering acne inflammation and other P. acnes-associated diseases.	Univ Gottingen, Inst Microbiol & Genet, Gottingen Genom Lab, D-37077 Gottingen, Germany; Univ Ulm, Dept Microbiol & Biotechnol, D-89069 Ulm, Germany	University of Gottingen; Ulm University	Bruggemann, H (corresponding author), Inst Pasteur, Lab Genom Microbial Pathogens, 28 Rue Dr Roux, F-75724 Paris, France.	hbruegg@pasteur.fr; ggottsc@gwdg.de		Liesegang, Heiko/0000-0003-1792-2047; Bruggemann, Holger/0000-0001-7433-0190				BOOTH RJ, 1993, INFECT IMMUN, V61, P1509, DOI 10.1128/IAI.61.4.1509-1515.1993; Comfort D, 2004, INFECT IMMUN, V72, P2710, DOI 10.1128/IAI.72.5.2710-2722.2004; Csukas Z, 2004, MICROB PATHOGENESIS, V36, P171, DOI 10.1016/j.micpath.2003.09.002; Farrar MD, 2000, FEMS MICROBIOL LETT, V191, P183, DOI 10.1016/S0378-1097(00)00387-6; GRIBBON EM, 1993, J GEN MICROBIOL, V139, P1745, DOI 10.1099/00221287-139-8-1745; HERMANS PWM, 1995, INFECT IMMUN, V63, P954, DOI 10.1128/IAI.63.3.954-960.1995; Holland KT, 1998, DERMATOLOGY, V196, P67, DOI 10.1159/000017870; HUJER S, UNPUB; Ingham E, 1999, CURR OPIN INFECT DIS, V12, P191, DOI 10.1097/00001432-199906000-00006; Jakab E, 1996, YALE J BIOL MED, V69, P477; Jappe U, 2002, BRIT J DERMATOL, V146, P202, DOI 10.1046/j.1365-2133.2002.04602.x; Koreck A, 2003, DERMATOLOGY, V206, P96, DOI 10.1159/000068476; Lang SH, 2003, J BIOL CHEM, V278, P38167, DOI 10.1074/jbc.M303544200; Makris G, 2004, MICROBIOL-SGM, V150, P2005, DOI 10.1099/mic.0.26942-0; Miskin JE, 1997, MICROBIOL-UK, V143, P1745, DOI 10.1099/00221287-143-5-1745; Singh KK, 2001, INFECT IMMUN, V69, P4185, DOI 10.1128/IAI.69.6.4185-4191.2001; Steiner B, 1997, CAN J MICROBIOL, V43, P315, DOI 10.1139/m97-044; VANDERENDE A, 1995, J BACTERIOL, V177, P2475, DOI 10.1128/jb.177.9.2475-2480.1995; Yamada T, 2002, J PATHOL, V198, P541, DOI 10.1002/path.1243	19	307	410	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 30	2004	305	5684					671	673		10.1126/science.1100330	http://dx.doi.org/10.1126/science.1100330			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	842GQ	15286373				2022-12-24	WOS:000222992100049
J	Angelaki, DE; Shaikh, AG; Green, AM; Dickman, JD				Angelaki, DE; Shaikh, AG; Green, AM; Dickman, JD			Neurons compute internal models of the physical laws of motion	NATURE			English	Article							APERTURE PROBLEM; PROJECTIONS; HUMANS; MONKEY; CEREBELLUM; DYNAMICS; AFFERENT; THALAMUS; NUCLEI; CUES	A critical step in self-motion perception and spatial awareness is the integration of motion cues from multiple sensory organs that individually do not provide an accurate representation of the physical world. One of the best-studied sensory ambiguities is found in visual processing, and arises because of the inherent uncertainty in detecting the motion direction of an untextured contour moving within a small aperture(1-4). A similar sensory ambiguity arises in identifying the actual motion associated with linear accelerations sensed by the otolith organs in the inner ear(5,6). These internal linear accelerometers respond identically during translational motion ( for example, running forward) and gravitational accelerations experienced as we reorient the head relative to gravity ( that is, head tilt). Using new stimulus combinations, we identify here cerebellar and brainstem motion-sensitive neurons that compute a solution to the inertial motion detection problem. We show that the firing rates of these populations of neurons reflect the computations necessary to construct an internal model representation of the physical equations of motion.	Washington Univ, Sch Med, Dept Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Angelaki, DE (corresponding author), Washington Univ, Sch Med, Dept Neurobiol, St Louis, MO 63110 USA.	angelaki@pcg.wustl.edu						ADELSON EH, 1982, NATURE, V300, P523, DOI 10.1038/300523a0; ANGAUT P, 1970, BRAIN RES, V24, P49, DOI 10.1016/0006-8993(70)90273-8; Angelaki DE, 1999, J NEUROSCI, V19, P316, DOI 10.1523/JNEUROSCI.19-01-00316.1999; Angelaki DE, 2003, J NEUROSCI, V23, P2971; Angelaki DE, 2000, J NEUROPHYSIOL, V84, P2113, DOI 10.1152/jn.2000.84.4.2113; ASAMURA C, 1983, BRAIN RES REV, V5, P237; BATTON RR, 1977, J COMP NEUROL, V174, P281, DOI 10.1002/cne.901740206; CARLETON SC, 1984, BRAIN RES, V294, P281, DOI 10.1016/0006-8993(84)91040-0; Dickman JD, 2002, J NEUROPHYSIOL, V88, P3518, DOI 10.1152/jn.00518.2002; Draper N.R., 1998, WILEY SERIES PROBABI, V326; Einstein A., 1907, JAHRB RADIOAKT ELEKT, V4, P411, DOI DOI 10.1007/978-3-322-83770-7_6; FERNANDEZ C, 1971, J NEUROPHYSIOL, V34, P661, DOI 10.1152/jn.1971.34.4.661; FERNANDEZ C, 1976, J NEUROPHYSIOL, V39, P970, DOI 10.1152/jn.1976.39.5.970; Goldstein H., 2002, CLASSICAL MECH, Vthird; Green AM, 2004, J NEUROPHYSIOL, V92, P905, DOI 10.1152/jn.01234.2003; Green AM, 2003, J NEUROSCI, V23, P9265; Gribble PL, 2002, NATURE, V417, P938, DOI 10.1038/nature00834; KALIL K, 1981, J COMP NEUROL, V195, P25, DOI 10.1002/cne.901950105; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; KOTCHABHAKDI N, 1978, BRAIN RES, V142, P142, DOI 10.1016/0006-8993(78)90183-X; LANG W, 1979, BRAIN RES, V177, P3, DOI 10.1016/0006-8993(79)90914-4; Merfeld DM, 2002, J NEUROPHYSIOL, V87, P819, DOI 10.1152/jn.00485.2001; Merfeld DM, 1999, NATURE, V398, P615, DOI 10.1038/19303; Movshon Adelson, 1985, PATTERN RECOGNITION, V54, P117, DOI 10.1098/rstb.1998.0333; Newlands SD, 2003, J COMP NEUROL, V466, P31, DOI 10.1002/cne.10876; NEWLANDS SD, 2004, SEMICIRCULAR CANAL I; Pack CC, 2001, NATURE, V409, P1040, DOI 10.1038/35059085; Padoa-Schioppa C, 2002, NEURON, V36, P751, DOI 10.1016/S0896-6273(02)01028-0; SHIMOJO S, 1989, VISION RES, V29, P619, DOI 10.1016/0042-6989(89)90047-3; Zupan LH, 2000, J NEUROPHYSIOL, V84, P2001, DOI 10.1152/jn.2000.84.4.2001	30	223	227	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2004	430	6999					560	564		10.1038/nature02754	http://dx.doi.org/10.1038/nature02754			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841QI	15282606				2022-12-24	WOS:000222946100048
J	Chartier-Harlin, MC; Kachergus, J; Roumier, C; Mouroux, V; Douay, X; Lincoln, S; Levecque, C; Larvor, L; Andrieux, J; Hulihan, M; Waucquier, N; Defebvre, L; Amouyel, P; Farrer, M; Destee, A				Chartier-Harlin, MC; Kachergus, J; Roumier, C; Mouroux, V; Douay, X; Lincoln, S; Levecque, C; Larvor, L; Andrieux, J; Hulihan, M; Waucquier, N; Defebvre, L; Amouyel, P; Farrer, M; Destee, A			alpha-synuclein locus duplication as a cause of familial Parkinson's disease	LANCET			English	Article								Genomic triplication of the alpha-synuclein gene (SNCA) has been reported to cause hereditary early-onset parkinsonism with dementia. These findings prompted us to screen for multiplication of the SNCA locus in nine families in whom parkinsonism segregates as an autosomal dominant trait. One kindred was identified with SNCA duplication by semiquantitative PCR and confirmed by fluorescent in-situ hybridisation analysis in peripheral leucocytes. By contrast with SNCA triplication families, the clinical phenotype of SNCA duplication closely resembles idiopathic Parkinson's disease, which has a late age-of-onset, progresses slowly, and in which neither cognitive decline nor dementia are prominent. These findings suggest a direct relation between SNCA gene dosage and disease progression.	Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; INSERM, U508, F-59019 Lille, France; INSERM, U524, F-59045 Lille, France; CHU Lille, EA MENRT 2683, Dept Neurol, Movement Disorder Clin, Lille, France	Mayo Clinic; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille	Farrer, M (corresponding author), Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA.	farrer.matthew@mayo.edu	LICEND, CEMND/F-1296-2015; Chartier-Harlin, Marie-Christine/L-4527-2018	Chartier-Harlin, Marie-Christine/0000-0001-6416-6526; Amouyel, Philippe/0000-0001-9088-234X; Farrer, Matthew/0000-0003-1159-5321; Levecque, Clotilde/0000-0002-0519-337X				Farrer M, 2000, MOVEMENT DISORD, V15, P1075, DOI 10.1002/1531-8257(200011)15:6<1075::AID-MDS1004>3.0.CO;2-2; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Farrer M, 2001, HUM MOL GENET, V10, P1847, DOI 10.1093/hmg/10.17.1847; Golbe LI, 2004, ANN NEUROL, V55, P153, DOI 10.1002/ana.20036; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278	5	1460	1509	2	98	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 25	2004	364	9440					1167	1169		10.1016/S0140-6736(04)17103-1	http://dx.doi.org/10.1016/S0140-6736(04)17103-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857FT	15451224				2022-12-24	WOS:000224102400030
J	Humbles, AA; Lloyd, CM; McMillan, SJ; Friend, DS; Xanthou, G; McKenna, EE; Ghiran, S; Gerard, NP; Yu, CN; Orkin, SH; Gerard, C				Humbles, AA; Lloyd, CM; McMillan, SJ; Friend, DS; Xanthou, G; McKenna, EE; Ghiran, S; Gerard, NP; Yu, CN; Orkin, SH; Gerard, C			A critical role for eosinophils in allergic airways remodeling	SCIENCE			English	Article							SUBEPITHELIAL FIBROSIS; BRONCHIAL-ASTHMA; INFLAMMATION; EXPRESSION; HYPERREACTIVITY; BIOPSIES; GATA-1; MOUSE; LEADS	Features of chronic asthma include airway hyperresponsiveness, inflammatory infiltrates, and structural changes in the airways, termed remodeling. The contribution of eosinophils, cells associated with asthma and allergy, remains to be established. We show that in mice with a total ablation of the eosinophil lineage, increases in airway hyperresponsiveness and mucus secretion were similar to those observed in wild-type mice, but eosinophil-deficient mice were significantly protected from peribronchiolar collagen deposition and increases in airway smooth muscle. These data suggest that eosinophils contribute substantially to airway remodeling but are not obligatory for allergen-induced lung dysfunction, and support an important role for eosinophil-targeted therapies in chronic asthma.	Harvard Univ, Childrens Hosp, Sch Med, Dept Pediat, Boston, MA 02115 USA; Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Biomed Sci, London SW7 2AZ, England; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02111 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA 02114 USA; Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Imperial College London; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute	Humbles, AA (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Dept Pediat, Boston, MA 02115 USA.	alison.humbles@childrens.harvard.edu; c.lloyd@imperial.ac.uk	Xanthou, Georgina/AAH-8682-2019	Yu, Channing/0000-0002-3231-2565; Lloyd, Clare/0000-0001-8977-6726	Wellcome Trust [087618] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL010463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039759] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bandeira-Melo C, 2003, PROSTAG LEUKOTR ESS, V69, P135, DOI 10.1016/S0952-3278(03)00074-7; Beller TC, 2004, P NATL ACAD SCI USA, V101, P3047, DOI 10.1073/pnas.0400235101; Blyth DI, 2000, AM J RESP CELL MOL, V23, P241, DOI 10.1165/ajrcmb.23.2.3999; Bousquet J, 2000, AM J RESP CRIT CARE, V161, P1720, DOI 10.1164/ajrccm.161.5.9903102; BREWSTER CEP, 1990, AM J RESP CELL MOL, V3, P507, DOI 10.1165/ajrcmb/3.5.507; Busse W, 1999, AM J RESP CRIT CARE, V160, P1035, DOI 10.1164/ajrccm.160.3.9902064; Chapman HA, 2004, J CLIN INVEST, V113, P148, DOI 10.1172/JCI200420729; Cho JY, 2004, J CLIN INVEST, V113, P551, DOI 10.1172/JCI200419133; Elias JA, 1999, J CLIN INVEST, V104, P1001, DOI 10.1172/JCI8124; Flood-Page P, 2003, J CLIN INVEST, V112, P1029, DOI 10.1172/JCI200317974; GLEICH GJ, 1993, ANNU REV MED, V44, P85, DOI 10.1146/annurev.med.44.1.85; Hamelmann E, 1997, AM J RESP CRIT CARE, V156, P766, DOI 10.1164/ajrccm.156.3.9606031; HUMBLES AA, UNPUB; JEFFERY PK, 1989, AM REV RESPIR DIS, V140, P1745, DOI 10.1164/ajrccm/140.6.1745; Lee JJ, 1997, J EXP MED, V185, P2143, DOI 10.1084/jem.185.12.2143; LENDRUM AC, 1962, J CLIN PATHOL, V15, P401, DOI 10.1136/jcp.15.5.401; MARTIN TR, 1988, J APPL PHYSIOL, V64, P2318, DOI 10.1152/jappl.1988.64.6.2318; MCMILLAN S, 2004, CLIN EXP ALLERGY, V34, P1; Migliaccio AR, 2003, J EXP MED, V197, P281, DOI 10.1084/jem.20021149; Minshall EM, 1997, AM J RESP CELL MOL, V17, P326, DOI 10.1165/ajrcmb.17.3.2733; Moir LM, 2003, AM J PHYSIOL-LUNG C, V284, pL148, DOI 10.1152/ajplung.00105.2002; Ohno I, 1996, AM J RESP CELL MOL, V15, P404, DOI 10.1165/ajrcmb.15.3.8810646; Rankin JA, 1996, P NATL ACAD SCI USA, V93, P7821, DOI 10.1073/pnas.93.15.7821; Temann UA, 1998, J EXP MED, V188, P1307, DOI 10.1084/jem.188.7.1307; Vignola AM, 1997, AM J RESP CRIT CARE, V156, P591, DOI 10.1164/ajrccm.156.2.9609066; WANNER A, 1990, CHEST, V97, pS11; Wenzel SE, 1999, AM J RESP CRIT CARE, V160, P1001, DOI 10.1164/ajrccm.160.3.9812110; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909	29	685	722	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1776	1779		10.1126/science.1100283	http://dx.doi.org/10.1126/science.1100283			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	856IS	15375268				2022-12-24	WOS:000224039500042
J	Xiong, ZG; Zhu, XM; Chu, XP; Minami, M; Hey, J; Wei, WL; MacDonald, JF; Wemmie, JA; Price, MP; Welsh, MJ; Simon, RP				Xiong, ZG; Zhu, XM; Chu, XP; Minami, M; Hey, J; Wei, WL; MacDonald, JF; Wemmie, JA; Price, MP; Welsh, MJ; Simon, RP			Neuroprotection in ischemia: Blocking calcium-permeable acid-sensing ion channels	CELL			English	Article							NMDA RECEPTOR ACTIVATION; D-ASPARTATE RECEPTORS; GATED NA+ CHANNEL; CATION CHANNEL; GLUTAMATE NEUROTOXICITY; GLUCOSE DEPRIVATION; CEREBRAL-ISCHEMIA; NEURONAL INJURY; SENSORY NEURONS; CELL-CULTURE	Ca2+ toxicity remains the central focus of ischemic brain injury. The mechanism by which toxic Ca2+ loading of cells occurs in the ischemic brain has become less clear as multiple human trials of glutamate antagonists have failed to show effective neuroprotection in stroke. Acidosis is a common feature of ischemia and is assumed to play a critical role in brain injury; however, the mechanism(s) remain ill defined. Here, we show that acidosis activates Ca2+-permeable acid-sensing ion channels (ASICs), inducing glutamate receptor-independent, Ca2+-dependent, neuronal injury inhibited by ASIC blockers. Cells lacking endogenous ASICs are resistant to acid injury, while transfection of Ca2+-permeable ASIC1a establishes sensitivity. In focal ischemia, intracerebroventricular injection of ASIC1 a blockers or knockout of the ASIC1 a gene protects the brain from ischemic injury and does so more potently than glutamate antagonism. Thus, acidosis injures the brain via membrane receptor-based mechanisms with resultant toxicity of [Ca2+](i), disclosing new potential therapeutic targets for stroke.	Robert S Dow Neurobiol Labs Legacy Res, Portland, OR 97232 USA; Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; Univ Iowa, Dept Vet Affairs Med Ctr, Iowa City, IA 52242 USA; Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Oregon Hlth & Sci Univ, Dept Neurol Physiol & Pharmacol, Portland, OR 97239 USA	University of Toronto; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Iowa; Howard Hughes Medical Institute; University of Iowa; Oregon Health & Science University	Xiong, ZG (corresponding author), Robert S Dow Neurobiol Labs Legacy Res, Portland, OR 97232 USA.	zxiong@downeurobiology.org	Minami, Manabu/H-8540-2016	Wemmie, John/0000-0001-7531-9065; Chu, Xiang-Ping/0000-0002-6781-0468; Welsh, Michael/0000-0002-1646-6206				Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Akopian AN, 2000, NEUROREPORT, V11, P2217, DOI 10.1097/00001756-200007140-00031; Allen NJ, 2002, J PHYSIOL-LONDON, V543, P521, DOI 10.1113/jphysiol.2002.020297; Bassilana F, 1997, J BIOL CHEM, V272, P28819, DOI 10.1074/jbc.272.46.28819; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; Benos DJ, 1999, J PHYSIOL-LONDON, V520, P631, DOI 10.1111/j.1469-7793.1999.00631.x; Benson CJ, 1999, CIRC RES, V84, P921; BEVAN S, 1991, J PHYSIOL-LONDON, V433, P145, DOI 10.1113/jphysiol.1991.sp018419; Bianchi L, 2002, NEURON, V34, P337, DOI 10.1016/S0896-6273(02)00687-6; Chen CC, 1998, P NATL ACAD SCI USA, V95, P10240, DOI 10.1073/pnas.95.17.10240; Chen CC, 2002, P NATL ACAD SCI USA, V99, P8992, DOI 10.1073/pnas.122245999; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; CHOI DW, 1988, TRENDS NEUROSCI, V11, P465, DOI 10.1016/0166-2236(88)90200-7; CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; Chu XP, 2002, J NEUROPHYSIOL, V87, P2555, DOI 10.1152/jn.00741.2001; de la Rosa DA, 2003, J PHYSIOL-LONDON, V546, P77, DOI 10.1113/jphysiol.2002.030692; de la Rosa DA, 2002, P NATL ACAD SCI USA, V99, P2326, DOI 10.1073/pnas.042688199; Dingledine R, 1999, PHARMACOL REV, V51, P7; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; GIFFARD RG, 1990, BRAIN RES, V506, P339, DOI 10.1016/0006-8993(90)91276-M; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; Grunder S, 2000, NEUROREPORT, V11, P1607; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; Johnson MB, 2001, J CEREBR BLOOD F MET, V21, P734, DOI 10.1097/00004647-200106000-00011; KAKU DA, 1991, BRAIN RES, V554, P344, DOI 10.1016/0006-8993(91)90214-G; KAKU DA, 1993, SCIENCE, V260, P1516, DOI 10.1126/science.8389056; KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; KRISHTAL OA, 1981, NEUROSCIENCE, V6, P2599, DOI 10.1016/0306-4522(81)90105-6; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; LITT L, 1985, J CEREBR BLOOD F MET, V5, P537, DOI 10.1038/jcbfm.1985.81; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; MacGregor DG, 2003, J NEUROCHEM, V85, P1402, DOI 10.1046/j.1471-4159.2003.01772.x; McDonald JW, 1998, J NEUROSCI, V18, P6290; MCLENNAN H, 1983, PROG NEUROBIOL, V20, P251, DOI 10.1016/0301-0082(83)90004-7; MELDRUM BS, 1995, ANN NY ACAD SCI, V757, P492, DOI 10.1111/j.1749-6632.1995.tb17509.x; Miyamoto O, 2000, NEUROLOGY, V54, P362, DOI 10.1212/WNL.54.2.362; NEDERGAARD M, 1991, AM J PHYSIOL, V260, pR581, DOI 10.1152/ajpregu.1991.260.3.R581; Pearigen P, 1996, BRAIN RES, V725, P184; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Price MP, 1996, J BIOL CHEM, V271, P7879, DOI 10.1074/jbc.271.14.7879; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; REHNCRONA S, 1985, ANN EMERG MED, V14, P770, DOI 10.1016/S0196-0644(85)80055-X; ROTHMAN SM, 1986, ANN NEUROL, V19, P105, DOI 10.1002/ana.410190202; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; Siesjo BK, 1996, ADV NEUROL, V71, P209; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; SIMON RP, 1985, J PHARMACOL EXP THER, V234, P830; Sluka KA, 2003, PAIN, V106, P229, DOI 10.1016/S0304-3959(03)00269-0; Stenzel-Poore MP, 2003, LANCET, V362, P1028, DOI 10.1016/S0140-6736(03)14412-1; SWANSON RA, 1995, J CEREBR BLOOD F MET, V15, P417, DOI 10.1038/jcbfm.1995.52; TANG CM, 1990, P NATL ACAD SCI USA, V87, P6445, DOI 10.1073/pnas.87.16.6445; Tariot PN, 2004, JAMA-J AM MED ASSOC, V291, P317, DOI 10.1001/jama.291.3.317; TOMBAUGH GC, 1993, J NEUROCHEM, V61, P793, DOI 10.1111/j.1471-4159.1993.tb03589.x; TRAYNELIS SF, 1990, NATURE, V345, P347, DOI 10.1038/345347a0; Ugawa S, 2002, J CLIN INVEST, V110, P1185, DOI 10.1172/JCI200215709; Varming T, 1999, NEUROPHARMACOLOGY, V38, P1875, DOI 10.1016/S0028-3908(99)00079-9; Wahlgren NG, 2004, CEREBROVASC DIS, V17, P153, DOI 10.1159/000074808; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Waldmann R, 1999, ANN NY ACAD SCI, V868, P67, DOI 10.1111/j.1749-6632.1999.tb11274.x; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2003, J NEUROSCI, V23, P5496; WESTERGAARD E, 1969, ACTA ANAT, V74, P405; Xiong ZG, 1997, P NATL ACAD SCI USA, V94, P7012, DOI 10.1073/pnas.94.13.7012; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100; Ying WH, 1999, J NEUROCHEM, V73, P1549, DOI 10.1046/j.1471-4159.1999.0731549.x	70	789	854	1	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2004	118	6					687	698		10.1016/j.cell.2004.08.026	http://dx.doi.org/10.1016/j.cell.2004.08.026			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	855RW	15369669	Bronze			2022-12-24	WOS:000223992400006
J	Priori, SG; Napolitano, C; Schwartz, PJ; Grillo, M; Bloise, R; Ronchetti, E; Moncalvo, C; Tulipani, C; Veia, A; Bottelli, G; Nastoli, J				Priori, SG; Napolitano, C; Schwartz, PJ; Grillo, M; Bloise, R; Ronchetti, E; Moncalvo, C; Tulipani, C; Veia, A; Bottelli, G; Nastoli, J			Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ARRHYTHMIAS	Context Data on the efficacy of beta-blockers in the 3 most common genetic long QT syndrome (LQTS) loci are limited. Objective To describe and assess outcome in a large systematically genotyped population of beta-blocker-treated LQTS patients. Design, Setting, and Patients Consecutive LQTS-genotyped patients (n=335) in Italy treated with beta-blockers for an average of 5 years. Main Outcome Measures Cardiac events (syncope, ventricular tachycardia/torsades de pointes, cardiac arrest, and sudden cardiac death) while patients received beta-blocker therapy according to genotype. Results Cardiac events among patients receiving beta-blocker therapy occurred in 19 of 187 (10%) LQT1 patients, 27 of 120 (23%) LQT2 patients, and 9 of 28 (32%) LQT3 patients (P<.001). The risk of cardiac events was higher among LQT2 (adjusted relative risk, 2.81; 95% confidence interval [CI], 1.50-5.27; P=.001) and LQT3 (adjusted relative risk, 4.00; 95% CI, 2.45-8.03; P<.001) patients than among LQT1 patients, suggesting inadequate protection from beta-blocker therapy. Other important predictors of risk were a QT interval corrected for heart rate that was more than 500 ms in patients receiving therapy (adjusted relative risk, 2.01; 95% CI, 1.16-3.51; P=.01) and occurrence of a first cardiac event before the age of 7 years (adjusted RR, 4.34; 95% CI, 2.35-8.03; P<.001). Conclusion Among patients with genetic LQTS treated with &beta;-blockers, there is a high rate of cardiac events, particularly among patients with LQT2 and LQT3 genotypes.	Univ Pavia, Maugeri Fdn, IRCCS, I-27100 Pavia, Italy; Policlin San Matteo, IRCCS, Dept Cardiol, I-27100 Pavia, Italy	Istituti Clinici Scientifici Maugeri IRCCS; University of Pavia; IRCCS Fondazione San Matteo; University of Pavia	Priori, SG (corresponding author), Univ Pavia, Maugeri Fdn, IRCCS, Via Ferrata 8, I-27100 Pavia, Italy.	spriori@fsm.it	bloise, raffaella/AAC-2922-2020; Napolitano, Carlo/K-4760-2016; Priori, Silvia G G/A-6116-2014; napolitano, carlo/ABI-4608-2020; Priori, Silvia G/ABH-6894-2020; Schwartz, Peter J/J-4267-2016	bloise, raffaella/0000-0003-3485-9596; Napolitano, Carlo/0000-0002-7643-4628; Priori, Silvia G G/0000-0001-6877-0288; napolitano, carlo/0000-0002-7643-4628; Priori, Silvia G/0000-0001-6877-0288; Schwartz, Peter J/0000-0003-0367-1048; ronchetti, elena/0000-0002-9185-7848; Nastoli, janni/0000-0002-5888-5951	Telethon [GP0227Y01] Funding Source: Medline	Telethon(Fondazione Telethon)		Groh WJ, 1996, AM J CARDIOL, V78, P703, DOI 10.1016/S0002-9149(96)00403-3; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Moss AJ, 2000, CIRCULATION, V101, P616, DOI 10.1161/01.CIR.101.6.616; Priori SG, 2001, EUR HEART J, V22, P1374, DOI 10.1053/euhj.2001.2824; Priori SG, 2003, NEW ENGL J MED, V348, P1866, DOI 10.1056/NEJMoa022147; ROMANO C, 1963, Clin Pediatr (Bologna), V45, P656; Schwartz PJ, 2001, CIRCULATION, V103, P89; Schwartz PJ, 2004, CIRCULATION, V109, P1826, DOI 10.1161/01.CIR.0000125523.14403.1E; SCHWARTZ PJ, 2000, CARDIAC ELECTROPHYSI, P597; WARD O C, 1964, J Ir Med Assoc, V54, P103	10	417	432	0	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 15	2004	292	11					1341	1344		10.1001/jama.292.11.1341	http://dx.doi.org/10.1001/jama.292.11.1341			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853YL	15367556	Bronze			2022-12-24	WOS:000223866800026
J	Abzhanov, A; Protas, M; Grant, BR; Grant, PR; Tabin, CJ				Abzhanov, A; Protas, M; Grant, BR; Grant, PR; Tabin, CJ			Bmp4 and morphological variation of beaks in Darwin's finches	SCIENCE			English	Article								Darwin's finches are a classic example of species diversification by natural selection. Their impressive variation in beak morphology is associated with the exploitation of a variety of ecological niches, but its developmental basis is unknown. We performed a comparative analysis of expression patterns of various growth factors in species comprising the genus Geospiza. We found that expression of Bmp4 in the mesenchyme of the upper beaks strongly correlated with deep and broad beak morphology. When misexpressed in chicken embryos, Bmp4 caused morphological transformations paralleling the beak morphology of the large ground finch G. magnirostris.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Harvard University; Harvard Medical School; Princeton University	Tabin, CJ (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.				NIDDK NIH HHS [P01 DK56246] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK056246] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BOWMAN ROBERT I., 1961, UNIV CALIFORNIA PUBL ZOOL, V58, P1; Darwin C, 1988, VOYAGE BEAGLE; Freeman S., 2003, EVOLUTIONARY ANAL; Futuyma DJ., 1998, EVOL BIOL; Grant P.R., 1999, RECOGNITION STATES L, V2; GRANT PR, 1981, PROC R SOC SER B-BIO, V212, P403, DOI 10.1098/rspb.1981.0046; Kanzler B, 2000, DEVELOPMENT, V127, P1095; Lack D., 1947, DARWINS FINCHES; Petren K, 1999, P ROY SOC B-BIOL SCI, V266, P321, DOI 10.1098/rspb.1999.0641; PRICE TD, 1985, AM NAT, V125, P169, DOI 10.1086/284336; Schluter D, 2000, ECOLOGY ADAPTIVE RAD; Schneider RA, 2003, SCIENCE, V299, P565, DOI 10.1126/science.1077827; Schneider RA, 2001, DEVELOPMENT, V128, P2755	13	540	561	6	341	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 3	2004	305	5689					1462	1465		10.1126/science.1098095	http://dx.doi.org/10.1126/science.1098095			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852NK	15353802				2022-12-24	WOS:000223761900048
J	Griffin, AS; West, SA; Buckling, A				Griffin, AS; West, SA; Buckling, A			Cooperation and competition in pathogenic bacteria	NATURE			English	Article							CYSTIC-FIBROSIS PATIENTS; PSEUDOMONAS-AERUGINOSA; VISCOUS POPULATIONS; EVOLUTION; VIRULENCE; ALTRUISM; CONFLICT; RELATEDNESS; PARASITES; INFECTION	Explaining altruistic cooperation is one of the greatest challenges for evolutionary biology(1-3). One solution to this problem is if costly cooperative behaviours are directed towards relatives(4,5). This idea of kin selection has been hugely influential and applied widely from microorganisms to vertebrates(2-10). However, a problem arises if there is local competition for resources, because this leads to competition between relatives, reducing selection for cooperation(3,11-14). Here we use an experimental evolution approach to test the effect of the scale of competition, and how it interacts with relatedness. The cooperative trait that we examine is the production of siderophores, iron-scavenging agents, in the pathogenic bacterium Pseudomonas aeruginosa(15-17). As expected, our results show that higher levels of cooperative siderophore production evolve in the higher relatedness treatments. However, our results also show that more local competition selects for lower levels of siderophore production and that there is a significant interaction between relatedness and the scale of competition, with relatedness having less effect when the scale of competition is more local. More generally, the scale of competition is likely to be of particular importance for the evolution of cooperation in microorganisms, and also the virulence of pathogenic microorganisms, because cooperative traits such as siderophore production have an important role in determining virulence(6,9,17-19).	Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland; Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of Edinburgh; University of Bath	Griffin, AS (corresponding author), Univ Edinburgh, Inst Cell Anim & Populat Biol, Kings Bldg,W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.	a.griffin@ed.ac.uk	West, Stuart A/M-3608-2014; Griffin, Ashleigh/C-6244-2014	West, Stuart A/0000-0003-2152-3153; Griffin, Ashleigh/0000-0001-7674-9825; Buckling, Angus/0000-0003-1170-4604				Brown SP, 1999, P ROY SOC B-BIOL SCI, V266, P1899, DOI 10.1098/rspb.1999.0864; Brown SP, 2002, TRENDS MICROBIOL, V10, P401, DOI 10.1016/S0966-842X(02)02413-7; Crespi BJ, 2001, TRENDS ECOL EVOL, V16, P178, DOI 10.1016/S0169-5347(01)02115-2; De Vos D, 2001, ARCH MICROBIOL, V175, P384, DOI 10.1007/s002030100278; Frank S. A., 1998, FDN SOCIAL EVOLUTION, DOI DOI 10.1515/9780691206820; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Gandon S, 2001, NATURE, V414, P751, DOI 10.1038/414751a; Grafen A, 1984, BEHAV ECOLOGY EVOLUT, V2, P62; Griffin AS, 2003, SCIENCE, V302, P634, DOI 10.1126/science.1089402; GUERINOT ML, 1994, ANNU REV MICROBIOL, V48, P743, DOI 10.1146/annurev.mi.48.100194.003523; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; HAMILTON WD, 1996, NARROW ROADS GENE LA, V1; HOOGKAMPKORSTANJE JAA, 1995, J CLIN MICROBIOL, V33, P572, DOI 10.1128/JCM.33.3.572-575.1995; KELLER L, 2002, ENCY EVOLUTION, P595; Meyer JM, 1996, INFECT IMMUN, V64, P518, DOI 10.1128/IAI.64.2.518-523.1996; Pepper JW, 2000, J THEOR BIOL, V206, P355, DOI 10.1006/jtbi.2000.2132; QUELLER DC, 1994, EVOL ECOL, V8, P70, DOI 10.1007/BF01237667; Queller DC, 1998, BIOSCIENCE, V48, P165, DOI 10.2307/1313262; Rainey PB, 2003, NATURE, V425, P72, DOI 10.1038/nature01906; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Smith J. M., 1995, MAJOR TRANSITIONS EV; Strassmann JE, 2000, NATURE, V408, P965, DOI 10.1038/35050087; TAYLOR PD, 1992, EVOL ECOL, V6, P352, DOI 10.1007/BF02270971; Velicer GJ, 2003, TRENDS MICROBIOL, V11, P330, DOI 10.1016/S0966-842X(03)00152-5; Velicer GJ, 2003, NATURE, V425, P75, DOI 10.1038/nature01908; West SA, 2001, NATURE, V409, P510, DOI 10.1038/35054057; West SA, 2003, P ROY SOC B-BIOL SCI, V270, P37, DOI 10.1098/rspb.2002.2209; West SA, 2002, SCIENCE, V296, P72, DOI 10.1126/science.1065507; WILSON DS, 1992, EVOL ECOL, V6, P331, DOI 10.1007/BF02270969	30	675	689	8	336	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 26	2004	430	7003					1024	1027		10.1038/nature02744	http://dx.doi.org/10.1038/nature02744			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849CD	15329720	Green Published			2022-12-24	WOS:000223514900042
J	Nagao, K; Adachi, Y; Yanagida, M				Nagao, K; Adachi, Y; Yanagida, M			Separase-mediated cleavage of cohesin at interphase is required for DNA repair	NATURE			English	Article							SISTER-CHROMATID SEPARATION; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; S-PHASE; SACCHAROMYCES-CEREVISIAE; DAMAGE CHECKPOINT; CUT2 PROTEOLYSIS; EXCISION-REPAIR; BUDDING YEAST; ANAPHASE	Sister chromatids are held together by cohesins(1). At anaphase, separase is activated by degradation of its inhibitory partner, securin(2,3). Separase then cleaves cohesins(4-6), thus allowing sister chromatid separation. Fission yeast securin (Cut2) has destruction boxes and a separase (Cut1) interaction site in the amino and carboxyl terminus, respectively(7,8). Here we show that securin is essential for separase stability and also for proper repair of DNA damaged by ultraviolet, X-ray and g-ray irradiation. The cut2(EA2) mutant is defective in the repair of ultraviolet damage lesions, although the DNA damage checkpoint is activated normally. In double mutant analysis of ultraviolet sensitivity, checkpoint kinase chk1 (ref. 9) and excision repair rad13 (ref. 10) mutants were additive with cut2(EA2), whereas recombination repair rhp51 (ref. 11) and cohesin subunit rad21 (ref. 12) mutants were not. Cohesin was hyper-modified on ultraviolet irradiation in a Rad3 kinase-dependent way(13). Experiments using either mutant cohesin that cannot be cleaved by separase or a protease-dead separase provide evidence that this DNA repair function of securin-separase acts through the cleavage of cohesin. We propose that the securin-separase complex might aid DNA repair by removing local cohesin in interphase cells.	Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Biostudies, Dept Gene Mech, Sakyo Ku, Kyoto 6068501, Japan; Okinawa Inst Sci & Technol, Initial Res Project, Okinawa 9042234, Japan	Kyoto University; Kyoto University; Okinawa Institute of Science & Technology Graduate University	Yanagida, M (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Yoshida Honmachi, Kyoto 6068501, Japan.	yanagida@kozo.lif.kyoto-u.ac.jp		Nagao, Koji/0000-0003-1418-6988				Aono N, 2002, NATURE, V417, P197, DOI 10.1038/417197a; Bentley NJ, 1996, EMBO J, V15, P6641, DOI 10.1002/j.1460-2075.1996.tb01054.x; Bernal JA, 2002, NAT GENET, V32, P306, DOI 10.1038/ng997; BIRKENBIHL RP, 1992, NUCLEIC ACIDS RES, V20, P6605, DOI 10.1093/nar/20.24.6605; CARR AM, 1993, NUCLEIC ACIDS RES, V21, P1345, DOI 10.1093/nar/21.6.1345; CohenFix O, 1996, GENE DEV, V10, P3081, DOI 10.1101/gad.10.24.3081; Esashi F, 1999, MOL CELL, V4, P167, DOI 10.1016/S1097-2765(00)80364-0; Funabiki H, 1996, NATURE, V381, P438, DOI 10.1038/381438a0; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; HIRANO T, 1986, EMBO J, V5, P2973, DOI 10.1002/j.1460-2075.1986.tb04594.x; Jager H, 2001, GENE DEV, V15, P2572, DOI 10.1101/gad.207301; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; Kumada K, 1998, CURR BIOL, V8, P633, DOI 10.1016/S0960-9822(98)70250-7; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; MURAKAMI H, 1995, NATURE, V374, P817, DOI 10.1038/374817a0; MURIS DFR, 1993, NUCLEIC ACIDS RES, V21, P4586, DOI 10.1093/nar/21.19.4586; Nakamura T, 2002, GENES CELLS, V7, P1113, DOI 10.1046/j.1365-2443.2002.00586.x; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; Rao H, 2001, NATURE, V410, P955, DOI 10.1038/35073627; Saka Y, 1997, GENE DEV, V11, P3387, DOI 10.1101/gad.11.24.3387; Sanchez Y, 1999, SCIENCE, V286, P1166, DOI 10.1126/science.286.5442.1166; Stewart E, 1997, EMBO J, V16, P2682, DOI 10.1093/emboj/16.10.2682; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; UZAWA S, 1990, CELL, V62, P913, DOI 10.1016/0092-8674(90)90266-H; WALWORTH N, 1993, NATURE, V363, P368, DOI 10.1038/363368a0; Yamamoto A, 1996, J CELL BIOL, V133, P99, DOI 10.1083/jcb.133.1.99; Yonemasu R, 1997, NUCLEIC ACIDS RES, V25, P1553, DOI 10.1093/nar/25.8.1553	29	109	111	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 26	2004	430	7003					1044	1048		10.1038/nature02803	http://dx.doi.org/10.1038/nature02803			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849CD	15329725				2022-12-24	WOS:000223514900047
J	Spahn, CMT; Jan, E; Mulder, A; Grassucci, RA; Sarnow, P; Frank, J				Spahn, CMT; Jan, E; Mulder, A; Grassucci, RA; Sarnow, P; Frank, J			Cryo-EM visualization of a viral internal ribosome entry site bound to human ribosomes: The IRES functions as an RNA-Based translation factor	CELL			English	Article							CRICKET PARALYSIS VIRUS; COLI 70S RIBOSOME; METHIONINE-INDEPENDENT INITIATION; 80 S RIBOSOME; ANGSTROM RESOLUTION; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; ELECTRON-MICROSCOPY; EXPANSION SEGMENTS; CRYOELECTRON MICROSCOPY	Internal initiation of protein synthesis in eukaryotes is accomplished by recruitment of ribosomes to structured internal ribosome entry sites (IRESs), which are located in certain viral and cellular messenger RNAs. An IRES element in cricket paralysis virus (CrPV) can directly assemble 80S ribosomes in the absence of canonical initiation factors and initiator tRNA. Here we present cryo-EM structures of the CrPV IRES bound to the human ribosomal 40S subunit and to the 80S ribosome. The CrPV IRES adopts a defined, elongate structure within the ribosomal intersubunit space and forms specific contacts with components of the ribosomal A, P, and E sites. Conformational changes in the ribosome as well as within the IRES itself show that CrPV IRES actively manipulates the ribosome. CrPV-Iike IRES elements seem to act as RNA-based translation factors.	New York State Dept Hlth, Wadsworth Ctr Labs & Res, Howard Hughes Med Inst, Hlth Res Inc, Albany, NY 12201 USA; SUNY Albany, Dept Biomed Sci, Albany, NY 10012 USA; Charite Univ Med Berlin, Inst Med Phys & Biophys, D-10117 Berlin, Germany; Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; Purdue Univ, Dept Biol, W Lafayette, IN 47906 USA	Health Research Inc; Howard Hughes Medical Institute; State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Stanford University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Frank, J (corresponding author), New York State Dept Hlth, Wadsworth Ctr Labs & Res, Howard Hughes Med Inst, Hlth Res Inc, Empire State Plaza, Albany, NY 12201 USA.	joachim@wadsworth.org	Jan, Eric/O-1923-2019	Sarnow, Peter/0000-0002-2043-2770	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055440, R37GM029169, R01GM029169, R01GM055979] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR01219] Funding Source: Medline; NIGMS NIH HHS [GM55979, R037 GM29169, R01 GM55440] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal RK, 2000, J CELL BIOL, V150, P447, DOI 10.1083/jcb.150.3.447; Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; Alkemar G, 2004, RNA, V10, P403, DOI 10.1261/rna.5135204; Beckmann R, 2001, CELL, V107, P361, DOI 10.1016/S0092-8674(01)00541-4; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Carter AP, 2001, SCIENCE, V291, P498, DOI 10.1126/science.1057766; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Doudna JA, 2002, CELL, V109, P153, DOI 10.1016/S0092-8674(02)00725-0; Dube P, 1998, J MOL BIOL, V279, P403, DOI 10.1006/jmbi.1998.1804; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Frank J, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P45; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; FRANK J, 1995, NATURE, V376, P441, DOI 10.1038/376441a0; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Gao HX, 2003, CELL, V113, P789, DOI 10.1016/S0092-8674(03)00427-6; Gerbi S.A., 1996, RIBOSOMAL RNA STRUCT, P71; Gomez-Lorenzo MG, 2000, EMBO J, V19, P2710, DOI 10.1093/emboj/19.11.2710; Jan E, 2003, P NATL ACAD SCI USA, V100, P15410, DOI 10.1073/pnas.2535183100; Jan E, 2002, J MOL BIOL, V324, P889, DOI 10.1016/S0022-2836(02)01099-9; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kanamori Y, 2001, RNA, V7, P266, DOI 10.1017/S1355838201001741; Lata KR, 1996, J MOL BIOL, V262, P43, DOI 10.1006/jmbi.1996.0497; MATASOVA NB, 1991, ANAL BIOCHEM, V198, P219, DOI 10.1016/0003-2697(91)90416-Q; Morgan DG, 2000, J MOL BIOL, V301, P301, DOI 10.1006/jmbi.2000.3947; Morgan DG, 2002, J MOL BIOL, V324, P871, DOI 10.1016/S0022-2836(02)01111-7; Nishiyama T, 2003, NUCLEIC ACIDS RES, V31, P2434, DOI 10.1093/nar/gkg336; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Pestova TV, 2003, GENE DEV, V17, P181, DOI 10.1101/gad.1040803; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Pestova TV, 1996, MOL CELL BIOL, V16, P6859, DOI 10.1128/mcb.16.12.6859; Sachs AB, 2000, CELL, V101, P243, DOI 10.1016/S0092-8674(00)80834-X; Sasaki J, 2000, P NATL ACAD SCI USA, V97, P1512, DOI 10.1073/pnas.010426997; Sasaki J, 1999, J VIROL, V73, P1219, DOI 10.1128/JVI.73.2.1219-1226.1999; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; Sonenberg N, 2003, CURR OPIN STRUC BIOL, V13, P56, DOI 10.1016/S0959-440X(03)00009-5; Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Spahn CMT, 2001, MOL CELL, V7, P1037, DOI 10.1016/S1097-2765(01)00238-6; Spahn CMT, 2001, SCIENCE, V291, P1959, DOI 10.1126/science.1058409; Stark H, 2000, CELL, V100, P301, DOI 10.1016/S0092-8674(00)80666-2; Thompson SR, 2001, P NATL ACAD SCI USA, V98, P12972, DOI 10.1073/pnas.241286698; Vagner S, 2001, EMBO REP, V2, P893, DOI 10.1093/embo-reports/kve208; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; WAGENKNECHT T, 1988, J MOL BIOL, V199, P137, DOI 10.1016/0022-2836(88)90384-1; Wilson JE, 2000, CELL, V102, P511, DOI 10.1016/S0092-8674(00)00055-6; Wilson JE, 2000, MOL CELL BIOL, V20, P4990, DOI 10.1128/MCB.20.14.4990-4999.2000; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4	50	209	217	2	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2004	118	4					465	475		10.1016/j.cell.2004.08.001	http://dx.doi.org/10.1016/j.cell.2004.08.001			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	850YS	15315759	Bronze			2022-12-24	WOS:000223650900009
J	Zucchero, TM; Cooper, ME; Maher, BS; Daack-Hirsch, S; Nepomuceno, B; Ribeiro, L; Caprau, D; Christensen, K; Suzuki, Y; Machida, J; Natsume, N; Yoshiura, KI; Vieira, AR; Orioli, IM; Castilla, EE; Moreno, L; Arcos-Burgos, M; Lidral, AC; Field, LL; Liu, YE; Ray, A; Goldstein, TH; Schultz, RE; Shi, M; Johnson, MK; Kondo, S; Schutte, BC; Marazita, ML; Murray, JC				Zucchero, TM; Cooper, ME; Maher, BS; Daack-Hirsch, S; Nepomuceno, B; Ribeiro, L; Caprau, D; Christensen, K; Suzuki, Y; Machida, J; Natsume, N; Yoshiura, KI; Vieira, AR; Orioli, IM; Castilla, EE; Moreno, L; Arcos-Burgos, M; Lidral, AC; Field, LL; Liu, YE; Ray, A; Goldstein, TH; Schultz, RE; Shi, M; Johnson, MK; Kondo, S; Schutte, BC; Marazita, ML; Murray, JC			Interferon regulatory factor 6 (IRF6) gene variants and the risk of isolated cleft lip or palate	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AUTOSOMAL MAJOR LOCUS; FAMILY-BASED TESTS; LINKAGE ANALYSIS; UNIFIED APPROACH; CLINICAL-TRIALS; ASSOCIATION; MSX1; METAANALYSIS; FREQUENCIES; REGIONS	BACKGROUND: Cleft lip or palate (or the two in combination) is a common birth defect that results from a mixture of genetic and environmental factors. We searched for a specific genetic factor contributing to this complex trait by examining large numbers of affected patients and families and evaluating a specific candidate gene. METHODS: We identified the gene that encodes interferon regulatory factor 6 (IRF6) as a candidate gene on the basis of its involvement in an autosomal dominant form of cleft lip and palate, Van der Woude's syndrome. A single-nucleotide polymorphism in this gene results in either a valine or an isoleucine at amino acid position 274 (V274I). We carried out transmission-disequilibrium testing for V274I in 8003 individual subjects in 1968 families derived from 10 populations with ancestry in Asia, Europe, and South America, haplotype and linkage analyses, and case-control analyses, and determined the risk of cleft lip or palate that is associated with genetic variation in IRF6. RESULTS: Strong evidence of overtransmission of the valine (V) allele was found in the entire population data set (P<10(sup -9)); moreover, the results for some individual populations from South America and Asia were highly significant. Variation at IRF6 was responsible for 12 percent of the genetic contribution to cleft lip or palate and tripled the risk of recurrence in families that had already had one affected child. CONCLUSIONS: DNA-sequence variants associated with IRF6 are major contributors to cleft lip, with or without cleft palate. The contribution of variants in single genes to cleft lip or palate is an important consideration in genetic counseling.	Univ Iowa, Coll Dent, Iowa City, IA 52242 USA; Univ Pittsburgh, Sch Dent Med, Pittsburgh, PA USA; HOPE Fdn, Bacolod City, Philippines; Univ Sao Paulo, Hosp Rehabil Craniofacial Anomalies, Sao Paulo, Brazil; Univ So Denmark, Inst Publ Hlth, Odense, Denmark; Aichi Gakuin Univ, Sch Dent, Nagoya, Aichi 464, Japan; Nagasaki Univ, Sch Med, Nagasaki 852, Japan; Univ Fed Rio de Janeiro, Estudio Collaborat Latino Amer Malformac Congenit, Rio De Janeiro, Brazil; Oswaldo Cruz Fdn, ECLAMC, Rio De Janeiro, Brazil; Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; Univ Antioquia, Inst Biol, Medellin, Colombia; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; Zhabei Genet Inst, Shanghai, Peoples R China	University of Iowa; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Universidade de Sao Paulo; University of Southern Denmark; Aichi Gakuin University; Nagasaki University; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad de Antioquia; University of British Columbia	Murray, JC (corresponding author), Univ Iowa, Coll Dent, S Grand Ave,2182 ML, Iowa City, IA 52242 USA.	jeff-murray@uiowa.edu	Maher, Brion S/F-9185-2010; Bicudo, Lucilene/ABA-5679-2020; Cooper, Mark/AAC-5326-2020; Christensen, Kaare/C-2360-2009; Arcos-Burgos, Mauricio/H-1326-2017	Christensen, Kaare/0000-0002-5429-5292; Daack-Hirsch, Sandra/0000-0003-1192-7154; Arcos-Burgos, Mauricio/0000-0002-8529-0574	NIDCR NIH HHS [R01 DE014667-08, R01 DE016148, DE09886, P60 DE13076, DE14667, DE08559, R01 DE014667-04, K02 DE015291-02, R01 DE014667-02, R01 DE014667-01, K02 DE015291-04, K02 DE015291-05, K02 DE015291-03, R01 DE014667-07, R01 DE014667-06, DE11948, R01 DE014667-05, K02 DE015291, K02 DE015291-01, R01 DE014667, DE13513, R01 DE014667-03] Funding Source: Medline; NIEHS NIH HHS [ES10876] Funding Source: Medline; NIGMS NIH HHS [GM08629] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016148, R37DE008559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE014667, P60DE013076, R01DE013513, R01DE011948, R01DE009886, K02DE015291, R01DE008559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008629] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; BERLIN JA, 1989, STAT MED, V8, P141, DOI 10.1002/sim.4780080202; BURDICK AB, 1985, J CRAN GENET DEV BIO, V5, P181; Cann HM, 2002, SCIENCE, V296, P261; Christensen K, 2004, BRIT MED J, V328, P1405, DOI 10.1136/bmj.38106.559120.7C; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; Field L. Leigh, 1994, European Journal of Human Genetics, V2, P159; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Horvath S, 2004, GENET EPIDEMIOL, V26, P61, DOI 10.1002/gepi.10295; Houdayer C, 2001, AM J MED GENET, V104, P86, DOI 10.1002/1096-8628(20011115)104:1<86::AID-AJMG10053>3.0.CO;2-E; Jezewski PA, 2003, J MED GENET, V40, P399, DOI 10.1136/jmg.40.6.399; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Laird NM, 2000, GENET EPIDEMIOL, V19, pS36, DOI 10.1002/1098-2272(2000)19:1+<::AID-GEPI6>3.3.CO;2-D; Marazita ML, 2004, AM J HUM GENET, V75, P161, DOI 10.1086/422475; Marazita ML, 2002, AM J HUM GENET, V71, P349, DOI 10.1086/341944; Marazita ML, 2002, CLEFT PALATE-CRAN J, V39, P149, DOI 10.1597/1545-1569(2002)039<0149:NCLWOW>2.0.CO;2; MARAZITA ML, 1992, AM J HUM GENET, V51, P648; Moreno LM, 2004, AM J MED GENET A, V125A, P135, DOI 10.1002/ajmg.a.20425; Mossey P., 2002, CLEFT LIP PALATE, P127; Murray JC, 1997, CLEFT PALATE-CRAN J, V34, P7, DOI 10.1597/1545-1569(1997)034<0007:CAESOC>2.3.CO;2; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; RAY AK, 1993, AM J HUM GENET, V52, P1006; Romitti PA, 1999, TERATOLOGY, V59, P39, DOI 10.1002/(SICI)1096-9926(199901)59:1<39::AID-TERA9>3.0.CO;2-7; Schaid DJ, 1999, AM J EPIDEMIOL, V149, P706; Schliekelman P, 2002, AM J HUM GENET, V71, P1369, DOI 10.1086/344779; Schultz RE, 2004, AM J MED GENET A, V125A, P17, DOI 10.1002/ajmg.a.20424; Scott L, 2000, GENET EPIDEMIOL, V19, P381, DOI 10.1002/1098-2272(200012)19:4<381::AID-GEPI9>3.0.CO;2-B; Shi M, 2003, BIRTH DEFECTS RES A, V67, P545, DOI 10.1002/bdra.10076; Sobel E, 1996, AM J HUM GENET, V58, P1323; Terwilliger J., 1994, HDB HUMAN GENETIC LI; van den Boogaard MJH, 2000, NAT GENET, V25, P125; van den Boogaard MJH, 2000, NAT GENET, V24, P342, DOI 10.1038/74155; Vieira AR, 2003, J DENT RES, V82, P289, DOI 10.1177/154405910308200409; Weinberg CR, 1999, AM J HUM GENET, V64, P1186, DOI 10.1086/302337	38	436	468	0	39	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 19	2004	351	8					769	780		10.1056/NEJMoa032909	http://dx.doi.org/10.1056/NEJMoa032909			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	847CY	15317890	Green Accepted			2022-12-24	WOS:000223367900009
J	Koshiba, T; Detmer, SA; Kaiser, JT; Chen, HC; McCaffery, JM; Chan, DC				Koshiba, T; Detmer, SA; Kaiser, JT; Chen, HC; McCaffery, JM; Chan, DC			Structural basis of mitochondrial tethering by mitofusin complexes	SCIENCE			English	Article							MEMBRANE-FUSION; MAMMALIAN-CELLS; MORPHOLOGY; DYNAMICS; MECHANISMS; DIVISION; DESIGN	Vesicle fusion involves vesicle tethering, docking, and membrane merger. We show that mitofusin, an integral mitochondrial membrane protein, is required on adjacent mitochondria to mediate fusion, which indicates that mitofusin complexes act in trans ( that is, between adjacent mitochondria). A heptad repeat region (HR2) mediates mitofusin oligomerization by assembling a dimeric, antiparallel coiled coil. The transmembrane segments are located at opposite ends of the 95 angstrom coiled coil and provide a mechanism for organelle tethering. Consistent with this proposal, truncated mitofusin, in an HR2-dependent manner, causes mitochondria to become apposed with a uniform gap. Our results suggest that HR2 functions as a mitochondrial tether before fusion.	CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Div Chem, Pasadena, CA 91125 USA; Johns Hopkins Univ, Howard Hughes Med Inst, Baltimore, MD 21218 USA; Johns Hopkins Univ, Dept Biol, Integrated Imaging Ctr, Baltimore, MD 21218 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University	Chan, DC (corresponding author), CALTECH, Div Biol, 1200 E Calif Blvd,MC114-96, Pasadena, CA 91125 USA.	dchan@caltech.edu	Koshiba, Takumi/A-3996-2013	Koshiba, Takumi/0000-0001-8535-5043	NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062967] Funding Source: NIH RePORTER; NCRR NIH HHS [S10 RR019409-01] Funding Source: Medline; NIGMS NIH HHS [R01 GM62967] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Chen HC, 2004, CURR TOP DEV BIOL, V59, P119, DOI 10.1016/S0070-2153(04)59005-1; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588; Dumas JJ, 2001, MOL CELL, V8, P947, DOI 10.1016/S1097-2765(01)00385-9; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Gurnon DG, 2003, J AM CHEM SOC, V125, P7518, DOI 10.1021/ja0357590; Ishihara N, 2003, BIOCHEM BIOPH RES CO, V301, P891, DOI 10.1016/S0006-291X(03)00050-0; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; MEEUSEN S, UNPUB; Mellman I, 2000, CELL, V100, P99, DOI 10.1016/S0092-8674(00)81687-6; Mozdy AD, 2003, NAT REV MOL CELL BIO, V4, P468, DOI 10.1038/nrm1125; Oakley MG, 2001, CURR OPIN STRUC BIOL, V11, P450, DOI 10.1016/S0959-440X(00)00232-3; Rojo M, 2002, J CELL SCI, V115, P1663; Santel A, 2003, J CELL SCI, V116, P2763, DOI 10.1242/jcs.00479; Santel A, 2001, J CELL SCI, V114, P867; Shaw JM, 2002, TRENDS CELL BIOL, V12, P178, DOI 10.1016/S0962-8924(01)02246-2; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Whyte JRC, 2002, J CELL SCI, V115, P2627; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	22	634	665	3	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2004	305	5685					858	862		10.1126/science.1099793	http://dx.doi.org/10.1126/science.1099793			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297672				2022-12-24	WOS:000223104900047
J	Li, ZB; Kesselman, E; Talmon, Y; Hillmyer, MA; Lodge, TP				Li, ZB; Kesselman, E; Talmon, Y; Hillmyer, MA; Lodge, TP			Multicompartment micelles from ABC miktoarm stars in water	SCIENCE			English	Article							FLUOROCARBON; HYDROCARBON; NANOTECHNOLOGY; POLYMERS; STRATEGY	By combining three mutually immiscible polymeric components in a mixed-arm star block terpolymer architecture, we have observed the formation of a previously unknown class of multicompartment micelles in dilute aqueous solution. Connection of water-soluble poly(ethylene oxide) and two hydrophobic but immiscible components (a polymeric hydrocarbon and a perfluorinated polyether) at a common junction leads to molecular frustration when dispersed in aqueous solution. The incompatible hydrophobic blocks form cores that are protected from the water by the poly(ethylene oxide) blocks, but both are forced to make contact with the poly(ethylene oxide) by virtue of the chain architecture. The structures that emerge depend on the relative lengths of the blocks and can be tuned from discrete multicompartment micelles to extended wormlike structures with segmented cores.	Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; Univ Minnesota, Dept Chem Engn & Mat Sci, Minneapolis, MN 55455 USA; Technion Israel Inst Technol, Dept Chem Engn, IL-32000 Haifa, Israel	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Technion Israel Institute of Technology	Hillmyer, MA (corresponding author), Univ Minnesota, Dept Chem, 207 Pleasant St SE, Minneapolis, MN 55455 USA.	hillmyer@chem.umn.edu; lodge@chem.umn.edu	Talmon, Yeshayahu/N-1076-2019; Li, Zhibo/K-1614-2013	Talmon, Yeshayahu/0000-0002-9854-3972; Li, Zhibo/0000-0001-9512-1507; Hillmyer, Marc/0000-0001-8255-3853; Lodge, Timothy/0000-0001-5916-8834				Bailey TS, 2002, MACROMOLECULES, V35, P7007, DOI 10.1021/ma011716x; Balsamo V, 2003, MACROMOLECULES, V36, P4515, DOI 10.1021/ma020129o; BATES FS, 1991, SCIENCE, V251, P898, DOI 10.1126/science.251.4996.898; Collier JH, 2001, ANNU REV MATER RES, V31, P237, DOI 10.1146/annurev.matsci.31.1.237; Danino D, 2001, COLLOID SURFACE A, V183, P113, DOI 10.1016/S0927-7757(01)00543-X; Discher DE, 2002, SCIENCE, V297, P967, DOI 10.1126/science.1074972; Dormidontova EE, 1997, MACROMOLECULES, V30, P1980, DOI 10.1021/ma961076b; Gohy JF, 2001, ANGEW CHEM INT EDIT, V40, P3214, DOI 10.1002/1521-3773(20010903)40:17<3214::AID-ANIE3214>3.0.CO;2-F; Goldacker T, 1999, NATURE, V398, P137, DOI 10.1038/18191; Hadjichristidis N, 1999, J POLYM SCI POL CHEM, V37, P857, DOI 10.1002/(SICI)1099-0518(19990401)37:7<857::AID-POLA1>3.0.CO;2-P; HALPERIN A, 1992, ADV POLYM SCI, V100, P31; Hamley I. W., 1998, PHYS BLOCK COPOLYMER; Jain S, 2003, SCIENCE, V300, P460, DOI 10.1126/science.1082193; Kisak ET, 2004, CURR MED CHEM, V11, P199, DOI 10.2174/0929867043456197; Kotzev A, 2002, MACROMOLECULES, V35, P1091, DOI 10.1021/ma011047n; Laschewsky A, 2003, CURR OPIN COLLOID IN, V8, P274, DOI 10.1016/S1359-0294(03)00049-9; Li Z.B., UNPUB; Lodge TP, 2004, MACROMOLECULES, V37, P6680, DOI 10.1021/ma048708b; Lodge TP, 2003, MACROMOL CHEM PHYSIC, V204, P265, DOI 10.1002/macp.200290073; Park C, 2003, POLYMER, V44, P6725, DOI 10.1016/j.polymer.2003.08.011; Park M, 1997, SCIENCE, V276, P1401, DOI 10.1126/science.276.5317.1401; Riess G, 2003, PROG POLYM SCI, V28, P1107, DOI 10.1016/S0079-6700(03)00015-7; Savic R, 2003, SCIENCE, V300, P615, DOI 10.1126/science.1078192; SEMENOV AN, 1995, MACROMOLECULES, V28, P7491, DOI 10.1021/ma00126a029; Shimomura M, 2001, CURR OPIN COLLOID IN, V6, P11, DOI 10.1016/S1359-0294(00)00081-9; Sioula S, 1998, MACROMOLECULES, V31, P8429, DOI 10.1021/ma980622t; Stahler K, 1999, LANGMUIR, V15, P7565, DOI 10.1021/la990431z; Weberskirch R, 2000, MACROMOL CHEM PHYSIC, V201, P995, DOI 10.1002/1521-3935(20000601)201:10<995::AID-MACP995>3.0.CO;2-T; Zhou ZL, 2003, J AM CHEM SOC, V125, P10182, DOI 10.1021/ja036551h	29	892	911	6	430	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2004	306	5693					98	101		10.1126/science.1103350	http://dx.doi.org/10.1126/science.1103350			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459387				2022-12-24	WOS:000224304000044
J	Potts, M; Campbell, M				Potts, M; Campbell, M			Three meetings and fewer funerals - misoprostol in postpartum haemorrhage	LANCET			English	Editorial Material							MORTALITY		Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Potts, M (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	potts@socrates.berkeley.edu						AbouZahr C, 2003, BRIT MED BULL, V67, P1, DOI 10.1093/bmb/ldg015; FORTNEY JA, 1986, AM J PUBLIC HEALTH, V76, P134, DOI 10.2105/AJPH.76.2.134; Goldberg AB, 2001, NEW ENGL J MED, V344, P38, DOI 10.1056/NEJM200101043440107; Tsu VD, 2004, LANCET, V363, P75, DOI 10.1016/S0140-6736(03)15180-X	4	16	16	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 25	2004	364	9440					1110	1111		10.1016/S0140-6736(04)17120-1	http://dx.doi.org/10.1016/S0140-6736(04)17120-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857FT	15451208				2022-12-24	WOS:000224102400009
J	Mundil, R; Ludwig, KR; Metcalfe, I; Renne, PR				Mundil, R; Ludwig, KR; Metcalfe, I; Renne, PR			Age and timing of the Permian mass extinctions: U/Pb dating of closed-system zircons	SCIENCE			English	Article							TRIASSIC BOUNDARY; END; IMPACT; PB; GEOCHRONOLOGY	The age and timing of the Permian-Triassic mass extinction have been difficult to determine because zircon populations from the type sections are typically affected by pervasive lead loss and contamination by indistinguishable older xenocrysts. Zircons from nine ash beds within the Shangsi and Meishan sections (China), pretreated by annealing followed by partial attack with hydrofluoric acid, result in suites of consistent and concordant uranium/lead (U/Pb) ages, eliminating the effects of lead loss. The U/Pb age of the main pulse of the extinction is 252.6 +/- 0.2 million years, synchronous with the Siberian flood volcanism, and it occurred within the quoted uncertainty.	Berkeley Geochronol Ctr, Berkeley, CA 94709 USA; Univ New England, Asia Ctr, Armidale, NSW 2351, Australia; Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA	Berkeley Geochronolgy Center; University of New England; University of California System; University of California Berkeley	Mundil, R (corresponding author), Berkeley Geochronol Ctr, 2455 Ridge Rd, Berkeley, CA 94709 USA.		Metcalfe, Ian/AAK-3429-2020; Mundil, Roland/E-5174-2011	Metcalfe, Ian/0000-0003-3538-1686; Renne, Paul/0000-0003-1769-5235				Basu AR, 2003, SCIENCE, V302, P1388, DOI 10.1126/science.1090852; BAUD A, 1989, GEOL RUNDSCH, V78, P649, DOI 10.1007/BF01776196; Becker L, 2004, SCIENCE, V304, P1469, DOI 10.1126/science.1093925; Becker L, 2001, SCIENCE, V291, P1530, DOI 10.1126/science.1057243; Bowring SA, 1998, SCIENCE, V280, P1039, DOI 10.1126/science.280.5366.1039; Brown SJA, 1999, GEOLOGY, V27, P1035, DOI 10.1130/0091-7613(1999)027<1035:SUPDOT>2.3.CO;2; Buck C.E., 1996, BAYESIAN APPROACH IN; Cherniak DJ, 2001, CHEM GEOL, V172, P5, DOI 10.1016/S0009-2541(00)00233-3; Courtillot VE, 2003, CR GEOSCI, V335, P113, DOI 10.1016/S1631-0713(03)00006-3; Farley KA, 2001, SCIENCE, V293, P2343; Jin YG, 2000, SCIENCE, V289, P432, DOI 10.1126/science.289.5478.432; Koeberl C, 2002, GEOLOGY, V30, P855, DOI 10.1130/0091-7613(2002)030<0855:EPCBBI>2.0.CO;2; KROGH TE, 1982, GEOCHIM COSMOCHIM AC, V46, P637, DOI 10.1016/0016-7037(82)90165-X; Krull ES, 2000, GEOL SOC AM BULL, V112, P1459, DOI 10.1130/0016-7606(2000)112<1459:CDPFPA>2.0.CO;2; Kwon JY, 2002, MATH GEOL, V34, P457, DOI 10.1023/A:1015035228810; Lee JKW, 1997, NATURE, V390, P159, DOI 10.1038/36554; LI ZS, 1986, ACTA GEOL SIN-ENGL, V60, P1; Litton C.D., 1995, ARCHAEOMETRY, V37, P1, DOI DOI 10.1111/J.1475-4754.1995.TB00723.X; Ludwig K.R, 2003, USERS MANUAL ISOPLOT; Ludwig KR, 1998, GEOCHIM COSMOCHIM AC, V62, P665, DOI 10.1016/S0016-7037(98)00059-3; MATTINSON JM, 1994, CONTRIB MINERAL PETR, V116, P117, DOI 10.1007/BF00310694; MATTINSON JM, UNPUB; MATTINSON JM, 2001, AM GEOPH UN M SAN FR; Min KW, 2000, GEOCHIM COSMOCHIM AC, V64, P73, DOI 10.1016/S0016-7037(99)00204-5; Mundil R, 2001, EARTH PLANET SC LETT, V187, P131, DOI 10.1016/S0012-821X(01)00274-6; NICHOLLS G, 1998, 407 U AUCKL; Nicoll RS, 2002, J ASIAN EARTH SCI, V20, P609, DOI 10.1016/S1367-9120(02)00021-4; Ramsey CB, 1998, RADIOCARBON, V40, P461; Reid MR, 1997, EARTH PLANET SC LETT, V150, P27, DOI 10.1016/S0012-821X(97)00077-0; RENNE PR, 1995, SCIENCE, V269, P1413, DOI 10.1126/science.269.5229.1413; Ryskin G, 2003, GEOLOGY, V31, P741, DOI 10.1130/G19518.1; STANLEY SM, 1994, SCIENCE, V266, P1340, DOI 10.1126/science.266.5189.1340; STEIN C, 1954, 3 BERK S MATH STAT P; *STEIN C, 1955, 3 BERK S MATH STAT P; Yin H.F., 1992, PERMOTRIASSIC EVENTS, P1; Yin HF, 2001, EPISODES, V24, P102; Zhou MF, 2002, EARTH PLANET SC LETT, V196, P113, DOI 10.1016/S0012-821X(01)00608-2	37	487	540	5	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1760	1763		10.1126/science.1101012	http://dx.doi.org/10.1126/science.1101012			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	856IS	15375264				2022-12-24	WOS:000224039500037
J	Ponti, A; Machacek, M; Gupton, SL; Waterman-Storer, CM; Danuser, G				Ponti, A; Machacek, M; Gupton, SL; Waterman-Storer, CM; Danuser, G			Two distinct actin networks drive the protrusion of migrating cells	SCIENCE			English	Article							FLUORESCENT SPECKLE MICROSCOPY; FILAMENTS; MOTILITY; POLYMERIZATION; ELONGATION	Cell migration initiates by extension of the actin cytoskeleton at the leading edge. Computational analysis of fluorescent speckle microscopy movies of migrating epithelial cells revealed this process is mediated by two spatially colocalized but kinematically, kinetically, molecularly, and functionally distinct actin networks. A lamelhpodium network assembled at the leading edge but completely disassembled within 1 to 3 micrometers. It was weakly coupled to the rest of the cytoskeleton and promoted the random protrusion and retraction of the leading edge. Productive cell advance was a function of the second colocalized network, the lamella, where actomyosin contraction was integrated with substrate adhesion.	Scripps Res Inst TSRI, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Waterman-Storer, CM (corresponding author), Scripps Res Inst TSRI, Dept Cell Biol, La Jolla, CA 92037 USA.	waterman@scripps.edu; gdanuser@scripps.edu		Danuser, Gaudenz/0000-0001-8583-2014; Waterman, Clare/0000-0001-6142-6775	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067230, U01GM067230] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM67230] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abraham VC, 1999, BIOPHYS J, V77, P1721, DOI 10.1016/S0006-3495(99)77018-9; Cramer LP, 1999, CURR BIOL, V9, P1095, DOI 10.1016/S0960-9822(99)80478-3; Danuser G, 2003, J MICROSC-OXFORD, V211, P191, DOI 10.1046/j.1365-2818.2003.01222.x; Fischer RS, 2003, J CELL BIOL, V161, P371, DOI 10.1083/jcb.200209057; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Higashida C, 2004, SCIENCE, V303, P2007, DOI 10.1126/science.1093923; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Ponti A, 2003, BIOPHYS J, V84, P3336, DOI 10.1016/S0006-3495(03)70058-7; SAMPATH P, 1991, BIOCHEMISTRY-US, V30, P1973, DOI 10.1021/bi00221a034; Small JV, 1999, CURR OPIN CELL BIOL, V11, P54, DOI 10.1016/S0955-0674(99)80007-6; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; Vallotton P, 2003, BIOPHYS J, V85, P1289, DOI 10.1016/S0006-3495(03)74564-0; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057	18	578	587	2	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1782	1786		10.1126/science.1100533	http://dx.doi.org/10.1126/science.1100533			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	856IS	15375270				2022-12-24	WOS:000224039500044
J	Quigley, JG; Yang, ZT; Worthington, MT; Phillips, JD; Sabo, KM; Sabath, DE; Berg, CL; Sassa, S; Wood, BL; Abkowitz, JL				Quigley, JG; Yang, ZT; Worthington, MT; Phillips, JD; Sabo, KM; Sabath, DE; Berg, CL; Sassa, S; Wood, BL; Abkowitz, JL			Identification of a human heme exporter that is essential for erythropoiesis	CELL			English	Article							FELINE LEUKEMIA-VIRUS; RED-CELL APLASIA; SUBGROUP-C; BINDING PROTEIN; ERYTHROID-DIFFERENTIATION; ERYTHROLEUKEMIA-CELLS; ANEMIA RETROVIRUS; SURFACE RECEPTOR; IRON; TRANSPORTER	FLVCR, a member of the major facilitator superfamily of transporter proteins, is the cell surface receptor for feline leukemia virus, subgroup C. Retroviral interference with FLVCR display results in a loss of erythroid progenitors (colony-forming units-erythroid, CFU-E) and severe anemia in cats. In this report, we demonstrate that human FLVCR exports cytoplasmic heme and hypothesize that human FLVCR is required on developing erythroid cells to protect them from heme toxicity. Inhibition of FLVCR in K562 cells decreases heme export, impairs their erythroid maturation and leads to apoptosis. FLVCR is upregulated on CFU-E, indicating that heme export is important in primary cells at this stage. Studies of FLVCR expression in cell lines suggest this exporter also impacts heme trafficking in intestine and liver. To our knowledge, this is the first description of a mammalian heme transporter.	Univ Washington, Dept Med Hematol, Seattle, WA 98195 USA; Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; Univ Virginia, Dept Med Gastroenterol, Charlottesville, VA 22908 USA; Univ Utah, Dept Med, Salt Lake City, UT 84132 USA; Rockefeller Univ, Lab Biochem Hematol, New York, NY 10021 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Virginia; Utah System of Higher Education; University of Utah; Rockefeller University	Abkowitz, JL (corresponding author), Univ Washington, Dept Med Hematol, Seattle, WA 98195 USA.	janabk@u.washington.edu	Quigley, John/X-4366-2019	quigley, john/0000-0003-3116-4545	NCRR NIH HHS [RR00037] Funding Source: Medline; NHLBI NIH HHS [HL31823] Funding Source: Medline; NIDDK NIH HHS [DK32890, R01 DK020503, DK20503] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL031823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK020503, R37DK020503, R01DK032890] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abbott BL, 2003, HEMATOL ONCOL, V21, P115, DOI 10.1002/hon.714; ABKOWITZ JL, 1987, J CLIN INVEST, V80, P1056, DOI 10.1172/JCI113160; BENZ EJ, 1980, P NATL ACAD SCI-BIOL, V77, P3509, DOI 10.1073/pnas.77.6.3509; Blackmon BJ, 2002, ARCH BIOCHEM BIOPHYS, V407, P196, DOI 10.1016/S0003-9861(02)00471-X; BORSOOK H, 1969, BLOOD-J HEMATOL, V34, P32, DOI 10.1182/blood.V34.1.32.32; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; CARPENTER CE, 1992, CRIT REV FOOD SCI, V31, P333, DOI 10.1080/10408399209527576; Charles RJ, 1996, BLOOD, V87, P4831, DOI 10.1182/blood.V87.11.4831.bloodjournal87114831; DEAN GA, 1992, J VIROL, V66, P5561, DOI 10.1128/JVI.66.9.5561-5568.1992; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; FUJITA H, 1989, BRIT J HAEMATOL, V73, P557, DOI 10.1111/j.1365-2141.1989.tb00297.x; GALBRAITH RA, 1990, J HEPATOL, V10, P305, DOI 10.1016/0168-8278(90)90137-G; Harlow E, 1988, ANTIBODIES LAB MANUA; HOLDEN SA, 1983, EXP HEMATOL, V11, P953; IBRAHIM NG, 1982, BRIT J HAEMATOL, V50, P17, DOI 10.1111/j.1365-2141.1982.tb01886.x; IWAHARA S, 1995, BIOCHEMISTRY-US, V34, P13398, DOI 10.1021/bi00041a017; Jonker JW, 2002, P NATL ACAD SCI USA, V99, P15649, DOI 10.1073/pnas.202607599; KINNESAFFRAN E, 1989, METHOD ENZYMOL, V172, P3; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Lipovich L, 2002, GENE, V286, P203, DOI 10.1016/S0378-1119(02)00457-2; LUBBEN M, 1994, J BIOL CHEM, V269, P21473; Mitchell BA, 1999, J BIOL CHEM, V274, P3541, DOI 10.1074/jbc.274.6.3541; Nakajima O, 1999, EMBO J, V18, P6282, DOI 10.1093/emboj/18.22.6282; NEYFAKH AA, 1991, P NATL ACAD SCI USA, V88, P4781, DOI 10.1073/pnas.88.11.4781; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; ONIONS D, 1982, NATURE, V296, P156, DOI 10.1038/296156a0; PAO SS, 1994, MICROBIOL MOL BIOL R, V62, P1; PAPAYANNOPOULOU T, 1987, BLOOD, V70, P1764; PONKA P, 1982, BIOCHIM BIOPHYS ACTA, V720, P96, DOI 10.1016/0167-4889(82)90043-X; Ponka P, 1997, BLOOD, V89, P1; Quigley JG, 2000, BLOOD, V95, P1093, DOI 10.1182/blood.V95.3.1093.003k01_1093_1099; Rafie-Kolpin M, 2000, J BIOL CHEM, V275, P5171, DOI 10.1074/jbc.275.7.5171; RIEDEL N, 1988, P NATL ACAD SCI USA, V85, P2758, DOI 10.1073/pnas.85.8.2758; RIEDEL N, 1986, J VIROL, V60, P242, DOI 10.1128/JVI.60.1.242-250.1986; RIGBY MA, 1992, J GEN VIROL, V73, P2839, DOI 10.1099/0022-1317-73-11-2839; Rudra-Ganguly N, 1998, BBA-GENE STRUCT EXPR, V1443, P407, DOI 10.1016/S0167-4781(98)00241-3; RUTHERFORD TR, 1979, NATURE, V280, P164, DOI 10.1038/280164a0; Ryter SW, 2000, FREE RADICAL BIO MED, V28, P289, DOI 10.1016/S0891-5849(99)00223-3; SASSA S, 1976, J EXP MED, V143, P305, DOI 10.1084/jem.143.2.305; Smith K.M., 1975, PORPHYRINS METALLOPO; Tailor CS, 1999, J VIROL, V73, P6500, DOI 10.1128/JVI.73.8.6500-6505.1999; Taketani S, 1998, J BIOL CHEM, V273, P31388, DOI 10.1074/jbc.273.47.31388; TAKEUCHI Y, 1992, J VIROL, V66, P1219, DOI 10.1128/JVI.66.2.1219-1222.1992; Uzel C, 1998, SEMIN HEMATOL, V35, P27; Wandersman C, 2000, CURR OPIN MICROBIOL, V3, P215, DOI 10.1016/S1369-5274(00)00078-3; WARDROP KJ, 1986, AM J VET RES, V47, P2274; WEISS RA, 1995, CELL, V82, P531, DOI 10.1016/0092-8674(95)90024-1; WICKREMA A, 1992, BLOOD, V80, P1940, DOI 10.1182/blood.V80.8.1940.1940; Worthington MT, 2001, AM J PHYSIOL-GASTR L, V280, pG1172, DOI 10.1152/ajpgi.2001.280.6.G1172	49	307	320	3	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2004	118	6					757	766		10.1016/j.cell.2004.08.014	http://dx.doi.org/10.1016/j.cell.2004.08.014			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	855RW	15369674	Bronze			2022-12-24	WOS:000223992400011
J	Singh, JA				Singh, JA			Standards of care in the antiretroviral rollout world	LANCET			English	Editorial Material							PERINATAL TRANSMISSION; TRIALS		CAPRISA, Durban, South Africa; Univ KwaZulu Natal, Howard Coll, Sch Law, ZA-4041 Durban, South Africa; Univ Toronto, Joint Ctr Bioeth, Toronto, ON, Canada	University of Kwazulu Natal; University of Toronto	Singh, JA (corresponding author), CAPRISA, Durban, South Africa.	singhj9@ukzn.ac.za	Singh, Jerome Amir/ABG-1573-2021					Angell M, 1997, NEW ENGL J MED, V337, P847, DOI 10.1056/NEJM199709183371209; Council for International Organizations of Medical Sciences WHO, 2002, INT ETH GUID BIOM RE; hhs, 1979, BELM REP ETH PRINC G; Institute of Medicine, 2004, SCAL TREATM GLOB AID; Karim SSA, 1998, AM J PUBLIC HEALTH, V88, P564, DOI 10.2105/AJPH.88.4.564; Lurie P, 1997, NEW ENGL J MED, V337, P853, DOI 10.1056/NEJM199709183371212; *OHCHR UNAIDS, HIV AIDS HUM RIGHTS; *TREATM ACT CAMP A, 2004, 1 TREATM ACT CAMP AI; *WHO, TREAT 3 MILL 2005 MA; *WHO, 2003, SCAL ANT THER RES SE; *WHO, 2004, 3 5 PROGR REP; World Medical Association, DECL HELS ETH PRINC	12	5	5	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 11	2004	364	9438					920	922		10.1016/S0140-6736(04)17040-2	http://dx.doi.org/10.1016/S0140-6736(04)17040-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853MF	15364176				2022-12-24	WOS:000223831000009
J	Meng, QJ; Liu, JY; Varricchio, DJ; Huang, T; Gao, CL				Meng, QJ; Liu, JY; Varricchio, DJ; Huang, T; Gao, CL			Parental care in an ornithischian dinosaur	NATURE			English	Article							BIRDS		Dalian Nat Hist Museum, Dalian, Peoples R China; Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA; Paleo World Res Fdn, Asian Operat B122 2, Taipei 106, Taiwan	Montana State University System; Montana State University Bozeman	Meng, QJ (corresponding author), Dalian Nat Hist Museum, 40 Xicun St, Dalian, Peoples R China.	djv@montana.edu		Huang, Timothy/0000-0001-5381-2596				[Anonymous], 1985, NATL GEOGRAPHIC SOC; Bakker RT, 2004, LIFE O PAST, P301; Carpenter K., 1999, EGGS NESTS BABY DINO; Erickson GM, 2000, ZOOL J LINN SOC-LOND, V130, P551, DOI 10.1006/zjls.2000.0243; Geist NR, 1996, SCIENCE, V272, P712, DOI 10.1126/science.272.5262.712; Gill FB, 1990, ORNITHOLOGY; Groenewald GH, 2001, PALAIOS, V16, P148, DOI 10.2307/3515526; Horner JR, 2000, ANNU REV EARTH PL SC, V28, P19, DOI 10.1146/annurev.earth.28.1.19; Kavanau JL., 1987, LOVEBIRDS COCKATIELS; MAGNUSSON WE, 1989, REPROD CROCODILES AL, P118; Tullberg BS, 2002, PHILOS T R SOC B, V357, P251, DOI 10.1098/rstb.2001.0932; WESOLOWSKI T, 1994, AM NAT, V143, P39, DOI 10.1086/285595; Zhou ZH, 2003, NATURE, V421, P807, DOI 10.1038/nature01420	13	70	76	2	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 9	2004	431	7005					145	146		10.1038/431145a	http://dx.doi.org/10.1038/431145a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HI	15356619	Green Published			2022-12-24	WOS:000223746000032
J	Salic, A; Waters, JC; Mitchison, TJ				Salic, A; Waters, JC; Mitchison, TJ			Vertebrate shugoshin links sister centromere cohesion and kinetochore microtubule stability in mitosis	CELL			English	Article							MEIOSIS-I; CHROMOSOME CONGRESSION; CHROMATID COHESION; AURORA-B; CENP-E; SPINDLE; ANAPHASE; PROTEIN; ATTACHMENT; CLEAVAGE	Drosophila MEI-S332 and fungal Sgo1 genes are essential for sister centromere cohesion in meiosis I. We demonstrate that the related vertebrate Sgo localizes to kinetochores and is required to prevent premature sister centromere separation in mitosis, thus providing an explanation for the differential cohesion observed between the arms and the centromeres of mitotic sister chromatids. Sgo is degraded by the anaphase-promoting complex, allowing the separation of sister centromeres in anaphase. Intriguingly, we show that Sgo interacts strongly with microtubules in vitro and that it regulates kinetochore microtubule stability in vivo, consistent with a direct microtubule interaction. Sgo is thus critical for mitotic progression and chromosome segregation and provides an unexpected link between sister centromere cohesion and microtubule interactions at kinetochores.	Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Salic, A (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, 240 Longwood Ave, Boston, MA 02115 USA.	adrian_salic@hms.harvard.edu	Salic, Adrian/GXG-1611-2022					Buonomo SBC, 2000, CELL, V103, P387, DOI 10.1016/S0092-8674(00)00131-8; Carninci P, 2000, GENOME RES, V10, P1617, DOI 10.1101/gr.145100; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; DeLuca JG, 2002, J CELL BIOL, V159, P549, DOI 10.1083/jcb.200208159; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Funabiki H, 2000, CELL, V102, P411, DOI 10.1016/S0092-8674(00)00047-7; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376; Katis VL, 2004, CURR BIOL, V14, P560, DOI 10.1016/j.cub.2004.03.001; KERREBROCK AW, 1995, CELL, V83, P247, DOI 10.1016/0092-8674(95)90166-3; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; LI XT, 1995, NATURE, V373, P630, DOI 10.1038/373630a0; Marston AL, 2004, SCIENCE, V303, P1367, DOI 10.1126/science.1094220; Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596; McCleland ML, 2003, GENE DEV, V17, P101, DOI 10.1101/gad.1040903; McEwen BF, 1998, CHROMOSOMA, V107, P366, DOI 10.1007/s004120050320; MITCHISON TJ, 1989, J CELL BIOL, V109, P637, DOI 10.1083/jcb.109.2.637; Moore DP, 1998, J CELL BIOL, V140, P1003, DOI 10.1083/jcb.140.5.1003; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Rabitsch KP, 2004, CURR BIOL, V14, P287, DOI 10.1016/j.cub.2004.01.051; RATTNER JB, 1993, CELL MOTIL CYTOSKEL, V26, P214, DOI 10.1002/cm.970260305; Rieder CL, 1999, J CELL SCI, V112, P2607; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Scanlan M J, 2001, Cancer Immun, V1, P4; SKIBBENS RV, 1993, J CELL BIOL, V122, P859, DOI 10.1083/jcb.122.4.859; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Taylor SS, 1997, CELL, V89, P727, DOI 10.1016/S0092-8674(00)80255-X; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Vagnarelli P, 2004, EMBO REP, V5, P167, DOI 10.1038/sj.embor.7400077; Waters JC, 1999, CURR BIOL, V9, P649, DOI 10.1016/S0960-9822(99)80287-5; Waters JC, 1996, J CELL SCI, V109, P2823; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; ZHAI Y, 1995, J CELL BIOL, V131, P721, DOI 10.1083/jcb.131.3.721	37	250	255	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 3	2004	118	5					567	578		10.1016/j.cell.2004.08.016	http://dx.doi.org/10.1016/j.cell.2004.08.016			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852BN	15339662	Bronze			2022-12-24	WOS:000223730300008
J	Stroud, RM; Nittler, LR; Alexander, CMO				Stroud, RM; Nittler, LR; Alexander, CMO			Polymorphism in presolar Al2O3 grains from asymptotic giant branch stars	SCIENCE			English	Article							TRANSMISSION ELECTRON-MICROSCOPY; DUST FEATURES; AMORPHIZATION; GRAPHITE; EMISSION; SPECTRA; ORIGIN; GAS	We report microstructural and isotopic analyses of two presolar Al2O3 grains. Aluminum oxide is important cosmically, because its presence has been detected in the infrared spectra of the circumstellar envelopes of O-rich asymptotic giant branch stars and because it is predicted to be the first solid to condense in these stellar environments. The two grain structures, one corundum and the other amorphous, confirm that asymptotic giant branch stars produce both phases. The variation in structure and Ti content demonstrates that Al2O3 can condense in the absence of TiO2 seed clusters but that Ti may be important in determining the crystal structure.	USN, Res Lab, Washington, DC 20375 USA; Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA	United States Department of Defense; United States Navy; Naval Research Laboratory; Carnegie Institution for Science	Stroud, RM (corresponding author), USN, Res Lab, Code 6360, Washington, DC 20375 USA.	stroud@nrl.navy.mil	Stroud, Rhonda M/S-4584-2018; Alexander, Conel M. O'D./N-7533-2013; Stroud, Rhonda M./C-5503-2008; Stroud, Rhonda/GQZ-0151-2022	Stroud, Rhonda M/0000-0001-5242-8015; Alexander, Conel M. O'D./0000-0002-8558-1427; Stroud, Rhonda M./0000-0001-5242-8015; Stroud, Rhonda/0000-0001-5242-8015				Bernatowicz TJ, 1996, ASTROPHYS J, V472, P760, DOI 10.1086/178105; Boothroyd AI, 1999, ASTROPHYS J, V510, P232, DOI 10.1086/306546; Choi BG, 1998, SCIENCE, V282, P1284, DOI 10.1126/science.282.5392.1284; Clayton DD, 2004, ANNU REV ASTRON ASTR, V42, P39, DOI 10.1146/annurev.astro.42.053102.134022; Croat TK, 2003, GEOCHIM COSMOCHIM AC, V67, P4705, DOI 10.1016/S0016-7037(03)00463-0; Daulton TL, 2002, SCIENCE, V296, P1852, DOI 10.1126/science.1071136; Daulton TL, 1996, GEOCHIM COSMOCHIM AC, V60, P4853, DOI 10.1016/S0016-7037(96)00223-2; Draine BT, 2003, ANNU REV ASTRON ASTR, V41, P241, DOI 10.1146/annurev.astro.41.011802.094840; Dwek E, 1996, ASTROPHYS J, V457, P244, DOI 10.1086/176725; Gail HP, 1998, FARADAY DISCUSS, V109, P303, DOI 10.1039/a709290c; Gail HP, 2003, LECT NOTES PHYS, V609, P55; Glaccum W, 1995, ASTR SOC P, V73, P395; Heaney PJ, 2001, AM MINERAL, V86, P1094; Jager C, 2003, ASTRON ASTROPHYS, V401, P57, DOI 10.1051/0004-6361:20030002; Jeong KS, 1999, IAU SYMP, P233; Jones AP, 1996, ASTROPHYS J, V469, P740, DOI 10.1086/177823; Lee MR, 2003, MINERAL MAG, V67, P581, DOI 10.1180/0026461036730119; Levin I, 1998, J AM CERAM SOC, V81, P1995; LITTLEMARENIN IR, 1986, 88342 NASA, P137; Lodders K, 1999, IAU SYMP, P279; Lodders K, 1997, AIP CONF PROC, P391, DOI 10.1063/1.53317; Nittler LR, 1997, ASTROPHYS J, V483, P475, DOI 10.1086/304234; Nittler LR, 2003, EARTH PLANET SC LETT, V209, P259, DOI 10.1016/S0012-821X(02)01153-6; NITTLER LR, 2001, METEORIT PLANET SCI, V36, pA149; Posch T, 1999, ASTRON ASTROPHYS, V352, P609; SALPETER EE, 1977, ANNU REV ASTRON ASTR, V15, P267, DOI 10.1146/annurev.aa.15.090177.001411; Sloan GC, 2003, ASTROPHYS J, V594, P483, DOI 10.1086/376857; Sogawa H, 1999, ASTROPHYS J, V516, pL33, DOI 10.1086/311992; Speck AK, 2000, ASTRON ASTROPHYS SUP, V146, P437, DOI 10.1051/aas:2000274; Stround RM, 2002, METEORIT PLANET SCI, V37, pA137; TIELENS AGGM, 1994, ASTROPHYS J, V431, P321, DOI 10.1086/174488; TIELENS AGGM, 1990, FROM MIRAS TO PLANETARY NEBULAE : WHICH PATH FOR STELLAR EVOLUTION ?, P186; Wang SX, 1997, J APPL PHYS, V81, P587, DOI 10.1063/1.364219; Zinkle SJ, 1996, NUCL INSTRUM METH B, V116, P92, DOI 10.1016/0168-583X(96)00016-X; Zinner E, 1998, ANNU REV EARTH PL SC, V26, P147, DOI 10.1146/annurev.earth.26.1.147	35	79	79	2	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2004	305	5689					1455	1457		10.1126/science.1101099	http://dx.doi.org/10.1126/science.1101099			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852NK	15353800				2022-12-24	WOS:000223761900046
J	Levine, F; Mercola, M				Levine, F; Mercola, M			No pancreatic endocrine stem cells?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BETA-CELLS		Burnham Inst, San Diego, CA USA; Univ Calif San Diego, San Diego, CA 92103 USA	University of California System; University of California San Diego	Levine, F (corresponding author), Burnham Inst, San Diego, CA USA.		Levine, Fred/L-2693-2013	Levine, Fred/0000-0002-7336-2526				BONNERWEIR S, 1993, DIABETES, V42, P1715, DOI 10.2337/diabetes.42.12.1715; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Guo CY, 2002, GENESIS, V32, P8, DOI 10.1002/gene.10021; Halvorsen TL, 2000, J ENDOCRINOL, V166, P103, DOI 10.1677/joe.0.1660103; HAYEK A, 1995, DIABETES, V44, P1458, DOI 10.2337/diabetes.44.12.1458	5	9	13	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 2	2004	351	10					1024	1026		10.1056/NEJMcibr041779	http://dx.doi.org/10.1056/NEJMcibr041779			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	850UB	15342812				2022-12-24	WOS:000223637400015
J	Pawlak, DB; Kushner, JA; Ludwig, DS				Pawlak, DB; Kushner, JA; Ludwig, DS			Effects of dietary glycaemic index on adiposity, glucose homoeostasis, and plasma lipids in animals	LANCET			English	Article							INSULIN-RESISTANCE; OBESITY; RISK; ADIPONECTIN; LOAD; FAT; SECRETION; PROFILE; FIBER; RATS	Background Clinical studies suggest a role for dietary glycaemic index (GI) in bodyweight regulation and diabetes risk. However, partly because manipulation of GI can produce changes in potentially confounding dietary factors such as fibre content, palatability, and energy density, its relevance to human health remains controversial. This study examined the independent effects of GI in animals. Methods Partially pancreatectomised male Sprague-Dawley rats were given diets with identical nutrients, except for the type of starch: high-GI (n=11) or low-GI (n=10). The animals were fed in a controlled way to maintain the same mean bodyweight in the two groups for 18 weeks. Further experiments examined the effects of GI in rats in a crossover design and C57BL/6J mice in a parallel design. Findings Despite having similar mean bodyweight (547.9 [SE 13.4] vs 549.2 [15.2] g), rats given high-GI food had more body fat (97.8 [13.6] vs 57.3 [7.2] g; p=0.0152) and less lean body mass (450.1 [9.6] vs 491.9 [11.7] g; p=0.0120) than those given low-GI food. The high-GI group also had greater increases over time in the areas under the curve for blood glucose and plasma insulin after oral glucose, lower plasma adiponectin concentrations, higher plasma triglyceride concentrations, and severe disruption of islet-cell architecture. Mice on the high-GI diet had almost twice the body fat of those on the low-GI diet after 9 weeks. Interpretation These findings provide a mechanistic basis for interpretation of studies of GI in human beings. Relevance to practice The term GI describes how a food, meal, or diet affects blood sugar during the postprandial. period. GI as an independent factor can cause obesity and increase risks of diabetes and heart disease in animals. Use of low-GI diets in prevention and treatment of human disease merits thorough examination.	Childrens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Ludwig, DS (corresponding author), Childrens Hosp, Dept Med, 300 Longwood Ave, Boston, MA 02115 USA.	david.ludwig@childrens.harvard.edu	Kushner, Jake A/AAF-5049-2022; Kushner, Jake A/AFJ-8198-2022	Kushner, Jake A/0000-0002-3646-1744; Kushner, Jake A/0000-0002-3646-1744; Ludwig, David/0000-0003-3307-8544	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007277] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059240] Funding Source: NIH RePORTER; NICHD NIH HHS [T32HD07277] Funding Source: Medline; NIDDK NIH HHS [1R01DK059240] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bouche C, 2002, DIABETES CARE, V25, P822, DOI 10.2337/diacare.25.5.822; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; CUMMINGS JH, 1995, AM J CLIN NUTR, V61, p938S, DOI 10.1093/ajcn/61.4.938S; Cusin Isabelle, 1992, International Journal of Obesity, V16, pS1; Finegood DT, 2001, DIABETES, V50, P1021, DOI 10.2337/diabetes.50.5.1021; FROST G, 1994, DIABETIC MED, V11, P397, DOI 10.1111/j.1464-5491.1994.tb00292.x; JENKINS DJA, 1987, AM J CLIN NUTR, V46, P968, DOI 10.1093/ajcn/46.6.968; Kabir M, 1998, J NUTR, V128, P35, DOI 10.1093/jn/128.1.35; Kim JK, 2000, J CLIN INVEST, V105, P1791, DOI 10.1172/JCI8305; KLOPPEL G, SURV SYNTH PATHOL RE, V4, P110; Koyama M, 1998, AM J PATHOL, V153, P537, DOI 10.1016/S0002-9440(10)65596-4; Kushner JA, 2002, J CLIN INVEST, V109, P1193, DOI 10.1172/JCI200214439; LAJVARDI A, 1993, J NUTR, V123, P2059; LEAHY JL, 1988, J CLIN INVEST, V81, P1407, DOI 10.1172/JCI113470; LererMetzger M, 1996, BRIT J NUTR, V75, P723, DOI 10.1079/BJN19960176; Liu SM, 2000, AM J CLIN NUTR, V71, P1455; Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414; Ludwig DS, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.3.e26; Morita T, 1999, J NUTR, V129, P2081, DOI 10.1093/jn/129.11.2081; OSCAI LB, 1982, AM J PHYSIOL, V242, pR212, DOI 10.1152/ajpregu.1982.242.3.R212; PIROZZO S, 2002, COCHRANE LIB; RASTOGI GK, 1973, DIABETES, V22, P804, DOI 10.2337/diab.22.11.804; ROTHWELL NJ, 1979, BRIT J NUTR, V41, P625, DOI 10.1079/BJN19790078; Salmeron J, 1997, JAMA-J AM MED ASSOC, V277, P472, DOI 10.1001/jama.277.6.472; Salmeron J, 1997, DIABETES CARE, V20, P545, DOI 10.2337/diacare.20.4.545; Senn S, 2002, CROSS OVER TRIALS CL; Song SH, 2003, ENDOCRINOLOGY, V144, P3399, DOI 10.1210/en.2003-0056; Spieth LE, 2000, ARCH PEDIAT ADOL MED, V154, P947, DOI 10.1001/archpedi.154.9.947; Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6; TISAVIPAT A, 1974, J APPL PHYSIOL, V37, P699, DOI 10.1152/jappl.1974.37.5.699; West DB, 1998, AM J CLIN NUTR, V67, p505S, DOI 10.1093/ajcn/67.3.505S; Willett W C, 2002, Obes Rev, V3, P59, DOI 10.1046/j.1467-789X.2002.00060.x; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Zietz B, 2003, FEBS LETT, V545, P103, DOI 10.1016/S0014-5793(03)00568-4	34	234	240	2	39	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 28	2004	364	9436					778	785		10.1016/S0140-6736(04)16937-7	http://dx.doi.org/10.1016/S0140-6736(04)16937-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	849VO	15337404				2022-12-24	WOS:000223569600029
J	Morris, KV; Chan, SWL; Jacobsen, SE; Looney, DJ				Morris, KV; Chan, SWL; Jacobsen, SE; Looney, DJ			Small interfering RNA-induced transcriptional gene silencing in human cells	SCIENCE			English	Article							NOVO DNA METHYLATION; ELONGATION FACTOR-1-ALPHA; NUCLEAR EXPORT; HAIRPIN RNAS; METHYLTRANSFERASES; HETEROCHROMATIN; MAINTENANCE; DROSOPHILA; MICRORNAS; MECHANISM	Small interfering RNA (siRNA) and rnicroRNA silence genes at the transcriptional, posttranscriptional, and/or translational level. Using human tissue culture cells, we show that promoter-directed siRNA inhibits transcription of an integrated, proviral, elongation factor 1 alpha (EF1A) promoter-green fluorescent protein reporter gene and of endogenous EF1A. Silencing was associated with DNA methylation of the targeted sequence, and it required either active transport of siRNA into the nucleus or permeabilization of the nuclear envelope by lentiviral transduction. These results demonstrate that siRNA-directed transcriptional silencing is conserved in mammals, providing a means to inhibit mammalian gene function.	Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; VA San Diego Healthcare Syst, Infect Dis, San Diego, CA 92161 USA	University of California System; University of California San Diego; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Morris, KV (corresponding author), Beckman Res Inst, Div Mol Biol, 1450 E Duarte Rd, Duarte, CA 91010 USA.	kmorris@coh.org	morris, kevin v/B-5481-2011	Morris, Kevin/0000-0002-0157-0553	NIAID NIH HHS [P01 AI45992, P30 AI36214, AI07384] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI045992, P30AI036214] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Cao XF, 2003, CURR BIOL, V13, P2212, DOI 10.1016/j.cub.2003.11.052; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Chan SWL, 2004, SCIENCE, V303, P1336, DOI 10.1126/science.1095989; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Jones L, 2001, CURR BIOL, V11, P747, DOI 10.1016/S0960-9822(01)00226-3; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Matzke M, 2001, SCIENCE, V293, P1080, DOI 10.1126/science.1063051; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Morris KV, 2004, MOL THER, V10, P181, DOI 10.1016/j.ymthe.2004.03.019; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pal-Bhadra M, 2004, SCIENCE, V303, P669, DOI 10.1126/science.1092653; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Schramke V, 2003, SCIENCE, V301, P1069, DOI 10.1126/science.1086870; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Sherman MP, 2002, MICROBES INFECT, V4, P67, DOI 10.1016/S1286-4579(01)01511-8; Sijen T, 2001, CURR BIOL, V11, P436, DOI 10.1016/S0960-9822(01)00116-6; Simeoni F, 2003, NUCLEIC ACIDS RES, V31, P2717, DOI 10.1093/nar/gkg385; Tijsterman M, 2002, ANNU REV GENET, V36, P489, DOI 10.1146/annurev.genet.36.043002.091619; Tufarelli C, 2003, NAT GENET, V34, P157, DOI 10.1038/ng1157; UETSUKI T, 1989, J BIOL CHEM, V264, P5791; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; WAKABAYASHIITO N, 1994, J BIOL CHEM, V269, P29831; WASSENEGGER M, 1994, CELL, V76, P567, DOI 10.1016/0092-8674(94)90119-8; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	31	746	844	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 27	2004	305	5688					1289	1292		10.1126/science.1101372	http://dx.doi.org/10.1126/science.1101372			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850PJ	15297624				2022-12-24	WOS:000223624600041
J	Harfe, BD; Scherz, PJ; Nissim, S; Tian, F; McMahon, AP; Tabin, CJ				Harfe, BD; Scherz, PJ; Nissim, S; Tian, F; McMahon, AP; Tabin, CJ			Evidence for an expansion-based temporal Shh gradient in specifying vertebrate digit identities	CELL			English	Article							DEVELOPING CHICK LIMB; SONIC-HEDGEHOG; RETINOIC ACID; POLARIZING ACTIVITY; SIGNALING ACTIVITY; LOCAL APPLICATION; REPORTER STRAIN; FEEDBACK LOOP; LONG-RANGE; EXPRESSION	The zone of polarizing activity (ZPA) in the posterior limb bud produces Sonic Hedgehog (Shh) protein, which plays a critical role in establishing distinct fates along the anterior-posterior axis. This activity has been modeled as a concentration-dependent response to a diffusible morphogen. Using recombinase base mapping in the mouse, we determine the ultimate fate of the Shh-producing cells. Strikingly, the descendants of the Shh-producing cells encompass all cells in the two most posterior digits and also contribute to the middle digit. Our analysis suggests that, while specification of the anterior digits depends upon differential concentrations of Shh, the length of time of exposure to Shh is critical in the specification of the differences between the most posterior digits. Genetic studies of the effects of limiting accessibility of Shh within the limb support this, model, in which the effect of the Shh morphogen is dictated by a temporal as well as a spatial gradient.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; Harvard Univ, Biolabs, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; State University System of Florida; University of Florida; Harvard University	Tabin, CJ (corresponding author), Harvard Univ, Sch Med, Dept Genet, NRB Room 360,77 Ave Louis Pasteur, Boston, MA 02115 USA.	tabin@genetics.med.harvard.edu	McMahon, Andrew P/ABE-7520-2020	Nissim, Sahar/0000-0002-2303-6415	NIAMS NIH HHS [AR08642] Funding Source: Medline; NICHD NIH HHS [HD32443] Funding Source: Medline; NINDS NIH HHS [NS33642] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032443, R01HD032443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR008642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS033642, R01NS033642] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Burke R, 1999, CELL, V99, P803, DOI 10.1016/S0092-8674(00)81677-3; Caspary T, 2002, CURR BIOL, V12, P1628, DOI 10.1016/S0960-9822(02)01147-8; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Drossopoulou G, 2000, DEVELOPMENT, V127, P1337; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; FRANCIS PH, 1994, DEVELOPMENT, V120, P209; Goff DJ, 1997, DEVELOPMENT, V124, P627; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Guo QX, 2003, DEV BIOL, V264, P166, DOI 10.1016/j.ydbio.2003.08.012; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HELMS J, 1994, DEVELOPMENT, V120, P3267; Karp SJ, 2000, DEVELOPMENT, V127, P543; Kraus P, 2001, MECH DEVELOP, V100, P45, DOI 10.1016/S0925-4773(00)00492-5; LAUFER E, 1994, CELL, V79, P993, DOI 10.1016/0092-8674(94)90030-2; Le YZ, 1999, ANAL BIOCHEM, V270, P334, DOI 10.1006/abio.1999.4110; Leone DP, 2003, MOL CELL NEUROSCI, V22, P430, DOI 10.1016/S1044-7431(03)00029-0; Lewis PM, 2001, CELL, V105, P599, DOI 10.1016/S0092-8674(01)00369-5; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; LOPEZMARTINEZ A, 1995, CURR BIOL, V5, P791, DOI 10.1016/S0960-9822(95)00156-4; Ma Y, 2002, CELL, V111, P63, DOI 10.1016/S0092-8674(02)00977-7; Mao XH, 1999, P NATL ACAD SCI USA, V96, P5037, DOI 10.1073/pnas.96.9.5037; Marigo V, 1996, DEV BIOL, V180, P273, DOI 10.1006/dbio.1996.0300; Marigo V, 1996, DEVELOPMENT, V122, P1225; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Murtaugh LC, 1999, GENE DEV, V13, P225, DOI 10.1101/gad.13.2.225; NISWANDER L, 1994, NATURE, V371, P609, DOI 10.1038/371609a0; Park HL, 2000, DEVELOPMENT, V127, P1593; Pathi S, 2001, MECH DEVELOP, V106, P107, DOI 10.1016/S0925-4773(01)00427-0; Pearse RV, 2001, DEV BIOL, V239, P15, DOI 10.1006/dbio.2001.0430; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Sanz-Ezquerro JJ, 2000, DEVELOPMENT, V127, P4811; Saunders J. W., 1968, EPITHELIAL MESENCHYM, P78; Saunders J.W., 1967, MAJOR PROBLEMS DEV B, P289; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SUMMERBELL D, 1983, J EMBRYOL EXP MORPH, V78, P269; TIAN H, 2004, IN PRESS DEVELOPEMEN; TICKLE C, 1981, NATURE, V289, P295, DOI 10.1038/289295a0; TICKLE C, 1982, NATURE, V296, P564, DOI 10.1038/296564a0; TICKLE C, 1975, NATURE, V254, P199, DOI 10.1038/254199a0; TICKLE C, 1995, CURR OPIN GENET DEV, V5, P478, DOI 10.1016/0959-437X(95)90052-I; Vargesson N, 1997, DEVELOPMENT, V124, P1909; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wilkinson DG, 1992, WHOLE MOUNT IN SITU, P75; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Yang Y, 1997, DEVELOPMENT, V124, P4393	46	730	742	3	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2004	118	4					517	528		10.1016/j.cell.2004.07.024	http://dx.doi.org/10.1016/j.cell.2004.07.024			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	850YS	15315763	Bronze			2022-12-24	WOS:000223650900013
J	Kozar, K; Ciemerych, MA; Rebel, VI; Shigematsu, H; Zagozdon, A; Sicinska, E; Geng, Y; Yu, QY; Bhattacharya, S; Bronson, RT; Akashi, K; Sicinski, P				Kozar, K; Ciemerych, MA; Rebel, VI; Shigematsu, H; Zagozdon, A; Sicinska, E; Geng, Y; Yu, QY; Bhattacharya, S; Bronson, RT; Akashi, K; Sicinski, P			Mouse development and cell proliferation in the absence of D-cyclins	CELL			English	Article							HEMATOPOIETIC STEM-CELLS; RETINOBLASTOMA PROTEIN; DEPENDENT KINASES; CDK INHIBITORS; MICE; PROGRESSION; PROGENITOR; P27(KIP1); BMI-1; PHOSPHORYLATION	D-type cyclins (cyclins D1, D2, and D3 are regarded as essential links between cell environment and the core cell cycle machinery. We tested the requirement for D-cyclins in mouse development and in proliferation by generating mice lacking all D-cyclins. We found that these cyclin D1(-/-)D2(-/-)D3(-/-) mice develop until mid/late gestation and die due to heart abnormalities combined with a severe anemia. Our analyses revealed that the D-cyclin; are critically required for the expansion of hematopoietic stem cells. In contrast, cyclin D-deficient fibroblasts proliferate nearly normally but show increased requirement for mitogenic stimulation in cell cycle re-entry. We found that the proliferation of cyclin D1(-/-)D2(-/-)D3(-/-) cells is resistant to the inhibition by p16(INK4a), but it critically depends on CDK2. Lastly, we found that cells lacking D-cyclins display reduced susceptibility to the oncogenic transformation. Our results reveal the presence of alternative mechanisms that allow cell cycle progression in a cyclin D-indeperdent fashion.	Harvard Univ, Sch Med, Dept Canc Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; Univ Oxford, Dept Cardiovasc Med, Oxford OX3 7BN, England; Tufts Univ, Sch Vet Med, North Grafton, MA 01536 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Oxford; Tufts University	Sicinski, P (corresponding author), Harvard Univ, Sch Med, Dept Canc Biol, Boston, MA 02115 USA.	peter_sicinski@dfci.harvard.edu	Bhattacharya, Shoumo/F-4127-2010	Bhattacharya, Shoumo/0000-0002-5571-0478; Ciemerych, Maria A./0000-0003-0387-4179; Rebel, Vivienne/0000-0002-3862-3903; Kozar-Kaminska, Katarzyna/0000-0002-2397-2975	NCI NIH HHS [CA85296, CA108420] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA085296, R01CA108420] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Berthet C, 2003, CURR BIOL, V13, P1775, DOI 10.1016/j.cub.2003.09.024; Bouchard C, 1999, EMBO J, V18, P5321, DOI 10.1093/emboj/18.19.5321; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Ciemerych MA, 2002, GENE DEV, V16, P3277, DOI 10.1101/gad.1023602; Colucci F, 2000, J IMMUNOL, V164, P5140, DOI 10.4049/jimmunol.164.10.5140; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; FANTL V, 1995, GENE DEV, V9, P2364, DOI 10.1101/gad.9.19.2364; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; Huard JMT, 1999, DEVELOPMENT, V126, P1927; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Lam EWF, 2000, J BIOL CHEM, V275, P3479, DOI 10.1074/jbc.275.5.3479; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; MATSUSHIME H, 1991, CELL, V65, P701, DOI 10.1016/0092-8674(91)90101-4; Meyer CA, 2000, EMBO J, V19, P4533, DOI 10.1093/emboj/19.17.4533; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; MOTOKURA T, 1991, NATURE, V350, P512, DOI 10.1038/350512a0; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Park M, 1999, DEVELOPMENT, V126, P4849; Perez-Roger I, 1999, EMBO J, V18, P5310, DOI 10.1093/emboj/18.19.5310; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; SERRANO M, 1995, SCIENCE, V267, P249, DOI 10.1126/science.7809631; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sicinska E, 2003, CANCER CELL, V4, P451, DOI 10.1016/S1535-6108(03)00301-5; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; Sicinski P, 1996, NATURE, V384, P470, DOI 10.1038/384470a0; Solvason N, 2000, INT IMMUNOL, V12, P631, DOI 10.1093/intimm/12.5.631; SPANGRUDE GJ, 1990, J IMMUNOL, V145, P3661; Sucov HM, 1998, ANNU REV PHYSIOL, V60, P287, DOI 10.1146/annurev.physiol.60.1.287; Traver D, 2001, BLOOD, V98, P627, DOI 10.1182/blood.V98.3.627; Tsutsui T, 1999, MOL CELL BIOL, V19, P7011; WEINSTATSASLOW D, 1995, NAT MED, V1, P1257, DOI 10.1038/nm1295-1257; YUE X, 1991, CELL, V65, P691, DOI 10.1016/0092-8674(91)90100-D; Zarkowska T, 1997, J BIOL CHEM, V272, P12738, DOI 10.1074/jbc.272.19.12738	38	514	534	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2004	118	4					477	491		10.1016/j.cell.2004.07.025	http://dx.doi.org/10.1016/j.cell.2004.07.025			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	850YS	15315760	Bronze			2022-12-24	WOS:000223650900010
J	Regev-Yochay, G; Dagan, R; Raz, M; Carmeli, Y; Shainberg, B; Derazne, E; Rahavi, G; Rubinstein, E				Regev-Yochay, G; Dagan, R; Raz, M; Carmeli, Y; Shainberg, B; Derazne, E; Rahavi, G; Rubinstein, E			Association between carriage of Streptococcus pneumoniae and Staphylococcus aureus in children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							METHICILLIN-RESISTANT; NASAL CARRIAGE; COMMUNITY; COLONIZATION; INHABITANTS; PREVALENCE; CAVITIES; VACCINE	Context Widespread pneumococcal conjugate vaccination may bring about epidemiologic changes in upper respiratory tract flora of children. Of particular significance may be an interaction between Streptococcus pneumoniae and Staphylococcus aureus, in view of the recent emergence of community-acquired methicillin-resistant S aureus. Objective To examine the prevalence and risk factors of carriage of S pneumoniae and S aureus in the prevaccination era in young children. Design, Setting, and Patients Cross-sectional surveillance study of nasopharyngeal carriage of S pneumoniae and nasal carriage of S aureus by 790 children aged 40 months or younger seen at primary care clinics in central Israel during February 2002. Main Outcome Measures Carriage rates of S pneumoniae (by serotype) and S aureus; risk factors associated with carriage of each pathogen. Results Among 790 children screened, 43% carried S pneumoniae and 10% carried S aureus. Staphylococcus aureus carriage among S pneumoniae carriers was 6.5% vs 12.9% in S pneumoniae noncarriers. Streptococcus pneumoniae carriage among S aureus carriers was 27.5% vs 44.8% in S aureus noncarriers. Only 2.8% carried both pathogens concomitantly vs 4.3% expected dual carriage (P=.03). Risk factors for S pneumoniae carriage (attending day care, having young siblings, and age older than 3 months) were negatively associated with S aureus carriage. Conclusions Streptococcus pneumoniae carriage, specifically of vaccine-type strains, is negatively associated with S aureus carriage in children. The implications of these findings in the pneumococcal vaccine era require further investigation.	Chaim Sheba Med Ctr, IL-52621 Tel Hashomer, Israel; Tel Aviv Univ, Sackler Sch Med, Sourasky Med Ctr, IL-69978 Tel Aviv, Israel; Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel; Soroka Univ, Med Ctr, Beer Sheva, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Ben Gurion University; Ben Gurion University; Soroka Medical Center	Regev-Yochay, G (corresponding author), Chaim Sheba Med Ctr, Infect Dis Unit, IL-52621 Ramat Gan, Israel.	gili.regev@sheba.health.gov.il		Regev-Yochay, Gili/0000-0001-7163-4607				Balmer P, 2002, J MED MICROBIOL, V51, P717, DOI 10.1099/0022-1317-51-9-717; BERGOVAC J, 1993, EUR J EPIDEMIOL, V9, P405; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Givon-Lavi N, 2003, PEDIATR INFECT DIS J, V22, P524, DOI 10.1097/00006454-200306000-00008; GRAY BM, 1980, J INFECT DIS, V142, P923, DOI 10.1093/infdis/142.6.923; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Nakamura MM, 2002, PEDIATR INFECT DIS J, V21, P917, DOI 10.1097/00006454-200210000-00006; *NAT COMM CLIN LAB, 2001, PUBL NAT COMM CLIN L; Peacock SJ, 2003, J CLIN MICROBIOL, V41, P5718, DOI 10.1128/JCM.41.12.5718-5725.2003; Pericone CD, 2000, INFECT IMMUN, V68, P3990, DOI 10.1128/IAI.68.7.3990-3997.2000; POUTREL B, 1980, ANN RECH VET, V11, P327; Rao GG, 1998, DRUGS, V55, P323, DOI 10.2165/00003495-199855030-00001; Regev-Yochay G, 2004, CLIN INFECT DIS, V38, P632, DOI 10.1086/381547; Shopsin B, 2000, J INFECT DIS, V182, P359, DOI 10.1086/315695; Uehara Y, 2001, CLIN INFECT DIS, V32, P1408, DOI 10.1086/320179; Uehara Y, 2000, J HOSP INFECT, V44, P127, DOI 10.1053/jhin.1999.0680; Vandenesch F, 2003, EMERG INFECT DIS, V9, P978; Veenhoven R, 2003, LANCET, V361, P2189, DOI 10.1016/S0140-6736(03)13772-5; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102	19	215	220	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2004	292	6					716	720		10.1001/jama.292.6.716	http://dx.doi.org/10.1001/jama.292.6.716			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844RM	15304469	Bronze			2022-12-24	WOS:000223177300026
J	Cohen, JC; Kiss, RS; Pertsemlidis, A; Marcel, YL; McPherson, R; Hobbs, HH				Cohen, JC; Kiss, RS; Pertsemlidis, A; Marcel, YL; McPherson, R; Hobbs, HH			Multiple rare Alleles contribute to low plasma levels of HDL cholesterol	SCIENCE			English	Article							ABCA1 GENE; FAMILIAL HYPOALPHALIPOPROTEINEMIA; EFFLUX; DISEASE; SUSCEPTIBILITY; DEFICIENCY; MUTATIONS; VARIANTS	Heritable variation in complex traits is generally considered to be conferred by common DNA sequence polymorphisms. We tested whether rare DNA sequence variants collectively contribute to variation in plasma levels of high-density lipoprotein cholesterol (HDL-C). We sequenced three candidate genes (ABCA1, APOA1, and LCAT) that cause Mendelian forms of low HDL-C levels in individuals from a population-based study. Nonsynonymous sequence variants were significantly more common (16% versus 2%) in individuals with low HDL-C (<fifth percentile) than in those with high HDL-C (>95th percentile). Similar findings were obtained in an independent population, and biochemical studies indicated that most sequence variants in the low HDL-C group were functionally important. Thus, rare alleles with major phenotypic effects contribute significantly to low plasma HDL-C levels in the general population.	Univ Texas, SW Med Ctr, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Human Nutr, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Ottawa, Inst Heart, Lipoprot & Atherosclerosis Res Grp, Ottawa, ON K7Y 4W7, Canada	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Ottawa; University of Ottawa Heart Institute	Cohen, JC (corresponding author), Univ Texas, SW Med Ctr, Donald W Reynolds Cardiovasc Clin Res Ctr, Dallas, TX 75390 USA.	jonathan.cohen@utsouthwestern.edu; ymarcel@ottawaheart.ca	Pertsemlidis, Alexander/Q-7899-2017	Pertsemlidis, Alexander/0000-0003-1624-9372	NHLBI NIH HHS [UO1-HL66880, HL53917] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066880, R01HL053917] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ASSMANN G, 1993, CIRCULATION, V87, P28; Hayden MR, 2000, CURR OPIN LIPIDOL, V11, P117, DOI 10.1097/00041433-200004000-00003; Hovingh GK, 2003, J LIPID RES, V44, P1251, DOI 10.1194/jlr.M300080-JLR200; Kuivenhoven JA, 1997, J LIPID RES, V38, P191; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Mott S, 2000, ATHEROSCLEROSIS, V152, P457, DOI 10.1016/S0021-9150(99)00498-0; Pennacchio LA, 2002, HUM MOL GENET, V11, P3031, DOI 10.1093/hmg/11.24.3031; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Singaraja RR, 2003, ARTERIOSCL THROM VAS, V23, P1322, DOI 10.1161/01.ATV.0000078520.89539.77; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; Tregouet DA, 2004, ARTERIOSCL THROM VAS, V24, P775, DOI 10.1161/01.ATV.0000121573.29550.1a; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; [No title captured]	15	839	864	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2004	305	5685					869	872		10.1126/science.1099870	http://dx.doi.org/10.1126/science.1099870			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297675				2022-12-24	WOS:000223104900050
J	Kosman, D; Mizutani, CM; Lemons, D; Cox, WG; McGinnis, W; Bier, E				Kosman, D; Mizutani, CM; Lemons, D; Cox, WG; McGinnis, W; Bier, E			Multiplex detection of RNA expression in Drosophila embryos	SCIENCE			English	Article							HYBRIDIZATION		Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; Mol Probes Inc, Eugene, OR 97402 USA	University of California System; University of California San Diego	Bier, E (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.	ebier@ucsd.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029870] Funding Source: NIH RePORTER; NINDS NIH HHS [NS29870] Funding Source: Medline; PHS HHS [28315] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Hughes SC, 1998, BIOTECHNIQUES, V24, P530, DOI 10.2144/98244bm01; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; OFARRELL PH, 1989, SCIENCE, V246, P635, DOI 10.1126/science.2683080; Stathopoulos A, 2002, CELL, V111, P687, DOI 10.1016/S0092-8674(02)01087-5; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; Wilkie GS, 1999, CURR BIOL, V9, P1263, DOI 10.1016/S0960-9822(99)80509-0	8	276	304	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					846	846		10.1126/science.1099247	http://dx.doi.org/10.1126/science.1099247			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297669				2022-12-24	WOS:000223104900042
J	Oinuma, I; Ishikawa, Y; Katoh, H; Negishi, M				Oinuma, I; Ishikawa, Y; Katoh, H; Negishi, M			The semaphorin 4D receptor plexin-B1 is a GTPase activating protein for R-Ras	SCIENCE			English	Article							ACTIVE RAC; RHO; SIGNALS; RND1; FAMILY	Plexins are cell surface receptors for semaphorin molecules, and their interaction governs cell adhesion and migration in a variety of tissues. We report that the Semaphorin 4D (Sema4D) receptor Plexin-B1 directly stimulates the intrinsic guanosine triphosphatase ( GTPase) activity of R-Ras, a member of the Ras superfamily of small GTP-binding proteins that has been implicated in promoting cell adhesion and neurite outgrowth. This activity required the interaction of Plexin-B1 with Rnd1, a small GTP-binding protein of the Rho family. Down-regulation of R-Ras activity by the Plexin-B1-Rnd1 complex was essential for the Sema4D-induced growth cone collapse in hippocampal neurons. Thus, Plexin-B1 mediates Sema4D-induced repulsive axon guidance signaling by acting as a GTPase activating protein for R-Ras.	Kyoto Univ, Grad Sch Biostudies, Mol Neurobiol Lab, Sakyo Ku, Kyoto 6068502, Japan	Kyoto University	Negishi, M (corresponding author), Kyoto Univ, Grad Sch Biostudies, Mol Neurobiol Lab, Sakyo Ku, Kyoto 6068502, Japan.	mnegishi@pharm.kyoto-u.ac.jp		Katoh, Hironori/0000-0002-8191-8117				Aurandt J, 2002, P NATL ACAD SCI USA, V99, P12085, DOI 10.1073/pnas.142433199; Barberis D, 2004, FASEB J, V18, P592, DOI 10.1096/fj.03-0957fje; Driessens MHE, 2002, FEBS LETT, V529, P168, DOI 10.1016/S0014-5793(02)03323-9; Driessens MHE, 2001, CURR BIOL, V11, P339, DOI 10.1016/S0960-9822(01)00092-6; Goshima Y, 2002, J CLIN INVEST, V109, P993, DOI 10.1172/JCI200215467; Hu HL, 2001, NEURON, V32, P39, DOI 10.1016/S0896-6273(01)00453-6; Ishikawa Y, 2003, J NEUROSCI, V23, P11065; Ivins JK, 2000, J NEUROSCI, V20, P6551, DOI 10.1523/JNEUROSCI.20-17-06551.2000; Keely PJ, 1999, J CELL BIOL, V145, P1077, DOI 10.1083/jcb.145.5.1077; Kinbara K, 2003, NAT REV MOL CELL BIO, V4, P767, DOI 10.1038/nrm1229; Nakamura F, 2000, J NEUROBIOL, V44, P219, DOI 10.1002/1097-4695(200008)44:2<219::AID-NEU11>3.0.CO;2-W; Nobes CD, 1998, J CELL BIOL, V141, P187, DOI 10.1083/jcb.141.1.187; Oinuma I, 2003, J BIOL CHEM, V278, P25671, DOI 10.1074/jbc.M303047200; Perrot V, 2002, J BIOL CHEM, V277, P43115, DOI 10.1074/jbc.M206005200; Raper JA, 2000, CURR OPIN NEUROBIOL, V10, P88, DOI 10.1016/S0959-4388(99)00057-4; RHOM B, 2000, FEBS LETT, V486, P68; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Serini G, 2003, NATURE, V424, P391, DOI 10.1038/nature01784; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Van Triest M, 2001, METHOD ENZYMOL, V333, P343; Yamamoto T, 1995, J BIOL CHEM, V270, P30557, DOI 10.1074/jbc.270.51.30557; Zanata SM, 2002, J NEUROSCI, V22, P471, DOI 10.1523/JNEUROSCI.22-02-00471.2002; Zhang ZH, 1996, CELL, V85, P61, DOI 10.1016/S0092-8674(00)81082-X	26	309	324	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					862	865		10.1126/science.1097545	http://dx.doi.org/10.1126/science.1097545			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297673				2022-12-24	WOS:000223104900048
J	Peeters, FJC; Acheson, R; Brummer, GJA; de Ruijter, WPM; Schneider, RR; Ganssen, GM; Ufkes, E; Kroon, D				Peeters, FJC; Acheson, R; Brummer, GJA; de Ruijter, WPM; Schneider, RR; Ganssen, GM; Ufkes, E; Kroon, D			Vigorous exchange between the Indian and Atlantic oceans at the end of the past five glacial periods	NATURE			English	Article							SEA-SURFACE TEMPERATURE; SOUTH-ATLANTIC; OVERTURNING CIRCULATION; RECORD; COMMUNICATION; FLUCTUATIONS; OCEANOGRAPHY; SECTOR; HEAT	The magnitude of heat and salt transfer between the Indian and Atlantic oceans through 'Agulhas leakage' is considered important for balancing the global thermohaline circulation(1-3). Increases or reductions of this leakage lead to strengthening or weakening of the Atlantic meridional overturning and associated variation of North Atlantic Deep Water formation(4-6). Here we show that modern Agulhas waters, which migrate into the south Atlantic Ocean in the form of an Agulhas ring, contain a characteristic assemblage of planktic foraminifera. We use this assemblage as a modern analogue to investigate the Agulhas leakage history over the past 550,000 years from a sediment record in the Cape basin. Our reconstruction indicates that Indian - Atlantic water exchange was highly variable: enhanced during present and past interglacials and largely reduced during glacial intervals. Coherent variability of Agulhas leakage with northern summer insolation suggests a teleconnection to the monsoon system. The onset of increased Agulhas leakage during late glacial conditions took place when glacial ice volume was maximal, suggesting a crucial role for Agulhas leakage in glacial terminations, timing of interhemispheric climate change(7) and the resulting resumption of the Atlantic meridional overturning circulation(6).	Free Univ Amsterdam, Fac Earth & Life Sci, Dept Paleoecol & Paleoclimatol, NL-1081 HV Amsterdam, Netherlands; Netherlands Inst Sea Res, Dept Marine Chem & Geol, NL-1790 AB Den Burg, Texel, Netherlands; Univ Edinburgh, Grant Inst Geol, Sch Geosci, Edinburgh EH9 3JW, Midlothian, Scotland; Univ Utrecht, Inst Marine & Atmospher Res Utrecht, Fac Phys & Astron, NL-3584 CC Utrecht, Netherlands; Univ Bordeaux 1, Dept Geol & Oceanog, CNRS, UMR EPOC 5805, F-33405 Talence, France	Vrije Universiteit Amsterdam; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); University of Edinburgh; Utrecht University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite de Bordeaux	Peeters, FJC (corresponding author), Free Univ Amsterdam, Fac Earth & Life Sci, Dept Paleoecol & Paleoclimatol, Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.	frank.peeters@falw.vu.nl	Brummer, Gerard J/I-1187-2014; de Ruijter, Wilhelmus/I-2541-2016	Peeters, Frank J.C./0000-0002-5678-9288; Ufkes, E./0000-0003-3257-0203				Be A. W. H, 1977, Micropaleontology, V23, P369, DOI 10.2307/1485406; Be A.W.H., 1971, MICROPALEONTOLOGY OC, P105; Chen MT, 2002, MAR GEOL, V180, P163, DOI 10.1016/S0025-3227(01)00212-2; de Ruijter WPM, 1999, J GEOPHYS RES-OCEANS, V104, P20885, DOI 10.1029/1998JC900099; de Ruijter WPM, 2004, DEEP-SEA RES PT I, V51, P383, DOI 10.1016/j.dsr.2003.10.011; Flores JA, 1999, MAR MICROPALEONTOL, V37, P1, DOI 10.1016/S0377-8398(99)00012-2; Garzoli SL, 1996, J GEOPHYS RES-OCEANS, V101, P897, DOI 10.1029/95JC03221; Gordon AL, 2003, NATURE, V421, P904, DOI 10.1038/421904a; GORDON AL, 1992, J GEOPHYS RES-OCEANS, V97, P7223, DOI 10.1029/92JC00485; Gordon AL, 1996, NATURE, V382, P399, DOI 10.1038/382399a0; Hodell DA, 2000, GLOBAL PLANET CHANGE, V24, P7, DOI 10.1016/S0921-8181(99)00069-7; Howard WR, 1992, PALEOCEANOGRAPHY, V7, P79, DOI 10.1029/91PA02994; Imbrie J., 1984, MILANKOVITCH CLIMA 1, P269; Knorr G, 2003, NATURE, V424, P532, DOI 10.1038/nature01855; Kunz-Pirrung M, 2002, PALAEOGEOGR PALAEOCL, V182, P305, DOI 10.1016/S0031-0182(01)00501-6; Lutjeharms JRE, 1996, SOUTH ATLANTIC, P125; LUTJEHARMS JRE, 2000, S AFR J SCI, V96; Macdonald AM, 1996, NATURE, V382, P436, DOI 10.1038/382436a0; Niebler HS, 1998, MAR MICROPALEONTOL, V34, P213, DOI 10.1016/S0377-8398(98)00009-7; Pahnke K, 2003, SCIENCE, V301, P948, DOI 10.1126/science.1084451; Paillard D., 1996, EOS T AM GEOPHYS UN, V77, P379, DOI 10.1029/96EO00259; Rau AJ, 2002, MAR GEOL, V180, P183, DOI 10.1016/S0025-3227(01)00213-4; Sachs JP, 2001, SCIENCE, V293, P2077, DOI 10.1126/science.1063584; Schneider RR, 1999, RECONSTRUCTING OCEAN HISTORY, P33; Schouten MW, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014542; Ufkes E, 2000, MAR MICROPALEONTOL, V40, P23, DOI 10.1016/S0377-8398(00)00030-X; van Aken HM, 2003, DEEP-SEA RES PT II, V50, P167, DOI 10.1016/S0967-0645(02)00383-1; Weijer W, 2002, GLOBAL PLANET CHANGE, V34, P293, DOI 10.1016/S0921-8181(02)00121-2; Weijer W, 2001, J PHYS OCEANOGR, V31, P2385, DOI 10.1175/1520-0485(2001)031<2385:SOTAOC>2.0.CO;2; Winter A, 1990, PALEOCEANOGRAPHY, V5, P479, DOI 10.1029/PA005i004p00479; Wunsch C, 2003, QUATERNARY SCI REV, V22, P1631, DOI 10.1016/S0277-3791(03)00152-5	31	280	283	2	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2004	430	7000					661	665		10.1038/nature02785	http://dx.doi.org/10.1038/nature02785			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843LM	15295596	Green Published			2022-12-24	WOS:000223085400041
J	Krasilnikov, AS; Xiao, YH; Pan, T; Mondragon, A				Krasilnikov, AS; Xiao, YH; Pan, T; Mondragon, A			Basis for structural diversity in homologous RNAs	SCIENCE			English	Article							RIBONUCLEASE-P RNA; CRYSTAL-STRUCTURE; FOLDING MOTIF; RIBOZYME; DOMAIN	Large RNA molecules, such as ribozymes, fold with well-defined tertiary structures that are important for their activity. There are many instances of ribozymes with identical function but differences in their secondary structures, suggesting alternative tertiary folds. Here, we report a crystal structure of the 161-nucleotide specificity domain of an A-type ribonuclease P that differs in secondary and tertiary structure from the specificity domain of a B-type molecule. Despite the differences, the cores of the domains have similar three-dimensional structure. Remarkably, the similar geometry of the cores is stabilized by a different set of interactions involving distinct auxiliary elements.	Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	Northwestern University; University of Chicago	Mondragon, A (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA.	a-mondragon@northwestern.edu						Altman S., 1999, RNA WORLD, P351; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BROWN JW, 1994, NUCLEIC ACIDS RES, V22, P3660, DOI 10.1093/nar/22.17.3660; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678; Chen JL, 1997, RNA, V3, P557; Chen JL, 1998, EMBO J, V17, P1515, DOI 10.1093/emboj/17.5.1515; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Frank DN, 1998, ANNU REV BIOCHEM, V67, P153, DOI 10.1146/annurev.biochem.67.1.153; Haas ES, 1996, NUCLEIC ACIDS RES, V24, P4775, DOI 10.1093/nar/24.23.4775; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Krasilnikov AS, 2003, RNA, V9, P640, DOI 10.1261/rna.2202703; Krasilnikov AS, 2003, NATURE, V421, P760, DOI 10.1038/nature01386; LAGRANDEUR TE, 1994, EMBO J, V13, P3945, DOI 10.1002/j.1460-2075.1994.tb06710.x; Loria A, 1996, RNA, V2, P551; Massire C, 1998, J MOL BIOL, V279, P773, DOI 10.1006/jmbi.1998.1797; Moore PB, 1999, ANNU REV BIOCHEM, V68, P287, DOI 10.1146/annurev.biochem.68.1.287; Nagaswamy U, 2002, RNA, V8, P1112, DOI 10.1017/S135583820202006X; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; Odell L, 1998, NUCLEIC ACIDS RES, V26, P3717, DOI 10.1093/nar/26.16.3717; PAN T, 1995, BIOCHEMISTRY-US, V34, P902, DOI 10.1021/bi00003a024	21	117	126	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2004	306	5693					104	107		10.1126/science.1101489	http://dx.doi.org/10.1126/science.1101489			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459389				2022-12-24	WOS:000224304000046
J	Sesma, A; Osbourn, AE				Sesma, A; Osbourn, AE			The rice leaf blast pathogen undergoes developmental processes typical of root-infecting fungi	NATURE			English	Article							MAGNAPORTHE-GRISEA; SP-NOV; PENETRATION; GENE; RESISTANCE; BIOLOGY; PROTEIN	Pathogens have evolved different strategies to overcome the various barriers that they encounter during infection of their hosts(1). The rice blast fungus Magnaporthe grisea causes one of the most damaging diseases of cultivated rice and has emerged as a paradigm system for investigation of foliar pathogenicity. This fungus undergoes a series of well-defined developmental steps during leaf infection, including the formation of elaborate penetration structures (appressoria). This process has been studied in great detail(2), and over thirty M. grisea genes that condition leaf infection have been identified(3). Here we show a new facet of the M. grisea life cycle: this fungus can undergo a different ( and previously uncharacterized) set of programmed developmental events that are typical of root-infecting pathogens. We also show that root colonization can lead to systemic invasion and the development of classical disease symptoms on the aerial parts of the plant. Gene-for-gene type specific disease resistance that is effective against rice blast in leaves also operates in roots. These findings have significant implications for fungal development, epidemiology, plant breeding and disease control.	John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Osbourn, AE (corresponding author), John Innes Ctr Plant Sci Res, Sainsbury Lab, Colney Lane, Norwich NR4 7UH, Norfolk, England.	annie.osbourn@sainsbury-laboratory.ac.uk	Sesma, Ane/A-8883-2010; Sesma, Ane/AAF-4796-2021	Sesma, Ane/0000-0003-3982-8932; 				Cannon P. F., 1994, Systema Ascomycetum, V13, P25; CHUMLEY FG, 1990, MOL PLANT MICROBE IN, V3, P135, DOI 10.1094/MPMI-3-135; deJong JC, 1997, NATURE, V389, P244, DOI 10.1038/38418; Dufresne M, 2001, MOL PLANT MICROBE IN, V14, P300, DOI 10.1094/MPMI.2001.14.3.300; Farman ML, 2002, MOL PLANT MICROBE IN, V15, P6, DOI 10.1094/MPMI.2002.15.1.6; GANGOPADHYAY S, 1986, International Journal of Tropical Plant Diseases, V4, P187; HORNBY D, 1981, BIOL CONTROL TAKE AL; Hornby D, 1998, TAKE ALL DIS CEREALS; Howard RJ, 1996, ANNU REV MICROBIOL, V50, P491, DOI 10.1146/annurev.micro.50.1.491; Inoue I, 2002, PLANT CELL, V14, P1869, DOI 10.1105/tpc.002576; LANDSCHOOT PJ, 1989, MYCOL RES, V93, P59, DOI 10.1016/S0953-7562(89)80137-6; Lorang JM, 2001, APPL ENVIRON MICROB, V67, P1987, DOI 10.1128/AEM.67.5.1987-1994.2001; Mendgen K, 1996, ANNU REV PHYTOPATHOL, V34, P367, DOI 10.1146/annurev.phyto.34.1.367; MITCHELL TK, 1995, PLANT CELL, V7, P1869, DOI 10.1105/tpc.7.11.1869; Ou SH, 1985, RICE DIS; Resendes CM, 2001, NEW PHYTOL, V150, P563, DOI 10.1046/j.1469-8137.2001.00131.x; Rho HS, 2001, MOL CELLS, V12, P407; Rodrigues FA, 2003, PHYTOPATHOLOGY, V93, P535, DOI 10.1094/PHYTO.2003.93.5.535; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; SCOTT DB, 1983, T BRIT MYCOL SOC, V81, P77, DOI 10.1016/S0007-1536(83)80206-X; Sosnowski M, 2001, PLANT PATHOL, V50, P808, DOI 10.1046/j.1365-3059.2001.00631.x; Sweigard JA, 1997, FUNGAL GENET NEWSL, V44, P52, DOI DOI 10.4148/1941-4765.1287; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Tucker SL, 2001, ANNU REV PHYTOPATHOL, V39, P385, DOI 10.1146/annurev.phyto.39.1.385; VALENT B, 1991, GENETICS, V127, P87; Vereijssen J, 2004, EUR J PLANT PATHOL, V110, P103, DOI 10.1023/B:EJPP.0000010130.38700.88; Xu JR, 1997, MOL PLANT MICROBE IN, V10, P187, DOI 10.1094/MPMI.1997.10.2.187	29	247	272	1	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 30	2004	431	7008					582	586		10.1038/nature02880	http://dx.doi.org/10.1038/nature02880			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15457264				2022-12-24	WOS:000224156700050
J	Wallace, SC; Wang, XM				Wallace, SC; Wang, XM			Two new carnivores from an unusual late Tertiary forest biota in eastern North America	NATURE			English	Article							EARLY PLIOCENE; PLANTS	Late Cenozoic terrestrial fossil records of North America are biased by a predominance of mid-latitude deposits, mostly in the western half of the continent. Consequently, the biological history of eastern North America, including the eastern deciduous forest, remains largely hidden. Unfortunately, vertebrate fossil sites from this vast region are rare(1,2), and few pertain to the critically important late Tertiary period, during which intensified global climatic changes took place(3,4). Moreover, strong phylogenetic affinities between the flora of eastern North America and eastern Asia clearly demonstrate formerly contiguous connections, but disparity among shared genera ( eastern Asia - eastern North America disjunction) implies significant periods of separation since at least the Miocene epoch(1,2). Lacustrine sediments deposited within a former sinkhole in the southern Appalachian Mountains provide a rare example of a late Miocene to early Pliocene terrestrial biota from a forested ecosystem(5). Here we show that the vertebrate remains contained within this deposit represent a unique combination of North American and Eurasian taxa. A new genus and species of the red ( lesser) panda ( Pristinailurus bristoli), the earliest and most primitive so far known, was recovered. Also among the fauna are a new species of Eurasian badger (Arctomeles dimolodontus) and the largest concentration of fossil tapirs ever recorded. Cladistical analyses of the two new carnivores strongly suggest immigration events that were earlier than and distinct from previous records(6,7), and that the close faunal affinities between eastern North America and eastern Asia in the late Tertiary period are consistent with the contemporaneous botanical record(8,9).	Nat Hist Museum Los Angeles, Dept Vertebrate Paleontol, Los Angeles, CA 90007 USA; E Tennessee State Univ, Dept Phys Astron & Geol, Johnson City, TN 37614 USA	East Tennessee State University	Wang, XM (corresponding author), Nat Hist Museum Los Angeles, Dept Vertebrate Paleontol, 900 Exposit Blvd, Los Angeles, CA 90007 USA.	xwang@nhm.org	Wang, Xiaoming/I-9033-2019	Wang, Xiaoming/0000-0003-1610-3840				[Anonymous], [No title captured]; BOYDDAWKINS W, 1888, Q J GEOL SOC LOND, V44, P228; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; EMRY RJ, 1998, GEOLOGY PALEONTOLOGY, P153; Farlow JO, 2001, AM MIDL NAT, V145, P367, DOI 10.1674/0003-0031(2001)145[0367:TPCSBA]2.0.CO;2; Ginsburg Leonard, 2001, Geodiversitas, V23, P81; HULBERT RCJ, IN PRESS B FLA MUS N; HUNT RM, 1998, EVOLUTION TERTIARY M, V1, P174; Jacobs BF, 1999, ANN MO BOT GARD, V86, P590, DOI 10.2307/2666186; KORMOS TH, 1935, MITTEILUNGEN JB KONI, V30, P1; Kundrat M., 1997, Journal of Vertebrate Paleontology, V17, p58A; MACFADDEN BJ, 1988, NATURE, V336, P466, DOI 10.1038/336466a0; MacFadden BJ, 1998, PALEOBIOLOGY, V24, P274; Morlo Michael, 2001, Palaeontologische Zeitschrift, V75, P163; Pagani M, 1999, SCIENCE, V285, P876, DOI 10.1126/science.285.5429.876; Parmalee PW, 2002, ANN CARNEGIE MUS, V71, P233; Qian H, 2000, NATURE, V407, P180, DOI 10.1038/35025052; Schlosser M., 1899, MITTHEILUNGEN JB KON, V13, P66; SCHMIDTKITTLER N, 1995, VERTEBRATE LOCALITY, P75; Stach J., 1951, Acta Geologica Polonica, V2, P129; Tedford RH, 2003, NATURE, V425, P388, DOI 10.1038/nature01892; TEDFORD RH, 1977, NATURE, V265, P621, DOI 10.1038/265621a0; Tedford RH, 2001, J VERTEBR PALEONTOL, V21, P311, DOI 10.1671/0272-4634(2001)021[0311:PATBUC]2.0.CO;2; Tedford Richard H., 2004, P169; VOORHIES MR, 1979, SCIENCE, V206, P331, DOI 10.1126/science.206.4416.331; WALLACE SC, 2002, J VERT PALEONTOL, V22, P117; Wang XM, 1997, J VERTEBR PALEONTOL, V17, P184, DOI 10.1080/02724634.1997.10010963; Wen J, 1999, ANNU REV ECOL SYST, V30, P421, DOI 10.1146/annurev.ecolsys.30.1.421; Zdansky O., 1924, Palaeontologia Sinica Series C, V2, P1; [No title captured]	30	72	74	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 30	2004	431	7008					556	559		10.1038/nature02819	http://dx.doi.org/10.1038/nature02819			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15457257				2022-12-24	WOS:000224156700043
J	McVernon, J; Trotter, CL; Slack, MPE; Ramsay, ME				McVernon, J; Trotter, CL; Slack, MPE; Ramsay, ME			Trends in Haemophilus influenzae type b infections in adults in England and Wales: surveillance study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CONJUGATE VACCINE; IMMUNITY; DISEASE; IMPACT; HIB; COLONIZATION; EPIGLOTTITIS; CARRIAGE; CHILDREN	Objective To describe invasive Haemophilus influenzae type b (Hib) infections in individuals aged 15 years or older in England and Wales between 1991 and 2003. Design Prospective, laboratory based surveillance of invasive Hib infections and cross sectional seroprevalence study. Setting England and Wales. Participants Cases were confirmed by isolation of H influenzae from a normally sterile site, or from a non-sterile site in cases with a diagnosis of epiglottitis. Excess serum samples collected from English 30-39 year olds as part of a national serosurvey were identified for the years 1990, 1994, 1997, 2000, and 2002. Main outcome measures The number of invasive Hib infections from 1991 to 2003. Population immunity to H influenzae type b in English adults was also measured. Results After routine infant immunisation was introduced in October 1992, adult Hib infections decreased initially but then rose from a low in 1998 to reach prevaccine levels in 2003. An associated fall in median Hib antibody concentrations occurred, from 1.29 mug/ml (95% confidence interval 0.90 to 1.64) in 1991 to 0.70 mug/ml (0.57 to 0.89) in 1994 (P=0.006), with no significant change observed thereafter. Conclusions Although immunisation of infants resulted in an initial decline in Hib infections in adults, a resurgence in reported cases occurred in 2002-3. This rise was associated with an increase in cases in children and evidence of reduced immunity in older unimmunised cohorts. Childhood immunisation programmes may have unanticipated effects on the epidemiology of disease in older age groups, and surveillance strategies must be targeted at entire populations.	Hlth Protect Agcy, Ctr Communicable Dis Surveillance, Immunisat Dept, London NW9 5EQ, England; Hlth Protect Agcy, Ctr Communicable Dis Surveillance, Stat Modelling & Econ Dept, London NW9 5EQ, England; John Radcliffe Hosp, Hlth Protect Agcy Specialist & Reference Microbio, Haemophilus Reference Unit, Oxford OX3 9DU, England	Health Protection Agency; Health Protection Agency; University of Oxford	Ramsay, ME (corresponding author), Hlth Protect Agcy, Ctr Communicable Dis Surveillance, Immunisat Dept, London NW9 5EQ, England.	mary.ramsay@hpa.org.uk	Trotter, Caroline L/H-5077-2013; Ramsay, Mary Elizabeth/S-8281-2016	Ramsay, Mary Elizabeth/0000-0002-7156-7640; McVernon, Jodie/0000-0001-9774-1961; Trotter, Caroline/0000-0003-4000-2708				BARBOUR ML, 1995, J INFECT DIS, V171, P93, DOI 10.1093/infdis/171.1.93; BOISVERT PL, 1948, AM J DIS CHILD, V75, P427; *DEP HLTH, 2003, BOOST VACC OFF FOLL; European Union Invasive Bacterial Infections Surveillance Network, 2006, INV HAEM INFL EUR 20; GLODE MP, 1984, PEDIATR INFECT DIS J, V3, P548, DOI 10.1097/00006454-198411000-00013; *HLTH PROT AG, Q COMM DIS REP COVER; Kelly H, 2002, VACCINE, V20, P3130, DOI 10.1016/S0264-410X(02)00255-4; Leino T, 2000, EPIDEMIOL INFECT, V125, P583, DOI 10.1017/S0950268800004799; McVernon J, 2004, EPIDEMIOL INFECT, V132, P765, DOI 10.1017/S0950268804002122; McVernon J, 2003, LANCET, V361, P1521, DOI 10.1016/S0140-6736(03)13171-6; MICHAELS RH, 1977, J INFECT DIS, V136, P222, DOI 10.1093/infdis/136.2.222; *NAT STAT ONL, BIRTH STAT BIRTHS PA; Osborne K, 2000, INT J EPIDEMIOL, V29, P362, DOI 10.1093/ije/29.2.362; PHIPPS DC, 1990, J IMMUNOL METHODS, V135, P121, DOI 10.1016/0022-1759(90)90264-V; Ramsay ME, 2003, J INFECT DIS, V188, P481, DOI 10.1086/376997; Ramsay ME, 2003, BRIT MED J, V326, P365, DOI 10.1136/bmj.326.7385.365; Rijkers GT, 2003, LANCET, V361, P1563, DOI 10.1016/S0140-6736(03)13201-1; Sarangi J, 2000, EPIDEMIOL INFECT, V124, P441, DOI 10.1017/S0950268899003611; Slack MPE, 1998, PEDIATR INFECT DIS J, V17, pS204, DOI 10.1097/00006454-199809001-00026; Trotter C L, 2003, Commun Dis Public Health, V6, P55; Trotter CL, 2003, LANCET, V361, P1523, DOI 10.1016/S0140-6736(03)13172-8; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823	22	51	54	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 18	2004	329	7467					655	658		10.1136/bmj.329.7467.655	http://dx.doi.org/10.1136/bmj.329.7467.655			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856JU	15374916	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000224042300019
J	Sacchini, V; Borgen, PI				Sacchini, V; Borgen, PI			Can radiation therapy for breast cancer be avoided?	LANCET			English	Editorial Material							CONSERVING SURGERY; RADIOTHERAPY; IMPACT		Mem Sloan Kettering Canc Ctr, Dept Surg, Breast Serv, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Sacchini, V (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, Breast Serv, New York, NY 10021 USA.	sacchinv@mskcc.org						Early Breast Canc Trialists Collaborat, 2000, LANCET, V355, P1757, DOI 10.1016/S0140-6736(00)02263-7; Hughes KS, 2004, NEW ENGL J MED, V351, P971, DOI 10.1056/NEJMoa040587; Mor V, 2000, SURGERY, V128, P847, DOI 10.1067/msy.2000.109530; Veronesi Umberto, 2003, Breast J, V9, P106, DOI 10.1046/j.1524-4741.2003.09208.x; Vinh-Hung V, 2004, JNCI-J NATL CANCER I, V96, P115, DOI 10.1093/jnci/djh013; Vinh-Hung V, 2003, RADIOTHER ONCOL, V67, P147, DOI 10.1016/S0167-8140(03)00002-1; Vinh-Hung V, 2002, RADIOTHER ONCOL, V64, P281, DOI 10.1016/S0167-8140(02)00105-6	7	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 11	2004	364	9438					916	917		10.1016/S0140-6736(04)17037-2	http://dx.doi.org/10.1016/S0140-6736(04)17037-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853MF	15364173				2022-12-24	WOS:000223831000006
J	Gauderman, WJ; Avol, E; Gilliland, F; Vora, H; Thomas, D; Berhane, K; McConnell, R; Kuenzli, N; Lurmann, F; Rappaport, E; Margolis, H; Bates, D; Peters, J				Gauderman, WJ; Avol, E; Gilliland, F; Vora, H; Thomas, D; Berhane, K; McConnell, R; Kuenzli, N; Lurmann, F; Rappaport, E; Margolis, H; Bates, D; Peters, J			The effect of air pollution on lung development from 10 to 18 years of age	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SOUTHERN CALIFORNIA COMMUNITIES; OBSTRUCTIVE RESPIRATORY-DISEASE; PULMONARY-FUNCTION; FUNCTION GROWTH; CHRONIC EXPOSURE; UCLA POPULATION; PREADOLESCENT CHILDREN; PARTICULATE MATTER; DIFFERING LEVELS; FOLLOW-UP	Background: Whether exposure to air pollution adversely affects the growth of lung function during the period of rapid lung development that occurs between the ages of 10 and 18 years is unknown. Methods: In this prospective study, we recruited 1759 children (average age, 10 years) from schools in 12 southern California communities and measured lung function annually for eight years. The rate of attrition was approximately 10 percent per year. The communities represented a wide range of ambient exposures to ozone, acid vapor, nitrogen dioxide, and particulate matter. Linear regression was used to examine the relationship of air pollution to the forced expiratory volume in one second (FEV1) and other spirometric measures. Results: Over the eight-year period, deficits in the growth of FEV1 were associated with exposure to nitrogen dioxide (P=0.005), acid vapor (P=0.004), particulate matter with an aerodynamic diameter of less than 2.5 microm (PM2.5) (P=0.04), and elemental carbon (P=0.007), even after adjustment for several potential confounders and effect modifiers. Associations were also observed for other spirometric measures. Exposure to pollutants was associated with clinically and statistically significant deficits in the FEV1 attained at the age of 18 years. For example, the estimated proportion of 18-year-old subjects with a low FEV1 (defined as a ratio of observed to expected FEV1 of less than 80 percent) was 4.9 times as great at the highest level of exposure to PM2.5 as at the lowest level of exposure (7.9 percent vs. 1.6 percent, P=0.002). Conclusions: The results of this study indicate that current levels of air pollution have chronic, adverse effects on lung development in children from the age of 10 to 18 years, leading to clinically significant deficits in attained FEV1 as children reach adulthood.	Univ So Calif, Dept Prevent Med, Los Angeles, CA 90089 USA; Sonoma Technol, Petaluma, CA USA; State Calif, Air Resouces Board, Sacramento, CA USA; Univ British Columbia, Vancouver, BC V5Z 1M9, Canada	University of Southern California; University of British Columbia	Gauderman, WJ (corresponding author), Univ So Calif, Dept Prevent Med, 1540 Alcazar St,Suite 220, Los Angeles, CA 90089 USA.	jimg@usc.edu	Kuenzli, Nino/F-7195-2014; Fahimifar, Sepideh/M-5303-2019	Kuenzli, Nino/0000-0001-8360-080X; 	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011627, P30ES007048] Funding Source: NIH RePORTER; NIEHS NIH HHS [1P01ES11627, 5P30ES07048] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ASHLEY F, 1975, ANN INTERN MED, V82, P739, DOI 10.7326/0003-4819-82-6-739; Avol E.L., 1998, RES REP HLTH EFF I, V82, P1; Avol EL, 2001, AM J RESP CRIT CARE, V164, P2067, DOI 10.1164/ajrccm.164.11.2102005; Bascom R, 1996, AM J RESP CRIT CARE, V153, P477, DOI 10.1164/ajrccm.153.2.8564086; Bascom R, 1996, AM J RESP CRIT CARE, V153, P3, DOI 10.1164/ajrccm.153.1.8542133; Churg A, 2003, ENVIRON HEALTH PERSP, V111, P714, DOI 10.1289/ehp.6042; DETELS R, 1991, AM J PUBLIC HEALTH, V81, P350, DOI 10.2105/AJPH.81.3.350; DETELS R, 1987, CHEST, V92, P594, DOI 10.1378/chest.92.4.594; DOCKERY DW, 1989, AM REV RESPIR DIS, V139, P587, DOI 10.1164/ajrccm/139.3.587; *ENV PROT AG, 2003, 454K03001 ENV PROT A; FRIEDMAN GD, 1976, NEW ENGL J MED, V294, P1071, DOI 10.1056/NEJM197605132942001; Frischer T, 1999, AM J RESP CRIT CARE, V160, P390, DOI 10.1164/ajrccm.160.2.9809075; Gauderman WJ, 2000, AM J RESP CRIT CARE, V162, P1383; Gauderman WJ, 2002, AM J RESP CRIT CARE, V166, P76, DOI 10.1164/rccm.2111021; Hole DJ, 1996, BRIT MED J, V313, P711; Horak F, 2002, EUR RESPIR J, V19, P838, DOI 10.1183/09031936.02.00512001; Jedrychowski W, 1999, ENVIRON HEALTH PERSP, V107, P669, DOI 10.2307/3434460; KANNEL WB, 1983, AM HEART J, V105, P311, DOI 10.1016/0002-8703(83)90532-X; Knuiman MW, 1999, ANN EPIDEMIOL, V9, P297, DOI 10.1016/S1047-2797(98)00066-0; Mckean MC, 2001, EUR RESPIR J, V18, P23, DOI 10.1183/09031936.01.00073101; NIOSH, 1999, 5040 NIOSH; Ochs M, 2004, AM J RESP CRIT CARE, V169, P120, DOI 10.1164/rccm.200308-1107OC; Peters JM, 1999, AM J RESP CRIT CARE, V159, P760, DOI 10.1164/ajrccm.159.3.9804143; Peters JM, 1999, AM J RESP CRIT CARE, V159, P768, DOI 10.1164/ajrccm.159.3.9804144; Raizenne M, 1996, ENVIRON HEALTH PERSP, V104, P506, DOI 10.2307/3432991; Sarnat JA, 2001, ENVIRON HEALTH PERSP, V109, P1053, DOI 10.2307/3454961; SAS Institute, 2002, SAS STAT US GUID VER, VSixth; Schroeder EB, 2003, AM J EPIDEMIOL, V158, P1171, DOI 10.1093/aje/kwg276; Schunemann HJ, 2000, CHEST, V118, P656, DOI 10.1378/chest.118.3.656; SCHWARTZ J, 1989, ENVIRON RES, V50, P309, DOI 10.1016/S0013-9351(89)80012-X; Sherwin RP, 2000, VIRCHOWS ARCH, V437, P422, DOI 10.1007/s004280000262; TAGER IB, 1985, AM REV RESPIR DIS, V131, P752; Tager IB, 1999, AM J RESP CRIT CARE, V160, P387; TAGER IB, 1983, NEW ENGL J MED, V309, P699, DOI 10.1056/NEJM198309223091204; TASHKIN DP, 1994, AM J RESP CRIT CARE, V149, P1209, DOI 10.1164/ajrccm.149.5.8173761; Tolocka MP, 2001, AEROSOL SCI TECH, V34, P88; WANG XB, 1993, AM REV RESPIR DIS, V148, P1502, DOI 10.1164/ajrccm/148.6_Pt_1.1502; WANG XB, 1994, AM J RESP CRIT CARE, V149, P1420, DOI 10.1164/ajrccm.149.6.8004293; WARE JH, 1986, AM REV RESPIR DIS, V133, P834	39	895	922	4	179	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 9	2004	351	11					1057	1067		10.1056/NEJMoa040610	http://dx.doi.org/10.1056/NEJMoa040610			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	852CX	15356303	Bronze			2022-12-24	WOS:000223733900005
J	Hsu, GW; Ober, M; Carell, T; Beese, LS				Hsu, GW; Ober, M; Carell, T; Beese, LS			Error-prone replication of oxidatively damaged DNA by a high-fidelity DNA polymerase	NATURE			English	Article							STEADY-STATE; INSERTION; MUTATIONS; KINETICS; CRYSTAL; EXO(-); SITE; 8-OXO-7,8-DIHYDROGUANINE; RESOLUTION; FRAGMENT	Aerobic respiration generates reactive oxygen species that can damage guanine residues and lead to the production of 8-oxoguanine (8oxoG), the major mutagenic oxidative lesion in the genome(1). Oxidative damage is implicated in ageing(2) and cancer, and its prevalence presents a constant challenge to DNA polymerases that ensure accurate transmission of genomic information. When these polymerases encounter 8oxoG, they frequently catalyse misincorporation of adenine in preference to accurate incorporation of cytosine(3). This results in the propagation of G to T transversions, which are commonly observed somatic mutations associated with human cancers(4,5). Here, we present sequential snapshots of a high-fidelity DNA polymerase during both accurate and mutagenic replication of 8oxoG. Comparison of these crystal structures reveals that 8oxoG induces an inversion of the mismatch recognition mechanisms that normally proofread DNA, such that the 8oxoG.adenine mismatch mimics a cognate base pair whereas the 8oxoG.cytosine base pair behaves as a mismatch. These studies reveal a fundamental mechanism of error-prone replication and show how 8oxoG, and DNA lesions in general, can form mismatches that evade polymerase error-detection mechanisms, potentially leading to the stable incorporation of lethal mutations.	Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; Univ Munich, Dept Chem & Biochem, D-81377 Munich, Germany	Duke University; University of Munich	Beese, LS (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.	lsb@biochem.duke.edu	beese, lorena/G-4993-2010; Carell, Thomas/G-4799-2012	Carell, Thomas/0000-0001-7898-2831				BOOSALIS MS, 1987, J BIOL CHEM, V262, P14689; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CULP SJ, 1989, CHEM RES TOXICOL, V2, P416, DOI 10.1021/tx00012a010; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Freisinger E, 2004, EMBO J, V23, P1494, DOI 10.1038/sj.emboj.7600158; Furge LL, 1997, BIOCHEMISTRY-US, V36, P6475, DOI 10.1021/bi9627267; GOODMAN MF, 1993, CRIT REV BIOCHEM MOL, V28, P83, DOI 10.3109/10409239309086792; Goodman MF, 1997, P NATL ACAD SCI USA, V94, P10493, DOI 10.1073/pnas.94.20.10493; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Hainaut P, 1998, NUCLEIC ACIDS RES, V26, P205, DOI 10.1093/nar/26.1.205; Johnson SJ, 2004, CELL, V116, P803, DOI 10.1016/S0092-8674(04)00252-1; Johnson SJ, 2003, P NATL ACAD SCI USA, V100, P3895, DOI 10.1073/pnas.0630532100; Kiefer JR, 1998, NATURE, V391, P304, DOI 10.1038/34693; Kiefer JR, 1997, STRUCTURE, V5, P95, DOI 10.1016/S0969-2126(97)00169-X; Kool ET, 2002, ANNU REV BIOCHEM, V71, P191, DOI 10.1146/annurev.biochem.71.110601.135453; KOUCHAKDJIAN M, 1991, BIOCHEMISTRY-US, V30, P1403, DOI 10.1021/bi00219a034; Krahn JM, 2003, STRUCTURE, V11, P121, DOI 10.1016/S0969-2126(02)00930-9; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Ling H, 2003, NATURE, V424, P1083, DOI 10.1038/nature01919; Lowe LG, 1996, BIOCHEMISTRY-US, V35, P9840, DOI 10.1021/bi960485x; Miller H, 1997, BIOCHEMISTRY-US, V36, P15336, DOI 10.1021/bi971927n; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; OTWINOWSKI Z, 1997, ENZYMOLOGY MACROMO A; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; vanAalten DMF, 1996, J COMPUT AID MOL DES, V10, P255, DOI 10.1007/BF00355047	27	252	258	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 9	2004	431	7005					217	221		10.1038/nature02908	http://dx.doi.org/10.1038/nature02908			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HI	15322558				2022-12-24	WOS:000223746000051
J	Anttila, T; Helkala, EL; Viitanen, M; Kareholt, I; Fratiglioni, L; Winblad, B; Soininen, H; Tuomilehto, J; Nissinen, A; Kivipelto, M				Anttila, T; Helkala, EL; Viitanen, M; Kareholt, I; Fratiglioni, L; Winblad, B; Soininen, H; Tuomilehto, J; Nissinen, A; Kivipelto, M			Alcohol drinking in middle age and subsequent risk of mild cognitive impairment and dementia in old age: a prospective population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E; NORTH-KARELIA; AVERAGE VOLUME; E GENOTYPE; CONSUMPTION; COMMUNITY; SMOKING; PERFORMANCE; PATTERNS	Objective To evaluate the relation between midlife alcohol consumption and mild cognitive impairment and dementia in old age, and the possible modification of this relation by apolipoprotein E. Design Prospective, population based study. Setting Populations of Kuopio and Joensuu, eastern Finland. Participants Of 1464 men and women aged 65-79 years randomly selected from population based samples studied in 1972 or 1977,1018 (70%) were re-examined in 1998 (after an average follow up of 23 years). Main outcome measures Mild cognitive impairment and dementia in old age. Results Participants who drank no alcohol at midlife and those who drank alcohol frequently were both twice as likely to have mild cognitive impairment in old age as those participants who drank alcohol infrequently. The risk of dementia related to alcohol drinking was modified by the presence of the apolipoprotein e4 allele. ne carriers of apolipoprotein e4 had an increased risk of dementia with increasing alcohol consumption: compared with non-carriers who never drank, the odds ratio for carriers who never drank was 0.6, for infrequent drinkers it was 2.3, and for frequent drinkers was 3.6 (die overall interaction term "drinking frequency*apolipoprotein e4" was significant (P = 0.04), as were the interactions "infrequent drinking*apolipoprotein c4" (P = 0.02) and "frequent drinking*apolipoprotein e4" (P = 0.03)). Non-carriers of apolipoprotein e4 had similar odds ratios for dementia irrespective of alcohol consumption. Conclusion Alcohol drinking in middle age showed a U shaped relation with risk of mild cognitive impairment in old age. Risk of dementia increased with increasing alcohol consumption only in those individuals carrying the apolipoprotein e4 allele.	Karolinska Inst, Neurotec, Div Geriatr Epidemiol, Aging Res Ctr, S-11382 Stockholm, Sweden; Univ Kuopio, Dept Publ Hlth & Gen Practice, FIN-70211 Kuopio, Finland; Karolinska Univ Hosp, Karolinska Inst, Neurotec, Div Geriatr Med, S-14186 Huddinge, Sweden; Univ Kuopio, Dept Neurol & Neurosci, FIN-70211 Kuopio, Finland; Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, SF-00300 Helsinki, Finland	Karolinska Institutet; University of Eastern Finland; Karolinska Institutet; Karolinska University Hospital; University of Eastern Finland; Finland National Institute for Health & Welfare	Kivipelto, M (corresponding author), Karolinska Inst, Neurotec, Div Geriatr Epidemiol, Aging Res Ctr, Box 6401, S-11382 Stockholm, Sweden.	Miia.Kivipelto@uku.fi	Kivipelto, Miia/AAS-3557-2021; Viitanen, Matti/AAY-5163-2020	Kivipelto, Miia/0000-0003-0992-3875				Agarwal DP, 2002, ALCOHOL ALCOHOLISM, V37, P409, DOI 10.1093/alcalc/37.5.409; Braak E, 1999, EUR ARCH PSY CLIN N, V249, P14; Carmelli D, 1999, NEUROEPIDEMIOLOGY, V18, P125, DOI 10.1159/000026204; Cervilla JA, 2000, J NEUROL NEUROSUR PS, V68, P622, DOI 10.1136/jnnp.68.5.622; Commenges D, 2000, EUR J EPIDEMIOL, V16, P357, DOI 10.1023/A:1007614613771; Dufouil C, 2000, EPIDEMIOLOGY, V11, P280, DOI 10.1097/00001648-200005000-00009; Feunekes GIJ, 1999, AM J EPIDEMIOL, V150, P105; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galanis DJ, 2000, AM J PUBLIC HEALTH, V90, P1254, DOI 10.2105/AJPH.90.8.1254; GRAVES AB, 1991, INT J EPIDEMIOL, V20, pS48, DOI 10.1093/ije/20.Supplement_2.S48; HEBERT LE, 1992, AM J EPIDEMIOL, V135, P347, DOI 10.1093/oxfordjournals.aje.a116296; HEBERT LE, 1993, AM J EPIDEMIOL, V137, P881, DOI 10.1093/oxfordjournals.aje.a116749; Huang WY, 2002, J CLIN EPIDEMIOL, V55, P959, DOI 10.1016/S0895-4356(02)00462-6; Kalmijn S, 2002, AM J EPIDEMIOL, V156, P936, DOI 10.1093/aje/kwf135; Kauhanen J, 1999, ARTERIOSCL THROM VAS, V19, P3001, DOI 10.1161/01.ATV.19.12.3001; Kivipelto M, 2001, NEUROLOGY, V56, P1683, DOI 10.1212/WNL.56.12.1683; Larrieu S, 2002, NEUROLOGY, V59, P1594, DOI 10.1212/01.WNL.0000034176.07159.F8; Launer LJ, 1996, AM J EPIDEMIOL, V143, P219; Leroi I, 2002, AM J EPIDEMIOL, V156, P747, DOI 10.1093/aje/kwf107; Lindsay J, 2002, AM J EPIDEMIOL, V156, P445, DOI 10.1093/aje/kwf074; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mukamal KJ, 2003, JAMA-J AM MED ASSOC, V289, P1405, DOI 10.1001/jama.289.11.1405; Orgogozo JM, 1997, REV NEUROL-FRANCE, V153, P185; PETERSEN RC, 1995, JAMA-J AM MED ASSOC, V273, P1274, DOI 10.1001/jama.273.16.1274; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; PUSKA P, 1979, BRIT MED J, V2, P1173, DOI 10.1136/bmj.2.6199.1173; PUSKA P, 1983, BRIT MED J, V287, P1840, DOI 10.1136/bmj.287.6408.1840; Rehm J, 2003, ADDICTION, V98, P1209, DOI 10.1046/j.1360-0443.2003.00467.x; Rehm J, 2003, EUR ADDICT RES, V9, P147, DOI 10.1159/000072221; Ruitenberg A, 2002, LANCET, V359, P281, DOI 10.1016/S0140-6736(02)07493-7; SAUNDERS PA, 1991, BRIT J PSYCHIAT, V159, P213, DOI 10.1192/bjp.159.2.213; Smith GE, 1996, AGING NEUROPSYCHOL C, V3, P141, DOI 10.1080/13825589608256619; The 1999 ESPAD Report, 2000, 1999 ESPAD REPORT AL; Thomas VS, 2001, J AM GERIATR SOC, V49, P415, DOI 10.1046/j.1532-5415.2001.49085.x; Truelsen T, 2002, NEUROLOGY, V59, P1313, DOI 10.1212/01.WNL.0000031421.50369.E7; TSUKAMOTO K, 1993, J LAB CLIN MED, V121, P598; VARTIAINEN E, 1994, INT J EPIDEMIOL, V23, P495, DOI 10.1093/ije/23.3.495	39	187	198	2	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 4	2004	329	7465					539	542A		10.1136/bmj.38181.418958.BE	http://dx.doi.org/10.1136/bmj.38181.418958.BE			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	853DE	15304383	Green Published, Bronze, Green Submitted			2022-12-24	WOS:000223805800018
J	Roth, GS; Mattison, JA; Ottinger, MA; Chachich, ME; Lane, MA; Ingram, DK				Roth, GS; Mattison, JA; Ottinger, MA; Chachich, ME; Lane, MA; Ingram, DK			Aging in rhesus monkeys: Relevance to human health interventions	SCIENCE			English	Editorial Material							NONHUMAN PRIMATE MODELS; AGE-RELATED DECLINE; CALORIC RESTRICTION; DIETARY RESTRICTION; CYTOKINE PRODUCTION; METABOLIC SYNDROME; BRAIN; LONGEVITY; MENOPAUSE; RATS	Progress in gerontologicat research has been promoted through the use of numerous animal models, which have helped identify possible mechanisms of aging and age-related chronic diseases and evaluate possible interventions with potential relevance to human aging and disease. Further development of nonhuman primate models, particularly rhesus monkeys, could accelerate this progress, because their closer genetic relationship to humans produces a highly similar aging phenotype. Because the relatively tong lives of primates increase the administrative and economic demands on research involving them, new emphasis has emerged on increasing the efficient use of these valuable resources through cooperative, interdisciplinary research.	NIA, Lab Expt Gerontol, Intramural Res Program, Gerontol Res Ctr,NIH, Baltimore, MD 21224 USA; Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University System of Maryland; University of Maryland College Park	Ingram, DK (corresponding author), NIA, Lab Expt Gerontol, Intramural Res Program, Gerontol Res Ctr,NIH, 5600 Nathan Shock Dr, Baltimore, MD 21224 USA.	ingramd@grc.nia.nih.gov			NATIONAL INSTITUTE ON AGING [Z01AG000304] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BASKERVILLE A, 1992, J COMP PATHOL, V107, P49, DOI 10.1016/0021-9975(92)90095-C; Bellino FL, 2003, BIOL REPROD, V68, P10, DOI 10.1095/biolreprod.102.005215; Black A, 2001, BONE, V28, P295, DOI 10.1016/S8756-3282(00)00452-X; Bodkin NL, 2003, HORM METAB RES, V35, P617, DOI 10.1055/s-2003-43510; Bodkin NL, 2003, J GERONTOL A-BIOL, V58, P212; BODKIN NL, 1995, J GERONTOL A-BIOL, V50, pB142, DOI 10.1093/gerona/50A.3.B142; Brewer M, 2001, COMPARATIVE MED, V51, P424; Calhoun ME, 2004, J COMP NEUROL, V475, P238, DOI 10.1002/cne.20181; CHAKRABORTY M, 1995, CANCER RES, V55, P1525; CLARKSON TB, 1994, JAMA-J AM MED ASSOC, V271, P317; Colman RJ, 1999, METHODS AGING RES, P249; Duan HL, 2003, CEREB CORTEX, V13, P950, DOI 10.1093/cercor/13.9.950; Dunbar CE, 2001, J INTERN MED, V249, P329, DOI 10.1046/j.1365-2796.2001.00805.x; Dunnett SB, 2001, TRENDS PHARMACOL SCI, V22, P211, DOI 10.1016/S0165-6147(00)01707-7; FANTON JW, 1991, RADIAT RES, V126, P141, DOI 10.2307/3577812; Gilardi KVK, 1997, BIOL REPROD, V57, P335, DOI 10.1095/biolreprod57.2.335; Grondin R, 2002, BRAIN, V125, P2191, DOI 10.1093/brain/awf234; HEILBRONN L, 2004, 33 ANN M AM AG ASS S; Herndon JG, 1998, NEUROBIOL AGING, V19, P267, DOI 10.1016/S0197-4580(98)00054-2; HUBBARD GB, 1985, VET PATHOL, V22, P88, DOI 10.1177/030098588502200116; KALER LW, 1986, ENDOCRINOLOGY, V119, P566, DOI 10.1210/endo-119-2-566; KAUFMAN PL, 1982, EXP EYE RES, V34, P287, DOI 10.1016/0014-4835(82)90061-6; Keuker JIH, 2003, NEUROBIOL AGING, V24, P157, DOI 10.1016/S0197-4580(02)00062-3; Kim JJ, 2001, CLIN CANCER RES, V7, p882S; Kim MJ, 1997, J NUTR, V127, P2293, DOI 10.1093/jn/127.12.2293; Kordower JH, 2003, ANN NEUROL, V53, pS120, DOI 10.1002/ana.10485; Kramer PA, 2002, J ORTHOP RES, V20, P399, DOI 10.1016/S0736-0266(01)00122-X; Lane MA, 1997, J CLIN ENDOCR METAB, V82, P2093, DOI 10.1210/jc.82.7.2093; Lane MA, 1996, P NATL ACAD SCI USA, V93, P4159, DOI 10.1073/pnas.93.9.4159; Mascarucci P, 2001, AGING-CLIN EXP RES, V13, P85, DOI 10.1007/BF03351530; Matochik JA, 2000, NEUROBIOL AGING, V21, P591, DOI 10.1016/S0197-4580(00)00134-2; Mattison JA, 2003, EXP GERONTOL, V38, P35, DOI 10.1016/S0531-5565(02)00146-8; MATTISON JA, IN PRESS NEUROBIOL A; Morris ED, 1999, J CEREBR BLOOD F MET, V19, P218, DOI 10.1097/00004647-199902000-00013; Moscrip TD, 2000, J GERONTOL A-BIOL, V55, pB373, DOI 10.1093/gerona/55.8.B373; Oliver WR, 2001, P NATL ACAD SCI USA, V98, P5306, DOI 10.1073/pnas.091021198; Peters A, 2002, PROG BRAIN RES, V136, P455; Price DL, 1991, BRAIN PATHOL, V1, P287, DOI 10.1111/j.1750-3639.1991.tb00672.x; Ramsey JJ, 2000, EXP GERONTOL, V35, P1131, DOI 10.1016/S0531-5565(00)00166-2; Rapp PR, 2003, J NEUROSCI, V23, P5708; Rink L, 1998, MECH AGEING DEV, V102, P199, DOI 10.1016/S0047-6374(97)00153-X; Roth GS, 1997, J GERONTOL A-BIOL, V52, pB98, DOI 10.1093/gerona/52A.2.B98; ROTH GS, 1995, NAT MED, V1, P414, DOI 10.1038/nm0595-414; Roth GS, 2002, SCIENCE, V297, P811, DOI 10.1126/science.1071851; Roth GS, 2001, J CLIN ENDOCR METAB, V86, P3292, DOI 10.1210/jc.86.7.3292; SCHWARTZ SM, 1992, AM J PHYS ANTHROPOL, V89, P109, DOI 10.1002/ajpa.1330890110; Sell DR, 1996, P NATL ACAD SCI USA, V93, P485, DOI 10.1073/pnas.93.1.485; SEPEHR S, 2003, ACTA NEUROPATHOL, V105, P145; Small SA, 2004, P NATL ACAD SCI USA, V101, P7181, DOI 10.1073/pnas.0400285101; Smith DE, 1999, P NATL ACAD SCI USA, V96, P10893, DOI 10.1073/pnas.96.19.10893; Smucny DA, 2004, J MED PRIMATOL, V33, P48, DOI 10.1111/j.1600-0684.2003.00052.x; Steinbaum SR, 2004, PROG CARDIOVASC DIS, V46, P321, DOI 10.1016/j.pcad.2003.08.005; Torre P, 2000, HEARING RES, V142, P131, DOI 10.1016/S0378-5955(00)00025-3; Uno H, 1996, NEUROBIOL AGING, V17, P275, DOI 10.1016/0197-4580(95)02063-2; Valverde CR, 2000, COMPARATIVE MED, V50, P540; Voytko ML, 2001, SYNAPSE, V39, P95, DOI 10.1002/1098-2396(20010101)39:1<95::AID-SYN12>3.0.CO;2-2; Voytko ML, 1999, NEUROBIOL AGING, V20, P617, DOI 10.1016/S0197-4580(99)00097-4; Weindruch R., 1988, RETARDATION AGING DI; Winegar DA, 2001, J LIPID RES, V42, P1543; Wise PM, 2002, RECENT PROG HORM RES, V57, P235, DOI 10.1210/rp.57.1.235; Zhang ZM, 2000, J GERONTOL A-BIOL, V55, pB473, DOI 10.1093/gerona/55.10.B473	61	243	250	2	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2004	305	5689					1423	1426		10.1126/science.1102541	http://dx.doi.org/10.1126/science.1102541			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852NK	15353793				2022-12-24	WOS:000223761900036
J	Escher, M; Perneger, TV; Chevrolet, JC				Escher, M; Perneger, TV; Chevrolet, JC			National questionnaire survey on what influences doctors' decisions about admission to intensive care	BRITISH MEDICAL JOURNAL			English	Article							ILL PATIENTS; UNIT; TRIAGE; PHYSICIANS; RESUSCITATION; CANCER; ALLOCATION; RESOURCES; JUDGMENT; SUPPORT	Objectives To determine what influences doctors' decisions about admission of patients to intensive care. Design National questionnaire survey using eight clinical vignettes involving hypothetical patients. Setting Switzerland. Participants 402 Swiss doctors specialising in intensive care. Main outcome measures Rating of factors influencing decisions on admission and response to eight hypothetical clinical scenarios. Results Of 381 doctors agreeing to participate, 232 (61%) returned questionnaires. Most rated as important or very important the prognosis of the underlying disease (82%) and of the acute illness (81%) and the patients' wishes (71%). Few considered the important socioeconomic circumstances of the patient (20%), religious beliefs (3%) and emotional state (6%). In the vignettes, underlying disease (cancer versus non-cancerous disease) was not associated with admission to intensive care, but four other factors were: patients' wishes (odds ratio 3.0, 95% confidence interval 2.0 to 4.6), upbeat personality (2.9, 1.9 to 4.4), younger age (1.5, 1.1 to 2.2), and a greater number of beds available in intensive care (1.8, 1.2 to 2.5). Conclusions Doctors' decisions to admit patients to intensive care are influenced by patients' wishes and ethically problematic non-medical factors such as a patient's personality or availability of beds. Patients with cancer are not discriminated against.	Univ Hosp Geneva, Div Clin Pharmacol & Toxicol, CH-1211 Geneva 14, Switzerland; Univ Hosp Geneva, Qual Care Unit, CH-1211 Geneva, Switzerland; Univ Hosp Geneva, Med Intens Care Div, CH-1211 Geneva 14, Switzerland	University of Geneva; University of Geneva; University of Geneva	Escher, M (corresponding author), Univ Hosp Geneva, Div Clin Pharmacol & Toxicol, CH-1211 Geneva 14, Switzerland.	monica.escher@hcuge.ch						Azoulay E, 2000, CRIT CARE MED, V28, P3044, DOI 10.1097/00003246-200008000-00061; Azoulay E, 2001, CRIT CARE MED, V29, P2132, DOI 10.1097/00003246-200111000-00014; Claessens MT, 2000, J AM GERIATR SOC, V48, pS146, DOI 10.1111/j.1532-5415.2000.tb03124.x; Coppola KM, 2001, ARCH INTERN MED, V161, P431, DOI 10.1001/archinte.161.3.431; Egol A, 1999, CRIT CARE MED, V27, P633; EISENBERG JM, 1979, ANN INTERN MED, V90, P957, DOI 10.7326/0003-4819-90-6-957; ELY JW, 1992, J AM GERIATR SOC, V40, P471, DOI 10.1111/j.1532-5415.1992.tb02013.x; Furnham A, 2000, J SOC BEHAV PERS, V15, P185; Ghusn HF, 1997, J AM GERIATR SOC, V45, P1118, DOI 10.1111/j.1532-5415.1997.tb05977.x; Hanson LC, 1996, ARCH INTERN MED, V156, P785, DOI 10.1001/archinte.156.7.785; JACOBS P, 1990, CRIT CARE MED, V18, P1282, DOI 10.1097/00003246-199011000-00020; Joynt GM, 2001, INTENS CARE MED, V27, P1459, DOI 10.1007/s001340101041; KOHLENBERGER C, 1994, JAMA-J AM MED ASSOC, V271, P1200; Lanken PN, 1997, AM J RESP CRIT CARE, V156, P1282; LAWRENCE VA, 1987, ARCH INTERN MED, V147, P1637, DOI 10.1001/archinte.147.9.1637; NUCKTON TJ, 1995, ARCH INTERN MED, V155, P1087, DOI 10.1001/archinte.155.10.1087; Redelmeier DA, 2001, CAN MED ASSOC J, V164, P358; Sprung CL, 1997, INTENS CARE MED, V23, P1011, DOI 10.1007/s001340050449; SUHL J, 1994, ARCH INTERN MED, V154, P90, DOI 10.1001/archinte.154.1.90; Tanvetyanon T, 2003, CRIT CARE MED, V31, P60, DOI 10.1097/00003246-200301000-00009; Tarnow-Mordi WO, 2000, LANCET, V356, P185, DOI 10.1016/S0140-6736(00)02478-8; Vincent JL, 1998, INTENS CARE MED, V24, P1251, DOI 10.1007/s001340050758; WACHTER RM, 1989, ANN INTERN MED, V111, P525, DOI 10.7326/0003-4819-111-6-525	23	80	84	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 21	2004	329	7463					425	428		10.1136/bmj.329.7463.425	http://dx.doi.org/10.1136/bmj.329.7463.425			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	849EA	15321898	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000223520300015
J	Pedersen, TH; Nielsen, OB; Lamb, GD; Stephenson, DG				Pedersen, TH; Nielsen, OB; Lamb, GD; Stephenson, DG			Intracellular acidosis enhances the excitability of working muscle	SCIENCE			English	Article							FROG SKELETAL-MUSCLE; CHLORIDE CONDUCTANCE; LACTIC-ACID; FIBERS; RAT; POTASSIUM; CHANNELS; FATIGUE; TWITCH; PH	Intracellular acidification of skeletal muscles is commonly thought to contribute to muscle fatigue. However, intracellular acidosis also acts to preserve muscle excitability when muscles become depolarized, which occurs with working muscles. Here, we show that this process may be mediated by decreased chloride permeability, which enables action potentials to still be propagated along the internal network of tubules in a muscle fiber (the T system) despite muscle depolarization. These results implicate chloride ion channels in muscle function and emphasize that intracellular acidosis of muscle has protective effects during muscle fatigue.	La Trobe Univ, Dept Zool, Melbourne, Vic 3086, Australia; Univ Aarhus, Dept Physiol, DK-8000 Aarhus, Denmark	La Trobe University; Aarhus University	Stephenson, DG (corresponding author), La Trobe Univ, Dept Zool, Melbourne, Vic 3086, Australia.	G.Stephenson@zoo.latrobe.edu.au		Holm Pedersen, Thomas/0000-0002-1060-4989; Nielsen, Ole Baekgaard/0000-0003-3535-7862				Balog EM, 2001, J APPL PHYSIOL, V90, P228, DOI 10.1152/jappl.2001.90.1.228; BRETAG AH, 1987, PHYSIOL REV, V67, P618, DOI 10.1152/physrev.1987.67.2.618; Coonan JR, 1998, J PHYSIOL-LONDON, V509, P551, DOI 10.1111/j.1469-7793.1998.551bn.x; DULHUNTY AF, 1979, J MEMBRANE BIOL, V45, P293, DOI 10.1007/BF01869290; FITTS RH, 1994, PHYSIOL REV, V74, P49, DOI 10.1152/physrev.1994.74.1.49; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HODGKIN AL, 1959, J PHYSIOL-LONDON, V148, P127, DOI 10.1113/jphysiol.1959.sp006278; HUTTER OF, 1967, J PHYSIOL-LONDON, V189, P403, DOI 10.1113/jphysiol.1967.sp008176; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; LAMB GD, 1994, J PHYSIOL-LONDON, V478, P331, DOI 10.1113/jphysiol.1994.sp020253; Launikonis BS, 2004, J GEN PHYSIOL, V123, P231, DOI 10.1085/jgp.200308946; Nielsen OB, 2001, J PHYSIOL-LONDON, V536, P161, DOI 10.1111/j.1469-7793.2001.t01-1-00161.x; Ortenblad N, 2003, J PHYSIOL-LONDON, V548, P139, DOI 10.1113/jphysiol.2002.036657; PALADE PT, 1977, J GEN PHYSIOL, V69, P325, DOI 10.1085/jgp.69.3.325; Posterino GS, 2000, J PHYSIOL-LONDON, V527, P131, DOI 10.1111/j.1469-7793.2000.t01-2-00131.x; Posterino GS, 2001, PFLUG ARCH EUR J PHY, V442, P197, DOI 10.1007/s004240100528; Ruff RL, 1996, ACTA PHYSIOL SCAND, V156, P159, DOI 10.1046/j.1365-201X.1996.189000.x; Sejersted OM, 2000, PHYSIOL REV, V80, P1411, DOI 10.1152/physrev.2000.80.4.1411; Sjogaard G, 1990, Acta Physiol Scand Suppl, V593, P1; Stephenson DG, 1998, ACTA PHYSIOL SCAND, V162, P229, DOI 10.1046/j.1365-201X.1998.0304f.x; Westerblad H, 2002, NEWS PHYSIOL SCI, V17, P17	21	224	231	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 20	2004	305	5687					1144	1147		10.1126/science.1101141	http://dx.doi.org/10.1126/science.1101141			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849RD	15326352				2022-12-24	WOS:000223557400045
J	Roper, C; Pearce, R; Nair, S; Sharp, B; Nosten, F; Anderson, T				Roper, C; Pearce, R; Nair, S; Sharp, B; Nosten, F; Anderson, T			Intercontinental spread of pyrimethamine-resistant malaria	SCIENCE			English	Article							ANTIMALARIAL-DRUG-RESISTANCE; PLASMODIUM-FALCIPARUM; MUTATIONS		Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; SW Fdn Biomed Res, San Antonio, TX 78284 USA; MRC, Durban, South Africa; Shoklo Malaria Res Unit, Mae Sot, Tak, Thailand	University of London; London School of Hygiene & Tropical Medicine; Texas Biomedical Research Institute; Mahidol University	Roper, C (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	cally.roper@lshtm.ac.uk	Nosten, Francois/AAC-5509-2019; Roper, Cally/K-2989-2013	Nosten, Francois/0000-0002-7951-0745; Roper, Cally/0000-0002-6545-309X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI048071] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Cortese JF, 2002, J INFECT DIS, V186, P999, DOI 10.1086/342946; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Nair S, 2003, MOL BIOL EVOL, V20, P1526, DOI 10.1093/molbev/msg162; Plowe CV, 1997, J INFECT DIS, V176, P1590, DOI 10.1086/514159; Roper C, 2003, LANCET, V361, P1174, DOI 10.1016/S0140-6736(03)12951-0; Ryan ET, 2000, NEW ENGL J MED, V342, P1716, DOI 10.1056/NEJM200006083422306; White N, 1999, PHILOS T R SOC B, V354, P739, DOI 10.1098/rstb.1999.0426; WHITE NJ, 1992, J ANTIMICROB CHEMOTH, V30, P571, DOI 10.1093/jac/30.5.571; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813	9	374	378	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 20	2004	305	5687					1124	1124		10.1126/science.1098876	http://dx.doi.org/10.1126/science.1098876			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849RD	15326348				2022-12-24	WOS:000223557400037
J	Edwards, M; Richardson, AJ				Edwards, M; Richardson, AJ			Impact of climate change on marine pelagic phenology and trophic mismatch	NATURE			English	Article							NORTH-SEA; PHYTOPLANKTON BLOOMS; CONSEQUENCES; TEMPERATURE; COPEPODS; GROWTH	Phenology, the study of annually recurring life cycle events such as the timing of migrations and flowering, can provide particularly sensitive indicators of climate change(1). Changes in phenology may be important to ecosystem function because the level of response to climate change may vary across functional groups and multiple trophic levels. The decoupling of phenological relationships will have important ramifications for trophic interactions, altering food-web structures and leading to eventual ecosystem-level changes. Temperate marine environments may be particularly vulnerable to these changes because the recruitment success of higher trophic levels is highly dependent on synchronization with pulsed planktonic production(2,3). Using long-term data of 66 plankton taxa during the period from 1958 to 2002, we investigated whether climate warming signals(4) are emergent across all trophic levels and functional groups within an ecological community. Here we show that not only is the marine pelagic community responding to climate changes, but also that the level of response differs throughout the community and the seasonal cycle, leading to a mismatch between trophic levels and functional groups.	The Lab, Sir Alister Hardy Fdn Ocean Sci, Plymouth PL1 2PB, Devon, England		Edwards, M (corresponding author), The Lab, Sir Alister Hardy Fdn Ocean Sci, Citadel Hill, Plymouth PL1 2PB, Devon, England.	maed@sahfos.ac.uk	Richardson, Anthony J/B-3649-2010	Richardson, Anthony J/0000-0002-9289-7366; Edwards, Martin/0000-0002-5716-4714				Beaugrand G, 2003, PROG OCEANOGR, V58, P235, DOI 10.1016/j.pocean.2003.08.006; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Colebrook J. M., 1965, Bulletin of Marine Ecology, V6, P123; COLEBROOK JM, 1979, MAR BIOL, V51, P23, DOI 10.1007/BF00389027; Cushing D. H., 1990, ADV MAR BIOL, P250, DOI DOI 10.1016/S0065-2881(08)60202-3); Eilertsen HC, 2000, S AFR J MARINE SCI, V22, P323, DOI 10.2989/025776100784125717; EILERTSEN HC, 1995, MAR ECOL PROG SER, V116, P303, DOI 10.3354/meps116303; Greve W, 1996, ICES J MAR SCI, V53, P951, DOI 10.1006/jmsc.1996.0117; Greve W., 2004, PHENOLOGY INTEGRATIV, P385; Harrington R, 1999, TRENDS ECOL EVOL, V14, P146, DOI 10.1016/S0169-5347(99)01604-3; Hirst AG, 2003, LIMNOL OCEANOGR, V48, P1988, DOI 10.4319/lo.2003.48.5.1988; Hjort J., 1914, RAPP P V REUN CONS I, V20, P1; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; Lindley JA, 1998, INVERTEBR REPROD DEV, V33, P209, DOI 10.1080/07924259.1998.9652633; McCarty JP, 2001, CONSERV BIOL, V15, P320, DOI 10.1046/j.1523-1739.2001.015002320.x; McQuoid MR, 1996, J PHYCOL, V32, P889, DOI 10.1111/j.0022-3646.1996.00889.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pyper BJ, 1998, CAN J FISH AQUAT SCI, V55, P2127; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Schiermeier Q, 2004, NATURE, V428, P4, DOI 10.1038/428004a; Siegismund F, 2001, CLIMATE RES, V18, P39, DOI 10.3354/cr018039; Sverdrup H.U., 1953, ICES J MAR SCI, V18, P287, DOI [10.1093/icesjms/18.3.287, DOI 10.1093/ICESJMS/18.3.287]; TOWNSEND DW, 1992, NATURE, V360, P59, DOI 10.1038/360059a0; van Haren H, 1998, J MAR RES, V56, P655, DOI 10.1357/002224098765213621; VANBEUSEKOM JEE, 1994, 6471 DAN ENV PROT AG; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WARNER AJ, 1994, PROG OCEANOGR, V34, P237, DOI 10.1016/0079-6611(94)90011-6; WEAR RG, 1974, J MAR BIOL ASSOC UK, V54, P745, DOI 10.1017/S0025315400022918	29	1490	1535	15	948	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2004	430	7002					881	884		10.1038/nature02808	http://dx.doi.org/10.1038/nature02808			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318219				2022-12-24	WOS:000223369800039
J	Steinbrook, R				Steinbrook, R			Antiretroviral medications - From Thailand to Africa	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	2	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 19	2004	351	8					739	739		10.1056/NEJMp048201	http://dx.doi.org/10.1056/NEJMp048201			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	847CY	15317884				2022-12-24	WOS:000223367900003
J	Kawakubo, M; Ito, Y; Okimura, Y; Kobayashi, M; Sakura, K; Kasama, S; Fukuda, MN; Fukuda, M; Katsuyama, T; Nakayama, J				Kawakubo, M; Ito, Y; Okimura, Y; Kobayashi, M; Sakura, K; Kasama, S; Fukuda, MN; Fukuda, M; Katsuyama, T; Nakayama, J			Natural antibiotic function of a human gastric mucin against Helicobacter pylori infection	SCIENCE			English	Article							EXPRESSION CLONING; MUCOUS CELLS; GLYCOSYLATION; AUTOIMMUNITY; ADHESIN; FORMS	Helicobacter pylori infects the stomachs of nearly a half the human population, yet most infected individuals remain asymptomatic, which suggests that there is a host defense against this bacterium. Because H. pylori is rarely found in deeper portions of the gastric mucosa, where O-glycans are expressed that have terminal alpha1,4-linked N-acetylglucosamine, we tested whether these O-glycans might affect H. pylori growth. Here, we report that these O-glycans have antimicrobial activity against H. pylori, inhibiting its biosynthesis of cholesteryl-alpha-D-glucopyranoside, a major cell wall component. Thus, the unique O-glycans in gastric mucin appeared to function as a natural antibiotic, protecting the host from H. pylori infection.	Shinshu Univ, Sch Med, Dept Pathol, Matsumoto, Nagano 3908621, Japan; Shinshu Univ, Sch Med, Dept Lab Med, Matsumoto, Nagano 3908621, Japan; Shinshu Univ, Grad Sch Med, Inst Organ Transplants Reconstruct Med & Tissue E, Matsumoto, Nagano 3908621, Japan; Burnham Inst, Canc Res Ctr, Glycobiol Program, La Jolla, CA 92037 USA	Shinshu University; Shinshu University; Shinshu University; Sanford Burnham Prebys Medical Discovery Institute	Nakayama, J (corresponding author), Shinshu Univ, Sch Med, Dept Pathol, Asahi 3-1-1, Matsumoto, Nagano 3908621, Japan.	jun@hsp.md.shinshu-u.ac.jp		KAWAKUBO, MASATOMO/0000-0001-5106-5742	NATIONAL CANCER INSTITUTE [P01CA071932, R37CA033000, R01CA033000] Funding Source: NIH RePORTER; NCI NIH HHS [CA 71932, CA 33000] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akama TO, 2002, SCIENCE, V295, P124, DOI 10.1126/science.1065570; Cave D R, 2001, Semin Gastrointest Dis, V12, P196; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Enroth H, 1999, HELICOBACTER, V4, P7, DOI 10.1046/j.1523-5378.1999.09034.x; Finlay J, 2003, J ANTIMICROB CHEMOTH, V52, P18, DOI 10.1093/jac/dkg286; Hidaka E, 2001, GUT, V49, P474, DOI 10.1136/gut.49.4.474; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; HIRAI Y, 1995, J BACTERIOL, V177, P5327, DOI 10.1128/jb.177.18.5327-5333.1995; Horii T, 2002, HELICOBACTER, V7, P39, DOI 10.1046/j.1523-5378.2002.00054.x; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; INAMOTO Y, 1993, J CLIN GASTROENTEROL, V17, pS136, DOI 10.1097/00004836-199312001-00024; Ishihara K, 1996, BIOCHEM J, V318, P409, DOI 10.1042/bj3180409; ITO Y, UNPUB; KAWAKUBO M, UNPUB; Lowe JB, 2001, CELL, V104, P809, DOI 10.1016/S0092-8674(01)00277-X; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Nakayama J, 1996, J BIOL CHEM, V271, P3684; NAKAYAMA J, 1995, P NATL ACAD SCI USA, V92, P7031, DOI 10.1073/pnas.92.15.7031; Nakayama J, 1999, P NATL ACAD SCI USA, V96, P8991, DOI 10.1073/pnas.96.16.8991; OTA H, 1991, HISTOCHEM J, V23, P22, DOI 10.1007/BF01886504; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; SIPPONEN P, 1993, SCAND J GASTROENTERO, V28, P3, DOI 10.3109/00365529309098333; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Yeh JC, 2001, CELL, V105, P957, DOI 10.1016/S0092-8674(01)00394-4	26	256	272	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2004	305	5686					1003	1006		10.1126/science.1099250	http://dx.doi.org/10.1126/science.1099250			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845ND	15310903				2022-12-24	WOS:000223250700048
J	Anselmo, J; Cao, DC; Karrison, T; Weiss, RE; Refetoff, S				Anselmo, J; Cao, DC; Karrison, T; Weiss, RE; Refetoff, S			Fetal loss associated with excess thyroid hormone exposure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RECEPTOR-BETA; RESISTANCE; PREGNANCY; HYPERTHYROIDISM; MUTATIONS; ABORTION; DISEASE; WOMEN; RISK; GENE	Context Maternal hypothyroidism and hyperthyroidism have deleterious effects on the outcome of pregnancy. While the effects of thyroid hormone (TH) deprivation on the fetus, independently from that on the mother, can be studied in infants with congenital hypothyroidism, this is not the case in those with fetal thyrotoxicosis. Objective To study the effects of TH excess on fetuses carried by mothers with resistance to TH (RTH) who are euthyroid despite high TH levels but who may carry normal fetuses that are exposed to high maternal hormone levels. Design, Setting, and Participants Retrospective study of 167 members of an Azorean family with RTH. Affected individuals had the RTH phenotype (high serum concentration of free thyroxine and triiodothyronine without suppressed thyrotropin) confirmed by genotyping to identify the Arg243-->Gln mutation in the TH receptor p gene. Main Outcome Measures Pregnancy outcome of affected mothers vs that of unaffected mothers carrying fetuses conceived by affected fathers, as well as that of unaffected first-degree relatives and outcomes from the general island population. Comparison of birth weights and blood concentrations of thyrotropin (TSH) obtained during routine neonatal screening of infants born to these 3 groups. Results Thirty-six couples with complete information belonged to 1 of 3 groups: affected mothers (n=9), affected fathers (n=9), and unaffected relatives (n=18). Mean miscarriage rates were 22.9%, 2.0%, and 4.4%, respectively (chi(2)=8.66, P=.01). Affected mothers had an increased rate of miscarriage (z=3.10, P=.002, by Wilcoxon rank-sum test). They had marginally higher than expected numbers of affected offspring, ie, 20 affected and 11 unaffected children (P=.07), while affected fathers had 15 affected and 12 unaffected children (P=.35). Unaffected infants born to affected mothers were significantly smaller than affected infants, having a mean SD score for gestational age of -1.79 (SD, 0.86) vs -0.06 (SD, 1.11) to -0.22 (SD, 0.70) for all other groups (P<.001). Only unaffected infants born to affected mothers had undetectable blood levels of TSH. Conclusion There was a higher rate of miscarriage in mothers affected by RTH that may have involved predominantly unaffected fetuses. The lower birth weight and suppressed levels of TSH in unaffected infants born to affected mothers indicates that the high maternal TH levels produce fetal thyrotoxicosis. These data indicate a direct toxic effect of TH excess on the fetus.	Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; Univ Chicago, Comm Genet, Chicago, IL 60637 USA; Univ Chicago, Comm Mol Med, Chicago, IL 60637 USA; Hosp Espirito Santo, Endocrinol Unit, Ponta Delgada, Azores, Portugal; Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Chicago, Comm Mol Med, Chicago, IL 60637 USA; Univ Chicago, Comm Nutr Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago	Refetoff, S (corresponding author), Univ Chicago, Dept Med, MC 3090,5841 S Maryland Ave, Chicago, IL 60637 USA.	refetoff@uchicago.edu	Refetoff, Samuel/ABB-1263-2021; Cao, Dingcai/E-8404-2010	Refetoff, Samuel/0000-0003-0164-8231; 	NATIONAL CENTER FOR RESEARCH RESOURCES [K24RR018372] Funding Source: NIH RePORTER; NCRR NIH HHS [RR18372, RR00055] Funding Source: Medline; NIDDK NIH HHS [DK58258, DK17050] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abramson J, 2001, THYROID, V11, P57, DOI 10.1089/10507250150500676; Anselmo J, 2001, J CLIN ENDOCR METAB, V86, P4273, DOI 10.1210/jc.86.9.4273; BECKS GP, 1991, MED CLIN N AM, V75, P121, DOI 10.1016/S0025-7125(16)30475-8; BURROW GN, 1994, NEW ENGL J MED, V331, P1072; Collingwood TN, 1998, EMBO J, V17, P4760, DOI 10.1093/emboj/17.16.4760; de La Rochebrochard E, 2002, HUM REPROD, V17, P1649, DOI 10.1093/humrep/17.6.1649; Galton VA, 1999, J CLIN INVEST, V103, P979, DOI 10.1172/JCI6073; Glinoer D, 1997, ENDOCR REV, V18, P404, DOI 10.1210/er.18.3.404; Glinoer D, 2000, THYROID, V10, P871, DOI 10.1089/thy.2000.10.871; HARAKAWA S, 1989, ACTA ENDOCRINOL-COP, V121, P739, DOI 10.1530/acta.0.1210739; KOPP P, 1995, NEW ENGL J MED, V332, P150, DOI 10.1056/NEJM199501193320304; Mestman JH, 1997, CLIN OBSTET GYNECOL, V40, P45, DOI 10.1097/00003081-199703000-00007; Mestman JH, 1998, ENDOCRIN METAB CLIN, V27, P127, DOI 10.1016/S0889-8529(05)70303-0; MILLS JL, 1988, NEW ENGL J MED, V319, P1617, DOI 10.1056/NEJM198812223192501; MORREALE DE, 2000, J CLIN ENDOCR METAB, V85, P3975, DOI DOI 10.1210/JCEM.85.11.6961; Muller AF, 1999, FERTIL STERIL, V71, P30, DOI 10.1016/S0015-0282(98)00394-X; Phoojaroenchanachai M, 2001, CLIN ENDOCRINOL, V54, P365, DOI 10.1046/j.1365-2265.2001.01224.x; REFETOFF S, 1993, ENDOCR REV, V14, P348, DOI 10.1210/er.14.3.348; REFETOFF S, 1967, J CLIN ENDOCR METAB, V27, P279, DOI 10.1210/jcem-27-2-279; Refetoff S, 2001, METABOLIC MOL BASES, P4029; Safer JD, 1998, J BIOL CHEM, V273, P30175, DOI 10.1074/jbc.273.46.30175; WEISS RE, 1993, J CLIN INVEST, V91, P2408, DOI 10.1172/JCI116474; Yagi H, 1997, J CLIN ENDOCR METAB, V82, P1608, DOI 10.1210/jc.82.5.1608	23	171	178	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2004	292	6					691	695		10.1001/jama.292.6.691	http://dx.doi.org/10.1001/jama.292.6.691			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844RM	15304465				2022-12-24	WOS:000223177300022
J	McSween, HY; Arvidson, RE; Bell, JF; Blaney, D; Cabrol, NA; Christensen, PR; Clark, BC; Crisp, JA; Crumpler, LS; Des Marais, DJ; Farmer, JD; Gellert, R; Ghosh, A; Gorevan, S; Graff, T; Grant, J; Haskin, LA; Herkenhoff, KE; Johnson, JR; Jolliff, BL; Klingelhoefer, G; Knudson, AT; McLEnnan, S; Milam, KA; Moersch, JE; Morris, RV; Rieder, R; Ruff, SW; de Souza, PA; Squyres, SW; Wanke, H; Wang, A; Wyatt, MB; Yen, A; Zipfel, J				McSween, HY; Arvidson, RE; Bell, JF; Blaney, D; Cabrol, NA; Christensen, PR; Clark, BC; Crisp, JA; Crumpler, LS; Des Marais, DJ; Farmer, JD; Gellert, R; Ghosh, A; Gorevan, S; Graff, T; Grant, J; Haskin, LA; Herkenhoff, KE; Johnson, JR; Jolliff, BL; Klingelhoefer, G; Knudson, AT; McLEnnan, S; Milam, KA; Moersch, JE; Morris, RV; Rieder, R; Ruff, SW; de Souza, PA; Squyres, SW; Wanke, H; Wang, A; Wyatt, MB; Yen, A; Zipfel, J			Basaltic rocks analyzed by the Spirit rover in Gusev Crater	SCIENCE			English	Article							CHEMICAL CLASSIFICATION; PATHFINDER SITE; VOLCANIC-ROCKS; SOILS; MARS	The Spirit landing site in Gusev Crater on Mars contains dark, fine-grained, vesicular rocks interpreted as lavas. Pancam and Mini-Thermal Emission Spectrometer (Mini-TES) spectra suggest that all of these rocks are similar but have variable coatings and dust mantles. Magnified images of brushed and abraded rock surfaces show alteration rinds and veins. Rock interiors contain less than or equal to25% megacrysts. Chemical analyses of rocks by the Alpha Particle X-ray Spectrometer are consistent with picritic basalts, containing normative olivine, pyroxenes, plagioclase, and accessory FeTi oxides. Mossbauer, Pancam, and Mini-TES spectra confirm the presence of olivine, magnetite, and probably pyroxene. These basalts extend the known range of rock compositions composing the martian crust.	Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; Lockheed Martin Corp, Littleton, CO 80127 USA; New Mexico Museum Nat Hist & Sci, Albuquerque, NM 87104 USA; Max Planck Inst Chem, D-55099 Mainz, Germany; Honeybee Robot, New York, NY 10012 USA; Smithsonian Inst, Natl Air & Space Museum, Washington, DC 20560 USA; US Geol Survey, Flagstaff, AZ 86001 USA; Univ Mainz, Inst Anorgan & Analyt Chem, D-6500 Mainz, Germany; SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; Co Vale Rio Doce, BR-29090900 Vitoria, ES, Brazil	University of Tennessee System; University of Tennessee Knoxville; Washington University (WUSTL); Cornell University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Arizona State University; Arizona State University-Tempe; Lockheed Martin; Max Planck Society; Smithsonian Institution; United States Department of the Interior; United States Geological Survey; Johannes Gutenberg University of Mainz; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER	McSween, HY (corresponding author), Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA.	mcsween@utk.edu	de Souza, Paulo/W-2993-2019; de Souza, Paulo/P-7294-2019; Crisp, Joy/H-8287-2016; Johnson, Jeffrey R/F-3972-2015; de Souza, Paulo A/B-8961-2008; Moersch, Jeffrey E/F-7189-2010; Farmer, Jack D/B-9343-2019	de Souza, Paulo/0000-0002-0091-8925; Crisp, Joy/0000-0002-3202-4416; Johnson, Jeffrey R/0000-0002-5586-4901; de Souza, Paulo A/0000-0002-0091-8925; Moersch, Jeffrey E/0000-0003-3433-9419; McLennan, Scott/0000-0003-4259-7178				Arvidson RE, 2004, SCIENCE, V305, P821, DOI 10.1126/science.1099922; Bell JF, 2004, SCIENCE, V305, P800, DOI 10.1126/science.1100175; Bruckner J, 2003, J GEOPHYS RES-PLANET, V108, DOI [10.1029/2003JE002060, 10.1029/2003JE002150]; Christensen PR, 2004, SCIENCE, V305, P837, DOI 10.1126/science.1100564; Gellert R, 2004, SCIENCE, V305, P829, DOI 10.1126/science.1099913; GHIORSO MS, 1995, CONTRIB MINERAL PETR, V119, P197, DOI 10.1007/BF00307281; Grant JA, 2004, SCIENCE, V305, P807, DOI 10.1126/science.1099849; Herkenhoff KE, 2004, SCIENCE, V305, P824, DOI 10.1126/science.1100015; Hoefen TM, 2003, SCIENCE, V302, P627, DOI 10.1126/science.1089647; IRVINE TN, 1971, CAN J EARTH SCI, V8, P523, DOI 10.1139/e71-055; LEBAS MJ, 1986, J PETROL, V27, P745, DOI 10.1093/petrology/27.3.745; McSween H.Y., 1998, PLANETARY MAT, V36; McSween HY, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002175; Morris RV, 2004, SCIENCE, V305, P833, DOI 10.1126/science.1100020; Squyres SW, 2004, SCIENCE, V305, P794, DOI 10.1126/science.3050794; Wanke H, 2001, SPACE SCI REV, V96, P317, DOI 10.1023/A:1011961725645	16	225	225	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2004	305	5685					842	845		10.1126/science.3050842	http://dx.doi.org/10.1126/science.3050842			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297668				2022-12-24	WOS:000223104900041
J	Holleman, A; Cheok, MH; den Boer, ML; Yang, WJ; Veerman, AJP; Kazemier, KM; Pei, DQ; Cheng, C; Pui, CH; Relling, MV; Janka-Schaub, GE; Pieters, R; Evans, WE				Holleman, A; Cheok, MH; den Boer, ML; Yang, WJ; Veerman, AJP; Kazemier, KM; Pei, DQ; Cheng, C; Pui, CH; Relling, MV; Janka-Schaub, GE; Pieters, R; Evans, WE			Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							METABOLIZING ENZYMES; IN-VIVO; CHILDHOOD; SENSITIVITY; PHARMACOGENOMICS; CLASSIFICATION; ASPARAGINASE; PREDICTION; PROFILES; PROTEINS	BACKGROUND: Childhood acute lymphoblastic leukemia (ALL) is curable with chemotherapy in approximately 80 percent of patients. However, the cause of treatment failure in the remaining 20 percent of patients is largely unknown. METHODS: We tested leukemia cells from 173 children for sensitivity in vitro to prednisolone, vincristine, asparaginase, and daunorubicin. The cells were then subjected to an assessment of gene expression with the use of 14,500 probe sets to identify differentially expressed genes in drug-sensitive and drug-resistant ALL. Gene-expression patterns that differed according to sensitivity or resistance to the four drugs were compared with treatment outcome in the original 173 patients and an independent cohort of 98 children treated with the same drugs at another institution. RESULTS: We identified sets of differentially expressed genes in B-lineage ALL that were sensitive or resistant to prednisolone (33 genes), vincristine (40 genes), asparaginase (35 genes), or daunorubicin (20 genes). A combined gene-expression score of resistance to the four drugs, as compared with sensitivity to the four, was significantly and independently related to treatment outcome in a multivariate analysis (hazard ratio for relapse, 3.0; P=0.027). Results were confirmed in an independent population of patients treated with the same medications (hazard ratio for relapse, 11.85; P=0.019). Of the 124 genes identified, 121 have not previously been associated with resistance to the four drugs we tested. CONCLUSIONS: Differential expression of a relatively small number of genes is associated with drug resistance and treatment outcome in childhood ALL.	St Jude Childrens Res Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; Erasmus Univ, Med Ctr, Sophia Childrens Hosp, Div Pediat Hematol Oncol, Rotterdam, Netherlands; St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; Pharmacogenet Res Network, Pharmacogenet Anticanc Agents Res Grp, Memphis, TN USA; Univ Tennessee, Coll Pharm, Memphis, TN USA; Univ Tennessee, Coll Med, Memphis, TN USA; Free Univ Amsterdam, Med Ctr, Dept Pediat Hematol Oncol, Amsterdam, Netherlands; Childrens Univ Hosp, German Cooperat Study Grp Childhood Acute Lymphob, Dept Hematol Oncol, Hamburg, Germany	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Vrije Universiteit Amsterdam; University of Hamburg; University Medical Center Hamburg-Eppendorf	Evans, WE (corresponding author), St Jude Childrens Res Hosp, Dept Pharmaceut Sci, 332 N Lauderdale St, Memphis, TN 38105 USA.	william.evans@stjude.org	Veerman, Anjo/AAT-2443-2020; Relling, Mary/N-5032-2018; Cheok, Meyling/AFS-4025-2022; Cheok, Meyling h/C-3822-2014; Cheng, Cheng/N-8075-2018; Pui, Ching-Hon/N-8076-2018; Evans, William E./C-2069-2012	Cheok, Meyling/0000-0002-7820-8026; Cheok, Meyling h/0000-0002-7820-8026; Pui, Ching-Hon/0000-0003-0303-5658; Evans, William E./0000-0002-9333-5322; de Haar-Holleman, Amy/0000-0003-4929-2860; den Boer, Monique/0000-0002-5795-2921; Veerman, Anjo JP/0000-0002-9309-301X	NCI NIH HHS [P30 CA21765, R01 CA51001, R01 CA78224, R37 CA36401] Funding Source: Medline; NIGMS NIH HHS [U01 GM61394, U01 GM61393] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765, R01CA078224, R37CA036401, R01CA051001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061393, U01GM061394] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Cheok MH, 2003, NAT GENET, V34, P85, DOI 10.1038/ng1151; Cheok MH, 2003, NAT GENET, V34, P231, DOI 10.1038/ng0603-231b; Den Boer ML, 2003, J CLIN ONCOL, V21, P3262, DOI 10.1200/JCO.2003.11.031; Dudoit S, 2003, BIOINFORMATICS, V19, P1090, DOI 10.1093/bioinformatics/btg038; DUI JP, 2003, ZHONGHUA ZHONG LIU Z, V25, P21; Evans WE, 2004, NATURE, V429, P464, DOI 10.1038/nature02626; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gu LB, 2002, BLOOD, V99, P3367, DOI 10.1182/blood.V99.9.3367; Harms DO, 2003, BLOOD, V102, P2736, DOI 10.1182/blood-2002-08-2372; Hongo T, 2002, INT J HEMATOL, V76, P251, DOI 10.1007/BF02982795; Kaspers GJL, 1997, BLOOD, V90, P2723, DOI 10.1182/blood.V90.7.2723.2723_2723_2729; Kearns PR, 2001, BLOOD, V97, P393, DOI 10.1182/blood.V97.2.393; Krajinovic M, 2002, CLIN CANCER RES, V8, P802; Martell RL, 1997, BRIT J CANCER, V75, P161, DOI 10.1038/bjc.1997.27; McLeod HL, 2000, LEUKEMIA, V14, P567, DOI 10.1038/sj.leu.2401723; PIETERS R, 1991, LANCET, V338, P399, DOI 10.1016/0140-6736(91)91029-T; Pieters R, 2003, INT J HEMATOL, V78, P402, DOI 10.1007/BF02983812; Prokop A, 2000, LEUKEMIA, V14, P1606, DOI 10.1038/sj.leu.2401866; Pui CH, 2001, LANCET ONCOL, V2, P597, DOI 10.1016/S1470-2045(01)00516-2; Pui CH, 1998, NEW ENGL J MED, V339, P605, DOI 10.1056/NEJM199808273390907; Pui CH, 2003, JAMA-J AM MED ASSOC, V290, P2001, DOI 10.1001/jama.290.15.2001; Ramakers-van Woerden NL, 2000, BLOOD, V96, P1094; Ramakers-van Woerden NL, 2001, BRIT J HAEMATOL, V112, P680, DOI 10.1046/j.1365-2141.2001.02586.x; Ross ME, 2003, BLOOD, V102, P2951, DOI 10.1182/blood-2003-01-0338; Stam RW, 2003, BLOOD, V101, P1270, DOI 10.1182/blood-2002-05-1600; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; VAN AL, 1997, GENE DEV, V11, P2295; van den Heuvel-Eibrink MM, 2000, INT J CLIN PHARM TH, V38, P94; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Zembutsu H, 2002, CANCER RES, V62, P518	34	453	474	1	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 5	2004	351	6					533	542		10.1056/NEJMoa033513	http://dx.doi.org/10.1056/NEJMoa033513			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843HS	15295046				2022-12-24	WOS:000223069900006
J	Juurlink, DN; Mamdani, MM; Lee, DS; Kopp, A; Austin, PC; Laupacis, A; Redelmeier, DA				Juurlink, DN; Mamdani, MM; Lee, DS; Kopp, A; Austin, PC; Laupacis, A; Redelmeier, DA			Rates of hyperkalemia after publication of the randomized aldactone evaluation study	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LIFE-THREATENING HYPERKALEMIA; CONGESTIVE-HEART-FAILURE; TIME-SERIES; SPIRONOLACTONE; GUIDELINES; PREVALENCE; INHIBITORS; MORBIDITY	BACKGROUND: The Randomized Aldactone Evaluation Study (RALES) demonstrated that spironolactone significantly improves outcomes in patients with severe heart failure. Use of angiotensin-converting-enzyme (ACE) inhibitors is also indicated in these patients. However, life-threatening hyperkalemia can occur when these drugs are used together. METHODS: We conducted a population-based time-series analysis to examine trends in the rate of spironolactone prescriptions and the rate of hospitalization for hyperkalemia in ambulatory patients before and after the publication of RALES. We linked prescription-claims data and hospital-admission records for more than 1.3 million adults 66 years of age or older in Ontario, Canada, for the period from 1994 through 2001. RESULTS: Among patients treated with ACE inhibitors who had recently been hospitalized for heart failure, the spironolactone-prescription rate was 34 per 1000 patients in 1994, and it increased immediately after the publication of RALES, to 149 per 1000 patients by late 2001 (P<0.001). The rate of hospitalization for hyperkalemia rose from 2.4 per 1000 patients in 1994 to 11.0 per 1000 patients in 2001 (P<0.001), and the associated mortality rose from 0.3 per 1000 to 2.0 per 1000 patients (P<0.001). As compared with expected numbers of events, there were 560 (95 percent confidence interval, 285 to 754) additional hyperkalemia-related hospitalizations and 73 (95 percent confidence interval, 27 to 120) additional hospital deaths during 2001 among older patients with heart failure who were treated with ACE inhibitors in Ontario. Publication of RALES was not associated with significant decreases in the rates of readmission for heart failure or death from all causes. CONCLUSIONS: The publication of RALES was associated with abrupt increases in the rate of prescriptions for spironolactone and in hyperkalemia-associated morbidity and mortality. Closer laboratory monitoring and more judicious use of spironolactone may reduce the occurrence of this complication.	Univ Toronto, Dept Med, Toronto, ON, Canada; Univ Toronto, Dept Pharm, Toronto, ON, Canada; Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada; Inst Clin Evaluat Sci, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto	Juurlink, DN (corresponding author), Sunnybrook & Womens Coll Hlth Sci Ctr, G Wing 106,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	dnj@ices.on.ca	Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285				Antrobus J H, 1993, J Cardiothorac Vasc Anesth, V7, P76, DOI 10.1016/1053-0770(93)90124-4; Berry C, 2001, Heart, V85, pE8, DOI 10.1136/heart.85.4.e8; Bozkurt B, 2003, J AM COLL CARDIOL, V41, P211, DOI 10.1016/S0735-1097(02)02694-3; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; DICKEY DA, 1979, J AM STAT ASSOC, V74, P427, DOI 10.2307/2286348; Ghali WA, 2000, LANCET, V355, P579, DOI 10.1016/S0140-6736(05)73234-7; Hamad A, 2001, AM J NEPHROL, V21, P241, DOI 10.1159/000046255; Helfenstein U, 1996, Stat Methods Med Res, V5, P3, DOI 10.1177/096228029600500102; Hunt SA, 2001, J AM COLL CARDIOL, V38, P2101, DOI 10.1016/S0735-1097(01)01683-7; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Jarman PR, 2003, BRIT MED J, V327, P812, DOI 10.1136/bmj.327.7418.812; JARMAN PR, 1995, POSTGRAD MED J, V71, P551, DOI 10.1136/pgmj.71.839.551; Jong P, 2003, CIRCULATION, V108, P184, DOI 10.1161/01.CIR.0000080290.39027.48; Juurlink DN, 2003, JAMA-J AM MED ASSOC, V289, P1652, DOI 10.1001/jama.289.13.1652; LARGE DM, 1984, POSTGRAD MED J, V60, P370, DOI 10.1136/pgmj.60.703.370; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; LJUNG GM, 1978, BIOMETRIKA, V65, P297, DOI 10.2307/2335207; Majumdar SR, 2003, AM J MED, V115, P467, DOI 10.1016/S0002-9343(03)00422-4; Masoudi FA, 2003, AM HEART J, V146, P250, DOI 10.1016/S0002-8703(03)00189-3; Pindyck R.S., 2013, ECONOMETRIC MODELS E; Pitt B, 1996, AM J CARDIOL, V78, P902; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Schepkens H, 2001, AM J MED, V110, P438, DOI 10.1016/S0002-9343(01)00642-8; Svensson M, 2003, BRIT MED J, V327, P1141, DOI 10.1136/bmj.327.7424.1141; van Walraven C, 1998, JAMA-J AM MED ASSOC, V280, P2028, DOI 10.1001/jama.280.23.2028; Vanpee D, 2000, AGING-CLIN EXP RES, V12, P315, DOI 10.1007/BF03339853; vanWalraven C, 2000, JAMA-J AM MED ASSOC, V283, P481; Wrenger E, 2003, BRIT MED J, V327, P147, DOI 10.1136/bmj.327.7407.147	29	1205	1230	0	24	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 5	2004	351	6					543	551		10.1056/NEJMoa040135	http://dx.doi.org/10.1056/NEJMoa040135			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843HS	15295047				2022-12-24	WOS:000223069900007
J	Xiao, T; Takagi, J; Coller, BS; Wang, JH; Springer, TA				Xiao, T; Takagi, J; Coller, BS; Wang, JH; Springer, TA			Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics	NATURE			English	Article							GLYCOPROTEIN-IIB-IIIA; INSIDE-OUT ACTIVATION; LIGAND-BINDING; CRYSTAL-STRUCTURE; A-DOMAIN; EXTRACELLULAR SEGMENT; SIGNAL-TRANSDUCTION; BETA(3) SUBUNIT; HYBRID DOMAIN; GPIIB-IIIA	Integrins are important adhesion receptors in all Metazoa that transmit conformational change bidirectionally across the membrane. Integrin alpha and beta subunits form a head and two long legs in the ectodomain and span the membrane. Here, we define with crystal structures the atomic basis for allosteric regulation of the conformation and affinity for ligand of the integrin ectodomain, and how fibrinogen- mimetic therapeutics bind to platelet integrin alpha(IIb)beta(3). Allostery in the beta(3)I domain alters three metal binding sites, associated loops and alpha1- and alpha7-helices. Piston-like displacement of the alpha7-helix causes a 62degrees reorientation between the beta(3)I and hybrid domains. Transmission through the rigidly connected plexin/semaphorin/integrin ( PSI) domain in the upper beta(3) leg causes a 70 Angstrom separation between the knees of the alpha and beta legs. Allostery in the head thus disrupts interaction between the legs in a previously described low-affinity bent integrin conformation, and leg extension positions the high-affinity head far above the cell surface.	Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Rockefeller Univ, Lab Blood & Vasc Biol, New York, NY 10021 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Rockefeller University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Springer, TA (corresponding author), Harvard Univ, Sch Med, CBR Inst Biomed Res, 200 Longwood Ave, Boston, MA 02115 USA.	springer@cbr.med.harvard.edu	Xiao, Tsan Sam/A-8590-2010; Xiao, Tsan/I-7616-2013	Xiao, Tsan Sam/0000-0001-9688-475X; Xiao, Tsan/0000-0001-9688-475X	NHLBI NIH HHS [P01 HL048675] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adair BD, 2002, P NATL ACAD SCI USA, V99, P14059, DOI 10.1073/pnas.212498199; ARTONI A, 2004, IN PRESS P NATL ACAD; Beglova N, 2002, NAT STRUCT BIOL, V9, P282, DOI 10.1038/nsb779; Bork P, 1999, TRENDS BIOCHEM SCI, V24, P261, DOI 10.1016/S0968-0004(99)01416-4; CALVETE JJ, 1991, BIOCHEM J, V274, P63, DOI 10.1042/bj2740063; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Chen JF, 2003, NAT STRUCT BIOL, V10, P995, DOI 10.1038/nsb1011; CHEN JF, IN PRESS J BIOL CHEM; Coller BS, 1997, J CLIN INVEST, V99, P1467, DOI 10.1172/JCI119307; COLLER BS, 1983, J CLIN INVEST, V72, P325, DOI 10.1172/JCI110973; DU XP, 1991, CELL, V65, P409, DOI 10.1016/0092-8674(91)90458-B; Egbertson MS, 1999, J MED CHEM, V42, P2409, DOI 10.1021/jm980722p; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Gottschalk KE, 2002, ANGEW CHEM INT EDIT, V41, P3767, DOI 10.1002/1521-3773(20021018)41:20<3767::AID-ANIE3767>3.0.CO;2-T; Hughes PE, 1998, TRENDS CELL BIOL, V8, P359, DOI 10.1016/S0962-8924(98)01339-7; Kamata T, 2001, J BIOL CHEM, V276, P44275, DOI 10.1074/jbc.M107021200; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; KUNICKI TJ, 1995, BLOOD CELL MOL DIS, V21, P131, DOI 10.1006/bcmd.1995.0015; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Love CA, 2003, NAT STRUCT BIOL, V10, P843, DOI 10.1038/nsb977; Luo BH, 2004, PLOS BIOL, V2, P776, DOI 10.1371/journal.pbio.0020153; Luo BH, 2004, J BIOL CHEM, V279, P27466, DOI 10.1074/jbc.M404354200; Luo BH, 2004, J BIOL CHEM, V279, P10215, DOI 10.1074/jbc.M312732200; Luo BH, 2003, J BIOL CHEM, V278, P17185, DOI 10.1074/jbc.M301516200; Luo BH, 2003, P NATL ACAD SCI USA, V100, P2403, DOI 10.1073/pnas.0438060100; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Mould AP, 2003, J BIOL CHEM, V278, P39993, DOI 10.1074/jbc.M304627200; Mould AP, 2003, J BIOL CHEM, V278, P17028, DOI 10.1074/jbc.M213139200; Mould AP, 2002, J BIOL CHEM, V277, P19800, DOI 10.1074/jbc.M201571200; NEWMAN PJ, 1989, J CLIN INVEST, V83, P1778, DOI 10.1172/JCI114082; PERUTZ MF, 1989, Q REV BIOPHYS, V22, P139, DOI 10.1017/S0033583500003826; Puzon-McLaughlin W, 2000, J BIOL CHEM, V275, P7795, DOI 10.1074/jbc.275.11.7795; SCARBOROUGH RM, 1993, J BIOL CHEM, V268, P1066; Scarborough RM, 2000, J MED CHEM, V43, P3453, DOI 10.1021/jm000022w; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Springer TA, 2002, CURR OPIN STRUC BIOL, V12, P802, DOI 10.1016/S0959-440X(02)00384-6; SPRINGER TA, 2004, CELL SURFACE RECEPTO; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2003, EMBO J, V22, P4607, DOI 10.1093/emboj/cdg445; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Tozer EC, 1996, J BIOL CHEM, V271, P21978, DOI 10.1074/jbc.271.36.21978; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; von der Mark H, 2002, J BIOL CHEM, V277, P6012, DOI 10.1074/jbc.M102188200; Watkins NA, 2002, BLOOD, V99, P1833, DOI 10.1182/blood.V99.5.1833; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yang W, 2004, P NATL ACAD SCI USA, V101, P2333, DOI 10.1073/pnas.0307291101; ZAVORTINK M, 1993, CELL ADHES COMMUN, V1, P251, DOI 10.3109/15419069309097258	50	629	651	0	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 4	2004	432	7013					59	67		10.1038/nature02976	http://dx.doi.org/10.1038/nature02976			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	867PQ	15378069	Green Accepted			2022-12-24	WOS:000224854900038
J	Suh, GSB; Wong, AM; Hergarden, AC; Wang, JW; Simon, AF; Benzer, S; Axel, R; Anderson, DJ				Suh, GSB; Wong, AM; Hergarden, AC; Wang, JW; Simon, AF; Benzer, S; Axel, R; Anderson, DJ			A single population of olfactory sensory neurons mediates an innate avoidance behaviour in Drosophila	NATURE			English	Article							ANTENNAL LOBE; MUSHROOM BODIES; MANDUCA-SEXTA; CENTRAL PROJECTIONS; SPHINX MOTH; MELANOGASTER; LEPIDOPTERA; ATTRACTION; RESPONSES; MOSQUITOS	All animals exhibit innate behaviours in response to specific sensory stimuli that are likely to result from the activation of developmentally programmed neural circuits. Here we observe that Drosophila exhibit robust avoidance to odours released by stressed flies. Gas chromatography and mass spectrometry identifies one component of this 'Drosophila stress odorant (dSO)' as CO2. CO2 elicits avoidance behaviour, at levels as low as 0.1%. We used two-photon imaging with the Ca2+-sensitive fluorescent protein G-CaMP to map the primary sensory neurons governing avoidance to CO2. CO2 activates only a single glomerulus in the antennal lobe, the V glomerulus; moreover, this glomerulus is not activated by any of 26 other odorants tested. Inhibition of synaptic transmission in sensory neurons that innervate the V glomerulus, using a temperature-sensitive Shibire gene (Shi(ts))(1), blocks the avoidance response to CO2. Inhibition of synaptic release in the vast majority of other olfactory receptor neurons has no effect on this behaviour. These data demonstrate that the activation of a single population of sensory neurons innervating one glomerulus is responsible for an innate avoidance behaviour in Drosophila.	CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; CALTECH, Div Biol 216 76 & 156 29, Pasadena, CA 91125 USA; Columbia Univ Coll Phys & Surg, New York, NY 10032 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; Columbia University	Anderson, DJ (corresponding author), CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA.	wuwei@caltech.edu	Simon, Anne/J-9199-2015; Wang, Jing W/C-3885-2008	Simon, Anne/0000-0002-6509-4541; Wang, Jing W/0000-0001-6291-5802; Suh, Greg/0000-0003-4381-658X; Axel, Richard/0000-0002-3141-4076				Anton S, 1996, CIBA F SYMP, V200, P184; ANTON S, 1996, CIBA F SYMP, V200, P226; ANTON S, 1996, CIBA F SYMP, V200, P192; Beck CDO, 2000, J NEUROSCI, V20, P2944; BOGNER F, 1986, J COMP PHYSIOL A, V158, P741, DOI 10.1007/BF01324818; CHRISTENSEN TA, 1995, CHEM SENSES, V20, P313, DOI 10.1093/chemse/20.3.313; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Distler PG, 1997, J EXP BIOL, V200, P1873; DUDAI Y, 1976, P NATL ACAD SCI USA, V73, P1684, DOI 10.1073/pnas.73.5.1684; Enserink M, 2002, SCIENCE, V298, P90, DOI 10.1126/science.298.5591.90; Galizia CG, 1999, NAT NEUROSCI, V2, P473, DOI 10.1038/8144; Hansson BS, 2003, J COMP PHYSIOL A, V189, P301, DOI 10.1007/s00359-003-0403-5; Heimbeck G, 2001, P NATL ACAD SCI USA, V98, P15336, DOI 10.1073/pnas.011314898; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; KENT KS, 1986, CELL TISSUE RES, V245, P237; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(01)00263-X; SHOREY HH, 1973, ANNU REV ENTOMOL, V18, P349, DOI 10.1146/annurev.en.18.010173.002025; Stange G., 1996, Advances in Bioclimatology, V4, P223; Stange G, 1999, MICROSC RES TECHNIQ, V47, P416, DOI 10.1002/(SICI)1097-0029(19991215)47:6<416::AID-JEMT5>3.0.CO;2-X; Stensmyr MC, 2003, J EXP BIOL, V206, P715, DOI 10.1242/jeb.00143; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang YL, 2003, CURR BIOL, V13, P1900, DOI 10.1016/j.cub.2003.10.003; Wang YL, 2001, NEURON, V29, P267, DOI 10.1016/S0896-6273(01)00196-9; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782	32	390	394	3	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2004	431	7010					854	859		10.1038/nature02980	http://dx.doi.org/10.1038/nature02980			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861RE	15372051				2022-12-24	WOS:000224435500049
J	Fiser, J; Chiu, CY; Weliky, M				Fiser, J; Chiu, CY; Weliky, M			Small modulation of ongoing cortical dynamics by sensory input during natural vision	NATURE			English	Article							RESPONSE VARIABILITY; VISUAL-CORTEX; NEURONS; INFORMATION; MECHANISMS; DISCHARGE; SCENES; CELLS	During vision, it is believed that neural activity in the primary visual cortex is predominantly driven by sensory input from the environment. However, visual cortical neurons respond to repeated presentations of the same stimulus with a high degree of variability(1-4). Although this variability has been considered to be noise owing to random spontaneous activity within the cortex(5-7), recent studies show that spontaneous activity has a highly coherent spatio-temporal structure(8-13). This raises the possibility that the pattern of this spontaneous activity may shape neural responses during natural viewing conditions to a larger extent than previously thought. Here, we examine the relationship between spontaneous activity and the response of primary visual cortical neurons to dynamic natural-scene and random-noise film images in awake, freely viewing ferrets from the time of eye opening to maturity. The correspondence between evoked neural activity and the structure of the input signal was weak in young animals, but systematically improved with age. This improvement was linked to a shift in the dynamics of spontaneous activity. At all ages including the mature animal, correlations in spontaneous neural firing were only slightly modified by visual stimulation, irrespective of the sensory input. These results suggest that in both the developing and mature visual cortex, sensory evoked neural activity represents the modulation and triggering of ongoing circuit dynamics by input signals, rather than directly reflecting the structure of the input signal itself.	Univ Rochester, Ctr Visual Sci, Rochester, NY 14627 USA; Univ Rochester, Interdepartmental Program Neruosci, Rochester, NY 14627 USA; Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA	University of Rochester; University of Rochester; University of Rochester	Weliky, M (corresponding author), Univ Rochester, Ctr Visual Sci, Rochester, NY 14627 USA.	weliky@cvs.rochester.edu	Fiser, József/A-2877-2009	Fiser, Jozsef/0000-0002-7064-0690; Chiu, Chiayu/0000-0001-5809-6306				Anderson J, 2000, NAT NEUROSCI, V3, P617, DOI 10.1038/75797; ARIELI A, 1995, J NEUROPHYSIOL, V73, P2072, DOI 10.1152/jn.1995.73.5.2072; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Azouz R, 1999, J NEUROSCI, V19, P2209; Chiu CY, 2001, J NEUROSCI, V21, P8906, DOI 10.1523/JNEUROSCI.21-22-08906.2001; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; Gallant JL, 1998, NEUROREPORT, V9, P1673, DOI 10.1097/00001756-199805110-00075; Gao WJ, 1999, J COMP NEUROL, V409, P261, DOI 10.1002/(SICI)1096-9861(19990628)409:2<261::AID-CNE7>3.0.CO;2-R; GAWNE TJ, 1993, J NEUROSCI, V13, P2758; HENRY GH, 1973, VISION RES, V13, P1771, DOI 10.1016/0042-6989(73)90094-1; Hirsch JA, 2002, J PHYSIOL-LONDON, V540, P335, DOI 10.1113/jphysiol.2001.012777; Kara P, 2000, NEURON, V27, P635, DOI 10.1016/S0896-6273(00)00072-6; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Lennie P, 2003, CURR BIOL, V13, P493, DOI 10.1016/S0960-9822(03)00135-0; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Nirenberg S, 2003, P NATL ACAD SCI USA, V100, P7348, DOI 10.1073/pnas.1131895100; Pola G, 2003, NETWORK-COMP NEURAL, V14, P35, DOI 10.1088/0954-898X/14/1/303; Pouget A, 2003, ANNU REV NEUROSCI, V26, P381, DOI 10.1146/annurev.neuro.26.041002.131112; SCHILLER PH, 1976, BRAIN RES, V105, P347, DOI 10.1016/0006-8993(76)90432-7; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shu YS, 2003, J NEUROSCI, V23, P10388; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; VOGELS R, 1989, EXP BRAIN RES, V77, P432, DOI 10.1007/BF00275002; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; Weliky M, 2003, NEURON, V37, P703, DOI 10.1016/S0896-6273(03)00022-9; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	27	302	303	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 30	2004	431	7008					573	578		10.1038/nature02907	http://dx.doi.org/10.1038/nature02907			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15457262				2022-12-24	WOS:000224156700048
J	Zhu, RX; Potts, R; Xie, F; Hoffman, KA; Deng, CL; Shi, CD; Pan, YX; Wang, HQ; Shi, RP; Wang, YC; Shi, GH; Wu, NQ				Zhu, RX; Potts, R; Xie, F; Hoffman, KA; Deng, CL; Shi, CD; Pan, YX; Wang, HQ; Shi, RP; Wang, YC; Shi, GH; Wu, NQ			New evidence on the earliest human presence at high northern latitudes in northeast Asia	NATURE			English	Article							INDONESIA; HOMINIDS; DMANISI; GEORGIA; CHINA; HOMO; JAVA; AGE	The timing of early human dispersal to Asia is a central issue in the study of human evolution. Excavations in predominantly lacustrine sediments at Majuangou, Nihewan basin, north China, uncovered four layers of indisputable hominin stone tools. Here we report magnetostratigraphic results that constrain the age of the four artefact layers to an interval of nearly 340,000 yr between the Olduvai subchron and the Cobb Mountain event. The lowest layer, about 1.66 million years old (Myr), provides the oldest record of stone-tool processing of animal tissues in east Asia. The highest layer, at about 1.32 Myr, correlates with the stone tool layer at Xiaochangliang(1), previously considered the oldest archaeological site in this region. The findings at Majuangou indicate that the oldest known human presence in northeast Asia at 40degreesN is only slightly younger than that in western Asia(2,3). This result implies that a long yet rapid migration from Africa, possibly initiated during a phase of warm climate, enabled early human populations to inhabit northern latitudes of east Asia over a prolonged period.	Chinese Acad Sci, Inst Geol & Geophys, Paleomagnetism Lab, Beijing 100029, Peoples R China; Natl Museum Nat Hist, Human Origins Program, Washington, DC 20560 USA; Hebei Prov Inst Cultural Rel, Shijiazhuang 050000, Peoples R China; Calif Polytech State Univ San Luis Obispo, Dept Phys, San Luis Obispo, CA 93410 USA	Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS; Smithsonian Institution; Smithsonian National Museum of Natural History; California State University System; California Polytechnic State University San Luis Obispo	Zhu, RX (corresponding author), Chinese Acad Sci, Inst Geol & Geophys, Paleomagnetism Lab, Beijing 100029, Peoples R China.	rxzhucn@yahoo.com; potts.rick@nmnh.si.edu	Pan, Yongxin/B-4302-2008; Deng, Chenglong/B-8881-2009; Zhu, Rixiang/F-2126-2018; Deng, Chenglong/B-8871-2009	Pan, Yongxin/0000-0002-4227-3061; Zhu, Rixiang/0000-0002-4985-925X; Deng, Chenglong/0000-0003-1848-3170				AN ZH, 1989, QUATERNARY RES, V32, P213, DOI 10.1016/0033-5894(89)90077-X; Berggren WA, 1995, GEOCHRONOLOGY TIME S, V54, P129, DOI DOI 10.2110/PEC.95.04.0129; Clark PU, 1999, SCIENCE, V286, P1104, DOI 10.1126/science.286.5442.1104; de Heinzelin J, 1999, SCIENCE, V284, P625; Gabunia L, 2000, SCIENCE, V288, P1019, DOI 10.1126/science.288.5468.1019; HPICR, 1998, PAP ARCH HEB PROV, P30; HUANG WP, 1991, WUSHAN HOMINID SITE, P105; Larick R, 2001, P NATL ACAD SCI USA, V98, P4866, DOI 10.1073/pnas.081077298; Li H.M., 1982, QUATERNARY GEOLOGY E, P33; Potts R, 1999, J HUM EVOL, V37, P747, DOI 10.1006/jhev.1999.0344; Potts R., 1988, EARLY HOMINID ACTIVI; POTTS R, 2001, HUMAN ROOTS AFRICA A, P5; Qiu Z.X., 2000, QUATERNARY SCI, V20, P142; Semaw S, 1997, NATURE, V385, P333, DOI 10.1038/385333a0; Singer BS, 1999, J GEOPHYS RES-SOL EA, V104, P679, DOI 10.1029/1998JB900016; SWISHER CC, 1994, SCIENCE, V263, P1118, DOI 10.1126/science.8108729; Tang Yingjun, 1995, Vertebrata Palasiatica, V33, P74; Tian J, 2002, EARTH PLANET SC LETT, V203, P1015, DOI 10.1016/S0012-821X(02)00923-8; Vekua A, 2002, SCIENCE, V297, P85, DOI 10.1126/science.1072953; Wei Q., 1994, ACTA ANTHR SIN, V13, P223; Wei Q., 1997, EVIDENCE EVOLUTION E, P193; Zhu RX, 2003, EARTH-SCI REV, V61, P341, DOI 10.1016/S0012-8252(02)00132-0; Zhu RX, 2001, NATURE, V413, P413, DOI 10.1038/35096551	23	235	307	4	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 30	2004	431	7008					559	562		10.1038/nature02829	http://dx.doi.org/10.1038/nature02829			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15457258				2022-12-24	WOS:000224156700044
J	Fenton, L				Fenton, L			Preventing HIV/AIDS through poverty reduction: the only sustainable solution?	LANCET			English	Editorial Material									UCL, Int Hlth & Med Educ Ctr, London N19 5LW, England	University of London; University College London	Fenton, L (corresponding author), UCL, Int Hlth & Med Educ Ctr, Archway Campus, London N19 5LW, England.	lynda.fenton@doctors.org.uk						Ainsworth M., 1998, CONFRONTING AIDS EVI; Bloom D. E., 2002, HLTH WEALTH AIDS POV; COHEN D, 2000, SEPED C PAPER SERIES, V2; Collins J., 2000, 4 UNRISDUNAIDS; Horton R, 2000, LANCET, V356, P225; Stillwaggon E, 2002, J DEV STUD, V38, P1, DOI 10.1080/00220380412331322561; 2003, LANCET, V362, P9383	7	86	87	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 25	2004	364	9440					1186	1187		10.1016/S0140-6736(04)17109-2	http://dx.doi.org/10.1016/S0140-6736(04)17109-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	857FT	15451230				2022-12-24	WOS:000224102400036
J	Aide, TM; Grau, HR				Aide, TM; Grau, HR			Ecology - Globalization, migration, and Latin American ecosystems	SCIENCE			English	Editorial Material									Univ Puerto Rico, Dept Biol, San Juan, PR 00931 USA; Univ Nacl Tucuman, Lab Invest Ecol Yungas, RA-4107 San Miguel De Tucuman, Argentina	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; Universidad Nacional de Tucuman	Aide, TM (corresponding author), Univ Puerto Rico, Dept Biol, San Juan, PR 00931 USA.	tmaide@yahoo.com; chilograu@yahoo.com.ar						Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Fearnside PM, 2001, ENVIRON CONSERV, V28, P23, DOI 10.1017/S0376892901000030; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Grau HR, 2003, BIOSCIENCE, V53, P1159, DOI 10.1641/0006-3568(2003)053[1159:TECOSA]2.0.CO;2; GRAU HR, UNPUB ENV CONSERV; Houghton RA, 1999, TELLUS B, V51, P298, DOI 10.1034/j.1600-0889.1999.00013.x; Janzen DH, 2002, HANDBOOK OF ECOLOGICAL RESTORATION, VOL 2, P559; JANZEN DH, COMMUNICATION; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Lugo AE, 2002, LANDSCAPE ECOL, V17, P601, DOI 10.1023/A:1021419815480; Mather AS, 1998, AREA, V30, P117, DOI 10.1111/j.1475-4762.1998.tb00055.x; PRESTON D, 1996, LATIN AM DEV GEOGRAP, P165; Waggoner PE, 2001, POPUL DEV REV, V27, P239, DOI 10.1111/j.1728-4457.2001.00239.x	13	353	379	2	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2004	305	5692					1915	1916		10.1126/science.1103179	http://dx.doi.org/10.1126/science.1103179			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857RM	15448256				2022-12-24	WOS:000224136000031
J	Anderson, DG; Burdick, JA; Langer, R				Anderson, DG; Burdick, JA; Langer, R			Materials science - Smart biomaterials	SCIENCE			English	Editorial Material							EXTRACELLULAR MATRICES; DRUG-DELIVERY; MICROCHIP; RELEASE; CELLS		MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Anderson, DG (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	rlanger@mit.edu						Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981; Anseth KS, 2002, MRS BULL, V27, P130, DOI 10.1557/mrs2002.49; Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5; Grayson ACR, 2003, NAT MATER, V2, P767, DOI 10.1038/nmat998; Lahann J, 2003, SCIENCE, V299, P371, DOI 10.1126/science.1078933; Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388; Lee KY, 2000, NATURE, V408, P998, DOI 10.1038/35050141; Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102; Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818; McFadden P, 2002, SCIENCE, V297, P2075, DOI 10.1126/science.297.5589.2075; PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835; Saltzman WM, 2002, NAT REV DRUG DISCOV, V1, P177, DOI 10.1038/nrd744; Santini JT, 1999, NATURE, V397, P335, DOI 10.1038/16898; Shea LD, 1999, NAT BIOTECHNOL, V17, P551, DOI 10.1038/9853; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874	16	239	251	2	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2004	305	5692					1923	1924		10.1126/science.1099987	http://dx.doi.org/10.1126/science.1099987			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857RM	15448260				2022-12-24	WOS:000224136000036
J	Lee, JJ; Dimina, D; Macias, MP; Ochkur, SI; McGarry, MP; O'Neill, KR; Protheroe, C; Pero, R; Nguyen, T; Cormier, SA; Lenkiewicz, E; Colbert, D; Rinaldi, L; Ackerman, SJ; Irvin, CG; Lee, NA				Lee, JJ; Dimina, D; Macias, MP; Ochkur, SI; McGarry, MP; O'Neill, KR; Protheroe, C; Pero, R; Nguyen, T; Cormier, SA; Lenkiewicz, E; Colbert, D; Rinaldi, L; Ackerman, SJ; Irvin, CG; Lee, NA			Defining a link with asthma in mice congenitally deficient in eosinophils	SCIENCE			English	Article							AIRWAYS HYPERREACTIVITY; TRANSGENIC MICE; MOUSE; GENE; EXPRESSION; CLONING; IL-5; HYPERRESPONSIVENESS; IDENTIFICATION; INFLAMMATION	Eosinophils are often dominant inflammatory cells present in the lungs of asthma patients. Nonetheless, the role of these leukocytes remains poorly understood. We have created a transgenic line of mice (PHIL) that are specifically devoid of eosinophils, but otherwise have a full complement of hematopoietically derived cells. Allergen challenge of PHIL mice demonstrated that eosinophils were required for pulmonary mucus accumulation and the airway hyperresponsiveness associated with asthma. The development of an eosinophil-less mouse now permits an unambiguous assessment of a number of human diseases that have been linked to this granulocyte, including allergic diseases, parasite infections, and tumorigenesis.	Mayo Clin Arizona, Div Pulm Med, Scottsdale, AZ 85259 USA; Mayo Clin Arizona, Dept Biochem & Mol Biol, Scottsdale, AZ 85259 USA; Mayo Clin Arizona, Div Hematol Oncol, Scottsdale, AZ 85259 USA; Univ Vermont, Dept Med, Vermont Lung Ctr, Burlington, VT 05405 USA; Univ Illinois, Coll Med, Dept Biochem & Mol Biol, Chicago, IL 60612 USA	Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; University of Vermont; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lee, JJ (corresponding author), Mayo Clin Arizona, Div Pulm Med, Scottsdale, AZ 85259 USA.	jjlee@mayo.edu; nlee@mayo.edu	Cormier, Stephania A/I-7382-2017	Cormier, Stephania A/0000-0002-6050-6172	NCRR NIH HHS [NCRR-COBRE P20RR1555] Funding Source: Medline; NHLBI NIH HHS [HL058723, P01-HL67004, HLEB67273, HL065228, HL10105] Funding Source: Medline; NIAID NIH HHS [AI025230, AI033043] Funding Source: Medline; NIAMS NIH HHS [F32 AR008545-01, AR08545, F32 AR008545-03, F32 AR008545-02, F32 AR008545] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR001555] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL010105, R01HL067273, R01HL058723, R01HL065228, P01HL067004, R56HL058723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI025230, R01AI033043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR008545] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; Busse WW, 2001, NEW ENGL J MED, V344, P350, DOI 10.1056/NEJM200102013440507; BUSSE WW, 1993, AM REV RESPIR DIS, V147, P20; Cho JY, 2004, J CLIN INVEST, V113, P551, DOI 10.1172/JCI200419133; Collier RJ, 2001, TOXICON, V39, P1793, DOI 10.1016/S0041-0101(01)00165-9; Cormier SA, 2001, MAMM GENOME, V12, P352, DOI 10.1007/s003350020007; Denzler KL, 2000, J IMMUNOL, V165, P5509, DOI 10.4049/jimmunol.165.10.5509; Denzler KL, 2001, J IMMUNOL, V167, P1672, DOI 10.4049/jimmunol.167.3.1672; Flood-Page P, 2003, J CLIN INVEST, V112, P1029, DOI 10.1172/JCI200317974; Henderson WR, 1997, J CLIN INVEST, V100, P3083, DOI 10.1172/JCI119863; Hogan SP, 1998, J IMMUNOL, V161, P1501; Horton MA, 1996, J LEUKOCYTE BIOL, V60, P285, DOI 10.1002/jlb.60.2.285; Huber HL, 1922, ARCH INTERN MED, V30, P689, DOI 10.1001/archinte.1922.00110120002001; Irvin CG, 1997, AM J PHYSIOL-LUNG C, V272, pL1053, DOI 10.1152/ajplung.1997.272.6.L1053; Justice JP, 2002, AM J PHYSIOL-LUNG C, V282, pL302, DOI 10.1152/ajplung.00158.2001; Justice JP, 2003, AM J PHYSIOL-LUNG C, V284, pL169, DOI 10.1152/ajplung.00260.2002; LARSON KA, 1995, J IMMUNOL, V155, P3002; Larson KA, 1996, P NATL ACAD SCI USA, V93, P12370, DOI 10.1073/pnas.93.22.12370; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Lee JJ, 1997, J EXP MED, V185, P2143, DOI 10.1084/jem.185.12.2143; Macias MP, 2000, J LEUKOCYTE BIOL, V67, P567, DOI 10.1002/jlb.67.4.567; Mattes J, 2002, J EXP MED, V195, P1433, DOI 10.1084/jem.20020009; O'Byrne P, 1998, J ALLERGY CLIN IMMUN, V102, pS85, DOI 10.1016/S0091-6749(98)70036-3; OCHKUR SI, UNPUB; PALMITER RD, 1987, CELL, V50, P435, DOI 10.1016/0092-8674(87)90497-1; PAUL CC, 1994, J LEUKOCYTE BIOL, V56, P74, DOI 10.1002/jlb.56.1.74; Shen HHH, 2003, J IMMUNOL, V170, P3296, DOI 10.4049/jimmunol.170.6.3296; Shi HZ, 2000, J CLIN INVEST, V105, P945, DOI 10.1172/JCI8945	28	558	581	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1773	1776		10.1126/science.1099472	http://dx.doi.org/10.1126/science.1099472			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	856IS	15375267	Green Submitted			2022-12-24	WOS:000224039500041
J	Yurimoto, H; Kuramoto, K				Yurimoto, H; Kuramoto, K			Molecular cloud origin for the oxygen isotope heterogeneity in the solar system	SCIENCE			English	Article							ROTATIONAL-EXCITATION; INTERSTELLAR CLOUDS; CARBON-MONOXIDE; CHEMISTRY; CO; PHOTODISSOCIATION; METEORITES; EXTINCTION; NEBULA; GRAIN	Meteorites and their components have anomalous oxygen isotopic compositions characterized by large variations in O-18/O-16 and O-17/O-16 ratios. On the basis of recent observations of star-forming regions and models of accreting protoplanetary disks, we suggest that these variations may originate in a parent molecular cloud by ultraviolet photodissociation processes. Materials with anomalous isotopic compositions were then transported into the solar nebula by icy dust grains during the collapse of the cloud. The icy dust grains drifted toward the Sun in the disk, and their subsequent evaporation resulted in the O-17- and O-18-enrichment of the inner disk gas.	Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan; Hokkaido Univ, Div Earth & Planetary Sci, Sapporo, Hokkaido 0600810, Japan	Tokyo Institute of Technology; Hokkaido University	Yurimoto, H (corresponding author), Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan.	yuri@geo.titech.ac.jp	Yurimoto, Hisayoshi/S-9938-2018	Yurimoto, Hisayoshi/0000-0003-0702-0533; Kuramoto, Kiyoshi/0000-0002-6757-8064				Ando M, 2002, ASTROPHYS J, V574, P187, DOI 10.1086/340922; BALLY J, 1982, ASTROPHYS J, V255, P143, DOI 10.1086/159812; Beckwith S. V. W., 2000, Protostars and planets 4, P533; Bergin EA, 2000, ASTROPHYS J, V539, pL129, DOI 10.1086/312843; Calvet N., 2000, Protostars and planets 4, P377; Choi BG, 1998, NATURE, V392, P577, DOI 10.1038/33356; CHU YH, 1983, ASTROPHYS J, V267, P151, DOI 10.1086/160852; CLAYTON RN, 1993, ANNU REV EARTH PL SC, V21, P115, DOI 10.1146/annurev.earth.21.1.115; Clayton RN, 2002, NATURE, V415, P860, DOI 10.1038/415860b; CLAYTON RN, 1988, PHILOS T R SOC A, V325, P483, DOI 10.1098/rsta.1988.0062; Connolly HC, 1998, SCIENCE, V280, P62, DOI 10.1126/science.280.5360.62; CUZZI JN, IN PRESS ASTROPHYS J; GLASSGOLD AE, 1985, ASTROPHYS J, V290, P615, DOI 10.1086/163019; Greenberg JM, 1998, ASTRON ASTROPHYS, V330, P375; Hayashi C., 1985, PROTOSTARS PLANETS, P1100; KITAMURA Y, 1983, MOON PLANETS, V29, P199, DOI 10.1007/BF00928327; Kobayashi S, 2003, GEOCHEM J, V37, P663, DOI 10.2343/geochemj.37.663; Kurtz S., 2000, Protostars and planets 4, P299; LADA CJ, 1994, ASTROPHYS J, V429, P694, DOI 10.1086/174354; LANGER WD, 2000, PROTOSTARS PLANETS, V4, P29; LYONS JR, 2004, LUNAR PLANET SCI, V35, P1970; Marechal P, 1997, ASTRON ASTROPHYS, V324, P221; Marechal P, 1997, ASTRON ASTROPHYS, V328, P617; Nittler LR, 1998, NATURE, V393, P222, DOI 10.1038/30377; Ruffle DP, 2001, MON NOT R ASTRON SOC, V324, P1054, DOI 10.1046/j.1365-8711.2001.04394.x; Sheffer Y, 2002, ASTROPHYS J, V574, pL171, DOI 10.1086/342501; STEVENSON DJ, 1988, ICARUS, V75, P146, DOI 10.1016/0019-1035(88)90133-9; THIEMENS MH, 1983, SCIENCE, V219, P1073, DOI 10.1126/science.219.4588.1073; Thiemens MH, 1999, SCIENCE, V283, P341, DOI 10.1126/science.283.5400.341; van Dishoeck E. F., 1993, PROTOSTARS PLANETS, P163; VANDISHOECK EF, 1988, ASTROPHYS J, V334, P771, DOI 10.1086/166877; Warin S, 1996, ASTRON ASTROPHYS, V308, P535; Weidenschilling S.J., 1993, PROTOSTARS PLANETS, P1031; Whittet DCB, 2001, ASTROPHYS J, V547, P872, DOI 10.1086/318421; Yurimoto H, 2002, METEORIT PLANET SCI, V37, pA153	35	321	322	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1763	1766		10.1126/science.1100989	http://dx.doi.org/10.1126/science.1100989			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	856IS	15375265				2022-12-24	WOS:000224039500038
J	Karlawish, JH; Bonnie, RJ; Appelbaum, PS; Lyketsos, C; James, B; Knopman, D; Patusky, C; Kane, RA; Karlan, PS				Karlawish, JH; Bonnie, RJ; Appelbaum, PS; Lyketsos, C; James, B; Knopman, D; Patusky, C; Kane, RA; Karlan, PS			Addressing the ethical, legal, and social issues raised by voting by persons with dementia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PREVALENCE	This article addresses an emerging policy problem in the United States: participation in the electoral process by citizens with dementia. At present, health care professionals, family caregivers, and long-term care staff lack adequate guidance to decide whether individuals with dementia should be precluded from or assisted in casting a ballot. Voting by persons with dementia raises a series of important questions about the autonomy of individuals with dementia, the integrity of the electoral process, and the prevention of fraud. Three subsidiary issues warrant special attention: development of a method to assess capacity to vote; identification of appropriate kinds of assistance to enable persons with cognitive impairment to vote; and formulation of uniform and workable policies for voting in long-term care settings. In some instances, extrapolation from existing policies and research permits reasonable recommendations to guide policy and practice. However, in other instances, additional research is necessary.	Univ Penn, Inst Aging, Dept Med, Ctr Bioeth, Philadelphia, PA 19104 USA; Univ Penn, Fels Inst Govt, Philadelphia, PA 19104 USA; Univ Virginia, Sch Law, Charlottesville, VA 22903 USA; Univ Virginia, Sch Med, Charlottesville, VA 22908 USA; Univ Virginia, Inst Law Psychiat & Publ Policy, Charlottesville, VA USA; Univ Massachusetts, Sch Med, Dept Psychiat, Worcester, MA 01655 USA; Johns Hopkins Univ, Dept Psychiat, Div Geriatr Psychiat & Neuropsychiat, Baltimore, MD USA; Mayo Clin, Dept Neurol, Alzheimers Dis Res Ctr, Rochester, MN USA; Univ Minnesota, Sch Publ Hlth, Long Term Care Resources Ctr, Minneapolis, MN USA; Stanford Univ, Sch Law, Stanford, CA 94305 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Virginia; University of Virginia; University of Virginia; University of Massachusetts System; University of Massachusetts Worcester; Johns Hopkins University; Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; Stanford University	Karlawish, JH (corresponding author), Univ Penn, Inst Aging, Dept Med, Ctr Bioeth, 3615 Chestnut St, Philadelphia, PA 19104 USA.	jasonkar@mail.med.upenn.edu		James, Bryan/0000-0003-1932-151X	NIA NIH HHS [U19 AG010483] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [U19AG010483] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		*ADM AG, OLD AM MONTH; ALVAREZ M, 2003, ABSENTEE VOTES COUNT; Appelbaum PS, 2000, MACARTHUR COMPETENCE; Buchanan AE, 1989, DECIDING OTHERS ETHI; *FED EL COMM, NAT REG FORM; *FED EL COMM, FED EL 2000 EL RES U; Goffman Erving, 1961, ASYLUMS, pxiii; Grisso T, 1998, MACARTHUR COMPETENCE; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; HISCHMAN KB, 2004, J GERIATR PSYCHIA NE, V17, P55; ISSACHAROFF S, 2001, LAW DEMOCRACY LEGAL; Karlawish JHT, 2002, NEUROLOGY, V58, P1100, DOI 10.1212/WNL.58.7.1100; Karlawish JHT, 2001, NEUROLOGY, V56, P789, DOI 10.1212/WNL.56.6.789; Keyssar Alexander, 2000, RIGHT VOTE CONTESTED; Magaziner J, 2000, GERONTOLOGIST, V40, P663, DOI 10.1093/geront/40.6.663; OSULLIVAN JL, 2002, J HLTH CARE LAW POLI, V4, P325; Ott BR, 2003, NEUROLOGY, V60, P1546, DOI 10.1212/01.WNL.0000061481.46191.75; PRESLEY SA, 2000, WASHINGTON POST 0103, pA1; risso T, 2002, EVALUATING COMPETENC, P309; ROSENBLATT A, IN PRESS J AM GERIAT; SALES BD, 1982, DISABLED PERSONS LAW, V1, P99; SHERMAN J, 2004, LONDON TIMES    0611, P11; *TASK FORC NAT COM, 2001, TASK FORC REP ACC RE; TATE A, 2000, CHICAGO REPORTER NOV, V29, P10; *U PENNS ALZH DIS, DEV PRACT GUID VOT P; 2000, ALZHEIMER PAGE; 2001, FED REG, V66, P512; 2001, NEWSDAY         0812, pA22	28	45	46	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 15	2004	292	11					1345	1350		10.1001/jama.292.11.1345	http://dx.doi.org/10.1001/jama.292.11.1345			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853YL	15367557	Green Submitted			2022-12-24	WOS:000223866800027
J	Pui, CH; Relling, MV				Pui, CH; Relling, MV			Can the genotoxicity of chemotherapy be predicted?	LANCET			English	Editorial Material							ACUTE LYMPHOBLASTIC-LEUKEMIA; CHILDHOOD-CANCER; CHILDREN; SURVIVORS		St Jude Childrens Res Hosp, Memphis, TN 38105 USA; Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38105 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Pui, CH (corresponding author), St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA.	Ching-hon.pui@stjude.org	Pui, Ching-Hon/N-8076-2018	Pui, Ching-Hon/0000-0003-0303-5658	NATIONAL CANCER INSTITUTE [P01CA071907, R29CA051001, R37CA036401, P30CA021765, R01CA078224, R01CA051001, R01CA036401, U01CA060419, R01CA060419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061393] Funding Source: NIH RePORTER; NCI NIH HHS [CA 71907, CA 71970, CA 78224, CA 36401, CA 21765, CA 60419, CA 51001] Funding Source: Medline; NIGMS NIH HHS [GM 61393, GM 61374] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bhatia S, 2002, NAT REV CANCER, V2, P124, DOI 10.1038/nrc722; CROM WR, 1987, CLIN PHARMACOKINET, V12, P168, DOI 10.2165/00003088-198712030-00002; Evans WE, 2004, NATURE, V429, P464, DOI 10.1038/nature02626; Fuscoe JC, 1998, MUTAT RES-GEN TOX EN, V419, P107, DOI 10.1016/S1383-5718(98)00129-6; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Neglia JP, 2001, J NATL CANCER I, V93, P618, DOI 10.1093/jnci/93.8.618; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Pui CH, 2000, BRIT J HAEMATOL, V109, P13, DOI 10.1046/j.1365-2141.2000.01843.x; Rice SC, 2004, CANCER RES, V64, P4464, DOI 10.1158/0008-5472.CAN-03-3940; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6	10	5	5	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 11	2004	364	9438					917	918		10.1016/S0140-6736(04)17038-4	http://dx.doi.org/10.1016/S0140-6736(04)17038-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853MF	15364174				2022-12-24	WOS:000223831000007
J	Ehrlich, M; Boll, W; van Oijen, A; Hariharan, R; Chandran, K; Nibert, ML; Kirchhausen, T				Ehrlich, M; Boll, W; van Oijen, A; Hariharan, R; Chandran, K; Nibert, ML; Kirchhausen, T			Endocytosis by random initiation and stabilization of clathrin-coated pits	CELL			English	Article							MEDIATED ENDOCYTOSIS; VESICLE FORMATION; PLASMA-MEMBRANE; AP COMPLEXES; DYNAMIN; FIBROBLASTS; RECEPTOR; CELL; DIFFUSION; SIGNALS	Clathrin-coated vesicles carry traffic from the plasma membrane to endosomes. We report here the real-time visualization of cargo sorting and endocytosis by clathrin-coated pits in living cells. We have detected the formation of coats by monitoring incorporation of fluorescently tagged clathrin or its adaptor AP-2; we have also followed clathrin-mediated uptake of transferrin and of single LDL or reovirus particles. The intensity of a cargo-loaded clathrin cluster grows steadily during its lifetime, and the time required to complete assembly is proportional to the size of the cargo particle. These results are consistent with a nucleation-growth mechanism and an approximately constant growth rate. There are no strongly preferred nucleation sites. A proportion of the nucleation events are weak and short lived. Cargo incorporation occurs primarily or exclusively in a newly formed coated pit. Our data lead to a model in which coated pits initiate randomly but collapse unless stabilized, perhaps by cargo capture.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, CBR Inst Biomed Res, Boston, MA 02115 USA; Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Indian Inst Sci, Dept Comp Sci, Bangalore 560012, Karnataka, India; Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Indian Institute of Science (IISC) - Bangalore; Harvard University; Harvard Medical School	Kirchhausen, T (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 200 Longwood Ave, Boston, MA 02115 USA.	kirchhausen@crystal.harvard.edu	Chandran, Kartik/I-2232-2012; van Oijen, Antoine/I-3167-2014	van Oijen, Antoine/0000-0002-1794-5161; Ehrlich, Marcelo/0000-0002-2352-1808	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036548] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM36548] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Clairmont KB, 1997, CELL MOL LIFE SCI, V53, P611, DOI 10.1007/s000180050080; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; David C, 1996, P NATL ACAD SCI USA, V93, P331, DOI 10.1073/pnas.93.1.331; De Tulleo L, 1998, EMBO J, V17, P4585, DOI 10.1093/emboj/17.16.4585; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Forrest JC, 2003, J BIOL CHEM, V278, P48434, DOI 10.1074/jbc.M305649200; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; GALLUSSER A, 1993, EMBO J, V12, P5237, DOI 10.1002/j.1460-2075.1993.tb06219.x; GOLDSTEIN B, 1981, P NATL ACAD SCI USA, V7, P5695; HANSEN SH, 1992, EXP CELL RES, V199, P19, DOI 10.1016/0014-4827(92)90457-J; HEUSER J, 1989, J CELL BIOL, V108, P401, DOI 10.1083/jcb.108.2.401; Kirchhausen T, 2000, ANNU REV BIOCHEM, V69, P699, DOI 10.1146/annurev.biochem.69.1.699; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837; Merrifield CJ, 2004, EUR J CELL BIOL, V83, P13, DOI 10.1078/0171-9335-00356; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Musacchio A, 1999, MOL CELL, V3, P761, DOI 10.1016/S1097-2765(01)80008-3; Newmyer SL, 2003, DEV CELL, V4, P929, DOI 10.1016/S1534-5807(03)00157-6; Orth JD, 2003, CURR OPIN CELL BIOL, V15, P31, DOI 10.1016/S0955-0674(02)00010-8; PAUL RW, 1989, VIROLOGY, V172, P382, DOI 10.1016/0042-6822(89)90146-3; Rapoport I, 1997, EMBO J, V16, P2240, DOI 10.1093/emboj/16.9.2240; Rappoport JZ, 2003, J CELL SCI, V116, P847, DOI 10.1242/jcs.00289; Rappoport JZ, 2003, J BIOL CHEM, V278, P47357, DOI 10.1074/jbc.C300390200; REYNOLDS GD, 1985, AM J PATHOL, V121, P200; RIPLEY BD, 1976, J APPL PROBAB, V13, P255, DOI 10.2307/3212829; SAKO Y, 1994, J CELL BIOL, V125, P1251, DOI 10.1083/jcb.125.6.1251	30	658	671	4	59	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 3	2004	118	5					591	605		10.1016/j.cell.2004.08.017	http://dx.doi.org/10.1016/j.cell.2004.08.017			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852BN	15339664	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000223730300010
J	Reed, MB; Domenech, P; Manca, C; Su, H; Barczak, AK; Kreiswirth, BN; Kaplan, G; Barry, CE				Reed, MB; Domenech, P; Manca, C; Su, H; Barczak, AK; Kreiswirth, BN; Kaplan, G; Barry, CE			A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response	NATURE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; GENE; SUPPRESSION; COMPLEX; LEPRAE; BIOSYNTHESIS; VIRULENT; FAMILY; MICE	Fifty million new infections with Mycobacterium tuberculosis occur annually, claiming 2 - 3 million lives from tuberculosis worldwide(1). Despite the apparent lack of significant genetic heterogeneity between strains of M. tuberculosis(2,3), there is mounting evidence that considerable heterogeneity exists in molecules important in disease pathogenesis. These differences may manifest in the ability of some isolates to modify the host cellular immune response, thereby contributing to the observed diversity of clinical outcomes(4-7). Here we describe the identification and functional relevance of a highly biologically active lipid species - a polyketide synthase-derived phenolic glycolipid (PGL) produced by a subset of M. tuberculosis isolates belonging to the W-Beijing family(8) that show 'hyperlethality' in murine disease models. Disruption of PGL synthesis results in loss of this hypervirulent phenotype without significantly affecting bacterial load during disease. Loss of PGL was found to correlate with an increase in the release of the pro-inflammatory cytokines tumour-necrosis factor-alpha and interleukins 6 and 12 in vitro. Furthermore, the overproduction of PGL by M. tuberculosis or the addition of purified PGL to monocyte-derived macrophages was found to inhibit the release of these pro-inflammatory mediators in a dose-dependent manner.	NIAID, TB Res Sect, NIH, Rockville, MD 20852 USA; Publ Hlth Res Inst, Lab Mycobacterial Immun & Pathogenesis, Newark, NJ 07103 USA; Publ Hlth Res Inst, TB Ctr, Newark, NJ 07103 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Barry, CE (corresponding author), NIAID, TB Res Sect, NIH, 12441 Parklawn Dr, Rockville, MD 20852 USA.	clifton_barry@nih.gov	Barry, III, Clifton/H-3839-2012; Barry, Clifton E/ABE-7992-2020	Barry, III, Clifton/0000-0002-2927-270X; Barry, Clifton E/0000-0002-2927-270X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054338, Z01AI000783] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AI000783-11] Funding Source: Medline; NIAID NIH HHS [R01 AI054338, R01 AI054338-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Constant P, 2002, J BIOL CHEM, V277, P38148, DOI 10.1074/jbc.M206538200; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; FOURNIE JJ, 1989, INFECT IMMUN, V57, P3653, DOI 10.1128/IAI.57.11.3653-3659.1989; Gaora PO, 1997, MED PRIN PRACT, V6, P91; GARBE TR, 1994, MICROBIOL-SGM, V140, P133, DOI 10.1099/13500872-140-1-133; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hashimoto K, 2002, INFECT IMMUN, V70, P5167, DOI 10.1128/IAI.70.9.5167-5176.2002; HUNTER SW, 1981, J BACTERIOL, V147, P728, DOI 10.1128/JB.147.3.728-735.1981; Kolattukudy PE, 1997, MOL MICROBIOL, V24, P263, DOI 10.1046/j.1365-2958.1997.3361705.x; Manca C, 1999, J IMMUNOL, V162, P6740; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; MANCA C, IN PRESS INFECT IMMU; Marmiesse M, 2004, MICROBIOL-SGM, V150, P483, DOI 10.1099/mic.0.26662-0; MEHRA V, 1984, NATURE, V308, P194, DOI 10.1038/308194a0; Ng V, 2000, CELL, V103, P511, DOI 10.1016/S0092-8674(00)00142-2; North RJ, 1999, INFECT IMMUN, V67, P5483, DOI 10.1128/IAI.67.10.5483-5485.1999; Pelicic V, 1997, P NATL ACAD SCI USA, V94, P10955, DOI 10.1073/pnas.94.20.10955; SILVA CL, 1993, INT J LEPROSY, V61, P107; Sirakova TD, 2001, J BIOL CHEM, V276, P16833, DOI 10.1074/jbc.M011468200; Slayden R A, 2001, Methods Mol Med, V54, P229, DOI 10.1385/1-59259-147-7:229; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Tiruviluamala P, 2002, ANNU REV PUBL HEALTH, V23, P403, DOI 10.1146/annurev.publhealth.23.100901.140519; VACHULA M, 1989, J IMMUNOL, V142, P1696; Valway SE, 1998, NEW ENGL J MED, V338, P633, DOI 10.1056/NEJM199803053381001; Vergne I, 1998, FRONT BIOSCI, V3, pd865	30	570	594	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 2	2004	431	7004					84	87		10.1038/nature02837	http://dx.doi.org/10.1038/nature02837			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850VC	15343336				2022-12-24	WOS:000223641500046
J	Smith, GCS; Wood, AM; Pell, JP; White, IR; Crossley, JA; Dobbie, R				Smith, GCS; Wood, AM; Pell, JP; White, IR; Crossley, JA; Dobbie, R			Second-trimester maternal serum levels of alpha-fetoprotein and the subsequent risk of sudden infant death syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SCOTLAND; WEIGHT; BIRTH; FETAL	BACKGROUND: Unexplained stillbirth and the sudden infant death syndrome (SIDS) share some features. A raised maternal serum level of alpha-fetoprotein during the second trimester of pregnancy is a marker of placental dysfunction and a strong predictor of the risk of unexplained stillbirth. It is unknown whether alpha-fetoprotein levels also predict the risk of SIDS. METHODS: We linked a prenatal-screening database for women in western Scotland with databases of maternity, perinatal death, and birth and death certifications to assess the association between second-trimester levels of maternal serum alpha-fetoprotein and the subsequent risk of SIDS. RESULTS: Among 214,532 women with singleton births, there were 114 cases of SIDS (incidence, 2.7 per 10,000 births among women with alpha-fetoprotein levels in the lowest quintile and 7.5 per 10,000 births among those with levels in the highest quintile). When the lowest quintile was used as a referent, the unadjusted odds ratios for SIDS for the second through fifth quintiles were 1.7 (95 percent confidence interval, 0.8 to 3.5), 1.8 (95 percent confidence interval, 0.9 to 3.7), 2.5 (95 percent confidence interval, 1.3 to 4.8), and 2.8 (95 percent confidence interval, 1.4 to 5.4), respectively (P for trend = 0.001). The risk of SIDS varied inversely with the birth-weight percentile and the gestational age at delivery; after adjustment for these factors, the odds ratios for SIDS were 1.7 (95 percent confidence interval, 0.8 to 3.5), 1.7 (95 percent confidence interval, 0.8 to 3.5), 2.2 (95 percent confidence interval, 1.1 to 4.4), and 2.2 (95 percent confidence interval, 1.1 to 4.3), respectively (P for trend = 0.01). CONCLUSIONS: There is a direct association between second-trimester maternal serum alpha-fetoprotein levels and the risk of SIDS, which may be mediated in part through impaired fetal growth and preterm birth.	Univ Cambridge, Dept Obstet & Gynaecol, Cambridge, England; Inst Publ Hlth, MRC, Biostat Unit, Cambridge, England; Greater Glasgow Hlth Board, Dept Publ Hlth, Glasgow, Lanark, Scotland; Yorkhill Natl Hlth Serv Trust, Inst Med Genet, Glasgow, Lanark, Scotland; Common Serv Agcy, Informat & Stat Div, Edinburgh, Midlothian, Scotland	University of Cambridge; MRC Biostatistics Unit; University of Cambridge; University of Glasgow	Smith, GCS (corresponding author), Univ Cambridge, Rosie Matern Hosp, Dept Obstet & Gynaecol, Robinson Way, Cambridge CB2 2QQ, England.	gcss2@cam.ac.uk	Smith, Gordon/A-8070-2008; Wood, Angela/GZA-5762-2022	Smith, Gordon/0000-0003-2124-0997; Wood, Angela/0000-0002-7937-304X; White, Ian/0000-0002-6718-7661; Pell, Jill/0000-0002-8898-7035				Alm B, 2001, ARCH DIS CHILD, V84, P24, DOI 10.1136/adc.84.1.24; Brooke H, 1997, BMJ-BRIT MED J, V314, P1516, DOI 10.1136/bmj.314.7093.1516; CAMPBELL S, 1993, ULTRASOUND OBST GYN, P1431; COLE SK, 1980, PERINATAL AUDIT SURV, P39; Crossley J A, 1994, J Med Screen, V1, P180; *CROWN OFF, 1998, DEATH PROC FISC; EVANS E, 1990, CLIN APPL ULTRASONIC; Fifer WP, 2002, SEMIN PERINATOL, V26, P89, DOI 10.1053/sper.2002.29854; HANSON M, 1994, ADV EXP MED BIOL, V360, P99; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; *INF STAT DIV NHS, 2001, SCOTT PER INF MORT R; Kendrick Stephen, 1993, Health Bulletin (Edinburgh), V51, P72; MCLOONE P, 1994, BRIT MED J, V309, P1465, DOI 10.1136/bmj.309.6967.1465; Mizejewski GJ, 2001, EXP BIOL MED, V226, P377, DOI 10.1177/153537020122600503; Neveux LM, 1996, PRENATAL DIAG, V16, P1115, DOI 10.1002/(SICI)1097-0223(199612)16:12<1115::AID-PD3>3.0.CO;2-6; Sadler DW, 1998, J CLIN PATHOL, V51, P689, DOI 10.1136/jcp.51.9.689; Shinozuka N, 2000, AM J PHYSIOL-HEART C, V278, pH41, DOI 10.1152/ajpheart.2000.278.1.H41; Smith GCS, 2000, AM J EPIDEMIOL, V151, P614, DOI 10.1093/oxfordjournals.aje.a010249; Sullivan FM, 2002, PAEDIATR PERINAT EP, V16, P96; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; WALLER DK, 1993, EPIDEMIOLOGY, V4, P471, DOI 10.1097/00001648-199309000-00014; Waller DK, 1996, OBSTET GYNECOL, V88, P816; WALSH S, 1995, MED HYPOTHESES, V45, P73, DOI 10.1016/0306-9877(95)90206-6	23	29	32	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 2	2004	351	10					978	986		10.1056/NEJMoa040963	http://dx.doi.org/10.1056/NEJMoa040963			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	850UB	15342806				2022-12-24	WOS:000223637400008
J	Montoya, JP; Holl, CM; Zehr, JP; Hansen, A; Villareal, TA; Capone, DG				Montoya, JP; Holl, CM; Zehr, JP; Hansen, A; Villareal, TA; Capone, DG			High rates of N-2 fixation by unicellular diazotrophs in the oligotrophic Pacific Ocean	NATURE			English	Article							NORTH-ATLANTIC OCEAN; CYANOBACTERIUM TRICHODESMIUM-THIEBAUTII; NITROGEN-FIXATION; MARINE CYANOBACTERIUM; EXTENSIVE BLOOM; SITU RATES; DENITRIFICATION; SPP.; GENE	The availability of nitrogen is important in regulating biological productivity in marine environments. Deepwater nitrate has long been considered the major source of new nitrogen supporting primary production in oligotrophic regions of the open ocean, but recent studies have showed that biological N-2 fixation has a critical role in supporting oceanic new production(1-7). Large colonial cyanobacteria in the genus Trichodesmium and the heterocystous endosymbiont Richelia have traditionally been considered the dominant marine N-2 fixers, but unicellular diazotrophic cyanobacteria and bacterioplankton have recently been found in the picoplankton and nanoplankton community of the North Pacific central gyre, and a variety of molecular and isotopic evidence suggests that these unicells could make a major contribution to the oceanic N budget(8). Here we report rates of N-2 fixation by these small, previously overlooked diazotrophs that, although spatially variable, can equal or exceed the rate of N-2 fixation reported for larger, more obvious organisms. Direct measurements of N-15(2) fixation by small diazotrophs in various parts of the Pacific Ocean, including the waters off Hawaii where the unicellular diazotrophs were first characterized, show that N-2 fixation by unicellular diazotrophs can support a significant fraction of total new production in oligotrophic waters.	Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA; Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA; Univ Hawaii, Sch Ocean & Earth Sci & Technol, Honolulu, HI 96822 USA; Univ Texas, Inst Marine Sci, Port Aransas, TX 78373 USA; Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; Univ So Calif, Wrigley Inst Environm Studies, Los Angeles, CA 90089 USA	University System of Georgia; Georgia Institute of Technology; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of Hawaii System; University of Texas System; University of Southern California; University of Southern California	Montoya, JP (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	j.montoya@biology.gatech.edu	Villareal, Tracy A/I-9462-2012; Zehr, Jonathan P/B-3513-2014; Montoya, Joseph/C-3115-2013	Villareal, Tracy A/0000-0002-5717-8163; Zehr, Jonathan P/0000-0002-5691-5408; Montoya, Joseph/0000-0001-7197-4660				Allen CB, 1996, DEEP-SEA RES PT I, V43, P917, DOI 10.1016/0967-0637(96)00022-2; Aufdenkampe AK, 2002, DEEP-SEA RES PT II, V49, P2619, DOI 10.1016/S0967-0645(02)00051-6; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; Capone DG, 1998, MAR ECOL PROG SER, V172, P281, DOI 10.3354/meps172281; CAPONE DG, 1990, APPL ENVIRON MICROB, V56, P3532, DOI 10.1128/AEM.56.11.3532-3536.1990; Carpenter EJ, 2004, DEEP-SEA RES PT I, V51, P173, DOI 10.1016/j.dsr.2003.10.006; CARPENTER EJ, 1991, SCIENCE, V254, P1356, DOI 10.1126/science.254.5036.1356; CARPENTER EJ, 1977, LIMNOL OCEANOGR, V22, P60, DOI 10.4319/lo.1977.22.1.0060; Carpenter EJ, 1999, MAR ECOL PROG SER, V185, P273, DOI 10.3354/meps185273; Chen YB, 1996, J PHYCOL, V32, P916, DOI 10.1111/j.0022-3646.1996.00916.x; Deutsch C, 2001, GLOBAL BIOGEOCHEM CY, V15, P483, DOI 10.1029/2000GB001291; Dore JE, 2002, LIMNOL OCEANOGR, V47, P1595, DOI 10.4319/lo.2002.47.6.1595; Falcon LI, 2004, APPL ENVIRON MICROB, V70, P765, DOI 10.1128/AEM.70.2.765-770.2004; GOERING JJ, 1966, LIMNOL OCEANOGR, V11, P614, DOI 10.4319/lo.1966.11.4.0614; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; GUNDERSEN KR, 1976, PAC SCI, V30, P45; Karl D, 1997, NATURE, V388, P533, DOI 10.1038/41474; Lee K, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014198; Lipschultz F, 1996, BIOGEOCHEMISTRY, V35, P261, DOI 10.1007/BF02179830; Michaels AF, 1996, BIOGEOCHEMISTRY, V35, P181, DOI 10.1007/BF02179827; Montoya JP, 2002, LIMNOL OCEANOGR, V47, P1617, DOI 10.4319/lo.2002.47.6.1617; Montoya JP, 1996, APPL ENVIRON MICROB, V62, P986, DOI 10.1128/AEM.62.3.986-993.1996; Orcutt KM, 2001, DEEP-SEA RES PT II, V48, P1583, DOI 10.1016/S0967-0645(00)00157-0; Saino T, 1977, BIOL NITROGEN FIXATI; Smith W., 1998, EOS T AM GEOPHYS UN, V79, P579, DOI [DOI 10.1029/98E000426, DOI 10.1029/98EO00426]; Tillett D, 2000, J PHYCOL, V36, P251, DOI 10.1046/j.1529-8817.2000.99079.x; ZEHR JP, 1989, APPL ENVIRON MICROB, V55, P2522, DOI 10.1128/AEM.55.10.2522-2526.1989; Zehr JP, 2001, METHOD MICROBIOL, V30, P271, DOI 10.1016/S0580-9517(01)30049-1; Zehr JP, 2001, NATURE, V412, P635, DOI 10.1038/35088063	29	444	466	4	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 26	2004	430	7003					1027	1031		10.1038/nature02824	http://dx.doi.org/10.1038/nature02824			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849CD	15329721				2022-12-24	WOS:000223514900043
J	Tanimoto, H; Heisenberg, M; Gerber, B				Tanimoto, H; Heisenberg, M; Gerber, B			Event timing turns punishment to reward	NATURE			English	Editorial Material							SYNAPTIC MODIFICATION; DOPAMINE NEURONS; INHIBITION		Univ Wurzburg, Biozentrum, Lehrstuhl Genet & Neurobiol, D-97074 Wurzburg, Germany	University of Wurzburg	Tanimoto, H (corresponding author), Univ Wurzburg, Biozentrum, Lehrstuhl Genet & Neurobiol, D-97074 Wurzburg, Germany.	hiromut@biozentrum.uni-wuerzburg.de	Tanimoto, Hiromu/J-6810-2016	Gerber, Bertram/0000-0003-3003-0051				Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Hellstern F, 1998, LEARN MEMORY, V4, P429, DOI 10.1101/lm.4.5.429; RESCORLA RA, 1965, J COMP PHYSIOL PSYCH, V59, P406, DOI 10.1037/h0022060; Schwaerzel M, 2002, NEURON, V35, P951, DOI 10.1016/S0896-6273(02)00832-2; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; SOLOMON RL, 1974, PSYCHOL REV, V81, P119, DOI 10.1037/h0036128; Tobler PN, 2003, J NEUROSCI, V23, P10402; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Wagner A.R., 1981, P5	11	126	126	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 26	2004	430	7003					983	983		10.1038/430983a	http://dx.doi.org/10.1038/430983a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849CD	15329711	Bronze			2022-12-24	WOS:000223514900031
J	Leung, TH; Hoffmann, A; Baltimore, D				Leung, TH; Hoffmann, A; Baltimore, D			One nucleotide in a kappa B site can determine cofactor specificity for NF-kappa B dimers	CELL			English	Article							BETA GENE-EXPRESSION; TRANSCRIPTION FACTORS; GLUCOCORTICOID-RECEPTOR; IMMUNE-RESPONSES; DNA-BINDING; COOPERATIVE INTERACTION; VIRUS INDUCTION; IFN-GAMMA; C-MYC; ACTIVATION	The transcription factor NF-kappaB regulates a wide variety of genes involved in multiple processes. Although the apparent consensus sequence of DNA binding sites for NF-kappaB (kappaB sites) is very broad, the sites active in any one gene show remarkable evolutionary stability. Using a lentivirus-based methodology for implantation of gene regulatory sequences we show that for genes with two kappaB sites both are required for activity. Swapping sites between kappaB-dependent genes altered NF-kappaB dimer specificity of the promoters and revealed that two kappaB sites can function together as a module to regulate gene activation. Further, although the sequence of the kappaB site is important for determining kappaB family member specificity, rather than determining the ability of a particular dimer to bind effectively, the sequence affect which coactivators will form productive interactions, with the bound NF-kappaB dinner. This suggests that binding sites may impart a specific configuration to bound transcription factors.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Baltimore, D (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	baltimo@caltech.edu	Hoffmann, Ary/R-2972-2019	Hoffmann, Ary/0000-0001-9497-7645	NIGMS NIH HHS [R01-GM39458-20] Funding Source: Medline; PHS HHS [R01-A1042549-061] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039458] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akira S, 2003, J BIOL CHEM, V278, P38105, DOI 10.1074/jbc.R300028200; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Berkowitz B, 2002, J BIOL CHEM, V277, P24694, DOI 10.1074/jbc.M200006200; Boyd KE, 1999, MOL CELL BIOL, V19, P8393; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; Brown CT, 2002, DEV BIOL, V246, P86, DOI 10.1006/dbio.2002.0619; Chen FE, 1999, ONCOGENE, V18, P6845, DOI 10.1038/sj.onc.1203224; Chen-Park FE, 2002, J BIOL CHEM, V277, P24701, DOI 10.1074/jbc.M200007200; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Escalante CR, 2002, STRUCTURE, V10, P383, DOI 10.1016/S0969-2126(02)00723-2; Falvo JV, 1995, CELL, V83, P1101, DOI 10.1016/0092-8674(95)90137-X; FRANZOSO G, 1992, NATURE, V359, P339, DOI 10.1038/359339a0; FUJITA T, 1992, GENE DEV, V6, P775, DOI 10.1101/gad.6.5.775; FUJITA T, 1993, GENE DEV, V7, P354; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; KUNSCH C, 1992, MOL CELL BIOL, V12, P442; Lee GR, 2003, IMMUNITY, V19, P145, DOI 10.1016/S1074-7613(03)00179-1; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P1068, DOI 10.1093/nar/18.4.1068; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; OHMORI Y, 1995, J IMMUNOL, V154, P5235; OHMORI Y, 1993, J BIOL CHEM, V268, P6677; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; PERKINS ND, 1994, MOL CELL BIOL, V14, P6570, DOI 10.1128/MCB.14.10.6570; PERKINS ND, 1993, EMBO J, V12, P3551, DOI 10.1002/j.1460-2075.1993.tb06029.x; Phillips K, 2000, J MOL BIOL, V302, P1023, DOI 10.1006/jmbi.2000.4107; Pierer M, 2004, J IMMUNOL, V172, P1256, DOI 10.4049/jimmunol.172.2.1256; Ping DS, 1999, J IMMUNOL, V162, P727; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Rastinejad F, 2001, CURR OPIN STRUC BIOL, V11, P33, DOI 10.1016/S0959-440X(00)00165-2; Re F, 2001, J BIOL CHEM, V276, P37692, DOI 10.1074/jbc.M105927200; Rogatsky I, 2003, P NATL ACAD SCI USA, V100, P13845, DOI 10.1073/pnas.2336092100; Rogatsky I, 2002, P NATL ACAD SCI USA, V99, P16701, DOI 10.1073/pnas.262671599; Rothenberg EV, 1996, P NATL ACAD SCI USA, V93, P9358, DOI 10.1073/pnas.93.18.9358; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; Sakaguchi S, 2003, BIOCHEM BIOPH RES CO, V306, P860, DOI 10.1016/S0006-291X(03)01049-0; Serbina NV, 2003, IMMUNITY, V19, P891, DOI 10.1016/S1074-7613(03)00330-3; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Sheppard KA, 1999, MOL CELL BIOL, V19, P6367; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; THANOS D, 1995, MOL CELL BIOL, V15, P152, DOI 10.1128/MCB.15.1.152; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; Wietek C, 2003, J BIOL CHEM, V278, P50923, DOI 10.1074/jbc.M308135200; Xu Y, 1996, IMMUNITY, V4, P377, DOI 10.1016/S1074-7613(00)80251-4; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	54	331	342	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2004	118	4					453	464		10.1016/j.cell.2004.08.007	http://dx.doi.org/10.1016/j.cell.2004.08.007			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	850YS	15315758	Bronze			2022-12-24	WOS:000223650900008
J	Pelling, AE; Sehati, S; Gralla, EB; Valentine, JS; Gimzewski, JK				Pelling, AE; Sehati, S; Gralla, EB; Valentine, JS; Gimzewski, JK			Local nanomechanical motion of the cell wall of Saccharomyces cerevisiae	SCIENCE			English	Article							SPONTANEOUS OSCILLATIONS; MECHANICAL-PROPERTIES; MICROBIAL-CELLS; FORCE; ELASTICITY; MOVEMENT; PULSE	We demonstrate that the cell wall of living Saccharomyces cerevisiae (baker's yeast) exhibits local temperature-dependent nanomechanical motion at characteristic frequencies. The periodic motions in the range of 0.8 to 1.6 kHz with amplitudes of similar to3 nm were measured using the cantilever of an atomic force microscope (AFM). Exposure of the cells to a metabolic inhibitor causes the periodic motion to cease. From the strong frequency dependence on temperature, we derive an activation energy of 58 kj/mol, which is consistent with the cell's metabolism involving molecular motors such as kinesin, dynein, and myosin. The magnitude of the forces observed (similar to10 nN) suggests concerted nanomechanical activity is operative in the cell.	Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Gimzewski, JK (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.	gim@chem.ucla.edu	Valentine, Joan S/B-6665-2008	Valentine, Joan S/0000-0002-7174-925X; Pelling, Andrew/0000-0003-3732-7472; gimzewski, james/0000-0003-4333-6957	NIDDK NIH HHS [DK46828] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046828] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		A-Hassan E, 1998, BIOPHYS J, V74, P1564, DOI 10.1016/S0006-3495(98)77868-3; Arnoldi M, 2000, PHYS REV E, V62, P1034, DOI 10.1103/PhysRevE.62.1034; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Bowen WR, 2001, J COLLOID INTERF SCI, V237, P54, DOI 10.1006/jcis.2001.7437; Charras GT, 2002, BIOPHYS J, V82, P2970, DOI 10.1016/S0006-3495(02)75638-5; Ding DQ, 1998, J CELL SCI, V111, P701; Domke J, 1999, EUR BIOPHYS J BIOPHY, V28, P179, DOI 10.1007/s002490050198; Doyle T, 1996, P NATL ACAD SCI USA, V93, P3886, DOI 10.1073/pnas.93.9.3886; Gad M, 1997, CELL BIOL INT, V21, P697, DOI 10.1006/cbir.1997.0214; HARRIS CM, 1988, SHOCK VIBRATION HDB; HOH JH, 1994, J CELL SCI, V107, P1105; Howard J, 1997, NATURE, V389, P561, DOI 10.1038/39247; JOHNSTON M, 1992, MOL BIOL YEAST SACCH; Julicher F, 2001, CR ACAD SCI IV-PHYS, V2, P849, DOI 10.1016/S1296-2147(01)01228-8; Julicher F, 1997, PHYS REV LETT, V78, P4510, DOI 10.1103/PhysRevLett.78.4510; KAMIMURA S, 1989, NATURE, V340, P476, DOI 10.1038/340476a0; KASAS S, 1995, BIOPHYS J, V68, P1678, DOI 10.1016/S0006-3495(95)80344-9; Kawaguchi K, 2000, BIOCHEM BIOPH RES CO, V272, P895, DOI 10.1006/bbrc.2000.2856; Kawaguchi K, 2001, CELL MOTIL CYTOSKEL, V49, P41, DOI 10.1002/cm.1019; Levy R, 2002, NANOTECHNOLOGY, V13, P33, DOI 10.1088/0957-4484/13/1/307; Maksym GN, 2000, J APPL PHYSIOL, V89, P1619, DOI 10.1152/jappl.2000.89.4.1619; Rotsch C, 1997, CELL BIOL INT, V21, P685, DOI 10.1006/cbir.1997.0213; Szabo B, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041910; Touhami A, 2003, LANGMUIR, V19, P4539, DOI 10.1021/la034136x; Vilfan A, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.114101; Yasuda K, 1996, BIOPHYS J, V70, P1823, DOI 10.1016/S0006-3495(96)79747-3; Zhang PC, 2001, NATURE, V413, P428, DOI 10.1038/35096578	27	279	292	4	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 20	2004	305	5687					1147	1150		10.1126/science.1097640	http://dx.doi.org/10.1126/science.1097640			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849RD	15326353				2022-12-24	WOS:000223557400046
J	Greenwood, B				Greenwood, B			Between hope and a hard place	NATURE			English	Article							MALARIA; MORTALITY		London Sch Hyg & Trop Med, Malaria Ctr, London, England	University of London; London School of Hygiene & Tropical Medicine	Greenwood, B (corresponding author), London Sch Hyg & Trop Med, Malaria Ctr, London, England.							[Anonymous], 2003, AFR MAL REP 2003; Coleman PG, 2004, TROP MED INT HEALTH, V9, P433, DOI 10.1111/j.1365-3156.2004.01225.x; Korenromp EL, 2003, LANCET INFECT DIS, V3, P349, DOI 10.1016/S1473-3099(03)00657-1; Phillips-Howard PA, 2003, AM J TROP MED HYG, V68, P23, DOI 10.4269/ajtmh.2003.68.23; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a	5	19	20	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 19	2004	430	7002					926	927		10.1038/430926a	http://dx.doi.org/10.1038/430926a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318230				2022-12-24	WOS:000223369800053
J	Mishima, M; Pavicic, V; Gruneberg, N; Nigg, EA; Glotzer, M				Mishima, M; Pavicic, V; Gruneberg, N; Nigg, EA; Glotzer, M			Cell cycle regulation of central spindle assembly	NATURE			English	Article							CYTOKINESIS; PROTEIN; KINESIN; COMPLEX; MITOSIS; INCENP; MCAK; PHOSPHORYLATION; LOCALIZATION; PHOSPHATASE	The bipolar mitotic spindle is responsible for segregating sister chromatids at anaphase. Microtubule motor proteins generate spindle bipolarity and enable the spindle to perform mechanical work(1). A major change in spindle architecture occurs at anaphase onset when central spindle assembly begins. This structure regulates the initiation of cytokinesis and is essential for its completion(2). Central spindle assembly requires the central-spindlin complex composed of the Caenorhabditis elegans ZEN-4 (mammalian orthologue MKLP1) kinesin-like protein and the Rho family GAP CYK-4 (MgcRacGAP). Here we describe a regulatory mechanism that controls the timing of central spindle assembly. The mitotic kinase Cdk1/cyclin B phosphorylates the motor domain of ZEN-4 on a conserved site within a basic amino-terminal extension characteristic of the MKLP1 subfamily. Phosphorylation by Cdk1 diminishes the motor activity of ZEN-4 by reducing its affinity for microtubules. Preventing Cdk1 phosphorylation of ZEN-4/MKLP1 causes enhanced metaphase spindle localization and defects in chromosome segregation. Thus, phosphoregulation of the motor domain of MKLP1 kinesin ensures that central spindle assembly occurs at the appropriate time in the cell cycle and maintains genomic stability.	Res Inst Mol Pathol, A-1030 Vienna, Austria; Max Planck Inst Biochem, D-82152 Martinsried, Germany	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Max Planck Society	Glotzer, M (corresponding author), Res Inst Mol Pathol, Dr Bohrgasse 7, A-1030 Vienna, Austria.	mglotzer@imp.univie.ac.at	Gruneberg, Ulrike/AAY-2351-2020	Gruneberg, Ulrike/0000-0001-8344-0500; Mishima, Masanori/0000-0002-8908-7485; Glotzer, Michael/0000-0002-8723-7232; nigg, erich/0000-0003-4835-5719				Adams RR, 2001, TRENDS CELL BIOL, V11, P49, DOI 10.1016/S0962-8924(00)01880-8; Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; BERLINER E, 1994, J BIOL CHEM, V269, P8610; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Glotzer M, 2001, ANNU REV CELL DEV BI, V17, P351, DOI 10.1146/annurev.cellbio.17.1.351; Gray CH, 2003, EMBO J, V22, P3524, DOI 10.1093/emboj/cdg348; Gruneberg U, 2002, J CELL BIOL, V158, P901, DOI 10.1083/jcb.200202054; Jantsch-Plunger V, 2000, J CELL BIOL, V149, P1391, DOI 10.1083/jcb.149.7.1391; Kaitna S, 2000, CURR BIOL, V10, P1172, DOI 10.1016/S0960-9822(00)00721-1; Kikkawa M, 2001, NATURE, V411, P439, DOI 10.1038/35078000; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Matuliene J, 2002, MOL BIOL CELL, V13, P1832, DOI 10.1091/mbc.01-10-0504; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Mello C, 1995, METHOD CELL BIOL, V48, P451; Minestrini G, 2003, MOL BIOL CELL, V14, P4028, DOI 10.1091/mbc.E03-04-0214; Mishima M, 2002, DEV CELL, V2, P41, DOI 10.1016/S1534-5807(01)00110-1; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; NISLOW C, 1992, NATURE, V359, P543, DOI 10.1038/359543a0; Ohi R, 2004, MOL BIOL CELL, V15, P2895, DOI 10.1091/mbc.E04-02-0082; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; Parry DH, 2001, CURR BIOL, V11, P671, DOI 10.1016/S0960-9822(01)00204-4; Patra D, 1998, GENE DEV, V12, P2549, DOI 10.1101/gad.12.16.2549; Pereira G, 2003, SCIENCE, V302, P2120, DOI 10.1126/science.1091936; Powers J, 1998, CURR BIOL, V8, P1133, DOI 10.1016/S0960-9822(98)70470-1; Raich WB, 1998, MOL BIOL CELL, V9, P2037, DOI 10.1091/mbc.9.8.2037; Romano A, 2003, J CELL BIOL, V161, P229, DOI 10.1083/jcb.200207117; Scholey JM, 2003, NATURE, V422, P746, DOI 10.1038/nature01599; SELLITTO C, 1988, J CELL BIOL, V106, P431, DOI 10.1083/jcb.106.2.431; Wheatley SP, 1997, J CELL BIOL, V138, P385, DOI 10.1083/jcb.138.2.385	30	210	215	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2004	430	7002					908	913		10.1038/nature02767	http://dx.doi.org/10.1038/nature02767			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15282614				2022-12-24	WOS:000223369800046
J	She, XW; Horvath, JE; Jiang, ZS; Liu, G; Furey, TS; Christ, L; Clark, R; Graves, T; Gulden, CL; Alkan, C; Bailey, JA; Sahinalp, C; Rocchi, M; Haussler, D; Wilson, RK; Miller, W; Schwartz, S; Eichler, EE				She, XW; Horvath, JE; Jiang, ZS; Liu, G; Furey, TS; Christ, L; Clark, R; Graves, T; Gulden, CL; Alkan, C; Bailey, JA; Sahinalp, C; Rocchi, M; Haussler, D; Wilson, RK; Miller, W; Schwartz, S; Eichler, EE			The structure and evolution of centromeric transition regions within the human genome	NATURE			English	Article							RECENT SEGMENTAL DUPLICATIONS; ALPHA-SATELLITE DNA; GENETIC DEFINITION; SEQUENCE; EXPANSION; PRIMATES; REPEAT; ORIGIN	An understanding of how centromeric transition regions are organized is a critical aspect of chromosome structure and function; however, the sequence context of these regions has been difficult to resolve on the basis of the draft genome sequence. We present a detailed analysis of the structure and assembly of all human pericentromeric regions (5 megabases). Most chromosome arms ( 35 out of 43) show a gradient of dwindling transcriptional diversity accompanied by an increasing number of interchromosomal duplications in proximity to the centromere. At least 30% of the centromeric transition region structure originates from euchromatic gene-containing segments of DNA that were duplicatively transposed towards pericentromeric regions at a rate of six-seven events per million years during primate evolution. This process has led to the formation of a minimum of 28 new transcripts by exon exaptation and exon shuffling, many of which are primarily expressed in the testis. The distribution of these duplicated segments is nonrandom among pericentromeric regions, suggesting that some regions have served as preferential acceptors of euchromatic DNA.	Case Western Reserve Univ, Sch Med, Ctr Computat Genom, Dept Genet, Cleveland, OH 44106 USA; Case Western Reserve Univ, Sch Med, Ctr Human Genet, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA; Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, UCSC Genome Bioinformat Grp, Santa Cruz, CA 95064 USA; Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; Simon Fraser Univ, Sch Comp Sci, Burnaby, BC V5A 1S6, Canada; Univ Bari, DAPEG, Sez Genet, I-70126 Bari, Italy; Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; University of Washington; University of Washington Seattle; University of California System; University of California Santa Cruz; Washington University (WUSTL); Simon Fraser University; Universita degli Studi di Bari Aldo Moro; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Eichler, EE (corresponding author), Case Western Reserve Univ, Sch Med, Ctr Computat Genom, Dept Genet, Cleveland, OH 44106 USA.	eee@gs.washington.edu	Wilson, Richard K./AAF-4139-2019; Sahinalp, Suleyman Cenk/X-7843-2018; Alkan, Can/D-2982-2009	Wilson, Richard K./0000-0002-1992-1358; Sahinalp, Suleyman Cenk/0000-0002-5050-0682; Alkan, Can/0000-0002-5443-0706; Rocchi, Mariano/0000-0002-9451-5616; Furey, Terry/0000-0001-5546-9672	Telethon [E.0672] Funding Source: Medline	Telethon(Fondazione Telethon)		Alexandrov I, 2001, CHROMOSOMA, V110, P253, DOI 10.1007/s004120100146; Bailey JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r23; Bailey JA, 2003, AM J HUM GENET, V73, P823, DOI 10.1086/378594; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2002, AM J HUM GENET, V70, P83, DOI 10.1086/338458; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; BALDINI A, 1993, HUM GENET, V90, P577; Copenhaver GP, 1999, SCIENCE, V286, P2468, DOI 10.1126/science.286.5449.2468; Courseaux A, 2003, GENOME RES, V13, P369, DOI 10.1101/gr.490303; Crosier M, 2002, GENOME RES, V12, P67, DOI 10.1101/gr.213702; Eder V, 2003, MOL BIOL EVOL, V20, P1506, DOI 10.1093/molbev/msg165; Eichler EE, 2001, TRENDS GENET, V17, P661, DOI 10.1016/S0168-9525(01)02492-1; Eichler EE, 1998, GENOME RES, V8, P758, DOI 10.1101/gr.8.8.758; Golfier G, 2003, GENE, V312, P51, DOI 10.1016/S0378-1119(03)00673-5; Guy J, 2003, GENOME RES, V13, P159, DOI 10.1101/gr.644503; Hillier LW, 2003, NATURE, V424, P157, DOI 10.1038/nature01782; Horvath JE, 2001, HUM MOL GENET, V10, P2215, DOI 10.1093/hmg/10.20.2215; Horvath JE, 2003, MOL BIOL EVOL, V20, P1463, DOI 10.1093/molbev/msg158; Horvath JE, 2000, HUM MOL GENET, V9, P113, DOI 10.1093/hmg/9.1.113; Horvath JE, 2000, GENOME RES, V10, P839, DOI 10.1101/gr.10.6.839; *INT SYST HUM CYT, 1981, CYTOGENET CELL GENET, V31, P1; Istrail S, 2004, P NATL ACAD SCI USA, V101, P1916, DOI 10.1073/pnas.0307971100; Jackson M, 2003, CURR OPIN GENET DEV, V13, P629, DOI 10.1016/j.gde.2003.10.011; Jackson MS, 1999, HUM MOL GENET, V8, P205, DOI 10.1093/hmg/8.2.205; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee C, 1997, HUM GENET, V100, P291, DOI 10.1007/s004390050508; Leem SH, 2004, GENOME RES, V14, P239, DOI 10.1101/gr.1929904; Liu G, 2003, GENOME RES, V13, P358, DOI 10.1101/gr.923303; Locke DP, 2003, GENOME RES, V13, P347, DOI 10.1101/gr.1003303; LOCKE DP, IN PRESS CYTOGENET G; Nagaki K, 2004, NAT GENET, V36, P138, DOI 10.1038/ng1289; RUDD MK, IN PRES TRENDS GENET; SCHNEIDER M, 1979, MATURITAS, V1, P153, DOI 10.1016/0378-5122(79)90002-1; Schueler MG, 2001, SCIENCE, V294, P109, DOI 10.1126/science.1065042; Thomas JW, 2003, GENOME RES, V13, P55, DOI 10.1101/gr.791403; Tuzun E, 2004, GENOME RES, V14, P493, DOI 10.1101/gr.1907504; Ventura M, 2003, GENOME RES, V13, P2059, DOI 10.1101/gr.1155103; Ventura M, 2001, GENOME RES, V11, P595, DOI 10.1101/gr.152101; WILLARD HF, 1987, J MOL EVOL, V25, P207, DOI 10.1007/BF02100014; YUNIS JJ, 1982, SCIENCE, V215, P1525, DOI 10.1126/science.7063861	40	151	155	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2004	430	7002					857	864		10.1038/nature02806	http://dx.doi.org/10.1038/nature02806			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318213				2022-12-24	WOS:000223369800033
J	Jiang, QX; Wang, DN; MacKinnon, R				Jiang, QX; Wang, DN; MacKinnon, R			Electron microscopic analysis of KvAP voltage-dependent K+ channels in an open conformation	NATURE			English	Article							ION CHANNELS; ANGULAR RECONSTITUTION; GATING CHARGE; S4 SEGMENT; RESOLUTION; CRYOMICROSCOPY; ORIENTATION; PERSPECTIVE; MOVEMENTS; PROTEIN	Voltage-dependent ion channels serve as field-effect transistors by opening a gate in response to membrane voltage changes(1). The gate's response to voltage is mediated by voltage sensors(2), which are arginine-containing structures that must move with respect to the membrane electric field. We have analysed by electron microscopy a voltage-dependent K+ channel from Aeropyrum pernix (KvAP)(3). Fab fragments were attached to 'voltage sensor paddles' and identified in the electron microscopy map at 10.5 Angstrom resolution. The extracellular surface location of the Fab fragments in the map is consistent with the membrane-depolarized, open conformation of the channel in electrophysiological experiments. Comparison of the map with a crystal structure(4) demonstrates that the voltage sensor paddles are 'up' ( that is, near the channel's extracellular surface) and situated at the protein - lipid interface. This finding supports the hypothesis that in response to changes in voltage the sensors move at the protein - lipid interface(5) rather than in a gating pore surrounded by protein(6,7).	Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Rockefeller Univ, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA; NYU, Med Ctr, Skirball Inst Biomol Med, New York, NY 10016 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; New York University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.	mackinn@rockefeller.edu	Jiang, Qiu-Xing/ABF-1143-2021	Wang, Da-Neng/0000-0002-6496-4699				Adrian M, 1998, MICRON, V29, P145, DOI 10.1016/S0968-4328(97)00068-1; Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Bezanilla F, 2002, J GEN PHYSIOL, V120, P465, DOI 10.1085/jgp.20028660; CHANDY KG, 1995, LIGAND VOLTAGE GATED, P1; Conway JF, 2003, J VIROL, V77, P6466, DOI 10.1128/JVI.77.11.6466-6473.2003; Frank J, 2002, ANNU REV BIOPH BIOM, V31, P303, DOI 10.1146/annurev.biophys.31.082901.134202; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; Gandhi CS, 2003, NEURON, V40, P515, DOI 10.1016/S0896-6273(03)00646-9; Golas MM, 2003, SCIENCE, V300, P980, DOI 10.1126/science.1084155; Hawkes P W., 1980, COMPUTER PROCESSING, P1; HENDERSON R, 1995, Q REV BIOPHYS, V28, P171, DOI 10.1017/S003358350000305X; Horn R, 2002, J GEN PHYSIOL, V120, P449, DOI 10.1085/jgp.20028658; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Neale EJ, 2003, J BIOL CHEM, V278, P29079, DOI 10.1074/jbc.M301991200/6493; Orlova EV, 1997, J MOL BIOL, V271, P417, DOI 10.1006/jmbi.1997.1182; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Ruta V, 2003, NATURE, V422, P180, DOI 10.1038/nature01473; Sander B, 2003, J STRUCT BIOL, V142, P392, DOI 10.1016/S1047-8477(03)00072-8; SAXTON WO, 1982, J MICROSC-OXFORD, V127, P127, DOI 10.1111/j.1365-2818.1982.tb00405.x; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P111, DOI 10.1016/0304-3991(87)90078-7; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P95, DOI 10.1016/0304-3991(87)90010-6; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004	30	95	98	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2004	430	7001					806	810		10.1038/nature02735	http://dx.doi.org/10.1038/nature02735			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306816				2022-12-24	WOS:000223233600048
J	Arvidson, RE; Anderson, RC; Bartlett, P; Bell, JF; Blaney, D; Christensen, PR; Chu, P; Crumpler, L; Davis, K; Ehlmann, BL; Fergason, R; Golombek, MP; Gorevan, S; Grant, JA; Greeley, R; Guinness, EA; Haldemann, AFC; Herkenhoff, K; Johnson, J; Landis, G; Li, R; Lindemann, R; McSween, H; Ming, DW; Myrick, T; Richter, L; Seelos, FP; Squyres, SW; Sullivan, RJ; Wang, A; Wilson, J				Arvidson, RE; Anderson, RC; Bartlett, P; Bell, JF; Blaney, D; Christensen, PR; Chu, P; Crumpler, L; Davis, K; Ehlmann, BL; Fergason, R; Golombek, MP; Gorevan, S; Grant, JA; Greeley, R; Guinness, EA; Haldemann, AFC; Herkenhoff, K; Johnson, J; Landis, G; Li, R; Lindemann, R; McSween, H; Ming, DW; Myrick, T; Richter, L; Seelos, FP; Squyres, SW; Sullivan, RJ; Wang, A; Wilson, J			Localization and physical properties experiments conducted by Spirit at Gusev crater	SCIENCE			English	Article							PATHFINDER	The precise location and relative elevation of Spirit during its traverses from the Columbia Memorial station to Bonneville crater were determined with bundle-adjusted retrievals from rover wheel turns, suspension and tilt angles, and overlapping images. Physical properties experiments show a decrease of 0.2% per Mars solar day in solar cell output resulting from deposition of airborne dust, cohesive soil-like deposits in plains and hollows, bright and dark rock coatings, and relatively weak volcanic rocks of basaltic composition. Volcanic, impact, aeolian, and water-related processes produced the encountered landforms and materials.	Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Honeybee Robot, New York, NY 10012 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; New Mexico Museum Nat Hist & Sci, Albuquerque, NM 87104 USA; Smithsonian Inst, Natl Air & Space Museum, Ctr Earth & Planetary Studies, Washington, DC 20560 USA; US Geol Survey, Flagstaff, AZ 86001 USA; NASA, Glenn Res Ctr, Cleveland, OH 44135 USA; Ohio State Univ, Dept Civil & Environm Engn & Geodet Sci, Columbus, OH 43210 USA; Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; Deutsch Luft & Raumfahrt Inst Raumsimulat, D-51170 Cologne, Germany	Washington University (WUSTL); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Cornell University; Arizona State University; Arizona State University-Tempe; Smithsonian Institution; United States Department of the Interior; United States Geological Survey; National Aeronautics & Space Administration (NASA); NASA Glenn Research Center; University System of Ohio; Ohio State University; University of Tennessee System; University of Tennessee Knoxville; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER	Arvidson, RE (corresponding author), Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA.		Seelos, Frank/C-7875-2016; Haldemann, Albert F C/I-9224-2012	Seelos, Frank/0000-0001-9721-941X; Haldemann, Albert F C/0000-0003-3741-8841				Bell JF, 2004, SCIENCE, V305, P800, DOI 10.1126/science.1100175; Christensen PR, 2004, SCIENCE, V305, P837, DOI 10.1126/science.1100564; Grant JA, 2004, SCIENCE, V305, P807, DOI 10.1126/science.1099849; Greeley R, 2004, SCIENCE, V305, P810, DOI 10.1126/science.1100108; Herkenhoff KE, 2004, SCIENCE, V305, P824, DOI 10.1126/science.1100015; Landis GA, 2000, J GEOPHYS RES-PLANET, V105, P1855, DOI 10.1029/1999JE001029; McSween HY, 2004, SCIENCE, V305, P842, DOI 10.1126/science.3050842; Mischna MA, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002051; Moore HJ, 1999, J GEOPHYS RES-PLANET, V104, P8729, DOI 10.1029/1998JE900005; Squyres SW, 2004, SCIENCE, V305, P794, DOI 10.1126/science.3050794	10	143	154	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2004	305	5685					821	824		10.1126/science.1099922	http://dx.doi.org/10.1126/science.1099922			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297662				2022-12-24	WOS:000223104900035
J	Gellert, R; Rieder, R; Anderson, RC; Bruckner, J; Clark, BC; Dreibus, G; Economou, T; Klingelhofer, G; Lugmair, GW; Ming, DW; Squyres, SW; d'Uston, C; Wanke, H; Yen, A; Zipfel, J				Gellert, R; Rieder, R; Anderson, RC; Bruckner, J; Clark, BC; Dreibus, G; Economou, T; Klingelhofer, G; Lugmair, GW; Ming, DW; Squyres, SW; d'Uston, C; Wanke, H; Yen, A; Zipfel, J			Chemistry of rocks and soils in Gusev crater from the alpha particle x-ray spectrometer	SCIENCE			English	Article							CHEMICAL-COMPOSITION; PATHFINDER SITE; MARS; ROVER	The alpha particle x-ray spectrometer on the Spirit rover determined major and minor elements of soils and rocks in Gusev crater in order to unravel the crustal evolution of planet Mars. The composition of soils is similar to those at previous landing sites, as a result of global mixing and distribution by dust storms. Rocks ( fresh surfaces exposed by the rock abrasion tool) resemble volcanic rocks of primitive basaltic composition with low intrinsic potassium contents. High abundance of bromine ( up to 170 parts per million) in rocks may indicate the alteration of surfaces formed during a past period of aqueous activity in Gusev crater.	Max Planck Inst Chem, D-55128 Mainz, Germany; Johannes Gutenberg Univ Mainz, Inst Anorgan & Analyt Chem, D-55128 Mainz, Germany; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Lockheed Martin Corp, Littleton, CO 80127 USA; Univ Chicago, Enrico Fermi Inst, Lab Atmospher & Space Res, Chicago, IL 60637 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; Cornell Univ, Ctr Radiophys & Space Res, Ithaca, NY 14853 USA; Ctr Etud Spatiale Rayonnements, F-31028 Toulouse, France	Max Planck Society; Johannes Gutenberg University of Mainz; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Lockheed Martin; University of Chicago; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Cornell University	Gellert, R (corresponding author), Max Planck Inst Chem, JJ Becher Weg 27, D-55128 Mainz, Germany.	gellert@mpch-mainz.mpg.de						BANIN A., 2000, MARS, P594; Bruckner J, 2003, J GEOPHYS RES-PLANET, V108, DOI [10.1029/2003JE002060, 10.1029/2003JE002150]; CLARK BC, 1979, GEOPHYS RES LETT, V6, P811, DOI 10.1029/GL006i010p00811; CLARK BC, 1982, J GEOPHYS RES, V87, P59, DOI 10.1029/JB087iB12p10059; DREIBUS G, UNPUB; Dreibus G., 2003, INT S EV SOL SYST MA, P19; Foley CN, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002019; GOREVAN SP, 2003, J GEOPHYS RES-PLANET, V108; Herkenhoff KE, 2004, SCIENCE, V305, P824, DOI 10.1126/science.1100015; McSween HY, 2004, SCIENCE, V305, P842, DOI 10.1126/science.3050842; Newsom HE, 1997, J GEOPHYS RES-PLANET, V102, P19345, DOI 10.1029/97JE01687; Rieder R, 1997, SCIENCE, V278, P1771, DOI 10.1126/science.278.5344.1771; Rieder R., 2003, Journal of Geophysical Research, V108, pROV7, DOI 10.1029/2003JE002150; Squyres SW, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002121; SUTTON SR, 2002, LUNAR PLANET SCI, V33, P1278; WANKE H, 1994, PHILOS T R SOC A, V349, P285, DOI 10.1098/rsta.1994.0132; Wanke H, 2001, SPACE SCI REV, V96, P317, DOI 10.1023/A:1011961725645	17	244	247	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					829	832		10.1126/science.1099913	http://dx.doi.org/10.1126/science.1099913			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297665				2022-12-24	WOS:000223104900038
J	Dennis, C				Dennis, C			Cooling off	NATURE			English	News Item																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 5	2004	430	7000					605	605						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843LM	15309806				2022-12-24	WOS:000223085400015
J	Parker, M; Ashcroft, R; Wilkie, AOM; Kent, A				Parker, M; Ashcroft, R; Wilkie, AOM; Kent, A			Ethical review of research into rare genetic disorders	BRITISH MEDICAL JOURNAL			English	Article								Although some work on rare diseases is clearly clinical investigation and some clearly research, much activity falls uneasily between the two. Where should we draw the line and how can we ensure research gets appropriate ethical review?	Univ Oxford, Dept Publ Hlth, Oxford OX3 7LF, England; John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England; Univ London Imperial Coll Sci Technol & Med, Med Eth Unit, London W6 8RP, England; Genet Interest Grp, London N1 3QP, England	University of Oxford; University of Oxford; Imperial College London	Parker, M (corresponding author), Univ Oxford, Dept Publ Hlth, Oxford OX3 7LF, England.	Michael.parker@ethox.ox.ac.uk	Wilkie, Andrew/AAC-3820-2020	Wilkie, Andrew/0000-0002-2972-5481				*DEP HLTH, 2003, RES GOV FRAM HLTH SO; *DEP HLTH, GOOD PRACT CONS IMPL; *GEN MED COUNC, 2000, CONF PROT PROV INF	3	29	29	1	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 31	2004	329	7460					288	289		10.1136/bmj.329.7460.288	http://dx.doi.org/10.1136/bmj.329.7460.288			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BY	15284160	Green Published, Green Submitted			2022-12-24	WOS:000223133300029
J	Bishop, KN; Holmes, RK; Sheehy, AM; Malim, MH				Bishop, KN; Holmes, RK; Sheehy, AM; Malim, MH			APOBEC-mediated editing of viral RNA	SCIENCE			English	Article							ENZYMES; DEAMINATION		Kings Coll London, Guys Kings & St Thomas Sch Med, Dept Infect Dis, London SE1 9RT, England	University of London; King's College London	Malim, MH (corresponding author), Kings Coll London, Guys Kings & St Thomas Sch Med, Dept Infect Dis, London SE1 9RT, England.	michael.malim@kcl.ac.uk		Malim, Michael/0000-0002-7699-2064				Anant S, 2003, TRENDS MOL MED, V9, P147, DOI 10.1016/S1471-4914(03)00032-7; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046; BISHOP KN, 2004, IN PRESS CARR BIOL; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Turelli P, 2004, SCIENCE, V303, P1829, DOI 10.1126/science.1092066; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591	7	187	206	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 30	2004	305	5684					645	645		10.1126/science.1100658	http://dx.doi.org/10.1126/science.1100658			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	842GQ	15286366				2022-12-24	WOS:000222992100039
J	Stecyk, JAW; Stenslokken, KO; Farrell, AP; Nilsson, GE				Stecyk, JAW; Stenslokken, KO; Farrell, AP; Nilsson, GE			Maintained cardiac pumping in anoxic crucian carp	SCIENCE			English	Article							CARDIOVASCULAR-RESPONSES; 5-DEGREES-C; 22-DEGREES; HYPOXIA; TURTLE; OXYGEN		Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; Univ Oslo, Dept Mol Biosci, Physiol Programme, N-0316 Oslo, Norway	Simon Fraser University; University of Oslo	Stecyk, JAW (corresponding author), Simon Fraser Univ, Dept Biol Sci, 8888 Univ Dr, Burnaby, BC V5A 1S6, Canada.	jstecyk@interchange.ubc.ca	Nilsson, Goran E/K-7668-2012; Stecyk, Jonathan/B-4530-2013; Nilsson, Göran Erik/Q-6129-2019	Nilsson, Goran E/0000-0002-3195-3053; Stecyk, Jonathan/0000-0002-0973-9472; Stenslokken, Kare-Olav/0000-0003-2962-4143				AXELSSON M, 1990, J EXP BIOL, V151, P297; Hicks JMT, 2000, J EXP BIOL, V203, P3775; Hicks JMT, 2000, J EXP BIOL, V203, P3765; Jackson DC, 2002, J PHYSIOL-LONDON, V543, P731, DOI 10.1113/jphysiol.2002.024729; JACKSON DC, 1968, J APPL PHYSIOL, V24, P503, DOI 10.1152/jappl.1968.24.4.503; Nilsson GE, 2001, NEWS PHYSIOL SCI, V16, P217; Stecyk JAW, 2002, J EXP BIOL, V205, P759	7	94	97	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 1	2004	306	5693					77	77		10.1126/science.1100763	http://dx.doi.org/10.1126/science.1100763			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459381				2022-12-24	WOS:000224304000038
J	Meeusen, S; McCaffery, JM; Nunnari, J				Meeusen, S; McCaffery, JM; Nunnari, J			Mitochondrial fusion intermediates revealed in vitro	SCIENCE			English	Article							DYNAMIN-RELATED GTPASE; DOMINANT OPTIC ATROPHY; OUTER-MEMBRANE; SACCHAROMYCES-CEREVISIAE; PROTEIN; FISSION; MGM1P; APOPTOSIS; FZO1P; YEAST	The events that occur during the fusion of double-membraned mitochondria are unknown. As an essential step toward determining the mechanism of mitochondria) fusion, we have captured this event in vitro. Mitochondrial outer and inner membrane fusion events were separable and mechanistically distinct, but both required guanosine 5'-triphosphate hydrolysis. Homotypic trans interactions of the ancient outer transmembrane guanosine triphosphatase, Fzo1, were required to promote the fusion of mitochondrial outer membranes, whereas electrical potential was also required for fusion of inner membranes. Our conclusions provide fundamental insights into the molecular events driving mitochondrial fusion and advance our understanding of the evolution of mitochondria) fusion in eukaryotic cells.	Univ Calif Davis, Ctr Genet & Dev, Sect Mol & Cellular Biol, Davis, CA 95616 USA; Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA; Johns Hopkins Univ, Integrated Imaging Ctr, Baltimore, MD 21218 USA	University of California System; University of California Davis; Johns Hopkins University; Johns Hopkins University	Nunnari, J (corresponding author), Univ Calif Davis, Ctr Genet & Dev, Sect Mol & Cellular Biol, Davis, CA 95616 USA.	jmnunnari@ucdavis.edu			NCRR NIH HHS [S10 RR019409-01] Funding Source: Medline; NIGMS NIH HHS [R01-GM62942A] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062942] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alexander C, 2000, NAT GENET, V26, P211, DOI 10.1038/79944; Belenkiy R, 2000, BBA-BIOMEMBRANES, V1467, P207, DOI 10.1016/S0005-2736(00)00222-4; Caldon CE, 2003, CURR OPIN MICROBIOL, V6, P135, DOI 10.1016/S1369-5274(03)00037-7; Delettre C, 2000, NAT GENET, V26, P207, DOI 10.1038/79936; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Fritz S, 2001, J CELL BIOL, V152, P683, DOI 10.1083/jcb.152.4.683; Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Karbowski M, 2004, J CELL BIOL, V164, P493, DOI 10.1083/jcb.200309082; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; Nunnari J, 1997, MOL BIOL CELL, V8, P1233, DOI 10.1091/mbc.8.7.1233; Osteryoung KW, 2003, SCIENCE, V302, P1698, DOI 10.1126/science.1082192; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Rapaport D, 1998, J BIOL CHEM, V273, P20150, DOI 10.1074/jbc.273.32.20150; Sesaki H, 2004, J BIOL CHEM, V279, P28298, DOI 10.1074/jbc.M401363200; Sesaki H, 2003, MOL BIOL CELL, V14, P2342, DOI 10.1091/mbc.E02-12-0788; Sesaki H, 2001, J CELL BIOL, V152, P1123, DOI 10.1083/jcb.152.6.1123; SIMON VR, 1995, J CELL BIOL, V130, P345, DOI 10.1083/jcb.130.2.345; Wong ED, 2003, J CELL BIOL, V160, P303, DOI 10.1083/jcb.200209015; Wong ED, 2000, J CELL BIOL, V151, P341, DOI 10.1083/jcb.151.2.341; Zuchner S, 2004, NAT GENET, V36, P449, DOI 10.1038/ng1341	23	329	351	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1747	1752		10.1126/science.1100612	http://dx.doi.org/10.1126/science.1100612			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	856IS	15297626	Bronze			2022-12-24	WOS:000224039500033
J	Kreicbergs, U; Valdimarsdottir, U; Onelov, E; Henter, JI; Steineck, G				Kreicbergs, U; Valdimarsdottir, U; Onelov, E; Henter, JI; Steineck, G			Talking about death with children who have severe malignant disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TERMINALLY-ILL CHILDREN; SIOP WORKING COMMITTEE; PSYCHOSOCIAL ISSUES; OF-LIFE; CANCER; ASSISTANCE; GUIDELINES; CARE	Background: One of the questions faced by the parents of a child who is terminally ill with a malignant disease is whether or not they should talk about death with their child. Methods: In 2001, we attempted to contact all parents in Sweden who had lost a child to cancer between 1992 and 1997. Among 561 eligible parents, 449 answered a questionnaire, and 429 stated whether or not they had talked about death with their child. Results: None of the 147 parents who talked with their child about death regretted it. In contrast, 69 of 258 parents (27 percent) who did not talk with their child about death regretted not having done so. Parents who sensed that their child was aware of his or her imminent death were more likely to regret not having talked about it (47 percent, as compared with 13 percent of parents who did not sense this awareness in their child; relative risk, 3.7; 95 percent confidence interval, 2.3 to 6.0). The same variable was related to having talked about death (50 percent vs. 13 percent; relative risk, 3.8; 95 percent confidence interval, 2.6 to 5.6), as was being religious (42 percent vs. 25 percent; relative risk, 1.7; 95 percent confidence interval, 1.2 to 2.3). The child's age was related to both having talked about death and the parents' regretting not having talked about it. Conclusions: Parents who sense that their child is aware of his or her imminent death more often later regret not having talked with their child than do parents who do not sense this awareness in their child; overall, no parent in this cohort later regretted having talked with his or her child about death.	Karolinska Inst, Karolinska Hosp Z6 01, Dept Pathol & Oncol, Div Clin Canc Epidemiol, SE-17176 Stockholm, Sweden; Karolinska Inst, Childhood Canc Res Unit, SE-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Steineck, G (corresponding author), Karolinska Inst, Karolinska Hosp Z6 01, Dept Pathol & Oncol, Div Clin Canc Epidemiol, SE-17176 Stockholm, Sweden.	gunnar.steineck@onkpat.ki.se	Steineck, Gunnar/W-1515-2019	Steineck, Gunnar/0000-0002-0787-3969; Valdimarsdottir, Unnur/0000-0001-5382-946X; Henter, Jan-Inge/0000-0002-0629-2126				Bergmark K, 1999, NEW ENGL J MED, V340, P1383, DOI 10.1056/NEJM199905063401802; Bluebond-Langner M, 1978, TERMINALLY ILL CHILD, P166; GOLDMAN A, 1993, PEDIATR HEMAT ONCOL, V10, P223, DOI 10.3109/08880019309029488; Henningsohn L, 2001, EUR UROL, V40, P151, DOI 10.1159/000049766; Hilden JM, 2001, J CLIN ONCOL, V19, P205, DOI 10.1200/JCO.2001.19.1.205; Hilden JM, 2000, J CLIN ONCOL, V18, P3193, DOI 10.1200/JCO.2000.18.17.3193; Himelstein BP, 2004, NEW ENGL J MED, V350, P1752, DOI 10.1056/NEJMra030334; KREICHBERGS U, 2004, PSYCHOL MED, V34, P1; Masera G, 1999, MED PEDIATR ONCOL, V32, P44, DOI 10.1002/(SICI)1096-911X(199901)32:1<44::AID-MPO9>3.0.CO;2-P; Nitschke R, 2000, MED PEDIATR ONCOL, V34, P268; Nitschke R, 2000, MED PEDIATR ONCOL, V34, P271, DOI 10.1002/(SICI)1096-911X(200004)34:4<271::AID-MPO10>3.0.CO;2-0; Radestad I, 1996, BRIT MED J, V312, P1505, DOI 10.1136/bmj.312.7045.1505; RAIMBAULT G, 1981, ACTA PAEDIATR SCAND, V70, P179, DOI 10.1111/j.1651-2227.1981.tb05538.x; ROTHMAN KJ, 1998, MODERN EPIDEMIOLOGY, P271; *SAS I INC, 1999, SAS STAT US GUID VER, P1365; SPINETTA J J, 1981, Journal of Pediatric Psychology, V6, P251, DOI 10.1093/jpepsy/6.3.251; SPINETTA JJ, 1973, PEDIATRICS, V52, P841; SPINETTA JJ, 1974, PSYCHOL BULL, V81, P256, DOI 10.1037/h0036229; Steineck G, 1998, ACTA ONCOL, V37, P15, DOI 10.1080/028418698423131; Steineck G, 2002, ACTA ONCOL, V41, P244, DOI 10.1080/02841860260088782; Steineck G, 2002, NEW ENGL J MED, V347, P790, DOI 10.1056/NEJMoa021483; Valdimarsdottir U, 2002, BRIT J CANCER, V86, P1540, DOI 10.1038/sj.bjc.6600271; VALDIMARSDOTTIR U, 2003, THESIS KAROLINSKA I	23	291	292	1	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 16	2004	351	12					1175	1186		10.1056/NEJMoa040366	http://dx.doi.org/10.1056/NEJMoa040366			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853WS	15371575				2022-12-24	WOS:000223861300006
J	Richardson, AJ; Schoeman, DS				Richardson, AJ; Schoeman, DS			Climate impact on plankton ecosystems in the Northeast Atlantic	SCIENCE			English	Article							MARINE-PHYTOPLANKTON; PATTERNS; BIODIVERSITY; TEMPERATURE; RECRUITMENT; OSCILLATION; INDICATOR; FISHERIES; TRENDS	It is now widely accepted that global warming is occurring, yet its effects on the world's largest ecosystem, the marine pelagic realm, are largely unknown. We show that sea surface warming in the Northeast Atlantic is accompanied by increasing phytoplankton abundance in cooler regions and decreasing phytoplankton abundance in warmer regions. This impact propagates up the food web (bottom-up control) through copepod herbivores to zooplankton carnivores because of tight trophic coupling. Future warming is therefore likely to alter the spatial distribution of primary and secondary pelagic production, affecting ecosystem services and placing additional stress on already-depleted fish and mammal populations.	Sir Alister Hardy Fdn Ocean Sci Lab, Plymouth PL1 2PB, Devon, England; Univ Port Elizabeth, Dept Zool, Port Elizabeth, South Africa	Nelson Mandela University	Richardson, AJ (corresponding author), Sir Alister Hardy Fdn Ocean Sci Lab, Citadel Hill, Plymouth PL1 2PB, Devon, England.	anr@sahfos.ac.uk	Richardson, Anthony J/B-3649-2010	Richardson, Anthony J/0000-0002-9289-7366; Schoeman, David/0000-0003-1258-0885				AEBISCHER NJ, 1990, NATURE, V347, P753, DOI 10.1038/347753a0; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Bouman HA, 2003, MAR ECOL PROG SER, V258, P19, DOI 10.3354/meps258019; Carder KL, 1999, J GEOPHYS RES-OCEANS, V104, P5403, DOI 10.1029/1998JC900082; COLEBROOK J M, 1975, Bulletins of Marine Ecology, V8, P143; Cury P, 2000, ICES J MAR SCI, V57, P603, DOI 10.1006/jmsc.2000.0712; CUSHING DH, 1989, J PLANKTON RES, V11, P1, DOI 10.1093/plankt/11.1.1; Daskalov GM, 2002, MAR ECOL PROG SER, V225, P53, DOI 10.3354/meps225053; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Fromentin JM, 1996, MAR ECOL PROG SER, V134, P111, DOI 10.3354/meps134111; Houghton J. T., 2001, CLIMATE CHANGE 2001; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Irigoien X, 2004, NATURE, V429, P863, DOI 10.1038/nature02593; Li WKW, 2002, NATURE, V419, P154, DOI 10.1038/nature00994; Micheli F, 1999, SCIENCE, V285, P1396, DOI 10.1126/science.285.5432.1396; O'Brien CM, 2000, NATURE, V404, P142, DOI 10.1038/35004654; Parsons LS, 2001, PROG OCEANOGR, V49, P167, DOI 10.1016/S0079-6611(01)00021-0; Planque B, 1999, CAN J FISH AQUAT SCI, V56, P2069, DOI 10.1139/cjfas-56-11-2069; Pyper BJ, 1998, CAN J FISH AQUAT SCI, V55, P2127; Reid PC, 2003, PROG OCEANOGR, V58, P117, DOI 10.1016/j.pocean.2003.08.002; ROEMMICH D, 1995, SCIENCE, V267, P1324, DOI 10.1126/science.267.5202.1324; Sathyendranath S, 2001, INT J REMOTE SENS, V22, P249, DOI 10.1080/014311601449925; Shurin JB, 2002, ECOL LETT, V5, P785, DOI 10.1046/j.1461-0248.2002.00381.x; Worm B, 2003, ECOLOGY, V84, P162, DOI 10.1890/0012-9658(2003)084[0162:MAOCSI]2.0.CO;2	26	544	576	7	263	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2004	305	5690					1609	1612		10.1126/science.1100958	http://dx.doi.org/10.1126/science.1100958			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	854GV	15361622				2022-12-24	WOS:000223891200040
J	Joensuu, H; Lehtimaki, T; Holli, K; Elomaa, L; Turpeenniemi-Hujanen, T; Kataja, V; Anttila, A; Lundin, M; Isola, J; Lundin, J				Joensuu, H; Lehtimaki, T; Holli, K; Elomaa, L; Turpeenniemi-Hujanen, T; Kataja, V; Anttila, A; Lundin, M; Isola, J; Lundin, J			Risk for distant recurrence of breast cancer detected by mammography screening or other methods	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTERVAL CARCINOMAS; PROGNOSTIC-FACTORS; SURVIVAL; PROGRAM; DISEASE; COHORT; WOMEN; NATIONWIDE; FEATURES; TRIAL	Context Selection of systemic adjuvant therapies for women diagnosed as having breast cancer is based on risk estimations for cancer recurrence. In such estimations, tumors detected by mammography screening are considered to be associated with a similar risk of recurrence as tumors of similar size found by other methods. Objective To compare the risk of recurrence and survival among women with cancerous tumors detected by mammography screening compared with other methods (outside of screening). Design, Setting, and Patients Retrospective study comparing clinical, histopathological, and biological features of cancerous tumors detected by mammography screening compared with tumors detected outside of screening. Women diagnosed as having breast cancer in 1991 or 1992 were identified from the Finnish Cancer Registry (n=2842). The median follow-up time was 9.5 years. Cancer biological variables were analyzed from tumor tissue microarrays using immunohistochemistry or in situ hybridization and included ERBB2, TP53, and MK167 expression and ERBB2 amplification data. Main Outcome Measures Univariate and multivariate analyses of potential risk factors for distant recurrence of breast cancer and 10-year survival. Results Of the 1983 women with unilateral invasive breast cancer, data on tumor diameter were available for 1918 women. Women with cancerous tumors detected by mammography screening had better estimated 10-year distant disease-free survival than women with tumors found outside of screening (tumor size of less than or equal to 10 mm [n=386] 92% vs 85% [P=.04]; 11-20 mm [n=808] 88% vs 76% [P<.001]; 21-30 mm [n=409] 86% vs 63% [P=.008]; >30 mm [n=315] 68% vs 50% [P=.12], respectively). In a Cox multivariate model that included cancer biological factors, the relative hazard ratio for distant recurrence among women with tumors detected outside of screening (HR, 1.90; 95% confidence interval, 1.15-3.11) was significantly higher than among women with tumors detected by mammography screening (P=.01). Breast cancer diagnosis by mammography screening was an independent prognostic variable reducing the relative HR for distant recurrence. This effect was equal to or greater than the effect of 1-cm decrease in tumor diameter (HR, 1.20; 95% confidence interval, 1.10-1.31). Conclusions Cancerous tumors detected by mammography screening are associated with a better prognosis than tumors of similar size found outside of screening. The risk of distant metastases is overestimated for women diagnosed as having cancer by mammography screening unless the method of detection is taken into account in risk estimations.	Univ Helsinki, Cent Hosp, Dept Oncol, FIN-00029 Helsinki, Finland; Tampere Univ Hosp, Dept Pallliat Med, Tampere, Finland; Tampere Univ Hosp, Dept Oncol, Tampere, Finland; Univ Turku, Cent Hosp, Dept Oncol, FIN-20520 Turku, Finland; Oulu Univ, Cent Hosp, Dept Radiotherapy & Oncol, SF-90220 Oulu, Finland; Kuopio Univ Hosp, Dept Oncol, Kuopio, Finland; Finnish Canc Registry, FIN-00170 Helsinki, Finland; Tampere Univ, Inst Med Technol, Tampere, Finland; Folkhalsan Res Ctr, Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital; Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital; University of Turku; University of Oulu; Kuopio University Hospital; University of Eastern Finland; Finnish Cancer Registry; Tampere University; Folkhalsan Research Center	Joensuu, H (corresponding author), Univ Helsinki, Cent Hosp, Dept Oncol, Haartmaninkatu 4,POB 180, FIN-00029 Helsinki, Finland.	heikki.joensuu@hus.fi	Lundin, Johan/I-1843-2018; Lehtimäki, Terho/AAD-1094-2022; Lundin, Johan/AAC-8510-2020	Lundin, Johan/0000-0002-2681-4139; Lehtimäki, Terho/0000-0002-2555-4427; Lundin, Johan/0000-0002-2681-4139; Joensuu, Heikki/0000-0003-0281-2507; Kataja, Vesa/0000-0003-4846-4843				[Anonymous], 1981, HIST TYP BREAST TUM; BREKELMANS CT, 1995, EUR J CANCER, V31A, P1830, DOI 10.1016/0959-8049(95)00324-C; Burrell HC, 1996, RADIOLOGY, V199, P811, DOI 10.1148/radiology.199.3.8638010; Colacurci N, 2001, MATURITAS, V40, P159, DOI 10.1016/S0378-5122(01)00232-8; COX DR, 1972, J R STAT SOC B, V34, P187; Crosier M, 1999, CLIN CANCER RES, V5, P2682; DALAND E. M., 1927, Surgery, Gynecology and Obstetrics, V44, P264; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; FRISELL J, 1992, BREAST CANCER RES TR, V24, P11, DOI 10.1007/BF01832353; Gilliland FD, 2000, J NATL CANCER I, V92, P743, DOI 10.1093/jnci/92.9.743; Goldhirsch A, 2001, J CLIN ONCOL, V19, P3817, DOI 10.1200/JCO.2001.19.18.3817; Groenendijk RPR, 2000, BRIT J CANCER, V82, P381; Hakama M, 1997, BRIT MED J, V314, P864; HOLFORD TR, 1991, J CLIN EPIDEMIOL, V44, P29, DOI 10.1016/0895-4356(91)90198-I; HOLMBERG LH, 1986, LANCET, V2, P27; IKEDA DM, 1992, AM J ROENTGENOL, V159, P287, DOI 10.2214/ajr.159.2.1632342; JOENSUU H, 1995, J CLIN ONCOL, V13, P62, DOI 10.1200/JCO.1995.13.1.62; Klemi PJ, 2003, BREAST, V12, P308, DOI 10.1016/S0960-9776(03)00096-1; KLEMI PJ, 1992, BRIT MED J, V304, P467, DOI 10.1136/bmj.304.6825.467; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Lee AKC, 1997, CANCER-AM CANCER SOC, V79, P761, DOI 10.1002/(SICI)1097-0142(19970215)79:4<761::AID-CNCR13>3.3.CO;2-K; Lundin J, 2001, J CLIN ONCOL, V19, P28, DOI 10.1200/JCO.2001.19.1.28; Magee B, 1999, CLIN ONCOL-UK, V11, P40, DOI 10.1053/clon.1999.9007; MANTEL N, 1959, J NATL CANCER I, V22, P719; Moody-Ayers SY, 2000, ARCH INTERN MED, V160, P1109, DOI 10.1001/archinte.160.8.1109; NIELSEN M, 1987, BRIT J CANCER, V56, P814, DOI 10.1038/bjc.1987.296; Nielsen M, 1989, APMIS Suppl, V10, P1; PEETERS PHM, 1989, BRIT J CANCER, V59, P929, DOI 10.1038/bjc.1989.196; Porter PL, 1999, J NATL CANCER I, V91, P2020, DOI 10.1093/jnci/91.23.2020; Rampaul RS, 2001, EUR J SURG ONCOL, V27, P229, DOI 10.1053/ejso.2001.1114; Schroen AA, 1996, J SURG ONCOL, V63, P141, DOI 10.1002/(SICI)1096-9098(199611)63:3<141::AID-JSO2>3.0.CO;2-D; SENIE RT, 1994, CANCER-AM CANCER SOC, V73, P1666, DOI 10.1002/1097-0142(19940315)73:6<1666::AID-CNCR2820730619>3.0.CO;2-E; Tabar L, 2000, LANCET, V355, P429; TABAR L, 1992, RADIOL CLIN N AM, V30, P187; Vitak B, 1998, EUR RADIOL, V8, P639, DOI 10.1007/s003300050452; VONROSEN A, 1985, BREAST CANCER RES TR, V6, P221, DOI 10.1007/BF01806772; WADE P, 1946, BRIT J RADIOL, V19, P272, DOI 10.1259/0007-1285-19-223-272; Welch HG, 1997, ANN INTERN MED, V127, P1023, DOI 10.7326/0003-4819-127-11-199712010-00014; Yassin M M, 2003, Asian J Surg, V26, P101, DOI 10.1016/S1015-9584(09)60229-3; Zahl PH, 2004, BMJ-BRIT MED J, V328, P921, DOI 10.1136/bmj.38044.666157.63	40	148	151	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 1	2004	292	9					1064	1073		10.1001/jama.292.9.1064	http://dx.doi.org/10.1001/jama.292.9.1064			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	849VH	15339900				2022-12-24	WOS:000223568700022
J	Cuervo, AM; Stefanis, L; Fredenburg, R; Lansbury, PT; Sulzer, D				Cuervo, AM; Stefanis, L; Fredenburg, R; Lansbury, PT; Sulzer, D			Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy	SCIENCE			English	Article							RAT-LIVER LYSOSOMES; PARKINSONS-DISEASE; CYTOSOLIC PROTEINS; SELECTIVE UPTAKE; PROTEASOME; NEURONS; SYSTEM; AGGREGATION; MECHANISMS; PATHWAY	Aberrant alpha-synuclein degradation is implicated in Parkinson's disease pathogenesis because the protein accumulates in the Lewy inclusion bodies associated with the disease. Little is known, however, about the pathways by which wild-type alpha-synuclein is normally degraded. We found that wild-type alpha-synuclein was selectively translocated into lysosomes for degradation by the chaperone-mediated autophagy pathway. The pathogenic A53T and A30P alpha-synuctein mutants bound to the receptor for this pathway on the lysosomal membrane, but appeared to act as uptake blockers, inhibiting both their own degradation and that of other substrates. These findings may underlie the toxic gain-of-function by the mutants.	Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Dept Anat & Struct Biol, Bronx, NY 10461 USA; Acad Athens, Fdn Biomed Res, Neurobiol Lab, Athens 11527, Greece; Columbia Univ, Dept Neurol & Pathol, New York, NY 10032 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Ctr Neurol Dis,Dept Neurol, Cambridge, MA 02139 USA; Columbia Univ, Dept Neurosci, New York State Psychiat Inst, Dept Psychiat, New York, NY 10032 USA; Columbia Univ, Dept Neurosci, New York State Psychiat Inst, Dept Neurol, New York, NY 10032 USA	Yeshiva University; Albert Einstein College of Medicine; Academy of Athens; Columbia University; Harvard University; Brigham & Women's Hospital; Columbia University; New York State Psychiatry Institute; Columbia University; New York State Psychiatry Institute	Cuervo, AM (corresponding author), Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Dept Anat & Struct Biol, Bronx, NY 10461 USA.	amcuervo@aecom.yu.edu	Stefanis, Leonidas/AAD-7192-2019	Cuervo, Ana Maria/0000-0002-0771-700X	NATIONAL INSTITUTE ON AGING [R01AG021904] Funding Source: NIH RePORTER; NIA NIH HHS [AG021904] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Ancolio K, 2000, NEUROSCI LETT, V285, P79, DOI 10.1016/S0304-3940(00)01049-1; Bennett MC, 1999, J BIOL CHEM, V274, P33855, DOI 10.1074/jbc.274.48.33855; Cuervo AM, 1998, J MOL MED-JMM, V76, P6, DOI 10.1007/s109-1998-8099-y; CUERVO AM, 1994, J BIOL CHEM, V269, P26374; Cuervo AM, 1997, J BIOL CHEM, V272, P5606, DOI 10.1074/jbc.272.9.5606; Cuervo AM, 2004, TRENDS CELL BIOL, V14, P70, DOI 10.1016/j.tcb.2003.12.002; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dice J. F., 2000, LYSOSOMAL PATHWAYS P; DICE JF, 1990, TRENDS BIOCHEM SCI, V15, P305, DOI 10.1016/0968-0004(90)90019-8; Fuertes G, 2003, BIOCHEM J, V375, P75, DOI 10.1042/BJ20030282; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Grantcharova V, 2001, CURR OPIN STRUC BIOL, V11, P70, DOI 10.1016/S0959-440X(00)00176-7; Larsen KE, 2002, HISTOL HISTOPATHOL, V17, P897, DOI 10.14670/HH-17.897; Lee HJ, 2004, J NEUROSCI, V24, P1888, DOI 10.1523/JNEUROSCI.3809-03.2004; Massey A., UNPUB; McNaught KSP, 2001, NAT REV NEUROSCI, V2, P589, DOI 10.1038/35086067; Nussbaum RL, 1997, HUM MOL GENET, V6, P1687, DOI 10.1093/hmg/6.10.1687; Paxinou E, 2001, J NEUROSCI, V21, P8053, DOI 10.1523/JNEUROSCI.21-20-08053.2001; Rideout HJ, 2002, MOL CELL NEUROSCI, V21, P223, DOI 10.1006/mcne.2002.1173; Rideout HJ, 2001, J NEUROCHEM, V78, P899, DOI 10.1046/j.1471-4159.2001.00474.x; Salvador N, 2000, J BIOL CHEM, V275, P27447; Stefanis L, 2001, J NEUROSCI, V21, P9549, DOI 10.1523/JNEUROSCI.21-24-09549.2001; Tofaris GK, 2001, FEBS LETT, V509, P22, DOI 10.1016/S0014-5793(01)03115-5; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Wilson CA, 2004, J CELL BIOL, V165, P335, DOI 10.1083/jcb.200403061	28	1465	1509	1	162	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 27	2004	305	5688					1292	1295		10.1126/science.1101738	http://dx.doi.org/10.1126/science.1101738			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850PJ	15333840				2022-12-24	WOS:000223624600042
J	Begum, NA; Kinoshita, K; Kakazu, N; Muramatsu, M; Nagaoka, H; Shinkura, R; Biniszkiewicz, D; Boyer, LA; Jaenisch, R; Honjo, T				Begum, NA; Kinoshita, K; Kakazu, N; Muramatsu, M; Nagaoka, H; Shinkura, R; Biniszkiewicz, D; Boyer, LA; Jaenisch, R; Honjo, T			Uracil DNA glycosylase activity is dispensable for immunloglobulin class switch	SCIENCE			English	Article							SINGLE-STRANDED-DNA; CYTIDINE DEAMINASE AID; SOMATIC HYPERMUTATION; CRYSTAL-STRUCTURE; HISTONE H2AX; RECOMBINATION; ENZYME; MICE; REPLICATION; MUTATIONS	Activation-induced cytidine deaminase (AID) is required for the DNA cleavage step in immunoglobulin class switch recombination (CSR). AID is proposed to deaminate cytosine to generate uracil (U) in either mRNA or DNA. In the second instance, DNA cleavage depends on uracil DNA glycosylase (UNG) for removal of U. Using phosphorylated histone gamma-H2AX focus formation as a marker of DNA cleavage, we found that the UNG inhibitor Ugi did not inhibit DNA cleavage in immunoglobulin heavy chain (IgH) locus during CSR, even though Ugi blocked UNG binding to DNA and strongly inhibited CSR. Strikingly, UNG mutants that had lost the capability of removing U rescued CSR in UNG(-/-) B cells. These results indicate that UNG is involved in the repair step of CSR yet by an unknown mechanism. The dispensability of U removal in the DNA cleavage step of CSR requires a reconsideration of the model of DNA deamination by AID.	Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Targeting Canc Prevent, Kamigyo Ku, Kyoto 6028566, Japan; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Kyoto University; Kyoto Prefectural University of Medicine; Massachusetts Institute of Technology (MIT); Whitehead Institute	Honjo, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Med Chem & Mol Biol, Sakyo Ku, Kyoto 6068501, Japan.	honjo@mfour.med.kyoto-u.ac.jp	Honjo, Tasuku/N-4470-2016; Muramatsu, Masamichi/C-4339-2015	Muramatsu, Masamichi/0000-0002-0153-3533; Begum, Nasim/0000-0001-7177-188X				Anant S, 2001, CURR OPIN LIPIDOL, V12, P159, DOI 10.1097/00041433-200104000-00009; Bosma GC, 2002, J EXP MED, V196, P1483, DOI 10.1084/jem.20001871; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; De Silva FS, 2003, J VIROL, V77, P159, DOI 10.1128/JVI.77.1.159-166.2003; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; Doi T, 2003, P NATL ACAD SCI USA, V100, P2634, DOI 10.1073/pnas.0437710100; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Honjo T, 2004, IMMUNITY, V20, P659, DOI 10.1016/j.immuni.2004.05.011; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Imai K, 2003, NAT IMMUNOL, V4, P1023, DOI 10.1038/ni974; Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101; Kinoshita K, 2001, P NATL ACAD SCI USA, V98, P12620, DOI 10.1073/pnas.221454398; Manis JP, 2002, IMMUNITY, V16, P607, DOI 10.1016/S1074-7613(02)00306-0; Martin A, 2003, J EXP MED, V198, P1171, DOI 10.1084/jem.20030880; MOL CD, 1995, CELL, V80, P869, DOI 10.1016/0092-8674(95)90290-2; MOL CD, 1995, CELL, V82, P701, DOI 10.1016/0092-8674(95)90467-0; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nagaoka H, 2002, J EXP MED, V195, P529, DOI 10.1084/jem.20012144; Nambu Y, 2003, SCIENCE, V302, P2137, DOI 10.1126/science.1092481; Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Shinkura R, 2004, NAT IMMUNOL, V5, P707, DOI 10.1038/ni1086; Sohail A, 2003, NUCLEIC ACIDS RES, V31, P2990, DOI 10.1093/nar/gkg464	29	91	91	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 20	2004	305	5687					1160	1163		10.1126/science.1098444	http://dx.doi.org/10.1126/science.1098444			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849RD	15326357				2022-12-24	WOS:000223557400050
J	Lee, C; Hong, B; Choi, JM; Kim, Y; Watanabe, S; Ishimi, Y; Enomoto, T; Tada, S; Kim, YC; Cho, YJ				Lee, C; Hong, B; Choi, JM; Kim, Y; Watanabe, S; Ishimi, Y; Enomoto, T; Tada, S; Kim, YC; Cho, YJ			Structural basis for inhibition of the replication licensing factor Cdt1 by geminin	NATURE			English	Article							DNA-REPLICATION; BACILLUS-SUBTILIS; PROTEIN; RECOGNITION; BINDING; CDC6	To maintain chromosome stability in eukaryotic cells, replication origins must be licensed by loading mini-chromosome maintenance (MCM2-7) complexes once and only once per cell cycle(1-9). This licensing control is achieved through the activities of geminin(10-12) and cyclin-dependent kinases(9,13,14). Geminin binds tightly to Cdt1, an essential component of the replication licensing system(6,15-18), and prevents the inappropriate reinitiation of replication on an already fired origin. The inhibitory effect of geminin is thought to prevent the interaction between Cdt1 and the MCM helicase(19,20). Here we describe the crystal structure of the mouse geminin-Cdt1 complex using tGeminin (residues 79-157, truncated geminin) and tCdt1 (residues 172-368, truncated Cdt1). The amino-terminal region of a coiled-coil dimer of tGeminin interacts with both N-terminal and carboxy-terminal parts of tCdt1. The primary interface relies on the steric complementarity between the tGeminin dimer and the hydrophobic face of the two short N-terminal helices of tCdt1 and, in particular, Pro 181, Ala 182, Tyr 183, Phe 186 and Leu 189. The crystal structure, in conjunction with our biochemical data, indicates that the N-terminal region of tGeminin might be required to anchor tCdt1, and the C-terminal region of tGeminin prevents access of the MCM complex to tCdt1 through steric hindrance.	Pohang Univ Sci & Technol, Natl Creat Res Ctr Struct Biol, Pohang, Kyungbook, South Korea; Pohang Univ Sci & Technol, Dept Life Sci, Pohang, Kyungbook, South Korea; Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; Mitsubishi Kagaku Inst Life Sci, Biomol & Technol Dept, Tokyo 1948511, Japan; Argonne Natl Lab, Struct Biol Ctr, Biosci Div, Argonne, IL 60439 USA	Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); Tohoku University; Mitsubishi Kagaku Institute of Life Sciences (MITILS); United States Department of Energy (DOE); Argonne National Laboratory	Cho, YJ (corresponding author), Pohang Univ Sci & Technol, Natl Creat Res Ctr Struct Biol, Hyoja Dong,San 31, Pohang, Kyungbook, South Korea.	yunje@postech.ac.kr	Lee, Changwook/D-6010-2011	Kim, Youngchang/0000-0002-1610-4889; Choi, Jung Min/0000-0003-2450-3916				Arentson E, 2002, ONCOGENE, V21, P1150, DOI 10.1038/sj.onc.1205175; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Blow JJ, 2002, TRENDS CELL BIOL, V12, P72, DOI 10.1016/S0962-8924(01)02203-6; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUSSIERE DE, 1995, CELL, V80, P651; Coleman TR, 1996, CELL, V87, P53, DOI 10.1016/S0092-8674(00)81322-7; Cook JG, 2004, J BIOL CHEM, V279, P9625, DOI 10.1074/jbc.M311933200; Diffley JFX, 2001, CURR BIOL, V11, pR367, DOI 10.1016/S0960-9822(01)00196-8; Gautam A, 2001, J BIOL CHEM, V276, P23471, DOI 10.1074/jbc.M009537200; HOFMANN JFX, 1994, EMBO J, V13, P425, DOI 10.1002/j.1460-2075.1994.tb06277.x; Kearsey SE, 2003, MOL CELL, V12, P1067, DOI 10.1016/S1097-2765(03)00441-6; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P829, DOI 10.1107/S0907444996001783; Li A, 2004, NAT CELL BIOL, V6, P260, DOI 10.1038/ncb1100; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Shreeram S, 2003, Prog Cell Cycle Res, V5, P287; Shreeram S, 2002, ONCOGENE, V21, P6624, DOI 10.1038/sj.onc.1205910; Tada S, 2001, NAT CELL BIOL, V3, P107, DOI 10.1038/35055000; Tanaka S, 2002, NAT CELL BIOL, V4, P198, DOI 10.1038/ncb757; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Whittaker AJ, 2000, GENE DEV, V14, P1765; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Yamaguchi R, 2003, CELL, V113, P115, DOI 10.1016/S0092-8674(03)00200-9; Yanagi K, 2002, J BIOL CHEM, V277, P40871, DOI 10.1074/jbc.M206202200; You ZY, 1999, MOL CELL BIOL, V19, P8003	29	113	119	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2004	430	7002					913	917		10.1038/nature02813	http://dx.doi.org/10.1038/nature02813			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15286659				2022-12-24	WOS:000223369800047
J	Rowan, R				Rowan, R			Coral bleaching - Thermal adaptation in reef coral symbionts	NATURE			English	Editorial Material							CLIMATE-CHANGE; PHOTOINHIBITION; PHOTOSYNTHESIS		Univ Guam, Marine Lab, Mangilao, GU 96923 USA	University of Guam	Rowan, R (corresponding author), Univ Guam, Marine Lab, Mangilao, GU 96923 USA.	rrowan@uog9.uog.edu						Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Coles SL, 2003, ADV MAR BIOL, V46, P183, DOI 10.1016/S0065-2881(03)46004-5; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Huner NPA, 1998, TRENDS PLANT SCI, V3, P224, DOI 10.1016/S1360-1385(98)01248-5; Jones RJ, 2001, PLANT CELL ENVIRON, V24, P89, DOI 10.1046/j.1365-3040.2001.00648.x; LONG SP, 1994, ANNU REV PLANT PHYS, V45, P633, DOI 10.1146/annurev.pp.45.060194.003221; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; ROWAN R, 1991, SCIENCE, V251, P1348, DOI 10.1126/science.251.4999.1348; ROWAN R, UNPUB ECOLOGY; Warner ME, 1999, P NATL ACAD SCI USA, V96, P8007, DOI 10.1073/pnas.96.14.8007; Werner C, 2001, PLANT CELL ENVIRON, V24, P27, DOI 10.1046/j.1365-3040.2001.00651.x	12	467	491	3	216	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 12	2004	430	7001					742	742		10.1038/430742a	http://dx.doi.org/10.1038/430742a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306800	Bronze			2022-12-24	WOS:000223233600031
J	Sachs, JD				Sachs, JD			Seeking a global solution	NATURE			English	Editorial Material									Columbia Univ, Earth Inst, New York, NY 10027 USA	Columbia University	Sachs, JD (corresponding author), Columbia Univ, Earth Inst, 535 W 116th St, New York, NY 10027 USA.								0	11	11	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 12	2004	430	7001					725	726		10.1038/430725a	http://dx.doi.org/10.1038/430725a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306785				2022-12-24	WOS:000223233600017
J	HATSOPOULOS, N; GABBIANI, F; LAURENT, G				HATSOPOULOS, N; GABBIANI, F; LAURENT, G			ELEMENTARY COMPUTATION OF OBJECT APPROACH BY A WIDE-FIELD VISUAL NEURON	SCIENCE			English	Article							MOVEMENT DETECTOR SYSTEM; ORTHOPTERAN DCMD NEURON; SENSORY ANALYZER; MOVING-OBJECTS; FLOW-FIELD; REEVALUATION; COLLISION; RESPONSES; VISION; MOTION	An essential function of the brain is to detect threats, such as those posed by objects or predators on a collision course. A wide-field, movement-sensitive visual neuron in the brain of the locust was studied by presenting simulated approaching, receding, and translating objects. The neuron's responses could be described simply by multiplying the velocity of the image edge (d theta/dt) with an exponential function of the size of the object's image on the retina (e(-alpha theta)). Because this product peaks before the image reaches its maximum size during approach, this neuron can anticipate collision. The neuron's activity peaks approximately when the approaching object reaches a certain angular size. Because this neuron receives distinct inputs about image size and velocity, the dendritic tree of a single neuron may function as a biophysical device that can carry out a multiplication of two independent input signals.	CALTECH,DIV BIOL,PASADENA,CA 91125	California Institute of Technology			Laurent, Gilles/A-4583-2012	Laurent, Gilles/0000-0002-2296-114X				[Anonymous], 1989, ANALOG VLSI IMPLEMEN; BORST A, 1988, NATURWISSENSCHAFTEN, V75, P265, DOI 10.1007/BF00378023; Gibson J. J, 1979, ECOLOGICAL APPROACH; GIBSON JJ, 1957, PSYCHOL REV, V64, P288, DOI 10.1037/h0044277; HOLMQVIST MH, 1991, J COMP PHYSIOL A, V169, P451, DOI 10.1007/BF00197657; KOCH C, 1987, SYNAPTIC FUNCTION, P637; LEE DN, 1981, NATURE, V293, P293, DOI 10.1038/293293a0; LEE DN, 1992, J COMP PHYSIOL A, V171, P563, DOI 10.1007/BF00194105; LEE DN, 1980, PHILOS T R SOC B, V290, P169, DOI 10.1098/rstb.1980.0089; LEE DN, 1976, PERCEPTION, V5, P437, DOI 10.1068/p050437; OSHEA M, 1976, J EXP BIOL, V65, P289; OSHEA M, 1974, J COMP PHYSIOL, V91, P257, DOI 10.1007/BF00698057; PALKA J, 1967, J INSECT PHYSIOL, V13, P235, DOI 10.1016/0022-1910(67)90151-5; RIND FC, 1984, J EXP BIOL, V110, P143; RIND FC, 1992, J NEUROPHYSIOL, V68, P1654, DOI 10.1152/jn.1992.68.5.1654; RIND FC, 1987, J COMP PHYSIOL A, V161, P477, DOI 10.1007/BF00603973; ROWELL CHF, 1977, J EXP BIOL, V68, P157; SCHLOTTERER GR, 1977, CAN J ZOOL, V55, P1372, DOI 10.1139/z77-179; SIMMONS PJ, 1992, J NEUROPHYSIOL, V68, P1667, DOI 10.1152/jn.1992.68.5.1667; WAGNER H, 1982, NATURE, V297, P147, DOI 10.1038/297147a0; WANG YC, 1992, NATURE, V356, P236, DOI 10.1038/356236a0	21	197	199	0	22	AMER ASSOC ADVAN SCIENCE	WASHINGTON	1333 H ST NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 10	1995	270	5238					1000	1003		10.1126/science.270.5238.1000	http://dx.doi.org/10.1126/science.270.5238.1000			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TD878	15290817				2022-12-24	WOS:A1995TD87800053
J	Toyoshima, C; Nomura, H; Tsuda, T				Toyoshima, C; Nomura, H; Tsuda, T			Lumenal gating mechanism revealed in calcium pump crystal structures with phosphate analogues	NATURE			English	Article							SARCOPLASMIC-RETICULUM CA2+-ATPASE; P-TYPE ATPASES; INSENSITIVE PHOSPHOENZYME INTERMEDIATE; RESPONSE REGULATOR PROTEIN; HIGH-AFFINITY; A-DOMAIN; ADENOSINE-TRIPHOSPHATASE; FUNCTIONAL CONSEQUENCES; PHOSPHORYL TRANSFER; TRANSPORT SITES	P-type ion transporting ATPases are ATP-powered ion pumps that establish ion concentration gradients across biological membranes. Transfer of bound cations to the lumenal or extracellular side occurs while the ATPase is phosphorylated. Here we report at 2.3 Angstrom resolution the structure of the calcium-ATPase of skeletal muscle sarcoplasmic reticulum, a representative P-type ATPase that is crystallized in the absence of Ca2+ but in the presence of magnesium fluoride, a stable phosphate analogue. This and other crystal structures determined previously provide atomic models for all four principal states in the reaction cycle. These structures show that the three cytoplasmic domains rearrange to move six out of ten transmembrane helices, thereby changing the affinity of the Ca2+-binding sites and the gating of the ion pathway. Release of ADP triggers the opening of the lumenal gate and release of phosphate its closure, effected mainly through movement of the A-domain, the actuator of transmembrane gates.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	University of Tokyo	Toyoshima, C (corresponding author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan.	ct@iam.u-tokyo.ac.jp	Toyoshima, Chikashi/R-4153-2019	Toyoshima, Chikashi/0000-0001-9640-0778				ALBERS RW, 1967, ANNU REV BIOCHEM, V36, P727, DOI 10.1146/annurev.bi.36.070167.003455; BRANDL CJ, 1987, J BIOL CHEM, V262, P3768; BRUNGER AT, 1990, ACTA CRYSTALLOGR A, V46, P46, DOI 10.1107/S0108767389009633; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHAMPEIL P, 1988, J BIOL CHEM, V263, P12288; CLARKE DM, 1990, J BIOL CHEM, V265, P14088; Clausen JD, 2004, P NATL ACAD SCI USA, V101, P2776, DOI 10.1073/pnas.0400122101; Clausen JD, 2001, J BIOL CHEM, V276, P35741, DOI 10.1074/jbc.M105434200; COLL RJ, 1984, J BIOL CHEM, V259, P4249; COLL RJ, 1992, J BIOL CHEM, V267, P21584; DAIHO T, 1993, BIOCHEMISTRY-US, V32, P10021, DOI 10.1021/bi00089a018; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; Danko S, 2001, FEBS LETT, V505, P129, DOI 10.1016/S0014-5793(01)02801-0; Danko S, 2001, FEBS LETT, V489, P277, DOI 10.1016/S0014-5793(01)02111-1; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; Graham DL, 2002, CHEM BIOL, V9, P375, DOI 10.1016/S1074-5521(02)00112-6; Inesi G, 2004, J BIOL CHEM, V279, P31629, DOI 10.1074/jbc.M403211200; JUUL B, 1995, J BIOL CHEM, V270, P20123, DOI 10.1074/jbc.270.34.20123; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kato S, 2003, J BIOL CHEM, V278, P9624, DOI 10.1074/jbc.M208861200; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kuhlbrandt W, 2004, NAT REV MOL CELL BIO, V5, P282, DOI 10.1038/nrm1354; Lenoir G, 2004, J BIOL CHEM, V279, P9156, DOI 10.1074/jbc.M311411200; Lewis RJ, 1999, J MOL BIOL, V294, P9, DOI 10.1006/jmbi.1999.3261; MACLENNAN DH, 1985, NATURE, V316, P696, DOI 10.1038/316696a0; MARUYAMA K, 1989, J BIOL CHEM, V264, P13038; MCINTOSH DB, 1983, BIOCHEMISTRY-US, V22, P2867, DOI 10.1021/bi00281a015; Moller JV, 2002, J BIOL CHEM, V277, P38647, DOI 10.1074/jbc.M204603200; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; MURPHY AJ, 1992, J BIOL CHEM, V267, P5229; OGURUSU T, 1991, J BIOCHEM-TOKYO, V109, P472, DOI 10.1093/oxfordjournals.jbchem.a123406; ORLOWSKI S, 1991, BIOCHEMISTRY-US, V30, P352, DOI 10.1021/bi00216a007; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palmgren MG, 1998, BBA-BIOENERGETICS, V1365, P37, DOI 10.1016/S0005-2728(98)00041-3; POST RL, 1972, J BIOL CHEM, V247, P6530; Ridder IS, 1999, BIOCHEM J, V339, P223, DOI 10.1042/0264-6021:3390223; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; STOKES DL, 1990, BIOPHYS J, V57, P1, DOI 10.1016/S0006-3495(90)82501-7; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Toyoshima C, 2002, NATURE, V418, P605, DOI 10.1038/nature00944; TROULLIER A, 1992, J BIOL CHEM, V267, P22821; Wang WR, 2002, J MOL BIOL, V319, P421, DOI 10.1016/S0022-2836(02)00324-8; Yamasaki K, 2004, J BIOL CHEM, V279, P2202, DOI 10.1074/jbc.M309398200; Yamasaki K, 2002, J BIOL CHEM, V277, P13615, DOI 10.1074/jbc.M200625200; Zhang PJ, 1998, NATURE, V392, P835, DOI 10.1038/33959	47	364	376	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 18	2004	432	7015					361	368		10.1038/nature02981	http://dx.doi.org/10.1038/nature02981			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	871UX	15448704				2022-12-24	WOS:000225161400047
J	Maldonado, RA; Irvine, DJ; Schreiber, R; Glimcher, LH				Maldonado, RA; Irvine, DJ; Schreiber, R; Glimcher, LH			A role for the immunological synapse in lineage commitment of CD4 lymphocytes	NATURE			English	Article							HELPER T-CELLS; LIPID RAFTS; LEISHMANIA-MAJOR; INTERFERON-GAMMA; IL-2 PRODUCTION; DIFFERENTIATION; PHOSPHORYLATION; MICRODOMAINS; INHIBITION; ACTIVATION	Activation of the naive T-helper lymphocyte (Thp) directs it down one of two major developmental pathways called Th1 and Th2. Signals transmitted by T cell, co-stimulatory and cytokine receptors control Thp lineage commitment but the mechanism by which these signals are integrated remains a mystery. The interferon-gamma ( IFNGR) and interleukin 4 (IL-4R) cytokine receptors, in particular, direct the earliest stages of T-helper commitment. Here we report that on engagement of the T-cell receptor (TCR) on Thp cells, rapid co-polarization of IFNGR with the TCR occurs within the developing immunological synapse. Thp cells from the intrinsically Th1-like C57BL/6 mouse strain have significantly more receptor co-polarization than Th2-prone BALB/c Thp cells. Remarkably, in the presence of IL-4, a cytokine required for Th2 differentiation, IFNGR co-polarization with TCR is prevented. This inhibition depends on Stat6, the transcription factor downstream of IL-4R that is required for Th2 differentiation. This cytokine receptor crossregulation provides an explanation for the effect of IL-4 in inhibiting Th1 differentiation. These observations suggest a scenario in which physical co-polarization of critical receptors directs the fate of the naive Thp, and offer a novel function for the immunological synapse in directing cell differentiation. They further suggest a new mechanism of membrane-bound signalling control by the physical disruption of large receptor-rich domains on signalling through a functionally antagonistic receptor.	Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; MIT, Dept Mat Sci & Engn, Biol Engn Div, Cambridge, MA 02139 USA; Washington Univ, Sch Med, Ctr Immunol, Dept Pathol & Immunol, St Louis, MO 63110 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Massachusetts Institute of Technology (MIT); Washington University (WUSTL); Harvard University; Harvard Medical School	Glimcher, LH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	lglimche@hsph.harvard.edu		Schreiber, Robert/0000-0003-1590-2341				Balamuth F, 2001, IMMUNITY, V15, P729, DOI 10.1016/S1074-7613(01)00223-0; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Chen CH, 2003, J EXP MED, V197, P1689, DOI 10.1084/jem.20021170; Fowell DJ, 1999, BIOESSAYS, V21, P510, DOI 10.1002/(SICI)1521-1878(199906)21:6&lt;510::AID-BIES7&gt;3.0.CO;2-5; Gamero AM, 2000, J BIOL CHEM, V275, P16574, DOI 10.1074/jbc.M910149199; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Granucci F, 2001, NAT IMMUNOL, V2, P882, DOI 10.1038/ni0901-882; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Launois P, 1997, IMMUNITY, V6, P541, DOI 10.1016/S1074-7613(00)80342-8; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; Lee KH, 2002, SCIENCE, V295, P1539, DOI 10.1126/science.1067710; Madrenas J, 2003, IMMUNITY, V18, P459, DOI 10.1016/S1074-7613(03)00089-X; Manes S, 2001, SEMIN IMMUNOL, V13, P147, DOI 10.1006/smim.2000.0306; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; POO WJ, 1988, NATURE, V332, P378, DOI 10.1038/332378a0; Reichert P, 2001, J IMMUNOL, V166, P4278, DOI 10.4049/jimmunol.166.7.4278; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Takaoka A, 2000, SCIENCE, V288, P2357, DOI 10.1126/science.288.5475.2357; Trambas CM, 2003, NAT IMMUNOL, V4, P399, DOI 10.1038/ni0503-399; Tsui-Pierchala BA, 2002, TRENDS NEUROSCI, V25, P412, DOI 10.1016/S0166-2236(02)02215-4; Vereb G, 2000, P NATL ACAD SCI USA, V97, P6013, DOI 10.1073/pnas.97.11.6013; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Watzl C, 2003, J EXP MED, V197, P77, DOI 10.1084/jem.20020427; Welte T, 1999, SCIENCE, V283, P222, DOI 10.1126/science.283.5399.222; Zhang YK, 2001, J EXP MED, V194, P165, DOI 10.1084/jem.194.2.165; Zhu JF, 2000, J EXP MED, V192, P1125, DOI 10.1084/jem.192.8.1125; Zhu JF, 2003, IMMUNITY, V19, P739, DOI 10.1016/S1074-7613(03)00292-9	30	152	155	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 30	2004	431	7008					527	532		10.1038/nature02916	http://dx.doi.org/10.1038/nature02916			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15386021				2022-12-24	WOS:000224156700035
J	Yaffe, MJ				Yaffe, MJ			What should the burden of proof be for acceptance of a new breast-cancer screening technique?	LANCET			English	Editorial Material							FOLLOW-UP; MAMMOGRAPHY; PROGRESSION; MORTALITY		Univ Toronto, Dept Med Imaging, Toronto, ON M4N 3M5, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M4N 3M5, Canada	University of Toronto; University of Toronto	Yaffe, MJ (corresponding author), Univ Toronto, Dept Med Imaging, Toronto, ON M4N 3M5, Canada.	martin.yaffe@swri.ca						*AM COLL RAD IM NE, CURR PROT; GUSTERSON BA, 1995, DRUG HORMONAL RESIST, P39; Hayes DF, 1996, JNCI-J NATL CANCER I, V88, P1456, DOI 10.1093/jnci/88.20.1456; Heimann R, 1998, J CLIN ONCOL, V16, P2686, DOI 10.1200/JCO.1998.16.8.2686; Heimann R, 2000, EUR J CANCER, V36, P1631, DOI 10.1016/S0959-8049(00)00151-9; Hellman S, 2000, CANCER J, V6, pS131; Hendrick R E, 1997, J Natl Cancer Inst Monogr, P87; Irwig L, 2004, BRIT J CANCER, V90, P2118, DOI 10.1038/sj.bjc.6601836; Kriege M, 2004, NEW ENGL J MED, V351, P427, DOI 10.1056/NEJMoa031759; NYSTROM L, 1993, LANCET, V341, P973, DOI 10.1016/0140-6736(93)91067-V; Tabar L, 2000, RADIOL CLIN N AM, V38, P625, DOI 10.1016/S0033-8389(05)70191-3; Tabar L, 2003, LANCET, V361, P1405, DOI 10.1016/S0140-6736(03)13143-1; TRUDEAU ME, IN PRESS BREAST CANC; WARNER E, IN PRESS JAMA	14	9	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 25	2004	364	9440					1111	1112		10.1016/S0140-6736(04)17121-3	http://dx.doi.org/10.1016/S0140-6736(04)17121-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857FT	15451209				2022-12-24	WOS:000224102400010
J	Miller, C; Thomsen, LE; Gaggero, C; Mosseri, R; Ingmer, H; Cohen, SN				Miller, C; Thomsen, LE; Gaggero, C; Mosseri, R; Ingmer, H; Cohen, SN			SOS response induction by beta-lactams and bacterial defense against antibiotic lethality	SCIENCE			English	Article							PENICILLIN-BINDING-PROTEINS; ESCHERICHIA-COLI PLASMIDS; CELL-DIVISION; GENE-EXPRESSION; MUTANTS; REPLICATION; INHERITANCE; CHROMOSOMES; INVOLVEMENT; PSC101	The SOS response aids bacterial propagation by inhibiting cell division during repair of DNA damage. We report that inactivation of the ftsl gene product, penicillin binding protein 3, by either beta-lactam antibiotics or genetic mutation induces SOS in Escherichia coli through the DpiBA two-component signal transduction system. This event, which requires the SOS-promoting recA and lexA genes as well as dpiA, transiently halts bacterial cell division, enabling survival to otherwise lethal antibiotic exposure. Our findings reveal defective cell wait synthesis as an unexpected initiator of the bacterial SOS response, indicate that beta-lactam antibiotics are extracellular stimuli of this response, and demonstrate a novel mechanism for mitigation of antimicrobial lethality.	Stanford Univ, Dept Genet, Stanford, CA 94305 USA; Royal Vet & Agr Univ, Dept Vet Pathobiol, DK-1870 Frederiksberg C, Denmark	Stanford University; University of Copenhagen	Cohen, SN (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	sncohen@stanford.edu		Ingmer, Hanne/0000-0002-8350-5631; Thomsen, Line Elnif/0000-0001-5460-9178	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI008619] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI08619] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bacolla A, 2001, J BIOL CHEM, V276, P18597, DOI 10.1074/jbc.M100845200; Beaber JW, 2004, NATURE, V427, P72, DOI 10.1038/nature02241; BIEK DP, 1989, J BACTERIOL, V171, P2066, DOI 10.1128/jb.171.4.2066-2074.1989; BOTT M, 1995, MOL MICROBIOL, V18, P533, DOI 10.1111/j.1365-2958.1995.mmi_18030533.x; BOTTA GA, 1981, J BACTERIOL, V145, P333, DOI 10.1128/JB.145.1.333-340.1981; Chadwick D., 1997, ANTIBIOTIC RESISTANC; Chen J., COMMUNICATION; Denome SA, 1999, J BACTERIOL, V181, P3981, DOI 10.1128/JB.181.13.3981-3993.1999; Goh EB, 2002, P NATL ACAD SCI USA, V99, P17025, DOI 10.1073/pnas.252607699; Hendricks EC, 2000, MOL MICROBIOL, V36, P973, DOI 10.1046/j.1365-2958.2000.01920.x; Hoch JA, 1995, 2 COMPONENT SIGNAL T; HUISMAN O, 1984, P NATL ACAD SCI-BIOL, V81, P4490, DOI 10.1073/pnas.81.14.4490; Ingmer H, 1998, MOL MICROBIOL, V29, P49, DOI 10.1046/j.1365-2958.1998.00895.x; Miller C, 2003, J BACTERIOL, V185, P6025, DOI 10.1128/JB.185.20.6025-6031.2003; Nguyen-Disteche M, 1998, CELL MOL LIFE SCI, V54, P309, DOI 10.1007/s000180050157; OHMORI H, 1995, J BACTERIOL, V177, P156, DOI 10.1128/jb.177.1.156-165.1995; Pogliano J, 1997, P NATL ACAD SCI USA, V94, P559, DOI 10.1073/pnas.94.2.559; Sambrook JFE, 1989, MOL CLONING LAB MANU; Shaw KJ, 2003, J MOL MICROB BIOTECH, V5, P105, DOI 10.1159/000069981; Sleator RD, 2000, INT J FOOD MICROBIOL, V60, P261, DOI 10.1016/S0168-1605(00)00316-0; SPRATT BG, 1975, P NATL ACAD SCI USA, V72, P2999, DOI 10.1073/pnas.72.8.2999; SPRATT BG, 1977, J BACTERIOL, V131, P293, DOI 10.1128/JB.131.1.293-305.1977; TOMASZ A, 1974, MODE ACTION ANTIBIOT, P439; Utaida S, 2003, MICROBIOL-SGM, V149, P2719, DOI 10.1099/mic.0.26426-0; WALKER GC, 1984, MICROBIOL REV, V48, P60, DOI 10.1128/MMBR.48.1.60-93.1984	25	397	431	5	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2004	305	5690					1629	1631		10.1126/science.1101630	http://dx.doi.org/10.1126/science.1101630			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	854GV	15308764				2022-12-24	WOS:000223891200046
J	Mulligan, SJ; MacVicar, BA				Mulligan, SJ; MacVicar, BA			Calcium transients in astrocyte endfeet cause cerebrovascular constrictions	NATURE			English	Article							CEREBRAL-BLOOD-FLOW; ARACHIDONIC-ACID; BRAIN-SLICES; PHOTOLYSIS; MICROSCOPY; EXCITATION; 20-HETE; CORTEX	Cerebral blood flow (CBF) is coupled to neuronal activity and is imaged in vivo to map brain activation(1). CBF is also modified by afferent projection fibres that release vasoactive neurotransmitters(2,3) in the perivascular region, principally on the astrocyte endfeet(4,5) that outline cerebral blood vessels(6). However, the role of astrocytes in the regulation of cerebrovascular tone remains uncertain. Here we determine the impact of intracellular Ca2+ concentrations ([Ca2+](i)) in astrocytes on the diameter of small arterioles by using two-photon Ca2+ uncaging(7,8) to increase [Ca2+](i). Vascular constrictions occurred when Ca2+ waves evoked by uncaging propagated into the astrocyte endfeet and caused large increases in [Ca2+](i). The vasoactive neurotransmitter noradrenaline(2,3) increased [Ca2+](i) in the astrocyte endfeet, the peak of which preceded the onset of arteriole constriction. Depressing increases in astrocyte [Ca2+](i) with BAPTA inhibited the vascular constrictions in noradrenaline. We find that constrictions induced in the cerebrovasculature by increased [Ca2+](i) in astrocyte endfeet are generated through the phospholipase A(2)-arachidonic acid pathway and 20-hydroxyeicosatetraenoic acid production. Vasoconstriction by astrocytes is a previously unknown mechanism for the regulation of CBF.	Univ British Columbia, Dept Psychiat, Brain Res Inst, Vancouver, BC V6T 2B5, Canada	University of British Columbia	MacVicar, BA (corresponding author), Univ British Columbia, Dept Psychiat, Brain Res Inst, 2211 Wesbrook Mall, Vancouver, BC V6T 2B5, Canada.	bmacvica@interchange.ubc.ca	MacVicar, Brian/P-1553-2015; MacVicar, Brian/AAI-7729-2020	MacVicar, Brian/0000-0003-4596-4623; MacVicar, Brian/0000-0003-4596-4623				Basarsky TA, 1998, J NEUROSCI, V18, P7189; Brown EB, 1999, BIOPHYS J, V76, P489, DOI 10.1016/S0006-3495(99)77217-6; Chaigneau E, 2003, P NATL ACAD SCI USA, V100, P13081, DOI 10.1073/pnas.2133652100; Chillon J., 2002, CEREBRAL BLOOD FLOW, P395; Cohen Z, 1997, J CEREBR BLOOD F MET, V17, P894, DOI 10.1097/00004647-199708000-00008; Dreier JP, 2001, J PHYSIOL-LONDON, V531, P515, DOI 10.1111/j.1469-7793.2001.0515i.x; DUFFY S, 1995, J NEUROSCI, V15, P5535; Duffy S, 1996, J NEUROSCI, V16, P71; Farooqui AA, 1997, J NEUROCHEM, V69, P889; Gebremedhin D, 2000, CIRC RES, V87, P60, DOI 10.1161/01.RES.87.1.60; GOADSBY PJ, 2002, CEREBRAL BLOOD FLOW, P172; KANG J, 2000, IMAGING NEURONS LAB; KATSUKI H, 1995, PROG NEUROBIOL, V46, P607, DOI 10.1016/0301-0082(95)00016-O; Miyata N, 2001, BRIT J PHARMACOL, V133, P325, DOI 10.1038/sj.bjp.0704101; Paspalas CD, 1996, GLIA, V17, P133, DOI 10.1002/(SICI)1098-1136(199606)17:2<133::AID-GLIA5>3.0.CO;2-3; RAICHLE ME, 1975, P NATL ACAD SCI USA, V72, P3726, DOI 10.1073/pnas.72.9.3726; Roman RJ, 2002, PHYSIOL REV, V82, P131, DOI 10.1152/physrev.00021.2001; Simard M, 2003, J NEUROSCI, V23, P9254; Soeller C, 1999, MICROSC RES TECHNIQ, V47, P182; STREET IP, 1993, BIOCHEMISTRY-US, V32, P5935, DOI 10.1021/bi00074a003; WALZ W, 1988, BRAIN RES, V443, P321, DOI 10.1016/0006-8993(88)91626-5; Xu C, 1996, P NATL ACAD SCI USA, V93, P10763, DOI 10.1073/pnas.93.20.10763; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	24	642	666	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 9	2004	431	7005					195	199		10.1038/nature02827	http://dx.doi.org/10.1038/nature02827			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HI	15356633				2022-12-24	WOS:000223746000047
J	Luoma, P; Melberg, A; Rinne, JO; Kaukonen, JA; Nupponen, NN; Chalmers, RM; Oldfors, A; Rautakorpi, I; Peltonen, L; Majamaa, K; Somer, H; Suomalainen, A				Luoma, P; Melberg, A; Rinne, JO; Kaukonen, JA; Nupponen, NN; Chalmers, RM; Oldfors, A; Rautakorpi, I; Peltonen, L; Majamaa, K; Somer, H; Suomalainen, A			Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study	LANCET			English	Article							PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; AUTOSOMAL-DOMINANT; MULTIPLE DELETIONS; MTDNA DELETIONS; POLG MUTATIONS; DISEASE; FEATURES; DISORDERS; ENCEPHALOMYOPATHY; HYPOGONADISM	Background Mutations in the gene encoding mitochondrial DNA polymerase gamma (POLG), the enzyme that synthesises mitochondrial DNA (mtDNA), have been associated with a mitochondrial disease-autosomal dominant or recessive progressive external ophthalmoplegia-and multiple deletions of mtDNA. Mitochondrial dysfunction is also suspected to participate in the pathogenesis of Parkinson's disease. However, no primary gene defects affecting mitochondrial proteins causing mendelian transmission of parkinsonism have been characterised. We aimed to analyse the gene sequence of POLG in patients with progressive external ophthalmoplegia and their healthy relatives. Methods In seven families of various ethnic origins we assessed patients with progressive external ophthalmoplegia and unaffected individuals by clinical, biochemical, morphological, and molecular genetic characterisation and positron emission tomography (PET). Findings We recorded mutations in POLG in members of all seven families. Clinical assessment showed significant cosegregation of parkinsonism with POLG mutations (p<0.0001), and PET findings were consistent with dopaminergic neuron loss. Post-mortem examination in two individuals showed loss of pigmented neurons and pigment phagocytosis in substantia nigra without Lewy bodies. Furthermore, most women with progressive external ophthalmoplegia had early menopause before age 35 years. The POLG gene defect resulted in secondary accumulation of mtDNA deletions in patients' tissues. Interpretation Dysfunction of mitochondrial POLG causes a severe progressive multisystem disorder including parkinsonism and premature menopause, which are not typical of mitochondrial disease. Cosegregation of parkinsonism and POLG mutations in our families suggests that when defective, this gene can underlie mendelian transmission of parkinsonism. Relevance to practice Awareness that mitochondrial POLG mutations can underlie parkinsonism is important for clinicians working in diagnosis of movement disorders, as well as for studies of the genetics of Parkinson's disease. Further, progressive external ophthalmoplegia with muscle weakness and neuropathy can mask symptoms of parkinsonism, and clinicians should pay special attention to detect and treat parkinsonism in those individuals.	Univ Helsinki, Biomedicum Helsinki, Programme Neurosci, FIN-00290 Helsinki, Finland; Univ Helsinki, Biomedicum Helsinki, Dept Neurol, FIN-00290 Helsinki, Finland; Univ Helsinki, Biomedicum Helsinki, Dept Oncol, FIN-00290 Helsinki, Finland; Univ Helsinki, Cent Hosp, Helsinki, Finland; Natl Publ Hlth Inst, Dept Mol Med, Helsinki, Finland; Univ Helsinki, Dept Med Genet, Helsinki, Finland; Univ Uppsala Hosp, Dept Neurosci & Neurol, Uppsala, Sweden; Univ Turku, Turku PET Ctr, Turku, Finland; Inst Neurol, Univ Dept Clin Neurol, London WC1N 3BG, England; Gothenburg Univ, Sahlgrens Hosp, Dept Pathol, S-41345 Gothenburg, Sweden; Cent Hosp Lapland, Dept Neurol, Rovaniemi, Finland; Univ Oulu, Bioctr, Oulu, Finland; Univ Oulu, Dept Neurol, Oulu, Finland	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare; University of Helsinki; Uppsala University; Uppsala University Hospital; University of Turku; University of London; University College London; Sahlgrenska University Hospital; University of Gothenburg; University of Oulu; University of Oulu	Suomalainen, A (corresponding author), Univ Helsinki, Biomedicum Helsinki, Programme Neurosci, Room C522B,Haartmaninkatu 8, FIN-00290 Helsinki, Finland.	anu.wartiovaara@helsinki.fi	Majamaa, Kari/A-1344-2012	Majamaa, Kari/0000-0002-9070-3791; Oldfors, Anders/0000-0002-5758-7397; Suomalainen-Wartiovaara, Anu/0000-0003-4833-5195				Beal MF, 2000, TRENDS NEUROSCI, V23, P298, DOI 10.1016/S0166-2236(00)01584-8; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Bose HS, 2002, NATURE, V417, P87, DOI 10.1038/417087a; Casali C, 2001, NEUROLOGY, V56, P802, DOI 10.1212/WNL.56.6.802; Chalmers RM, 1996, J NEUROL SCI, V143, P41, DOI 10.1016/S0022-510X(96)00032-9; CHECCARELLI N, 1994, J NEUROL SCI, V123, P74, DOI 10.1016/0022-510X(94)90206-2; de Rijk MC, 2000, NEUROLOGY, V54, pS21; Dekker MCJ, 2003, BRAIN, V126, P1722, DOI 10.1093/brain/awg172; Filosto M, 2003, ARCH NEUROL-CHICAGO, V60, P1279, DOI 10.1001/archneur.60.9.1279; Gu GY, 2002, J NEUROPATH EXP NEUR, V61, P634, DOI 10.1093/jnen/61.7.634; Guttman M, 2003, MOVEMENT DISORD, V18, P313, DOI 10.1002/mds.10333; Kaukonen J, 2000, SCIENCE, V289, P782, DOI 10.1126/science.289.5480.782; Kaukonen J, 1999, AM J HUM GENET, V65, P256, DOI 10.1086/302445; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; Lamantea E, 2002, ANN NEUROL, V52, P211, DOI 10.1002/ana.10278; LESTIENNE P, 1990, J NEUROCHEM, V55, P1810, DOI 10.1111/j.1471-4159.1990.tb04973.x; Lewis S, 2002, J NEUROL SCI, V201, P39, DOI 10.1016/S0022-510X(02)00190-9; LUNDBERG PO, 1962, ACTA NEUROL SCAND, V38, P142; Melberg A, 1996, MUSCLE NERVE, V19, P1561, DOI 10.1002/(SICI)1097-4598(199612)19:12<1561::AID-MUS5>3.0.CO;2-8; Moslemi AR, 1999, NEUROLOGY, V53, P79, DOI 10.1212/WNL.53.1.79; Orth M, 2002, NEUROCHEM INT, V40, P533, DOI 10.1016/S0197-0186(01)00124-3; Orth M, 2001, AM J MED GENET, V106, P27, DOI 10.1002/ajmg.1425; OZAWA T, 1990, BIOCHEM BIOPH RES CO, V172, P483, DOI 10.1016/0006-291X(90)90698-M; Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200; Rinne JO, 1999, SYNAPSE, V31, P119, DOI 10.1002/(SICI)1098-2396(199902)31:2<119::AID-SYN4>3.3.CO;2-F; Shults CW, 2002, ARCH NEUROL-CHICAGO, V59, P1541, DOI 10.1001/archneur.59.10.1541; Siciliano G, 2001, J NEUROL NEUROSUR PS, V71, P685, DOI 10.1136/jnnp.71.5.685; Speciale SG, 2002, NEUROTOXICOL TERATOL, V24, P607, DOI 10.1016/S0892-0362(02)00222-2; Spelbrink JN, 2001, NAT GENET, V28, P223, DOI 10.1038/90058; *STANF GEN TECHN C, DHPLC MELT PROGR; Suomalainen A, 1997, NEUROLOGY, V48, P1244, DOI 10.1212/WNL.48.5.1244; SUOMALAINEN A, 1992, J CLIN INVEST, V90, P61, DOI 10.1172/JCI115856; Suomalainen A, 2001, AM J MED GENET, V106, P53, DOI 10.1002/ajmg.1379; Suomalainen A, 2000, MOL BIOTECHNOL, V15, P123, DOI 10.1385/MB:15:2:123; Van Goethem G, 2001, NAT GENET, V28, P211, DOI 10.1038/90034; Van Goethem G, 2003, HUM MUTAT, V22, P175, DOI 10.1002/humu.10246; Van Goethem G, 2003, EUR J HUM GENET, V11, P547, DOI 10.1038/sj.ejhg.5201002; Van Goethem G, 2003, NEUROMUSCULAR DISORD, V13, P133, DOI 10.1016/S0960-8966(02)00216-X; ZEVIANI M, 1989, NATURE, V339, P309, DOI 10.1038/339309a0; Zhang J, 2002, PARKINSONISM RELAT D, V8, P165, DOI 10.1016/S1353-8020(01)00041-4	40	421	438	2	25	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 4	2004	364	9437					875	882		10.1016/S0140-6736(04)16983-3	http://dx.doi.org/10.1016/S0140-6736(04)16983-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	851KY	15351195				2022-12-24	WOS:000223685200034
J	Giulini, A; Wang, J; Jackson, D				Giulini, A; Wang, J; Jackson, D			Control of phyllotaxy by the cytokinin-inducible response regulator homologue ABPHYL1	NATURE			English	Article							TRANSCRIPTION FACTOR; GENE ENCODES; SHOOT; EXPRESSION; PATTERN; MAIZE; PHOSPHORELAY; GROWTH; AMP1	Phyllotaxy describes the geometric pattern of leaves and flowers, and has intrigued botanists and mathematicians for centuries(1,2). How these patterns are initiated is poorly understood, and this is partly due to the paucity of mutants(3). Signalling by the plant hormone auxin appears to determine the site of leaf initiation; however, this observation does not explain how distinct patterns of phyllotaxy are initiated(4). abphyl1 (abph1) mutants of maize initiate leaves in a decussate pattern ( that is, paired at 1808), in contrast to the alternating or distichous phyllotaxy observed in wild-type maize and other grasses(5). Here we show that ABPH1 is homologous to two-component response regulators and is induced by the plant hormone cytokinin. ABPH1 is expressed in the embryonic shoot apical meristem, and its spatial expression pattern changes rapidly with cytokinin treatment. We propose that ABPH1 controls phyllotactic patterning by negatively regulating the cytokinin-induced expansion of the shoot meristem, thereby limiting the space available for primordium initiation at the apex.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Jackson, D (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	jacksond@cshl.edu						Asakura Y, 2003, PLANT MOL BIOL, V52, P331, DOI 10.1023/A:1023971315108; Brandstatter I, 1998, PLANT CELL, V10, P1009, DOI 10.1105/tpc.10.6.1009; CALLOS JD, 1994, PLANT J, V6, P1, DOI 10.1046/j.1365-313X.1994.6010001.x; CHAUDHURY AM, 1993, PLANT J, V4, P907, DOI 10.1046/j.1365-313X.1993.04060907.x; Che P, 2002, PLANT CELL, V14, P2771, DOI 10.1105/tpc.006668; D'Agostino IB, 2000, PLANT PHYSIOL, V124, P1706, DOI 10.1104/pp.124.4.1706; Falke JJ, 1997, ANNU REV CELL DEV BI, V13, P457, DOI 10.1146/annurev.cellbio.13.1.457; GREEN PB, 1994, J EXP BOT, V45, P1775, DOI 10.1093/jxb/45.Special_Issue.1775; GREYSON RI, 1978, CAN J BOT, V56, P1545, DOI 10.1139/b78-183; Helliwell CA, 2001, PLANT CELL, V13, P2115, DOI 10.1105/tpc.13.9.2115; Hutchison CE, 2002, PLANT CELL, V14, pS47, DOI 10.1105/tpc.010444; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Jackson D, 1999, DEVELOPMENT, V126, P315; JACKSON D, 1994, DEVELOPMENT, V120, P405; Jean R. V., 1994, PHYLLOTAXIS SYSTEMIC; Klar AJS, 2002, NATURE, V417, P595, DOI 10.1038/417595a; Kuhlemeier C, 2001, TRENDS PLANT SCI, V6, P187, DOI 10.1016/S1360-1385(01)01894-5; Lohrmann J, 2001, MOL GENET GENOMICS, V265, P2, DOI 10.1007/s004380000400; Mok DWS, 2001, ANNU REV PLANT PHYS, V52, P89, DOI 10.1146/annurev.arplant.52.1.89; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; ROBERTS J, 1994, J CURRICULUM SUPERVI, V9, P136; Sakai H, 2001, SCIENCE, V294, P1519, DOI 10.1126/science.1065201; Sakakibara H, 1998, PLANT J, V14, P337, DOI 10.1046/j.1365-313X.1998.00134.x; SCHWABE WW, 1984, POSITIONAL CONTROLS; Sheen J, 2002, SCIENCE, V296, P1650, DOI 10.1126/science.1071883; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; Taguchi-Shiobara F, 2001, GENE DEV, V15, P2755, DOI 10.1101/gad.208501; Taniguchi M, 1998, FEBS LETT, V429, P259, DOI 10.1016/S0014-5793(98)00611-5; To JPC, 2004, PLANT CELL, V16, P658, DOI 10.1105/tpc.018978; Werner T, 2001, P NATL ACAD SCI USA, V98, P10487, DOI 10.1073/pnas.171304098	30	212	234	4	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 26	2004	430	7003					1031	1034		10.1038/nature02778	http://dx.doi.org/10.1038/nature02778			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849CD	15329722				2022-12-24	WOS:000223514900044
J	Reddy, KC; Villeneuve, AM				Reddy, KC; Villeneuve, AM			C-elegans HIM-17 links chromatin modification and competence for initiation of meiotic recombination	CELL			English	Article							DOUBLE-STRAND BREAKS; CAENORHABDITIS-ELEGANS; CROSSING-OVER; HISTONE DEACETYLASE; DNA-REPLICATION; PROTEIN; MEIOSIS; GENE; PATHWAY; COMPLEX	Initiation of meiotic recombination by double-strand breaks (DSBs) must occur in a controlled fashion to avoid jeopardizing genome integrity. Here, we identify chromatin-associated protein HIM-17 as a link between chromatin state and DSB formation during C. elegans meiosis. Dependencies of several meiotic prophase events on HIM-17 parallel those seen for DSB-generating enzyme SPO-11: HIM-17 is essential for DSB formation but dispensable for homolog synapsis. Crossovers and chiasmata are eliminated in him-17 null mutants but are restored by artificially induced DSBs, indicating that all components required to convert DSBs into chiasmata are present. Unlike SPO-11, HIM-17 is also required for proper accumulation of histone H3 methylation at lysine 9 on meiotic prophase chromosomes. HIM-17 shares structural features with three proteins that interact genetically with LIN-35/Rb, a known component of chromatin-modifying complexes. Furthermore, DSB levels and incidence of chiasmata can be modulated by loss of LIN-35/Rb. These and other data suggest that chromatin state governs the timing of DSB competence.	Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Villeneuve, AM (corresponding author), Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.	villen@cmgm.stanford.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053804, R01GM067268] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM053804, R01 GM067268, R01GM67268, R01GM53804] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alpi A, 2003, CHROMOSOMA, V112, P6, DOI 10.1007/s00412-003-0237-5; Arora C, 2004, MOL CELL, V13, P549, DOI 10.1016/S1097-2765(04)00063-2; ASHLEY T, 1995, CHROMOSOMA, V104, P19, DOI 10.1007/BF00352222; Barlow AL, 1997, EMBO J, V16, P5207, DOI 10.1093/emboj/16.17.5207; BARNES TM, 1995, GENETICS, V141, P159; Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; Borde V, 2000, SCIENCE, V290, P806, DOI 10.1126/science.290.5492.806; Boxem M, 2001, DEVELOPMENT, V128, P4349; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; BRENNER S, 1974, GENETICS, V77, P71; CAO L, 1990, CELL, V61, P1089, DOI 10.1016/0092-8674(90)90072-M; Chin GM, 2001, GENE DEV, V15, P522, DOI 10.1101/gad.864101; CLARK SG, 1994, GENETICS, V137, P987; Colaiacovo MP, 2003, DEV CELL, V5, P463, DOI 10.1016/S1534-5807(03)00232-6; Colaiacovo MP, 2002, GENETICS, V162, P113; Davis L, 2001, GENETICS, V157, P1179; DEMBURG AF, 1998, CELL, V94, P387; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Evans DH, 1997, GENETICS, V146, P1253; Fan QQ, 1996, MOL CELL BIOL, V16, P2037; Fay DS, 2003, DEVELOPMENT, V130, P3319, DOI 10.1242/dev.00561; FERGUSON EL, 1989, GENETICS, V123, P109; Franklin AE, 1999, PLANT CELL, V11, P809, DOI 10.1105/tpc.11.5.809; Furuse M, 1998, EMBO J, V17, P6412, DOI 10.1093/emboj/17.21.6412; Gardiner JM, 1997, GENETICS, V146, P1265; GOLDSTEIN P, 1982, CHROMOSOMA, V86, P577, DOI 10.1007/BF00330128; Hsieh J, 1999, GENE DEV, V13, P2958, DOI 10.1101/gad.13.22.2958; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jiao K, 2003, MOL CELL BIOL, V23, P5928, DOI 10.1128/MCB.23.16.5928-5938.2003; JOHZUKA K, 1995, GENETICS, V139, P1521; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kee K, 2002, GENETICS, V160, P111; Kee K, 2004, EMBO J, V23, P1815, DOI 10.1038/sj.emboj.7600184; Keeney S, 1996, GENES CELLS, V1, P475, DOI 10.1046/j.1365-2443.1996.d01-257.x; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kelly KO, 2000, GENETICS, V156, P617; Kelly WG, 2002, DEVELOPMENT, V129, P479; KLECKNER N, 2004, IN PRESS P NATL ACAD; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Lee CC, 1998, EMBO J, V17, P4166, DOI 10.1093/emboj/17.14.4166; Lu XW, 1998, CELL, V95, P981, DOI 10.1016/S0092-8674(00)81722-5; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; MacQueen AJ, 2002, GENE DEV, V16, P2428, DOI 10.1101/gad.1011602; MacQueen AJ, 2001, GENE DEV, V15, P1674, DOI 10.1101/gad.902601; Magnaghi-Jaulin L, 1998, NATURE, V391, P601, DOI 10.1038/35410; Moens PB, 1997, CHROMOSOMA, V106, P207, DOI 10.1007/s004120050241; Nielsen SJ, 2001, NATURE, V412, P561, DOI 10.1038/35087620; Ohta K, 1998, P NATL ACAD SCI USA, V95, P646, DOI 10.1073/pnas.95.2.646; OHTA K, 1994, EMBO J, V13, P5754, DOI 10.1002/j.1460-2075.1994.tb06913.x; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; Pasierbek P, 2001, GENE DEV, V15, P1349, DOI 10.1101/gad.192701; Praitis V, 2001, GENETICS, V157, P1217; Priess J. R., 1997, C ELEGANS 2; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Rinaldo C, 2002, GENETICS, V160, P471; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; Roussigne M, 2003, TRENDS BIOCHEM SCI, V28, P66, DOI 10.1016/S0968-0004(02)00013-0; Smith KN, 2001, CURR BIOL, V11, P88, DOI 10.1016/S0960-9822(01)00026-4; Solari F, 2000, CURR BIOL, V10, P223, DOI 10.1016/S0960-9822(00)00343-2; STOLAZZI A, 2003, GENE DEV, V17, P2675; SUN H, 1989, NATURE, V338, P87, DOI 10.1038/338087a0; Takanami T, 1998, DNA Res, V5, P373, DOI 10.1093/dnares/5.6.373; TERASAWA M, 1995, GENE DEV, V9, P925, DOI 10.1101/gad.9.8.925; Tesse S, 2003, P NATL ACAD SCI USA, V100, P12865, DOI 10.1073/pnas.2034282100; Thomas JH, 1999, DEVELOPMENT, V126, P3449; VILLENEUVE AM, 1994, GENETICS, V136, P887; Villeneuve AM, 2001, CELL, V106, P647, DOI 10.1016/S0092-8674(01)00500-1; WEINTRAUB SJ, 1995, NATURE, V375, P812, DOI 10.1038/375812a0; WILLIAMS BD, 1992, GENETICS, V131, P609; WU TC, 1994, SCIENCE, V263, P515, DOI 10.1126/science.8290959; Yamada T, 2004, EMBO J, V23, P1792, DOI 10.1038/sj.emboj.7600138; Zalevsky J, 1999, GENETICS, V153, P1271; Zetka MC, 1999, GENE DEV, V13, P2258, DOI 10.1101/gad.13.17.2258	76	119	129	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2004	118	4					439	452		10.1016/j.cell.2004.07.026	http://dx.doi.org/10.1016/j.cell.2004.07.026			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	850YS	15315757	Bronze			2022-12-24	WOS:000223650900007
J	Popescu, G; Robert, A; Howe, JR; Auerbach, A				Popescu, G; Robert, A; Howe, JR; Auerbach, A			Reaction mechanism determines NMDA receptor response to repetitive stimulation	NATURE			English	Article							METHYL-D-ASPARTATE; GLUTAMATE; SYNAPSES; TRANSMITTER; CHANNELS; NEURONS; AMPA; NONSATURATION; KINETICS; SUBUNIT	At central excitatory synapses, N-methyl-D-aspartate (NMDA) receptors, which have a high affinity for glutamate(1), produce a slowly rising synaptic current in response to a single transmitter pulse and an additional current after a second, closely timed stimulus(2). Here we show, by examining the kinetics of transmitter binding and channel gating in single-channel currents from recombinant NR1/NR2A receptors, that the synaptic response to trains of impulses is determined by the molecular reaction mechanism of the receptor. The rate constants estimated for the activation reaction predict that, after binding neurotransmitter, receptors hesitate for similar to4 ms in a closed high-affinity conformation before they either proceed towards opening or release neurotransmitter, with about equal probabilities. Because only about half of the initially fully occupied receptors become active, repetitive stimulation elicits currents with distinct waveforms depending on pulse frequency. This high-affinity/low-efficiency activation mechanism might serve as a link between stimulation frequency and the directionality of the ensuing synaptic plasticity.	SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA; SUNY Buffalo, Ctr Single Mol Biophys, Buffalo, NY 14214 USA; Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Yale University	Popescu, G (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, Buffalo, NY 14214 USA.	popescu@buffalo.edu	popescu, gabriela k/AAB-6155-2022	popescu, gabriela k/0000-0003-4658-2002	NIDA NIH HHS [F32 DA015164] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA015164] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Anson LC, 1998, J NEUROSCI, V18, P581; Anson LC, 2000, J PHYSIOL-LONDON, V527, P225, DOI 10.1111/j.1469-7793.2000.00225.x; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Chen NS, 2001, MOL PHARMACOL, V59, P212, DOI 10.1124/mol.59.2.212; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Diamond JS, 1997, J NEUROSCI, V17, P4672; Franks KM, 2002, BIOPHYS J, V83, P2333, DOI 10.1016/S0006-3495(02)75248-X; Frerking M, 1996, CURR OPIN NEUROBIOL, V6, P395, DOI 10.1016/S0959-4388(96)80125-5; Ishikawa T, 2002, NEURON, V34, P613, DOI 10.1016/S0896-6273(02)00692-X; Magleby KL, 2004, TRENDS NEUROSCI, V27, P231, DOI 10.1016/j.tins.2004.03.001; MAGLEBY KL, 1983, J PHYSIOL-LONDON, V344, P605, DOI 10.1113/jphysiol.1983.sp014958; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; McAllister AK, 2000, P NATL ACAD SCI USA, V97, P6173, DOI 10.1073/pnas.100126497; Min MY, 1998, NEURON, V21, P561, DOI 10.1016/S0896-6273(00)80566-8; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; Popescu G, 2004, NEUROSCIENTIST, V10, P192, DOI 10.1177/1073858404263483; Popescu G, 2003, NAT NEUROSCI, V6, P476, DOI 10.1038/nn1044; Qin F, 2000, BIOPHYS J, V79, P1915, DOI 10.1016/S0006-3495(00)76441-1; Qin F, 2004, BIOPHYS J, V86, P1488, DOI 10.1016/S0006-3495(04)74217-4; Qin F, 1997, P ROY SOC B-BIOL SCI, V264, P375, DOI 10.1098/rspb.1997.0054; Robert A, 2001, J NEUROSCI, V21, P5574, DOI 10.1523/JNEUROSCI.21-15-05574.2001; TRAYNELIS SF, 1990, NATURE, V345, P347, DOI 10.1038/345347a0; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781	29	102	105	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 12	2004	430	7001					790	793		10.1038/nature02775	http://dx.doi.org/10.1038/nature02775			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306812				2022-12-24	WOS:000223233600044
J	Gregori, L; McCombie, N; Palmer, D; Birch, P; Sowemimo-Coker, S; Giulivi, A; Rohwer, RG				Gregori, L; McCombie, N; Palmer, D; Birch, P; Sowemimo-Coker, S; Giulivi, A; Rohwer, RG			Effectiveness of leucoreduction for removal of infectivity of transmissible spongiform encephalopathies from blood	LANCET			English	Article							CREUTZFELDT-JAKOB-DISEASE; COMPONENTS	In 1999, the UK implemented universal leucoreduction as a precaution against transmission of variant Creutzfeldt-Jakob disease by transfusion of domestic blood or red blood cells. We aimed to assess how effectively leucoreduction reduced infectivity of transmissible spongiform encephalopathies (TSEs) in blood. 450 mL of whole blood collected and pooled from scrapie-infected hamsters was leucoreduced with a commercial filter. Blood cell concentrations were quantified, and infectivity titres measured. Blood cell recovery and white blood cell removal complied with American Association of Blood Banks standards. Leucofiltration removed 42% (SD 12) of the total TSE infectivity in endogenously infected blood. Leucoreduction is necessary for the removal of white-cell-associated TSE infectivity from blood; however, it is not, by itself, sufficient to remove all blood-borne TSE infectivity.	Univ Maryland, Vet Affairs Med Ctr, Vet Affairs Maryland Hlth Care Syst, Baltimore, MD 21201 USA; Hlth Canada, Ctr Infect Dis Prevent & Control, Ottawa, ON K1A 0L2, Canada; Canadian Blood Serv, Ottawa, ON, Canada; Pall Corp, Port Washington, NY USA	University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA); Health Canada; Canadian Blood Services; Pall Corporation	Rohwer, RG (corresponding author), Univ Maryland, Vet Affairs Med Ctr, Vet Affairs Maryland Hlth Care Syst, 10 N Greene St, Baltimore, MD 21201 USA.	rrohwer@umaryland.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063930] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-63930] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Brown P, 1999, TRANSFUSION, V39, P1169, DOI 10.1046/j.1537-2995.1999.39111169.x; Brown P, 1998, TRANSFUSION, V38, P810, DOI 10.1046/j.1537-2995.1998.38998408999.x; Holada K, 2002, J VIROL, V76, P4649, DOI 10.1128/JVI.76.9.4649-4650.2002; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Prowse CV, 2000, VOX SANG, V79, P248, DOI 10.1046/j.1423-0410.2000.7940248.x; Williamson LM, 2000, BRIT J HAEMATOL, V110, P256, DOI 10.1046/j.1365-2141.2000.02062.x; 1998, AABB BLOOD BANK OPER, P24	7	154	156	1	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 7	2004	364	9433					529	531		10.1016/S0140-6736(04)16812-8	http://dx.doi.org/10.1016/S0140-6736(04)16812-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BS	15302197				2022-12-24	WOS:000223132700033
J	Paul, BJ; Barker, MM; Ross, W; Schneider, DA; Webb, C; Foster, JW; Gourse, RL				Paul, BJ; Barker, MM; Ross, W; Schneider, DA; Webb, C; Foster, JW; Gourse, RL			DksA: A critical component of the transcription initiation machinery that potentiates the regulation of rRNA promoters by ppGpp and the initiating NTP	CELL			English	Article							RATE-DEPENDENT CONTROL; ESCHERICHIA-COLI; GROWTH-RATE; SALMONELLA-TYPHIMURIUM; NUCLEOSIDE TRIPHOSPHATE; IN-VITRO; MUTANTS; 5'-DIPHOSPHATE; POLYMERASE; PROTEASE	Ribosomal RNA (rRNA) transcription is regulated primarily at the level of initiation from rRNA promoters. The unusual kinetic properties of these promoters result in their specific regulation by two small molecule signals, ppGpp and the initiating NTP, that bind to RNA polymerase (RNAP) at all promoters. We show here that DksA, a protein previously unsuspected as a transcription factor, is absolutely required for rRNA regulation. InDeltadksA mutants, rRNA promoters are unresponsive to changes in amino acid availability, growth rate, or growth phase. In vitro, DksA binds to RNAP, reduces open complex lifetime, inhibits rRNA promoter activity, and amplifies effects of ppGpp and the initiating NTP on rRNA transcription, explaining the dksA requirement in vivo. These results expand our molecular understanding of rRNA transcription regulation, may explain previously described pleiotropic effects of dksA, and illustrate how transcription factors that do not bind DNA can nevertheless potentiate RNAP for regulation.	Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; Univ S Alabama, Coll Med, Dept Microbiol & Immunol, Mobile, AL 36688 USA	University of Wisconsin System; University of Wisconsin Madison; University of South Alabama	Gourse, RL (corresponding author), Univ Wisconsin, Dept Bacteriol, 420 Henry Mall, Madison, WI 53706 USA.	rgourse@bact.wisc.edu		Schneider, David/0000-0003-0635-5091	NIGMS NIH HHS [R01 GM37048, R37 GM037048] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037048, R37GM037048] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Afflerbach H, 1998, MOL MICROBIOL, V28, P641, DOI 10.1046/j.1365-2958.1998.00829.x; Artsimovitch I, 2004, CELL, V117, P299, DOI 10.1016/S0092-8674(04)00401-5; Barker MM, 2001, J BACTERIOL, V183, P6315, DOI 10.1128/JB.183.21.6315-6323.2001; Barker MM, 2001, J MOL BIOL, V305, P673, DOI 10.1006/jmbi.2000.4327; Barker MM, 2001, J MOL BIOL, V305, P689, DOI 10.1006/jmbi.2000.4328; Bartlett MS, 1998, J MOL BIOL, V279, P331, DOI 10.1006/jmbi.1998.1779; BARTLETT MS, 1994, J BACTERIOL, V176, P5560, DOI 10.1128/JB.176.17.5560-5564.1994; Bass S, 1996, J BACTERIOL, V178, P1154, DOI 10.1128/jb.178.4.1154-1161.1996; BOKAL AJ, 1995, J MOL BIOL, V245, P197, DOI 10.1006/jmbi.1994.0016; Branny P, 2001, J BACTERIOL, V183, P1531, DOI 10.1128/JB.183.5.1531-1539.2001; Brown L, 2002, J BACTERIOL, V184, P4455, DOI 10.1128/JB.184.16.4455-4465.2002; Choy HE, 2000, J BIOL CHEM, V275, P6783, DOI 10.1074/jbc.275.10.6783; CONDON C, 1995, MICROBIOL REV, V59, P623, DOI 10.1128/MMBR.59.4.623-645.1995; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Gaal T, 1997, SCIENCE, V278, P2092, DOI 10.1126/science.278.5346.2092; GAAL T, 1990, P NATL ACAD SCI USA, V87, P5533, DOI 10.1073/pnas.87.14.5533; Gaal T, 2001, MOL MICROBIOL, V42, P939, DOI 10.1046/j.1365-2958.2001.02703.x; GOURSE RL, 1988, NUCLEIC ACIDS RES, V16, P9789, DOI 10.1093/nar/16.20.9789; Gourse RL, 1996, ANNU REV MICROBIOL, V50, P645, DOI 10.1146/annurev.micro.50.1.645; Hirsch M, 2002, J BACTERIOL, V184, P5077, DOI 10.1128/JB.184.18.5077-5087.2002; Hogg T, 2004, CELL, V117, P57, DOI 10.1016/S0092-8674(04)00260-0; Ishii Y, 2000, BIOSCI BIOTECH BIOCH, V64, P799, DOI 10.1271/bbb.64.799; KANG PJ, 1990, J BACTERIOL, V172, P2055, DOI 10.1128/jb.172.4.2055-2064.1990; Murray HD, 2004, MOL MICROBIOL, V52, P1375, DOI 10.1111/j.1365-2958.2004.04060.x; Murray HD, 2003, MOL CELL, V12, P125, DOI 10.1016/S1097-2765(03)00266-1; Murray HD, 2003, J BACTERIOL, V185, P28, DOI 10.1128/JB.185.1.28-34.2003; Perederina A, 2004, CELL, V118, P297, DOI 10.1016/j.cell.2004.06.030; SANDS MK, 1952, J BACTERIOL, V63, P505, DOI 10.1128/JB.63.4.505-511.1952; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; Schneider DA, 2004, J BIOL CHEM, V279, P8262, DOI 10.1074/jbc.M311996200; Schneider DA, 2003, METHOD ENZYMOL, V370, P606; Schneider DA, 2003, J BACTERIOL, V185, P6185, DOI 10.1128/JB.185.20.6185-6191.2003; Schneider DA, 2003, CURR OPIN MICROBIOL, V6, P151, DOI 10.1016/S1369-5274(03)00038-9; Schneider DA, 2002, P NATL ACAD SCI USA, V99, P8602, DOI 10.1073/pnas.132285199; STEPHENS JC, 1975, P NATL ACAD SCI USA, V72, P4389, DOI 10.1073/pnas.72.11.4389; Turner AK, 1998, INFECT IMMUN, V66, P2099, DOI 10.1128/IAI.66.5.2099-2106.1998; Webb C, 1999, MOL MICROBIOL, V34, P112, DOI 10.1046/j.1365-2958.1999.01581.x; XIAO H, 1991, J BIOL CHEM, V266, P5980; Zhou YN, 1998, P NATL ACAD SCI USA, V95, P2908, DOI 10.1073/pnas.95.6.2908	39	368	378	2	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2004	118	3					311	322		10.1016/j.cell.2004.07.009	http://dx.doi.org/10.1016/j.cell.2004.07.009			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846XP	15294157	Bronze			2022-12-24	WOS:000223353100008
J	Denver, DR; Morris, K; Lynch, M; Thomas, WK				Denver, DR; Morris, K; Lynch, M; Thomas, WK			High mutation rate and predominance of insertions in the Caenorhabditis elegans nuclear genome	NATURE			English	Article							DROSOPHILA-MELANOGASTER; DNA-SEQUENCES; EVOLUTION; SELECTION; NUCLEOTIDE; GENES	Mutations have pivotal functions in the onset of genetic diseases and are the fundamental substrate for evolution. However, present estimates of the spontaneous mutation rate and spectrum are derived from indirect and biased measurements. For instance, mutation rate estimates for Caenorhabditis elegans are extrapolated from observations on a few genetic loci with visible phenotypes and vary over an order of magnitude(1). Alternative approaches in mammals, relying on phylogenetic comparisons of pseudogene loci(2) and fourfold degenerate codon positions(3), suffer from uncertainties in the actual number of generations separating the compared species and the inability to exclude biases associated with natural selection. Here we provide a direct and unbiased estimate of the nuclear mutation rate and its molecular spectrum with a set of C. elegans mutation-accumulation lines that reveal a mutation rate about tenfold higher than previous indirect estimates and an excess of insertions over deletions. Because deletions dominate patterns of C. elegans pseudogene variation(4,5), our observations indicate that natural selection might be significant in promoting small genome size, and challenge the prevalent assumption that pseudogene divergence accurately reflects the spontaneous mutation spectrum.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; Univ New Hampshire, Hubbard Ctr Genome Studies, Durham, NH 03824 USA	Indiana University System; Indiana University Bloomington; University System Of New Hampshire; University of New Hampshire	Denver, DR (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	ddenver@bio.indiana.edu						Balakirev ES, 2003, ANNU REV GENET, V37, P123, DOI 10.1146/annurev.genet.37.040103.103949; Charlesworth B, 1996, NATURE, V384, P315, DOI 10.1038/384315a0; Davies EK, 1999, SCIENCE, V285, P1748, DOI 10.1126/science.285.5434.1748; Denver DR, 2004, J MOL EVOL, V58, P584, DOI 10.1007/s00239-004-2580-4; Denver DR, 2003, MOL BIOL EVOL, V20, P393, DOI 10.1093/molbev/msg044; Denver DR, 2000, SCIENCE, V289, P2342, DOI 10.1126/science.289.5488.2342; Drake JW, 1998, GENETICS, V148, P1667; Gunsalus KC, 2004, NUCLEIC ACIDS RES, V32, pD406, DOI 10.1093/nar/gkh110; Hahn MW, 2003, MOL BIOL EVOL, V20, P901, DOI 10.1093/molbev/msg096; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Hill F, 2000, EMBO REP, V1, P29, DOI 10.1093/embo-reports/kvd015; Hirotsune S, 2003, NATURE, V423, P91, DOI 10.1038/nature01535; Keightley PD, 1998, GENETICS, V148, P753; KONDRASHOV AS, 1994, P ROY SOC B-BIOL SCI, V258, P221, DOI 10.1098/rspb.1994.0166; Kumar S, 2002, P NATL ACAD SCI USA, V99, P803, DOI 10.1073/pnas.022629899; LANGLEY CH, 1976, MUTAT RES, V36, P385, DOI 10.1016/0027-5107(76)90248-7; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Marais G, 2001, P NATL ACAD SCI USA, V98, P5688, DOI 10.1073/pnas.091427698; Nachman MW, 2000, GENETICS, V156, P297; NACLERIO G, 1992, J MOL BIOL, V226, P159, DOI 10.1016/0022-2836(92)90131-3; Ochman H, 2003, MOL BIOL EVOL, V20, P2091, DOI 10.1093/molbev/msg229; Petrov DA, 1996, NATURE, V384, P346, DOI 10.1038/384346a0; Petrov DA, 2000, J HERED, V91, P221, DOI 10.1093/jhered/91.3.221; Richterich P, 1998, GENOME RES, V8, P251, DOI 10.1101/gr.8.3.251; Robertson HM, 2000, GENOME RES, V10, P192, DOI 10.1101/gr.10.2.192; SEIN LD, 2003, PLOS BIOL, V1, P166; Vassilieva LL, 2000, EVOLUTION, V54, P1234, DOI 10.1111/j.0014-3820.2000.tb00557.x; Witherspoon DJ, 2003, J MOL EVOL, V56, P751, DOI 10.1007/s00239-002-2450-x; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305	29	266	275	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 5	2004	430	7000					679	682		10.1038/nature02697	http://dx.doi.org/10.1038/nature02697			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843LM	15295601				2022-12-24	WOS:000223085400046
J	Wolfraim, LA; Fernandez, TM; Mamura, M; Fuller, WL; Kumar, R; Cole, DE; Byfield, S; Felici, A; Flanders, KC; Walz, TM; Roberts, AB; Aplan, PD; Balis, FM; Letterio, JJ				Wolfraim, LA; Fernandez, TM; Mamura, M; Fuller, WL; Kumar, R; Cole, DE; Byfield, S; Felici, A; Flanders, KC; Walz, TM; Roberts, AB; Aplan, PD; Balis, FM; Letterio, JJ			Loss of Smad3 in acute T-cell lymphoblastic leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TGF-BETA; P27(KIP1); EXPRESSION; INHIBITOR; LYMPHOMAS; GROWTH; MICE	BACKGROUND: The receptors for transforming growth factor (beta) (TGF-(beta)) and their signaling intermediates make up an important tumor-suppressor pathway. The role of one of these intermediates -- Smad3 -- in the pathogenesis of lymphoid neoplasia is unknown. METHODS: We measured Smad3 messenger RNA (mRNA) and protein in leukemia cells obtained at diagnosis from 19 children with acute leukemia, including 10 with T-cell acute lymphoblastic leukemia (ALL), 7 with pre-B-cell ALL, and 2 with acute nonlymphoblastic leukemia (ANLL). All nine exons of the SMAD3 gene (MADH3) were sequenced. Mice in which one or both alleles of Smad3 were inactivated were used to evaluate the role of Smad3 in the response of normal T cells to TGF-(beta) and in the susceptibility to spontaneous leukemogenesis in mice in which both alleles of the tumor suppressor p27(sup Kip1) were deleted. RESULTS: Smad3 protein was absent in T-cell ALL but present in pre-B-cell ALL and ANLL. No mutations were found in the MADH3 gene in T-cell ALL, and Smad3 mRNA was present in T-cell ALL and normal T cells at similar levels. In mice, the loss of one allele for Smad3 impairs the inhibitory effect of TGF-(beta) on the proliferation of normal T cells and works in tandem with the homozygous inactivation of p27(sup Kip1) to promote T-cell leukemogenesis. CONCLUSIONS: Loss of Smad3 protein is a specific feature of pediatric T-cell ALL. A reduction in Smad3 expression and the loss of p27(sup Kip1) work synergistically to promote T-cell leukemogenesis in mice.	NCI, LCRC, CCR, NIH, Bethesda, MD 20892 USA; NCI, Pediat Oncol Branch, CCR, NIH, Bethesda, MD 20892 USA; NCI, Genet Branch, CCR, NIH, Bethesda, MD 20892 USA; Linkoping Univ Hosp, Fac Hlth Sci, Div Oncol, Dept Biomed & Surg, S-58185 Linkoping, Sweden	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Linkoping University	Letterio, JJ (corresponding author), NCI, LCRC, CCR, NIH, Bldg 41,Rm C629,41 Lib Dr, Bethesda, MD 20892 USA.	letterij@mail.nih.gov	Aplan, Peter D/K-9064-2016	Balis, Frank/0000-0002-8117-6926; Mamura, Mizuko/0000-0003-4531-0144	DIVISION OF BASIC SCIENCES - NCI [Z01BC005051, Z01BC010049] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [Z01SC006880, ZIASC010378, Z01SC010378, ZIASC006880] Funding Source: NIH RePORTER	DIVISION OF BASIC SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chervinsky DS, 1999, MOL CELL BIOL, V19, P5025; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Derynck R, 2001, NAT GENET, V29, P351; Flanders KC, 2001, DEV DYNAM, V220, P141, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1096>3.0.CO;2-4; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Komuro Hiroaki, 1999, Neoplasia (New York), V1, P253, DOI 10.1038/sj.neo.7900033; Lin ZS, 2003, BRIT J HAEMATOL, V121, P739, DOI 10.1046/j.1365-2141.2003.04354.x; Margolin J.F., 2002, PRINCIPLES PRACTICE, P489; MOROSETTI R, 1995, BLOOD, V86, P1924, DOI 10.1182/blood.V86.5.1924.bloodjournal8651924; Piekarz RL, 2001, BLOOD, V98, P2865, DOI 10.1182/blood.V98.9.2865; Porter PL, 1997, NAT MED, V3, P222, DOI 10.1038/nm0297-222; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280	13	121	130	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 5	2004	351	6					552	559		10.1056/NEJMoa031197	http://dx.doi.org/10.1056/NEJMoa031197			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843HS	15295048				2022-12-24	WOS:000223069900008
J	Zeitlin, P				Zeitlin, P			Can curcumin cure cystic fibrosis?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CFTR FUNCTION		Johns Hopkins Univ, Sch Med, Div Pediat Resp Sci, Baltimore, MD 21205 USA	Johns Hopkins University	Zeitlin, P (corresponding author), Johns Hopkins Univ, Sch Med, Div Pediat Resp Sci, Baltimore, MD 21205 USA.			Zeitlin, Pamela/0000-0002-2719-1834				Egan ME, 2004, SCIENCE, V304, P600, DOI 10.1126/science.1093941; Illek B, 1999, AM J PHYSIOL-CELL PH, V277, pC833, DOI 10.1152/ajpcell.1999.277.4.C833; Wilschanski M, 2003, NEW ENGL J MED, V349, P1433, DOI 10.1056/NEJMoa022170; Yerxa BR, 2002, J PHARMACOL EXP THER, V302, P871, DOI 10.1124/jpet.102.035485; Zeitlin PL, 2002, MOL THER, V6, P119, DOI 10.1006/mthe.2002.0639	5	32	34	0	3	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 5	2004	351	6					606	608		10.1056/NEJMcibr041584	http://dx.doi.org/10.1056/NEJMcibr041584			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843HS	15295056				2022-12-24	WOS:000223069900017
J	Rouse, GW; Goffredi, SK; Vrijenhoek, RC				Rouse, GW; Goffredi, SK; Vrijenhoek, RC			Osedax: Bone-eating marine worms with dwarf males	SCIENCE			English	Article							MOLECULAR EVIDENCE; VESTIMENTIFERA; POGONOPHORANS; WHALES; VENT	We describe a new genus, Osedax, and two new species of annelids with females that consume the bones of dead whales via ramifying roots. Molecular and morphological evidence revealed that Osedax belongs to the Siboglinidae, which includes pogonophoran and vestimentiferan worms from deep-sea vents, seeps, and anoxic basins. Osedax has skewed sex ratios with numerous dwarf (paedomorphic) males that live in the tubes of females. DNA sequences reveal that the two Osedax species diverged about 42 million years ago and currently maintain large populations ranging from 10(5) to 10(6) adult females.	Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; S Australian Museum, Adelaide, SA 5000, Australia; Univ Adelaide, Adelaide, SA 5005, Australia	Monterey Bay Aquarium Research Institute; University of Adelaide	Vrijenhoek, RC (corresponding author), Monterey Bay Aquarium Res Inst, 7700 Sandholdt Rd, Moss Landing, CA 95039 USA.	vrijen@mbari.org	Rouse, Greg W/F-2611-2010; Rouse, Gregory/AAW-1494-2021	Rouse, Greg W/0000-0001-9036-9263; Rouse, Gregory/0000-0001-9036-9263				Chevaldonne P, 2002, CAH BIOL MAR, V43, P367; GINGERICH PD, 1990, SCIENCE, V249, P154, DOI 10.1126/science.249.4965.154; GOFFREDI SK, UNPUB; GOFFREDI SK, IN PRESS DEEP SEA RE, V1; Halanych KM, 2001, BIOL BULL, V201, P65, DOI 10.2307/1543527; JONES ML, 1981, SCIENCE, V213, P333, DOI 10.1126/science.213.4505.333; Julian D, 1999, J EXP BIOL, V202, P2245; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; McHugh D, 1997, P NATL ACAD SCI USA, V94, P8006, DOI 10.1073/pnas.94.15.8006; Pilger J., 1978, P103; Roman J, 2003, SCIENCE, V301, P508, DOI 10.1126/science.1084524; Rouse GW, 2001, ZOOL J LINN SOC-LOND, V132, P55, DOI 10.1111/j.1096-3642.2001.tb02271.x; Smith CR, 2003, OCEANOGR MAR BIOL, V41, P311; Southward EC, 1999, HYDROBIOLOGIA, V402, P185, DOI 10.1023/A:1003796626851; Southward Eve C., 1993, P327; Van Dover CL, 2002, SCIENCE, V295, P1253, DOI 10.1126/science.1067361; VANDOVER CL, 2000, ECOLOGY DEEP SEA HYD, P411	17	245	251	3	189	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 30	2004	305	5684					668	671		10.1126/science.1098650	http://dx.doi.org/10.1126/science.1098650			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	842GQ	15286372	Green Submitted			2022-12-24	WOS:000222992100048
J	Vogeley, L; Sineshchekov, OA; Trivedi, VD; Sasaki, J; Spudich, JL; Luecke, H				Vogeley, L; Sineshchekov, OA; Trivedi, VD; Sasaki, J; Spudich, JL; Luecke, H			Anabaena sensory rhodopsin: A photochromic color 0 sensor at 2.0 angstrom	SCIENCE			English	Article							LIGHT; BACTERIORHODOPSIN	Microbial sensory rhodopsins are a family of membrane-embedded photoreceptors in prokaryotic and eukaryotic organisms. Structures of archaeal rhodopsins, which function as light-driven ion pumps or photosensors, have been reported. We present the structure of a eubacterial rhodopsin, which differs from those of previously characterized archaeal rhodopsins in its chromophore and cytoplasmic-side portions. Anabaena sensory rhodopsin exhibits light-induced interconversion between stable 13-cis and all-trans states of the retinylidene protein. The ratio of its cis and trans chromophore forms depends on the wavelength of illumination, thus providing a mechanism for a single protein to signal the color of light, for example, to regulate color-sensitive processes such as chromatic adaptation in photosynthesis. Its cytoplasmic half channel, highly hydrophobic in the archaeal rhodopsins, contains numerous hydrophilic residues networked by water molecules, providing a connection from the photoactive site to the cytoplasmic surface believed to interact with the receptor's soluble 14-kilodalton transducer.	Univ Texas, Sch Med, Dept Biochem & Mol Biol, Ctr Membrane Biol, Houston, TX 77030 USA; Univ Texas, Sch Med, Dept Microbiol & Mol Genet, Houston, TX 77030 USA; Moscow MV Lomonosov State Univ, Dept Biol, Moscow, Russia; Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Informat & Comp Sci, Irvine, CA 92697 USA	University of Texas System; University of Texas System; Lomonosov Moscow State University; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Spudich, JL (corresponding author), Univ Texas, Sch Med, Dept Biochem & Mol Biol, Ctr Membrane Biol, Houston, TX 77030 USA.	john.l.spudich@uth.tmc.edu; hudel@uci.edu	Luecke, Hartmut/F-4712-2012	Luecke, Hartmut/0000-0002-4938-0775	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM027750, R01GM059970, R01GM067808] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Cartailler JP, 2004, STRUCTURE, V12, P133, DOI 10.1016/j.str.2003.12.001; Gartner W., 2000, HDB BIOL PHYS, V3, P297; Gordeliy VI, 2002, NATURE, V419, P484, DOI 10.1038/nature01109; Grossman AR, 2001, J BIOL CHEM, V276, P11449, DOI 10.1074/jbc.R100003200; Gyula N, 2003, CURR OPIN PLANT BIOL, V6, P446, DOI 10.1016/S1369-5266(03)00082-7; Jung KH, 2003, MOL MICROBIOL, V47, P1513, DOI 10.1046/j.1365-2958.2003.03395.x; Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390; Luecke H, 2001, SCIENCE, V293, P1499, DOI 10.1126/science.1062977; Luecke H, 1998, SCIENCE, V280, P1934, DOI 10.1126/science.280.5371.1934; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; MacColl R, 1998, J STRUCT BIOL, V124, P311, DOI 10.1006/jsbi.1998.4062; Royant A, 2001, P NATL ACAD SCI USA, V98, P10131, DOI 10.1073/pnas.181203898; Sineshchekov OA, 2004, PHOTOCH PHOTOBIO SCI, V3, P548, DOI 10.1039/b316207a; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; SINESHCHEKOV OA, UNPUB; Singh B, 2001, CURR MICROBIOL, V43, P265, DOI 10.1007/s002840010299; SPUDICH JL, 1984, NATURE, V312, P509, DOI 10.1038/312509a0; Spudich JL, 2000, ANNU REV CELL DEV BI, V16, P365, DOI 10.1146/annurev.cellbio.16.1.365; SPUDICH JL, IN PRESS HDB PHOTOSE; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; WAGNER G, 2001, ESP REV SERIES PHOTO, P421; Wang H.S.., 2002, ARABIDOPSIS BOOK, P1	23	184	189	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 19	2004	306	5700					1390	1393		10.1126/science.1103943	http://dx.doi.org/10.1126/science.1103943			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	873SP	15459346	Green Accepted			2022-12-24	WOS:000225301600057
J	Gally, C; Eimer, S; Richmond, JE; Bessereau, JL				Gally, C; Eimer, S; Richmond, JE; Bessereau, JL			A transmembrane protein required for acetylcholine receptor clustering in Caenorhabditis elegans	NATURE			English	Article							LEVAMISOLE RESISTANCE; AMPA RECEPTORS; CUB-DOMAIN; GENE; GABA; MUTANTS; SYNAPSE; MODULE	Clustering neurotransmitter receptors at the synapse is crucial for efficient neurotransmission. Here we identify a Caenorhabditis elegans locus, lev-10, required for postsynaptic aggregation of ionotropic acetylcholine receptors (AChRs). lev-10 mutants were identified on the basis of weak resistance to the anthelminthic drug levamisole, a nematode-specific cholinergic agonist that activates AChRs present at neuromuscular junctions (NMJs) resulting in muscle hypercontraction and death at high concentrations(1-3). In lev-10 mutants, the density of levamisole-sensitive AChRs at NMJs is markedly reduced, yet the number of functional AChRs present at the muscle cell surface remains unchanged. LEV-10 is a transmembrane protein localized to cholinergic NMJs and required in body-wall muscles for AChR clustering. We also show that the LEV-10 extracellular region, containing five predicted CUB domains and one LDLa domain, is sufficient to rescue AChR aggregation in lev-10 mutants. This suggests a mechanism for AChR clustering that relies on extracellular protein - protein interactions. Such a mechanism is likely to be evolutionarily conserved because CUB/LDL transmembrane proteins similar to LEV-10, but lacking any assigned function, are expressed in the mammalian nervous system and might be used to cluster ionotropic receptors in vertebrates.	Ecole Normale Super, INSERM, U497, F-75005 Paris, France; Univ Illinois, Chicago, IL 60607 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Bessereau, JL (corresponding author), Ecole Normale Super, INSERM, U497, 46 Rue Ulm, F-75005 Paris, France.	jlbesse@wotan.ens.fr	Eimer, Stefan/B-1865-2013; Bessereau, Jean-Louis/M-2988-2017	Bessereau, Jean-Louis/0000-0002-3088-7621	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041477] Funding Source: NIH RePORTER; NINDS NIH HHS [R01NS41477-03, R01 NS041477-02, R01 NS041477, R01 NS041477-01A1, R01 NS041477-03] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; Bamber BA, 1999, J NEUROSCI, V19, P5348; Bessereau JL, 2001, NATURE, V413, P70, DOI 10.1038/35092567; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; Christensen EI, 2002, NAT REV MOL CELL BIO, V3, P258, DOI 10.1038/nrm778; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Duerr JS, 2001, AM J PHYSIOL-CELL PH, V280, pC1616, DOI 10.1152/ajpcell.2001.280.6.C1616; Fleming JT, 1997, J NEUROSCI, V17, P5843; Gally C, 2003, J NEUROSCI, V23, P2591; Herz J, 2002, ANNU REV BIOCHEM, V71, P405, DOI 10.1146/annurev.biochem.71.110601.135342; LEWIS JA, 1980, GENETICS, V95, P905; LEWIS JA, 1980, NEUROSCIENCE, V5, P967, DOI 10.1016/0306-4522(80)90180-3; LEWIS JA, 1987, J NEUROSCI, V7, P3059; McKay JP, 2004, GENETICS, V166, P161, DOI 10.1534/genetics.166.1.161; Michishita M, 2003, BIOCHEM BIOPH RES CO, V306, P680, DOI 10.1016/S0006-291X(03)01035-0; Miller T, 2000, J AGING PHYS ACTIV, V8, P289; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; OKKEMA PG, 1993, GENETICS, V135, P385; Ono F, 2004, J NEUROSCI, V24, P5475, DOI 10.1523/JNEUROSCI.0851-04.2004; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; RAIZEN DM, 1995, GENETICS, V141, P1365; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; Stohr H, 2002, GENE, V286, P223, DOI 10.1016/S0378-1119(02)00438-9; Tomita S, 2004, SCIENCE, V303, P1508, DOI 10.1126/science.1090262; Yochem J, 1998, GENETICS, V149, P1323; Zheng Y, 2004, NATURE, V427, P451, DOI 10.1038/nature02244	28	110	115	0	9	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 30	2004	431	7008					578	582		10.1038/nature02893	http://dx.doi.org/10.1038/nature02893			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15457263	Green Accepted			2022-12-24	WOS:000224156700049
J	Smeeth, L; Cook, C; Fombonne, E; Heavey, L; Rodrigues, LC; Smith, PG; Hall, AJ				Smeeth, L; Cook, C; Fombonne, E; Heavey, L; Rodrigues, LC; Smith, PG; Hall, AJ			MMR vaccination and pervasive developmental disorders: a case-control study	LANCET			English	Article							MUMPS-RUBELLA VACCINATION; PRACTICE RESEARCH DATABASE; EPIDEMIOLOGIC EVIDENCE; CAUSAL ASSOCIATION; NO EVIDENCE; MEASLES; AUTISM; CHILDREN; POPULATION; IMMUNIZATION	Background Concern that measles-mumps-rubella (MMR) vaccination might cause autism has led to a fall in vaccine coverage. We investigated whether MMR vaccination is associated with an increased risk of autism or other pervasive developmental disorders. Methods We did a matched case-control study using the UK General Practice Research Database. Cases were people born in 1973 or later who had first recorded diagnosis of pervasive developmental disorder while registered with a contributing general practice between 1987 and 2001. Controls were matched on age, sex, and general practice. Findings 1294 cases and 4469 controls were included. 1010 cases (78.1%) had MMR vaccination recorded before diagnosis, compared with 3671 controls (82.1%) before the age at which their matched case was diagnosed. After adjustment for age at joining the database, the odds ratio for association between MMR and pervasive developmental disorder was 0 . 86 (95% CI 0 . 68-1.09). Findings were similar when restricted to children with a diagnosis of autism, to those vaccinated with MMR before the third birthday, or to the period before media coverage of the hypothesis linking MMR with autism. Interpretation Our findings suggest that MMR vaccination is not associated with an increased risk of pervasive developmental disorders.	Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Sci, London WC1E 7HT, England; Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; McGill Univ, Montreal Childrens Hosp, Dept Psychiat, Montreal, PQ H3A 2T5, Canada; Kings Coll London, Inst Psychiat, London WC2R 2LS, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; McGill University; University of London; King's College London	Smeeth, L (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Sci, Keppel St, London WC1E 7HT, England.	autism@lshtm.ac.uk	Fombonne, Eric/M-4893-2018; smith, peter/ABH-9627-2020; RODRIGUES, LAURA CUNHA/AAO-4130-2021; Smeeth, Liam/X-5862-2018	Fombonne, Eric/0000-0002-8605-3538; smith, peter/0000-0003-0080-7560; Smeeth, Liam/0000-0002-9168-6022; Rodrigues, Laura Cunha/0000-0001-9008-660X	Medical Research Council [G108/492] Funding Source: Medline; MRC [G108/492] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BURTON D, 2000, OPENING STATEMENT CH; Chen W, 2004, PSYCHOL MED, V34, P543, DOI 10.1017/S0033291703001259; CLAYTON D, 1993, CONDITIONAL LOGISTIC, P290; Dales L, 2001, JAMA-J AM MED ASSOC, V285, P1183, DOI 10.1001/jama.285.9.1183; *DEP HLTH, 2002, DEPT HLTH STAT B; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DeStefano F, 2004, PEDIATRICS, V113, P259, DOI 10.1542/peds.113.2.259; DeStefano Frank, 2004, Expert Rev Vaccines, V3, P19, DOI 10.1586/14760584.3.1.19; DeWilde S, 2001, BRIT J GEN PRACT, V51, P226; *DIR PUBL HLTH, 2002, MEASL LOND INC CURR; Farrington CP, 2001, VACCINE, V19, P3632, DOI 10.1016/S0264-410X(01)00097-4; FINE PEM, 1992, AM J EPIDEMIOL, V136, P121, DOI 10.1093/oxfordjournals.aje.a116479; Fombonne E, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-5; Fombonne E, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e58; Furlano RI, 2001, J PEDIATR-US, V138, P366, DOI 10.1067/mpd.2001.111323; Geier DA, 2004, MED SCI MONITOR, V10, pPI33; GILLBERG C, 1998, AUTISM, V2, P423; Hollowell J, 1997, Popul Trends, P36; Jansen VAA, 2003, SCIENCE, V301, P804, DOI 10.1126/science.1086726; Jefferson T, 2003, VACCINE, V21, P3954, DOI 10.1016/S0264-410X(03)00271-8; Jick H, 2003, PHARMACOTHERAPY, V23, P1524, DOI 10.1592/phco.23.15.1524.31955; Jick H, 2003, EPIDEMIOLOGY, V14, P630, DOI 10.1097/01.EDE.0000082044.88833.c4; Kaye JA, 2001, BRIT MED J, V322, P460, DOI 10.1136/bmj.322.7284.460; Loff B, 1998, LANCET, V352, P1368, DOI 10.1016/S0140-6736(05)60771-4; Madsen KM, 2002, NEW ENGL J MED, V347, P1477, DOI 10.1056/NEJMoa021134; Makela A, 2002, PEDIATRICS, V110, P957, DOI 10.1542/peds.110.5.957; MANTEL N, 1959, J NATL CANCER I, V22, P719; Miller Elizabeth, 2003, Semin Pediatr Infect Dis, V14, P199, DOI 10.1016/S1045-1870(03)00034-7; NAZARETH I, 1993, BRIT MED J, V307, P32, DOI 10.1136/bmj.307.6895.32; *OFF NAT STAT, 1998, SER OFF NAT STAT MB6, V1; Patja A, 2000, PEDIATR INFECT DIS J, V19, P1127, DOI 10.1097/00006454-200012000-00002; Ramsay ME, 2002, BRIT J GEN PRACT, V52, P912; Rapin I, 1997, NEW ENGL J MED, V337, P97, DOI 10.1056/NEJM199707103370206; SALISBURY D, 1996, IMMUNISATION INFECT; Smeeth L, 2002, LANCET, V359, P2112, DOI 10.1016/S0140-6736(02)08918-3; Smeeth L, 2001, BMC PUBLIC HEALTH, V1, DOI 10.1186/1471-2458-1-2; Spitzer WO, 2003, NEW ENGL J MED, V348, P951; Taylor B, 2002, BRIT MED J, V324, P393, DOI 10.1136/bmj.324.7334.393; Taylor B, 1999, LANCET, V353, P2026, DOI 10.1016/S0140-6736(99)01239-8; Uhlmann V, 2002, J CLIN PATHOL-MOL PA, V55, P84, DOI 10.1136/mp.55.2.84; Van Staa TP, 1994, PHARMACOEPIDEM DR S, V3, P15, DOI DOI 10.1002/PDS.2630030106; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0; Wakefield AJ, 2000, AM J GASTROENTEROL, V95, P2285; Wakefield Andrew J., 2000, Adverse Drug Reactions and Toxicological Reviews, V19, P265; Walley T, 1997, LANCET, V350, P1097, DOI 10.1016/S0140-6736(97)04248-7; Wilson K, 2003, ARCH PEDIAT ADOL MED, V157, P628, DOI 10.1001/archpedi.157.7.628; 2003, DRUG THER B, V41, P25	47	129	134	1	51	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 11	2004	364	9438					963	969		10.1016/S0140-6736(04)17020-7	http://dx.doi.org/10.1016/S0140-6736(04)17020-7			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853MF	15364187				2022-12-24	WOS:000223831000026
J	Kunde, VG; Flasar, FM; Jennings, DE; Bezard, B; Strobel, DF; Conrath, BJ; Nixon, CA; Bjoraker, GL; Romani, PN; Achterberg, RK; Simon-Miller, AA; Irwin, P; Brasunas, JC; Pearl, JC; Smith, MD; Orton, GS; Gierasch, PJ; Spilker, LJ; Carlson, RC; Mamoutkine, AA; Calcutt, SB; Read, PL; Taylor, FW; Fouchet, T; Parrish, P; Barucci, A; Courtin, R; Coustenis, A; Gautier, D; Lellouch, E; Marten, A; Prange, R; Biraud, Y; Ferrari, C; Owen, TC; Abbas, MM; Samuelson, RE; Raulin, F; Ade, P; Cesarsky, CJ; Grossman, KU; Coradini, A				Kunde, VG; Flasar, FM; Jennings, DE; Bezard, B; Strobel, DF; Conrath, BJ; Nixon, CA; Bjoraker, GL; Romani, PN; Achterberg, RK; Simon-Miller, AA; Irwin, P; Brasunas, JC; Pearl, JC; Smith, MD; Orton, GS; Gierasch, PJ; Spilker, LJ; Carlson, RC; Mamoutkine, AA; Calcutt, SB; Read, PL; Taylor, FW; Fouchet, T; Parrish, P; Barucci, A; Courtin, R; Coustenis, A; Gautier, D; Lellouch, E; Marten, A; Prange, R; Biraud, Y; Ferrari, C; Owen, TC; Abbas, MM; Samuelson, RE; Raulin, F; Ade, P; Cesarsky, CJ; Grossman, KU; Coradini, A			Jupiter's atmospheric composition from the Cassini thermal infrared spectroscopy experiment	SCIENCE			English	Article							COMET SHOEMAKER-LEVY-9; JOVIAN SYSTEM; HCN; STRATOSPHERE; PRECIPITATION; EXCITATION; VOYAGER-1; EVOLUTION; IMPACTS; IO	The Composite Infrared Spectrometer observed Jupiter in the thermal infrared during the swing-by of the Cassini spacecraft. Results include the detection of two new stratospheric species, the methyl radical and diacetylene, gaseous species present in the north and south auroral infrared hot spots; determination of the variations with latitude of acetylene and ethane, the latter a tracer of atmospheric motion; observations of unexpected spatial distributions of carbon dioxide and hydrogen cyanide, both considered to be products of comet Shoemaker-Levy 9 impacts; characterization of the morphology of the auroral infrared hot spot acetylene emission; and a new evaluation of the energetics of the northern auroral infrared hot spot.	Univ Maryland, Dept Astron, College Pk, MD 20742 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Observ Paris, LESIA, CNRS, UMR8109, F-91925 Meudon, France; Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Space Sci & Applicat Inc, Lanham, MD 20706 USA; Univ Oxford, Clarendon Lab, Oxford OX1 3PU, England; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; CEA Saclay, Serv Astrophys, F-91191 Gif Sur Yvette, France; Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA; NASA, George C Marshall Space Flight Ctr, Huntsville, AL 35812 USA; Univ Paris 07, LISA, CNRS, UMR 7583, F-94010 Creteil, France; Univ Paris 12, LISA, CNRS, UMR 7583, F-94010 Creteil, France; Cardiff Univ, Sch Phys & Astron, Cardiff CF24 3YB, S Glam, Wales; European So Observ, D-85748 Garching, Germany; Gesamthsch Wuppertal, Dept Phys, D-5600 Wuppertal 1, Germany; CNR, Inst Astrophys Spatiale, Area Recerca Tor Vergata, I-00133 Rome, Italy	University System of Maryland; University of Maryland College Park; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite; Johns Hopkins University; Cornell University; University of Oxford; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Hawaii System; National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Cardiff University; European Southern Observatory; University of Wuppertal; Consiglio Nazionale delle Ricerche (CNR)	Kunde, VG (corresponding author), Univ Maryland, Dept Astron, College Pk, MD 20742 USA.	Virgil.G.Kunde.1@gsfc.nasa.gov	Ferrari, Cécile/P-9735-2016; Orton, Glenn/AAD-9862-2020; Flasar, F Michael/C-8509-2012; Jennings, Donald/D-7978-2012; Smith, Michael/C-8875-2012; brasunas, john/I-2798-2013; Strobel, Darrell5/AAO-6643-2021; Nixon, Conor A/A-8531-2009; Fouchet, Thierry/C-6374-2017; Elbaz, David/AAB-4141-2020; Simon, Amy/C-8020-2012; Bjoraker, Gordon L/D-5032-2012; Romani, Paul N/D-2729-2012	Ferrari, Cécile/0000-0001-5962-7439; Strobel, Darrell5/0000-0002-0944-8675; Nixon, Conor A/0000-0001-9540-9121; Fouchet, Thierry/0000-0001-9040-8285; Elbaz, David/0000-0002-7631-647X; Simon, Amy/0000-0003-4641-6186; Taylor, Fred/0000-0002-0675-9769; Irwin, Patrick Gerard Joseph/0000-0002-6772-384X; Achterberg, Richard/0000-0002-7643-7626; Ade, Peter/0000-0002-5127-0401; Bezard, Bruno/0000-0002-5433-5661; Calcutt, Simon/0000-0002-0102-3170				ANICICH VG, 1986, ASTROPHYS J SUPPL S, V62, P553, DOI 10.1086/191151; Banaszkiewicz M, 2000, ICARUS, V147, P386, DOI 10.1006/icar.2000.6448; Bezard B, 1997, ICARUS, V125, P94, DOI 10.1006/icar.1996.5610; BUNCE EW, 2004, IN PRESS J GEOPHYS R; CALDWELL J, 1980, ICARUS, V44, P667, DOI 10.1016/0019-1035(80)90135-9; Clarke JT, 2002, NATURE, V415, P997, DOI 10.1038/415997a; CONNERNEY JEP, 1993, SCIENCE, V262, P1035, DOI 10.1126/science.262.5136.1035; Coustenis A, 1999, PLANET SPACE SCI, V47, P1305, DOI 10.1016/S0032-0633(99)00053-7; DROSSART P, 1993, J GEOPHYS RES-PLANET, V98, P18803, DOI 10.1029/93JE01801; Flasar FM, 2004, NATURE, V427, P132, DOI 10.1038/nature02142; GEHRELS N, 1983, J GEOPHYS RES-SPACE, V88, P5537, DOI 10.1029/JA088iA07p05537; Gladstone GR, 1996, ICARUS, V119, P1, DOI 10.1006/icar.1996.0001; Gladstone GR, 2002, NATURE, V415, P1000, DOI 10.1038/4151000a; Griffith CA, 2004, ICARUS, V170, P58, DOI 10.1016/j.icarus.2004.02.006; HANEL R, 1979, SCIENCE, V204, P972, DOI 10.1126/science.204.4396.972-a; HANEL R, 1979, SCIENCE, V206, P952, DOI 10.1126/science.206.4421.952; Hill TW, 2001, J GEOPHYS RES-SPACE, V106, P8101, DOI 10.1029/2000JA000302; Ingersoll AP, 1998, ICARUS, V135, P251, DOI 10.1006/icar.1998.5971; KIM SJ, 1985, ICARUS, V64, P233, DOI 10.1016/0019-1035(85)90088-0; Kunde V, 1996, P SOC PHOTO-OPT INS, V2803, P162, DOI 10.1117/12.253416; LELLOUCH E, 1995, NATURE, V373, P592, DOI 10.1038/373592a0; Lellouch E, 2002, ICARUS, V159, P112, DOI 10.1006/icar.2002.6929; MARTEN A, 1995, GEOPHYS RES LETT, V22, P1589, DOI 10.1029/95GL00949; Moreno R, 2003, PLANET SPACE SCI, V51, P591, DOI 10.1016/S0032-0633(03)00072-2; Moses J. I., 1996, COLLISION COMET SHOE; MOSES JI, IN PRESS JUPITER PLA; NOLL KS, 1996, COLLISION COMET SHOE; ORTON G, 2003, B AM ASTRON SOC, V35; ORTON GS, 1991, SCIENCE, V252, P537, DOI 10.1126/science.252.5005.537; Pallier L, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018041; Pallier L, 2001, PLANET SPACE SCI, V49, P1159, DOI 10.1016/S0032-0633(01)00023-X; Porco CC, 2003, SCIENCE, V299, P1541, DOI 10.1126/science.1079462; Prange R, 1998, J GEOPHYS RES-PLANET, V103, P20195, DOI 10.1029/98JE01128; PRANGE R, 2003, AM GEOPH UN FALL M; REGO D, 1994, J GEOPHYS RES-PLANET, V99, P17075, DOI 10.1029/93JE03432; SCHOEBERL MR, 1992, J GEOPHYS RES-ATMOS, V97, P7859, DOI 10.1029/91JD02168; Strobel D.F., 1983, INT REV PHYS CHEM, V3, P145, DOI [10.1080/01442358309353342, DOI 10.1080/01442358309353342]; WAITE JH, 1983, J GEOPHYS RES-SPACE, V88, P6143, DOI 10.1029/JA088iA08p06143	38	53	53	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 10	2004	305	5690					1582	1586		10.1126/science.1100240	http://dx.doi.org/10.1126/science.1100240			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	854GV	15319491				2022-12-24	WOS:000223891200034
J	Sininger, YS; Cone-Wesson, B				Sininger, YS; Cone-Wesson, B			Asymmetric cochlear processing mimics hemispheric specialization	SCIENCE			English	Article							EVOKED OTOACOUSTIC EMISSIONS; NEONATAL HEARING IMPAIRMENT; OLIVOCOCHLEAR SYSTEM; PERINATAL-PERIOD; IDENTIFICATION; MECHANISMS		Univ Calif Los Angeles, David Geffen Sch Med, Div Head & Neck Surg, Ctr Hlth Sci 62 132, Los Angeles, CA 90095 USA; Univ Arizona, Dept Speech Language & Hearing Sci, Tucson, AZ 85721 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Arizona	Sininger, YS (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Head & Neck Surg, Ctr Hlth Sci 62 132, Los Angeles, CA 90095 USA.	ysininger@mednet.ucla.edu						Aidan D, 1997, ACTA OTO-LARYNGOL, V117, P25, DOI 10.3109/00016489709117986; Dehaene-Lambertz G, 2000, J COGNITIVE NEUROSCI, V12, P449, DOI 10.1162/089892900562264; Gorga MP, 2000, EAR HEARING, V21, P400, DOI 10.1097/00003446-200010000-00007; KEMP DT, 1978, J ACOUST SOC AM, V64, P1386, DOI 10.1121/1.382104; KIMURA D, 1964, Q J EXP PSYCHOL, V16, P355, DOI 10.1080/17470216408416391; Moore JK, 1999, AUDIOL NEURO-OTOL, V4, P311, DOI 10.1159/000013855; Moore JK, 2002, ANN OTO RHINOL LARYN, V111, P7, DOI 10.1177/00034894021110S502; MORLET T, 1993, ACTA OTO-LARYNGOL, V113, P271, DOI 10.3109/00016489309135808; Norton SJ, 2000, EAR HEARING, V21, P425, DOI 10.1097/00003446-200010000-00008; Shera CA, 2004, EAR HEARING, V25, P86, DOI 10.1097/01.AUD.0000121200.90211.83; VEUILLET E, 1991, J NEUROPHYSIOL, V65, P724, DOI 10.1152/jn.1991.65.3.724; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7	12	73	80	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2004	305	5690					1581	1581		10.1126/science.1100646	http://dx.doi.org/10.1126/science.1100646			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	854GV	15361617				2022-12-24	WOS:000223891200033
J	Chen, IA; Roberts, RW; Szostak, JW				Chen, IA; Roberts, RW; Szostak, JW			The emergence of competition between model protocells	SCIENCE			English	Article							VESICLES; GROWTH	The transition from independent molecular entities to cellular structures with integrated behaviors was a crucial aspect of the origin of life. We show that simple physical principles can mediate a coordinated interaction between genome and compartment boundary, independent of any genomic functions beyond self-replication. RNA, encapsulated in fatty acid vesicles, exerts an osmotic pressure on the vesicle membrane that drives the uptake of additional membrane components, leading to membrane growth at the expense of relaxed vesicles, which shrink. Thus, more efficient RNA replication could cause faster cell growth, leading to the emergence of Darwinian evolution at the cellular level.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Massachusetts Gen Hosp, Howard Hughes Med Inst, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Program Biophys, Cambridge, MA 02138 USA; CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; California Institute of Technology	Szostak, JW (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA.	szostak@molbio.mgh.harvard.edu		Chen, Irene/0000-0001-6040-7927	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008313, T32GM007753] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bartel David P., 1999, Trends in Cell Biology, V9, pM9, DOI 10.1016/S0962-8924(99)01669-4; Chen IA, 2004, BIOPHYS J, V87, P988, DOI 10.1529/biophysj.104.039875; Chen IA, 2004, P NATL ACAD SCI USA, V101, P7965, DOI 10.1073/pnas.0308045101; FERRELL JE, 1985, BIOCHEMISTRY-US, V24, P2857, DOI 10.1021/bi00333a007; GEBICKI JM, 1973, NATURE, V243, P232, DOI 10.1038/243232a0; Hanczyc MM, 2003, SCIENCE, V302, P618, DOI 10.1126/science.1089904; Jin AJ, 1999, EUR BIOPHYS J BIOPHY, V28, P187, DOI 10.1007/s002490050199; JONES JD, 1989, BIOCHEMISTRY-US, V28, P129, DOI 10.1021/bi00427a019; Landweber LF, 1998, BIOSCIENCE, V48, P94, DOI 10.2307/1313134; MCLEAN LR, 1981, BIOCHEMISTRY-US, V20, P2893, DOI 10.1021/bi00513a028; Monnard PA, 2002, ASTROBIOLOGY, V2, P139, DOI 10.1089/15311070260192237; Morowitz H.J., 1992, BEGINNINGS CELLULAR; MUI BLS, 1993, BIOPHYS J, V64, P443, DOI 10.1016/S0006-3495(93)81385-7; NEEDHAM D, 1990, BIOPHYS J, V58, P997, DOI 10.1016/S0006-3495(90)82444-9; Olbrich K, 2000, BIOPHYS J, V79, P321, DOI 10.1016/S0006-3495(00)76294-1; Shoemaker SD, 2002, IND ENG CHEM RES, V41, P324, DOI 10.1021/ie010049t; Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176; WALDE P, 1994, J AM CHEM SOC, V116, P11649, DOI 10.1021/ja00105a004; Watson J. D., 1965, MOL BIOL GENE; Zhang FL, 1996, BIOCHEMISTRY-US, V35, P16055, DOI 10.1021/bi961685b	20	297	311	1	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2004	305	5689					1474	1476		10.1126/science.1100757	http://dx.doi.org/10.1126/science.1100757			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852NK	15353806	Green Accepted			2022-12-24	WOS:000223761900052
J	Mazelin, L; Bernet, A; Bonod-Bidaud, C; Pays, L; Arnaud, S; Gespach, C; Bredesen, DE; Scoazec, JY; Mehlen, P				Mazelin, L; Bernet, A; Bonod-Bidaud, C; Pays, L; Arnaud, S; Gespach, C; Bredesen, DE; Scoazec, JY; Mehlen, P			Netrin-1 controls colorectal tumorigenesis by regulating apoptosis	NATURE			English	Article							CANCER DCC; RECEPTORS UNC5H; GENE; SUPPRESSOR; DEPENDENCE; MECHANISM; TUMORS; MICE	The expression of the protein DCC ( deleted in colorectal cancer) is lost or markedly reduced in numerous cancers and in the majority of colorectal cancers due to loss of heterozygosity in chromosome 18q, and has therefore been proposed to be a tumour suppressor(1). However, the rarity of mutations found in DCC, the lack of cancer predisposition of DCC mutant mice, and the presence of other tumour suppressor genes in 18q have raised doubts about the function of DCC as a tumour suppressor(2). Unlike classical tumour suppressors, DCC has been shown to induce apoptosis conditionally: by functioning as a dependence receptor, DCC induces apoptosis unless DCC is engaged by its ligand, netrin-1 (ref. 3). Here we show that inhibition of cell death by enforced expression of netrin-1 in mouse gastrointestinal tract leads to the spontaneous formation of hyperplastic and neoplastic lesions. Moreover, in the adenomatous polyposis coli mutant background associated with adenoma formation, enforced expression of netrin-1 engenders aggressive adenocarcinomatous malignancies. These data demonstrate that netrin-1 can promote intestinal tumour development, probably by regulating cell survival. Thus, a netrin-1 receptor or receptors function as conditional tumour suppressors.	Univ Lyon, CNRS,UMR 5534, Apoptosis Differentiat Lab, Eqiuipe Labellisee La Ligue Mol & Cellular Genet, F-69622 Villeurbanne, France; Hop St Antoine, INSERM, U482, F-75571 Paris, France; Buck Inst Age Res, Novato, CA 94945 USA; INSERM, U45, F-69437 Lyon, France; ANIPATH, F-69437 Lyon, France; Ctr Leon Berard, F-69373 Lyon, France	Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Buck Institute for Research on Aging; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard	Mehlen, P (corresponding author), Univ Lyon, CNRS,UMR 5534, Apoptosis Differentiat Lab, Eqiuipe Labellisee La Ligue Mol & Cellular Genet, F-69622 Villeurbanne, France.	mehlen@univ-lyon1.fr	Mazelin, Laetitia/AAD-9319-2020; Bernet, Agnes/GSN-2702-2022; bonod-bidaud, christelle/AAN-9236-2021	Mazelin, Laetitia/0000-0002-4001-2132; Pays, Laurent/0000-0003-0720-2273; BONOD, Christelle/0000-0002-7180-2727				Bordeaux MC, 2000, EMBO J, V19, P4056, DOI 10.1093/emboj/19.15.4056; Bredesen DE, 1998, CELL DEATH DIFFER, V5, P365, DOI 10.1038/sj.cdd.4400378; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FODDE R, 1994, P NATL ACAD SCI USA, V91, P8969, DOI 10.1073/pnas.91.19.8969; Forcet C, 2002, NATURE, V417, P443, DOI 10.1038/nature748; Hsu Y H, 2001, Kaohsiung J Med Sci, V17, P351; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; KLINGELHUTZ AJ, 1993, ONCOGENE, V8, P95; Llambi F, 2001, EMBO J, V20, P2715, DOI 10.1093/emboj/20.11.2715; Mehlen P, 2004, APOPTOSIS, V9, P37, DOI 10.1023/B:APPT.0000012120.66221.b2; Mehlen P, 1998, NATURE, V395, P801, DOI 10.1038/27441; Meyerhardt JA, 1999, CELL GROWTH DIFFER, V10, P35; RABIZADEH S, 1993, SCIENCE, V261, P345, DOI 10.1126/science.8332899; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Simon TC, 1997, J BIOL CHEM, V272, P10652; Stupack DG, 2001, J CELL BIOL, V155, P459, DOI 10.1083/jcb.200106070; Tanikawa C, 2003, NAT CELL BIOL, V5, P216, DOI 10.1038/ncb943; Thibert C, 2003, SCIENCE, V301, P843, DOI 10.1126/science.1085405; Thiebault K, 2003, P NATL ACAD SCI USA, V100, P4173, DOI 10.1073/pnas.0738063100	22	234	251	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 2	2004	431	7004					80	84		10.1038/nature02788	http://dx.doi.org/10.1038/nature02788			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850VC	15343335				2022-12-24	WOS:000223641500045
J	Kim, H; Rogers, MJ; Richmond, JE; McIntire, SL				Kim, H; Rogers, MJ; Richmond, JE; McIntire, SL			SNF-6 is an acetylcholine transporter interacting with the dystrophin complex in Caenorhabditis elegans	NATURE			English	Article							NEUROMUSCULAR-JUNCTION; GLYCOPROTEIN COMPLEX; GENETIC-EVIDENCE; MUSCLE-FIBERS; TIME-COURSE; MUTATIONS; DYSTROBREVIN; PHENOTYPES; MUTANTS; CALCIUM	Muscular dystrophies are among the most common human genetic diseases and are characterized by progressive muscle degeneration. Muscular dystrophies result from genetic defects in components of the dystrophin-glycoprotein complex (DGC), a multimeric complex found in the muscle cell plasma membrane(1). The DGC links the intracellular cytoskeleton to the extracellular matrix and is thought to be important for maintaining the mechanical integrity of muscles(2) and organizing signalling molecules(3). The exact role of the DGC in the pathogenesis of disease has, however, remained uncertain(4). Mutations in Caenorhabditis elegans DGC genes lead to specific defects in coordinated movement and can also cause muscle degeneration(5-7). Here we show that mutations in the gene snf-6 result in phenotypes indistinguishable from those of the DGC mutants, and that snf-6 encodes a novel acetylcholine/choline transporter. SNF-6 mediates the uptake of acetylcholine at neuromuscular junctions during periods of increased synaptic activity. SNF-6 also interacts with the DGC, and mutations in DGC genes cause a loss of SNF-6 at neuromuscular junctions. Improper clearing of acetylcholine and prolonged excitation of muscles might contribute to the pathogenesis of muscular dystrophies.	Univ Calif San Francisco, Dept Neurol, Program Neurosci, Ernest Gallo & Res Ctr, Emeryville, CA 94608 USA; Univ Calif San Francisco, Dept Neurol, Program Biomed Sci, Ernest Gallo & Res Ctr, Emeryville, CA 94608 USA; Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	McIntire, SL (corresponding author), Univ Calif San Francisco, Dept Neurol, Program Neurosci, Ernest Gallo & Res Ctr, 5858 Horton St,Suite 200, Emeryville, CA 94608 USA.	slm@itsa.ucsf.edu		Kim, Hongkyun/0000-0002-4879-7122; Rogers, Matthew/0000-0001-5908-7962	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041477] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS041477-03, R01 NS041477-02, R01 NS041477, R01 NS041477-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bessou C, 1998, NEUROGENETICS, V2, P61, DOI 10.1007/s100480050053; BRENNER S, 1974, GENETICS, V77, P71; Burton EA, 2001, CONT NEUROS, P239; Davies AG, 2003, CELL, V115, P655, DOI 10.1016/S0092-8674(03)00979-6; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; Froehner SC, 1997, SOC GEN PHY, V52, P197; Gieseler K, 1999, FEBS LETT, V461, P59, DOI 10.1016/S0014-5793(99)01421-0; Gieseler K, 1999, NEUROGENETICS, V2, P87, DOI 10.1007/s100480050057; Gieseler K, 2000, CURR BIOL, V10, P1092, DOI 10.1016/S0960-9822(00)00691-6; Gieseler K, 2001, J MOL BIOL, V307, P107, DOI 10.1006/jmbi.2000.4480; Giugia JB, 1999, FEBS LETT, V463, P270, DOI 10.1016/S0014-5793(99)01651-8; Grady RM, 2000, NEURON, V25, P279, DOI 10.1016/S0896-6273(00)80894-6; Grisoni K, 2002, GENE, V294, P77, DOI 10.1016/S0378-1119(02)00762-X; JACKSON MJ, 1985, CLIN CHIM ACTA, V147, P215, DOI 10.1016/0009-8981(85)90202-5; KARPATI G, 1988, MUSCLE NERVE, V11, P795, DOI 10.1002/mus.880110802; Kramarcy NR, 2000, MOL CELL NEUROSCI, V15, P262, DOI 10.1006/mcne.1999.0823; LEONARD JP, 1979, J CELL BIOL, V82, P811, DOI 10.1083/jcb.82.3.811; Mariol MC, 2001, CURR BIOL, V11, P1691, DOI 10.1016/S0960-9822(01)00528-0; MCARDLE A, 1994, MUSCLE NERVE, V17, P1378, DOI 10.1002/mus.880171206; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Miyabayashi T, 1999, DEV BIOL, V215, P314, DOI 10.1006/dbio.1999.9470; POTTER LT, 1970, J PHYSIOL-LONDON, V206, P145, DOI 10.1113/jphysiol.1970.sp009003; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; SAELENS JK, 1965, J PHARMACOL EXP THER, V147, P336; SALPETER MM, 1979, J NEUROCYTOL, V8, P95, DOI 10.1007/BF01206461; Shioi G, 2001, GENETICS, V157, P1611; WATERSTON RH, 1984, J MOL BIOL, V180, P473, DOI 10.1016/0022-2836(84)90023-8; WEBSTER C, 1988, CELL, V52, P503, DOI 10.1016/0092-8674(88)90463-1	28	39	52	0	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 19	2004	430	7002					891	896		10.1038/nature02798	http://dx.doi.org/10.1038/nature02798			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318222				2022-12-24	WOS:000223369800042
J	Paz-y-Mino, G; Bond, AB; Kamil, AC; Balda, RP				Paz-y-Mino, G; Bond, AB; Kamil, AC; Balda, RP			Pinyon jays use transitive inference to predict social dominance	NATURE			English	Article							VOCAL RECOGNITION; INFORMATION; EVOLUTION	Living in large, stable social groups is often considered to favour the evolution of enhanced cognitive abilities, such as recognizing group members, tracking their social status and inferring relationships among them(1-4). An individual's place in the social order can be learned through direct interactions with others, but conflicts can be time-consuming and even injurious. Because the number of possible pairwise interactions increases rapidly with group size, members of large social groups will benefit if they can make judgments about relationships on the basis of indirect evidence(5). Transitive reasoning should therefore be particularly important for social individuals, allowing assessment of relationships from observations of interactions among others. Although a variety of studies have suggested that transitive inference may be used in social settings(6-10), the phenomenon has not been demonstrated under controlled conditions in animals. Here we show that highly social pinyon jays (Gymnorhinus cyanocephalus) draw sophisticated inferences about their own dominance status relative to that of strangers that they have observed interacting with known individuals. These results directly demonstrate that animals use transitive inference in social settings and imply that such cognitive capabilities are widespread among social species.	Univ Nebraska, Sch Biol Sci, Ctr Avian Cognit, Lincoln, NE 68588 USA; Univ Nebraska, Dept Psychol, Lincoln, NE 68588 USA; No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Northern Arizona University	Bond, AB (corresponding author), Univ Nebraska, Sch Biol Sci, Ctr Avian Cognit, Lincoln, NE 68588 USA.	abond@unl.edu; akamil@unl.edu		Paz-y-Mino-C, Guillermo/0000-0003-4040-140X				Balda Russell P., 1996, Current Ornithology, V13, P33; Balda Russell P., 2002, Birds of North America, V605, P1; Bergman TJ, 2003, SCIENCE, V302, P1234, DOI 10.1126/science.1087513; Bond AB, 2003, ANIM BEHAV, V65, P479, DOI 10.1006/anbe.2003.2101; CHASE ID, 1994, ANIM BEHAV, V48, P393, DOI 10.1006/anbe.1994.1253; CHENEY DL, 1980, ANIM BEHAV, V28, P362, DOI 10.1016/S0003-3472(80)80044-3; De Waal FBM, 2003, ANIMAL SOCIAL COMPLEXITY, P230; Hogue ME, 1996, BEHAV PROCESS, V38, P241, DOI 10.1016/S0376-6357(96)00035-6; Holekamp KE, 1999, ANIM BEHAV, V58, P383, DOI 10.1006/anbe.1999.1157; Humphrey N. K., 1976, GROWING POINTS ETHOL, P303; Huntingford F.A., 1987, ANIMAL CONFLICT; JOLLY A, 1966, SCIENCE, V153, P501, DOI 10.1126/science.153.3735.501; Kummer H., 1997, HUMAN NATURE BIOL SO, P157; Marzluff J. M., 1992, PINYON JAY; Oliveira RF, 1998, P ROY SOC B-BIOL SCI, V265, P1045, DOI 10.1098/rspb.1998.0397; Peake TM, 2002, P ROY SOC B-BIOL SCI, V269, P1925, DOI 10.1098/rspb.2002.2112; ROHWER S, 1982, AM ZOOL, V22, P531; *SAS I INC, 2000, SAS V8; Seyfarth RM, 2003, ANIMAL SOCIAL COMPLEXITY, P207; Silk JB, 1999, BEHAVIOUR, V136, P679, DOI 10.1163/156853999501522	20	230	236	4	101	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2004	430	7001					778	781		10.1038/nature02723	http://dx.doi.org/10.1038/nature02723			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306809	Green Published			2022-12-24	WOS:000223233600041
J	Lopez-Vaamonde, C; Koning, JW; Brown, RM; Jordan, WC; Bourke, AFG				Lopez-Vaamonde, C; Koning, JW; Brown, RM; Jordan, WC; Bourke, AFG			Social parasitism by male-producing reproductive workers in a eusocial insect	NATURE			English	Article							BOMBUS-TERRESTRIS HYMENOPTERA; BUMBLE BEES; MALE PARENTAGE; QUEEN CONFLICT; SEX-RATIOS; APIDAE; MICROSATELLITES; HYPNORUM; COLONIES; HONEYBEE	The evolution of extreme cooperation, as found in eusocial insects ( those with a worker caste), is potentially undermined by selfish reproduction among group members(1-3). In some eusocial Hymenoptera ( ants, bees and wasps), workers can produce male offspring from unfertilized eggs(4). Kin selection theory predicts levels of worker reproduction as a function of the relatedness structure of the workers' natal colony and the colony-level costs of worker reproduction(5,6). However, the theory has been only partially successful in explaining levels of worker reproduction(7-9). Here we show that workers of a eusocial bumble bee (Bombus terrestris) enter unrelated, conspecific colonies in which they then produce adult male offspring, and that such socially parasitic workers reproduce earlier and are significantly more reproductive and aggressive than resident workers that reproduce within their own colonies. Explaining levels of worker reproduction, and hence the potential of worker selfishness to undermine the evolution of cooperation, will therefore require more than simply a consideration of the kin-selected interests of resident workers. It will also require knowledge of the full set of reproductive options available to workers, including intraspecific social parasitism.	Zool Soc London, Inst Zool, London NW1 4RY, England	Zoological Society of London	Lopez-Vaamonde, C (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.	carlos.lopez.vaamonde@ioz.ac.uk; andrew.bourke@ioz.ac.uk	Bourke, Andrew F. G./E-5271-2011; Vaamonde, Carlos Lopez/A-5548-2009	Vaamonde, Carlos Lopez/0000-0003-2278-2368; Koning, Will/0000-0002-9895-1140				AKRE R D, 1976, Journal of the Kansas Entomological Society, V49, P63; Bloch G, 1999, P ROY SOC B-BIOL SCI, V266, P2465, DOI 10.1098/rspb.1999.0947; BOURKE AFG, 1988, Q REV BIOL, V63, P291, DOI 10.1086/415930; Bourke AFG, 1997, PHILOS T ROY SOC B, V352, P1921, DOI 10.1098/rstb.1997.0179; Bourke AFG, 2001, P ROY SOC B-BIOL SCI, V268, P347, DOI 10.1098/rspb.2000.1381; Brown MJF, 2003, MOL ECOL, V12, P1599, DOI 10.1046/j.1365-294X.2003.01840.x; BULMER MG, 1981, J THEOR BIOL, V93, P239, DOI 10.1016/0022-5193(81)90068-0; Chapman RE, 2003, MOL ECOL, V12, P2801, DOI 10.1046/j.1365-294X.2003.01957.x; DUCHATEAU MJ, 1988, BEHAVIOUR, V107, P186, DOI 10.1163/156853988X00340; Duchateau MJ, 1996, P 20 INT C ENT FIR, P404; Estoup A, 1996, MOL ECOL, V5, P19, DOI 10.1111/j.1365-294X.1996.tb00288.x; ESTOUP A, 1995, MOL ECOL, V4, P89, DOI 10.1111/j.1365-294X.1995.tb00195.x; Foster KR, 2000, NATURE, V407, P692, DOI 10.1038/35037665; Goulson D., 2003, BUMBLEBEES THEIR BEH; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hammond RL, 2003, J EVOLUTION BIOL, V16, P446, DOI 10.1046/j.1420-9101.2003.00544.x; HARDER LD, 1986, HOLARCTIC ECOL, V9, P99; Holehouse KA, 2003, INSECT SOC, V50, P277, DOI 10.1007/s00040-003-0672-6; Keller L, 1999, LEVELS SELECTION EVO; Lopez-Vaamonde C, 2003, ANIM BEHAV, V66, P577, DOI 10.1006/anbe.2003.2205; Martin SJ, 2002, NATURE, V415, P163, DOI 10.1038/415163a; Moritz RFA, 2004, ANIM BEHAV, V67, P681, DOI 10.1016/j.anbehav.2003.08.004; OWEN RE, 1982, BEHAV ECOL SOCIOBIOL, V11, P91, DOI 10.1007/BF00300097; Paxton RJ, 2001, MOL ECOL, V10, P2489, DOI 10.1046/j.0962-1083 .2001.01377.x; Queller DC, 2000, PHILOS T R SOC B, V355, P1647, DOI 10.1098/rstb.2000.0727; RATNIEKS FLW, 1992, J THEOR BIOL, V158, P33, DOI 10.1016/S0022-5193(05)80647-2; Schmid-Hempel R, 2000, INSECT SOC, V47, P36, DOI 10.1007/s000400050006; Sundstrom L, 2001, HEREDITY, V86, P515, DOI 10.1046/j.1365-2540.2001.00884.x; Toth E, 2004, INSECT SOC, V51, P1, DOI 10.1007/s00040-003-0707-z; VANHONK CGJ, 1981, BEHAV ECOL SOCIOBIOL, V9, P9, DOI 10.1007/BF00299847	30	124	127	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2004	430	6999					557	560		10.1038/nature02769	http://dx.doi.org/10.1038/nature02769			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841QI	15282605				2022-12-24	WOS:000222946100047
J	Kuiken, T; Rimmelzwaan, G; van Riel, D; van Amerongen, G; Baars, M; Fouchier, R; Osterhaus, A				Kuiken, T; Rimmelzwaan, G; van Riel, D; van Amerongen, G; Baars, M; Fouchier, R; Osterhaus, A			Avian H5N1 influenza in cats	SCIENCE			English	Article							VIRUSES		Erasmus Med Ctr, Dept Virol, NL-3015 GE Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Kuiken, T (corresponding author), Erasmus Med Ctr, Dept Virol, NL-3015 GE Rotterdam, Netherlands.	t.kuiken@erasmusmc.nl	Fouchier, Ron A/A-1911-2014	Fouchier, Ron A/0000-0001-8095-2869; van Riel, Debby/0000-0001-9753-3564; Osterhaus, Albert/0000-0002-6074-1172				HINSHAW VS, 1981, INFECT IMMUN, V34, P354, DOI 10.1128/IAI.34.2.354-361.1981; Rimmelzwaan GF, 2001, J VIROL, V75, P6687, DOI 10.1128/JVI.75.14.6687-6691.2001; Sturm-Ramirez KM, 2004, J VIROL, V78, P4892, DOI 10.1128/JVI.78.9.4892-4901.2004; Webby RJ, 2003, SCIENCE, V302, P1519, DOI 10.1126/science.1090350; *WHO, 2004, CONF HUM CAS AV INFL; [No title captured]	6	302	348	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	2004	306	5694					241	241		10.1126/science.1102287	http://dx.doi.org/10.1126/science.1102287			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861MC	15345779				2022-12-24	WOS:000224419700029
J	Gai', DH; Zhao, R; Li, DW; Finkielstein, CV; Chen, XS				Gai', DH; Zhao, R; Li, DW; Finkielstein, CV; Chen, XS			Mechanisms of conformational change for a replicative hexameric helicase of SV40 large tumor antigen	CELL			English	Article							LARGE T-ANTIGEN; MINICHROMOSOME MAINTENANCE PROTEIN; BOVINE MITOCHONDRIAL F-1-ATPASE; SIMIAN VIRUS-40 DNA; IN-VITRO; CRYSTAL-STRUCTURE; SIMIAN-VIRUS-40 ORIGIN; SEQUENTIAL HYDROLYSIS; ESCHERICHIA-COLI; ATP SYNTHASE	The large tumor antigen (LTag) of simian virus 40, an AAA(+) protein, is a hexameric helicase essential for viral DNA replication in eukaryotic cells. LTag functions as an efficient molecular machine powered by ATP binding and hydrolysis for origin DNA melting and replication fork unwinding. To understand how ATP binding and hydrolysis are coupled to conformational changes, we have determined high-resolution structures (similar to1.9 Angstrom) of LTag hexamers in distinct nucleotide binding states. The structural differences of LTag in various nucleotide states detail the molecular mechanisms of conformational changes triggered by ATP binding/hydrolysis and reveal a potential mechanism of concerted nucleotide binding and hydrolysis. During these conformational changes, the angles and orientations between domains of a monomer alter, creating an "iris"-like motion in the hexamer. Additionally, six unique P hairpins on the channel surface move longitudinally along the central channel, possibly serving as a motor for pulling DNA into the LTag double hexamer for unwinding.	Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, Denver, CO 80262 USA; Univ So Calif, Dept Mol & Computat Biol, Los Angeles, CA 90089 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Southern California	Chen, XS (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Genet, 4200 E 9th Ave, Denver, CO 80262 USA.	xiaojiang.chen@usc.edu	Li, Dawei/I-8751-2016	Li, Dawei/0000-0003-4133-1263; finkielstein, carla/0000-0002-8417-4643	PHS HHS [NIH-R01] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; ARTHUR AK, 1988, J VIROL, V62, P1999, DOI 10.1128/JVI.62.6.1999-2006.1988; BOROWIEC JA, 1990, CELL, V60, P181, DOI 10.1016/0092-8674(90)90730-3; BOROWIEC JA, 1991, J VIROL, V65, P1228, DOI 10.1128/JVI.65.3.1228-1235.1991; BRUNGER AT, 1998, CRYSTALLOGRAPHY NMR; Brush GS, 1995, METHOD ENZYMOL, V262, P522; Bullock PA, 1997, CRIT REV BIOCHEM MOL, V32, P503, DOI 10.3109/10409239709082001; BULLOCK PA, 1991, MOL CELL BIOL, V11, P2350, DOI 10.1128/MCB.11.5.2350; Campbell KS, 1997, GENE DEV, V11, P1098, DOI 10.1101/gad.11.9.1098; Chong JPJ, 2000, P NATL ACAD SCI USA, V97, P1530, DOI 10.1073/pnas.030539597; Crampton DJ, 2004, P NATL ACAD SCI USA, V101, P4373, DOI 10.1073/pnas.0400968101; DEAN FB, 1987, P NATL ACAD SCI USA, V84, P16, DOI 10.1073/pnas.84.1.16; FANNING E, 1992, ANNU REV BIOCHEM, V61, P55; FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P8960, DOI 10.1021/bi00028a004; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Gomez-Lorenzo MG, 2003, EMBO J, V22, P6205, DOI 10.1093/emboj/cdg612; Hingorani MM, 1997, P NATL ACAD SCI USA, V94, P5012, DOI 10.1073/pnas.94.10.5012; Huang SG, 1998, BIOCHEMISTRY-US, V37, P15336, DOI 10.1021/bi981094g; Kelman Z, 1999, P NATL ACAD SCI USA, V96, P14783, DOI 10.1073/pnas.96.26.14783; Kim DE, 1999, J BIOL CHEM, V274, P11623, DOI 10.1074/jbc.274.17.11623; Leslie AGW, 1999, BIOCHEM SOC T, V27, P37, DOI 10.1042/bst0270037; Levin MK, 2003, J BIOL CHEM, V278, P23311, DOI 10.1074/jbc.M301283200; Li DW, 2003, NATURE, V423, P512, DOI 10.1038/nature01691; Maegley KA, 1996, P NATL ACAD SCI USA, V93, P8160, DOI 10.1073/pnas.93.16.8160; Menz RI, 2001, FEBS LETT, V494, P11, DOI 10.1016/S0014-5793(01)02302-X; Neuwald AF, 1999, GENOME RES, V9, P27; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petsko CA, 2000, P NATL ACAD SCI USA, V97, P538, DOI 10.1073/pnas.97.2.538; Rittinger K, 1998, NATURE, V392, P448, DOI 10.1038/33043; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Simmons DT, 2000, ADV VIRUS RES, V55, P75, DOI 10.1016/S0065-3527(00)55002-7; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Smelkova NV, 1998, J VIROL, V72, P8676, DOI 10.1128/JVI.72.11.8676-8681.1998; STILLMAN B, 1985, EMBO J, V4, P2933, DOI 10.1002/j.1460-2075.1985.tb04026.x; STILLMAN B, 1994, CELL, V78, P725, DOI 10.1016/S0092-8674(94)90362-X; STILLMAN BW, 1985, MOL CELL BIOL, V5, P2051, DOI 10.1128/MCB.5.8.2051; Stitt BL, 1998, J BIOL CHEM, V273, P26477, DOI 10.1074/jbc.273.41.26477; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Sullivan CS, 2002, MICROBIOL MOL BIOL R, V66, P179, DOI 10.1128/MMBR.66.2.179-202.2002; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; TSURIMOTO T, 1991, J BIOL CHEM, V266, P1950; WAGA S, 1994, NATURE, V369, P207, DOI 10.1038/369207a0; WALKER JE, 1994, CURR OPIN STRUC BIOL, V4, P912, DOI 10.1016/0959-440X(94)90274-7; WESSEL R, 1992, J VIROL, V66, P804, DOI 10.1128/JVI.66.2.804-815.1992; Wittinghofer A, 1998, BIOL CHEM, V379, P933; WOBBE CR, 1987, P NATL ACAD SCI USA, V84, P1834, DOI 10.1073/pnas.84.7.1834	48	253	260	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 1	2004	119	1					47	60		10.1016/j.cell.2004.09.017	http://dx.doi.org/10.1016/j.cell.2004.09.017			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	859UE	15454080	Bronze			2022-12-24	WOS:000224292600008
J	Fernandes, CC; Podos, J; Lundberg, JG				Fernandes, CC; Podos, J; Lundberg, JG			Amazonian ecology: Tributaries enhance the diversity of electric fishes	SCIENCE			English	Article							RIVER-BASIN; GYMNOTIFORMES; ORGANIZATION; CHANNEL	Neotropical rivers support a diverse array of endemic taxa, including electric fishes of the order Gymnotiformes. A comprehensive survey of the main channels of the Amazon River and its major tributaries (>2000-kilometer transect) yielded 43 electric fish species. Biogeographical analyses suggest that local mainstem electric fish diversity is enhanced by tributaries. Mainstem species richness tends to increase downstream of tributary confluences, and species composition is most similar between tributaries and adjacent downstream mainstem locations. These findings support a "nodal" or heterogeneous model of riverine community organization across a particularly extensive and diverse geographical region.	Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; Univ Massachusetts, Grad Program Organism & Evolutionary Biol, Amherst, MA 01003 USA; Inst Nacl de Pesquisas da Amazonia, BR-69083 Manaus, Amazonas, Brazil; Acad Nat Sci Philadelphia, Dept Ichthyol, Philadelphia, PA 19103 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; Institute Nacional de Pesquisas da Amazonia; Drexel University	Fernandes, CC (corresponding author), Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA.	cristina@bio.umass.edu	Podos, Jeff/I-3843-2019; Fernandes, Cristina/B-4343-2019	Podos, Jeffrey/0000-0002-2546-7999; Fernandes, Cristina/0000-0002-9670-8198				AYRES JM, 1992, AM NAT, V140, P531, DOI 10.1086/285427; Benda L, 2004, BIOSCIENCE, V54, P413, DOI 10.1641/0006-3568(2004)054[0413:TNDHHC]2.0.CO;2; CAPPARELLA AP, 1991, ACTA C INT ORNITHOL, V20, P307; Fernandes CC, 1997, ECOL FRESHW FISH, V6, P36, DOI 10.1111/j.1600-0633.1997.tb00140.x; Fernandes CC, 2002, COPEIA, P52, DOI 10.1643/0045-8511(2002)002[0052:LOAEFS]2.0.CO;2; Fernandes CC, 1998, COPEIA, P730; GORMAN OT, 1986, AM NAT, V128, P611, DOI 10.1086/284592; Goulding M., 1988, RIO NEGRO RICH LIFE; HOPKINS CD, 1988, ANNU REV NEUROSCI, V11, P497, DOI 10.1146/annurev.ne.11.030188.002433; IBARRA M, 1989, COPEIA, P364; KULLANDER S, 2003, CHECK LIST FRESH WAT; Lowe-McConnell R.H, 1987, ECOLOGICAL STUDIES T; LUNDBERG JG, 1987, SCIENCE, V237, P81, DOI 10.1126/science.237.4810.81; Lundberg JG, 1996, COPEIA, P657; Lundberg JG, 2000, ANN MO BOT GARD, V87, P26, DOI 10.2307/2666207; Lundberg John G., 1998, P13; Mago-Leccia F., 1994, ELECT FISHES CONTINE; Matthews W. J., 1998, PATTERNS FRESHWATER; MEADE RH, 1991, ENVIRON GEOL WATER S, V18, P105, DOI 10.1007/BF01704664; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; OSBORNE LL, 1992, CAN J FISH AQUAT SCI, V49, P671, DOI 10.1139/f92-076; Patton JL, 2000, B AM MUS NAT HIST, P1, DOI 10.1206/0003-0090(2000)244<0001:MOTRJA>2.0.CO;2; PYDANIEL LR, UNPUB; Rice SP, 2001, CAN J FISH AQUAT SCI, V58, P824, DOI 10.1139/cjfas-58-4-824; RICHEY JE, 1991, BIOGEOCHEMISTRY MAJO, P51; SIOLI H, 1975, COUPLING LAND WATER, P199; STEWART DJ, 1987, POLITECNICA B, V1, P9; WALLACE AR, 1876, P ZOOL SOC LOND, V20, P107	28	137	150	4	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2004	305	5692					1960	1962		10.1126/science.1101240	http://dx.doi.org/10.1126/science.1101240			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857RM	15448270				2022-12-24	WOS:000224136000048
J	Di Paolo, G; Moskowitz, HS; Gipson, K; Wenk, MR; Voronov, S; Obayashi, M; Flavell, R; Fitzsimonds, RM; Ryan, TA; De Camilli, P				Di Paolo, G; Moskowitz, HS; Gipson, K; Wenk, MR; Voronov, S; Obayashi, M; Flavell, R; Fitzsimonds, RM; Ryan, TA; De Camilli, P			Impaired PtdIns(4,5)P-2 synthesis in nerve terminals produces defects in synaptic vesicle trafficking	NATURE			English	Article							TRANSMITTER RELEASE; MEMBRANE; POOL; ENDOCYTOSIS; CLATHRIN; TRANSMISSION; DOMAIN; ARF6; PHOSPHOINOSITIDES; SYNAPTOJANIN	Phosphatidylinositol-4,5-bisphosphate (PtdIns(4,5) P-2) has an important function in cell regulation both as a precursor of second messenger molecules and by means of its direct interactions with cytosolic and membrane proteins. Biochemical studies have suggested a role for PtdIns(4,5) P-2 in clathrin coat dynamics, and defects in its dephosphorylation at the synapse produce an accumulation of coated endocytic intermediates. However, the involvement of PtdIns(4,5) P-2 in synaptic vesicle exocytosis remains unclear. Here, we show that decreased levels of PtdIns(4,5) P-2 in the brain and an impairment of its depolarization-dependent synthesis in nerve terminals lead to early postnatal lethality and synaptic defects in mice. These include decreased frequency of miniature currents, enhanced synaptic depression, a smaller readily releasable pool of vesicles, delayed endocytosis and slower recycling kinetics. Our results demonstrate a critical role for PtdIns(4,5) P-2 synthesis in the regulation of multiple steps of the synaptic vesicle cycle.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Physiol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06510 USA; Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Yale University; Cornell University	De Camilli, P (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA.	pietro.decamilli@yale.edu	Ryan, Timothy/AAO-8286-2020; Wenk, Markus Rene/D-1441-2014	Ryan, Timothy/0000-0003-2533-9548; Fitzsimonds, Reiko/0000-0002-0576-9885	NINDS NIH HHS [R01 NS036942] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036942] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aikawa Y, 2003, J CELL BIOL, V162, P647, DOI 10.1083/jcb.200212142; Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; AUDIGIER SMP, 1988, P NATL ACAD SCI USA, V85, P2859, DOI 10.1073/pnas.85.8.2859; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Czech MP, 2003, ANNU REV PHYSIOL, V65, P791, DOI 10.1146/annurev.physiol.65.092101.142522; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Doughman RL, 2003, J MEMBRANE BIOL, V194, P77, DOI 10.1007/s00232-003-2027-7; Evans PR, 2002, CURR OPIN STRUC BIOL, V12, P814, DOI 10.1016/S0959-440X(02)00395-0; Fesce R, 1999, NAT CELL BIOL, V1, pE3, DOI 10.1038/8950; Fitzsimonds RM, 1997, NATURE, V388, P439, DOI 10.1038/41267; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Harris TW, 2000, J CELL BIOL, V150, P589, DOI 10.1083/jcb.150.3.589; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Holz RW, 2000, J BIOL CHEM, V275, P17878, DOI 10.1074/jbc.M000925200; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Kashani AH, 2001, J PHYSIOL-LONDON, V530, P243, DOI 10.1111/j.1469-7793.2001.0243l.x; Khvotchev M, 1998, J BIOL CHEM, V273, P21451, DOI 10.1074/jbc.273.34.21451; Kim WT, 2002, P NATL ACAD SCI USA, V99, P17143, DOI 10.1073/pnas.222657399; Krauss M, 2003, J CELL BIOL, V162, P113, DOI 10.1083/jcb.200301006; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Luthi A, 2001, J NEUROSCI, V21, P9101, DOI 10.1523/JNEUROSCI.21-23-09101.2001; Martin TFJ, 2001, CURR OPIN CELL BIOL, V13, P493, DOI 10.1016/S0955-0674(00)00241-6; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; Micheva KD, 2003, NAT NEUROSCI, V6, P925, DOI 10.1038/nn1114; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; Neeb A, 1999, EUR J CELL BIOL, V78, P533, DOI 10.1016/S0171-9335(99)80018-1; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Ryan TA, 1999, J NEUROSCI, V19, P1317; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; Takei K, 1998, CELL, V94, P131, DOI 10.1016/S0092-8674(00)81228-3; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; Valtorta Flavia, 1994, Seminars in Cell Biology, V5, P211, DOI 10.1006/scel.1994.1027; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; WANG SSH, 1995, NEURON, V15, P755, DOI 10.1016/0896-6273(95)90167-1; Wenk MR, 2003, NAT BIOTECHNOL, V21, P813, DOI 10.1038/nbt837; Wenk MR, 2001, NEURON, V32, P79, DOI 10.1016/S0896-6273(01)00456-1; Wiedemann C, 1998, J NEUROSCI, V18, P5594	48	280	290	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 23	2004	431	7007					415	422		10.1038/nature02896	http://dx.doi.org/10.1038/nature02896			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15386003				2022-12-24	WOS:000224000500031
J	Doulatov, S; Hodes, A; Dai, LX; Mandhana, N; Liu, M; Deora, R; Simons, RW; Zimmerly, S; Miller, JF				Doulatov, S; Hodes, A; Dai, LX; Mandhana, N; Liu, M; Deora, R; Simons, RW; Zimmerly, S; Miller, JF			Tropism switching in Bordetella bacteriophage defines a family of diversity-generating retroelements	NATURE			English	Article							SITE-SPECIFIC RECOMBINATION; PERTUSSIS; DNA; RETROTRANSPOSITION; RETROVIRUSES; INTEGRATION; EXPRESSION; MECHANISMS; EVOLUTION; PEPTIDES	Bordetella bacteriophages generate diversity in a gene that specifies host tropism(1). This microevolutionary adaptation is produced by a genetic element that combines the basic retroelement life cycle of transcription, reverse transcription and integration with site-directed, adenine-specific mutagenesis. Central to this process is a reverse transcriptase-mediated exchange between two repeats; one serving as a donor template (TR) and the other as a recipient of variable sequence information (VR)(1). Here we describe the genetic basis for diversity generation. The directionality of information transfer is determined by a 21-base-pair sequence present at the 3' end of VR. On the basis of patterns of marker transfer in response to variant selective pressures, we propose that a TR reverse transcript is mutagenized, integrated into VR as a single non-coding strand, and then partially converted to the parental VR sequence. This allows the diversity-generating system to minimize variability to the subset of bases under selection. Using the Bordetella phage cassette as a signature, we have identified numerous related elements in diverse bacteria. These elements constitute a new family of retroelements with the potential to confer selective advantages to their host genomes.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of Calgary	Miller, JF (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	jfmiller@ucla.edu						Adams MH, 1959, BACTERIOPHAGES; AKERLEY BJ, 1995, CELL, V80, P611, DOI 10.1016/0092-8674(95)90515-4; Bonen L, 2001, TRENDS GENET, V17, P322, DOI 10.1016/S0168-9525(01)02324-1; Bushman FD, 2003, CELL, V115, P135, DOI 10.1016/S0092-8674(03)00760-8; COTTER PA, 2000, PRINCIPLES BACTERIAL, P619; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Emsley P, 1996, NATURE, V381, P90, DOI 10.1038/381090a0; Fairbrother WJ, 1998, BIOCHEMISTRY-US, V37, P17754, DOI 10.1021/bi981931e; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Gifford R, 2003, VIRUS GENES, V26, P291, DOI 10.1023/A:1024455415443; Hallet B, 1997, FEMS MICROBIOL REV, V21, P157, DOI 10.1016/S0168-6445(97)00055-7; Kazazian HH, 2002, CELL, V110, P277, DOI 10.1016/S0092-8674(02)00868-1; Kidwell MG, 2001, EVOLUTION, V55, P1, DOI 10.1111/j.0014-3820.2001.tb01268.x; KING JC, 1985, PRECISION FREQUENCY, V1, P147; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Liu MS, 2004, J BACTERIOL, V186, P1503, DOI 10.1128/JB.186.5.1503-1517.2004; Liu MS, 2002, SCIENCE, V295, P2091, DOI 10.1126/science.1067467; Mattoo S, 2001, FRONT BIOSCI-LANDMRK, V6, pE168, DOI 10.2741/Mattoo; Morrish TA, 2002, NAT GENET, V31, P159, DOI 10.1038/ng898; ORGEL LE, 1980, NATURE, V284, P604, DOI 10.1038/284604a0; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Pena CEA, 2000, P NATL ACAD SCI USA, V97, P7760, DOI 10.1073/pnas.140014297; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Uhl MA, 1996, EMBO J, V15, P1028, DOI 10.1002/j.1460-2075.1996.tb00440.x; van den Berg BM, 1999, INFECT IMMUN, V67, P1056, DOI 10.1128/IAI.67.3.1056-1062.1999; Wank H, 1999, MOL CELL, V4, P239, DOI 10.1016/S1097-2765(00)80371-8; Wrighton NC, 1996, SCIENCE, V273, P458, DOI 10.1126/science.273.5274.458	27	127	135	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 23	2004	431	7007					476	481		10.1038/nature02833	http://dx.doi.org/10.1038/nature02833			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15386016				2022-12-24	WOS:000224000500046
J	Mecklenbrauker, I; Kalled, SL; Leitges, M; Mackay, F; Tarakhovsky, A				Mecklenbrauker, I; Kalled, SL; Leitges, M; Mackay, F; Tarakhovsky, A			Regulation of B-cell survival by BAFF-dependent PKC delta-mediated nuclear signalling	NATURE			English	Article							KINASE-C-DELTA; REACTIVE LYMPHOCYTES-B; HISTONE H2B; PROTEOLYTIC ACTIVATION; AUTOIMMUNE-DISEASE; APOPTOTIC CELLS; TRANSGENIC MICE; PHOSPHORYLATION; IDENTIFICATION; NF-KAPPA-B2	Approximately 65% of B cells generated in human bone marrow are potentially harmful autoreactive B cells(1). Most of these cells are clonally deleted in the bone marrow, while those autoreactive B cells that escape to the periphery are anergized or perish before becoming mature B cells(2-5). Escape of self-reactive B cells from tolerance permits production of pathogenic auto-antibodies(6); recent studies suggest that extended B lymphocyte survival is a cause of autoimmune disease in mice and humans(7). Here we report a mechanism for the regulation of peripheral B-cell survival by serine/threonine protein kinase Cdelta (PKCdelta): spontaneous death of resting B cells is regulated by nuclear localization of PKCdelta that contributes to phosphorylation of histone H2B at serine 14 (S14-H2B). We show that treatment of B cells with the potent B-cell survival factor BAFF ('B-cell-activating factor belonging to the TNF family') prevents nuclear accumulation of PKCdelta. Our data suggest the existence of a previously unknown BAFF-induced and PKCdelta-mediated nuclear signalling pathway which regulates B-cell survival.	Rockefeller Univ, Lab Lymphocyte Signaling, New York, NY 10021 USA; Biogen Idec Inc, Cambridge, MA 02142 USA; Max Planck Inst Expt Endocrinol, D-30625 Hannover, Germany; St Vincent Hosp, Garvan Inst Med Res, Darlinghurst, NSW 2010, Australia	Rockefeller University; Biogen; Max Planck Society; Garvan Institute of Medical Research; St Vincents Hospital Sydney	Tarakhovsky, A (corresponding author), Rockefeller Univ, Lab Lymphocyte Signaling, 1230 York Ave, New York, NY 10021 USA.	tarakho@mail.rockefeller.edu	Leitges, Michael/AAN-1953-2021; Mackay, Fabienne/B-7440-2008	Mackay, Fabienne/0000-0002-6074-2693				Ajiro K, 2000, J BIOL CHEM, V275, P439, DOI 10.1074/jbc.275.1.439; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Claudio E, 2002, NAT IMMUNOL, V3, P958, DOI 10.1038/ni842; DeVries TA, 2002, EMBO J, V21, P6050, DOI 10.1093/emboj/cdf606; Emoto Y, 1995, EMBO J, V14, P6148, DOI 10.1002/j.1460-2075.1995.tb00305.x; ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0; Fernandez-Capetillo O, 2004, J EXP MED, V199, P1671, DOI 10.1084/jem.20032247; Ghayur T, 1996, J EXP MED, V184, P2399, DOI 10.1084/jem.184.6.2399; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Goodnow CC, 1996, P NATL ACAD SCI USA, V93, P2264, DOI 10.1073/pnas.93.6.2264; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; HARTLEY SB, 1991, NATURE, V353, P765, DOI 10.1038/353765a0; Karpusas M, 2002, J MOL BIOL, V315, P1145, DOI 10.1006/jmbi.2001.5296; Kayagaki N, 2002, IMMUNITY, V17, P515, DOI 10.1016/S1074-7613(02)00425-9; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; Khare SD, 2000, P NATL ACAD SCI USA, V97, P3370, DOI 10.1073/pnas.050580697; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Mackay F, 2002, CURR OPIN IMMUNOL, V14, P783, DOI 10.1016/S0952-7915(02)00407-7; Mecklenbrauker I, 2002, NATURE, V416, P860, DOI 10.1038/416860a; MISCHAK H, 1993, J BIOL CHEM, V268, P6090; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; Pelletier M, 2003, J BIOL CHEM, V278, P33127, DOI 10.1074/jbc.M305754200; Reyland ME, 1999, J BIOL CHEM, V274, P19115, DOI 10.1074/jbc.274.27.19115; Saijo K, 2002, J EXP MED, V195, P1647, DOI 10.1084/jem.20020408; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Woodland RT, 1996, J IMMUNOL, V156, P2143; Yan MH, 2001, CURR BIOL, V11, P1547, DOI 10.1016/S0960-9822(01)00481-X	30	121	128	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 23	2004	431	7007					456	461		10.1038/nature02955	http://dx.doi.org/10.1038/nature02955			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15361883				2022-12-24	WOS:000224000500042
J	Castro-Rodriguez, I; Nakai, H; Zakharov, LN; Rheingold, AL; Meyer, K				Castro-Rodriguez, I; Nakai, H; Zakharov, LN; Rheingold, AL; Meyer, K			A linear, O-coordinated eta(1)-CO2 bound to uranium	SCIENCE			English	Article							CARBON-DIOXIDE; TRIVALENT URANIUM; COMPLEXES; CO2; REACTIVITY; TRIAZACYCLONONANE; DINITROGEN; CHEMISTRY; MONOXIDE	The electron-rich, six-coordinate tris-aryloxide uranium(III) complex [(((ArO)-Ar-Ad)(3)tacn)U-III] [where ((ArOH)-Ar-Ad)(3)tacn = 1,4,7-tris(3-adamantyl-5-tert-butyl-2-hydroxybenzyl)-1,4,7-triazacyclononane] reacts rapidly with CO, to yield [(((ArO)-Ar-Ad)(3)tacn)U-IV(CO2)], a complex in which the CO2 ligand is linearly coordinated to the metal through its oxygen atom (eta(1)-OCO). The latter complex has been crystallographically and spectroscopically characterized. The inequivalent O-C-O bond lengths [1.122 angstroms (Angstrom) for the O-C bond adjacent to uranium and 1.277 Angstrom for the other], considered together with magnetization data and electronic and vibrational-spectra, support the following bonding model: U-IV=O=C-.-O- H <----> U-IV-O=C-O-. In these charge-separated resonance structures, the uranium center is oxidized to uranium(IV) and the CO2 ligand reduced by one electron.	Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Meyer, K (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr,MC 0358, La Jolla, CA 92093 USA.	kmeyer@ucsd.edu	Rheingold, Arnold/U-4735-2019; Meyer, Karsten/G-2570-2012	Rheingold, Arnold/0000-0003-4472-8127; Meyer, Karsten/0000-0002-7844-2998; Nakai, Hidetaka/0000-0002-8548-1987	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007233] Funding Source: NIH RePORTER; NIDDK NIH HHS [3 T32 DK07233-2651] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andrews L, 2000, J AM CHEM SOC, V122, P11440, DOI 10.1021/ja0016699; ARESTA M, 1975, J CHEM SOC CHEM COMM, P636, DOI 10.1039/c39750000636; ARESTA M, 1977, J CHEM SOC DALTON, P708, DOI 10.1039/dt9770000708; BRENNAN JG, 1986, J AM CHEM SOC, V108, P335, DOI 10.1021/ja00262a046; Castro-Rodriguez I, 2003, J AM CHEM SOC, V125, P15734, DOI 10.1021/ja0379316; Castro-Rodriguez I, 2003, J AM CHEM SOC, V125, P4565, DOI 10.1021/ja028342n; Castro-Rodriguez I, 2002, CHEM COMMUN, P2764, DOI 10.1039/b208473b; Clark D. L., 1997, INORG SYNTH, V31, P307; Conejo MD, 1999, CHEM-EUR J, V5, P3000; Diaconescu PL, 2000, J AM CHEM SOC, V122, P6108, DOI 10.1021/ja994484e; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; FREUND HJ, 1986, SURF SCI, V172, P1, DOI 10.1016/0039-6028(86)90580-7; Gibson DH, 1999, COORDIN CHEM REV, V185-6, P335, DOI 10.1016/S0010-8545(99)00021-1; Gibson DH, 1996, CHEM REV, V96, P2063, DOI 10.1021/cr940212c; HERSKOVITZ T, 1977, J AM CHEM SOC, V99, P2391, DOI 10.1021/ja00449a087; Katz J., 1980, CHEM ACTINIDE ELEMEN; Lee HJ, 2001, J MOL BIOL, V308, P937, DOI 10.1006/jmbi.2001.4649; Mauser H, 2001, J AM CHEM SOC, V123, P10821, DOI 10.1021/ja011362p; Nakai H, 2004, INORG CHEM, V43, P855, DOI 10.1021/ic035142j; Odom AL, 1998, J AM CHEM SOC, V120, P5836, DOI 10.1021/ja980095t; Roussel P, 1998, J AM CHEM SOC, V120, P1070, DOI 10.1021/ja972933+; Souter PF, 1997, J AM CHEM SOC, V119, P7350, DOI 10.1021/ja971038n	22	285	290	1	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1757	1759		10.1126/science.1102602	http://dx.doi.org/10.1126/science.1102602			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	856IS	15375263				2022-12-24	WOS:000224039500036
J	Jourdie, V; Moureau, B; Bennett, ATD; Heeb, P				Jourdie, V; Moureau, B; Bennett, ATD; Heeb, P			Ultraviolet reflectance by the skin of nestlings	NATURE			English	Editorial Material							COLOR; VISION		Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland; Univ Neuchatel, Dept Zool, CH-2007 Neuchatel, Switzerland; Univ Bristol, Sch Biol Sci, Bristol BS8 1UG, Avon, England	University of Lausanne; University of Neuchatel; University of Bristol	Jourdie, V (corresponding author), Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland.	philipp.heeb@ie-zea.unil.ch	Bennett, Andrew T.D. T.D./P-2670-2016; Vazquez-Dominguez, Guillermo GVD/L-7818-2014	Bennett, Andrew T.D. T.D./0000-0001-8512-2805; 				Andersson S, 1997, P ROY SOC B-BIOL SCI, V264, P1587, DOI 10.1098/rspb.1997.0221; Bennett ATD, 1996, NATURE, V380, P433, DOI 10.1038/380433a0; BENNETT ATD, 1994, AM NAT, V144, P848, DOI 10.1086/285711; Cuthill IC, 2000, ADV STUD BEHAV, V29, P159, DOI 10.1016/S0065-3454(08)60105-9; Heeb P, 2003, ANIM BEHAV, V66, P637, DOI 10.1006/anbe.2003.2238; Hunt S, 2003, P R SOC LOND S, V270, P25; Kilner R, 1997, P ROY SOC B-BIOL SCI, V264, P963, DOI 10.1098/rspb.1997.0133; Prum RO, 2003, J EXP BIOL, V206, P2409, DOI 10.1242/jeb.00431; Sheldon BC, 1999, NATURE, V402, P874, DOI 10.1038/47239; VIITALA J, 1995, NATURE, V373, P425, DOI 10.1038/373425a0	10	78	78	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 16	2004	431	7006					262	262		10.1038/431262a	http://dx.doi.org/10.1038/431262a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372020	Bronze			2022-12-24	WOS:000223864000028
J	Watson, JT; Pertel, PE; Jones, RC; Siston, AM; Paul, WS; Austin, CC; Gerber, SI				Watson, JT; Pertel, PE; Jones, RC; Siston, AM; Paul, WS; Austin, CC; Gerber, SI			Clinical characteristics and functional outcomes of West Nile fever	ANNALS OF INTERNAL MEDICINE			English	Article							VIRUS-INFECTION; NEW-YORK; OUTBREAK; ENCEPHALITIS; EPIDEMIC	Background: West Nile fever, considered a nonsevere manifestation of West Nile virus infection, has not been clinically well described in the United States. In 2002, Illinois had 884 documented cases of West Nile virus infection with 66 associated deaths. Objective: To describe the symptoms and functional outcomes of West Nile fever. Design: Case series. Setting: Illinois. Patients: 98 community-dwelling patients with laboratory evidence of West Nile virus infection but no history of clinical evidence of meningitis, encephalitis, or acute flaccid paralysis. Intervention: Outpatient interviews. Measurements: Presence and duration of patient-reported symptoms of infection, symptom-associated absenteeism, health care use, and impact on daily activities. Results: Of 98 patients, 96% had fatigue for a median of 36 days, 81% had fever for a median of 5 days, 71% had headache for a median of 10 days, 61% had muscle weakness for a median of 28 days, and 53% had difficulty concentrating for a median of 14 days. Thirty respondents reported hospitalization, with a median stay of 5 days. At 30 days after onset, 63% of respondents continued to have symptoms. Duration did not vary significantly with increased age. Among the 72 patients who normally attended work or school, 57 (79%) could not attend because of illness (median absence, 10 days). Limitations: Recall bias could have been introduced by the delay between illness onset and interview and by self-reporting of illness information. Conclusions: West Nile fever is a more severe illness than has previously been documented. Mandatory reporting of West Nile fever cases in addition to West Nile meningoencephalitis cases could allow more accurate and timely recognition of the geographic distribution of West Nile virus infections and could inform public health interventions.	Chicago Dept Publ Hlth, Chicago, IL 60612 USA; Illinois Dept Publ Hlth, Springfield, IL 62761 USA; Ctr Dis Control & Prevent, Atlanta, GA USA	Chicago Department of Public Health; Centers for Disease Control & Prevention - USA	Watson, JT (corresponding author), Chicago Dept Publ Hlth, 2160 W Ogden, Chicago, IL 60612 USA.	watson_john@cdph.org						*CDCP, ENC MEN ARB 2001 CAS; *CDCP, 2004, W NIL VIR 2002 CAS C; Chowers MY, 2001, EMERG INFECT DIS, V7, P675; Hubalek Z, 1999, EMERG INFECT DIS, V5, P643, DOI 10.3201/eid0505.990505; Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000; Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000; Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0; Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401; Petersen LR, 2001, EMERG INFECT DIS, V7, P611; Petersen LR, 2003, JAMA-J AM MED ASSOC, V290, P524, DOI 10.1001/jama.290.4.524; Petersen LR, 2002, ANN INTERN MED, V137, P173, DOI 10.7326/0003-4819-137-3-200208060-00009; Platonov AE, 2001, EMERG INFECT DIS, V7, P128, DOI 10.3201/eid0701.010118; Sejvar JJ, 2003, JAMA-J AM MED ASSOC, V290, P511, DOI 10.1001/jama.290.4.511; *SER W NIL VIR INF, 2001, MMWR-MORBID MORTAL W, V50, P37; SMITHBURN K. C, 1940, AMER JOUR TROP MED, V20, P471; Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7; 2000, MMWR MORB MORTAL WKL, V49, P1044; 2002, MMWR MORB MORTAL WKL, V51, P1072; 2002, MMWR MORB MORTAL WKL, V51, P497	19	135	148	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 7	2004	141	5					360	365		10.7326/0003-4819-141-5-200409070-00010	http://dx.doi.org/10.7326/0003-4819-141-5-200409070-00010			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	852CW	15353427				2022-12-24	WOS:000223733800004
J	Opdal, SH; Rognum, TO				Opdal, SH; Rognum, TO			New insight into sudden infant-death syndrome	LANCET			English	Editorial Material							SEROTONIN TRANSPORTER GENE; RISK		Rikshosp Univ Hosp, Inst Forens Med, N-0027 Oslo, Norway	University of Oslo; National Hospital Norway	Opdal, SH (corresponding author), Rikshosp Univ Hosp, Inst Forens Med, N-0027 Oslo, Norway.	siriop@ulrik.uio.no						Blackwell CC, 1999, FEMS IMMUNOL MED MIC, V25, P1, DOI 10.1111/j.1574-695X.1999.tb01320.x; Guntheroth WG, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.5.e64; Heininger U, 2004, PEDIATRICS, V114, pE9, DOI 10.1542/peds.114.1.e9; Hunt CE, 2001, AM J RESP CRIT CARE, V164, P346, DOI 10.1164/ajrccm.164.3.9910045; Kinney HC, 2001, J NEUROPATH EXP NEUR, V60, P228, DOI 10.1093/jnen/60.3.228; Krous HF, 2004, PEDIATRICS, V114, P234, DOI 10.1542/peds.114.1.234; Lindgren C, 1997, EUR J PEDIATR, V156, P405, DOI 10.1007/s004310050626; Narita N, 2001, PEDIATRICS, V107, P690, DOI 10.1542/peds.107.4.690; Opdal SH, 2003, HUM IMMUNOL, V64, P1183, DOI 10.1016/j.humimm.2003.08.359; Opdal SH, 1999, EUR J PEDIATR, V158, P210, DOI 10.1007/s004310051051; Puffenberger EG, 2004, P NATL ACAD SCI USA, V101, P11689, DOI 10.1073/pnas.0401194101; ROGNUM TO, 1993, ACTA PAEDIATR, V82, P82, DOI 10.1111/j.1651-2227.1993.tb12886.x; Vege A, 1999, FEMS IMMUNOL MED MIC, V25, P67, DOI 10.1111/j.1574-695X.1999.tb01328.x; VEGE A, 1995, ACTA PAEDIATR, V84, P193, DOI 10.1111/j.1651-2227.1995.tb13608.x; Weese-Mayer DE, 2004, PEDIATR RES, V56, P391, DOI 10.1203/01.PDR.0000136285.91048.4A; Weese-Mayer DE, 2003, AM J MED GENET A, V117A, P268, DOI 10.1002/ajmg.a.20005	16	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 4	2004	364	9437					825	826		10.1016/S0140-6736(04)16998-5	http://dx.doi.org/10.1016/S0140-6736(04)16998-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	851KY	15351175				2022-12-24	WOS:000223685200009
J	Fortney, JJ				Fortney, JJ			Looking into the giant planets	SCIENCE			English	Editorial Material							EQUATION-OF-STATE; PHASE-SEPARATION; HELIUM; JUPITER; SATURN; DEUTERIUM; EVOLUTION; HYDROGEN		NASA, Planetary Syst Branch, Ames Res Ctr, Moffett Field, CA 94035 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Fortney, JJ (corresponding author), NASA, Planetary Syst Branch, Ames Res Ctr, Moffett Field, CA 94035 USA.	jfortney@arc.nasa.gov	Fortney, Jonathan/F-8813-2014	Fortney, Jonathan/0000-0002-9843-4354				CASTILLO JF, COMMUNICATION; Collins GW, 1998, SCIENCE, V281, P1178, DOI 10.1126/science.281.5380.1178; Conrath BJ, 2000, ICARUS, V144, P124, DOI 10.1006/icar.1999.6265; FLASAR FM, COMMUNICATION; Fortney JJ, 2004, ASTROPHYS J, V608, P1039, DOI 10.1086/420765; Fortney JJ, 2003, ICARUS, V164, P228, DOI 10.1016/S0019-1035(03)00130-1; Hubbard WB, 1999, PLANET SPACE SCI, V47, P1175, DOI 10.1016/S0032-0633(99)00042-2; Knudson MD, 2003, J PHYS A-MATH GEN, V36, P6149, DOI 10.1088/0305-4470/36/22/342; PFAFFENZELLER O, 1995, PHYS REV LETT, V74, P2599, DOI 10.1103/PhysRevLett.74.2599; SALPETER EE, 1973, ASTROPHYS J, V181, pL83, DOI 10.1086/181190; Saumon D, 2004, ASTROPHYS J, V609, P1170, DOI 10.1086/421257; SMOLUCHO.R, 1967, NATURE, V215, P691, DOI 10.1038/215691a0; STEVENSON DJ, 1975, PHYS REV B, V12, P3999, DOI 10.1103/PhysRevB.12.3999; STEVENSON DJ, 1977, ASTROPHYS J SUPPL S, V35, P239, DOI 10.1086/190479; von Zahn U, 1998, J GEOPHYS RES-PLANET, V103, P22815, DOI 10.1029/98JE00695	15	15	15	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 3	2004	305	5689					1414	1415		10.1126/science.1101352	http://dx.doi.org/10.1126/science.1101352			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852NK	15353790	Green Published			2022-12-24	WOS:000223761900033
J	Liu, JD; Carmell, MA; Rivas, FV; Marsden, CG; Thomson, JM; Song, JJ; Hammond, SM; Joshua-Tor, L; Hannon, GJ				Liu, JD; Carmell, MA; Rivas, FV; Marsden, CG; Thomson, JM; Song, JJ; Hammond, SM; Joshua-Tor, L; Hannon, GJ			Argonaute2 is the catalytic engine of mammalian RNAi	SCIENCE			English	Article							DOUBLE-STRANDED-RNA; CAENORHABDITIS-ELEGANS; MESSENGER-RNA; INTERFERING RNA; C-ELEGANS; DROSOPHILA; GENE; CLEAVAGE; MICRORNA; PIWI	Gene silencing through RNA interference (RNAi) is carried out by RISC, the RNA-induced silencing complex. RISC contains two signature components, small interfering RNAs (siRNAs) and Argonaute family proteins. Here, we show that the multiple Argonaute proteins present in mammals are both biologically and biochemically distinct, with a single mammalian family member, Argonaute2, being responsible for messenger RNA cleavage activity. This protein is essential for mouse development, and cells tacking Argonaute2 are unable to mount an experimental response to siRNAs. Mutations within a cryptic ribonuclease H domain within Argonaute2, as identified by comparison with the structure of an archeal. Argonaute protein, inactivate RISC. Thus, our evidence supports a model in which Argonaute contributes "Slicer" activity to RISC, providing the catalytic engine for RNAi.	Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Genet Program, Stony Brook, NY 11794 USA; Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of North Carolina; University of North Carolina Chapel Hill	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.edu	Song, Ji-Joon/C-1721-2011; Hannon, Gregory/AAB-3568-2019	Joshua-Tor, Leemor/0000-0001-8185-8049				Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Carmell MA, 2004, NAT STRUCT MOL BIOL, V11, P214, DOI 10.1038/nsmb729; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Cerutti L, 2000, TRENDS BIOCHEM SCI, V25, P481, DOI 10.1016/S0968-0004(00)01641-8; Chapados BR, 2001, J MOL BIOL, V307, P541, DOI 10.1006/jmbi.2001.4494; Conway SJ, 2003, GENESIS, V35, P1, DOI 10.1002/gene.10152; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hutvagner G, 2002, CURR OPIN GENET DEV, V12, P225, DOI 10.1016/S0959-437X(02)00290-3; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; Sasaki T, 2003, GENOMICS, V82, P323, DOI 10.1016/S0888-7543(03)00129-0; Schwarz DS, 2004, CURR BIOL, V14, P787, DOI 10.1016/j.cub.2004.03.008; Sijen T, 2003, NATURE, V426, P310, DOI 10.1038/nature02107; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; YANG W, 1995, STRUCTURE, V3, P131, DOI 10.1016/S0969-2126(01)00142-3; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zheng BH, 1999, NUCLEIC ACIDS RES, V27, P2354, DOI 10.1093/nar/27.11.2354	43	1921	2073	6	255	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2004	305	5689					1437	1441		10.1126/science.1102513	http://dx.doi.org/10.1126/science.1102513			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852NK	15284456	Bronze			2022-12-24	WOS:000223761900040
J	Casali, A; Struhl, G				Casali, A; Struhl, G			Reading the Hedgehog morphogen gradient by measuring the ratio of bound to unbound Patched protein	NATURE			English	Article							CUBITUS INTERRUPTUS; DROSOPHILA EMBRYOS; MEMBRANE-PROTEIN; SONIC HEDGEHOG; GENE ENCODES; POLARITY; RECEPTOR; PATTERN; SIGNAL; FORMS	Morphogens are 'form-generating' substances that spread from localized sites of production and specify distinct cellular outcomes at different concentrations. A cell's perception of morphogen concentration is thought to be determined by the number of active receptors, with inactive receptors making little if any contribution(1). Patched (Ptc)(2-5), the receptor for the morphogen Hedgehog (Hh)(6-12), is active in the absence of ligand and blocks the expression of target genes by inhibiting Smoothened (Smo), an essential transducer of the Hh signal(3,13-16). Hh binding to Ptc abrogates the ability of Ptc to inhibit Smo, thereby unleashing Smo activity and inducing target gene expression(2,3,12-16). Here, we show that a cell's measure of ambient Hh concentration is not determined solely by the number of active (unliganded) Ptc molecules. Instead, we find that Hh-bound Ptc can titrate the inhibitory action of unbound Ptc. Furthermore, we demonstrate that this effect is sufficient to allow normal reading of the Hh gradient in the presence of a form of Ptc that cannot bind the ligand(12) but retains its ability to inhibit Smo. These results support a model in which the ratio of bound to unbound Ptc molecules determines the cellular response to Hh.	Columbia Univ, Howard Hughes Med Inst, Dept Genet & Dev, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Struhl, G (corresponding author), Columbia Univ, Howard Hughes Med Inst, Dept Genet & Dev, New York, NY 10032 USA.	gs20@columbia.edu	Casali, Andreu/Z-5620-2019; Casali, Andreu/ABD-5226-2021	Casali, Andreu/0000-0003-1738-869X				Alcedo J, 2000, MOL CELL, V6, P457, DOI 10.1016/S1097-2765(00)00044-7; Alcedo J, 1996, CELL, V86, P221, DOI 10.1016/S0092-8674(00)80094-X; Aza-Blanc P, 1999, TRENDS GENET, V15, P458, DOI 10.1016/S0168-9525(99)01869-7; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; CAPDEVILA J, 1994, EMBO J, V13, P71, DOI 10.1002/j.1460-2075.1994.tb06236.x; Chen Y, 1996, CELL, V87, P553, DOI 10.1016/S0092-8674(00)81374-4; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Greenwood S, 1997, DEVELOPMENT, V124, P4879; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; Hepker J, 1997, DEVELOPMENT, V124, P549; HOOPER JE, 1989, CELL, V59, P751, DOI 10.1016/0092-8674(89)90021-4; HOOPER JE, 1994, NATURE, V372, P461, DOI 10.1038/372461a0; Ingham PW, 2000, CURR BIOL, V10, P1315, DOI 10.1016/S0960-9822(00)00755-7; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; INGHAM PW, 1991, NATURE, V353, P184, DOI 10.1038/353184a0; Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; Methot N, 1999, CELL, V96, P819, DOI 10.1016/S0092-8674(00)80592-9; Mullor JL, 1997, DEVELOPMENT, V124, P1227; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; NAKANO Y, 1989, NATURE, V341, P508, DOI 10.1038/341508a0; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Strigini M, 1997, DEVELOPMENT, V124, P4697; Struhl G, 1997, DEVELOPMENT, V124, P2143; TABATA T, 1994, CELL, V76, P89, DOI 10.1016/0092-8674(94)90175-9; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; vandenHeuvel M, 1996, NATURE, V382, P547, DOI 10.1038/382547a0; Vervoort M, 1999, CURR BIOL, V9, P632, DOI 10.1016/S0960-9822(99)80285-1	30	94	95	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 2	2004	431	7004					76	80		10.1038/nature02835	http://dx.doi.org/10.1038/nature02835			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850VC	15300262				2022-12-24	WOS:000223641500044
J	Malumbres, M; Sotillo, R; Santamaria, D; Galan, J; Cerezo, A; Ortega, S; Dubus, P; Barbacid, M				Malumbres, M; Sotillo, R; Santamaria, D; Galan, J; Cerezo, A; Ortega, S; Dubus, P; Barbacid, M			Mammalian cells cycle without the D-type cyclin-elependent kinases Cdk4 and Cdk6	CELL			English	Article							PROTEIN-KINASES; MICE; PROGRESSION; CANCER; G(1); IDENTIFICATION; PROLIFERATION; ONCOGENESIS; REGULATORS; DISRUPTION	Cdk4 and Cdk6 are thought to be essential for initiation of the cell cycle in response to mitogenic stimuli. Previous studies have shown that Cdk4 is dispensable for proliferation in most cell types, an observation attributed to a putative a compensatory role by Cdk6. Cdk6-null mice are viable and develop normally although hematopoiesis is slightly impaired. Embryos defective for Cdk4 and CdK6 die during the late stages of embryonic development due to severe anemia. However, these embryos display normal organogenesis and most cell types proliferate normally. In vitro, embryonic fibroblasts lacking Cdk4 and Cdk6 proliferate and become immortal upon serial passage. Moreover, quiescent Cdk4/Cdk6-null cells respond to serum stimulation and enter S phase with normal kinetics although with lower efficiency. These results indicate that D-type cyclin-dependent kinases are not essential for cell cycle entry and suggest the existence of alternative mechanisms to initiate cell proliferation upon mitogenic stimulation.	CNIO, Mol Oncol Program, E-28029 Madrid, Spain; Univ Bordeaux 2, EA2406, F-33076 Bordeaux, France	Centro Nacional de Investigaciones Oncologicas (CNIO); UDICE-French Research Universities; Universite de Bordeaux	Malumbres, M (corresponding author), CNIO, Mol Oncol Program, E-28029 Madrid, Spain.	malumbres@cnio.es; barbacid@cnio.es	Santamaria, David/D-3930-2011; Holt, Janet E/B-2415-2013; Cerezo, Ana/F-4403-2011; Malumbres, Marcos/E-8834-2011	Santamaria, David/0000-0002-4711-3569; Malumbres, Marcos/0000-0002-0829-6315; Galan, Javier/0000-0002-1160-8279; Cerezo Montemayor, Ana/0000-0003-0275-0844; Sotillo, Rocio/0000-0002-0855-7917; Dubus, Pierre/0000-0003-1803-4711				Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Amanatullah DF, 2001, METHOD ENZYMOL, V333, P116; Berthet C, 2003, CURR BIOL, V13, P1775, DOI 10.1016/j.cub.2003.09.024; Ciemerych MA, 2002, GENE DEV, V16, P3277, DOI 10.1101/gad.1023602; Classon M, 2002, NAT REV CANCER, V2, P910, DOI 10.1038/nrc950; FANTL V, 1995, GENE DEV, V9, P2364, DOI 10.1101/gad.9.19.2364; Geng Y, 2003, CELL, V114, P431, DOI 10.1016/S0092-8674(03)00645-7; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; LUKAS J, 1995, ONCOGENE, V10, P2125; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Martin J, 2003, ONCOGENE, V22, P5261, DOI 10.1038/sj.onc.1206506; MATSUSHIME H, 1992, CELL, V71, P323, DOI 10.1016/0092-8674(92)90360-O; Matushansky I, 2000, P NATL ACAD SCI USA, V97, P14317, DOI 10.1073/pnas.250488697; Meyer CA, 2000, EMBO J, V19, P4533, DOI 10.1093/emboj/19.17.4533; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; MEYERSON M, 1994, MOL CELL BIOL, V14, P2077, DOI 10.1128/MCB.14.3.2077; Moons DS, 2002, ENDOCRINOLOGY, V143, P3001, DOI 10.1210/en.143.8.3001; Morris EJ, 2001, ADV CANCER RES, V82, P1, DOI 10.1016/S0065-230X(01)82001-7; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Parisi T, 2003, EMBO J, V22, P4794, DOI 10.1093/emboj/cdg482; Park M, 1999, DEVELOPMENT, V126, P4849; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Ren SJ, 2004, CELL, V117, P239, DOI 10.1016/S0092-8674(04)00300-9; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sicinska E, 2003, CANCER CELL, V4, P451, DOI 10.1016/S1535-6108(03)00301-5; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; Sicinski P, 1996, NATURE, V384, P470, DOI 10.1038/384470a0; Sotillo R, 2001, EMBO J, V20, P6637, DOI 10.1093/emboj/20.23.6637; Stacey D, 2002, CURR OPIN GENET DEV, V12, P44, DOI 10.1016/S0959-437X(01)00262-3; Steinman RA, 2002, ONCOGENE, V21, P3403, DOI 10.1038/sj.onc.1205325; Stevaux O, 2002, CURR OPIN CELL BIOL, V14, P684, DOI 10.1016/S0955-0674(02)00388-5; Sweeney KJ, 1997, ONCOGENE, V14, P1329, DOI 10.1038/sj.onc.1200951; Traver D, 2001, BLOOD, V98, P627, DOI 10.1182/blood.V98.3.627; Tsutsui T, 1999, MOL CELL BIOL, V19, P7011; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; XIONG Y, 1992, CELL, V71, P505, DOI 10.1016/0092-8674(92)90518-H; Ye X, 2001, P NATL ACAD SCI USA, V98, P1682, DOI 10.1073/pnas.041596198	42	595	613	2	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2004	118	4					493	504		10.1016/j.cell.2004.08.002	http://dx.doi.org/10.1016/j.cell.2004.08.002			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	850YS	15315761	Bronze			2022-12-24	WOS:000223650900011
J	Hemingway, J				Hemingway, J			Taking aim at mosquitoes	NATURE			English	Article							INSECTICIDE RESISTANCE; GENOME SEQUENCE; PLASMODIUM		Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	Liverpool School of Tropical Medicine; University of Liverpool	Hemingway, J (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.			Hemingway, Janet/0000-0002-3200-7173				Abraham EG, 2004, J BIOL CHEM, V279, P5573, DOI 10.1074/jbc.M307582200; Brooke BD, 2001, B ENTOMOL RES, V91, P265, DOI 10.1079/BER2001108; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Lindblade KA, 2004, JAMA-J AM MED ASSOC, V291, P2571, DOI 10.1001/jama.291.21.2571; McCarroll L, 2000, NATURE, V407, P961, DOI 10.1038/35039671; Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Srinivasan P, 2004, J BIOL CHEM, V279, P5581, DOI 10.1074/jbc.M307587200	9	16	20	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 19	2004	430	7002					936	936		10.1038/430936a	http://dx.doi.org/10.1038/430936a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318236	Green Accepted			2022-12-24	WOS:000223369800059
J	Mandavilli, A				Mandavilli, A			Struggling to make an impact	NATURE			English	Editorial Material																		2002, NATURE, V419, P422; 2004, NATURE, V429, P588	2	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 19	2004	430	7002					935	935		10.1038/430935a	http://dx.doi.org/10.1038/430935a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318235	Bronze			2022-12-24	WOS:000223369800058
J	Mocumbi, P				Mocumbi, P			Plague of my people	NATURE			English	Editorial Material																			0	5	5	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 19	2004	430	7002					925	925		10.1038/430925a	http://dx.doi.org/10.1038/430925a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318229	Bronze			2022-12-24	WOS:000223369800052
J	Zou, SM; Dodd, RY; Stramer, SL; Strong, DM				Zou, SM; Dodd, RY; Stramer, SL; Strong, DM		Tissue Safety Study Grp	Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; BLOOD-DONORS; VIRAL-INFECTIONS; PREVALENCE; RISK; NAT; MARKERS; TIME	BACKGROUND: Tissue-banking organizations in the United States have introduced various review and testing procedures to reduce the risk of the transmission of viral infections from tissue grafts. We estimated the current probability of undetected viremia with hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), and human T-lymphotropic virus (HTLV) among tissue donors. METHODS: Rates of prevalence of hepatitis B surface antigen (HBsAg) and antibodies against HIV (anti-HIV), HCV (anti-HCV), and HTLV (anti-HTLV) were determined among 11,391 donors to five tissue banks in the United States. The data were compared with those of first-time blood donors in order to generate estimated incidence rates among tissue donors. The probability of viremia undetected by screening at the time of tissue donation was estimated on the basis of the incidence estimates and the window periods for these infections. RESULTS: The prevalence of confirmed positive tests among tissue donors was 0.093 percent for anti-HIV, 0.229 percent for HBsAg, 1.091 percent for anti-HCV, and 0.068 percent for anti-HTLV. The incidence rates were estimated to be 30.118, 18.325, 12.380, and 5.586 per 100,000 person-years, respectively. The estimated probability of viremia at the time of donation was 1 in 55,000, 1 in 34,000, 1 in 42,000, and 1 in 128,000, respectively. CONCLUSIONS: The prevalence rates of HBV, HCV, HIV, and HTLV infections are lower among tissue donors than in the general population. However, the estimated probability of undetected viremia at the time of tissue donation is higher among tissue donors than among first-time blood donors. The addition of nucleic acid-amplification testing to the screening of tissue donors should reduce the risk of these infections among recipients of donated tissues.	Amer Red Cross, Transmissible Dis Dept, Rockville, MD 20855 USA; Puget Sound Blood Ctr, NW Tissue Ctr, Seattle, WA 98104 USA	American Red Cross; Puget Sound Blood Center	Zou, SM (corresponding author), Amer Red Cross, Transmissible Dis Dept, 15601 Crabbs Branch Way, Rockville, MD 20855 USA.	zous@usa.redcross.org	Abrams, William R/A-5782-2008					Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; *AM ASS TISS BANKS, 2002, 2002 ANN REG SURV AC; [Anonymous], 2002, STAND TISS BANK; Busch MP, 2004, TRANSFUS CLIN BIOL, V11, P26, DOI 10.1016/j.tracli.2003.12.003; BUSCH MP, 1995, TRANSFUSION, V35, P91, DOI 10.1046/j.1537-2995.1995.35295125745.x; Dodd R Y, 2000, Dev Biol (Basel), V102, P19; Dodd RY, 2000, ANN MED, V32, P469, DOI 10.3109/07853890009002022; Dodd RY, 2002, TRANSFUSION, V42, P975, DOI 10.1046/j.1537-2995.2002.00174.x; Eastlund T., 2004, ADV TISSUE BANKING, V7, P51, DOI DOI 10.1142/9789812796646_0003; Glynn SA, 2000, JAMA-J AM MED ASSOC, V284, P229, DOI 10.1001/jama.284.2.229; Jackson BR, 2003, TRANSFUSION, V43, P721, DOI 10.1046/j.1537-2995.2003.00392.x; Janssen RS, 1999, JAMA-J AM MED ASSOC, V281, P1893; JOYCE MJ, 2004, AM AC ORTH SURG 71 A; Karon JM, 2001, AM J PUBLIC HEALTH, V91, P1060, DOI 10.2105/AJPH.91.7.1060; Korelitz JJ, 1997, TRANSFUSION, V37, P634, DOI 10.1046/j.1537-2995.1997.37697335159.x; Lackritz EM, 1995, NEW ENGL J MED, V333, P1721, DOI 10.1056/NEJM199512283332601; McQuillan GM, 1999, AM J PUBLIC HEALTH, V89, P14, DOI 10.2105/AJPH.89.1.14; PETERSEN LR, 1994, TRANSFUSION, V34, P283, DOI 10.1046/j.1537-2995.1994.34494233574.x; Scardino MK, 2002, CORNEA, V21, P798, DOI 10.1097/00003226-200211000-00014; Schreiber GB, 1996, NEW ENGL J MED, V334, P1685, DOI 10.1056/NEJM199606273342601; Stramer SL, 2000, TRANSFUSION, V40, P1165, DOI 10.1046/j.1537-2995.2000.40101165.x; Stramer SL, 2001, TRANSFUSION, V41, P1079; 2003, MMWR MORB MORTAL WKL, V52, P273; 2000, CRYSTAL BALL SOFTWAR	24	143	151	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 19	2004	351	8					751	759		10.1056/NEJMoa032510	http://dx.doi.org/10.1056/NEJMoa032510			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	847CY	15317888				2022-12-24	WOS:000223367900007
J	Isbister, GK				Isbister, GK			Necrotic arachnidism: the mythology of a modern plague	LANCET			English	Editorial Material							WHITE-TAILED SPIDER; DISGUST SENSITIVITY; CLINICAL TOXINOLOGY; LAMPONA-CYLINDRATA; MISS-MUFFET; BITE; ETIOLOGY; LOXOSCELES; DIAGNOSIS; PHOBIAS		Univ Newcastle, Newcastle Mater Misericordiae Hosp, Clin Envenoming Res Grp, Waratah, NSW 2298, Australia	Calvary Mater Newcastle Hospital; University of Newcastle	Isbister, GK (corresponding author), Univ Newcastle, Newcastle Mater Misericordiae Hosp, Clin Envenoming Res Grp, Waratah, NSW 2298, Australia.	gsbite@femtree.com	Isbister, Geoffrey K/G-8052-2015	Isbister, Geoffrey K/0000-0003-1519-7419				ATKINSON RK, 1991, COMP BIOCHEM PHYS C, V98, P441, DOI 10.1016/0742-8413(91)90230-Q; *AUSTR TRANSP SAF, 2002, ROAD CRASH DAT RAT A; Bettini S, 1978, ARTHROPOD VENOMS, P103; Davey G.C., 1991, ANXIETY RES, V4, P299, DOI [https://doi.org/10.1080/08917779208248798, DOI 10.1080/08917779208248798, 10.1080/08917779208248798]; DAVEY GCL, 1994, BRIT J PSYCHOL, V85, P541, DOI 10.1111/j.2044-8295.1994.tb02540.x; DAVEY GCL, 1994, SOC ANIM, V2, P17, DOI 10.1163/156853094X00045; DAVEY GCL, 1993, BEHAV RES THER, V31, P41, DOI 10.1016/0005-7967(93)90041-R; FUTRELL JM, 1992, AM J MED SCI, V304, P261, DOI 10.1097/00000441-199210000-00008; GRAY M, 1989, MED J AUSTRALIA, V151, P114, DOI 10.5694/j.1326-5377.1989.tb101182.x; Isbister GK, 2004, INTERN MED J, V34, P38, DOI 10.1111/j.1444-0903.2004.00506.x; Isbister GK, 2003, MED J AUSTRALIA, V179, P199, DOI 10.5694/j.1326-5377.2003.tb05499.x; Isbister GK, 2002, QJM-INT J MED, V95, P723, DOI 10.1093/qjmed/95.11.723; Isbister GK, 2002, J TOXICOL-CLIN TOXIC, V40, P231, DOI 10.1081/CLT-120005493; KEMP DR, 1990, MED J AUSTRALIA, V152, P669, DOI 10.5694/j.1326-5377.1990.tb125430.x; MARETIC Z, 1979, OTHER EUROPEAN ARANE, P172; MCGAIN F, 2000, BEE WASP STING RELAT; MENZIES RG, 1995, CLIN PSYCHOL REV, V15, P23, DOI 10.1016/0272-7358(94)00039-5; Merckelbach H, 1997, BEHAV RES THER, V35, P1031, DOI 10.1016/S0005-7967(97)00054-5; MORFORD MPO, CLASSICAL MYTHOLOGY, pCH8; RAVEN RJ, 1991, MED J AUSTRALIA, V154, P208; RIBEIRO LA, 1990, TOXICON, V28, P715, DOI 10.1016/0041-0101(90)90260-E; Sams HH, 2001, J AM ACAD DERMATOL, V44, P561, DOI 10.1067/mjd.2001.112385; Sezerino UM, 1998, T ROY SOC TROP MED H, V92, P546, DOI 10.1016/S0035-9203(98)90909-9; SOUTHCOTT RV, 1976, MED J AUSTRALIA, V1, P406, DOI 10.5694/j.1326-5377.1976.tb140704.x; SPRING WJ, 1987, MED J AUSTRALIA, V147, P605, DOI 10.5694/j.1326-5377.1987.tb133700.x; STGEORGE I, 1991, NEW ZEAL MED J, V104, P207; Sutherland S, 2001, AUSTR ANIMAL TOXINS; SUTHERLAND SK, 1987, MED J AUSTRALIA, V147, P531, DOI 10.5694/j.1326-5377.1987.tb133672.x; SUTHERLAND SK, 1982, TOXICON S1, V20, P59; VEST DK, 1987, TOXICON, V25, P175, DOI 10.1016/0041-0101(87)90239-X; Vetter RS, 2002, ANN EMERG MED, V39, P544, DOI 10.1067/mem.2002.123594; White J, 2003, MED J AUSTRALIA, V179, P180, DOI 10.5694/j.1326-5377.2003.tb05493.x; White J, 2003, J TOXICOL-CLIN TOXIC, V41, P263, DOI 10.1081/CLT-120021112; WHITE J, 1989, MED J AUSTRALIA, V150, P401, DOI 10.5694/j.1326-5377.1989.tb136536.x; 1996, ADVERSE DRUG REACT T, V15, P199	35	26	28	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 7	2004	364	9433					549	553		10.1016/S0140-6736(04)16816-5	http://dx.doi.org/10.1016/S0140-6736(04)16816-5			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BS	15302201				2022-12-24	WOS:000223132700037
J	Manoli, DS; Baker, BS				Manoli, DS; Baker, BS			Median bundle neurons coordinate behaviours during Drosophila male courtship	NATURE			English	Article							DETERMINATION GENE FRUITLESS; MALE SEXUAL-BEHAVIOR; EXPRESSION PATTERNS; MELANOGASTER; PROTEIN; MUTANT; ORIENTATION; ENCODES; DOMAIN; ROLES	Throughout the animal kingdom the innate nature of basic behaviour routines suggests that the underlying neuronal substrates necessary for their execution are genetically determined and developmentally programmed(1-2). Complex innate behaviours require proper timing and ordering of individual component behaviours. In Drosophila melanogaster, analyses of combinations of mutations of the fruitless (fru) gene have shown that male-specific isoforms (Fru(M)) of the Fru transcription factor are necessary for proper execution of all steps of the innate courtship ritual(3-9). Here, we eliminate Fru(M) expression in one group of about 60 neurons in the Drosophila central nervous system and observe severely contracted courtship behaviour, including rapid courtship initiation, absence of orienting and tapping, and the simultaneous occurrence of wing vibration, licking and attempted copulation. Our results identify a small group of median bundle neurons, that in wild-type Drosophila appropriately trigger the sequential execution of the component behaviours that constitute the Drosophila courtship ritual.	Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Neurosci Program, Stanford, CA 94305 USA	Stanford University; Stanford University	Baker, BS (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	bbaker@cmgm.stanford.edu		Manoli, Devanand/0000-0002-7238-2330				ALONSOPIMENTEL H, 1994, CELL TISSUE RES, V275, P467, DOI 10.1007/BF00318816; Anand A, 2001, GENETICS, V158, P1569; Baker BS, 2001, CELL, V105, P13, DOI 10.1016/S0092-8674(01)00293-8; Billuart P, 2001, CELL, V107, P195, DOI 10.1016/S0092-8674(01)00522-0; Emmons SW, 2003, J NEUROBIOL, V54, P93, DOI 10.1002/neu.10163; Gaines P, 2000, GENETICS, V154, P1627; Goodwin SF, 2000, GENETICS, V154, P725; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Ito H, 1996, P NATL ACAD SCI USA, V93, P9687, DOI 10.1073/pnas.93.18.9687; LAND MF, 1974, J COMP PHYSIOL, V89, P331, DOI 10.1007/BF00695351; Lee G, 2001, J NEUROBIOL, V47, P121, DOI 10.1002/neu.1021; Lee G, 2000, J NEUROBIOL, V43, P404, DOI 10.1002/1097-4695(20000615)43:4<404::AID-NEU8>3.0.CO;2-D; MANNING AUBREY, 1959, BEHAVIOUR, V15, P123; Melnattur K, 2002, GENESIS, V34, P29, DOI 10.1002/gene.10151; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Santel A, 1997, MECH DEVELOP, V64, P19, DOI 10.1016/S0925-4773(97)00031-2; SHANBHAG SR, 1992, CELL TISSUE RES, V267, P273, DOI 10.1007/BF00302965; SPIETH HERMAN T., 1940, JOUR NEW YORK ENT SOC, V48, P379; SPIETH HT, 1974, ANNU REV ENTOMOL, V19, P385, DOI 10.1146/annurev.en.19.010174.002125; STONE GN, 1995, ECOL ENTOMOL, V20, P169, DOI 10.1111/j.1365-2311.1995.tb00443.x; Villella A, 1997, GENETICS, V147, P1107; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Zars T, 2000, LEARN MEMORY, V7, P18, DOI 10.1101/lm.7.1.18	25	62	64	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2004	430	6999					564	569		10.1038/nature02713	http://dx.doi.org/10.1038/nature02713			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841QI	15282607				2022-12-24	WOS:000222946100049
J	Ferbitz, L; Maier, T; Patzelt, H; Bukau, B; Deuerling, E; Ban, N				Ferbitz, L; Maier, T; Patzelt, H; Bukau, B; Deuerling, E; Ban, N			Trigger factor in complex with the ribosome forms a molecular cradle for nascent proteins	NATURE			English	Article							NEWLY SYNTHESIZED PROTEINS; ESCHERICHIA-COLI; PEPTIDE; DOMAINS; DNAK; ISOMERASE; CYTOSOL; BINDING; CHAINS	During protein biosynthesis, nascent polypeptide chains that emerge from the ribosomal exit tunnel encounter ribosome-associated chaperones, which assist their folding to the native state(1,2). Here we present a 2.7 Angstrom crystal structure of Escherichia coli trigger factor, the best-characterized chaperone of this type, together with the structure of its ribosome-binding domain in complex with the Haloarcula marismortui large ribosomal subunit. Trigger factor adopts a unique conformation resembling a crouching dragon with separated domains forming the amino-terminal ribosome-binding 'tail', the peptidylprolyl isomerase 'head', the carboxy-terminal 'arms' and connecting regions building up the 'back'. From its attachment point on the ribosome, trigger factor projects the extended domains over the exit of the ribosomal tunnel, creating a protected folding space where nascent polypeptides may be shielded from proteases and aggregation. This study sheds new light on our understanding of co-translational protein folding, and suggests an unexpected mechanism of action for ribosome-associated chaperones.	ETH Honggerberg, ETH Zurich, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; Univ Heidelberg, Zentrum Mol Biol, D-69120 Heidelberg, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Ruprecht Karls University Heidelberg	Ban, N (corresponding author), ETH Honggerberg, ETH Zurich, Inst Mol Biol & Biophys, HPK Gebaude, CH-8093 Zurich, Switzerland.	e.deuerling@zmbh.uni-heidelberg.de; ban@mol.biol.ethz.ch	Maier, Timm/A-8835-2016	Maier, Timm/0000-0002-7459-1363; Bukau, Bernd/0000-0003-0521-7199; Patzelt, Holger/0000-0001-9886-8374				Agashe VR, 2004, CELL, V117, P199, DOI 10.1016/S0092-8674(04)00299-5; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; Behrens S, 2001, EMBO J, V20, P285, DOI 10.1093/emboj/20.1.285; Bitto E, 2003, J BIOL CHEM, V278, P49316, DOI 10.1074/jbc.M308853200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Halic M, 2004, NATURE, V427, P808, DOI 10.1038/nature02342; Hardesty B, 2001, PROG NUCLEIC ACID RE, V66, P41; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hesterkamp T, 1997, J BIOL CHEM, V272, P21865, DOI 10.1074/jbc.272.35.21865; Hesterkamp T, 1996, P NATL ACAD SCI USA, V93, P4437, DOI 10.1073/pnas.93.9.4437; JONES TA, 1990, CRYSTALLOGRAPHIC MOD, P189; Kramer G, 2004, J BACTERIOL, V186, P3777, DOI 10.1128/JB.186.12.3777-3784.2004; Kramer G, 2004, J BIOL CHEM, V279, P14165, DOI 10.1074/jbc.M313635200; Kramer G, 2002, NATURE, V419, P171, DOI 10.1038/nature01047; Kristensen O, 2003, STRUCTURE, V11, P1547, DOI 10.1016/j.str.2003.11.003; Maier R, 2003, J MOL BIOL, V326, P585, DOI 10.1016/S0022-2836(02)01427-4; Netzer WJ, 1997, NATURE, V388, P343, DOI 10.1038/41024; Nicola AV, 1999, NAT CELL BIOL, V1, P341, DOI 10.1038/14032; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patzelt H, 2002, BIOL CHEM, V383, P1611, DOI 10.1515/BC.2002.182; Pool MR, 2002, SCIENCE, V297, P1345, DOI 10.1126/science.1072366; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4; Vogtherr M, 2002, J MOL BIOL, V318, P1097, DOI 10.1016/S0022-2836(02)00112-2	30	292	294	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 30	2004	431	7008					590	596		10.1038/nature02899	http://dx.doi.org/10.1038/nature02899			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15334087	Green Published			2022-12-24	WOS:000224156700052
J	Testa, G; Harris, J				Testa, G; Harris, J			Ethical aspects of ES cell-derived gametes	SCIENCE			English	Editorial Material							GERM-CELLS; DERIVATION		Tech Univ Dresden, BIOTEC, Dept Genom, D-8027 Dresden, Germany; Univ Manchester, Manchester Sch Law, Manchester M13 9PL, Lancs, England	Technische Universitat Dresden; University of Manchester	Testa, G (corresponding author), Tech Univ Dresden, BIOTEC, Dept Genom, D-8027 Dresden, Germany.	testa@mpi-cbg.de		Testa, Giuseppe/0000-0002-9104-0918				Dennis C, 2003, NATURE, V424, P364, DOI 10.1038/424364a; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Golombok S., 1999, WHAT IS PARENT SOCIO, P161; HARRIS J, 2004, CLONING, P52; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Kass L R, 1998, Valparaiso Univ Law Rev, V32, P679; Kono T, 2004, NATURE, V428, P860, DOI 10.1038/nature02402; *NCHS, 1996, FERT FAM PLANN WOM H; Surani MA, 2004, NATURE, V427, P106, DOI 10.1038/427106a; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100	10	25	26	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1719	1719		10.1126/science.1103083	http://dx.doi.org/10.1126/science.1103083			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	856IS	15375251	Green Submitted			2022-12-24	WOS:000224039500022
J	Schmid, MF; Sherman, MB; Matsudaira, P; Chiu, W				Schmid, MF; Sherman, MB; Matsudaira, P; Chiu, W			Structure of the acrosomal bundle	NATURE			English	Article							LIMULUS SPERM; F-ACTIN; 3-DIMENSIONAL STRUCTURE; CRYSTAL-STRUCTURE; FILAMENTS; SCRUIN; STATE; TWIST; NUCLEOTIDE; RESOLUTION	In the unactivated Limulus sperm, a 60-mum-long bundle of actin filaments crosslinked by the protein scruin is bent and twisted into a coil around the base of the nucleus. At fertilization, the bundle uncoils and fully extends in five seconds to support a finger of membrane known as the acrosomal process. This biological spring is powered by stored elastic energy and does not require the action of motor proteins or actin polymerization(1). In a 9.5-Angstrom electron cryomicroscopic structure of the extended bundle, we show that twist, tilt and rotation of actin scruin subunits deviate widely from a 'standard' F-actin filament. This variability in structural organization allows filaments to pack into a highly ordered and rigid bundle in the extended state and suggests a mechanism for storing and releasing energy between coiled and extended states without disassembly.	Baylor Coll Med, Natl Ctr Macromol Imaging, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; Whitehead Inst, Dept Biol, Cambridge, MA 02142 USA; MIT, Div Biol Engn, Cambridge, MA 02142 USA	Baylor College of Medicine; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Chiu, W (corresponding author), Baylor Coll Med, Natl Ctr Macromol Imaging, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	wah@bcm.tmc.edu	Matsudaira, Paul/H-1475-2012	Matsudaira, Paul/0000-0002-8399-3276; Schmid, Michael/0000-0003-1077-5750				Borovikov YS, 2004, BIOPHYS J, V86, P3020, DOI 10.1016/S0006-3495(04)74351-9; BULLITT ESA, 1988, J CELL BIOL, V107, P597, DOI 10.1083/jcb.107.2.597; DEROSIER D, 1980, J MOL BIOL, V137, P375, DOI 10.1016/0022-2836(80)90163-1; Dominguez R, 2003, BIOPHYS J, V85, P2073, DOI 10.1016/S0006-3495(03)74635-9; Egelman EH, 2001, NAT STRUCT BIOL, V8, P735, DOI 10.1038/nsb0901-735; EGELMAN EH, 1982, NATURE, V298, P131, DOI 10.1038/298131a0; Galkin VE, 2003, J MOL BIOL, V325, P623, DOI 10.1016/S0022-2836(02)01309-8; Galkin VE, 2002, NAT STRUCT BIOL, V9, P518, DOI 10.1038/nsb811; Galkin VE, 2002, J CELL BIOL, V157, P243, DOI 10.1083/jcb.200111097; Galkin VE, 2001, J CELL BIOL, V153, P75, DOI 10.1083/jcb.153.1.75; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Graceffa P, 2003, J BIOL CHEM, V278, P34172, DOI 10.1074/jbc.M303689200; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; Jiang W, 2001, J MOL BIOL, V308, P1033, DOI 10.1006/jmbi.2001.4633; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Mahadevan L, 2000, SCIENCE, V288, P95, DOI 10.1126/science.288.5463.95; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Orlova A, 2001, J MOL BIOL, V312, P95, DOI 10.1006/jmbi.2001.4945; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; Sablin EP, 2002, P NATL ACAD SCI USA, V99, P10945, DOI 10.1073/pnas.152329899; Sanders MC, 1996, J BIOL CHEM, V271, P2651, DOI 10.1074/jbc.271.5.2651; SCHMID MF, 1994, J CELL BIOL, V124, P341, DOI 10.1083/jcb.124.3.341; SCHMID MF, 1993, J MOL BIOL, V230, P384, DOI 10.1006/jmbi.1993.1155; Schmid MF, 2003, J STRUCT BIOL, V144, P195, DOI 10.1016/j.jsb.2003.09.024; Sherman MB, 1999, J MOL BIOL, V294, P139, DOI 10.1006/jmbi.1999.3222; Shin JH, 2004, J MOL BIOL, V337, P255, DOI 10.1016/j.jmb.2004.01.028; Shin JH, 2003, J CELL BIOL, V162, P1183, DOI 10.1083/jcb.200304006; TILNEY LG, 1975, J CELL BIOL, V64, P289, DOI 10.1083/jcb.64.2.289; WAY M, 1995, J CELL BIOL, V128, P51, DOI 10.1083/jcb.128.1.51	30	71	71	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 2	2004	431	7004					104	107		10.1038/nature02881	http://dx.doi.org/10.1038/nature02881			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850VC	15343340				2022-12-24	WOS:000223641500051
J	Monteleoni, C; Clark, E				Monteleoni, C; Clark, E			Using rapid-cycle quality improvement methodology to reduce feeding tubes in patients with advanced dementia: before and after study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NUTRITION; SURVIVAL; PROLONG	Problem Despite lack of evidence that enteral feeding tubes benefit patients with dementia, and often contrary to the wishes of patient and family, patients with dementia who have difficulty swallowing or reduced food intake often receive feeding tubes when hospitalised for an acute illness. Design We conducted a retrospective chart review of all patients receiving percutaneous endoscopic gastrostomy or jejunostomy tubes between March and September 2002. QI interventions including a palliative care consulting service and educational programmes were instituted. We conducted a second chart review for all patients receiving feeding tubes between March and September 2003. Setting 652 bed urban acute care hospital. Key measures for improvement We measured the number of feeding tubes placed in patients with dementia, the number of feeding tubes placed in patients with dementia capable of taking food by mouth, and the number of feeding tubes placed in patients with dementia with an advance directive stating the wish to forgo artificial nutrition and hydration. Strategies for change Medical and allied health staff received educational programmes on end of life care and on feeding management of patients with dementia. A palliative care consulting team was established. Effects of change After the interventions, the number of feeding tubes Placed in all patients and in patients with dementia was greatly reduced. Lessons learnt Multidisciplinary involvement, including participation by die administration, was essential to effect change in practice. The intensive focus on a particular issue and rapid change led to "culture shift" within the hospital community. The need to establish unified goals of care for each patient was highlighted. Background A growing body of research over the past decade has questioned the utility of placing feeding tubes (percutaneous endoscopic gastrostomy (PEG) or jejunostomy) in patients with advanced dementia.(1) Studies have found no evidence that feeding tubes in this population prevent aspiration,(2,3) prolong life,(4-6) improve overall function,(7) or reduce pressure sores.(8) Additionally, the quality of life of a patient with advanced dementia can be adversely affected when a feeding tube is inserted. The patient may require wrist restraints to prevent pulling on the tube(1-3) or may develop cellulitis at the gastrostomy site, develop decubitus ulcers,(1) be deprived of the social interaction and pleasure surrounding meals,(9,10) and require placement in a nursing home. Unfortunately, many doctors are unfamiliar with this literature or face barriers-attitudinal, institutional, or imposed by the healthcare industry-to applying its findings to their practice.(11) Thus feeding tubes are placed in patients who will not benefit from this intervention and whose quality of life in the terminal stage of their illness will be adversely affected. With the expected increase of elderly people with dementia,(12) a great change in doctors' knowledge, attitudes, and practice is necessary to prevent even greater numbers of patients receiving this futile treatment.	Lenox Hill Hosp, New York, NY 10021 USA	Northwell Health	Monteleoni, C (corresponding author), Lenox Hill Hosp, 100 E 77th St, New York, NY 10021 USA.	cmonteleoni@lenoxhill.net						Ahronheim JC, 1996, CLIN GERIATR MED, V12, P379; Berwick DM, 1996, BRIT MED J, V312, P619, DOI 10.1136/bmj.312.7031.619; CIOCON JO, 1988, ARCH INTERN MED, V148, P429, DOI 10.1001/archinte.148.2.429; COBBS EL, 2002, GERIATRICS REV SYLLA, P117; FINUCANE TE, 1995, J AM GERIATR SOC, V43, P447, DOI 10.1111/j.1532-5415.1995.tb05822.x; Finucane TE, 1996, LANCET, V348, P1421, DOI 10.1016/S0140-6736(96)03369-7; Finucane TE, 1999, JAMA-J AM MED ASSOC, V282, P1365, DOI 10.1001/jama.282.14.1365; KAW M, 1995, DIGEST DIS SCI, V40, P921; Meier DE, 1997, ANN INTERN MED, V127, P225, DOI 10.7326/0003-4819-127-3-199708010-00008; Meier DE, 2001, ARCH INTERN MED, V161, P2386; Mitchell SL, 1998, J GERONTOL A-BIOL, V53, pM207, DOI 10.1093/gerona/53A.3.M207; Murphy LM, 2003, ARCH INTERN MED, V163, P1351, DOI 10.1001/archinte.163.11.1351; PECK A, 1991, J AM GERIATR SOC, V39, P732; *UN HOSP FUND, 2003, PALL CAR QUAL IMPR C; [No title captured]	15	75	79	1	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 28	2004	329	7464					491	494		10.1136/bmj.329.7464.491	http://dx.doi.org/10.1136/bmj.329.7464.491			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	851KS	15331474	Green Published			2022-12-24	WOS:000223684600016
J	de Quervain, DJF; Fischbacher, U; Treyer, V; Schelthammer, M; Schnyder, U; Buck, A; Fehr, E				de Quervain, DJF; Fischbacher, U; Treyer, V; Schelthammer, M; Schnyder, U; Buck, A; Fehr, E			The neural basis of altruistic punishment	SCIENCE			English	Article							INCREASING MONETARY REWARD; PREFRONTAL CORTEX; DORSAL STRIATUM; NEURONAL-ACTIVITY; DECISION-MAKING; BRAIN ACTIVITY; RESPONSES; EXPECTATION; COOPERATION; EVOLUTION	Many people voluntarily incur costs to punish violations of social norms. Evolutionary models and empirical evidence indicate that such altruistic punishment has been a decisive force in the evolution of human cooperation. We used (H2O)-O-15 positron emission tomography to examine the neural basis for altruistic punishment of defectors in an economic exchange. Subjects could punish defection either symbolically or effectively. Symbolic punishment did not reduce the defector's economic payoff, whereas effective punishment did reduce the payoff. We scanned the subjects' brains while they learned about the defector's abuse of trust and determined the punishment. Effective punishment, as compared with symbolic punishment, activated the dorsal striatum, which has been implicated in the processing of rewards that accrue as a result of goal-directed actions. Moreover, subjects with stronger activations in the dorsal striatum were willing to incur greater costs in order to punish. Our findings support the hypothesis that people derive satisfaction from punishing norm violations and that the activation in the dorsal striatum reflects the anticipated satisfaction from punishing defectors.	Univ Zurich, Div Psychiat Res, CH-8029 Zurich, Switzerland; Univ Zurich, Inst Empir Res Econ, CH-8006 Zurich, Switzerland; Univ Zurich Hosp, PET Ctr, CH-8091 Zurich, Switzerland; Univ Zurich Hosp, Dept Psychiat, CH-8091 Zurich, Switzerland; Coll Helveticum, CH-8092 Zurich, Switzerland	University of Zurich; University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	de Quervain, DJF (corresponding author), Univ Zurich, Div Psychiat Res, Lenggstr 31, CH-8029 Zurich, Switzerland.	quervain@bti.unizh.ch; efehr@iew.unizh.ch	Treyer, Valerie/G-6986-2018; Fischbacher, Urs/H-2693-2014	Treyer, Valerie/0000-0002-4584-3031; Fischbacher, Urs/0000-0002-5115-8815; de Quervain, Dominique/0000-0001-7131-2464; Schnyder, Ulrich/0000-0003-3556-7990				Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; APICELLA P, 1991, EXP BRAIN RES, V85, P491; Arana FS, 2003, J NEUROSCI, V23, P9632; BATSON CD, 1987, J PERS SOC PSYCHOL, V53, P594, DOI 10.1037/0022-3514.53.3.594; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bowles S, 2004, THEOR POPUL BIOL, V65, P17, DOI 10.1016/j.tpb.2003.07.001; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Breiter HC, 1997, NEURON, V19, P591, DOI 10.1016/S0896-6273(00)80374-8; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Delgado MR, 2003, COGN AFFECT BEHAV NE, V3, P27, DOI 10.3758/CABN.3.1.27; Delgado MR, 2004, CEREB CORTEX, V14, P1022, DOI 10.1093/cercor/bhh062; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Elliott R, 2003, J NEUROSCI, V23, P303; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P814, DOI 10.1152/jn.1989.61.4.814; Hollerman JR, 1998, J NEUROPHYSIOL, V80, P947, DOI 10.1152/jn.1998.80.2.947; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Koepp MJ, 1998, NATURE, V393, P266, DOI 10.1038/30498; Krawczyk DC, 2002, NEUROSCI BIOBEHAV R, V26, P631, DOI 10.1016/S0149-7634(02)00021-0; Martin-Soelch C, 2003, EUR J NEUROSCI, V18, P680, DOI 10.1046/j.1460-9568.2003.02791.x; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Moll J, 2002, J NEUROSCI, V22, P2730, DOI 10.1523/JNEUROSCI.22-07-02730.2002; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; RABIN M, 1993, AM ECON REV, V83, P1281; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Salinas JA, 1998, BEHAV NEUROSCI, V112, P812, DOI 10.1037/0735-7044.112.4.812; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; SCHULTZ W, 1988, EXP BRAIN RES, V71, P431; Singer T, 2004, NEURON, V41, P653, DOI 10.1016/S0896-6273(04)00014-5; Sober E., 1998, OTHERS EVOLUTION PSY; Stein EA, 1998, AM J PSYCHIAT, V155, P1009, DOI 10.1176/ajp.155.8.1009; Wagner AD, 2001, NEUROIMAGE, V14, P1337, DOI 10.1006/nimg.2001.0936	41	972	981	5	245	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 27	2004	305	5688					1254	1258		10.1126/science.1100735	http://dx.doi.org/10.1126/science.1100735			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850PJ	15333831	Green Submitted			2022-12-24	WOS:000223624600031
J	Klein, DE; Nappi, VM; Reeves, GT; Shvartsman, SY; Lemmon, MA				Klein, DE; Nappi, VM; Reeves, GT; Shvartsman, SY; Lemmon, MA			Argos inhibits epidermal growth factor receptor signalling by ligand sequestration	NATURE			English	Article							SECRETED SPITZ; DROSOPHILA; PATHWAY; SULFATE; BINDING; ACTIVATION; PROTEINS	The epidermal growth factor receptor ( EGFR) has critical functions in development and in many human cancers(1-3). During development, the spatial extent of EGFR signalling is regulated by feedback loops comprising both well-understood activators and less well-characterized inhibitors(3,4). In Drosophila melanogaster the secreted protein Argos functions as the only known extracellular inhibitor of EGFR(5), with clearly identified roles in multiple stages of development(3). Argos is only expressed when the Drosophila EGFR (DER) is activated at high levels(6), and downregulates further DER signalling. Although there is ample genetic evidence that Argos inhibits DER activation, the biochemical mechanism has not been established. Here we show that Argos inhibits DER signalling without interacting directly with the receptor, but instead by sequestering the DER-activating ligand Spitz. Argos binds tightly to the EGF motif of Spitz and forms a 1:1 ( Spitz: Argos) complex that does not bind DER in vitro or at the cell surface. Our results provide an insight into the mechanism of Argos function, and suggest new strategies for EGFR inhibitor design.	Univ Penn, Sch Med, Dept Biochem & Biophys, Stellar Chance Labs 809C, Philadelphia, PA 19104 USA; Princeton Univ, Dept Chem Engn, Carl Icahn Lab, Princeton, NJ 08544 USA; Princeton Univ, Lewis Sigler Inst Integrat Genom, Carl Icahn Lab, Princeton, NJ 08544 USA	University of Pennsylvania; Princeton University; Princeton University	Lemmon, MA (corresponding author), Univ Penn, Sch Med, Dept Biochem & Biophys, Stellar Chance Labs 809C, 422 Curie Blvd, Philadelphia, PA 19104 USA.	mlemmon@mail.med.upenn.edu	Shvartsman, Stanislav/GPP-4025-2022	Shvartsman, Stanislav/0000-0002-9152-9334; Lemmon, Mark/0000-0002-3379-5319; Klein, Daryl/0000-0002-7188-0450	NCI NIH HHS [R01 CA125432, R01 CA079992] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA079992, R01CA125432] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arend WP, 1998, ANNU REV IMMUNOL, V16, P27, DOI 10.1146/annurev.immunol.16.1.27; Barkai N, 2002, CURR BIOL, V12, pR493, DOI 10.1016/S0960-9822(02)00967-3; Duan C, 2002, J ENDOCRINOL, V175, P41, DOI 10.1677/joe.0.1750041; Ferguson KM, 2000, EMBO J, V19, P4632, DOI 10.1093/emboj/19.17.4632; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; FREEMAN M, 1992, CELL, V69, P963, DOI 10.1016/0092-8674(92)90615-J; Golembo M, 1996, DEVELOPMENT, V122, P223; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; Howes R, 1998, J BIOL CHEM, V273, P4275, DOI 10.1074/jbc.273.7.4275; Jin MH, 2000, MOL CELL BIOL, V20, P2098, DOI 10.1128/MCB.20.6.2098-2107.2000; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kramer KL, 2003, ANNU REV GENET, V37, P461, DOI 10.1146/annurev.genet.37.061103.090226; Mantovani A, 2001, TRENDS IMMUNOL, V22, P328, DOI 10.1016/S1471-4906(01)01941-X; Mattoon D, 2004, P NATL ACAD SCI USA, V101, P923, DOI 10.1073/pnas.0307286101; Paine-Saunders S, 2002, J BIOL CHEM, V277, P2089, DOI 10.1074/jbc.M109151200; Powell AK, 2004, GLYCOBIOLOGY, V14, p17R, DOI 10.1093/glycob/cwh051; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; SCHLESSINGER J, 1978, P NATL ACAD SCI USA, V75, P2659, DOI 10.1073/pnas.75.6.2659; SCHWEITZER R, 1995, NATURE, V376, P699, DOI 10.1038/376699a0; SCHWEITZER R, 1995, GENE DEV, V9, P1518, DOI 10.1101/gad.9.12.1518; Shilo BZ, 2003, EXP CELL RES, V284, P140, DOI 10.1016/S0014-4827(02)00094-0; Shvartsman SY, 2002, DEVELOPMENT, V129, P2577; Verveer PJ, 2000, SCIENCE, V290, P1567, DOI 10.1126/science.290.5496.1567; Vinos J, 2000, ONCOGENE, V19, P3560, DOI 10.1038/sj.onc.1203702; Wasserman JD, 1998, CELL, V95, P355, DOI 10.1016/S0092-8674(00)81767-5; Wiley HS, 2003, TRENDS CELL BIOL, V13, P43; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	27	104	109	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 26	2004	430	7003					1040	1044		10.1038/nature02840	http://dx.doi.org/10.1038/nature02840			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849CD	15329724				2022-12-24	WOS:000223514900046
J	Kuwana, M; Okazaki, Y; Yasuoka, H; Kawakami, Y; Ikeda, Y				Kuwana, M; Okazaki, Y; Yasuoka, H; Kawakami, Y; Ikeda, Y			Defective vasculogenesis in systemic sclerosis	LANCET			English	Article							ENDOTHELIAL PROGENITOR CELLS; GROWTH-FACTOR; HUMAN CYTOMEGALOVIRUS; RHEUMATOID-ARTHRITIS; ANGIOGENESIS; MOBILIZATION; SCLERODERMA; EXPRESSION; APOPTOSIS; ANTIBODY	Background Typical vascular features of systemic sclerosis include low capillary density and vascular obliteration. The formation and repair of blood vessels in adults involve vasculogenesis, which is mediated through the recruitment of bone-marrow-derived circulating endothelial precursors (CEP). We investigated whether vasculogenesis is impaired in patients with systemic sclerosis. Methods Peripheral blood was obtained from 11 patients with systemic sclerosis, 11 with rheumatoid arthritis, and 11 healthy controls. Factors potentially affecting the CEP number were matched among the three groups. CEP (identified as circulating cells positive for CD34, CD133, and the type 2 receptor for vascular endothelial growth factor) were quantified by cell sorting and three-colour flow cytometry. The circulating concentrations of angiogenic factors were measured by ELISA. The potential of CEP to differentiate into endothelial cells was assessed by the upregulation of von Willebrand factor after in-vitro maturation treatment. Findings The absolute number of CEP was much lower in patients with systemic sclerosis than in patients with rheumatoid arthritis or healthy controls (median 274 [IQR 178-395] vs 1154 [653-1524] and 1074 [713-1186] per 20 mL peripheral blood, respectively; p<0.0001 by Kruskal-Wallis test. Paradoxically, circulating concentrations of most angiogenic factors were significantly higher in patients with systemic sclerosis than in healthy controls. The proportion of CEP that differentiated into endothelial cells was significantly lower in patients with systemic sclerosis than in healthy controls (p<0.0001, Mann-Whitney test). Interpretation Insufficient vascular repair machinery due to defective vasculogenesis might contribute to vasculopathy in systemic sclerosis. Relevance to practice As well as providing an important insight into the pathogenesis of this disorder, these findings suggest that dysregulated vasculogenesis might be important in other disorders with abnormalities in vascular formation, including those with excessive formation of new vessels such as cancer and those with deficient vessel formation such as atherosclerosis. Circulating endothelial precursors could be a novel target for therapeutic strategies for ischaemic complications in patients with systemic sclerosis.	Keio Univ, Sch Med, Inst Adv Med Res, Shinjuku Ku, Tokyo 1608582, Japan; Keio Univ, Sch Med, Dept Internal Med, Tokyo 1608582, Japan	Keio University; Keio University	Kuwana, M (corresponding author), Keio Univ, Sch Med, Inst Adv Med Res, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	kuwanam@sc.itc.keio.ac.jp	Kuwana, Masataka/L-2918-2013; Yasuoka, Hidekata/AAC-6277-2019; Kawakami, Yutaka/E-7429-2013; Yasuoka, Hidekata/L-3041-2013	Kawakami, Yutaka/0000-0003-4836-2855; 				[Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Bhattacharya V, 2000, BLOOD, V95, P581, DOI 10.1182/blood.V95.2.581; Caprioli A, 1998, P NATL ACAD SCI USA, V95, P1641, DOI 10.1073/pnas.95.4.1641; CHEN ZY, 1984, AM J MED, V77, P812, DOI 10.1016/0002-9343(84)90517-5; Clements PJ, 1996, SYSTEMIC SCLEROSIS, P389; Distler O, 2002, ARTHRITIS RES, V4, DOI 10.1186/ar596; Freedman SB, 2002, ANN INTERN MED, V136, P54, DOI 10.7326/0003-4819-136-1-200201010-00011; Gehling UM, 2000, BLOOD, V95, P3106; Gill M, 2001, CIRC RES, V88, P167; Heeschen C, 2003, BLOOD, V102, P1340, DOI 10.1182/blood-2003-01-0223; Kawaguchi Y, 1999, J RHEUMATOL, V26, P1012; LeRoy EC, 1996, RHEUM DIS CLIN N AM, V22, P675, DOI 10.1016/S0889-857X(05)70295-7; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; Lunardi C, 2000, NAT MED, V6, P1183, DOI 10.1038/80533; Mackiewicz Z, 2002, CLIN EXP RHEUMATOL, V20, P641; Maini R, 1999, LANCET, V354, P1932, DOI 10.1016/S0140-6736(99)05246-0; Murayama T, 2002, EXP HEMATOL, V30, P967, DOI 10.1016/S0301-472X(02)00867-6; Pandey JP, 1998, ARTHRITIS RHEUM, V41, P10, DOI 10.1002/1529-0131(199801)41:1<10::AID-ART2>3.0.CO;2-P; Papadaki HA, 2002, BLOOD, V99, P1610, DOI 10.1182/blood.V99.5.1610; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Rajagopalan S, 2003, AM HEART J, V145, P1114, DOI 10.1016/S0002-8703(03)00102-9; Schachna L, 2002, CURR OPIN RHEUMATOL, V14, P686, DOI 10.1097/00002281-200211000-00010; Sgonc R, 2000, ARTHRITIS RHEUM-US, V43, P2550, DOI 10.1002/1529-0131(200011)43:11<2550::AID-ANR24>3.0.CO;2-H; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Vasa M, 2001, CIRC RES, V89, pE1, DOI 10.1161/hh1301.093953; Vasa M, 2001, CIRCULATION, V103, P2885, DOI 10.1161/hc2401.092816; Weber AJ, 2000, JOINT BONE SPINE, V67, P366	31	211	222	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 14	2004	364	9434					603	610		10.1016/S0140-6736(04)16853-0	http://dx.doi.org/10.1016/S0140-6736(04)16853-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845WD	15313361				2022-12-24	WOS:000223275100033
J	Zhang, YL; Blattman, JN; Kennedy, NJ; Duong, J; Nguyen, T; Wang, Y; Davis, RJ; Greenberg, PD; Flavell, RA; Dong, C				Zhang, YL; Blattman, JN; Kennedy, NJ; Duong, J; Nguyen, T; Wang, Y; Davis, RJ; Greenberg, PD; Flavell, RA; Dong, C			Regulation of innate and adaptive immune responses by MAP kinase phosphatase 5	NATURE			English	Article							RECOGNITION; FAMILY; JNK	Mitogen-activated protein ( MAP) kinases are essential regulators in immune responses(1), and their activities are modulated by kinases and phosphatases. MAP kinase phosphatase (MKP) is a family of dual-specificity phosphatases whose function is evolutionarily conserved(2,3). A number of mammalian MKPs have been identified so far(2,3), but their specific physiological functions in negative regulation of MAP kinases have not been genetically defined. Here we examine innate and adaptive immune responses in the absence of MKP5. JNK activity was selectively increased in Mkp5 ( also known as Dusp10)-deficient mouse cells. Mkp5-deficient cells produced greatly enhanced levels of pro-inflammatory cytokines during innate immune responses and exhibited greater T-cell activation than their wild-type counterparts. However, Mkp5-deficient T cells proliferated poorly upon activation, which resulted in increased resistance to experimental autoimmune encephalomyelitis. By contrast, Mkp5-deficient CD4(+) and CD8(+) effector T cells produced significantly increased levels of cytokines compared with wild-type cells, which led to much more robust and rapidly fatal immune responses to secondary infection with lymphocytic choriomeningitis virus. Therefore, MKP5 has a principal function in both innate and adaptive immune responses, and represents a novel target for therapeutic intervention of immune diseases.	Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Univ Massachusetts, Howard Hughes Med Inst, Worcester, MA 01605 USA; Yale Univ, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; Yale University	Flavell, RA (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	richard.flavell@yale.edu; cdong@mdanderson.org	dong, chen/B-3181-2009	dong, chen/0000-0002-0084-9130				Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Camps M, 2000, FASEB J, V14, P6, DOI 10.1096/fasebj.14.1.6; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Rincon M, 1998, EMBO J, V17, P2817, DOI 10.1093/emboj/17.10.2817; Rincon Mercedes, 1997, Genes and Function, V1, P51; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tanoue T, 1999, J BIOL CHEM, V274, P19949, DOI 10.1074/jbc.274.28.19949; Theodosiou A, 1999, ONCOGENE, V18, P6981, DOI 10.1038/sj.onc.1203185; Theodosiou A, 2002, GENOME BIOL, V3	13	186	192	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2004	430	7001					793	797		10.1038/nature02764	http://dx.doi.org/10.1038/nature02764			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306813				2022-12-24	WOS:000223233600045
J	Jagsi, R; Lehmann, S				Jagsi, R; Lehmann, S			The ethics of medical education	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LEGAL IMPLICATIONS; INFORMED CONSENT; STUDENT DOCTOR; CARE; RESIDENTS; ATTITUDES; PATIENT		Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiat Oncol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Gen Med & Primary Care, Boston, MA 02120 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Lehmann, S (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Radiat Oncol, Boston, MA 02114 USA.	llehmann1@partners.org		Jagsi, Reshma/0000-0001-6562-1228				ANNAS GJ, 1980, B NEW YORK ACAD MED, V56, P403; BASSON MD, 1982, HASTINGS CENT REP, V12, P27; BEATTY ME, 1995, ACAD MED, V70, P175, DOI 10.1097/00001888-199503000-00002; Brody BA, 1998, ETHICS BIOMEDICAL RE; Butters JM, 1996, ACAD MED, V71, P583, DOI 10.1097/00001888-199606000-00008; COHEN DL, 1987, J MED EDUC, V62, P789; COHEN DL, 1988, J MED EDUC, V63, P821; Coldicott Y, 2003, BRIT MED J, V326, P97, DOI 10.1136/bmj.326.7380.97; Diekema DS, 1996, AM J EMERG MED, V14, P6, DOI 10.1016/S0735-6757(96)90002-9; Doyal L, 2001, BRIT MED J, V322, P685, DOI 10.1136/bmj.322.7288.685; Frank SH, 1997, JAMA-J AM MED ASSOC, V278, P712, DOI 10.1001/jama.278.9.712; Hicks LK, 2001, BRIT MED J, V322, P709, DOI 10.1136/bmj.322.7288.709; KAPP MB, 1983, J MED EDUC, V58, P293; KING D, 1992, MED EDUC, V26, P360, DOI 10.1111/j.1365-2923.1992.tb00186.x; Magrane D, 1996, OBSTET GYNECOL, V88, P298, DOI 10.1016/0029-7844(96)00191-3; Marracino RK, 1998, J GEN INTERN MED, V13, P266, DOI 10.1046/j.1525-1497.1998.00078.x; RICH EC, 1990, JAMA-J AM MED ASSOC, V263, P953; Vinicky J K, 1991, J Clin Ethics, V2, P35; WILLIG C, 1992, J COMMUNITY APPL SOC, V2, P217, DOI 10.1002/casp.2450020306	19	29	31	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 7	2004	329	7461					332	334		10.1136/bmj.329.7461.332	http://dx.doi.org/10.1136/bmj.329.7461.332			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	846FF	15297341	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000223300300024
J	Xiong, Y; Steitz, TA				Xiong, Y; Steitz, TA			Mechanism of transfer RNA maturation by CCA-adding enzyme without using an oligonucleotide template	NATURE			English	Article							DNA-POLYMERASE-BETA; NUCLEOTIDYLTRANSFERASE SUPERFAMILY; POLYMERIZATION; COMPLEXES; ATP	Transfer RNA nucleotidyltransferases (CCA-adding enzymes) are responsible for the maturation or repair of the functional 30 end of tRNAs by means of the addition of the essential nucleotides CCA. However, it is unclear how tRNA nucleotidyltransferases polymerize CCA onto the 30 terminus of immature tRNAs without using a nucleic acid template. Here we describe the crystal structure of the Archaeoglobus fulgidus tRNA nucleotidyltransferase in complex with tRNA. We also present ternary complexes of this enzyme with both RNA duplex mimics of the tRNA acceptor stem that terminate with the nucleotides C74 or C75, as well as the appropriate incoming nucleoside 5'-triphosphates. A single nucleotide-binding pocket exists whose specificity for both CTP and ATP is determined by the protein side chain of Arg 224 and backbone phosphates of the tRNA, which are non-complementary to and thus exclude UTP and GTP. Discrimination between CTP or ATP at a given addition step and at termination arises from changes in the size and shape of the nucleotide binding site that is progressively altered by the elongating 30 end of the tRNA.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Dept Chem, New Haven, CT 06520 USA; Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute	Steitz, TA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	eatherton@csb.yale.edu	Steitz, Thomas A./C-6559-2009					AEBI M, 1990, J BIOL CHEM, V265, P16216; Augustin MA, 2003, J MOL BIOL, V328, P985, DOI 10.1016/S0022-2836(03)00381-4; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; DEUTSCHER MP, 1972, J BIOL CHEM, V247, P459; DEUTSCHER MP, 1982, ENZYMES, V15, P183, DOI DOI 10.1016/S1874-6047(08)60279-6; Green R, 1997, ANNU REV BIOCHEM, V66, P679, DOI 10.1146/annurev.biochem.66.1.679; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P345, DOI 10.1016/S0968-0004(00)89071-4; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P941, DOI 10.1107/S0907444999001031; Li F, 2002, CELL, V111, P815, DOI 10.1016/S0092-8674(02)01115-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Okabe M, 2003, EMBO J, V22, P5918, DOI 10.1093/emboj/cdg563; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; Shi PY, 1998, EMBO J, V17, P3197, DOI 10.1093/emboj/17.11.3197; Shi PY, 1998, RNA, V4, P276; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tomari Y, 2000, GENES CELLS, V5, P689, DOI 10.1046/j.1365-2443.2000.00360.x; Xiong Y, 2003, MOL CELL, V12, P1165, DOI 10.1016/S1097-2765(03)00440-4; Yue DX, 1996, RNA, V2, P895; ZHU LQ, 1987, EMBO J, V6, P2473, DOI 10.1002/j.1460-2075.1987.tb02528.x	26	97	103	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2004	430	7000					640	645		10.1038/nature02711	http://dx.doi.org/10.1038/nature02711			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843LM	15295590				2022-12-24	WOS:000223085400035
J	Dhar, G; Sanders, ER; Johnson, RC				Dhar, G; Sanders, ER; Johnson, RC			Architecture of the Hin synaptic complex during recombination: The recombinase subunits translocate with the DNA strands	CELL			English	Article							GAMMA-DELTA-RESOLVASE; SITE-SPECIFIC RECOMBINATION; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; INVERSION; ENHANCER; EXCHANGE; MECHANISM; INVERTASOME; ACTIVATION	Most site-specific recombinases can be grouped into two mechanistically distinct families. Whereas tyrosine recombinases exchange DNA strands through a Holliday intermediate, serine recombinases such as Hin generate double-strand breaks in each recombining partner. Here, site-directed protein crosslinking is used to elucidate the configuration of protein subunits and DNA within the Hin synaptic complex and to follow the movement of protein subunits during DNA strand exchange. Our results show that the protein interface mediating synapsis is localized to a region within the catalytic domains, thereby positioning the DNA strands on the outside of the Hin tetrameric complex. Unexpected crosslinks between residues within the dimerization helices provide evidence for a conformational change that accompanies DNA cleavage. We demonstrate that the Hin subunits, which are linked to the cleaved DNA ends by serine-phosphodiester bonds translocate between synapsed dimers to exchange the DNA strands.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Johnson, RC (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.	rcjohnson@mednet.ucla.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038509, R37GM038509] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM38509] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Burke ME, 2004, MOL MICROBIOL, V51, P837, DOI 10.1046/j.1365-2958.2003.03831.x; Chen Y, 2000, MOL CELL, V6, P885, DOI 10.1016/S1097-2765(05)00088-2; Chiu TK, 2002, EMBO J, V21, P801, DOI 10.1093/emboj/21.4.801; CRAIG NL, 2002, MOBILE DNA 2; Gopaul DN, 1998, EMBO J, V17, P4175, DOI 10.1093/emboj/17.14.4175; Grindley NDF, 2002, MOBILE DNA, P272; Guo F, 1997, NATURE, V389, P40, DOI 10.1038/37925; HAFFTER P, 1988, EMBO J, V7, P3991, DOI 10.1002/j.1460-2075.1988.tb03287.x; Haykinson MJ, 1996, CURR BIOL, V6, P163, DOI 10.1016/S0960-9822(02)00449-9; HEICHMAN KA, 1991, GENE DEV, V5, P1622, DOI 10.1101/gad.5.9.1622; HEICHMAN KA, 1990, SCIENCE, V249, P511, DOI 10.1126/science.2166334; HUGHES RE, 1993, EMBO J, V12, P1447, DOI 10.1002/j.1460-2075.1993.tb05788.x; Jayaram M., 2002, MOBILE DNA, P192; JOHNSON RC, 1985, CELL, V41, P781, DOI 10.1016/S0092-8674(85)80059-3; JOHNSON RC, 1987, NATURE, V329, P462, DOI 10.1038/329462a0; JOHNSON RC, 1986, CELL, V46, P531, DOI 10.1016/0092-8674(86)90878-0; Johnson RC, 2002, MOBILE DNA, P230; KANAAR R, 1990, CELL, V62, P353, DOI 10.1016/0092-8674(90)90372-L; KANAAR R, 1988, P NATL ACAD SCI USA, V85, P752, DOI 10.1073/pnas.85.3.752; KLIPPEL A, 1988, EMBO J, V7, P3983, DOI 10.1002/j.1460-2075.1988.tb03286.x; Lee HJ, 2003, MOL CELLS, V16, P377; Leschziner AE, 2003, MOL CELL, V12, P775, DOI 10.1016/S1097-2765(03)00351-4; LIM HM, 1994, J BIOL CHEM, V269, P31134; Merickel SK, 2004, MOL MICROBIOL, V51, P1143, DOI 10.1046/j.1365-2958.2003.03890.x; Merickel SK, 1998, GENE DEV, V12, P2803, DOI 10.1101/gad.12.17.2803; NUNESDUBY SE, 1995, CURR BIOL, V5, P139, DOI 10.1016/S0960-9822(95)00035-2; Pan B, 2001, J MOL BIOL, V310, P1089, DOI 10.1006/jmbi.2001.4821; Pan B, 1997, PROTEIN SCI, V6, P1237, DOI 10.1002/pro.5560060612; Rice P. A., 2002, MOBILE DNA, P219; RICE PA, 1994, STRUCTURE, V2, P371, DOI 10.1016/S0969-2126(00)00039-3; RICE PA, 1994, EMBO J, V13, P1514, DOI 10.1002/j.1460-2075.1994.tb06413.x; Sanders ER, 2004, J MOL BIOL, V340, P753, DOI 10.1016/j.jmb.2004.05.027; SANDERSON MR, 1990, CELL, V63, P1323, DOI 10.1016/0092-8674(90)90427-G; Sarkis GJ, 2001, MOL CELL, V8, P623, DOI 10.1016/S1097-2765(01)00334-3; SILVERMAN M, 1980, COLD SPRING HARB SYM, V45, P17, DOI 10.1101/SQB.1981.045.01.005; STARK WM, 1989, CELL, V58, P779, DOI 10.1016/0092-8674(89)90111-6; STARK WM, 1991, EMBO J, V10, P3541, DOI 10.1002/j.1460-2075.1991.tb04918.x; Van Duyne G.D., 2002, MOBILE DNA, VII, P93; YANG W, 1995, CELL, V82, P193, DOI 10.1016/0092-8674(95)90307-0; ZIEG J, 1977, SCIENCE, V196, P170, DOI 10.1126/science.322276	40	33	35	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 1	2004	119	1					33	45		10.1016/j.cell.2004.09.010	http://dx.doi.org/10.1016/j.cell.2004.09.010			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	859UE	15454079	Bronze			2022-12-24	WOS:000224292600007
J	Furness, C; Sharma, R; Harnden, A				Furness, C; Sharma, R; Harnden, A			10-minute consultation - Morbilliform rash	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Oxford Green Coll, Oxford OX2 6HG, England; Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England	University of Oxford; University of Oxford	Harnden, A (corresponding author), Univ Oxford Green Coll, Oxford OX2 6HG, England.	anthony.harnden@dphpc.ox.ac.uk							0	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 25	2004	329	7468					719	719		10.1136/bmj.329.7468.719	http://dx.doi.org/10.1136/bmj.329.7468.719			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	858RV	15388614	Green Submitted, Bronze, Green Published			2022-12-24	WOS:000224210300019
J	Offit, K; Groeger, E; Turner, S; Wadsworth, EA; Weiser, MA				Offit, K; Groeger, E; Turner, S; Wadsworth, EA; Weiser, MA			The "duty to warn" a patient's family members about hereditary disease risks	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEOPLASIA TYPE 2A; ADENOMATOUS POLYPOSIS; GENETIC-DISEASE; CANCER; INFORMATION; MUTATIONS; RELATIVES; CARRIERS; BREAST; BRCA1	Genetic tests for adult-onset disorders, including common forms of cancer, are now commercially available, and tests for genetic polymorphisms that predict drug effects or toxicity after treatment are under development. For each of these circumstances, testing of 1 individual may imply an increased risk to his/her relative. The obligation, if any, to warn family members of the identification of a genetic mutation has generated concerns regarding the conflict between the physician's ethical obligations to respect the privacy of genetic information vs the potential liabilities resulting from the physician's failure to notify at-risk relatives. A duty to warn relatives about risks due to some infectious agents has been assumed by state and local health agencies, and the duty to breach confidentiality to warn of imminent harm has been the subject of case law. In general, the special nature of genetic tests has been viewed as a barrier to physicians' breaching the confidentiality of personal genetic information. However, the failure to warn family members about hereditary disease risks has already resulted in 3 lawsuits against physicians in the United States. While the findings of case law and the state and federal statutes that bear on the issue of "duty to warn" of inherited health risk are still being defined, we believe that health care professionals have a responsibility to encourage but not to coerce the sharing of genetic information in families, while respecting the boundaries imposed by the law and by the ethical practice of medicine.	Mem Sloan Kettering Canc Ctr, Dept Med, Clin Genet Serv, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Off Legal Affairs, New York, NY 10021 USA; Ropes & Gray LLP, Washington, DC 20037 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Offit, K (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Clin Genet Serv, 1275 York Ave, New York, NY 10021 USA.	offitk@mskcc.org						Beauchamp TL., 1994, PRINCIPLES BIOMEDICA; Bruinooge SS, 2003, J CLIN ONCOL, V21, P2397, DOI 10.1200/JCO.2003.03.189; Burke W, 2002, AM J EPIDEMIOL, V156, P311, DOI 10.1093/aje/kwf055; Burnett J W, 1999, Houst Law Rev, V36, P559; Chasman DI, 2004, JAMA-J AM MED ASSOC, V291, P2821, DOI 10.1001/jama.291.23.2821; Clayton EW, 2003, NEW ENGL J MED, V349, P562, DOI 10.1056/NEJMra012577; *COUNC ETH JUD AFF, 2A02 CEJA; Dugan RB, 2003, AM J MED GENET C, V119C, P27, DOI 10.1002/ajmg.c.10005; Falk MJ, 2003, AM J MED GENET A, V120A, P374, DOI 10.1002/ajmg.a.20227; Giardiello FM, 2002, NEW ENGL J MED, V346, P1054, DOI 10.1056/NEJMoa012015; *I MED COMM ASS GE, 1994, ASS GEN RISKS IMPL H; JARVINEN HJ, 1995, GASTROENTEROLOGY, V108, P1405, DOI 10.1016/0016-5085(95)90688-6; Kauff ND, 2002, NEW ENGL J MED, V346, P1609, DOI 10.1056/NEJMoa020119; Keeton WP, 1984, PROSSER KEETONS HORN; Knoppers BM, 1998, AM J HUM GENET, V62, P474; LI FP, 1992, J NATL CANCER I, V84, P1156, DOI 10.1093/jnci/84.15.1156; LINDEN AM, 1993, CANADIAN TORT LAW; LIPS CJM, 1994, NEW ENGL J MED, V331, P828, DOI 10.1056/NEJM199409293311302; MACKLIN R, 1992, GENE MAPPING USING L, P157; Offit K, 1998, CLIN CANC GENETICS R; OFFIT K, 2004, AM SOC CLIN ONCOLOGY; President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, 1998, SCREEN COUNS GEN CON; Sankar P, 2003, ANNU REV MED, V54, P393, DOI 10.1146/annurev.med.54.101601.152131; Satagopan JM, 2001, CANCER EPIDEM BIOMAR, V10, P467; Scheuer L, 2002, J CLIN ONCOL, V20, P1260, DOI 10.1200/JCO.2002.20.5.1260; Steinbach G, 2000, NEW ENGL J MED, V342, P1946, DOI 10.1056/NEJM200006293422603; Sudell A, 2001, J Contemp Health Law Policy, V18, P273; *US DEP HHS, OCR PRIV BRIEF SUMM; WELLS SA, 1994, ANN SURG, V220, P237, DOI 10.1097/00000658-199409000-00002	29	183	184	0	22	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 22	2004	292	12					1469	1473		10.1001/jama.292.12.1469	http://dx.doi.org/10.1001/jama.292.12.1469			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856FT	15383518				2022-12-24	WOS:000224031800029
J	Takhar, AS; Palaniappan, P; Dhingsa, R; Lobo, DN				Takhar, AS; Palaniappan, P; Dhingsa, R; Lobo, DN			Recent developments in diagnosis of pancreatic cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Review							OF-THE-ART; DUCTAL ADENOCARCINOMA; COMPUTED-TOMOGRAPHY; TUMORS; NEOPLASMS; CT; ULTRASONOGRAPHY; RESECTABILITY; EXPRESSION; CARCINOMA		Univ Nottingham Hosp, Queens Med Ctr, Sect Surg, Nottingham NG7 2UH, England; Univ Nottingham Hosp, Queens Med Ctr, Dept Radiol, Nottingham NG7 2UH, England	University of Nottingham; University of Nottingham	Lobo, DN (corresponding author), Univ Nottingham Hosp, Queens Med Ctr, Sect Surg, Nottingham NG7 2UH, England.	dileep.lobo@nottingham.ac.uk	Lobo, Dileep/AAC-6207-2020	Lobo, Dileep/0000-0003-1187-5796				Adamek HE, 2000, LANCET, V356, P190, DOI 10.1016/S0140-6736(00)02479-X; Berberat P, 1999, WORLD J SURG, V23, P882, DOI 10.1007/s002689900593; Beyer T, 2000, J NUCL MED, V41, P1369; Brand R, 2001, CANCER J, V7, P287; Clarke DL, 2003, J AM COLL SURGEONS, V196, P119, DOI 10.1016/S1072-7515(02)01609-5; Conio M, 2001, CRIT REV ONCOL HEMAT, V37, P127, DOI 10.1016/S1040-8428(00)00108-6; Cooperman AM, 2000, J CLIN GASTROENTEROL, V31, P107, DOI 10.1097/00004836-200009000-00004; DiMagno EP, 1999, ANN ONCOL, V10, P140, DOI 10.1023/A:1008382029375; FUHRMAN GM, 1994, AM J SURG, V167, P104, DOI 10.1016/0002-9610(94)90060-4; GRAHAM RA, 1994, J SURG ONCOL, V55, P92, DOI 10.1002/jso.2930550206; Grutzmann R, 2004, BRIT J CANCER, V90, P1053, DOI 10.1038/sj.bjc.6601645; Gullo L, 1999, ANN ONCOL, V10, P79, DOI 10.1023/A:1008349122106; Hanbidge AE, 2002, CAN J GASTROENTEROL, V16, P101, DOI 10.1155/2002/184370; Haycox A, 1998, ALIMENT PHARM THER, V12, P937; Hosten N, 2000, LANCET, V356, P909, DOI 10.1016/S0140-6736(00)02683-0; Jemal A, 2003, CA-CANCER J CLIN, V53, P5, DOI 10.3322/canjclin.53.1.5; Kalra MK, 2003, BRIT J RADIOL, V76, P857, DOI 10.1259/bjr/16642775; Kitano M, 2004, GUT, V53, P854, DOI 10.1136/gut.2003.029934; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Mertz HR, 2000, GASTROINTEST ENDOSC, V52, P367, DOI 10.1067/mge.2000.107727; Midwinter MJ, 1999, BRIT J SURG, V86, P189, DOI 10.1046/j.1365-2168.1999.01042.x; *NAT CANC GUID GRO, 2001, GUID COMM CANC SERV; Neoptolemos JP, 2004, NEW ENGL J MED, V350, P1200, DOI 10.1056/NEJMoa032295; Ozkan H, 2003, HEPATO-GASTROENTEROL, V50, P1669; Pisters PWT, 2001, BRIT J SURG, V88, P325, DOI 10.1046/j.1365-2168.2001.01695.x; Plebani M, 1995, INT J BIOL MARKER, V10, P189, DOI 10.1177/172460089501000401; Potter MW, 2000, SURG ONCOL, V9, P103, DOI 10.1016/S0960-7404(01)00005-6; Quinn M, 2001, CANC TRENDS ENGLAND; RICHTER JM, 1989, ARCH INTERN MED, V149, P2292, DOI 10.1001/archinte.149.10.2292; Rickes S, 2002, SCAND J GASTROENTERO, V37, P1313, DOI 10.1080/003655202761020605; Saruc M, 2003, PANCREAS, V26, P381, DOI 10.1097/00006676-200305000-00012; Sewnath ME, 2002, ANN SURG, V236, P17, DOI 10.1097/00000658-200207000-00005; STEINER E, 1989, AM J ROENTGENOL, V152, P487, DOI 10.2214/ajr.152.3.487; Takamura M, 2003, CANCER SCI, V94, P425, DOI 10.1111/j.1349-7006.2003.tb01459.x; Tamm EP, 2003, AM J ROENTGENOL, V180, P1311, DOI 10.2214/ajr.180.5.1801311; Vargas R, 2004, AM J ROENTGENOL, V182, P419, DOI 10.2214/ajr.182.2.1820419; Yeo Theresa Pluth, 2002, Curr Probl Cancer, V26, P176, DOI 10.1067/mcn.2002.129579	37	57	68	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 18	2004	329	7467					668	673		10.1136/bmj.329.7467.668	http://dx.doi.org/10.1136/bmj.329.7467.668			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856JU	15374918	Green Published			2022-12-24	WOS:000224042300024
J	Northrup, AB; MacMillan, DWC				Northrup, AB; MacMillan, DWC			Two-step synthesis of carbohydrates by selective aldol reactions	SCIENCE			English	Article							DIELS-ALDER REACTION; ASYMMETRIC-SYNTHESIS; ALDEHYDES; HEXOSES; SUGARS; ROUTE	Studies of carbohydrates have been hampered by the lack of chemical strategies for the expeditious construction and coupling of differentially protected monosaccharides. Here, a synthetic route based on aldol coupling of three aldehydes is presented for the de novo production of polyol differentiated hexoses in only two chemical steps. The dimerization of alpha-oxyaldehydes, catalyzed by L-proline, is then followed by a tandem Mukaiyama aldol addition-cyclization step catalyzed by a Lewis acid. Differentially protected glucose, allose, and mannose stereoisomers can each be selected, in high yield and stereochemical purity, simply by changing the solvent and Lewis acid used. The reaction sequence also efficiently produces C-13-labeled analogs, as well as structural variants such as 2-amino- and 2-thio-substituted derivatives.	CALTECH, Dept Chem, Pasadena, CA 91125 USA	California Institute of Technology	MacMillan, DWC (corresponding author), CALTECH, Dept Chem, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	dmacmill@caltech.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066142] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM66142-01, R01 GM066142] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bataille C, 2002, J ORG CHEM, V67, P8054, DOI 10.1021/jo0204193; BOGER DL, 1988, J ORG CHEM, V53, P5793, DOI 10.1021/jo00259a040; DANISHEFSKY S, 1985, J AM CHEM SOC, V107, P7761, DOI 10.1021/ja00311a089; Davies SG, 2002, SYNLETT, P1637, DOI 10.1055/s-2002-34215; Denmark SE, 2001, ANGEW CHEM INT EDIT, V40, P4759, DOI 10.1002/1521-3773(20011217)40:24<4759::AID-ANIE4759>3.0.CO;2-G; EDER U, 1971, ANGEW CHEM INT EDIT, V10, P496, DOI 10.1002/anie.197104961; Ernst, 2000, CARBOHYD CHEM-SPR; HAJOS ZG, 1974, J ORG CHEM, V39, P1615, DOI 10.1021/jo00925a003; KO SY, 1983, SCIENCE, V220, P949, DOI 10.1126/science.220.4600.949; List B, 2002, TETRAHEDRON, V58, P5573, DOI 10.1016/S0040-4020(02)00516-1; List B, 2000, J AM CHEM SOC, V122, P2395, DOI 10.1021/ja994280y; Movassaghi M, 2002, SCIENCE, V298, P1904, DOI 10.1126/science.1076547; Nicolaou K. C., 1999, BIOORGANIC CHEM CARB, P134; Northrup AB, 2004, ANGEW CHEM INT EDIT, V43, P2152, DOI 10.1002/anie.200453716; Northrup AB, 2002, J AM CHEM SOC, V124, P6798, DOI 10.1021/ja0262378; Takeuchi M, 1999, SYNTHESIS-STUTTGART, P341; TIETZE LF, 1994, SYNLETT, P509; Vogel P., 2001, GLYCOSCIENCE, V2, P1023	18	345	354	3	161	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1752	1755		10.1126/science.1101710	http://dx.doi.org/10.1126/science.1101710			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	856IS	15308765				2022-12-24	WOS:000224039500034
J	Kim, SK; Rulifson, EJ				Kim, SK; Rulifson, EJ			Conserved mechanisms of glucose sensing and regulation by Drosophila corpora cardiaca cells	NATURE			English	Article							ADIPOKINETIC HORMONE-RELEASE; SENSITIVE K+ CHANNELS; INSULIN-LIKE PEPTIDES; PANCREATIC A-CELLS; SULFONYLUREA RECEPTOR; CORPUS CARDIACUM; GLUCAGON; GROWTH; NEURONS; LOCUST	Antagonistic activities of glucagon and insulin control metabolism in mammals, and disruption of this balance underlies diabetes pathogenesis. Insulin-producing cells (IPCs) in the brain of insects such as Drosophila also regulate serum glucose(1,2), but it remains unclear whether insulin is the sole hormonal regulator of glucose homeostasis and whether mechanisms of glucose-sensing and response in IPCs resemble those in pancreatic islets. Here we show, by targeted cell ablation, that Drosophila corpora cardiaca (CC) cells(3-5) of the ring gland are also essential for larval glucose homeostasis. Unlike IPCs, CC cells express Drosophila cognates of sulphonylurea receptor (Sur) and potassium channel (Ir), proteins that comprise ATP-sensitive potassium channels regulating hormone secretion by islets and other mammalian glucose-sensing cells(6-8). They also produce adipokinetic hormone, a polypeptide with glucagon-like functions. Glucose regulation by CC cells is impaired by exposure to sulphonylureas, drugs that target the Sur subunit. Furthermore, ubiquitous expression of an akh transgene reverses the effect of CC ablation on serum glucose. Thus, Drosophila CC cells are crucial regulators of glucose homeostasis and they use glucose-sensing and response mechanisms similar to islet cells.	Stanford Univ, Sch Med, Beckman Ctr B300, Dept Dev Biol,Oncol Div, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Beckman Ctr B300, Dept Med,Oncol Div, Stanford, CA 94305 USA; Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	Stanford University; Stanford University; University of Pennsylvania	Kim, SK (corresponding author), Stanford Univ, Sch Med, Beckman Ctr B300, Dept Dev Biol,Oncol Div, Stanford, CA 94305 USA.	seungkim@cmgm.stanford.edu		Kim, Seung/0000-0001-6135-7810				AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Bokvist K, 1999, PFLUG ARCH EUR J PHY, V438, P428, DOI 10.1007/s004240051058; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; COPENHAVER PF, 1991, DEVELOPMENT, V113, P111; DEVELASCO B, IN PRESS DEV BIOL; Doring F, 2002, J BIOL CHEM, V277, P25554, DOI 10.1074/jbc.M202385200; Gelling RW, 2003, P NATL ACAD SCI USA, V100, P1438, DOI 10.1073/pnas.0237106100; Gopel SO, 2000, J PHYSIOL-LONDON, V528, P509, DOI 10.1111/j.1469-7793.2000.00509.x; Hoy M, 2000, J PHYSIOL-LONDON, V527, P109, DOI 10.1111/j.1469-7793.2000.00109.x; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; McNabb SL, 1997, NEURON, V19, P813, DOI 10.1016/S0896-6273(00)80963-0; Miki T, 2001, NAT NEUROSCI, V4, P507, DOI 10.1038/87455; Nasonkin I, 1999, J BIOL CHEM, V274, P29420, DOI 10.1074/jbc.274.41.29420; NOYES BE, 1995, MOL CELL ENDOCRINOL, V109, P133, DOI 10.1016/0303-7207(95)03492-P; ORCHARD I, 1981, J NEUROBIOL, V12, P143, DOI 10.1002/neu.480120204; Ostergard T, 2004, J CLIN ENDOCR METAB, V89, P297, DOI 10.1210/jc.2003-031011; PANNABECKER T, 1987, BRAIN RES, V423, P13, DOI 10.1016/0006-8993(87)90819-5; PANNABECKER T, 1989, BRAIN RES, V477, P38, DOI 10.1016/0006-8993(89)91392-9; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; Passier PCCM, 1997, J ENDOCRINOL, V153, P299, DOI 10.1677/joe.0.1530299; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Seino S, 2003, PROG BIOPHYS MOL BIO, V81, P133, DOI 10.1016/S0079-6107(02)00053-6; Staubli F, 2002, P NATL ACAD SCI USA, V99, P3446, DOI 10.1073/pnas.052556499; STURGESS NC, 1985, LANCET, V2, P474; TOMANCAK P, BERKELEY DROSOPHILA; TRUBE G, 1986, PFLUG ARCH EUR J PHY, V407, P493, DOI 10.1007/BF00657506; Van der Horst DJ, 2003, COMP BIOCHEM PHYS B, V136, P217, DOI 10.1016/S1096-4959(03)00151-9; Veelaert D, 1998, INT REV CYTOL, V182, P249, DOI 10.1016/S0074-7696(08)62171-3; Yu DH, 2003, J NEUROSCI, V23, P64	30	320	328	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 16	2004	431	7006					316	320		10.1038/nature02897	http://dx.doi.org/10.1038/nature02897			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372035				2022-12-24	WOS:000223864000043
J	van Halteren, HK; Bongaerts, GPA; Wagener, DJT				van Halteren, HK; Bongaerts, GPA; Wagener, DJT			Cancer and psychosocial distress: frequent companions	LANCET			English	Editorial Material									Oosterschelde Hosp, Dept Internal Med, Goes, Netherlands; Univ Med Ctr, Dept Med Microbiol, Nijmegen, Netherlands; Univ Med Ctr, Dept Med Oncol, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	van Halteren, HK (corresponding author), Oosterschelde Hosp, Dept Internal Med, Goes, Netherlands.	Hvanhalteren@soz.nl						Carlson LE, 2004, BRIT J CANCER, V90, P2297, DOI 10.1038/sj.bjc.6601887; Derogatis, 2001, BRIEF SYMPTOM INVENT; National Comprehensive Cancer Network, NCCN CLIN PRACT GUID; Ross L, 2002, EUR J CANCER, V38, P1447, DOI 10.1016/S0959-8049(02)00126-0	4	2	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 4	2004	364	9437					824	825		10.1016/S0140-6736(04)16997-3	http://dx.doi.org/10.1016/S0140-6736(04)16997-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	851KY	15351174				2022-12-24	WOS:000223685200008
J	Ugalde, JA; Chang, BSW; Matz, MV				Ugalde, JA; Chang, BSW; Matz, MV			Evolution of coral pigments recreated	SCIENCE			English	Article							FEATURES		Univ Florida, Whitney Lab, Gainesville, FL 32611 USA; Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA; Univ Chile, Lab Bioinformat & Gene Express, Santiago, Chile; Univ Toronto, Dept Zool, Toronto, ON, Canada	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Universidad de Chile; University of Toronto	Matz, MV (corresponding author), Univ Florida, Whitney Lab, Gainesville, FL 32611 USA.	matz@whitney.ufl.edu	Ugalde, Juan Antonio/GLV-2034-2022; Ugalde, Juan/E-7070-2010; Matz, Mikhail V/K-4392-2017	Ugalde, Juan Antonio/0000-0001-6638-0817; Ugalde, Juan/0000-0001-6638-0817; Matz, Mikhail V/0000-0001-5453-9819				Kelmanson IV, 2003, MOL BIOL EVOL, V20, P1125, DOI 10.1093/molbev/msg130; Lenski RE, 2003, NATURE, V423, P139, DOI 10.1038/nature01568; Miyawaki A, 2003, CURR OPIN CHEM BIOL, V7, P557, DOI 10.1016/S1367-5931(03)00097-8; Shagin DA, 2004, MOL BIOL EVOL, V21, P841, DOI 10.1093/molbev/msh079; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	5	96	99	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2004	305	5689					1433	1433		10.1126/science.1099597	http://dx.doi.org/10.1126/science.1099597			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852NK	15353795				2022-12-24	WOS:000223761900038
J	Beatty, CD; Beirinckx, K; Sherratt, TN				Beatty, CD; Beirinckx, K; Sherratt, TN			The evolution of mullerian mimicry in multispecies communities	NATURE			English	Article							NATURAL-SELECTION; APOSEMATIC PREY; WARNING SIGNALS; COLOR	Prey species that are unprofitable to attack often share conspicuous colours and patterns with other coexisting defended species(1-6). This phenomenon, termed mullerian mimicry(2,3), has long been explained as a consequence of selection on defended prey to adopt a common way of advertising their unprofitability(7,8). However, studies using two unpalatable prey types have not always supported this theory(9-12). Here we show, using a system of humans hunting for computer-generated prey, that predators do not always generate strong selection for mimicry when there are two unprofitable prey types. By contrast, we demonstrate that when predators are faced with a range of different prey species, selection on unprofitable prey to resemble one another can be intense. Here the primary selective force is not one in which predators evaluate the profitabilities of distinct prey types independently, but one in which predators learn better to avoid unprofitable phenotypes that share traits distinguishing them from profitable prey(13,14). This need to simplify decision making readily facilitates the spread of imperfect mimetic forms from rarity, and suggests that mullerian mimicry is more likely to arise in multispecies communities.	Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada	Carleton University	Sherratt, TN (corresponding author), Carleton Univ, Dept Biol, 1125 Colonel Dr, Ottawa, ON K1S 5B6, Canada.	sherratt@ccs.carleton.ca	Beatty, Christopher/ABE-6438-2020	Beatty, Christopher/0000-0003-2641-0000				Alatalo RV, 1996, NATURE, V382, P708, DOI 10.1038/382708a0; Bates HW., 1862, T LINN SOC LOND, V1, P495, DOI DOI 10.1111/J.1096-3642.1860.TB00146.X; BEATTY CD, UNPUB ANIM BEHAV; BENSON WW, 1972, SCIENCE, V176, P936, DOI 10.1126/science.176.4037.936; Dukas R, 2002, PHILOS T R SOC B, V357, P1539, DOI 10.1098/rstb.2002.1063; Fisher R. A., 1930, GENETICAL THEORY NAT, DOI 10.5962/bhl.title.27468; Glanville PW, 1997, OIKOS, V80, P565, DOI 10.2307/3546630; Gotmark F, 1995, OIKOS, V74, P475, DOI 10.2307/3545993; GREENWOOD JJD, 1989, BIOL J LINN SOC, V36, P213, DOI 10.1111/j.1095-8312.1989.tb00491.x; GREENWOOD JJD, 1981, HEREDITY, V47, P27, DOI 10.1038/hdy.1981.56; Kapan DD, 2001, NATURE, V409, P338, DOI 10.1038/35053066; Lindstrom L, 2001, P NATL ACAD SCI USA, V98, P9181, DOI 10.1073/pnas.161071598; M?ller F., 1878, ZOOL ANZ, V1, P54; MacDougall A, 1998, ANIM BEHAV, V55, P1281, DOI 10.1006/anbe.1997.0702; MALLET J, 1995, BIOL J LINN SOC, V55, P159, DOI 10.1006/bijl.1995.0034; Mallet J, 1999, ANNU REV ECOL SYST, V30, P201, DOI 10.1146/annurev.ecolsys.30.1.201; Mallet J, 2001, P NATL ACAD SCI USA, V98, P8928, DOI 10.1073/pnas.171326298; MALLET J, 1989, EVOLUTION, V43, P421, DOI 10.1111/j.1558-5646.1989.tb04237.x; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; MULLER F, 1879, P ENTOMOL SOC LOND, pR20; PEARCE JM, 1994, ANIMAL LEARNING COGN, P110; Poulton EB, 1890, COLOURS ANIMALS THEI; Rowe C, 2004, P ROY SOC B-BIOL SCI, V271, P407, DOI 10.1098/rspb.2003.2615; Ruxton GD, 1998, NATURE, V394, P833, DOI 10.1038/29652; SBORDONI V, 1979, ECOL ENTOMOL, V4, P83, DOI 10.1111/j.1365-2311.1979.tb00563.x; SHEPARD RN, 1961, PSYCHOL MONOGR, V75, P1, DOI 10.1037/h0093825; Sherratt TN, 2003, AM NAT, V162, P377, DOI 10.1086/378047; Shettleworth, 2010, COGNITION EVOLUTION; Symula R, 2001, P ROY SOC B-BIOL SCI, V268, P2415, DOI 10.1098/rspb.2001.1812; TURNER JRG, 1984, BIOL BUTTERFLIES, P141	30	85	85	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 2	2004	431	7004					63	67		10.1038/nature02818	http://dx.doi.org/10.1038/nature02818			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850VC	15343332				2022-12-24	WOS:000223641500041
J	Harbison, CT; Gordon, DB; Lee, TI; Rinaldi, NJ; Macisaac, KD; Danford, TW; Hannett, NM; Tagne, JB; Reynolds, DB; Yoo, J; Jennings, EG; Zeitlinger, J; Pokholok, DK; Kellis, M; Rolfe, PA; Takusagawa, KT; Lander, ES; Gifford, DK; Fraenkel, E; Young, RA				Harbison, CT; Gordon, DB; Lee, TI; Rinaldi, NJ; Macisaac, KD; Danford, TW; Hannett, NM; Tagne, JB; Reynolds, DB; Yoo, J; Jennings, EG; Zeitlinger, J; Pokholok, DK; Kellis, M; Rolfe, PA; Takusagawa, KT; Lander, ES; Gifford, DK; Fraenkel, E; Young, RA			Transcriptional regulatory code of a eukaryotic genome	NATURE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; BINDING-SITES; SEQUENCES; GCN4; PROTEINS; DATABASE; MOTIFS; GENES	DNA-binding transcriptional regulators interpret the genome's regulatory code by binding to specific sequences to induce or repress gene expression(1). Comparative genomics has recently been used to identify potential cis-regulatory sequences within the yeast genome on the basis of phylogenetic conservation(2-6), but this information alone does not reveal if or when transcriptional regulators occupy these binding sites. We have constructed an initial map of yeast's transcriptional regulatory code by identifying the sequence elements that are bound by regulators under various conditions and that are conserved among Saccharomyces species. The organization of regulatory elements in promoters and the environment-dependent use of these elements by regulators are discussed. We find that environment-specific use of regulatory elements predicts mechanistic models for the function of a large population of yeast's transcriptional regulators.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; Broad Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	efraenkel@wi.mit.edu; young@wi.mit.edu	Rinaldi, Nicola J/J-5858-2017; Kellis, Manolis/ABE-7385-2020; Young, Richard A/F-6495-2012	Rinaldi, Nicola J/0000-0002-0358-0747; Kellis, Manolis/0000-0001-7113-9630; Young, Richard A/0000-0001-8855-8647; Tagne, Jean-Bosco/0000-0003-1830-9156; Fraenkel, Ernest/0000-0001-9249-8181	NHGRI NIH HHS [R01 HG002668-01, R01 HG004037, R01 HG002668] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004037, R01HG002668] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Albrecht G, 1998, J BIOL CHEM, V273, P12696, DOI 10.1074/jbc.273.21.12696; AXELROD JD, 1991, MOL CELL BIOL, V11, P564, DOI 10.1128/MCB.11.1.564; Bailey T L, 1995, Proc Int Conf Intell Syst Mol Biol, V3, P21; Baur M, 1997, MOL CELL BIOL, V17, P4330, DOI 10.1128/MCB.17.8.4330; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Blanchette M, 2003, NUCLEIC ACIDS RES, V31, P3840, DOI 10.1093/nar/gkg606; Chi Y, 2001, GENE DEV, V15, P1078, DOI 10.1101/gad.867501; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; CUNNINGHAM TS, 1993, J BACTERIOL, V175, P5851, DOI 10.1128/JB.175.18.5851-5861.1993; DONAHUE TF, 1983, CELL, V32, P89, DOI 10.1016/0092-8674(83)90499-3; Hodges PE, 1999, NUCLEIC ACIDS RES, V27, P69, DOI 10.1093/nar/27.1.69; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; KIRKPATRICK CR, 1995, MOL CELL BIOL, V15, P4021; Knuppel R, 1994, J Comput Biol, V1, P191, DOI 10.1089/cmb.1994.1.191; KORNITZER D, 1994, EMBO J, V13, P6021, DOI 10.1002/j.1460-2075.1994.tb06948.x; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; MA J, 1987, CELL, V50, P137, DOI 10.1016/0092-8674(87)90670-2; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Pritsker M, 2004, GENOME RES, V14, P99; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Wang T, 2003, BIOINFORMATICS, V19, P2369, DOI 10.1093/bioinformatics/btg329; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Zeitlinger J, 2003, CELL, V113, P395, DOI 10.1016/S0092-8674(03)00301-5; Zhu J, 1999, BIOINFORMATICS, V15, P607, DOI 10.1093/bioinformatics/15.7.607	30	1640	1691	1	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 2	2004	431	7004					99	104		10.1038/nature02800	http://dx.doi.org/10.1038/nature02800			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850VC	15343339	Green Accepted			2022-12-24	WOS:000223641500050
J	Zhang, JS; Kalkum, M; Yamamura, S; Chait, BT; Roeder, RG				Zhang, JS; Kalkum, M; Yamamura, S; Chait, BT; Roeder, RG			E protein silencing by the leukemogenic AML1-ETO fusion protein	SCIENCE			English	Article							LOOP-HELIX PROTEINS; TRANSLOCATION; EXPANSION; LEUKEMIA; TRANSCRIPTION; REGULATORS; EXPRESSION; PROMOTES; BINDING; MODEL	The AML1-ETO fusion protein, generated by the t(8;21) chromosomal translocation, is causally involved in nearly 15% of acute myeloid leukemia (AML) cases. This study shows that AML1-ETO, as well as ETO, inhibits transcriptional activation by E proteins through stable interactions that preclude recruitment of p300/CREB-binding protein (CBP) coactivators. These interactions are mediated by a conserved ETO TAF4 homology domain and a 17-amino acid p300/CBP and ETO target motif within AD1 activation domains of E proteins. In t(8;21) leukemic cells, very stable interactions between AML1-ETO and E proteins underlie a t(8;21) translocation-specific silencing of E protein function through an aberrant cofactor exchange mechanism. These studies identify E proteins as AML1-ETO targets whose dysregulation may be important for t(8;21) leukemogenesis, as well as an E protein silencing mechanism that is distinct from that associated with differentiation-inhibitory proteins.	Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA; Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10021 USA	Rockefeller University; Rockefeller University	Roeder, RG (corresponding author), Rockefeller Univ, Biochem & Mol Biol Lab, 1230 York Ave, New York, NY 10021 USA.	roeder@mail.rockefeller.edu		Zhang, Jinsong/0000-0002-8798-7316; Kalkum, Markus/0000-0002-9506-671X				Calabi F, 2001, MOL CELL BIOL, V21, P5658, DOI 10.1128/MCB.21.16.5658-5666.2001; de Guzman CG, 2002, MOL CELL BIOL, V22, P5506, DOI 10.1128/MCB.22.15.5506-5517.2002; Engel I, 1999, P NATL ACAD SCI USA, V96, P996, DOI 10.1073/pnas.96.3.996; Engel I, 2004, EMBO J, V23, P202, DOI 10.1038/sj.emboj.7600017; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; HU JS, 1992, MOL CELL BIOL, V12, P1031, DOI 10.1128/MCB.12.3.1031; Hug BA, 2004, ONCOGENE, V23, P4270, DOI 10.1038/sj.onc.1207674; Hug BA, 2002, CANCER RES, V62, P2906; Kitabayashi I, 1998, MOL CELL BIOL, V18, P846, DOI 10.1128/MCB.18.2.846; LASSAR AB, 1991, CELL, V66, P305, DOI 10.1016/0092-8674(91)90620-E; Licht JD, 2001, ONCOGENE, V20, P5660, DOI 10.1038/sj.onc.1204593; Markus M, 2002, J BIOL CHEM, V277, P6469, DOI 10.1074/jbc.M110659200; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; MIYOSHI H, 1993, EMBO J, V12, P2715, DOI 10.1002/j.1460-2075.1993.tb05933.x; Mulloy JC, 2002, BLOOD, V99, P15, DOI 10.1182/blood.V99.1.15; Okuda T, 1998, BLOOD, V91, P3134, DOI 10.1182/blood.V91.9.3134.3134_3134_3143; Pagliuca A, 2000, CANCER RES, V60, P1376; Quong MW, 2002, ANNU REV IMMUNOL, V20, P301, DOI 10.1146/annurev.immunol.20.092501.162048; Rhoades KL, 2000, BLOOD, V96, P2108; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Scandura JM, 2002, ONCOGENE, V21, P3422, DOI 10.1038/sj.onc.1205315; Schwieger M, 2002, J EXP MED, V196, P1227, DOI 10.1084/jem.20020824; Sjogren H, 2000, CANCER RES, V60, P6832; ZHANG J, UNPUB	24	163	170	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 27	2004	305	5688					1286	1289		10.1126/science.1097937	http://dx.doi.org/10.1126/science.1097937			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850PJ	15333839				2022-12-24	WOS:000223624600040
J	Schulze, MB; Manson, JE; Ludwig, DS; Colditz, GA; Stampfer, MJ; Willett, WC; Hu, FB				Schulze, MB; Manson, JE; Ludwig, DS; Colditz, GA; Stampfer, MJ; Willett, WC; Hu, FB			Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FRUCTOSE CORN SYRUP; FOOD-FREQUENCY QUESTIONNAIRE; GLYCEMIC INDEX; BODY-WEIGHT; COFFEE CONSUMPTION; PHYSICAL-ACTIVITY; SOFT DRINK; MELLITUS; RISK; VALIDITY	Context Sugar-sweetened beverages like soft drinks and fruit punches contain large amounts of readily absorbable sugars and may contribute to weight gain and an increased risk of type 2 diabetes, but these relationships have been minimally addressed in adults. Objective To examine the association between consumption of sugar-sweetened beverages and weight change and risk of type 2 diabetes in women. Design, Setting, and Participants Prospective cohort analyses conducted from 1991 to 1999 among women in the Nurses' Health Study II. The diabetes analysis included 91249 women free of diabetes and other major chronic diseases at baseline in 1991. The weight change analysis included 51603 women for whom complete dietary information and body weight were ascertained in 1991, 1995, and 1999. We identified 741 incident cases of confirmed type 2 diabetes during 716300 person-years of follow-up. Main Outcome Measures Weight gain and incidence of type 2 diabetes. Results Those with stable consumption patterns had no difference in weight gain, but weight gain over a 4-year period was highest among women who increased their sugar-sweetened soft drink consumption from 1 or fewer drinks per week to 1 or more drinks per day (multivariate-adjusted means, 4.69 kg for 1991 to 1995 and 4.20 kg for 1995 to 1999) and was smallest among women who decreased their intake (1.34 and 0.15 kg for the 2 periods, respectively) after adjusting for lifestyle and dietary confounders. increased consumption of fruit punch was also associated with greater weight gain compared with decreased consumption. After adjustment for potential confounders, women consuming 1 or more sugar-sweetened soft drinks per day had a relative risk [RR] of type 2 diabetes of 1.83 (95% confidence interval [CI], 1.42-2.36; P<.001 for trend) compared with those who consumed less than 1 of these beverages per month. Similarly, consumption of fruit punch was associated with increased diabetes risk (RR for &GE;1 drink per day compared with <1 drink per month, 2.00; 95% Cl, 1.33-3.03; P=.001). Conclusion Higher consumption of sugar-sweetened beverages is associated with a greater magnitude of weight gain and an increased risk for development of type 2 diabetes in women, possibly by providing excessive calories and large amounts of rapidly absorbable sugars.	Harvard Univ, Sch Publ Hlth, Dept Nutr, Div Prevent Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Div Prevent Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; Harvard Univ, Sch Med, Boston, MA USA; Childrens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Schulze, MB (corresponding author), German Inst Human Nutr, Dept Epidemiol, Arthur Scheunert Allee 114-116, D-14558 Nuthetal, Germany.	mschulze@channing.harvard.edu	Hu, Frank/C-1919-2013; Colditz, Graham/A-3963-2009; Schulze, Matthias B/AAH-6906-2021	Colditz, Graham/0000-0002-7307-0291; Schulze, Matthias B/0000-0002-0830-5277; Ludwig, David/0000-0003-3307-8544	NATIONAL CANCER INSTITUTE [R01CA050385] Funding Source: NIH RePORTER; NCI NIH HHS [CA50385] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; AKGUN S, 1985, DIABETES CARE, V8, P279, DOI 10.2337/diacare.8.3.279; Almiron-Roig E, 2003, PHYSIOL BEHAV, V79, P767, DOI 10.1016/S0031-9384(03)00212-9; [Anonymous], 2003, MMWR-MORBID MORTAL W, V52, P833; Beridot-Therond ME, 1998, APPETITE, V31, P67, DOI 10.1006/appe.1997.0153; Bray GA, 2004, AM J CLIN NUTR, V79, P537; Centre for Disease Control and Prevention, 2002, NAT DIAB FACT SHEET; DECASTRO JM, 1993, PHYSIOL BEHAV, V53, P1133, DOI 10.1016/0031-9384(93)90370-U; DiMeglio DP, 2000, INT J OBESITY, V24, P794, DOI 10.1038/sj.ijo.0801229; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; Foster-Powell K, 2002, AM J CLIN NUTR, V76, P5, DOI 10.1093/ajcn/76.1.5; French SA, 2003, J AM DIET ASSOC, V103, P1326, DOI 10.1016/S0002-8223(03)01076-9; Gavin JR, 1997, DIABETES CARE, V20, P1183; HARRIS M, 1979, DIABETES, V28, P1039; Hofmann SM, 2002, DIABETES, V51, P2082, DOI 10.2337/diabetes.51.7.2082; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Hu FB, 1999, AM J CLIN NUTR, V69, P243; Janssens JP, 1999, EUR J CANCER PREV, V8, P289, DOI 10.1097/00008469-199908000-00004; Kuczmarski MF, 2001, J AM DIET ASSOC, V101, P28, DOI 10.1016/S0002-8223(01)00008-6; Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1; MANSON JE, 1991, LANCET, V338, P774, DOI 10.1016/0140-6736(91)90664-B; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; Mokdad AH, 2000, DIABETES CARE, V23, P1278, DOI 10.2337/diacare.23.9.1278; PUTNAM JJ, STAT B FOOD RURAL EC, V965; Raben A, 2002, AM J CLIN NUTR, V76, P721, DOI 10.1093/ajcn/76.4.721; ROLLS BJ, 1990, PHYSIOL BEHAV, V48, P19, DOI 10.1016/0031-9384(90)90254-2; Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; Schulze MB, 2004, AM J CLIN NUTR, V80, P348, DOI 10.1093/ajcn/80.2.348; SCLAFANI A, 1991, BRAIN RES BULL, V27, P383, DOI 10.1016/0361-9230(91)90129-8; TORDOFF MG, 1990, AM J CLIN NUTR, V51, P963, DOI 10.1093/ajcn/51.6.963; *USDA, 1992, COMP FOODS RAW PROC; van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X; Vlassara H, 2002, P NATL ACAD SCI USA, V99, P15596, DOI 10.1073/pnas.242407999; WILLETT W, 1983, AM J EPIDEMIOL, V117, P651, DOI 10.1093/oxfordjournals.aje.a113598; Willett W, 2002, AM J CLIN NUTR, V76, p274S, DOI 10.1093/ajcn/76.1.274S; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991	38	1071	1112	3	213	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 25	2004	292	8					927	934		10.1001/jama.292.8.927	http://dx.doi.org/10.1001/jama.292.8.927			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	847WR	15328324				2022-12-24	WOS:000223429200017
J	Wilga, CD; Lauder, GV				Wilga, CD; Lauder, GV			Biomechanics - Hydrodynamic function of the shark's tail	NATURE			English	Editorial Material							CAUDAL FIN LOCOMOTION; HETEROCERCAL TAIL; WAKE DYNAMICS; FISHES		Univ Rhode Isl, Dept Biol Sci, Kingston, RI 02881 USA; Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA	University of Rhode Island; Harvard University	Wilga, CD (corresponding author), Univ Rhode Isl, Dept Biol Sci, Kingston, RI 02881 USA.	cwilga@uri.edu						ALEXANDER RM, 1965, J EXP BIOL, V43, P131; Drucker EG, 1999, J EXP BIOL, V202, P2393; Ferry LA, 1996, J EXP BIOL, V199, P2253; GROVE A. J., 1936, ANN AND MAG NAT HIST, V17, P280; Lauder GV, 2000, AM ZOOL, V40, P101, DOI 10.1668/0003-1569(2000)040[0101:FOTCFD]2.0.CO;2; LAUDER GV, 1989, AM ZOOL, V29, P85; Nauen JC, 2002, J EXP BIOL, V205, P1709; THOMSON K S, 1976, Paleobiology, V2, P19; Webster DR, 1998, PHYS FLUIDS, V10, P400, DOI 10.1063/1.869531; Webster DR, 1997, PHYS FLUIDS, V9, P655, DOI 10.1063/1.869223; Wilga CD, 2002, J EXP BIOL, V205, P2365	11	78	80	9	164	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 19	2004	430	7002					850	850		10.1038/430850a	http://dx.doi.org/10.1038/430850a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318211	Bronze			2022-12-24	WOS:000223369800031
J	Wilson, JF				Wilson, JF			Searching for epilepsy solutions	ANNALS OF INTERNAL MEDICINE			English	Editorial Material												jenwilson@acponline.org	Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136					0	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 17	2004	141	4					329	332		10.7326/0003-4819-141-4-200408170-00032	http://dx.doi.org/10.7326/0003-4819-141-4-200408170-00032			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	846BX	15313762				2022-12-24	WOS:000223290900025
J	Voets, T; Droogmans, G; Wissenbach, U; Janssens, A; Flockerzi, V; Nilius, B				Voets, T; Droogmans, G; Wissenbach, U; Janssens, A; Flockerzi, V; Nilius, B			The principle of temperature-dependent gating in cold- and heat-sensitive TRP channels	NATURE			English	Article							CAPSAICIN-RECEPTOR; EVOKED ACTIVATION; ION-CHANNEL; VOLTAGE; MECHANISMS	The mammalian sensory system is capable of discriminating thermal stimuli ranging from noxious cold to noxious heat. Principal temperature sensors belong to the TRP cation channel family, but the mechanisms underlying the marked temperature sensitivity of opening and closing ('gating') of these channels are unknown. Here we show that temperature sensing is tightly linked to voltage-dependent gating in the cold-sensitive channel TRPM8 and the heat-sensitive channel TRPV1. Both channels are activated upon depolarization, and changes in temperature result in graded shifts of their voltage-dependent activation curves. The chemical agonists menthol ( TRPM8) and capsaicin ( TRPV1) function as gating modifiers, shifting activation curves towards physiological membrane potentials. Kinetic analysis of gating at different temperatures indicates that temperature sensitivity in TRPM8 and TRPV1 arises from a tenfold difference in the activation energies associated with voltage-dependent opening and closing. Our results suggest a simple unifying principle that explains both cold and heat sensitivity in TRP channels.	Katholieke Univ Leuven, Physiol Lab, B-3000 Louvain, Belgium; Univ Saarland, Fak Med, D-66421 Homburg, Germany	KU Leuven; Saarland University	Voets, T (corresponding author), Katholieke Univ Leuven, Physiol Lab, Campus Gasthuisberg, B-3000 Louvain, Belgium.	Thomas.Voets@med.kuleuven.ac.be	Voets, Thomas/AAD-4389-2019; Voets, Thomas/E-2466-2012	Voets, Thomas/0000-0001-5526-5821; Voets, Thomas/0000-0001-5526-5821; Janssens, Annelies/0000-0002-6735-8248				Behrendt HJ, 2004, BRIT J PHARMACOL, V141, P737, DOI 10.1038/sj.bjp.0705652; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Chung MK, 2003, J BIOL CHEM, V278, P32037, DOI 10.1074/jbc.M303251200; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Guler AD, 2002, J NEUROSCI, V22, P6408; Gunthorpe MJ, 2000, J PHYSIOL-LONDON, V525, P747, DOI 10.1111/j.1469-7793.2000.t01-1-00747.x; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hofmann T, 2003, CURR BIOL, V13, P1153, DOI 10.1016/S0960-9822(03)00431-7; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Liu BY, 2003, BIOPHYS J, V85, P2988, DOI 10.1016/S0006-3495(03)74719-5; MARSH D, 1991, CHEM PHYS LIPIDS, V57, P109, DOI 10.1016/0009-3084(91)90071-I; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Nilius B, 2003, J BIOL CHEM, V278, P30813, DOI 10.1074/jbc.M305127200; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Tiwari JK, 1999, EUR BIOPHYS J BIOPHY, V28, P338, DOI 10.1007/s002490050216; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; VANLUNTEREN E, 1993, J PHYSIOL-LONDON, V466, P81; Vlachova V, 2003, J NEUROSCI, V23, P1340, DOI 10.1523/JNEUROSCI.23-04-01340.2003; Voets T, 2003, J MEMBRANE BIOL, V192, P1, DOI 10.1007/s00232-002-1059-8; Watanabe H, 2002, J BIOL CHEM, V277, P47044, DOI 10.1074/jbc.M208277200; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	31	728	776	1	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2004	430	7001					748	754		10.1038/nature02732	http://dx.doi.org/10.1038/nature02732			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306801	Green Published			2022-12-24	WOS:000223233600033
J	Seward, JF; Zhang, JX; Maupin, TJ; Mascola, L; Jumaan, AO				Seward, JF; Zhang, JX; Maupin, TJ; Mascola, L; Jumaan, AO			Contagiousness of varicella in vaccinated cases - A household contact study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; FAMILY CONTACTS; OUTBREAK; CHILDREN; SCHOOL; POSTLICENSURE; INFECTIONS; CHICKENPOX; AGE	Context Limited data are available on the contagiousness of vaccinated varicella cases Objectives To describe secondary attack rates within households according to disease history and vaccination status of the primary case and household contacts and to estimate varicella vaccine effectiveness. Design, Setting, and Patients Population-based, active varicella surveillance project in a community of approximately 320000 in Los Angeles County, California, during 1997 and 2001. Varicella cases were reported by child care centers, private and public schools, and health care clinicians and were investigated to collect demographic, clinical, medical, and vaccination data. Information on household contacts' age, varicella history, and vaccination status was collected. Main Outcome Measures Varicella secondary attack rate among household contacts; vaccine effectiveness using secondary attack rates in unvaccinated and vaccinated children and adolescents. Results A total of 6316 varicella cases were reported. Among children and adolescents aged 1 to 14 years, secondary attack rates varied according to age and by disease and vaccination status of the primary case and exposed household contacts. Among contacts aged 1 to 14 years exposed to unvaccinated cases, the secondary attack rate was 71.5% if they were unvaccinated and 15.1% if they were vaccinated (risk ratio [RR], 0.21; 95% confidence interval [CI], 0.15-0.30). Overall, vaccinated cases were half as contagious as unvaccinated cases. However, vaccinated cases with 50 lesions or more were similarly contagious as unvaccinated cases whereas those with fewer than 50 lesions were only one third as contagious (secondary attack rate, 23.4%; RR, 0.32 [95% CI, 0.19-0.53]). Vaccine effectiveness for prevention of all disease was 78.9% (95% CI, 69.7%-85.3%); moderate disease, 92% (50-500 lesions) and 100% (clinician visit); and severe disease, 100%. Conclusions Under conditions of intense exposure, varicella vaccine was highly effective in preventing moderate and severe disease and about 80% effective in preventing all disease. Breakthrough varicella cases in household settings were half as contagious as unvaccinated persons with varicella, although contagiousness varied with numbers of lesions.	Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; Los Angeles Cty Dept Hlth Serv, Los Angeles, CA USA	Centers for Disease Control & Prevention - USA	Seward, JF (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd,MS E-62, Atlanta, GA 30333 USA.	jseward@cdc.gov						ARBETER AM, 1986, PEDIATRICS, V78, P748; ASANO Y, 1977, PEDIATRICS, V59, P3; BALFOUR HH, 1990, J PEDIATR-US, V116, P633, DOI 10.1016/S0022-3476(05)81618-X; BERNSTEIN HH, 1993, PEDIATRICS, V92, P833; *CDCP, 2003, MMWR-MORBID MORTAL W, V52, P545; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P884; Clements DA, 1999, PEDIATR INFECT DIS J, V18, P1047, DOI 10.1097/00006454-199912000-00004; Dworkin MS, 2002, CLIN INFECT DIS, V35, P102, DOI 10.1086/340868; Galil K, 2002, J INFECT DIS, V186, P102, DOI 10.1086/341089; Galil K, 2002, NEW ENGL J MED, V347, P1909, DOI 10.1056/NEJMoa021662; Galil K, 2002, PEDIATR INFECT DIS J, V21, P931, DOI 10.1097/00006454-200210000-00009; Gershon AA, 2002, NEW ENGL J MED, V347, P1962, DOI 10.1056/NEJMe020138; Hall S, 2002, PEDIATRICS, V109, P1068, DOI 10.1542/peds.109.6.1068; HOBBS F, 2002, CENSUS 2000 SPECIAL; HOPESIMPSON RE, 1952, LANCET, V2, P549, DOI DOI 10.1016/S0140-6736(52)91357-3; Izurieta HS, 1997, JAMA-J AM MED ASSOC, V278, P1495, DOI 10.1001/jama.278.18.1495; JUNKER AK, 1991, PEDIATR INFECT DIS J, V10, P569, DOI 10.1097/00006454-199108000-00004; Kann Laura, 1996, Morbidity and Mortality Weekly Report, V45, P1; Kleinbaum DG, 1982, EPIDEMIOLOGIC RES PR; Kuter B, 2004, PEDIATR INFECT DIS J, V23, P132, DOI 10.1097/01.inf.0000109287.97518.67; Lieu TA, 1998, PEDIATR INFECT DIS J, V17, P120, DOI 10.1097/00006454-199802000-00008; Meyer PA, 2000, J INFECT DIS, V182, P383, DOI 10.1086/315714; ORENSTEIN WA, 1985, B WORLD HEALTH ORGAN, V63, P1055; ROSS AH, 1962, NEW ENGL J MED, V267, P369, DOI 10.1056/NEJM196208232670801; Seward JF, 2002, JAMA-J AM MED ASSOC, V287, P606, DOI 10.1001/jama.287.5.606; Tugwell BD, 2004, PEDIATRICS, V113, P455, DOI 10.1542/peds.113.3.455; Vazquez M, 2004, JAMA-J AM MED ASSOC, V291, P851, DOI 10.1001/jama.291.7.851; Vazquez M, 2001, NEW ENGL J MED, V344, P955, DOI 10.1056/NEJM200103293441302; WATSON BM, 1993, PEDIATRICS, V91, P17; Wharton M, 1996, INFECT DIS CLIN N AM, V10, P571, DOI 10.1016/S0891-5520(05)70313-5	30	124	138	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2004	292	6					704	708		10.1001/jama.292.6.704	http://dx.doi.org/10.1001/jama.292.6.704			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844RM	15304467	Bronze			2022-12-24	WOS:000223177300024
J	Daly, MJ; Gaidamakova, EK; Matrosova, VY; Vasilenko, A; Zhai, M; Venkateswaran, A; Hess, M; Omelchenko, MV; Kostandarithes, HM; Makarova, KS; Wackett, LP; Fredrickson, JK; Ghosal, D				Daly, MJ; Gaidamakova, EK; Matrosova, VY; Vasilenko, A; Zhai, M; Venkateswaran, A; Hess, M; Omelchenko, MV; Kostandarithes, HM; Makarova, KS; Wackett, LP; Fredrickson, JK; Ghosal, D			Accumulation of Mn(II) in, Deinococcus radiodurans facilitates gamma-radiation resistance	SCIENCE			English	Article							IONIZING-RADIATION; MICROCOCCUS-RADIODURANS; SUPEROXIDE-DISMUTASE; TARGETED MUTAGENESIS; HYDROGEN-PEROXIDE; GENOME SEQUENCE; BACTERIUM; IRON; DNA; RADIORESISTANCE	Deinococcus radiodurans is extremely resistant to ionizing radiation. How this bacterium can grow under chronic gamma radiation [50 grays (Gy) per hour] or recover from acute doses greater than 10 kGy is unknown. We show that D. radiodurans accumulates very high intracellular manganese and low iron levels compared with radiation-sensitive bacteria and that resistance exhibits a concentration-dependent response to manganous chloride [Mn(II)]. Among the most radiation-resistant bacterial groups reported, Deinococcus, Enterococcus, Lactobacillus, and cyanobacteria accumulate Mn(II). in contrast, Shewanella oneidensis and Pseudomonas putida have high iron but low intracellular manganese concentrations and are very sensitive. We propose that Mn(II) accumulation facilitates recovery from radiation injury.	Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; NIH, Bethesda, MD 20894 USA; Pacific NW Natl Lab, Richland, WA 99352 USA; Univ Minnesota, St Paul, MN 55108 USA	Uniformed Services University of the Health Sciences - USA; National Institutes of Health (NIH) - USA; United States Department of Energy (DOE); Pacific Northwest National Laboratory; University of Minnesota System; University of Minnesota Twin Cities	Daly, MJ (corresponding author), Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.	mdaly@usuhs.mil	Matrosova, Vera/AAX-4125-2020; Hess, Matthias/R-3006-2017; Hess, Matthias/B-1783-2012	Hess, Matthias/0000-0003-0321-0380; 				ARCHIBALD FS, 1986, INFECT IMMUN, V51, P631, DOI 10.1128/IAI.51.2.631-641.1986; Billi D, 2000, APPL ENVIRON MICROB, V66, P1489, DOI 10.1128/AEM.66.4.1489-1492.2000; DALY MJ, 1994, J BACTERIOL, V176, P3508, DOI 10.1128/JB.176.12.3508-3517.1994; Daly MJ, 1996, J BACTERIOL, V178, P4461, DOI 10.1128/jb.178.15.4461-4471.1996; GUTMAN PD, 1993, J BACTERIOL, V175, P3581, DOI 10.1128/jb.175.11.3581-3590.1993; HANSEN MT, 1978, J BACTERIOL, V134, P71, DOI 10.1128/JB.134.1.71-75.1978; HASTINGS JW, 1986, APPL ENVIRON MICROB, V52, P898, DOI 10.1128/AEM.52.4.898-901.1986; Heidelberg JF, 2002, NAT BIOTECHNOL, V20, P1118, DOI 10.1038/nbt749; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Jakubovics NS, 2001, MICROBIOL-SGM, V147, P1709, DOI 10.1099/00221287-147-7-1709; Keren N, 2002, BIOCHEMISTRY-US, V41, P15085, DOI 10.1021/bi026892s; LEIBOWITZ PJ, 1976, PHOTOCHEM PHOTOBIOL, V23, P45; Levin-Zaidman S, 2003, SCIENCE, V299, P254, DOI 10.1126/science.1077865; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; Makarova KS, 2001, MICROBIOL MOL BIOL R, V65, P44, DOI 10.1128/MMBR.65.1.44-79.2001; Markillie LM, 1999, J BACTERIOL, V181, P666, DOI 10.1128/JB.181.2.666-669.1999; Mattimore V, 1996, J BACTERIOL, V178, P633, DOI 10.1128/jb.178.3.633-637.1996; Mehr IJ, 1998, MOL MICROBIOL, V30, P697, DOI 10.1046/j.1365-2958.1998.01089.x; OYAIZU H, 1987, INT J SYST BACTERIOL, V37, P62, DOI 10.1099/00207713-37-1-62; Posey JE, 2000, SCIENCE, V288, P1651, DOI 10.1126/science.288.5471.1651; Reelfs O, 2004, J INVEST DERMATOL, V122, P1440, DOI 10.1111/j.0022-202X.2004.22620.x; REPINE JE, 1981, P NATL ACAD SCI-BIOL, V78, P1001, DOI 10.1073/pnas.78.2.1001; THORNLEY MJ, 1965, ARCH MIKROBIOL, V51, P267, DOI 10.1007/BF00408143; van Gerwen SJC, 1999, J FOOD PROTECT, V62, P1024, DOI 10.4315/0362-028X-62.9.1024; Venkateswaran A, 2000, APPL ENVIRON MICROB, V66, P2620, DOI 10.1128/AEM.66.6.2620-2626.2000; WANG P, 1995, CAN J MICROBIOL, V41, P170, DOI 10.1139/m95-023; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571	27	458	481	5	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 5	2004	306	5698					1025	1028		10.1126/science.1103185	http://dx.doi.org/10.1126/science.1103185			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	869RG	15459345				2022-12-24	WOS:000225001100041
J	Mittendorfer-Rutz, E; Rasmussen, F; Wasserman, D				Mittendorfer-Rutz, E; Rasmussen, F; Wasserman, D			Restricted fetal growth and adverse maternal psychosocial and socioeconomic conditions as risk factors for suicidal behaviour of offspring: a cohort study	LANCET			English	Article							28-YEAR FOLLOW-UP; BODY-MASS INDEX; BIRTH COHORT; PERINATAL COMPLICATIONS; PSYCHIATRIC-DISORDERS; ADOLESCENT SUICIDE; PRENATAL EXPOSURE; EARLY ADULTHOOD; SCHIZOPHRENIA; ASSOCIATION	Background Until now, sparse and contradictory results about an association between adverse neonatal, obstetric, and maternal conditions and heightened suicide risk in adolescents have been reported. The aims of this study were to investigate the relations between fetal growth, obstetric complications, and the mother's psychosocial and socioeconomic situation and the risk in early adulthood of suicide and attempted suicide in the offspring. Methods Obstetric, neonatal, and maternal risk factors for suicide and attempted suicide in 713 370 young adults, born in Sweden between 1973 and 1980, who were followed-up until Dec 31, 1999, were examined by data linkage between Swedish registers. Univariate and multivariate hazard ratios, derived from proportional-hazard models, were estimated. Findings Significantly raised risk of attempted suicide was reported for individuals of short birth length, adjusted for gestational age (hazard ratio 1.29, 95% Cl 1.18-1.41, p < 0.0001); born fourth or more in birth order (1.79, 1.62-1.97, p < 0.0001); born to mothers with a low educational level (1.36, 1.27-1.46, p < 0.0001) (attributable proportion 10.3%); and those who, at time of delivery, had mothers aged 19 years or younger (2.09, 1.89-2.32, p < 0.0001). Significant predictors of suicide were low birthweight, adjusted for gestational age (2.23, 1.43-3.46, p < 0.0001), and teenage motherhood (2.30, 1.64-3.22, p < 0.0001). Interpretation Multiparity and low maternal education predicted suicide attempt, whereas restricted fetal growth and teenage motherhood were associated with both suicide completion and attempt in offspring.	Natl Inst Psychosocial Med, Ctr Suicide Res & Prevent Mental Ill Hlth, Swedish Natl & Stockholm Cty Council, Stockholm, Sweden; Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden	Karolinska Institutet	Wasserman, D (corresponding author), Natl Ctr Suicide Res & Prevent Mental Ill Hlth, Box 230, SE-17177 Stockholm, Sweden.	Danuta.Wasserman@ipm.ki.se		Rasmussen, Finn/0000-0001-7915-7809				Aberg A, 1992, Int J Technol Assess Health Care, V8 Suppl 1, P20; ALLEBECK P, 1991, SCAND J SOC MED, V19, P242, DOI 10.1177/140349489101900405; ALLEBECK P, 1992, PUBLIC HEALTH, V106, P375, DOI 10.1016/S0033-3506(05)80186-6; ANDREWS JA, 1992, J AM ACAD CHILD PSY, V31, P655, DOI 10.1097/00004583-199207000-00012; BARKER DJP, 1995, BRIT MED J, V311, P1203, DOI 10.1136/bmj.311.7014.1203; Bennedsen BE, 1999, BRIT J PSYCHIAT, V175, P239, DOI 10.1192/bjp.175.3.239; BROWN AS, 1995, BRIT J PSYCHIAT, V166, P601, DOI 10.1192/bjp.166.5.601; CNATTINGIUS S, 1990, SCAND J SOC MED, V18, P143, DOI 10.1177/140349489001800209; Fergusson DM, 1999, J CHILD PSYCHOL PSYC, V40, P479, DOI 10.1111/1469-7610.00464; Gale CR, 2004, BRIT J PSYCHIAT, V184, P28, DOI 10.1192/bjp.184.1.28; Godfrey KM, 2000, AM J CLIN NUTR, V71, p1344S, DOI 10.1093/ajcn/71.5.1344s; Gunther N, 2003, SOC PSYCH PSYCH EPID, V38, P101, DOI 10.1007/s00127-003-0607-6; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Jiang GX, 1999, ACTA PSYCHIAT SCAND, V100, P433, DOI 10.1111/j.1600-0447.1999.tb10893.x; Jones PB, 1998, AM J PSYCHIAT, V155, P355, DOI 10.1176/ajp.155.3.355; Kemppainen L, 2000, SOC PSYCH PSYCH EPID, V35, P104, DOI 10.1007/s001270050191; Kessler RC, 1997, AM J PSYCHIAT, V154, P1405; Lawrence C, 1989, Acta Paediatr Scand Suppl, V350, P55; LEWINSOHN PM, 1994, J CONSULT CLIN PSYCH, V62, P297, DOI 10.1037/0022-006X.62.2.297; Li CI, 2003, PAEDIATR PERINAT EP, V17, P164, DOI 10.1046/j.1365-3016.2003.00487.x; Madge N, 1999, EUR CHILD ADOLES PSY, V8, P283, DOI 10.1007/s007870050103; Neugebauer R, 1999, JAMA-J AM MED ASSOC, V282, P455, DOI 10.1001/jama.282.5.455; Neugebauer R, 1998, ACTA PSYCHIAT SCAND, V97, P412, DOI 10.1111/j.1600-0447.1998.tb10024.x; Nilsson PM, 2001, INT J EPIDEMIOL, V30, P75, DOI 10.1093/ije/30.1.75; Olausson PO, 2001, FAM PLANN PERSPECT, V33, P70, DOI 10.2307/2673752; SALK L, 1985, LANCET, V1, P624; Wahlbeck K, 2001, ARCH GEN PSYCHIAT, V58, P48, DOI 10.1001/archpsyc.58.1.48; Walker A, 1999, CHILD ADOL PSYCH CL, V8, P845	28	127	128	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 25	2004	364	9440					1135	1140		10.1016/S0140-6736(04)17099-2	http://dx.doi.org/10.1016/S0140-6736(04)17099-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	857FT	15451220				2022-12-24	WOS:000224102400026
J	Blackburn, TM; Cassey, P; Duncan, RP; Evans, KL; Gaston, KJ				Blackburn, TM; Cassey, P; Duncan, RP; Evans, KL; Gaston, KJ			Avian extinction and mammalian introductions on oceanic islands	SCIENCE			English	Article							PREHISTORIC EXTINCTIONS; PATTERNS; BIRDS	The arrival of humans on oceanic islands has precipitated a wave of extinctions among the islands' native birds. Nevertheless, the magnitude of this extinction event varies markedly between avifaunas. We show that the probability that a bird species has been extirpated from each of 220 oceanic islands is positively correlated with the number of exotic predatory mamma[ species established on those islands after European colonization and that the effect of these predators is greater on island endemic species. In contrast, the proportions of currently threatened species are independent of the numbers of exotic mammalian predator species, suggesting that the principal threat to island birds has changed through time as species susceptible to exotic predators have been driven extinct.	Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; Lincoln Univ, Bioprotect & Ecol Div, Lincoln, New Zealand; Landcare Res, Lincoln, New Zealand; Univ Sheffield, Dept Anim & Plant Sci, Biodivers & Macroecol Grp, Sheffield S10 2TN, S Yorkshire, England	University of Birmingham; Lincoln University - New Zealand; Landcare Research - New Zealand; University of Sheffield	Blackburn, TM (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.	t.blackburn@bham.ac.uk	Duncan, Richard P/E-7899-2013; Bond, Alexander L/A-3786-2010; Blackburn, Tim/AAC-3144-2019; Duncan, Richard/ABD-4099-2020; Blackburn, Tim M/A-7685-2011	Duncan, Richard P/0000-0003-2295-449X; Blackburn, Tim/0000-0003-0152-2663; Duncan, Richard/0000-0003-2295-449X; Cassey, Phillip/0000-0002-2626-0172				Ashmole NP, 1994, SEABIRDS ISLANDS THR, P94; Atkinson I., 2000, INVASIVE SPECIES PAC, P19; Atkinson I.A.E., 1985, CONSERVATION ISLAND, V3rd ed, pp., P35; Balmford A, 1996, TRENDS ECOL EVOL, V11, P193, DOI 10.1016/0169-5347(96)10026-4; Biber E, 2002, ECOGRAPHY, V25, P661, DOI 10.1034/j.1600-0587.2002.t01-1-250603.x; Blackburn TM, 2004, ECOGRAPHY, V27, P124, DOI 10.1111/j.0906-7590.2004.03775.x; Burnham KP, 2001, WILDLIFE RES, V28, P111, DOI 10.1071/WR99107; Case TJ, 1996, BIOL CONSERV, V78, P69, DOI 10.1016/0006-3207(96)00019-5; Cassels R., 1984, P741; Curnutt J, 2001, STUD AVIAN BIOL-SER, P15; Diamond J.M., 1984, P824; Diamond J.M., 1984, P191; DIAMOND JM, 1989, PHILOS T ROY SOC B, V325, P469, DOI 10.1098/rstb.1989.0100; FLANNERTY TF, 1994, FUTURE EATERS; GASTON KJ, 2002, ENCY EVOLUTION, V1, P344; Grayson DK, 2001, J WORLD PREHIST, V15, P1, DOI 10.1023/A:1011165119141; Holdaway Richard N., 1999, P189; Holdaway RN, 2000, SCIENCE, V287, P2250, DOI 10.1126/science.287.5461.2250; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; *LYNX ED BIRDLIFE, 2000, THREAT BIRDS WORLD; MAC ARTHUR ROBERT H., 1967; MacPhee R.D.E., 1999, EXTINCTIONS NEAR TIM; Martin P.S., 1984, P354; Martin P.S., 1999, EXTINCTIONS NEAR TIM, P17, DOI DOI 10.1007/978-1-4757-5202-1_2; MARTIN PS, 2001, ENCY BIODIVERSITY, V3, P825; Martin PS, 1984, QUATERNARY EXTINCTIO; MILBERG P, 1993, ECOGRAPHY, V16, P229, DOI 10.1111/j.1600-0587.1993.tb00213.x; Pimm Stuart L., 1995, P75; Roberts RG, 2001, SCIENCE, V292, P1888, DOI 10.1126/science.1060264; Roff DA, 2003, EVOL ECOL RES, V5, P759; STEADMAN DW, 1995, SCIENCE, V267, P1123, DOI 10.1126/science.267.5201.1123; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857	32	560	590	5	228	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2004	305	5692					1955	1958		10.1126/science.1101617	http://dx.doi.org/10.1126/science.1101617			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857RM	15448269				2022-12-24	WOS:000224136000046
J	Weuve, J; Kang, JH; Manson, JE; Breteler, MMB; Ware, JH; Grodstein, F				Weuve, J; Kang, JH; Manson, JE; Breteler, MMB; Ware, JH; Grodstein, F			Physical activity, including walking, and cognitive function in older women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALZHEIMERS-DISEASE; IMPAIRMENT; EXERCISE; COMMUNITY; DEMENTIA; HEALTH; AGE; MACARTHUR; DECLINE; POPULATION	Context Physical activity may help maintain cognitive function in older adults. Objective To examine the relation of long-term regular physical activity, including walking, to cognitive function, Design Women reported participation in leisure-time physical activities on biennial mailed questionnaires beginning in 1986. We assessed long-term activity by averaging energy expenditures from questionnaires in 1986 through participants' baseline cognitive assessments (1995 to 2001). We used linear regression to estimate adjusted mean differences in baseline cognitive performance and cognitive decline over 2 years, across levels of physical activity and walking. Setting and Participants Nurses' Health Study, including 18766 US women aged 70 to 81 years. Main Outcome Measure Validated telephone assessments of cognition administered twice approximately 2 years apart (1995 to 2001 and 1997 to 2003), including tests of general cognition, verbal memory, category fluency, and attention. Results Higher levels of activity were associated with better cognitive performance. On a global score combining results of all 6 tests, women in the second through fifth quintiles of energy expenditure scored an average of 0.06, 0.06, 0.09, and 0.10 Standard units higher than women in the lowest quintile (P for trend <.001). Compared with women in the lowest physical activity quintile, we found a 20% lower risk of cognitive impairment for women in the highest quintile of activity. Among women performing the equivalent of walking at an easy pace for at least 1.5 h/wk, mean global scores were 0.06 to 0.07 units higher compared with walking less than 40 min/wk (P <=.003). We also observed less cognitive decline among women who were more active, especially those in the 2 highest quintiles of energy expenditure. Women in the fourth and fifth quintiles had mean changes in global scores that were 0.04 (95% confidence interval, 0.02-0.10) and 0.06 (95% confidence interval, 0.02-0.11) standard units better than those in the lowest quintile. Conclusion Long-term regular physical activity, including walking, is associated with significantly better cognitive function and less cognitive decline in older women.	Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Channing Lab, Boston, MA USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Div Prevent Med, Boston, MA USA; Erasmus MC, Dept Epidemiol & Biostat, Rotterdam, Netherlands	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Erasmus University Rotterdam; Erasmus MC	Weuve, J (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Landmark Ctr,East Wing,3rd Floor,401 Pk Dr, Boston, MA 02215 USA.	jweuve@hsph.harvard.edu	Breteler, Monique M.B./J-5058-2014	Breteler, Monique M.B./0000-0002-0626-9305	NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015424] Funding Source: NIH RePORTER; NCI NIH HHS [CA87969] Funding Source: Medline; NIA NIH HHS [AG000158, AG15424] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; ALBERT M, 1991, INT J NEUROSCI, V57, P167, DOI 10.3109/00207459109150691; Albert MS, 1995, PSYCHOL AGING, V10, P578, DOI 10.1037/0882-7974.10.4.578; [Anonymous], 1996, PHYS ACT HLTH REP SU, P175; Bennett DA, 2002, NEUROLOGY, V59, P198, DOI 10.1212/WNL.59.2.198; BERKMAN LF, 1993, J CLIN EPIDEMIOL, V46, P1129, DOI 10.1016/0895-4356(93)90112-E; BLACK JE, 1990, P NATL ACAD SCI USA, V87, P5568, DOI 10.1073/pnas.87.14.5568; Brandt J., 1988, NEUROPSY NEUROPSY BE, V1, P111; Bretsky P, 2003, NEUROLOGY, V60, P1077, DOI 10.1212/01.WNL.0000055875.26908.24; Carmelli D, 1997, NEUROEPIDEMIOLOGY, V16, P285, DOI 10.1159/000109699; Chandra V, 1998, J GERIATR PSYCH NEUR, V11, P11, DOI 10.1177/089198879801100104; Chodzko-Zajko W J, 1994, Exerc Sport Sci Rev, V22, P195; Churchill JD, 2002, NEUROBIOL AGING, V23, P941, DOI 10.1016/S0197-4580(02)00028-3; CLARKSONSMITH L, 1990, PSYCHOL AGING, V5, P437; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Colditz GA, 1997, J WOMENS HEALTH, V6, P49, DOI 10.1089/jwh.1997.6.49; EMERY CF, 1995, GERONTOLOGIST, V35, P378, DOI 10.1093/geront/35.3.378; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; GANGULI M, 1993, J GERONTOL, V48, pM152, DOI 10.1093/geronj/48.4.M152; GomezPinilla F, 1997, BRAIN RES, V764, P1, DOI 10.1016/S0006-8993(97)00375-2; Goodglass H, 1983, ASSESSMENT APHASIA; Ho SC, 2001, INT J EPIDEMIOL, V30, P1389, DOI 10.1093/ije/30.6.1389; HULTSCH DF, 1993, J GERONTOL, V48, pP1, DOI 10.1093/geronj/48.1.P1; KAWAS C, 1994, ARCH NEUROL-CHICAGO, V51, P901, DOI 10.1001/archneur.1994.00540210073015; Kawas CH, 2003, NEUROLOGY, V60, P1089, DOI 10.1212/01.WNL.0000055813.36504.BF; Kramer AF, 1999, NATURE, V400, P418, DOI 10.1038/22682; Laurin D, 2001, ARCH NEUROL-CHICAGO, V58, P498, DOI 10.1001/archneur.58.3.498; Lezak M., 1995, NEUROPSYCHOLOGICAL A, P335; LINN RT, 1995, ARCH NEUROL-CHICAGO, V52, P485, DOI 10.1001/archneur.1995.00540290075020; Mulsant BH, 2003, ARCH GEN PSYCHIAT, V60, P198, DOI 10.1001/archpsyc.60.2.198; NEEPER SA, 1995, NATURE, V373, P109, DOI 10.1038/373109a0; ROGERS RL, 1990, J AM GERIATR SOC, V38, P123, DOI 10.1111/j.1532-5415.1990.tb03472.x; SCHERR PA, 1988, AM J EPIDEMIOL, V128, P1084; Schuit AJ, 2001, MED SCI SPORT EXER, V33, P772; Small BJ, 2003, ACTA NEUROL SCAND, V107, P29, DOI 10.1034/j.1600-0404.107.s179.6.x; Small BJ, 2000, ARCH NEUROL-CHICAGO, V57, P839, DOI 10.1001/archneur.57.6.839; Taddei S, 2000, CIRCULATION, V101, P2896, DOI 10.1161/01.CIR.101.25.2896; Thompson PD, 2001, MED SCI SPORT EXER, V33, pS438, DOI 10.1097/00005768-200106001-00012; U.S. Bureau of the Census, 1996, CURR POP REP SPEC ST, P23; van Dam RM, 2002, MED SCI SPORT EXER, V34, P1132, DOI 10.1097/00005768-200207000-00013; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; Wareham NJ, 2000, AM J EPIDEMIOL, V152, P132, DOI 10.1093/aje/152.2.132; Watson GS, 2003, NEUROLOGY, V60, P1899, DOI 10.1212/01.WNL.0000065916.25128.25; Williams P, 1997, AUST NZ J PUBL HEAL, V21, P45, DOI 10.1111/j.1467-842X.1997.tb01653.x; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; Yaffe K, 2001, ARCH INTERN MED, V161, P1703, DOI 10.1001/archinte.161.14.1703; Yaffe K, 2001, NEW ENGL J MED, V344, P1207, DOI 10.1056/NEJM200104193441604	47	764	790	0	95	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 22	2004	292	12					1454	1461		10.1001/jama.292.12.1454	http://dx.doi.org/10.1001/jama.292.12.1454			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	856FT	15383516	Bronze			2022-12-24	WOS:000224031800027
J	Harling, R; Hayward, A; Watson, JM				Harling, R; Hayward, A; Watson, JM			Implications of the incidence of influenza-like illness in nursing homes for influenza chemoprophylaxis: descriptive study	BRITISH MEDICAL JOURNAL			English	Article									UCL, Royal Free Hosp, Ctr Infect Dis Epidemiol, Dept Primary Care & Populat Sci, London NW3 2PF, England; Hlth Protect Agcy, Ctr Communicable Dis Surveillance, Dept Resp Dis, London NW9 5EQ, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Health Protection Agency	Harling, R (corresponding author), UCL, Royal Free Hosp, Ctr Infect Dis Epidemiol, Dept Primary Care & Populat Sci, London NW3 2PF, England.	r.harling@pcps.ucl.ac.uk	Hayward, Andrew C/C-3268-2013	Hayward, Andrew C/0000-0002-3549-6232				Cooper NJ, 2003, BRIT MED J, V326, P1235, DOI 10.1136/bmj.326.7401.1235; Department of Health, 2002, RES CAR NURS HOM SEC; Govaert TME, 1998, FAM PRACT, V15, P16, DOI 10.1093/fampra/15.1.16; *HLTH PROT AG, HPA NAT SURV INFL WE; *NAT I CLIN EXC, 2003, TECHN APPR GUID, V67	5	12	12	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 18	2004	329	7467					663	664		10.1136/bmj.38204.674595.AE	http://dx.doi.org/10.1136/bmj.38204.674595.AE			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856JU	15333451	Green Published, Bronze, Green Submitted			2022-12-24	WOS:000224042300022
J	Fridman, E; Carrari, F; Liu, YS; Fernie, AR; Zamir, D				Fridman, E; Carrari, F; Liu, YS; Fernie, AR; Zamir, D			Zooming in on a quantitative trait for tomato yield using interspecific introgressions	SCIENCE			English	Article							BACKCROSS QTL ANALYSIS; GENETIC ARCHITECTURE; SUGAR CONTENT; INVERTASE; IDENTIFICATION; DISSECTION; PENNELLII; GENOMICS; LEVEL; CROSS	To explore natural biodiversity we developed and examined introgression lines (ILs) containing chromosome segments of wild species (Solanum pennellii) in the background of the cultivated tomato (S. lycopersicum). We identified Brix9-2-5, which is a S. pennellii quantitative trait locus (QTL) that increases sugar yield of tomatoes and was mapped within a flower- and fruit-specific invertase (LIN5). QTL analysis representing five different tomato species delimited the functional polymorphism of Brix-9-2-5 to an amino acid near the catalytic site of the invertase crystal, affecting enzyme kinetics and fruit sink strength. These results underline the power of diverse ILs for high-resolution perspectives on complex phenotypes.	Hebrew Univ Jerusalem, Fac Agr, Robert H Smith Inst Plant Sci & Genet Agr, IL-76100 Rehovot, Israel; Max Planck Inst Mol Pflanzenphysiol, D-14476 Golm, Germany	Hebrew University of Jerusalem; Max Planck Society	Zamir, D (corresponding author), Hebrew Univ Jerusalem, Fac Agr, Robert H Smith Inst Plant Sci & Genet Agr, POB 12, IL-76100 Rehovot, Israel.	zamir@agri.huji.ac.il		Fridman, Eyal/0000-0003-1275-7791				Alberto F, 2004, J BIOL CHEM, V279, P18903, DOI 10.1074/jbc.M313911200; Bernacchi D, 1998, THEOR APPL GENET, V97, P170, DOI 10.1007/s001220050882; El-Assal SED, 2001, NAT GENET, V29, P435, DOI 10.1038/ng767; ESHED Y, 1995, GENETICS, V141, P1147; Frary A, 2004, THEOR APPL GENET, V108, P485, DOI 10.1007/s00122-003-1422-x; Freimer N, 2003, NAT GENET, V34, P15, DOI 10.1038/ng0503-15; Fridman E, 2003, PLANT PHYSIOL, V131, P603, DOI 10.1104/pp.014431; Fridman E, 2000, P NATL ACAD SCI USA, V97, P4718, DOI 10.1073/pnas.97.9.4718; Fridman E, 2002, MOL GENET GENOMICS, V266, P821, DOI 10.1007/s00438-001-0599-4; Fulton TM, 2000, THEOR APPL GENET, V100, P1025, DOI 10.1007/s001220051384; Ge H, 2003, TRENDS GENET, V19, P551, DOI 10.1016/j.tig.2003.08.009; GOZALBO D, 1990, CURR GENET, V17, P77, DOI 10.1007/BF00313252; Gur A, 2004, PLOS BIOL, V2, P1610, DOI 10.1371/journal.pbio.0020245; Gur A, 2004, TRENDS PLANT SCI, V9, P107, DOI 10.1016/j.tplants.2004.01.003; Knapp S, 2004, COMP FUNCT GENOM, V5, P285, DOI 10.1002/cfg.393; Koch K, 2004, CURR OPIN PLANT BIOL, V7, P235, DOI 10.1016/j.pbi.2004.03.014; Koornneef M, 2004, ANNU REV PLANT BIOL, V55, P141, DOI 10.1146/annurev.arplant.55.031903.141605; Liu YS, 2003, PLANT BIOTECHNOL J, V1, P195, DOI 10.1046/j.1467-7652.2003.00018.x; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; Mackay TFC, 2004, CURR OPIN GENET DEV, V14, P253, DOI 10.1016/j.gde.2004.04.003; Maloof JN, 2001, NAT GENET, V29, P441, DOI 10.1038/ng777; Paran I, 2003, TRENDS GENET, V19, P303, DOI 10.1016/S0168-9525(03)00117-3; Singer JB, 2004, SCIENCE, V304, P445, DOI 10.1126/science.1093139; Stam LF, 1996, GENETICS, V144, P1559; Tang GQ, 1999, PLANT CELL, V11, P177, DOI 10.1105/tpc.11.2.177; Tanksley SD, 1996, THEOR APPL GENET, V92, P213, DOI 10.1007/BF00223378; Zamir D, 2001, NAT REV GENET, V2, P983, DOI 10.1038/35103590	27	360	397	9	121	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1786	1789		10.1126/science.1101666	http://dx.doi.org/10.1126/science.1101666			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	856IS	15375271				2022-12-24	WOS:000224039500045
J	Bahatyrova, S; Frese, RN; Siebert, CA; Olsen, JD; van der Werf, KO; van Grondelle, R; Niederman, RA; Bullough, PA; Otto, C; Hunter, CN				Bahatyrova, S; Frese, RN; Siebert, CA; Olsen, JD; van der Werf, KO; van Grondelle, R; Niederman, RA; Bullough, PA; Otto, C; Hunter, CN			The native architecture of a photosynthetic membrane	NATURE			English	Article							LIGHT-HARVESTING COMPLEX; ATOMIC-FORCE MICROSCOPY; RHODOBACTER-SPHAEROIDES; CORE COMPLEX; RHODOPSEUDOMONAS-SPHAEROIDES; RHODOSPIRILLUM-RUBRUM; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; PROTEIN SUBUNITS; ANTENNA COMPLEX	In photosynthesis, the harvesting of solar energy and its subsequent conversion into a stable charge separation are dependent upon an interconnected macromolecular network of membrane-associated chlorophyll-protein complexes. Although the detailed structure of each complex has been determined(1-4), the size and organization of this network are unknown. Here we show the use of atomic force microscopy to directly reveal a native bacterial photosynthetic membrane. This first view of any multi-component membrane shows the relative positions and associations of the photosynthetic complexes and reveals crucial new features of the organization of the network: we found that the membrane is divided into specialized domains each with a different network organization and in which one type of complex predominates. Two types of organization were found for the peripheral light-harvesting LH2 complex. In the first, groups of 10-20 molecules of LH2 form light-capture domains that interconnect linear arrays of dimers of core reaction centre (RC)-light-harvesting 1 (RC-LH1-PufX) complexes; in the second they were found outside these arrays in larger clusters. The LH1 complex is ideally positioned to function as an energy collection hub, temporarily storing it before transfer to the RC where photochemistry occurs: the elegant economy of the photosynthetic membrane is demonstrated by the close packing of these linear arrays, which are often only separated by narrow 'energy conduits' of LH2 just two or three complexes wide.	Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA; Univ Twente, Biophys Tech Grp, Dept Sci & Technol, BMTI,MESA, NL-7500 AE Enschede, Netherlands; Vrije Univ Amsterdam, Fac Sci, NL-1081 HV Amsterdam, Netherlands	University of Sheffield; Rutgers State University New Brunswick; University of Twente; Vrije Universiteit Amsterdam	Hunter, CN (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England.	c.n.hunter@shef.ac.uk	Otto, Cees/H-8421-2019	Siebert, charles/0000-0002-8126-1979; Bullough, Per/0000-0001-8147-1127; frese, raoul/0000-0001-8243-9954				AAGAARD J, 1972, PHOTOCHEM PHOTOBIOL, V15, P209, DOI 10.1111/j.1751-1097.1972.tb06240.x; ALLEN JP, 1987, P NATL ACAD SCI USA, V84, P6162, DOI 10.1073/pnas.84.17.6162; Bahatyrova S, 2004, J BIOL CHEM, V279, P21327, DOI 10.1074/jbc.M313039200; BEEKMAN LMP, 1994, BIOCHEMISTRY-US, V33, P3143, DOI 10.1021/bi00177a001; BERRY EA, IN PRESS PHOTOSYN RE; Boekema EJ, 2000, J MOL BIOL, V301, P1123, DOI 10.1006/jmbi.2000.4037; DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0; Feniouk BA, 2002, BIOPHYS J, V82, P1115, DOI 10.1016/S0006-3495(02)75470-2; Fotiadis D, 2004, J BIOL CHEM, V279, P2063, DOI 10.1074/jbc.M310382200; Frese RN, 2000, P NATL ACAD SCI USA, V97, P5197, DOI 10.1073/pnas.090083797; Hess S, 1995, P NATL ACAD SCI USA, V92, P12333, DOI 10.1073/pnas.92.26.12333; HUNTER CN, 1985, BIOCHIM BIOPHYS ACTA, V807, P44, DOI 10.1016/0005-2728(85)90051-9; Jamieson SJ, 2002, EMBO J, V21, P3927, DOI 10.1093/emboj/cdf410; Katona G, 2003, J MOL BIOL, V331, P681, DOI 10.1016/S0022-2836(03)00751-4; MCDERMOTT G, 1995, NATURE, V374, P517, DOI 10.1038/374517a0; MONGER TG, 1977, BIOCHIM BIOPHYS ACTA, V460, P393, DOI 10.1016/0005-2728(77)90080-9; Muller DJ, 2003, J MOL BIOL, V327, P925, DOI 10.1016/S0022-2836(03)00206-7; NIEDERMAN RA, 1979, BIOCHIM BIOPHYS ACTA, V555, P210, DOI 10.1016/0005-2736(79)90161-5; Roszak AW, 2003, SCIENCE, V302, P1969, DOI 10.1126/science.1088892; Scheuring S, 2004, J BIOL CHEM, V279, P3620, DOI 10.1074/jbc.M310050200; Scheuring S, 2003, P NATL ACAD SCI USA, V100, P1690, DOI 10.1073/pnas.0437992100; Scheuring S, 2003, J MOL BIOL, V325, P569, DOI 10.1016/S0022-2836(02)01241-X; Siebert CA, 2004, EMBO J, V23, P690, DOI 10.1038/sj.emboj.7600092; Sturgis JN, 1996, ARCH MICROBIOL, V165, P235, DOI 10.1007/s002030050321; VANDERWERF KO, 1993, REV SCI INSTRUM, V64, P2892, DOI 10.1063/1.1144378; VISSCHER KJ, 1989, PHOTOSYNTH RES, V22, P211, DOI 10.1007/BF00048300; VOS M, 1988, BIOCHIM BIOPHYS ACTA, V933, P132, DOI 10.1016/0005-2728(88)90063-1; Walz T, 1998, J MOL BIOL, V282, P833, DOI 10.1006/jmbi.1998.2050	28	383	401	3	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 26	2004	430	7003					1058	1062		10.1038/nature02823	http://dx.doi.org/10.1038/nature02823			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849CD	15329728	Green Accepted			2022-12-24	WOS:000223514900050
J	Kohli, P; Harrell, CC; Cao, ZH; Gasparac, R; Tan, WH; Martin, CR				Kohli, P; Harrell, CC; Cao, ZH; Gasparac, R; Tan, WH; Martin, CR			DNA-functionalized nanotube membranes with single-base mismatch selectivity	SCIENCE			English	Article							TRANSPORT	We describe synthetic membranes in which the molecular recognition chemistry used to accomplish selective permeation is DNA hybridization. These membranes contain template-synthesized gold nanotubes with inside diameters of 12 nanometers, and a "transporter" DNA-hairpin molecule is attached to the inside walls of these nanotubes. These DNA-functionalized nanotube membranes selectively recognize and transport the DNA strand that is complementary to the transporter strand, relative to DNA strands that are not complementary to the transporter. Under optimal conditions, single-base mismatch transport selectivity can be obtained.	Univ Florida, Dept Chem, Gainesville, FL 32611 USA; Univ Florida, Ctr Res Bionano Interface, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Martin, CR (corresponding author), Univ Florida, Dept Chem, Gainesville, FL 32611 USA.	crmartin@chern.ufl.edu	Martin, Charles/AAA-1040-2019; Tan, Weihong/AAA-4536-2020					Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Bonnet G, 1999, P NATL ACAD SCI USA, V96, P6171, DOI 10.1073/pnas.96.11.6171; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dubertret B, 2001, NAT BIOTECHNOL, V19, P365, DOI 10.1038/86762; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Hall MC, 2001, J MOL BIOL, V312, P637, DOI 10.1006/jmbi.2001.4958; Hill, 2001, ION CHANNELS EXCITAB, P441; Howorka S, 2001, NAT BIOTECHNOL, V19, P636, DOI 10.1038/90236; Jirage KB, 1997, SCIENCE, V278, P655, DOI 10.1126/science.278.5338.655; Lakshmi BB, 1997, NATURE, V388, P758, DOI 10.1038/41978; Lee SB, 2002, SCIENCE, V296, P2198, DOI 10.1126/science.1071396; MARTIN CR, 1994, SCIENCE, V266, P1961, DOI 10.1126/science.266.5193.1961; Martin CR, 2001, J PHYS CHEM B, V105, P1925, DOI 10.1021/jp003486e; MULDER M, 1996, BASIC PRINCIPLES MEM, P342; OSADA Y, 1992, MEMBRANE SCI TECHNOL, P377	15	282	293	2	140	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2004	305	5686					984	986		10.1126/science.1100024	http://dx.doi.org/10.1126/science.1100024			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845ND	15310896				2022-12-24	WOS:000223250700041
J	Somorjai, GA				Somorjai, GA			On the move	NATURE			English	Editorial Material									Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Somorjai, GA (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.		Anderson, David G/E-6125-2014	Anderson, David G/0000-0002-9624-5867				Somorjai G.A., 2010, INTRO SURFACE CHEM C; Thomas J. M., 1997, PRINCIPLES PRACTICE; TSOU CL, 1993, SCIENCE, V262, P380, DOI 10.1126/science.8211158	3	33	33	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 12	2004	430	7001					730	730		10.1038/430730a	http://dx.doi.org/10.1038/430730a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306789				2022-12-24	WOS:000223233600022
J	Melese, M; Chidambaram, JD; Alemayelm, W; Lee, DC; Yi, EH; Cevallos, V; Zhou, ZX; Donnellan, C; Saidel, M; Whitcher, JP; Gaynor, BD; Lietman, TM				Melese, M; Chidambaram, JD; Alemayelm, W; Lee, DC; Yi, EH; Cevallos, V; Zhou, ZX; Donnellan, C; Saidel, M; Whitcher, JP; Gaynor, BD; Lietman, TM			Feasibility of eliminating ocular Chlamydia trachomatis with repeat mass antibiotic treatments	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COST-SAVING STRATEGY; URINE SPECIMENS; AZITHROMYCIN; INFECTION; DISEASE; NEPAL; BLINDNESS; PROGRAMS; AREAS; PCR	Context Mass antibiotic administrations for ocular chlamydial infection play a key role in the World Health Organization's trachoma control program. Mathematical models suggest that it is possible to eliminate trachoma locally with repeat mass treatment, depending on the coverage level of the population, frequency of mass treatments, and rate that infection returns into a community after each mass treatment. Precise estimates of this latter parameter have never been reported. Objective To determine the rate at which chlamydial infection returns to a population after mass treatment and to estimate the treatment frequency required for elimination of ocular chlamydia from a community. Design, Setting, and Participants Longitudinal cohort study of 24 randomly selected villages from the Gurage Zone in Ethiopia conducted February 2003 to October 2003. A total of 1332 children aged 1 to 5 years were monitored for prevalence of ocular chlamydial infection pretreatment and 2 and 6 months posttreatment. Interventions All individuals older than 1 year were eligible for single-dose oral azithromycin treatment. Pregnant women were offered tetracycline eye ointment. Main Outcome Measures Prevalence of ocular chlamydial infection, measured by polymerase chain reaction, in children aged 1 to 5 years, in each of 24 villages at each time point was used to estimate the rate of return of infection and the treatment frequency necessary for elimination. Results The prevalence of. infection was 56.3% pretreatment (95% confidence interval [CI], 47.5%-65.1%), 6.7% 2 months posttreatment (95% Cl, 4.2%-9.2%), and 11.0% 6 months posttreatment (95% CI, 7.3%-14.7%). Infection returned after treatment at an exponential rate of 12.3% per month (95% Cl, 4.6%-19.9% per month). The minimum treatment frequency necessary for elimination was calculated to be once every 11.6 months (95% Cl, 7.2-30.9 months), given a coverage level of 80%. Thus, biannual treatment, already being performed in some areas, was estimated to be more than frequent enough to eventually eliminate infection. Conclusion The rate at which ocular chlamydial infection returns to a community after mass treatment suggests that elimination of infection in a hyperendemic area is feasible with biannual mass antibiotic administrations and attainable coverage levels.	Univ Calif San Francisco, FI Proctor Fdn, WHO Collaborating Ctr, San Francisco, CA 94143 USA; ORBIS Int, Addis Ababa, Ethiopia; Univ Calif San Francisco, Inst Global Hlth, Dept Ophthalmol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Inst Global Hlth, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; World Health Organization; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lietman, TM (corresponding author), Univ Calif San Francisco, FI Proctor Fdn, WHO Collaborating Ctr, Room 307,95 Kirkhan St, San Francisco, CA 94143 USA.	tml@itsa.ucsf.edu		Chidambaram, Jaya/0000-0001-5438-2858	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048789, R21AI055752] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI48789, R21 AI055752] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bird M, 2003, J INFECT DIS, V187, P1669, DOI 10.1086/374743; Diamant J, 2001, Ophthalmic Epidemiol, V8, P109, DOI 10.1076/opep.8.2.109.4156; Dolin PJ, 1997, LANCET, V349, P1511, DOI 10.1016/S0140-6736(97)01355-X; Dowdle W R, 1998, Bull World Health Organ, V76 Suppl 2, P22; Emerson PM, 2000, TROP MED INT HEALTH, V5, P515, DOI 10.1046/j.1365-3156.2000.00603.x; Farid M. A., 1980, World Health Forum, V1, P8; FRIEDERICH R, 1982, ANN OPHTHALMOL, V14, P38; Fry AM, 2002, CLIN INFECT DIS, V35, P395, DOI 10.1086/341414; Gaynor BD, 2003, EMERG INFECT DIS, V9, P596, DOI 10.3201/eid0905.020577; Henderson D A, 1998, Bull World Health Organ, V76 Suppl 2, P17; Hoechsmann A, 2001, Ophthalmic Epidemiol, V8, P145, DOI 10.1076/opep.8.2.145.4169; Holm SO, 2001, B WORLD HEALTH ORGAN, V79, P194; Jha H, 2002, CLIN INFECT DIS, V35, P765, DOI 10.1086/342298; JONES RB, 1990, J INFECT DIS, V162, P1309, DOI 10.1093/infdis/162.6.1309; Kacena KA, 1998, J CLIN MICROBIOL, V36, P481, DOI 10.1128/JCM.36.2.481-485.1998; KATZ J, 1993, INT J EPIDEMIOL, V22, P709, DOI 10.1093/ije/22.4.709; Lietman T, 1999, NAT MED, V5, P572, DOI 10.1038/8451; McOrist S, 2000, TRENDS MICROBIOL, V8, P483, DOI 10.1016/S0966-842X(00)01854-0; Morre SA, 2000, J CLIN MICROBIOL, V38, P1679; Murray DM, 1998, DESIGN ANAL GROUP RA; Peeling RW, 1998, SEX TRANSM INFECT, V74, P66, DOI 10.1136/sti.74.1.66; Saltelli A., 2000, SENSITIVITY ANAL; Schachter J, 1999, LANCET, V354, P630, DOI 10.1016/S0140-6736(98)12387-5; TAYLOR HR, 1990, SCIENCE, V250, P116, DOI 10.1126/science.2218502; THYLEFORS B, 1995, B WORLD HEALTH ORGAN, V73, P115; Wawer MJ, 1999, LANCET, V353, P525, DOI 10.1016/S0140-6736(98)06439-3; World Health Organization, 1997, 1 M WHO ALL GLOB EL	27	97	99	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 11	2004	292	6					721	725		10.1001/jama.292.6.721	http://dx.doi.org/10.1001/jama.292.6.721			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844RM	15304470	Bronze, Green Accepted			2022-12-24	WOS:000223177300027
J	Schulz, KG; Zondervan, I; Gerringa, LJA; Timmermans, KR; Veldhuis, MJW; Riebesell, U				Schulz, KG; Zondervan, I; Gerringa, LJA; Timmermans, KR; Veldhuis, MJW; Riebesell, U			Effect of trace metal availability on coccolithophorid calcification	NATURE			English	Article							SUB-ARCTIC PACIFIC; CADMIUM CONCENTRATIONS; MARINE-PHYTOPLANKTON; GREENLAND ICE; CARBONIC-ACID; ZINC; SEAWATER; IRON; DISSOCIATION; COMPLEXATION	The deposition of atmospheric dust into the ocean has varied considerably over geological time(1,2). Because some of the trace metals contained in dust are essential plant nutrients which can limit phytoplankton growth in parts of the ocean, it has been suggested that variations in dust supply to the surface ocean might influence primary production(3,4). Whereas the role of trace metal availability in photosynthetic carbon fixation has received considerable attention, its effect on biogenic calcification is virtually unknown. The production of both particulate organic carbon and calcium carbonate (CaCO3) drives the ocean's biological carbon pump. The ratio of particulate organic carbon to CaCO3 export, the so-called rain ratio, is one of the factors determining CO2 sequestration in the deep ocean. Here we investigate the influence of the essential trace metals iron and zinc on the prominent CaCO3-producing microalga Emiliania huxleyi. We show that whereas at low iron concentrations growth and calcification are equally reduced, low zinc concentrations result in a de-coupling of the two processes. Despite the reduced growth rate of zinc-limited cells, CaCO3 production rates per cell remain unaffected, thus leading to highly calcified cells. These results suggest that changes in dust deposition can affect biogenic calcification in oceanic regions characterized by trace metal limitation, with possible consequences for CO2 partitioning between the atmosphere and the ocean.	Alfred Wegener Inst Polar & Marine Res, D-27515 Bremerhaven, Germany; Leibniz Inst Marine Sci IFM GEOMAR, D-24105 Kiel, Germany; Netherlands Inst Sea Res, NL-1790 AB Den Burg, Texel, Netherlands	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ)	Schulz, KG (corresponding author), Alfred Wegener Inst Polar & Marine Res, POB 120161, D-27515 Bremerhaven, Germany.	kschulz@ifm-geomar.de	Riebesell, Ulf/AAC-9717-2020; Schulz, Kai/AEZ-9073-2022; Schulz, Kai G./Q-5608-2017	Schulz, Kai/0000-0002-8481-4639; Schulz, Kai G./0000-0002-8481-4639; timmermans, klaas/0000-0002-3214-4354; Riebesell, Ulf/0000-0002-9442-452X				Boyd P.W., 2000, CHANGING OCEAN CARBO, p[61, 107]; Broecker WS, 1987, GLOBAL BIOGEOCHEM CY, V1, P15, DOI 10.1029/GB001i001p00015; Broecker WS, 1982, TRACERS SEA; BRULAND KW, 1989, LIMNOL OCEANOGR, V34, P269, DOI 10.4319/lo.1989.34.2.0269; CANDELONE JP, 1995, J GEOPHYS RES-ATMOS, V100, P16605, DOI 10.1029/95JD00989; COALE KH, 1991, LIMNOL OCEANOGR, V36, P1851, DOI 10.4319/lo.1991.36.8.1851; CONKRIGHT ME, 1994, 1 NOAA NESDIS US DEP, V1; Crawford DW, 2003, LIMNOL OCEANOGR, V48, P1583, DOI 10.4319/lo.2003.48.4.1583; Dickson A.G., 1994, HDB METHODS ANAL VAR; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Duce RA, 1991, GLOBAL BIOGEOCHEM CY, V5, P193, DOI 10.1029/91GB01778; Ellwood MJ, 2001, MAR CHEM, V75, P33, DOI 10.1016/S0304-4203(01)00024-X; Hong SM, 1997, ATMOS ENVIRON, V31, P2235, DOI 10.1016/S1352-2310(97)00029-0; Hong SM, 1996, EARTH PLANET SC LETT, V143, P233, DOI 10.1016/0012-821X(96)00137-9; Kremling K, 2001, DEEP-SEA RES PT I, V48, P2541, DOI 10.1016/S0967-0637(01)00036-X; Liu XW, 2002, MAR CHEM, V77, P43, DOI 10.1016/S0304-4203(01)00074-3; Lohan MC, 2002, DEEP-SEA RES PT II, V49, P5793, DOI 10.1016/S0967-0645(02)00215-1; Mahowald N, 1999, J GEOPHYS RES-ATMOS, V104, P15895, DOI 10.1029/1999JD900084; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Millero FJ, 1998, AQUAT GEOCHEM, V4, P153, DOI 10.1023/A:1009656023546; MILLIMAN JD, 1993, GLOBAL BIOGEOCHEM CY, V7, P927, DOI 10.1029/93GB02524; MOREL FMM, 1994, NATURE, V369, P740, DOI 10.1038/369740a0; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Pettit L. D., 2001, IUPAC STABILITY CONS; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Stoll MHC, 2001, ANAL CHEM, V73, P4111, DOI 10.1021/ac010303r; Sunda W, 2003, MAR CHEM, V84, P35, DOI 10.1016/S0304-4203(03)00101-4; Sunda WG, 1995, LIMNOL OCEANOGR, V40, P1404, DOI 10.4319/lo.1995.40.8.1404; Zondervan I, 2002, J EXP MAR BIOL ECOL, V272, P55, DOI 10.1016/S0022-0981(02)00037-0	30	76	79	2	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 5	2004	430	7000					673	676		10.1038/nature02631	http://dx.doi.org/10.1038/nature02631			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843LM	15295599	Green Published			2022-12-24	WOS:000223085400044
J	Khaw, KT; Wareham, N; Bingham, S; Luben, R; Welch, A; Day, N				Khaw, KT; Wareham, N; Bingham, S; Luben, R; Welch, A; Day, N			Association of hemoglobin A(1c) with cardiovascular disease and mortality in adults: The European prospective investigation into cancer in Norfolk	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; RISK-FACTOR; GLYCATED HEMOGLOBIN; GLUCOSE-TOLERANCE; DIABETES-MELLITUS; FASTING GLYCEMIA; PLASMA-GLUCOSE; LIFE-STYLE; PREVENTION; CLASSIFICATION	Background: increasing evidence suggests a continuous relationship between blood glucose concentrations and cardiovascular risk, even below diagnostic threshold levels for diabetes. Objective: To examine the relationship between hemoglobin A(1c), cardiovascular disease, and total mortality. Design: Prospective population study. Setting: Norfolk, United Kingdom. Participants: 4662 men and 5570 women who were 45 to 79 years of age and were residents of Norfolk. Measurements: Hemoglobin A(1c) and cardiovascular disease risk factors were assessed from 1995 to 1997, and cardiovascular disease events and mortality were assessed during the follow-up period to 2003. Results: In men and women, the relationship between hemoglobin A(1c) and cardiovascular disease (806 events) and between hemoglobin A(1c) and all-cause mortality (521 deaths) was continuous and significant throughout the whole distribution. The relationship was apparent in persons without known diabetes. Persons with hemoglobin A(1c) concentrations less than 5% had the lowest rates of cardiovascular disease and mortality. An increase in hemoglobin A(1c) of 1 percentage point was associated with a relative risk for death from any cause of 1.24 (95% Cl, 1.14 to 1.34; P < 0.001) in men and with a relative risk of 1.28 (Cl, 1.06 to 1.32; P < 0.001) in women. These relative risks were independent of age, body mass index, waist-to-hip ratio, systolic blood pressure, serum cholesterol concentration, cigarette smoking, and history of cardiovascular disease. When persons with known diabetes, hemoglobin Ale concentrations of 7% or greater, or a history of cardiovascular disease were excluded, the result was similar (adjusted relative risk, 1.26 [Cl, 1.04 to 1.52]; P = 0.02). Fifteen percent (68 of 521) of the deaths in the sample occurred in persons with diabetes (4% of the sample), but 72% (375 of 521) occurred in persons with HbA(1c) concentrations between 5% and 6.9%. Limitations: Whether HbA(1c) concentrations and cardiovascular disease are causally related cannot be concluded from an observational study; intervention studies are needed to determine whether decreasing HbA(1c) concentrations would reduce cardiovascular disease. Conclusions: The risk for cardiovascular disease and total mortality associated with hemoglobin A(1c) concentrations increased continuously through the sample distribution. Most of the events in the sample occurred in persons with moderately elevated HbA(1c) concentrations. These findings support the need for randomized trials of interventions to reduce hemoglobin A(1c) concentrations in persons without diabetes.	Univ Cambridge, Epidemiol Unit, MRC, Cambridge CB2 2AH, England; MRC, Dunn Nutr Unit, Cambridge CB4 1XJ, England	University of Cambridge	Khaw, KT (corresponding author), Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Clin Gerontol Unit, Box 251, Cambridge CB2 2QQ, England.	kk101@medschl.cam.ac.uk	Luben, Robert N/H-5519-2015; Khaw, Kay-Tee/AAZ-3209-2021; Welch, Ailsa Ann/A-4850-2008	Luben, Robert N/0000-0002-5088-6343; Welch, Ailsa Ann/0000-0002-6702-3704				Alberti KGMM, 1998, DIABETIC MED, V15, P535, DOI 10.1002/(SICI)1096-9136(199807)15:7<535::AID-DIA670>3.3.CO;2-H; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Balkau B, 1998, DIABETES CARE, V21, P360, DOI 10.2337/diacare.21.3.360; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Day N, 1999, BRIT J CANCER, V80, P95; de Vegt F, 1999, DIABETOLOGIA, V42, P926, DOI 10.1007/s001250051249; FULLER JH, 1979, J CHRON DIS, V32, P721, DOI 10.1016/0021-9681(79)90051-1; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gavin JR, 1999, DIABETES CARE, V22, pS5; Gerstein HC, 1997, DIABETIC MED, V14, pS25, DOI 10.1002/(SICI)1096-9136(199708)14:3+<S25::AID-DIA441>3.3.CO;2-T; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Harding AH, 2001, DIABETES CARE, V24, P1911, DOI 10.2337/diacare.24.11.1911; Khaw KT, 2001, BMJ-BRIT MED J, V322, P15, DOI 10.1136/bmj.322.7277.15; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lloyd-Jones DM, 1998, ANN INTERN MED, V129, P1020, DOI 10.7326/0003-4819-129-12-199812150-00005; Marshall SM, 2000, DIABETIC MED, V17, P5, DOI 10.1046/j.1464-5491.2000.00228.x; MCCANCE DR, 1994, BRIT MED J, V308, P1323, DOI 10.1136/bmj.308.6940.1323; Meigs JB, 2002, DIABETES CARE, V25, P1845, DOI 10.2337/diacare.25.10.1845; Park S, 1996, DIABETES CARE, V19, P450, DOI 10.2337/diacare.19.5.450; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; PYORALA K, 1979, J CHRON DIS, V32, P729, DOI 10.1016/0021-9681(79)90052-3; PYORALA K, 1994, EUR HEART J, V15, P1300; ROSE G, 1981, BMJ-BRIT MED J, V282, P1847, DOI 10.1136/bmj.282.6279.1847; Sargeant LA, 2001, EUR J CLIN NUTR, V55, P342, DOI 10.1038/sj.ejcn.1601162; SCHEIDTNAVE C, 1991, AM J EPIDEMIOL, V133, P565, DOI 10.1093/oxfordjournals.aje.a115928; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Unwin N, 2002, DIABETIC MED, V19, P708, DOI 10.1046/j.1464-5491.2002.00835.x; Vinicor F, 2003, LANCET, V361, P544, DOI 10.1016/S0140-6736(03)12561-5; Wood D, 1998, HEART, V80, pS1; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	32	740	788	0	25	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 21	2004	141	6					413	420		10.7326/0003-4819-141-6-200409210-00006	http://dx.doi.org/10.7326/0003-4819-141-6-200409210-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856TM	15381514				2022-12-24	WOS:000224067900001
J	Gerald, D; Berra, E; Frapart, YM; Chan, DA; Giaccia, AJ; Mansuy, D; Pouyssegur, J; Yaniv, M; Mechta-Grigoriou, F				Gerald, D; Berra, E; Frapart, YM; Chan, DA; Giaccia, AJ; Mansuy, D; Pouyssegur, J; Yaniv, M; Mechta-Grigoriou, F			JunD reduces tumor angiogenesis by protecting cells from oxidative stress	CELL			English	Article							HYPOXIA-INDUCIBLE FACTOR; ENDOTHELIAL GROWTH-FACTOR; MITOCHONDRIAL RESPIRATORY-CHAIN; GENE-EXPRESSION; FACTOR-I; TRANSCRIPTIONAL RESPONSE; PARAMAGNETIC-RESONANCE; PROLYL HYDROXYLATION; CYCLE PROGRESSION; MESSENGER-RNA	Reactive oxygen species (ROS) are implicated in the pathophysiology of various diseases, including cancer. In this study, we show that JunD, a member of the AP-1 family of transcription factors, reduces tumor angiogenesis by limiting Ras-mediated production of ROS. Using junD-deficient cells, we demonstrate that JunD regulates genes involved in antioxidant defense, H2O2 production, and angiogenesis. The accumulation of H2O2 in junD(-/-) cells decreases the availability of Fell and reduces the activity of HIF prolyl hydroxylases (PHDs) that target hypoxia-inducible factors-alpha (HIF(alpha) for degradation. Subsequently, HIF-alpha proteins accumulate and enhance the transcription of VEGF-A, a potent proangiogenic factor. Our study uncovers the mechanism by which JunD protects cells from oxidative stress and exerts an antiangiogenic effect. Furthermore, we provide new insights into the regulation of PHD activity, allowing immediate reactive adaptation to changes in O-2 or iron levels in the cell.	Inst Pasteur, Unit Gene Express & Dis, CNRS, URA 1644, F-75724 Paris 15, France; CNRS, Inst Signaling Dev Biol & Canc Res, UMR 6543, Ctr Antoine Lacassagne, F-06189 Nice, France; Univ Paris 05, Lab Chim Biochim Pharmacol & Toxicol, CNRS, UMR 8601, F-75270 Paris 06, France; Stanford Univ, Dept Radiat Oncol, Sch Med, Stanford, CA 94305 USA	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UNICANCER; Centre Antoine Lacassagne; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; Stanford University	Mechta-Grigoriou, F (corresponding author), Inst Pasteur, Unit Gene Express & Dis, CNRS, URA 1644, 25 Rue Docteur Roux, F-75724 Paris 15, France.	fmechta@pasteur.fr	MECHTA-GRIGORIOU, Fatima/C-5253-2017; Berra, Edurne/F-9692-2011; Chan, Doris/O-1227-2014	MECHTA-GRIGORIOU, Fatima/0000-0002-3751-6989; Berra, Edurne/0000-0002-3820-5744; Chan, Doris/0000-0002-4990-986X; Yves-Michel, FRAPART/0000-0003-3854-3580				Agani FH, 2000, J BIOL CHEM, V275, P35863, DOI 10.1074/jbc.M005643200; Arbiser JL, 2002, P NATL ACAD SCI USA, V99, P715, DOI 10.1073/pnas.022630199; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Benjamin LE, 1997, P NATL ACAD SCI USA, V94, P8761, DOI 10.1073/pnas.94.16.8761; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; BOS JL, 1989, CANCER RES, V49, P4682; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; CAMMACK R, 1993, METHOD ENZYMOL, V227, P353, DOI 10.1016/0076-6879(93)27014-8; Chan DA, 2002, J BIOL CHEM, V277, P40112, DOI 10.1074/jbc.M206922200; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chen CH, 2001, J BIOL CHEM, V276, P9519, DOI 10.1074/jbc.M010144200; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fandrey J, 2000, ADV EXP MED BIOL, V475, P153; Feger F, 2001, CANCER RES, V61, P5289; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; Giaccia A, 2003, NAT REV DRUG DISCOV, V2, P803, DOI 10.1038/nrd1199; Guichet A, 1997, NATURE, V385, P548, DOI 10.1038/385548a0; IKEDA E, 1995, J BIOL CHEM, V270, P19761, DOI 10.1074/jbc.270.34.19761; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kim W, 2003, CURR OPIN GENET DEV, V13, P55, DOI 10.1016/S0959-437X(02)00010-2; Knowles HJ, 2003, CANCER RES, V63, P1764; KOVARY K, 1991, MOL CELL BIOL, V11, P4466, DOI 10.1128/MCB.11.9.4466; Lallemand D, 1997, ONCOGENE, V14, P819, DOI 10.1038/sj.onc.1200901; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Leppa S, 1999, ONCOGENE, V18, P6158, DOI 10.1038/sj.onc.1203173; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Liu Q, 2004, P NATL ACAD SCI USA, V101, P4302, DOI 10.1073/pnas.0400265101; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Mechta F, 1997, ONCOGENE, V14, P837, DOI 10.1038/sj.onc.1200900; Mechta-Grigoriou F, 2001, ONCOGENE, V20, P2378, DOI 10.1038/sj.onc.1204381; Mitsushita J, 2004, CANCER RES, V64, P3580, DOI 10.1158/0008-5472.CAN-03-3909; Peeper DS, 1997, NATURE, V386, P177, DOI 10.1038/386177a0; PFARR CM, 1994, CELL, V76, P747, DOI 10.1016/0092-8674(94)90513-4; Pugh CW, 2003, SEMIN CANCER BIOL, V13, P83, DOI 10.1016/S1044-579X(02)00103-7; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Quinn J, 2002, MOL BIOL CELL, V13, P805, DOI 10.1091/mbc.01-06-0288; Richard DE, 2000, J BIOL CHEM, V275, P26765; ROSCHE B, 1995, BIOCHIM BIOPHYS ACTA, V1252, P117; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Srinivas V, 2001, J BIOL CHEM, V276, P21995, DOI 10.1074/jbc.C100177200; Suzuki YJ, 1997, FREE RADICAL BIO MED, V22, P269, DOI 10.1016/S0891-5849(96)00275-4; TISCHER E, 1991, J BIOL CHEM, V266, P11947; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Townsend DM, 2003, ONCOGENE, V22, P7369, DOI 10.1038/sj.onc.1206940; Ubbink M, 2002, ANNU REV BIOPH BIOM, V31, P393, DOI 10.1146/annurev.biophys.31.091701.171000; Vaux EC, 2001, BLOOD, V98, P296, DOI 10.1182/blood.V98.2.296; Venugopal R, 1998, ONCOGENE, V17, P3145, DOI 10.1038/sj.onc.1202237; Wagner EF, 2001, ONCOGENE, V20, P2334, DOI 10.1038/sj.onc.1204416; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; Wang MC, 2003, DEV CELL, V5, P811, DOI 10.1016/S1534-5807(03)00323-X; Weitzman JB, 2000, MOL CELL, V6, P1109, DOI 10.1016/S1097-2765(00)00109-X; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188	58	451	468	1	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2004	118	6					781	794		10.1016/j.cell.2004.08.025	http://dx.doi.org/10.1016/j.cell.2004.08.025			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	855RW	15369676	Bronze			2022-12-24	WOS:000223992400013
J	Pelkmans, L; Burli, T; Zerial, M; Helenius, A				Pelkmans, L; Burli, T; Zerial, M; Helenius, A			Caveolin-stabilized membrane domains as multifunctional transport and sorting devices in endocytic membrane traffic	CELL			English	Article							CHOLERA-TOXIN; IN-VIVO; GOLGI; INTERNALIZATION; SIMIAN-VIRUS-40; ENDOSOME; PATHWAY; RAB5; INHIBITION; CELLS	Endocytosis comprises several routes of internalization. An outstanding question is whether the caveolar and endosomal pathways intersect. Following transport of the caveolar protein Caveolin-1 and two cargo complexes, Simian Virus 40 and Cholera toxin, in live cells, we uncovered a Rab5-dependent pathway in which caveolar vesicles are targeted to early endosomes and form distinct and stable membrane domains. In endosomes, the low pH selectively allowed the toxin to diffuse out of the caveolar domains into the surrounding membrane, while the virus remained trapped. Thus, we conclude that, unlike cyclic assembly and disassembly of coat proteins in vesicular transport, oligomeric complexes of caveolin-1 confer permanent structural stability to caveolar vesicles that transiently interact with endosomes to form subdomains and release cargo selectively by compartment-specific cues.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; Swiss Fed Inst Technol, Inst Biochem, CH-8093 Zurich, Switzerland	Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich	Pelkmans, L (corresponding author), Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.	pelkmans@mpi-cbg.de		Pelkmans, Lucas/0000-0002-6754-9730				Anderson HA, 1996, MOL BIOL CELL, V7, P1825, DOI 10.1091/mbc.7.11.1825; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Bacia K, 2002, BIOPHYS J, V83, P1184, DOI 10.1016/S0006-3495(02)75242-9; Barbero P, 2002, J CELL BIOL, V156, P511, DOI 10.1083/jcb.200109030; Benmerah A, 1999, J CELL SCI, V112, P1303; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; DUPREE P, 1993, EMBO J, V12, P1597, DOI 10.1002/j.1460-2075.1993.tb05804.x; Fernandez I, 2002, P NATL ACAD SCI USA, V99, P11193, DOI 10.1073/pnas.172196599; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; Gagescu R, 2000, MOL BIOL CELL, V11, P2775, DOI 10.1091/mbc.11.8.2775; Gaidarov I, 1999, NAT CELL BIOL, V1, P1, DOI 10.1038/8971; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; HEYNINGEN SV, 1974, SCIENCE, V183, P656, DOI DOI 10.1126/SCIENCE.183.4125.656; JANICOT M, 1991, J BIOL CHEM, V266, P12858; Kaiser RD, 1998, BBA-BIOMEMBRANES, V1375, P13, DOI 10.1016/S0005-2736(98)00127-8; KARTENBECK J, 1989, J CELL BIOL, V109, P2721, DOI 10.1083/jcb.109.6.2721; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Lanzetti L, 2000, NATURE, V408, P374, DOI 10.1038/35042605; Lebrand C, 2002, EMBO J, V21, P1289, DOI 10.1093/emboj/21.6.1289; McBride HM, 1999, CELL, V98, P377, DOI 10.1016/S0092-8674(00)81966-2; McCann JA, 1997, BIOCHEMISTRY-US, V36, P9169, DOI 10.1021/bi962996p; McNally JG, 1999, METHODS, V19, P373, DOI 10.1006/meth.1999.0873; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; MONIER S, 1995, MOL BIOL CELL, V6, P911, DOI 10.1091/mbc.6.7.911; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; Nichols BJ, 2002, NAT CELL BIOL, V4, P374, DOI 10.1038/ncb787; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; Panopoulou E, 2002, J BIOL CHEM, V277, P18046, DOI 10.1074/jbc.M107983200; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; PARTON RG, 1994, J CELL BIOL, V127, P1199, DOI 10.1083/jcb.127.5.1199; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Peters PJ, 2003, J CELL BIOL, V162, P703, DOI 10.1083/jcb.200304140; Pfeffer S, 2003, CELL, V112, P507, DOI 10.1016/S0092-8674(03)00118-1; Presley JF, 2002, NATURE, V417, P187, DOI 10.1038/417187a; Puri V, 2001, J CELL BIOL, V154, P535, DOI 10.1083/jcb.200102084; Razani B, 2001, J BIOL CHEM, V276, P6727, DOI 10.1074/jbc.M008340200; Richards AA, 2002, MOL BIOL CELL, V13, P1750, DOI 10.1091/mbc.01-12-0592; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Sandvig K, 2002, FEBS LETT, V529, P49, DOI 10.1016/S0014-5793(02)03182-4; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Stang E, 1997, MOL BIOL CELL, V8, P47, DOI 10.1091/mbc.8.1.47; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Thomsen P, 2002, MOL BIOL CELL, V13, P238, DOI 10.1091/mbc.01-06-0317; TRAN D, 1987, P NATL ACAD SCI USA, V84, P7957, DOI 10.1073/pnas.84.22.7957; Tsai B, 2003, EMBO J, V22, P4346, DOI 10.1093/emboj/cdg439; UPCROFT P, 1987, J GEN VIROL, V68, P2477, DOI 10.1099/0022-1317-68-9-2477; Waguri S, 2003, MOL BIOL CELL, V14, P142, DOI 10.1091/mbc.E02-06-0338; White J, 1999, J CELL BIOL, V147, P743, DOI 10.1083/jcb.147.4.743; YGUERABIDE J, 1982, BIOPHYS J, V40, P69, DOI 10.1016/S0006-3495(82)84459-7; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	56	400	413	3	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2004	118	6					767	780		10.1016/j.cell.2004.09.003	http://dx.doi.org/10.1016/j.cell.2004.09.003			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	855RW	15369675	Bronze			2022-12-24	WOS:000223992400012
J	Rassenti, LZ; Huynh, L; Toy, TL; Chen, L; Keating, MJ; Gribben, JG; Neuberg, DS; Flinn, IW; Rai, KR; Byrd, JC; Kay, NE; Greaves, A; Weiss, A; Kipps, TJ				Rassenti, LZ; Huynh, L; Toy, TL; Chen, L; Keating, MJ; Gribben, JG; Neuberg, DS; Flinn, IW; Rai, KR; Byrd, JC; Kay, NE; Greaves, A; Weiss, A; Kipps, TJ			ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VARIABLE-REGION MUTATIONS; V-H GENES; CD38 EXPRESSION; B-CELLS; PHENOTYPE	BACKGROUND: The course of chronic lymphocytic leukemia (CLL) is variable. In aggressive disease, the CLL cells usually express an unmutated immunoglobulin heavy-chain variable-region gene (IgV(sub H)) and the 70-kD zeta-associated protein (ZAP-70), whereas in indolent disease, the CLL cells usually express mutated IgV(sub H) but lack expression of ZAP-70. METHODS: We evaluated the CLL B cells from 307 patients with CLL for ZAP-70 and mutations in the rearranged IgV(sub H) gene. We then investigated the association between the results and the time from diagnosis to initial therapy. RESULTS: We found that ZAP-70 was expressed above a defined threshold level in 117 of the 164 patients with an unmutated IgV(sub H) gene (71 percent), but in only 24 of the 143 patients with a mutated IgV(sub H) gene (17 percent, P<0.001). Among the patients with ZAP-70-positive CLL cells, the median time from diagnosis to initial therapy in those who had an unmutated IgV(sub H) gene (2.8 years) was not significantly different from the median time in those who had a mutated IgV(sub H) gene (4.2 years, P=0.07). However, the median time from diagnosis to initial treatment in each of these groups was significantly shorter than the time in patients with ZAP-70-negative CLL cells who had either mutated or unmutated IgV(sub H) genes (P<0.001). The median time from diagnosis to initial therapy among patients who did not have ZAP-70 was 11.0 years in those with a mutated IgV(sub H) gene and 7.1 years in those with an unmutated IgV(sub H) gene (P<0.001). CONCLUSIONS: Although the presence of an unmutated IgV(sub H) gene is strongly associated with the expression of ZAP-70, ZAP-70 is a stronger predictor of the need for treatment in B-cell CLL.	Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; Chron Lymphocyt Leukemia Res Consortium, La Jolla, CA USA; Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Johns Hopkins, Kimmel Canc Ctr, Baltimore, MD USA; Long Isl Jewish Med Ctr, New Hyde Pk, NY 11042 USA; Ohio State Univ, Columbus, OH 43210 USA; Mayo Clin, Rochester, MN USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Diego; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Dana-Farber Cancer Institute; Johns Hopkins University; Northwell Health; University System of Ohio; Ohio State University; Mayo Clinic; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Kipps, TJ (corresponding author), Univ Calif San Diego, Sch Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	tkipps@ucsd.edu	Jones, Jeffrey A/E-9827-2013	Flinn, Ian/0000-0001-6724-290X	NATIONAL CANCER INSTITUTE [P01CA081534] Funding Source: NIH RePORTER; NCI NIH HHS [P01-CA81534] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chen LG, 2002, BLOOD, V100, P4609, DOI 10.1182/blood-2002-06-1683; Cheson BD, 1996, BLOOD, V87, P4990, DOI 10.1182/blood.V87.12.4990.bloodjournal87124990; Crespo M, 2003, NEW ENGL J MED, V348, P1764, DOI 10.1056/NEJMoa023143; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Dighiero G, 1998, NEW ENGL J MED, V338, P1506, DOI 10.1056/NEJM199805213382104; Dighiero G, 2000, NEW ENGL J MED, V343, P1799, DOI 10.1056/NEJM200012143432410; ELDER ME, 1994, SCIENCE, V264, P1596, DOI 10.1126/science.8202712; Fais F, 1998, J CLIN INVEST, V102, P1515, DOI 10.1172/JCI3009; Hamblin TJ, 2002, BLOOD, V99, P1023, DOI 10.1182/blood.V99.3.1023; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; Kabat EA, 1991, SEQUENCES PROTEINS I; Keating Michael J, 2003, Hematology Am Soc Hematol Educ Program, P153, DOI 10.1182/asheducation-2003.1.153; KIPPS TJ, 2001, WILLIAMS HEMATOLOGY, P1163; Klein U, 2001, J EXP MED, V194, P1625, DOI 10.1084/jem.194.11.1625; Krober A, 2002, BLOOD, V100, P1410, DOI 10.1182/blood.V100.4.1410.h81602001410_1410_1416; Lin K, 2002, BLOOD, V100, P1404, DOI 10.1182/blood-2001-11-0066; Lin K, 2002, BLOOD, V100, P2291; Maloum K, 2000, BLOOD, V96, P377, DOI 10.1182/blood.V96.1.377.013k56f_377_379; Orchard JA, 2004, LANCET, V363, P105, DOI 10.1016/S0140-6736(03)15260-9; Oscier DG, 2002, BLOOD, V100, P1177, DOI 10.1182/blood.V100.4.1177.h81602001177_1177_1184; RAI KR, 2000, HEMATOLOGY BASIC PRI, P1350; Rassenti LZ, 1997, J EXP MED, V185, P1435, DOI 10.1084/jem.185.8.1435; Rosenwald A, 2001, J EXP MED, V194, P1639, DOI 10.1084/jem.194.11.1639; Tobin G, 2002, BLOOD, V99, P2262, DOI 10.1182/blood.V99.6.2262; Tobin G, 2003, BLOOD, V101, P4952, DOI 10.1182/blood-2002-11-3485; Wiestner A, 2003, BLOOD, V101, P4944, DOI 10.1182/blood-2002-10-3306	27	702	759	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 26	2004	351	9					893	901		10.1056/NEJMoa040857	http://dx.doi.org/10.1056/NEJMoa040857			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	849BM	15329427				2022-12-24	WOS:000223512500011
J	West, MA; Wallin, RPA; Matthews, SP; Svensson, HG; Zaru, R; Ljunggren, HG; Prescott, AR; Watts, C				West, MA; Wallin, RPA; Matthews, SP; Svensson, HG; Zaru, R; Ljunggren, HG; Prescott, AR; Watts, C			Enhanced dendritic cell antigen capture via toll-like receptor-induced actin remodeling	SCIENCE			English	Article							CLASS-I; MACROPINOCYTOSIS; MATURATION; PODOSOMES; CYTOSKELETON	Microbial products are sensed through Toll-like receptors (TLRs) and trigger a program of dendritic cell (DC) maturation that enables DCs to activate T cells. Although an accepted hallmark of this response is eventual down-regulation of DC endocytic capacity, we show that TLR ligands first acutely stimulate antigen macropinocytosis, leading to enhanced presentation on class I and class 11 major histocompatibility complex molecules. Simultaneously, actin-rich podosomes disappear, which suggests a coordinated redeployment of actin to fuel endocytosis. These reciprocal changes are transient and require p38 and extracellular signal-regulated kinase activation. Thus, the DC actin cytoskeleton can be rapidly mobilized in response to innate immune stimuli to enhance antigen capture and presentation.	Univ Dundee, Sch Life Sci, Wellcome Trust Bioctr, Div Cell Biol & Immunol, Dundee DD1 5EH, Scotland; Karolinska Inst, Ctr Microbiol & Tumor Biol, Stockholm, Sweden; Karolinska Univ Hosp, Karolinska Inst, Dept Med, Ctr Infect Med, Stockholm, Sweden	University of Dundee; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Watts, C (corresponding author), Univ Dundee, Sch Life Sci, Wellcome Trust Bioctr, Div Cell Biol & Immunol, Dundee DD1 5EH, Scotland.	c.watts@dundee.ac.uk	Prescott, Alan/Y-5956-2018	Prescott, Alan/0000-0002-0747-7317; Watts, Colin/0000-0001-6183-2087; Matthews, Stephen/0000-0003-3556-962X; Zaru, Rossana/0000-0002-3358-4423	Medical Research Council [G0100536] Funding Source: Medline; MRC [G0100536] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Akira S, 2003, J BIOL CHEM, V278, P38105, DOI 10.1074/jbc.R300028200; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Boes M, 2003, J IMMUNOL, V171, P4081, DOI 10.4049/jimmunol.171.8.4081; Burns S, 2004, CELL MOTIL CYTOSKEL, V57, P118, DOI 10.1002/cm.10163; Burns S, 2001, BLOOD, V98, P1142, DOI 10.1182/blood.V98.4.1142; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; Delamarre L, 2003, J EXP MED, V198, P111, DOI 10.1084/jem.20021542; Destaing O, 2003, MOL BIOL CELL, V14, P407, DOI 10.1091/mbc.E02-07-0389; Evans JG, 2003, J CELL BIOL, V161, P697, DOI 10.1083/jcb.200212037; Garrett WS, 2000, CELL, V102, P325, DOI 10.1016/S0092-8674(00)00038-6; Granucci F, 2001, EUR J IMMUNOL, V31, P2539, DOI 10.1002/1521-4141(200109)31:9<2539::AID-IMMU2539>3.0.CO;2-9; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; HAN J, 1994, SCIENCE, V265, P808, DOI 10.1126/science.7914033; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kleijmeer M, 2001, J CELL BIOL, V155, P53, DOI 10.1083/jcb.200103071; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; Lelouard H, 2002, NATURE, V417, P177, DOI 10.1038/417177a; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Ochoa GC, 2000, J CELL BIOL, V150, P377, DOI 10.1083/jcb.150.2.377; Regnault A, 1999, J EXP MED, V189, P371, DOI 10.1084/jem.189.2.371; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; West MA, 1999, EUR J IMMUNOL, V29, P3450, DOI 10.1002/(SICI)1521-4141(199911)29:11<3450::AID-IMMU3450>3.0.CO;2-A; West MA, 2000, CURR BIOL, V10, P839, DOI 10.1016/S0960-9822(00)00595-9	30	395	415	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 20	2004	305	5687					1153	1157		10.1126/science.1099153	http://dx.doi.org/10.1126/science.1099153			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849RD	15326355				2022-12-24	WOS:000223557400048
J	Butler, D				Butler, D			Power to the people	NATURE			English	Article																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 19	2004	430	7002					928	929		10.1038/430928a	http://dx.doi.org/10.1038/430928a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318231	Bronze			2022-12-24	WOS:000223369800054
J	Doms, RW				Doms, RW			Viral entry denied	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PROTEIN; FUSION		Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA	University of Pennsylvania	Doms, RW (corresponding author), Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.							Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Moore JP, 2003, P NATL ACAD SCI USA, V100, P10598, DOI 10.1073/pnas.1932511100; Sui JH, 2004, P NATL ACAD SCI USA, V101, P2536, DOI 10.1073/pnas.0307140101	3	6	9	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 19	2004	351	8					743	744		10.1056/NEJMp048058	http://dx.doi.org/10.1056/NEJMp048058			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	847CY	15317885				2022-12-24	WOS:000223367900004
J	Vennerstrom, JL; Arbe-Barnes, S; Brun, R; Charman, SA; Chiu, FCK; Chollet, J; Dong, YX; Dorn, A; Hunziker, D; Matile, H; McIntosh, K; Padmanilayam, M; Tomas, JS; Scheurer, C; Scorneaux, B; Tang, YQ; Urwyler, H; Wittlin, S; Charman, WN				Vennerstrom, JL; Arbe-Barnes, S; Brun, R; Charman, SA; Chiu, FCK; Chollet, J; Dong, YX; Dorn, A; Hunziker, D; Matile, H; McIntosh, K; Padmanilayam, M; Tomas, JS; Scheurer, C; Scorneaux, B; Tang, YQ; Urwyler, H; Wittlin, S; Charman, WN			Identification of an antimalarial synthetic trioxolane drug development candidate	NATURE			English	Article							PLASMODIUM-FALCIPARUM; QINGHAOSU ARTEMISININ; OZONIDES; PHARMACOKINETICS; ABSORPTION; RESISTANCE; PEROXIDES; DISCOVERY; INVITRO; DESIGN	The discovery of artemisinin more than 30 years ago provided a completely new antimalarial structural prototype; that is, a molecule with a pharmacophoric peroxide bond in a unique 1,2,4-trioxane heterocycle(1). Available evidence(2-4) suggests that artemisinin and related peroxidic antimalarial drugs exert their parasiticidal activity subsequent to reductive activation by haem, released as a result of haemoglobin digestion by the malaria-causing parasite. This irreversible redox reaction produces carbon-centred free radicals, leading to alkylation of haem(5) and proteins ( enzymes) 6, one of which-the sarcoplasmic-endoplasmic reticulum ATPase PfATP6 (ref. 7)-may be critical to parasite survival. Notably, there is no evidence of drug resistance to any member of the artemisinin family of drugs(8). The chemotherapy of malaria has benefited greatly from the semi-synthetic artemisinins artemether and artesunate as they rapidly reduce parasite burden, have good therapeutic indices and provide for successful treatment outcomes(9). However, as a drug class, the artemisinins suffer from chemical(10) ( semisynthetic availability, purity and cost), biopharmaceutical(11) (poor bioavailability and limiting pharmacokinetics) and treatment(8,11) (non-compliance with long treatment regimens and recrudescence) issues that limit their therapeutic potential. Here we describe how a synthetic peroxide antimalarial drug development candidate was identified in a collaborative drug discovery project.	Univ Nebraska, Med Ctr, Coll Pharm, Omaha, NE 68198 USA; Swiss Trop Inst, Hemel Hempstead HP1 1JY, Herts, England; Monash Univ, Victorian Coll Pharm, Parkville, Vic 3052, Australia; F Hoffmann La Roche & Co Ltd, CH-4070 Basel, Switzerland; Basilea Pharmaceut Ltd, CH-4058 Basel, Switzerland	University of Nebraska System; University of Nebraska Medical Center; Monash University; Roche Holding; Basilea Pharmaceutica Ltd.	Vennerstrom, JL (corresponding author), Univ Nebraska, Med Ctr, Coll Pharm, 986025 Nebraska Med Ctr, Omaha, NE 68198 USA.	jvenners@unmc.edu	Hua, QX/HGE-3640-2022; Charman, Susan A/E-2221-2011	Charman, Susan A/0000-0003-1753-8213; Charman, William/0000-0002-7051-2023				Abe M, 1999, J AM CHEM SOC, V121, P6556, DOI 10.1021/ja990807v; AVERY MA, 1992, J AM CHEM SOC, V114, P974, DOI 10.1021/ja00029a028; CHAWIRA AN, 1987, J TROP MED HYG, V90, P1; Crespi CL, 1997, ANAL BIOCHEM, V248, P188, DOI 10.1006/abio.1997.2145; CUMMING JN, 1997, ADV PHARMACOL, V37, P254; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; Eckstein-Ludwig U, 2003, NATURE, V424, P957, DOI 10.1038/nature01813; Gordi T, 2004, TOXICOL LETT, V147, P99, DOI 10.1016/j.toxlet.2003.12.009; Griesbaum K, 1997, LIEBIGS ANN-RECL, P1381; Jefford CW, 2001, CURR MED CHEM, V8, P1803, DOI 10.2174/0929867013371608; KEUL H, 1975, CHEM BER-RECL, V108, P1207, DOI 10.1002/cber.19751080427; KLAYMAN DL, 1985, SCIENCE, V228, P1049, DOI 10.1126/science.3887571; LI AG, 1998, J PHARM PHARMACOL, V50, P173; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Meshnick SR, 2002, INT J PARASITOL, V32, P1655, DOI 10.1016/S0020-7519(02)00194-7; Nwaka S, 2003, NAT REV DRUG DISCOV, V2, P919, DOI 10.1038/nrd1230; Palm K, 1997, PHARMACEUT RES, V14, P568, DOI 10.1023/A:1012188625088; Ridley RG, 2002, NATURE, V415, P686, DOI 10.1038/415686a; Ridley RG, 1997, ANTIMICROB AGENTS CH, V41, P677, DOI 10.1128/AAC.41.3.677; Robert A, 2002, CHEM COMMUN, P414, DOI 10.1039/b110817b; Smith DA, 1996, MED RES REV, V16, P243; Tang YQ, 2004, MED RES REV, V24, P425, DOI 10.1002/med.10066; van de Waterbeemd H, 2001, J MED CHEM, V44, P1313, DOI 10.1021/jm000407e; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; Vennerstrom J. L., 2002, Patent No. [US6486- 199B1, 6486199]; VENNERSTROM JL, 2002, Patent No. 0219767; Vyas N, 2002, ANTIMICROB AGENTS CH, V46, P105, DOI 10.1128/AAC.46.1.105-109.2002; White N, 1999, PHILOS T R SOC B, V354, P739, DOI 10.1098/rstb.1999.0426; White NJ, 1997, ANTIMICROB AGENTS CH, V41, P1413, DOI 10.1128/AAC.41.7.1413; Wu YK, 2002, ACCOUNTS CHEM RES, V35, P255, DOI 10.1021/ar000080b	30	537	575	3	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2004	430	7002					900	904		10.1038/nature02779	http://dx.doi.org/10.1038/nature02779			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	847DA	15318224				2022-12-24	WOS:000223369800044
J	Baker, AC; Starger, CJ; McClanahan, TR; Glynn, PW				Baker, AC; Starger, CJ; McClanahan, TR; Glynn, PW			Corals' adaptive response to climate change	NATURE			English	Editorial Material							REEF CORALS; FLEXIBILITY; HYPOTHESIS; MORTALITY; DIVERSITY; PATTERNS; ECOLOGY		Wildlife Conservat Soc, Marine Program, Bronx, NY 10460 USA; Columbia Univ, Ctr Environm Res & Conservat, New York, NY 10027 USA; Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA	Wildlife Conservation Society; Columbia University; Columbia University; University of Miami	Baker, AC (corresponding author), Wildlife Conservat Soc, Marine Program, Bronx, NY 10460 USA.	abaker@wcs.org	McClanahan, Tim/K-4998-2019	Starger, Craig/0000-0003-2444-6632; Baker, Andrew/0000-0002-7866-2587; McClanahan, Timothy/0000-0001-5821-3584				Baker AC, 2001, NATURE, V411, P765, DOI 10.1038/35081151; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; BUDDEMEIER RW, 1993, BIOSCIENCE, V43, P320, DOI 10.2307/1312064; Coles SL, 2003, ADV MAR BIOL, V46, P183, DOI 10.1016/S0065-2881(03)46004-5; Glynn PW, 2001, B MAR SCI, V69, P79; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; Little AF, 2004, SCIENCE, V304, P1492, DOI 10.1126/science.1095733; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; Sheppard CRC, 2003, NATURE, V425, P294, DOI 10.1038/nature01987; Toller WW, 2001, BIOL BULL-US, V201, P360, DOI 10.2307/1543614; Ware JR, 1996, ECOL MODEL, V84, P199, DOI 10.1016/0304-3800(94)00132-4; Wilkinson C., 2002, STATUS CORAL REEFS W	13	566	593	4	290	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 12	2004	430	7001					741	741		10.1038/430741a	http://dx.doi.org/10.1038/430741a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306799	Bronze			2022-12-24	WOS:000223233600030
J	Bertelsen, P; Goetz, W; Madsen, MB; Kinch, KM; Hviid, SF; Knudsen, JM; Gunnlaugsson, HP; Merrison, J; Nornberg, P; Squyres, SW; Bell, JF; Herkenhoff, KE; Gorevan, S; Yen, AS; Myrick, T; Klingelhofer, G; Rieder, R; Gellert, R				Bertelsen, P; Goetz, W; Madsen, MB; Kinch, KM; Hviid, SF; Knudsen, JM; Gunnlaugsson, HP; Merrison, J; Nornberg, P; Squyres, SW; Bell, JF; Herkenhoff, KE; Gorevan, S; Yen, AS; Myrick, T; Klingelhofer, G; Rieder, R; Gellert, R			Magnetic Properties Experiments on the Mars exploration Rover Spirit at Gusev crater	SCIENCE			English	Article							IRON-OXIDES; MOSSBAUER; SPECTROMETER; SOILS; ROCKS	The magnetic properties experiments are designed to help identify the magnetic minerals in the dust and rocks on Mars-and to determine whether liquid water was involved in the formation and alteration of these magnetic minerals. Almost all of the dust particles suspended in the martian atmosphere must contain ferrimagnetic minerals (such as maghemite or magnetite) in an amount of similar to2% by weight. The most magnetic fraction of the dust appears darker than the average dust. Magnetite was detected in the first two rocks ground by Spirit.	Univ Copenhagen, Danish Space Res Inst, Ctr Planetary Sci, DK-2100 Copenhagen, Denmark; Univ Copenhagen, Niels Bohr Inst Astron Phys & Geophys, DK-2100 Copenhagen, Denmark; Univ Aarhus, Dept Phys & Astron, DK-8000 Aarhus, Denmark; Max Planck Inst Aeron, D-37191 Katlenburg Lindau, Germany; Univ Aarhus, Dept Earth Sci, DK-8000 Aarhus, Denmark; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; US Geol Survey, Branch Astrogeol, Flagstaff, AZ 86001 USA; Honeybee Robot Ltd, New York, NY 10012 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Johannes Gutenberg Univ Mainz, Inst Inorgan & Analyt Chem, D-55099 Mainz, Germany; Max Planck Inst Chem, D-55020 Mainz, Germany	Technical University of Denmark; University of Copenhagen; University of Copenhagen; Niels Bohr Institute; Aarhus University; Max Planck Society; Aarhus University; Cornell University; United States Department of the Interior; United States Geological Survey; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Johannes Gutenberg University of Mainz; Max Planck Society	Bertelsen, P (corresponding author), Univ Copenhagen, Danish Space Res Inst, Ctr Planetary Sci, DK-2100 Copenhagen, Denmark.	preben@fys.ku.dk	Kinch, Kjartan Bergeron/C-5742-2015; Madsen, Morten Bo/D-2082-2011; Nornberg, Per/A-6228-2012; merrison, jonathan p/L-6524-2018; Gunnlaugsson, Haraldur/L-6535-2016	Kinch, Kjartan Bergeron/0000-0002-4629-8880; Madsen, Morten Bo/0000-0001-8909-5111; merrison, jonathan p/0000-0003-4362-6356; Gunnlaugsson, Haraldur/0000-0002-8958-0245				ASHWAL LD, 1977, J GEOPHYS RES, V82, P1315, DOI 10.1029/JB082i008p01315; Bell JF, 2004, SCIENCE, V305, P800, DOI 10.1126/science.1100175; BELL JF, 1990, J GEOPHYS RES-SOLID, V95, P14447, DOI 10.1029/JB095iB09p14447; Gorevan SP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002061; Herkenhoff KE, 2004, SCIENCE, V305, P824, DOI 10.1126/science.1100015; Madsen MB, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002029; Madsen MB, 1999, J GEOPHYS RES-PLANET, V104, P8761, DOI 10.1029/1998JE900006; Morris RV, 2004, SCIENCE, V305, P833, DOI 10.1126/science.1100020; MORRIS RV, 1989, J GEOPHYS RES-SOLID, V94, P2760, DOI 10.1029/JB094iB03p02760; MORRIS RV, 1993, GEOCHIM COSMOCHIM AC, V57, P4597, DOI 10.1016/0016-7037(93)90185-Y; Rieder R, 1997, SCIENCE, V278, P1771, DOI 10.1126/science.278.5344.1771; Smith PH, 1997, J GEOPHYS RES-PLANET, V102, P4003, DOI 10.1029/96JE03568; Squyres SW, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002121	13	69	72	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					827	829		10.1126/science.1100112	http://dx.doi.org/10.1126/science.1100112			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297664				2022-12-24	WOS:000223104900037
J	Hock, H; Hamblen, MJ; Rooke, HM; Schindler, JW; Saleque, S; Fujiwara, Y; Orkin, SH				Hock, H; Hamblen, MJ; Rooke, HM; Schindler, JW; Saleque, S; Fujiwara, Y; Orkin, SH			Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells	NATURE			English	Article							IN-VIVO; TRANSGENIC MICE; DIFFERENTIATION; EXPANSION; CAPACITY; BMI-1; MYC	Haematopoietic stem cells (HSCs) sustain blood production throughout life. HSCs are capable of extensive proliferative expansion, as a single HSC may reconstitute lethally irradiated hosts(1). In steady-state, HSCs remain largely quiescent and self-renew at a constant low rate, forestalling their exhaustion during adult life(2,3). Whereas nuclear regulatory factors promoting proliferative programmes of HSCs in vivo and ex vivo have been identified(4-6), transcription factors restricting their cycling have remained elusive. Here we report that the zinc-finger repressor Gfi-1 (growth factor independent 1), a cooperating oncogene in lymphoid cells(7,8), unexpectedly restricts proliferation of HSCs. After loss of Gfi-1, HSCs display elevated proliferation rates as assessed by 5-bromodeoxyuridine incorporation and cell-cycle analysis. Gfi-1(-/-) HSCs are functionally compromised in competitive repopulation and serial transplantation assays, and are rapidly out-competed in the bone marrow of mouse chimaeras generated with Gfi-1(-/-) embryonic stem cells. Thus, Gfi-1 is essential to restrict HSC proliferation and to preserve HSC functional integrity.	Harvard Univ, Childrens Hosp, Sch Med, Div Hematol Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute	Orkin, SH (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Div Hematol Oncol, Boston, MA 02115 USA.	stuart_orkin@dfci.harvard.edu						Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Akagi K, 2004, NUCLEIC ACIDS RES, V32, pD523, DOI 10.1093/nar/gkh013; Allsopp RC, 2001, J EXP MED, V193, P917, DOI 10.1084/jem.193.8.917; CHAN WY, 1998, TOP ENDOCRINOL, V8, P9; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; GILKS CB, 1993, MOL CELL BIOL, V13, P1759, DOI 10.1128/MCB.13.3.1759; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Phillips RL, 2000, SCIENCE, V288, P1635, DOI 10.1126/science.288.5471.1635; ROSS EAM, 1982, J EXP MED, V155, P432, DOI 10.1084/jem.155.2.432; Saleque S, 2002, GENE DEV, V16, P301, DOI 10.1101/gad.959102; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; Scheijen B, 1997, J VIROL, V71, P9, DOI 10.1128/JVI.71.1.9-16.1997; SPANGRUDE GJ, 1995, BLOOD, V85, P1006, DOI 10.1182/blood.V85.4.1006.bloodjournal8541006; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; Yucel R, 2003, J EXP MED, V197, P831, DOI 10.1084/jem.20021417; Zhu JF, 2002, IMMUNITY, V16, P733, DOI 10.1016/S1074-7613(02)00317-5	23	419	430	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 21	2004	431	7011					1002	1007		10.1038/nature02994	http://dx.doi.org/10.1038/nature02994			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	863TI	15457180				2022-12-24	WOS:000224585600048
J	Wang, HB; Wang, LJ; Erdjument-Bromage, H; Vidal, M; Tempst, P; Jones, RS; Zhang, Y				Wang, HB; Wang, LJ; Erdjument-Bromage, H; Vidal, M; Tempst, P; Jones, RS; Zhang, Y			Role of histone H2A ubiquitination in polycomb silencing	NATURE			English	Article							H3 LYSINE-27 METHYLATION; RING FINGER PROTEINS; TRANSCRIPTIONAL ACTIVATION; LIGASE ACTIVITY; RAD6; COMPLEX; CORE; UBIQUITYLATION; RECRUITMENT; DROSOPHILA	Covalent modification of histones is important in regulating chromatin dynamics and transcription(1,2). One example of such modification is ubiquitination, which mainly occurs on histones H2A and H2B(3). Although recent studies have uncovered the enzymes involved in histone H2B ubiquitination(4-6) and a 'cross-talk' between H2B ubiquitination and histone methylation(7,8), the responsible enzymes and the functions of H2A ubiquitination are unknown. Here we report the purification and functional characterization of an E3 ubiquitin ligase complex that is specific for histone H2A. The complex, termed hPRC1L ( human Polycomb repressive complex 1-like), is composed of several Polycomb-group proteins including Ring1, Ring2, Bmi1 and HPH2. hPRC1L monoubiquitinates nucleosomal histone H2A at lysine 119. Reducing the expression of Ring2 results in a dramatic decrease in the level of ubiquitinated H2A in HeLa cells. Chromatin immunoprecipitation analysis demonstrated colocalization of dRing with ubiquitinated H2A at the PRE and promoter regions of the Drosophila Ubx gene in wing imaginal discs. Removal of dRing in SL2 tissue culture cells by RNA interference resulted in loss of H2A ubiquitination concomitant with derepression of Ubx. Thus, our studies identify the H2A ubiquitin ligase, and link H2A ubiquitination to Polycomb silencing.	Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; So Methodist Univ, Dept Biol Sci, Dallas, TX 75275 USA; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; Ctr Invest Biol, Dept Desarrollo & Biol Celular, E-28040 Madrid, Spain	University of North Carolina; University of North Carolina Chapel Hill; Southern Methodist University; Memorial Sloan Kettering Cancer Center; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Zhang, Y (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	yi_zhang@med.unc.edu	; Vidal, Miguel/M-8861-2016	Wang, Hengbin/0000-0003-2414-0609; Erdjument-Bromage, Hediye/0000-0003-0224-3594; Tempst, Paul/0000-0002-6680-3987; Zhang, Yi/0000-0002-2789-0811; Vidal, Miguel/0000-0003-4374-6761				Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Devroe E, 2004, J BIOL CHEM, V279, P24444, DOI 10.1074/jbc.M401999200; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Francis NJ, 2001, MOL CELL, V8, P545, DOI 10.1016/S1097-2765(01)00316-1; Fritsch C, 2003, MECH DEVELOP, V120, P949, DOI 10.1016/S0925-4773(03)00083-2; Gorfinkiel N, 2004, MECH DEVELOP, V121, P449, DOI 10.1016/j.mod.2004.03.019; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Hwang WW, 2003, MOL CELL, V11, P261, DOI 10.1016/S1097-2765(02)00826-2; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kao CF, 2004, GENE DEV, V18, P184, DOI 10.1101/gad.1149604; Lee SJ, 2001, FEBS LETT, V503, P61, DOI 10.1016/S0014-5793(01)02689-8; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; NICKEL BE, 1989, BIOCHEMISTRY-US, V28, P964, DOI 10.1021/bi00429a007; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Satijn DPE, 1997, MOL CELL BIOL, V17, P4105, DOI 10.1128/MCB.17.7.4105; Schoorlemmer J, 1997, EMBO J, V16, P5930, DOI 10.1093/emboj/16.19.5930; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; VASSILEV AP, 1995, J CELL SCI, V108, P1205; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Wang HB, 2003, MOL CELL, V12, P475, DOI 10.1016/j.molcel.2003.08.007; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Zhang Y, 2003, GENE DEV, V17, P2733, DOI 10.1101/gad.1156403; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	29	1236	1295	3	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 14	2004	431	7010					873	878		10.1038/nature02985	http://dx.doi.org/10.1038/nature02985			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861RE	15386022				2022-12-24	WOS:000224435500053
J	Stephens, P; Hunter, C; Bignell, G; Edkins, S; Davies, H; Teague, J; Stevens, C; O'Meara, S; Smith, R; Parker, A; Barthorpe, A; Blow, M; Brackenbury, L; Butler, A; Clarke, O; Cole, J; Dicks, E; Dike, A; Drozd, A; Edwards, K; Forbes, S; Foster, R; Gray, K; Greenman, C; Halliday, K; Hills, K; Kosmidou, V; Lugg, R; Menzies, A; Perry, J; Petty, R; Raine, K; Ratford, L; Shepherd, R; Small, A; Stephens, Y; Tofts, C; Varian, J; West, S; Widaa, S; Yates, A; Brasseur, F; Cooper, CS; Flanagan, AM; Knowles, M; Leung, SY; Louis, DN; Looijenga, LHJ; Malkowicz, B; Pierotti, MA; Teh, B; Chenevix-Trench, G; Weber, BL; Yuen, ST; Harris, G; Goldstraw, P; Nicholson, AG; Futreal, PA; Wooster, R; Stratton, MR				Stephens, P; Hunter, C; Bignell, G; Edkins, S; Davies, H; Teague, J; Stevens, C; O'Meara, S; Smith, R; Parker, A; Barthorpe, A; Blow, M; Brackenbury, L; Butler, A; Clarke, O; Cole, J; Dicks, E; Dike, A; Drozd, A; Edwards, K; Forbes, S; Foster, R; Gray, K; Greenman, C; Halliday, K; Hills, K; Kosmidou, V; Lugg, R; Menzies, A; Perry, J; Petty, R; Raine, K; Ratford, L; Shepherd, R; Small, A; Stephens, Y; Tofts, C; Varian, J; West, S; Widaa, S; Yates, A; Brasseur, F; Cooper, CS; Flanagan, AM; Knowles, M; Leung, SY; Louis, DN; Looijenga, LHJ; Malkowicz, B; Pierotti, MA; Teh, B; Chenevix-Trench, G; Weber, BL; Yuen, ST; Harris, G; Goldstraw, P; Nicholson, AG; Futreal, PA; Wooster, R; Stratton, MR		Canc Genome Project Collaborat Grp	Intragenic ERBB2 kinase mutations in tumours	NATURE			English	Article							LUNG-CANCER		Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England; Ludwig Inst Canc Res, B-1200 Brussels, Belgium; Inst Canc Res, Sutton SM2 5NG, Surrey, England; UCL, Inst Orthopaed, Stanmore HA7 4LP, Middx, England; St James Univ Hosp, Canc Res UK Clin Ctr, Leeds LS9 7TF, W Yorkshire, England; Univ Hong Kong, Queen Mary Hosp, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; Massachusetts Gen Hosp E, Mol Pathol Unit, Charlestown, MA 02129 USA; Erasmus MC Univ Med Ctr Rotterdam, Dr Daniel Den Hoed Canc Ctr, Josephine Nefkens Inst, Lab Pathol Expt Pathooncol, NL-3000 DR Rotterdam, Netherlands; Univ Penn, Div Urol, Philadelphia, PA 19104 USA; Inst Nazl Tumori, Milan, Italy; Inst Mol Oncol, FIRC, Milan, Italy; Van Andel Res Inst, Canc Genet Lab, Grand Rapids, MI 49503 USA; Royal Brisbane Hosp, Queensland Inst Med Res, Herston, Qld 4029, Australia; Univ Penn, Ctr Canc, Philadelphia, PA 19104 USA; Royal Brompton Hosp, London SW3 6NP, England	Wellcome Trust Sanger Institute; Ludwig Institute for Cancer Research; University of London; Institute of Cancer Research - UK; University of London; University College London; Cancer Research UK; Saint James's University Hospital; University of Leeds; University of Hong Kong; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; University of Pennsylvania; Fondazione IRCCS Istituto Nazionale Tumori Milan; IFOM - FIRC Institute of Molecular Oncology; Van Andel Institute; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; University of Pennsylvania; Royal Brompton Hospital	Stephens, P (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England.		Chenevix-Trench, Georgia/AAV-2014-2020; Yuen, Siu/K-6311-2014; Looijenga, Leendert/B-8145-2019; Leung, Suet Yi/C-4340-2009; Blow, Matthew/G-6369-2012; Pierotti, Marco Alessandro/AAC-4728-2022; Leung, Suet Yi/T-9620-2019	Chenevix-Trench, Georgia/0000-0002-1878-2587; Looijenga, Leendert/0000-0002-8146-1911; Blow, Matthew/0000-0002-8844-9149; Pierotti, Marco Alessandro/0000-0002-7431-8332; Yates, Andrew/0000-0002-8886-4772; Edkins, Sarah/0000-0003-0717-1972; Knowles, Margaret/0000-0002-9363-8657; Raine, Keiran/0000-0002-5634-1539; Leung, Suet Yi/0000-0001-8614-4619; Flanagan, Adrienne/0000-0002-2832-1303; Hunter, Christopher/0000-0002-1335-0881; Gray, Kristian/0000-0002-7035-7107				Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Hirsch FR, 2004, SEMIN ONCOL, V31, P75, DOI 10.1053/j.seminoncol.2003.12.018; Klapper LN, 2000, ADV CANCER RES, V77, P25; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Rosell R, 2004, J CLIN ONCOL, V22, P1171, DOI 10.1200/JCO.2004.01.904; Sawyers CL, 2003, GENE DEV, V17, P2998, DOI 10.1101/gad.1152403; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106	8	602	631	3	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 30	2004	431	7008					525	526		10.1038/431525b	http://dx.doi.org/10.1038/431525b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15457249				2022-12-24	WOS:000224156700034
J	Ao, W; Gaudet, J; Kent, WJ; Muttumu, S; Mango, SE				Ao, W; Gaudet, J; Kent, WJ; Muttumu, S; Mango, SE			Environmentally induced foregut remodeling by PHA-4/FoxA and DAF-12/NHR	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; GENE-EXPRESSION; DNA-BINDING; DEVELOPMENTAL AGE; ENCODES; ISOFORMS; RECEPTOR; CEH-22	Growth and development of the Caenorhabditis elegans foregut (pharynx) depends on coordinated gene expression, mediated by pharynx defective (PHA)-4/FoxA in combination with additional, largely unidentified transcription factors. Here, we used whole genome analysis to establish clusters of genes expressed in different pharyngeal cell types. We created an expectation maximization algorithm to identify cis-regulatory elements that activate expression within the pharyngeal gene clusters. One of these elements mediates the response to environmental conditions within pharyngeal muscles and is recognized by the nuclear hormone receptor (NHR) DAF-12. Our data suggest that PHA-4 and DAF-12 endow the pharynx with transcriptional plasticity to respond to diverse developmental and physiological cues. Our combination of bioinformatics and in vivo analysis has provided a powerful means for genome-wide investigation of transcriptional control.	Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; Univ Calif Santa Cruz, Genome Bioinformat Grp, Santa Cruz, CA 95064 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of California System; University of California Santa Cruz	Mango, SE (corresponding author), Univ Utah, Huntsman Canc Inst, 2000 Circle Hope, Salt Lake City, UT 84112 USA.	susan.mango@hci.utah.edu		Mango, Susan/0000-0002-2146-3237	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056264] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM056264-08S1, R01 GM056264, R01-GM56264, R01 GM056264-08, R01 GM056264-07] Funding Source: Medline; PHS HHS [2P303A42014] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALBERT PS, 1988, DEV BIOL, V126, P270, DOI 10.1016/0012-1606(88)90138-8; Antebi A, 2000, GENE DEV, V14, P1512; Antebi A, 1998, DEVELOPMENT, V125, P1191; AO W, UNPUB; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Beaster-Jones L, 2004, J MOL BIOL, V339, P695, DOI 10.1016/j.jmb.2004.04.030; Finch CE, 2001, ANNU REV GENOM HUM G, V2, P435, DOI 10.1146/annurev.genom.2.1.435; Fire A, 1998, GREEN FLUORESCENT PROTEIN: PROPERTIES, APPLICATIONS, AND PROTOCOLS, P153; Gaudet J, 2002, SCIENCE, V295, P821, DOI 10.1126/science.1065175; GAUDET J, IN PRESS PLOS BIOL; Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5; Horner MA, 1998, GENE DEV, V12, P1947, DOI 10.1101/gad.12.13.1947; Jia KL, 2002, DEVELOPMENT, V129, P221; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; KISPERT A, 1993, EMBO J, V12, P3211, DOI 10.1002/j.1460-2075.1993.tb05990.x; LARSEN PL, 1995, GENETICS, V139, P1567; Li SL, 2003, MOL BIOL CELL, V14, P2630, DOI 10.1091/mbc.E02-11-0716; MANGO SE, 1994, DEVELOPMENT, V120, P3019; Mann RS, 2002, CURR OPIN GENET DEV, V12, P592, DOI 10.1016/S0959-437X(02)00344-1; MILLER DM, 1986, P NATL ACAD SCI USA, V83, P2305, DOI 10.1073/pnas.83.8.2305; Okkema PG, 1997, DEVELOPMENT, V124, P3965; OKKEMA PG, 1994, DEVELOPMENT, V120, P2175; RIDDLE DL, 1981, NATURE, V290, P668, DOI 10.1038/290668a0; Snow MI, 2000, BBA-GENE STRUCT EXPR, V1494, P104, DOI 10.1016/S0167-4781(00)00224-4; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Thatcher JD, 1999, DEVELOPMENT, V126, P97; Thatcher JD, 2001, DEV BIOL, V229, P480, DOI 10.1006/dbio.2000.9978; Vilimas T, 2004, DEV BIOL, V266, P388, DOI 10.1016/j.ydbio.2003.10.015; Wang J, 2003, DEVELOPMENT, V130, P1621, DOI 10.1242/dev.00363; WANG MM, 1993, NATURE, V364, P121, DOI 10.1038/364121a0	32	135	145	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1743	1746		10.1126/science.1102216	http://dx.doi.org/10.1126/science.1102216			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	856IS	15375261				2022-12-24	WOS:000224039500032
J	Zhou, RH; Huang, XH; Margulis, CJ; Berne, BJ				Zhou, RH; Huang, XH; Margulis, CJ; Berne, BJ			Hydrophobic collapse in multidomain protein folding	SCIENCE			English	Article							MOLECULAR-DYNAMICS; FREE-ENERGY; WATER; HYDRATION; DEPENDENCE; SIMULATION; SOLUTES	We performed molecular dynamics simulations of the collapse of a two-domain protein, the BphC enzyme, into a globular structure to examine how water molecules mediate hydrophobic collapse of proteins. in the interdomain region, liquid water persists with a density 10 to 15% lower than in the bulk, even at small domain separations. Water depletion and hydrophobic collapse occur on a nanosecond time scale, which is two orders of magnitude slower than that found in the collapse of idealized paraffin-like plates. When the electrostatic protein-water forces are turned off, a dewetting transition occurs in the interdomain region and the collapse speeds up by more than an order of magnitude. When attractive van der Waals forces are turned off as well, the dewetting in the interdomain region is more profound, and the collapse is even faster.	IBM Corp, Thomas J Watson Res Ctr, Computat Biol Ctr, Yorktown Hts, NY 10598 USA; Columbia Univ, Dept Chem, New York, NY 10027 USA	International Business Machines (IBM); Columbia University	Zhou, RH (corresponding author), IBM Corp, Thomas J Watson Res Ctr, Computat Biol Ctr, 1101 Kitchawan Rd, Yorktown Hts, NY 10598 USA.	ruhongz@us.ibm.com; berne@chem.columbia.edu	Huang, Xuhui/ABE-3207-2021	Huang, Xuhui/0000-0002-7119-9358; Zhou, Ruhong/0000-0001-8624-5591; Margulis, Claudio/0000-0003-1671-9784	NIGMS NIH HHS [GM4330] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ashbaugh HS, 2001, J AM CHEM SOC, V123, P10721, DOI 10.1021/ja016324k; Ball P, 2003, NATURE, V423, P25, DOI 10.1038/423025a; Chandler D, 2002, NATURE, V417, P491, DOI 10.1038/417491a; Cheng YK, 1998, NATURE, V392, P696, DOI 10.1038/33653; Huang DM, 2000, P NATL ACAD SCI USA, V97, P8324, DOI 10.1073/pnas.120176397; Huang DM, 2002, J PHYS CHEM B, V106, P2047, DOI 10.1021/jp013289v; Huang X, 2003, P NATL ACAD SCI USA, V100, P11953, DOI 10.1073/pnas.1934837100; Hummer G, 2001, NATURE, V414, P188, DOI 10.1038/35102535; Hummer G, 2000, CHEM PHYS, V258, P349, DOI 10.1016/S0301-0104(00)00115-4; Jensen TR, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.086101; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Leung K, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.065502; Leung K, 2000, J CHEM PHYS, V113, P5845, DOI 10.1063/1.1290479; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lum K, 1997, PHYS REV E, V56, pR6283, DOI 10.1103/PhysRevE.56.R6283; Lum K, 1998, INT J THERMOPHYS, V19, P845, DOI 10.1023/A:1022643006849; Lum K, 1999, J PHYS CHEM B, V103, P4570, DOI 10.1021/jp984327m; Mountain RD, 2003, J AM CHEM SOC, V125, P1950, DOI 10.1021/ja020496f; PANGALI C, 1979, J CHEM PHYS, V71, P2982, DOI 10.1063/1.438702; Paulaitis ME, 2002, ADV PROTEIN CHEM, V62, P283; Pratt LR, 2002, ANNU REV PHYS CHEM, V53, P409, DOI 10.1146/annurev.physchem.53.090401.093500; Steitz R, 2003, LANGMUIR, V19, P2409, DOI 10.1021/la026731p; Stillinger FH, 1973, J SOLUTION CHEM, V2, P141, DOI 10.1007/BF00651970; ten Wolde PR, 2002, P NATL ACAD SCI USA, V99, P6539, DOI 10.1073/pnas.052153299; WALLQVIST A, 1995, J PHYS CHEM-US, V99, P2885, DOI 10.1021/j100009a052; WALLQVIST A, 1995, J PHYS CHEM-US, V99, P2893, DOI 10.1021/j100009a053; Zhou RH, 2003, PROTEINS, V52, P561, DOI 10.1002/prot.10419	27	469	478	2	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2004	305	5690					1605	1609		10.1126/science.1101176	http://dx.doi.org/10.1126/science.1101176			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	854GV	15361621				2022-12-24	WOS:000223891200039
J	Seo, HC; Edvardsen, RB; Maeland, AD; Bjordal, M; Jensen, MF; Hansen, A; Flaat, M; Weissenbach, J; Lehrach, H; Wincker, P; Reinhardt, R; Chourrout, D				Seo, HC; Edvardsen, RB; Maeland, AD; Bjordal, M; Jensen, MF; Hansen, A; Flaat, M; Weissenbach, J; Lehrach, H; Wincker, P; Reinhardt, R; Chourrout, D			Hox cluster disintegration with persistent anteroposterior order of expression in Oikopleura dioica	NATURE			English	Article							CIONA-INTESTINALIS; CAENORHABDITIS-ELEGANS; GENE; GENOME; VERTEBRATES; PHYLOGENY; EVOLUTION; CHORDATE; EMBRYOS; ORIGINS	Tunicate embryos and larvae have small cell numbers and simple anatomical features in comparison with other chordates, including vertebrates. Although they branch near the base of chordate phylogenetic trees(1), their degree of divergence from the common chordate ancestor remains difficult to evaluate. Here we show that the tunicate Oikopleura dioica has a complement of nine Hox genes in which all central genes are lacking but a full vertebrate-like set of posterior genes is present. In contrast to all bilaterians studied so far, Hox genes are not clustered in the Oikopleura genome. Their expression occurs mostly in the tail, with some tissue preference, and a strong partition of expression domains in the nerve cord, in the notochord and in the muscle. In each tissue of the tail, the anteroposterior order of Hox gene expression evokes spatial collinearity, with several alterations. We propose a relationship between the Hox cluster breakdown, the separation of Hox expression domains, and a transition to a determinative mode of development.	Bergen High Technol Ctr, Sars Ctr Marine Mol Biol, N-5008 Bergen, Norway; Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Genoscope Ctr Natl Sequencage, F-91000 Evry, France; CNRS, UMR 8030, F-91000 Evry, France	Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA	Chourrout, D (corresponding author), Bergen High Technol Ctr, Sars Ctr Marine Mol Biol, Thormohlensgaten 55, N-5008 Bergen, Norway.	Daniel.Chourrout@sars.uib.no		Edvardsen, Rolf/0000-0001-8430-8042; Reinhardt, Richard/0000-0001-9376-2132				Aboobaker AA, 2003, CURR BIOL, V13, P37, DOI 10.1016/S0960-9822(02)01399-4; AKAM M, 1989, CELL, V57, P347, DOI 10.1016/0092-8674(89)90909-4; [Anonymous], 2002, PAUP 4 0 PHYLOGENETI; AVEROF M, 1995, NATURE, V376, P420, DOI 10.1038/376420a0; Balavoine G, 2002, MOL PHYLOGENET EVOL, V24, P366, DOI 10.1016/S1055-7903(02)00237-3; Bassham S, 2000, DEV BIOL, V220, P322, DOI 10.1006/dbio.2000.9647; Boutanaev AM, 2002, NATURE, V420, P666, DOI 10.1038/nature01216; BURGLIN TR, 1993, CURR OPIN GENET DEV, V3, P615, DOI 10.1016/0959-437X(93)90097-9; Cowing D, 1996, NATURE, V382, P353, DOI 10.1038/382353a0; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Ferrier DEK, 2000, EVOL DEV, V2, P284, DOI 10.1046/j.1525-142x.2000.00070.x; Ferrier DEK, 2002, MOL PHYLOGENET EVOL, V24, P412, DOI 10.1016/S1055-7903(02)00204-X; Finnerty JR, 2003, INT J DEV BIOL, V47, P523; Gionti M, 1998, DEV GENES EVOL, V207, P515, DOI 10.1007/s004270050142; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; Lacalli TC, 1999, BIOL REV, V74, P177, DOI 10.1017/S0006323199005319; Locascio A, 1999, DEVELOPMENT, V126, P4737; Nagatomo K, 2003, GENE EXPR PATTERNS, V3, P273, DOI 10.1016/S1567-133X(03)00051-6; Powers TP, 2004, CURR BIOL, V14, pR183, DOI 10.1016/j.cub.2004.02.015; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Seo HC, 2001, SCIENCE, V294, P2506, DOI 10.1126/science.294.5551.2506; Spada F, 2001, J BIOL CHEM, V276, P20624, DOI 10.1074/jbc.M100438200; Spagnuolo A, 2003, GENE, V309, P71, DOI 10.1016/S0378-1119(03)00488-8; vanderHoeven F, 1996, CELL, V85, P1025, DOI 10.1016/S0092-8674(00)81303-3; VonAllmen G, 1996, NATURE, V380, P116, DOI 10.1038/380116a0; Wada H, 1998, MOL BIOL EVOL, V15, P1189, DOI 10.1093/oxfordjournals.molbev.a026026; WELSCH U, 1969, Z ZELLFORSCH MIK ANA, V93, P547	28	243	252	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 2	2004	431	7004					67	71		10.1038/nature02709	http://dx.doi.org/10.1038/nature02709			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850VC	15343333				2022-12-24	WOS:000223641500042
J	Flore, O				Flore, O			Kaposi's sarcoma	LANCET			English	Editorial Material							EXPRESSION; CELLS; AIDS; INVITRO; GENE		NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; NYU, Sch Med, Dept Dermatol, New York, NY 10016 USA	New York University; New York University	Flore, O (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.	ornella.flore@med.nyu.edu						ALBRECHT JC, 1992, J VIROL, V66, P5047, DOI 10.1128/JVI.66.8.5047-5058.1992; BABA M, 1987, ANTIVIR RES, V7, P99, DOI 10.1016/0166-3542(87)90025-8; BERAL V, 1990, LANCET, V335, P123, DOI 10.1016/0140-6736(90)90001-L; Jussila L, 1998, CANCER RES, V58, P1599; Kaposi M., 1872, ARCH DERMATOL SYPHIL, V4, P265, DOI 10.1007/BF01830024; NICKOLOFF BJ, 1989, AM J PATHOL, V135, P793; Roizman B, 1996, FIELDS VIROLOGY, P2221; ROTH WK, 1988, INT J CANCER, V42, P767, DOI 10.1002/ijc.2910420523; RUTGERS JL, 1986, AM J PATHOL, V122, P493; Sturzl M, 1998, AIDS, V12, P1105; Wang HW, 2004, NAT GENET, V36, P687, DOI 10.1038/ng1384	11	6	7	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 28	2004	364	9436					740	741		10.1016/S0140-6736(04)16952-3	http://dx.doi.org/10.1016/S0140-6736(04)16952-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	849VO	15337387				2022-12-24	WOS:000223569600008
J	Rohling, EJ; Marsh, R; Wells, NC; Siddall, M; Edwards, NR				Rohling, EJ; Marsh, R; Wells, NC; Siddall, M; Edwards, NR			Similar meltwater contributions to glacial sea level changes from Antarctic and northern ice sheets	NATURE			English	Article							CLIMATE-CHANGE; GREENLAND; RECORD; CYCLE; INSTABILITY; MAXIMUM; EVENTS; PERIOD; MODEL; CORE	The period between 75,000 and 20,000 years ago was characterized by high variability in climate(1-12) and sea level(13,14). Southern Ocean records of ice-rafted debris(15) suggest a significant contribution to the sea level changes from melt water of Antarctic origin, in addition to likely contributions from northern ice sheets, but the relative volumes of melt water from northern and southern sources have yet to be established. Here we simulate the first-order impact of a range of relative meltwater releases from the two polar regions on the distribution of marine oxygen isotopes, using an intermediate complexity model. By comparing our simulations with oxygen isotope data from sediment cores, we infer that the contributions from Antarctica and the northern ice sheets to the documented sea level rises between 65,000 and 35,000 years ago(13) were approximately equal, each accounting for a rise of about 15 m. The reductions in Antarctic ice volume implied by our analysis are comparable to that inferred previously for the Antarctic contribution to meltwater pulse 1A (refs 16, 17), which occurred about 14,200 years ago, during the last deglaciation.	Southampton Oceanog Ctr, Southampton SO14 3ZH, Hants, England; Univ Bern, NCCR Climate, CH-3012 Bern, Switzerland	NERC National Oceanography Centre; University of Southampton; University of Bern	Rohling, EJ (corresponding author), Southampton Oceanog Ctr, Southampton SO14 3ZH, Hants, England.	e.rohling@soc.soton.ac.uk	Marsh, Robert/G-4988-2013; Rohling, Eelco J/B-9736-2008	Rohling, Eelco J/0000-0001-5349-2158; Marsh, Robert/0000-0002-1051-8749	Natural Environment Research Council [NER/T/S/2002/00455] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Anderson JB, 2002, QUATERNARY SCI REV, V21, P49, DOI 10.1016/S0277-3791(01)00083-X; ANNAN JD, IN PRESS OCEAN MODEL; Barrett P.J, 1996, TERRA ANTARCTICA, V3, P103; Blunier T, 1998, NATURE, V394, P739, DOI 10.1038/29447; Broecker WS, 2000, EARTH-SCI REV, V51, P137, DOI 10.1016/S0012-8252(00)00019-2; Clark PU, 2002, SCIENCE, V295, P2438; Cutler KB, 2003, EARTH PLANET SC LETT, V206, P253, DOI 10.1016/S0012-821X(02)01107-X; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; Denton GH, 2002, QUATERNARY SCI REV, V21, P193, DOI 10.1016/S0277-3791(01)00090-7; EDWARDS NR, 2004, UNPUB CLIM DYN; Ganopolski A, 2001, NATURE, V409, P153, DOI 10.1038/35051500; GROOTES PM, 1993, NATURE, V366, P552, DOI 10.1038/366552a0; Hemming SR, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000128; Huybrechts P, 2002, QUATERNARY SCI REV, V21, P203, DOI 10.1016/S0277-3791(01)00082-8; Indermuhle A, 2000, GEOPHYS RES LETT, V27, P735, DOI 10.1029/1999GL010960; Kanfoush SL, 2000, SCIENCE, V288, P1815, DOI 10.1126/science.288.5472.1815; LANGWAY CC, 1985, GEOPHYS MONOGR AM GE, V33; Leuschner DC, 2000, QUATERNARY SCI REV, V19, P243, DOI 10.1016/S0277-3791(99)00064-5; Pahnke K, 2003, SCIENCE, V301, P948, DOI 10.1126/science.1084451; PELTIER WR, 1994, SCIENCE, V265, P195, DOI 10.1126/science.265.5169.195; RAHMSTORF S, 1994, NATURE, V372, P82, DOI 10.1038/372082a0; Rahmstorf S, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017115; RAHMSTORF S, 1995, NATURE, V378, P145, DOI 10.1038/378145a0; Rohling EJ, 2003, CLIM DYNAM, V20, P257, DOI 10.1007/s00382-002-0266-4; Shackleton NJ, 2000, PALEOCEANOGRAPHY, V15, P565, DOI 10.1029/2000PA000513; Siddall M, 2003, NATURE, V423, P853, DOI 10.1038/nature01690; Stenni B, 2004, EARTH PLANET SC LETT, V217, P183, DOI 10.1016/S0012-821X(03)00574-0; Stocker TF, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000920; Voelker AHL, 2002, QUATERNARY SCI REV, V21, P1185, DOI 10.1016/S0277-3791(01)00139-1; Weaver AJ, 2003, SCIENCE, V299, P1709, DOI 10.1126/science.1081002	30	71	73	1	387	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 26	2004	430	7003					1016	1021		10.1038/nature02859	http://dx.doi.org/10.1038/nature02859			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849CD	15329718				2022-12-24	WOS:000223514900040
J	Ramiro, AR; Jankovic, M; Eisenreich, T; Difilippantonio, S; Chen-Kiang, S; Muramatsu, M; Hongo, T; Nussenzweig, A; Nussenzweig, MC				Ramiro, AR; Jankovic, M; Eisenreich, T; Difilippantonio, S; Chen-Kiang, S; Muramatsu, M; Hongo, T; Nussenzweig, A; Nussenzweig, MC			AID is required for c-myc/IgH chromosome translocations in vivo	CELL			English	Article							CLASS-SWITCH RECOMBINATION; CYTIDINE DEAMINASE AID; DOUBLE-STRAND BREAKS; MYC ONCOGENE; SOMATIC HYPERMUTATION; B-CELLS; BURKITT-LYMPHOMA; CIRCULAR DNA; NEOPLASTIC DEVELOPMENT; MURINE PLASMACYTOMAS	Chromosome translocations between c-myc and immunoglobulin (Ig) are associated with Burkitt's lymphoma in humans and with pristane- and IL6-induced plasmacytomas in mice. These translocations frequently involve Ig switch regions, suggesting that they might be the result of aberrant Ig class switch recombination (CSR). However, a direct link between CSR and chromosome translocations has not been established. We have examined c-myc/IgH translocations in IL6 transgenic mice that are mutant for activation induced cytidine deaminase (AID), the enzyme that initiates CSR. Her a we report that AID is essential for the c-myc/IgH chromosome translocations induced by IL6.	Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; Cornell Univ, Weill Med Coll, Dept Pathol, New York, NY 10021 USA; Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan	Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Cornell University; Kyoto University	Ramiro, AR (corresponding author), Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA.	nussen@mail.rockefeller.edu	Nussenzweig, Michel/AAE-7292-2019; Muramatsu, Masamichi/C-4339-2015; Ramiro, Almudena R/H-6037-2015	Muramatsu, Masamichi/0000-0002-0153-3533; Ramiro, Almudena R/0000-0002-7539-3844	NATIONAL CANCER INSTITUTE [Z01BC010283, ZIABC010283] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS JM, 1982, P NATL ACAD SCI-BIOL, V79, P6966, DOI 10.1073/pnas.79.22.6966; ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; ADAMS JM, 1983, P NATL ACAD SCI-BIOL, V80, P1982, DOI 10.1073/pnas.80.7.1982; ARMITAGE JO, 2001, HARRISONS PRINCIPLES, P715; Casellas R, 1998, EMBO J, V17, P2404, DOI 10.1093/emboj/17.8.2404; CREWS S, 1982, SCIENCE, V218, P1319, DOI 10.1126/science.7146913; DALLAFAVERA R, 1983, SCIENCE, V219, P963, DOI 10.1126/science.6401867; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Difilippantonio MJ, 2002, J EXP MED, V196, P469, DOI 10.1084/jem.20020851; Ehrenstein MR, 1999, EMBO J, V18, P3484, DOI 10.1093/emboj/18.12.3484; ERIKSON J, 1983, P NATL ACAD SCI-BIOL, V80, P820, DOI 10.1073/pnas.80.3.820; GAUWERKY CE, 1993, SEMIN CANCER BIOL, V4, P333; HAMLYN PH, 1983, NATURE, V304, P135, DOI 10.1038/304135a0; HONJO T, 1978, P NATL ACAD SCI USA, V75, P2140, DOI 10.1073/pnas.75.5.2140; IWASATO T, 1990, CELL, V62, P143, DOI 10.1016/0092-8674(90)90248-D; Kim N, 1999, J EXP MED, V190, P21, DOI 10.1084/jem.190.1.21; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; Kovalchuk AL, 2000, LEUKEMIA, V14, P1127, DOI 10.1038/sj.leu.2401767; Kovalchuk AL, 1997, ONCOGENE, V15, P2369, DOI 10.1038/sj.onc.1201409; Kovalchuk AL, 2000, LEUKEMIA, V14, P909, DOI 10.1038/sj.leu.2401676; Kovalchuk AL, 2002, P NATL ACAD SCI USA, V99, P1509, DOI 10.1073/pnas.022643999; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; LEDER P, 1983, SCIENCE, V222, P765, DOI 10.1126/science.6356357; Machida K, 2004, P NATL ACAD SCI USA, V101, P4262, DOI 10.1073/pnas.0303971101; Manis JP, 1998, J EXP MED, V187, P2081, DOI 10.1084/jem.187.12.2081; MARCU KB, 1983, P NATL ACAD SCI-BIOL, V80, P519, DOI 10.1073/pnas.80.2.519; MATSUOKA M, 1990, CELL, V62, P135, DOI 10.1016/0092-8674(90)90247-C; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Morse L, 1997, IMMUNITY, V6, P47, DOI 10.1016/S1074-7613(00)80241-1; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Muschen M, 2000, J EXP MED, V192, P1833, DOI 10.1084/jem.192.12.1833; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Potter M, 2003, IMMUNOL REV, V194, P177, DOI 10.1034/j.1600-065X.2003.00061.x; POTTER M, 1992, CARCINOGENESIS, V13, P1681, DOI 10.1093/carcin/13.10.1681; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7; ROTH DB, 1992, CELL, V69, P41, DOI 10.1016/0092-8674(92)90117-U; ROTH DB, 1992, CELL, V70, P983, DOI 10.1016/0092-8674(92)90248-B; Schrader CE, 1999, J EXP MED, V190, P323, DOI 10.1084/jem.190.3.323; Schrader CE, 2002, J EXP MED, V195, P367, DOI 10.1084/jem.20011877; Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; STANTON LW, 1983, NATURE, V303, P401, DOI 10.1038/303401a0; SUEMATSU S, 1992, P NATL ACAD SCI USA, V89, P232, DOI 10.1073/pnas.89.1.232; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; VONSCHWEDLER U, 1990, NATURE, V345, P452, DOI 10.1038/345452a0; Wakeland E, 1997, IMMUNOL TODAY, V18, P472, DOI 10.1016/S0167-5699(97)01126-2; Wiesendanger M, 2000, J EXP MED, V191, P579, DOI 10.1084/jem.191.3.579; Wuerffel RA, 1997, J IMMUNOL, V159, P4139; Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	59	349	359	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2004	118	4					431	438		10.1016/j.cell.2004.08.006	http://dx.doi.org/10.1016/j.cell.2004.08.006			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	850YS	15315756	Bronze			2022-12-24	WOS:000223650900006
J	Attaran, A				Attaran, A			Where did it all go wrong?	NATURE			English	Article							ROLL BACK MALARIA		Univ Ottawa, Ottawa, ON K1N 6N5, Canada	University of Ottawa	Attaran, A (corresponding author), Univ Ottawa, Ottawa, ON K1N 6N5, Canada.							[Anonymous], 2003, AFR MAL REP 2003; Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; MCCARTHY FD, 2000, 2303 WORLD BANK; Narasimhan V, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-8; Snow RW, 2003, TRENDS PARASITOL, V19, P363, DOI 10.1016/S1471-4922(03)00168-5; SPIELMAN A, 1993, J MED ENTOMOL, V30, P6, DOI 10.1093/jmedent/30.1.6; World Health Organization, 2001, MACR HLTH INV HLTH E; Yamey G, 2004, BRIT MED J, V328, P1086, DOI 10.1136/bmj.328.7448.1086	8	10	10	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2004	430	7002					932	933		10.1038/430932a	http://dx.doi.org/10.1038/430932a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318233				2022-12-24	WOS:000223369800056
J	Clayton, J; Butler, D; Hull, K				Clayton, J; Butler, D; Hull, K			The long and winding road	NATURE			English	Article																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 19	2004	430	7002					937	937		10.1038/430937a	http://dx.doi.org/10.1038/430937a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318237	Bronze			2022-12-24	WOS:000223369800060
J	Johnston, RE				Johnston, RE			A candidate vaccine for severe acute respiratory syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MICE		Univ N Carolina, Carolina Vaccine Inst, Chapel Hill, NC 27514 USA	University of North Carolina; University of North Carolina Chapel Hill	Johnston, RE (corresponding author), Univ N Carolina, Carolina Vaccine Inst, Chapel Hill, NC 27514 USA.							[Anonymous], 2003, MMWR MORB MORTAL WKL, V52, P226; FLEMING JO, 1983, VIROLOGY, V131, P296, DOI 10.1016/0042-6822(83)90498-1; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; WILLIAMS RS, 1991, P NATL ACAD SCI USA, V88, P2726, DOI 10.1073/pnas.88.7.2726; Yang ZY, 2004, NATURE, V428, P561, DOI 10.1038/nature02463; 2003, MMWR MORB MORTAL WKL, V52, P284	6	5	5	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 19	2004	351	8					827	828		10.1056/NEJMcibr041657	http://dx.doi.org/10.1056/NEJMcibr041657			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	847CY	15317899				2022-12-24	WOS:000223367900019
J	Wood, MJ; Storz, G; Tjandra, N				Wood, MJ; Storz, G; Tjandra, N			Structural basis for redox regulation of Yap1 transcription factor localization	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; NUCLEAR-LOCALIZATION; OXIDATIVE STRESS; RECEPTOR; DOMAIN; NMR; MACROMOLECULES; ACTIVATION; MECHANISM; TRANSPORT	The ability of organisms to alter their gene expression patterns in response to environmental changes is essential for viability. A central regulator of the response to oxidative stress in Saccharomyces cerevisiae is the Yap1 transcription factor. Upon activation by increased levels of reactive oxygen species, Yap1 rapidly redistributes to the nucleus where it regulates the expression of up to 70 genes(1-3). Here we identify a redox-regulated domain of Yap1 and determine its high-resolution solution structure. In the active oxidized form, a nuclear export signal (NES) in the carboxy-terminal cysteine-rich domain is masked by disulphide-bond-mediated interactions with a conserved amino-terminal alpha-helix. Point mutations that weaken the hydrophobic interactions between the N-terminal alpha-helix and the C-terminal NES-containing domain abolished redox-regulated changes in subcellular localization of Yap1. Upon reduction of the disulphide bonds, Yap1 undergoes a change to an unstructured conformation that exposes the NES and allows redistribution to the cytoplasm. These results reveal the structural basis of redox-dependent Yap1 localization and provide a previously unknown mechanism of transcription factor regulation by reversible intramolecular disulphide bond formation.	NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA; NHLBI, Biophys Chem Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Storz, G (corresponding author), NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA.	storzg@mail.nih.gov; nico@helix.nih.gov		Storz, Gisela/0000-0001-6698-1241	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001608] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001608] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL001048, ZIAHL001048] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Cavanagh J., 1995, PROTEIN NMR SPECTROS; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; CLORE GM, 1994, SCIENCE, V265, P386, DOI 10.1126/science.8023159; CLORE GM, 1994, METHOD ENZYMOL, V239, P349; Coleman ST, 1999, MOL CELL BIOL, V19, P8302; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delaunay A, 2000, EMBO J, V19, P5157, DOI 10.1093/emboj/19.19.5157; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Demarest SJ, 2002, NATURE, V415, P549, DOI 10.1038/415549a; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Godon C, 1998, J BIOL CHEM, V273, P22480, DOI 10.1074/jbc.273.35.22480; Graumann J, 2001, STRUCTURE, V9, P377, DOI 10.1016/S0969-2126(01)00599-8; Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176; Isoyama T, 2001, J BIOL CHEM, V276, P21863, DOI 10.1074/jbc.M009258200; Kaffman A, 1999, ANNU REV CELL DEV BI, V15, P291, DOI 10.1146/annurev.cellbio.15.1.291; Kau TR, 2004, NAT REV CANCER, V4, P106, DOI 10.1038/nrc1274; Kim PW, 2003, SCIENCE, V301, P1725, DOI 10.1126/science.1085643; Kuge S, 1997, EMBO J, V16, P1710, DOI 10.1093/emboj/16.7.1710; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; SIKORSKI RS, 1989, GENETICS, V122, P19; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tjandra N, 1997, NAT STRUCT BIOL, V4, P732, DOI 10.1038/nsb0997-732; Vijayalakshmi J, 2001, STRUCTURE, V9, P367, DOI 10.1016/S0969-2126(01)00597-4; Wood MJ, 2003, BIOCHEMISTRY-US, V42, P11982, DOI 10.1021/bi035003d; Yan C, 1998, EMBO J, V17, P7416, DOI 10.1093/emboj/17.24.7416; Zhu JY, 1998, CELL, V93, P851, DOI 10.1016/S0092-8674(00)81445-2	29	130	134	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2004	430	7002					917	921		10.1038/nature02790	http://dx.doi.org/10.1038/nature02790			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318225				2022-12-24	WOS:000223369800048
J	Peden, AH; Head, MW; Ritchie, DL; Bell, JE; Ironside, JW				Peden, AH; Head, MW; Ritchie, DL; Bell, JE; Ironside, JW			Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient	LANCET			English	Article							CREUTZFELDT-JAKOB-DISEASE; PRION PROTEIN; ACCUMULATION	We report a case of preclinical variant Creutzfeldt-Jakob disease (vCJD) in a patient who died from a nonneurological disorder 5 years after receiving a blood transfusion from a donor who subsequently developed vCJD. Protease-resistant prion protein (PrPres) was detected by western blot, paraffin-embedded tissue blot, and immunohistochemistry in the spleen, but not in the brain. Immunohistochemistry for prion protein was also positive in a cervical lymph node. The patient was a heterozygote at codon 129 of PRNP, suggesting that susceptibility to vCJD infection is not confined to the methionine homozygous PRNP genotype. These findings have major implications for future estimates and surveillance of vCJD in the UK.	Univ Edinburgh, Western Gen Hosp, Sch Mol & Clin Med, Natl Creutzfeldt Jakob Dis Surveillance Unit, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Ironside, JW (corresponding author), Univ Edinburgh, Western Gen Hosp, Sch Mol & Clin Med, Natl Creutzfeldt Jakob Dis Surveillance Unit, Edinburgh EH4 2XU, Midlothian, Scotland.	james.ironside@ed.ac.uk		Head, Mark/0000-0003-2034-8613; Ironside, James/0000-0001-5869-2108				Glatzel M, 2003, NEW ENGL J MED, V349, P1812, DOI 10.1056/NEJMoa030351; Head MW, 2004, AM J PATHOL, V164, P143, DOI 10.1016/S0002-9440(10)63105-7; Hilton DA, 2004, J CLIN PATHOL, V57, P300, DOI 10.1136/jcp.2003.012278; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X	5	674	695	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 7	2004	364	9433					527	529		10.1016/S0140-6736(04)16811-6	http://dx.doi.org/10.1016/S0140-6736(04)16811-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BS	15302196				2022-12-24	WOS:000223132700032
J	Greten, FR; Eckmann, L; Greten, TF; Park, JM; Li, ZW; Egan, LJ; Kagnoff, MF; Karin, M				Greten, FR; Eckmann, L; Greten, TF; Park, JM; Li, ZW; Egan, LJ; Kagnoff, MF; Karin, M			IKK beta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer	CELL			English	Article							NF-KAPPA-B; COLORECTAL-CANCER; ULCERATIVE-COLITIS; EPITHELIAL-CELLS; ACTIVATION; APOPTOSIS; INHIBITION; EXPRESSION; KINASE; PREVENTION	A link between inflammation and cancer has long been suspected, but its molecular nature remained ill defined. A key player in inflammation is transcription factor NF-kappaB whose activity is triggered in response to infectious agents and proinflammatory cytokines via the IkappaB kinase (IKK) complex. Using a colitis-associated cancer model, we show that although deletion of IKKbeta in intestinal epithelial cells does not decrease inflammation, it leads to a dramatic decrease in tumor incidence without affecting tumor size. This is linked to increased epithelial apoptosis during tumor promotion. Deleting IKKbeta in myeloid cells, however, results in a significant decrease in tumor size. This deletion diminishes expression of proinflammatory cytokines that may serve as tumor growth factors, without affecting apoptosis. Thus, specific inactivation of the IKK/NF-kappaB pathway in two different cell types can attenuate formation of inflammation-associated tumors. In addition to suppressing apoptosis in advanced tumors, IKKbeta may link inflammation to cancer.	Univ Calif San Diego, Lab Gene Regulat & Signal Transduct, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30655 Hannover, Germany; H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; Mayo Clin, Gastroenterol Res Unit, Rochester, MN 55905 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Hannover Medical School; H Lee Moffitt Cancer Center & Research Institute; Mayo Clinic	Karin, M (corresponding author), Univ Calif San Diego, Lab Gene Regulat & Signal Transduct, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Greten, Tim F/B-3127-2015; Greten, Florian R/AAF-5196-2020	Greten, Tim F/0000-0002-0806-2535; Greten, Florian R/0000-0002-3928-6080	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043477, R01AI056075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK035108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER; NIAID NIH HHS [AI43477, AI56075] Funding Source: Medline; NIDDK NIH HHS [DK35108] Funding Source: Medline; NIEHS NIH HHS [ES10337] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Amit S, 2003, SEMIN CANCER BIOL, V13, P15, DOI 10.1016/S1044-579X(02)00096-2; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; Cao YX, 2001, CELL, V107, P763, DOI 10.1016/S0092-8674(01)00599-2; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Chen LW, 2003, NAT MED, V9, P575, DOI 10.1038/nm849; Chung DC, 2000, GASTROENTEROLOGY, V119, P854, DOI 10.1053/gast.2000.16507; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Dajee M, 2003, NATURE, V421, P639, DOI 10.1038/nature01283; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; DRISCOLL KE, 1995, J LEUKOCYTE BIOL, V58, P359, DOI 10.1002/jlb.58.3.359; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Eaden J, 2000, ALIMENT PHARM THERAP, V14, P145; Eferl R, 2003, CELL, V112, P181, DOI 10.1016/S0092-8674(03)00042-4; Egan LJ, 2004, P NATL ACAD SCI USA, V101, P2452, DOI 10.1073/pnas.0306734101; Ekbom A, 1998, J Gastrointest Surg, V2, P312, DOI 10.1016/S1091-255X(98)80067-X; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gilmore TD, 1999, ONCOGENE, V18, P6925, DOI 10.1038/sj.onc.1203222; Girnun GD, 2002, P NATL ACAD SCI USA, V99, P13771, DOI 10.1073/pnas.162480299; Gupta RA, 2001, NAT REV CANCER, V1, P11, DOI 10.1038/35094017; Hacker H, 2002, CANCER CELL, V2, P431, DOI 10.1016/S1535-6108(02)00213-1; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hardwick JCH, 2001, ONCOGENE, V20, P819, DOI 10.1038/sj.onc.1204162; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Iwamoto M, 1996, J PATHOL, V180, P152; Janne PA, 2000, NEW ENGL J MED, V342, P1960, DOI 10.1056/NEJM200006293422606; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lind DS, 2001, SURGERY, V130, P363, DOI 10.1067/msy.2001.116672; MacMaster JF, 2003, INFLAMM RES, V52, P508, DOI 10.1007/s00011-003-1206-4; Maeda S, 2003, IMMUNITY, V19, P725, DOI 10.1016/S1074-7613(03)00301-7; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Morteau O, 2000, J CLIN INVEST, V105, P469, DOI 10.1172/JCI6899; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Munkholm P, 2003, ALIMENT PHARM THER, V18, P1, DOI 10.1046/j.1365-2036.18.s2.2.x; Murano M, 2000, CLIN EXP IMMUNOL, V120, P51, DOI 10.1046/j.1365-2249.2000.01183.x; Okayasu I, 1996, GUT, V39, P87, DOI 10.1136/gut.39.1.87; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; PEGG AE, 1984, CANCER INVEST, V2, P223, DOI 10.3109/07357908409104376; Rogler G, 1998, GASTROENTEROLOGY, V115, P357, DOI 10.1016/S0016-5085(98)70202-1; SELTZ CS, 1998, P NATL ACAD SCI USA, V95, P2307; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Steinbach G, 2000, NEW ENGL J MED, V342, P1946, DOI 10.1056/NEJM200006293422603; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Toft NJ, 1999, P NATL ACAD SCI USA, V96, P3911, DOI 10.1073/pnas.96.7.3911; van Hogerlinden M, 1999, CANCER RES, V59, P3299; van Hogerlinden M, 2002, ONCOGENE, V21, P4969, DOI 10.1038/sj.onc.1205620; WOTHERSPOON AC, 1991, LANCET, V338, P1175, DOI 10.1016/0140-6736(91)92035-Z; Yamamoto Y, 1999, J BIOL CHEM, V274, P27307, DOI 10.1074/jbc.274.38.27307; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948; Yu HG, 2003, ONCOLOGY-BASEL, V65, P37, DOI 10.1159/000071203; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500	65	1959	2081	9	126	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2004	118	3					285	296		10.1016/j.cell.2004.07.013	http://dx.doi.org/10.1016/j.cell.2004.07.013			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846XP	15294155	Bronze			2022-12-24	WOS:000223353100006
J	Junge, HJ; Rhee, JS; Jahn, O; Varoqueaux, F; Spiess, J; Waxham, MN; Rosenmund, C; Brose, N				Junge, HJ; Rhee, JS; Jahn, O; Varoqueaux, F; Spiess, J; Waxham, MN; Rosenmund, C; Brose, N			Calmodulin and Munc13 form a Ca2+ sensor/effector complex that controls short-term synaptic plasticity	CELL			English	Article							CORTICOTROPIN-RELEASING FACTOR; READILY RELEASABLE POOL; TRANSMITTER RELEASE; BINDING-PROTEIN; DEPRESSION; VESICLES; CALCIUM; UNC-13; TRANSMISSION; FACILITATION	The efficacy of synaptic transmission between neurons can be altered transiently during neuronal network activity. This phenomenon of short-term plasticity is a key determinant of network properties; is involved in many physiological processes such as motor control, sound localization, or sensory adaptation; and is critically dependent on cytosolic [Call]. However, the underlying molecular mechanisms and the identity of the Ca2+ sensor/effector complexes involved are unclear. We now identify a conserved calmodulin binding site in UNC-13/Munc13s, which are essential regulators of synaptic vesicle priming and synaptic efficacy. Ca2+ sensor/effector complexes consisting of calmodulin and Munc13s regulate synaptic vesicle priming and synaptic efficacy in response to a residual [Ca2+] signal and thus shape short-term plasticity characteristics during periods of sustained synaptic activity.	Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany; Max Planck Inst Expt Med, Dept Mol Neuroendocrinol, D-37075 Gottingen, Germany; Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany; Univ Texas, Sch Med, Dept Neurobiol & Anat, Houston, TX 77030 USA	Max Planck Society; Max Planck Society; Max Planck Society; University of Texas System	Brose, N (corresponding author), Max Planck Inst Expt Med, Dept Mol Neurobiol, Hermann Rein Str 3, D-37075 Gottingen, Germany.	brose@em.mpg.de	Jahn, Olaf/AAD-8212-2020; Varoqueaux, Frederique/AAC-1834-2021; Rosenmund, Christian/AAC-3596-2020	Jahn, Olaf/0000-0002-3397-8924; Varoqueaux, Frederique/0000-0002-3614-3121; Rosenmund, Christian/0000-0002-3905-2444; Waxham, M. Neal/0000-0003-4801-1190; JUNGE, HARALD/0000-0003-2458-6010				Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; Betz A, 1997, J BIOL CHEM, V272, P2520; Brose N, 2000, CURR OPIN NEUROBIOL, V10, P303, DOI 10.1016/S0959-4388(00)00105-7; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; Cook DL, 2003, NATURE, V421, P66, DOI 10.1038/nature01248; Dittman JS, 1998, J NEUROSCI, V18, P6147; Dittman JS, 2000, J NEUROSCI, V20, P1374; Eccles JC, 1941, J NEUROPHYSIOL, V4, P362, DOI 10.1152/jn.1941.4.5.362; Felmy F, 2003, NEURON, V37, P801, DOI 10.1016/S0896-6273(03)00085-0; FENG TP, 1941, CHIN J PHYSL, V13, P79; Jahn O, 2002, P NATL ACAD SCI USA, V99, P12055, DOI 10.1073/pnas.192449299; Jahn O, 2001, PEPTIDES, V22, P47, DOI 10.1016/S0196-9781(00)00356-9; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; KUSANO K, 1975, J PHYSIOL-LONDON, V245, P13, DOI 10.1113/jphysiol.1975.sp010832; LILEY AW, 1953, J NEUROPHYSIOL, V16, P509, DOI 10.1152/jn.1953.16.5.509; Nadim F, 2000, CURR OPIN NEUROBIOL, V10, P683, DOI 10.1016/S0959-4388(00)00159-8; ONEIL KT, 1989, PROTEINS, V6, P284, DOI 10.1002/prot.340060311; Pyott SJ, 2002, J PHYSIOL-LONDON, V539, P523, DOI 10.1113/jphysiol.2001.013277; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; Rosenmund C, 2002, NEURON, V33, P411, DOI 10.1016/S0896-6273(02)00568-8; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Sakaba T, 2001, NEURON, V32, P1119, DOI 10.1016/S0896-6273(01)00543-8; Stevens CF, 1998, NEURON, V21, P415, DOI 10.1016/S0896-6273(00)80550-4; Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Xu XZS, 1998, J BIOL CHEM, V273, P31297, DOI 10.1074/jbc.273.47.31297; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	35	177	182	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2004	118	3					389	401		10.1016/j.cell.2004.06.029	http://dx.doi.org/10.1016/j.cell.2004.06.029			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846XP	15294163	Bronze			2022-12-24	WOS:000223353100014
J	Chen, XY; Duanmu, H; Wan, LY; Zhao, FZ; Wang, LX; Tu, DH; Du, X; Kim, SJ; Watt, C; Williams, B; Chin, D; Dye, C				Chen, XY; Duanmu, H; Wan, LY; Zhao, FZ; Wang, LX; Tu, DH; Du, X; Kim, SJ; Watt, C; Williams, B; Chin, D; Dye, C		China Tuberculosis Control Collabo	The effect of tuberculosis control in China	LANCET			English	Article							IMPACT	Background China has 1 . 4 million new cases of tuberculosis every year, more than any country except India. A new tuberculosis control project based on short-course chemotherapy was introduced in half the country in 1991, after a national survey of tuberculosis prevalence in 1990. Another survey was done in 2000 to re-evaluate the national tuberculosis burden, providing the opportunity to assess the effect of the control project. Methods The survey in 2000 identified 375 599 eligible individuals at 257 investigation points chosen from all 31 mainland provinces by stratified random sampling. Children (aged 0-14 years) were suspected of having tuberculosis if they had an induration of 10 mm or greater after a tuberculin skin test, and an abnormal fluorograph. Adults were suspected if they had a persistent cough, abnormal fluorograph, or both. Tuberculosis was diagnosed by chest radiograph, sputum-smear microscopy, and culture. Findings 365 097 people were examined (97% of those eligible). Prevalences of pulmonary, culture-positive, and smear-positive tuberculosis in 2000 were 367 (95% CI 340-397), 160 (144-177), and 122 (110-137) per 100 000 population, respectively. Between 1990 and 2000, prevalences of these three forms of the disease had fallen, respectively, by 32% (5-68), 37% (7-66), and 32% (9-51) more in areas in which the project was implemented than in non-project areas. For culture-positive disease, a 30% (9-48) reduction was directly attributable to the project. Interpretation Between 1991 and 2000, prevalence of tuberculosis was reduced significantly in areas of China by use of short-course chemotherapy following WHO guidelines. We estimate that in 2000, in a population of more than half a billion, there were 382 000 fewer prevalent culture-positive cases and 280 000 fewer prevalent smear-positive cases than there would otherwise have been.	WHO, CH-1211 Geneva 27, Switzerland; Minist Hlth, Dept Dis Control, Beijing, Peoples R China; Korean Inst TB, Seoul, South Korea	World Health Organization	Chen, XY (corresponding author), WHO, CH-1211 Geneva 27, Switzerland.		Dye, Christopher/AIC-4659-2022					Cauthen GM, 2002, B WORLD HEALTH ORGAN, V80, P503; Chen XY, 2002, B WORLD HEALTH ORGAN, V80, P430; Corbett EL, 2003, ARCH INTERN MED, V163, P1009, DOI 10.1001/archinte.163.9.1009; Davison A. C., 1997, BOOTSTRAP METHODS TH; Dye C, 2002, B WORLD HEALTH ORGAN, V80, P437; Dye C, 2000, INT J EPIDEMIOL, V29, P558, DOI 10.1093/ije/29.3.558; *MIN HLTH PEOPL RE, 2000, REP NAT RAND SURV EP; *MIN PUBL HLTH PEO, 1990, NAT RAND SURV EP TUB; Styblo K., 1985, B INT UNION TUBERC, V60, P117; *UN STAT DIV, MILL IND DAT; *WHO, WHOCDSTB2002, V297, P1; WHO, 2002, WHO TRADITIONAL MED, DOI DOI 10.1002/0470853093; Zhang LX, 2000, INT J TUBERC LUNG D, V4, P904; Zhao FZ, 1996, LANCET, V347, P358, DOI 10.1016/S0140-6736(96)90537-1	14	148	151	0	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 31	2004	364	9432					417	422						6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	842IX	15288739				2022-12-24	WOS:000222998600031
J	Gao, M; Labuda, T; Xia, Y; Gallagher, E; Fang, D; Liu, YC; Karin, M				Gao, M; Labuda, T; Xia, Y; Gallagher, E; Fang, D; Liu, YC; Karin, M			Jun turnover is controlled through JNK-dependent phosphorylation of the E3 ligase itch	SCIENCE			English	Article							ACTIVATED PROTEIN-KINASES; N-TERMINAL KINASE; C-JUN; CELL DIFFERENTIATION; UBIQUITIN LIGASE; TRANSCRIPTION; EXPRESSION; APOPTOSIS; INHIBITOR	The turnover of Jun proteins, like that of other transcription factors, is regulated through ubiquitin-dependent proteolysis. Usually, such processes are regulated by extracellular stimuli through phosphorylation of the target protein, which allows recognition by F box-containing E3 ubiquitin ligases. In the case of c-Jun and JunB, we found that extracellular stimuli also modulate protein turnover by regulating the activity of an E3 ligase by means of its phosphorylation. Activation of the Jun amino-terminal kinase (JNK) mitogen-activated protein kinase cascade after T cell stimulation accelerated degradation of c-Jun and JunB through phosphorylation-dependent activation of the E3 ligase Itch. This pathway modulates cytokine production by effector T cells.	Univ Calif San Diego, Lab Gene Regulat & Signal Transduct, Dept Pharmacol, Sch Med, La Jolla, CA 92093 USA; Univ Copenhagen, Dept Med Microbiol & Immunol, DK-2200 Copenhagen N, Denmark; Univ Copenhagen, Inst Mol Biol, DK-2200 Copenhagen N, Denmark; La Jolla Inst Allergy & Immunol, Div Cell Biol, San Diego, CA 92121 USA	University of California System; University of California San Diego; University of Copenhagen; University of Copenhagen; La Jolla Institute for Immunology	Karin, M (corresponding author), Univ Calif San Diego, Lab Gene Regulat & Signal Transduct, Dept Pharmacol, Sch Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Fang, Deyu/I-7245-2013	Fang, Deyu/0000-0002-4211-2751; LIU, YUN-CAI/0000-0002-0996-7109	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI048542, R01AI043477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R37ES004151, R01ES004151, R01ES006376] Funding Source: NIH RePORTER; NIAID NIH HHS [AI43477, R21AI48542] Funding Source: Medline; NIEHS NIH HHS [ES04151, ES06376] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Dong C, 2000, NATURE, V405, P91, DOI 10.1038/35011091; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Fuchs SY, 1996, ONCOGENE, V13, P1531; Gao M., UNPUB; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Hartenstein B, 2002, EMBO J, V21, P6321, DOI 10.1093/emboj/cdf648; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HSIEH CS, 1995, J EXP MED, V181, P713, DOI 10.1084/jem.181.2.713; Jackson PK, 2002, MOL CELL, V9, P923, DOI 10.1016/S1097-2765(02)00538-5; Kallunki T, 1996, CELL, V87, P929, DOI 10.1016/S0092-8674(00)81999-6; KARIN M, 1995, J BIOL CHEM, V270, P16483, DOI 10.1074/jbc.270.28.16483; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Li BY, 1999, EMBO J, V18, P420, DOI 10.1093/emboj/18.2.420; MINDEN A, 1994, SCIENCE, V266, P1719, DOI 10.1126/science.7992057; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Musti AM, 1997, SCIENCE, V275, P400, DOI 10.1126/science.275.5298.400; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Sabapathy K, 2001, J EXP MED, V193, P317, DOI 10.1084/jem.193.3.317; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; Varshavsky A, 2003, NAT CELL BIOL, V5, P373, DOI 10.1038/ncb0503-373; Zhang L, 2003, EMBO J, V22, P4443, DOI 10.1093/emboj/cdg440	26	328	341	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 8	2004	306	5694					271	275		10.1126/science.1099414	http://dx.doi.org/10.1126/science.1099414			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861MC	15358865				2022-12-24	WOS:000224419700039
J	Armbrust, EV; Berges, JA; Bowler, C; Green, BR; Martinez, D; Putnam, NH; Zhou, SG; Allen, AE; Apt, KE; Bechner, M; Brzezinski, MA; Chaal, BK; Chiovitti, A; Davis, AK; Demarest, MS; Detter, JC; Glavina, T; Goodstein, D; Hadi, MZ; Hellsten, U; Hildebrand, M; Jenkins, BD; Jurka, J; Kapitonov, VV; Kroger, N; Lau, WWY; Lane, TW; Larimer, FW; Lippmeier, JC; Lucas, S; Medina, M; Montsant, A; Obornik, M; Parker, MS; Palenik, B; Pazour, GJ; Richardson, PM; Rynearson, TA; Saito, MA; Schwartz, DC; Thamatrakoln, K; Valentin, K; Vardi, A; Wilkerson, FP; Rokhsar, DS				Armbrust, EV; Berges, JA; Bowler, C; Green, BR; Martinez, D; Putnam, NH; Zhou, SG; Allen, AE; Apt, KE; Bechner, M; Brzezinski, MA; Chaal, BK; Chiovitti, A; Davis, AK; Demarest, MS; Detter, JC; Glavina, T; Goodstein, D; Hadi, MZ; Hellsten, U; Hildebrand, M; Jenkins, BD; Jurka, J; Kapitonov, VV; Kroger, N; Lau, WWY; Lane, TW; Larimer, FW; Lippmeier, JC; Lucas, S; Medina, M; Montsant, A; Obornik, M; Parker, MS; Palenik, B; Pazour, GJ; Richardson, PM; Rynearson, TA; Saito, MA; Schwartz, DC; Thamatrakoln, K; Valentin, K; Vardi, A; Wilkerson, FP; Rokhsar, DS			The genome of the diatom Thalassiosira pseudonana: Ecology, evolution, and metabolism	SCIENCE			English	Article							GENE-TRANSFER; OCEAN; SILICA; POLYAMINES; PROTEINS; NUCLEUS; FAMILY; LIGHT	Diatoms are unicellular algae with plastids acquired by secondary endosymbiosis. They are responsible for similar to20% of global carbon fixation. We report the 34 million-base pair draft nuclear genome of the marine diatom Thalassiosira pseudonana and its 129 thousand-base pair ptastid and 44 thousand-base pair mitochondrial genomes. Sequence and optical restriction mapping revealed 24 diploid nuclear chromosomes. We identified novel genes for silicic acid transport and formation of silica-based cell walls, high-affinity iron uptake, biosynthetic enzymes for several types of polyunsaturated fatty acids, use of a range of nitrogenous compounds, and a complete urea cycle, all attributes that allow diatoms to prosper in aquatic environments.	Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53201 USA; Stn Zool, Plant Mol Biol Lab, I-80121 Naples, Italy; Ecole Normale Super, Dept Biol, F-75230 Paris, France; Univ British Columbia, Dept Bot, Vancouver, BC V6T 1Z4, Canada; Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA; Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; Princeton Univ, Dept Geosci, Princeton, NJ 08540 USA; Martek Biosci Corp, Columbia, MD 21045 USA; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; Univ Melbourne, Sch Bot, Melbourne, Vic 3010, Australia; Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; Sandia Natl Labs, Lockheed Martin Corp, Livermore, CA 94551 USA; Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA; Genet Informat Res Inst, Mountain View, CA 94043 USA; Univ Regensburg, Lehrstuhl Biochem 1, D-93053 Regensburg, Germany; Sandia Natl Labs, Biosyst Res Dept, Livermore, CA 94551 USA; Oak Ridge Natl Lab, Genome Anal Grp, Oak Ridge, TN 37831 USA; Univ Hull, Dept Biol Sci, Kingston Upon Hull HU6 7RX, N Humberside, England; Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany; San Francisco State Univ, Romberg Tiburon Ctr, Tiburon, CA 94920 USA; Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA	University of Washington; University of Washington Seattle; University of Wisconsin System; University of Wisconsin Milwaukee; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); University of British Columbia; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Princeton University; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of Melbourne; University of California System; University of California San Diego; Scripps Institution of Oceanography; Lockheed Martin; United States Department of Energy (DOE); Sandia National Laboratories; University of California System; University of California Santa Cruz; University of Regensburg; United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Hull; University of Massachusetts System; University of Massachusetts Worcester; Woods Hole Oceanographic Institution; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; California State University System; San Francisco State University; University of California System; University of California Berkeley	Armbrust, EV (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	armbrust@ocean.washington.edu; dsrokhsar@lbl.gov	Bowler, Chris/AAC-6256-2019; Obornik, Miroslav/G-9350-2014; Zhou, Shiguo/B-3832-2011; Berges, John A/D-9520-2012; Putnam, Nicholas/B-9968-2008; Saito, Mak/ADT-4986-2022; Palenik, Brian/AAA-1822-2020; Valentin, Klaus/G-5862-2014; Allen, Andrew E/C-4896-2012; Green, Beverley R./AAJ-5199-2021	Zhou, Shiguo/0000-0001-7421-2506; Berges, John A/0000-0002-3124-4783; Putnam, Nicholas/0000-0002-1315-782X; Palenik, Brian/0000-0002-3717-9046; Valentin, Klaus/0000-0001-7401-9423; Allen, Andrew E/0000-0001-5911-6081; Green, Beverley R./0000-0002-4021-9387; Lippmeier, J./0000-0002-8157-1491; Vardi, Assaf/0000-0002-7079-0234; Lane, Todd/0000-0002-5816-2649; Parker, Micaela/0000-0003-1007-4612; Bowler, Chris/0000-0003-3835-6187; Rokhsar, Daniel/0000-0002-8704-2224; Pazour, Gregory/0000-0002-6285-8796; Goodstein, David/0000-0001-6287-2697; Thamatrakoln, Kimberlee/0000-0002-8029-5026				Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Archibald JM, 2003, P NATL ACAD SCI USA, V100, P7678, DOI 10.1073/pnas.1230951100; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Brzezinski MA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014349; Cha JN, 1999, P NATL ACAD SCI USA, V96, P361, DOI 10.1073/pnas.96.2.361; CLINE K, 2003, LIGHT HARVESTING ANT, V13, P353; Coale KH, 2004, SCIENCE, V304, P408, DOI 10.1126/science.1089778; Coffino P, 2000, P NATL ACAD SCI USA, V97, P4421, DOI 10.1073/pnas.97.9.4421; Damste JSS, 2004, SCIENCE, V304, P584, DOI 10.1126/science.1096806; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Douglas S, 2001, NATURE, V410, P1091, DOI 10.1038/35074092; DUNSTAN GA, 1993, J APPL PHYCOL, V5, P71, DOI 10.1007/BF02182424; DUNSTAN GA, 1994, PHYTOCHEMISTRY, V35, P155, DOI 10.1016/S0031-9422(00)90525-9; Falciatore A, 2002, ANNU REV PLANT BIOL, V53, P109, DOI 10.1146/annurev.arplant.53.091701.153921; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Foth BJ, 2003, SCIENCE, V299, P705, DOI 10.1126/science.1078599; Fulda M, 2002, PLANT J, V32, P93, DOI 10.1046/j.1365-313X.2002.01405.x; Hackett JD, 2004, CURR BIOL, V14, P213, DOI 10.1016/j.cub.2004.01.032; Hamm CE, 2003, NATURE, V421, P841, DOI 10.1038/nature01416; Hildebrand M, 1997, NATURE, V385, P688, DOI 10.1038/385688b0; Klein ATJ, 2002, J BIOL CHEM, V277, P25011, DOI 10.1074/jbc.M203254200; Kroger N, 2000, PROTIST, V151, P263, DOI 10.1078/1434-4610-00024; KROGER N, 1994, EMBO J, V13, P4676, DOI 10.1002/j.1460-2075.1994.tb06791.x; Kroth PG, 2002, INT REV CYTOL, V221, P191; Leblanc C, 1999, PLANT MOL BIOL, V40, P1031, DOI 10.1023/A:1006256300969; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Mann DG, 1999, PHYCOLOGIA, V38, P437, DOI 10.2216/i0031-8884-38-6-437.1; Martin W, 2003, P NATL ACAD SCI USA, V100, P8612, DOI 10.1073/pnas.1633606100; MCLACHLA.J, 1965, CAN J BOTANY, V43, P707, DOI 10.1139/b65-079; Moore JK, 2001, DEEP-SEA RES PT II, V49, P463; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Palenik B, 2003, NATURE, V424, P1037, DOI 10.1038/nature01943; Parkinson J, 1999, TRENDS BIOTECHNOL, V17, P190, DOI 10.1016/S0167-7799(99)01321-9; POULSEN N, IN PRESS J BIOL CHEM; Ragni M, 2004, J PLANKTON RES, V26, P433, DOI 10.1093/plankt/fbh044; Reinfelder JR, 2000, NATURE, V407, P996, DOI 10.1038/35039612; Robinson NJ, 1999, NATURE, V397, P694, DOI 10.1038/17800; Round F.E., 1990, DIATOMS BIOL MORPHOL, P747, DOI 10.1017/S0025315400059245; Stewart V, 2003, J BACTERIOL, V185, P2104, DOI 10.1128/JB.185.7.2104-2111.2003; Sumper M, 2004, J MATER CHEM, V14, P2059, DOI 10.1039/b401028k; TREGUER P, 1995, SCIENCE, V268, P375, DOI 10.1126/science.268.5209.375; Volcani B., 1981, SILICON SILICEOUS ST, P157; Walbot V, 2000, CURR OPIN PLANT BIOL, V3, P103, DOI 10.1016/S1369-5266(99)00051-5; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; Yanovsky MJ, 2003, NAT REV MOL CELL BIO, V4, P265, DOI 10.1038/nrm1077; Zhang XP, 2002, TRENDS PLANT SCI, V7, P14, DOI 10.1016/S1360-1385(01)02180-X	48	1457	1567	20	683	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2004	306	5693					79	86		10.1126/science.1101156	http://dx.doi.org/10.1126/science.1101156			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459382	Green Submitted			2022-12-24	WOS:000224304000039
J	Turner, G; Harrison, TM; Holland, G; Mojzsis, SJ; Gilmour, J				Turner, G; Harrison, TM; Holland, G; Mojzsis, SJ; Gilmour, J			Extinct Pu-244 in ancient zircons	SCIENCE			English	Article							XENON; AGES	We have found evidence, in the form of fissiogenic xenon isotopes, for in situ decay of Pu-244 in individual 4.1- to 4.2-billion-year-old zircons from the Jack Hills region of Western Australia. Because of its short half-life, 82 million years, Pu-244 was extinct within 600 million years of Earth's formation. Detrital zircons are the only known relics to have survived from this period, and a study of their Pu geochemistry will allow us to date ancient metamorphic events and determine the terrestrial Pu/U ratio for comparison with the solar ratio.	Univ Manchester, Dept Earth Sci, Manchester M13 9PL, Lancs, England; Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; Univ Calif Los Angeles, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA; Univ Colorado, Dept Geol Sci, Ctr Astrobiol, Boulder, CO 80309 USA	University of Manchester; Australian National University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Colorado System; University of Colorado Boulder	Turner, G (corresponding author), Univ Manchester, Dept Earth Sci, Manchester M13 9PL, Lancs, England.	grenville.turner@man.ac.uk	Harrison, Timothy M/E-7443-2012; MOJZSIS, STEPHEN/AAU-9527-2020; Gilmour, Jamie/G-7515-2011	MOJZSIS, STEPHEN/0000-0003-0000-125X; Gilmour, Jamie/0000-0003-1990-8636				ALLEGRE CJ, 1987, EARTH PLANET SC LETT, V81, P127, DOI 10.1016/0012-821X(87)90151-8; ALLEGRE CJ, 1983, NATURE, V303, P762, DOI 10.1038/303762a0; CAMERON AGW, 1993, PHYS REP, V227, P283, DOI 10.1016/0370-1573(93)90073-M; CLAYTON DD, 1983, ASTROPHYS J, V268, P381, DOI 10.1086/160962; FROUDE DO, 1983, NATURE, V304, P616, DOI 10.1038/304616a0; GILMOUR JD, 1994, REV SCI INSTRUM, V65, P617, DOI 10.1063/1.1145127; Goriely S, 2001, ASTRON ASTROPHYS, V379, P1113, DOI 10.1051/0004-6361:20011368; Harrison TM, 2003, GEOCHIM COSMOCHIM AC, V67, pA135; Honda M, 2003, EARTH PLANET SC LETT, V207, P69, DOI 10.1016/S0012-821X(02)01147-0; Hudson G.B., 1989, LUNAR PLANETARY SCI, V19, P547; KROGH TE, 1982, GEOCHIM COSMOCHIM AC, V46, P637, DOI 10.1016/0016-7037(82)90165-X; Kunz J, 1998, SCIENCE, V280, P877, DOI 10.1126/science.280.5365.877; LUGMAIR GW, 1977, EARTH PLANET SC LETT, V35, P273, DOI 10.1016/0012-821X(77)90131-5; Meyer BS, 2000, SPACE SCI REV, V92, P133, DOI 10.1023/A:1005282825778; Miura YN, 1998, GEOCHIM COSMOCHIM AC, V62, P2369, DOI 10.1016/S0016-7037(98)00118-5; Mojzsis SJ, 2001, NATURE, V409, P178, DOI 10.1038/35051557; ONIONS RK, 1994, EARTH PLANET SC LETT, V124, P131, DOI 10.1016/0012-821X(94)00070-0; Pellas P, 1997, GEOCHIM COSMOCHIM AC, V61, P3477, DOI 10.1016/S0016-7037(97)00167-1; PORCELLI D, 1995, GEOCHIM COSMOCHIM AC, V59, P4921, DOI 10.1016/0016-7037(95)00336-3; Shukolyukov A, 1996, GEOCHIM COSMOCHIM AC, V60, P2453, DOI 10.1016/0016-7037(96)00085-3; SHUKOLYUKOV YA, 1994, NOBLE GAS GEOCHEMIST, P125; STAUDACHER T, 1986, EARTH PLANET SC LETT, V60, P389; WASSERBURG GJ, 1996, APJ, V466, P109; Wilde SA, 2001, NATURE, V409, P175, DOI 10.1038/35051550	24	53	53	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2004	306	5693					89	91		10.1126/science.1101014	http://dx.doi.org/10.1126/science.1101014			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459384				2022-12-24	WOS:000224304000041
J	Li, C; Rieppel, O; LaBarbera, MC				Li, C; Rieppel, O; LaBarbera, MC			A Triassic aquatic protorosaur with an extremely long neck	SCIENCE			English	Article									Chinese Acad Sci, IVPP, Beijing 100044, Peoples R China; Field Museum Nat Hist, Dept Geol, Chicago, IL 60605 USA; Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA	Chinese Academy of Sciences; Field Museum of Natural History (Chicago); University of Chicago	Li, C (corresponding author), Chinese Acad Sci, IVPP, POB 643, Beijing 100044, Peoples R China.	lichun@pa.lvpp.ac.cn						Chun L, 2003, ACTA GEOL SIN-ENGL, V77, P419; Parra-Olea G, 2001, P NATL ACAD SCI USA, V98, P7888, DOI 10.1073/pnas.131203598; Rieppel Olivier, 2003, Atti della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale in Milano, V144, P359; TAYLOR MA, 1989, NATURE, V341, P688, DOI 10.1038/341688a0; TSCHANZ K, 1988, PALAEONTOLOGY, V31, P997; Tschanz K., 1986, THESIS U ZURICH	6	44	56	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2004	305	5692					1931	1931		10.1126/science.1100498	http://dx.doi.org/10.1126/science.1100498			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857RM	15448262				2022-12-24	WOS:000224136000038
J	Stolow, A; Jonas, DM				Stolow, A; Jonas, DM			Multidimensional snapshots of chemical dynamics	SCIENCE			English	Editorial Material							RESOLVED PHOTOELECTRON-SPECTROSCOPY; MOLECULAR-DYNAMICS; CRYSTALLOGRAPHY; TRANSITION; PEPTIDE		Natl Res Council Canada, Steacie Inst Mol Sci, Ottawa, ON K1A 0R6, Canada; Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	National Research Council Canada; University of Colorado System; University of Colorado Boulder	Stolow, A (corresponding author), Natl Res Council Canada, Steacie Inst Mol Sci, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.	albert.stolow@nrc.ca; david.jonas@colorado.edu	Stolow, Albert/AAN-5609-2020; Jonas, David M/A-7491-2008	Jonas, David M/0000-0002-1085-8161				Benesch F, 2004, OPT LETT, V29, P1028, DOI 10.1364/OL.29.001028; Blanchet V, 1999, NATURE, V401, P52, DOI 10.1038/43410; Bredenbeck J, 2003, J PHYS CHEM B, V107, P8654, DOI 10.1021/jp034552q; Davies JA, 2000, PHYS REV LETT, V84, P5983, DOI 10.1103/PhysRevLett.84.5983; DeCamp MF, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.165502; Hanold KA, 1996, PHYS REV LETT, V77, P3335, DOI 10.1103/PhysRevLett.77.3335; Johnson SL, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.157403; Jonas DM, 2003, ANNU REV PHYS CHEM, V54, P425, DOI 10.1146/annurev.physchem.54.011002.103907; Jonas DM, 2003, SCIENCE, V300, P1515, DOI 10.1126/science.1085687; Kienberger R, 2004, NATURE, V427, P817, DOI 10.1038/nature02277; Lehr L, 1999, SCIENCE, V284, P635, DOI 10.1126/science.284.5414.635; Moffat K, 2003, FARADAY DISCUSS, V122, P65, DOI 10.1039/b201620f; Niikura H, 2003, NATURE, V421, P826, DOI 10.1038/nature01430; Ruan CY, 2004, P NATL ACAD SCI USA, V101, P1123, DOI 10.1073/pnas.0307302101; Schotte F, 2003, SCIENCE, V300, P1944, DOI 10.1126/science.1078797; Siwick BJ, 2003, SCIENCE, V302, P1382, DOI 10.1126/science.1090052; Sporlein S, 2002, P NATL ACAD SCI USA, V99, P7998, DOI 10.1073/pnas.122238799; Stolow A, 2004, CHEM REV, V104, P1719, DOI 10.1021/cr020683w; 2004, S EM ULTR SPEC CHEM	19	28	28	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 10	2004	305	5690					1575	1577		10.1126/science.1103195	http://dx.doi.org/10.1126/science.1103195			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	854GV	15361614				2022-12-24	WOS:000223891200030
J	Elemans, CPH; Spierts, ILY; Muller, UK; van Leeuwen, JL; Goller, F				Elemans, CPH; Spierts, ILY; Muller, UK; van Leeuwen, JL; Goller, F			Superfast muscles control dove's trill	NATURE			English	Article							VOCALIZATIONS; SYRINX; SONG		Univ Wageningen & Res Ctr, Expt Zool Grp, NL-6709 PG Wageningen, Netherlands; Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Wageningen University & Research; Utah System of Higher Education; University of Utah	Elemans, CPH (corresponding author), Univ Wageningen & Res Ctr, Expt Zool Grp, NL-6709 PG Wageningen, Netherlands.	coen.elemans@wur.nl	van Leeuwen, Johan/N-3437-2019; van Leeuwen, Johan L/B-7897-2011	van Leeuwen, Johan/0000-0002-4433-880X; Elemans, Coen/0000-0001-6306-5715				Beckers GJL, 2003, J EXP BIOL, V206, P1833, DOI 10.1242/jeb.00364; Fee MS, 1998, NATURE, V395, P67, DOI 10.1038/25725; FLETCHER NH, 1988, J THEOR BIOL, V135, P455, DOI 10.1016/S0022-5193(88)80270-4; Gardner T, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.208101; Goller F, 1997, J EXP BIOL, V200, P2165; Goller F, 1998, NATURE, V395, P11, DOI 10.1038/25589; Goller F, 1996, J NEUROPHYSIOL, V75, P867, DOI 10.1152/jn.1996.75.2.867; Greenwalt C.H., 1968, BIRD SONG ACOUSTICS; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Larsen ON, 1999, P ROY SOC B-BIOL SCI, V266, P1609, DOI 10.1098/rspb.1999.0822; Rome LC, 1999, P NATL ACAD SCI USA, V96, P5826, DOI 10.1073/pnas.96.10.5826; Young IS, 2001, P ROY SOC B-BIOL SCI, V268, P1965, DOI 10.1098/rspb.2001.1731	12	52	55	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 9	2004	431	7005					146	146		10.1038/431146a	http://dx.doi.org/10.1038/431146a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HI	15356620	Bronze, Green Published			2022-12-24	WOS:000223746000033
J	Walensky, LD; Kung, AL; Escher, I; Malia, TJ; Barbuto, S; Wright, RD; Wagner, G; Verdine, GL; Korsmeyer, SJ				Walensky, LD; Kung, AL; Escher, I; Malia, TJ; Barbuto, S; Wright, RD; Wagner, G; Verdine, GL; Korsmeyer, SJ			Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix	SCIENCE			English	Article							CELL-PENETRATING PEPTIDES; CHROMOSOMAL BREAKPOINT; PROTEIN TRANSDUCTION; FOLLICULAR LYMPHOMA; NMR STRUCTURE; CYTOCHROME-C; DEATH; DOMAIN; BAK; MACROPINOCYTOSIS	BCL-2 family proteins constitute a critical control point for the regulation of apoptosis. Protein interaction between BCL-2 members is a prominent mechanism of control and is mediated through the amphipathic alpha-helical BH3 segment, an essential death domain. We used a chemical strategy, termed hydrocarbon stapling, to generate BH3 peptides with improved pharmacologic properties. The stapled peptides, called "stabilized alpha-helix of BCL-2 domains" (SAHBs), proved to be helical, protease-resistant, and cell-permeable molecules that bound with increased affinity to multidomain BCL-2 member pockets. A SAHB of the BH3 domain from the BID protein specifically activated the apoptotic pathway to kill leukemia cells. In addition, SAHB effectively inhibited the growth of human leukemia xenografts in vivo. Hydrocarbon stapling of native peptides may provide a useful strategy for experimental and therapeutic modulation of protein-protein interactions in many signaling pathways.	Dana Farber Canc Inst, Howard Hughes Med Inst, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Pediat Hematol Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Childrens Hosp Boston, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; MIT, Dept Chem, Cambridge, MA 02139 USA	Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Verdine, GL (corresponding author), Dana Farber Canc Inst, Howard Hughes Med Inst, Boston, MA 02115 USA.	verdine@chemistry.harvard.edu; stantey_korsmeyer@dfci.harvard.edu	Kung, Andrew L/AEU-0826-2022; Kung, Andrew/AAL-2384-2020	Kung, Andrew L/0000-0002-9091-488X; 	NCI NIH HHS [R37CA50239] Funding Source: Medline; NHLBI NIH HHS [K08 HL074049, K08HL074049] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA050239] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL074049] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; Armstrong SA, 2003, CANCER CELL, V3, P173, DOI 10.1016/S1535-6108(03)00003-5; BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; Blackwell HE, 1998, ANGEW CHEM INT EDIT, V37, P3281, DOI 10.1002/(SICI)1521-3773(19981217)37:23<3281::AID-ANIE3281>3.0.CO;2-V; BRACKEN C, 1994, J AM CHEM SOC, V116, P6431, DOI 10.1021/ja00093a052; CHITTENDEN T, 1995, EMBO J, V14, P5589, DOI 10.1002/j.1460-2075.1995.tb00246.x; CLEARY ML, 1985, P NATL ACAD SCI USA, V82, P7439, DOI 10.1073/pnas.82.21.7439; Console S, 2003, J BIOL CHEM, V278, P35109, DOI 10.1074/jbc.M301726200; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Drin G, 2003, J BIOL CHEM, V278, P31192, DOI 10.1074/jbc.M303938200; FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; LEUC A, 2003, P NATL ACAD SCI USA, V100, P11273; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Phelan JC, 1997, J AM CHEM SOC, V119, P455, DOI 10.1021/ja9611654; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Schafmeister CE, 2000, J AM CHEM SOC, V122, P5891, DOI 10.1021/ja000563a; Schleiff E, 1997, J BIOL CHEM, V272, P17784, DOI 10.1074/jbc.272.28.17784; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Scorrano L, 2003, SCIENCE, V300, P135, DOI 10.1126/science.1081208; TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; WALENSKY LD, UNPUB; Wang K, 1996, GENE DEV, V10, P2859, DOI 10.1101/gad.10.22.2859; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; WILLIAMS RM, 1991, J AM CHEM SOC, V113, P9276, DOI 10.1021/ja00024a038; YAN B, 2004, BIOORG MED CHEM LETT, V14, P1403	31	1049	1231	8	271	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2004	305	5689					1466	1470		10.1126/science.1099191	http://dx.doi.org/10.1126/science.1099191			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852NK	15353804	Green Accepted			2022-12-24	WOS:000223761900050
J	Wang, YQ; Zhang, DX; Renner, SS; Chen, ZY				Wang, YQ; Zhang, DX; Renner, SS; Chen, ZY			A new self-pollination mechanism	NATURE			English	Editorial Material							ZINGIBERACEAE; POLLEN		Chinese Acad Sci, S China Bot Garden, Guangzhou 510650, Peoples R China; Zhongkai Agrotech Coll, Guangzhou 510225, Peoples R China; Univ Munich, Dept Biol, D-80638 Munich, Germany	Chinese Academy of Sciences; South China Botanical Garden, CAS; University of Munich	Wang, YQ (corresponding author), Chinese Acad Sci, S China Bot Garden, Guangzhou 510650, Peoples R China.	dx-zhang@scib.ac.cn		Zhang, Dianxiang/0000-0001-6549-8872				Barrett SCH, 2003, PHILOS T R SOC B, V358, P991, DOI 10.1098/rstb.2003.1301; DOBSON HEM, 1988, AM J BOT, V75, P170, DOI 10.2307/2443884; HESLOPHARRISON Y, 1977, ANN BOT-LONDON, V41, P1233, DOI 10.1093/oxfordjournals.aob.a085414; KRONESTEDT E, 1981, NORD J BOT, V1, P523; Larsen K, 2002, NORD J BOT, V22, P409, DOI 10.1111/j.1756-1051.2002.tb01392.x; LARSEN K, 1972, Notes from the Royal Botanic Garden Edinburgh, V31, P287; LARSEN KAI, 1964, BOT TIDSSKR, V60, P165; ROSE MJ, 1995, PLANT SYST EVOL, V195, P61, DOI 10.1007/BF00982315; Williams KJ, 2004, AM J BOT, V91, P100, DOI 10.3732/ajb.91.1.100	9	42	62	9	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 2	2004	431	7004					39	40		10.1038/431039b	http://dx.doi.org/10.1038/431039b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850VC	15343325				2022-12-24	WOS:000223641500032
J	Tamura, K; Schimmel, P				Tamura, K; Schimmel, P			Chiral-selective aminoacylation of an RNA minihelix	SCIENCE			English	Article									Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute	Schimmel, P (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	schimmel@scripps.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM015539, R37GM015539] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM15539] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bolli M, 1997, CHEM BIOL, V4, P309, DOI 10.1016/S1074-5521(97)90074-0; JOYCE GF, 1984, NATURE, V310, P602, DOI 10.1038/310602a0; MAIZELS N, 1994, P NATL ACAD SCI USA, V91, P6729, DOI 10.1073/pnas.91.15.6729; Pizzarello S, 2004, SCIENCE, V303, P1151, DOI 10.1126/science.1093057; PROFY AT, 1984, J MOL EVOL, V20, P147, DOI 10.1007/BF02257375; Rodin S, 1996, P NATL ACAD SCI USA, V93, P4537, DOI 10.1073/pnas.93.10.4537	6	70	73	3	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 27	2004	305	5688					1253	1253		10.1126/science.1099141	http://dx.doi.org/10.1126/science.1099141			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850PJ	15333830				2022-12-24	WOS:000223624600030
J	Munro, AJ				Munro, AJ			Oesophageal cancer: a view over overviews	LANCET			English	Editorial Material									Univ Dundee, Dept Surg & Mol Oncol, Dundee, Scotland	University of Dundee	Munro, AJ (corresponding author), Univ Dundee, Dept Surg & Mol Oncol, Dundee, Scotland.	a.j.munro@dundee.ac.uk						ARNOTT SJ, 2004, COCHRANE LIB; BEDENNE L, 2002, AM SOC CLINL ONCOL P, V519; Fiorica F, 2004, GUT, V53, P925, DOI 10.1136/gut.2003.025080; *IARC, 2000, GLOBOCAN; MALTHANER R, 2004, COCHRANE LIB; *SCOTT AUD GASTR C, 2002, SCOTT AUD GASTR CANC; Sur RK, 2002, INT J RADIAT ONCOL, V53, P127, DOI 10.1016/S0360-3016(02)02702-5; Wong R, 2004, COCHRANE LIB	8	18	20	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 14	2004	364	9434					566	568		10.1016/S0140-6736(04)16868-2	http://dx.doi.org/10.1016/S0140-6736(04)16868-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845WD	15313344				2022-12-24	WOS:000223275100010
J	Singer, M; De Santis, V; Vitale, D; Jeffcoate, W				Singer, M; De Santis, V; Vitale, D; Jeffcoate, W			Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation	LANCET			English	Article							NITRIC-OXIDE SYNTHASE; SEPTIC SHOCK; OXYGEN-CONSUMPTION; MITOCHONDRIAL DYSFUNCTION; SKELETAL-MUSCLE; SEPSIS; RAT; HYPERGLYCEMIA; VASOPRESSIN; INHIBITION	Sepsis and other critical illnesses produce a biphasic inflammatory, immune, hormonal, and metabolic response. The acute phase is marked by an abrupt rise in the secretion of so-called stress hormones with an associated increase in mitochondrial and metabolic activity. The combination of severe inflammation and secondary changes in endocrine profile diminish energy production, metabolic rate, and normal cellular processes, leading to multiple organ dysfunction. This perceived failure of organs might instead be a potentially protective mechanism, because reduced cellular metabolism could increase the chances of survival of cells, and thus organs, in the face of an overwhelming insult. We propose that, first, multiple organ failure induced by critical illness is primarily a functional, rather than structural, abnormality. Indeed, it may not be failure as such, but a potentially protective, reactive mechanism. Second, the decline in organ function is triggered by a decrease in mitochondrial activity and oxidative phosphorylation, leading to reduced cellular metabolism. Third, this effect on mitochondria might be the consequence of acute-phase changes in hormones and inflammatory mediators.	UCL, Wolfson Inst Biomed Res, Bloomsbury Inst Intens Care Med, London WC1E 6BT, England; UCL, Dept Med, London WC1E 6BT, England; Univ Roma La Sapienza, Dept Anaesthesia, Rome, Italy; City Hosp, Dept Endocrinol & Diabet, Nottingham NG5 1PB, England	University of London; University College London; University of London; University College London; Sapienza University Rome; University of Nottingham	Singer, M (corresponding author), UCL, Wolfson Inst Biomed Res, Bloomsbury Inst Intens Care Med, Gower St, London WC1E 6BT, England.	m.singer@ucl.ac.uk	Singer, Mervyn/J-4425-2012; Singer, Mervyn/Q-6142-2019; De Santis, Vincenzo/AAM-7960-2020	Singer, Mervyn/0000-0002-1042-6350; Singer, Mervyn/0000-0002-1042-6350; De Santis, Vincenzo/0000-0002-5105-7969				Acker CG, 2000, KIDNEY INT, V57, P293, DOI 10.1046/j.1523-1755.2000.00827.x; Agwunobi AO, 2000, J CLIN ENDOCR METAB, V85, P3770, DOI 10.1210/jc.85.10.3770; Annane D, 2000, JAMA-J AM MED ASSOC, V283, P1038, DOI 10.1001/jama.283.8.1038; BOEKSTEGERS P, 1991, INFECTION, V19, P317, DOI 10.1007/BF01645355; Borutaite V, 2000, BBA-BIOENERGETICS, V1459, P405, DOI 10.1016/S0005-2728(00)00178-X; Boulos M, 2003, CRIT CARE MED, V31, P353, DOI 10.1097/01.CCM.0000050074.82486.B2; Brealey David, 2002, Lancet (North American Edition), V360, P219, DOI 10.1016/S0140-6736(02)09459-X; Costamagna ME, 1998, THYROID, V8, P1127, DOI 10.1089/thy.1998.8.1127; De Backer D, 2002, AM J RESP CRIT CARE, V166, P98, DOI 10.1164/rccm.200109-016OC; Duclos M, 2001, PFLUG ARCH EUR J PHY, V443, P218, DOI 10.1007/s004240100675; HAYES MA, 1994, NEW ENGL J MED, V330, P1717, DOI 10.1056/NEJM199406163302404; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; King CJ, 1999, CRIT CARE MED, V27, P2518, DOI 10.1097/00003246-199911000-00032; KREYMANN G, 1993, CRIT CARE MED, V21, P1012, DOI 10.1097/00003246-199307000-00015; Lee S, 1999, J NEUROSCI, V19, P7640, DOI 10.1523/JNEUROSCI.19-17-07640.1999; Ligtenberg JJM, 2001, INTENS CARE MED, V27, P1567, DOI 10.1007/s001340101050; Noble JS, 2001, ANAESTHESIA, V56, P124, DOI 10.1046/j.1365-2044.2001.01841.x; Nogueira V, 2002, J BIOENERG BIOMEMBR, V34, P55, DOI 10.1023/A:1013822820840; PALAZZO MG, 1991, INTENS CARE MED, V17, P325, DOI 10.1007/BF01716190; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; RIVIER C, 1994, J NEUROSCI, V14, P1985; Robb SJ, 2002, INTENS CARE MED, V28, pS64; ROTHWELL PM, 1995, CRIT CARE MED, V23, P78, DOI 10.1097/00003246-199501000-00015; Scheller K, 2003, INT REV CYTOL, V222, P1; Short KR, 2001, AM J PHYSIOL-ENDOC M, V280, pE761, DOI 10.1152/ajpendo.2001.280.5.E761; Singer M, 1999, BIOCHEM SOC SYMP, V66, P149, DOI 10.1042/bss0660149; Sugita H, 2002, AM J PHYSIOL-ENDOC M, V282, pE386, DOI 10.1152/ajpendo.00087.2001; Takala J, 1999, NEW ENGL J MED, V341, P785, DOI 10.1056/NEJM199909093411102; Tsai AG, 2003, AM J PHYSIOL-HEART C, V285, pH1537, DOI 10.1152/ajpheart.00176.2003; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Van den Berghe G, 1998, J CLIN ENDOCR METAB, V83, P1827, DOI 10.1210/jc.83.6.1827; Venditti P, 2003, ARCH BIOCHEM BIOPHYS, V411, P121, DOI 10.1016/S0003-9861(02)00720-8; WANG XM, 1993, BURNS, V19, P110, DOI 10.1016/0305-4179(93)90030-C; Weekers F, 2003, ENDOCRINOLOGY, V144, P5329, DOI 10.1210/en.2003-0697; Zell R, 1997, MOL CELL BIOCHEM, V177, P61, DOI 10.1023/A:1006896832582	35	334	366	0	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 7	2004	364	9433					545	548		10.1016/S0140-6736(04)16815-3	http://dx.doi.org/10.1016/S0140-6736(04)16815-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BS	15302200				2022-12-24	WOS:000223132700036
J	Bennett, CL; Luminari, S; Nissenson, AR; Tallman, MS; Klinge, SA; McWilliams, N; McKoy, JM; Kim, B; Lyons, EA; Trifilio, SM; Raisch, DW; Evens, AM; Kuzel, TM; Schumock, GT; Belknap, SM; Locatelli, F; Rossert, J; Casadevall, N				Bennett, CL; Luminari, S; Nissenson, AR; Tallman, MS; Klinge, SA; McWilliams, N; McKoy, JM; Kim, B; Lyons, EA; Trifilio, SM; Raisch, DW; Evens, AM; Kuzel, TM; Schumock, GT; Belknap, SM; Locatelli, F; Rossert, J; Casadevall, N			Pure red-cell aplasia and epoetin therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; ANTIERYTHROPOIETIN ANTIBODIES	BACKGROUND: Between 1988 and 1998, antibody-associated pure red-cell aplasia was reported in three patients who had undergone treatment with recombinant human erythropoietin (epoetin). Between 1998 and 2000, 13 such cases were reported from France -- 12 in patients who had received the Eprex formulation of epoetin alfa and 1 in a patient who had received Neorecormon (a formulation of epoetin beta); both are products that are marketed outside the United States. METHODS: We obtained reports of epoetin-associated pure red-cell aplasia from the Food and Drug Administration and from the manufacturers of Eprex, Epogen (another formulation of epoetin alfa), and Neorecormon. The numbers of case reports and estimates of exposure-adjusted incidence were analyzed according to the product, the cause of anemia, the route of administration, the country in which pure red-cell aplasia was identified, and the date on which pure red-cell aplasia was reported. RESULTS: Between January 1998 and April 2004, 175 cases of epoetin-associated pure red-cell aplasia were reported for Eprex, 11 cases for Neorecormon, and 5 cases for Epogen. Over half these cases had occurred in France, Canada, the United Kingdom, and Spain. Between 2001 and 2003, the estimated exposure-adjusted incidence was 18 cases per 100,000 patient-years for the Eprex formulation without human serum albumin, 6 per 100,000 patient-years for the Eprex formulation with human serum albumin, 1 case per 100,000 patient-years for Neorecormon, and 0.2 case per 100,000 patient-years for Epogen. After procedures were adopted to ensure appropriate storage, handling, and administration of Eprex to patients with chronic kidney disease, the exposure-adjusted incidence decreased by 83 percent worldwide. CONCLUSIONS: After the peak incidence of Eprex-associated pure red-cell aplasia was reached in 2001, interventions designed in response to drug-monitoring programs worldwide resulted in a reduction of more than 80 percent in the incidence of pure red-cell aplasia due to Eprex.	Northwestern Univ, Feinberg Sch Med, Jesse Brown Vet Affairs Med Ctr, Midw Ctr Hlth Serv Res & Policy Studies, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Med, Div Hematol & Oncol, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Med, Div Geriatr, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Med, Div Gen Internal Med, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Inst Hlth Serv Res & Policy Studies, Chicago, IL 60611 USA; Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; NW Mem Hosp, Dept Pharm, Chicago, IL 60611 USA; Univ Illinois, Coll Pharm, Ctr Pharmacoecon Res, Chicago, IL USA; Univ Modena & Reggio Emilia, Dipartimento Oncol & Ematol, Modena, Italy; Univ Calif Los Angeles, David Geffen Sch Med, Div Nephrol, Los Angeles, CA USA; Univ New Mexico, Vet Affairs Cooperat Study Program Clin Res Pharm, Albuquerque, NM 87131 USA; A Manzoni Hosp, Dept Nephrol & Dialysis, Lecce, Italy; Univ Paris 06, Tenon Hosp, Dept Nephrol, Paris, France; Hop Hotel Dieu, Dept Hematol, Paris, France; INSERM, U352, Paris, France	Northwestern University; Feinberg School of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern Memorial Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Universita di Modena e Reggio Emilia; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of New Mexico; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Bennett, CL (corresponding author), Jesse Brown Vet Affairs Med Ctr, Midw Ctr Hlth Serv & Policy Res, 333 E Huron St,Suite 277, Chicago, IL 60611 USA.	cbenne@northwestern.edu	Luminari, Stefano/J-5916-2014; Bennett, Charles L/C-2050-2008; MCKOY, JUNE/GRJ-5660-2022	Luminari, Stefano/0000-0001-8446-2285; Evens, Andrew/0000-0002-6900-1824; Belknap, Steven/0000-0002-3670-7409	NATIONAL CANCER INSTITUTE [P30CA060553, R01CA102713] Funding Source: NIH RePORTER; NCI NIH HHS [1R01CA 102713-01, P 30 CA60553] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		*AG ESP MED, 2002, NOT INF EP ALF CONTR; *AG FRANC SEC SAN, 2002, LETT PRESCR EPR INF; *ARZN DTSCH ARZT, 2002, ART ANW NUR INTR APP; BERGREM H, 1993, ERYTHROPOIETIN, P265; Casadevall N, 2002, NEW ENGL J MED, V346, P469, DOI 10.1056/NEJMoa011931; Gershon SK, 2002, NEW ENGL J MED, V346, P1584; Hynes DM, 2002, AM J MED, V112, P169, DOI 10.1016/S0002-9343(01)01103-2; Kaufman J S, 1998, Am J Kidney Dis, V32, pS147, DOI 10.1016/S0272-6386(98)70178-7; Kaufman JS, 1998, NEW ENGL J MED, V339, P578, DOI 10.1056/NEJM199808273390902; Knauss MD, 2002, AM J HEALTH-SYST PH, V59, P1783, DOI 10.1093/ajhp/59.18.1783; Ladewski, 2004, J CLIN ONCOL, V22, P1169, DOI 10.1200/JCO.2004.01.914; Ladewski LA, 2003, J CLIN ONCOL, V21, P3859, DOI 10.1200/JCO.2003.04.537; Li JZ, 2001, BLOOD, V98, P3241, DOI 10.1182/blood.V98.12.3241; Locatelli F, 2004, NEPHROL DIAL TRANSPL, V19, P121, DOI 10.1093/ndt/gfg458; Locatelli F, 2003, ARTIF ORGANS, V27, P755, DOI 10.1046/j.1525-1594.2003.00991.x; Locatelli F, 2004, NEPHROL DIAL TRANSPL, V19, P288, DOI 10.1093/ndt/gfg489; *MED CONTR AG, EPR EP ALF PUR RED C; *MIN SAL, 2002, NOT INF IMP EP ALF G; Peces R, 1996, NEW ENGL J MED, V335, P523, DOI 10.1056/NEJM199608153350717; Porter S, 2001, J PHARM SCI-US, V90, P1; Prabhakar SS, 1997, CLIN NEPHROL, V47, P331; Rossert J, 2004, J AM SOC NEPHROL, V15, P398, DOI 10.1097/01.ASN.0000107561.59698.42; *SWISSM, 2003, PUR RED CELL APL; *THER GOODS ADM, 2002, AUSTR ADV DRUG REACT, V21; *THER PROD DIR, IMP SAF INF EPR EP A; Verhelst D, 2004, LANCET, V363, P1768, DOI 10.1016/S0140-6736(04)16302-2; 2004, JOHNSON JOHNSON 0120; 2003, NEORECORMON EPOETIN; 2003, WHO PHARMACEUT NEWSL; 2002, JOHNSON JOHNSON 1202; 2004, INFORMATION HEALTHCA; 2003, PROCRIT EPOETIN ALFA	32	282	307	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 30	2004	351	14					1403	1408		10.1056/NEJMoa040528	http://dx.doi.org/10.1056/NEJMoa040528			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857XT	15459301				2022-12-24	WOS:000224153900008
J	Chesebro, B				Chesebro, B			Biomedicine - A fresh look at BSE	SCIENCE			English	Editorial Material							BOVINE SPONGIFORM ENCEPHALOPATHY; CREUTZFELDT-JAKOB-DISEASE; PRION PROTEIN		NIAID, Rocky Mt Labs, Persistent Viral Dis Lab, Hamilton, MT 59840 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Chesebro, B (corresponding author), NIAID, Rocky Mt Labs, Persistent Viral Dis Lab, Hamilton, MT 59840 USA.	bschesebro@nih.gov						Biacabe AG, 2004, EMBO REP, V5, P110, DOI 10.1038/sj.embor.7400054; Casalone C, 2004, P NATL ACAD SCI USA, V101, P3065, DOI 10.1073/pnas.0305777101; Chesebro B, 1998, SCIENCE, V279, P42, DOI 10.1126/science.279.5347.42; Chiesa R, 2003, J VIROL, V77, P7611, DOI 10.1128/JVI.77.13.7611-7622.2003; Hill AF, 1999, J GEN VIROL, V80, P11, DOI 10.1099/0022-1317-80-1-11; Houston EF, 2002, J GEN VIROL, V83, P1247, DOI 10.1099/0022-1317-83-5-1247; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Smith PG, 2003, BRIT MED BULL, V66, P185, DOI 10.1093/bmb/66.1.185; Weissmann C, 1997, CURR OPIN NEUROBIOL, V7, P695, DOI 10.1016/S0959-4388(97)80091-8; WESTAWAY D, 1994, CELL, V76, P117, DOI 10.1016/0092-8674(94)90177-5; Yamakawa Y, 2003, JPN J INFECT DIS, V56, P221	12	16	17	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 24	2004	305	5692					1918	+		10.1126/science.1103581	http://dx.doi.org/10.1126/science.1103581			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857RM	15448258				2022-12-24	WOS:000224136000033
J	Chien, MC; Morozova, I; Shi, SD; Sheng, HT; Chen, J; Gomez, SM; Asamani, G; Hill, K; Nuara, J; Feder, M; Rineer, J; Greenberg, JJ; Steshenko, V; Park, SH; Zhao, BH; Teplitskaya, E; Edwards, JR; Pampou, S; Georghiou, A; Chou, IC; Iannuccilli, W; Ulz, ME; Kim, DH; Geringer-Sameth, A; Goldsberry, C; Morozov, P; Fischer, SG; Segal, G; Qu, XY; Rzhetsky, A; Zhang, PS; Cayanis, E; De Jong, PJ; Ju, JY; Kalachikov, S; Shuman, HA; Russo, JJ				Chien, MC; Morozova, I; Shi, SD; Sheng, HT; Chen, J; Gomez, SM; Asamani, G; Hill, K; Nuara, J; Feder, M; Rineer, J; Greenberg, JJ; Steshenko, V; Park, SH; Zhao, BH; Teplitskaya, E; Edwards, JR; Pampou, S; Georghiou, A; Chou, IC; Iannuccilli, W; Ulz, ME; Kim, DH; Geringer-Sameth, A; Goldsberry, C; Morozov, P; Fischer, SG; Segal, G; Qu, XY; Rzhetsky, A; Zhang, PS; Cayanis, E; De Jong, PJ; Ju, JY; Kalachikov, S; Shuman, HA; Russo, JJ			The genomic sequence of the accidental pathogen Legionella pneumophila	SCIENCE			English	Article							IV SECRETION SYSTEM; COXIELLA-BURNETII; LEGIONNAIRES-DISEASE; VIRULENCE SYSTEM; DOT/ICM SYSTEM	We present the genomic sequence of Legionella pneumophila, the bacteria[ agent of Legionnaires' disease, a potentially fatal pneumonia acquired from aerosolized contaminated fresh water. The genome includes a 45-kilobase pair element that can exist in chromosomal and episomal forms, selective expansions of important gene families, genes for unexpected metabolic pathways, and previously unknown candidate virulence determinants. We highlight the genes that may account for Legionella's ability to survive in protozoa, mammalian macrophages, and inhospitable environmental niches and that may define new therapeutic targets.	Columbia Univ Coll Phys & Surg, Columbia Genome Ctr, New York, NY 10032 USA; Inst Pasteur, Unite Biochim & Biol Mol Insectes, F-75015 Paris, France; Roswell Pk Canc Inst, BACPAC Resources Lab, Buffalo, NY 14263 USA; Columbia Univ, Fu Fdn Sch Engn & Appl Sci, Dept Chem Engn, New York, NY 10027 USA; Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; Columbia Univ Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA	Columbia University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Roswell Park Cancer Institute; Columbia University; Tel Aviv University; Columbia University	Russo, JJ (corresponding author), Columbia Univ Coll Phys & Surg, Columbia Genome Ctr, 630 W 168th St, New York, NY 10032 USA.	jjr4@columbia.edu	Morozov, Pavel/GQP-7206-2022; rzhetsky, andrey/B-6118-2012; Segal, Gil/H-7987-2019	rzhetsky, andrey/0000-0001-6959-7405; Segal, Gil/0000-0003-0392-253X; Geringer-Sameth, Alex/0000-0002-1269-6047; Gomez, Shawn/0000-0002-8251-4552	NIAID NIH HHS [U01 1 AI 4437, AI 23549] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023549] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Brassinga AKC, 2003, J BACTERIOL, V185, P4630, DOI 10.1128/JB.185.15.4630-4637.2003; Chen J, 2004, SCIENCE, V303, P1358, DOI 10.1126/science.1094226; Cirillo SLG, 2000, MICROBIOL-SGM, V146, P1345, DOI 10.1099/00221287-146-6-1345; De Biase D, 1999, MOL MICROBIOL, V32, P1198, DOI 10.1046/j.1365-2958.1999.01430.x; DEFELIPE KS, UNPUB; Fernandez-Leborans G, 2000, ECOTOX ENVIRON SAFE, V47, P266, DOI 10.1006/eesa.2000.1944; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; FRASER DW, 1977, NEW ENGL J MED, V297, P1189, DOI 10.1056/NEJM197712012972201; Gao LY, 2000, ENVIRON MICROBIOL, V2, P79, DOI 10.1046/j.1462-2920.2000.00076.x; GEORGE JR, 1980, J CLIN MICROBIOL, V11, P286, DOI 10.1128/JCM.11.3.286-291.1980; Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101; Nagai H, 2003, CELL MICROBIOL, V5, P373, DOI 10.1046/j.1462-5822.2003.00285.x; Nagai H, 2002, SCIENCE, V295, P679, DOI 10.1126/science.1067025; Rendulic S, 2004, SCIENCE, V303, P689, DOI 10.1126/science.1093027; Segal G, 1999, MOL MICROBIOL, V34, P799, DOI 10.1046/j.1365-2958.1999.01642.x; Segal G, 1998, P NATL ACAD SCI USA, V95, P1669, DOI 10.1073/pnas.95.4.1669; Seshadri R, 2003, P NATL ACAD SCI USA, V100, P5455, DOI 10.1073/pnas.0931379100; Sturgill-Koszycki S, 2000, J EXP MED, V192, P1261, DOI 10.1084/jem.192.9.1261; Vogel JP, 1998, SCIENCE, V279, P873, DOI 10.1126/science.279.5352.873; Zamboni DS, 2003, MOL MICROBIOL, V49, P965, DOI 10.1046/j.1365-2958.2003.03626.x; Zusman T, 2003, INFECT IMMUN, V71, P3714, DOI 10.1128/IAI.71.7.3714-3723.2003	21	385	816	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2004	305	5692					1966	1968		10.1126/science.1099776	http://dx.doi.org/10.1126/science.1099776			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857RM	15448271				2022-12-24	WOS:000224136000050
J	Heymann, DL; Aylward, RB				Heymann, DL; Aylward, RB			Global health - Eradicating polio	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									WHO, Polio Eradicat Initiat, CH-1211 Geneva, Switzerland	World Health Organization	Heymann, DL (corresponding author), WHO, Polio Eradicat Initiat, CH-1211 Geneva, Switzerland.							[Anonymous], 2003, Wkly Epidemiol Rec, V78, P241; [Anonymous], 1995, WHOEPIGEN956; Plotkin SA, 2001, CLIN INFECT DIS, V32, P1068, DOI 10.1086/319612; *WHO, IN PRESS REP WHO CON; World Health Organization, 2004, GEN DECL ER POL	5	37	40	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 23	2004	351	13					1275	1277		10.1056/NEJMp048204	http://dx.doi.org/10.1056/NEJMp048204			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	855TP	15385650	Green Accepted			2022-12-24	WOS:000223997700001
J	Yen, L; Svendsen, J; Lee, JS; Gray, JT; Magnier, M; Baba, T; D'Amato, RJ; Mulligan, RC				Yen, L; Svendsen, J; Lee, JS; Gray, JT; Magnier, M; Baba, T; D'Amato, RJ; Mulligan, RC			Exogenous control of mammalian gene expression through modulation of RNA self-cleavage	NATURE			English	Article							HAMMERHEAD-RIBOZYME; IN-VITRO; SYSTEM; IDENTIFICATION; INHIBITION; CELLS	Recent studies on the control of specific metabolic pathways in bacteria have documented the existence of entirely RNA-based mechanisms for controlling gene expression. These mechanisms involve the modulation of translation, transcription termination or RNA self-cleavage through the direct interaction of specific intracellular metabolites and RNA sequences(1-4). Here we show that an analogous RNA-based gene regulation system can effectively be designed for mammalian cells via the incorporation of sequences encoding self-cleaving RNA motifs(5) into the transcriptional unit of a gene or vector. When correctly positioned, the sequences lead to potent inhibition of gene or vector expression, owing to the spontaneous cleavage of the RNA transcript. Administration of either oligonucleotides complementary to regions of the self-cleaving motif or a specific small molecule results in the efficient induction of gene expression, owing to inhibition of self-cleavage of the messenger RNA. Efficient regulation of transgene expression is shown in a variety of mammalian cell lines and live animals. In conjunction with other emerging technologies(6), this methodology may be particularly applicable to the development of gene regulation systems tailored to any small inducer molecule, and provide a novel means of biological sensing in vivo that may have an important application in the regulated delivery of protein therapeutics.	Harvard Univ, Sch Med, Harvard Inst Human Genet, Dept Genet, Boston, MA 02115 USA; Childrens Hosp, Div Mol Med, Boston, MA 02115 USA; Childrens Hosp, Dept Surg, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital	Mulligan, RC (corresponding author), Harvard Univ, Sch Med, Harvard Inst Human Genet, Dept Genet, Boston, MA 02115 USA.	mulligan@receptor.med.harvard.edu	Wilson, Matthew H/K-3193-2013; Gray, John T/D-2916-2016	Gray, John T/0000-0002-1888-4612				ASZALOS A, 1966, J ANTIBIOT, V19, P285; Braasch DA, 2002, BIOCHEMISTRY-US, V41, P4503, DOI 10.1021/bi0122112; Breaker RR, 2002, CURR OPIN BIOTECH, V13, P31, DOI 10.1016/S0958-1669(02)00281-1; Cech TR, 2004, NATURE, V428, P263, DOI 10.1038/428263a; CECH TR, 1990, BIOSCIENCE REP, V10, P239, DOI 10.1007/BF01117241; CHOWRIRA BM, 1994, J BIOL CHEM, V269, P25856; Conaty J, 1999, NUCLEIC ACIDS RES, V27, P2400, DOI 10.1093/nar/27.11.2400; Contag PR, 1998, NAT MED, V4, P245, DOI 10.1038/nm0298-245; Ferbeyre G, 1998, MOL CELL BIOL, V18, P3880, DOI 10.1128/MCB.18.7.3880; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Hermann T, 1998, J MOL BIOL, V276, P903, DOI 10.1006/jmbi.1997.1590; HERTEL KJ, 1992, NUCLEIC ACIDS RES, V20, P3252, DOI 10.1093/nar/20.12.3252; Jenne A, 2001, NAT BIOTECHNOL, V19, P56, DOI 10.1038/83513; Mandal M, 2004, NAT STRUCT MOL BIOL, V11, P29, DOI 10.1038/nsmb710; Morcos PA, 2001, GENESIS, V30, P94, DOI 10.1002/gene.1039; Murray JB, 1996, BIOCHEM J, V317, P855, DOI 10.1042/bj3170855; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Rivera VM, 1996, NAT MED, V2, P1028, DOI 10.1038/nm0996-1028; Rojas AA, 2000, NUCLEIC ACIDS RES, V28, P4037, DOI 10.1093/nar/28.20.4037; RUFFNER DE, 1990, BIOCHEMISTRY-US, V29, P10695, DOI 10.1021/bi00499a018; Silverman SK, 2003, RNA, V9, P377, DOI 10.1261/rna.2200903; STAGE TK, 1995, RNA, V1, P95; Suhr ST, 1998, P NATL ACAD SCI USA, V95, P7999, DOI 10.1073/pnas.95.14.7999; Tor Y, 1998, CHEM BIOL, V5, pR277, DOI 10.1016/S1074-5521(98)90286-1; VONAHSEN U, 1991, NATURE, V353, P368, DOI 10.1038/353368a0; WANG YL, 1994, P NATL ACAD SCI USA, V91, P8180, DOI 10.1073/pnas.91.17.8180; Wilson DS, 1999, ANNU REV BIOCHEM, V68, P611, DOI 10.1146/annurev.biochem.68.1.611; Winkler W, 2002, NATURE, V419, P952, DOI 10.1038/nature01145; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362; Zillmann M, 1997, RNA, V3, P734	30	200	226	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 23	2004	431	7007					471	476		10.1038/nature02844	http://dx.doi.org/10.1038/nature02844			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15386015				2022-12-24	WOS:000224000500045
J	Abbott, RD; White, LR; Ross, GW; Masaki, KH; Curb, JD; Petrovitch, H				Abbott, RD; White, LR; Ross, GW; Masaki, KH; Curb, JD; Petrovitch, H			Walking and dementia in physically capable elderly men	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HONOLULU-HEART-PROGRAM; JAPANESE-AMERICAN MEN; ALZHEIMERS-DISEASE; LEISURE ACTIVITIES; COGNITIVE DECLINE; APOLIPOPROTEIN-E; OLDER PERSONS; RISK-FACTORS; INCIDENT AD; HEALTH	Context Evidence suggests that physical activity may be related to the clinical expression of dementia. Whether the association includes low-intensity activity such as walking is not known. Objective To examine the association between walking and future risk of dementia in older men. Design Prospective cohort study. Setting and Participants Distance walked per day was assessed from 1991 to 1993 in 2257 physically capable men aged 71 to 93 years in the Honolulu-Asia Aging Study. Follow-up for incident dementia was based on neurological assessment at 2 repeat examinations (1994-1996 and 1997-1999). Main Outcome Measures Overall dementia, Alzheimer disease, and vascular dementia. Results During the course of follow-up, 158 cases of dementia were identified (15.6/ 1000 person-years). After adjusting for age, men who walked the least (<0.25 mile/d) experienced a 1.8-fold excess risk of dementia compared with those who walked more than 2 mile/d (17.8 vs 10.3/1000 person-years; relative hazard [RH], 1.77; 95% confidence interval [CI], 1.04-3.01). Compared with men who walked the most (>2 mile/d), an excess risk of dementia was also observed in those who walked 0.25 to 1 mile/d (17.6 vs 10.3/1000 person-years; RH, 1.71; 95% Cl, 1.02-2.86). These associations persisted after accounting for other factors, including the possibility that limited amounts of walking could be the result of a decline in physical function due to preclinical dementia. Conclusions Findings suggest that walking is associated with a reduced risk of dementia. Promoting active lifestyles in physically capable men could help late-life cognitive function.	Univ Virginia, Sch Med, Div Biostat & Epidemiol, Charlottesville, VA 22908 USA; Pacific Hlth Res Inst, Honolulu, HI USA; Dept Vet Affairs, Honolulu, HI USA; Kuakini Med Ctr, Honolulu Asia Aging Study, Honolulu, HI USA; Univ Hawaii, John A Burns Sch Med, Dept Geriatr Med, Honolulu, HI 96822 USA; Univ Hawaii, John A Burns Sch Med, Dept Med, Honolulu, HI 96822 USA	University of Virginia; Pacific Health Research & Education Institute; University of Hawaii System; University of Hawaii System	Abbott, RD (corresponding author), Univ Virginia Hlth Syst, Dept Hlth Evaluat Sci, POB 800717, Charlottesville, VA 22908 USA.	rda3e@virginia.edu			DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC005102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG017155, N01AG042149] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-05102] Funding Source: Medline; NIA NIH HHS [1-R01-AG17155-01A1, N01-AG-4-2149] Funding Source: Medline; NINDS NIH HHS [1-R01-NS41265-01] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABBOTT RD, 1985, AM J EPIDEMIOL, V121, P465, DOI 10.1093/oxfordjournals.aje.a114019; ABBOTT RD, 1994, AM J EPIDEMIOL, V139, P881, DOI 10.1093/oxfordjournals.aje.a117094; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; CHIU HC, 1992, NEUROLOGY, V42, P473; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; COX DR, 1972, J R STAT SOC B, V34, P187; FABRIGOULE C, 1995, J AM GERIATR SOC, V43, P485, DOI 10.1111/j.1532-5415.1995.tb06093.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hakim AA, 1998, NEW ENGL J MED, V338, P94, DOI 10.1056/NEJM199801083380204; Hakim AA, 1999, CIRCULATION, V100, P9, DOI 10.1161/01.CIR.100.1.9; HARRIS T, 1988, JAMA-J AM MED ASSOC, V259, P1520; Havlik RJ, 2000, NEUROLOGY, V54, P1526, DOI 10.1212/WNL.54.7.1526; JORM AF, 1989, PSYCHOL MED, V19, P1015, DOI 10.1017/S0033291700005742; Kalmijn S, 2000, ARTERIOSCL THROM VAS, V20, P2255, DOI 10.1161/01.ATV.20.10.2255; KANNEL WB, 1979, ARCH INTERN MED, V139, P857, DOI 10.1001/archinte.139.8.857; Kramer AF, 1999, NATURE, V400, P418, DOI 10.1038/22682; LANE PW, 1982, BIOMETRICS, V38, P613, DOI 10.2307/2530043; Laurin D, 2001, ARCH NEUROL-CHICAGO, V58, P498, DOI 10.1001/archneur.58.3.498; Lindsay J, 2002, AM J EPIDEMIOL, V156, P445, DOI 10.1093/aje/kwf074; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Ross GW, 1997, JAMA-J AM MED ASSOC, V277, P800, DOI 10.1001/jama.277.10.800; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Scarmeas N, 2003, ARCH NEUROL-CHICAGO, V60, P359, DOI 10.1001/archneur.60.3.359; Scarmeas N, 2001, NEUROLOGY, V57, P2236, DOI 10.1212/WNL.57.12.2236; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Teng E L, 1994, Int Psychogeriatr, V6, P45, DOI 10.1017/S1041610294001602; Tyas SL, 2003, NEUROBIOL AGING, V24, P589, DOI 10.1016/S0197-4580(02)00156-2; Verghese J, 2003, NEW ENGL J MED, V348, P2508, DOI 10.1056/NEJMoa022252; White L, 1996, JAMA-J AM MED ASSOC, V276, P955, DOI 10.1001/jama.276.12.955; Wilson RS, 2002, NEUROLOGY, V59, P1910, DOI 10.1212/01.WNL.0000036905.59156.A1; Wilson RS, 2002, JAMA-J AM MED ASSOC, V287, P742, DOI 10.1001/jama.287.6.742; Yaffe K, 2001, ARCH INTERN MED, V161, P1703, DOI 10.1001/archinte.161.14.1703; YANO K, 1984, AM J EPIDEMIOL, V119, P653, DOI 10.1093/oxfordjournals.aje.a113787; YOSHITAKE T, 1995, NEUROLOGY, V45, P1161, DOI 10.1212/WNL.45.6.1161; YOUNG DR, 1995, J AM GERIATR SOC, V43, P845, DOI 10.1111/j.1532-5415.1995.tb05525.x	35	469	490	4	58	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 22	2004	292	12					1447	1453		10.1001/jama.292.12.1447	http://dx.doi.org/10.1001/jama.292.12.1447			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856FT	15383515	Bronze			2022-12-24	WOS:000224031800026
J	Weber, KL; Sokac, AM; Berg, JS; Cheney, RE; Bement, WM				Weber, KL; Sokac, AM; Berg, JS; Cheney, RE; Bement, WM			A microtubule-binding myosin required for nuclear anchoring and spindle assembly	NATURE			English	Article							UNCONVENTIONAL MYOSIN; OOCYTE MATURATION; XENOPUS-OOCYTES; EGG CORTEX; IN-VITRO; F-ACTIN; MICROFILAMENTS; FERTILIZATION; MOVEMENT; PROTEIN	Proper spindle positioning and orientation are essential for asymmetric cell division and require microtubule-actin filament (F-actin) interactions in many systems(1,2). Such interactions are particularly important in meiosis(3), where they mediate nuclear anchoring(4-6), as well as meiotic spindle assembly and rotation(7,8), two processes required for asymmetric cell division. Myosin-10 proteins are phosphoinositide-binding(9), actin-based motors that contain carboxy-terminal MyTH4 and FERM domains of unknown function(10). Here we show that Xenopus laevis myosin-10 (Myo10) associates with microtubules in vitro and in vivo, and is concentrated at the point where the meiotic spindle contacts the F-actin-rich cortex. Microtubule association is mediated by the MyTH4-FERM domains, which bind directly to purified microtubules. Disruption of Myo10 function disrupts nuclear anchoring, spindle assembly and spindle-F-actin association. Thus, this myosin has a novel and critically important role during meiosis in integrating the F- actin and microtubule cytoskeletons.	Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; Univ Wisconsin, Mol & Cellular Biol Program, Madison, WI 53706 USA; Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of North Carolina; University of North Carolina Chapel Hill	Bement, WM (corresponding author), Univ Wisconsin, Dept Zool, Madison, WI 53706 USA.	wmbement@wisc.edu	Bement, William/AAA-5444-2021	Cheney, Richard/0000-0001-6565-7888; Berg, Jonathan/0000-0003-2360-2664	NIDCD NIH HHS [R01 DC003299] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003299] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ALEXANDRE H, 1989, DEV BIOL, V136, P311, DOI 10.1016/0012-1606(89)90258-3; BEMENT WM, 1994, P NATL ACAD SCI USA, V91, P6549, DOI 10.1073/pnas.91.14.6549; Berg JS, 2000, J CELL SCI, V113, P3439; Cao TT, 2004, MOL BIOL CELL, V15, P151, DOI 10.1091/mbc.E03-07-0504; Cox D, 2002, NAT CELL BIOL, V4, P469, DOI 10.1038/ncb805; GARD DL, 1993, DEV BIOL, V159, P298, DOI 10.1006/dbio.1993.1242; GARD DL, 1995, ZYGOTE, V3, P17, DOI 10.1017/S0967199400002331; GARD DL, 1991, DEV BIOL, V143, P346, DOI 10.1016/0012-1606(91)90085-H; Gundersen GG, 2003, SCIENCE, V300, P2040, DOI 10.1126/science.1084938; Homma K, 2001, J BIOL CHEM, V276, P34348, DOI 10.1074/jbc.M104785200; Huang JD, 1999, NATURE, V397, P267, DOI 10.1038/16722; Isakoff SJ, 1998, EMBO J, V17, P5374, DOI 10.1093/emboj/17.18.5374; Kim NH, 2000, ZYGOTE, V8, P25, DOI 10.1017/S0967199400000794; Lantz VA, 1998, J CELL BIOL, V140, P897, DOI 10.1083/jcb.140.4.897; LESSMAN CA, 1987, CELL DIFFER DEV, V20, P239, DOI 10.1016/0045-6039(87)90469-6; Mandato CA, 2003, CURR BIOL, V13, P1096, DOI 10.1016/S0960-9822(03)00420-2; Narasimhulu SB, 1998, PLANT CELL, V10, P957, DOI 10.1105/tpc.10.6.957; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Rogers SL, 1999, J CELL BIOL, V146, P1265, DOI 10.1083/jcb.146.6.1265; SARDET C, 1992, DEVELOPMENT, V115, P221; Sardet C, 2002, DEV BIOL, V241, P1, DOI 10.1006/dbio.2001.0474; SHIMIZU T, 1990, ANN NY ACAD SCI, V582, P260; Sokac AM, 2000, INT REV CYTOL, V200, P197, DOI 10.1016/S0074-7696(00)00005-X; Sokac AM, 2003, NAT CELL BIOL, V5, P727, DOI 10.1038/ncb1025; Sun QY, 2001, BIOL REPROD, V64, P879, DOI 10.1095/biolreprod64.3.879; Tokuo H, 2004, BIOCHEM BIOPH RES CO, V319, P214, DOI 10.1016/j.bbrc.2004.04.167; Weber KL, 2002, J CELL SCI, V115, P1373; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Wolfrum U, 1998, CELL MOTIL CYTOSKEL, V40, P261, DOI 10.1002/(SICI)1097-0169(1998)40:3<261::AID-CM5>3.3.CO;2-#; Yonezawa S, 2003, DEV GROWTH DIFFER, V45, P175	30	192	198	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2004	431	7006					325	329		10.1038/nature02834	http://dx.doi.org/10.1038/nature02834			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372037				2022-12-24	WOS:000223864000045
J	Koh, LP; Dunn, RR; Sodhi, NS; Colwell, RK; Proctor, HC; Smith, VS				Koh, LP; Dunn, RR; Sodhi, NS; Colwell, RK; Proctor, HC; Smith, VS			Species coextinctions and the biodiversity crisis	SCIENCE			English	Article							EVOLUTIONARY HISTORY; EXTINCTION; PHILOPTERIDAE; CONSERVATION; PHTHIRAPTERA; BUTTERFLIES; SINGAPORE; TAXONOMY	To assess the coextinction of species (the loss of a species upon the loss of another), we present a probabilistic model, scaled with empirical data. The model examines the relationship between coextinction levels (proportion of species extinct) of affiliates and their hosts across a wide range of coevolved interspecific systems: pollinating Ficus wasps and Ficus, parasites and their hosts, butterflies and their larval host plants, and ant butterflies and their host ants. Applying a nomographic method based on mean host specificity (number of host species per affiliate species), we estimate that 6300 affiliate species are "coendangered" with host species currently listed as endangered. Current extinction estimates need to be recalibrated by taking species coextinctions into account.	Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; Curtin Univ Technol, Dept Environm Biol, Perth, WA 6845, Australia; Univ Connecticut, Dept Ecol & Evolutionary Biol, Storrs, CT 06269 USA; Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; Univ Glasgow, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland	National University of Singapore; Curtin University; University of Connecticut; University of Alberta; University of Glasgow	Sodhi, NS (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.	dbsns@nus.edu.sg	Proctor, Heather C./A-2677-2014; Smith, Vincent/AAK-7335-2020; Dunn, Robert/B-1360-2013; Colwell, Robert K/C-7276-2015; Koh, Lian Pin/A-5794-2010	Proctor, Heather C./0000-0002-4920-9556; Smith, Vincent/0000-0001-5297-7452; Koh, Lian Pin/0000-0001-8152-3871; Dunn, Robert/0000-0002-6030-4837				Amaral LAN, 1999, PHYS REV LETT, V82, P652, DOI 10.1103/PhysRevLett.82.652; Boswell GP, 1998, P ROY SOC B-BIOL SCI, V265, P1921, DOI 10.1098/rspb.1998.0521; Brook BW, 2003, NATURE, V424, P420, DOI 10.1038/nature01795; Castelletta M, 2000, CONSERV BIOL, V14, P1870, DOI 10.1111/j.1523-1739.2000.99285.x; Clayton DH, 1999, ANN ENTOMOL SOC AM, V92, P675, DOI 10.1093/aesa/92.5.675; COLWELL RK, IN PRESS ECOLOGY; Colwell RK, ESTIMATES STAT ESTIM; Colwell Robert K., 1994, P23; Donovan TM, 1997, ECOLOGY, V78, P2064, DOI 10.1890/0012-9658(1997)078[2064:VILSEE]2.0.CO;2; Gilbert L. E., 1980, Conservation biology. An evolutionary-ecological perspective., P11; Gotwald WH, 1995, CORNELL SERIES ARTHR; HILTONTAYLOR C, 2000, 2000 INT UNION CONSE; Koh LP, 2004, BIOTROPICA, V36, P272, DOI 10.1111/j.1744-7429.2004.tb00319.x; Nee S, 1997, SCIENCE, V278, P692, DOI 10.1126/science.278.5338.692; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; Price RD, 2000, J PARASITOL, V86, P948, DOI 10.1645/0022-3395(2000)086[0948:PLDUTO]2.0.CO;2; Purvis A, 2000, SCIENCE, V288, P328, DOI 10.1126/science.288.5464.328; STORK NE, 1993, NATURE, V366, P307, DOI 10.1038/366307a0; Thomas JA, 2004, SCIENCE, V303, P1879, DOI 10.1126/science.1095046; WINDSOR DA, 1995, CONSERV BIOL, V9, P1, DOI 10.1046/j.1523-1739.1995.09010001.x	20	375	390	9	247	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2004	305	5690					1632	1634		10.1126/science.1101101	http://dx.doi.org/10.1126/science.1101101			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	854GV	15361627				2022-12-24	WOS:000223891200047
J	Skaar, EP; Humayun, M; Bae, T; DeBord, KL; Schneewind, O				Skaar, EP; Humayun, M; Bae, T; DeBord, KL; Schneewind, O			Iron-source preference of Staphylococcus aureus infections	SCIENCE			English	Article							MODEL HOST; TRANSPORT; PROTEIN; IDENTIFICATION; SIDEROPHORE; VIRULENCE; MEMBRANE; GENES; HEMIN	Although bacteria use different iron compounds in vitro, the possibility that microbes distinguish between these iron sources during infection has hitherto not been examined. We applied stable isotope labeling to detect source-specific iron by mass spectrometry and show that Staphylococcus aureus preferentially imports heme iron over transferrin iron. By combining this approach with computational genome analysis, we identified hts (heme transport system), a gene cluster that promotes preferred heme iron import by S. aureus. Heme iron scavenging by means of hts is required for staphylococcal pathogenesis in animal hosts, indicating that heme iron is the preferred iron source during the initiation of infection.	Univ Chicago, Comm Microbiol, Chicago, IL 60637 USA; Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Schneewind, O (corresponding author), Univ Chicago, Comm Microbiol, 920 E 58th St, Chicago, IL 60637 USA.	oschnee@bsd.uchicago.edu	Humayun, Munir/A-1247-2007	Humayun, Munir/0000-0001-8516-9435; Bae, Taeok/0000-0002-0576-2851	NIAID NIH HHS [AI52474] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052474] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALBUS A, 1991, INFECT IMMUN, V59, P1008, DOI 10.1128/IAI.59.3.1008-1014.1991; ANBAR AD, 2004, FRONTIERS BOULDER, V217, P223; Beard BL, 1999, SCIENCE, V285, P1889, DOI 10.1126/science.285.5435.1889; BERNHEIMER AW, 1968, J BACTERIOL, V96, P487, DOI 10.1128/JB.96.2.487-491.1968; Braun V, 2002, CURR OPIN MICROBIOL, V5, P194, DOI 10.1016/S1369-5274(02)00298-9; Braun V, 2001, INT J MED MICROBIOL, V291, P67, DOI 10.1078/1438-4221-00103; Bullen J. J., 1999, IRON INFECT MOL PHYS; CRICHTON R, 2001, INORGANIC BIOCH IRON, V2; Dale SE, 2004, INFECT IMMUN, V72, P29, DOI 10.1128/IAI.72.1.29-37.2004; Drazek ES, 2000, MOL MICROBIOL, V36, P68, DOI 10.1046/j.1365-2958.2000.01818.x; Escolar L, 1999, J BACTERIOL, V181, P6223, DOI 10.1128/JB.181.20.6223-6229.1999; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Heinrichs JH, 1999, J BACTERIOL, V181, P1436, DOI 10.1128/JB.181.5.1436-1443.1999; Kloek AP, 1996, J MOL EVOL, V43, P101, DOI 10.1007/BF02337354; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; McKenney D, 1999, SCIENCE, V284, P1523, DOI 10.1126/science.284.5419.1523; Morrissey JA, 2000, INFECT IMMUN, V68, P6281, DOI 10.1128/IAI.68.11.6281-6288.2000; Posey JE, 2000, SCIENCE, V288, P1651, DOI 10.1126/science.288.5471.1651; Sebulsky MT, 2000, J BACTERIOL, V182, P4394, DOI 10.1128/JB.182.16.4394-4400.2000; Sifri CD, 2003, INFECT IMMUN, V71, P2208, DOI 10.1128/IAI.71.4.2208-2217.2003; Skaar EP, 2004, J BIOL CHEM, V279, P436, DOI 10.1074/jbc.M307952200; SMITH A, 1979, BIOCHEM J, V182, P47, DOI 10.1042/bj1820047; STOJILJKOVIC I, 1994, MOL MICROBIOL, V13, P719, DOI 10.1111/j.1365-2958.1994.tb00465.x; VONWACHENFELDT C, 1990, J BIOL CHEM, V265, P13939; Walczyk T, 2002, SCIENCE, V295, P2065, DOI 10.1126/science.1069389	26	321	336	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2004	305	5690					1626	1628		10.1126/science.1099930	http://dx.doi.org/10.1126/science.1099930			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	854GV	15361626				2022-12-24	WOS:000223891200045
J	Bowers, S				Bowers, S			COPD is not a death sentence	LANCET			English	Article												sgbowers@fast.net							0	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 4	2004	364	9437					896	896		10.1016/S0140-6736(04)16985-7	http://dx.doi.org/10.1016/S0140-6736(04)16985-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	851KY	15351197				2022-12-24	WOS:000223685200036
J	Blanpain, C; Lowry, WE; Geoghegan, A; Polak, L; Fuchs, E				Blanpain, C; Lowry, WE; Geoghegan, A; Polak, L; Fuchs, E			Self-renewal, multipotency, and the existence of two cell populations within an epithelial stem cell niche	CELL			English	Article							LABEL-RETAINING CELLS; HAIR FOLLICLE; MOUSE EPIDERMIS; IN-VIVO; GROWTH; SKIN; KERATINOCYTE; MULTIPLICATION; MORPHOGENESIS; INDUCTION	In adult skin, each hair follicle contains a reservoir of stem cells (the bulge), which can be mobilized to regenerate the new follicle with each hair cycle and to reepithelialize epidermis during wound repair. Here we report new methods that permit their clonal analyses and engraftment and demonstrate the two defining features of stem cells, namely self-renewal and multipotency. We also show that, within the bulge, there are two distinct populations, one of which maintains basal lamina contact and temporally precedes the other, which is suprabasal and arises only after the start of the first postnatal hair cycle. This spatial distinction endows them with discrete transcriptional programs, but surprisingly, both populations are growth inhibited in the niche but can self-renew in vitro and make epidermis and hair when grafted. These findings suggest that the niche microenvironment imposes intrinsic "stemness" features without restricting the establishment of epithelial polarity and changes in gene expression.	Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016; Blanpain, Cedric/ABD-8392-2021		NIAMS NIH HHS [R01 AR050452-04, AR 050452, AR 31737] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR031737, R01AR050452] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Bennett WR, 2003, DEVELOPMENT, V130, P1079, DOI 10.1242/dev.00333; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; JAHODA CAB, 1984, NATURE, V311, P560, DOI 10.1038/311560a0; Li A, 2004, J CLIN INVEST, V113, P390, DOI 10.1172/JCI.200419140; LICHTI U, 1993, J INVEST DERMATOL, V101, pS124, DOI 10.1111/1523-1747.ep12363165; Lin HF, 2002, NAT REV GENET, V3, P931, DOI 10.1038/nrg952; Martin KH, 2002, SCIENCE, V296, P1652, DOI 10.1126/science.296.5573.1652; Morris RJ, 1999, J INVEST DERMATOL, V112, P470, DOI 10.1046/j.1523-1747.1999.00537.x; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Panteleyev AA, 2001, J CELL SCI, V114, P3419; Poblet E, 2003, J INVEST DERMATOL, V121, P1220, DOI 10.1046/j.1523-1747.2003.12550_2.x; POTTEN CS, 1988, J CELL SCI, P45; POTTEN CS, 1974, CELL TISSUE KINET, V7, P77, DOI 10.1111/j.1365-2184.1974.tb00401.x; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; RHEINWALD JG, 1977, NATURE, V265, P421, DOI 10.1038/265421a0; ROCHAT A, 1994, CELL, V76, P1063, DOI 10.1016/0092-8674(94)90383-2; SEGRE JA, 1995, GENOMICS, V28, P549, DOI 10.1006/geno.1995.1187; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Tani H, 2000, P NATL ACAD SCI USA, V97, P10960, DOI 10.1073/pnas.97.20.10960; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Triel C, 2004, EXP CELL RES, V295, P79, DOI 10.1016/j.yexcr.2003.11.032; TURNBAR T, 2004, SCIENCE, V303, P359; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Vasioukhin V, 2001, CELL, V104, P605, DOI 10.1016/S0092-8674(01)00246-X; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; WEINBERG WC, 1993, J INVEST DERMATOL, V100, P229, DOI 10.1111/1523-1747.ep12468971; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	37	1030	1097	2	91	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 3	2004	118	5					635	648		10.1016/j.cell.2004.08.012	http://dx.doi.org/10.1016/j.cell.2004.08.012			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852BN	15339667	Bronze			2022-12-24	WOS:000223730300013
J	Delprato, A; Merithew, E; Lambright, DG				Delprato, A; Merithew, E; Lambright, DG			Structure, exchange determinants, and family-wide rab specificity of the tandem helical bundle and Vps9 domains of Rabex-5	CELL			English	Article							SMALL GTPASE RAB5; NUCLEOTIDE-EXCHANGE; CRYSTAL-STRUCTURE; SPASTIC PARALYSIS; BINDING PROTEIN; PH DOMAIN; EFFECTOR; EEA1; ACTIVATION; RABAPTIN-5	The Rab5 GTPase, an essential regulator of endocytosis and endosome biogenesis, is activated by guanine-nucleotide exchange factors (GEFs) that contain a Vps9 domain. Here, we show that the catalytic core of the Rab GEF Rabex-5 has a tandem architecture consisting of a Vps9 domain stabilized by an indispensable helical bundle. A family-wide analysis of Rab specificity demonstrates high selectivity for Rab5 subfamily GTPases. Conserved exchange determinants map to a common surface of the Vps9 domain, which recognizes invariant aromatic residues in the switch regions of Rab GTPases and selects for for the Rab5 subfamily by requiring a small nonacidic residue preceding a critical phenylalanine in the switch I region. These and other observations reveal unexpected similarity with the Arf exchange site in the Sec7 domain.	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Lambright, DG (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	david.lambright@umassmed.edu			NIDDK NIH HHS [DK60564] Funding Source: Medline; NIGMS NIH HHS [GM56324] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK060564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056324] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Afar DEH, 1997, IMMUNITY, V6, P773, DOI 10.1016/S1074-7613(00)80452-5; Alexandrov K, 2001, METHOD ENZYMOL, V329, P14; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burd CG, 1996, MOL CELL BIOL, V16, P2369; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; De Renzis S, 2002, NAT CELL BIOL, V4, P124, DOI 10.1038/ncb744; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Devon RS, 2003, CLIN GENET, V64, P210, DOI 10.1034/j.1399-0004.2003.00138.x; Dhaka A, 2003, J NEUROSCI, V23, P748; Esters H, 2001, J MOL BIOL, V310, P141, DOI 10.1006/jmbi.2001.4735; Eymard-Pierre E, 2002, AM J HUM GENET, V71, P518, DOI 10.1086/342359; Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD222, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Gournier H, 1998, EMBO J, V17, P1930, DOI 10.1093/emboj/17.7.1930; Gros-Louis F, 2003, ANN NEUROL, V53, P144, DOI 10.1002/ana.10422; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; Hama H, 1999, J BIOL CHEM, V274, P15284, DOI 10.1074/jbc.274.21.15284; Han LM, 1997, P NATL ACAD SCI USA, V94, P4954, DOI 10.1073/pnas.94.10.4954; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kajiho H, 2003, J CELL SCI, V116, P4159, DOI 10.1242/jcs.00718; Kauppi M, 2002, J CELL SCI, V115, P899; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Lippe R, 2001, MOL BIOL CELL, V12, P2219, DOI 10.1091/mbc.12.7.2219; Macia E, 2001, J BIOL CHEM, V276, P24925, DOI 10.1074/jbc.M103284200; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Mattera R, 2003, EMBO J, V22, P78, DOI 10.1093/emboj/cdg015; McBride HM, 1999, CELL, V98, P377, DOI 10.1016/S0092-8674(00)81966-2; Merithew E, 2003, J BIOL CHEM, V278, P8494, DOI 10.1074/jbc.M211514200; Mesa R, 2001, J CELL SCI, V114, P4041; Mills IG, 1998, CURR BIOL, V8, P881, DOI 10.1016/S0960-9822(07)00351-X; Mossessova E, 2003, MOL CELL, V12, P1403, DOI 10.1016/S1097-2765(03)00475-1; Mossessova E, 1998, CELL, V92, P415, DOI 10.1016/S0092-8674(00)80933-2; Nielsen E, 2000, J CELL BIOL, V151, P601, DOI 10.1083/jcb.151.3.601; Nimnual AS, 1998, SCIENCE, V279, P560, DOI 10.1126/science.279.5350.560; Nuoffer C, 1997, MOL BIOL CELL, V8, P1305, DOI 10.1091/mbc.8.7.1305; Opdam FJM, 2000, EUR J CELL BIOL, V79, P308, DOI 10.1078/S0171-9335(04)70034-5; Otomo A, 2003, HUM MOL GENET, V12, P1671, DOI 10.1093/hmg/ddg184; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Pereira-Leal JB, 2000, J MOL BIOL, V301, P1077, DOI 10.1006/jmbi.2000.4010; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Renault L, 2003, NATURE, V426, P525, DOI 10.1038/nature02197; Rodriguez-Gabin AG, 2001, J NEUROSCI RES, V66, P1149, DOI 10.1002/jnr.1253.abs; Rossman KL, 2003, J BIOL CHEM, V278, P18393, DOI 10.1074/jbc.M300127200; Rossman KL, 2002, EMBO J, V21, P1315, DOI 10.1093/emboj/21.6.1315; Rossman KL, 2002, J BIOL CHEM, V277, P50893, DOI 10.1074/jbc.M208580200; Segev N, 2001, CURR OPIN CELL BIOL, V13, P500, DOI 10.1016/S0955-0674(00)00242-8; Simon I, 1996, J BIOL CHEM, V271, P20470, DOI 10.1074/jbc.271.34.20470; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Soisson SM, 1998, CELL, V95, P259, DOI 10.1016/S0092-8674(00)81756-0; STENMARK H, 1995, CELL, V83, P423, DOI 10.1016/0092-8674(95)90120-5; Tall GG, 2001, DEV CELL, V1, P73, DOI 10.1016/S1534-5807(01)00008-9; Wang Y, 2002, MOL CELL BIOL, V22, P916, DOI 10.1128/MCB.22.3.916-926.2001; Whitehead IP, 1997, BIOCHIM BIOPHYS ACTA, V1332, P1; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Yamanaka K, 2003, P NATL ACAD SCI USA, V100, P16041, DOI 10.1073/pnas.2635267100; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhu ZY, 2001, BIOCHEMISTRY-US, V40, P3027, DOI 10.1021/bi002680o	63	129	133	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 3	2004	118	5					607	617		10.1016/j.cell.2004.08.009	http://dx.doi.org/10.1016/j.cell.2004.08.009			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852BN	15339665	Bronze			2022-12-24	WOS:000223730300011
J	Fyhn, M; Molden, S; Witter, MP; Moser, EI; Moser, MB				Fyhn, M; Molden, S; Witter, MP; Moser, EI; Moser, MB			Spatial representation in the entorhinal cortex	SCIENCE			English	Article							POSITIONAL FIRING PROPERTIES; HEAD-DIRECTION CELLS; FREELY-MOVING RATS; PARAHIPPOCAMPAL REGION; HIPPOCAMPAL-LESIONS; UNIT-ACTIVITY; PLACE CELLS; MEMORY; NEURONS; ORGANIZATION	As the interface between hippocampus and neocortex, the entorhinal cortex is likely to play a pivotal role in memory. To determine how information is represented in this area, we measured spatial modulation of neural activity in layers of medial entorhinal cortex projecting to the hippocampus. Close to the postrhinal-entorhinal border, entorhinal neurons had stable and discrete multipeaked place fields, predicting the rat's location as accurately as place cells in the hippocampus. Precise positional modulation was not observed more ventromedially in the entorhinal cortex or upstream in the postrhinal cortex, suggesting that sensory input is transformed into durable allocentric spatial representations internally in the dorsocaudal medial entorhinal cortex.	Norwegian Univ Sci & Technol, Med Tech Res Ctr, Ctr Biol Memory, N-7489 Trondheim, Norway; Vrije Univ Amsterdam Med Ctr, Dept Anat, Neurosci Res Inst, Amsterdam, Netherlands	Norwegian University of Science & Technology (NTNU); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Moser, EI (corresponding author), Norwegian Univ Sci & Technol, Med Tech Res Ctr, Ctr Biol Memory, N-7489 Trondheim, Norway.	edvard.moser@cbm.ntnu.no						BARNES CA, 1990, PROG BRAIN RES, V83, P287; Bostock E, 1991, Hippocampus, V1, P193, DOI 10.1002/hipo.450010207; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Burwell RD, 1998, NEUROREPORT, V9, P3013, DOI 10.1097/00001756-199809140-00017; Burwell RD, 2003, NEUROSCIENCE, V119, P577, DOI 10.1016/S0306-4522(03)00160-X; Burwell RD, 2000, ANN NY ACAD SCI, V911, P25; Calton JL, 2003, J NEUROSCI, V23, P9719; CHEN LL, 1994, EXP BRAIN RES, V101, P8, DOI 10.1007/BF00243212; Dolorfo CL, 1998, J COMP NEUROL, V398, P49, DOI 10.1002/(SICI)1096-9861(19980817)398:1<49::AID-CNE4>3.0.CO;2-9; Dolorfo CL, 1998, J COMP NEUROL, V398, P25; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Iijima T, 1996, SCIENCE, V272, P1176, DOI 10.1126/science.272.5265.1176; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; JUNG MW, 1994, J NEUROSCI, V14, P7347; Lavenex P, 2000, HIPPOCAMPUS, V10, P420, DOI 10.1002/1098-1063(2000)10:4<420::AID-HIPO8>3.3.CO;2-X; LEE I, 2003, SOC NEUR ABSTR, V91, P11; LEUTGEB S, 2003, SOC NEUR ABSTR, V91, P5; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; MCNAUGHTON BL, 1989, NEUROSCIENCE CONNECT, P1; MOSER E, 1993, J NEUROSCI, V13, P3916; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; Nadel L, 2000, HIPPOCAMPUS, V10, P352, DOI 10.1002/1098-1063(2000)10:4<352::AID-HIPO2>3.3.CO;2-4; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; QUIRK GJ, 1992, J NEUROSCI, V12, P1945; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; TAUBE JS, 1990, J NEUROSCI, V10, P420; van Haeften T, 2003, HIPPOCAMPUS, V13, P943, DOI 10.1002/hipo.10144; vanHaeften T, 1997, J NEUROSCI, V17, P862; Wirth S, 2003, SCIENCE, V300, P1578, DOI 10.1126/science.1084324; WITTER MP, 1989, PROG NEUROBIOL, V33, P161, DOI 10.1016/0301-0082(89)90009-9; Witter MP, 2000, ANN NY ACAD SCI, V911, P1; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4	37	815	843	10	146	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 27	2004	305	5688					1258	1264		10.1126/science.1099901	http://dx.doi.org/10.1126/science.1099901			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850PJ	15333832				2022-12-24	WOS:000223624600032
J	Seckl, MJ; Gillmore, R; Foskett, M; Sebire, NJ; Rees, H; Newlands, ES				Seckl, MJ; Gillmore, R; Foskett, M; Sebire, NJ; Rees, H; Newlands, ES			Routine terminations of pregnancy - should we screen for gestational trophoblastic neoplasia?	LANCET			English	Article							METHOTREXATE; EPIDEMIOLOGY; TUMORS	After termination of pregnancy for non-medical reasons, the products of conception are often not routinely examined for gestational trophoblastic neoplasia. Between 1995 and 2001 we identified 15 women without and 36 women with a pathological diagnosis of gestational trophoblastic neoplasia at the time of their pregnancy termination. Women without a diagnosis were significantly more likely to have subsequent life-threatening complications of gestational trophoblastic neoplasia (four of 15 vs none of 36; p=0.003), and to require surgical intervention (15 of 15 vs one of 36; p<0.0001) and chemotherapy (nine of 15 vs two of 36; p<0.0001). All women should be screened for gestational trophoblastic neoplasia after termination of pregnancy.	Univ London Imperial Coll Sci Technol & Med, Gestat Trophoblast Dis Unit, Dept Med Oncol, London W6 8RF, England	Imperial College London	Seckl, MJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Gestat Trophoblast Dis Unit, Dept Med Oncol, Charing Cross & Hammersmith Hosp Campus,Fulham Pa, London W6 8RF, England.	m.seckl@imperial.co.uk	sebire, neil J/C-4960-2008	Sebire, Neil/0000-0001-5348-9063				JACOBS PA, 1982, BRIT J OBSTET GYNAEC, V89, P258, DOI 10.1111/j.1471-0528.1982.tb04693.x; McNeish IA, 2002, J CLIN ONCOL, V20, P1838, DOI 10.1200/JCO.2002.07.166; Papadopoulos AJ, 2002, J REPROD MED, V47, P460; Rustin GJS, 1996, J CLIN ONCOL, V14, P2769, DOI 10.1200/JCO.1996.14.10.2769; Seckl MJ, 2000, LANCET, V356, P36, DOI 10.1016/S0140-6736(00)02432-6; Steigrad SJ, 2003, BEST PRACT RES CL OB, V17, P837, DOI 10.1016/S1521-6934(03)00049-X; THOMAS J, 2001, NATL AUDIT INDUCED A	7	31	33	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 21	2004	364	9435					705	707		10.1016/S0140-6736(04)16898-0	http://dx.doi.org/10.1016/S0140-6736(04)16898-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	847WO	15325836				2022-12-24	WOS:000223428900033
J	Prescher, JA; Dube, DH; Bertozzi, CR				Prescher, JA; Dube, DH; Bertozzi, CR			Chemical remodelling of cell surfaces in living animals	NATURE			English	Article							SIALIC-ACID; STAUDINGER LIGATION; GLYCOSYLATION; BIOSYNTHESIS; IDENTIFICATION; GLYCOPROTEINS; EXPRESSION; CHEMISTRY; PROTEINS; MOLECULE	Cell surfaces are endowed with biological functionality designed to mediate extracellular communication. The cell-surface repertoire can be expanded to include abiotic functionality through the biosynthetic introduction of unnatural sugars into cellular glycans, a process termed metabolic oligosaccharide engineering(1,2). This technique has been exploited in fundamental studies of glycan-dependent cell-cell and virus-cell interactions(3-5) and also provides an avenue for the chemical remodelling of living cells(6-8). Unique chemical functional groups can be delivered to cell-surface glycans by metabolism of the corresponding unnatural precursor sugars. These functional groups can then undergo covalent reaction with exogenous agents bearing complementary functionality. The exquisite chemical selectivity required of this process is supplied by the Staudinger ligation of azides and phosphines, a reaction that has been performed on cultured cells without detriment to their physiology(7,9). Here we demonstrate that the Staudinger ligation can be executed in living animals, enabling the chemical modification of cells within their native environment. The ability to tag cell-surface glycans in vivo may enable therapeutic targeting and noninvasive imaging of changes in glycosylation during disease progression.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Bertozzi, CR (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	crb@berkeley.edu						Buttner B, 2002, J NEUROSCI, V22, P8869; Charter NW, 2002, J BIOL CHEM, V277, P9255, DOI 10.1074/jbc.M111619200; CODINGTON JF, 1979, BIOCHEMISTRY-US, V18, P2145, DOI 10.1021/bi00578a002; Dube DH, 2003, CURR OPIN CHEM BIOL, V7, P616, DOI 10.1016/j.cbpa.2003.08.006; Fukuda M, 1996, CANCER RES, V56, P2237; Hang HC, 2003, P NATL ACAD SCI USA, V100, P14846, DOI 10.1073/pnas.2335201100; Jurisson SS, 1999, CHEM REV, V99, P2205, DOI 10.1021/cr980435t; Kavarana MJ, 1999, J MED CHEM, V42, P221, DOI 10.1021/jm9708036; KAYSER H, 1992, J BIOL CHEM, V267, P16934; Keppler OT, 2001, GLYCOBIOLOGY, V11, p11R, DOI 10.1093/glycob/11.2.11R; KEPPLER OT, 1995, J BIOL CHEM, V270, P1308, DOI 10.1074/jbc.270.3.1308; Kiick KL, 2002, P NATL ACAD SCI USA, V99, P19, DOI 10.1073/pnas.012583299; Kim YJ, 1997, GLYCOCONJUGATE J, V14, P569, DOI 10.1023/A:1018580324971; Kohn M, 2004, ANGEW CHEM INT EDIT, V43, P3106, DOI 10.1002/anie.200401744; Kolb HC, 2003, DRUG DISCOV TODAY, V8, P1128, DOI 10.1016/S1359-6446(03)02933-7; Luchansky SJ, 2003, METHOD ENZYMOL, V362, P249; LUCHANSKY SJ, IN PRESS BIOCHEMISTR; Mahal LK, 1997, SCIENCE, V276, P1125, DOI 10.1126/science.276.5315.1125; Martin DC, 1999, J CELL BIOL, V146, P881, DOI 10.1083/jcb.146.4.881; Morton CL, 2000, CANCER RES, V60, P4206; Ovaa H, 2003, ANGEW CHEM INT EDIT, V42, P3626, DOI 10.1002/anie.200351314; REICHNER JS, 1988, J BIOL CHEM, V263, P16316; Renkonen J, 2002, AM J PATHOL, V161, P543, DOI 10.1016/S0002-9440(10)64210-1; Saxon E, 2002, J AM CHEM SOC, V124, P14893, DOI 10.1021/ja027748x; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; SELL S, 1990, HUM PATHOL, V21, P1003, DOI 10.1016/0046-8177(90)90250-9; Shaw CF, 1999, CHEM REV, V99, P2589, DOI 10.1021/cr980431o; SOARES ER, 1979, BIOCHEM GENET, V17, P577, DOI 10.1007/BF00502119; Stasche R, 1997, J BIOL CHEM, V272, P24319, DOI 10.1074/jbc.272.39.24319; Vocadlo DJ, 2003, P NATL ACAD SCI USA, V100, P9116, DOI 10.1073/pnas.1632821100	30	551	594	23	260	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2004	430	7002					873	877		10.1038/nature02791	http://dx.doi.org/10.1038/nature02791			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318217				2022-12-24	WOS:000223369800037
J	Zhang, SF; Ma, C; Chalfie, M				Zhang, SF; Ma, C; Chalfie, M			Combinatorial marking of cells and organelles with reconstituted fluorescent proteins	CELL			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; MOTOR-NEURONS; SYNAPTIC-TRANSMISSION; GENE-EXPRESSION; COMPLEMENTATION; IDENTIFICATION; VISUALIZATION; HOMEOPROTEIN; SENSITIVITY	Expression of GFP and other fluorescent proteins depends on cis-regulatory elements. Because these elements rarely direct expression to specific cell types, GFP production cannot always be sufficiently limited. Here we show that reconstitution of GFP, YFP, and CFP previously split into two polypeptides yields fluorescent products when coexpressed in C. elegans. Because this reconstitution involves two components, it can confirm cellular coexpression and identify cells expressing a previously uncharacterized promoter. By choosing promoters whose expression patterns overlap for a single cell type, we can produce animals with fluorescence only in those cells. Furthermore, when one partial GFP polypeptide is fused with a subcellularly localized protein or peptide, this restricted expression leads to the fluorescent marking of cellular components in a subset of cells.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Chalfie, M (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	mc21@columbia.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030997, R37GM030997] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM30997, R37 GM030997] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abedi MR, 1998, NUCLEIC ACIDS RES, V26, P623, DOI 10.1093/nar/26.2.623; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; BRENNER S, 1974, GENETICS, V77, P71; Brons-Poulsen J, 1998, MOL CELL PROBE, V12, P345, DOI 10.1006/mcpr.1998.0187; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHALFIE M, 2004, GREEN FLUORESCENT PR; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; Doi N, 1999, FEBS LETT, V453, P305, DOI 10.1016/S0014-5793(99)00732-2; Du HP, 2001, GENETICS, V158, P197; Ghosh I, 2000, J AM CHEM SOC, V122, P5658, DOI 10.1021/ja994421w; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Lickteig KM, 2001, J NEUROSCI, V21, P2001, DOI 10.1523/JNEUROSCI.21-06-02001.2001; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; MILLER DM, 1995, DEVELOPMENT, V121, P2877; Miller DM, 1999, BIOTECHNIQUES, V26, P914, DOI 10.2144/99265rr01; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Nonet ML, 1998, J NEUROSCI, V18, P70; OKKEMA PG, 1994, DEVELOPMENT, V120, P2175; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Ozawa T, 2000, ANAL CHEM, V72, P5151, DOI 10.1021/ac000617z; Ozawa T, 2001, ANAL CHEM, V73, P5866, DOI 10.1021/ac010717k; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Poyurovsky MV, 2003, MOL CELL, V12, P875, DOI 10.1016/S1097-2765(03)00400-3; Umezawa Y, 2003, CHEM REC, V3, P22, DOI 10.1002/tcr.10049; WAY JC, 1989, GENE DEV, V3, P1823, DOI 10.1101/gad.3.12a.1823; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Winnier AR, 1999, GENE DEV, V13, P2774, DOI 10.1101/gad.13.21.2774; Wu J, 2001, GENE DEV, V15, P789, DOI 10.1101/gad.857401; Zhang Y, 2002, NATURE, V418, P331, DOI 10.1038/nature00891	34	109	169	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 1	2004	119	1					137	+		10.1016/j.cell.2004.09.012	http://dx.doi.org/10.1016/j.cell.2004.09.012			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	859UE	15454087	Bronze			2022-12-24	WOS:000224292600015
J	Falkowski, PG; Davis, CS				Falkowski, PG; Davis, CS			Natural proportions	NATURE			English	Article									Rutgers State Univ, Inst Marine & Coastal Sci, Princeton, NJ 08540 USA; Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA	Rutgers State University New Brunswick; Woods Hole Oceanographic Institution	Falkowski, PG (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, Princeton, NJ 08540 USA.							Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Hedin LO, 2004, P NATL ACAD SCI USA, V101, P10849, DOI 10.1073/pnas.0404222101; Redfield A. C., 1934, P176; Sterner R.W., 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444	4	42	46	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 9	2004	431	7005					131	131		10.1038/431131a	http://dx.doi.org/10.1038/431131a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HI	15356609	Bronze			2022-12-24	WOS:000223746000019
J	Kalisz, S; Vogler, DW; Hanley, KM				Kalisz, S; Vogler, DW; Hanley, KM			Context-dependent autonomous self-fertilization yields reproductive assurance and mixed mating	NATURE			English	Article							INBREEDING DEPRESSION; CROSS-FERTILIZATION; EVOLUTION; PLANTS; POLLINATION; ECOLOGY; SYSTEMS; COST	The evolution of self-fertilization in hermaphrodites is opposed by costs that decrease the value of self progeny relative to that of outcross progeny1-3. However, self-fertilization is common in plants(4); 20% are highly selfing and 33% are intermediate between selfing and outcrossing(5). Darwin(6) proposed an adaptive benefit of self-pollination in providing reproductive assurance when outcrossing is impossible(6-9). Moreover, if outcross pollen receipt is inconsistent within or between years, these conditions likewise favour self-pollination(10), and this can result in a mixture of self and outcross seed production ( mixed mating). Despite wide acceptance, the reproductive assurance hypothesis has lacked the support of complete empirical evidence to show that variable pollination can create both the ecological and genetic conditions favouring self-pollination. We recently showed in Collinsia verna that during periods of infrequent pollinator visits, autonomous self-pollination boosted seed output per flower(11), the key ecological condition. Here we show low inbreeding depression and marker-based estimates of selfing, demonstrating that when the pollination environment in wild populations necessitates reproductive assurance, selfing rates increase. We provide a complete demonstration of reproductive assurance under variable pollination environments and mechanistically link reproductive assurance to intermediate selfing rates through mixed mating.	Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; SUNY Coll Oneonta, Dept Biol, Oneonta, NY 13820 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; State University of New York (SUNY) System	Kalisz, S (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.	kalisz@pitt.edu						BAKER HG, 1955, EVOLUTION, V9, P347, DOI 10.2307/2405656; Barrett SCH, 2002, NAT REV GENET, V3, P274, DOI 10.1038/nrg776; Barrett SCH, 1996, PHILOS T R SOC B, V351, P1271, DOI 10.1098/rstb.1996.0110; Barrett SCH, 2003, PHILOS T R SOC B, V358, P991, DOI 10.1098/rstb.2003.1301; BURD M, 1994, BOT REV, V60, P83, DOI 10.1007/BF02856594; Byers DL, 1999, ANNU REV ECOL SYST, V30, P479, DOI 10.1146/annurev.ecolsys.30.1.479; Cruden R.W., 1989, EVOLUTIONARY ECOLOGY, P171; Darwin C. R., 1876, EFFECTS CROSS SELF F; Fausto JA, 2001, AM J BOT, V88, P1794, DOI 10.2307/3558355; Fisher RA, 1941, ANN EUGENIC, V11, P53, DOI 10.1111/j.1469-1809.1941.tb02272.x; HARDER LD, 1995, NATURE, V373, P512, DOI 10.1038/373512a0; Herlihy CR, 2002, NATURE, V416, P320, DOI 10.1038/416320a; HOLSINGER KE, 1991, TRENDS ECOL EVOL, V6, P307, DOI 10.1016/0169-5347(91)90033-T; HOLSINGER KE, 1991, AM NAT, V138, P606, DOI 10.1086/285237; Holsinger KE, 2000, P NATL ACAD SCI USA, V97, P7037, DOI 10.1073/pnas.97.13.7037; Husband BC, 1996, EVOLUTION, V50, P54, DOI 10.2307/2410780; JARNE P, 1993, ANNU REV ECOL SYST, V24, P441, DOI 10.1146/annurev.es.24.110193.002301; Johnston MO, 1998, GENETICA, V102-3, P267, DOI 10.1023/A:1017039010191; KALISZ S, 1989, EVOLUTION, V43, P1263, DOI 10.1111/j.1558-5646.1989.tb02573.x; Kalisz S, 2003, ECOLOGY, V84, P2928, DOI 10.1890/02-0519; Kalisz S, 1999, AM J BOT, V86, P1239, DOI 10.2307/2656771; LANDE R, 1985, EVOLUTION, V39, P24, DOI 10.1111/j.1558-5646.1985.tb04077.x; LLOYD DG, 1992, INT J PLANT SCI, V153, P370, DOI 10.1086/297041; LLOYD DG, 1992, INT J PLANT SCI, V153, P358, DOI 10.1086/297040; Ritland K., MULTILOCUS MATING SY; Schoen DJ, 1996, PHILOS T R SOC B, V351, P1281, DOI 10.1098/rstb.1996.0111; SCHOEN DJ, 1992, INT J PLANT SCI, V153, P381, DOI 10.1086/297042; SCHOEN DJ, 1991, EVOLUTION, V45, P1651, DOI [10.1111/j.1558-5646.1991.tb02670.x, 10.2307/2409786]; Stebbins G.L., 1974, FLOWERING PLANTS EVO, DOI 10.4159/harvard.9780674864856; Vogler DW, 2001, EVOLUTION, V55, P202, DOI 10.1111/j.0014-3820.2001.tb01285.x	30	327	349	2	92	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 19	2004	430	7002					884	887		10.1038/nature02776	http://dx.doi.org/10.1038/nature02776			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318220				2022-12-24	WOS:000223369800040
J	Daley, GQ				Daley, GQ			Missed opportunities in embryonic stem-cell research	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Childrens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Daley, GQ (corresponding author), Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.							COOK G, 2004, BOSTON GLOBE    0523, pA14; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330	2	27	30	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 12	2004	351	7					627	628		10.1056/NEJMp048200	http://dx.doi.org/10.1056/NEJMp048200			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845FZ	15302910				2022-12-24	WOS:000223225500001
J	Hedwig, B; Poulet, JFA				Hedwig, B; Poulet, JFA			Complex auditory behaviour emerges from simple reactive steering	NATURE			English	Article							PATTERN-RECOGNITION; TEMPORAL PATTERN; FEMALE CRICKETS; CALLING SONG; ACOUSTIC COMMUNICATION; PHONOTACTIC BEHAVIOR; GRYLLUS-BIMACULATUS; FLYING CRICKETS; GRYLLIDAE; SYSTEM	The recognition and localization of sound signals is fundamental to acoustic communication(1,2). Complex neural mechanisms are thought to underlie the processing of species-specific sound patterns even in animals with simple auditory pathways(3,4). In female crickets, which orient towards the male's calling song, current models propose pattern recognition mechanisms based on the temporal structure of the song(5-7). Furthermore, it is thought that localization is achieved by comparing the output of the left and right recognition networks, which then directs the female to the pattern that most closely resembles the species-specific song(8-10). Here we show, using a highly sensitive method for measuring the movements of female crickets, that when walking and flying each sound pulse of the communication signal releases a rapid steering response. Thus auditory orientation emerges from reactive motor responses to individual sound pulses. Although the reactive motor responses are not based on the song structure, a pattern recognition process may modulate the gain of the responses on a longer timescale. These findings are relevant to concepts of insect auditory behaviour and to the development of biologically inspired robots performing cricket-like auditory orientation(11-13).	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge	Hedwig, B (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	bh202@cam.ac.uk; jfap2@cam.ac.uk		Poulet, James/0000-0003-0296-5415	Biotechnology and Biological Sciences Research Council [S19133] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		ARKIN RC, 1998, BEHAV BASED ROBOTICS, P24302; Balakrishnan R, 2001, J COMP PHYSIOL A, V187, P255, DOI 10.1007/s003590100197; CADE WH, 1979, CAN ENTOMOL, V111, P741, DOI 10.4039/Ent111741-6; DOHERTY JA, 1985, J EXP BIOL, V114, P17; DOHERTY JA, 1991, J COMP PHYSIOL A, V168, P213, DOI 10.1007/BF00218413; GERHARD HC, 2002, ACOUSTIC COMMUNICATI, P24302; Hedwig B, 2000, J NEUROSCI METH, V100, P165, DOI 10.1016/S0165-0270(00)00255-7; Hennig RM, 2003, J COMP PHYSIOL A, V189, P589, DOI 10.1007/s00359-003-0438-7; HOY RR, 1978, FED PROC, V37, P2316; Huber F., 1990, Advances in the Study of Behavior, V19, P299, DOI 10.1016/S0065-3454(08)60206-5; MOISEFF A, 1978, P NATL ACAD SCI USA, V75, P4052, DOI 10.1073/pnas.75.8.4052; MURPHEY RK, 1972, J EXP BIOL, V56, P335; Nabatiyan A, 2003, J NEUROPHYSIOL, V90, P2484, DOI 10.1152/jn.00259.2003; Pollack G, 2000, CURR OPIN NEUROBIOL, V10, P763, DOI 10.1016/S0959-4388(00)00161-6; POLLACK GS, 1986, J COMP PHYSIOL A, V158, P549, DOI 10.1007/BF00603799; Pollack GS, 2001, CURR OPIN NEUROBIOL, V11, P734, DOI 10.1016/S0959-4388(01)00277-X; POLLACK GS, 1981, J INSECT PHYSIOL, V27, P41, DOI 10.1016/0022-1910(81)90030-5; POPOV AV, 1977, J COMP PHYSIOL, V119, P111, DOI 10.1007/BF00655876; Schildberger K., 1989, P423; SCHILDBERGER K, 1984, J COMP PHYSIOL, V155, P171, DOI 10.1007/BF00612635; SCHMITZ B, 1982, J COMP PHYSIOL, V148, P431, DOI 10.1007/BF00619782; STABEL J, 1989, J COMP PHYSIOL A, V165, P165, DOI 10.1007/BF00619191; ULAGARAJ SM, 1973, SCIENCE, V182, P1278, DOI 10.1126/science.182.4118.1278; VONHELVERSEN D, 1995, J COMP PHYSIOL A, V177, P767, DOI 10.1007/BF00187635; Webb B, 2002, NATURE, V417, P359, DOI 10.1038/417359a; Webb B, 2000, BIOL CYBERN, V82, P247, DOI 10.1007/s004220050024; WEBER T, 1988, J COMP PHYSIOL A, V163, P13, DOI 10.1007/BF00611992; WEBER T, 1981, J COMP PHYSIOL, V141, P215, DOI 10.1007/BF01342668; Weber T., 1989, P310; WEBSTER DB, 1992, EVOLUTIONARY BIOL HE, P24302	30	84	85	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2004	430	7001					781	785		10.1038/nature02787	http://dx.doi.org/10.1038/nature02787			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306810				2022-12-24	WOS:000223233600042
J	Roth, M; Johnson, PRA; Borger, P; Bihl, MP; Rudiger, JJ; King, GG; Ge, Q; Hostettler, K; Burgess, JK; Black, JL; Tamm, M				Roth, M; Johnson, PRA; Borger, P; Bihl, MP; Rudiger, JJ; King, GG; Ge, Q; Hostettler, K; Burgess, JK; Black, JL; Tamm, M			Dysfunctional interaction of C/EBP alpha and the glucocorticoid receptor in asthmatic bronchial smooth-muscle cells	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; HUMAN LUNG FIBROBLASTS; RAT HEPATOMA-CELLS; NF-KAPPA-B; EPITHELIAL-CELLS; BETA ISOFORMS; IN-VIVO; PROLIFERATION; EXPRESSION; INHIBITION	BACKGROUND: Increased proliferation of bronchial smooth-muscle cells may lead to increased muscle mass in the airways of patients with asthma. The antiproliferative effect of glucocorticoids in bronchial smooth-muscle cells in subjects without asthma is mediated by a complex of the glucocorticoid receptor and the CCAAT/enhancer binding protein (alpha) (C/EBP(alpha)). We examined the signaling pathway controlling the inhibitory effect of glucocorticoids on cell proliferation and interleukin-6 synthesis in bronchial smooth-muscle cells of subjects with asthma and those without asthma. METHODS: Lines of bronchial smooth-muscle cells were established from cells from 20 subjects with asthma, 8 subjects with emphysema, and 26 control subjects. Cell proliferation was determined by means of cell counts and [(sup 3)H]thymidine incorporation. Signal transduction was studied by means of an electrophoretic DNA mobility-shift assay, a supershift electrophoretic-mobility assay, immunoblotting, use of C/EBP(alpha) antisense oligonucleotides, and use of a human C/EBP(alpha) expression vector. Interleukin-6 release was determined by means of an enzyme-linked immunosorbent assay. RESULTS: Glucocorticoids activated the glucocorticoid receptor and inhibited serum-induced secretion of interleukin-6 in bronchial smooth-muscle cells from both subjects with asthma and those without asthma; however, glucocorticoids inhibited proliferation only in bronchial smooth-muscle cells from subjects without asthma. C/EBP(alpha) protein was detected by immunoblotting in all bronchial smooth-muscle cells from subjects without asthma but not in those with asthma, whereas the protein was expressed in lymphocytes from both groups of subjects. C/EBP(alpha) antisense oligonucleotides or the glucocorticoid-receptor inhibitor mifepristone reversed the antiproliferative effect of glucocorticoids in bronchial smooth-muscle cells from subjects without asthma. When bronchial smooth-muscle cells from subjects with asthma were transiently transfected with an expression vector for human C/EBP(alpha), two forms of the protein were expressed, and subsequent administration of glucocorticoids inhibited cell proliferation. CONCLUSIONS: We hypothesize that a cell-type-specific absence of C/EBP(alpha) is responsible for the enhanced proliferation of bronchial smooth-muscle cells derived from subjects with asthma and that it explains the failure of glucocorticoids to inhibit proliferation in vitro.	Univ Sydney, Dept Pharmacol, Sydney, NSW 2006, Australia; Univ Sydney, Woolcock Inst Med Res, Sydney, NSW 2006, Australia; Univ Basel Hosp, Dept Res, CH-4031 Basel, Switzerland; Univ Basel Hosp, Dept Internal Med, CH-4031 Basel, Switzerland	University of Sydney; University of Sydney; Woolcock Institute of Medical Research; University of Basel; University of Basel	Roth, M (corresponding author), Univ Sydney, Dept Pharmacol, Sydney, NSW 2006, Australia.		Burgess, Janette K/A-3597-2010; Ge, Qi/D-3988-2013; Burgess, Janette/M-7117-2019; Roth, Michael/H-8657-2019; Black, Judith L/C-6559-2008	Roth, Michael/0000-0002-8139-2821; Hostettler, Katrin/0000-0001-8118-7441; Burgess, Janette/0000-0001-9868-9966				Adcock IM, 1996, AM J RESP CRIT CARE, V154, P771, DOI 10.1164/ajrccm.154.3.8810618; Adcock IM, 2001, IMMUNOL CELL BIOL, V79, P376, DOI 10.1046/j.1440-1711.2001.01025.x; Bellia V, 2003, CHEST, V123, P1066, DOI 10.1378/chest.123.4.1066; Biola A, 2000, FEBS LETT, V487, P229, DOI 10.1016/S0014-5793(00)02297-3; Cha HH, 1998, J BIOL CHEM, V273, P1998, DOI 10.1074/jbc.273.4.1998; CORRIGAN CJ, 1991, AM REV RESPIR DIS, V144, P1016, DOI 10.1164/ajrccm/144.5.1016; Cram EJ, 1998, J BIOL CHEM, V273, P2008, DOI 10.1074/jbc.273.4.2008; DEMOLY P, 1994, AM J RESP CRIT CARE, V150, P214, DOI 10.1164/ajrccm.150.1.7912988; Eaton EM, 2001, J CELL PHYSIOL, V189, P91, DOI 10.1002/jcp.1139; EATON EM, 2002, J CELL PHYSL, V190, P131; Eickelberg O, 1999, J BIOL CHEM, V274, P1005, DOI 10.1074/jbc.274.2.1005; ELDEIRY WS, 1995, CANCER RES, V55, P2910; Fernandes D, 1999, AM J RESP CELL MOL, V21, P77, DOI 10.1165/ajrcmb.21.1.3396; Gagliardo R, 2000, AM J RESP CRIT CARE, V162, P7, DOI 10.1164/ajrccm.162.1.9911032; Gotoh T, 1997, J BIOL CHEM, V272, P3694, DOI 10.1074/jbc.272.6.3694; Gougat C, 2002, J MOL MED-JMM, V80, P309, DOI 10.1007/s00109-001-0302-6; Hirst SJ, 1998, AM J RESP CRIT CARE, V158, pS201, DOI 10.1164/ajrccm.158.supplement_2.13tac190; Jeffery PK, 2001, AM J RESP CRIT CARE, V164, pS28, DOI 10.1164/ajrccm.164.supplement_2.2106061; JEFFERY PK, 1994, AM J RESP CRIT CARE, V150, pS6, DOI 10.1164/ajrccm/150.5_Pt_2.S6; Johnson PRA, 2001, AM J RESP CRIT CARE, V164, P474, DOI 10.1164/ajrccm.164.3.2010109; Korn SH, 2001, EUR RESPIR J, V17, P1070, DOI 10.1183/09031936.01.00073301; LANE SJ, 1994, AM J RESP CELL MOL, V11, P42, DOI 10.1165/ajrcmb.11.1.8018337; O'Rourke JP, 1999, BIOCHEM BIOPH RES CO, V262, P696, DOI 10.1006/bbrc.1999.1256; Pang LH, 2000, AM J RESP CELL MOL, V23, P79, DOI 10.1165/ajrcmb.23.1.3985; Parkin SE, 2002, J BIOL CHEM, V277, P23563, DOI 10.1074/jbc.M202184200; Paschen W, 1998, MOL BRAIN RES, V60, P115, DOI 10.1016/S0169-328X(98)00180-6; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Ramos RA, 1999, FASEB J, V13, P169, DOI 10.1096/fasebj.13.1.169; Roth M, 2002, LANCET, V360, P1293, DOI 10.1016/S0140-6736(02)11319-5; Rudiger JJ, 2002, FASEB J, V16, P177, DOI 10.1096/fj.01-0226com; Sousa AR, 2000, J ALLERGY CLIN IMMUN, V105, P943, DOI 10.1067/mai.2000.106486; Stewart AG, 1995, BRIT J PHARMACOL, V116, P3219, DOI 10.1111/j.1476-5381.1995.tb15127.x; Stocklin E, 1996, NATURE, V383, P726, DOI 10.1038/383726a0; Sutherland ER, 2003, J ALLERGY CLIN IMMUN, V112, P819, DOI 10.1016/S0091-6749(03)02011-6; TIMICHENKO NA, 1996, GENE DEV, V10, P804; TIMICHENKO NA, 1997, MOL CELL BIOL, V17, P7353; TSAI MJ, 1994, ANNU REV BIOCHEM, V63, P451, DOI 10.1146/annurev.biochem.63.1.451; van der Velden VHJ, 1998, MEDIAT INFLAMM, V7, P229, DOI 10.1080/09629359890910; Wilson SJ, 2001, AM J RESP CRIT CARE, V164, P1047, DOI 10.1164/ajrccm.164.6.2010045; Zhang ZX, 1997, J BIOL CHEM, V272, P30607, DOI 10.1074/jbc.272.49.30607; ZITNIK RJ, 1994, AM J RESP CELL MOL, V10, P643, DOI 10.1165/ajrcmb.10.6.7516173	41	209	217	0	3	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 5	2004	351	6					560	574		10.1056/NEJMoa021660	http://dx.doi.org/10.1056/NEJMoa021660			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843HS	15295049				2022-12-24	WOS:000223069900009
J	Black, BE; Foltz, DR; Chakravarthy, S; Luger, K; Woods, VL; Cleveland, DW				Black, BE; Foltz, DR; Chakravarthy, S; Luger, K; Woods, VL; Cleveland, DW			Structural determinants for generating centromeric chromatin	NATURE			English	Article							NUCLEOSOME CORE PARTICLE; CENP-A; PROTEIN; DNA; ORGANIZATION; NONDISJUNCTION; KINETOCHORES; CHROMOSOMES; ACTIVATION; DOMAIN	Mammalian centromeres are not defined by a consensus DNA sequence. In all eukaryotes a hallmark of functional centromeres - both normal ones and those formed aberrantly at atypical loci - is the accumulation of centromere protein A (CENP-A), a histone variant that replaces H3 in centromeric nucleosomes(1-7). Here we show using deuterium exchange/mass spectrometry coupled with hydrodynamic measures that CENP-A and histone H4 form sub-nucleosomal tetramers that are more compact and conformationally more rigid than the corresponding tetramers of histones H3 and H4. Substitution into histone H3 of the domain of CENP-A responsible for compaction is sufficient to direct it to centromeres. Thus, the centromere-targeting domain of CENP-A confers a unique structural rigidity to the nucleosomes into which it assembles, and is likely to have a role in maintaining centromere identity.	Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Colorado State University	Cleveland, DW (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	vwoods@ucsd.edu; dcleveland@ucsd.edu	Cleveland, Don/AAN-9783-2021	Foltz, Daniel/0000-0001-7423-6188; SCHNIZER-LUGER, KAROLINE/0000-0001-5136-5331; Cleveland, Don/0000-0002-1934-3682				Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Blower MD, 2002, DEV CELL, V2, P319, DOI 10.1016/S1534-5807(02)00135-1; Blower MD, 2001, NAT CELL BIOL, V3, P730, DOI 10.1038/35087045; Buchwitz BJ, 1999, NATURE, V401, P547, DOI 10.1038/44062; Choo KHA, 2001, DEV CELL, V1, P165, DOI 10.1016/S1534-5807(01)00028-4; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Depinet TW, 1997, HUM MOL GENET, V6, P1195, DOI 10.1093/hmg/6.8.1195; duSart D, 1997, NAT GENET, V16, P144; EARNSHAW WC, 1985, CHROMOSOMA, V91, P313, DOI 10.1007/BF00328227; EARNSHAW WC, 1987, J CELL BIOL, V104, P817, DOI 10.1083/jcb.104.4.817; EICKBUSH TH, 1978, BIOCHEMISTRY-US, V17, P4955, DOI 10.1021/bi00616a016; Glowczewski L, 2000, MOL CELL BIOL, V20, P5700, DOI 10.1128/MCB.20.15.5700-5711.2000; Goshima G, 2003, J CELL BIOL, V160, P25, DOI 10.1083/jcb.200210005; Hamuro Y, 2003, J MOL BIOL, V327, P1065, DOI 10.1016/S0022-2836(03)00234-1; Haushalter KA, 2003, NAT REV MOL CELL BIO, V4, P613, DOI 10.1038/nrm1177; Hoofnagle AN, 2003, ANNU REV BIOPH BIOM, V32, P1, DOI 10.1146/annurev.biophys.32.110601.142417; Howman EV, 2000, P NATL ACAD SCI USA, V97, P1148, DOI 10.1073/pnas.97.3.1148; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Ohzeki J, 2002, J CELL BIOL, V159, P765, DOI 10.1083/jcb.200207112; PALMER DK, 1985, MOL CELL BIOL, V5, P173, DOI 10.1128/MCB.5.1.173; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Rudd MK, 2003, MOL CELL BIOL, V23, P7689, DOI 10.1128/MCB.23.21.7689-7697.2003; Schueler MG, 2001, SCIENCE, V294, P109, DOI 10.1126/science.1065042; Shelby RD, 1997, J CELL BIOL, V136, P501, DOI 10.1083/jcb.136.3.501; Shelby RD, 2000, J CELL BIOL, V151, P1113, DOI 10.1083/jcb.151.5.1113; STOLER S, 1995, GENE DEV, V9, P573, DOI 10.1101/gad.9.5.573; Sullivan BA, 2001, NAT REV GENET, V2, P584, DOI 10.1038/35084512; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Vermaak D, 2002, MOL CELL BIOL, V22, P7553, DOI 10.1128/MCB.22.21.7553-7561.2002	30	322	340	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2004	430	6999					578	582		10.1038/nature02766	http://dx.doi.org/10.1038/nature02766			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841QI	15282608				2022-12-24	WOS:000222946100052
J	Kassar-Duchossoy, L; Gayraud-Morel, B; Gomes, D; Rocancourt, D; Buckingham, M; Shinin, V; Tajbakhsh, S				Kassar-Duchossoy, L; Gayraud-Morel, B; Gomes, D; Rocancourt, D; Buckingham, M; Shinin, V; Tajbakhsh, S			Mrf4 determines skeletal muscle identity in Myf5 : Myod double-mutant mice	NATURE			English	Article							PROGENITOR CELLS; GENE-EXPRESSION; MYF-5; MYOD; MOUSE; SPECIFICATION; ACTIVATION; DISRUPTION; MYOGENESIS; MARKER	In vertebrates, skeletal muscle is a model for the acquisition of cell fate from stem cells(1). Two determination factors of the basic helix - loop - helixmyogenic regulatory factor (MRF) family, Myf5 and Myod, are thought to direct this transition because double-mutant mice totally lack skeletal muscle fibres and myoblasts(2-4). In the absence of these factors, progenitor cells remain multipotent and can change their fate(5,6). Gene targeting studies have revealed hierarchical relationships between these and the other MRF genes, Mrf4 and myogenin, where the latter are regarded as differentiation genes(7). Here we show, using an allelic series of three Myf5 mutants that differentially affect the expression of the genetically linked Mrf4 gene, that skeletal muscle is present in the new Myf5: Myod double- null mice only when Mrf4 expression is not compromised. This finding contradicts the widely held view thatmyogenic identity is conferred solely byMyf5 and Myod, and identifies Mrf4 as a determination gene. We revise the epistatic relationship of the MRFs, in which both Myf5 and Mrf4 act upstream of Myod to direct embryonic multipotent cells into the myogenic lineage.	CNRS, URA 2578, Dept Dev Biol, F-75724 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Tajbakhsh, S (corresponding author), CNRS, URA 2578, Dept Dev Biol, 25 Rue Dr Roux, F-75724 Paris 15, France.	shaht@pasteur.fr		Gayraud-Morel, Barbara/0000-0002-1168-8504; Shinin, Vasily/0000-0002-4285-6515				Bergstrom DA, 2001, MOL CELL BIOL, V21, P2404, DOI 10.1128/MCB.21.7.2404-2412.2001; BOBER E, 1991, J CELL BIOL, V113, P1255, DOI 10.1083/jcb.113.6.1255; BRAUN T, 1992, CELL, V71, P369, DOI 10.1016/0092-8674(92)90507-9; Carvajal JJ, 2001, DEVELOPMENT, V128, P1857; Daubas P, 2000, DEVELOPMENT, V127, P319; Hadchouel J, 2000, DEVELOPMENT, V127, P4455; Kablar B, 2003, DEV BIOL, V258, P307, DOI 10.1016/S0012-1606(03)00139-8; Kablar B, 1997, DEVELOPMENT, V124, P4729; Kablar B, 1999, DEV BIOL, V206, P219, DOI 10.1006/dbio.1998.9126; Kaul A, 2000, CELL, V102, P17, DOI 10.1016/S0092-8674(00)00006-4; Kress C, 1998, MAMM GENOME, V9, P998, DOI 10.1007/s003359900914; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Lu JR, 2002, SCIENCE, V298, P2378, DOI 10.1126/science.1078273; Maroto M, 1997, CELL, V89, P139, DOI 10.1016/S0092-8674(00)80190-7; Moran JL, 1999, NATURE, V399, P742, DOI 10.1038/21560; NABESHIMA Y, 1993, NATURE, V364, P532, DOI 10.1038/364532a0; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; Pham CTN, 1996, P NATL ACAD SCI USA, V93, P13090, DOI 10.1073/pnas.93.23.13090; Rawls A, 1998, DEVELOPMENT, V125, P2349; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; Summerbell D, 2002, MECH DEVELOP, V117, P331, DOI 10.1016/S0925-4773(02)00208-3; Tajbakhsh S, 2000, CURR TOP DEV BIOL, V48, P225; Tajbakhsh S, 1995, DEVELOPMENT, V121, P4077; Tajbakhsh S, 2003, CURR OPIN GENET DEV, V13, P413, DOI 10.1016/S0959-437X(03)00090-X; Tajbakhsh S, 1996, NATURE, V384, P266, DOI 10.1038/384266a0; Tajbakhsh S, 1997, CELL, V89, P127, DOI 10.1016/S0092-8674(00)80189-0; Tallquist MD, 2000, DEVELOPMENT, V127, P5059; Wang YK, 1997, DEVELOPMENT, V124, P2507; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704	29	456	484	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 23	2004	431	7007					466	471		10.1038/nature02876	http://dx.doi.org/10.1038/nature02876			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15386014				2022-12-24	WOS:000224000500044
J	Mori, M; Abegg, MH; Gahwiler, BH; Gerber, U				Mori, M; Abegg, MH; Gahwiler, BH; Gerber, U			A frequency-dependent switch from inhibition to excitation in a hippocampal unitary circuit	NATURE			English	Article							MOSSY FIBER SYNAPSES; RAT HIPPOCAMPUS; SLICE CULTURES; SYNAPTIC CONNECTIONS; PYRAMIDAL CELLS; CA3 NEURONS; ORGANIZATION; CONDUCTANCE; DEPRESSION; INVITRO	The hippocampus, a brain structure essential for memory and cognition, is classically represented as a trisynaptic excitatory circuit. Recent findings challenge this view, particularly with regard to the mossy fibre input to CA3, the second synapse in the trisynaptic pathway(1). Thus, the powerful mossy fibre input to CA3 pyramidal cells might mediate both synaptic excitation and inhibition(2,3). Here we show, by recording from connected cell pairs in rat entorhinal - hippocampal slice cultures, that single action potentials in a dentate granule cell evoke a net inhibitory signal in a pyramidal cell. The hyperpolarization is due to disynaptic feedforward inhibition, which overwhelms monosynaptic excitation. Interestingly, this net inhibitory synaptic response changes to an excitatory signal when the frequency of presynaptic action potentials increases. The process responsible for this switch involves the facilitation of monosynaptic excitatory transmission coupled with rapid depression of inhibitory circuits. This ability to immediately switch the polarity of synaptic responses constitutes a novel synaptic mechanism, which might be crucial to the state-dependent processing of information in associative hippocampal networks.	Univ Zurich, Brain Res Inst, CH-8057 Zurich, Switzerland	University of Zurich	Mori, M (corresponding author), Univ Zurich, Brain Res Inst, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	mori@hifo.unizh.ch						Acsady L, 1998, J NEUROSCI, V18, P3386; Bischofberger J, 2002, TRENDS NEUROSCI, V25, P600, DOI 10.1016/S0166-2236(02)02259-2; BROWN TH, 1983, J NEUROPHYSIOL, V50, P487, DOI 10.1152/jn.1983.50.2.487; CHICUREL ME, 1992, J COMP NEUROL, V325, P169, DOI 10.1002/cne.903250204; DEBANNE D, 1995, J NEUROPHYSIOL, V73, P1282, DOI 10.1152/jn.1995.73.3.1282; Debanne D, 1997, NATURE, V389, P286, DOI 10.1038/38502; Feldmeyer D, 1999, J PHYSIOL-LONDON, V521, P169, DOI 10.1111/j.1469-7793.1999.00169.x; FROTSCHER M, 1988, NEUROSCIENCE, V24, P541, DOI 10.1016/0306-4522(88)90348-X; FROTSCHER M, 1989, EXP BRAIN RES, V75, P441; Gahwiler BH, 1998, CULTURING NERVE CELL, P461; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; Hallermann S, 2003, P NATL ACAD SCI USA, V100, P8975, DOI 10.1073/pnas.1432836100; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; JUNG MW, 1993, HIPPOCAMPUS, V3, P165, DOI 10.1002/hipo.450030209; Kobayashi K, 2004, NEURON, V41, P445, DOI 10.1016/S0896-6273(03)00873-0; Liang Y, 2002, J NEUROPHYSIOL, V87, P1132, DOI 10.1152/jn.00661.2001; Llano I, 2000, NAT NEUROSCI, V3, P1256, DOI 10.1038/81781; MILES R, 1990, J PHYSIOL-LONDON, V428, P61, DOI 10.1113/jphysiol.1990.sp018200; MILES R, 1986, J PHYSIOL-LONDON, V373, P397, DOI 10.1113/jphysiol.1986.sp016055; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; SCHWARTZKROIN PA, 1990, PROG BRAIN RES, V83, P269; SIEGEL SJ, 1994, P NATL ACAD SCI USA, V91, P564, DOI 10.1073/pnas.91.2.564; Spruston N, 1997, J COMP NEUROL, V385, P427; THOMPSON SM, 1989, J NEUROPHYSIOL, V61, P501, DOI 10.1152/jn.1989.61.3.501; Varela JA, 1999, J NEUROSCI, V19, P4293; Walker MC, 2001, NEURON, V29, P703, DOI 10.1016/S0896-6273(01)00245-8; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180; ZIMMER J, 1984, J COMP NEUROL, V228, P432, DOI 10.1002/cne.902280310	30	138	139	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 23	2004	431	7007					453	456		10.1038/nature02854	http://dx.doi.org/10.1038/nature02854			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15386013				2022-12-24	WOS:000224000500041
J	Rauch, EM; Bar-Yam, Y				Rauch, EM; Bar-Yam, Y			Theory predicts the uneven distribution of genetic diversity within species	NATURE			English	Article							GEOGRAPHIC BARRIERS; BIODIVERSITY; POPULATIONS; GENEALOGIES; COALESCENT; DISPERSAL; HOTSPOTS; SIZE	Global efforts to conserve species have been strongly influenced by the heterogeneous distribution of species diversity across the Earth. This is manifest in conservation efforts focused on diversity hotspots(1-3). The conservation of genetic diversity within an individual species(4,5) is an important factor in its survival in the face of environmental changes and disease(6,7). Here we show that diversity within species is also distributed unevenly. Using simple genealogical models, we show that genetic distinctiveness has a scale-free power law distribution. This property implies that a disproportionate fraction of the diversity is concentrated in small sub-populations, even when the population is well-mixed. Small groups are of such importance to overall population diversity that even without extrinsic perturbations, there are large fluctuations in diversity owing to extinctions of these small groups. We also show that diversity can be geographically non-uniform potentially including sharp boundaries between distantly related organisms - without extrinsic causes such as barriers to gene flow or past migration events. We obtained these results by studying the fundamental scaling properties of genealogical trees. Our theoretical results agree with field data from global samples of Pseudomonas bacteria. Contrary to previous studies(8), our results imply that diversity loss owing to severe extinction events is high, and focusing conservation efforts on highly distinctive groups can save much of the diversity.	MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; New England Complex Syst Inst, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT)	Rauch, EM (corresponding author), MIT, Comp Sci & Artificial Intelligence Lab, 32 Vassar St, Cambridge, MA 02139 USA.	rauch@necsi.org						Amos W, 2001, HEREDITY, V87, P257, DOI 10.1046/j.1365-2540.2001.00940.x; Bar-Yam Y, 2004, COMPLEXITY, V9, P15, DOI 10.1002/cplx.20029; BARTON NH, 1995, PHILOS T ROY SOC B, V349, P49, DOI 10.1098/rstb.1995.0090; Cann RL, 2001, SCIENCE, V291, P1742, DOI 10.1126/science.1058948; Cho JC, 2000, APPL ENVIRON MICROB, V66, P5448, DOI 10.1128/AEM.66.12.5448-5456.2000; Crozier RH, 1997, ANNU REV ECOL SYST, V28, P243, DOI 10.1146/annurev.ecolsys.28.1.243; EHRLICH PR, 1991, SCIENCE, V253, P758, DOI 10.1126/science.253.5021.758; FAITH DP, 1994, BIOL CONSERV, V68, P69, DOI 10.1016/0006-3207(94)90548-7; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Fisher R., 1930, P ROY SOC EDINB, V50, P205; Frankham R, 1999, ANIM CONSERV, V2, P255, DOI 10.1111/j.1469-1795.1999.tb00071.x; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Irwin DE, 2002, EVOLUTION, V56, P2383; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nee S, 1997, SCIENCE, V278, P692, DOI 10.1126/science.278.5338.692; Nei M, 1987, MOL EVOLUTIONARY GEN; Notohara M, 2001, J APPL PROBAB, V38, P1; PRENDERGAST JR, 1993, NATURE, V365, P335, DOI 10.1038/365335a0; Wakeley J, 2003, MOL BIOL EVOL, V20, P208, DOI 10.1093/molbev/msg024; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; WATTERSON GA, 1982, ADV APPL PROBAB, V14, P206, DOI 10.2307/1426517; Whitaker RJ, 2003, SCIENCE, V301, P976, DOI 10.1126/science.1086909; Wilkins JF, 2002, GENETICS, V161, P873; Willis KJ, 2000, SCIENCE, V287, P1406, DOI 10.1126/science.287.5457.1406; Wright S, 1943, GENETICS, V28, P114	28	44	45	0	37	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 23	2004	431	7007					449	452		10.1038/nature02745	http://dx.doi.org/10.1038/nature02745			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15386012				2022-12-24	WOS:000224000500040
J	Rolett, B; Diamond, J				Rolett, B; Diamond, J			Environmental predictors of pre-European deforestation on Pacific islands	NATURE			English	Article								Some Pacific island societies, such as those of Easter Island and Mangareva, inadvertently contributed to their own collapse by causing massive deforestation(1-7). Others retained forest cover and survived(3,8,9). How can those fateful differences be explained? Although the answers undoubtedly involve both different cultural responses of peoples and different susceptibilities of environments, how can one determine which environmental factors predispose towards deforestation and which towards replacement of native trees with useful introduced tree species? Here we code European-contact conditions and nine environmental variables for 81 sites on 69 Pacific islands from Yap in the west to Easter in the east, and from Hawaii in the north to New Zealand in the south. We thereby detect statistical decreases in deforestation and/or forest replacement with island rainfall, elevation, area, volcanic ash fallout, Asian dust transport and makatea terrain ( uplifted reef), and increases with latitude, age and isolation. Comparative analyses of deforestation therefore lend themselves to much more detailed interpretations than previously possible. These results might be relevant to similar deforestation-associated collapses ( for example, Fertile Crescent, Maya and Anasazi) or the lack thereof ( Japan and highland New Guinea) elsewhere in the world.	Univ Hawaii, Dept Anthropol, Honolulu, HI 96822 USA; Univ Calif Los Angeles, Dept Geog, Los Angeles, CA 90095 USA	University of Hawaii System; University of California System; University of California Los Angeles	Rolett, B (corresponding author), Univ Hawaii, Dept Anthropol, Honolulu, HI 96822 USA.	rolett@hawaii.edu						Austin AT, 1998, OECOLOGIA, V113, P519, DOI 10.1007/s004420050405; BARRAU J, 1958, BISHOP MUS B, V219; Bellwood P.S., 1987, POLYNESIANS PREHISTO; BETANCOURT JL, 1981, SCIENCE, V214, P656, DOI 10.1126/science.214.4521.656; Brieman L, 1984, CLASSIFICATION REGRE; Chadwick OA, 1999, NATURE, V397, P491, DOI 10.1038/17276; Flenley John, 2002, ENIGMAS EASTER ISLAN; Ginoux P, 2001, J GEOPHYS RES-ATMOS, V106, P20255, DOI 10.1029/2000JD000053; Haberle S.G., 1998, AUST ARCHAEOL, V47, P1, DOI DOI 10.1080/03122417.1998.11681610; JENNRICH R, 1995, INTRO COMPUTATIONAL, pCH9; Kirch PV, 1997, AM ANTHROPOL, V99, P30, DOI 10.1525/aa.1997.99.1.30; Mieth A, 2003, RAPA NUI J, V17, P34; Redman C.L., 1999, HUMAN IMPACT ANCIENT; Spriggs M., 1997, ISLAND MELANESIANS; Totman Conrad, 1989, GREEN ARCHIPELAGO FO; Vinton Kirch P., 2017, ROAD WINDS; Webster David, 2002, FALL ANCIENT MAYA	17	107	110	0	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 23	2004	431	7007					443	446		10.1038/nature02801	http://dx.doi.org/10.1038/nature02801			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15386010				2022-12-24	WOS:000224000500038
J	Yoda, K; Tomonaga, T				Yoda, K; Tomonaga, T			Centromere identity originates in the structure of CENP-A/H4 tetramer itself: a mechanism for aneuploidy	LANCET			English	Editorial Material							CENP-A; HISTONE H3; CHROMATIN		Nagoya Univ, Biosci & Biotechnol Ctr, Chikusa Ku, Nagoya, Aichi 4648601, Japan; Chiba Univ, Grad Sch Med, Dept Mol Diag, Chiba, Japan	Nagoya University; Chiba University	Yoda, K (corresponding author), Nagoya Univ, Biosci & Biotechnol Ctr, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	i45156a@nucc.cc.nagoya-u.ac.jp						Black BE, 2004, NATURE, V430, P578, DOI 10.1038/nature02766; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; EARNSHAW WC, 1985, CHROMOSOMA, V91, P313, DOI 10.1007/BF00328227; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; PALMER DK, 1985, MOL CELL BIOL, V5, P173, DOI 10.1128/MCB.5.1.173; RAJAGOPALAN H, 2003, NAT REV CANCER, V3, P3511; SART D, 1997, NAT GENET, V16, P144; Shelby RD, 1997, J CELL BIOL, V136, P501, DOI 10.1083/jcb.136.3.501; SULLIVAN KF, 1994, J CELL BIOL, V127, P581, DOI 10.1083/jcb.127.3.581; Tomonaga T, 2003, CANCER RES, V63, P3511; WILLARD HF, 1990, TRENDS GENET, V6, P410, DOI 10.1016/0168-9525(90)90302-M; Yoda K, 2000, P NATL ACAD SCI USA, V97, P7266, DOI 10.1073/pnas.130189697	12	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 18	2004	364	9439					1022	1024		10.1016/S0140-6736(04)17077-3	http://dx.doi.org/10.1016/S0140-6736(04)17077-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	855FT	15380953				2022-12-24	WOS:000223959300009
J	Vieites, DR; Nieto-Roman, S; Barluenga, M; Palanca, A; Vences, M; Meyer, A				Vieites, DR; Nieto-Roman, S; Barluenga, M; Palanca, A; Vences, M; Meyer, A			Post-mating clutch piracy in an amphibian	NATURE			English	Article							MULTIPLE PATERNITY; RANA-TEMPORARIA; BOREAL POPULATION; COMMON FROGS; BODY-SIZE; SELECTION; SUCCESS; SYSTEMS	Female multiple mating and alternative mating systems can decrease the opportunity for sexual selection(1-3). Sperm competition is often the outcome of females mating with multiple males and has been observed in many animals(1,4-7), and alternative reproductive systems are widespread among species with external fertilization and parental care(3,8-10). Multiple paternity without associated complex behaviour related to mating or parental care is also seen in simultaneously spawning amphibians(11-15) and fishes(16) that release gametes into water. Here we report 'clutch piracy' in a montane population of the common frog Rana temporaria, a reproductive behaviour previously unknown in vertebrates with external fertilization. Males of this species clasp the females and the pair deposits one spherical clutch of eggs. No parental care is provided. 'Pirate' males search for freshly laid clutches, clasp them as they would do a female and fertilize the eggs that were left unfertilized by the 'parental' male. This behaviour does not seem to be size-dependent, and some males mate with a female and perform clutch piracy in the same season. Piracy affected 84% of the clutches and in some cases increased the proportion of eggs fertilized, providing direct fitness benefits both for the pirate males and the females(17). Sexual selection probably caused by a strong male-biased sex ratio-occurs in this population, as indicated by size-assortative mating; however, clutch piracy may reduce its impact. This provides a good model to explore how alternative mating strategies can affect the intensity of sexual selection.	Univ Vigo, Fac Ciencias Biol, Dept Ecol & Biol Anim, Lab Anat Anim, Vigo 36201, Spain; Univ Konstanz, Dept Biol, Lehrstuhl Zool & Evolut Biol, D-78457 Constance, Germany; Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, NL-1092 AD Amsterdam, Netherlands; Univ Amsterdam, Museum Zool, NL-1092 AD Amsterdam, Netherlands	Universidade de Vigo; University of Konstanz; University of Amsterdam; University of Amsterdam	Vieites, DR (corresponding author), Univ Calif Berkeley, Museum Vertebrate Zool, 3101 Valley Life Sci Bldg, Berkeley, CA 94720 USA.	vieites@berkeley.edu	Vences, Miguel/E-5573-2010; Barluenga, Marta/ABA-4194-2020; Vieites, David/B-4481-2009; Soler, Antonio Palanca/B-4206-2010; Meyer, Axel/C-9826-2009	Barluenga, Marta/0000-0003-1514-0586; Vieites, David/0000-0001-5551-7419; Meyer, Axel/0000-0002-0888-8193; Vences, Miguel/0000-0003-0747-0817				Avise JC, 2002, ANNU REV GENET, V36, P19, DOI 10.1146/annurev.genet.36.030602.090831; Bekkevold D, 2002, MOL ECOL, V11, P91, DOI 10.1046/j.0962-1083.2001.01424.x; Birkhead Timothy R., 1997, P121; Byrne PG, 2002, J EVOLUTION BIOL, V15, P347, DOI 10.1046/j.1420-9101.2002.00409.x; Byrne PG, 1999, P ROY SOC B-BIOL SCI, V266, P717, DOI 10.1098/rspb.1999.0695; Clutton-Brock T. H., 1991, MONOGRAPHS BEHAV ECO; DORGEIX CA, 1995, MOL ECOL, V4, P505, DOI 10.1111/j.1365-294X.1995.tb00245.x; Duellman WE, 1986, BIOL AMPHIBIANS, P1; ELMBERG J, 1987, HOLARCTIC ECOL, V10, P193; ELMBERG J, 1990, CAN J ZOOL, V68, P121, DOI 10.1139/z90-017; ELMBERG J, 1991, BEHAV ECOL SOCIOBIOL, V28, P125; Foerster K, 2003, NATURE, V425, P714, DOI 10.1038/nature01969; Garner TWJ, 2003, P ROY SOC B-BIOL SCI, V270, P619, DOI 10.1098/rspb.2002.2284; GIBBONS MM, 1986, J ZOOL, V209, P579, DOI 10.1111/j.1469-7998.1986.tb03613.x; Grossenbacher K., 1997, ATLAS AMPHIBIANS REP, P158; Jennions MD, 2000, BIOL REV, V75, P21, DOI 10.1017/S0006323199005423; Jones AG, 1998, EVOLUTION, V52, P848, DOI [10.2307/2411279, 10.1111/j.1558-5646.1998.tb03709.x]; Jones AG, 2001, P NATL ACAD SCI USA, V98, P9151, DOI 10.1073/pnas.171310198; Laurila A, 1998, BIOL J LINN SOC, V63, P221; Lode T, 2004, NATURWISSENSCHAFTEN, V91, P44, DOI 10.1007/s00114-003-0491-7; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Neff BD, 2004, P NATL ACAD SCI USA, V101, P2381, DOI 10.1073/pnas.0307522100; Neff BD, 2002, J FISH BIOL, V61, P739, DOI 10.1111/j.1095-8649.2002.tb00908.x; Olsson M, 2001, J HERED, V92, P190, DOI 10.1093/jhered/92.2.190; Pearse DE, 2001, J HERED, V92, P206, DOI 10.1093/jhered/92.2.206; Rico C, 1992, MOL ECOL, V1, P79, DOI 10.1111/j.1365-294X.1992.tb00159.x; Roberts JD, 1999, ANIM BEHAV, V57, P721, DOI 10.1006/anbe.1998.1019; Shuster S. M., 2003, MONOGRAPHS BEHAV ECO; Taborsky M, 2001, J HERED, V92, P100, DOI 10.1093/jhered/92.2.100; Vos CC, 2001, HEREDITY, V86, P598, DOI 10.1046/j.1365-2540.2001.00865.x	30	93	102	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2004	431	7006					305	308		10.1038/nature02879	http://dx.doi.org/10.1038/nature02879			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372032	Green Submitted			2022-12-24	WOS:000223864000040
J	Rao, BL; Basu, A; Wairagkar, NS; Gore, MM; Arankalle, VA; Thakare, JP; Jadi, RS; Rao, KA; Mishra, AC				Rao, BL; Basu, A; Wairagkar, NS; Gore, MM; Arankalle, VA; Thakare, JP; Jadi, RS; Rao, KA; Mishra, AC			A large outbreak of acute encephalitis with high fatality rate in children in Andhra Pradesh, India, in 2003, associated with Chandipura virus	LANCET			English	Article							FEBRILE ILLNESS; ASSAY; TRANSMISSION; ANIMALS; PCR	Background An outbreak of acute encephalitis of unknown origin with high case fatality (183 of 329 cases) was reported in children from Andhra Pradesh state in southern India during 2003. We investigated the causative agent. Methods Cell lines and peripheral blood lymphocyte co-cultures were used to isolate the causative agent from clinical samples. Identity of the agent was established by electron microscopy and serological and molecular assays. Findings Clinical samples tested negative for IgM antibodies to Japanese encephalitis, West Nile, dengue, and measles viruses, and for RNA of coronavirus, paramyxovirus, enterovirus, and influenza viruses. Virus was isolated from six patients with encephalitis and was identified as Chandipura virus by electron microscopy, complement fixation, and neutralisation tests. Chandipura virus RNA was detected in clinical samples from nine patients. Sequencing of five of these RNA samples showed 96.7-97.5% identity with the reference strain of 1965. Chandipura viral antigen and RNA were detected in brain tissue of a deceased child by immunofluorescent antibody test and PCR. Neutralising, IgG, and IgM antibodies to Chandipura virus were present in some patients' serum samples. Serum samples obtained after 4 days of illness were more frequently positive for IgM to Chandipura virus than were those obtained earlier (p<0.001). A similar trend was noted for neutralising antibodies. Interpretation Our findings suggest that this outbreak of acute encephalitis in Andhra Pradesh was associated with Chandipura virus, adding to the evidence suggesting that this virus should be considered as an important emerging pathogen.	Natl Inst Virol, Pune 411001, Maharashtra, India; Karimnagar Dist Hosp, Karimnagar, Andhra Pradesh, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV)	Mishra, AC (corresponding author), Natl Inst Virol, 20A Dr Ambedkar Rd, Pune 411001, Maharashtra, India.	acm1750@rediffmail.com	Jadi, Ramesh/AAV-2059-2020	Jadi, Ramesh/0000-0002-5710-4893; Arankalle, Vidya/0000-0002-9940-3437				BANERJEE K, 1984, VIRUS ECOLOGY, P109; BHATT PN, 1967, INDIAN J MED RES, V55, P1295; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; de Mattos C, 2001, FIELDS VIROLOGY, P1245; DHANDA V, 1970, INDIAN J MED RES, V58, P179; GORE MM, 1985, INDIAN J MED RES, V81, P343; ILKAL MA, 1991, ACTA VIROL, V35, P27, DOI 10.1016/0166-0934(91)90082-B; John T Jacob, 2003, Indian Pediatr, V40, P863; KELKAR SD, 1976, INDIAN J MED RES, V64, P814; KEMP GE, 1975, B WORLD HEALTH ORGAN, V52, P615; KUMAR S, 2001, MEGA2 1 MOL EVOLUTIO; NAJIB KHAN, 1954, Indian Journal of Medical Sciences, V8, P597; NERURKAR LS, 1984, J CLIN MICROBIOL, V20, P109, DOI 10.1128/JCM.20.1.109-114.1984; Poddar SK, 2002, J CLIN LAB ANAL, V16, P163, DOI 10.1002/jcla.10036; RAO TR, 1967, INDIAN J MED RES, V55, P1306; Read SJ, 1999, J CLIN MICROBIOL, V37, P1352, DOI 10.1128/JCM.37.5.1352-1355.1999; RODRIGUE.FM, 1972, B WORLD HEALTH ORGAN, V46, P173; RODRIGUES FM, 1984, INDIAN J MED RES S, P1; RODRIGUES JJ, 1983, INDIAN J MED RES, V77, P303; SEVER JL, 1962, J IMMUNOL, V88, P320; Stephensen CB, 1999, VIRUS RES, V60, P181, DOI 10.1016/S0168-1702(99)00017-9; TESH RB, 1993, AM J TROP MED HYG, V32, P621; Traore-Lamizana M, 2001, J MED ENTOMOL, V38, P480, DOI 10.1603/0022-2585-38.4.480	23	131	142	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 4	2004	364	9437					869	874		10.1016/S0140-6736(04)16982-1	http://dx.doi.org/10.1016/S0140-6736(04)16982-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	851KY	15351194	Green Published, Bronze			2022-12-24	WOS:000223685200033
J	Jaffe, H				Jaffe, H			Whatever happened to the US AIDS epidemic?	SCIENCE			English	Editorial Material							HIV; MEN		Univ Oxford, Dept Publ Hlth, Oxford OX3 7LF, England	University of Oxford	Jaffe, H (corresponding author), Univ Oxford, Dept Publ Hlth, Old Rd Campus, Oxford OX3 7LF, England.	harold.jaffe@dphpc.ox.ac.uk						BOZZETTE SA, 2003, NEW ENGL J MED, V344, P817; BROOKMEYER R, 1991, SCIENCE, V253, P37, DOI 10.1126/science.2063206; *CDC, 2003, MMWR-MORBID MORTAL W, V52, P329; *CDCP, 2002, CAS HIV INF AIDS US; *CDCP, FACT SHEET PUBLIC HL; Centers for Disease Control and Prevention, UNPUB; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P1229; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1013; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1051; [Anonymous], 2001, MMWR Recomm Rep, V50, P1; FLEMING PL, 2002, 9 C RETR OPP INF SEA; *KAIS FAM FDN, 2004, SURV AM HIV AIDS 1; KAMIMOTO L, 2004, 11 C RETR OPP INF SA; LYTER DW, 1987, PUBLIC HEALTH REP, V102, P468; MECKLER L, 2002, WASHINGTON POST 0123, pA15; Montgomery JP, 2003, AIDS CARE, V15, P829, DOI 10.1080/09540120310001618676; Stoneburner RL, 2004, SCIENCE, V304, P714, DOI 10.1126/science.1093166; American Medical Association, 2004, MMWR Recomm Rep, V53, P1; Urbina A, 2004, CLIN INFECT DIS, V38, P890, DOI 10.1086/381975; *US BUR JUST, US DEP JUST BUR JUST; Valdiserri RO, 2004, AIDS EDUC PREV, V16, P426, DOI 10.1521/aeap.16.5.426.48738; *WASH POST KAIS FA, 2002, NAT SURV PUBL ATT HI; WATTERS JK, 1994, JAMA-J AM MED ASSOC, V271, P115, DOI 10.1001/jama.271.2.115	23	25	26	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 27	2004	305	5688					1243	1244		10.1126/science.1101136	http://dx.doi.org/10.1126/science.1101136			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850PJ	15333825				2022-12-24	WOS:000223624600025
J	Leonard, MB; Feldman, HI; Shults, J; Zemel, BS; Foster, BJ; Stallings, VA				Leonard, MB; Feldman, HI; Shults, J; Zemel, BS; Foster, BJ; Stallings, VA			Long-term, high-dose glucocorticoids and bone mineral content in childhood glucocorticoid-sensitive nephrotic syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							X-RAY ABSORPTIOMETRY; GLOMERULAR-FILTRATION RATE; CHILDREN; DENSITY; DISEASE; OSTEOPENIA; FRACTURES; GROWTH; RISK; OSTEOPOROSIS	BACKGROUND: Glucocorticoids suppress bone formation, impair growth, and induce obesity. We determined the effects of long-term treatment with glucocorticoids on bone mineral content in children with glucocorticoid-sensitive nephrotic syndrome, a disorder with minimal known independent effects on bone. METHODS: We performed dual-energy x-ray absorptiometry of the whole body and spine in 60 children and adolescents with the nephrotic syndrome and 195 control subjects. We used linear regression analysis of log-transformed values to compare the bone mineral content in patients with that in controls. RESULTS: Patients had received an average of 23,000 mg of glucocorticoids and were shorter (P=0.008) and had a greater body-mass index (P<0.001) than controls. The bone mineral content of the spine, adjusted for bone area, age, sex, degree of maturation (Tanner stage), and race, did not differ significantly between patients and controls (ratio, 0.99; 95 percent confidence interval, 0.96 to 1.02; P=0.51). After adjustment for the z score for body-mass index, the bone mineral content of the spine was significantly lower in patients than in controls (0.96; 95 percent confidence interval, 0.92 to 0.99; P=0.01). Whole-body bone mineral content, adjusted for height, age, sex, degree of maturation, and race, was significantly higher in patients than in controls (ratio, 1.11; 95 percent confidence interval, 1.05 to 1.18; P<0.001); however, the addition of the z score for body-mass index to the model eliminated the association with the nephrotic syndrome (ratio, 0.99; 95 percent confidence interval, 0.94 to 1.03; P=0.55). CONCLUSIONS: Intermittent treatment with high-dose glucocorticoids during growth does not appear to be associated with deficits in the bone mineral content of the spine or whole body relative to age, bone size, sex, and degree of maturation. Glucocorticoid-induced increases in body-mass index were associated with increased whole-body bone mineral content and maintenance of the bone mineral content of the spine.	Childrens Hosp Philadelphia, Dept Pediat, CHOP N, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Leonard, MB (corresponding author), Childrens Hosp Philadelphia, Dept Pediat, CHOP N, Rm 1564, Philadelphia, PA 19104 USA.	leonard@email.chop.edu	Zemel, Babette S./D-1117-2009	Zemel, Babette S./0000-0002-6164-7348	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000240] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK058200, K08DK002523, T32DK007785] Funding Source: NIH RePORTER; NCRR NIH HHS [M01RR00240] Funding Source: Medline; NIDDK NIH HHS [T32 DK007785, 1-R03-DK058200, K08-DK02523] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bhudhikanok GS, 1996, PEDIATRICS, V97, P103; Boot AM, 1998, GUT, V42, P188, DOI 10.1136/gut.42.2.188; BRODEHL J, 1991, EUR J PEDIATR, V150, P380, DOI 10.1007/BF02093714; Canalis E, 2002, J PEDIATR ENDOCR MET, V15, P1341; CARTER DR, 1992, J BONE MINER RES, V7, P137; Daniel V, 1997, CLIN NEPHROL, V47, P289; Ellis KJ, 2001, J BONE MINER RES, V16, P1658, DOI 10.1359/jbmr.2001.16.9.1658; Ferraris JR, 2000, PEDIATR NEPHROL, V14, P682, DOI 10.1007/s004670000337; Freundlich M, 2004, PEDIATR NEPHROL, V19, P400, DOI 10.1007/s00467-003-1378-8; FREUNDLICH M, 1985, PEDIATRICS, V76, P280; Gafni RI, 2004, J PEDIATR-US, V144, P253, DOI 10.1016/j.jpeds.2003.08.054; Gafni RI, 2002, FASEB J, V16, P736, DOI 10.1096/fj.01-0640fje; Goulding A, 1998, J BONE MINER RES, V13, P143, DOI 10.1359/jbmr.1998.13.1.143; GRYMONPREZ A, 1995, PEDIATR NEPHROL, V9, P278, DOI 10.1007/BF02254183; Gulati S, 2003, AM J KIDNEY DIS, V41, P1163, DOI 10.1016/S0272-6386(03)00348-2; Khosla S, 2001, ENDOCRINOLOGY, V142, P5050, DOI 10.1210/en.142.12.5050; Krebs NF, 2003, PEDIATRICS, V112, P424, DOI 10.1542/peds.112.2.424; LAAN RF, 1994, ANN INTERN MED, V119, P963; Landin LA, 1997, J PEDIATR ORTHOP B, V6, P79, DOI 10.1097/01202412-199704000-00002; Leonard MB, 1998, J BONE MINER RES, V13, P1687, DOI 10.1359/jbmr.1998.13.11.1687; Leonard MB, 2004, BONE, V34, P1044, DOI 10.1016/j.bone.2003.12.003; Leonard MB, 2004, AM J CLIN NUTR, V80, P514, DOI 10.1093/ajcn/80.2.514; Leonard MB, 2002, PEDIATR CLIN N AM, V49, P143, DOI 10.1016/S0031-3955(03)00113-5; Leonard MB, 1999, J PEDIATR-US, V135, P182, DOI 10.1016/S0022-3476(99)70020-X; Lien G, 2003, ARTHRITIS RHEUM-US, V48, P2214, DOI 10.1002/art.11097; Ma DQ, 2003, J BONE MINER RES, V18, P1970, DOI 10.1359/jbmr.2003.18.11.1970; Ogden CL, 2002, PEDIATRICS, V109, P45, DOI 10.1542/peds.109.1.45; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; Parfitt AM, 1996, J BONE MINER RES, V11, P150; Petit MA, 2002, J BONE MINER RES, V17, P363, DOI 10.1359/jbmr.2002.17.3.363; PRENTICE A, 1994, AM J CLIN NUTR, V60, P837; SCHWARTZ GJ, 1984, J PEDIATR-US, V104, P849, DOI 10.1016/S0022-3476(84)80479-5; Seeman E, 1997, J BONE MINER RES, V12, P509, DOI 10.1359/jbmr.1997.12.4.509; Stewart WA, 2003, ARTHRITIS RHEUM, V48, P2294, DOI 10.1002/art.11211; Tanner J.M., 1962, GROWTH ADOLESCENCE, V2nd ed.; Taylor A, 1997, J BONE MINER RES, V12, P652, DOI 10.1359/jbmr.1997.12.4.652; van Staa TP, 2002, OSTEOPOROSIS INT, V13, P777, DOI 10.1007/s001980200108; Van Staa TP, 2003, J BONE MINER RES, V18, P913, DOI 10.1359/jbmr.2003.18.5.913; 1981, J PEDIAT, V98, P561	39	144	152	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 26	2004	351	9					868	875		10.1056/NEJMoa040367	http://dx.doi.org/10.1056/NEJMoa040367			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	849BM	15329424				2022-12-24	WOS:000223512500008
J	Gregory, R				Gregory, R			The blind leading the sighted	NATURE			English	Editorial Material									Univ Bristol, Dept Expt Psychol, Bristol BS8 1TN, Avon, England	University of Bristol	Gregory, R (corresponding author), Univ Bristol, Dept Expt Psychol, Bristol BS8 1TN, Avon, England.								0	8	9	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 19	2004	430	7002					836	836		10.1038/430836a	http://dx.doi.org/10.1038/430836a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318199	Bronze			2022-12-24	WOS:000223369800021
J	Loh, AN; Bauer, JE; Druffel, ERM				Loh, AN; Bauer, JE; Druffel, ERM			Variable ageing and storage of dissolved organic components in the open ocean	NATURE			English	Article							PACIFIC-OCEAN; BLACK CARBON; MATTER; RADIOCARBON; SEDIMENTS; WATER; SEA; ENVIRONMENTS; FRACTIONS	Seawater dissolved organic matter (DOM) is the largest reservoir of exchangeable organic carbon in the ocean, comparable in quantity to atmospheric carbon dioxide(1,2). The composition, turnover times and fate of all but a few planktonic constituents of this material are, however, largely unknown(3,4). Models of ocean carbon cycling are thus limited by the need for information on temporal scales of carbon storage in DOM subcomponents, produced via the 'biological pump', relative to their recycling by bacteria(3,4). Here we show that carbohydrate- and protein-like substances in the open Atlantic and Pacific oceans, though often significantly aged, comprise younger fractions of the DOM, whereas dissolved lipophilic material exhibits up to similar to90 per cent fossil character. In contrast to the millennial mean ages of DOM observed throughout the water column, weighted mean turnover times of DOM in the surface ocean are only decadal in magnitude. An observed size-age continuum further demonstrates that small dissolved molecules are the most highly aged forms of organic matter, cycling much more slowly than larger, younger dissolved and particulate precursors, and directly links oceanic organic matter age and size with reactivity(3,5).	Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA; Coll William & Mary, Sch Marine Sci, Gloucester Point, VA 23062 USA	University of California System; University of California Irvine; William & Mary	Loh, AN (corresponding author), Florida Gulf Coast Univ, Coll Arts & Sci, Div Ecol Studies, 10501 FGCU Blvd S, Ft Myers, FL 33965 USA.	anloh@fgcu.edu						Aluwihare LI, 2002, DEEP-SEA RES PT II, V49, P4421, DOI 10.1016/S0967-0645(02)00124-8; Aluwihare LI, 1997, NATURE, V387, P166, DOI 10.1038/387166a0; Amon RMW, 1996, LIMNOL OCEANOGR, V41, P41, DOI 10.4319/lo.1996.41.1.0041; BAUER JE, 1992, NATURE, V357, P667, DOI 10.1038/357667a0; Benner R., 2002, BIOGEOCHEMISTRY MARI, P5990, DOI DOI 10.1016/B978-012323841-2/50005-1; Carlson C., 2002, BIOGEOCHEMISTRY MARI, P91, DOI DOI 10.1016/B978-012323841-2/50006-3; Clark LL, 1998, NATURE, V393, P426, DOI 10.1038/30881; Druffel ERM, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017423; DRUFFEL ERM, 1992, J GEOPHYS RES-OCEANS, V97, P15639, DOI 10.1029/92JC01511; Eglinton TI, 1997, SCIENCE, V277, P796, DOI 10.1126/science.277.5327.796; Eglinton TI, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000269; GOERICKE R, 1994, STABLE ISOTOPES ECOL, P181; Hedges JI, 2000, ORG GEOCHEM, V31, P945, DOI 10.1016/S0146-6380(00)00096-6; HEDGES JI, 1995, MAR CHEM, V49, P81, DOI 10.1016/0304-4203(95)00008-F; HEDGES JI, 1992, MAR CHEM, V39, P67, DOI 10.1016/0304-4203(92)90096-S; Hwang JS, 2003, SCIENCE, V299, P881, DOI 10.1126/science.1078508; LOH AN, 2002, THESIS COLL WILLIAM; Masiello CA, 1998, SCIENCE, V280, P1911, DOI 10.1126/science.280.5371.1911; Masiello CA, 2002, GEOCHIM COSMOCHIM AC, V66, P1025, DOI 10.1016/S0016-7037(01)00831-6; SANTSCHI PH, 1995, GEOCHIM COSMOCHIM AC, V59, P625, DOI 10.1016/0016-7037(94)00378-Y; SOFER Z, 1980, ANAL CHEM, V52, P1389, DOI 10.1021/ac50058a063; STUIVER M, 1983, SCIENCE, V219, P849, DOI 10.1126/science.219.4586.849; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Trumbore SE, 1995, DAHL WS ENV, V16, P7; VOGEL JS, 1987, NUCL INSTRUM METH B, V29, P50, DOI 10.1016/0168-583X(87)90202-3; Wakeham SG, 1997, DEEP-SEA RES PT II, V44, P2131, DOI 10.1016/S0967-0645(97)00035-0; Wang XC, 2001, GEOPHYS RES LETT, V28, P3313, DOI 10.1029/2001GL013430; Wang XC, 1998, GEOCHIM COSMOCHIM AC, V62, P1365, DOI 10.1016/S0016-7037(98)00074-X; Whelan J.K., 1993, ORG GEOCHEM, P289; WILLIAMS PM, 1987, NATURE, V330, P246, DOI 10.1038/330246a0	30	134	140	8	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2004	430	7002					877	881		10.1038/nature02780	http://dx.doi.org/10.1038/nature02780			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318218	Green Published			2022-12-24	WOS:000223369800038
J	Piffanelli, P; Ramsay, L; Waugh, R; Benabdelmouna, A; D'Hont, A; Hollricher, K; Jorgensen, JH; Schulze-Lefert, P; Panstruga, R				Piffanelli, P; Ramsay, L; Waugh, R; Benabdelmouna, A; D'Hont, A; Hollricher, K; Jorgensen, JH; Schulze-Lefert, P; Panstruga, R			A barley cultivation-associated polymorphism conveys resistance to powdery mildew	NATURE			English	Article							MLO FAMILY; DIVERSITY; GENE; DEFENSE; PROTEIN; GENOME; PLANTS	Barley ( Hordeum vulgare) has played a pivotal role in Old World agriculture since its domestication about 10,000 yr ago(1). Barley plants carrying loss-of-function alleles (mlo) of the Mlo locus are resistant against all known isolates of the widespread powdery mildew fungus(2). The sole mlo resistance allele recovered so far from a natural habitat, mlo-11, was originally retrieved from Ethiopian landraces and nowadays controls mildew resistance in the majority of cultivated European spring barley elite varieties(2). Here we use haplotype analysis to show that the mlo-11 allele probably arose once after barley domestication. Resistance in mlo-11 plants is linked to a complex tandem repeat array inserted upstream of the wild-type gene. The repeat units consist of a truncated Mlo gene comprising 3.5 kilobases (kb) of 50-regulatory sequence plus 1.1 kb of coding sequence. These generate aberrant transcripts that impair the accumulation of both Mlo wild-type transcript and protein. We exploited the meiotic instability of mlo-11 resistance and recovered susceptible revertants in which restoration of Mlo function was accompanied by excision of the repeat array. We infer cis-dependent perturbation of transcription machinery assembly by transcriptional interference in mlo-11 plants as a likely mechanism leading to disease resistance.	Max Planck Inst Zuchtungsforsch, Dept Plant Microbe Interact, D-50829 Cologne, Germany; John Innes Ctr Plant Sci Res, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; Scottish Crop Res Inst, Genome Unit, Dundee DD2 5DA, Scotland; CIRAD, F-34398 Montpellier 5, France; Max Planck Inst Zuchtungsforsch, Dept Plant Breeding & Yield Physiol, D-50829 Cologne, Germany; Riso Natl Lab, Res Dept, DK-4000 Roskilde, Denmark; Max Planck Inst Zuchtungsforsch, Dept Plant Microbe Interact, D-50829 Cologne, Germany	Max Planck Society; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; James Hutton Institute; CIRAD; Max Planck Society; Technical University of Denmark; Max Planck Society	Schulze-Lefert, P (corresponding author), Max Planck Inst Zuchtungsforsch, Dept Plant Microbe Interact, Carl von Linne Weg 10, D-50829 Cologne, Germany.	schlef@mpiz-koeln.mpg.de	Bruening, Stefan/B-8505-2011; Schulze-Lefert, Paul/B-6707-2011; Schulze-Lefert, Paul/A-7746-2008; DHONT, Angélique/AAL-8074-2021; Panstruga, Ralph/F-3340-2011	Panstruga, Ralph/0000-0002-3756-8957; Benabdelmouna, Abdellah/0000-0003-1910-219X				Badr A, 2000, MOL BIOL EVOL, V17, P499, DOI 10.1093/oxfordjournals.molbev.a026330; Benabdelmouna A, 2001, THEOR APPL GENET, V103, P668, DOI 10.1007/s001220100596; Buschges R, 1997, CELL, V88, P695, DOI 10.1016/S0092-8674(00)81912-1; Chopra S, 2003, GENETICS, V163, P1135; Collins NC, 2003, NATURE, V425, P973, DOI 10.1038/nature02076; Devoto A, 1999, J BIOL CHEM, V274, P34993, DOI 10.1074/jbc.274.49.34993; Devoto A, 2003, J MOL EVOL, V56, P77, DOI 10.1007/s00239-002-2382-5; Eszterhas SK, 2002, MOL CELL BIOL, V22, P469, DOI 10.1128/MCB.22.2.469-479.2002; Fransz PF, 1996, PLANT J, V9, P421, DOI 10.1046/j.1365-313X.1996.09030421.x; GIESSEN J. E., 1956, Zeitschrift fur Pflanzenzuchtung, V35, P377; Gutierrez C, 1999, CELL MOL LIFE SCI, V56, P313, DOI 10.1007/s000180050433; Henikoff S, 1998, BIOESSAYS, V20, P532, DOI 10.1002/(SICI)1521-1878(199807)20:7<532::AID-BIES3>3.3.CO;2-0; JORGENSEN JH, 1994, CRIT REV PLANT SCI, V13, P97, DOI 10.1080/713608055; JORGENSEN JH, 1992, EUPHYTICA, V63, P141, DOI 10.1007/BF00023919; JORGENSEN JH, 1976, BARLEY GENET, V3, P446; Kapitonov VV, 2001, P NATL ACAD SCI USA, V98, P8714, DOI 10.1073/pnas.151269298; Kim MC, 2002, NATURE, V416, P447, DOI 10.1038/416447a; Matus IA, 2002, GENOME, V45, P1095, DOI 10.1139/G02-071; NEGASSA M, 1985, HEREDITAS, V102, P113, DOI 10.1111/j.1601-5223.1985.tb00472.x; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Pakniyat H, 1997, GENOME, V40, P332, DOI 10.1139/g97-046; Panstruga R, 2003, MICROBES INFECT, V5, P429, DOI 10.1016/S1286-4579(03)00053-4; Panstruga R, 1998, NUCLEIC ACIDS RES, V26, P1056, DOI 10.1093/nar/26.4.1056; Piffanelli P, 2002, PLANT PHYSIOL, V129, P1076, DOI 10.1104/pp.010954; Simons G, 1997, GENOMICS, V44, P61, DOI 10.1006/geno.1997.4844; Stam M, 2002, GENE DEV, V16, P1906, DOI 10.1101/gad.1006702; Thomas WTB, 1998, MOL BREEDING, V4, P381, DOI 10.1023/A:1009646115967	27	125	142	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2004	430	7002					887	891		10.1038/nature02781	http://dx.doi.org/10.1038/nature02781			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318221				2022-12-24	WOS:000223369800041
J	Mysliwiec, PA; Brown, ML; Klabunde, CN; Ransohoff, DF				Mysliwiec, PA; Brown, ML; Klabunde, CN; Ransohoff, DF			Are physicians doing too much colonoscopy? A national survey of colorectal surveillance after polypectomy	ANNALS OF INTERNAL MEDICINE			English	Article							CANCER-SOCIETY GUIDELINES; SCREENING COLONOSCOPY; ASYMPTOMATIC ADULTS; CLINICAL GUIDELINES; PRACTICE PATTERNS; POLYP GUIDELINE; UNITED-STATES; RISK; UPDATE; CARE	Background: increasing use of colonoscopy for colorectal cancer screening and surveillance of colorectal adenomas after polypectomy has given rise to concerns about the availability of endoscopic resources in the United States. Guidelines recommend surveillance after polypectomy at 3 to 5 years for a small adenoma, and follow-up is not advised for hyperplastic polyps. The intensity of physicians' surveillance is largely unstudied. Objective: To survey practicing gastroenterologists and general surgeons about their perceived need for the frequency of surveillance after polypectomy, to compare survey responses to practice guidelines, and to identify factors influencing their recommendations for surveillance. Design: Survey study conducted by the National Cancer Institute. Setting: A nationally representative study of physicians in the United States. Participants: 349 gastroenterologists and 316 general surgeons. Measurements: Questionnaires mailed in 1999 and 2000 assessed physicians' recommendations for surveillance after polypectomy in asymptomatic, average-risk patients. Results: Response rates were 83%. Among gastroenterologists (317 of 349) and surgeons (125 of 316) who perform screening colonoscopy, 24% (95% Cl, 19.3% to 28.7%) of gastroenterologists and 54% (Cl, 44.9% to 62.5%) of surgeons recommend surveillance for a hyperplastic polyp. For a small adenoma, most physicians recommended surveillance colonoscopy and more than 50% recommended examinations every 3 years or more often. Physicians indicated that published evidence was very influential in their practice (83% [Cl, 78.8% to 87.2%] of gastroenterologists and 78% [Cl, 72.5% to 86.8%] of surgeons). By contrast, only half of respondents reported that guidelines were very influential. Limitations: The study was based on physicians' self-reported practice patterns. Results may overestimate or underestimate the performance of surveillance colonoscopy. Conclusions: Some surveillance colonoscopy seems to be inappropriately performed and in excess of guidelines, particularly for hyperplastic polyps and low-risk lesions such as a small adenoma. These results suggest unnecessary demand for endoscopic resources.	NCI, Bethesda, MD 20892 USA; Univ N Carolina, Chapel Hill, NC USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of North Carolina; University of North Carolina Chapel Hill	Brown, ML (corresponding author), NCI, Executive Plaza N 4005,6130 Executive Blvd, Bethesda, MD 20892 USA.	mb53o@nih.gov			DIVISION OF CANCER CONTROL &POPULATION SCIENCE [N01PC085169] Funding Source: NIH RePORTER; NCI NIH HHS [N01-PC-85169] Funding Source: Medline	DIVISION OF CANCER CONTROL &POPULATION SCIENCE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Control & Population Sciences); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		*AM SOC GASTR END, 1997, COL SCREEN SURV IND, V1030; *AM SOC GASTR END, 1997, COL SCREEN SURV IND; ATKIN WS, 1992, NEW ENGL J MED, V326, P658, DOI 10.1056/NEJM199203053261002; BOND JH, 1993, ANN INTERN MED, V119, P836, DOI 10.7326/0003-4819-119-8-199310150-00010; Bond JH, 2000, AM J GASTROENTEROL, V95, P3053; Brown ML, 2003, AM J MED, V115, P129, DOI 10.1016/S0002-9343(03)00297-3; Byers T, 1997, CA-CANCER J CLIN, V47, P154, DOI 10.3322/canjclin.47.3.154; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; CANNONALBRIGHT LA, 1994, AM J GASTROENTEROL, V89, P827; Cram P, 2003, ARCH INTERN MED, V163, P1601, DOI 10.1001/archinte.163.13.1601; Cruz-Correa M, 2001, ARCH INTERN MED, V161, P2588, DOI 10.1001/archinte.161.21.2588; *CTR MED MED SERV, MED INF RES; Eisenberg JM, 2002, MED CARE, V40, P1016, DOI 10.1097/00005650-200211000-00004; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Guyatt GH, 2000, BRIT MED J, V320, P954, DOI 10.1136/bmj.320.7240.954; Harewood GC, 2004, CLIN GASTROENTEROL H, V2, P72, DOI 10.1016/S1542-3565(03)00294-5; HEDBERG CA, 2002, LETT HLTH INSURANCE; HILLMAN AL, 1991, HEALTH AFFAIR, V10, P138, DOI 10.1377/hlthaff.10.4.138; Imperiale TF, 2000, NEW ENGL J MED, V343, P169, DOI 10.1056/NEJM200007203430302; KODNER IJ, 1999, PRINCIPLES SURG, P1342; KOLATA G, 2003, NY TIMES        1208, pA23; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Lieberman DA, 2000, GASTROENTEROLOGY, V118, P619, DOI 10.1016/S0016-5085(00)70269-1; LOMAS J, 1989, NEW ENGL J MED, V321, P1306, DOI 10.1056/NEJM198911093211906; MAGUIRE PO, 2002, ACP OBSERVER, V1, P16; MONTANO DE, 1995, AM J PUBLIC HEALTH, V85, P795, DOI 10.2105/AJPH.85.6.795; Nelson DB, 2002, GASTROINTEST ENDOSC, V55, P307, DOI 10.1067/mge.2002.121883; NEUGUT AI, 1995, GASTROENTEROLOGY, V108, P402, DOI 10.1016/0016-5085(95)90066-7; Pickhardt PJ, 2003, NEW ENGL J MED, V349, P2191, DOI 10.1056/NEJMoa031618; Podolsky DK, 2000, NEW ENGL J MED, V343, P207, DOI 10.1056/NEJM200007203430309; Prajapati DN, 2003, AM J GASTROENTEROL, V98, P194; Ransohoff DF, 2002, GASTROENTEROL CLIN N, V31, P1031, DOI 10.1016/S0889-8553(02)00059-6; Rex DK, 2001, GASTROINTEST ENDOSC, V54, P662, DOI 10.1067/mge.2001.117594; REX DK, 1991, GASTROENTEROLOGY, V100, P64, DOI 10.1016/0016-5085(91)90583-7; Rosson RS, 2003, ANN INTERN MED, V138, P356, DOI 10.7326/0003-4819-138-4-200302180-00022; Simmang CL, 1999, DIS COLON RECTUM, V42, P1123, DOI 10.1007/BF02238562; Smith RA, 2001, CA-CANCER J CLIN, V51, P38, DOI 10.3322/canjclin.51.1.38; VATN MH, 1982, CANCER, V49, P819, DOI 10.1002/1097-0142(19820215)49:4<819::AID-CNCR2820490435>3.0.CO;2-D; WAYE JD, 1982, ENDOSCOPY, V14, P79, DOI 10.1055/s-2007-1021585; WILLIAMS AR, 1982, GUT, V23, P835, DOI 10.1136/gut.23.10.835; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594; WINAWER SJ, 1993, NEW ENGL J MED, V328, P901, DOI 10.1056/NEJM199304013281301; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Zauber AG, 2000, GASTROENTEROLOGY, V118, pA187, DOI 10.1016/S0016-5085(00)82821-8	45	262	266	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 17	2004	141	4					264	271		10.7326/0003-4819-141-4-200408170-00006	http://dx.doi.org/10.7326/0003-4819-141-4-200408170-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	846BX	15313742				2022-12-24	WOS:000223290900003
J	Orach, CG; De Brouwere, V				Orach, CG; De Brouwere, V			Postemergency health services for refugee and host populations in Uganda, 1999-2002	LANCET			English	Article								Since 1990, Uganda has hosted an estimated 200000 refugees in postemergency settlements interspersed within host communities. We investigated the extent to which obstetric needs were met in the refugee and host populations during 1999-2002. Between September and December, 2000, we retrospectively collected data from 1999 and 2000 on major obstetric interventions for absolute maternal indications from all five hospitals in Arua, Adjumani, and Moyo districts, Uganda. The same data were collected prospectively for 2001. We did community-based maternal mortality surveys on refugee and host populations in Adjumani district in 2002. Rates of major obstetric interventions were significantly higher for refugees than for the host population who live in the same rural areas as refugees (1.01% [95% CI 0.77-1.25] vs 0.45% [0.38-0.52]; p<0.0001). Rates of major obstetric interventions were also significantly higher for refugees than for the host population who live in rural areas without refugees (1.01% [0.77-1.25] vs 0.40% [0.36-0.441; p<0.0001). Maternal mortality was 2.5 times higher in the host population than in refugees in the Adjumani district (322 per 100000 births [247-396] vs 130 [81-179]. Refugees had better access to health services than did the rural host population in the northern Ugandan communities that we surveyed.	Makerere Univ, Inst Publ Hlth, Kampala, Uganda; Free Univ Brussels, B-1050 Brussels, Belgium; Inst Trop Med, B-2000 Antwerp, Belgium	Makerere University; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Institute of Tropical Medicine (ITM)	Orach, CG (corresponding author), Makerere Univ, Inst Publ Hlth, POB 7072, Kampala, Uganda.	cgorach@iph.ac.ug						CDC (Centers for Disease Control and Prevention), 1993, MMWR RECOMM REP, V41, P1; *GOU UNHCR, 1999, SELF REL REF HOST AR; Goyens P., 1996, Journal of Refugee Studies, V9, P268, DOI 10.1093/jrs/9.3.268; Hynes M, 2002, JAMA-J AM MED ASSOC, V288, P595, DOI 10.1001/jama.288.5.595; Van Damme W, 1998, LANCET, V351, P1609, DOI 10.1016/S0140-6736(97)10348-8	5	26	26	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 14	2004	364	9434					611	612		10.1016/S0140-6736(04)16854-2	http://dx.doi.org/10.1016/S0140-6736(04)16854-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845WD	15313362				2022-12-24	WOS:000223275100034
J	Huisken, J; Swoger, J; Del Bene, F; Wittbrodt, J; Stelzer, EHK				Huisken, J; Swoger, J; Del Bene, F; Wittbrodt, J; Stelzer, EHK			Optical sectioning deep inside live embryos by selective plane illumination microscopy	SCIENCE			English	Article							GENE-EXPRESSION; FLUORESCENCE MICROSCOPY; THETA MICROSCOPY; CELL; AXIS; TOMOGRAPHY; RESOLUTION; SPECIMENS; MEDAKA; TOOL	Large, living biological specimens present challenges to existing optical imaging techniques because of their absorptive and scattering properties. We developed selective plane illumination microscopy (SPIM) to generate multidimensional images of samples up to a few millimeters in size. The system combines two-dimensional illumination with orthogonal camera-based detection to achieve high-resolution, optically sectioned imaging throughout the sample, with minimal photodamage and at speeds capable of capturing transient biological phenomena. We used SPIM to visualize all muscles in vivo in the transgenic Medaka line Arnie, which expresses green fluorescent protein in muscle tissue. We also demonstrate that SPIM can be applied to visualize the embryogenesis of the relatively opaque Drosophila melanogaster in vivo.	European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Huisken, J (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	huisken@embl.de; stelzer@embl.de	Swoger, Jim/H-7651-2015; Huisken, Jan/B-2472-2009; Wittbrodt, Joachim/D-4735-2014; del bene, filippo/D-1245-2010; Stelzer, Ernst H K/A-7648-2011	Swoger, Jim/0000-0003-3805-0073; Huisken, Jan/0000-0001-7250-3756; Wittbrodt, Joachim/0000-0001-8550-7377; del bene, filippo/0000-0001-8551-2846; Stelzer, Ernst H K/0000-0003-1545-0736				Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Edwards KA, 1997, DEV BIOL, V191, P103, DOI 10.1006/dbio.1997.8707; Hove JR, 2003, NATURE, V421, P172, DOI 10.1038/nature01282; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; IWAMATSU T, 1994, ZOOL SCI, V11, P825; Kikuchi S, 1997, OPT COMMUN, V138, P21, DOI 10.1016/S0030-4018(97)00054-0; Lindek S, 1999, J MOD OPTIC, V46, P843, DOI 10.1080/095003499149575; Louie AY, 2000, NAT BIOTECHNOL, V18, P321, DOI 10.1038/73780; Megason SG, 2003, MECH DEVELOP, V120, P1407, DOI 10.1016/j.mod.2003.07.005; PAWLEY JB, 1995, HDB BIOL CONFOCAL MI; Ruffins SW, 2002, CURR OPIN NEUROBIOL, V12, P580, DOI 10.1016/S0959-4388(02)00366-5; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; SHAW PJ, 1990, J MICROSC-OXFORD, V158, P165, DOI 10.1111/j.1365-2818.1990.tb02989.x; STELZER EHK, 1994, OPT COMMUN, V111, P536, DOI 10.1016/0030-4018(94)90533-9; STELZER EHK, 1995, J MICROSC-OXFORD, V179, P1, DOI 10.1111/j.1365-2818.1995.tb03608.x; Swoger J, 2003, OPT LETT, V28, P1654, DOI 10.1364/OL.28.001654; Webb DJ, 2003, NAT CELL BIOL, V5, P690, DOI 10.1038/ncb0803-690; Weninger WJ, 2002, NAT GENET, V30, P59, DOI 10.1038/ng785; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704	21	1509	1592	30	350	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2004	305	5686					1007	1009		10.1126/science.1100035	http://dx.doi.org/10.1126/science.1100035			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845ND	15310904				2022-12-24	WOS:000223250700049
J	Proft, M; Struhl, K				Proft, M; Struhl, K			MAP kinase-mediated stress relief that precedes and regulates the timing of transcriptional induction	CELL			English	Article							ACTIVATED PROTEIN-KINASE; YEAST SACCHAROMYCES-CEREVISIAE; OSMOTIC-STRESS; SIGNAL-TRANSDUCTION; BUDDING YEAST; ENVIRONMENTAL-CHANGES; SALT STRESS; IN-VIVO; POL-II; HOG1	In yeast, hyperosmotic stress causes an immediate dissociation of most proteins from chromatin, presumably because cells are unprepared for, and initially unresponsive to, increased ion concentrations in the nucleus. Osmotic stress activates Hog1 MAP kinase which phosphorylates at least two proteins located at the plasma membrane, the Nha1 Na+/H+ antiporter and the Tok1 potassium channel. Hog1 phosphorylation stimulates Nha1 activity, and this is crucial for the rapid reassociation of proteins with their target sites in chromatin. This initial response to hyperosmolarity precedes and temporally regulates the activation of stress-response genes that depends on Hog1 phosphorylation of transcription factors in the nucleus. Thus, a single MAP kinase coordinates temporally, spatially, and mechanistically distinct responses to stress, thereby providing very rapid stress relief that facilitates subsequent changes in gene expression that permit long-term adaptation to harsh environmental conditions.	Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Struhl, K (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	kevin@hms.harvard.edu	Proft, Markus/K-2323-2014	Proft, Markus/0000-0002-6788-5830	NIGMS NIH HHS [GM30186] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030186, R01GM030186] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alepuz PM, 2003, EMBO J, V22, P2433, DOI 10.1093/emboj/cdg243; Alepuz PM, 2001, MOL CELL, V7, P767, DOI 10.1016/S1097-2765(01)00221-0; Banuelos MA, 1998, MICROBIOL-UK, V144, P2749, DOI 10.1099/00221287-144-10-2749; Bilsland-Marchesan E, 2000, MOL CELL BIOL, V20, P3887, DOI 10.1128/MCB.20.11.3887-3895.2000; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; de Nadal E, 2003, MOL CELL BIOL, V23, P229, DOI 10.1128/MCB.23.1.229-237.2003; Elion EA, 2000, CURR OPIN MICROBIOL, V3, P573, DOI 10.1016/S1369-5274(00)00143-0; FERRANDO A, 1995, MOL CELL BIOL, V15, P5470; Ferrigno P, 1998, EMBO J, V17, P5606, DOI 10.1093/emboj/17.19.5606; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gustin MC, 1998, MICROBIOL MOL BIOL R, V62, P1264, DOI 10.1128/MMBR.62.4.1264-1300.1998; Kamauchi S, 2002, J BIOCHEM, V131, P821, DOI 10.1093/oxfordjournals.jbchem.a003171; KETCHUM KA, 1995, NATURE, V376, P690, DOI 10.1038/376690a0; Kinclova O, 2001, MOL MICROBIOL, V40, P656, DOI 10.1046/j.1365-2958.2001.02412.x; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; Marquez JA, 1996, FEBS LETT, V382, P89, DOI 10.1016/0014-5793(96)00157-3; Mason PB, 2003, MOL CELL BIOL, V23, P8323, DOI 10.1128/MCB.23.22.8323-8333.2003; Ng HH, 2003, P NATL ACAD SCI USA, V100, P1820, DOI 10.1073/pnas.0437846100; Pascual-Ahuir A, 2001, J BIOL CHEM, V276, P37373, DOI 10.1074/jbc.M105755200; Posas F, 2000, J BIOL CHEM, V275, P17249, DOI 10.1074/jbc.M910016199; Posas F, 1997, SCIENCE, V276, P1702, DOI 10.1126/science.276.5319.1702; Posas F, 1998, CURR OPIN MICROBIOL, V1, P175, DOI 10.1016/S1369-5274(98)80008-8; Prior C, 1996, FEBS LETT, V387, P89, DOI 10.1016/0014-5793(96)00470-X; Proft M, 1999, MOL CELL BIOL, V19, P537; Proft M, 2002, MOL CELL, V9, P1307, DOI 10.1016/S1097-2765(02)00557-9; Proft M, 2001, EMBO J, V20, P1123, DOI 10.1093/emboj/20.5.1123; Reiser V, 1999, MOL BIOL CELL, V10, P1147, DOI 10.1091/mbc.10.4.1147; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; Rep M, 1999, MOL CELL BIOL, V19, P5474; Serrano R, 2001, CURR OPIN CELL BIOL, V13, P399, DOI 10.1016/S0955-0674(00)00227-1; Teige M, 2001, P NATL ACAD SCI USA, V98, P5625, DOI 10.1073/pnas.091610798; Van Wuytswinkel O, 2000, MOL MICROBIOL, V37, P382, DOI 10.1046/j.1365-2958.2000.02002.x	36	162	168	2	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2004	118	3					351	361		10.1016/j.cell.2004.07.016	http://dx.doi.org/10.1016/j.cell.2004.07.016			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846XP	15294160	Bronze			2022-12-24	WOS:000223353100011
J	Giron, D; Dunn, DW; Hardy, ICW; Strand, MR				Giron, D; Dunn, DW; Hardy, ICW; Strand, MR			Aggression by polyembryonic wasp soldiers correlates with kinship but not resource competition	NATURE			English	Article							COPIDOSOMA-FLORIDANUM; VISCOUS POPULATIONS; INCLUSIVE FITNESS; EVOLUTION; ALTRUISM; INVERTEBRATES; RELATEDNESS; ENVIRONMENT; ALLOCATION; RELATIVES	Kin selection theory predicts that individuals will show less aggression and more altruism towards relatives(1,2). However, recent theoretical developments suggest that with limited dispersal, competition between relatives can override the effects of relatedness(3-9). The predicted and opposing influences of relatedness and competition are difficult to approach experimentally because conditions that increase average relatedness among individuals also tend to increase competition. Polyembryonic wasps in the family Encyrtidae are parasites whose eggs undergo clonal division to produce large broods(10). These insects have also evolved a caste system: some embryos in a clone develop into reproductive larvae that mature into adults, whereas others develop into sterile soldier larvae that defend siblings from competitors(11-14). In a brood from a single egg, reproductive altruism by soldiers reflects clone-level allocation to defence at the cost of reproduction, with no conflict between individuals. When multiple eggs are laid into a host, inter-clone conflicts of interest arise. Here we report that soldier aggression in Copidosoma floridanum is inversely related to the genetic relatedness of competitors but shows no correlation with the level of resource competition.	Univ Georgia, Dept Entomol, Athens, GA 30602 USA; Univ Nottingham, Sch Biosci, Loughborough LE12 5RD, Leics, England	University System of Georgia; University of Georgia; University of Nottingham	Strand, MR (corresponding author), Univ Georgia, Dept Entomol, Athens, GA 30602 USA.	mrstrand@bugs.ent.uga.edu	Giron, David/B-9108-2013	Giron, David/0000-0001-8356-0983				Abbot P, 2001, P NATL ACAD SCI USA, V98, P12068, DOI 10.1073/pnas.201212698; Buss LW, 1987, EVOLUTION INDIVIDUAL, DOI 10.1515/9781400858712; CROZIER RH, 1986, EVOLUTION, V40, P1100, DOI 10.1111/j.1558-5646.1986.tb00578.x; CRUZ YP, 1981, NATURE, V294, P446, DOI 10.1038/294446a0; DONNELL D, IN PRESS P NATL ACAD; GIRON D, 2004, P R SOC LOND S; Grafen A, 1984, BEHAV ECOLOGY EVOLUT, V2, P62; GRBIC M, 1992, NATURE, V360, P254, DOI 10.1038/360254a0; Grbic M, 1996, DEVELOPMENT, V122, P795; GROSBERG RK, 1988, Q REV BIOL, V63, P377, DOI 10.1086/416026; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Harvey JA, 2000, NATURE, V406, P183, DOI 10.1038/35018074; Ode PJ, 2002, SEX RATIOS: CONCEPTS AND RESEARCH METHODS, P218, DOI 10.1017/CBO9780511542053.011; ODE PJ, 1995, J ANIM ECOL, V64, P213, DOI 10.2307/5756; QUELLER DC, 1994, EVOL ECOL, V8, P70, DOI 10.1007/BF01237667; Queller DC, 2000, PHILOS T R SOC B, V355, P1647, DOI 10.1098/rstb.2000.0727; STRAND MR, 1989, ENTOMOL EXP APPL, V50, P37, DOI 10.1007/BF00190127; Strand MR, 1997, CURR TOP DEV BIOL, V35, P121, DOI 10.1016/S0070-2153(08)60258-6; STRAND MR, 1989, J INSECT BEHAV, V2, P355, DOI 10.1007/BF01068061; Strand MR, 2003, ENCY INSECTS, P928; Strassmann JE, 2000, NATURE, V408, P965, DOI 10.1038/35050087; TAYLOR PD, 1992, P ROY SOC B-BIOL SCI, V249, P299, DOI 10.1098/rspb.1992.0118; TAYLOR PD, 1992, EVOL ECOL, V6, P352, DOI 10.1007/BF02270971; West SA, 2001, NATURE, V409, P510, DOI 10.1038/35054057; West SA, 2002, SCIENCE, V296, P72, DOI 10.1126/science.1065507; WILSON DS, 1992, EVOL ECOL, V6, P331, DOI 10.1007/BF02270969	27	90	94	2	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2004	430	7000					676	679		10.1038/nature02721	http://dx.doi.org/10.1038/nature02721			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843LM	15295600				2022-12-24	WOS:000223085400045
J	Nitta, R; Kikkawa, M; Okada, Y; Hirokawa, N				Nitta, R; Kikkawa, M; Okada, Y; Hirokawa, N			KIF1A alternately uses two loops to bind microtubules	SCIENCE			English	Article							KINESIN MOTOR; MECHANISM; PROCESSIVITY; ATPASE; MYOSIN; MODEL; DYNAMICS; ACTIN	The motor protein kinesin moves along microtubules, driven by adenosine triphosphate (ATP) hydrolysis. However, it remains unclear how kinesin converts the chemical energy into mechanical movement. We report crystal structures of monomeric kinesin KIF1A with three transition-state analogs: adenylyl imidodiphosphate (AMP-PNP), adenosine diphosphate (ADP)-vanadate, and ADP-AlFx (aluminofluoride complexes). These structures, together with known structures of the ADP-bound state and the adenylyl-(beta, gamma-methylene) diphosphate (AMP-PCP)-bound state, show that kinesin uses two microtubule-binding loops in an alternating manner to change its interaction with microtubules during the ATP hydrolysis cycle; loop L11 is extended in the AMP-PNP structure, whereas loop L12 is extended in the ADP structure. ADP-vanadate displays an intermediate structure in which a conformational change in two switch regions causes both loops to be raised from the microtubule, thus actively detaching kinesin.	Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, Tokyo 1130033, Japan; Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA	University of Tokyo; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Hirokawa, N (corresponding author), Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, Tokyo 1130033, Japan.	hirokawa@m.u-tokyo.ac.jp	Okada, Yasushi/N-5067-2015; Nitta, Ryo/C-3727-2017; Kikkawa, Masahide/I-7958-2015	Okada, Yasushi/0000-0003-2601-3689; Nitta, Ryo/0000-0002-6537-9272; Kikkawa, Masahide/0000-0001-7656-8194				Crevel IMTC, 2004, EMBO J, V23, P23, DOI 10.1038/sj.emboj.7600042; Farrell CM, 2002, J BIOL CHEM, V277, P17079, DOI 10.1074/jbc.M108793200; Furch M, 1999, J MOL BIOL, V290, P797, DOI 10.1006/jmbi.1999.2921; GEEVES MA, 1991, BIOCHEM J, V274, P1; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Johnson DA, 2001, CHEM REV, V101, P2243, DOI 10.1021/cr000226k; Kikkawa M, 2000, CELL, V100, P241, DOI 10.1016/S0092-8674(00)81562-7; Kikkawa M, 2001, NATURE, V411, P439, DOI 10.1038/35078000; Klumpp LM, 2004, P NATL ACAD SCI USA, V101, P3444, DOI 10.1073/pnas.0307691101; KORETZ JF, 1975, J BIOL CHEM, V250, P6344; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Mackey AT, 2000, BIOCHEMISTRY-US, V39, P1346, DOI 10.1021/bi991918+; Matthies HJG, 2001, MOL BIOL CELL, V12, P4000, DOI 10.1091/mbc.12.12.4000; MIDELFORT CF, 1981, P NATL ACAD SCI-BIOL, V78, P2067, DOI 10.1073/pnas.78.4.2067; Nishiyama M, 2001, NAT CELL BIOL, V3, P425, DOI 10.1038/35070116; Ogawa T, 2004, CELL, V116, P591, DOI 10.1016/S0092-8674(04)00129-1; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; Okada Y, 2003, NATURE, V424, P574, DOI 10.1038/nature01804; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; Pechatnikova E, 1999, BIOPHYS J, V77, P1003, DOI 10.1016/S0006-3495(99)76951-1; Reubold TF, 2003, NAT STRUCT BIOL, V10, P826, DOI 10.1038/nsb987; Rosenfeld SS, 1996, J BIOL CHEM, V271, P9473, DOI 10.1074/jbc.271.16.9473; Schnitzer MJ, 2000, NAT CELL BIOL, V2, P718, DOI 10.1038/35036345; Sindelar CV, 2002, NAT STRUCT BIOL, V9, P844, DOI 10.1038/nsb852; Smith CA, 1996, BIOCHEMISTRY-US, V35, P5404, DOI 10.1021/bi952633+; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Tesmer JJG, 1998, CURR OPIN STRUC BIOL, V8, P713, DOI 10.1016/S0959-440X(98)80090-0; Woehlke G, 1997, CELL, V90, P207, DOI 10.1016/S0092-8674(00)80329-3; YOUNT RG, 1995, BIOPHYS J, V68, pS44; Yun MY, 2001, EMBO J, V20, P2611, DOI 10.1093/emboj/20.11.2611	30	143	152	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 30	2004	305	5684					678	683		10.1126/science.1096621	http://dx.doi.org/10.1126/science.1096621			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	842GQ	15286375				2022-12-24	WOS:000222992100052
J	Wills-Karp, M; Karp, CL				Wills-Karp, M; Karp, CL			Chitin checking - Novel insights into asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACIDIC MAMMALIAN CHITINASE		Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45221 USA; Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Div Mol Immunol, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University of Cincinnati	Wills-Karp, M (corresponding author), Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45221 USA.			Karp, Christopher/0000-0002-0832-2659				Boot RG, 2001, J BIOL CHEM, V276, P6770, DOI 10.1074/jbc.M009886200; Herrera-Estrella A, 1999, EXS, V87, P171; Shibata Y, 2000, J IMMUNOL, V164, P1314, DOI 10.4049/jimmunol.164.3.1314; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336	5	24	26	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 30	2004	351	14					1455	1457		10.1056/NEJMcibr041294	http://dx.doi.org/10.1056/NEJMcibr041294			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857XT	15459309				2022-12-24	WOS:000224153900017
J	Hayashi, T; Fujita, Y; Iwasaki, O; Adachi, Y; Takahashi, K; Yanagida, M				Hayashi, T; Fujita, Y; Iwasaki, O; Adachi, Y; Takahashi, K; Yanagida, M			Mis16 and Mis18 are required for CENP-A loading and histone deacetylation at centromeres	CELL			English	Article							BUDDING YEAST KINETOCHORE; CULTURED-MAMMALIAN-CELLS; FISSION YEAST; CHROMOSOME SEGREGATION; SACCHAROMYCES-CEREVISIAE; NEGATIVE REGULATOR; OUTER KINETOCHORE; EQUAL SEGREGATION; PROTEIN; GENE	Centromeres contain specialized chromatin that includes the centromere-specific histone H3 variant, spCENP-A/Cnp1. Here we report identification of five fission yeast centromere proteins, Mis14-18. Mis14 is recruited to kinetochores independently of CENP-A, and, conversely, CENP-A does not require Mis14 to associate with centromeres. In contrast, Mis15, Mis16 (strong similarity with human RbAp48 and RbAp46), Mis17, and Mis18 are all part of the CENP-A recruitment pathway. Mis15 and Mis17form an evolutionarily conserved complex that also includes Mis6. Mis16 and Mis18 form a complex and maintain the deacetylated state of histones specifically in the central core of centromeres. Mis16 and Mis18 are the most upstream factors in kinetochore assembly as they can associate with kinetochores in all kinetochore mutants except for mis18 and mis16, respectively. RNAi knockdown in human cells shows that Mis16 function is conserved as RbAp48 and RbAp46 are both required for localization of human CENP-A.	Kyoto Univ, Dept Gene Mechanisms, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan	Kyoto University	Yanagida, M (corresponding author), Kyoto Univ, Dept Gene Mechanisms, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan.	yanagida@kozo.lif.kyoto-u.ac.jp						ADACHI Y, 1989, J CELL BIOL, V108, P1195, DOI 10.1083/jcb.108.4.1195; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Chen ES, 2003, MOL CELL, V11, P175, DOI 10.1016/S1097-2765(03)00011-X; CHIKASHIGE Y, 1989, CELL, V57, P739, DOI 10.1016/0092-8674(89)90789-7; De Wulf P, 2003, GENE DEV, V17, P2902, DOI 10.1101/gad.1144403; EARNSHAW WC, 1985, CHROMOSOMA, V92, P290, DOI 10.1007/BF00329812; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Euskirchen GM, 2002, EUKARYOT CELL, V1, P229, DOI 10.1128/EC.1.2.229-240.2002; Furuyama T, 2003, GENESIS, V35, P114, DOI 10.1002/gene.10173; Goshima G, 1999, GENE DEV, V13, P1664, DOI 10.1101/gad.13.13.1664; Goshima G, 2000, CELL, V100, P619, DOI 10.1016/S0092-8674(00)80699-6; Goshima G, 2003, J CELL BIOL, V160, P25, DOI 10.1083/jcb.200210005; Harborth J, 2001, J CELL SCI, V114, P4557; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; Henikoff S, 2003, NATURE, V423, P814, DOI 10.1038/423814a; Henikoff S, 2000, P NATL ACAD SCI USA, V97, P716, DOI 10.1073/pnas.97.2.716; Hennig L, 2003, DEVELOPMENT, V130, P2555, DOI 10.1242/dev.00470; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jin QW, 2002, MOL CELL BIOL, V22, P7168, DOI 10.1128/MCB.22.20.7168-7183.2002; Krude T, 1999, EUR J BIOCHEM, V263, P1, DOI 10.1046/j.1432-1327.1999.00508.x; Martinez-Balbas MA, 1998, P NATL ACAD SCI USA, V95, P132, DOI 10.1073/pnas.95.1.132; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; Measday V, 2002, GENE DEV, V16, P101, DOI 10.1101/gad.949302; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nabeshima K, 1997, METHOD ENZYMOL, V283, P459; Nakayama J, 2003, EMBO J, V22, P2776, DOI 10.1093/emboj/cdg248; Nekrasov VS, 2003, MOL BIOL CELL, V14, P4931, DOI 10.1091/mbc.E03-06-0419; PALMER DK, 1987, J CELL BIOL, V104, P805, DOI 10.1083/jcb.104.4.805; Pidoux AL, 2003, J CELL BIOL, V161, P295, DOI 10.1083/jcb.200212110; Pinsky BA, 2003, DEV CELL, V5, P735, DOI 10.1016/S1534-5807(03)00322-8; Pot I, 2003, MOL BIOL CELL, V14, P460, DOI 10.1091/mbc.E02-08-0517; QIAN YW, 1993, NATURE, V364, P648, DOI 10.1038/364648a0; QIAN YW, 1995, J BIOL CHEM, V270, P25507, DOI 10.1074/jbc.270.43.25507; Saitoh S, 1997, CELL, V90, P131, DOI 10.1016/S0092-8674(00)80320-7; Scharfenberger M, 2003, EMBO J, V22, P6584, DOI 10.1093/emboj/cdg636; STOLER S, 1995, GENE DEV, V9, P573, DOI 10.1101/gad.9.5.573; Straight AF, 1996, CURR BIOL, V6, P1599, DOI 10.1016/S0960-9822(02)70783-5; TAKAHASHI K, 1994, MOL BIOL CELL, V5, P1145, DOI 10.1091/mbc.5.10.1145; TAKAHASHI K, 1992, MOL BIOL CELL, V3, P819, DOI 10.1091/mbc.3.7.819; Takahashi K, 2000, SCIENCE, V288, P2215, DOI 10.1126/science.288.5474.2215; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; Westermann S, 2003, J CELL BIOL, V163, P215, DOI 10.1083/jcb.200305100	42	323	340	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2004	118	6					715	729		10.1016/j.cell.2004.09.002	http://dx.doi.org/10.1016/j.cell.2004.09.002			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	855RW	15369671	Bronze			2022-12-24	WOS:000223992400008
J	Burls, A; Jobanputra, P				Burls, A; Jobanputra, P			The trials of anakinra	LANCET			English	Editorial Material							RHEUMATOID-ARTHRITIS		Univ Birmingham, Dept Epidemiol & Publ Hlth, W Midlands Hlth Technol Assessment Collaborat, Birmingham B15 2TT, W Midlands, England; Univ Hosp Birmingham NHS Trust, Selly Oak Hosp, Dept Rheumatol, Birmingham, W Midlands, England	University of Birmingham	Burls, A (corresponding author), Univ Birmingham, Dept Epidemiol & Publ Hlth, W Midlands Hlth Technol Assessment Collaborat, Birmingham B15 2TT, W Midlands, England.	A.J.Burls@bham.ac.uk	Burls, Amanda J.E./D-7641-2011; Jobanputra, Paresh/R-2311-2019	Jobanputra, Paresh/0000-0002-2712-667X; Burls, Amanda/0000-0001-9540-622X				Braddock M, 2004, NAT REV DRUG DISCOV, V3, P1, DOI 10.1038/nrd1342; Buch MH, 2004, ARTHRITIS RHEUM-US, V50, P725, DOI 10.1002/art.20115; CLARK W, 2004, HLTH TECH ASSESS, V8; Fleischmann RM, 2003, ARTHRITIS RHEUM-US, V48, P927, DOI 10.1002/art.10870; *FOOD DRUG ADM CTR, 103950 BLA STN FOOD; Genovese MC, 2004, ARTHRITIS RHEUM-US, V50, P1412, DOI 10.1002/art.20221; JOBANPUTRA P, 2002, HLTH TECH ASSESS, V6; NICE, 2002, GUID US ET INFL TREA; *NICE, 2003, AN RHEUM ARTHR; Parmar MKB, 1996, J NATL CANCER I, V88, P1645, DOI 10.1093/jnci/88.22.1645	10	14	17	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 4	2004	364	9437					827	828		10.1016/S0140-6736(04)16999-7	http://dx.doi.org/10.1016/S0140-6736(04)16999-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	851KY	15351176				2022-12-24	WOS:000223685200010
J	Hallam, SJ; Putnam, N; Preston, CM; Detter, JC; Rokhsar, D; Richardson, PM; DeLong, EF				Hallam, SJ; Putnam, N; Preston, CM; Detter, JC; Rokhsar, D; Richardson, PM; DeLong, EF			Reverse methanogenesis: Testing the hypothesis with environmental genomics	SCIENCE			English	Article							METHANE-OXIDIZING ARCHAEA; MARINE-SEDIMENTS; ANAEROBIC OXIDATION; CARBONATES; PATHWAYS; BACTERIA; GENES	Microbial methane consumption in anoxic sediments significantly impacts the global environment by reducing the flux of greenhouse gases from ocean to atmosphere. Despite its significance, the biological mechanisms controlling anaerobic methane oxidation are not well characterized. One current model suggests that relatives of methane-producing Archaea, developed the capacity to reverse methanogenesis and thereby to consume methane to produce cellular carbon and energy. We report here a test of the "reverse-methanogenesis" hypothesis by genomic analyses of methane-oxidizing Archaea, from deep-sea sediments. Our results show that nearly all genes typically associated with methane production are present in one specific group of archaeal methanotrophs. These genome-based observations support previous hypotheses and provide an informed foundation for metabolic modeling of anaerobic methane oxidation.	Monterey Bay Aquarium Res Inst, Moss Landing, CA 95064 USA; Joint Genome Inst, Walnut Creek, CA 94598 USA	Monterey Bay Aquarium Research Institute; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI	DeLong, EF (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	delong@mit.edu	Putnam, Nicholas/B-9968-2008	Putnam, Nicholas/0000-0002-1315-782X; Rokhsar, Daniel/0000-0002-8704-2224				Angelaccio S, 2003, J BIOL CHEM, V278, P41789, DOI 10.1074/jbc.M306747200; Boetius A, 2000, NATURE, V407, P623, DOI 10.1038/35036572; Borowski WS, 1999, MAR GEOL, V159, P131, DOI 10.1016/S0025-3227(99)00004-3; Chistoserdova L, 2000, MICROBIOL-SGM, V146, P233, DOI 10.1099/00221287-146-1-233; D'Hondt S, 2002, SCIENCE, V295, P2067, DOI 10.1126/science.1064878; DeLong EF, 2002, CURR OPIN MICROBIOL, V5, P520, DOI 10.1016/S1369-5274(02)00353-3; Hallam SJ, 2003, APPL ENVIRON MICROB, V69, P5483, DOI 10.1128/AEM.69.9.5483-5491.2003; Hinrichs KU, 1999, NATURE, V398, P802, DOI 10.1038/19751; Hoehler TM, 1996, MICROBIAL GROWTH ON C(1) COMPOUNDS, P326; IVERSEN N, 1985, LIMNOL OCEANOGR, V30, P944, DOI 10.4319/lo.1985.30.5.0944; Jiang GQ, 2003, NATURE, V426, P822, DOI 10.1038/nature02201; Kruger M, 2003, NATURE, V426, P878, DOI 10.1038/nature02207; KUHNER CH, 1993, J BACTERIOL, V175, P3195, DOI 10.1128/JB.175.10.3195-3203.1993; KULM LD, 1986, SCIENCE, V231, P561, DOI 10.1126/science.231.4738.561; Marx CJ, 2004, J BACTERIOL, V186, P2173, DOI 10.1128/JB.186.7.2173-2178.2004; Michaelis W, 2002, SCIENCE, V297, P1013, DOI 10.1126/science.1072502; Orphan VJ, 2002, P NATL ACAD SCI USA, V99, P7663, DOI 10.1073/pnas.072210299; Orphan VJ, 2001, SCIENCE, V293, P484, DOI 10.1126/science.1061338; Orphan VJ, 2001, APPL ENVIRON MICROB, V67, P1922, DOI 10.1128/AEM.67.4.1922-1934.2001; PAULL CK, 1992, PALAIOS, V7; Reeburgh WS, 1996, MICROBIAL GROWTH ON C(1) COMPOUNDS, P334; Reeve JN, 1997, J BACTERIOL, V179, P5975, DOI 10.1128/jb.179.19.5975-5986.1997; Thauer RK, 1998, MICROBIOL-UK, V144, P2377, DOI 10.1099/00221287-144-9-2377; ZEHNDER AJB, 1979, J BACTERIOL, V137, P420, DOI 10.1128/JB.137.1.420-432.1979	24	470	514	12	177	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2004	305	5689					1457	1462		10.1126/science.1100025	http://dx.doi.org/10.1126/science.1100025			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852NK	15353801				2022-12-24	WOS:000223761900047
J	Wojtowicz, WM; Flanagan, JJ; Millard, SS; Zipursky, SL				Wojtowicz, WM; Flanagan, JJ; Millard, SS; Zipursky, SL			Alternative splicing of Drosophila Dscam generates axon guidance receptors that exhibit isoform-specific homophilic binding	CELL			English	Article							CELL-ADHESION MOLECULE; SUPERFAMILY; EXPRESSION; DIVERSITY; NEUREXINS; NEURONS; FAMILY; GROWTH; MEMBER	Dscam is an immunoglobulin (Ig) superfamily protein required for the formation of neuronal connections in Drosophila. Through alternative splicing, Dscam potentially gives rise to 19,008 different extracellular domains linked to one of two alternative transmembrane segments, resulting in 38,016 isoforms. All isoforms share the same domain structure but contain variable amino acid sequences within three Ig domains in the extracellular region. We demonstrate that different isoforms exhibit different binding specificity. Each isoform binds to itself but does not bind or binds poorly to other isoforms. The amino acid sequences of all three variable Ig domains determine binding specificity. Even closely related isoforms sharing nearly identical amino acid sequences exhibit isoform-specific binding. We propose that this preferential homophilic binding specificity regulates interactions between cells and contributes to the formation of complex patterns of neuronal connections.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Howard Hughes Med Inst, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Zipursky, SL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.	zipursky@hhmi.ucla.edu	Millard, Sean/A-8522-2013	Millard, Sean/0000-0001-8573-4625; Zipursky, Stephen/0000-0001-5630-7181	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS044582, T32NS007101] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [GM07185, T32 GM007185] Funding Source: Medline; NINDS NIH HHS [F31 NS044582, F31NS044582, 5 T32 NS07101, T32 NS007101] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agarwala KL, 2001, BIOCHEM BIOPH RES CO, V285, P760, DOI 10.1006/bbrc.2001.5214; Agarwala KL, 2000, MOL BRAIN RES, V79, P118, DOI 10.1016/S0169-328X(00)00108-X; Clemens JC, 1996, J BIOL CHEM, V271, P17002, DOI 10.1074/jbc.271.29.17002; De Angelis E, 1999, EMBO J, V18, P4744, DOI 10.1093/emboj/18.17.4744; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; GRAVELEY BR, 2004, IN PRESS ORG EVOLUTI; Hansen MJ, 2004, NEURON, V42, P717, DOI 10.1016/j.neuron.2004.05.009; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; Higashijima S, 1996, DEVELOPMENT, V122, P527; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; McLaughlin T, 2003, DEVELOPMENT, V130, P2407, DOI 10.1242/dev.00467; McLaughlin T, 2003, CURR OPIN NEUROBIOL, V13, P57, DOI 10.1016/S0959-4388(03)00014-X; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Uemura T, 1998, CELL, V93, P1095, DOI 10.1016/S0092-8674(00)81452-X; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Wang J, 2002, NEURON, V33, P559, DOI 10.1016/S0896-6273(02)00570-6; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Yamakawa K, 1998, HUM MOL GENET, V7, P227, DOI 10.1093/hmg/7.2.227; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020	31	235	242	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 3	2004	118	5					619	633		10.1016/j.cell.2004.08.021	http://dx.doi.org/10.1016/j.cell.2004.08.021			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852BN	15339666	Green Accepted, Bronze			2022-12-24	WOS:000223730300012
J	Day, C; Degenhardt, L; Gilmour, S; Hall, W				Day, C; Degenhardt, L; Gilmour, S; Hall, W			Effects of reduction in heroin supply on injecting drug use: analysis of data from needle and syringe programmes	BRITISH MEDICAL JOURNAL			English	Article							AUSTRALIA		Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2052, Australia; Univ Queensland, Off Publ Policy & Eth, Inst Mol Biosci, Brisbane, Qld 4072, Australia	University of New South Wales Sydney; University of Queensland	Day, C (corresponding author), Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2052, Australia.	carolyn.day@unsw.edu.au	Hall, Wayne D/A-3283-2008; Degenhardt, Louisa J/D-4515-2012	Hall, Wayne D/0000-0003-1984-0096; Degenhardt, Louisa J/0000-0002-8513-2218				Darke S, 2002, ADDICTION, V97, P179, DOI 10.1046/j.1360-0443.2002.00032.x; Degenhardt L., 2004, CAUSES COURSE CONSEQ; Law MG, 2003, INT J EPIDEMIOL, V32, P717, DOI 10.1093/ije/dyg101; *NAT CTR HIV EP CL, 2003, HIV AIDS VIR HEP SEX; TOPP L, 2002, AUSTR DRUG TRENDS 20	5	30	30	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 21	2004	329	7463					428	429		10.1136/bmj.38201.410255.55	http://dx.doi.org/10.1136/bmj.38201.410255.55			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	849EA	15292056	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000223520300016
J	Leiman, PG; Chipman, PR; Kostyuchenko, VA; Mesyanzhinov, VV; Rossmann, MG				Leiman, PG; Chipman, PR; Kostyuchenko, VA; Mesyanzhinov, VV; Rossmann, MG			Three-dimensional rearrangement of proteins in the tail of bacteriophage T4 on infection of its host	CELL			English	Article							BASEPLATE MORPHOGENESIS; CONTRACTILE TAIL; GENETIC-CONTROL; ELECTRON MICROSCOPE; T4 BACTERIOPHAGES; ESCHERICHIA COLI; SHEATH PROTEIN; PRODUCT; DNA; EVOLUTION	The contractile tail of bacteriophage T4 undergoes major structural transitions when the virus attaches to the host cell surface. The baseplate at the distal end of the tail changes from a hexagonal to a star shape. This causes the sheath around the tail tube to contract and the tail tube to protrude from the baseplate and pierce the outer cell membrane and the cell wall before reaching the inner cell membrane for subsequent viral DNA injection. Analogously, the T4 tail can be contracted by treatment with 3 M urea. The structure of the T4 contracted tail, including the head-tail joining region, has been determined by cryo-electron microscopy to 17 Angstrom resolution. This 1200 Angstrom-long, 20 MDa structure has been interpreted in terms of multiple copies of its approximately 20 component proteins. A comparison with the metastable hexagonal baseplate of the mature virus shows that the baseplate proteins move as rigid bodies relative to each other during the structural change.	Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; Shemyakin Ovchinnikov Inst Bioorgan Chem, Lab Mol Bioengn, Moscow 117997, Russia	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Rossmann, MG (corresponding author), Purdue Univ, Dept Biol Sci, 915 W State St, W Lafayette, IN 47907 USA.	mgr@indiana.bio.purdue.edu	Leiman, Petr G/E-5120-2010	Leiman, Petr G/0000-0002-9091-0918; Chipman, Paul/0000-0003-3652-4087; Kostyuchenko, Victor/0000-0001-9751-307X				ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; ABULADZE NK, 1994, VIROLOGY, V199, P301, DOI 10.1006/viro.1994.1128; Ackermann HW, 2003, RES MICROBIOL, V154, P245, DOI 10.1016/S0923-2508(03)00067-6; AMOS LA, 1975, J MOL BIOL, V99, P51, DOI 10.1016/S0022-2836(75)80158-6; Arisaka F, 1981, Prog Clin Biol Res, V64, P365; ARISAKA F, 1990, BIOCHEMISTRY-US, V29, P5057, DOI 10.1021/bi00473a009; Baker TS, 1999, MICROBIOL MOL BIOL R, V63, P862, DOI 10.1128/MMBR.63.4.862-922.1999; Black Lindsay W., 1994, P218; CASPAR DLD, 1980, BIOPHYS J, V32, P103, DOI 10.1016/S0006-3495(80)84929-0; Cerritelli ME, 1996, J MOL BIOL, V260, P767, DOI 10.1006/jmbi.1996.0436; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; Conway JF, 2001, SCIENCE, V292, P744, DOI 10.1126/science.1058069; Coombs D, 1994, MOL BIOL BACTERIOPHA, P259; COOMBS DH, 1977, J MOL BIOL, V116, P375, DOI 10.1016/0022-2836(77)90076-6; CRAWFORD JT, 1980, J MOL BIOL, V139, P679, DOI 10.1016/0022-2836(80)90054-6; CROWTHER RA, 1977, J MOL BIOL, V116, P489, DOI 10.1016/0022-2836(77)90081-X; Desplats C, 2003, RES MICROBIOL, V154, P259, DOI 10.1016/S0923-2508(03)00069-X; DRIEDONKS RA, 1981, J MOL BIOL, V152, P641, DOI 10.1016/0022-2836(81)90121-2; DUDA RL, 1985, P NATL ACAD SCI USA, V82, P5550, DOI 10.1073/pnas.82.16.5550; Eiserling Frederick A., 1994, P209; FOKINE A, IN PRESS P NATL ACAD; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Goldberg Edward, 1994, P347; Gowen B, 2003, J VIROL, V77, P7863, DOI 10.1128/JVI.77.14.7863-7871.2003; Hendrix RW, 2002, THEOR POPUL BIOL, V61, P471, DOI 10.1006/tpbi.2002.1590; Kanamaru S, 2002, NATURE, V415, P553, DOI 10.1038/415553a; Kellenberger E, 1996, BIOPHYS CHEM, V59, P41, DOI 10.1016/0301-4622(95)00117-4; KIKUCHI Y, 1975, J MOL BIOL, V99, P695, DOI 10.1016/S0022-2836(75)80180-X; KIKUCHI Y, 1975, J SUPRAMOL STR CELL, V3, P24, DOI 10.1002/jss.400030104; KIKUCHI Y, 1975, J MOL BIOL, V99, P645, DOI 10.1016/S0022-2836(75)80178-1; KIKUCHI Y, 1975, J MOL BIOL, V99, P673, DOI 10.1016/S0022-2836(75)80179-3; KING J, 1971, J MOL BIOL, V58, P693, DOI 10.1016/0022-2836(71)90034-9; KING J, 1968, J MOL BIOL, V32, P231, DOI 10.1016/0022-2836(68)90007-7; Kleywegt GJ, 1999, ACTA CRYSTALLOGR D, V55, P941, DOI 10.1107/S0907444999001031; Kostyuchenko VA, 1999, STRUCTURE, V7, P1213, DOI 10.1016/S0969-2126(00)80055-6; Kostyuchenko VA, 2003, NAT STRUCT BIOL, V10, P688, DOI 10.1038/nsb970; Leiman PG, 2003, CELL MOL LIFE SCI, V60, P2356, DOI 10.1007/s00018-003-3072-1; Leiman PG, 2000, J MOL BIOL, V301, P975, DOI 10.1006/jmbi.2000.3989; Leiman PG, 2003, J MOL BIOL, V328, P821, DOI 10.1016/S0022-2836(03)00366-8; Miller ES, 2003, MICROBIOL MOL BIOL R, V67, P86, DOI 10.1128/MMBR.67.1.86-156.2003; Monod C, 1997, J MOL BIOL, V267, P237, DOI 10.1006/jmbi.1996.0867; MOODY MF, 1981, J MOL BIOL, V150, P217, DOI 10.1016/0022-2836(81)90450-2; MOODY MF, 1967, J MOL BIOL, V25, P167, DOI 10.1016/0022-2836(67)90136-2; MOODY MF, 1973, J MOL BIOL, V80, P613, DOI 10.1016/0022-2836(73)90200-3; Moore SD, 2002, CURR BIOL, V12, pR96, DOI 10.1016/S0960-9822(02)00670-X; Newcomb WW, 2001, J VIROL, V75, P10923, DOI 10.1128/JVI.75.22.10923-10932.2001; Orlova EV, 2003, EMBO J, V22, P1255, DOI 10.1093/emboj/cdg123; Rossmann MG, 2001, J STRUCT BIOL, V136, P190, DOI 10.1006/jsbi.2002.4435; SIMON LD, 1967, VIROLOGY, V32, P298, DOI 10.1016/0042-6822(67)90278-4; SIMON LD, 1967, VIROLOGY, V32, P279, DOI 10.1016/0042-6822(67)90277-2; Simpson AA, 2000, NATURE, V408, P745, DOI 10.1038/35047129; TAKEDA S, 1990, BIOCHEMISTRY-US, V29, P5050, DOI 10.1021/bi00473a008; Tao YZ, 1997, STRUCTURE, V5, P789, DOI 10.1016/S0969-2126(97)00233-5; Thomassen E, 2003, J MOL BIOL, V331, P361, DOI 10.1016/s0022-2836(03)00755-1; Vianelli A, 2000, J BACTERIOL, V182, P680, DOI 10.1128/JB.182.3.680-688.2000; WATTS NR, 1990, J MOL BIOL, V216, P312; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Xu ZH, 1998, J STRUCT BIOL, V124, P129, DOI 10.1006/jsbi.1998.4060; Zhao L, 2003, J BACTERIOL, V185, P1693, DOI 10.1128/JB.185.5.1693-1700.2003	59	208	229	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2004	118	4					419	429		10.1016/j.cell.2004.07.022	http://dx.doi.org/10.1016/j.cell.2004.07.022			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	850YS	15315755	Bronze			2022-12-24	WOS:000223650900005
J	Snow, RW				Snow, RW			The invisible victims	NATURE			English	Article							MALARIA; FUTURE		Kenya Med Res Inst Wellcome Trust Collaborat Prog, Nairobi, Kenya	Kenya Medical Research Institute	Snow, RW (corresponding author), Kenya Med Res Inst Wellcome Trust Collaborat Prog, Nairobi, Kenya.		Snow, Robert William/AFR-1436-2022	Snow, Robert William/0000-0003-3725-6088				Hay SI, 2004, LANCET INFECT DIS, V4, P327, DOI 10.1016/S1473-3099(04)01043-6; MONASCH R, IN PRESS AM J TROP M; Rogers DJ, 2002, NATURE, V415, P710, DOI 10.1038/415710a; Snow RW, 2001, TRENDS PARASITOL, V17, P593, DOI 10.1016/S1471-4922(01)02031-1; SNOW RW, 2003, 11 DCPP; United Nations Development Program, 2003, HUM DEV REP 2003 MIL; 2000, ABUJA DECLARATION RO	7	8	8	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 19	2004	430	7002					934	935		10.1038/430934a	http://dx.doi.org/10.1038/430934a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318234	Bronze			2022-12-24	WOS:000223369800057
J	Marbaix, E; Waignein, F; Camby, P; Escribano, ILD; Bernard, P; Sempoux, C				Marbaix, E; Waignein, F; Camby, P; Escribano, ILD; Bernard, P; Sempoux, C			Intranuclear biotin	LANCET			English	Editorial Material									Univ Catholique Louvain, Clin Univ St Luc, Dept Pathol, B-1200 Brussels, Belgium; Univ Catholique Louvain, Clin Univ St Luc, Dept Obstet, B-1200 Brussels, Belgium	Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Marbaix, E (corresponding author), Univ Catholique Louvain, Clin Univ St Luc, Dept Pathol, B-1200 Brussels, Belgium.			Sempoux, Christine/0000-0003-1375-3979					0	0	0	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 7	2004	364	9433					532	532		10.1016/S0140-6736(04)16813-X	http://dx.doi.org/10.1016/S0140-6736(04)16813-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BS	15302198				2022-12-24	WOS:000223132700034
J	Price, RN; Uhlemann, AC; Brockman, A; McGready, R; Ashley, E; Phaipun, L; Patel, R; Laing, K; Looareesuwan, S; White, NJ; Nosten, F; Krishna, S				Price, RN; Uhlemann, AC; Brockman, A; McGready, R; Ashley, E; Phaipun, L; Patel, R; Laing, K; Looareesuwan, S; White, NJ; Nosten, F; Krishna, S			Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number	LANCET			English	Article							WESTERN BORDER; INCREASED SENSITIVITY; DRUG SUSCEPTIBILITY; ARTESUNATE; MALARIA; ANTIMALARIALS; POLYMORPHISMS; AMPLIFICATION; COMBINATION; POPULATION	Background The borders of Thailand harbour the world's most multidrug resistant Plasmodium falciparum parasites. In 1984 mefloquine was introduced as treatment for uncomplicated falciparum malaria, but substantial resistance developed within 6 years. A combination of artesunate with mefloquine now cures more than 95% of acute infections. For both treatment regimens, the underlying mechanisms of resistance are not known. Methods The relation between polymorphisms in the P falciparum multidrug resistant gene 1 (pfmdr1) and the in-vitro and in-vivo responses to mefloquine were assessed in 618 samples from patients with falciparum malaria studied prospectively over 12 years. pfmdr1 copy number was assessed by a robust real-time PCR assay. Single nucleotide polymorphisms of pfmdr1, P falciparum chloroquine resistance transporter gene (pfcrt) and P falciparum Ca2+ ATPase gene (pfATP6) were assessed by PCR-restriction fragment length polymorphism. Findings Increased copy number of pfmdr1 was the most important determinant of in-vitro and in-vivo resistance to mefloquine, and also to reduced artesunate sensitivity in vitro. In a Cox regression model with control for known confounders, increased pfmdr1 copy number was associated with an attributable hazard ratio (AHR) for treatment failure of 6.3 (95% CI 2.9-13.8, p<0.001) after mefloquine monotherapy and 5.4 (2.0-14.6, p=0.001) after artesunate-mefloquine therapy. Single nucleotide polymorphisms in pfmdr1 were associated with increased mefloquine susceptibility in vitro, but not in vivo. Interpretation Amplification in pfmdr1 is the main cause of resistance to mefloquine in falciparum malaria. Relevance to practice Multidrug resistant P falciparum malaria is common in southeast Asia, but difficult to identify and treat. Genes that encode parasite transport proteins maybe involved in export of drugs and so cause resistance. In this study we show that increase in copy number of pfmdr1, a gene encoding a parasite transport protein, is the best overall predictor of treatment failure with mefloquine. Increase in pfmdr1 copy number predicts failure even after chemotherapy with the highly effective combination of mefloquine and 3 days' artesunate. Monitoring of pfmdr1 copy number will be useful in epidemiological surveys of drug resistance in P falciparum, and potentially for predicting treatment failure in individual patients.	Univ London St Georges Hosp, Sch Med, Dept Cellular & Mol Med Infect Dis, London SW17 0RE, England; John Radcliffe Hosp, Nuffield Dept Clin Med, Ctr Vaccinol & Trop Med, Oxford OX3 9DU, England; Shoklo Malaria Res Unit, Mae Sot, Tak Province, Thailand; Charles Darwin Univ, Menzies Sch Hlth Res, Darwin, NT, Australia; Mahidol Univ, Fac Trop Med, Bangkok, Thailand	St Georges University London; University of Oxford; Mahidol University; Charles Darwin University; Menzies School of Health Research; Mahidol University	Krishna, S (corresponding author), Univ London St Georges Hosp, Sch Med, Dept Cellular & Mol Med Infect Dis, London SW17 0RE, England.	s.krishna@sghms.ac.uk	McGready, Rose/A-3290-2014; White, Nick/AAC-6527-2019; White, Nicholas J/I-4629-2012; Nosten, Francois/AAC-5509-2019	McGready, Rose/0000-0003-1621-3257; White, Nick/0000-0002-1897-1978; Nosten, Francois/0000-0002-7951-0745; Price, Richard/0000-0003-2000-2874; Krishna, Sanjeev/0000-0003-0066-0634; Laing, Ken/0000-0003-1883-3433	Wellcome Trust [074637] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adagu IS, 2001, PARASITOLOGY, V123, P219, DOI 10.1017/S0031182001008344; BARNES DA, 1992, EMBO J, V11, P3067, DOI 10.1002/j.1460-2075.1992.tb05378.x; Basco LK, 1996, EXP PARASITOL, V82, P97, DOI 10.1006/expr.1996.0013; Basco LK, 1995, MOL BIOCHEM PARASIT, V74, P157, DOI 10.1016/0166-6851(95)02492-1; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brockman A, 1999, AM J TROP MED HYG, V60, P14, DOI 10.4269/ajtmh.1999.60.14; Brockman A, 2000, T ROY SOC TROP MED H, V94, P537, DOI 10.1016/S0035-9203(00)90080-4; Djimde A, 2001, NEW ENGL J MED, V344, P257, DOI 10.1056/NEJM200101253440403; Duraisingh MT, 2000, MOL BIOCHEM PARASIT, V108, P13, DOI 10.1016/S0166-6851(00)00201-2; Eckstein-Ludwig U, 2003, NATURE, V424, P957, DOI 10.1038/nature01813; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; FOOTE SJ, 1994, ACTA TROP, V56, P157, DOI 10.1016/0001-706X(94)90061-2; FOOTE SJ, 1989, CELL, V57, P921, DOI 10.1016/0092-8674(89)90330-9; Korenromp EL, 2003, LANCET INFECT DIS, V3, P349, DOI 10.1016/S1473-3099(03)00657-1; Krishna S, 2001, ANTIMICROB AGENTS CH, V45, P509, DOI 10.1128/AAC.45.2.509-516.2001; Luxemburger C, 1996, T ROY SOC TROP MED H, V90, P105, DOI 10.1016/S0035-9203(96)90102-9; Nosten F, 2000, LANCET, V356, P297, DOI 10.1016/S0140-6736(00)02505-8; Pickard AL, 2003, ANTIMICROB AGENTS CH, V47, P2418, DOI 10.1128/AAC.47.8.2418-2423.2003; Plowe CV, 2001, INFEC DIS S, P173; Price R, 1997, MOL BIOCHEM PARASIT, V85, P161, DOI 10.1016/S0166-6851(96)02822-8; Price RN, 1999, ANTIMICROB AGENTS CH, V43, P2943, DOI 10.1128/AAC.43.12.2943; Price RN, 1997, T ROY SOC TROP MED H, V91, P574, DOI 10.1016/S0035-9203(97)90032-8; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; Simpson JA, 1999, CLIN PHARMACOL THER, V66, P472, DOI 10.1016/S0009-9236(99)70010-X; terKuile FO, 1995, T ROY SOC TROP MED H, V89, P660, DOI 10.1016/0035-9203(95)90435-2; Thomas SM, 2002, AM J TROP MED HYG, V66, P474, DOI 10.4269/ajtmh.2002.66.474; Vaidya AB, 2001, INFEC DIS S, P203; White N, 1999, PHILOS T R SOC B, V354, P739, DOI 10.1098/rstb.1999.0426; WILSON CM, 1993, MOL BIOCHEM PARASIT, V57, P151, DOI 10.1016/0166-6851(93)90252-S; Zalis MG, 1998, AM J TROP MED HYG, V58, P630, DOI 10.4269/ajtmh.1998.58.630	30	606	619	0	32	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 31	2004	364	9432					438	447		10.1016/S0140-6736(04)16767-6	http://dx.doi.org/10.1016/S0140-6736(04)16767-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	842IX	15288742	Green Accepted			2022-12-24	WOS:000222998600034
J	Wang, Y; Wysocka, J; Sayegh, J; Lee, YH; Perlin, JR; Leonelli, L; Sonbuchner, LS; McDonald, CH; Cook, RG; Dou, Y; Roeder, RG; Clarke, S; Stallcup, MR; Allis, CD; Coonrod, SA				Wang, Y; Wysocka, J; Sayegh, J; Lee, YH; Perlin, JR; Leonelli, L; Sonbuchner, LS; McDonald, CH; Cook, RG; Dou, Y; Roeder, RG; Clarke, S; Stallcup, MR; Allis, CD; Coonrod, SA			Human PAD4 regulates histone arginine methylation levels via demethylimination	SCIENCE			English	Article							TRANSCRIPTIONAL ACTIVATION; RECEPTOR; RNA; DIMETHYLAMINOHYDROLASE; ACETYLATION; RESIDUES; PRMT1; H4	Methylation of arginine (Arg) and lysine residues in histories has been correlated with epigenetic forms of gene regulation. Although histone methyltransferases are known, enzymes that demethylate histories have not been identified. Here, we demonstrate that human peptidylarginine deiminase 4 (PAD4) regulates histone Arg methylation by converting methyl-Arg to citrulline and releasing methylamine. PAD4 targets multiple sites in histones H3 and H4, including those sites methylated by coactivators CARM1 (H3 Arg(17)) and PRMT1 (H4 Arg(3)). A decrease of histone Arg methylation, with a concomitant increase of citrullination, requires PAD4 activity in human HL-60 granulocytes. Moreover, PAD4 activity is linked with the transcriptional regulation of estrogen-responsive genes in MCF-7 cells. These data suggest that PAD4 mediates gene expression by regulating Arg methylation and citrullination in histories.	Rockefeller Univ, Lab Chromatin Biol, New York, NY 10021 USA; Cornell Univ, Dept Med Genet, Weill Med Coll, New York, NY 10021 USA; Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ So Calif, Dept Pathol, Los Angeles, CA 90089 USA; Baylor Coll Med, Dept Microbiol & Immunol, Houston, TX 77030 USA; Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA	Rockefeller University; Cornell University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Southern California; Baylor College of Medicine; Rockefeller University	Allis, CD (corresponding author), Rockefeller Univ, Lab Chromatin Biol, Box 78,1230 York Ave, New York, NY 10021 USA.	alliscd@rockefeller.edu; scc2003@med.cornell.edu	Leonelli, Lauriebeth/GYU-8762-2022; Lee, Young-Ho/G-2361-2014; zhang, shijun/K-3688-2013	Leonelli, Lauriebeth/0000-0001-7536-523X; Lee, Young-Ho/0000-0001-6415-4912; Wang, Yanming/0000-0002-0710-043X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038353] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK055274, R01DK055274] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026020] Funding Source: NIH RePORTER; NICHD NIH HHS [HD R01 38353] Funding Source: Medline; NIDDK NIH HHS [DK55274] Funding Source: Medline; NIGMS NIH HHS [GM R01 50659, GM R01 26020] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		An W, 2004, CELL, V117, P735, DOI 10.1016/j.cell.2004.05.009; Arita K, 2004, NAT STRUCT MOL BIOL, V11, P777, DOI 10.1038/nsmb799; Bannister AJ, 2002, CELL, V109, P801, DOI 10.1016/S0092-8674(02)00798-5; Barber CM, 2004, CHROMOSOMA, V112, P360, DOI 10.1007/s00412-004-0281-9; Bauer UM, 2002, EMBO REP, V3, P39, DOI 10.1093/embo-reports/kvf013; Boisvert FM, 2003, MOL CELL PROTEOMICS, V2, P1319, DOI 10.1074/mcp.M300088-MCP200; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; Chen DG, 1999, SCIENCE, V284, P2174, DOI 10.1126/science.284.5423.2174; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Georgieva EI, 1999, ANAL BIOCHEM, V269, P399, DOI 10.1006/abio.1999.4050; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hagiwara T, 2002, BIOCHEM BIOPH RES CO, V290, P979, DOI 10.1006/bbrc.2001.6303; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Mowen KA, 2001, CELL, V104, P731, DOI 10.1016/S0092-8674(02)08085-6; Murray-Rust J, 2001, NAT STRUCT BIOL, V8, P679, DOI 10.1038/90387; Nakatani T, 2002, J BIOL CHEM, V277, P9562, DOI 10.1074/jbc.M110132200; OGAWA T, 1989, J BIOL CHEM, V264, P10205; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; SAYEGH J, UNPUB; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strahl BD, 2001, CURR BIOL, V11, P996, DOI 10.1016/S0960-9822(01)00294-9; Tse C, 1998, MOL CELL BIOL, V18, P4629, DOI 10.1128/MCB.18.8.4629; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; WANG Y, UNPUB; XIE H, 1990, Methods (Orlando), V1, P276, DOI 10.1016/S1046-2023(05)80328-7; Xu W, 2001, SCIENCE, V294, P2507, DOI 10.1126/science.1065961; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	31	705	743	1	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 8	2004	306	5694					279	283		10.1126/science.1101400	http://dx.doi.org/10.1126/science.1101400			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	861MC	15345777				2022-12-24	WOS:000224419700041
J	Van Valkenburgh, B; Wang, XM; Damuth, J				Van Valkenburgh, B; Wang, XM; Damuth, J			Cope's rule, hypercarnivory, and extinction in North American canids	SCIENCE			English	Article							POPULATION-DENSITY; BODY-MASS; EVOLUTION; SIZE	Over the past 50 million years, successive clades of large carnivorous mammals diversified and then declined to extinction. In most instances, the cause of the decline remains a puzzle. Here we argue that energetic constraints and pervasive selection for larger size (Cope's rule) in carnivores lead to dietary specialization (hypercarnivory) and increased vulnerability to extinction. In two major clades of extinct North American canids, the evolution of large size was associated with a dietary shift to hypercarnivory and a decline in species durations. Thus, selection for attributes that promoted individual success resulted in progressive evolutionary failure of their clades.	Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; Natl Hist Museum Los Angeles Cty, Dept Vertebrate Paleontol, Los Angeles, CA 90007 USA; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Los Angeles; University of California System; University of California Santa Barbara	Van Valkenburgh, B (corresponding author), Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA.	bvanval@ucla.edu	Self, Casey J/B-6871-2011; Wang, Xiaoming/I-9033-2019	Wang, Xiaoming/0000-0003-1610-3840; Damuth, John/0000-0002-1635-9726				Alroy J, 1998, SCIENCE, V280, P731, DOI 10.1126/science.280.5364.731; Barry JC, 2002, PALEOBIOLOGY, V28, P1, DOI 10.1666/0094-8373(2002)28[1:FAECIT]2.0.CO;2; Baskin J.A., 1998, EVOLUTION TERTIARY M, V1, P144; BEHRENSMEYER AK, 1979, PALEOBIOLOGY, V5, P12, DOI 10.1017/S0094837300006254; Carbone C, 1999, NATURE, V402, P286, DOI 10.1038/46266; DAMUTH J, 1993, NATURE, V365, P748, DOI 10.1038/365748a0; DAMUTH J, 1982, PALEOBIOLOGY, V8, P434, DOI 10.1017/S009483730000717X; DAMUTH J, 1981, NATURE, V290, P699, DOI 10.1038/290699a0; DAMUTH J, 1987, BIOL J LINN SOC, V31, P193, DOI 10.1111/j.1095-8312.1987.tb01990.x; Jablonski D, 1997, NATURE, V385, P250, DOI 10.1038/385250a0; Jacobs L.L., 1998, EVOLUTION TERTIARY M; McKinney M.L., 1990, P75; Palomares F, 1999, AM NAT, V153, P492, DOI 10.1086/303189; Purvis A, 2000, P ROY SOC B-BIOL SCI, V267, P1947, DOI 10.1098/rspb.2000.1234; SKINNER MF, 1984, B AM MUS NAT HIST, V178, P217; Stanley S.M., 1979, MACROEVOLUTION PATTE; STANLEY SM, 1973, EVOLUTION, V27, P1, DOI 10.1111/j.1558-5646.1973.tb05912.x; TEDFORD RH, 1978, NUTR MANAGEMENT DOGS, pM23; Van Valkenburgh B, 1999, ANNU REV EARTH PL SC, V27, P463, DOI 10.1146/annurev.earth.27.1.463; van Valkenburgh B., 1990, P181; Van Valkenburgh B, 2003, B AM MUS NAT HIST, P147, DOI 10.1206/0003-0090(2003)279<0147:C>2.0.CO;2; Van Valkenburgh Blaire, 2001, P101; VANVALKENBURGH B, 1993, SYM ZOOL S, P15; VANVALKENBURGH B, 1991, PALEOBIOLOGY, V17, P340, DOI 10.1017/S0094837300010691; VANVALKENBURGH B, 2002, FOSSIL RECORD PREDA, V8, P267; VOORHIES MR, 1990, 8209 U NEBR; Wang XM, 1999, B AM MUS NAT HIST, P1; WANG XM, 1994, B AM MUS NAT HIST, P1	28	185	186	1	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2004	306	5693					101	104		10.1126/science.1102417	http://dx.doi.org/10.1126/science.1102417			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459388				2022-12-24	WOS:000224304000045
J	Tatem, AJ; Guerra, CA; Atkinson, PM; Hay, SI				Tatem, AJ; Guerra, CA; Atkinson, PM; Hay, SI			Momentous sprint at the 2156 Olympics?	NATURE			English	Article									Univ Oxford, Dept Zool, TALA Res Grp, Oxford OX1 3PS, England; Univ Southampton, Sch Geog, Southampton SO17 1BJ, Hants, England; KEMRI Wellcome Trust Res Labs, Publ Hlth Grp, Nairobi, Kenya	University of Oxford; University of Southampton	Tatem, AJ (corresponding author), Univ Oxford, Dept Zool, TALA Res Grp, S Parks Rd, Oxford OX1 3PS, England.	andy.tatem@zoology.oxford.ac.uk	Hay, Simon Iain/F-8967-2015; Atkinson, Peter M/L-9508-2013	Hay, Simon Iain/0000-0002-0611-7272; Atkinson, Peter/0000-0002-5489-6880	Wellcome Trust [069045] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		GILKS WR, 1994, STATISTICIAN, V43, P169, DOI 10.2307/2348941; Holden C, 2004, SCIENCE, V305, P639, DOI 10.1126/science.305.5684.639; RENDELL M, 2003, OLYMPICS ATHENS ATHE, P338; Vogel G, 2004, SCIENCE, V305, P632, DOI 10.1126/science.305.5684.632; WHIPP BJ, 1992, NATURE, V355, P25, DOI 10.1038/355025a0	5	53	54	1	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 30	2004	431	7008					525	525		10.1038/431525a	http://dx.doi.org/10.1038/431525a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15457248	Bronze, Green Accepted			2022-12-24	WOS:000224156700033
J	Tice, MM; Lowe, DR				Tice, MM; Lowe, DR			Photosynthetic microbial mats in the 3,416-Myr-old ocean	NATURE			English	Article							BARBERTON GREENSTONE-BELT; SOUTH-AFRICA; SWAZILAND SUPERGROUP; CHERTS; SEDIMENTOLOGY; GEOCHEMISTRY; MICROFOSSILS; AUSTRALIA	Recent re-evaluations of the geological record of the earliest life on Earth have led to the suggestion that some of the oldest putative microfossils(1) and carbonaceous matter were formed through abiotic hydrothermal processes(2,3). Similarly, many early Archaean ( more than 3,400-Myr-old) cherts have been reinterpreted as hydrothermal deposits rather than products of normal marine sedimentary processes(2,4,5). Here we present the results of a field, petrographic and geochemical study testing these hypotheses for the 3,416-Myr-old Buck Reef Chert, South Africa. From sedimentary structures and distributions of sand and mud, we infer that deposition occurred in normal open shallow to deep marine environments. The siderite enrichment that we observe in deep-water sediments is consistent with a stratified early ocean(6,7). We show that most carbonaceous matter was formed by photosynthetic mats within the euphotic zone and distributed as detrital matter by waves and currents to surrounding environments. We find no evidence that hydrothermal processes had any direct role in the deposition of either the carbonaceous matter or the enclosing sediments. Instead, we conclude that photosynthetic organisms had evolved and were living in a stratified ocean supersaturated in dissolved silica(8,9) 3,416 Myr ago.	Stanford Univ, Dept Geog & Environm Sci, Stanford, CA 94305 USA	Stanford University	Tice, MM (corresponding author), Stanford Univ, Dept Geog & Environm Sci, Stanford, CA 94305 USA.	mtice@pangea.stanford.edu						BOGGS S., 1995, PRINCIPLES SEDIMENTO; Brasier MD, 2002, NATURE, V416, P76, DOI 10.1038/416076a; DEWIT MJ, 1982, ECON GEOL, V77, P1783, DOI 10.2113/gsecongeo.77.8.1783; Garcia-Ruiz JM, 2003, SCIENCE, V302, P1194, DOI 10.1126/science.1090163; Horita J, 1999, SCIENCE, V285, P1055, DOI 10.1126/science.285.5430.1055; KLEIN C, 1989, ECON GEOL, V84, P1733, DOI 10.2113/gsecongeo.84.7.1733; Knauth LP, 2003, GEOL SOC AM BULL, V115, P566, DOI 10.1130/0016-7606(2003)115<0566:HACTIF>2.0.CO;2; LALLI CM, 1997, BIOL OCEANOGRAPHY IN; LILJESTRAND FL, 1999, GEOL S AM S, P83, DOI 10.1130/0-8137-2329-9.83; Lowe DR, 2003, GEOLOGY, V31, P909, DOI 10.1130/G19664.1; LOWE DR, 1994, NOBEL S, V84, P24; Madigan MT, 1997, BROCK BIOL MICROORGA; PARIS I, 1985, J GEOL, V93, P111, DOI 10.1086/628935; Schidlowski M, 2000, MICROBIAL SEDIMENTS, P84; SCHOPF JW, 1987, SCIENCE, V237, P70, DOI 10.1126/science.11539686; SIEVER R, 1992, GEOCHIM COSMOCHIM AC, V56, P3265, DOI 10.1016/0016-7037(92)90303-Z; SIMONSON BM, 1993, PRECAMBRIAN RES, V60, P287, DOI 10.1016/0301-9268(93)90052-4; Sumner DY, 1997, PALAIOS, V12, P302, DOI 10.2307/3515333; Tice MM, 2004, GEOLOGY, V32, P37, DOI 10.1130/G19915.1; Walsh M.M., 1999, GEOL S AM S, P329; Westall F, 2001, PRECAMBRIAN RES, V106, P93, DOI 10.1016/S0301-9268(00)00127-3	21	322	348	2	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 30	2004	431	7008					549	552		10.1038/nature02888	http://dx.doi.org/10.1038/nature02888			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15457255				2022-12-24	WOS:000224156700041
J	Cockell, CS; Stokes, MD				Cockell, CS; Stokes, MD			Ecology - Widespread colonization by polar hypoliths	NATURE			English	Editorial Material									British Antarctic Survey, NERC, Cambridge CB3 0ET, England; Scripps Inst Oceanog, Marine Phys Lab, La Jolla, CA 92037 USA	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of California System; University of California San Diego; Scripps Institution of Oceanography	Cockell, CS (corresponding author), British Antarctic Survey, NERC, High Cross, Cambridge CB3 0ET, England.	csco@bas.ac.uk						BLISS LC, 1984, HOLARCTIC ECOL, V7, P305; BROADY PA, 1981, BRIT PHYCOL J, V16, P231, DOI 10.1080/00071618100650241; Cockell CS, 2003, POLAR BIOL, V26, P62, DOI 10.1007/s00300-002-0438-z; Cockell CS, 2002, METEORIT PLANET SCI, V37, P1287, DOI 10.1111/j.1945-5100.2002.tb01029.x; GOLUBIC S, 1981, J SEDIMENT PETROL, V51, P475; Kessler MA, 2003, SCIENCE, V299, P380, DOI 10.1126/science.1077309; Schlesinger WH, 2003, ECOLOGY, V84, P3222, DOI 10.1890/02-0549; Smith MC, 2000, ANTARCT SCI, V12, P177, DOI 10.1017/S0954102000000237	8	78	84	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 23	2004	431	7007					414	414		10.1038/431414a	http://dx.doi.org/10.1038/431414a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15386002	Bronze			2022-12-24	WOS:000224000500030
J	Pikarsky, E; Porat, RM; Stein, I; Abramovitch, R; Amit, S; Kasem, S; Gutkovich-Pyest, E; Urieli-Shoval, S; Galun, E; Ben-Neriah, Y				Pikarsky, E; Porat, RM; Stein, I; Abramovitch, R; Amit, S; Kasem, S; Gutkovich-Pyest, E; Urieli-Shoval, S; Galun, E; Ben-Neriah, Y			NF-kappa B functions as a tumour promoter in inflammation-associated cancer	NATURE			English	Article							HEPATOCELLULAR-CARCINOMA; MOUSE MODEL; DNA-DAMAGE; IKK-BETA; LIVER; APOPTOSIS; MICE; ACTIVATION; INHIBITION; TARGET	The causes of sporadic human cancer are seldom recognized, but it is estimated that carcinogen exposure and chronic inflammation are two important underlying conditions for tumour development, the latter accounting for approximately 20% of human cancer(1). Whereas the causal relationship between carcinogen exposure and cancer has been intensely investigated(2), the molecular and cellular mechanisms linking chronic inflammation to tumorigenesis remain largely unresolved(1). We proposed that activation of the nuclear factor kappaB (NF-kappaB), a hallmark of inflammatory responses(3) that is frequently detected in tumours(4,5), may constitute a missing link between inflammation and cancer. To test this hypothesis, we studied the Mdr2-knockout mouse strain, which spontaneously develops cholestatic hepatitis followed by hepatocellular carcinoma(6), a prototype of inflammation-associated cancer(7). We monitored hepatitis and cancer progression in Mdr2-knockout mice, and here we show that the inflammatory process triggers hepatocyte NF-kappaB through upregulation of tumour-necrosis factor-alpha (TNFalpha) in adjacent endothelial and inflammatory cells. Switching off NF-kappaB in mice from birth to seven months of age, using a hepatocyte-specific inducible IkappaB-super-repressor transgene, had no effect on the course of hepatitis, nor did it affect early phases of hepatocyte transformation. By contrast, suppressing NF-kappaB inhibition through anti-TNFalpha treatment or induction of IkappaB-superrepressor in later stages of tumour development resulted in apoptosis of transformed hepatocytes and failure to progress to hepatocellular carcinoma. Our studies thus indicate that NF-kappaB is essential for promoting inflammation-associated cancer, and is therefore a potential target for cancer prevention in chronic inflammatory diseases.	Hadassah Hebrew Univ Med Ctr, Dept Pathol, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91120 Jerusalem, Israel; Goldyne Savad Inst Gene Therapy, IL-91120 Jerusalem, Israel; Hadassah Univ Hosp, Hematol Unit, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Pikarsky, E (corresponding author), Hadassah Hebrew Univ Med Ctr, Dept Pathol, IL-91120 Jerusalem, Israel.	peli@hadassah.org.il; yinon@cc.huji.ac.il	pikarsky, eli/GXV-7099-2022; Galun, Eithan/AAD-9117-2022; Ben-Neriah, Yinon/L-6285-2019	Galun, Eithan/0000-0002-6243-6702; pikarsky, eli/0000-0003-4186-7105				Balmain A, 2000, CARCINOGENESIS, V21, P371, DOI 10.1093/carcin/21.3.371; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Block TM, 2003, ONCOGENE, V22, P5093, DOI 10.1038/sj.onc.1206557; Bruix J, 2004, CANCER CELL, V5, P215, DOI 10.1016/S1535-6108(04)00058-3; Chaisson ML, 2002, J CLIN INVEST, V110, P193, DOI 10.1172/JCI200215295; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; De Vree JML, 2000, GASTROENTEROLOGY, V119, P1720, DOI 10.1053/gast.2000.20222; Eferl R, 2003, CELL, V112, P181, DOI 10.1016/S0092-8674(03)00042-4; Ehrhardt H, 2003, ONCOGENE, V22, P3842, DOI 10.1038/sj.onc.1206520; Friedberg EC, 2004, CURR OPIN GENET DEV, V14, P5, DOI 10.1016/j.gde.2003.11.001; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Gupta S, 2000, SEMIN CANCER BIOL, V10, P161; Kennedy NJ, 2003, CELL CYCLE, V2, P199, DOI 10.4161/cc.2.3.388; Lavon I, 2000, NAT MED, V6, P573, DOI 10.1038/75057; Lavon I, 2003, CANCER RES, V63, P25; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lin A, 2003, SEMIN CANCER BIOL, V13, P107, DOI 10.1016/S1044-579X(02)00128-1; Maeda S, 2003, IMMUNITY, V19, P725, DOI 10.1016/S1074-7613(03)00301-7; MAUAD TH, 1994, AM J PATHOL, V145, P1237; MAYO MW, 2000, BIOCHIM BIOPHYS ACTA, V1470, P55; Nakamoto Y, 1998, J EXP MED, V188, P341, DOI 10.1084/jem.188.2.341; Papa S, 2004, NAT CELL BIOL, V6, P146, DOI 10.1038/ncb1093; Radisky D, 2001, SEMIN CANCER BIOL, V11, P87, DOI 10.1006/scbi.2000.0360; Staudt LM, 2003, NEW ENGL J MED, V348, P1777, DOI 10.1056/NEJMra020067; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Wang JS, 1999, MUTAT RES-FUND MOL M, V424, P167, DOI 10.1016/S0027-5107(99)00017-2; Wilson J, 2002, SEMIN CANCER BIOL, V12, P113, DOI 10.1006/scbi.2001.0419	27	1997	2127	10	202	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 23	2004	431	7007					461	466		10.1038/nature02924	http://dx.doi.org/10.1038/nature02924			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15329734				2022-12-24	WOS:000224000500043
J	Beliveau, R; Gingras, D				Beliveau, R; Gingras, D			Green tea: prevention and treatment of cancer by nutraceuticals	LANCET			English	Editorial Material									Hop Ste Justine UQAM, Ctr Canc Charles Bruneau, Mol Med Lab, Montreal, PQ H3T 1C, Canada	University of Quebec; University of Quebec Montreal	Beliveau, R (corresponding author), Hop Ste Justine UQAM, Ctr Canc Charles Bruneau, Mol Med Lab, Montreal, PQ H3T 1C, Canada.	beliveau.richard@uqam.ca						Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Cao YH, 1999, NATURE, V398, P381, DOI 10.1038/18793; de Botton S, 2004, J CLIN ONCOL, V22, P1404, DOI 10.1200/JCO.2004.09.008; Demeule Michel, 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P441, DOI 10.2174/1568011023353930; Folkman J, 2003, CURR MOL MED, V3, P643, DOI 10.2174/1566524033479465; GAO YT, 1994, JNCI-J NATL CANCER I, V86, P855, DOI 10.1093/jnci/86.11.855; Gescher AJ, 2001, LANCET ONCOL, V2, P371, DOI 10.1016/S1470-2045(00)00392-2; Lamy S, 2002, CANCER RES, V62, P381; Lee YK, 2004, BLOOD, V104, P788, DOI 10.1182/blood-2003-08-2763; Pisters KMW, 2001, J CLIN ONCOL, V19, P1830, DOI 10.1200/JCO.2001.19.6.1830	10	33	35	3	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 18	2004	364	9439					1021	1022		10.1016/S0140-6736(04)17076-1	http://dx.doi.org/10.1016/S0140-6736(04)17076-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	855FT	15380952				2022-12-24	WOS:000223959300008
J	Levey, DJ; Duncan, RS; Levins, CF				Levey, DJ; Duncan, RS; Levins, CF			Use of dung as a tool by burrowing owls	NATURE			English	Editorial Material							CALEDONIAN CROWS; ECOLOGY		Univ Florida, Dept Zool, Gainesville, FL 32611 USA; Birmingham So Coll, Div Sci & Math, Birmingham, AL 35254 USA	State University System of Florida; University of Florida	Levey, DJ (corresponding author), Univ Florida, Dept Zool, POB 118525, Gainesville, FL 32611 USA.	dlevey@zoo.ufl.edu						Cristol DA, 1997, AUK, V114, P296, DOI 10.2307/4089172; HAUG EA, 1993, BURROWING OWL; HENRICH B, 1988, CONDOR, V90, P270; Hunt GR, 1996, NATURE, V379, P249, DOI 10.1038/379249a0; MARTIN DJ, 1973, CONDOR, V75, P446, DOI 10.2307/1366565; ROBINSON SK, 1994, WILSON BULL, V106, P567; Tebbich S, 2002, ECOL LETT, V5, P656, DOI 10.1046/j.1461-0248.2002.00370.x; Weir AAS, 2002, SCIENCE, V297, P981, DOI 10.1126/science.1073433; Woodruff R. E., 1973, SCARAB BEETLES FLORI	9	40	45	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 2	2004	431	7004					39	39		10.1038/431039a	http://dx.doi.org/10.1038/431039a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850VC	15343324				2022-12-24	WOS:000223641500031
J	Heathcote, J				Heathcote, J			Abnormal liver function found after an unplanned consultation: case outcome	BRITISH MEDICAL JOURNAL			English	Editorial Material									S View Lodge, Bromley BR1 3DR, Kent, England		Heathcote, J (corresponding author), S View Lodge, Bromley BR1 3DR, Kent, England.	james.heathcote@gp-G84001.nhs.uk							0	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 28	2004	329	7464					500	500		10.1136/bmj.329.7464.500	http://dx.doi.org/10.1136/bmj.329.7464.500			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	851KS	15331476	Green Published			2022-12-24	WOS:000223684600021
J	Sun, HM; Ringdahl, U; Homeister, JW; Fay, WP; Engleberg, NC; Yang, AY; Rozek, LS; Wang, XX; Sjobring, U; Ginsburg, D				Sun, HM; Ringdahl, U; Homeister, JW; Fay, WP; Engleberg, NC; Yang, AY; Rozek, LS; Wang, XX; Sjobring, U; Ginsburg, D			Plasminogen is a critical host pathogenicity factor for group A streptococcal infection	SCIENCE			English	Article							LIGNEOUS CONJUNCTIVITIS; PLASMIN(OGEN) SYSTEM; PROTEIN PAM; VIRULENCE; MICE; DEFICIENCY; STREPTOKINASE; THROMBOSIS; ACTIVATION; PYOGENES	Group A streptococci, a common human pathogen, secrete streptokinase, which activates the host's blood clot-dissolving protein, plasminogen. Streptokinase is highly specific for human plasminogen, exhibiting little or no activity against other mammalian species, including mouse. Here, a transgene expressing human plasminogen markedly increased mortality in mice infected with streptococci, and this susceptibility was dependent on bacterial streptokinase expression. Thus, streptokinase is a key pathogenicity factor and the primary determinant of host species specificity for group A streptococcal infection. In addition, local fibrin clot formation may be implicated in host defense against microbial pathogens.	Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; Lund Univ, Dept Lab Med, Sect Microbiol Immunol & Glycobiol, SE-22184 Lund, Sweden	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; Lund University	Ginsburg, D (corresponding author), Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.	ginsburg@umich.edu			NHLBI NIH HHS [P01HL057346] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057346] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bisno AL, 1996, NEW ENGL J MED, V334, P240, DOI 10.1056/NEJM199601253340407; Boyle MDP, 2000, METHODS, V21, P99, DOI 10.1006/meth.2000.0980; Braunwald E, 1996, NEW ENGL J MED, V334, P51, DOI 10.1056/NEJM199601043340113; BUGGE TH, 1995, GENE DEV, V9, P794, DOI 10.1101/gad.9.7.794; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Coleman JL, 1997, CELL, V89, P1111, DOI 10.1016/S0092-8674(00)80298-6; Collen D, 1998, NAT MED, V4, P279, DOI 10.1038/nm0398-279; Drew AF, 1998, BLOOD, V91, P1616, DOI 10.1182/blood.V91.5.1616.1616_1616_1624; Gladysheva IP, 2003, P NATL ACAD SCI USA, V100, P9168, DOI 10.1073/pnas.1631716100; Heath A, 1999, INFECT IMMUN, V67, P5298, DOI 10.1128/IAI.67.10.5298-5305.1999; Herwald H, 2004, CELL, V116, P367, DOI 10.1016/S0092-8674(04)00057-1; Johansson L, 2003, SCIENCE, V301, P373, DOI 10.1126/science.1086476; Khil J, 2003, J INFECT DIS, V188, P497, DOI 10.1086/377100; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; Li ZQ, 1999, J INFECT DIS, V179, P907, DOI 10.1086/314654; LIJNEN HR, 1994, EUR J BIOCHEM, V224, P863, DOI 10.1111/j.1432-1033.1994.00863.x; Lijnen HR, 1999, BLOOD, V93, P2274, DOI 10.1182/blood.V93.7.2274.407a30_2274_2281; MCCOY HE, 1991, J INFECT DIS, V164, P515, DOI 10.1093/infdis/164.3.515; MCKILLOP C, 1975, NATURE, V255, P638, DOI 10.1038/255638a0; PLOPLIS VA, 1995, CIRCULATION, V92, P2585, DOI 10.1161/01.CIR.92.9.2585; Ringdahl U, 1998, J BIOL CHEM, V273, P6424, DOI 10.1074/jbc.273.11.6424; Schott D, 1998, NEW ENGL J MED, V339, P1679, DOI 10.1056/NEJM199812033392305; SODEINDE OA, 1992, SCIENCE, V258, P1004, DOI 10.1126/science.1439793; Wistedt AC, 1998, J BIOL CHEM, V273, P24420, DOI 10.1074/jbc.273.38.24420	24	300	310	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 27	2004	305	5688					1283	1286		10.1126/science.1101245	http://dx.doi.org/10.1126/science.1101245			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850PJ	15333838				2022-12-24	WOS:000223624600039
J	Hiramatsu, K; Cui, LZ; Kuwahara-Arai, K				Hiramatsu, K; Cui, LZ; Kuwahara-Arai, K			Has vancomycin-resistant Staphylococcus aureus started going it alone?	LANCET			English	Editorial Material									Juntendo Univ, Postgrad Sch Med, Dept Microbiol & Infect Control Sci, Tokyo 1138421, Japan	Juntendo University	Hiramatsu, K (corresponding author), Juntendo Univ, Postgrad Sch Med, Dept Microbiol & Infect Control Sci, Tokyo 1138421, Japan.	hiram@med.juntendo.ac.jp		cui (Cui), long zhu (Longzhu)/0000-0002-8909-3885				ARTHUR M, 1992, J BACTERIOL, V174, P2582, DOI 10.1128/jb.174.8.2582-2591.1992; Chang S, 2003, NEW ENGL J MED, V348, P1342, DOI 10.1056/NEJMoa025025; Cui L, 2003, J CLIN MICROBIOL, V41, P5, DOI 10.1128/JCM.41.1.5-14.2003; Fridkin SK, 2003, CLIN INFECT DIS, V36, P429, DOI 10.1086/346207; Hiramatsu K, 2001, Lancet Infect Dis, V1, P147, DOI 10.1016/S1473-3099(01)00091-3; Hiramatsu K, 1997, LANCET, V350, P1670, DOI 10.1016/S0140-6736(97)07324-8; VOSS A, 1994, EUR J CLIN MICROBIOL, V13, P50, DOI 10.1007/BF02026127; Weigel LM, 2003, SCIENCE, V302, P1569, DOI 10.1126/science.1090956; Whitener CJ, 2004, CLIN INFECT DIS, V38, P1049, DOI 10.1086/382357	9	12	12	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 14	2004	364	9434					565	566		10.1016/S0140-6736(04)16867-0	http://dx.doi.org/10.1016/S0140-6736(04)16867-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845WD	15313343				2022-12-24	WOS:000223275100009
J	Deroche-Gamonet, V; Belin, D; Piazza, PV				Deroche-Gamonet, V; Belin, D; Piazza, PV			Evidence for addiction-like behavior in the rat	SCIENCE			English	Article							NUCLEUS-ACCUMBENS CORE; COCAINE-SEEKING; AMPHETAMINE; RELAPSE; PREDICT; VULNERABILITY; MODEL; BRAIN	Although the voluntary intake of drugs of abuse is a behavior largely preserved throughout phylogeny, it is currently unclear whether pathological drug use ("addiction") can be observed in species other than humans. Here, we report that behaviors that resemble three of the essential diagnostic criteria for addiction appear over time in rats trained to self-administer cocaine. As in humans, this addiction-like behavior is present only in a small proportion of subjects using cocaine and is highly predictive of relapse after withdrawal. These findings provide a new basis for developing a true understanding and treatment of addiction.	Univ Victor Segalen Bordeaux 2, Bordeaux Inst Neurosci, Lab Physiopathol Comportements, INSERM U588, F-33077 Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Piazza, PV (corresponding author), Univ Victor Segalen Bordeaux 2, Bordeaux Inst Neurosci, Lab Physiopathol Comportements, INSERM U588, Rue Camille St Saens, F-33077 Bordeaux, France.	piazza@bordeaux.inserm.fr	Deroche-Gamonet, Véronique/E-5728-2010; Belin, David/E-1231-2014	Belin, David/0000-0002-7383-372X; Deroche-Gamonet, Veronique/0000-0002-9704-6624				Abramson CI, 2000, ALCOHOL CLIN EXP RES, V24, P1153, DOI 10.1111/j.1530-0277.2000.tb02078.x; *AM PSYCH ASS WASH, 2000, DIAGN STAT MAN MENT; Anthony JC, 1994, EXP CLIN PSYCHOPHARM, V2, P244, DOI 10.1037/1064-1297.2.3.244; Cardinal RN, 2001, SCIENCE, V292, P2499, DOI 10.1126/science.1060818; Crowley TJ, 1998, DRUG ALCOHOL DEPEN, V49, P225, DOI 10.1016/S0376-8716(98)00016-7; DEJONG W, 1994, INT J ADDICT, V29, P681, DOI 10.3109/10826089409047904; DEWIT H, 1986, DRUG ALCOHOL DEPEN, V16, P341, DOI 10.1016/0376-8716(86)90068-2; Enoch Mary-Anne, 2003, Am J Pharmacogenomics, V3, P217, DOI 10.2165/00129785-200303040-00001; Everitt BJ, 2002, J NEUROSCI, V22, P3312; Fergusson DM, 2003, ARCH GEN PSYCHIAT, V60, P1033, DOI 10.1001/archpsyc.60.10.1033; GOLDBERG SR, 1969, SCIENCE, V166, P1303, DOI 10.1126/science.166.3910.1306; Homberg JR, 2002, EUR J NEUROSCI, V15, P1542, DOI 10.1046/j.1460-9568.2002.01976.x; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Ito R, 2004, NAT NEUROSCI, V7, P389, DOI 10.1038/nn1217; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; Kusayama T, 2000, NEUROREPORT, V11, P2511, DOI 10.1097/00001756-200008030-00033; Nestler EJ, 1997, SCIENCE, V278, P58, DOI 10.1126/science.278.5335.58; OBrien Cp E.R., 1986, BEHAV ANAL DRUG DEPE, P329; Piazza PV, 2000, J NEUROSCI, V20, P4226; PIAZZA PV, 1989, SCIENCE, V245, P1511, DOI 10.1126/science.2781295; PICKENS R, 1968, PSYCHOPHARMACOLOGIA, V12, P158, DOI 10.1007/BF00401545; Richardson NR, 1996, J NEUROSCI METH, V66, P1, DOI 10.1016/0165-0270(95)00153-0; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; SCHUSTER CR, 1969, ANNU REV PHARMACOLOG, V9, P483, DOI 10.1146/annurev.pa.09.040169.002411; Shaham Y, 2000, BRAIN RES REV, V33, P13, DOI 10.1016/S0165-0173(00)00024-2; Shaham Y, 2003, PSYCHOPHARMACOLOGY, V168, P3, DOI 10.1007/s00213-002-1224-x; Spanagel R, 1995, PSYCHOPHARMACOLOGY, V122, P369, DOI 10.1007/BF02246268; WEEKS JR, 1962, SCIENCE, V138, P143, DOI 10.1126/science.138.3537.143; Wise RA, 2002, NEURON, V36, P229, DOI 10.1016/S0896-6273(02)00965-0	29	791	808	2	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2004	305	5686					1014	1017		10.1126/science.1099020	http://dx.doi.org/10.1126/science.1099020			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845ND	15310906				2022-12-24	WOS:000223250700051
J	Fichet, G; Comoy, E; Duval, C; Antloga, K; Dehen, C; Charbonnier, A; McDonnell, G; Brown, P; Lasmezas, CI; Deslys, JP				Fichet, G; Comoy, E; Duval, C; Antloga, K; Dehen, C; Charbonnier, A; McDonnell, G; Brown, P; Lasmezas, CI; Deslys, JP			Novel methods for disinfection of prion-contaminated medical devices	LANCET			English	Article							CREUTZFELDT-JAKOB-DISEASE; BOVINE SPONGIFORM ENCEPHALOPATHY; TISSUE DISTRIBUTION; SCRAPIE AGENT; TRANSMISSION; DECONTAMINATION; INACTIVATION; INFECTIVITY; PROTEIN; HEALTH	Background The unique resistance of prions to classic methods of decontamination, and evidence that prion diseases can be transmitted iatrogenically by medical devices pose a serious infection control challenge to healthcare facilities. In view of the widespread tissue distribution of the variant Creutzfeldt-Jakob disease agent in human beings, new practicable decontamination procedures are urgently needed. Methods We adapted an in-vivo method using stainless steel wires contaminated with prions to the hamster-adapted scrapie strain 263K. A new in-vitro protocol of surface contamination compatible with subsequent biochemical detection of PrPres (protease-resistant form of the prion protein) from the treated surface was developed to explore the mechanisms of action of methods of decontamination under test. These models were used to investigate the effectiveness of innovative physical and chemical methods of prion inactivation. Findings Standard chemical decontamination methods (NaOH IN, NaOCl 20 000 ppm) and autoclaving in water at 134degreesC reduced infectivity by >5.6 log(10) lethal doses; autoclaving without immersion was somewhat less effective (4-4.5 log reduction). Three milder treatments, including a phenolic disinfectant, an alkaline cleaner, and the combination of an enzymatic cleaner and vaporised hydrogen peroxide (VHP) were also effective. VHP alone, which can be compatible with electronic components, achieved an approximately 4.5 log reduction in infectivity (equivalent to autoclaving without water immersion). Interpretation New decontamination procedures are proposed to ensure the safety of medical and surgical instruments as well as surfaces that cannot withstand the currently recommended prion inactivation procedures.	CEA, DSV, DRM, Grp Innovat Diagnost & Therapeut Infect Prions, F-92265 Fontenay Aux Roses, France; Anjou Rech Veolia Water, F-94417 St Maurice, France; Steris, Basingstoke, Hants, England; EFS Nord France, F-59800 Lille, France	CEA; Veolia; Universite de Lille - ISITE; Universite de Lille	Comoy, E (corresponding author), CEA, DSV, DRM, Grp Innovat Diagnost & Therapeut Infect Prions, 18 Route Panorama, F-92265 Fontenay Aux Roses, France.	emmanuel.comoy@cea.fr		Jas, Christelle/0000-0001-6311-6017	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002957] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adjou KT, 1999, J GEN VIROL, V80, P1079, DOI 10.1099/0022-1317-80-4-1079; Antloga K, 2000, ASAIO J, V46, pS69, DOI 10.1097/00002480-200011000-00040; Barret A, 2003, J VIROL, V77, P8462, DOI 10.1128/JVI.77.15.8462-8469.2003; BROWN P, 1982, J INFECT DIS, V145, P683, DOI 10.1093/infdis/145.2.683; BROWN P, 1994, ANN NEUROL, V35, P513, DOI 10.1002/ana.410350504; BROWN P, 1984, NEW ENGL J MED, V310, P727; Deslys JP, 2001, NATURE, V409, P476, DOI 10.1038/35054134; ERNST DR, 1993, J VIROL METHODS, V41, P193, DOI 10.1016/0166-0934(93)90126-C; Flechsig E, 2001, MOL MED, V7, P679, DOI 10.1007/BF03401958; GIBBS CJ, 1994, J NEUROL NEUROSUR PS, V57, P757, DOI 10.1136/jnnp.57.6.757; Head MW, 2004, AM J PATHOL, V164, P143, DOI 10.1016/S0002-9440(10)63105-7; Herzog C, 2004, LANCET, V363, P422, DOI 10.1016/S0140-6736(04)15487-1; Kasermann F, 2003, J GEN VIROL, V84, P3173, DOI 10.1099/vir.0.19355-0; KIMBERLIN RH, 1977, J GEN VIROL, V34, P295, DOI 10.1099/0022-1317-34-2-295; Krause J, 2001, CONTEMP TOP LAB ANIM, V40, P18; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee DC, 2000, J VIROL METHODS, V84, P77, DOI 10.1016/S0166-0934(99)00135-4; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; McDonnell G, 2003, CLIN INFECT DIS, V36, P1152, DOI 10.1086/374668; Race RE, 2004, J VIROL, V78, P2164, DOI 10.1128/JVI.78.4.2164-2165.2004; REED L. J., 1938, AMER JOUR HYG, V27, P493; TAYLOR DM, 1994, ARCH VIROL, V139, P313, DOI 10.1007/BF01310794; Taylor DM, 1998, VET MICROBIOL, V64, P33, DOI 10.1016/S0378-1135(98)00257-0; TAYLOR DM, 1991, VET MICROBIOL, V27, P19, DOI 10.1016/0378-1135(91)90059-O; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; *WHO, 1999, WHOCDSCSRAPH2003; Zobeley E, 1999, MOL MED, V5, P240, DOI 10.1007/BF03402121	27	163	172	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 7	2004	364	9433					521	526		10.1016/S0140-6736(04)16810-4	http://dx.doi.org/10.1016/S0140-6736(04)16810-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BS	15302195				2022-12-24	WOS:000223132700031
J	Nettles, JH; Li, HL; Cornett, B; Krahn, JM; Snyder, JP; Downing, KH				Nettles, JH; Li, HL; Cornett, B; Krahn, JM; Snyder, JP; Downing, KH			The binding mode of epothilone A on alpha,beta-tubulin by electron crystallography	SCIENCE			English	Article							CONFORMATION-ACTIVITY RELATIONSHIPS; POLYKETIDE NATURAL-PRODUCTS; COMMON PHARMACOPHORE; BIOLOGICAL-ACTIVITY; BETA-TUBULIN; CHEMICAL-SYNTHESIS; PACLITAXEL; MUTATIONS; TAXOL; STABILITY	The structure of epothilone A, bound to alpha, beta-tubulin in zinc-stabilized sheets, was determined by a combination of electron crystallography at 2.89 angstrom resolution and nuclear magnetic resonance-based conformational analysis. The complex explains both the broad-based epothilone structure-activity relationship and the known mutational resistance pro. le. Comparison with Taxol shows that the longstanding expectation of a common pharmacophore is not met, because each ligand exploits the tubulin-binding pocket in a unique and independent manner.	Emory Univ, Dept Chem, Atlanta, GA 30322 USA; Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; NIEHS, Struct Biol Lab, Res Triangle Pk, NC 27709 USA; Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA	Emory University; United States Department of Energy (DOE); Brookhaven National Laboratory; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Snyder, JP (corresponding author), Emory Univ, Dept Chem, 1515 Pierce Dr, Atlanta, GA 30322 USA.	snyder@euch4e.chem.emory.edu; khdowning@lbl.gov		Li, Huilin/0000-0001-8085-8928; Nettles, James/0000-0002-5683-8481				BOLLAG DM, 1995, CANCER RES, V55, P2325; Carlomagno T, 2003, ANGEW CHEM INT EDIT, V42, P2511, DOI 10.1002/anie.200351276; Giannakakou P, 2000, P NATL ACAD SCI USA, V97, P2904, DOI 10.1073/pnas.040546297; Giannakakou P, 1997, J BIOL CHEM, V272, P17118, DOI 10.1074/jbc.272.27.17118; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Guastalla JP, 2003, BRIT J CANCER, V89, pS16, DOI 10.1038/sj.bjc.6601496; Hardt IH, 2001, J NAT PROD, V64, P847, DOI 10.1021/np000629f; He LF, 2000, BIOCHEMISTRY-US, V39, P3972, DOI 10.1021/bi992518p; He LF, 2001, MOL CANCER THER, V1, P3; HOFLE G, 1993, CHEM ABSTR 52841, V120; Jimenez-Barbero Jesus, 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P91, DOI 10.2174/1568011023354416; Johnson J, 2000, ORG LETT, V2, P1537, DOI 10.1021/ol0058240; Kar S, 2003, EMBO J, V22, P70, DOI 10.1093/emboj/cdg001; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Nagano S, 2003, J BIOL CHEM, V278, P44886, DOI 10.1074/jbc.M308115200; Nicolaou KC, 2000, CHEM BIOL, V7, P593, DOI 10.1016/S1074-5521(00)00006-5; Nicolaou KC, 1998, ANGEW CHEM INT EDIT, V37, P2015, DOI 10.1002/(SICI)1521-3773(19980817)37:15<2014::AID-ANIE2014>3.0.CO;2-2; Nicolaou KC, 2003, ANGEW CHEM INT EDIT, V42, P3515, DOI 10.1002/anie.200351819; Nicolaou KC, 2001, J AM CHEM SOC, V123, P9313, DOI 10.1021/ja011338b; Nicolaou KC, 2001, CHEM COMMUN, P1523, DOI 10.1039/b104949f; Ojima I, 1999, P NATL ACAD SCI USA, V96, P4256, DOI 10.1073/pnas.96.8.4256; Regueiro-Ren A, 2002, ORG LETT, V4, P3815, DOI 10.1021/ol026589j; Regueiro-Ren A, 2001, ORG LETT, V3, P2693, DOI 10.1021/ol016273w; Rivkin A, 2003, J AM CHEM SOC, V125, P2899, DOI 10.1021/ja029695p; Singla AK, 2002, INT J PHARMACEUT, V235, P179, DOI 10.1016/S0378-5173(01)00986-3; Snyder JP, 2001, P NATL ACAD SCI USA, V98, P5312, DOI 10.1073/pnas.051309398; Taylor RE, 2004, ORG BIOMOL CHEM, V2, P127, DOI 10.1039/b312213c; Taylor RE, 2003, J AM CHEM SOC, V125, P26, DOI 10.1021/ja028196l; Verrills NM, 2003, CHEM BIOL, V10, P597, DOI 10.1016/S1074-5521(03)00141-8; Wang MM, 2000, J ORG CHEM, V65, P1059, DOI 10.1021/jo9916075; Wang MM, 1999, ORG LETT, V1, P43, DOI 10.1021/ol990521v; Wartmann M., 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P123, DOI 10.2174/1568011023354489	32	359	369	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					866	869		10.1126/science.1099190	http://dx.doi.org/10.1126/science.1099190			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297674				2022-12-24	WOS:000223104900049
J	D'Souza, V; Summers, MF				D'Souza, V; Summers, MF			Structural basis for packaging the dimeric genome of Moloney murine leukaemia virus	NATURE			English	Article							NUCLEOCAPSID PROTEIN; RETROVIRAL RNA; NMR STRUCTURE; ENCAPSIDATION SIGNAL; ZINC-FINGER; DIMERIZATION; RECOGNITION; ELEMENT; COMPLEX; VIRIONS	All retroviruses specifically package two copies of their genomes during virus assembly, a requirement for strand-transfer-mediated recombination during reverse transcription(1,2). Genomic RNA exists in virions as dimers, and the overlap of RNA elements that promote dimerization and encapsidation suggests that these processes may be coupled(3-5). Both processes are mediated by the nucleocapsid domain (NC) of the retroviral Gag polyprotein(3). Here we show that dimerization-induced register shifts in base pairing within the Psi-RNA packaging signal of Moloney murine leukaemia virus (MoMuLV) expose conserved UCUG elements that bind NC with high affinity ( dissociation constant = 75 +/- 12 nM). These elements are base-paired and do not bind NC in the monomeric RNA. The structure of the NC complex with a 101-nucleotide 'core encapsidation' segment of the MoMuLV Psi site(6) reveals a network of interactions that promote sequence- and structure-specific binding by NC's single CCHC zinc knuckle. Our findings support a structural RNA switch mechanism for genome encapsidation, in which protein binding sites are sequestered by base pairing in the monomeric RNA and become exposed upon dimerization to promote packaging of a diploid genome.	Univ Maryland Baltimore Cty, Howard Hughes Med Inst, Baltimore, MD 21250 USA; Univ Maryland Baltimore Cty, Dept Chem & Biochem, Baltimore, MD 21250 USA	Howard Hughes Medical Institute; University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland Baltimore County	Summers, MF (corresponding author), Univ Maryland Baltimore Cty, Howard Hughes Med Inst, 1000 Hilltop Circle, Baltimore, MD 21250 USA.	summers@hhmi.umbc.edu						Amarasinghe GK, 2000, J MOL BIOL, V301, P491, DOI 10.1006/jmbi.2000.3979; ANTAO VP, 1991, NUCLEIC ACIDS RES, V19, P5901, DOI 10.1093/nar/19.21.5901; BENDER MA, 1987, J VIROL, V61, P1639, DOI 10.1128/JVI.61.5.1639-1646.1987; Berkowitz R, 1996, CURR TOP MICROBIOL, V214, P177; BERKOWITZ RD, 1995, J VIROL, V69, P6445, DOI 10.1128/JVI.69.10.6445-6456.1995; D'Souza V, 2004, J MOL BIOL, V337, P427, DOI 10.1016/j.jmb.2004.01.037; D'Souza V, 2001, J MOL BIOL, V314, P217, DOI 10.1006/jmbi.2001.5139; De Guzman RN, 1998, SCIENCE, V279, P384, DOI 10.1126/science.279.5349.384; HIBBERT CS, IN PRESS J VIROL; HOUSSET V, 1993, J VIROL, V67, P2537, DOI 10.1128/JVI.67.5.2537-2545.1993; HU WS, 1990, SCIENCE, V250, P1227, DOI 10.1126/science.1700865; Huthoff H, 2001, RNA, V7, P143, DOI 10.1017/S1355838201001881; KAY LE, 1990, SCIENCE, V249, P411, DOI 10.1126/science.2377896; Kim CH, 2000, P NATL ACAD SCI USA, V97, P9396, DOI 10.1073/pnas.170283697; LEVIN JG, 1974, J VIROL, V14, P152, DOI 10.1128/JVI.14.1.152-161.1974; Ly H, 2002, J VIROL, V76, P3135, DOI 10.1128/JVI.76.7.3135-3144.2002; MANN R, 1983, CELL, V33, P153, DOI 10.1016/0092-8674(83)90344-6; MERIC C, 1989, J VIROL, V63, P1558; Mougel M, 1997, J VIROL, V71, P8061, DOI 10.1128/JVI.71.10.8061-8065.1997; Oroudjev EM, 1999, J MOL BIOL, V291, P603, DOI 10.1006/jmbi.1999.2984; Paillart JC, 2004, NAT REV MICROBIOL, V2, P461, DOI 10.1038/nrmicro903; PRATS AC, 1990, J VIROL, V64, P774, DOI 10.1128/JVI.64.2.774-783.1990; REIN A, 1994, J VIROL, V68, P6124, DOI 10.1128/JVI.68.9.6124-6129.1994; Sakuragi J, 2001, J VIROL, V75, P2557, DOI 10.1128/JVI.75.6.2557-2565.2001; Schuler W, 1999, BIOCHEMISTRY-US, V38, P12984, DOI 10.1021/bi990378d; TORRENT C, 1994, J MOL BIOL, V240, P434, DOI 10.1006/jmbi.1994.1459; TOUNEKTI N, 1992, J MOL BIOL, V223, P205, DOI 10.1016/0022-2836(92)90726-Z; VARMUS HE, 1982, SCIENCE, V216, P812, DOI 10.1126/science.6177038; Wuthrich K., 1986, NMR PROTEINS NUCL AC; YANG SL, 1994, EMBO J, V13, P713, DOI 10.1002/j.1460-2075.1994.tb06311.x	30	169	171	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 30	2004	431	7008					586	590		10.1038/nature02944	http://dx.doi.org/10.1038/nature02944			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15457265				2022-12-24	WOS:000224156700051
J	Kanan, MW; Rozenman, MM; Sakurai, K; Snyder, TM; Liu, DR				Kanan, MW; Rozenman, MM; Sakurai, K; Snyder, TM; Liu, DR			Reaction discovery enabled by DNA-templated synthesis and in vitro selection	NATURE			English	Article							ORGANIC-SYNTHESIS; CATALYSTS; CYCLOADDITION; COMBINATORIAL; FLUORESCENCE; EVOLUTION; ENZYMES	Current approaches to reaction discovery focus on one particular transformation. Typically, researchers choose substrates based on their predicted ability to serve as precursors for the target structure, then evaluate reaction conditions(1-6) for their ability to effect product formation. This approach is ideal for addressing specific reactivity problems, but its focused nature might leave many areas of chemical reactivity unexplored. Here we report a reaction discovery approach that uses DNA-templated organic synthesis(7-10) and in vitro selection to simultaneously evaluate many combinations of different substrates for bond-forming reactions in a single solution. Watson - Crick base pairing controls the effective molarities of substrates tethered to DNA strands; bond-forming substrate combinations are then revealed using in vitro selection for bond formation, PCR amplification and DNA microarray analysis. Using this approach, we discovered an efficient and mild carbon - carbon bond-forming reaction that generates an enone from an alkyne and alkene using an inorganic palladium catalyst. Although this approach is restricted to conditions and catalysts that are at least partially compatible with DNA, we expect that its versatility and efficiency will enable the discovery of additional reactions between a wide range of substrates.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA	Harvard University	Liu, DR (corresponding author), Harvard Univ, Dept Chem & Biol Chem, 12 Oxford St, Cambridge, MA 02138 USA.	liu@chemistry.harvard.edu	Liu, David R./HCH-3132-2022; Sakurai, Kaori/AAJ-7405-2021; Sakurai, Kaori/F-6238-2013	Sakurai, Kaori/0000-0002-1348-8530; Snyder, Thomas/0000-0001-7256-7821	NIGMS NIH HHS [R01 GM065865, R01 GM065865-03, R01 GM065865-04, R01 GM065865-02, R01 GM065865-01A2] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065865] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRESLOW R, 1995, ACCOUNTS CHEM RES, V28, P146, DOI 10.1021/ar00051a008; Burrows CJ, 1998, CHEM REV, V98, P1109, DOI 10.1021/cr960421s; Calderone CT, 2002, ANGEW CHEM INT EDIT, V41, P4104, DOI 10.1002/1521-3773(20021104)41:21<4104::AID-ANIE4104>3.0.CO;2-O; Crabtree R. H., 2001, ORGANOMETALLIC CHEM; Evans CA, 2002, CURR OPIN CHEM BIOL, V6, P333, DOI 10.1016/S1367-5931(02)00324-1; Gartner ZJ, 2002, ANGEW CHEM INT EDIT, V41, P1796, DOI 10.1002/1521-3773(20020517)41:10<1796::AID-ANIE1796>3.0.CO;2-Z; Gartner ZJ, 2001, J AM CHEM SOC, V123, P6961, DOI 10.1021/ja015873n; HECK RF, 1982, ORG REACTIONS, V27, P345; Joyce GF, 2004, ANNU REV BIOCHEM, V73, P791, DOI 10.1146/annurev.biochem.73.011303.073717; Kohli RM, 2002, NATURE, V418, P658, DOI 10.1038/nature00907; KRAMER MF, 2001, CURRENT PROTOCOLS MO, V2; Li C., 1997, ORGANIC REACTIONS AQ; Li XY, 2003, J AM CHEM SOC, V125, P10188, DOI 10.1021/ja035379e; Lober O, 2001, J AM CHEM SOC, V123, P4366, DOI 10.1021/ja005881o; MIYAURA N, 1995, CHEM REV, V95, P2457, DOI 10.1021/cr00039a007; Morgan, 1995, COMPREHENSIVE ORGANI, V5, P257; Reetz MT, 2001, ANGEW CHEM INT EDIT, V40, P284, DOI 10.1002/1521-3773(20010119)40:2<284::AID-ANIE284>3.0.CO;2-N; Rosenbaum DM, 2003, J AM CHEM SOC, V125, P13924, DOI 10.1021/ja038058b; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Schultz PG, 2002, NATURE, V418, P485, DOI 10.1038/418485a; SMIDT J, 1962, ANGEW CHEM INT EDIT, V74, P93, DOI 10.1002/ange.19620740302; SMIDT J, 1959, ANGEW CHEM INT EDIT, V71, P176, DOI 10.1002/ange.19590710503; Stambuli JP, 2003, CURR OPIN CHEM BIOL, V7, P420, DOI 10.1016/S1367-5931(03)00056-5; Stambuli JP, 2001, J AM CHEM SOC, V123, P2677, DOI 10.1021/ja0058435; Staunton J, 2001, NAT PROD REP, V18, P380, DOI 10.1039/a909079g; Taylor SJ, 1998, SCIENCE, V280, P267, DOI 10.1126/science.280.5361.267; TSUJI J, 1995, PALALDIUM REAGENTS C; WADSWORTH W, 1961, J AM CHEM SOC, V83, P1733, DOI 10.1021/ja01468a042; Wang Q, 2003, J AM CHEM SOC, V125, P3192, DOI 10.1021/ja021381e; Wilson DS, 1999, ANNU REV BIOCHEM, V68, P611, DOI 10.1146/annurev.biochem.68.1.611	30	212	269	4	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 30	2004	431	7008					545	549		10.1038/nature02920	http://dx.doi.org/10.1038/nature02920			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	857YP	15457254	Green Accepted			2022-12-24	WOS:000224156700040
J	Lopez-Rios, F; Illei, PB; Rusch, V; Ladanyi, M				Lopez-Rios, F; Illei, PB; Rusch, V; Ladanyi, M			Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids	LANCET			English	Article							LARGE T-ANTIGEN; HUMAN PLEURAL MESOTHELIOMA; HUMAN BRAIN-TUMORS; HUMAN-MALIGNANT MESOTHELIOMA; NON-HODGKIN-LYMPHOMA; DNA-SEQUENCES; HUMAN CANCERS; CELL-LINES; POLIOVIRUS VACCINES; MAMMALIAN-CELLS	Background PCR-based evidence of infection by simian virus 40 (SV40) has been reported in varying proportions of pleural mesotheliomas and other tumours, but data are conflicting and reproducibility limited. During a study of SV40 in relation to homozygous deletion of CDKN2A in mesotheliomas, we became concerned by inconsistent results and therefore used several independent techniques to investigate SV40 in these tumours. Methods High-quality DNA and RNA were extracted from 71 frozen mesothelioma samples. DNA PCR was done with four sets of primers for the SV40 T-antigen gene. RNA transcripts were examined by RT-PCR. Findings The first two primer sets for DNA PCR gave positive results in proportions similar to those reported in positive studies (56-62%) but there were unusual reproducibility difficulties. These primers were in a region of the T-antigen gene (nucleotides 4100-4713) that is present in many common laboratory plasmids. In assays with PCR primers not included within that region, only four cases (6%) showed products but these were too faint to suggest clonal infection. Further PCR assays confirmed that the SV40 sequences in the tumour samples had a deletion found only in plasmids, not in native functional SV40. Review of previous studies showed a similar pattern of discrepancies between SV40 T-antigen DNA PCR results obtained with primers within and beyond the region 4100-4713. All 71 mesotheliomas were negative for T-antigen transcripts by RT-PCR, and lacked T-antigen-positive tumour cells by immunohistochemistry. Interpretation Our data based on three independent experimental approaches do not support a significant role for SV40 in human mesotheliomas. The risk of false-positive results due to contamination by common laboratory plasmids containing SV40 sequences has been underestimated. Studies of SV40 based on PCR methods require careful primer design to reduce this risk. Relevance to practice This paper presents several lines of evidence against the proposed link between SV40 infection and human mesotheliomas. Studies reporting a high prevalence of SV40 DNA in human tumours have been based on molecular assays prone to false-positive results. Because SV40 appears unlikely to have a major role, if any, in human mesotheliomas, clinicians should continue to consider asbestos exposure as the most likely and most thoroughly established aetiological factor in individuals with this cancer.	Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Ladanyi, M (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA.	ladanyim@mskcc.org	Ladanyi, Marc/AAG-8585-2019	Rusch, Valerie/0000-0003-2345-6900				AMBINDER RF, 1986, J CLIN MICROBIOL, V24, P16, DOI 10.1128/JCM.24.1.16-20.1986; BERGSAGEL DJ, 1992, NEW ENGL J MED, V326, P988, DOI 10.1056/NEJM199204093261504; Brown F, 1998, DEV BIOL STAND, V94, P1; Butel JS, 1999, JNCI-J NATL CANCER I, V91, P119, DOI 10.1093/jnci/91.2.119; Cacciotti P, 2001, P NATL ACAD SCI USA, V98, P12032, DOI 10.1073/pnas.211026798; Capello D, 2003, LANCET, V361, P88, DOI 10.1016/S0140-6736(03)12157-5; CARBONE M, 1994, ONCOGENE, V9, P1781; Carbone M, 2003, INT J CANCER, V106, P140, DOI 10.1002/ijc.11189; Carbone M, 1997, ONCOGENE, V15, P1877, DOI 10.1038/sj.onc.1201375; de Sanjose S, 2003, INT J CANCER, V104, P522, DOI 10.1002/ijc.10993; DeLuca A, 1997, NAT MED, V3, P913, DOI 10.1038/nm0897-913; Dhaene K, 1999, VIRCHOWS ARCH, V435, P1, DOI 10.1007/s004280050387; Dobbelstein M, 1998, J GEN VIROL, V79, P3079, DOI 10.1099/0022-1317-79-12-3079; Emri S, 2000, ANTICANCER RES, V20, P891; Engels EA, 2003, JNCI-J NATL CANCER I, V95, P532, DOI 10.1093/jnci/95.7.532; Engels EA, 2002, INT J CANCER, V101, P348, DOI 10.1002/ijc.10621; Galateau-Salle F, 1998, J PATHOL, V184, P252, DOI 10.1002/(SICI)1096-9896(199803)184:3<252::AID-PATH15>3.0.CO;2-R; Gazdar AF, 2002, NAT REV CANCER, V2, P957, DOI 10.1038/nrc947; Gordon GJ, 2002, ONCOL REP, V9, P631; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; Griffiths DJ, 1998, DEV BIOL STAND, V94, P127; Hirvonen A, 1999, MOL CARCINOGEN, V26, P93, DOI 10.1002/(SICI)1098-2744(199910)26:2<93::AID-MC4>3.3.CO;2-Q; HOWELL MD, 1987, ANAL BIOCHEM, V161, P311, DOI 10.1016/0003-2697(87)90456-8; Hubner R, 2002, CANCER CAUSE CONTROL, V13, P121, DOI 10.1023/A:1014321729038; Illei PB, 2003, CLIN CANCER RES, V9, P2108; Jasani B, 2001, SEMIN CANCER BIOL, V11, P49, DOI 10.1006/scbi.2000.0346; Kim JYH, 2002, NEURO-ONCOLOGY, V4, P165, DOI 10.1093/neuonc/4.3.165; Klein G, 2002, ONCOGENE, V21, P1141, DOI 10.1038/sj.onc.1205173; Knowles WA, 2003, J MED VIROL, V71, P115, DOI 10.1002/jmv.10450; LEDNICKY JA, 1995, VIROLOGY, V212, P710, DOI 10.1006/viro.1995.1529; Leithner A, 2002, CANCER BIOL THER, V1, P375; Lin PP, 1999, CANCER RES, V59, P1428; MacKenzie J, 2003, J NATL CANCER I, V95, P1001, DOI 10.1093/jnci/95.13.1001; Martinelli M, 2002, AM J PATHOL, V161, P1127, DOI 10.1016/S0002-9440(10)64389-1; Martini F, 1996, CANCER RES, V56, P4820; Martini F, 2002, CANCER-AM CANCER SOC, V94, P1037, DOI 10.1002/cncr.10272; Mayall F, 2003, J CLIN PATHOL, V56, P728, DOI 10.1136/jcp.56.10.728; Mulatero C, 1999, THORAX, V54, P60, DOI 10.1136/thx.54.1.60; MULLIGAN RC, 1980, SCIENCE, V209, P1422, DOI 10.1126/science.6251549; NERENBERG MI, 1991, BIOTECHNIQUES, V11, P332; Pass HI, 1998, J THORAC CARDIOV SUR, V116, P854, DOI 10.1016/S0022-5223(98)00438-3; Pilatte Y, 2000, AM J RESP CELL MOL, V23, P788, DOI 10.1165/ajrcmb.23.6.4251; Prins JB, 1998, INT J CANCER, V75, P649, DOI 10.1002/(SICI)1097-0215(19980209)75:4<649::AID-IJC25>3.3.CO;2-L; Rollison DEM, 2003, CANCER EPIDEM BIOMAR, V12, P460; Saenz-Robles MT, 2001, ONCOGENE, V20, P7899, DOI 10.1038/sj.onc.1204936; SAGER R, 1981, CELL, V23, P41, DOI 10.1016/0092-8674(81)90268-3; Salewski H, 1999, CANCER RES, V59, P1980; Shah KV, 2000, REV MED VIROL, V10, P31, DOI 10.1002/(SICI)1099-1654(200001/02)10:1<31::AID-RMV260>3.0.CO;2-I; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Simsir A, 2001, DIAGN CYTOPATHOL, V25, P203, DOI 10.1002/dc.2039; Strickler HD, 1996, CANCER EPIDEM BIOMAR, V5, P473; Strickler HD, 2003, JNCI-J NATL CANCER I, V95, P38, DOI 10.1093/jnci/95.1.38; Strickler HD, 2001, CANCER EPIDEM BIOMAR, V10, P523; Strickler HD, 1998, JAMA-J AM MED ASSOC, V279, P292, DOI 10.1001/jama.279.4.292; Testa JR, 1998, CANCER RES, V58, P4505; Testa JR, 2001, SEMIN CANCER BIOL, V11, P31, DOI 10.1006/scbi.2000.0344; Tzeng YJ, 1998, ONCOGENE, V16, P2103, DOI 10.1038/sj.onc.1201733; Vilchez RA, 2002, LANCET, V359, P817, DOI 10.1016/S0140-6736(02)07950-3; Vilchez RA, 2003, J NATL CANCER I, V95, P687, DOI 10.1093/jnci/95.9.687; Vilchez RA, 2003, LANCET ONCOL, V4, P188, DOI 10.1016/S1470-2045(03)01024-6; Vilchez RA, 2002, J ACQ IMMUN DEF SYND, V29, P109, DOI 10.1097/00042560-200202010-00001; Vivaldi A, 2003, J CLIN ENDOCR METAB, V88, P892, DOI 10.1210/jc.2002-020436; Volter C, 1998, DEV BIOL STAND, V94, P137; Waheed I, 1999, CANCER RES, V59, P6068; XIAO S, 1995, ONCOGENE, V11, P511; zur Hansen H, 2003, INT J CANCER, V107, P687, DOI 10.1002/ijc.11517	66	149	153	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 25	2004	364	9440					1157	1166		10.1016/S0140-6736(04)17102-X	http://dx.doi.org/10.1016/S0140-6736(04)17102-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857FT	15451223				2022-12-24	WOS:000224102400029
J	Aubret, F; Shine, R; Bonnet, X				Aubret, F; Shine, R; Bonnet, X			Adaptive developmental plasticity in snakes	NATURE			English	Editorial Material									CNRS, CEBC, F-79360 Villiers En Bois, France; Univ Poitiers, Conseil Gen Deux Sevres, F-79360 Villiers En Bois, France; Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia; Univ Sydney, Sydney, NSW 2006, Australia	Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; University of Western Australia; University of Sydney	Aubret, F (corresponding author), CNRS, CEBC, F-79360 Villiers En Bois, France.	rics@bio.usyd.edu.au	Shine, Richard/B-8711-2008	Bonnet, Xavier/0000-0001-6150-8199				AUBRET F, 2003, AMPHIBIA-REPTILIA, V25, P9; BOCK WJ, 1980, AM ZOOL, V20, P217; COGGER HG, 1992, REPTILES AMPHIBIANS; Dudley SA, 1996, AM NAT, V147, P445, DOI 10.1086/285860; Forsman A, 1997, BIOL J LINN SOC, V62, P209, DOI 10.1006/bijl.1997.0148; Pigliucci M., 2001, SYN ECO EVO; SHINE R, 1987, HERPETOLOGICA, V43, P233	7	104	107	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2004	431	7006					261	262		10.1038/431261a	http://dx.doi.org/10.1038/431261a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372019				2022-12-24	WOS:000223864000027
J	Nalbant, P; Hodgson, L; Kraynov, V; Toutchkine, A; Hahn, KM				Nalbant, P; Hodgson, L; Kraynov, V; Toutchkine, A; Hahn, KM			Activation of endogenous Cdc42 visualized in living cells	SCIENCE			English	Article							ALDRICH-SYNDROME PROTEIN; RHO-GTPASES; COMPLEX; RAC; BINDING; WASP; FIBROBLASTS; NEUTROPHILS; FILOPODIA; POLARITY	Signaling proteins are tightly regulated spatially and temporally to perform multiple functions. For Cdc42 and other guanosine triphosphatases, the subcellular location of activation is a critical determinant of cell behavior. However, current approaches are limited in their ability to examine the dynamics of Cdc42 activity in living cells. We report the development of a biosensor capable of visualizing the changing activation of endogenous, unlabeled Cdc42 in living cells. With the use of a dye that reports protein interactions, the biosensor revealed localized activation in the trans-Golgi apparatus, microtubule-dependent Cdc42 activation at the cell periphery, and activation kinetics precisely coordinated with cell extension and retraction.	Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Hahn, KM (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA.	khahn@med.unc.edu	Toutchkine, Alexei/A-7600-2009; Krainov, Vladimir P./D-9224-2014	Hodgson, Louis/0000-0001-9188-7580; Hahn, Klaus/0000-0002-1970-7562	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057464, R55GM057464, U54GM064346] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM057464, GM57464, GM64346] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; BRIGHT GR, 1989, METHOD CELL BIOL, V30, P157; Cerione RA, 2004, TRENDS CELL BIOL, V14, P127, DOI 10.1016/j.tcb.2004.01.008; Erickson JW, 2001, CURR OPIN CELL BIOL, V13, P153, DOI 10.1016/S0955-0674(00)00192-7; Erickson JW, 1996, J BIOL CHEM, V271, P26850, DOI 10.1074/jbc.271.43.26850; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Higashida C, 2004, SCIENCE, V303, P2007, DOI 10.1126/science.1093923; Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311; Hoffman GR, 2000, CELL, V100, P345, DOI 10.1016/S0092-8674(00)80670-4; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Kjoller L, 1999, EXP CELL RES, V253, P166, DOI 10.1006/excr.1999.4674; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; MANDEVILLE JTH, 1995, BIOPHYS J, V68, P1207, DOI 10.1016/S0006-3495(95)80336-X; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; MILLER PJ, 1994, MOL CELL BIOL, V14, P1075, DOI 10.1128/MCB.14.2.1075; Nabi IR, 1999, J CELL SCI, V112, P1803; NOBES CD, 1995, BIOCHEM SOC T, V23, P456, DOI 10.1042/bst0230456; Palazzo Alexander F, 2002, Sci STKE, V2002, ppe31, DOI 10.1126/stke.2002.139.pe31; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; Rudolph MG, 1998, J BIOL CHEM, V273, P18067, DOI 10.1074/jbc.273.29.18067; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Seth A, 2003, BIOCHEMISTRY-US, V42, P3997, DOI 10.1021/bi026881z; Subauste MC, 2000, J BIOL CHEM, V275, P9725, DOI 10.1074/jbc.275.13.9725; Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174; Toutchkine A, 2003, J AM CHEM SOC, V125, P4132, DOI 10.1021/ja0290882; Vignal E, 2000, J BIOL CHEM, V275, P36457, DOI 10.1074/jbc.M003487200; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; Wu WJ, 2000, NATURE, V405, P800, DOI 10.1038/35015585	32	300	309	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2004	305	5690					1615	1619		10.1126/science.1100367	http://dx.doi.org/10.1126/science.1100367			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	854GV	15361624				2022-12-24	WOS:000223891200042
J	Eigenmann, PA; Haenggeli, CA				Eigenmann, PA; Haenggeli, CA			Food colourings and preservatives - allergy and hyperactivity	LANCET			English	Editorial Material							CHILDREN		Childrens Univ Hosp, CH-1211 Geneva 14, Switzerland	University of Geneva	Eigenmann, PA (corresponding author), Childrens Univ Hosp, CH-1211 Geneva 14, Switzerland.	Philippe.Eigenmann@hcuge.ch	Eigenmann, Philippe/A-6569-2017	Eigenmann, Philippe/0000-0003-1738-1826				Avery NJ, 2003, PEDIAT ALLERG IMM-UK, V14, P378, DOI 10.1034/j.1399-3038.2003.00072.x; Bateman B, 2004, ARCH DIS CHILD, V89, P506, DOI 10.1136/adc.2003.031435; EGGER J, 1992, LANCET, V339, P1150, DOI 10.1016/0140-6736(92)90742-L; Feingold B F, 1975, Am J Nurs, V75, P797, DOI 10.2307/3423460; Homer CJ, 2000, PEDIATRICS, V105, P1158; POLLOCK I, 1990, ARCH DIS CHILD, V65, P74, DOI 10.1136/adc.65.1.74; Warner J O, 1993, Pediatr Allergy Immunol, V4, P112, DOI 10.1111/j.1399-3038.1993.tb00078.x	7	22	22	0	12	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 4	2004	364	9437					823	824		10.1016/S0140-6736(04)16996-1	http://dx.doi.org/10.1016/S0140-6736(04)16996-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	851KY	15351173				2022-12-24	WOS:000223685200007
J	Dormitzer, PR; Nason, EB; Prasad, BVV; Harrison, SC				Dormitzer, PR; Nason, EB; Prasad, BVV; Harrison, SC			Structural rearrangements in the membrane penetration protein of a non-enveloped virus	NATURE			English	Article							RHESUS ROTAVIRUS VP4; CRYOELECTRON MICROSCOPY; 3-DIMENSIONAL STRUCTURE; CELL ENTRY; FUSION; HEMAGGLUTININ; RECONSTRUCTION; CLEAVAGE; BINDING; PERMEABILIZATION	Non-enveloped virus particles (those that lack a lipid-bilayer membrane) must breach the membrane of a target host cell to gain access to its cytoplasm. So far, the molecular mechanism of this membrane penetration step has resisted structural analysis. The spike protein VP4 is a principal component in the entry apparatus of rotavirus, a non-enveloped virus that causes gastroenteritis and kills 440,000 children each year(1). Trypsin cleavage of VP4 primes the virus for entry by triggering a rearrangement that rigidifies the VP4 spikes(2). We have determined the crystal structure, at 3.2 Angstrom resolution, of the main part of VP4 that projects from the virion. The crystal structure reveals a coiled-coil stabilized trimer. Comparison of this structure with the two-fold clustered VP4 spikes in a similar to12 Angstrom resolution image reconstruction from electron cryomicroscopy of trypsin-primed virions shows that VP4 also undergoes a second rearrangement, in which the oligomer reorganizes and each subunit folds back on itself, translocating a potential membrane-interaction peptide from one end of the spike to the other. This rearrangement resembles the conformational transitions of membrane fusion proteins of enveloped viruses(3-6).	Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Childrens Hosp, Mol Med Lab, Boston, MA 02115 USA; Howard Hughes Med Inst, Boston, MA 02115 USA; Baylor Coll Med, Berna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Baylor College of Medicine	Dormitzer, PR (corresponding author), Harvard Univ, Sch Med, Dept Pediat, 320 Longwood Ave, Boston, MA 02115 USA.	dormitze@crystal.harvard.edu		Prasad, B.V.Venkataram/0000-0002-1172-2071	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053174] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI053174-02, R01 AI053174-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arias CF, 1996, J VIROL, V70, P5832, DOI 10.1128/JVI.70.9.5832-5839.1996; Crawford SE, 2001, J VIROL, V75, P6052, DOI 10.1128/JVI.75.13.6052-6061.2001; CROWTHER RA, 1971, PHILOS T R SOC B, V261, P221, DOI 10.1098/rstb.1971.0054; Dormitzer PR, 2001, J VIROL, V75, P7339, DOI 10.1128/JVI.75.16.7339-7350.2001; Dormitzer PR, 2002, EMBO J, V21, P885, DOI 10.1093/emboj/21.5.885; Dowling W, 2000, J VIROL, V74, P6368, DOI 10.1128/JVI.74.14.6368-6376.2000; Gibbons DL, 2004, NATURE, V427, P320, DOI 10.1038/nature02239; Gilbert JM, 1998, J VIROL, V72, P5323, DOI 10.1128/JVI.72.6.5323-5327.1998; Graham KL, 2003, J VIROL, V77, P9969, DOI 10.1128/JVI.77.18.9969-9978.2003; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lawton JA, 1996, J STRUCT BIOL, V116, P209, DOI 10.1006/jsbi.1996.0032; Liemann S, 2002, CELL, V108, P283, DOI 10.1016/S0092-8674(02)00612-8; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; MACKOW ER, 1988, P NATL ACAD SCI USA, V85, P645, DOI 10.1073/pnas.85.3.645; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; OFFIT PA, 1986, J VIROL, V58, P700, DOI 10.1128/JVI.58.2.700-703.1986; Padilla JE, 2003, ACTA CRYSTALLOGR D, V59, P1124, DOI 10.1107/S0907444903007947; Parashar UD, 2003, EMERG INFECT DIS, V9, P565, DOI 10.3201/eid0905.020562; RUGGERI FM, 1991, J VIROL, V65, P2211, DOI 10.1128/JVI.65.5.2211-2219.1991; RUIGROK RWH, 1988, J GEN VIROL, V69, P2785, DOI 10.1099/0022-1317-69-11-2785; SHAW AL, 1993, CELL, V74, P693, DOI 10.1016/0092-8674(93)90516-S; TANIGUCHI K, 1988, J VIROL, V62, P2421, DOI 10.1128/JVI.62.7.2421-2426.1988; Tihova M, 2001, J MOL BIOL, V314, P985, DOI 10.1006/jmbi.2000.5238; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; Weissenhorn W, 1996, EMBO J, V15, P1507, DOI 10.1002/j.1460-2075.1996.tb00494.x; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080; YEAGER M, 1994, EMBO J, V13, P1011, DOI 10.1002/j.1460-2075.1994.tb06349.x; YEAGER M, 1990, J CELL BIOL, V110, P2133, DOI 10.1083/jcb.110.6.2133	30	164	178	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 26	2004	430	7003					1053	1058		10.1038/nature02836	http://dx.doi.org/10.1038/nature02836			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849CD	15329727	Green Accepted, Bronze			2022-12-24	WOS:000223514900049
J	Lloyd, S				Lloyd, S			Going into reverse	NATURE			English	Editorial Material									MIT, Dept Mech Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Lloyd, S (corresponding author), MIT, Dept Mech Engn, 3-160, Cambridge, MA 02139 USA.							Landauer R., 2003, MAXWELLS DEMON, VII	1	4	4	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 26	2004	430	7003					971	971		10.1038/430971a	http://dx.doi.org/10.1038/430971a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849CD	15329700	Bronze			2022-12-24	WOS:000223514900022
J	Ahn, S; Joyner, AL				Ahn, S; Joyner, AL			Dynamic changes in the response of cells to positive hedgehog signaling during mouse limb patterning	CELL			English	Article							APICAL ECTODERMAL RIDGE; SONIC-HEDGEHOG; CUBITUS-INTERRUPTUS; SPINAL-CORD; INDIAN-HEDGEHOG; TRANSCRIPTIONAL ACTIVATOR; RECOMBINASE ACTIVITY; POLARIZING ACTIVITY; CRE RECOMBINASE; NEURAL-TUBE	In the vertebrate limb, the posteriorly located zone of polarizing activity (ZPA) regulates digit identity through the morphogen Sonic Hedgehog (Shh). By genetically marking Shh-responding cells in mice, we have addressed whether the cumulative influence of positive Shh signaling over time and space reflects a linear gradient of Shh responsiveness and whether Shh could play additional roles in limb patterning. Our results show that all posterior limb mesenchyme cells, as well as the ectoderm, respond to Shh from the ZPA and become the bone, muscle, and skin of the posterior limb. Further, the readout of Shh activator function integrated over time and space does not display a stable and linear gradient along the A-P axis, as in a classical morphogen view. Finally, by fate mapping Shh-responding cells in Gli2 and Gli3 mutant limbs, we demonstrate that a specific level of positive Hh signaling is not required to specify digit identities.	NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; NYU, Sch Med, Dev Genet Program, Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; NYU, Sch Med, Dept Physiol & Neurosci, New York, NY 10016 USA	Howard Hughes Medical Institute; New York University; New York University; New York University; New York University	Joyner, AL (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, 540 1st Ave, New York, NY 10016 USA.	joyner@saturn.med.nyu.edu						AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; Bai CB, 2004, DEV CELL, V6, P103, DOI 10.1016/S1534-5807(03)00394-0; Bai CB, 2002, DEVELOPMENT, V129, P4753; BITGOOD MJ, 1995, DEV BIOL, V172, P126, DOI 10.1006/dbio.1995.0010; Bren-Mattison Y, 2002, DEV BIOL, V242, P130, DOI 10.1006/dbio.2001.0528; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Duprez D, 1999, MECH DEVELOP, V82, P151, DOI 10.1016/S0925-4773(99)00040-4; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Grindley JC, 1997, DEV BIOL, V188, P337, DOI 10.1006/dbio.1997.8644; Gritli-Linde A, 2001, DEV BIOL, V236, P364, DOI 10.1006/dbio.2001.0336; Guo QX, 2003, DEV BIOL, V264, P166, DOI 10.1016/j.ydbio.2003.08.012; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; Hynes M, 1997, NEURON, V19, P15, DOI 10.1016/S0896-6273(00)80344-X; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Iwasaki M, 1997, MECH DEVELOP, V69, P197, DOI 10.1016/S0925-4773(97)00145-7; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Karp SJ, 2000, DEVELOPMENT, V127, P543; Kimmel RA, 2000, GENE DEV, V14, P1377; Kraus P, 2001, MECH DEVELOP, V100, P45, DOI 10.1016/S0925-4773(00)00492-5; Lee J, 1997, DEVELOPMENT, V124, P2537; Lewis PM, 2001, CELL, V105, P599, DOI 10.1016/S0092-8674(01)00369-5; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; LOPEZMARTINEZ A, 1995, CURR BIOL, V5, P791, DOI 10.1016/S0960-9822(95)00156-4; Marigo V, 1996, DEV BIOL, V180, P273, DOI 10.1006/dbio.1996.0300; MASUYA H, 1995, GENE DEV, V9, P1645, DOI 10.1101/gad.9.13.1645; MATISE MP, 2001, GENE TARGETING, P101; Methot N, 1999, CELL, V96, P819, DOI 10.1016/S0092-8674(00)80592-9; Methot N, 2001, DEVELOPMENT, V128, P733; Mo R, 1997, DEVELOPMENT, V124, P113; Ohlmeyer JT, 1998, NATURE, V396, P749, DOI 10.1038/25533; Park HL, 2000, DEVELOPMENT, V127, P1593; Persson M, 2002, GENE DEV, V16, P2865, DOI 10.1101/gad.243402; Platt KA, 1997, MECH DEVELOP, V62, P121, DOI 10.1016/S0925-4773(96)00648-X; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; ROBINSON SP, 1991, DRUG METAB DISPOS, V19, P36; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Welscher PT, 2002, SCIENCE, V298, P827, DOI 10.1126/science.1075620; Wijgerde M, 2002, GENE DEV, V16, P2849, DOI 10.1101/gad.1025702; Yang Y, 1997, DEVELOPMENT, V124, P4393; Ying LT, 2000, NAT NEUROSCI, V3, P979, DOI 10.1038/79916; Zervas M, 2004, NEURON, V43, P345, DOI 10.1016/j.neuron.2004.07.010	50	377	391	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 20	2004	118	4					505	516		10.1016/j.cell.2004.07.023	http://dx.doi.org/10.1016/j.cell.2004.07.023			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	850YS	15315762	Bronze			2022-12-24	WOS:000223650900012
J	Tang, SM; Wolf, R; Xu, SP; Heisenberg, M				Tang, SM; Wolf, R; Xu, SP; Heisenberg, M			Visual pattern recognition in Drosophila is invariant for retinal position	SCIENCE			English	Article							FLIGHT ORIENTATION; FINE-STRUCTURE; YAW TORQUE; HONEYBEES; TEMPLATE; BEHAVIOR; VISION; MEMORY	Vision relies on constancy mechanisms. Yet, these are little understood, because they are difficult to investigate in freely moving organisms. One such mechanism, translation invariance, enables organisms to recognize visual patterns independent of the region of their visual field where they had originally seen them. Tethered flies ( Drosophila melanogaster) in a flight simulator can recognize visual patterns. Because their eyes are fixed in space and patterns can be displayed in defined parts of their visual field, they can be tested for translation invariance. Here, we show that flies recognize patterns at retinal positions where the patterns had not been presented before.	Acad Sinica, Inst Biophys, Beijing 100101, Peoples R China; Univ Wurzburg, Lehrstuhl Genet & Neurobiol, D-97074 Wurzburg, Germany	Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Wurzburg	Tang, SM (corresponding author), Acad Sinica, Inst Biophys, 15 Datun Rd, Beijing 100101, Peoples R China.	tang-shm@sohu.com; heisenberg@biozentrum.uni-wuerzburg.de						[Anonymous], 1988, EYE BRAIN VISION; BAUSENWEIN B, 1986, J NEUROGENET, V3, P87, DOI 10.3109/01677068609106897; BUCHNER E, 1971, THESIS U TUBINGEN; DILL M, 1995, LEARN MEMORY, V2, P152, DOI 10.1101/lm.2.3-4.152; DILL M, 1995, PHILOS T ROY SOC B, V349, P143, DOI 10.1098/rstb.1995.0100; DILL M, 1993, NATURE, V365, P751, DOI 10.1038/365751a0; DILL M, 1992, THESIS U WURZBURG; Efler D, 2000, VISION RES, V40, P3391, DOI 10.1016/S0042-6989(00)00189-9; Ernst R, 1999, VISION RES, V39, P3920, DOI 10.1016/S0042-6989(99)00114-5; Heisenberg M, 2001, LEARN MEMORY, V8, P1, DOI 10.1101/lm.8.1.1; HEISENBERG M, 1979, J COMP PHYSIOL, V130, P113, DOI 10.1007/BF00611046; HEISENBERG M, 1995, CURR OPIN NEUROBIOL, V5, P475, DOI 10.1016/0959-4388(95)80008-5; Heisenberg M., 1984, STUDIES BRAIN FUNCTI, V12; HENGSTENBERG R, 1971, KYBERNETIK, V9, P56, DOI 10.1007/BF00270852; Horridge GA, 1998, J INSECT PHYSIOL, V44, P343, DOI 10.1016/S0022-1910(97)00116-9; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; POSNER MI, 1980, J EXP PSYCHOL GEN, V109, P160, DOI 10.1037/0096-3445.109.2.160; SCHUSTER S, 1996, THESIS U TUBINGEN; SRINIVASAN MV, 1993, NATURE, V362, P539, DOI 10.1038/362539a0; SRINIVASAN MV, 1994, PHILOS T R SOC B, V343, P199, DOI 10.1098/rstb.1994.0021; TANG SJ, UNPUB, P95311; Tang SM, 2001, SCIENCE, V294, P1543, DOI 10.1126/science.1058237; VANHATEREN JH, 1990, J COMP PHYSIOL A, V167, P649, DOI 10.1007/BF00192658; WEHNER R, 1985, NATURE, V315, P228, DOI 10.1038/315228a0; WEHNER R, 1967, NATURE, V215, P1244, DOI 10.1038/2151244a0; WEHNER R, 1966, Z VERGL PHYSIOL, V52, P290, DOI 10.1007/BF02427714; WOLF R, 1980, J COMP PHYSIOL, V140, P69, DOI 10.1007/BF00613749; WOLF R, 1991, J COMP PHYSIOL A, V169, P699	28	68	68	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2004	305	5686					1020	1022		10.1126/science.1099839	http://dx.doi.org/10.1126/science.1099839			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845ND	15310908				2022-12-24	WOS:000223250700053
J	Vanderschuren, LJMJ; Everitt, BJ				Vanderschuren, LJMJ; Everitt, BJ			Drug seeking becomes compulsive after prolonged cocaine self-administration	SCIENCE			English	Article							ADDICTION; BEHAVIOR; SUPPRESSION; STIMULI; CORTEX; ABUSE; RATS	Compulsive drug use in the face of adverse consequences is a hallmark feature of addiction, yet there is little preclinical evidence demonstrating the actual progression from casual to compulsive drug use. Presentation of an aversive conditioned stimulus suppressed drug seeking in rats with limited cocaine self-administration experience, but no longer did so after an extended cocaine-taking history. In contrast, after equivalent extended sucrose experience, sucrose seeking was still suppressed by an aversive conditioned stimulus. Persistent cocaine seeking in the presence of signals of environmental adversity after a prolonged cocaine-taking history was not due to impaired fear conditioning, nor to an increase in the incentive value of cocaine, and may reflect the establishment of compulsive behavior.	Univ Utrecht, Med Ctr, Dept Pharmacol & Anat, Rudolf Magnus Inst Neurosci, NL-3584 CG Utrecht, Netherlands; Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England	Utrecht University; Utrecht University Medical Center; University of Cambridge	Vanderschuren, LJMJ (corresponding author), Univ Utrecht, Med Ctr, Dept Pharmacol & Anat, Rudolf Magnus Inst Neurosci, NL-3584 CG Utrecht, Netherlands.	l.j.m.j.vanderschuren@med.uu.nl	Vanderschuren, Louk/AAS-4391-2020	Everitt, Barry/0000-0003-4431-6536; Vanderschuren, Louk/0000-0002-5379-0363	MRC [G9537855] Funding Source: UKRI; Medical Research Council [G9537855] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ahmed SH, 1998, SCIENCE, V282, P298, DOI 10.1126/science.282.5387.298; *AM PSYCH ASS WASH, 1994, DIAGN STAT MAN MENT; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; BOUTON ME, 1980, ANIM LEARN BEHAV, V8, P429, DOI 10.3758/BF03199629; Everitt BJ, 2001, BRAIN RES REV, V36, P129, DOI 10.1016/S0165-0173(01)00088-1; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Graybiel AM, 2000, NEURON, V28, P343, DOI 10.1016/S0896-6273(00)00113-6; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V146, P373, DOI 10.1007/PL00005483; Kalivas PW, 2003, PSYCHOPHARMACOLOGY, V168, P44, DOI 10.1007/s00213-003-1393-2; Kearns DN, 2002, DRUG ALCOHOL DEPEN, V65, P253, DOI 10.1016/S0376-8716(01)00167-3; Killcross S, 2003, CEREB CORTEX, V13, P400, DOI 10.1093/cercor/13.4.400; Killcross S, 1997, NATURE, V388, P377, DOI 10.1038/41097; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; LEDOUX JE, 1984, J NEUROSCI, V4, P683; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; OBrien CP, 1996, LANCET, V347, P237, DOI 10.1016/S0140-6736(96)90409-2; Olmstead MC, 2000, PSYCHOPHARMACOLOGY, V152, P123, DOI 10.1007/s002130000498; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Rogers RD, 2001, CURR OPIN NEUROBIOL, V11, P250, DOI 10.1016/S0959-4388(00)00204-X; TIFFANY ST, 1990, PSYCHOL REV, V97, P147, DOI 10.1037/0033-295X.97.2.147; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x	21	524	537	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2004	305	5686					1017	1019		10.1126/science.1098975	http://dx.doi.org/10.1126/science.1098975			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845ND	15310907				2022-12-24	WOS:000223250700052
J	Percec, V; Dulcey, AE; Balagurusamy, VSK; Miura, Y; Smidrkal, J; Peterca, M; Nummelin, S; Edlund, U; Hudson, SD; Heiney, PA; Hu, DA; Magonov, SN; Vinogradov, SA				Percec, V; Dulcey, AE; Balagurusamy, VSK; Miura, Y; Smidrkal, J; Peterca, M; Nummelin, S; Edlund, U; Hudson, SD; Heiney, PA; Hu, DA; Magonov, SN; Vinogradov, SA			Self-assembly of amphiphilic dendritic dipeptides into helical pores	NATURE			English	Article							DENDRIMERS; CONDUCTION; POLYMERS; CHANNEL; SHAPE	Natural pore-forming proteins act as viral helical coats(1) and transmembrane channels(2-4), exhibit antibacterial activity(5) and are used in synthetic systems, such as for reversible encapsulation(6) or stochastic sensing(7). These diverse functions are intimately linked to protein structure(1-4). The close link between protein structure and protein function makes the design of synthetic mimics a formidable challenge, given that structure formation needs to be carefully controlled on all hierarchy levels, in solution and in the bulk. In fact, with few exceptions(8,9), synthetic pore structures capable of assembling into periodically ordered assemblies that are stable in solution and in the solid state(10-13) have not yet been realized. In the case of dendrimers, covalent(14) and non- covalent(15) coating and assembly of a range of different structures(15-17) has only yielded closed columns(18). Here we describe a library of amphiphilic dendritic dipeptides that self-assemble in solution and in bulk through a complex recognition process into helical pores. We find that the molecular recognition and self-assembly process is sufficiently robust to tolerate a range of modifications to the amphiphile structure, while preliminary proton transport measurements establish that the pores are functional. We expect that this class of self-assembling dendrimers will allow the design of a variety of biologically inspired systems with functional properties arising from their porous structure.	Univ Penn, Dept Chem, Roy & Diana Vagelos Labs, Philadelphia, PA 19104 USA; Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA; Natl Inst Stand & Technol, Gaithersburg, MD 20899 USA; Digital Instruments, Veeco Metrol Grp, Santa Barbara, CA 93110 USA; Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; National Institute of Standards & Technology (NIST) - USA; University of Pennsylvania	Percec, V (corresponding author), Univ Penn, Dept Chem, Roy & Diana Vagelos Labs, Philadelphia, PA 19104 USA.	percec@sas.upenn.edu	Nummelin, Sami/P-4185-2019; Peterca, Mihai/C-9504-2009; Nummelin, Sami J/O-5741-2015; Hudson, Steven/W-3211-2019; Hudson, Steven/AAB-2909-2019; Miura, Yoshiko/AAD-1166-2020; Percec, Virgil/H-6316-2014	Nummelin, Sami/0000-0003-2195-4818; Peterca, Mihai/0000-0002-7247-4008; Nummelin, Sami J/0000-0003-2195-4818; Hudson, Steven/0000-0002-3203-4833; Miura, Yoshiko/0000-0001-8590-6079; Percec, Virgil/0000-0001-5926-0489; /0000-0002-1631-1781; Balagurusamy, Venkat/0000-0002-1994-2634				Balagurusamy VSK, 1997, J AM CHEM SOC, V119, P1539, DOI 10.1021/ja963295i; Bayley H, 2001, NATURE, V413, P226, DOI 10.1038/35093038; Bong DT, 2001, ANGEW CHEM INT EDIT, V40, P988, DOI 10.1002/1521-3773(20010316)40:6<988::AID-ANIE9880>3.0.CO;2-N; Brunsveld L, 2000, J AM CHEM SOC, V122, P6175, DOI 10.1021/ja0005237; CHAN HS, 1995, PHILOS T R SOC B, V348, P61, DOI 10.1098/rstb.1995.0046; Cornelissen JJLM, 2001, SCIENCE, V293, P676, DOI 10.1126/science.1062224; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Emrick T, 1999, CURR OPIN COLLOID IN, V4, P15, DOI 10.1016/S1359-0294(99)00008-4; Engelkamp H, 1999, SCIENCE, V284, P785, DOI 10.1126/science.284.5415.785; Fernandez-Lopez S, 2001, NATURE, V412, P452, DOI 10.1038/35086601; Finikova O, 2003, J AM CHEM SOC, V125, P4882, DOI 10.1021/ja0341687; GHADIRI MR, 1993, NATURE, V366, P324, DOI 10.1038/366324a0; GHADIRI MR, 1994, NATURE, V369, P301, DOI 10.1038/369301a0; Hill DJ, 2001, CHEM REV, V101, P3893, DOI 10.1021/cr990120t; Hirschberg JHKK, 2000, NATURE, V407, P167, DOI 10.1038/35025027; Hudson SD, 1997, SCIENCE, V278, P449, DOI 10.1126/science.278.5337.449; Hummer G, 2001, NATURE, V414, P188, DOI 10.1038/35102535; Ishii D, 2003, NATURE, V423, P628, DOI 10.1038/nature01663; KLUG A, 1983, ANGEW CHEM INT EDIT, V22, P565, DOI 10.1002/anie.198305653; LEHN JM, 1995, SUPRAMOL CHEM, P118; Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519; Nelson JC, 1997, SCIENCE, V277, P1793, DOI 10.1126/science.277.5333.1793; Percec V, 1998, NATURE, V391, P161, DOI 10.1038/34384; Percec V, 2002, CHEM-EUR J, V8, P2011, DOI 10.1002/1521-3765(20020503)8:9<2011::AID-CHEM2011>3.0.CO;2-3; Percec V, 2001, J AM CHEM SOC, V123, P1302, DOI 10.1021/ja0037771; Percec V, 2002, NATURE, V419, P384, DOI 10.1038/nature01072; RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V; Sakai N, 2003, CHEM COMMUN, P2514, DOI 10.1039/b303649a; Schmitt JL, 2003, HELV CHIM ACTA, V86, P1598, DOI 10.1002/hlca.200390137; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218	30	537	545	4	288	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2004	430	7001					764	768		10.1038/nature02770	http://dx.doi.org/10.1038/nature02770			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306805				2022-12-24	WOS:000223233600037
J	Bell, JF; Squyres, SW; Arvidson, RE; Arneson, HM; Bass, D; Blaney, D; Cabrol, N; Calvin, W; Farmer, J; Farrand, WH; Goetz, W; Golombek, M; Grant, JA; Greeley, R; Guinness, E; Hayes, AG; Hubbard, MYH; Herkenhoff, KE; Johnson, MJ; Johnson, JR; Joseph, J; Kinch, KM; Lemmon, MT; Li, R; Madsen, MB; Maki, JN; Malin, M; McCartney, E; McLennan, S; McSween, HY; Ming, DW; Moersch, JE; Morris, RV; Dobrea, EZN; Parker, TJ; Proton, J; Rice, JW; Seelos, F; Soderblom, J; Soderblom, LA; Sohl-Dickstein, JN; Sullivan, RJ; Wolff, MJ; Wang, A				Bell, JF; Squyres, SW; Arvidson, RE; Arneson, HM; Bass, D; Blaney, D; Cabrol, N; Calvin, W; Farmer, J; Farrand, WH; Goetz, W; Golombek, M; Grant, JA; Greeley, R; Guinness, E; Hayes, AG; Hubbard, MYH; Herkenhoff, KE; Johnson, MJ; Johnson, JR; Joseph, J; Kinch, KM; Lemmon, MT; Li, R; Madsen, MB; Maki, JN; Malin, M; McCartney, E; McLennan, S; McSween, HY; Ming, DW; Moersch, JE; Morris, RV; Dobrea, EZN; Parker, TJ; Proton, J; Rice, JW; Seelos, F; Soderblom, J; Soderblom, LA; Sohl-Dickstein, JN; Sullivan, RJ; Wolff, MJ; Wang, A			Pancam multispectral imaging results from the Spirit Rover at Gusev crater	SCIENCE			English	Article							PATHFINDER LANDING SITE; MARS; REFLECTANCE; MINERALOGY; ROCKS; DUST; MOSSBAUER; ABUNDANCE; SOILS	Panoramic Camera images at Gusev crater reveal a rock-strewn surface interspersed with high-to moderate-albedo fine-grained deposits occurring in part as drifts or in small circular swales or hollows. Optically thick coatings of fine-grained ferric iron-rich dust dominate most bright soil and rock surfaces. Spectra of some darker rock surfaces and rock regions exposed by brushing or grinding show near-infrared spectral signatures consistent with the presence of mafic silicates such as pyroxene or olivine. Atmospheric observations show a steady decline in dust opacity during the mission, and astronomical observations captured solar transits by the martian moons, Phobos and Deimos, as well as a view of Earth from the martian surface.	Cornell Univ, Ithaca, NY 14853 USA; Washington Univ, St Louis, MO 63130 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; NASA, Ames Res Ctr, Search Extraterr Intelligence Inst, Moffett Field, CA 94035 USA; Univ Nevada, Reno, NV 89501 USA; Arizona State Univ, Tempe, AZ 85287 USA; Space Sci Inst, Boulder, CO 80301 USA; Univ Copenhagen, DK-2100 Copenhagen O, Denmark; Smithsonian Inst, Natl Air & Space Museum, Washington, DC 20560 USA; US Geol Survey, Flagstaff, AZ 86001 USA; Aarhus Univ, DK-8000 Aarhus C, Denmark; Texas A&M Univ, College Stn, TX 77843 USA; Ohio State Univ, Columbus, OH 43210 USA; Malin Space Sci Syst Inc, San Diego, CA 92191 USA; SUNY Stony Brook, Stony Brook, NY 11794 USA; Univ Tennessee, Knoxville, TN 37996 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA	Cornell University; Washington University (WUSTL); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Nevada System of Higher Education (NSHE); University of Nevada Reno; Arizona State University; Arizona State University-Tempe; University of Copenhagen; Smithsonian Institution; United States Department of the Interior; United States Geological Survey; Aarhus University; Texas A&M University System; Texas A&M University College Station; University System of Ohio; Ohio State University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Tennessee System; University of Tennessee Knoxville; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER	Bell, JF (corresponding author), Cornell Univ, Ithaca, NY 14853 USA.	jfb8@cornell.edu	Lemmon, Mark/X-2333-2019; Moersch, Jeffrey E/F-7189-2010; Madsen, Morten Bo/D-2082-2011; Seelos, Frank/C-7875-2016; Farmer, Jack D/B-9343-2019; Kinch, Kjartan Bergeron/C-5742-2015; Lemmon, Mark T/E-9983-2010; Johnson, Jeffrey R/F-3972-2015; Hayes, Alexander G/P-2024-2014	Lemmon, Mark/0000-0002-4504-5136; Moersch, Jeffrey E/0000-0003-3433-9419; Madsen, Morten Bo/0000-0001-8909-5111; Seelos, Frank/0000-0001-9721-941X; Kinch, Kjartan Bergeron/0000-0002-4629-8880; Lemmon, Mark T/0000-0002-4504-5136; Johnson, Jeffrey R/0000-0002-5586-4901; Hayes, Alexander G/0000-0001-6397-2630; Wang, Aimei/0000-0002-6575-4028; Soderblom, Jason/0000-0003-3715-6407; McLennan, Scott/0000-0003-4259-7178				ADAMS JB, 1974, J GEOPHYS RES, V79, P4829, DOI 10.1029/JB079i032p04829; Arvidson RE, 2004, SCIENCE, V305, P821, DOI 10.1126/science.1099922; BELL J, 2004, 8298 IAU; BELL JA, UNPUB; Bell JF, 1997, J GEOPHYS RES-PLANET, V102, P9109, DOI 10.1029/96JE03990; Bell JF, 2000, J GEOPHYS RES-PLANET, V105, P1721, DOI 10.1029/1999JE001060; Bell JF, 2002, ICARUS, V158, P56, DOI 10.1006/icar.2002.6865; BELL JF, 2003, J GEOPHYS RES-PLANET, V108, DOI DOI 10.1029/2003JE002070; Bertelsen P, 2004, SCIENCE, V305, P827, DOI 10.1126/science.1100112; Cabrol NA, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002026; CLOUTIS EA, 1986, J GEOPHYS RES-SOLID, V91, P1641, DOI 10.1029/JB091iB11p11641; Golombek MP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002035; GOLOMBEK MP, 2004, LUNAR PLANET SCI, V35; Grant JA, 2004, SCIENCE, V305, P807, DOI 10.1126/science.1099849; Greeley R, 2004, SCIENCE, V305, P810, DOI 10.1126/science.1100108; Hapke B., 1993, THEORY REFLECTANCE E; Herkenhoff KE, 2004, SCIENCE, V305, P824, DOI 10.1126/science.1100015; Johnson JR, 2003, ICARUS, V163, P330, DOI 10.1016/S0019-1035(03)00084-8; Johnson JR, 1999, J GEOPHYS RES-PLANET, V104, P8809, DOI 10.1029/98JE02247; KLINGELHOFER G, 2004, LUNAR PLANET SCI, V35, P2184; LEMMON M, UNPUB; LEMMON MT, COMMUNICATION; Madsen MB, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002029; Maki JN, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002077; MCCORD TB, 1982, J GEOPHYS RES, V87, P3021, DOI 10.1029/JB087iB04p03021; McSween HY, 2004, SCIENCE, V305, P842, DOI 10.1126/science.3050842; McSween HY, 1999, J GEOPHYS RES-PLANET, V104, P8679, DOI 10.1029/98JE02551; Morris RV, 2004, SCIENCE, V305, P833, DOI 10.1126/science.1100020; Morris RV, 2000, J GEOPHYS RES-PLANET, V105, P1757, DOI 10.1029/1999JE001059; MORRIS RV, 1989, J GEOPHYS RES-SOLID, V94, P2760, DOI 10.1029/JB094iB03p02760; OckertBell ME, 1997, J GEOPHYS RES-PLANET, V102, P9039, DOI 10.1029/96JE03991; Selsis F, 2004, ASTRON ASTROPHYS, V416, P783, DOI 10.1051/0004-6361:20031724; Wolff MJ, 1999, J GEOPHYS RES-PLANET, V104, P9027, DOI 10.1029/98JE01967; WOLFF MJ, 2004, P LUN PLAN SCI 35	34	130	132	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					800	806		10.1126/science.1100175	http://dx.doi.org/10.1126/science.1100175			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297658				2022-12-24	WOS:000223104900032
J	Hatsugai, N; Kuroyanagi, M; Yamada, K; Meshi, T; Tsuda, S; Kondo, M; Nishimura, M; Hara-Nishimura, I				Hatsugai, N; Kuroyanagi, M; Yamada, K; Meshi, T; Tsuda, S; Kondo, M; Nishimura, M; Hara-Nishimura, I			A plant vacuolar protease, VPE, mediates virus-induced hypersensitive cell death	SCIENCE			English	Article							PROCESSING ENZYME; PATHOGEN INTERACTIONS; STORAGE VACUOLES; LYTIC VACUOLES; APOPTOSIS; ENDOPEPTIDASE; PROTEINASE; PRECURSOR; CASPASES; REMOVAL	Programmed cell death (PCD) in animals depends on caspase protease activity. Plants also exhibit PCD, for example as a response to pathogens, although a plant caspase remains elusive. Here we show that vacuolar processing enzyme (VPE) is a protease essential for a virus-induced hypersensitive response that involves PCD. VPE deficiency prevented virus-induced hypersensitive cell death in tobacco plants. VPE is structurally unrelated to caspases, although VPE has a caspase-1 activity. Thus, plants have evolved a regulated cellular suicide strategy that, unlike PCD of animals, is mediated by VPE and the cellular vacuole.	Kyoto Univ, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan; Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi 4448585, Japan; Grad Univ Adv Studies, Sch Life Sci, Okazaki, Aichi 4448585, Japan; Natl Inst Agrobiol Sci, Tsukuba, Ibaraki 3058602, Japan; Natl Agr Res Ctr, Tsukuba, Ibaraki 3058602, Japan	Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; National Institute of Agrobiological Sciences - Japan; National Agriculture & Food Research Organization - Japan	Hara-Nishimura, I (corresponding author), Kyoto Univ, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan.	ihnishi@gr.bot.kyoto-u.ac.jp	Yamada, Kenji/C-4336-2018; Hatsugai, Noriyuki/O-9156-2015	Yamada, Kenji/0000-0003-4872-3729; Hatsugai, Noriyuki/0000-0002-5708-4263; Kuroyanagi, Miwa/0000-0003-4362-8415; Nishimura, Mikio/0000-0001-7960-9721				Angell SM, 1999, PLANT J, V20, P357, DOI 10.1046/j.1365-313X.1999.t01-1-00597.x; BECKER C, 1995, EUR J BIOCHEM, V228, P456, DOI 10.1111/j.1432-1033.1995.tb20284.x; Bozhkov PV, 2004, CELL DEATH DIFFER, V11, P175, DOI 10.1038/sj.cdd.4401330; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Goodman R.N., 1994, HYPERSENSITIVE REACT; Greenberg JT, 2004, CELL MICROBIOL, V6, P201, DOI 10.1111/j.1462-5822.2004.00361.x; Greenberg JT, 1997, ANNU REV PLANT PHYS, V48, P525, DOI 10.1146/annurev.arplant.48.1.525; Hara-Nishimura I, 1998, J PLANT PHYSIOL, V152, P668, DOI 10.1016/S0176-1617(98)80028-X; Hara-Nishimura I, 1998, HDB PROTEOLYTIC ENZY, P746; HARANISHIMURA I, 1991, FEBS LETT, V294, P89, DOI 10.1016/0014-5793(91)81349-D; HARANISHIMURA I, 1993, PLANT CELL, V5, P1651, DOI 10.1105/tpc.5.11.1651; HARANISHIMURA I, 2000, VACUOLAR COMPARTMENT, P20; HATSUGAI N, UNPUB; Hiraiwa N, 1999, FEBS LETT, V447, P213, DOI 10.1016/S0014-5793(99)00286-0; Hoeberichts FA, 2003, PLANTA, V217, P517, DOI 10.1007/s00425-003-1049-9; Jones AM, 2001, PLANT PHYSIOL, V125, P94, DOI 10.1104/pp.125.1.94; Kinoshita T, 1999, PLANT J, V19, P43, DOI 10.1046/j.1365-313X.1999.00497.x; Kuroyanagi M, 2002, PLANT CELL PHYSIOL, V43, P143, DOI 10.1093/pcp/pcf035; Lam E, 2000, PLANT MOL BIOL, V44, P417, DOI 10.1023/A:1026509012695; Lam E, 2001, NATURE, V411, P848, DOI 10.1038/35081184; Levine A, 1996, CURR BIOL, V6, P427, DOI 10.1016/S0960-9822(02)00510-9; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Mitsuhashi N, 2001, PLANT CELL, V13, P2361; Mittler R, 1997, J CELL SCI, V110, P1333; Shimada T, 2003, J BIOL CHEM, V278, P32292, DOI 10.1074/jbc.M305740200; Shirahama-Noda K, 2003, J BIOL CHEM, V278, P33194, DOI 10.1074/jbc.M302742200; Woltering EJ, 2002, PLANT PHYSIOL, V130, P1764, DOI 10.1104/pp.006338; Yamada K, 1999, J BIOL CHEM, V274, P2563, DOI 10.1074/jbc.274.4.2563	28	466	511	3	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					855	858		10.1126/science.1099859	http://dx.doi.org/10.1126/science.1099859			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297671				2022-12-24	WOS:000223104900046
J	Metcalf, B; Voss, L; Jeffery, A; Perkins, J; Wilkin, T				Metcalf, B; Voss, L; Jeffery, A; Perkins, J; Wilkin, T			Physical activity cost of the school run: impact on schoolchildren of being driven to school (EarlyBird 22)	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Med, Peninsula Med Sch, Derriford Hosp, Plymouth PL6 8DH, Devon, England	Derriford Hospital; University of Plymouth	Wilkin, T (corresponding author), Univ Med, Peninsula Med Sch, Derriford Hosp, Plymouth PL6 8DH, Devon, England.	T.Wilkin@pms.ac.uk		Jeffery, Alison/0000-0001-7539-5957				Cooper AR, 2003, AM J PREV MED, V25, P273, DOI 10.1016/S0749-3797(03)00205-8; *DEP ENV TRANSP RE, 2000, 199799 DEP ENV TRANS; Department for Education and Skills, 2003, TRAV SCH GOOD PRACT; Metcalf BS, 2002, MED SCI SPORT EXER, V34, P1533, DOI 10.1097/00005768-200209000-00022; Voss LD, 2003, J PEDIATR ENDOCR MET, V16, P1211	5	88	89	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 9	2004	329	7470					832	833		10.1136/bmj.38169.688102.F71	http://dx.doi.org/10.1136/bmj.38169.688102.F71			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	862EK	15317729	Green Submitted, Green Published, Bronze			2022-12-24	WOS:000224472800019
J	Qi, Y; Gregory, MA; Li, ZL; Brousal, JP; West, K; Hann, SR				Qi, Y; Gregory, MA; Li, ZL; Brousal, JP; West, K; Hann, SR			p19(ARF) directly and differentially controls the functions of c-Myc independently of p53	NATURE			English	Article							CELL-CYCLE PROGRESSION; INDUCED APOPTOSIS; TUMOR-SUPPRESSOR; P53-INDEPENDENT APOPTOSIS; FIBROBLASTS; INDUCTION; PROTEOLYSIS; EXPRESSION; INK4A/ARF; TARGET	Increased expression of the oncogenic transcription factor c-Myc causes unregulated cell cycle progression(1). c-Myc can also cause apoptosis, but it is not known whether the activation and/or repression of c-Myc target genes mediates these diverse functions of c-Myc. Because unchecked cell cycle progression leads to hyperproliferation and tumorigenesis, it is essential for tumour suppressors, such as p53 and p19(ARF) (ARF), to curb cell cycle progression in response to increased c-Myc (refs 2, 3). Increased c-Myc has previously been shown to induce ARF expression, which leads to cell cycle arrest or apoptosis through the activation of p53 (ref. 4). Here we show that ARF can inhibit c-Myc by a unique and direct mechanism that is independent of p53. When c-Myc increases, ARF binds with c-Myc and dramatically blocks c-Myc's ability to activate transcription and induce hyperproliferation and transformation. In contrast, c-Myc's ability to repress transcription is unaffected by ARF and c-Myc-mediated apoptosis is enhanced. These differential effects of ARF on c-Myc function suggest that separate molecular mechanisms mediate c-Myc-induced hyperproliferation and apoptosis. This direct feedback mechanism represents a p53-independent checkpoint to prevent c-Myc-mediated tumorigenesis.	Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA	Vanderbilt University	Hann, SR (corresponding author), Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, 221 Kirkland Hall, Nashville, TN 37232 USA.	steve.hann@vanderbilt.edu						Amanullah A, 2000, ONCOGENE, V19, P2967, DOI 10.1038/sj.onc.1203638; Conzen SD, 2000, MOL CELL BIOL, V20, P6008, DOI 10.1128/MCB.20.16.6008-6018.2000; Datta A, 2004, J BIOL CHEM, V279, P36698, DOI 10.1074/jbc.M312305200; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Fukatsu K, 1997, SEN-I GAKKAISHI, V53, P15, DOI 10.2115/fiber.53.15; Grandori C, 1997, TRENDS BIOCHEM SCI, V22, P177, DOI 10.1016/S0968-0004(97)01025-6; Greenberg RA, 1999, ONCOGENE, V18, P1219, DOI 10.1038/sj.onc.1202669; Gregory MA, 2003, J BIOL CHEM, V278, P51606, DOI 10.1074/jbc.M310722200; HARRINGTON EA, 1994, EMBO J, V13, P3286, DOI 10.1002/j.1460-2075.1994.tb06630.x; Haviernik P, 2003, ONCOGENE, V22, P1600, DOI 10.1038/sj.onc.1206268; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Korgaonkar C, 2002, MOL CELL BIOL, V22, P196, DOI 10.1128/MCB.22.1.196-206.2002; Lenahan MK, 1996, ONCOGENE, V12, P1847; Marhin WW, 1997, ONCOGENE, V14, P2825, DOI 10.1038/sj.onc.1201138; O'Hagan RC, 2000, GENE DEV, V14, P2185, DOI 10.1101/gad.827200; Oster SK, 2002, ADV CANCER RES, V84, P81, DOI 10.1016/S0065-230X(02)84004-0; Oster SK, 2000, MOL CELL BIOL, V20, P6768, DOI 10.1128/MCB.20.18.6768-6778.2000; Oster SK, 2003, ONCOGENE, V22, P1998, DOI 10.1038/sj.onc.1206228; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Sakamuro D, 1995, ONCOGENE, V11, P2411; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Soucek L, 2002, CANCER RES, V62, P3507; Trudel M, 1997, J EXP MED, V186, P1873, DOI 10.1084/jem.186.11.1873; Tsuji K, 2002, BIOCHEM BIOPH RES CO, V295, P621, DOI 10.1016/S0006-291X(02)00723-4; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Weber JD, 2000, GENE DEV, V14, P2358, DOI 10.1101/gad.827300; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010; Xiao QR, 1998, GENE DEV, V12, P3803, DOI 10.1101/gad.12.24.3803; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	30	178	190	2	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2004	431	7009					712	717		10.1038/nature02958	http://dx.doi.org/10.1038/nature02958			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15361884				2022-12-24	WOS:000224299300046
J	Bateman, JM; McNeill, H				Bateman, JM; McNeill, H			Temporal control of differentiation by the insulin receptor/Tor pathway in Drosophila	CELL			English	Article							CONTROLS PLANAR POLARITY; TOP MESSENGER-RNAS; CELL-GROWTH; TUMOR-SUPPRESSOR; EYE DEVELOPMENT; DIRECT TARGET; TRANSCRIPTION FACTORS; RHEB; KINASE; TSC1	Multicellular organisms must integrate growth and differentiation precisely to pattern complex tissues. Despite great progress in understanding how different cell fates are induced, it is poorly understood how differentiation decisions are temporally regulated. In a screen for patterning mutants, we isolated alleles of tsc1, a component of the insulin receptor (InR) growth control pathway. We find that loss of tsc1 disrupts patterning due to a loss of temporal control of differentiation. tsc1 controls the timing of differentiation downstream or in parallel to the RAS/MAPK pathway. Examination of InR, PI3K, PTEN, Tor, Rheb, and S6 kinase mutants demonstrates that increased InR signaling leads to precocious differentiation while decreased signaling leads to delays in differentiation. Importantly, cell fates are unchanged, but tissue organization is lost upon loss of developmental timing controls. These data suggest that intricate developmental decisions are coordinated with nutritional status and tissue growth by the InR signaling pathway.	Canc Res UK, London WC2A 3PX, England	Cancer Research UK	McNeill, H (corresponding author), Canc Res UK, 44 Lincolns Inn Fields, London WC2A 3PX, England.	helen.mcneill@cancer.org.uk	McNeill, Helen/E-4579-2013; Bateman, Joseph M/F-3625-2011	McNeill, Helen/0000-0003-1126-5154; Bateman, Joseph/0000-0003-0754-1785				Behan KJ, 2002, DEV GENES EVOL, V212, P267, DOI 10.1007/s00427-002-0241-4; BOHMANN D, 1994, CELL, V78, P973, DOI 10.1016/0092-8674(94)90273-9; Britton JS, 1998, DEVELOPMENT, V125, P2149; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; CAGAN RL, 1992, CELL, V69, P393, DOI 10.1016/0092-8674(92)90442-F; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; Daga A, 1996, GENE DEV, V10, P1194, DOI 10.1101/gad.10.10.1194; Datar SA, 2000, EMBO J, V19, P4543, DOI 10.1093/emboj/19.17.4543; DENOOIJ JC, 1995, SCIENCE, V270, P983, DOI 10.1126/science.270.5238.983; Fanto M, 2003, DEVELOPMENT, V130, P763, DOI 10.1242/dev.00304; Gao XS, 2001, GENE DEV, V15, P1383, DOI 10.1101/gad.901101; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; GOMEZ MR, 1999, TUBEROUS SCLEROSIS; HIGASHIJIMA SI, 1992, GENE DEV, V6, P50, DOI 10.1101/gad.6.1.50; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; JAN YN, 1985, J NEUROSCI, V5, P2453; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Kockel L, 1997, GENE DEV, V11, P1748, DOI 10.1101/gad.11.13.1748; LAI ZC, 1992, CELL, V70, P609, DOI 10.1016/0092-8674(92)90430-K; Lamb RF, 2000, NAT CELL BIOL, V2, P281, DOI 10.1038/35010550; Leevers Sally J., 2004, VVolume 42, P167; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Lewis J, 2003, CURR BIOL, V13, P1398, DOI 10.1016/S0960-9822(03)00534-7; McConnell S K, 1992, Curr Opin Neurobiol, V2, P23, DOI 10.1016/0959-4388(92)90156-F; McNeill H, 2000, NAT REV GENET, V1, P100, DOI 10.1038/35038540; Meyuhas O, 2000, COLD SPRING HARBOR M, V39, P671; MORATA G, 1975, NATURE, V255, P614, DOI 10.1038/255614a0; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Newsome TP, 2000, DEVELOPMENT, V127, P851; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Pasquinelli AE, 2002, ANNU REV CELL DEV BI, V18, P495, DOI 10.1146/annurev.cellbio.18.012502.105832; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Poethig RS, 2003, SCIENCE, V301, P334, DOI 10.1126/science.1085328; Potter CJ, 2001, CELL, V105, P357, DOI 10.1016/S0092-8674(01)00333-6; Prober DA, 2002, GENE DEV, V16, P2286, DOI 10.1101/gad.991102; REBAY I, 1995, CELL, V81, P857, DOI 10.1016/0092-8674(95)90006-3; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Song JB, 2003, SCIENCE, V300, P502, DOI 10.1126/science.1081203; Sparagana Steven P., 2000, Current Opinion in Neurology, V13, P115, DOI 10.1097/00019052-200004000-00001; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Stolovich M, 2002, MOL CELL BIOL, V22, P8101, DOI 10.1128/MCB.22.23.8101-8113.2002; Tang AH, 1997, CELL, V90, P459, DOI 10.1016/S0092-8674(00)80506-1; Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Thummel CS, 2001, DEV CELL, V1, P453, DOI 10.1016/S1534-5807(01)00060-0; Voas MG, 2004, DEV DYNAM, V229, P162, DOI 10.1002/dvdy.10449; WASSARMAN DA, 1994, GENE, V144, P309, DOI 10.1016/0378-1119(94)90396-4; Wolff Tanya, 1993, P1277; Xu CY, 2000, CELL, V103, P87, DOI 10.1016/S0092-8674(00)00107-0; XU T, 1993, DEVELOPMENT, V117, P1223; Yang CH, 1999, DEVELOPMENT, V126, P5857; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	54	86	90	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 1	2004	119	1					87	96		10.1016/j.cell.2004.08.028	http://dx.doi.org/10.1016/j.cell.2004.08.028			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	859UE	15454083	Bronze			2022-12-24	WOS:000224292600011
J	Collins, S; Bell, G				Collins, S; Bell, G			Phenotypic consequences of 1,000 generations of selection at elevated CO2 in a green alga	NATURE			English	Article							CHLAMYDOMONAS-REINHARDTII; ESCHERICHIA-COLI; DIVERSITY; RESPONSES; ENVIRONMENTS; MECHANISMS; RADIATION	Estimates of the effect of increasing atmospheric CO2 concentrations on future global plant production rely on the physiological response of individual plants or plant communities when exposed to high CO2 (refs 1 - 6). Plant populations may adapt to the changing atmosphere, however, such that the evolved plant communities of the next century are likely to be genetically different from contemporary communities(7-12). The properties of these future communities are unknown, introducing a bias of unknown sign and magnitude into projections of global carbon pool dynamics. Here we report a long-term selection experiment to investigate the phenotypic consequences of selection for growth at elevated CO2 concentrations. After about 1,000 generations, selection lines of the unicellular green alga Chlamydomonas failed to evolve specific adaptation to a CO2 concentration of 1,050 parts per million. Some lines, however, evolved a syndrome involving high rates of photosynthesis and respiration, combined with higher chlorophyll content and reduced cell size. These lines also grew poorly at ambient concentrations of CO2. We tentatively attribute this outcome to the accumulation of conditionally neutral mutations in genes affecting the carbon concentration mechanism.	McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Bell, G (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	graham.bell@mcgill.ca	Collins, Sinead/F-3788-2010	Collins, Sinead/0000-0003-3856-4285				Andalo C, 2001, ECOLOGY, V82, P157, DOI 10.1890/0012-9658(2001)082[0157:IAICUE]2.0.CO;2; Badger MR, 1998, CAN J BOT, V76, P1052, DOI 10.1139/b98-074; Badger Murray R., 2000, Advances in Photosynthesis, V9, P369; BAZZAZ FA, 1995, P NATL ACAD SCI USA, V92, P8161, DOI 10.1073/pnas.92.18.8161; Colman B, 2002, FUNCT PLANT BIOL, V29, P261, DOI 10.1071/PP01184; FALCONER DS, 1990, GENET RES, V56, P57, DOI 10.1017/S0016672300028883; Fuhrer J, 2003, AGR ECOSYST ENVIRON, V97, P1, DOI 10.1016/S0167-8809(03)00125-7; Griffin KL, 2001, P NATL ACAD SCI USA, V98, P2473, DOI 10.1073/pnas.041620898; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; Hillebrand H, 1999, J PHYCOL, V35, P403, DOI 10.1046/j.1529-8817.1999.3520403.x; Lee TD, 2001, NEW PHYTOL, V150, P405, DOI 10.1046/j.1469-8137.2001.00095.x; Luscher A, 1998, OECOLOGIA, V113, P37, DOI 10.1007/s004420050351; MacLean RC, 2002, AM NAT, V160, P569, DOI 10.1086/342816; Notley-McRobb L, 1999, ENVIRON MICROBIOL, V1, P33, DOI 10.1046/j.1462-2920.1999.00002.x; Potvin C, 1996, OECOLOGIA, V108, P683, DOI 10.1007/BF00329043; Raven JA, 2001, J PHYCOL, V37, P943, DOI 10.1046/j.1529-8817.2001.01079.x; RUBAN O, 2003, PHOTOSYNTHETICA, V41, P9; Saxe H, 1998, NEW PHYTOL, V139, P395, DOI 10.1046/j.1469-8137.1998.00221.x; Spalding MH, 2002, FUNCT PLANT BIOL, V29, P221, DOI 10.1071/PP01182; Sultemeyer D, 1998, CAN J BOT, V76, P962; SUZUKI K, 1989, PLANT PHYSIOL, V90, P1195, DOI 10.1104/pp.90.3.1195; Thyssen C, 2003, PLANTA, V217, P102, DOI 10.1007/s00425-002-0961-8; Tilman D, 2001, P NATL ACAD SCI USA, V98, P5433, DOI 10.1073/pnas.091093198; Travisano M, 1996, GENETICS, V143, P15; Turner PE, 2000, GENETICS, V156, P1465; Ward JK, 2000, OECOLOGIA, V123, P330, DOI 10.1007/s004420051019; Watson R, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, pIX; Xue XP, 1996, PLANT PHYSIOL, V112, P1005, DOI 10.1104/pp.112.3.1005; Yedid G, 2002, NATURE, V420, P810, DOI 10.1038/nature01151	29	246	255	4	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 30	2004	431	7008					566	569		10.1038/nature02945	http://dx.doi.org/10.1038/nature02945			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15457260				2022-12-24	WOS:000224156700046
J	Jiang, N; Bao, ZR; Zhang, XY; Eddy, SR; Wessler, SR				Jiang, N; Bao, ZR; Zhang, XY; Eddy, SR; Wessler, SR			Pack-MULE transposable elements mediate gene evolution in plants	NATURE			English	Article							DRAFT SEQUENCE; RICE; GENOME; IDENTIFICATION; DIVERSITY	Mutator-like transposable elements (MULEs) are found in many eukaryotic genomes and are especially prevalent in higher plants(1-3). In maize, rice and Arabidopsis a few MULEs were shown to carry fragments of cellular genes(4-6). These chimaeric elements are called Pack-MULEs in this study. The abundance of MULEs in rice and the availability of most of the genome sequence permitted a systematic analysis of the prevalence and nature of Pack-MULEs in an entire genome. Here we report that there are over 3,000 Pack-MULEs in rice containing fragments derived from more than 1,000 cellular genes. Pack-MULEs frequently contain fragments from multiple chromosomal loci that are fused to form new open reading frames, some of which are expressed as chimaeric transcripts. About 5% of the Pack-MULEs are represented in collections of complementary DNA. Functional analysis of amino acid sequences and proteomic data indicate that some captured gene fragments might be functional. Comparison of the cellular genes and Pack-MULE counterparts indicates that fragments of genomic DNA have been captured, rearranged and amplified over millions of years. Given the abundance of Pack-MULEs in rice and the widespread occurrence of MULEs in all characterized plant genomes, gene fragment acquisition by Pack-MULEs might represent an important new mechanism for the evolution of genes in higher plants.	Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; Washington Univ, Howard Hughes Med Inst, St Louis, MO 63108 USA; Washington Univ, Dept Genet, St Louis, MO 63108 USA	University System of Georgia; University of Georgia; Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL)	Wessler, SR (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.	suew@plantbio.uga.edu	Jiang, Ning/G-6546-2012	Eddy, Sean/0000-0001-6676-4706				Bao ZR, 2002, GENOME RES, V12, P1269, DOI 10.1101/gr.88502; BENNETZEN JL, 1994, THEOR APPL GENET, V87, P657, DOI 10.1007/BF00222890; Chalvet F, 2003, MOL BIOL EVOL, V20, P1362, DOI 10.1093/molbev/msg155; CRESSE AD, 1995, GENETICS, V140, P315; Emerson JJ, 2004, SCIENCE, V303, P537, DOI 10.1126/science.1090042; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Hanley S, 2000, PLANT J, V23, P557, DOI 10.1046/j.1365-313x.2000.00830.x; Jiang N, 2003, NATURE, V421, P163, DOI 10.1038/nature01214; Kikuchi S, 2003, SCIENCE, V301, P376, DOI 10.1126/science.1081288; Koller A, 2002, P NATL ACAD SCI USA, V99, P11969, DOI 10.1073/pnas.172183199; Kumar S., 2001, MEGA2 MOL EVOLUTIONA; Le QH, 2000, P NATL ACAD SCI USA, V97, P7376, DOI 10.1073/pnas.97.13.7376; LEVY AA, 1991, MOL GEN GENET, V229, P147, DOI 10.1007/BF00264223; Lisch D, 2002, TRENDS PLANT SCI, V7, P498, DOI 10.1016/S1360-1385(02)02347-6; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Normile D, 2002, SCIENCE, V296, P32, DOI 10.1126/science.296.5565.32; Sasaki T, 2002, NATURE, V420, P312, DOI 10.1038/nature01184; TALBERT LE, 1988, MOL BIOL EVOL, V5, P519; TAYLOR LP, 1985, EMBO J, V4, P869, DOI 10.1002/j.1460-2075.1985.tb03712.x; Turcotte K, 2001, PLANT J, V25, P169, DOI 10.1046/j.1365-313x.2001.00945.x; Walbot Virginia, 2002, P533; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Yu YS, 2003, SCIENCE, V300, P1566, DOI 10.1126/science.1083523; Yu ZH, 2000, GENETICS, V156, P2019	24	381	412	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 30	2004	431	7008					569	573		10.1038/nature02953	http://dx.doi.org/10.1038/nature02953			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15457261				2022-12-24	WOS:000224156700047
J	Rohde, DLT; Olson, S; Chang, JT				Rohde, DLT; Olson, S; Chang, JT			Modelling the recent common ancestry of all living humans	NATURE			English	Article							POPULATION; GENEALOGY	If a common ancestor of all living humans is defined as an individual who is a genealogical ancestor of all present-day people, the most recent common ancestor (MRCA) for a randomly mating population would have lived in the very recent past(1-3). However, the random mating model ignores essential aspects of population substructure, such as the tendency of individuals to choose mates from the same social group, and the relative isolation of geographically separated groups. Here we show that recent common ancestors also emerge from two models incorporating substantial population substructure. One model, designed for simplicity and theoretical insight, yields explicit mathematical results through a probabilistic analysis. A more elaborate second model, designed to capture historical population dynamics in a more realistic way, is analysed computationally through Monte Carlo simulations. These analyses suggest that the genealogies of all living humans overlap in remarkable ways in the recent past. In particular, the MRCA of all present-day humans lived just a few thousand years ago in these models. Moreover, among all individuals living more than just a few thousand years earlier than the MRCA, each present-day human has exactly the same set of genealogical ancestors.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Yale Univ, Dept Stat, New Haven, CT 06520 USA	Massachusetts Institute of Technology (MIT); Yale University	Rohde, DLT (corresponding author), MIT, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	dr@tedlab.mit.edu						Bonne-Tamir B, 2003, ANN HUM GENET, V67, P153, DOI 10.1046/j.1469-1809.2003.00024.x; Chang JT, 1999, ADV APPL PROBAB, V31, P1002, DOI 10.1239/aap/1029955256; Derrida B, 2000, PHYSICA A, V281, P1, DOI 10.1016/S0378-4371(00)00031-5; Derrida B, 2000, J THEOR BIOL, V203, P303, DOI 10.1006/jtbi.2000.1095; Fitzhugh W., 1988, CROSSROADS CONTINENT; Hey J, 2003, NAT REV GENET, V4, P535, DOI 10.1038/nrg1112; Hoerder D., 2002, CULTURES CONTACT WOR; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; JONES R, 1995, ANNU REV ANTHROPOL, V24, P423; Jorde L., 1980, CURRENT DEV ANTHR GE, V1, P135, DOI DOI 10.1007/978-1-4613-3084-4_7; MORTON NE, 1971, AM J HUM GENET, V23, P339; NOTOHARA M, 1990, J MATH BIOL, V29, P59, DOI 10.1007/BF00173909; Ohno S, 1996, P NATL ACAD SCI USA, V93, P15276, DOI 10.1073/pnas.93.26.15276; Pletcher SD, 1999, J EVOLUTION BIOL, V12, P430, DOI 10.1046/j.1420-9101.1999.00058.x; Stannard David E., 1992, AM HOLOCAUST COLUMBU; Thomson R, 2000, P NATL ACAD SCI USA, V97, P7360, DOI 10.1073/pnas.97.13.7360; *US NAT OFF VIT ST, 1956, VIT STAT SPEC REP, V43; Wachter K. W., 1980, GENEALOGICAL DEMOGRA, P85; WARD RH, 1970, AM J HUM GENET, V22, P538; WEISS KM, 1976, AM J PHYS ANTHROPOL, V44, P31, DOI 10.1002/ajpa.1330440106; Wilkinson-Herbots HM, 1998, J MATH BIOL, V37, P535, DOI 10.1007/s002850050140; Wiuf C, 1997, GENETICS, V147, P1459; Zerjal T, 2003, AM J HUM GENET, V72, P717, DOI 10.1086/367774	24	74	76	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 30	2004	431	7008					562	566		10.1038/nature02842	http://dx.doi.org/10.1038/nature02842			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857YP	15457259	Green Submitted			2022-12-24	WOS:000224156700045
J	Schroeder, SA				Schroeder, SA			The tobacco buyout and the FDA	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Calif San Francisco, Smoking Cessat Leadership Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Schroeder, SA (corresponding author), Univ Calif San Francisco, Smoking Cessat Leadership Ctr, San Francisco, CA 94143 USA.								0	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 30	2004	351	14					1377	1380		10.1056/NEJMp048218	http://dx.doi.org/10.1056/NEJMp048218			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857XT	15459295				2022-12-24	WOS:000224153900002
J	Ghosh, AK; Ghosh, K				Ghosh, AK; Ghosh, K			Misinterpretation of numbers: a potential source of physician's error	LANCET			English	Editorial Material							MEDICINE; TREAT		Mayo Clin Coll Med, Div Gen Internal Med, Rochester, MN 55905 USA	Mayo Clinic	Ghosh, AK (corresponding author), Mayo Clin Coll Med, Div Gen Internal Med, W 17-B, Rochester, MN 55905 USA.	ghosh.amit@mayo.edu						Brennan TA, 2000, NEW ENGL J MED, V342, P1123, DOI 10.1056/NEJM200004133421510; Ghosh AK, 2004, J GEN INTERN MED, V19, P184; Ghosh AK, 2004, J LAB CLIN MED, V144, P60, DOI 10.1016/j.lab.2004.05.013; Ghosh AK, 2004, QJM-INT J MED, V97, P53, DOI 10.1093/qjmed/hch010; GHOSH AK, 2002, J INVEST MED, V50, P243; Hoffrage U, 2000, SCIENCE, V290, P2261, DOI 10.1126/science.290.5500.2261; Kohn LT, 2000, ERR IS HUMAN BUILDIN; Kristiansen IS, 2002, J CLIN EPIDEMIOL, V55, P888, DOI 10.1016/S0895-4356(02)00432-8; Noguchi Y, 2002, J GEN INTERN MED, V17, P848, DOI 10.1046/j.1525-1497.2002.20139.x; Wheeler DW, 2004, J ROY SOC MED, V97, P380, DOI 10.1258/jrsm.97.8.380	10	8	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 25	2004	364	9440					1108	1110		10.1016/S0140-6736(04)17119-5	http://dx.doi.org/10.1016/S0140-6736(04)17119-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857FT	15451207				2022-12-24	WOS:000224102400008
J	He, YK; Tang, RH; Hao, Y; Stevens, RD; Cook, CW; Am, SM; Jing, LF; Yang, ZG; Chen, LG; Guo, FQ; Fiorani, F; Jackson, RB; Crawford, NM; Pei, ZM				He, YK; Tang, RH; Hao, Y; Stevens, RD; Cook, CW; Am, SM; Jing, LF; Yang, ZG; Chen, LG; Guo, FQ; Fiorani, F; Jackson, RB; Crawford, NM; Pei, ZM			Nitric oxide represses the Arabidopsis floral transition	SCIENCE			English	Article							FLOWERING-TIME; CIRCADIAN CLOCK; GENE-EXPRESSION; PLANTS; PROTEIN; REGULATOR; ENCODES	The correct timing of flowering is essential for plants to maximize reproductive success and is controlled by environmental and endogenous signals. We report that nitric oxide (NO) repressed the floral transition in Arabidopsis thaliana. Plants treated with NO, as well as a mutant overproducing NO (nox1), flowered late, whereas a mutant producing less NO (nos1) flowered early. NO suppressed CONSTANS and GIGANTEA gene expression and enhanced FLOWERING LOCUS C expression, which indicated that NO regulates the photoperiod and autonomous pathways. Because NO is induced by environmental stimuli and constitutively produced, it may integrate both external and internal cues into the floral decision.	Duke Univ, Dept Biol, Durham, NC 27708 USA; Capital Normal Univ, Dept Biol, Beijing 100037, Peoples R China; Duke Univ, Med Ctr, Mass Spectrometry Lab, Res Triangle Pk, NC 27709 USA; Duke Univ, Med Ctr, Orthopaed Res Lab, Durham, NC 27710 USA; Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	Duke University; Capital Normal University; Duke University; Duke University; University of California System; University of California San Diego	Pei, ZM (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	zpei@duke.edu	Fiorani, Fabio/F-4171-2011	Fiorani, Fabio/0000-0001-8775-1541; Jackson, Robert/0000-0001-8846-7147; Guo, Fang-Qing/0000-0001-6889-394X; Tang, Ruhang/0000-0003-4918-3525; Pei, Zhen-Ming/0000-0003-1473-696X				Beligni MV, 2000, PLANTA, V210, P215, DOI 10.1007/PL00008128; Blazquez MA, 1997, DEVELOPMENT, V124, P3835; Chandok MR, 2003, CELL, V113, P469, DOI 10.1016/S0092-8674(03)00350-7; Fowler S, 1999, EMBO J, V18, P4679, DOI 10.1093/emboj/18.17.4679; Guo FQ, 2003, SCIENCE, V302, P100, DOI 10.1126/science.1086770; HE Y, UNPUB; Hicks KA, 1996, SCIENCE, V274, P790, DOI 10.1126/science.274.5288.790; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Lamattina L, 2003, ANNU REV PLANT BIOL, V54, P109, DOI 10.1146/annurev.arplant.54.031902.134752; Leshem YY, 1996, J PLANT PHYSIOL, V148, P258, DOI 10.1016/S0176-1617(96)80251-3; LI HM, 1995, PLANT CELL, V7, P1599, DOI 10.1105/tpc.7.10.1599; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Morot-Gaudry-Talarmain Y, 2002, PLANTA, V215, P708, DOI 10.1007/s00425-002-0816-3; Mouradov A, 2002, PLANT CELL, V14, pS111, DOI 10.1105/tpc.001362; Onouchi H, 2000, PLANT CELL, V12, P885, DOI 10.1105/tpc.12.6.885; SCHMIDT HHHW, 1994, CELL, V78, P919, DOI 10.1016/0092-8674(94)90267-4; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Streatfield SJ, 1999, PLANT CELL, V11, P1609, DOI 10.1105/tpc.11.9.1609; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Sun TP, 2004, ANNU REV PLANT BIOL, V55, P197, DOI 10.1146/annurev.arplant.55.031903.141753; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996	23	416	470	7	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2004	305	5692					1968	1971		10.1126/science.1098837	http://dx.doi.org/10.1126/science.1098837			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857RM	15448272				2022-12-24	WOS:000224136000051
J	delBarco-Trillo, J; Ferkin, MH				delBarco-Trillo, J; Ferkin, MH			Male mammals respond to a risk of sperm competition conveyed by odours of conspecific males	NATURE			English	Article							COPULATORY-BEHAVIOR; MEADOW VOLES; EJACULATE; SCENT; GAMES	Sperm competition occurs when a female copulates with two or more males and the sperm of those males compete within the female's reproductive tract to fertilize her eggs(1,2). The frequent occurrence of sperm competition has forced males of many species to develop different strategies to overcome the sperm of competing males(1,3). A prevalent strategy is for males to increase their sperm investment ( total number of sperm allocated by a male to a particular female) after detecting a risk of sperm competition(1,3,4). It has been shown that the proportion of sperm that one male contributes to the sperm pool of a female is correlated with the proportion of offspring sired by that male(5,6). Therefore, by increasing his sperm investment a male may bias a potential spermcompetition in his favour(5,7,8). Here we show that male meadow voles, Microtus pennsylvanicus, increase their sperm investment when they mate in the presence of another male's odours. Such an increase in sperm investment does not occur by augmenting the frequency of ejaculations, but by increasing the amount of sperm in a similar number of ejaculations.	Univ Memphis, Dept Biol, Memphis, TN 38152 USA	University of Memphis	delBarco-Trillo, J (corresponding author), Univ Memphis, Dept Biol, Ellington Hall, Memphis, TN 38152 USA.	jtrillo@memphis.edu	Ferkin, Michael H/A-3968-2009; delBarco-Trillo, Javier/F-6728-2010	delBarco-Trillo, Javier/0000-0002-9948-6674				[Anonymous], [No title captured]; BAKER RR, 1995, HUMAN SPERM COMPETIT, P203; BELLIS MA, 1990, J MAMMAL, V71, P479, DOI 10.2307/1381968; Birkhead TR, 1992, SPERM COMPETITION BI; Birkhead TR, 1998, SPERM COMPETITION SE; BOONSTRA R, 1993, BEHAV ECOL, V4, P83, DOI 10.1093/beheco/4.1.83; Brown R. E., 1985, SOCIAL ODOURS MAMMAL, V1; Dewsbury D.A., 1984, P547; DEWSBURY DA, 1975, SCIENCE, V190, P947, DOI 10.1126/science.1188377; DEWSBURY DA, 1981, BEHAV ECOL SOCIOBIOL, V9, P121, DOI 10.1007/BF00293583; DEWSBURY DA, 1972, Q REV BIOL, V47, P1, DOI 10.1086/407097; DEWSBURY DA, 1982, AM NAT, V119, P601, DOI 10.1086/283938; Dziuk PJ, 1996, ANIM REPROD SCI, V43, P65, DOI 10.1016/0378-4320(95)01463-2; Ferkin MH, 2004, ETHOLOGY, V110, P257, DOI 10.1111/j.1439-0310.2004.00961.x; FERKIN MH, 1995, ANIM BEHAV, V49, P37, DOI 10.1016/0003-3472(95)80151-0; GAGE MJG, 1991, ANIM BEHAV, V42, P1036, DOI 10.1016/S0003-3472(05)80162-9; GINSBERG JR, 1989, TRENDS ECOL EVOL, V4, P74, DOI 10.1016/0169-5347(89)90152-3; GRAY GD, 1975, ANIM BEHAV, V23, P261, DOI 10.1016/0003-3472(75)90074-3; Johnston R.E., 1983, P3; Lezama V, 2001, APPL ANIM BEHAV SCI, V75, P55, DOI 10.1016/S0168-1591(01)00187-3; PARKER GA, 1990, P ROY SOC B-BIOL SCI, V242, P120, DOI 10.1098/rspb.1990.0114; Parker GA, 1997, P ROY SOC B-BIOL SCI, V264, P1793, DOI 10.1098/rspb.1997.0249; Pilastro A, 2002, P NATL ACAD SCI USA, V99, P9913, DOI 10.1073/pnas.152133499; Pizzari T, 2003, NATURE, V426, P70, DOI 10.1038/nature02004; Pound N, 1999, P ROY SOC B-BIOL SCI, V266, P1755, DOI 10.1098/rspb.1999.0842; ROBB GW, 1978, J REPROD FERTIL, V54, P103, DOI 10.1530/jrf.0.0540103; SCHWAGMEYER PL, 1990, ANIM BEHAV, V39, P156, DOI 10.1016/S0003-3472(05)80735-3; Simmons LW., 2001, MG BEH ECOL; Wedell N, 1999, P ROY SOC B-BIOL SCI, V266, P1033, DOI 10.1098/rspb.1999.0740; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8	30	135	139	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 23	2004	431	7007					446	449		10.1038/nature02845	http://dx.doi.org/10.1038/nature02845			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15386011				2022-12-24	WOS:000224000500039
J	Inoue, T; Oz, HS; Wiland, D; Gharib, S; Deshpande, R; Hill, RJ; Katz, WS; Sternberg, PW				Inoue, T; Oz, HS; Wiland, D; Gharib, S; Deshpande, R; Hill, RJ; Katz, WS; Sternberg, PW			C-elegans LIN-18 is a Ryk ortholog in parallel to LIN-17/frizzled in Wnt and functions signaling	CELL			English	Article							ASYMMETRIC CELL DIVISIONS; CAENORHABDITIS-ELEGANS; VULVAR DEVELOPMENT; GENE-EXPRESSION; RECEPTOR; PROTEIN; ENCODES; MUTATIONS; LINEAGES; HOMOLOG	Wnt proteins are intercellular signals that regulate various aspects of animal development. In Caenorhabditis elegans, mutations in lin-17, a Frizzled-class Wnt receptor, and in lin-18 affect cell fate patterning in the P7.p vulval lineage. We found that lin-18 encodes a member of the Ryk/Derailed family of tyrosine kinase-related receptors, recently found to function as Wnt receptors. Members of this family have nonactive kinase domains. The LIN-18 kinase domain is dispensable for LIN-18 function, while the Wnt binding WIF domain is required. We also found that Wnt proteins LIN-44, MOM-2, and CWN-2 redundantly regulate P7.p patterning. Genetic interactions indicate that LIN-17 and LIN-18 function independently of each other in parallel pathways, and different ligands display different receptor specificities. Thus, two independent Wnt signaling pathways, one employing a Ryk receptor and the other a Frizzled receptor, function in parallel to regulate cell fate patterning in the C. elegans vulva.	CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; Univ Kentucky, Coll Med, Dept Biochem, Lexington, KY 40536 USA; Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; Rush Univ, Dept Med, Ctr Med, Chicago, IL 60612 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; University of Kentucky; University System of Ohio; Ohio State University; Rush University	Sternberg, PW (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	pws@caltech.edu		Katz, Wendy/0000-0003-3038-6314				Burdine RD, 1998, DEVELOPMENT, V125, P1083; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; CALLAHAN CA, 1995, NATURE, V376, P171, DOI 10.1038/376171a0; CHAMBERLIN HM, 1995, DEV BIOL, V170, P679, DOI 10.1006/dbio.1995.1246; Eisenmann DM, 1998, DEVELOPMENT, V125, P3667; FERGUSON EL, 1987, NATURE, V326, P259, DOI 10.1038/326259a0; FERGUSON EL, 1985, GENETICS, V110, P17; George SE, 1998, CELL, V92, P633, DOI 10.1016/S0092-8674(00)81131-9; GEORGI LL, 1990, CELL, V61, P635, DOI 10.1016/0092-8674(90)90475-T; Gleason JE, 2002, GENE DEV, V16, P1281, DOI 10.1101/gad.981602; GREENSTEIN D, 1994, GENE DEV, V8, P1935, DOI 10.1101/gad.8.16.1935; GREENWALD IS, 1983, CELL, V34, P435, DOI 10.1016/0092-8674(83)90377-X; Halford MM, 2001, BIOESSAYS, V23, P34, DOI 10.1002/1521-1878(200101)23:1<34::AID-BIES1005>3.3.CO;2-4; Halford MM, 1999, J BIOL CHEM, V274, P7379, DOI 10.1074/jbc.274.11.7379; Halford MM, 2000, NAT GENET, V25, P414, DOI 10.1038/78099; HERMAN MA, 1994, DEVELOPMENT, V120, P1035; HERMAN MA, 1995, CELL, V83, P101, DOI 10.1016/0092-8674(95)90238-4; HILL RJ, 1992, NATURE, V358, P470, DOI 10.1038/358470a0; HOVENS CM, 1992, P NATL ACAD SCI USA, V89, P11818, DOI 10.1073/pnas.89.24.11818; Hsieh JC, 1999, NATURE, V398, P431, DOI 10.1038/18899; Inoue T, 2002, MECH DEVELOP, V119, pS203, DOI 10.1016/S0925-4773(03)00117-5; Jiang LI, 1998, DEVELOPMENT, V125, P2337; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Katso RM, 1999, MOL CELL BIOL, V19, P6427; KIMBLE J, 1981, DEV BIOL, V87, P286, DOI 10.1016/0012-1606(81)90152-4; Korswagen HC, 2002, BIOESSAYS, V24, P801, DOI 10.1002/bies.10145; Kroiher M, 2001, BIOESSAYS, V23, P69, DOI 10.1002/1521-1878(200101)23:1<69::AID-BIES1009>3.3.CO;2-B; MADURO M, 1995, GENETICS, V141, P977; Maloof JN, 1999, DEVELOPMENT, V126, P37; McEwen DG, 2000, CURR BIOL, V10, pR562, DOI 10.1016/S0960-9822(00)00611-4; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Natarajan L, 2001, GENETICS, V159, P159; Oates AC, 1998, MECH DEVELOP, V78, P165, DOI 10.1016/S0925-4773(98)00167-1; Palmer RE, 2002, DEV BIOL, V252, P202, DOI 10.1006/dbio.2002.0850; Patthy L, 2000, TRENDS BIOCHEM SCI, V25, P12, DOI 10.1016/S0968-0004(99)01504-2; PinkasKramarski R, 1996, EMBO J, V15, P2452, DOI 10.1002/j.1460-2075.1996.tb00603.x; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Prud'homme B, 2002, CURR BIOL, V12, P1395, DOI 10.1016/S0960-9822(02)01068-0; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Savant-Bhonsale S, 1999, GENE, V231, P155, DOI 10.1016/S0378-1119(99)00061-X; Sawa H, 1996, GENE DEV, V10, P2189, DOI 10.1101/gad.10.17.2189; SHACKLEFORD GM, 1993, ONCOGENE, V8, P1857; Sharma-Kishore R, 1999, DEVELOPMENT, V126, P691; Siegfried KR, 2002, DEVELOPMENT, V129, P443; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; STERNBERG PW, 1986, CELL, V44, P761, DOI 10.1016/0092-8674(86)90842-1; STERNBERG PW, 1988, DEV BIOL, V130, P67, DOI 10.1016/0012-1606(88)90414-9; STERNBERG PW, 1988, NATURE, V335, P551, DOI 10.1038/335551a0; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Thorpe CJ, 1997, CELL, V90, P695, DOI 10.1016/S0092-8674(00)80530-9; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; YOCHEM J, 1988, NATURE, V335, P547, DOI 10.1038/335547a0; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; Yoshikawa S, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-01-j0002.2001; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	57	141	153	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2004	118	6					795	806		10.1016/j.cell.2004.09.001	http://dx.doi.org/10.1016/j.cell.2004.09.001			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	855RW	15369677	Bronze			2022-12-24	WOS:000223992400014
J	Mancini, EJ; Kainov, DE; Grimes, JM; Tuma, R; Bamford, DH; Stuart, DI				Mancini, EJ; Kainov, DE; Grimes, JM; Tuma, R; Bamford, DH; Stuart, DI			Atomic snapshots of an RNA packaging motor reveal conformational changes linking ATP hydrolysis to RNA translocation	CELL			English	Article							NUCLEOSIDE TRIPHOSPHATASE P4; BLUETONGUE VIRUS CORE; T7 DNA HELICASE; BACTERIOPHAGE PHI-6; CRYSTAL-STRUCTURE; REPLICATIVE HELICASE; POLYMERASE COMPLEX; CATALYTIC SITES; PROTEIN; MECHANISM	Many viruses package their genome into preformed capsids using packaging motors powered by the hydrolysis of ATP. The hexameric ATPase P4 of dsRNA bacteriophage phi12, located at the vertices of the ico-sahedral capsid, is such a packaging motor. We have captured crystallographic structures of P4 for all the key points along the catalytic pathway, including apo, substrate analog bound, and product bound. Substrate and product binding have been observed as both binary complexes and ternary complexes with divalent cations. These structures reveal large movements of the putative RNA binding loop, which are coupled with nucleotide binding and hydrolysis, indicating how ATP hydrolysis drives RNA translocation through cooperative conformational changes. Two distinct conformations of bound nucleotide triphosphate suggest how hydrolysis is activated by RNA binding. This provides a model for chemomechanical coupling for a prototype of the large family of hexameric helicases and oligonucleotide translocating enzymes.	Univ Oxford, Div Struct Biol, Henry Wellcome Bldg Genom Med,Roosevelt Dr, Oxford OX3 7BN, England; Univ Helsinki, Inst Biotechnol, Helsinki 00014, Finland; Univ Helsinki, Fac Biosci, Viikki Bioctr, Helsinki 00014, Finland	University of Oxford; University of Helsinki; University of Helsinki	Stuart, DI (corresponding author), Univ Oxford, Div Struct Biol, Henry Wellcome Bldg Genom Med,Roosevelt Dr, Oxford OX3 7BN, England.	dave@strubi.ox.ac.uk	kainov, denis/I-5526-2019; Tuma, Roman/AAL-4436-2020; Mancini, Erika J/J-9880-2013	kainov, denis/0000-0001-7716-6955; Tuma, Roman/0000-0003-0047-0013; Mancini, Erika J/0000-0001-9591-7898; Bamford, Dennis/0000-0002-6438-8118; Stuart, David/0000-0002-3426-4210; Grimes, Jonathan Mark/0000-0001-9698-0389				Bamford DH, 2002, THEOR POPUL BIOL, V61, P461, DOI 10.1006/tpbi.2002.1591; BLACK LW, 1989, ANNU REV MICROBIOL, V43, P267, DOI 10.1146/annurev.micro.43.1.267; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Butcher SJ, 2001, NATURE, V410, P235, DOI 10.1038/35065653; Cassetti MC, 1998, J VIROL, V72, P5769, DOI 10.1128/JVI.72.7.5769-5780.1998; Catalano CE, 2000, CELL MOL LIFE SCI, V57, P128, DOI 10.1007/s000180050503; de Haas F, 1999, J MOL BIOL, V294, P357, DOI 10.1006/jmbi.1999.3260; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Diprose JM, 2001, EMBO J, V20, P7229, DOI 10.1093/emboj/20.24.7229; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Gomis-Ruth FX, 2001, NATURE, V409, P637, DOI 10.1038/35054586; GOTTLIEB P, 1991, VIROLOGY, V181, P589, DOI 10.1016/0042-6822(91)90892-F; GOTTLIEB P, 1994, VIROLOGY, V200, P42, DOI 10.1006/viro.1994.1160; Gouet P, 1999, CELL, V97, P481, DOI 10.1016/S0092-8674(00)80758-8; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; GUO PX, 1987, J MOL BIOL, V197, P229, DOI 10.1016/0022-2836(87)90121-5; Hingorani MM, 1997, P NATL ACAD SCI USA, V94, P5012, DOI 10.1073/pnas.94.10.5012; JONES TA, 1990, CRYSTALLOGRAPHIC MOD, P189; Juuti JT, 1998, J MOL BIOL, V279, P347, DOI 10.1006/jmbi.1998.1772; Kainov DE, 2004, NUCLEIC ACIDS RES, V32, P3515, DOI 10.1093/nar/gkh680; Kainov DE, 2003, J BIOL CHEM, V278, P48084, DOI 10.1074/jbc.M306928200; Kim DE, 2002, J MOL BIOL, V321, P807, DOI 10.1016/S0022-2836(02)00733-7; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Li DW, 2003, NATURE, V423, P512, DOI 10.1038/nature01691; Lisal J, 2004, J BIOL CHEM, V279, P1343, DOI 10.1074/jbc.M309587200; Mancini EJ, 2004, ACTA CRYSTALLOGR D, V60, P588, DOI 10.1107/S0907444904001052; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mindich L, 1999, MICROBIOL MOL BIOL R, V63, P149, DOI 10.1128/MMBR.63.1.149-160.1999; Mitchell MS, 2002, NUCLEIC ACIDS RES, V30, P4009, DOI 10.1093/nar/gkf524; MORITA M, 1993, VIROLOGY, V193, P748, DOI 10.1006/viro.1993.1183; Nadanaciva S, 1999, BIOCHEMISTRY-US, V38, P15493, DOI 10.1021/bi9917683; Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Niedenzu T, 2001, J MOL BIOL, V306, P479, DOI 10.1006/jmbi.2000.4398; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paatero AO, 1998, J VIROL, V72, P10058, DOI 10.1128/JVI.72.12.10058-10065.1998; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pirttimaa MJ, 2002, J VIROL, V76, P10122, DOI 10.1128/JVI.76.20.10122-10127.2002; Qiao J, 2003, J BACTERIOL, V185, P4572, DOI 10.1128/JB.185.15.4572-4577.2003; Qiao XY, 2003, J BACTERIOL, V185, P6409, DOI 10.1128/JB.185.21.6409-6414.2003; Reinisch KM, 2000, NATURE, V404, P960, DOI 10.1038/35010041; Roizman B, 1996, FIELDS VIROLOGY, P2231; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Simpson AA, 2000, NATURE, V408, P745, DOI 10.1038/35047129; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Skordalakes E, 2003, CELL, V114, P135, DOI 10.1016/S0092-8674(03)00512-9; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; Sprang SR, 1997, CURR OPIN STRUC BIOL, V7, P849, DOI 10.1016/S0959-440X(97)80157-1; STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0; STUART DI, 1979, J MOL BIOL, V134, P109, DOI 10.1016/0022-2836(79)90416-9; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; WEBER J, 1993, J BIOL CHEM, V268, P20126	55	141	144	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2004	118	6					743	755		10.1016/j.cell.2004.09.007	http://dx.doi.org/10.1016/j.cell.2004.09.007			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	855RW	15369673	Bronze			2022-12-24	WOS:000223992400010
J	Thompson, WW; Shay, DK; Weintraub, E; Brammer, I; Bridges, CB; Cox, NJ; Fukuda, K				Thompson, WW; Shay, DK; Weintraub, E; Brammer, I; Bridges, CB; Cox, NJ; Fukuda, K			Influenza-associated hospitalizations in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESPIRATORY SYNCYTIAL VIRUS; PANDEMIC INFLUENZA; OUTPATIENT VISITS; IMPACT; VACCINATION; EPIDEMICS; MORTALITY; CHILDREN; INFECTIONS; PNEUMONIA	Context Respiratory viral infections are responsible for a large number of hospitalizations in the United States each year. Objective To estimate annual influenza-associated hospitalizations in the United States by hospital discharge category, discharge type, and age group. Design, Setting, and Participants National Hospital Discharge Survey (NHDS) data and World Health Organization Collaborating Laboratories influenza surveillance data were used to estimate annual average numbers of hospitalizations associated with the circulation of influenza viruses from the 1979-1980 through the 2000-2001 seasons in the United States using age-specific Poisson regression models. Main Outcome Measures We estimated influenza-associated hospitalizations for primary and any listed pneumonia and influenza and respiratory and circulatory hospitalizations. Results Annual averages of 94735 (range, 18908-193561) primary and 133 900 (range, 30757-271529) any listed pneumonia and influenza hospitalizations were associated with influenza virus infections. Annual averages of 226 054 (range, 54523-430960) primary and 294128 (range, 86494-544909) any listed respiratory and circulatory hospitalizations were associated with influenza virus infections. Persons 85 years or older had the highest rates of influenza-associated primary respiratory and circulatory hospitalizations (1194.9 per 100000 persons). Children younger than 5 years (107.9 primary respiratory and circulatory hospitalizations per 100000 persons) had rates similar to persons aged 50 through 64 years. Estimated rates of influenza-associated hospitalizations were highest during seasons in which A(H3N2) viruses predominated, followed by B and A(H1N1) seasons. After adjusting for the length of each influenza season, influenza-associated primary pneumonia and influenza hospitalizations increased over time among the elderly. There were no significant increases in influenza-associated primary respiratory and circulatory hospitalizations after adjusting for the length of the influenza season. Conclusions Significant numbers of influenza-associated hospitalizations in the United States occur among the elderly, and the numbers of these hospitalizations have increased substantially over the last 2 decades due in part to the aging of the population. Children younger than 5 years had rates of influenza-associated hospitalizations similar to those among individuals aged 50 through 64 years. These findings highlight the need for improved influenza prevention efforts for both young and older US residents.	Ctr Dis Control & Prevent, Immunizat Safety Branch, Epidemiol & Surveillance Div, Natl Immunizat Program, Atlanta, GA 30333 USA; Ctr Dis Control & Prevent, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Thompson, WW (corresponding author), Ctr Dis Control & Prevent, Immunizat Safety Branch, Epidemiol & Surveillance Div, Natl Immunizat Program, 1600 Clifton Rd NE,MS E61, Atlanta, GA 30333 USA.	wct2@cdc.gov		Fukuda, Keiji/0000-0002-9598-9565; Shay, David/0000-0001-9619-4820				BARKER WH, 1980, AM J EPIDEMIOL, V112, P798, DOI 10.1093/oxfordjournals.aje.a113052; BARKER WH, 1986, AM J PUBLIC HEALTH, V76, P761, DOI 10.2105/AJPH.76.7.761; Brammer T L, 2000, MMWR CDC Surveill Summ, V49, P13; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P547; Dennison C, 2000, Vital Health Stat 1, P1; *EDW BROTH, 1978, INT CLASS DIS 9 REV, V1; FRANK AL, 1983, AM J EPIDEMIOL, V118, P313, DOI 10.1093/oxfordjournals.aje.a113638; Fukuda K, 2000, INT J CLIN PRACT, P37; Gensheimer KF, 2002, VACCINE, V20, pS63, DOI 10.1016/S0264-410X(02)00135-4; Gillum B.S., 1998, VITAL HLTH STAT 13, V133, p[i, 1]; Glezen WP, 2000, NEW ENGL J MED, V342, P1752; GLEZEN WP, 1980, AM J EPIDEMIOL, V111, P13, DOI 10.1093/oxfordjournals.aje.a112865; GLEZEN WP, 1982, EPIDEMIOL REV, V4, P25, DOI 10.1093/oxfordjournals.epirev.a036250; GRAVES EJ, 1997, VITAL HLTH STAT 13, V128, P1; Hall Margaret J, 2002, Adv Data, P1; HAUPT BJ, 1992, VITAL HLTH STAT 13, V111, P1; Iwane MK, 2004, PEDIATRICS, V113, P1758, DOI 10.1542/peds.113.6.1758; Izurieta HS, 2000, NEW ENGL J MED, V342, P232, DOI 10.1056/NEJM200001273420402; KOZAK LJ, 2002, VITAL HLTH STAT 13, V153, P1; Harper Scott A., 2004, Morbidity and Mortality Weekly Report, V53, P1; LAWRENCE L, 1999, ADV DATA, V308, P1; McBean AM, 2004, INT J INFECT DIS, V8, P227, DOI 10.1016/j.ijid.2004.04.013; MCBEAN AM, 1993, ARCH INTERN MED, V153, P2105, DOI 10.1001/archinte.153.18.2105; Meltzer MI, 1999, EMERG INFECT DIS, V5, P659, DOI 10.3201/eid0505.990507; Meyer KC, 2001, RESP PHYSIOL, V128, P23, DOI 10.1016/S0034-5687(01)00261-4; Miller RA, 1996, SCIENCE, V273, P70, DOI 10.1126/science.273.5271.70; MULLOOLY JP, 1982, AM J PUBLIC HEALTH, V72, P1008, DOI 10.2105/AJPH.72.9.1008; Neuzil KM, 2000, NEW ENGL J MED, V342, P225, DOI 10.1056/NEJM200001273420401; Neuzil KM, 2000, J PEDIATR-US, V137, P856, DOI 10.1067/mpd.2000.110445; Neuzil KM, 2002, J INFECT DIS, V185, P147, DOI 10.1086/338363; Nichol KL, 2003, VACCINE, V21, P1769, DOI 10.1016/S0264-410X(03)00070-7; Nichol KL, 2003, NEW ENGL J MED, V348, P1322, DOI 10.1056/NEJMoa025028; Nichol KL, 1999, ANN INTERN MED, V130, P397, DOI 10.7326/0003-4819-130-5-199903020-00003; Nichol KL, 1998, ARCH INTERN MED, V158, P1769, DOI 10.1001/archinte.158.16.1769; Nichols G, 1999, J ASIAN EARTH SCI, V17, P47, DOI 10.1016/S0743-9547(98)00034-8; Nordin J, 2001, J INFECT DIS, V184, P665, DOI 10.1086/323085; Simonsen L, 2000, J INFECT DIS, V181, P831, DOI 10.1086/315320; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; *US BUR CENS, 1990, INT EST POP AG SEX R; *US DEP HHS, 1999, 991232 PHS US DEP HH; Vu T, 2002, VACCINE, V20, P1831, DOI 10.1016/S0264-410X(02)00041-5	41	1682	1781	3	164	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 15	2004	292	11					1333	1340		10.1001/jama.292.11.1333	http://dx.doi.org/10.1001/jama.292.11.1333			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853YL	15367555				2022-12-24	WOS:000223866800025
J	Hruska, AJ				Hruska, AJ			The Global Fund's principal recipients ... or neglected partners	LANCET			English	Editorial Material											Hruska, AJ (corresponding author), Arrayan 2702,Dpto 304, Santiago, Chile.	ajhruska@umich.edu	Hruska, Allan/AAV-7547-2020	Hruska, Allan/0000-0003-0984-3816				RIVERS R, 2004, NEWSLETTER      0607; 2003, GLOBAL FUND FIGHT AI; 2004, AGUA BUENA ASOCIACIO	3	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 11	2004	364	9438					918	920		10.1016/S0140-6736(04)17039-6	http://dx.doi.org/10.1016/S0140-6736(04)17039-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853MF	15364175				2022-12-24	WOS:000223831000008
J	Ray, WA; Murray, KT; Meredith, S; Narasimhulu, SS; Hall, K; Stein, CM				Ray, WA; Murray, KT; Meredith, S; Narasimhulu, SS; Hall, K; Stein, CM			Oral erythromycin and the risk of sudden death from cardiac causes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TORSADES-DE-POINTES; PROLONGATION; ITRACONAZOLE; TERFENADINE; CISAPRIDE; MIDAZOLAM; PHARMACOEPIDEMIOLOGY; PHARMACOKINETICS; CLARITHROMYCIN; KETOCONAZOLE	Background: Oral erythromycin prolongs cardiac repolarization and is associated with case reports of torsades de pointes. Because erythromycin is extensively metabolized by cytochrome P-450 3A (CYP3A) isozymes, commonly used medications that inhibit the effects of CYP3A may increase plasma erythromycin concentrations, thereby increasing the risk of ventricular arrhythmias and sudden death. We studied the association between the use of erythromycin and the risk of sudden death from cardiac causes and whether this risk was increased with the concurrent use of strong inhibitors of CYP3A. Methods: We studied a previously identified Tennessee Medicaid cohort that included 1,249,943 person-years of follow-up and 1476 cases of confirmed sudden death from cardiac causes. The CYP3A inhibitors used in the study were nitroimidazole antifungal agents, diltiazem, verapamil, and troleandomycin; each doubles, at least, the area under the time-concentration curve for a CYP3A substrate. Amoxicillin, an antimicrobial agent with similar indications but which does not prolong cardiac repolarization, and former use of erythromycin also were studied, to assess possible confounding by indication. Results: The multivariate adjusted rate of sudden death from cardiac causes among patients currently using erythromycin was twice as high (incidence-rate ratio, 2.01; 95 percent confidence interval, 1.08 to 3.75; P=0.03) as that among those who had not used any of the study antibiotic medications. There was no significant increase in the risk of sudden death among former users of erythromycin (incidence-rate ratio, 0.89; 95 percent confidence interval, 0.72 to 1.09; P=0.26) or among those who were currently using amoxicillin (incidence-rate ratio, 1.18; 95 percent confidence interval, 0.59 to 2.36; P=0.65). The adjusted rate of sudden death from cardiac causes was five times as high (incidence-rate ratio, 5.35; 95 percent confidence interval, 1.72 to 16.64; P=0.004) among those who concurrently used CYP3A inhibitors and erythromycin as that among those who had used neither CYP3A inhibitors nor any of the study antibiotic medications. In contrast, there was no increase in the risk of sudden death among those who concurrently used amoxicillin and CYP3A inhibitors or those currently using any of the study antibiotic medications who had formerly used CYP3A inhibitors. Conclusions: The concurrent use of erythromycin and strong inhibitors of CYP3A should be avoided.	Vanderbilt Univ, Sch Med, Dept Prevent Med, Div Pharmacoepidemiol, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Div Cardiol, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Div Clin Pharmacol, Nashville, TN 37212 USA; Vanderbilt Univ, Sch Med, Div Rheumatol, Nashville, TN 37212 USA; Nashville Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Geriatric Research Education & Clinical Center	Ray, WA (corresponding author), Vanderbilt Univ, Sch Med, Dept Prevent Med, Div Pharmacoepidemiol, Nashville, TN 37212 USA.	cindy.naron@vanderbilt.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS010384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM031304] Funding Source: NIH RePORTER; AHRQ HHS [HS1-0384] Funding Source: Medline; NIGMS NIH HHS [GM-31304] Funding Source: Medline; FDA HHS [FD-U-001641] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); FDA HHS		Abernethy DR, 2001, CLIN PHARMACOL THER, V69, P96, DOI 10.1067/mcp.2001.114230; Ahonen J, 1997, EUR J CLIN PHARMACOL, V51, P415, DOI 10.1007/s002280050223; Albert CM, 1998, JAMA-J AM MED ASSOC, V279, P23, DOI 10.1001/jama.279.1.23; Curtis LH, 2003, AM J MED, V114, P135, DOI 10.1016/S0002-9343(02)01455-9; Damkier P, 1999, BRIT J CLIN PHARMACO, V48, P829, DOI 10.1046/j.1365-2125.1999.00099.x; De Ponti F, 2000, EUR J CLIN PHARMACOL, V56, P1, DOI 10.1007/s002280050714; Desta Z, 1998, J PHARMACOL EXP THER, V285, P428; Drici MD, 1998, JAMA-J AM MED ASSOC, V280, P1774, DOI 10.1001/jama.280.20.1774; FISHER ES, 1992, AM J PUBLIC HEALTH, V82, P243, DOI 10.2105/AJPH.82.2.243; Gil M, 2003, AM J CARDIOL, V92, P995, DOI 10.1016/S0002-9149(03)00906-8; Goldschmidt N, 2001, ANN PHARMACOTHER, V35, P1396; HINKLE LE, 1982, CIRCULATION, V65, P457, DOI 10.1161/01.CIR.65.3.457; HOFER CA, 1993, AM J MED, V95, P431, DOI 10.1016/0002-9343(93)90314-F; JOHNSON RE, 1991, J AM GERIATR SOC, V39, P1079, DOI 10.1111/j.1532-5415.1991.tb02872.x; KIRCH W, 1989, THER DRUG MONIT, V11, P411; Kivisto KT, 1997, CLIN PHARMACOL THER, V62, P348, DOI 10.1016/S0009-9236(97)90038-2; Koh TW, 2001, PACE, V24, P1575, DOI 10.1046/j.1460-9592.2001.01575.x; Lam YWF, 2003, J CLIN PHARMACOL, V43, P1274, DOI 10.1177/0091270003259216; Lamberg TS, 1998, CLIN PHARMACOL THER, V63, P640, DOI 10.1016/S0009-9236(98)90087-X; LANDRY JA, 1988, GERONTOLOGIST, V28, P672, DOI 10.1093/geront/28.5.672; LEISTER KA, 1981, MED CARE, V19, P658, DOI 10.1097/00005650-198106000-00008; MARCUS FI, 1988, AM J CARDIOL, V61, P8, DOI 10.1016/0002-9149(88)91295-7; Matsumoto S, 2001, BRIT J CLIN PHARMACO, V51, P133, DOI 10.1111/j.1365-2125.2001.01292.x; MONAHAN BP, 1990, JAMA-J AM MED ASSOC, V264, P2788, DOI 10.1001/jama.264.21.2788; MURRAY KT, 2004, CARDIOLOGY, P765; NICOLAU DP, 1992, J HEART LUNG TRANSPL, V11, P564; OLKKOLA KT, 1994, CLIN PHARMACOL THER, V55, P481, DOI 10.1038/clpt.1994.60; Ouellet D, 1998, CLIN PHARMACOL THER, V64, P355, DOI 10.1016/S0009-9236(98)90065-0; Paine MF, 2002, CLIN PHARMACOL THER, V72, P524, DOI 10.1067/mcp.2002.128387; PIPER JM, 1990, AM J EPIDEMIOL, V132, P561, DOI 10.1093/oxfordjournals.aje.a115692; Rawson NSB, 1995, STAT MED, V14, P2627, DOI 10.1002/sim.4780142404; Ray WA, 2004, CLIN PHARMACOL THER, V75, P234, DOI 10.1016/j.clpt.2003.09.019; RAY WA, 1989, AM J EPIDEMIOL, V129, P837, DOI 10.1093/oxfordjournals.aje.a115198; Ray WA, 2001, ARCH GEN PSYCHIAT, V58, P1161, DOI 10.1001/archpsyc.58.12.1161; Shaffer D, 2002, CLIN INFECT DIS, V35, P197, DOI 10.1086/340861; Simard C, 2001, EUR J CLIN PHARMACOL, V57, P229, DOI 10.1007/s002280100298; SISCOVICK DS, 1994, NEW ENGL J MED, V330, P1852, DOI 10.1056/NEJM199406303302603; Stanat SJC, 2003, MOL CELL BIOCHEM, V254, P1, DOI 10.1023/A:1027309703313; STROM BL, 1990, EPIDEMIOL REV, V12, P87, DOI 10.1093/oxfordjournals.epirev.a036064; Tschida SJ, 1996, PHARMACOTHERAPY, V16, P663; Varis T, 2000, CLIN PHARMACOL THER, V67, P215, DOI 10.1067/mcp.2000.104611; Vogt AW, 1997, ANESTH ANALG, V85, P1011, DOI 10.1097/00000539-199711000-00010; WAROT D, 1987, EUR J CLIN PHARMACOL, V32, P389, DOI 10.1007/BF00543975; WEST SL, 1995, AM J EPIDEMIOL, V142, P1103, DOI 10.1093/oxfordjournals.aje.a117563; WISEMAN LR, 1994, DRUGS, V47, P116, DOI 10.2165/00003495-199447010-00008	45	331	349	1	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 9	2004	351	11					1089	1096		10.1056/NEJMoa040582	http://dx.doi.org/10.1056/NEJMoa040582			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	852CX	15356306				2022-12-24	WOS:000223733900008
J	Siok, WT; Perfetti, CA; Jin, Z; Tan, LH				Siok, WT; Perfetti, CA; Jin, Z; Tan, LH			Biological abnormality of impaired reading is constrained by culture	NATURE			English	Article							LEFT PREFRONTAL CORTEX; HUMAN FRONTAL-CORTEX; WORKING-MEMORY; BRAIN ACTIVATION; NATIVE LANGUAGE; NEURAL SYSTEMS; FUNCTIONAL MRI; WORD FORM; DYSLEXIA; CHINESE	Developmental dyslexia is characterized by a severe reading problem in people who have normal intelligence and schooling(1-3). Impaired reading of alphabetic scripts is associated with dysfunction of left temporoparietal brain regions(2-5). These regions perform phonemic analysis and conversion of written symbols to phonological units of speech (grapheme-to-phoneme conversion); two central cognitive processes that mediate reading acquisition(6-7). Furthermore, it has been assumed that, in contrast to cultural diversities, dyslexia in different languages has a universal biological origin(1,8). Here we show using functional magnetic resonance imaging with reading-impaired Chinese children and associated controls, that functional disruption of the left middle frontal gyrus is associated with impaired reading of the Chinese language ( a logographic rather than alphabetic writing system). Reading impairment in Chinese is manifested by two deficits: one relating to the conversion of graphic form ( orthography) to syllable, and the other concerning orthography-to-semantics mapping. Both of these processes are critically mediated by the left middle frontal gyrus, which functions as a centre for fluent Chinese reading(9-11) that coordinates and integrates various information about written characters in verbal and spatial working memory. This finding provides an insight into the fundamental pathophysiology of dyslexia by suggesting that rather than having a universal origin, the biological abnormality of impaired reading is dependent on culture.	Univ Hong Kong, Dept Linguist, Cognit Neurosci Lab, Hong Kong, Hong Kong, Peoples R China; Univ Pittsburgh, Ctr Learning Res & Dev, Pittsburgh, PA 15260 USA; Beijing 306 Hosp, MRI Div, Beijing 100101, Peoples R China; NIMH, Neuropsychol Lab, NIH, Bethesda, MD 20892 USA	University of Hong Kong; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Tan, LH (corresponding author), Univ Hong Kong, Dept Linguist, Cognit Neurosci Lab, Hong Kong, Hong Kong, Peoples R China.	lihaitan@intra.nimh.nih.gov	Siok, Wai Ting/A-8392-2010	Siok, Wai Ting/0000-0002-2154-5996				Aylward EH, 2003, NEUROLOGY, V61, P212, DOI 10.1212/01.WNL.0000068363.05974.64; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; Courtney SM, 1998, SCIENCE, V279, P1347, DOI 10.1126/science.279.5355.1347; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; Eden GF, 2002, NAT NEUROSCI, V5, P1080, DOI 10.1038/nn946; Fiez JA, 2000, NAT NEUROSCI, V3, P3, DOI 10.1038/71078; Fox PT, 1996, NATURE, V382, P158, DOI 10.1038/382158a0; Fu SM, 2002, NEUROIMAGE, V17, P1538, DOI 10.1006/nimg.2002.1155; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; Gold BT, 2002, NEURON, V35, P803, DOI 10.1016/S0896-6273(02)00800-0; Horwitz B, 1998, P NATL ACAD SCI USA, V95, P8939, DOI 10.1073/pnas.95.15.8939; Kochunov P, 2003, NEUROREPORT, V14, P961, DOI 10.1097/01.wnr.0000075417.59944.00; Mattingly I, 1972, LANGUAGE EAR EYE, P133; Paulesu E, 2001, SCIENCE, V291, P2165, DOI 10.1126/science.1057179; Perfetti CA, 1999, READING CHINESE SCRIPT, P115; PERFETTI CA, IN PRESS PSYCHOL REV; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P878, DOI 10.1073/pnas.90.3.878; Price CJ, 1997, J COGNITIVE NEUROSCI, V9, P727, DOI 10.1162/jocn.1997.9.6.727; Rayner K, 2001, PSYCHOL SCI, P31, DOI 10.1111/1529-1006.00004; Shaywitz SE, 1998, P NATL ACAD SCI USA, V95, P2636, DOI 10.1073/pnas.95.5.2636; Siok WT, 2003, HUM BRAIN MAPP, V18, P201, DOI 10.1002/hbm.10094; Siok WT, 2001, DEV PSYCHOL, V37, P886, DOI 10.1037//0012-1649.37.6.886; SNYDER PJ, 1993, CORTEX, V29, P115, DOI 10.1016/S0010-9452(13)80216-X; Talairach J., 1988, COPLANAR STEREOTAXIC; Tan LH, 2001, NEUROIMAGE, V13, P836, DOI 10.1006/nimg.2001.0749; Tan LH, 2000, HUM BRAIN MAPP, V10, P16; Tan LH, 2003, HUM BRAIN MAPP, V18, P158, DOI 10.1002/hbm.10089; Temple E, 2003, P NATL ACAD SCI USA, V100, P2860, DOI 10.1073/pnas.0030098100; Turkeltaub PE, 2003, NAT NEUROSCI, V6, P767, DOI 10.1038/nn1065; Wagner AD, 2001, NEURON, V31, P329, DOI 10.1016/S0896-6273(01)00359-2; WANG WSY, 1973, SCI AM, V228, P50, DOI 10.1038/scientificamerican0273-50	31	330	369	6	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 2	2004	431	7004					71	76		10.1038/nature02865	http://dx.doi.org/10.1038/nature02865			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850VC	15343334				2022-12-24	WOS:000223641500043
J	Banks, E; Reeves, G; Beral, V; Bull, D; Crossley, B; Simmonds, M; Hilton, E; Bailey, S; Barrett, N; Briers, P; English, R; Jackson, A; Kutt, E; Lavelle, J; Rockall, L; Wallis, MG; Wilson, M; Patnick, J				Banks, E; Reeves, G; Beral, V; Bull, D; Crossley, B; Simmonds, M; Hilton, E; Bailey, S; Barrett, N; Briers, P; English, R; Jackson, A; Kutt, E; Lavelle, J; Rockall, L; Wallis, MG; Wilson, M; Patnick, J			Influence of personal characteristics of individual women on sensitivity and specificity of mammography in the Million Women Study: cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HORMONE REPLACEMENT THERAPY; BREAST DENSITY; PARENCHYMAL PATTERNS; SCREENING-PROGRAM; CANCER; INTERVAL; ESTROGEN; AGE; PREDICTORS; PROGESTIN	Objectives To examine how lifestyle, hormonal, and other factors influence the sensitivity and specificity of mammography. Methods Women recruited into the Million Women Study completed a questionnaire about various personal factors before routine mammographic screening. A sample of 12355 women aged 50-64 years were followed for outcome of screening and incident breast cancer in the next 12 months. Sensitivity and specificity were calculated by using standard definitions, with adjustment for potential confounding factors. Results Breast cancer was diagnosed in 726 (0.6%) women, 629 in screen positive and 97 in screen negative women; 3885 (3.2%) were screen positive but had no subsequent diagnosis of breast cancer. Overall sensitivity was 86.6% and specificity was 96.8%. Three factors had an adverse effect on both measures: use of hormone replacement therapy (sensitivity: 83.0% (95% confidence interval 77.4% to 87.6%), 84.7% (73.9% to 91.6%), and 92.1% (87.6% to 95.0%); specificity: 96.8% (96.6% to 97.0%), 97.8% (97.5% to 98.0%), and 98.1% (98.0% to 98.2%), respectively, for current, past, and never use); previous breast surgery v no previous breast surgery (sensitivity: 83.5% (75.7% to 89.1%) v 89.4% (86.5% to 91.8%); specificity: 96.2% (95.8% to 96.5%) v 97.4% (97.3% to 97.5%), respectively); and body mass index <25 v >= 25 (sensitivity: 85.7% (81.2% to 89.3%) v 91.0% (87.5% to 93.6%); specificity: 97.2% (97.0% to 97.3%) v 97.4% (97.3% to 97.6%), respectively). Neither sensitivity nor specificity varied significantly according to age, family history of breast cancer, parity, past oral contraceptive use, tubal ligation, physical activity, smoking, or alcohol consumption. Conclusions The efficiency, and possibly the effectiveness, of mammographic screening is lower in users of hormone replacement therapy, in women with previous breast surgery, and in thin women compared with other women.	Radcliffe Infirm, Canc Res UK, Epidemiol Unit, Oxford OX2 6HE, England; Princess Wales Community Hosp, Breast Screening Serv, Bromsgrove B61 0BB, Worcs, England; Charing Cross Hosp, W London Breast Screening Serv, London W6 8RF, England; Gloucestershire Breast Screening Serv, Cheltenham GL53 7AS, Glos, England; Churchill Hosp, Oxford Radcliffe Hosp NHS Trust, Breast Care Unit, Oxford OX3 7JH, England; Queen Alexandra Hosp, Patricia Massey Breast Screening Unit, Portsmouth PO6 3LY, Hants, England; Cent Hlth Clin, Avon Breast Screening, Bristol BS2 0JD, Avon, England; Royal Lancaster Infirm, N Lancashire Breast Screening Serv, Lancaster LA1 4GG, England; Worthing Dist Hosp, W Sussex Breast Screening Serv, Worthing BN11 2DH, W Sussex, England; Coventry & Warwick Hosp, Breast Screening Unit, Coventry CV1 4FH, W Midlands, England; Withington Hosp, Greater Manchester Breast Screening Serv, Nightingale Ctr, Manchester M20 0PT, Lancs, England; NHS Breast Screening Programme, Sheffield S11 9PS, S Yorkshire, England	Cancer Research UK; Radcliffe Infirmary; Imperial College London; Oxford University Hospitals NHS Foundation Trust; University of Oxford; Portsmouth Hospitals NHS Trust; Queen Alexandra Hospital	Banks, E (corresponding author), Radcliffe Infirm, Canc Res UK, Epidemiol Unit, Gibson Bldg, Oxford OX2 6HE, England.	emily.banks@anu.edu.au		Banks, Emily/0000-0002-4617-1302				Abbott S, 2002, BJOG-INT J OBSTET GY, V109, P1319; Banks E, 2004, BMJ-BRIT MED J, V328, P1291, DOI 10.1136/bmj.328.7451.1291; Banks E, 2002, J MED SCREEN, V9, P74, DOI 10.1136/jms.9.2.74; Banks E, 2001, J Epidemiol Biostat, V6, P357; Banks E, 2001, J MED SCREEN, V8, P29, DOI 10.1136/jms.8.1.29; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; BERAL V, IN PRESS MENOPAUSE H; Carney PA, 2003, ANN INTERN MED, V138, P168, DOI 10.7326/0003-4819-138-3-200302040-00008; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; Crane CEB, 2002, BREAST, V11, P131, DOI 10.1054/brst.2001.0371; DESTAVOLA BL, 1990, INT J EPIDEMIOL, V19, P247, DOI 10.1093/ije/19.2.247; Fisher MD, 2001, CLIN LYMPHOMA, V2, P84, DOI 10.1016/S1526-9655(11)70134-8; Greendale GA, 1999, ANN INTERN MED, V130, P262, DOI 10.7326/0003-4819-130-4_Part_1-199902160-00003; Kerlikowske K, 2000, ANN INTERN MED, V133, P855, DOI 10.7326/0003-4819-133-11-200012050-00009; Kerlikowske K, 1996, JAMA-J AM MED ASSOC, V276, P33, DOI 10.1001/jama.276.1.33; MA L, 1992, J NATL CANCER I, V84, P781, DOI 10.1093/jnci/84.10.781; Mandelson MT, 2000, J NATL CANCER I, V92, P1081, DOI 10.1093/jnci/92.13.1081; Porter PL, 1999, J NATL CANCER I, V91, P2020, DOI 10.1093/jnci/91.23.2020; Rosenberg RD, 1998, RADIOLOGY, V209, P511, DOI 10.1148/radiology.209.2.9807581; Sala E, 1998, J MED SCREEN, V5, P207, DOI 10.1136/jms.5.4.207; Schouten LJ, 1997, LANCET, V349, P1104, DOI 10.1016/S0140-6736(05)62329-X; The Million Women Study Collaborative Group, 1999, BREAST CANCER RES, V1, P73, DOI DOI 10.1186/BCR16; Wang HG, 2001, INT J CANCER, V94, P594, DOI 10.1002/ijc.1511	23	77	81	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 28	2004	329	7464					477	479		10.1136/bmj.329.7464.477	http://dx.doi.org/10.1136/bmj.329.7464.477			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	851KS	15331472	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000223684600011
J	Warnke, PH; Springer, ING; Wiltfang, J; Acil, Y; Eufinger, H; Wehmoller, M; Russo, PAJ; Bolte, H; Sherry, E; Behrens, E; Terheyden, H				Warnke, PH; Springer, ING; Wiltfang, J; Acil, Y; Eufinger, H; Wehmoller, M; Russo, PAJ; Bolte, H; Sherry, E; Behrens, E; Terheyden, H			Growth and transplantation of a custom vascularised bone graft in a man	LANCET			English	Article							HUMAN OSTEOGENIC PROTEIN-1; MANDIBULAR RECONSTRUCTION; MORPHOGENETIC PROTEIN-7; MINIATURE PIGS; RHOP-1; TISSUE	Background A major goal of research in bone transplantation is the ability to avoid creation of secondary bone defects. We aimed to repair an extended mandibular discontinuity defect by growth of a custom bone transplant inside the latissimus dorsi muscle of an adult male patient. Methods Three-dimensional computed tomography (CT) scanning and computer-aided design techniques were used to produce an ideal virtual replacement for the mandibular defect. These data were used to create a titanium mesh cage that was filled with bone mineral blocks and infiltrated with 7 mg recombinant human bone morphogenetic protein 7 and 20 mL of the patient's bone marrow. Thus prepared, the transplant was implanted into the latissimus dorsi muscle and 7 weeks later transplanted as a free bone-muscle flap to repair the mandibular defect. Findings In-vivo skeletal scintigraphy showed bone remodelling and mineralisation inside the mandibular transplant both before and after transplantation. CT provided radiological evidence of new bone formation. Postoperatively, the patient had an improved degree of mastication and was satisfied with the aesthetic outcome of the procedure. Interpretation Heterotopic bone induction to form a mandibular replacement inside the latissimus dorsi muscle in a human being is possible. This technique allows for a lower operative burden compared with conventional techniques by avoiding creation of a secondary bone defect. It also provides a good three-dimensional outcome.	Univ Kiel, Dept Oral & Maxillofacial Surg, D-24105 Kiel, Germany; Knappschaftskrankenhaus, Dept Oral & Maxillofacial Surg, Recklinghausen, Germany; Australian Natl Univ, Dept Rheumatol, Canberra, ACT, Australia; Univ Kiel, Dept Diagnost Radiol, Kiel, Germany; Univ Sydney, Dept Orthopaed Surg, Penrith, Australia	University of Kiel; Australian National University; University of Kiel; University of Sydney	Warnke, PH (corresponding author), Univ Kiel, Dept Oral & Maxillofacial Surg, Arnold Heller Str 16, D-24105 Kiel, Germany.	warnke@mkg.uni-kiel.de	Terheyden, Hendrik/HDM-7610-2022; Wiltfang, Jörg/B-1767-2010; Cruz e Silva, Odete/AAH-5595-2020	Terheyden, Hendrik/0000-0002-0709-114X; 				Cao YL, 1997, PLAST RECONSTR SURG, V100, P297, DOI 10.1097/00006534-199708000-00001; Friedlaender GE, 2001, J BONE JOINT SURG AM, V83A, pS151; Springer ING, 2002, BONE, V31, P230, DOI 10.1016/S8756-3282(02)00809-8; Terheyden H, 2001, INT J ORAL MAX SURG, V30, P373, DOI 10.1054/ijom.2001.0032; Terheyden H, 2004, INT J ORAL MAX SURG, V33, P164, DOI 10.1054/ijom.2003.0500; Terheyden H, 2003, INT J ORAL MAX SURG, V32, P528, DOI 10.1054/ijom.2002.0408; Terheyden H, 2001, INT J ORAL MAX SURG, V30, P469, DOI 10.1054/ijom.2000.0008; Terheyden H, 1999, INT J ORAL MAX SURG, V28, P461, DOI 10.1034/j.1399-0020.1999.280613.x; Vacanti JP, 2003, J GASTROINTEST SURG, V7, P831, DOI 10.1016/S1091-255X(03)00135-5; Vacanti JP, 1999, LANCET S1, V354, pSI32; Wang HM, 2004, J BIOMED MATER RES A, V68A, P219, DOI 10.1002/jbm.a.10129; Warnke PH, 2003, PLAST RECONSTR SURG, V111, P2471, DOI 10.1097/01.PRS.0000063110.10932.9B	12	505	536	0	65	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 28	2004	364	9436					766	770		10.1016/S0140-6736(04)16935-3	http://dx.doi.org/10.1016/S0140-6736(04)16935-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	849VO	15337402				2022-12-24	WOS:000223569600027
J	Clark, JM; Xu, X; Forster, CA; Wang, Y				Clark, JM; Xu, X; Forster, CA; Wang, Y			A Middle Jurassic 'sphenosuchian' from China and the origin of the crocodylian skull	NATURE			English	Article							BASAL CROCODYLOMORPH ARCHOSAURS; EVOLUTION; ONTOGENY	The skull of living crocodylians is highly solidified and the jaw closing muscles are enlarged(1), allowing for prey capture by prolonged crushing between the jaws. Living species are all semi-aquatic, with sprawling limbs and a broad body that moves mainly from side-to-side(2); however, fossils indicate that they evolved from terrestrial forms. The most cursorial of these fossils(3-6) are small, gracile forms often grouped together as the Sphenosuchia, with fully erect, slender limbs; their relationships, however, are poorly understood(5,7-10). A new crocodylomorph from deposits in northwestern China of the poorly known Middle Jurassic epoch possesses a skull with several adaptations typical of living crocodylians. Postcranially it is similar to sphenosuchians but with even greater adaptations for cursoriality in the forelimb. Here we show, through phylogenetic analysis, that it is the closest relative of the large group Crocodyliformes, including living crocodylians. Thus, important features of the modern crocodylian skull evolved during a phase when the postcranial skeleton was evolving towards greater cursoriality, rather than towards their current semi-aquatic habitus.	George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA; Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China; SUNY Stony Brook, Dept Anat Sci, Stony Brook, NY 11794 USA	George Washington University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Clark, JM (corresponding author), George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA.	jclark@gwu.edu						AGUE JJ, 1995, AM J SCI, V295, P1, DOI 10.2475/ajs.295.1.1; Benton M.J., 1988, PHYLOGENY CLASSIFICA, V35A, P295, DOI DOI 10.1017/S0016756800006476; Benton MJ, 2002, ZOOL J LINN SOC-LOND, V136, P25, DOI 10.1046/j.1096-3642.2002.00024.x; Brochu CA, 1996, J VERTEBR PALEONTOL, V16, P49, DOI 10.1080/02724634.1996.10011283; Chen Pei-ji, 1996, Museum of Northern Arizona Bulletin, V60, P395; CLARK JM, 1994, IN THE SHADOW OF THE DINOSAURS, P84; Clark JM, 2002, ZOOL J LINN SOC-LOND, V136, P77, DOI 10.1046/j.1096-3642.2002.00026.x; Clark JM, 2000, J VERTEBR PALEONTOL, V20, P683, DOI 10.1671/0272-4634(2000)020[0683:ANSOHA]2.0.CO;2; CLARK JM, 2001, DINOSAURS XINJIANG; Eberth DA, 2001, CAN J EARTH SCI, V38, P1627, DOI 10.1139/e01-067; Goslow, 2001, ANAL VERTEBRATE STRU; Iordansky N.N., 1973, P201; JENKINS FA, 1993, AM J SCI, V293A, P253, DOI 10.2475/ajs.293.A.253; Lucas S.G., 2002, CHINESE FOSSIL VERTE; MULLER GB, 1990, J MORPHOL, V203, P151, DOI 10.1002/jmor.1052030204; Osmolska H, 1997, ACTA PALAEONTOL POL, V42, P257; PARRISH JM, 1987, PALEOBIOLOGY, V13, P396; Salisbury SW, 2001, CROCODILIAN BIOLOGY AND EVOLUTION, P85; Sereno P.C., 1992, Journal of Vertebrate Paleontology, V12, P435; Sues HD, 2003, J VERTEBR PALEONTOL, V23, P329, DOI 10.1671/0272-4634(2003)023[0329:ANCAFT]2.0.CO;2; SWOFFORD DL, 2003, PAUP BETA 10 SOFTWAR; WALKER AD, 1970, PHILOS T ROY SOC B, V257, P323, DOI 10.1098/rstb.1970.0028; Wu Xiao-Chun, 1993, Journal of Vertebrate Paleontology, V13, P58	23	87	92	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 26	2004	430	7003					1021	1024		10.1038/nature02802	http://dx.doi.org/10.1038/nature02802			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849CD	15329719				2022-12-24	WOS:000223514900041
J	Douma, S; van Laar, T; Zevenhoven, J; Meuwissen, R; van Garderen, E; Peeper, DS				Douma, S; van Laar, T; Zevenhoven, J; Meuwissen, R; van Garderen, E; Peeper, DS			Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB	NATURE			English	Article							HUMAN NEUROBLASTOMAS; SIGNAL-TRANSDUCTION; KINASE RECEPTOR; EXPRESSION; APOPTOSIS; SURVIVAL; PATHWAY; ACTIVATION; MECHANISMS; INTEGRINS	Metastasis is a major factor in the malignancy of cancers, and is often responsible for the failure of cancer treatment. Anoikis ( apoptosis resulting from loss of cell-matrix interactions) has been suggested to act as a physiological barrier to metastasis; resistance to anoikis may allow survival of cancer cells during systemic circulation, thereby facilitating secondary tumour formation in distant organs(1-3). In an attempt to identify metastasis-associated oncogenes, we designed an unbiased, genome-wide functional screen solely on the basis of anoikis suppression. Here, we report the identification of TrkB, a neurotrophic tyrosine kinase receptor(4,5), as a potent and specific suppressor of caspase-associated anoikis of non-malignant epithelial cells. By activating the phosphatidylinositol-3-OH kinase/protein kinase B pathway, TrkB induced the formation of large cellular aggregates that survive and proliferate in suspension. In mice, these cells formed rapidly growing tumours that infiltrated lymphatics and blood vessels to colonize distant organs. Consistent with the ability of TrkB to suppress anoikis, metastases-whether small vessel infiltrates or large tumour nodules-contained very few apoptotic cells. These observations demonstrate the potent oncogenic effects of TrkB and uncover a specific pro-survival function that may contribute to its metastatic capacity, providing a possible explanation for the aggressive nature of human tumours that overexpress TrkB.	Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Dept Expt Anim Pathol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Peeper, DS (corresponding author), Netherlands Canc Inst, Div Mol Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	d.peeper@nki.nl	Peeper, Daniel/AAA-2430-2020	van Laar, Theo/0000-0002-0990-6234				Aoyama M, 2001, CANCER LETT, V164, P51, DOI 10.1016/S0304-3835(00)00715-1; Banks GB, 2002, INT J DEV BIOL, V46, P551; Bardelli A, 2003, SCIENCE, V300, P949, DOI 10.1126/science.1082596; Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; Eggert A, 2001, J CLIN ONCOL, V19, P689, DOI 10.1200/JCO.2001.19.3.689; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; GLASS DJ, 1991, CELL, V66, P405, DOI 10.1016/0092-8674(91)90629-D; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Ho R, 2002, CANCER RES, V62, P6462; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Jaboin J, 2003, CANCER LETT, V193, P109, DOI 10.1016/S0304-3835(02)00723-1; Khwaja A, 1997, EMBO J, V16, P2783, DOI 10.1093/emboj/16.10.2783; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; Koh EY, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf142; McFall A, 2001, MOL CELL BIOL, V21, P5488, DOI 10.1128/MCB.21.16.5488-5499.2001; NAKAGAWARA A, 1994, MOL CELL BIOL, V14, P759, DOI 10.1128/MCB.14.1.759; Peeper DS, 2002, NAT CELL BIOL, V4, P148, DOI 10.1038/ncb742; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Ruggeri BA, 1999, CURR MED CHEM, V6, P845; Ruoslahti E, 1997, CURR OPIN CELL BIOL, V9, P605, DOI 10.1016/S0955-0674(97)80112-3; Schmidt M, 2002, BRIT J CANCER, V87, P924, DOI 10.1038/sj.bjc.6600566; Shao JY, 2000, J BIOL CHEM, V275, P22916, DOI 10.1074/jbc.M002235200; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; SQUINTO SP, 1991, CELL, V65, P885, DOI 10.1016/0092-8674(91)90395-F; Vooijs M, 2002, CANCER RES, V62, P1862; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Zamzami N, 1996, J EXP MED, V183, P1533, DOI 10.1084/jem.183.4.1533	30	438	495	4	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 26	2004	430	7003					1034	1040		10.1038/nature02765	http://dx.doi.org/10.1038/nature02765			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849CD	15329723	Bronze			2022-12-24	WOS:000223514900045
J	Malinina, L; Malakhova, ML; Teplov, A; Brown, RE; Patel, DJ				Malinina, L; Malakhova, ML; Teplov, A; Brown, RE; Patel, DJ			Structural basis for glycosphingolipid transfer specificity	NATURE			English	Article							GLYCOLIPID TRANSFER PROTEIN; PHOSPHOLIPID TRANSFER PROTEINS; MACROMOLECULAR STRUCTURES; CRYSTAL-STRUCTURE; PIG BRAIN; PURIFICATION; RECOGNITION; REFINEMENT; ANGSTROM; COMPLEX	Lipid transfer proteins are important in membrane vesicle biogenesis and trafficking, signal transduction and immunological presentation processes(1-3). The conserved and ubiquitous mammalian glycolipid transfer proteins (GLTPs) serve as potential regulators of cell processes mediated by glycosphingolipids, ranging from differentiation and proliferation to invasive adhesion, neurodegeneration and apoptosis(4,5). Here we report crystal structures of apo-GLTP (1.65 Angstrom resolution) and lactosylceramide-bound (1.95 Angstrom) GLTP, in which the bound glycosphingolipid is sandwiched, after adaptive recognition, within a previously unknown two-layer all-alpha-helical topology. Glycosphingolipid binding specificity is achieved through recognition and anchoring of the sugar-amide headgroup to the GLTPlipid recognition centre and within the hydrophobic tunnel support a framework for understanding how GLTPs acquire and release glycosphingolipids during lipid intermembrane transfer and presentation processes.	Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10021 USA	University of Minnesota System; Memorial Sloan Kettering Cancer Center	Brown, RE (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	reb@umn.edu; pateld@mskcc.org	Malinina, Lucy/B-8161-2013	Malinina, Lucy/0000-0001-7973-1831; Brown, Rhoderick/0000-0002-7337-3604; Teplov, Alexei/0000-0003-4826-4518	NIGMS NIH HHS [R01 GM045928-13, R01 GM045928-08, R01 GM045928, R01 GM045928-11, R01 GM045928-10, R01 GM045928-12, R01 GM045928-07, R01 GM045928-09, R01 GM045928-14A1] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045928] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABE A, 1985, J BIOL CHEM, V260, P1231; Brodersen P, 2002, GENE DEV, V16, P490, DOI 10.1101/gad.218202; BROWN RE, 1990, BIOCHIM BIOPHYS ACTA, V1044, P77, DOI 10.1016/0005-2760(90)90221-I; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Dwek RA, 2002, NAT REV DRUG DISCOV, V1, P65, DOI 10.1038/nrd708; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Gadola SD, 2002, NAT IMMUNOL, V3, P721, DOI 10.1038/ni821; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P225, DOI 10.1073/pnas.012540899; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Li XM, 2002, BIOPHYS J, V83, P1535, DOI 10.1016/S0006-3495(02)73923-4; Lin X, 2000, J BIOL CHEM, V275, P5104, DOI 10.1074/jbc.275.7.5104; Mahfoud R, 2002, J BIOL CHEM, V277, P11292, DOI 10.1074/jbc.M111679200; Mattjus P, 2003, BIOCHEMISTRY-US, V42, P535, DOI 10.1021/bi026896x; METZ RJ, 1982, J BIOL CHEM, V257, P2901; Min KC, 2003, P NATL ACAD SCI USA, V100, P14713, DOI 10.1073/pnas.2136684100; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Roderick SL, 2002, NAT STRUCT BIOL, V9, P507, DOI 10.1038/nsb812; Rogers DP, 2000, INT REV CYTOL, V197, P35, DOI 10.1016/S0074-7696(00)97002-5; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Wirtz KWA, 1997, BIOCHEM J, V324, P353, DOI 10.1042/bj3240353; Wright CS, 2003, J MOL BIOL, V331, P951, DOI 10.1016/S0022-2836(03)00794-0; YAMADA K, 1985, J BIOL CHEM, V260, P4615; Zajonc DM, 2003, NAT IMMUNOL, V4, P808, DOI 10.1038/ni948; Zhou DP, 2004, SCIENCE, V303, P523, DOI 10.1126/science.1092009	30	102	103	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 26	2004	430	7003					1048	1053		10.1038/nature02856	http://dx.doi.org/10.1038/nature02856			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849CD	15329726	Green Accepted			2022-12-24	WOS:000223514900048
J	Diggs, C; Ewart, S; Moree, M				Diggs, C; Ewart, S; Moree, M			Strength in unity	NATURE			English	Article									USAID Malaria Vaccine Dev Program, Washington, DC 20523 USA	United States Agency for International Development (USAID)	Diggs, C (corresponding author), USAID Malaria Vaccine Dev Program, Washington, DC 20523 USA.								0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 19	2004	430	7002					938	939		10.1038/430938a	http://dx.doi.org/10.1038/430938a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318238	Bronze			2022-12-24	WOS:000223369800061
J	Grant, JA; Arvidson, R; Bell, JF; Cabrol, NA; Carr, MH; Christensen, P; Crumpler, L; Des Marais, DJ; Ehlmann, BL; Farmer, J; Golombek, M; Grant, FD; Greeley, R; Herkenhoff, K; Li, R; McSween, HY; Ming, DW; Moersch, J; Rice, JW; Ruff, S; Richter, L; Squyres, S; Sullivan, R; Weitz, C				Grant, JA; Arvidson, R; Bell, JF; Cabrol, NA; Carr, MH; Christensen, P; Crumpler, L; Des Marais, DJ; Ehlmann, BL; Farmer, J; Golombek, M; Grant, FD; Greeley, R; Herkenhoff, K; Li, R; McSween, HY; Ming, DW; Moersch, J; Rice, JW; Ruff, S; Richter, L; Squyres, S; Sullivan, R; Weitz, C			Surficial deposits at Gusev crater along Spirit Rover traverses	SCIENCE			English	Article							SIZE-FREQUENCY DISTRIBUTIONS; MAADIM-VALLIS; LANDING SITES; MARS; ROCKS; EROSION	The Mars Exploration Rover Spirit has traversed a fairly flat, rock-strewn terrain whose surface is shaped primarily by impact events, although some of the landscape has been altered by eolian processes. Impacts ejected basaltic rocks that probably were part of locally formed lava flows from at least 10 meters depth. Some rocks have been textured and/or partially buried by windblown sediments less than 2 millimeters in diameter that concentrate within shallow, partially filled, circular impact depressions referred to as hollows. The terrain traversed during the 90-sol (martian solar day) nominal mission shows no evidence for an ancient lake in Gusev crater.	Smithsonian Inst, Natl Air & Space Museum, Ctr Earth & Planetary Studies, Washington, DC 20560 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; NASA, Ames Res Ctr, SETI Inst, Div Space Sci, Moffett Field, CA 94035 USA; US Geol Survey, Menlo Pk, CA 94025 USA; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; New Mexico Museum Nat Hist & Sci, Albuquerque, NM 87104 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; US Geol Survey, Flagstaff, AZ 86001 USA; Ohio State Univ, Dept Civil & Environm Engn & Geodet Sci, Columbus, OH 43210 USA; Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; DLR, Inst Space Simulat, D-51170 Cologne, Germany; NASA Headquarters, Washington, DC 20560 USA	Smithsonian Institution; Washington University (WUSTL); Cornell University; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; United States Department of the Interior; United States Geological Survey; Arizona State University; Arizona State University-Tempe; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); United States Department of the Interior; United States Geological Survey; University System of Ohio; Ohio State University; University of Tennessee System; University of Tennessee Knoxville; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Helmholtz Association; German Aerospace Centre (DLR); National Aeronautics & Space Administration (NASA)	Grant, JA (corresponding author), Smithsonian Inst, Natl Air & Space Museum, Ctr Earth & Planetary Studies, Washington, DC 20560 USA.	grantj@nasm.si.edu	Farmer, Jack D/B-9343-2019; Moersch, Jeffrey E/F-7189-2010	Moersch, Jeffrey E/0000-0003-3433-9419				Arvidson RE, 2004, SCIENCE, V305, P821, DOI 10.1126/science.1099922; Bell JF, 2004, SCIENCE, V305, P800, DOI 10.1126/science.1100175; Cabrol NA, 1996, ICARUS, V123, P269, DOI 10.1006/icar.1996.0157; Cabrol NA, 1998, ICARUS, V132, P362, DOI 10.1006/icar.1998.5903; Cabrol NA, 1998, ICARUS, V133, P98, DOI 10.1006/icar.1998.5914; Christensen PR, 2004, SCIENCE, V305, P837, DOI 10.1126/science.1100564; Folk R. L, 1980, PETROLOGY SEDIMENTAR; Golombek M, 1997, J GEOPHYS RES-PLANET, V102, P4117, DOI 10.1029/96JE03319; Golombek MP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002074; Golombek MP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002035; Golombek MP, 2000, J GEOPHYS RES-PLANET, V105, P1841, DOI 10.1029/1999JE001043; GOLOMBEK MP, 2004, LUNAR PLANET SCI; Grant JA, 2004, PLANET SPACE SCI, V52, P11, DOI 10.1016/j.pss.2003.08.011; GRANT JA, 1993, J GEOPHYS RES-PLANET, V98, P11025, DOI 10.1029/93JE00121; GRANT JA, 1993, J GEOPHYS RES-PLANET, V98, P15033, DOI 10.1029/93JE01580; Greeley R, 2004, SCIENCE, V305, P810, DOI 10.1126/science.1100108; Hartmann WK, 1999, NATURE, V397, P586, DOI 10.1038/17545; Hartmann WK, 2001, ICARUS, V149, P37, DOI 10.1006/icar.2000.6532; Herkenhoff KE, 2004, SCIENCE, V305, P824, DOI 10.1126/science.1100015; Horz F, 1999, SCIENCE, V285, P2105, DOI 10.1126/science.285.5436.2105; HURST M, 2004, LUNAR PLANET SCI; Irwin RP, 2002, SCIENCE, V296, P2209, DOI 10.1126/science.1071143; IRWIN RP, 2004, LUNAR PLANET SCI; Komatsu G, 1997, J GEOPHYS RES-PLANET, V102, P4151, DOI 10.1029/96JE02564; Leeder M.R, 1982, SEDIMENTOLOGY PROCES; McSween HY, 2004, SCIENCE, V305, P842, DOI 10.1126/science.3050842; Melosh H.L, 1989, IMPACT CRATERING GEO; Milam KA, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002023; RICE JW, 2003, LUNAR PLANET SCI; Squyres SW, 2004, SCIENCE, V305, P794, DOI 10.1126/science.3050794	30	66	66	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					807	810		10.1126/science.1099849	http://dx.doi.org/10.1126/science.1099849			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297659				2022-12-24	WOS:000223104900033
J	Patrucco, E; Notte, A; Barberis, L; Selvetella, G; Maffei, A; Brancaccio, M; Marengo, S; Russo, G; Azzolino, O; Rybalkin, SD; Silengo, L; Altruda, F; Wetzker, R; Wymann, MP; Lembo, G; Hirsch, E				Patrucco, E; Notte, A; Barberis, L; Selvetella, G; Maffei, A; Brancaccio, M; Marengo, S; Russo, G; Azzolino, O; Rybalkin, SD; Silengo, L; Altruda, F; Wetzker, R; Wymann, MP; Lembo, G; Hirsch, E			PI3K gamma modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effects	CELL			English	Article							PHOSPHOINOSITIDE 3-KINASE GAMMA; CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; HEART-FAILURE; TRANSGENIC MICE; HYPERTROPHY; RECEPTOR; PROTEIN; ACTIVATION; PATHWAY; PHOSPHORYLATION	The G protein-coupled, receptor-activated phosphoinositide 3-kinase gamma (PI3Kgamma) mediates inflammatory responses and negatively controls cardiac contractility by reducing cAMP concentration. Here, we report that mice carrying a targeted mutation in the PI3Kgamma gene causing loss of kinase activity (PI3K-gamma(KD/KD)) display reduced inflammatory reactions but no alterations in cardiac contractility. We show that, in PI3K-gamma(KD/KD) hearts, cAMP levels are normal and that PI3Kgamma-deficient mice but not PI3Kgamma(KD/KD) mice develop dramatic myocardial damage after chronic pressure overload induced by transverse aortic constriction (TAC). Finally, our data indicate that PI3Kgamma is an essential component of a complex controlling PDE3B phosphodiesterase-mediated cAMP destruction. Thus, cardiac PI3Kgamma participates in two distinct signaling pathways: a kinase-dependent activity that controls PKB/Akt as well as MAPK phosphorylation and contributes to TAC-induced cardiac remodeling, and a kinase-independent activity that relies on protein interactions to regulate PDE3B activity and negatively modulates cardiac contractility.	San Giovanni Battista Hosp, Dept Genet Biol & Biochem, I-10126 Turin, Italy; San Giovanni Battista Hosp, Expt Med Res Ctr, I-10126 Turin, Italy; Neuromed Inst, Dept Neurocardiol, I-86077 Pozzilli, Isernia, Italy; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Hosp Jena, Res Unit Mol Cell Biol, D-07747 Jena, Germany; Univ Basel, Dept Clin & Biol Sci, CH-4301 Basel, Switzerland; Univ Roma La Sapienza, Dept Expt Med & Pathol, Rome, Italy	A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; IRCCS Neuromed; University of Washington; University of Washington Seattle; Friedrich Schiller University of Jena; University of Basel; Sapienza University Rome	Lembo, G (corresponding author), San Giovanni Battista Hosp, Dept Genet Biol & Biochem, Via Santena 5Bis, I-10126 Turin, Italy.	lernbo@neuromed.it; hirsch@unito.it	Wetzker, Reinhard/AAD-8713-2019; Wymann, Matthias P/C-3227-2008; maffei, angelo/AAC-2219-2020; Lembo, Giuseppe/AAE-8096-2020; Hirsch, Emilio/F-4848-2013; Selvetella, Giulio/J-4342-2012	Wymann, Matthias P/0000-0003-3349-4281; Lembo, Giuseppe/0000-0002-3510-223X; Hirsch, Emilio/0000-0002-9073-6024; maffei, angelo/0000-0002-7491-0344; Patrucco, Enrico/0000-0001-8060-5058	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK021723] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 21723] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alloatti G, 2003, CARDIOVASC RES, V60, P242, DOI 10.1016/j.cardiores.2003.08.008; Antos CL, 2001, CIRC RES, V89, P997, DOI 10.1161/hh2301.100003; Asai K, 1999, J CLIN INVEST, V104, P551, DOI 10.1172/JCI7418; BEAVO JA, 1995, PHYSIOL REV, V75, P725, DOI 10.1152/physrev.1995.75.4.725; Bondeva T, 1998, SCIENCE, V282, P293, DOI 10.1126/science.282.5387.293; Brancaccio M, 2003, NAT MED, V9, P68, DOI 10.1038/nm805; Brede M, 2002, CIRCULATION, V106, P2491, DOI 10.1161/01.CIR.0000036600.39600.66; Bueno OF, 2002, CIRC RES, V91, P776, DOI 10.1161/01.RES.0000038488.38975.1A; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Crackower MA, 2002, CELL, V110, P737, DOI 10.1016/S0092-8674(02)00969-8; Engelhardt S, 1999, P NATL ACAD SCI USA, V96, P7059, DOI 10.1073/pnas.96.12.7059; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Iwase M, 1996, CIRC RES, V78, P517, DOI 10.1161/01.RES.78.4.517; Kitamura T, 1999, MOL CELL BIOL, V19, P6286; Liao P, 2001, P NATL ACAD SCI USA, V98, P12283, DOI 10.1073/pnas.211086598; Manabe I, 2002, CIRC RES, V91, P1103, DOI 10.1161/01.RES.0000046452.67724.B8; Matsui T, 2002, J BIOL CHEM, V277, P22896, DOI 10.1074/jbc.M200347200; MOVSESIAN MA, 2002, BASIC RES CARDIOL S1, V97, P183; Nienaber JJ, 2003, J CLIN INVEST, V112, P1067, DOI 10.1172/JCI200318213; Oudit GY, 2003, CIRCULATION, V108, P2147, DOI 10.1161/01.CIR.0000091403.62293.2B; Prasad SVN, 2000, J BIOL CHEM, V275, P4693, DOI 10.1074/jbc.275.7.4693; Prasad SVN, 2003, TRENDS CARDIOVAS MED, V13, P206, DOI 10.1016/S1050-1738(03)00080-X; Prasad SVN, 2002, J CELL BIOL, V158, P563, DOI 10.1083/jcb.200202113; Rapacciuolo A, 2001, J AM COLL CARDIOL, V38, P876, DOI 10.1016/S0735-1097(01)01433-4; Rockman HA, 2002, NATURE, V415, P206, DOI 10.1038/415206a; Rondinone CM, 2000, J BIOL CHEM, V275, P10093, DOI 10.1074/jbc.275.14.10093; Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537; Stephens LR, 1997, CELL, V89, P105, DOI 10.1016/S0092-8674(00)80187-7; STOYANOV B, 1995, SCIENCE, V269, P590; Stoyanova S, 1997, BIOCHEM J, V324, P489, DOI 10.1042/bj3240489; THOMPSON WJ, 1971, J BIOL CHEM, V246, P3145; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Wymann MP, 2003, TRENDS PHARMACOL SCI, V24, P366, DOI 10.1016/S0165-6147(03)00163-9; Wymann MP, 2003, BIOCHEM SOC T, V31, P275, DOI 10.1042/bst0310275; Zhang D, 2000, NAT MED, V6, P556, DOI 10.1038/75037; Zhang SS, 2003, J CLIN INVEST, V111, P833, DOI 10.1172/JCI200316290	36	380	409	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2004	118	3					375	387		10.1016/j.cell.2004.07.017	http://dx.doi.org/10.1016/j.cell.2004.07.017			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846XP	15294162	Bronze			2022-12-24	WOS:000223353100013
J	Takeuchi, Y; Yoshizaki, G; Takeuchi, T				Takeuchi, Y; Yoshizaki, G; Takeuchi, T			Surrogate broodstock produces salmonids	NATURE			English	Editorial Material							PRIMORDIAL GERM-CELLS		Tokyo Univ Marine Sci & Technol, Dept Marine Biosci, Minato Ku, Tokyo 1088477, Japan; Japan Sci & Technol Corp, PRESTO, Kawaguchi, Saitama 3320012, Japan	Tokyo University of Marine Science & Technology; Japan Science & Technology Agency (JST)	Takeuchi, Y (corresponding author), Tokyo Univ Marine Sci & Technol, Dept Marine Biosci, Minato Ku, Tokyo 1088477, Japan.	goro@s.kaiyodai.ac.jp	YOSHIZAKI, Goro/O-1937-2014; Wei, Qiwei/B-6928-2014	Wei, Qiwei/0000-0002-6366-1020; Takeuchi, Yutaka/0000-0001-5450-4632				Bella DA, 2002, SCIENCE, V295, P1236; Kobayashi T, 2003, FISH PHYSIOL BIOCHEM, V28, P479, DOI 10.1023/B:FISH.0000030634.37486.fa; LAWRENCE PA, 1993, GENETICS, V134, P1145; McKay SJ, 1996, CAN J FISH AQUAT SCI, V53, P1165, DOI 10.1139/cjfas-53-5-1165; Ono T, 1996, EXP ANIM TOKYO, V45, P347, DOI 10.1538/expanim.45.347; Takeuchi Y, 2003, BIOL REPROD, V69, P1142, DOI 10.1095/biolreprod.103.017624; Takeuchi Y, 2002, BIOL REPROD, V67, P1087, DOI 10.1095/biolreprod67.4.1087; Wylie C, 1999, CELL, V96, P165, DOI 10.1016/S0092-8674(00)80557-7	8	130	144	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2004	430	7000					629	630		10.1038/430629a	http://dx.doi.org/10.1038/430629a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843LM	15295587				2022-12-24	WOS:000223085400032
J	Tomita, K; Fukai, S; Ishitani, R; Ueda, T; Takeuchi, N; Vassylyev, DG; Nureki, O				Tomita, K; Fukai, S; Ishitani, R; Ueda, T; Takeuchi, N; Vassylyev, DG; Nureki, O			Structural basis for template-independent RNA polymerization	NATURE			English	Article							CCA-ADDING ENZYME; DNA-POLYMERASE-BETA; CRYSTAL-STRUCTURES; ESCHERICHIA-COLI; NUCLEOTIDYLTRANSFERASE; COMPLEXES; SUBSTRATE; INSIGHTS; PRIMER; ATP	The 3'-terminal CCA nucleotide sequence ( positions 74 - 76) of transfer RNA is essential for amino acid attachment(1) and interaction with the ribosome(2-4) during protein synthesis. The CCA sequence is synthesized de novo and/or repaired by a template-independent RNA polymerase, 'CCA-adding enzyme', using CTP and ATP as substrates(5). Despite structural and biochemical studies(5-8), the mechanism by which the CCA-adding enzyme synthesizes the defined sequence without a nucleic acid template remains elusive. Here we present the crystal structure of Aquifex aeolicus CCA-adding enzyme, bound to a primer tRNA lacking the terminal adenosine and an incoming ATP analogue, at 2.8 Angstrom resolution. The enzyme enfolds the acceptor T helix of the tRNA molecule. In the catalytic pocket, C75 is adjacent to ATP, and their base moieties are stacked. The complementary pocket for recognizing C74-C75 of tRNA forms a 'protein template' for the penultimate two nucleotides, mimicking the nucleotide template used by template-dependent polymerases. These results are supported by systematic analyses of mutants. Our structure represents the 'pre-insertion' stage of selecting the incoming nucleotide and provides the structural basis for the mechanism underlying template-independent RNA polymerization.	Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Informat, Midori Ku, Yokohama, Kanagawa 2268501, Japan; Natl Inst Adv Ind Sci & Technol, Inst Biol Resources & Funct, Tsukuba, Ibaraki 3058666, Japan; Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba 2778562, Japan; Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; SPring 8, RIKEN Harima Inst, Cellular Signaling Lab, Mikazuki, Hyogo 6795148, Japan; JST, PRESTO, Kawaguchi, Saitama 3320012, Japan	Tokyo Institute of Technology; National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo; University of Tokyo; Japan Synchrotron Radiation Research Institute; RIKEN; Japan Science & Technology Agency (JST)	Nureki, O (corresponding author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Dept Biol Informat, Midori Ku, 4259 Nagatsuta Cho, Yokohama, Kanagawa 2268501, Japan.	onureki@bio.titech.ac.jp	Ueda, Takuya/K-5217-2014; Vassylyev, Dmitry/A-9005-2008; Tomita, Kozo/J-5746-2013; Fukai, Shuya/X-4838-2018; Tomita, Kozo/E-9390-2017	Ueda, Takuya/0000-0002-7760-8271; Fukai, Shuya/0000-0002-1241-1443; Tomita, Kozo/0000-0002-7374-3898				Augustin MA, 2003, J MOL BIOL, V328, P985, DOI 10.1016/S0022-2836(03)00381-4; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Deutscher M. P., 1983, ENZYMES NUCLEIC ACID, V2, P159; Green R, 1997, ANNU REV BIOCHEM, V66, P679, DOI 10.1146/annurev.biochem.66.1.679; HEGG LA, 1990, NUCLEIC ACIDS RES, V18, P5975, DOI 10.1093/nar/18.20.5975; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P345, DOI 10.1016/S0968-0004(00)89071-4; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim DF, 1999, MOL CELL, V4, P859, DOI 10.1016/S1097-2765(00)80395-0; Li F, 2002, CELL, V111, P815, DOI 10.1016/S0092-8674(02)01115-7; Martin G, 1996, EMBO J, V15, P2593, DOI 10.1002/j.1460-2075.1996.tb00617.x; Nissen P, 2000, SCIENCE, V289, P920, DOI 10.1126/science.289.5481.920; Okabe M, 2003, EMBO J, V22, P5918, DOI 10.1093/emboj/cdg563; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; RICE LM, 1994, PROTEINS, V19, P277, DOI 10.1002/prot.340190403; Shi PY, 1998, EMBO J, V17, P3197, DOI 10.1093/emboj/17.11.3197; Shi PY, 1998, RNA, V4, P276; Sprinzl M, 1979, Prog Nucleic Acid Res Mol Biol, V22, P1, DOI 10.1016/S0079-6603(08)60798-9; Temiakov D, 2004, CELL, V116, P381, DOI 10.1016/S0092-8674(04)00059-5; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tomita K, 2002, J BIOL CHEM, V277, P48192, DOI 10.1074/jbc.M207527200; Tomita K, 2001, SCIENCE, V294, P1334, DOI 10.1126/science.1063816; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; Xiong Y, 2003, MOL CELL, V12, P1165, DOI 10.1016/S1097-2765(03)00440-4; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5; Yue DX, 1996, RNA, V2, P895	30	82	85	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2004	430	7000					700	704		10.1038/nature02712	http://dx.doi.org/10.1038/nature02712			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843LM	15295603				2022-12-24	WOS:000223085400051
J	Daniels, MJ; Wang, YM; Lee, MY; Venkitaraman, AR				Daniels, MJ; Wang, YM; Lee, MY; Venkitaraman, AR			Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2	SCIENCE			English	Article							CHROMOSOME SEGREGATION; PHOSPHORYLATION; COMPLEX; INCENP; INSTABILITY; PROGRESSION; METAPHASE; MUTATIONS; SPINDLE; REPAIR	Germ-line mutations inactivating BRCA2 predispose to cancer. BRCA2-deficient cells exhibit alterations in chromosome number (aneuploidy), as well as structurally aberrant chromosomes. Here, we show that BRCA2 deficiency impairs the completion of cell division by cytokinesis. BRCA2 inactivation in murine embryo fibroblasts (MEFs) and HeLa cells by targeted gene disruption or RNA interference delays and prevents cell cleavage. impeded cell separation is accompanied by abnormalities in myosin II organization during the late stages in cytokinesis. BRCA2 may have a role in regulating these events, as it localizes to the cytokinetic midbody. Our findings thus link cytokinetic abnormalities to a hereditary cancer syndrome characterized by chromosomal instability and may help to explain why BRCA2-deficient tumors are frequently aneuploid.	Univ Cambridge, Canc Res UK, Dept Oncol, Cambridge CB2 2XZ, England; Hutchison MRC Res Ctr, MRC, Canc Cell Unit, Cambridge CB2 2XZ, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Venkitaraman, AR (corresponding author), Univ Cambridge, Canc Res UK, Dept Oncol, Hills Rd, Cambridge CB2 2XZ, England.	arv22@cam.ac.uk	Lee, MiYoung/G-3748-2014	Daniels, Matthew/0000-0002-9250-6214				Adams RR, 2001, J CELL BIOL, V153, P865, DOI 10.1083/jcb.153.4.865; Friedman LS, 1998, CANCER RES, V58, P1338; Glotzer M, 2001, ANNU REV CELL DEV BI, V17, P351, DOI 10.1146/annurev.cellbio.17.1.351; Goggins M, 1996, CANCER RES, V56, P5360; Gretarsdottir S, 1998, CANCER RES, V58, P859; Kaitna S, 2000, CURR BIOL, V10, P1172, DOI 10.1016/S0960-9822(00)00721-1; Lee M, 2004, ONCOGENE, V23, P865, DOI 10.1038/sj.onc.1207223; Lin HR, 2003, J BIOL CHEM, V278, P35979, DOI 10.1074/jbc.M210659200; Marmorstein LY, 2001, CELL, V104, P247, DOI 10.1016/S0092-8674(01)00209-4; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Nathanson KN, 2001, NAT MED, V7, P552, DOI 10.1038/87876; Patel KJ, 1998, MOL CELL, V1, P347, DOI 10.1016/S1097-2765(00)80035-0; Scholey JM, 2003, NATURE, V422, P746, DOI 10.1038/nature01599; Severson AF, 2000, CURR BIOL, V10, P1162, DOI 10.1016/S0960-9822(00)00715-6; Tutt A, 1999, CURR BIOL, V9, P1107, DOI 10.1016/S0960-9822(99)80479-5; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; WANG Y, UNPUB; Wheatley SP, 2001, CURR BIOL, V11, P886, DOI 10.1016/S0960-9822(01)00238-X; Yu VPCC, 2000, GENE DEV, V14, P1400	19	237	243	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 29	2004	306	5697					876	879		10.1126/science.1102574	http://dx.doi.org/10.1126/science.1102574			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	869FS	15375219				2022-12-24	WOS:000224969400048
J	Screaton, RA; Conkright, MD; Katoh, Y; Best, JL; Canettieri, G; Jeffries, S; Guzman, E; Niessen, S; Yates, JR; Takemori, H; Okamoto, M; Montminy, M				Screaton, RA; Conkright, MD; Katoh, Y; Best, JL; Canettieri, G; Jeffries, S; Guzman, E; Niessen, S; Yates, JR; Takemori, H; Okamoto, M; Montminy, M			The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector	CELL			English	Article							RENAL-TRANSPLANT RECIPIENTS; DEPENDENT PROTEIN-KINASE; SALT-INDUCIBLE KINASE; PANCREATIC BETA-CELL; TRANSCRIPTIONAL REGULATION; PHOSPHORYLATION; BINDING; IDENTIFICATION; ACTIVATION; LKB1	Elevations in circulating glucose and gut hormones during feeding promote pancreatic islet cell viability in part via the calcium- and cAMP-dependent activation of the transcription factor CREB. Here, we describe a signaling module that mediates the synergistic effects of these pathways on cellular gene expression by stimulating the dephosphorylation and nuclear entry of TORC2, a CREB coactivator. This module consists of the calcium-regulated phosphatase calcineurin and the Ser/Thr kinase SIK2, both of which associate with TORC2. Under resting conditions, TORC2 is sequestered in the cytoplasm via a phosphorylation-dependent interaction with 14-3-3 proteins. Triggering of the calcium and cAMP second messenger pathways by glucose and gut hormones disrupts TORC2:14-3-3 complexes via complementary effects on TORC2 dephosphorylation; calcium influx increases calcineurin activity, whereas cAMP inhibits SIK2 kinase activity. Our results illustrate how a phosphatase/kinase module connects two signaling pathways in response to nutrient and hormonal cues.	Osaka Univ, Grad Sch Med, Dept Biochem & Mol Biol, Suita, Osaka 5650871, Japan; Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Osaka University; Salk Institute; Scripps Research Institute	Takemori, H (corresponding author), Osaka Univ, Grad Sch Med, Dept Biochem & Mol Biol, H-1,2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	mr-mb002@pop.med.osaka-u.ac.jp; montminy@salk.edu		CANETTIERI, Gianluca/0000-0001-6694-2613; Screaton, Robert/0000-0002-4917-9473				Al-Uzri A, 2001, TRANSPLANTATION, V72, P1020, DOI 10.1097/00007890-200109270-00007; Asahara H, 2001, MOL CELL BIOL, V21, P7892, DOI 10.1128/MCB.21.23.7892-7900.2001; BONNI A, 1995, MOL CELL NEUROSCI, V6, P168, DOI 10.1006/mcne.1995.1015; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Chen MS, 2003, MOL CELL BIOL, V23, P7488, DOI 10.1128/MCB.23.21.7488-7497.2003; Chow CW, 2000, MOL CELL BIOL, V20, P702, DOI 10.1128/MCB.20.2.702-712.2000; Conkright MD, 2003, MOL CELL, V11, P1101, DOI 10.1016/S1097-2765(03)00134-5; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Doi J, 2002, J BIOL CHEM, V277, P15629, DOI 10.1074/jbc.M109365200; Durocher D, 2000, MOL CELL, V6, P1169, DOI 10.1016/S1097-2765(00)00114-3; Filler G, 2000, NEPHROL DIAL TRANSPL, V15, P867, DOI 10.1093/ndt/15.6.867; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; Hinke SA, 2004, J PHYSIOL-LONDON, V558, P369, DOI 10.1113/jphysiol.2004.064881; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hui HX, 2003, ENDOCRINOLOGY, V144, P1444, DOI 10.1210/en.2002-220897; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; Inada A, 2004, MOL CELL BIOL, V24, P2831, DOI 10.1128/MCB.24.7.2831-2841.2004; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; MacCoss MJ, 2002, P NATL ACAD SCI USA, V99, P7900, DOI 10.1073/pnas.122231399; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Montclare JK, 2001, NUCLEIC ACIDS RES, V29, P3311, DOI 10.1093/nar/29.16.3311; Newman JRS, 2003, SCIENCE, V300, P2097, DOI 10.1126/science.1084648; Okamoto M, 2004, TRENDS ENDOCRIN MET, V15, P21, DOI 10.1016/j.tem.2003.11.002; RADHAKRISHNAN I, 1997, CELL, V91, P7411; SCHWANINGER M, 1995, J BIOL CHEM, V270, P8860, DOI 10.1074/jbc.270.15.8860; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4	35	489	520	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 1	2004	119	1					61	74		10.1016/j.cell.2004.09.015	http://dx.doi.org/10.1016/j.cell.2004.09.015			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	859UE	15454081	Bronze, Green Published			2022-12-24	WOS:000224292600009
J	Steinbrook, R				Steinbrook, R			Medical marijuana, physician-assisted suicide, and the controlled substance act	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Joy JE, 1999, MARIJUANA MED ASSESS; Kassirer JP, 1997, NEW ENGL J MED, V336, P366, DOI 10.1056/NEJM199701303360509; Steinbrook R, 2002, NEW ENGL J MED, V346, P460, DOI 10.1056/NEJM200202073460624	3	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 30	2004	351	14					1380	1383		10.1056/NEJMp048222	http://dx.doi.org/10.1056/NEJMp048222			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	857XT	15459296				2022-12-24	WOS:000224153900003
J	Ibanez, P; Bonnet, AM; Debarges, B; Lohmann, E; Tison, F; Pollak, P; Agid, Y; Durr, A; Brice, A				Ibanez, P; Bonnet, AM; Debarges, B; Lohmann, E; Tison, F; Pollak, P; Agid, Y; Durr, A; Brice, A		French Parkinson's Disease Genetic	Causal relation between alpha-synuclein gene duplication and familial Parkinson's disease	LANCET			English	Article								The alpha-synuclein gene (SNCA) has been implicated in autosomal dominant forms,of Parkinson's disease. We screened 119 individuals from families with this rare form of the disease for SNCA duplications by 94 semiquantitative multiplex PCR. Two patients had duplications, which were confirmed by analysis of intragenic and flanking microsatellite markers. The phenotype in both patients was indistinguishable from idiopathic Parkinson's disease and no atypical features were present, by contrast with reports of families with triplication of the same gene. These results indicate that SNCA is more frequently associated with familial Parkinson's disease than previously thought, and that there is a clear dosage effect according to the number of supernumerary copies of this gene.	AP HP, Hop La Pitie Salpetriere, INSERM, U289, F-75651 Paris 13, France; AP HP, Hop La Pitie Salpetriere, Dept Genet Cytogenet & Embryol, F-75651 Paris 13, France; AP HP, CHU Pitie Salpetriere, Federat Neurol, F-75013 Paris, France; CHU Bordeaux, Hop Haut Leveque, Serv Neurol, Pessac, France; CHU Grenoble, Dept Neurol, F-38043 Grenoble, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Bordeaux; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Brice, A (corresponding author), AP HP, Hop La Pitie Salpetriere, INSERM, U289, 47 Blvd Hop, F-75651 Paris 13, France.	brice@ccr.jussieu.fr	brice, alexis/AAE-8275-2019; Brice, Alexis/A-2170-2009	brice, alexis/0000-0002-0941-3990; 				Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Lansbury PT, 2002, CURR OPIN GENET DEV, V12, P299, DOI 10.1016/S0959-437X(02)00302-7; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Vaughan JR, 1998, HUM MOL GENET, V7, P751, DOI 10.1093/hmg/7.4.751	5	785	806	2	34	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 25	2004	364	9440					1169	1171		10.1016/S0140-6736(04)17104-3	http://dx.doi.org/10.1016/S0140-6736(04)17104-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	857FT	15451225				2022-12-24	WOS:000224102400031
J	Millgate, AG; Pogson, BJ; Wilson, IW; Kutchan, TM; Zenk, MH; Gerlachll, WL; Fist, AJ; Larkin, PJ				Millgate, AG; Pogson, BJ; Wilson, IW; Kutchan, TM; Zenk, MH; Gerlachll, WL; Fist, AJ; Larkin, PJ			Analgesia - Morphine-pathway block in top1 poppies	NATURE			English	Editorial Material							ALKALOID BIOSYNTHESIS; CELL		CSIRO Plant Ind, Canberra, ACT 2601, Australia; Australian Natl Univ, Sch Biochem & Mol Biol, Canberra, ACT 0200, Australia; Leibniz Inst Plant Biochem, Dept Nat Prod Biotechnol, D-06120 Halle Saale, Germany; Univ Halle Wittenberg, Biozentrum, D-06120 Halle Saale, Germany; Johnson & Johnson, Strawberry Hills, NSW 2012, Australia; Tasmanian Alkaloids, Westbury, Tas 7303, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Australian National University; Leibniz Institut fur Pflanzenbiochemie; Martin Luther University Halle Wittenberg; Johnson & Johnson	Millgate, AG (corresponding author), CSIRO Plant Ind, Black Mt, Canberra, ACT 2601, Australia.	philip.larkin@csiro.au	Wilson, Iain/D-4839-2009; Pogson, Barry J/C-9953-2009; Kutchan, Toni/L-4625-2013; Larkin, Philip/AAU-3195-2021; Larkin, Philip J/A-9468-2008	Wilson, Iain/0000-0002-4626-8059; Pogson, Barry J/0000-0003-1869-2423; Larkin, Philip/0000-0002-2608-1924; Larkin, Philip J/0000-0002-2608-1924				Bird DA, 2003, PLANT CELL, V15, P2626, DOI 10.1105/tpc.015396; Bock A, 2002, PLANTA, V216, P57, DOI 10.1007/s00425-002-0867-5; BROCHMANNHANSSEN E, 1984, PLANTA MED, V50, P343, DOI 10.1055/s-2007-969727; De Luca V, 2000, TRENDS PLANT SCI, V5, P168, DOI 10.1016/S1360-1385(00)01575-2; Kutchan TM, 1996, GENE, V179, P73, DOI 10.1016/S0378-1119(96)00426-X; KUTCHAN TM, IN PRESS ADV PLANT B; PARKER HI, 1972, J AM CHEM SOC, V94, P1276, DOI 10.1021/ja00759a039; Zenk M.H., 1995, ORGANIC REACTIVITY P, P89	8	76	87	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 23	2004	431	7007					413	414		10.1038/431413a	http://dx.doi.org/10.1038/431413a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15386001				2022-12-24	WOS:000224000500029
J	[Anonymous]				[Anonymous]			Prescribing of lipid regulating drugs and admissions for myocardial infarction in England	BMJ-BRITISH MEDICAL JOURNAL			English	Article													Aylin, Paul/A-1073-2014	Bottle, Alex/0000-0001-9978-2011; Aylin, Paul/0000-0003-4589-1743; Majeed, Azeem/0000-0002-2357-9858					0	3	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 18	2004	329	7467					645	+		10.1136/bmj.329.7467.645	http://dx.doi.org/10.1136/bmj.329.7467.645			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856JU	15374914	Green Published			2022-12-24	WOS:000224042300015
J	Lisby, M; Barlow, JH; Burgess, RC; Rothstein, R				Lisby, M; Barlow, JH; Burgess, RC; Rothstein, R			Choreography of the DNA damage response: Spatiotemporal relationships among checkpoint and repair proteins	CELL			English	Article							DOUBLE-STRAND BREAKS; STALLED REPLICATION FORKS; SACCHAROMYCES-CEREVISIAE; S-PHASE; RAD52 PROTEIN; MRE11 COMPLEX; NUCLEAR FOCI; HOMOLOGOUS RECOMBINATION; TELOMERE MAINTENANCE; SENSITIVE MUTANTS	DNA repair is an essential process for preserving genome integrity in all organisms. In eukaryotes, recombinational repair is choreographed by multiprotein complexes that are organized into centers (foci). Here, we analyze the cellular response to DNA double-strand breaks (DSBs) and replication stress in Saccharomyces cerevisiae. The Mre11 nuclease and the ATM-related Tell kinase are the first proteins detected at DSBs. Next, the Rfa1 single-strand DNA binding protein relocalizes to the break and recruits other key checkpoint proteins. Later and only in S and G2 phase, the homologous recombination machinery assembles at the site. Unlike the response to DSBs, Mre11 and recombination proteins are not recruited to hydroxyurea-stalled replication forks unless the forks collapse. The cellular response to DSBs and DNA replication stress is likely directed by the Mre11 complex detecting and processing DNA ends in conjunction with Sae2 and by RP-A recognizing single-stranded DNA and recruiting additional checkpoint and repair proteins.	Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA; Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University; Columbia University	Rothstein, R (corresponding author), Columbia Univ Coll Phys & Surg, Dept Genet & Dev, 701 W 168th St, New York, NY 10032 USA.	rothstein@cancercenter.columbia.edu	Lisby, Michael/K-9814-2014	Lisby, Michael/0000-0002-4830-5247; Rothstein, Rodney/0000-0002-4107-9654				ALANI E, 1992, J MOL BIOL, V227, P54, DOI 10.1016/0022-2836(92)90681-9; Alexeev A, 2003, NAT STRUCT BIOL, V10, P182, DOI 10.1038/nsb901; ALLEN JB, 1994, GENE DEV, V8, P2401, DOI 10.1101/gad.8.20.2401; ANDERSEN AH, 1991, J BIOL CHEM, V266, P9203; Aten JA, 2004, SCIENCE, V303, P92, DOI 10.1126/science.1088845; Benson FE, 1998, NATURE, V391, P401, DOI 10.1038/34937; Borde V, 2004, MOL CELL, V13, P389, DOI 10.1016/S1097-2765(04)00034-6; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; Carson CT, 2003, EMBO J, V22, P6610, DOI 10.1093/emboj/cdg630; Chan SWL, 2003, MOL CELL, V11, P1379, DOI 10.1016/S1097-2765(03)00174-6; Chang M, 2002, P NATL ACAD SCI USA, V99, P16934, DOI 10.1073/pnas.262669299; Clever B, 1997, EMBO J, V16, P2535, DOI 10.1093/emboj/16.9.2535; Costanzo V, 2003, MOL CELL, V11, P203, DOI 10.1016/S1097-2765(02)00799-2; D'Amours D, 2001, GENE DEV, V15, P2238, DOI 10.1101/gad.208701; Davis AP, 2001, GENETICS, V159, P515; de Jager M, 2001, MOL CELL, V8, P1129, DOI 10.1016/S1097-2765(01)00381-1; de la Torre-Ruiz MA, 1998, EMBO J, V17, P2687, DOI 10.1093/emboj/17.9.2687; Desany BA, 1998, GENE DEV, V12, P2956, DOI 10.1101/gad.12.18.2956; Frank-Vaillant M, 2002, MOL CELL, V10, P1189, DOI 10.1016/S1097-2765(02)00705-0; Frei C, 2000, GENE DEV, V14, P81; Friedl AA, 1998, GENETICS, V148, P975; Fujimori A, 2001, EMBO J, V20, P5513, DOI 10.1093/emboj/20.19.5513; GAME JC, 1974, MUTAT RES, V24, P281, DOI 10.1016/0027-5107(74)90176-6; Gasior SL, 2001, P NATL ACAD SCI USA, V98, P8411, DOI 10.1073/pnas.121046198; Gasior SL, 1998, GENE DEV, V12, P2208, DOI 10.1101/gad.12.14.2208; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gilbert CS, 2001, MOL CELL, V8, P129, DOI 10.1016/S1097-2765(01)00267-2; Grenon M, 2001, NAT CELL BIOL, V3, P844, DOI 10.1038/ncb0901-844; HAAF T, 1995, P NATL ACAD SCI USA, V92, P2298, DOI 10.1073/pnas.92.6.2298; Haaf T, 1999, J CELL BIOL, V144, P11, DOI 10.1083/jcb.144.1.11; HAYS SL, 1995, P NATL ACAD SCI USA, V92, P6925, DOI 10.1073/pnas.92.15.6925; Hays SL, 1998, MOL CELL BIOL, V18, P4400, DOI 10.1128/MCB.18.7.4400; Jiang H, 1996, J BIOL CHEM, V271, P33181, DOI 10.1074/jbc.271.52.33181; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; KEENEY S, 1995, P NATL ACAD SCI USA, V92, P11274, DOI 10.1073/pnas.92.24.11274; Kim HS, 2003, DNA REPAIR, V2, P1321, DOI 10.1016/j.dnarep.2003.07.004; Kim HS, 2001, MOL CELL BIOL, V21, P3725, DOI 10.1128/MCB.21.11.3725-3737.2001; Klein HL, 1997, GENETICS, V147, P1533; Krejci L, 2001, MOL CELL BIOL, V21, P966, DOI 10.1128/MCB.21.3.966-976.2001; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee SE, 2001, CURR BIOL, V11, P1053, DOI 10.1016/S0960-9822(01)00296-2; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298; Lisby M, 2003, CELL CYCLE, V2, P479, DOI 10.4161/cc.2.5.483; Lobachev KS, 2002, CELL, V108, P183, DOI 10.1016/S0092-8674(02)00614-1; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Lucca C, 2004, ONCOGENE, V23, P1206, DOI 10.1038/sj.onc.1207199; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Majka J, 2003, P NATL ACAD SCI USA, V100, P2249, DOI 10.1073/pnas.0437148100; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Martin SG, 1999, CELL, V97, P621, DOI 10.1016/S0092-8674(00)80773-4; Maser RS, 1997, MOL CELL BIOL, V17, P6087, DOI 10.1128/MCB.17.10.6087; Melo J, 2002, CURR OPIN CELL BIOL, V14, P237, DOI 10.1016/S0955-0674(02)00312-5; Melo JA, 2001, GENE DEV, V15, P2809; Moreau S, 1999, MOL CELL BIOL, V19, P556; Moreau S, 2001, GENETICS, V159, P1423; Nakada D, 2003, GENE DEV, V17, P1957, DOI 10.1101/gad.1099003; Nelms BE, 1998, SCIENCE, V280, P590, DOI 10.1126/science.280.5363.590; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Nugent CI, 1998, CURR BIOL, V8, P657, DOI 10.1016/S0960-9822(98)70253-2; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; Paulovich AG, 1997, GENETICS, V145, P45; Petukhova G, 2000, GENE DEV, V14, P2206, DOI 10.1101/gad.826100; Raderschall E, 1999, P NATL ACAD SCI USA, V96, P1921, DOI 10.1073/pnas.96.5.1921; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; Rijkers T, 1998, MOL CELL BIOL, V18, P6423, DOI 10.1128/MCB.18.11.6423; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Shinohara M, 1997, GENETICS, V147, P1545; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Takata H, 2004, MOL CELL, V14, P515, DOI 10.1016/S1097-2765(04)00262-X; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Trujillo KM, 2001, J BIOL CHEM, V276, P35458, DOI 10.1074/jbc.M105482200; TRUJILLO KM, 2003, J BIOL CHEM, V49, P48967; Usui T, 2001, MOL CELL, V7, P1255, DOI 10.1016/S1097-2765(01)00270-2; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Van Dyck E, 1999, NATURE, V398, P728, DOI 10.1038/43942; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302; Zou L, 2003, P NATL ACAD SCI USA, V100, P13827, DOI 10.1073/pnas.2336100100; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	85	707	723	3	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2004	118	6					699	713		10.1016/j.cell.2004.08.015	http://dx.doi.org/10.1016/j.cell.2004.08.015			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	855RW	15369670	Bronze			2022-12-24	WOS:000223992400007
J	Senghas, A; Kita, S; Ozyurek, A				Senghas, A; Kita, S; Ozyurek, A			Children creating core properties of language: Evidence from an emerging sign language in Nicaragua	SCIENCE			English	Article							GESTURE	A new sign language has been created by deaf Nicaraguans over the past 25 years, providing an opportunity to observe the inception of universal hallmarks of language. We found that in their initial creation of the language, children analyzed complex events into basic elements and sequenced these elements into hierarchically structured expressions according to principles not observed in gestures accompanying speech in the surrounding language. Successive cohorts of learners extended this procedure, transforming Nicaraguan signing from its early gestural form into a linguistic system. We propose that this early segmentation and recombination reflect mechanisms with which children learn, and thereby perpetuate, language. Thus, children naturally possess learning abilities capable of giving language its fundamental structure.	Columbia Univ Barnard Coll, Dept Psychol, New York, NY 10027 USA; Univ Bristol, Dept Expt Psychol, Bristol BS8 1TN, Avon, England; Univ Nijmegen, FC Donders Ctr Cognit Neuroimaging, NL-6525 EK Nijmegen, Netherlands; Max Planck Inst Psycholinguist, NL-6525 XD Nijmegen, Netherlands; Koc Univ, Dept Psychol, TR-34450 Istanbul, Turkey	Columbia University; University of Bristol; Radboud University Nijmegen; Max Planck Society; Koc University	Senghas, A (corresponding author), Columbia Univ Barnard Coll, Dept Psychol, 3009 Broadway, New York, NY 10027 USA.	annie@alum.mit.edu	Galantucci, Bruno/E-5770-2010; Kita, Sotaro/B-2860-2008; ozyurek, asli/M-5366-2013	Kita, Sotaro/0000-0002-0088-3654; 	NIDCD NIH HHS [R01 DC05407, R01 DC005407, R01 DC00491] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005407, R01DC000491] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ANDERSEN RW, 1983, PIDGINISATION CREOLI, P1; BICKERTON D, 1984, BEHAV BRAIN SCI, V7, P173, DOI 10.1017/S0140525X00044149; Christiansen MH, 2003, TRENDS COGN SCI, V7, P300, DOI 10.1016/S1364-6613(03)00136-0; Coppola M., 2002, THESIS U ROCHESTER; DeGraff M., 1999, LANGUAGE CREATION LA; Goldin-Meadow S., 1982, LANG ACQUIS, P51; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Hockett C. F., 1987, REFURBISHING OUR FDN; HOLM J, 1988, PIDGINS CREOLES, V1; Jackendoff R., 2002, FDN LANGUAGE BRAIN, DOI 10.1093/acprof:oso/9780198270126.001.0001; Kegl J, 1999, LEARN DEV CONCEP CH, P179; Kirby S., 1999, FUNCTION SELECTION I; Kita S, 2003, J MEM LANG, V48, P16, DOI 10.1016/S0749-596X(02)00505-3; Lenneberg E.H., 1967, HOSP PRACT, V2, P59, DOI [10.1080/21548331.1967.11707799, DOI 10.1080/21548331.1967.11707799]; McNeill D., 1992, HAND MIND WHAT GESTU; MEIER RP, 1987, J MEM LANG, V26, P362, DOI 10.1016/0749-596X(87)90119-7; Morford JP, 1996, LANG COMMUN, V16, P165, DOI 10.1016/0271-5309(96)00008-0; NEWPORT EL, 1990, COGNITIVE SCI, V14, P11, DOI 10.1207/s15516709cog1401_2; PINKER S, 1990, BEHAV BRAIN SCI, V13, P707, DOI 10.1017/S0140525X00081061; POLICH L, IN PRESS BUT SIGN LA; Sankoff Gillian, 1973, KIVUNG, V6, P32; Senghas A, 2003, COGNITIVE DEV, V18, P511, DOI 10.1016/j.cogdev.2003.09.006; Senghas A, 2001, PSYCHOL SCI, V12, P323, DOI 10.1111/1467-9280.00359; Senghas A., 1995, THESIS MIT; SENGHAS RJ, 1997, THESIS U ROCHESTER; Talmy L., 1985, LANGUAGE TYPOLOGY SY, V3, P57, DOI DOI 10.1017/CB09780511618437; TOMASELLO M, 2003, LANGUAGE EVOLUTION, P94, DOI DOI 10.1093/ACPROF:OSO/9780199244843.003.0006; [No title captured]	28	300	304	1	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1779	1782		10.1126/science.1100199	http://dx.doi.org/10.1126/science.1100199			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	856IS	15375269	Green Submitted, Green Published			2022-12-24	WOS:000224039500043
J	Gliki, G; Ebnet, K; Aurrand-Lions, M; Imhof, BA; Adams, RH				Gliki, G; Ebnet, K; Aurrand-Lions, M; Imhof, BA; Adams, RH			Spermatid differentiation requires the assembly of a cell polarity complex downstream of junctional adhesion molecule-C	NATURE			English	Article							EPITHELIAL TIGHT JUNCTION; JAM FAMILY; ROLES; APKC; ESTABLISHMENT; DYNAMICS; NECTIN-2; ACROSOME; CDC42; PAR-6	During spermatogenesis in the mammalian testis, stem cells (spermatogonia) differentiate into spermatocytes, which subsequently undergo two consecutive meiotic divisions to give rise to haploid spermatids. These cells are initially round but progressively elongate, condense their nuclei, acquire flagellar and acrosomal structures, and shed a significant amount of their cytoplasm to form spermatozoa (the sperm cells) in a developmental cascade termed spermiogenesis(1,2). Defects in these processes will lead to a lack of mature sperm cells ( azoospermia), which is a major cause of male infertility in the human population(3). Here we report that a cell-surface protein of the immunoglobulin superfamily, junctional adhesion molecule-C (JAM-C), is critically required for the differentiation of round spermatids into spermatozoa in mice. We found that Jam-C is essential for the polarization of round spermatids, a function that we attribute to its role in the assembly of a cell polarity complex.	Canc Res UK London Res Inst, Vasc Dev Lab, London WC2A 3PX, England; Univ Hosp Munster, Inst Cell Biol, ZMBE, D-48149 Munster, Germany; Univ Geneva, CMU, Dept Pathol, CH-1211 Geneva, Switzerland	Cancer Research UK; University of Geneva	Adams, RH (corresponding author), Canc Res UK London Res Inst, Vasc Dev Lab, London WC2A 3PX, England.	ralf.adams@cancer.org.uk	Ebnet, Klaus T/C-8314-2009; Adams, Ralf H/AAE-9274-2019; Aurrand-Lions, Michel/O-9953-2016	Ebnet, Klaus T/0000-0002-0417-7888; Aurrand-Lions, Michel/0000-0002-8361-3034				Arrate MP, 2001, J BIOL CHEM, V276, P45826, DOI 10.1074/jbc.M105972200; Aurrand-Lions M, 2002, VASC PHARMACOL, V39, P239, DOI 10.1016/S1537-1891(03)00012-0; Bazzoni G, 2003, CURR OPIN CELL BIOL, V15, P525, DOI 10.1016/S0955-0674(03)00104-2; Bouchard MJ, 2000, MOL CELL BIOL, V20, P2865, DOI 10.1128/MCB.20.8.2865-2873.2000; Chavakis T, 2003, THROMB HAEMOSTASIS, V89, P13; Cheng CY, 2002, PHYSIOL REV, V82, P825, DOI 10.1152/physrev.00009.2002; Compagni A, 2003, DEV CELL, V5, P217, DOI 10.1016/S1534-5807(03)00198-9; Ebnet K, 2001, EMBO J, V20, P3738, DOI 10.1093/emboj/20.14.3738; Ebnet K, 2003, J CELL SCI, V116, P3879, DOI 10.1242/jcs.00704; Ebnet K, 2004, J CELL SCI, V117, P19, DOI 10.1242/jcs.00930; Erickson JW, 2001, CURR OPIN CELL BIOL, V13, P153, DOI 10.1016/S0955-0674(00)00192-7; Etienne-Manneville S, 2003, CURR OPIN CELL BIOL, V15, P67, DOI 10.1016/S0955-0674(02)00005-4; Ezeh UIO, 2000, HUM REPROD, V15, P2356, DOI 10.1093/humrep/15.11.2356; GRISWOLD MD, 1995, BIOL REPROD, V52, P211, DOI 10.1095/biolreprod52.2.211; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; Hutterer A, 2004, DEV CELL, V6, P845, DOI 10.1016/j.devcel.2004.05.003; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Kang-Decker N, 2001, SCIENCE, V294, P1531, DOI 10.1126/science.1063665; Kierszenbaum AL, 2003, MOL BIOL CELL, V14, P4628, DOI 10.1091/mbc.E03-04-0226; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; Liang TW, 2002, J IMMUNOL, V168, P1618, DOI 10.4049/jimmunol.168.4.1618; Lui WY, 2003, BIOL REPROD, V68, P1087, DOI 10.1095/biolreprod.102.010371; Mueller S, 2003, BIOL REPROD, V69, P1330, DOI 10.1095/biolreprod.102.014670; Muller WA, 2003, TRENDS IMMUNOL, V24, P327, DOI 10.1016/S1471-4906(03)00117-0; Nam SC, 2003, DEVELOPMENT, V130, P4363, DOI 10.1242/dev.00648; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Ozaki-Kuroda K, 2002, CURR BIOL, V12, P1145, DOI 10.1016/S0960-9822(02)00922-3; Roh MH, 2003, J CELL SCI, V116, P2895, DOI 10.1242/jcs.00500; Straight SW, 2004, MOL BIOL CELL, V15, P1981, DOI 10.1091/mbc.E03-08-0620; Wodarz A, 2002, NAT CELL BIOL, V4, pE39, DOI 10.1038/ncb0202-e39	30	199	212	1	11	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 16	2004	431	7006					320	324		10.1038/nature02877	http://dx.doi.org/10.1038/nature02877			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372036				2022-12-24	WOS:000223864000044
J	Wen, B; Li, H; Lu, DR; Song, XF; Zhang, F; He, YG; Li, F; Gao, Y; Mao, XY; Zhang, L; Qian, J; Tan, JZ; Jin, JZ; Huang, W; Deka, R; Su, B; Chakraborty, R; Jin, L				Wen, B; Li, H; Lu, DR; Song, XF; Zhang, F; He, YG; Li, F; Gao, Y; Mao, XY; Zhang, L; Qian, J; Tan, JZ; Jin, JZ; Huang, W; Deka, R; Su, B; Chakraborty, R; Jin, L			Genetic evidence supports demic diffusion of Han culture	NATURE			English	Article							INFERRING ADMIXTURE PROPORTIONS; Y-CHROMOSOME; CHINESE POPULATIONS; MITOCHONDRIAL-DNA; PARENTAL POPULATIONS; HUMAN-EVOLUTION; MOLECULAR-DATA; FREQUENCIES; HAPLOTYPES; DISTANCES	The spread of culture and language in human populations is explained by two alternative models: the demic diffusion model, which involves mass movement of people; and the cultural diffusion model, which refers to cultural impact between populations and involves limited genetic exchange between them(1). The mechanism of the peopling of Europe has long been debated, a key issue being whether the diffusion of agriculture and language from the Near East was concomitant with a large movement of farmers(1-3). Here we show, by systematically analysing Y-chromosome and mitochondrial DNA variation in Han populations, that the pattern of the southward expansion of Han culture is consistent with the demic diffusion model, and that males played a larger role than females in this expansion. The Han people, who all share the same culture and language, exceed 1.16 billion (2000 census), and are by far the largest ethnic group in the world. The expansion process of Han culture is thus of great interest to researchers in many fields.	Fudan Univ, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; Fudan Univ, Sch Life Sci, Ctr Anthropol Studies, Shanghai 200433, Peoples R China; Fudan Univ, Moragn Tan Inst Ctr Life Sci, Shanghai 200433, Peoples R China; Chinese Natl Human Genome Ctr, Shanghai 201203, Peoples R China; Univ Cincinnati, Dept Environm Hlth, Ctr Genome Informat, Cincinnati, OH 45267 USA; Chinese Acad Sci, Kunming Inst Zool, Key Lab Cellular & Mol Evolut, Kunming 650223, Peoples R China	Fudan University; Fudan University; Fudan University; University System of Ohio; University of Cincinnati; Chinese Academy of Sciences; Kunming Institute of Zoology	Jin, L (corresponding author), Fudan Univ, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	lijin@fudan.edu.cn	Li, Hui/A-2014-2010; Zhang, Liang/F-8064-2013; Jin, Li/M-5063-2019; Jin, Li/C-1468-2009; Zhang, Feng/C-7735-2009; Wen, Bo/P-5332-2019; mao, xianyun/B-4664-2014	Zhang, Liang/0000-0002-7672-1168; Jin, Li/0000-0002-4546-2415; Zhang, Feng/0000-0003-4556-8276; Wen, Bo/0000-0003-0394-7366; mao, xianyun/0000-0002-1236-4800; He, Yungang/0000-0002-2931-2871				Bertorelle G, 1998, MOL BIOL EVOL, V15, P1298, DOI 10.1093/oxfordjournals.molbev.a025858; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; CHAKRABORTY R, 1986, YEARB PHYS ANTHROPOL, V29, P1; Chikhi L, 2002, P NATL ACAD SCI USA, V99, P11008, DOI 10.1073/pnas.162158799; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; Du RF, 1997, SCI CHINA SER C, V40, P613, DOI 10.1007/BF02882691; Dupanloup I, 2001, MOL BIOL EVOL, V18, P672, DOI 10.1093/oxfordjournals.molbev.a003847; Ellis N, 2002, GENOME RES, V12, P339; EXCOFFIER L, 1992, GENETICS, V131, P479; FEI XT, 1999, PATTERN DIVERSITY UN; Jin L, 2000, NAT REV GENET, V1, P126, DOI 10.1038/35038565; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Kivisild T, 2002, MOL BIOL EVOL, V19, P1737, DOI 10.1093/oxfordjournals.molbev.a003996; ROBERTS DF, 1965, HUM BIOL, V37, P38; Sans M, 2002, AM J PHYS ANTHROPOL, V118, P33, DOI 10.1002/ajpa.10071; Schneider S., 2000, ARLEQUIN VER 2000 SO; SOKAL RR, 1991, NATURE, V351, P143, DOI 10.1038/351143a0; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Su B, 2000, HUM GENET, V107, P582, DOI 10.1007/s004390000406; Underhill PA, 2000, NAT GENET, V26, P358, DOI 10.1038/81685; Wallace DC, 1999, GENE, V238, P211, DOI 10.1016/S0378-1119(99)00295-4; Wang JL, 2003, GENETICS, V164, P747; Wen B, 2004, AM J HUM GENET, V74, P856, DOI 10.1086/386292; Wu S. D., 1997, ZHONGGUO YIMIN SHI; Xiao CJ, 2000, SCI CHINA SER C, V43, P472; XU YT, 2003, J CENTR U NATL, V30, P59; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; ZHAO T, 1989, HUM GENET, V83, P101, DOI 10.1007/BF00286699	29	297	334	3	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2004	431	7006					302	305		10.1038/nature02878	http://dx.doi.org/10.1038/nature02878			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372031				2022-12-24	WOS:000223864000039
J	Court, FA; Sherman, DL; Pratt, T; Garry, EM; Ribchester, RR; Cottrell, DF; Fleetwood-Walker, SM; Brophy, PJ				Court, FA; Sherman, DL; Pratt, T; Garry, EM; Ribchester, RR; Cottrell, DF; Fleetwood-Walker, SM; Brophy, PJ			Restricted growth of Schwann cells lacking Cajal bands slows conduction in myelinated nerves	NATURE			English	Article							PROTEIN MESSENGER-RNA; MICE; OLIGODENDROCYTES; MICROTUBULES; EXPRESSION; JUNCTION; PERIAXIN; FIBERS	Nerve impulses are propagated at nodes of Ranvier in the myelinated nerves of vertebrates. Internodal distances have been proposed to affect the velocity of nerve impulse conduction(1); however, direct evidence is lacking, and the cellular mechanisms that might regulate the length of the myelinated segments are unknown. Ramon y Cajal described longitudinal and transverse bands of cytoplasm or trabeculae in internodal Schwann cells and suggested that they had a nutritive function(2). Here we show that internodal growth in wild-type nerves is precisely matched to nerve extension, but disruption of the cytoplasmic bands in Periaxin-null mice impairs Schwann cell elongation during nerve growth. By contrast, myelination proceeds normally. The capacity of wild-type and mutant Schwann cells to elongate is cell-autonomous, indicating that passive stretching can account for the lengthening of the internode during limb growth. As predicted on theoretical grounds, decreased internodal distances strikingly decrease conduction velocities and so affect motor function. We propose that microtubule-based transport in the longitudinal bands of Cajal permits internodal Schwann cells to lengthen in response to axonal growth, thus ensuring rapid nerve impulse transmission.	Univ Edinburgh, Neurosci Res Ctr, Edinburgh EH9 1QH, Midlothian, Scotland	University of Edinburgh	Brophy, PJ (corresponding author), Univ Edinburgh, Neurosci Res Ctr, Edinburgh EH9 1QH, Midlothian, Scotland.	peter.brophy@ed.ac.uk	Court, Felipe/C-5911-2015	Ribchester, Richard/0000-0003-2670-6995; Pratt, Thomas/0000-0002-7105-3527; Court, Felipe/0000-0002-9394-7601; Court, Felipe/0000-0002-1384-2552				Ainger K, 1997, J CELL BIOL, V138, P1077, DOI 10.1083/jcb.138.5.1077; Anzini P, 1997, J NEUROSCI, V17, P4545; BRILL MH, 1977, J NEUROL NEUROSUR PS, V40, P769, DOI 10.1136/jnnp.40.8.769; Carson JH, 1997, CELL MOTIL CYTOSKEL, V38, P318, DOI 10.1002/(SICI)1097-0169(1997)38:4<318::AID-CM2>3.0.CO;2-#; Collinson JM, 1998, GLIA, V23, P11, DOI 10.1002/(SICI)1098-1136(199805)23:1<11::AID-GLIA2>3.0.CO;2-7; COLMAN DR, 1982, J CELL BIOL, V95, P598, DOI 10.1083/jcb.95.2.598; Fernan M., 1933, HISTOLOGY; Gillespie CS, 2000, NEURON, V26, P523, DOI 10.1016/S0896-6273(00)81184-8; GILLESPIE CS, 1994, NEURON, V12, P497, DOI 10.1016/0896-6273(94)90208-9; GRIFFITHS IR, 1989, J NEUROCYTOL, V18, P345, DOI 10.1007/BF01190837; HISCOE HB, 1947, ANAT REC, V99, P447, DOI 10.1002/ar.1090990404; Hursh JB, 1939, AM J PHYSIOL, V127, P131, DOI 10.1152/ajplegacy.1939.127.1.131; HUXLEY AF, 1949, J PHYSIOL-LONDON, V108, P315, DOI 10.1113/jphysiol.1949.sp004335; Komada M, 2002, J CELL BIOL, V156, P337, DOI 10.1083/jcb.200110003; McIntyre CC, 2002, J NEUROPHYSIOL, V87, P995, DOI 10.1152/jn.00353.2001; Pratt T, 2000, DEV BIOL, V228, P19, DOI 10.1006/dbio.2000.9935; RANVIER L, 1872, CR HEBD ACAD SCI, V75, P1129; SCHLAEPFER WW, 1973, J COMP NEUROL, V147, P255, DOI 10.1002/cne.901470207; Sherman DL, 2001, NEURON, V30, P677, DOI 10.1016/S0896-6273(01)00327-0; Tait S, 2000, J CELL BIOL, V150, P657, DOI 10.1083/jcb.150.3.657; TRAPP BD, 1995, J NEUROSCI, V15, P1797, DOI 10.1523/JNEUROSCI.15-03-01797.1995	21	168	174	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 9	2004	431	7005					191	195		10.1038/nature02841	http://dx.doi.org/10.1038/nature02841			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HI	15356632	Green Published			2022-12-24	WOS:000223746000046
J	Hierro, A; Sun, J; Rusnak, AS; Kim, J; Prag, G; Emr, SD; Hurley, JH				Hierro, A; Sun, J; Rusnak, AS; Kim, J; Prag, G; Emr, SD; Hurley, JH			Structure of the ESCRT-II endosomal trafficking complex	NATURE			English	Article							RECEPTOR DOWN-REGULATION; MULTIVESICULAR-BODY; UBIQUITIN LIGASE; PROTEIN; TSG101; MACHINERY; PATHWAY; SYSTEM; BODIES; DELTA	The multivesicular-body (MVB) pathway delivers transmembrane proteins and lipids to the lumen of the endosome. The multivesicular-body sorting pathway has crucial roles in growth-factor-receptor downregulation(1), developmental signalling(2-4), regulation of the immune response(5) and the budding of certain enveloped viruses such as human immunodeficiency virus(6). Ubiquitination is a signal for sorting into the MVB pathway(7,8), which also requires the functions of three protein complexes, termed ESCRT-I, -II and -III (endosomal sorting complex required for transport)(7,9,10). Here we report the crystal structure of the core of the yeast ESCRT-II complex, which contains one molecule of the Vps protein Vps22, the carboxy-terminal domain of Vps36 and two molecules of Vps25, and has the shape of a capital letter 'Y'. The amino-terminal coiled coil of Vps22 and the flexible linker leading to the ubiquitin-binding NZF domain of Vps36 both protrude from the tip of one branch of the 'Y'. Vps22 and Vps36 form nearly equivalent interactions with the two Vps25 molecules at the centre of the 'Y'. The structure suggests how ubiquitinated cargo could be passed between ESCRT components of the MVB pathway through the sequential transfer of ubiquitinated cargo from one complex to the next.	NIDDKD, Mol Biol Lab, NIH, US Dept Hlth & Human Serv, Bethesda, MD 20892 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Hurley, JH (corresponding author), NIDDKD, Mol Biol Lab, NIH, US Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	hurley@helix.nih.gov	Hierro, Aitor/F-9998-2011	Hierro, Aitor/0000-0002-7721-1581	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036118] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alam SL, 2004, EMBO J, V23, P1411, DOI 10.1038/sj.emboj.7600114; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2002, DEV CELL, V3, P283, DOI 10.1016/S1534-5807(02)00219-8; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Bache KG, 2003, J CELL BIOL, V162, P435, DOI 10.1083/jcb.200302131; Bilodeau PS, 2002, NAT CELL BIOL, V4, P534, DOI 10.1038/ncb815; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Deblandre GA, 2001, DEV CELL, V1, P795, DOI 10.1016/S1534-5807(01)00091-0; Fisher RD, 2003, J BIOL CHEM, V278, P28976, DOI 10.1074/jbc.M302596200; Futter CE, 1996, J CELL BIOL, V132, P1011, DOI 10.1083/jcb.132.6.1011; Gajiwala KS, 2000, CURR OPIN STRUC BIOL, V10, P110, DOI 10.1016/S0959-440X(99)00057-3; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Katzmann DJ, 2003, J CELL BIOL, V162, P413, DOI 10.1083/jcb.200302136; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kleijmeer M, 2001, J CELL BIOL, V155, P53, DOI 10.1083/jcb.200103071; Lai EC, 2001, DEV CELL, V1, P783, DOI 10.1016/S1534-5807(01)00092-2; Lu Q, 2003, P NATL ACAD SCI USA, V100, P7626, DOI 10.1073/pnas.0932599100; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Pavlopoulos E, 2001, DEV CELL, V1, P807, DOI 10.1016/S1534-5807(01)00093-4; RAYMOND CK, 1992, INT REV CYTOL, V139, P59, DOI 10.1016/S0074-7696(08)61410-2; Reggiori F, 2001, EMBO J, V20, P5176, DOI 10.1093/emboj/20.18.5176; Rost B, 2003, NUCLEIC ACIDS RES, V31, P3300, DOI 10.1093/nar/gkg508; Sundquist WI, 2004, MOL CELL, V13, P783, DOI 10.1016/S1097-2765(04)00129-7; Swanson KA, 2003, EMBO J, V22, P4597, DOI 10.1093/emboj/cdg471; Tan S, 2001, PROTEIN EXPRES PURIF, V21, P224, DOI 10.1006/prep.2000.1363; TEO H, IN PRESS J BIOL CHEM; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072	30	119	127	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 9	2004	431	7005					221	225		10.1038/nature02914	http://dx.doi.org/10.1038/nature02914			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HI	15329733	Green Published			2022-12-24	WOS:000223746000052
J	Cuthbert, GL; Daujat, S; Snowden, AW; Erdjument-Bromage, H; Hagiwara, T; Yamada, M; Schneider, R; Gregory, PD; Tempst, P; Bannister, AJ; Kouzarides, T				Cuthbert, GL; Daujat, S; Snowden, AW; Erdjument-Bromage, H; Hagiwara, T; Yamada, M; Schneider, R; Gregory, PD; Tempst, P; Bannister, AJ; Kouzarides, T			Histone deimination antagonizes arginine methylation	CELL			English	Article							IN-VIVO; GENE ACTIVATION; H3; RECEPTOR; PROMOTER; ACETYLATION; RESIDUES; H4	Methylation of arginine residues within histone H3 has been linked to active transcription. This modification appears on the estrogen-regulated pS2 promoter when the CARM1 methyltransferase is recruited during transcriptional activation. Here we describe a process, deimination, that converts histone arginine to citrulline and antagonizes arginine methylation. We show that peptidyl arginine deiminase 4 (PADI4) specifically deiminates, arginine residues R2, R8, R17, and R26 in the H3 tail. Deimination by PADI4 prevents arginine methylation by CARM1. Dimethylation of arginines prevents deimination by PADI4 although monomethylation still allows deimination to take place. In vivo targeting experiments on an endogenous promoter demonstrate that PADI4 can repress hormone receptor-mediated gene induction. Consistent with a repressive role for PADI4, this enzyme is recruited to the pS2 promoter following hormone induction when the gene is transcriptionally downregulated. The recruitment of PADI4 coincides with deimination of the histone H3 N-terminal tail. These results define deimination as a novel mechanism for antagonizing the transcriptional induction mediated by arginine methylation.	Univ Cambridge, Gurdon Inst, Cambridge CB2 1QR, England; Univ Cambridge, Dept Pathol, Cambridge CB2 1QR, England; Sangamo Biosci Inc, Point Richmond Tech Ctr 2, Richmond, CA 94804 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Yokohama City Univ, Grad Sch Integrated Sci, Kanazawa Ku, Yokohama, Kanagawa 2360027, Japan	University of Cambridge; University of Cambridge; Sangamo Therapeutics, Inc.; Memorial Sloan Kettering Cancer Center; Yokohama City University	Kouzarides, T (corresponding author), Univ Cambridge, Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QR, England.	tk106@mole.bio.cam.ac.uk	Daujat, Sylvain/A-6070-2017; zhang, shijun/K-3688-2013	Daujat, Sylvain/0000-0001-5107-119X; Tempst, Paul/0000-0002-6680-3987; Bannister, Andrew/0000-0002-6312-4436; Erdjument-Bromage, Hediye/0000-0003-0224-3594; Kouzarides, Tony/0000-0002-8918-4162; Gregory, Philip/0000-0001-9249-2468	NCI NIH HHS [P30 CA08748] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bannister AJ, 2002, CELL, V109, P801, DOI 10.1016/S0092-8674(02)00798-5; Bauer UM, 2002, EMBO REP, V3, P39, DOI 10.1093/embo-reports/kvf013; Daujat S, 2002, CURR BIOL, V12, P2090, DOI 10.1016/S0960-9822(02)01387-8; DEDON PC, 1991, ANAL BIOCHEM, V197, P83, DOI 10.1016/0003-2697(91)90359-2; Erdjument-Bromage H, 1998, J CHROMATOGR A, V826, P167, DOI 10.1016/S0021-9673(98)00705-5; Hagiwara T, 2002, BIOCHEM BIOPH RES CO, V290, P979, DOI 10.1006/bbrc.2001.6303; Khorasanizadeh S, 2004, CELL, V116, P259, DOI 10.1016/S0092-8674(04)00044-3; Ma H, 2001, CURR BIOL, V11, P1981, DOI 10.1016/S0960-9822(01)00600-5; Martens JHA, 2003, MOL CELL BIOL, V23, P1808, DOI 10.1128/MCB.23.5.1808-1816.2003; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Nakatani T, 2002, J BIOL CHEM, V277, P9562, DOI 10.1074/jbc.M110132200; Nicolas E, 2003, MOL CELL BIOL, V23, P1614, DOI 10.1128/MCB.23.5.1614-1622.2003; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b; SENSHU T, 1992, ANAL BIOCHEM, V203, P94, DOI 10.1016/0003-2697(92)90047-B; Snowden AW, 2002, CURR BIOL, V12, P2159, DOI 10.1016/S0960-9822(02)01391-X; Strahl BD, 2001, CURR BIOL, V11, P996, DOI 10.1016/S0960-9822(01)00294-9; Tempst Paul, 1994, Methods (Orlando), V6, P248, DOI 10.1006/meth.1994.1027; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Wang HB, 2001, SCIENCE, V293, P853, DOI 10.1126/science.1060781; Zhang LW, 2003, CHROMOSOMA, V112, P77, DOI 10.1007/s00412-003-0244-6	21	608	639	1	76	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 3	2004	118	5					545	553		10.1016/j.cell.2004.08.020	http://dx.doi.org/10.1016/j.cell.2004.08.020			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852BN	15339660	Bronze			2022-12-24	WOS:000223730300006
J	Galik, K; Senut, B; Pickford, M; Gommery, D; Treil, J; Kuperavage, AJ; Eckhardt, RB				Galik, K; Senut, B; Pickford, M; Gommery, D; Treil, J; Kuperavage, AJ; Eckhardt, RB			External and internal morphology of the BAR 1002 ' 00 Orrorin tugenensis femur	SCIENCE			English	Article							CORTICAL BONE; FEMORAL-NECK; HOMINID; MIOCENE	Late Miocene fossils from the Lukeino Formation in Kenya's Tugen Hills are assigned to Orrorin tugenensis. Of 20 fossils recovered there to date, 3 are proximal femurs. One of these, BAR 1002'00, preserves an intact head connected to the proximal shaft by an elongated neck. Although this fossil is comparable in size to Pan troglodytes, computerized tomography scans of the neck-shaft junction of BAR 1002'00 reveal that the cortex is markedly thinner superiorly than inferiorly, differing from the approximately equal cortical thicknesses observed in extant African apes, approaching the condition in later hominids, and indicating that O. tugenensis was bipedal.	Penn State Univ, Dept Kinesiol, Lab Comparat Morphol & Mech, University Pk, PA 16802 USA; Allegheny Gen Hosp, Orthopaed Biomech Lab, Pittsburgh, PA 15212 USA; Museum Natl Hist Nat, CNRS, UMR 5143, Dept Hist Terr, F-75231 Paris 05, France; Coll France, Chaire Paleonanthropol & Prehist, F-75231 Paris 05, France; CNRS, UPR 2147, F-75014 Paris, France; CNRS, GDR 983, F-75005 Paris, France; CNRS, UMR 8555, Serv Radiol, F-31300 Toulouse, France; Clin Pasteur, Serv Radiol, F-31300 Toulouse, France	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Allegheny General Hospital; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS)	Eckhardt, RB (corresponding author), Penn State Univ, Dept Kinesiol, Lab Comparat Morphol & Mech, University Pk, PA 16802 USA.	eyl@psu.edu						BEGUN D, 2004, SCIENCE, V303, P1503; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; Haile-Selassie Y, 2004, SCIENCE, V303, P1503, DOI 10.1126/science.1092978; Lovejoy CO, 2002, AM J PHYS ANTHROPOL, V119, P97, DOI 10.1002/ajpa.10111; Meijering EHW, 2001, MED IMAGE ANAL, V5, P111, DOI 10.1016/S1361-8415(00)00040-2; Ohman JC, 1997, AM J PHYS ANTHROPOL, V104, P117, DOI 10.1002/(SICI)1096-8644(199709)104:1<117::AID-AJPA8>3.0.CO;2-O; Pickford M, 2002, C R PALEVOL, V1, P191, DOI 10.1016/S1631-0683(02)00028-3; Rafferty KL, 1998, J HUM EVOL, V34, P361, DOI 10.1006/jhev.1997.0202; Sawada Y, 2002, CR PALEVOL, V1, P293, DOI 10.1016/S1631-0683(02)00036-2; Senut B, 2001, CR ACAD SCI II A, V332, P137, DOI 10.1016/S1251-8050(01)01529-4; SPOOR CF, 1993, AM J PHYS ANTHROPOL, V91, P469, DOI 10.1002/ajpa.1330910405	11	91	98	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2004	305	5689					1450	1453		10.1126/science.1098807	http://dx.doi.org/10.1126/science.1098807			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852NK	15353798				2022-12-24	WOS:000223761900044
J	Rajkovic, A; Pangas, SA; Ballow, D; Suzumori, N; Matzuk, MM				Rajkovic, A; Pangas, SA; Ballow, D; Suzumori, N; Matzuk, MM			NOBOX deficiency disrupts early folliculogenesis and oocyte-specific gene expression	SCIENCE			English	Article							TRANSCRIPTION FACTOR; GERM-CELLS; C-KIT; MICE; DIFFERENTIATION; LOCUS; MSY2	Primordial ovarian follicles in mice form when somatic cells surround individual oocytes. We show that lack of Nobox, an oocyte-specific homeobox gene, accelerates postnatal oocyte loss and abolishes the transition from primordial to growing follicles in mice. Follicles are replaced by fibrous tissue in female mice lacking Nobox in a manner similar to nonsyndromic ovarian failure in women. Genes preferentially expressed in oocytes, including Oct4 and Gdf9, are down-regulated in Nobox(-/-) mice, whereas ubiquitous genes such as Bmp4, Kit, and Bax remain unaffected. Therefore, Nobox is critical for specifying an oocyte-restricted gene expression pattern essential for postnatal follicle development.	Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Rajkovic, A (corresponding author), Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA.	rajkovic@bcm.tmc.edu		Suzumori, Nobuhiro/0000-0001-9003-1289; Pangas, Stephanie/0000-0001-5748-5844	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD033438] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD033438, R01HD042500, K12HD001426] Funding Source: NIH RePORTER; NICHD NIH HHS [HD01426, HD42500, HD007165, HD33438] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bachvarova R, 1985, Dev Biol (N Y 1985), V1, P453; Edelmann W, 1999, NAT GENET, V21, P123, DOI 10.1038/5075; Edelmann W, 1996, CELL, V85, P1125, DOI 10.1016/S0092-8674(00)81312-4; ENDERS GC, 1994, DEV BIOL, V163, P331, DOI 10.1006/dbio.1994.1152; Gu W, 1998, BIOL REPROD, V59, P1266, DOI 10.1095/biolreprod59.5.1266; MANOVA K, 1991, DEV BIOL, V146, P312, DOI 10.1016/0012-1606(91)90233-S; MATSUI Y, 1990, NATURE, V347, P667, DOI 10.1038/347667a0; Pepling ME, 2001, DEV BIOL, V234, P339, DOI 10.1006/dbio.2001.0269; Pesce M, 1998, MECH DEVELOP, V71, P89, DOI 10.1016/S0925-4773(98)00002-1; Soyal SM, 2000, DEVELOPMENT, V127, P4645; Suzumori N, 2002, MECH DEVELOP, V111, P137, DOI 10.1016/S0925-4773(01)00620-7; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Wu XM, 2003, NAT GENET, V33, P187, DOI 10.1038/ng1079; Yan CN, 2001, MOL ENDOCRINOL, V15, P854, DOI 10.1210/me.15.6.854; Yu JY, 2001, BIOL REPROD, V65, P1260, DOI 10.1095/biolreprod65.4.1260	15	380	413	2	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 20	2004	305	5687					1157	1159		10.1126/science.1099755	http://dx.doi.org/10.1126/science.1099755			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849RD	15326356				2022-12-24	WOS:000223557400049
J	Bouzat, C; Gumilar, F; Spitzmaul, G; Wang, HL; Rayes, D; Hansen, SB; Taylor, P; Sine, SM				Bouzat, C; Gumilar, F; Spitzmaul, G; Wang, HL; Rayes, D; Hansen, SB; Taylor, P; Sine, SM			Coupling of agonist binding to channel gating in an ACh-binding protein linked to an ion channel	NATURE			English	Article							ACETYLCHOLINE-RECEPTOR; LIGAND-BINDING; MOLECULAR DISSECTION; SUBUNIT INTERFACES; IDENTIFICATION; RESIDUES; KINETICS; REVEALS; DOMAIN	Neurotransmitter receptors from the Cys-loop superfamily couple the binding of agonist to the opening of an intrinsic ion pore in the final step in rapid synaptic transmission. Although atomic resolution structural data have recently emerged for individual binding(1) and pore domains(2), how they are linked into a functional unit remains unknown. Here we identify structural requirements for functionally coupling the two domains by combining acetylcholine (ACh)-binding protein, whose structure was determined at atomic resolution(1), with the pore domain from the serotonin type-3A (5-HT3A) receptor. Only when amino-acid sequences of three loops in ACh-binding protein are changed to their 5-HT3A counterparts does ACh bind with low affinity characteristic of activatable receptors, and trigger opening of the ion pore. Thus functional coupling requires structural compatibility at the interface of the binding and pore domains. Structural modelling reveals a network of interacting loops between binding and pore domains that mediates this allosteric coupling process.	Mayo Clin Coll Med, Dept Physiol & Biomed Engn, Receptor Biol Lab, Rochester, MN 55905 USA; Univ Nacl Sur, CONICET, Inst Invest Bioquim, RA-8000 Bahia Blanca, Buenos Aires, Argentina; Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	Mayo Clinic; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the South; University of California System; University of California San Diego	Sine, SM (corresponding author), Mayo Clin Coll Med, Dept Physiol & Biomed Engn, Receptor Biol Lab, Rochester, MN 55905 USA.	sine@mayo.edu	Spitzmaul, Guillermo/AAM-4785-2021; , Diego/AAH-4523-2020	Spitzmaul, Guillermo/0000-0001-5123-8914; Gumilar, Fernanda/0000-0002-7789-2647				Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Changeux JP, 1998, NEURON, V21, P959, DOI 10.1016/S0896-6273(00)80616-9; EISELE JL, 1993, NATURE, V366, P479, DOI 10.1038/366479a0; Gao F, 2003, J BIOL CHEM, V278, P23020, DOI 10.1074/jbc.M301151200; Grosman C, 2000, J GEN PHYSIOL, V116, P327, DOI 10.1085/jgp.116.3.327; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hansen SB, 2002, J BIOL CHEM, V277, P41299, DOI 10.1074/jbc.C200462200; JACKSON MB, 1989, P NATL ACAD SCI USA, V86, P2199, DOI 10.1073/pnas.86.7.2199; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Kelley SP, 2003, NATURE, V424, P321, DOI 10.1038/nature01788; LEE BS, 1991, J BIOL CHEM, V266, P11448; LIU Y, 1991, BIOPHYS J, V60, P424, DOI 10.1016/S0006-3495(91)82068-9; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Prince RJ, 1996, J BIOL CHEM, V271, P25770, DOI 10.1074/jbc.271.42.25770; Quiram PA, 1998, J BIOL CHEM, V273, P11001, DOI 10.1074/jbc.273.18.11001; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; SINE S, 1979, J BIOL CHEM, V254, P3315; SINE SM, 1993, P NATL ACAD SCI USA, V90, P9436, DOI 10.1073/pnas.90.20.9436; Sine SM, 2002, J NEUROBIOL, V53, P431, DOI 10.1002/neu.10139; Sine SM, 2002, J BIOL CHEM, V277, P29210, DOI 10.1074/jbc.M203396200; Spitzmaul G, 2001, MOL PHARMACOL, V60, P235, DOI 10.1124/mol.60.2.235; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; Unwin N, 2002, J MOL BIOL, V319, P1165, DOI 10.1016/S0022-2836(02)00381-9; Wang HL, 1999, NAT NEUROSCI, V2, P226, DOI 10.1038/6326	27	230	234	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2004	430	7002					896	900		10.1038/nature02753	http://dx.doi.org/10.1038/nature02753			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318223				2022-12-24	WOS:000223369800043
J	Perederina, A; Svetlov, V; Vassylyeva, MN; Tahirov, TH; Yokoyama, S; Artsimovitch, I; Vassylyev, DG				Perederina, A; Svetlov, V; Vassylyeva, MN; Tahirov, TH; Yokoyama, S; Artsimovitch, I; Vassylyev, DG			Regulation through the secondary channel-structural framework for ppGpp-DksA synergism during transcription	CELL			English	Article							CLEAVAGE FACTORS GREA; CRYSTAL-STRUCTURE; RIBONUCLEIC-ACID; RNA; ELONGATION; PROTEIN; RPOS; IDENTIFICATION; SUPPRESSORS; MECHANISM	Bacterial transcription is regulated by the alarmone ppGpp, which binds near the catalytic site of RNA polymerase (RNAP) and modulates its activity. We show that the DksA protein is a crucial component of ppGpp-dependent regulation. The 2.0 Angstrom resolution structure of Escherichia coli DksA reveals a globular domain and a coiled coil with two highly conserved Asp residues at its tip that is reminiscent of the transcript cleavage factor GreA. This structural similarity suggests that DksA coiled coil protrudes into the RNAP secondary channel to coordinate a ppGpp bound Mg2+ ion with the Asp residues, thereby stabilizing the ppGpp-RNAP complex. Biochemical analysis demonstrates that DksA affects transcript elongation, albeit differently from GreA; augments ppGpp effects on initiation; and binds directly to RNAP, positioning the Asp residues near the active site. Substitution of these residues eliminates the synergy between DksA and ppGpp. Thus, the secondary channel emerges as a common regulatory entrance for transcription factors.	RIKEN, Harima Inst SPring 8, Cellular Signaling Lab, Sayo, Hyogo 6795148, Japan; RIKEN, Harima Inst SPring 8, Stucturome Res Grp, Sayo, Hyogo 6795148, Japan; RIKEN, Harima Inst SPring 8, High Throughput Factory, Sayo, Hyogo 6795148, Japan; Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; RIKEN, Genom Sci Ctr, Yokohama, Kanagawa 2300045, Japan; Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan	RIKEN; RIKEN; RIKEN; University System of Ohio; Ohio State University; RIKEN; University of Tokyo	Vassylyev, DG (corresponding author), RIKEN, Harima Inst SPring 8, Cellular Signaling Lab, 1-1-1 Kouto,Mikazuki Cho, Sayo, Hyogo 6795148, Japan.	dmitry@yumiyoshi.harima.riken.go.jp	Vassylyev, Dmitry/A-9005-2008; Artsimovitch, Irina/L-3467-2019; Yokoyama, Shigeyuki/N-6911-2015	Yokoyama, Shigeyuki/0000-0003-3133-7338; Tahirov, Tahir/0000-0002-1238-0069				ABOUD M, 1975, J BIOL CHEM, V250, P2189; Artsimovitch I, 2000, J BACTERIOL, V182, P6027, DOI 10.1128/JB.182.21.6027-6035.2000; Artsimovitch I, 2004, CELL, V117, P299, DOI 10.1016/S0092-8674(04)00401-5; Artsimovitch I, 2002, CELL, V109, P193, DOI 10.1016/S0092-8674(02)00724-9; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bass S, 1996, J BACTERIOL, V178, P1154, DOI 10.1128/jb.178.4.1154-1161.1996; BORUKHOV S, 1993, CELL, V72, P459, DOI 10.1016/0092-8674(93)90121-6; Brown L, 2002, J BACTERIOL, V184, P4455, DOI 10.1128/JB.184.16.4455-4465.2002; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHASHEL M, 1969, NATURE, V221, P838, DOI 10.1038/221838a0; Choy HE, 2000, J BIOL CHEM, V275, P6783, DOI 10.1074/jbc.275.10.6783; Cramer P, 2004, CURR OPIN GENET DEV, V14, P218, DOI 10.1016/j.gde.2004.01.003; Fish RN, 2002, BBA-GENE STRUCT EXPR, V1577, P287, DOI 10.1016/S0167-4781(02)00459-1; GALLANT J, 1967, J MOL BIOL, V25, P545, DOI 10.1016/0022-2836(67)90205-7; Hirsch M, 2002, J BACTERIOL, V184, P5077, DOI 10.1128/JB.184.18.5077-5087.2002; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jude F, 2003, J BACTERIOL, V185, P3558, DOI 10.1128/JB.185.12.3558-3566.2003; KANG PJ, 1990, J BACTERIOL, V172, P2055, DOI 10.1128/jb.172.4.2055-2064.1990; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Koulich D, 1997, J BIOL CHEM, V272, P7201, DOI 10.1074/jbc.272.11.7201; Kulish D, 2000, J BIOL CHEM, V275, P12789, DOI 10.1074/jbc.275.17.12789; Laptenko O, 2003, EMBO J, V22, P6322, DOI 10.1093/emboj/cdg610; Lupas A, 1996, METHOD ENZYMOL, V266, P513; Marr MT, 2000, MOL CELL, V6, P1275, DOI 10.1016/S1097-2765(00)00126-X; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mogull SA, 2001, INFECT IMMUN, V69, P5742, DOI 10.1128/IAI.69.9.5742-5751.2001; Mukhopadhyay J, 2004, MOL CELL, V14, P739, DOI 10.1016/j.molcel.2004.06.010; Murphy H, 2003, METHOD ENZYMOL, V371, P596; Ohkubo S, 1997, J BACTERIOL, V179, P2089, DOI 10.1128/jb.179.6.2089-2091.1997; Opalka N, 2003, CELL, V114, P335, DOI 10.1016/S0092-8674(03)00600-7; ORLOVA M, 1995, P NATL ACAD SCI USA, V92, P4596, DOI 10.1073/pnas.92.10.4596; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paul BJ, 2004, CELL, V118, P311, DOI 10.1016/j.cell.2004.07.009; Sosunov V, 2003, EMBO J, V22, P2234, DOI 10.1093/emboj/cdg193; Sosunova E, 2003, P NATL ACAD SCI USA, V100, P15469, DOI 10.1073/pnas.2536698100; STEBBINS CE, 1995, NATURE, V373, P636, DOI 10.1038/373636a0; STEPHENS JC, 1975, P NATL ACAD SCI USA, V72, P4389, DOI 10.1073/pnas.72.11.4389; Takahashi K, 2004, P NATL ACAD SCI USA, V101, P4320, DOI 10.1073/pnas.0308555101; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; VASSYLYEVA MN, 2004, IN PRESS ACTA CRYSTA; Webb C, 1999, MOL MICROBIOL, V34, P112, DOI 10.1046/j.1365-2958.1999.01581.x; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; Yeates TO, 1997, METHOD ENZYMOL, V276, P344, DOI 10.1016/S0076-6879(97)76068-3	43	271	280	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2004	118	3					297	309		10.1016/j.cell.2004.06.030	http://dx.doi.org/10.1016/j.cell.2004.06.030			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846XP	15294156	Bronze			2022-12-24	WOS:000223353100007
J	Kyriacou, DN; Stein, AC; Yarnold, PR; Courtney, DM; Nelson, RR; Noskin, GA; Handler, JA; Frerichs, RR				Kyriacou, DN; Stein, AC; Yarnold, PR; Courtney, DM; Nelson, RR; Noskin, GA; Handler, JA; Frerichs, RR			Clinical predictors of bioterrorism-related inhalational anthrax	LANCET			English	Article							MANAGEMENT	Limitation of a bioterrorist anthrax attack will require rapid and accurate recognition of the earliest victims. To identify clinical characteristics of inhalational anthrax, we compared 47 historical cases (including 11 cases of bioterrorism-related anthrax) with 376 controls with community-acquired pneumonia or influenza-like illness. Nausea, vomiting, pallor or cyanosis, diaphoresis, altered mental status, and raised haematocrit were more frequently recorded in the inhalational anthrax cases than in either the community-acquired pneumonia or influenza-like illness controls. The most accurate predictor of anthrax was mediastinal widening or pleural effusion on a chest radiograph. This finding was 100% sensitive (95% CI 84.6-100.0) for inhalational anthrax, 71.8% specific (64.8-78.1) compared with community-acquired pneumonia, and 95.6% specific (90.0-98.5) compared with influenza-like illness. Our findings represent preliminary efforts toward identifying clinical predictors of inhalational anthrax.	Northwestern Univ, Feinberg Sch Med, Dept Emergency Med, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Div Infect Dis, Chicago, IL 60611 USA; Univ Calif Los Angeles, Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90024 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of California System; University of California Los Angeles	Kyriacou, DN (corresponding author), 259 Erie St,Suite 100, Chicago, IL 60611 USA.	dkyriacou@aol.com		Handler, Jonathan/0000-0002-0304-7539; Yarnold, Paul/0000-0002-1648-739X				Centers for Disease Control and Prevention, 2001, MMWR-MORBID MORTAL W, V50, P984; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P941; Fine MJ, 1999, ARCH INTERN MED, V159, P970, DOI 10.1001/archinte.159.9.970; Hupert N, 2003, ANN INTERN MED, V139, P337, DOI 10.7326/0003-4819-139-5_Part_1-200309020-00009; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Kuehnert MJ, 2003, CLIN INFECT DIS, V36, P328, DOI 10.1086/346035; Swartz MN, 2001, NEW ENGL J MED, V345, P1621, DOI 10.1056/NEJMra012892	7	31	32	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 31	2004	364	9432					449	452		10.1016/S0140-6736(04)16769-X	http://dx.doi.org/10.1016/S0140-6736(04)16769-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	842IX	15288744				2022-12-24	WOS:000222998600036
J	Legname, G; Baskakov, IV; Nguyen, HOB; Riesner, D; Cohen, FE; DeArmond, SJ; Prusiner, SB				Legname, G; Baskakov, IV; Nguyen, HOB; Riesner, D; Cohen, FE; DeArmond, SJ; Prusiner, SB			Synthetic mammalian prions	SCIENCE			English	Article							TRANSGENIC MICE; IN-VITRO; ALZHEIMERS-DISEASE; STRAIN VARIATION; SCRAPIE PRIONS; PROTEIN; CONFORMATION; INFECTIVITY; NEURODEGENERATION; ENCEPHALOPATHY	Recombinant mouse prion protein (recMoPrP) produced in Escherichia coli was polymerized into amyloid fibrils that represent a subset of beta sheet-rich structures. Fibrils consisting of recMoPrP(89-230) were inoculated intracerebrally into transgenic (Tg) mice expressing MoPrP(89-231). The mice developed neurologic dysfunction between 380 and 660 days after inoculation. Brain extracts showed protease-resistant PrP by Western blotting; these extracts transmitted disease to wild-type FVB mice and Tg mice overexpressing PrP, with incubation times of 150 and 90 days, respectively. Neuropathological findings suggest that a novel prion strain was created. Our results provide compelling evidence that prions are infectious proteins.	Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; Univ Dusseldorf, Inst Phys Biol, D-40225 Dusseldorf, Germany	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Heinrich Heine University Dusseldorf	Prusiner, SB (corresponding author), Univ Calif San Francisco, Inst Neurodegenerat Dis, San Francisco, CA 94143 USA.	stanley@itsa.ucsf.edu	Legname, Giuseppe/C-1723-2012	Legname, Giuseppe/0000-0003-0716-4393	NIA NIH HHS [AG021601, AG10770, AG02132] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG002132, P01AG010770, P01AG021601] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; Casalone C, 2004, P NATL ACAD SCI USA, V101, P3065, DOI 10.1073/pnas.0305777101; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; DeArmond SJ, 1997, NEURON, V19, P1337, DOI 10.1016/S0896-6273(00)80424-9; FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0; GAJDUSEK DC, 1993, BRIT MED BULL, V49, P913, DOI 10.1093/oxfordjournals.bmb.a072653; Gambetti P, 1999, NEW ENGL J MED, V340, P1675, DOI 10.1056/NEJM199905273402111; GORODINSKY A, 1995, J CELL BIOL, V129, P619, DOI 10.1083/jcb.129.3.619; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Hill AF, 1999, J GEN VIROL, V80, P11, DOI 10.1099/0022-1317-80-1-11; HSIAO KK, 1994, P NATL ACAD SCI USA, V91, P9126, DOI 10.1073/pnas.91.19.9126; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kaneko K, 2000, J MOL BIOL, V295, P997, DOI 10.1006/jmbi.1999.3386; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; LEGNAME G, UNPUB; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Maddelein ML, 2002, P NATL ACAD SCI USA, V99, P7402, DOI 10.1073/pnas.072199199; Mastrianni JA, 1999, NEW ENGL J MED, V340, P1630, DOI 10.1056/NEJM199905273402104; MCKINLEY MP, 1991, J VIROL, V65, P1340, DOI 10.1128/JVI.65.3.1340-1351.1991; Mehlhorn I, 1996, BIOCHEMISTRY-US, V35, P5528, DOI 10.1021/bi952965e; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Peretz D, 2002, NEURON, V34, P921, DOI 10.1016/S0896-6273(02)00726-2; Peters PJ, 2003, J CELL BIOL, V162, P703, DOI 10.1083/jcb.200304140; Post K, 2000, ARCH VIROL, P265; PRUSINER SB, 1989, ANNU REV MICROBIOL, V43, P345, DOI 10.1146/annurev.mi.43.100189.002021; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; Prusiner Stanley B., 2004, VVolume 41, P187; Prusiner Stanley B., 2004, VVolume 41, P89; Supattapone S, 2001, J VIROL, V75, P1408, DOI 10.1128/JVI.75.3.1408-1413.2001; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; TARABOULOS A, 1990, P NATL ACAD SCI USA, V87, P8262, DOI 10.1073/pnas.87.21.8262; Telling GC, 1996, GENE DEV, V10, P1736, DOI 10.1101/gad.10.14.1736; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Tremblay P, 2004, J VIROL, V78, P2088, DOI 10.1128/JVI.78.4.2088-2099.2004; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Will Robert G., 2004, VVolume 41, P629; Wille H, 1996, J MOL BIOL, V259, P608, DOI 10.1006/jmbi.1996.0343; Wille H, 1999, BIOPHYS J, V76, P1048, DOI 10.1016/S0006-3495(99)77270-X	41	831	855	1	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 30	2004	305	5684					673	676		10.1126/science.1100195	http://dx.doi.org/10.1126/science.1100195			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	842GQ	15286374				2022-12-24	WOS:000222992100050
J	Korzhnev, DM; Salvatella, X; Vendruscolo, M; Di Nardo, AA; Davidson, AR; Dobson, CM; Kay, LE				Korzhnev, DM; Salvatella, X; Vendruscolo, M; Di Nardo, AA; Davidson, AR; Dobson, CM; Kay, LE			Low-populated folding intermediates of Fyn SH3 characterized by relaxation dispersion NMR	NATURE			English	Article							TRANSITION-STATE; PROTEIN; DOMAIN; KINETICS	Many biochemical processes proceed through the formation of functionally significant intermediates(1,2). Although the identification and characterization of such species can provide vital clues about the mechanisms of the reactions involved, it is challenging to obtain information of this type in cases where the intermediates are transient or present only at low population(1-4). One important example of such a situation involves the folding behaviour of small proteins that represents a model for the acquisition of functional structure in biology(1). Here we use relaxation dispersion nuclear magnetic resonance (NMR) spectroscopy to identify, for two mutational variants of one such protein, the SH3 domain from Fyn tyrosine kinase(5), a low-population folding intermediate in equilibrium with its unfolded and fully folded states. By performing the NMR experiments at different temperatures, this approach has enabled characterization of the kinetics and energetics of the folding process as well as providing structures of the intermediates. A general strategy emerges for an experimental determination of the energy landscape of a protein by applying this methodology to a series of mutants whose intermediates have differing degrees of native-like structure.	Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Chem, Toronto, ON M5S 1A8, Canada; Univ Toronto, Prot Engn Network Ctr Excellence, Toronto, ON M5S 1A8, Canada; Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Cambridge	Kay, LE (corresponding author), Univ Toronto, Dept Mol & Med Genet, 100 Coll St, Toronto, ON M5S 1A8, Canada.	cmd44@cam.ac.uk; kay@pound.med.utoronto.ca	Di Nardo, Ariel A/P-4442-2017; Vendruscolo, Michele/F-5901-2012; Salvatella, Xavier/C-7337-2008	Di Nardo, Ariel A/0000-0003-2944-488X; Vendruscolo, Michele/0000-0002-3616-1610; Salvatella, Xavier/0000-0002-8371-4185				BAX A, 1994, CURR OPIN STRUC BIOL, V4, P738, DOI 10.1016/S0959-440X(94)90173-2; Daggett V, 2003, NAT REV MOL CELL BIO, V4, P497, DOI 10.1038/nrm1126; Di Nardo AA, 2004, P NATL ACAD SCI USA, V101, P7954, DOI 10.1073/pnas.0400550101; Dobson CM, 1998, ANGEW CHEM INT EDIT, V37, P868, DOI 10.1002/(SICI)1521-3773(19980420)37:7<868::AID-ANIE868>3.0.CO;2-H; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; DUNITZ JD, 1995, CHEM BIOL, V2, P709, DOI 10.1016/1074-5521(95)90097-7; Fersht A. R., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Grantcharova VP, 2000, P NATL ACAD SCI USA, V97, P7084, DOI 10.1073/pnas.97.13.7084; Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9; KAHN F, 2003, J MOL BIOL, V333, P169; Klein-Seetharaman J, 2002, SCIENCE, V295, P1719, DOI 10.1126/science.1067680; Martinez JC, 1999, NAT STRUCT BIOL, V6, P1010; Maxwell KL, 1998, BIOCHEMISTRY-US, V37, P16172, DOI 10.1021/bi981788p; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; NOBLE MEM, 1993, EMBO J, V12, P2617, DOI 10.1002/j.1460-2075.1993.tb05922.x; Northey JGB, 2002, NAT STRUCT BIOL, V9, P126, DOI 10.1038/nsb748; Northey JGB, 2002, J MOL BIOL, V320, P389, DOI 10.1016/S0022-2836(02)00445-X; OLIVEBERG M, 1995, P NATL ACAD SCI USA, V92, P8926, DOI 10.1073/pnas.92.19.8926; Paci E, 2002, J MOL BIOL, V324, P151, DOI 10.1016/S0022-2836(02)00944-0; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; Plaxco KW, 1998, BIOCHEMISTRY-US, V37, P2529, DOI 10.1021/bi972075u; Press WH, 1988, NUMERICAL RECIPES C; Sanchez IE, 2003, J MOL BIOL, V327, P867, DOI 10.1016/S0022-2836(03)00171-2; Tollinger M, 2001, J AM CHEM SOC, V123, P11341, DOI 10.1021/ja011300z; Vendruscolo M, 2001, NATURE, V409, P641, DOI 10.1038/35054591; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Xu XP, 2002, BIOPOLYMERS, V65, P408, DOI 10.1002/bip.10276	28	390	396	2	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2004	430	6999					586	590		10.1038/nature02655	http://dx.doi.org/10.1038/nature02655			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841QI	15282609				2022-12-24	WOS:000222946100054
J	Mack, MC; Schuur, EAG; Bret-Harte, MS; Shaver, GR; Chapin, FS				Mack, MC; Schuur, EAG; Bret-Harte, MS; Shaver, GR; Chapin, FS			Ecosystem carbon storage in arctic tundra reduced by long-term nutrient fertilization	NATURE			English	Article							LITTER DECOMPOSITION; SOILS; TEMPERATURE; RESPONSES; NITROGEN; CLIMATE; MINERALIZATION; TURNOVER; BALANCE; BIOMASS	Global warming is predicted to be most pronounced at high latitudes, and observational evidence over the past 25 years suggests that this warming is already under way(1). One-third of the global soil carbon pool is stored in northern latitudes(2), so there is considerable interest in understanding how the carbon balance of northern ecosystems will respond to climate warming(3,4). Observations of controls over plant productivity in tundra and boreal ecosystems(5,6) have been used to build a conceptual model of response to warming, where warmer soils and increased decomposition of plant litter increase nutrient availability, which, in turn, stimulates plant production and increases ecosystem carbon storage(6,7). Here we present the results of a long-term fertilization experiment in Alaskan tundra, in which increased nutrient availability caused a net ecosystem loss of almost 2,000 grams of carbon per square meter over 20 years. We found that annual aboveground plant production doubled during the experiment. Losses of carbon and nitrogen from deep soil layers, however, were substantial and more than offset the increased carbon and nitrogen storage in plant biomass and litter. Our study suggests that projected release of soil nutrients associated with high-latitude warming may further amplify carbon release from soils, causing a net loss of ecosystem carbon and a positive feedback to climate warming.	Univ Florida, Dept Bot, Gainesville, FL 32611 USA; Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK 99775 USA; Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA	State University System of Florida; University of Florida; University of Alaska System; University of Alaska Fairbanks; Marine Biological Laboratory - Woods Hole	Mack, MC (corresponding author), Univ Florida, Dept Bot, Gainesville, FL 32611 USA.	mcmack@ufl.edu	Chapin, F Stuart/AAZ-3931-2020	Chapin, F Stuart/0000-0002-2558-9910				Berg Bjorn, 1997, Environmental Reviews, V5, P1, DOI 10.1139/er-5-1-1; Bliss LC, 1992, ARCTIC ECOSYSTEMS CH; Bret-Harte MS, 2002, J ECOL, V90, P251, DOI 10.1046/j.1365-2745.2001.00657.x; CHAPIN FS, 1995, ECOLOGY, V76, P694, DOI 10.2307/1939337; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; GIBLIN AE, 1991, ECOL MONOGR, V61, P415, DOI 10.2307/2937049; GORHAM E, 1991, ECOL APPL, V1, P182, DOI 10.2307/1941811; Goulden ML, 1998, SCIENCE, V279, P214, DOI 10.1126/science.279.5348.214; Hobbie SE, 1998, ECOLOGY, V79, P1526; Hobbie SE, 2004, OECOLOGIA, V140, P113, DOI 10.1007/s00442-004-1556-9; Hobbie SE, 2002, PLANT SOIL, V242, P163, DOI 10.1023/A:1019670731128; Hobbie SE, 1996, ECOL MONOGR, V66, P503, DOI 10.2307/2963492; Hobbie SE, 2000, GLOBAL CHANGE BIOL, V6, P196, DOI 10.1046/j.1365-2486.2000.06021.x; Jonasson S, 1999, ECOLOGY, V80, P1828, DOI 10.1890/0012-9658(1999)080[1828:RIMAPT]2.0.CO;2; Kirschbaum MUF, 2000, BIOGEOCHEMISTRY, V48, P21, DOI 10.1023/A:1006238902976; McKane RB, 1997, ECOLOGY, V78, P1170, DOI 10.1890/0012-9658(1997)078[1170:CEOTCS]2.0.CO;2; Michaelson GJ, 1996, ARCTIC ALPINE RES, V28, P414, DOI 10.2307/1551852; Moore JC, 2003, ECOLOGY, V84, P846, DOI 10.1890/0012-9658(2003)084[0846:TIBDPI]2.0.CO;2; Nadelhoffer KJ, 2002, PLANT SOIL, V242, P107, DOI 10.1023/A:1019646124768; NADELHOFFER KJ, 1991, ECOLOGY, V72, P242, DOI 10.2307/1938918; Neff JC, 2002, NATURE, V419, P915, DOI 10.1038/nature01136; Oechel WC, 2000, NATURE, V406, P978, DOI 10.1038/35023137; Serreze MC, 2000, CLIMATIC CHANGE, V46, P159, DOI 10.1023/A:1005504031923; Shaver GR, 2001, ECOLOGY, V82, P3163, DOI 10.1890/0012-9658(2001)082[3163:SCIWFT]2.0.CO;2; SHAVER GR, 1991, ECOL MONOGR, V61, P1, DOI 10.2307/1942997; SHAVER GR, 1992, BIOSCIENCE, V42, P433, DOI 10.2307/1311862; Sturm M, 2001, NATURE, V411, P546, DOI 10.1038/35079180; *SYSTAT INC, 1997, SYST WIND STAT VERS; VITOUSEK P, 1982, AM NAT, V119, P553, DOI 10.1086/283931; Weintraub MN, 2003, ECOSYSTEMS, V6, P129, DOI 10.1007/s10021-002-0124-6	30	745	802	28	522	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 23	2004	431	7007					440	443		10.1038/nature02887	http://dx.doi.org/10.1038/nature02887			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15386009				2022-12-24	WOS:000224000500037
J	Naser, SA; Ghobrial, G; Romero, C; Valentine, JF				Naser, SA; Ghobrial, G; Romero, C; Valentine, JF			Culture of Mycobacterium avium subspecies paratuberculosis from the blood of patients with Crohn's disease	LANCET			English	Article							POLYMERASE-CHAIN-REACTION; LYMPH-NODES; TISSUE; IDENTIFICATION; MILK; SUSCEPTIBILITY; ASSOCIATION; MUTATION; BACILLI; COWS	Background Crohn's disease, a form of inflammatory bowel disease, resembles some aspects of tuberculosis, leprosy, and paratuberculosis. The role of Mycobacterium avium subspecies paratuberculosis (MAP) in Crohn's disease is controversial. Methods We tested for MAP by PCR and culture in buffy coat preparations from 28 individuals with Crohn's disease, nine with ulcerative colitis, and 15 without inflammatory bowel disease. Findings MAP DNA in uncultured buffy coats was identified by PCR in 13 (46%) individuals with Crohn's disease, four (45%) with ulcerative colitis, and three (20%) without inflammatory bowel disease. Viable MAP was cultured from the blood of 14 (50%) patients with Crohn's disease, two (22%) with ulcerative colitis, and none of the individuals without inflammatory bowel disease. Current use of immunosuppressive medication did not correlate with a positive MAP culture. Sequencing of PCR products from MAP cultures confirmed the presence of the MAP-specific IS900 fragment. Among 11 MAP isolates assessed, we identified nine strains that were not identical. Interpretation We detected viable MAP in peripheral blood in a higher proportion of individuals with Crohn's disease than in controls. These data contribute to the evidence that MAP might be a cause of Crohn's disease.	Univ Cent Florida, Dept Mol Biol & Microbiol, Orlando, FL 32816 USA; Univ Cent Florida, Burnett Coll Biomed Sci, Biomol Sci Ctr, Orlando, FL 32816 USA; Univ Florida, Dept Med, Gainesville, FL USA; Gainesville VAMC, Gainesville, FL USA	State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida; State University System of Florida; University of Florida	Naser, SA (corresponding author), Univ Cent Florida, Dept Mol Biol & Microbiol, Orlando, FL 32816 USA.	nasers@mail.ucf.edu	Valentine, John/L-6631-2019	Valentine, John/0000-0002-1894-9930	NIAID NIH HHS [R01-AI51251-01] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051251] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Bull TJ, 2003, J CLIN MICROBIOL, V41, P2915, DOI 10.1128/JCM.41.7.2915-2923.2003; Chen GI, 2002, CAN J GASTROENTEROL, V16, P29, DOI 10.1155/2002/219187; CHIODINI RJ, 1986, J CLIN MICROBIOL, V24, P357, DOI 10.1128/JCM.24.3.357-363.1986; CHIODINI RJ, 1989, CLIN MICROBIOL REV, V2, P90, DOI 10.1128/CMR.2.1.90-117.1989; Crohn BB, 1932, J AMER MED ASSOC, V99, P1323, DOI 10.1001/jama.1932.02740680019005; DALZEIL TK, 1913, BRIT MED J, V2, P1068; DeFrancesco MA, 1996, EUR J CLIN MICROBIOL, V15, P551, DOI 10.1007/BF01709362; Grant IR, 2002, APPL ENVIRON MICROB, V68, P2428, DOI 10.1128/AEM.68.5.2428-2435.2002; GREEN EP, 1989, NUCLEIC ACIDS RES, V17, P9063, DOI 10.1093/nar/17.22.9063; Greenstein RJ, 2004, LANCET, V364, P396, DOI 10.1016/S0140-6736(04)16781-0; Gwozdz JM, 2000, AUST VET J, V78, P622, DOI 10.1111/j.1751-0813.2000.tb11938.x; HAAGSMA J, 1989, SCAND J GASTROENTERO, V24, pS158; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; HARVEY RF, 1980, LANCET, V1, P514; Hermon-Taylor J, 1998, BRIT MED J, V316, P449, DOI 10.1136/bmj.316.7129.449; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; LISBY G, 1994, SCAND J GASTROENTERO, V29, P923, DOI 10.3109/00365529409094864; MARKESICH DC, 1988, J CLIN MICROBIOL, V26, P1600, DOI 10.1128/JCM.26.8.1600-1603.1988; MCFADDEN JJ, 1987, J CLIN MICROBIOL, V25, P796, DOI 10.1128/JCM.25.5.796-801.1987; Mishina D, 1996, P NATL ACAD SCI USA, V93, P9816, DOI 10.1073/pnas.93.18.9816; Naser SA, 2000, AM J GASTROENTEROL, V95, P1094, DOI 10.1111/j.1572-0241.2000.01954.x; Naser SA, 2002, MOL CELL PROBE, V16, P41, DOI 10.1006/mcpr.2001.0395; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; SANDERSON JD, 1992, GUT, V33, P890, DOI 10.1136/gut.33.7.890; Sands BE, 2004, GASTROENTEROLOGY, V126, P1518, DOI 10.1053/j.gastro.2004.02.072; SAXEGAARD F, 1985, J CLIN MICROBIOL, V22, P312, DOI 10.1128/JCM.22.2.312-313.1985; Schwartz D, 2000, CLIN MICROBIOL INFEC, V6, P303, DOI 10.1046/j.1469-0691.2000.00093.x; Shafran I, 2002, DIGEST LIVER DIS, V34, P22, DOI 10.1016/S1590-8658(02)80055-X; SWEENEY RW, 1992, J CLIN MICROBIOL, V30, P166, DOI 10.1128/JCM.30.1.166-171.1992; Zhang Y, 2004, FRONT BIOSCI-LANDMRK, V9, P1136, DOI 10.2741/1291	31	484	494	0	34	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 18	2004	364	9439					1039	1044		10.1016/S0140-6736(04)17058-X	http://dx.doi.org/10.1016/S0140-6736(04)17058-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	855FT	15380962				2022-12-24	WOS:000223959300022
J	Kim, HJ; Graham, DW; DiSpirito, AA; Alterman, MA; Galeva, N; Larive, CK; Asunskis, D; Sherwood, PMA				Kim, HJ; Graham, DW; DiSpirito, AA; Alterman, MA; Galeva, N; Larive, CK; Asunskis, D; Sherwood, PMA			Methanobactin, a copper-acquisition compound from methane-oxidizing bacteria	SCIENCE			English	Article							METHYLOSINUS-TRICHOSPORIUM OB3B; METHYLOCOCCUS-CAPSULATUS BATH; FORMALDEHYDE DEHYDROGENASE; MONOOXYGENASE ACTIVITY; SIDEROPHORE; EXPRESSION; PROTEIN; IONS	Siderophores are extracellular iron-binding compounds that mediate iron transport into many cells. We present evidence of analogous molecules for copper transport from methane-oxidizing bacteria, represented here by a small fluorescent chromopeptide (C45N12O14H62Cu, 1216 daltons) produced by Methylosinus trichosporium OB3b. The crystal structure of this compound, methanobactin, was resolved to 1.15 angstroms. It is composed of a tetrapeptide, a tripeptide, and several unusual moieties, including two 4-thionyl-5-hydroxy-imidazole chromophores that coordinate the copper, a pyrrolidine that confers a bend in the overall chain, and an amino-terminal isopropylester group. The copper coordination environment includes a dual nitrogen- and sulfur-donating system derived from the thionyl imidazolate moieties. Structural elucidation of this molecule has broad implications in terms of organo-copper chemistry, biological methane oxidation, and global carbon cycling.	Univ Kansas, Dept Civil Environm & Architectural Engn, Lawrence, KS 66045 USA; Univ Kansas, Biochem Res Serv Lab, Lawrence, KS 66045 USA; Univ Kansas, Mass Spectrometry Lab, Lawrence, KS 66045 USA; Univ Kansas, Dept Chem, Lawrence, KS 66045 USA; Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; Kansas State Univ, Dept Chem, Manhattan, KS 66506 USA	University of Kansas; University of Kansas; University of Kansas; University of Kansas; Iowa State University; Kansas State University	Graham, DW (corresponding author), Univ Kansas, Dept Civil Environm & Architectural Engn, Lawrence, KS 66045 USA.	dwgraham@ku.edu	Larive, Cynthia K/E-4640-2012	Sherwood, Peter/0000-0001-6487-0724; Graham, David W/0000-0002-9753-496X; Larive, Cynthia/0000-0003-3458-0771				BERSON O, 1998, ENVIRON SCI TECHNOL, V30, P802; Brantner CA, 1997, CAN J MICROBIOL, V43, P672, DOI 10.1139/m97-095; Bruckner C, 2000, INORG CHEM, V39, P6100, DOI 10.1021/ic0004636; Choi DW, 2003, J BACTERIOL, V185, P5755, DOI 10.1128/JB.185.19.5755-5764.2003; Claycomb GD, 2002, J VAC SCI TECHNOL A, V20, P1230, DOI 10.1116/1.1479357; Dalton H, 1984, MICROBIAL GROWTH C C, P1; DEMANGE P, 1988, BIOCHEMISTRY-US, V27, P2745, DOI 10.1021/bi00408a014; DEMANGE P, 1990, BIOCHEMISTRY-US, V29, P11041, DOI 10.1021/bi00502a005; DiSpirito AA, 1998, J BACTERIOL, V180, P3606, DOI 10.1128/JB.180.14.3606-3613.1998; DISPIRITO AA, 2004, Patent No. 60434873; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; FITCH MW, 1993, APPL ENVIRON MICROB, V59, P2771, DOI 10.1128/AEM.59.9.2771-2776.1993; Grabarse WG, 2000, J MOL BIOL, V303, P329, DOI 10.1006/jmbi.2000.4136; Huffman DL, 2001, ANNU REV BIOCHEM, V70, P677, DOI 10.1146/annurev.biochem.70.1.677; Karlsen OA, 2003, APPL ENVIRON MICROB, V69, P2386, DOI 10.1128/AEM.69.4.2386-2388.2003; Kim H.-J., UNPUB; Kim HJ, 2001, FEMS MICROBIOL LETT, V201, P133, DOI 10.1016/S0378-1097(01)00257-9; KIM HJ, 2003, THESIS U KANSAS; KNOSP O, 1984, J BACTERIOL, V159, P341, DOI 10.1128/JB.159.1.341-347.1984; Lontoh S, 1998, APPL ENVIRON MICROB, V64, P1106; NGUYEN HHT, 1994, J BIOL CHEM, V269, P14995; PELTOLA P, 1993, ARCH MICROBIOL, V159, P521, DOI 10.1007/BF00249029; PRIOR SD, 1985, J GEN MICROBIOL, V131, P155; Puig S, 2002, STRUCTURE, V10, P1292, DOI 10.1016/S0969-2126(02)00863-8; Rensing C, 2003, FEMS MICROBIOL REV, V27, P197, DOI 10.1016/S0168-6445(03)00049-4; Rosenzweig AC, 2002, CHEM BIOL, V9, P673, DOI 10.1016/S1074-5521(02)00156-4; Selmer T, 2000, J BIOL CHEM, V275, P3755, DOI 10.1074/jbc.275.6.3755; Sheldrick G. M., 1994, SHELXTL VERSION 5 RE; Stafford GP, 2003, MICROBIOL-SGM, V149, P1771, DOI 10.1099/mic.0.26060-0; Tate S, 1999, MICROBIOL-UK, V145, P159, DOI 10.1099/13500872-145-1-159; Tellez CM, 1998, APPL ENVIRON MICROB, V64, P1115; Vorholt JA, 1999, J BACTERIOL, V181, P5750, DOI 10.1128/JB.181.18.5750-5757.1999; Zahn JA, 1996, J BACTERIOL, V178, P1018, DOI 10.1128/jb.178.4.1018-1029.1996; Zahn JA, 2001, J BACTERIOL, V183, P6832, DOI 10.1128/JB.183.23.6832-6840.2001	34	246	261	3	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2004	305	5690					1612	1615		10.1126/science.1098322	http://dx.doi.org/10.1126/science.1098322			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	854GV	15361623				2022-12-24	WOS:000223891200041
J	Rivera, MC; Lake, JA				Rivera, MC; Lake, JA			The ring of life provides evidence for a genome fusion origin of eukaryotes	NATURE			English	Article							EVOLUTIONARY TREES; GENE-TRANSFER; PHYLOGENY; SEQUENCES; ARCHAEA; ARCHAEBACTERIA; NUCLEUS; RECONSTRUCTION; PROKARYOTES; EUBACTERIA	Genomes hold within them the record of the evolution of life on Earth. But genome fusions and horizontal gene transfer seem to have obscured sufficiently the gene sequence record such that it is difficult to reconstruct the phylogenetic tree of life. Here we determine the general outline of the tree using complete genome data from representative prokaryotes and eukaryotes and a new genome analysis method that makes it possible to reconstruct ancient genome fusions and phylogenetic trees. Our analyses indicate that the eukaryotic genome resulted from a fusion of two diverse prokaryotic genomes, and therefore at the deepest levels linking prokaryotes and eukaryotes, the tree of life is actually a ring of life. One fusion partner branches from deep within an ancient photosynthetic clade, and the other is related to the archaeal prokaryotes. The eubacterial organism is either a proteobacterium, or a member of a larger photosynthetic clade that includes the Cyanobacteria and the Proteobacteria.	Univ Calif Los Angeles, MCD Biol, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, IGPP, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Astrobiol Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Lake, JA (corresponding author), Univ Calif Los Angeles, MCD Biol, Inst Mol Biol, Los Angeles, CA 90095 USA.	lake@mbi.ucla.edu	Rivera, Maria/GYU-2150-2022					Adams KL, 2000, NATURE, V408, P354, DOI 10.1038/35042567; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Brochier C, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r17; Brown JR, 1997, MICROBIOL MOL BIOL R, V61, P456, DOI 10.1128/.61.4.456-502.1997; Campbell AM, 2000, THEOR POPUL BIOL, V57, P71, DOI 10.1006/tpbi.2000.1454; COLLURA RV, 1995, NATURE, V378, P485, DOI 10.1038/378485a0; Daubin V, 2002, GENOME RES, V12, P1080, DOI 10.1101/gr.187002; Dayhoff MO, 1978, ATLAS PROTEIN SEQUEN, V5; DICKERSON RE, 1980, DIFFRACTION RELATED, P227; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; ESSER C, 2004, MOL BIOL EVOL; Feng DF, 1997, P NATL ACAD SCI USA, V94, P13028, DOI 10.1073/pnas.94.24.13028; Fitz-Gibbon ST, 1999, NUCLEIC ACIDS RES, V27, P4218, DOI 10.1093/nar/27.21.4218; Gabaldon T, 2003, SCIENCE, V301, P609, DOI 10.1126/science.1085463; Galtier N, 1999, SCIENCE, V283, P220, DOI 10.1126/science.283.5399.220; Gogarten JP, 1997, ASM NEWS, V63, P404; GOGARTEN JP, 1989, P NATL ACAD SCI USA, V86, P6661, DOI 10.1073/pnas.86.17.6661; Gray MW, 1999, CURR OPIN GENET DEV, V9, P678, DOI 10.1016/S0959-437X(99)00030-1; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Gupta RS, 1998, MICROBIOL MOL BIOL R, V62, P1435, DOI 10.1128/MMBR.62.4.1435-1491.1998; GUPTA RS, 1994, P NATL ACAD SCI USA, V91, P2895, DOI 10.1073/pnas.91.8.2895; Horiike T, 2001, NAT CELL BIOL, V3, P210, DOI 10.1038/35055129; IWABE N, 1989, P NATL ACAD SCI USA, V86, P9355, DOI 10.1073/pnas.86.23.9355; Karlin S, 1997, J BACTERIOL, V179, P3899, DOI 10.1128/jb.179.12.3899-3913.1997; LAKE JA, 1988, NATURE, V331, P184, DOI 10.1038/331184a0; LAKE JA, 1995, P NATL ACAD SCI USA, V92, P9662, DOI 10.1073/pnas.92.21.9662; Lake JA, 1998, MOL BIOL EVOL, V15, P1224, DOI 10.1093/oxfordjournals.molbev.a026030; LAKE JA, 1982, P NATL ACAD SCI-BIOL, V79, P5948, DOI 10.1073/pnas.79.19.5948; LAKE JA, 1994, P NATL ACAD SCI USA, V91, P1455, DOI 10.1073/pnas.91.4.1455; Lake JA, 2004, MOL BIOL EVOL, V21, P681, DOI 10.1093/molbev/msh061; LAKE JA, 1994, P NATL ACAD SCI USA, V91, P2880, DOI 10.1073/pnas.91.8.2880; LAKE JA, 1974, RIBOSOMES, P543; LOCKHART PJ, 1994, MOL BIOL EVOL, V11, P605; Margulis L, 1970, ORIGIN EUKARYOTIC CE; Martin W, 1996, PLANT MOL BIOL, V32, P485, DOI 10.1007/BF00019100; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; Montague MG, 2000, P NATL ACAD SCI USA, V97, P5334, DOI 10.1073/pnas.97.10.5334; Moreira D, 1998, J MOL EVOL, V47, P517, DOI 10.1007/PL00006408; Ochman H, 2000, EMBO J, V19, P6637, DOI 10.1093/emboj/19.24.6637; PACE NR, 1986, CELL, V45, P325, DOI 10.1016/0092-8674(86)90315-6; Rivera MC, 1998, P NATL ACAD SCI USA, V95, P6239, DOI 10.1073/pnas.95.11.6239; RIVERA MC, 1992, SCIENCE, V257, P74, DOI 10.1126/science.1621096; Snel B, 1999, NAT GENET, V21, P108, DOI 10.1038/5052; Tekaia F, 1999, GENOME RES, V9, P550; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; WOESE CR, 1981, SCI AM, V244, P98, DOI 10.1038/scientificamerican0681-98; Wolf YI, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-8; ZISCHLER H, 1995, NATURE, V378, P489, DOI 10.1038/378489a0	49	329	356	1	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 9	2004	431	7005					152	155		10.1038/nature02848	http://dx.doi.org/10.1038/nature02848			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HI	15356622				2022-12-24	WOS:000223746000035
J	True, HL; Berlin, I; Lindquist, SL				True, HL; Berlin, I; Lindquist, SL			Epigenetic regulation of translation reveals hidden genetic variation to produce complex traits	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; YEAST PRION; PHENOTYPIC PLASTICITY; TERMINATION CODONS; SPECIES BARRIER; SUP35 PROTEIN; EVOLUTION; READTHROUGH; MECHANISM; CAPACITOR	Phenotypic plasticity and the exposure of hidden genetic variation both affect the survival and evolution of new traits(1-3), but their contributing molecular mechanisms are largely unknown. A single factor, the yeast prion [PSI+], may exert a profound effect on both(4). [PSI+] is a conserved, protein-based genetic element that is formed by a change in the conformation and function of the translation termination factor Sup35p(5), and is transmitted from mother to progeny. Curing cells of [PSI+] alters their survival in different growth conditions and produces a spectrum of phenotypes in different genetic backgrounds(4). Here we show, by examining three plausible explanations for this phenotypic diversity, that all traits tested involved [PSI+]-mediated read-through of nonsense codons. Notably, the phenotypes analysed were genetically complex, and genetic re-assortment frequently converted [PSI+]-dependent phenotypes to stable traits that persisted in the absence of [PSI+]. Thus, [PSI+] provides a temporary survival advantage under diverse conditions, increasing the likelihood that new traits will become fixed by subsequent genetic change. As an epigenetic mechanism that globally affects the relationship between genotype and phenotype, [PSI+] expands the conceptual framework for phenotypic plasticity, provides a one-step mechanism for the acquisition of complex traits and affords a route to the genetic assimilation of initially transient epigenetic traits.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute	Lindquist, SL (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lindquist_admin@wi.mit.edu	True, Heather/D-2979-2012					Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Behera N, 2004, J THEOR BIOL, V226, P177, DOI 10.1016/j.jtbi.2003.08.011; Bradley ME, 2003, YEAST, V20, P625, DOI 10.1002/yea.985; Chernoff YO, 2000, MOL MICROBIOL, V35, P865, DOI 10.1046/j.1365-2958.2000.01761.x; Chernoff YO, 1996, P NATL ACAD SCI USA, V93, P2517, DOI 10.1073/pnas.93.6.2517; DePace AH, 1998, CELL, V93, P1241, DOI 10.1016/S0092-8674(00)81467-1; Eaglestone SS, 1999, EMBO J, V18, P1974, DOI 10.1093/emboj/18.7.1974; FIROOZAN M, 1991, YEAST, V7, P173, DOI 10.1002/yea.320070211; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Guthrie C, 1991, GUIDE YEAST GENETICS; Harrison P, 2002, J MOL BIOL, V316, P409, DOI 10.1006/jmbi.2001.5343; Harrison PM, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-r40; Kushnirov VV, 2000, EMBO J, V19, P324, DOI 10.1093/emboj/19.3.324; LEEDS P, 1991, GENE DEV, V5, P2303, DOI 10.1101/gad.5.12a.2303; Liu JJ, 1999, NATURE, V400, P573, DOI 10.1038/23048; LUND PM, 1981, GENET RES, V37, P173, DOI 10.1017/S0016672300020140; Masel J, 2003, EVOLUTION, V57, P1498; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Nakayashiki T, 2001, MOL CELL, V7, P1121, DOI 10.1016/S1097-2765(01)00259-3; Namy O, 2003, NUCLEIC ACIDS RES, V31, P2289, DOI 10.1093/nar/gkg330; Namy O, 2002, MOL MICROBIOL, V43, P641, DOI 10.1046/j.1365-2958.2002.02770.x; Pigliucci M, 2003, EVOLUTION, V57, P1455; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Santoso A, 2000, CELL, V100, P277, DOI 10.1016/S0092-8674(00)81565-2; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; TERAVANESYAN MD, 1993, MOL MICROBIOL, V7, P683, DOI 10.1111/j.1365-2958.1993.tb01159.x; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; Uptain SM, 2002, ANNU REV MICROBIOL, V56, P703, DOI 10.1146/annurev.micro.56.013002.100603	30	262	280	0	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 9	2004	431	7005					184	187		10.1038/nature02885	http://dx.doi.org/10.1038/nature02885			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HI	15311209				2022-12-24	WOS:000223746000044
J	Gilbert, N; Boyle, S; Fiegler, H; Woodfine, K; Carter, NP; Bickmore, WA				Gilbert, N; Boyle, S; Fiegler, H; Woodfine, K; Carter, NP; Bickmore, WA			Chromatin architecture of the human genome: Gene-rich domains are enriched in open chromatin fibers	CELL			English	Article							HIGHER-ORDER STRUCTURE; HUMAN TRANSCRIPTOME MAP; BETA-GLOBIN GENE; INTERPHASE NUCLEI; EXPRESSED GENES; ACTIVE GENES; CHROMOSOMES; HYBRIDIZATION; LOCALIZATION; SEQUENCE	We present an analysis of chromatin fiber structure across the human genome. Compact and open chromatin fiber structures were separated by sucrose sedimentation and their distributions analyzed by hybridization to metaphase chromosomes and genomic microarrays. We show that compact chromatin fibers originate from some sites of heterochromatin (C-bands), and G-bands (euchromatin). Open chromatin fibers correlate with regions of highest gene density, but not with gene expression since inactive genes can be in domains of open chromatin, and active genes in regions of low gene density can be embedded in compact chromatin fibers. Moreover, we show that chromatin fiber structure impacts on further levels of chromatin condensation. Regions of open chromatin fibers are cytologically decondensed and have a distinctive nuclear organization. We suggest that domains of open chromatin may create an environment that facilitates transcriptional activation and could provide an evolutionary constraint to maintain clusters of genes together along chromosomes.	MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	University of Edinburgh; Wellcome Trust Sanger Institute	Bickmore, WA (corresponding author), MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland.	w.bickmore@hgu.mrc.ac.uk	Bickmore, Wendy A/C-7314-2013	Bickmore, Wendy A/0000-0001-6660-7735; Gilbert, Nick/0000-0003-0505-6081				BELLARD M, 1977, COLD SPRING HARB SYM, V42, P779, DOI 10.1101/SQB.1978.042.01.078; BELMONT AS, 1994, J CELL BIOL, V127, P287, DOI 10.1083/jcb.127.2.287; CAPLAN A, 1987, J MOL BIOL, V193, P57, DOI 10.1016/0022-2836(87)90626-7; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; CRAIG JM, 1994, NAT GENET, V7, P376, DOI 10.1038/ng0794-376; Croft JA, 1999, J CELL BIOL, V145, P1119, DOI 10.1083/jcb.145.6.1119; Fan JY, 2002, NAT STRUCT BIOL, V9, P172, DOI 10.1038/nsb767; FANTES J, 1995, HUM MOL GENET, V4, P415, DOI 10.1093/hmg/4.3.415; FANTES JA, 1992, AM J HUM GENET, V51, P1286; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Fiegler H, 2003, GENE CHROMOSOME CANC, V36, P361, DOI 10.1002/gcc.10155; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; FISHER EA, 1986, BIOCHEMISTRY-US, V25, P8010, DOI 10.1021/bi00372a033; Furey TS, 2003, HUM MOL GENET, V12, P1037, DOI 10.1093/hmg/ddg113; Ghirlando R, 2004, J MOL BIOL, V336, P597, DOI 10.1016/j.jmb.2003.12.049; Gilbert N, 2003, EMBO J, V22, P5540, DOI 10.1093/emboj/cdg520; Gilbert N, 2001, P NATL ACAD SCI USA, V98, P11949, DOI 10.1073/pnas.211322798; GREULICH KO, 1987, J MOL BIOL, V193, P709, DOI 10.1016/0022-2836(87)90353-6; HOLMQUIST GP, 1992, AM J HUM GENET, V51, P17; Jain AN, 2002, GENOME RES, V12, P325, DOI 10.1101/gr.210902; Jolly C, 2004, J CELL BIOL, V164, P25, DOI 10.1083/jcb.200306104; Kim Y, 2002, P NATL ACAD SCI USA, V99, P15381, DOI 10.1073/pnas.242536699; KIMURA T, 1983, NATURE, V306, P709, DOI 10.1038/306709a0; LANGMORE JP, 1983, J CELL BIOL, V96, P1120, DOI 10.1083/jcb.96.4.1120; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; Mahy NL, 2002, J CELL BIOL, V159, P753, DOI 10.1083/jcb.200207115; MCGHEE JD, 1983, CELL, V33, P831, DOI 10.1016/0092-8674(83)90025-9; McKittrick E, 2004, P NATL ACAD SCI USA, V101, P1525, DOI 10.1073/pnas.0308092100; Muller WG, 2001, J CELL BIOL, V154, P33, DOI 10.1083/jcb.200011069; NOLL H, 1989, METHOD ENZYMOL, V170, P55; Nye AC, 2002, MOL CELL BIOL, V22, P3437, DOI 10.1128/MCB.22.10.3437-3449.2002; Rizzi N, 2004, MOL BIOL CELL, V15, P543, DOI 10.1091/mbc.E03-07-0487; SACCONE S, 1993, P NATL ACAD SCI USA, V90, P11929, DOI 10.1073/pnas.90.24.11929; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Shaw-Smith C, 2004, J MED GENET, V41, P241, DOI 10.1136/jmg.2003.017731; Shiels C, 1997, GENOMICS, V44, P35, DOI 10.1006/geno.1997.4817; Sun FL, 2001, MOL CELL BIOL, V21, P2867, DOI 10.1128/MCB.21.8.2867-2879.2001; TAGARRO I, 1994, HUM GENET, V93, P383; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; Tsukamoto T, 2000, NAT CELL BIOL, V2, P871, DOI 10.1038/35046510; Tumbar T, 1999, J CELL BIOL, V145, P1341, DOI 10.1083/jcb.145.7.1341; VANDENENGH G, 1992, SCIENCE, V257, P1410, DOI 10.1126/science.1388286; vanHolde K, 1996, P NATL ACAD SCI USA, V93, P10548, DOI 10.1073/pnas.93.20.10548; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vermaak D, 2003, CURR OPIN CELL BIOL, V15, P266, DOI 10.1016/S0955-0674(03)00043-7; Versteeg R, 2003, GENOME RES, V13, P1998, DOI 10.1101/gr.1649303; Volpi EV, 2000, J CELL SCI, V113, P1565; WEINTRAUB H, 1976, SCIENCE, V193, P848, DOI 10.1126/science.948749; Wolffe AP., 1998, CHROMATIN STRUCTURE; WOODCOCK CLF, 1984, J CELL BIOL, V99, P42, DOI 10.1083/jcb.99.1.42; Woodfine K, 2004, HUM MOL GENET, V13, P191, DOI 10.1093/hmg/ddh016; Ye QN, 2001, J CELL BIOL, V155, P911, DOI 10.1083/jcb.200108049; Yokota H, 1997, CHROMOSOME RES, V5, P157, DOI 10.1023/A:1018438729203	54	372	383	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 3	2004	118	5					555	566		10.1016/j.cell.2004.08.011	http://dx.doi.org/10.1016/j.cell.2004.08.011			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852BN	15339661	Bronze			2022-12-24	WOS:000223730300007
J	Cowan, CR; Hyman, AA				Cowan, CR; Hyman, AA			Centrosomes direct cell polarity independently of microtubule assembly in C-elegans embryos	NATURE			English	Article							CAENORHABDITIS-ELEGANS; ANTEROPOSTERIOR AXIS; PROTEIN SPD-2; GAMMA-TUBULIN; SPINDLE; POLARIZATION; MATURATION; ESTABLISHMENT; DUPLICATION; DOMAINS	Polarity establishment requires a symmetry-breaking event, resulting in an axis along which determinants are segregated. In Caenorhabditis elegans, oocytes are apolar and are triggered to polarize rapidly along one axis after fertilization. The establishment of this first polarity axis is revealed by the asymmetric distribution of PAR proteins and cortical activity in the one-celled embryo. Current evidence suggests that the centrosome pronucleus complex contributed by the sperm is involved in defining the polarization axis(1-6). Here we directly assess the contribution of the centrosome to polarity establishment by laser ablating the centrosome before and during polarization. We find that the centrosome is required to initiate polarity but not to maintain it. Initiation of polarity coincides with the proximity of the centrosome to the cortex and the assembly of pericentriolar material on the immature sperm centrosome. Depletion of microtubules or the microtubule nucleator gamma-tubulin did not affect polarity establishment. These results demonstrate that the centrosome provides an initiating signal that polarizes C. elegans embryos and indicate that this signalling event might be independent of the role of the centrosome as a microtubule nucleator.	Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Cowan, CR (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	cowan@mpi-cbg.de	Hyman, Anthony A/B-3917-2017; Hyman, Tony/F-1923-2011	Hyman, Anthony A/0000-0003-3664-154X; Cowan, Carrie/0000-0002-2867-1733				ALBERTSON DG, 1984, DEV BIOL, V101, P61, DOI 10.1016/0012-1606(84)90117-9; Berdnik D, 2002, CURR BIOL, V12, P640, DOI 10.1016/S0960-9822(02)00766-2; Boyd L, 1996, DEVELOPMENT, V122, P3075; Cuenca AA, 2003, DEVELOPMENT, V130, P1255, DOI 10.1242/dev.00284; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Goldstein B, 1996, DEVELOPMENT, V122, P1467; Gonczy P, 1999, J CELL BIOL, V144, P927, DOI 10.1083/jcb.144.5.927; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Hamill DR, 2002, DEV CELL, V3, P673, DOI 10.1016/S1534-5807(02)00327-1; Hannak E, 2002, J CELL BIOL, V157, P591, DOI 10.1083/jcb.200202047; Hung TJ, 1999, DEVELOPMENT, V126, P127; Kemp CA, 2004, DEV CELL, V6, P511, DOI 10.1016/S1534-5807(04)00066-8; Kirkham M, 2003, CELL, V112, P575, DOI 10.1016/S0092-8674(03)00117-X; O'Connell KF, 2000, DEV BIOL, V222, P55, DOI 10.1006/dbio.2000.9714; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; Pelletier L, 2004, CURR BIOL, V14, P863, DOI 10.1016/j.cub.2004.04.012; Pichler S, 2000, DEVELOPMENT, V127, P2063; Piel M, 2001, SCIENCE, V291, P1550, DOI 10.1126/science.1057330; Praitis V, 2001, GENETICS, V157, P1217; Sadler PL, 2000, DEVELOPMENT, V127, P355; Stevenson VA, 2001, NAT CELL BIOL, V3, P68, DOI 10.1038/35050579; Strome S, 2001, MOL BIOL CELL, V12, P1751, DOI 10.1091/mbc.12.6.1751; Wallenfang MR, 2000, NATURE, V408, P89, DOI 10.1038/35040562	24	162	168	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 2	2004	431	7004					92	96		10.1038/nature02825	http://dx.doi.org/10.1038/nature02825			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850VC	15343338				2022-12-24	WOS:000223641500048
J	Holman, H				Holman, H			Chronic disease - The need for a new clinical education	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SELF-MANAGEMENT; CHRONIC ILLNESS; REGIONAL-VARIATIONS; CARE; OUTCOMES		Stanford Univ, Sch Med, Palo Alto, CA 94304 USA	Stanford University	Holman, H (corresponding author), Stanford Univ, Sch Med, 1000 Welch Rd,Suite 203, Palo Alto, CA 94304 USA.	Holman@stanford.edu						Adams K, 2003, PRIOR AR NAT ACT TRA; *AM HEALTHW, 2004, DEF PAT PHYS REL 21; Ashton CM, 2003, NEW ENGL J MED, V349, P1637, DOI 10.1056/NEJMsa003299; Beck A, 1997, J AM GERIATR SOC, V45, P543, DOI 10.1111/j.1532-5415.1997.tb03085.x; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909; CHRISTAKIS NA, 1995, JAMA-J AM MED ASSOC, V274, P706, DOI 10.1001/jama.274.9.706; Cuff N., 2004, IMPROVING MEDICAL ED; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Gerteis M., 1993, PATIENTS EYES UNDERS; Glasgow Russell E, 2003, Jt Comm J Qual Saf, V29, P563; GREENFIELD S, 1985, ANN INTERN MED, V102, P520, DOI 10.7326/0003-4819-102-4-520; Institute of Medicine, 2001, CROSSING QUALITY CHA; Institute of Medicine, 2003, HLTH PROF ED BRIDG Q; Kaplan SH, 1996, ANN INTERN MED, V124, P497, DOI 10.7326/0003-4819-124-5-199603010-00007; Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01; LORIG KR, 1993, ARTHRITIS RHEUM, V36, P439, DOI 10.1002/art.1780360403; Ludmerer K., 1999, TIME HEAL AM MED ED; PAWLSON LG, 1994, JOINT COMM J QUAL IM, V20, P33, DOI 10.1016/S1070-3241(16)30051-7; Pham HH, 2004, ACAD MED, V79, P32, DOI 10.1097/00001888-200401000-00009; Scott J, 1998, GERIATRICS, V53, P68; Starr P, 1982, SOCIAL TRANSFORMATIO; Stewart M, 2000, J FAM PRACTICE, V49, P796; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64; WASSON J, 1992, JAMA-J AM MED ASSOC, V267, P1788, DOI 10.1001/jama.267.13.1788	26	99	101	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 1	2004	292	9					1057	1059		10.1001/jama.292.9.1057	http://dx.doi.org/10.1001/jama.292.9.1057			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	849VH	15339897				2022-12-24	WOS:000223568700019
J	Dietzschold, B; Koprowski, H				Dietzschold, B; Koprowski, H			Rabies transmission from organ transplants in the USA	LANCET			English	Editorial Material							BAT RABIES		Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA	Jefferson University	Dietzschold, B (corresponding author), Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA.	b_dietzschold@mail.jci.tju.edu						*CDCP, 2004, MMWR-MORBID MORTAL W, V53, P586; Dietzschold B, 2000, J HUMAN VIROL, V3, P50; Morimoto K, 1996, P NATL ACAD SCI USA, V93, P5653, DOI 10.1073/pnas.93.11.5653; MURPHY FA, 1973, LAB INVEST, V28, P361; RAY NB, 1995, J VIROL, V69, P764, DOI 10.1128/JVI.69.2.764-772.1995; RUPPRECHT CE, 1995, EMERG INFECT DIS, V1, P107, DOI 10.3201/eid0104.950401; WARRELL MJ, 1995, LANCET, V346, P65, DOI 10.1016/S0140-6736(95)92106-0	7	25	27	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 21	2004	364	9435					648	649		10.1016/S0140-6736(04)16912-2	http://dx.doi.org/10.1016/S0140-6736(04)16912-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	847WO	15325815				2022-12-24	WOS:000223428900009
J	Steinbrook, R				Steinbrook, R			After Bangkok - Expanding the global response to AIDS	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Joint United Nations Program on HIV/AIDS, 2004, 2004 REP GLOB AIDS E; *US AID UNAIDS WHO, 2004, COV SEL SERV HIV AID; *WHO, 2004, WHO HIV AIDS PLAN JA; *WHO, 2004, 3 5 PROGR REP DEC 20	4	8	8	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 19	2004	351	8					738	+		10.1056/NEJMp048186	http://dx.doi.org/10.1056/NEJMp048186			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	847CY	15317883				2022-12-24	WOS:000223367900002
J	Kuper, J; Llamas, A; Hecht, HJ; Mendel, RR; Schwarz, G				Kuper, J; Llamas, A; Hecht, HJ; Mendel, RR; Schwarz, G			Structure of the molybdopterin-bound Cnx1G domain links molybdenum and copper metabolism	NATURE			English	Article							ESCHERICHIA-COLI MOEA; CRYSTAL-STRUCTURE; SULFITE OXIDASE; NITRATE REDUCTASE; SULFUR METABOLISM; MOLECULAR-BASIS; PROTEIN; COFACTOR; INSIGHTS; ENZYMES	The molybdenum cofactor is part of the active site of all molybdenum-dependent enzymes(1), except nitrogenase. The molybdenum cofactor consists of molybdopterin, a phosphorylated pyranopterin(2), with an ene-dithiolate coordinating molybdenum. The same pyranopterin-based cofactor is involved in metal coordination of the homologous tungsten-containing enzymes found in archea(3). The molybdenum cofactor is synthesized by a highly conserved biosynthetic pathway(4). In plants, the multidomain protein Cnx1 catalyses the insertion of molybdenum into molybdopterin. The Cnx1 G domain (Cnx1G), whose crystal structure has been determined in its apo form, binds molybdopterin with high affinity and participates in the catalysis of molybdenum insertion. Here we present two high-resolution crystal structures of Cnx1G in complex with molybdopterin and with adenylated molybdopterin ( molybdopterin - AMP), a mechanistically important intermediate. Molybdopterin - AMP is the reaction product of Cnx1G and is subsequently processed in a magnesium-dependent reaction by the amino-terminal E domain of Cnx1 to yield active molybdenum cofactor. The unexpected identification of copper bound to the molybdopterin dithiolate sulphurs in both structures, coupled with the observed copper inhibition of Cnx1G activity, provides a molecular link between molybdenum and copper metabolism.	Tech Univ Carolo Wilhelmina Braunschweig, Dept Plant Biol, D-38106 Braunschweig, Germany; German Res Ctr Biotechnol, D-38124 Braunschweig, Germany	Braunschweig University of Technology; Helmholtz Association; Helmholtz-Center for Infection Research	Schwarz, G (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Dept Plant Biol, Spielmannstr 7, D-38106 Braunschweig, Germany.	g.schwarz@tu-bs.de	Schwarz, Guenter/ABE-9643-2021; Llamas, Angel/B-7104-2015; Llamas, Angel/L-1638-2014	Schwarz, Guenter/0000-0002-2118-9338; Llamas, Angel/0000-0001-6042-9472; Llamas, Angel/0000-0001-6042-9472				Bertero MG, 2003, NAT STRUCT BIOL, V10, P681, DOI 10.1038/nsb969; CHAN MK, 1995, SCIENCE, V267, P1463, DOI 10.1126/science.7878465; Enemark JH, 2002, MET IONS BIOL SYST, V39, P621; Guse A, 2003, J BIOL CHEM, V278, P25302, DOI 10.1074/jbc.M302639200; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; JOHNSON JL, 1980, P NATL ACAD SCI-BIOL, V77, P3715, DOI 10.1073/pnas.77.6.3715; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kisker C, 1997, CELL, V91, P973, DOI 10.1016/S0092-8674(00)80488-2; Kuper J, 2000, P NATL ACAD SCI USA, V97, P6475, DOI 10.1073/pnas.110568497; Kuper J, 2003, ARCH BIOCHEM BIOPHYS, V411, P36, DOI 10.1016/S0003-9861(02)00714-2; Kuper J, 2003, FEMS MICROBIOL LETT, V218, P187, DOI 10.1016/S0378-1097(02)01121-7; Lake MW, 2001, NATURE, V414, P325, DOI 10.1038/35104586; MASON J, 1986, TOXICOLOGY, V42, P99, DOI 10.1016/0300-483X(86)90001-6; Mendel RR, 1999, CRIT REV PLANT SCI, V18, P33, DOI 10.1016/S0735-2689(99)00386-X; Mendel RR, 2002, MET IONS BIOL SYST, V39, P317; Mercer JFB, 2001, TRENDS MOL MED, V7, P64, DOI 10.1016/S1471-4914(01)01920-7; Moorhead GBG, 2003, EUR J BIOCHEM, V270, P1356, DOI 10.1046/j.1432-1033.2003.03509.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NASON A, 1971, P NATL ACAD SCI USA, V68, P3242, DOI 10.1073/pnas.68.12.3242; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; ROMAO MJ, 1995, SCIENCE, V270, P1170, DOI 10.1126/science.270.5239.1170; Santamaria-Araujo JA, 2004, J BIOL CHEM, V279, P15994, DOI 10.1074/jbc.M311815200; Schindelin H, 1996, SCIENCE, V272, P1615, DOI 10.1126/science.272.5268.1615; Schrader N, 2003, STRUCTURE, V11, P1251, DOI 10.1016/j.str.2003.09.001; Schrag JD, 2001, J MOL BIOL, V310, P419, DOI 10.1006/jmbi.2001.4771; Schwarz G, 2000, PLANT CELL, V12, P2455, DOI 10.1105/tpc.12.12.2455; SHIH VE, 1977, NEW ENGL J MED, V297, P1022, DOI 10.1056/NEJM197711102971902; Stiefel EI, 1996, SCIENCE, V272, P1599, DOI 10.1126/science.272.5268.1599; Xiang S, 2001, STRUCTURE, V9, P299, DOI 10.1016/S0969-2126(01)00588-3	30	152	159	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2004	430	7001					803	806		10.1038/nature02681	http://dx.doi.org/10.1038/nature02681			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306815				2022-12-24	WOS:000223233600047
J	Hultman, CM; Sparen, P				Hultman, CM; Sparen, P			Autism - prenatal insults or an epiphenomenon of a strongly genetic disorder?	LANCET			English	Editorial Material							PERINATAL RISK-FACTORS; SCHIZOPHRENIA		Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden	Karolinska Institutet	Hultman, CM (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden.	Christina.Hultman@meb.ki.se		Sparen, Par/0000-0002-5184-8971				Cnattingius S, 1999, ARCH GEN PSYCHIAT, V56, P634, DOI 10.1001/archpsyc.56.7.634; Constantino JN, 2004, J CHILD PSYCHOL PSYC, V45, P719, DOI 10.1111/j.1469-7610.2004.00266.x; Glasson EJ, 2004, ARCH GEN PSYCHIAT, V61, P618, DOI 10.1001/archpsyc.61.6.618; Hultman CM, 2002, EPIDEMIOLOGY, V13, P417, DOI 10.1097/00001648-200207000-00009; Hultman CM, 1999, BRIT MED J, V318, P421, DOI 10.1136/bmj.318.7181.421; Muhle R, 2004, PEDIATRICS, V113, pE472, DOI 10.1542/peds.113.5.e472; Nilsson E, 2002, SCHIZOPHR RES, V58, P221, DOI 10.1016/S0920-9964(01)00370-X; RODIER PM, 2004, CLIN MOL TERATOL, V70, P1	8	10	10	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 7	2004	364	9433					485	487		10.1016/S0140-6736(04)16825-6	http://dx.doi.org/10.1016/S0140-6736(04)16825-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BS	15302177				2022-12-24	WOS:000223132700008
J	Herkenhoff, KE; Squyres, SW; Arvidson, R; Bass, DS; Bell, JF; Bertelsen, P; Cabrol, NA; Gaddis, L; Hayes, AG; Hviid, SF; Johnson, JR; Kinch, KM; Madsen, MB; Maki, JN; McLennan, SM; McSween, HY; Rice, JW; Sims, M; Smith, PH; Soderblom, LA; Spanovich, N; Sullivan, R; Wang, A				Herkenhoff, KE; Squyres, SW; Arvidson, R; Bass, DS; Bell, JF; Bertelsen, P; Cabrol, NA; Gaddis, L; Hayes, AG; Hviid, SF; Johnson, JR; Kinch, KM; Madsen, MB; Maki, JN; McLennan, SM; McSween, HY; Rice, JW; Sims, M; Smith, PH; Soderblom, LA; Spanovich, N; Sullivan, R; Wang, A			Textures of the soils and rocks at Gusev crater from Spirit's Microscopic Imager	SCIENCE			English	Article							ROVER	The Microscopic Imager on the Spirit rover analyzed the textures of the soil and rocks at Gusev crater on Mars at a resolution of 100 micrometers. Weakly bound agglomerates of dust are present in the soil near the Columbia Memorial Station. Some of the brushed or abraded rock surfaces show igneous textures and evidence for alteration rinds, coatings, and veins consistent with secondary mineralization. The rock textures are consistent with a volcanic origin and subsequent alteration and/or weathering by impact events, wind, and possibly water.	US Geol Survey, Astrogeol Team, Flagstaff, AZ 86001 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Washington Univ, Dept Earth & Space Sci, St Louis, MO 63130 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Copenhagen, Danish Space Res Inst, Ctr Planetary Sci, DK-1168 Copenhagen, Denmark; Univ Copenhagen, Niels Bohr Inst Astron Phys & Geophys, DK-1168 Copenhagen, Denmark; NASA, Ames Res Ctr, SETI Inst, Moffett Field, CA 94035 USA; Max Planck Inst Aeron, D-37191 Katlenburg Lindau, Germany; Aarhus Univ, Inst Phys & Astron, Aarhus, Denmark; SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Washington Univ, Dept Earth & Space Sci, St Louis, MO 63130 USA; Washington Univ, McDonnell Ctr Space Sci, St Louis, MO 63130 USA	United States Department of the Interior; United States Geological Survey; Cornell University; Washington University (WUSTL); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Technical University of Denmark; University of Copenhagen; University of Copenhagen; Niels Bohr Institute; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Max Planck Society; Aarhus University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Tennessee System; University of Tennessee Knoxville; Arizona State University; Arizona State University-Tempe; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Arizona; Washington University (WUSTL); Washington University (WUSTL)	Herkenhoff, KE (corresponding author), US Geol Survey, Astrogeol Team, Flagstaff, AZ 86001 USA.	kherkenhoff@usgs.gov	Johnson, Jeffrey R/F-3972-2015; Kinch, Kjartan Bergeron/C-5742-2015; Sullivan, Robert/AAR-8193-2020; Hayes, Alexander G/P-2024-2014; Madsen, Morten Bo/D-2082-2011	Johnson, Jeffrey R/0000-0002-5586-4901; Kinch, Kjartan Bergeron/0000-0002-4629-8880; Hayes, Alexander G/0000-0001-6397-2630; Madsen, Morten Bo/0000-0001-8909-5111; McLennan, Scott/0000-0003-4259-7178; Wang, Aimei/0000-0002-6575-4028				Arvidson RE, 2004, SCIENCE, V305, P821, DOI 10.1126/science.1099922; Bell JF, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002070; Bell JF, 2004, SCIENCE, V305, P800, DOI 10.1126/science.1100175; Bertelsen P, 2004, SCIENCE, V305, P827, DOI 10.1126/science.1100112; Butler JB, 2001, J HYDRAUL RES, V39, P1, DOI DOI 10.1080/00221686.2001.9628276; Christensen PR, 2004, SCIENCE, V305, P837, DOI 10.1126/science.1100564; Gellert R, 2004, SCIENCE, V305, P829, DOI 10.1126/science.1099913; Gorevan SP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002061; Greeley R, 2004, SCIENCE, V305, P810, DOI 10.1126/science.1100108; Herkenhoff KE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002076; LANDIS G, 2004, LUNAR PLANETARY SCI, V35; Maki JN, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002077; McSween HY, 2004, SCIENCE, V305, P842, DOI 10.1126/science.3050842; Morris RV, 2004, SCIENCE, V305, P833, DOI 10.1126/science.1100020; Rubin DM, 2004, J SEDIMENT RES, V74, P160, DOI 10.1306/052203740160; Squyres SW, 2004, SCIENCE, V305, P794, DOI 10.1126/science.3050794; Squyres SW, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002121; WAGNER JA, UNPUB; Wentworth CK, 1922, J GEOL, V30, P377, DOI 10.1086/622910	19	110	112	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					824	826		10.1126/science.1100015	http://dx.doi.org/10.1126/science.1100015			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297663				2022-12-24	WOS:000223104900036
J	Baron, JM; Abuzahra, F				Baron, JM; Abuzahra, F			Evidence-based staging system for malignant melanoma: is new necessarily better?	LANCET			English	Editorial Material									Univ Hosp RWTH Aachen, Dept Dermatol & Allergol, D-52074 Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital	Baron, JM (corresponding author), Univ Hosp RWTH Aachen, Dept Dermatol & Allergol, D-52074 Aachen, Germany.	jensmalte.baron@post.rwth-aachen.de	Baron, Jens M/N-2934-2016	Baron, Jens M/0000-0002-1174-6946				Abuzahra F, 2004, LANCET ONCOL, V5, P250, DOI 10.1016/S1470-2045(04)01429-9; Balch CM, 2004, CA-CANCER J CLIN, V54, P131, DOI 10.3322/canjclin.54.3.131; Baron J. M., 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P393, DOI 10.2174/1568011033482224; Garbe C, 2003, CANCER-AM CANCER SOC, V97, P1737, DOI 10.1002/cncr.11250; KAUFMANN R, 1998, HAUTARZT, V48, P530; Kim Christina J, 2002, Cancer Control, V9, P9; Nambiar S, 2004, EXPERT REV MOL DIAGN, V4, P549, DOI 10.1586/14737159.4.4.549; Roberts DLL, 2002, BRIT J DERMATOL, V146, P7, DOI 10.1046/j.1365-2133.2001.04614.x	8	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JUL 31	2004	364	9432					395	396		10.1016/S0140-6736(04)16780-9	http://dx.doi.org/10.1016/S0140-6736(04)16780-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	842IX	15288720				2022-12-24	WOS:000222998600006
J	Kozer, E; Seto, W; Verjee, Z; Parshuram, C; Khattak, S; Koren, G; Jarvis, DA				Kozer, E; Seto, W; Verjee, Z; Parshuram, C; Khattak, S; Koren, G; Jarvis, DA			Prospective observational study on the incidence of medication errors during simulated resuscitation in a paediatric emergency department	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CHILDREN; EVENTS; CARE	Objectives To characterise the incidence and nature of medication errors during paediatric resuscitations. Design A prospective observational study of simulated emergencies. Setting Emergency department of a tertiary paediatric hospital. Participants Teams that included a clinician who commonly leads "real" resuscitations, at least two assisting physicians, and two or three paediatric nurses. Interventions The teams conducted eight mock resuscitations, including ordering medications. Exercises were videotaped and drugs ordered and administered during the resuscitation were recorded. Syringes and drugs prepared during the resuscitation were collected and analysed for concentrations and actual amounts. Main outcome measures Number and type of drug errors. Results Participants gave 125 orders for medications. In 21 (17%) of the orders the exact dose was not specified. Nine dosing errors occur-red during the ordering phase. Of these errors, five were intercepted before the drug reached the patient. Four 10-fold errors were identified. In nine (16%) out of 58 syringes analysed, measured drug concentrations showed a deviation of at least 20% from the ordered dose. A large deviation (at least 50%) from the expected dose was found in four (7%) cases. Conclusions Medication errors commonly occur during all stages of paediatric resuscitation. Many errors could be detected only by analysing syringe content, suggesting that such errors may be a major source of morbidity and mortality in resuscitated children.	Hosp Sick Children, Div Paediat Emergency Med, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Dept Pharm, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Dept Clin Biochem, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Div Clin Pharmacol & Toxicol, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Kozer, E (corresponding author), Assaf Harofeh Med Ctr, Paediat Emergency Serv, IL-70300 Zerifin, Israel.	erank@asaf.health.gov.il	Parshuram, Christopher/AAI-6669-2020; Koren, Gideon/AAG-7726-2019	Parshuram, Christopher/0000-0002-7744-481X; Koren, Gideon/0000-0002-9234-0875				Dean B, 2002, LANCET, V359, P1373, DOI 10.1016/S0140-6736(02)08350-2; KOREN G, 1994, J CLIN PHARMACOL, V34, P1043, DOI 10.1002/j.1552-4604.1994.tb01978.x; Kozer E, 2002, PEDIATRICS, V110, P737, DOI 10.1542/peds.110.4.737; Kozer E, 2002, NEW ENGL J MED, V346, P1175, DOI 10.1056/NEJM200204113461518; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; Lesar TS, 1997, JAMA-J AM MED ASSOC, V277, P312, DOI 10.1001/jama.277.4.312; Lesar TS, 1998, ARCH PEDIAT ADOL MED, V152, P340; Parshuram CS, 2003, CRIT CARE MED, V31, P2483, DOI 10.1097/01.CCM.0000089638.83803.B2; Schindler MB, 1996, NEW ENGL J MED, V335, P1473, DOI 10.1056/NEJM199611143352001; Shah AN, 2003, ARCH PEDIAT ADOL MED, V157, P229, DOI 10.1001/archpedi.157.3.229; Tissot E, 1999, INTENS CARE MED, V25, P353, DOI 10.1007/s001340050857	11	86	89	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 4	2004	329	7478					1321	1324		10.1136/bmj.38244.607083.55	http://dx.doi.org/10.1136/bmj.38244.607083.55			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	878PC	15454495	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000225657800020
J	Aida, M; Beis, D; Heidstra, R; Willemsen, V; Blilou, I; Galinha, C; Nussaume, L; Noh, YS; Amasino, R; Scheres, B				Aida, M; Beis, D; Heidstra, R; Willemsen, V; Blilou, I; Galinha, C; Nussaume, L; Noh, YS; Amasino, R; Scheres, B			The PLETHORA genes mediate patterning of the Arabidopsis root stem cell niche	CELL			English	Article							DEPENDENT AUXIN GRADIENTS; RADIAL ORGANIZATION; RESPONSE FACTORS; EMBRYO; MONOPTEROS; MERISTEM; TRANSCRIPTION; SCARECROW; MUTATION; THALIANA	A small organizing center, the quiescent center (QC), maintains stem cells in the Arabidopsis root and defines the stem cell niche. The phytohormone auxin influences the position of this niche by an unknown mechanism. Here, we identify the PLETHORA1 (PLT1) and PLT2 genes encoding AP2 class putative transcription factors, which are essential for QC specification and stem cell activity. The PLT genes are transcribed in response to auxin accumulation and are dependent on auxin response transcription factors. Distal PLT transcript accumulation creates an overlap with the radial expression domains of SHORT-ROOT and SCARECROW, providing positional information for the stem cell niche. Furthermore, the PLT genes are activated in the basal embryo region that gives rise to hypocotyl, root, and root stem cells and, when ectopically expressed, transform apical regions to these identities. Thus, the PLT genes are key effectors for establishment of the stem cell niche during embryonic pattern formation.	Univ Utrecht, Dept Mol Cell Biol, NL-3514 CH Utrecht, Netherlands; Univ Mediterranee, UMR 163 CNRS, CEA,DSVDEVM, LBDP, F-13108 St Paul Les Durance, France; Univ Wisconsin, Coll Agr & Life Sci, Dept Biochem, Madison, WI 53706 USA	Utrecht University; CEA; UDICE-French Research Universities; Aix-Marseille Universite; University of Wisconsin System; University of Wisconsin Madison	Scheres, B (corresponding author), Univ Utrecht, Dept Mol Cell Biol, Padualaan 8, NL-3514 CH Utrecht, Netherlands.	b.scheres@bio.uu.nl	Aida, Mitsuhiro/AAW-7703-2020; NUSSAUME, Laurent/AAB-8312-2020; NUSSAUME, Laurent/AAA-5980-2022	Aida, Mitsuhiro/0000-0001-9000-7502; NUSSAUME, Laurent/0000-0002-9445-2563; Blilou, Ikram/0000-0001-8003-3782; Beis, Dimitris/0000-0003-2579-7848; Scheres, Ben/0000-0001-5400-9578				Aida M, 2002, DEVELOPMENT, V129, P3965; Aida M, 1997, PLANT CELL, V9, P841, DOI 10.1105/tpc.9.6.841; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; BENFEY PN, 1993, DEVELOPMENT, V119, P57; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; BERLETH T, 1993, DEVELOPMENT, V118, P575; BRAND AH, 1993, DEVELOPMENT, V118, P401; Colon-Carmona A, 1999, PLANT J, V20, P503, DOI 10.1046/j.1365-313x.1999.00620.x; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; Friml J, 2003, PLANT J, V34, P115, DOI 10.1046/j.1365-313X.2003.01705.x; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Fukaki H, 1998, PLANT J, V14, P425, DOI 10.1046/j.1365-313X.1998.00137.x; Fukaki H, 2002, PLANT J, V29, P153, DOI 10.1046/j.0960-7412.2001.01201.x; Hamann T, 1999, DEVELOPMENT, V126, P1387; Hamann T, 2002, GENE DEV, V16, P1610, DOI 10.1101/gad.229402; Hardtke CS, 2004, DEVELOPMENT, V131, P1089, DOI 10.1242/dev.00925; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Helariutta Y, 2000, CELL, V101, P555, DOI 10.1016/S0092-8674(00)80865-X; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Hellmann H, 2003, EMBO J, V22, P3314, DOI 10.1093/emboj/cdg335; Hobbie L, 2000, DEVELOPMENT, V127, P23; Laux T, 2003, CELL, V113, P281, DOI 10.1016/S0092-8674(03)00312-X; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; MORRISON JFJ, 1995, PCR 2 PRACTICAL APPR, P165; Nakajima K, 2001, NATURE, V413, P307, DOI 10.1038/35095061; Parinov S, 1999, PLANT CELL, V11, P2263, DOI 10.1105/tpc.11.12.2263; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Riechmann JL, 1998, BIOL CHEM, V379, P633; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Sabatini S, 2003, GENE DEV, V17, P354, DOI 10.1101/gad.252503; SCHERES B, 1995, DEVELOPMENT, V121, P53; SCHERES B, 1994, DEVELOPMENT, V120, P2475; Schomburg FM, 2003, PLANT CELL, V15, P151, DOI 10.1105/tpc.005975; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Sussman MR, 2000, PLANT PHYSIOL, V124, P1465, DOI 10.1104/pp.124.4.1465; Swarup R, 2001, GENE DEV, V15, P2648, DOI 10.1101/gad.210501; Ulmasov T, 1999, P NATL ACAD SCI USA, V96, P5844, DOI 10.1073/pnas.96.10.5844; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; vandenBerg C, 1997, NATURE, V390, P287, DOI 10.1038/36856; Wada T, 1997, SCIENCE, V277, P1113, DOI 10.1126/science.277.5329.1113; Weigel D, 2002, NATURE, V415, P751, DOI 10.1038/415751a; Weijers D, 2001, DEVELOPMENT, V128, P4289; Willemsen V, 1998, DEVELOPMENT, V125, P521; Wysocka-Diller JW, 2000, DEVELOPMENT, V127, P595	45	775	840	7	173	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 1	2004	119	1					109	+		10.1016/j.cell.2004.09.018	http://dx.doi.org/10.1016/j.cell.2004.09.018			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	859UE	15454085	Green Published, Bronze			2022-12-24	WOS:000224292600013
J	Fujita, N; Jaye, DL; Geigerman, C; Akyildiz, A; Mooney, MR; Boss, JM; Wade, PA				Fujita, N; Jaye, DL; Geigerman, C; Akyildiz, A; Mooney, MR; Boss, JM; Wade, PA			MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte differentiation	CELL			English	Article							CLASS-II TRANSACTIVATOR; N-COR; HISTONE DEACETYLASE; PLASMA-CELLS; TRANSCRIPTIONAL REPRESSION; COREPRESSOR COMPLEX; GENE-EXPRESSION; POZ DOMAIN; BCL-6; SMRT	The transcriptional repressor BCL-6 regulates B lymphocyte cell fate during the germinal center reaction by preventing terminal differentiation of B lymphocytes into plasma cells until appropriate signals are received. Here, we report a cofactor, MTA3, a cell type-specific subunit of the corepressor complex Mi-2/ NuRD, for BCL-6-dependent cell fate determination. MTA3 is expressed in the same pattern in germinal centers as BCL-6. BCL-6 physically interacts with Mi-2/NuRD and this interaction is sensitive to BCL-6 acetylation status. Depletion of MTA3 by RNAi impairs BCL-6-dependent repression and alters the cell-specific transcriptional pattern characteristic of the B lymphocyte. Remarkably, exogenous expression of BCL-6 in a plasma cell line leads, in an MTA3-dependent manner, to repression of plasma cell-specific transcripts, reactivation of the B cell transcriptional program, expression of B lymphocyte cell surface markers, and reprogramming of cell fate.	Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Div Hematopathol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University	Wade, PA (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.	pwade@emory.edu	Wade, Paul A/D-2374-2019	Wade, Paul A/0000-0002-6042-357X; jaye, david/0000-0001-7977-6909	NIAID NIH HHS [AI34000] Funding Source: Medline; NIDDK NIH HHS [DK065961, DK60647] Funding Source: Medline; NIGMS NIH HHS [GM47310, GM20675] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI034000, R01AI034000, R56AI034000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK060647, R01DK065961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES101965] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047310] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABTS H, 1989, J IMMUNOL METHODS, V125, P19, DOI 10.1016/0022-1759(89)90073-2; ACCOLLA RS, 1983, J EXP MED, V157, P1053, DOI 10.1084/jem.157.3.1053; Ahmad KF, 2003, MOL CELL, V12, P1551, DOI 10.1016/S1097-2765(03)00454-4; Bereshchenko OR, 2002, NAT GENET, V32, P606, DOI 10.1038/ng1018; Bishop GA, 2003, CRIT REV IMMUNOL, V23, P149, DOI 10.1615/CritRevImmunol.v23.i3.10; Boss JM, 2003, CURR OPIN IMMUNOL, V15, P105, DOI 10.1016/S0952-7915(02)00015-8; Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; Calame KL, 2003, ANNU REV IMMUNOL, V21, P205, DOI 10.1146/annurev.immunol.21.120601.141138; Coffee B, 1999, NAT GENET, V22, P98, DOI 10.1038/8807; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; Dhordain P, 1998, NUCLEIC ACIDS RES, V26, P4645, DOI 10.1093/nar/26.20.4645; EPSTEIN MA, 1966, J NATL CANCER I, V37, P547; Fujita N, 2003, CELL, V113, P207, DOI 10.1016/S0092-8674(03)00234-4; GAZDAR AF, 1986, BLOOD, V67, P1542; Gyory I, 2004, NAT IMMUNOL, V5, P299, DOI 10.1038/ni1046; HARRIS NS, 1974, NATURE, V250, P507, DOI 10.1038/250507a0; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Huynh KD, 1998, ONCOGENE, V17, P2473, DOI 10.1038/sj.onc.1202197; Huynh KD, 2000, GENE DEV, V14, P1810; Ivanov AI, 2004, MOL BIOL CELL, V15, P176, DOI 10.1091/mbc.E03-05-0319; Jaskelioff M, 2003, NAT CELL BIOL, V5, P395, DOI 10.1038/ncb0503-395; Jaye DL, 2003, AM J PATHOL, V162, P1419, DOI 10.1016/S0002-9440(10)64275-7; Jaye DL, 2001, J IMMUNOL, V166, P7250, DOI 10.4049/jimmunol.166.12.7250; KLEIN G, 1975, INTERVIROLOGY, V5, P319, DOI 10.1159/000149930; Landry J, 2000, BIOCHEM BIOPH RES CO, V278, P685, DOI 10.1006/bbrc.2000.3854; Leon RP, 1998, P NATL ACAD SCI USA, V95, P13159, DOI 10.1073/pnas.95.22.13159; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Lin KI, 2003, IMMUNOL REV, V194, P19, DOI 10.1034/j.1600-065X.2003.00040.x; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; McHeyzer-Williams LJ, 2001, CURR OPIN HEMATOL, V8, P52, DOI 10.1097/00062752-200101000-00010; MONOD J, 1961, COLD SPRING HARB SYM, V26, P389, DOI 10.1101/SQB.1961.026.01.048; MuhlethalerMOttet A, 1997, EMBO J, V16, P2851, DOI 10.1093/emboj/16.10.2851; Nagarajan UM, 2002, J IMMUNOL, V169, P5078, DOI 10.4049/jimmunol.169.9.5078; NILSSON K, 1970, CLIN EXP IMMUNOL, V7, P477; Niu HF, 2002, HEMATOL ONCOL, V20, P155, DOI 10.1002/hon.689; Piskurich JF, 2000, NAT IMMUNOL, V1, P526, DOI 10.1038/82788; Shaffer AL, 2002, NAT REV IMMUNOL, V2, P920, DOI 10.1038/nri953; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; SLAVIN S, 1978, NATURE, V272, P624, DOI 10.1038/272624a0; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; Underhill C, 2000, J BIOL CHEM, V275, P40463, DOI 10.1074/jbc.M007864200; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; Urnov FD, 2000, EMBO J, V19, P4074, DOI 10.1093/emboj/19.15.4074; Wang LL, 2001, ONCOGENE, V20, P3716, DOI 10.1038/sj.onc.1204479; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Wong CW, 1998, J BIOL CHEM, V273, P27695, DOI 10.1074/jbc.273.42.27695; YE BHH, 1993, CANCER RES, V53, P2732; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; ZECH L, 1976, INT J CANCER, V17, P47, DOI 10.1002/ijc.2910170108; Zhang H, 2001, BBA-MOL CELL RES, V1540, P188, DOI 10.1016/S0167-4889(01)00128-8	54	260	277	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 1	2004	119	1					75	86		10.1016/j.cell.2004.09.014	http://dx.doi.org/10.1016/j.cell.2004.09.014			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	859UE	15454082	Bronze			2022-12-24	WOS:000224292600010
J	Mortuza, GB; Haire, LF; Stevens, A; Smerdon, SJ; Stoye, JP; Taylor, IA				Mortuza, GB; Haire, LF; Stevens, A; Smerdon, SJ; Stoye, JP; Taylor, IA			High-resolution structure of a retroviral capsid hexameric amino-terminal domain	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; REVERSE TRANSCRIPTION COMPLEXES; MURINE LEUKEMIA-VIRUS; CA PROTEIN; HIV-1; CORE; REPLICATION; INFECTION; FRAGMENT; EXCHANGE	Retroviruses are the aetiological agents of a range of human diseases including AIDS and T-cell leukaemias. They follow complex life cycles, which are still only partly understood at the molecular level. Maturation of newly formed retroviral particles is an essential step in production of infectious virions, and requires proteolytic cleavage of Gag polyproteins in the immature particle to form the matrix, capsid and nucleocapsid proteins present in the mature virion(1). Capsid proteins associate to form a dense viral core(2) that may be spherical, cylindrical or conical depending on the genus of the virus(3). Nonetheless, these assemblies all appear to be composed of a lattice formed from hexagonal rings, each containing six capsid monomers(2,4,5). Here, we describe the X-ray structure of an individual hexagonal assembly from N-tropic murine leukaemia virus (N-MLV). The interface between capsid monomers is generally polar, consistent with weak interactions within the hexamer. Similar architectures are probably crucial for the regulation of capsid assembly and disassembly in all retroviruses. Together, these observations provide new insights into retroviral uncoating and how cellular restriction factors may interfere with viral replication.	Natl Inst Med Res, Div Prot Struct, London NW7 1AA, England; Natl Inst Med Res, Div Virol, London NW7 1AA, England	MRC National Institute for Medical Research; MRC National Institute for Medical Research	Taylor, IA (corresponding author), Natl Inst Med Res, Div Prot Struct, Mill Hill, London NW7 1AA, England.	itaylor@nimr.mrc.ac.uk		Stoye, Jonathan/0000-0003-3377-323X; Smerdon, Stephen/0000-0001-5688-8465				Best S, 1996, NATURE, V382, P826, DOI 10.1038/382826a0; BOONE LR, 1983, J VIROL, V48, P110, DOI 10.1128/JVI.48.1.110-119.1983; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; Cornilescu CC, 2001, J MOL BIOL, V306, P783, DOI 10.1006/jmbi.2000.4395; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Fassati A, 2001, J VIROL, V75, P3626, DOI 10.1128/JVI.75.8.3626-3635.2001; Fassati A, 1999, J VIROL, V73, P8919, DOI 10.1128/JVI.73.11.8919-8925.1999; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; Gamble TR, 1996, CELL, V87, P1285, DOI 10.1016/S0092-8674(00)81823-1; Ganser BK, 2003, EMBO J, V22, P2886, DOI 10.1093/emboj/cdg276; Ganser-Pornillos BK, 2004, J VIROL, V78, P2545, DOI 10.1128/JVI.78.5.2545-2552.2004; Gitti RK, 1996, SCIENCE, V273, P231, DOI 10.1126/science.273.5272.231; Gross I, 1998, J VIROL, V72, P4798, DOI 10.1128/JVI.72.6.4798-4810.1998; Jin ZM, 1999, J MOL BIOL, V286, P83, DOI 10.1006/jmbi.1998.2443; KARAGEORGOS L, 1993, AIDS RES HUM RETROV, V9, P817, DOI 10.1089/aid.1993.9.817; Khorasanizadeh S, 1999, J MOL BIOL, V291, P491, DOI 10.1006/jmbi.1999.2986; Kingston RL, 2000, STRUCTURE, V8, P617, DOI 10.1016/S0969-2126(00)00148-9; Lanman J, 2004, NAT STRUCT MOL BIOL, V11, P676, DOI 10.1038/nsmb790; Lanman J, 2003, J MOL BIOL, V325, P759, DOI 10.1016/S0022-2836(02)01245-7; Li S, 2000, NATURE, V407, P409, DOI 10.1038/35030177; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Nandhagopal N, 2004, J MOL BIOL, V335, P275, DOI 10.1016/j.jmb.2003.10.034; Nermut MV, 1996, CURR TOP MICROBIOL, V214, P1; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Swanstrom R, 1997, RETROVIRUSES; Tang C, 2002, NAT STRUCT BIOL, V9, P537, DOI 10.1038/nsb806; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; von Schwedler UK, 2000, EMBO J, V19, P2391, DOI 10.1038/sj.emboj.7593063; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; von Schwedler UK, 1998, EMBO J, V17, P1555, DOI 10.1093/emboj/17.6.1555	31	161	162	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 23	2004	431	7007					481	485		10.1038/nature02915	http://dx.doi.org/10.1038/nature02915			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15386017				2022-12-24	WOS:000224000500047
J	Schumacher, MA; Allen, GS; Diel, M; Seidel, G; Hillen, W; Brennan, RG				Schumacher, MA; Allen, GS; Diel, M; Seidel, G; Hillen, W; Brennan, RG			Structural basis for allosteric control of the transcription regulator CcpA by the phosphoprotein HPr-Ser46-P	CELL			English	Article							CARBON CATABOLITE REPRESSION; GRAM-POSITIVE BACTERIA; CONTROL PROTEIN CCPA; BACILLUS-SUBTILIS; DNA-BINDING; HPR KINASE/PHOSPHORYLASE; PHOSPHOCARRIER PROTEIN; RESPONSIVE ELEMENTS; CRYSTAL-STRUCTURE; SENSOR ENZYME	Carbon catabolite repression (CCR) is one of the most fundamental environmental-sensing mechanisms in bacteria and imparts competitive advantage by establishing priorities in carbon metabolism. In gram-positive bacteria, the master transcription regulator of CCR is CcpA. CcpA is a Lacl-GaIR family member that employs, as an allosteric corepressor, the phosphoprotein HPr-Ser46-P, which is formed in glucose-replete conditions. Here we report structures of the Bacillus megaterium apoCcpA and a CcpA-(HPr-Ser46-P)-DNA complex. These structures reveal that HPr-Ser46-P mediates a novel two-component allosteric DNA binding activation mechanism that involves both rotation of the CcpA subdomains and relocation of pivot-point residue Thr61, which leads to juxtaposition of the DNA binding regions permitting "hinge" helix formation in the presence of cognate DNA. The structure of the CcpA-(HPr-Ser46-P)-cre complex also reveals the elegant mechanism by which CcpA family-specific interactions with HPr-Ser46-P residues Ser46-P and His15 partition the high-energy CCR and low-energy PTS pathways, the latter requiring HPr-His15-P.	Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; Univ Erlangen Nurnberg, Lehrstuhl Mikrobiol, Inst Mikrobiol Biochem & Genet, D-91058 Erlangen, Germany	Oregon Health & Science University; University of Erlangen Nuremberg	Brennan, RG (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA.	brennanr@ohsu.edu		Brennan, Richard/0000-0001-7647-485X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048593, T32AI007472] Funding Source: NIH RePORTER; NIAID NIH HHS [AI07472, AI48593] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Audette GF, 2000, J MOL BIOL, V303, P545, DOI 10.1006/jmbi.2000.4166; Aung-Hilbrich LM, 2002, J MOL BIOL, V319, P77, DOI 10.1016/S0022-2836(02)00245-0; Bell CE, 2000, NAT STRUCT BIOL, V7, P209; Bell CE, 2001, J MOL BIOL, V312, P921, DOI 10.1006/jmbi.2001.5024; Bruckner R, 2002, FEMS MICROBIOL LETT, V209, P141; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chauvaux S, 1998, J BACTERIOL, V180, P491, DOI 10.1128/JB.180.3.491-497.1998; DEUTSCHER J, 1983, P NATL ACAD SCI-BIOL, V80, P6790, DOI 10.1073/pnas.80.22.6790; Galinier A, 1999, J MOL BIOL, V286, P307, DOI 10.1006/jmbi.1998.2492; GALINIER A, 1997, P NATL ACAD SCI USA, V94, P8739; Gosseringer R, 1997, J MOL BIOL, V266, P665, DOI 10.1006/jmbi.1996.0820; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Henkin TM, 1996, FEMS MICROBIOL LETT, V135, P9; Jones BE, 1997, PROTEIN SCI, V6, P2107; Jones BE, 1997, J BIOL CHEM, V272, P26530, DOI 10.1074/jbc.272.42.26530; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kalodimos CG, 2002, EMBO J, V21, P2866, DOI 10.1093/emboj/cdf318; Kim JH, 1998, P NATL ACAD SCI USA, V95, P9590, DOI 10.1073/pnas.95.16.9590; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Kraus A, 1998, MOL MICROBIOL, V30, P955, DOI 10.1046/j.1365-2958.1998.01123.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; Magasanik B, 1970, LACTOSE OPERON, P189; Miwa Y, 2001, J BACTERIOL, V183, P5877, DOI 10.1128/JB.183.20.5877-5884.2001; Miwa Y, 2000, NUCLEIC ACIDS RES, V28, P1206, DOI 10.1093/nar/28.5.1206; Moreno MS, 2001, MOL MICROBIOL, V39, P1366, DOI 10.1046/j.1365-2958.2001.02328.x; Nessler S, 2003, J BACTERIOL, V185, P4003, DOI 10.1128/JB.185.14.4003-4010.2003; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Poncet S, 2004, BBA-PROTEINS PROTEOM, V1697, P123, DOI 10.1016/j.bbapap.2003.11.018; POSTMA PW, 1993, MICROBIOL REV, V57, P543, DOI 10.1128/MMBR.57.3.543-594.1993; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; Reizer J, 1996, J BACTERIOL, V178, P5480, DOI 10.1128/jb.178.18.5480-5486.1996; SAIER MH, 1995, TRENDS BIOCHEM SCI, V20, P267, DOI 10.1016/S0968-0004(00)89041-6; SCHUMACHER MA, 1995, CELL, V83, P147, DOI 10.1016/0092-8674(95)90243-0; SCHUMACHER MA, 1994, SCIENCE, V266, P763, DOI 10.1126/science.7973627; Steinhauer K, 2002, ACTA CRYSTALLOGR D, V58, P515, DOI 10.1107/S090744490102145X; Stulke J, 2000, ANNU REV MICROBIOL, V54, P849, DOI 10.1146/annurev.micro.54.1.849; Stulke J, 1998, NATURWISSENSCHAFTEN, V85, P583, DOI 10.1007/s001140050555; Turinsky AJ, 1998, J BACTERIOL, V180, P5961, DOI 10.1128/JB.180.22.5961-5967.1998; ULLMANN A, 1983, ADV CYCL NUCL RES<D>, V15, P1; Warner JB, 2003, MICROBIOL MOL BIOL R, V67, P475, DOI 10.1128/MMBR.67.4.475-490.2003; WEICKERT MJ, 1990, P NATL ACAD SCI USA, V87, P6238, DOI 10.1073/pnas.87.16.6238; WEICKERT MJ, 1992, J BIOL CHEM, V267, P15869; Yuan YP, 1998, BIOINFORMATICS, V14, P285, DOI 10.1093/bioinformatics/14.3.285; Zalieckas JM, 1998, MOL MICROBIOL, V27, P1031, DOI 10.1046/j.1365-2958.1998.00751.x; Zalieckas JM, 1999, J BACTERIOL, V181, P2883, DOI 10.1128/JB.181.9.2883-2888.1999	47	134	140	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 17	2004	118	6					731	741		10.1016/j.cell.2004.08.027	http://dx.doi.org/10.1016/j.cell.2004.08.027			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	855RW	15369672	Bronze			2022-12-24	WOS:000223992400009
J	Christian, P; Khatry, SK; West, KP				Christian, P; Khatry, SK; West, KP			Antenatal anthelmintic treatment, birthweight, and infant survival in rural Nepal	LANCET			English	Article							PREGNANT-WOMEN; SUPPLEMENTATION; THERAPY; ANEMIA; PLAINS; TRIAL	Anthelmintic treatment, which is recommended during pregnancy in areas where there is a high rate of anaemia, needs further investigation. We examined prospectively the association between anthelmintic treatment and maternal anaemia, birthweight, and infant mortality in a study of prenatal supplements, in which women received albendazole twice during pregnancy. Women given albendazole in the second trimester of pregnancy had a lower rate of severe anaemia during the third trimester. Birthweight of infants of women who had received two doses of albendazole rose by 59 g (95% CI 19-98), and infant mortality at 6 months fell by 41% (RR 0 . 59; 95% Cl 0 . 43-0.82). Antenatal anthelmintics could be effective in reducing maternal anaemia and improving birthweight and infant survival in hookworm-endemic regions.	Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Program Human Nutr, Dept Int Hlth, Baltimore, MD 21205 USA; Ctr Human Nutr, Baltimore, MD USA; Soc Prevent Blindness, Nepal Nutr Intervent Project, Kathmandu, Nepal	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Christian, P (corresponding author), Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Program Human Nutr, Dept Int Hlth, 615 N Wolfe St, Baltimore, MD 21205 USA.	pchristi@jhsph.edu						ATUKORALA TMS, 1994, AM J CLIN NUTR, V60, P286, DOI 10.1093/ajcn/60.2.286; Christian P, 2003, AM J CLIN NUTR, V78, P1194, DOI 10.1093/ajcn/78.6.1194; Christian P, 2003, BMJ-BRIT MED J, V326, P571, DOI 10.1136/bmj.326.7389.571; de Silva NR, 1999, LANCET, V353, P1145, DOI 10.1016/S0140-6736(98)06308-9; Dreyfuss ML, 2000, J NUTR, V130, P2527, DOI 10.1093/jn/130.10.2527; Navitsky RC, 1998, J PARASITOL, V84, P647, DOI 10.2307/3284746; Stoltzfus RJ, 1998, GUIDELINES USE IRON	7	133	138	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 11	2004	364	9438					981	983		10.1016/S0140-6736(04)17023-2	http://dx.doi.org/10.1016/S0140-6736(04)17023-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853MF	15364190				2022-12-24	WOS:000223831000029
J	Lin, HK; Bergmann, S; Pandolfi, PP				Lin, HK; Bergmann, S; Pandolfi, PP			Cytoplasmic PML function in TGF-beta signalling	NATURE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; MONOCYTIC DIFFERENTIATION; PREMATURE SENESCENCE; TUMOR SUPPRESSION; ANDROGEN RECEPTOR; PROTEIN ISOFORMS; ONCOGENIC RAS; CANCER-CELLS; GROWTH; ALPHA	Transforming growth factor beta (TGF-beta) is a pluripotent cytokine that controls key tumour suppressive functions(1-3), but cancer cells are often unresponsive to it(1,4). The promyelocytic leukaemia (PML) tumour suppressor of acute promyelocytic leukaemia (APL) accumulates in the PML nuclear body, but cytoplasmic PML isoforms of unknown function have also been described(5,6). Here we show that cytoplasmic Pml is an essential modulator of TGF-beta signalling. Pml-null primary cells are resistant to TGF-beta-dependent growth arrest, induction of cellular senescence and apoptosis. These cells also have impaired phosphorylation and nuclear translocation of the TGF-beta signalling proteins Smad2 and Smad3, as well as impaired induction of TGF-beta target genes. Expression of cytoplasmic Pml is induced by TGF-beta. Furthermore, cytoplasmic PML physically interacts with Smad2/3 and SARA (Smad anchor for receptor activation) and is required for association of Smad2/3 with SARA and for the accumulation of SARA and TGF-beta receptor in the early endosome. The PML-RARalpha oncoprotein of APL can antagonize cytoplasmic PML function and APL cells have defects in TGF-beta signalling similar to those observed in Pml-null cells. Our findings identify cytoplasmic PML as a critical TGF-beta regulator, and further implicate deregulated TGF-beta signalling in cancer pathogenesis.	Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol, Canc Biol & Genet Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Pandolfi, PP (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.	p-pandolfi@ski.mskcc.org						Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; ESCOLA JM, 1995, J CELL SCI, V108, P2337; FAGIOLI M, 1992, ONCOGENE, V7, P1083; Ferbeyre G, 2000, GENE DEV, V14, P2015; GRIGNANI F, 1993, CELL, V74, P423, DOI 10.1016/0092-8674(93)80044-F; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086; Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765; Kang HY, 2001, P NATL ACAD SCI USA, V98, P3018, DOI 10.1073/pnas.061305498; KASTNER P, 1992, EMBO J, V11, P629, DOI 10.1002/j.1460-2075.1992.tb05095.x; Katakura Y, 1999, BIOCHEM BIOPH RES CO, V255, P110, DOI 10.1006/bbrc.1999.0129; Kim SJ, 2003, LEUKEMIA, V17, P1731, DOI 10.1038/sj.leu.2403069; Kurokawa M, 1998, NATURE, V394, P92, DOI 10.1038/27945; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; Miyaki M, 1999, ONCOGENE, V18, P3098, DOI 10.1038/sj.onc.1202642; Panopoulou E, 2002, J BIOL CHEM, V277, P18046, DOI 10.1074/jbc.M107983200; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; TESTA U, 1993, J IMMUNOL, V150, P2418; TESTA U, 1994, CANCER RES, V54, P4508; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Turelli P, 2001, MOL CELL, V7, P1245, DOI 10.1016/S1097-2765(01)00255-6; Wang ZG, 1998, SCIENCE, V279, P1547; Zhu J, 2002, NAT REV CANCER, V2, P705, DOI 10.1038/nrc887	30	252	274	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 9	2004	431	7005					205	211		10.1038/nature02783	http://dx.doi.org/10.1038/nature02783			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HI	15356634				2022-12-24	WOS:000223746000049
J	Painter, TM; Diaby, KL; Matia, DM; Lin, LS; Sibailly, TS; Kouassi, MK; Ekpini, ER; Roels, TH; Wiktor, SZ				Painter, TM; Diaby, KL; Matia, DM; Lin, LS; Sibailly, TS; Kouassi, MK; Ekpini, ER; Roels, TH; Wiktor, SZ			Women's reasons for not participating in follow up visits before starting short course antiretroviral prophylaxis for prevention of mother to child transmission of HIV: qualitative interview study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SHORT-COURSE ZIDOVUDINE; COTE-DIVOIRE; PREGNANT-WOMEN; ORAL ZIDOVUDINE; BURKINA-FASO; ACCEPTABILITY; ABIDJAN; INTERVENTIONS; COHORT; RETURN	Objective To find out why pregnant women who receive HIV-1 positive test results and are offered short course antiretroviral prophylaxis to prevent transmission of HIV from mother to child do not participate in necessary follow up visits before starting prophylaxis. Design Qualitative interview study. Setting A programme aiming to prevent transmission of HIV from mother to child at a public antenatal clinic in Abidjan, Cote d'Ivoire. Participants Purposive sample of 27 women who had received HIV-1 positive test results and were invited to return for monthly follow up visits before starting prophylaxis with zidovudine at 36 weeks' gestation, but who had either refused or discontinued the visits. None of the women started prophylaxis. Results Most of the women explained their non-participation in follow up visits by referring to negative experiences that they had had while interacting with programme staff or to their views about the programme. Additional reasons concerned their disbelief of HIV positive test results and personal factors. Conclusions Difficulties experienced by women during their contacts with staff working on the prevention programme and negative views that they have about the programme can contribute to their non-participation in prophylaxis. Training and supervision of programme staff may increase the likelihood of positive interactions between staff and clients, thereby facilitating women's participation in preventing transmission of HIV from mother to child. Outreach and mobilisation in communities that are served by prevention programmes may complement these measures at programme level by contributing to increased social support for women's efforts to prevent transmission of HIV from mother to child.	Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA; US Embasy, CDC HIV, Projet RETRO CI, Abidjan 1712 01, Cote Ivoire; WHO, Div HIV AIDS, CH-1211 Geneva 27, Switzerland; US Embassy, Ctr Dis Control & Prevent, Global AIDS Program, Kigali, Rwanda; BOTUSA Project, Global AIDS Program, Gaborone, Botswana	Centers for Disease Control & Prevention - USA; World Health Organization	Painter, TM (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV STD & TB Prevent, 1600 Clifton Rd NE,Mail Stop E-37, Atlanta, GA 30333 USA.	tcp2@cdc.gov		Roels, Thierry/0000-0002-0886-5645				Allen S., 1999, PREVENTING HIV DEV C, P87; Carr R, 1998, FASEB J, V12, pA1; Cartoux M, 1998, AIDS, V12, P2489, DOI 10.1097/00002030-199818000-00019; Cartoux M, 1998, AIDS, V12, P2337, DOI 10.1097/00002030-199817000-00016; Dabis F, 1999, LANCET, V353, P786, DOI 10.1016/S0140-6736(98)11046-2; DEKONINCK M, 1997, RECHERCHES FEMINISTE, V10, P97; Ekouevi DK, 2004, JAIDS-J ACQ IMM DEF, V36, P755, DOI 10.1097/00126334-200406010-00014; EZOUA J, 2001, 12 INT C AIDS STD AF; Farquhar C., 2000, 13 INT AIDS C DURB S; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Issiaka S, 2001, AIDS CARE, V13, P123, DOI 10.1080/09540120020018224; Kiarie J, 2000, AIDS, V14, P1468, DOI 10.1097/00002030-200007070-00030; Ladner J, 1996, AIDS, V10, P69, DOI 10.1097/00002030-199601000-00010; Malonza IA, 2003, AIDS, V17, P113, DOI 10.1097/00002030-200301030-00015; McKenna SL, 1997, AIDS, V11, pS103; MOUZIN E, 2001, MTCT NEWS 2001, P2; Msellati P, 2001, B WORLD HEALTH ORGAN, V79, P641; MWAI C, 2001, 3 C GLOB STRAT PREV; Nebie Y, 2001, J ACQ IMMUN DEF SYND, V28, P367, DOI 10.1097/00126334-200112010-00010; Painter TM, 2001, SOC SCI MED, V53, P1397, DOI 10.1016/S0277-9536(00)00427-5; Prual A, 2000, HEALTH POLICY PLANN, V15, P11, DOI 10.1093/heapol/15.1.11; Seidel G, 2000, HEALTH POLICY PLANN, V15, P24, DOI 10.1093/heapol/15.1.24; Shaffer N, 1999, LANCET, V353, P773, DOI 10.1016/S0140-6736(98)10411-7; SIBAILLY TS, 2000, 13 INT AIDS C DURB S; Songok EM, 2003, AM J TROP MED HYG, V69, P8, DOI 10.4269/ajtmh.2003.69.8; Stringer EM, 2003, AIDS, V17, P1377, DOI 10.1097/00002030-200306130-00012; Temmerman M, 2003, AIDS, V17, P1239, DOI 10.1097/00002030-200305230-00016; Wiktor SZ, 1999, LANCET, V353, P781, DOI 10.1016/S0140-6736(98)10412-9; Wilkinson D, 1997, HEALTH POLICY PLANN, V12, P161, DOI 10.1093/heapol/12.2.161	29	76	77	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 4	2004	329	7465					543	546		10.1136/bmj.329.7465.543	http://dx.doi.org/10.1136/bmj.329.7465.543			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853DE	15345628	Green Submitted, Green Published, Bronze			2022-12-24	WOS:000223805800019
J	Li, L; Thomas, RM; Suzuki, H; De Brabander, JK; Wang, XD; Harran, PG				Li, L; Thomas, RM; Suzuki, H; De Brabander, JK; Wang, XD; Harran, PG			A small molecule Smac mimic potentiates TRAIL- and TNF alpha-mediated cell death	SCIENCE			English	Article							APOPTOSIS PROTEIN; STRUCTURAL BASIS; INHIBITOR; SMAC/DIABLO; EXPRESSION; BINDING; IDENTIFICATION; SUPPRESSION; ACTIVATION; C-IAP2	We describe the synthesis and properties of a small molecule mimic of Smac, a pro-apoptotic protein that functions by relieving inhibitor-of-apoptosis protein (IAP)-mediated suppression of caspase activity. The compound binds to X chromosome-encoded IAP (XIAP), cellular IAP 1 (clAP-1), and cellular IAP 2 (clAP-2) and synergizes with both tumor necrosis factor alpha (TNFalpha.) and TNF-related apoptosis-inducing ligand (TRAIL) to potently induce caspase activation and apoptosis in human cancer cells. The molecule has allowed a temporal, unbiased evaluation of the roles that IAP proteins play during signaling from TRAIL and TNF receptors. The compound is also a lead structure for the development of IAP antagonists potentially useful as therapy for cancer and inflammatory diseases.	Univ Texas, SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	De Brabander, JK (corresponding author), Univ Texas, SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	jdebra@biochem.swmed.edu; xwang@biochem.swmed.edu; pharra@biochem.swmed.edu			NCI NIH HHS [P01 CA95471] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA095471] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Arnt CR, 2002, J BIOL CHEM, V277, P44236, DOI 10.1074/jbc.M207578200; BERSCHEID R, 1992, SYNTHESIS-STUTTGART, P58; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; Chu ZL, 1997, P NATL ACAD SCI USA, V94, P10057, DOI 10.1073/pnas.94.19.10057; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Fox DA, 2000, ARCH INTERN MED, V160, P437, DOI 10.1001/archinte.160.4.437; Fulda S, 2002, NAT MED, V8, P808, DOI 10.1038/nm735; Hasegawa T, 2003, BLOOD, V101, P1164, DOI 10.1182/blood-2002-05-1505; Huang YH, 2003, J BIOL CHEM, V278, P49517, DOI 10.1074/jbc.M310061200; Imoto I, 2001, CANCER RES, V61, P6629; Krajewska M, 2003, CLIN CANCER RES, V9, P4914; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; Mammen M, 1998, ANGEW CHEM INT EDIT, V37, P2755; Pardo OE, 2003, MOL CELL BIOL, V23, P7600, DOI 10.1128/MCB.23.21.7600-7610.2003; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Uren AG, 1996, P NATL ACAD SCI USA, V93, P4974, DOI 10.1073/pnas.93.10.4974; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang XD, 2001, GENE DEV, V15, P2922; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; Yang LL, 2003, CANCER RES, V63, P831	25	565	629	7	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2004	305	5689					1471	1474		10.1126/science.1098231	http://dx.doi.org/10.1126/science.1098231			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	852NK	15353805				2022-12-24	WOS:000223761900051
J	Tzfira, T; Vaidya, M; Citovsky, V				Tzfira, T; Vaidya, M; Citovsky, V			Involvement of targeted proteolysis in plant genetic transformation by Agrobacterium	NATURE			English	Article							T-DNA TRANSFER; NUCLEAR-LOCALIZATION SIGNAL; NOPALINE STRAINS; BINDING-PROTEIN; VIRULENCE GENE; A-TUMEFACIENS; VIRD2 PROTEIN; CELLS; HOST; VIRE2	Genetic transformation of plant cells by Agrobacterium represents a unique case of trans-kingdom DNA transfer(1). During this process, Agrobacterium exports its transferred ( T) DNA and several virulence (Vir) proteins into the host cell(2), within which T-DNA nuclear import is mediated by VirD2 (ref. 3) and VirE2 ( ref. 4) and their host cell interactors AtKAP-alpha(5) and VIP1 (ref. 6), whereas its integration is mediated mainly by host cell proteins(7-9). The factors involved in the uncoating of T-DNA from its cognate proteins, which occurs before integration into the host genome, are still unknown. Here, we report that VirF - one of the few known exported Vir proteins whose function in the host cell remains unknown - is involved in targeted proteolysis of VIP1 and VirE2. We show that VirF localizes to the plant cell nucleus and interacts with VIP1, a nuclear protein. VirF, which contains an F-box motif(10), significantly destabilizes both VIP1 and VirE2 in yeast cells. Destabilization of VIP1 in the presence of VirF was then confirmed in planta. These results suggest that VIP1 and its cognate VirE2 are specifically targeted by the VirF-containing Skp1-Cdc53-cullin-F-box complex for proteolysis. The critical role of proteasomal degradation in Agrobacterium-mediated genetic transformation was also evident from inhibition of T-DNA expression by a proteasomal inhibitor.	SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Tzfira, T (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	ttzfira@ms.cc.sunysb.edu		Citovsky, Vitaly/0000-0003-2024-6844				Ballas N, 1997, P NATL ACAD SCI USA, V94, P10723, DOI 10.1073/pnas.94.20.10723; BUNDOCK P, 1995, EMBO J, V14, P3206, DOI 10.1002/j.1460-2075.1995.tb07323.x; CITOVSKY V, 1992, SCIENCE, V256, P1802, DOI 10.1126/science.1615325; Connelly JC, 1996, GENES CELLS, V1, P285, DOI 10.1046/j.1365-2443.1996.23024.x; del Pozo JC, 2000, PLANT MOL BIOL, V44, P123, DOI 10.1023/A:1006413007456; Deng WY, 1999, MOL MICROBIOL, V31, P1795, DOI 10.1046/j.1365-2958.1999.01316.x; DOMMISSE EM, 1990, PLANT SCI, V69, P249, DOI 10.1016/0168-9452(90)90124-7; Gelvin SB, 2000, ANNU REV PLANT PHYS, V51, P223, DOI 10.1146/annurev.arplant.51.1.223; Gelvin SB, 2003, MICROBIOL MOL BIOL R, V67, P16, DOI 10.1128/MMBR.67.1.16-37.2003; Goodin MM, 2002, PLANT J, V31, P375, DOI 10.1046/j.1365-313X.2002.01360.x; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; HOWARD EA, 1992, CELL, V68, P109, DOI 10.1016/0092-8674(92)90210-4; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; JARCHOW E, 1991, P NATL ACAD SCI USA, V88, P10426, DOI 10.1073/pnas.88.23.10426; Kunik T, 2001, P NATL ACAD SCI USA, V98, P1871, DOI 10.1073/pnas.041327598; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; MELCHERS LS, 1990, PLANT MOL BIOL, V14, P249, DOI 10.1007/BF00018565; Nagai H, 2003, CELL MICROBIOL, V5, P373, DOI 10.1046/j.1462-5822.2003.00285.x; Narasimhulu SB, 1996, PLANT CELL, V8, P873, DOI 10.1105/tpc.8.5.873; OTTEN L, 1984, MOL GEN GENET, V195, P159, DOI 10.1007/BF00332739; REGENSBURGTUINK AJG, 1993, NATURE, V363, P69, DOI 10.1038/363069a0; Schrammeijer B, 1998, MOL PLANT MICROBE IN, V11, P429, DOI 10.1094/MPMI.1998.11.5.429; Schrammeijer B, 2001, CURR BIOL, V11, P258, DOI 10.1016/S0960-9822(01)00069-0; STACHEL SE, 1989, NATURE, V340, P190, DOI 10.1038/340190a0; Tzfira T, 2001, EMBO J, V20, P3596, DOI 10.1093/emboj/20.13.3596; Tzfira T, 2002, P NATL ACAD SCI USA, V99, P10435, DOI 10.1073/pnas.162304099; Tzfira T, 2004, TRENDS GENET, V20, P375, DOI 10.1016/j.tig.2004.06.004; Tzfira T, 2002, TRENDS CELL BIOL, V12, P121, DOI 10.1016/S0962-8924(01)02229-2; Vergunst AC, 2000, SCIENCE, V290, P979, DOI 10.1126/science.290.5493.979; Zupan J, 2000, PLANT J, V23, P11, DOI 10.1046/j.1365-313x.2000.00808.x	30	186	207	3	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 2	2004	431	7004					87	92		10.1038/nature02857	http://dx.doi.org/10.1038/nature02857			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850VC	15343337				2022-12-24	WOS:000223641500047
J	Pignone, M				Pignone, M			Faecal occult-blood screening in Burgundy	LANCET			English	Editorial Material							COLORECTAL-CANCER MORTALITY		Univ N Carolina, Dept Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27707 USA; Cecil Sheps Ctr Hlth Serv Res, Chapel Hill, NC 27707 USA	University of North Carolina; University of North Carolina Chapel Hill	Pignone, M (corresponding author), Univ N Carolina, Dept Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27707 USA.	pignone@med.unc.edu		Pignone, Michael/0000-0002-6657-7342				Faivre J, 2004, GASTROENTEROLOGY, V126, P1674, DOI 10.1053/j.gastro.2004.02.018; Hardcastle JD, 1996, LANCET, V348, P1472, DOI 10.1016/S0140-6736(96)03386-7; KEWENTER J, 1994, SCAND J GASTROENTERO, V29, P468, DOI 10.3109/00365529409096840; Kronborg O, 1996, LANCET, V348, P1467, DOI 10.1016/S0140-6736(96)03430-7; Mandel JS, 1999, J NATL CANCER I, V91, P434, DOI 10.1093/jnci/91.5.434; Steele RJC, 2004, BMJ-BRIT MED J, V329, P133, DOI 10.1136/bmj.38153.491887.7C; Towler B, 1998, BRIT MED J, V317, P559, DOI 10.1136/bmj.317.7158.559	7	3	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 28	2004	364	9436					741	742		10.1016/S0140-6736(04)16953-5	http://dx.doi.org/10.1016/S0140-6736(04)16953-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	849VO	15337388				2022-12-24	WOS:000223569600009
J	Neumann, HPH; Pawlu, C; Peczkowska, M; Bausch, B; MeWhinney, SR; Muresan, M; Buchta, M; Franke, G; Klisch, J; Bley, TA; Hoegerle, S; Boedeker, CC; Opocher, G; Schipper, J; Januszewicz, A; Eng, C				Neumann, HPH; Pawlu, C; Peczkowska, M; Bausch, B; MeWhinney, SR; Muresan, M; Buchta, M; Franke, G; Klisch, J; Bley, TA; Hoegerle, S; Boedeker, CC; Opocher, G; Schipper, J; Januszewicz, A; Eng, C		European-Amer Paraganglioma Study Grp	Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ENDOCRINE NEOPLASIA TYPE-2; GERM-LINE MUTATIONS; COMPLEX-II GENE; HEREDITARY PARAGANGLIOMAS; PHEOCHROMOCYTOMA; MULTIPLE; SUSCEPTIBILITY; DISEASE; SURGERY; PET	Context Germline mutations of the genes encoding succinate dehydrogenase subunits B (SDHB) and D. (SDHD) predispose to paraganglioma syndromes type 4 (PGL-4) and type 1 (PGL-1), respectively. In both syndromes, pheochromocytomas as well as head and neck paragangliomas occur; however, details for individual risks and other clinical characteristics are unknown. Objective To determine the differences in clinical features in carriers of SDHB mutations and SDHD mutations. Design, Setting, and Patients Population-based genetic screening for SDHB and SDHD germline mutations in 417 unrelated patients with adrenal or extra-adrenal abdominal or thoracic pheochromocytomas (n =334) or head and neck paragangliomas (n =83), but without syndromic features, from 2 registries based in Germany and central Poland, conducted from April 1, 2000, until May 15, 2004. Main Outcome Measures Demographic and clinical findings with respect to gene mutation in SDHB vs SDHD compared with nonmutation carriers. Results A total of 49 (12%) of 417 registrants carried SDHB or SDHD mutations. In addition, 28 SDHB and 23 SDHD mutation carriers were newly detected among relatives of these carriers. Comparison of 53 SDHB and 47 SDHD total mutation carriers showed similar ages at diagnosis but differences in penetrance and of tumor manifestations. Head and neck paragangliomas (10/32 vs 27/34, respectively, P<.001) and multifocal (9/32 vs 25/34, respectively, P<.001) tumors were more frequent in carriers of SDHD mutations. In contrast, SDHB mutation carriers have an increased frequency of malignant disease (11/32 vs 0/34, P<.001). Renal cell cancer was observed in 2 SDHB mutation carriers and papillary thyroid cancer in 1 SDHB mutation carrier and 1 SDHD mutation carrier. Conclusions In contrast with SDHD mutation carriers (PGL-1) who have more frequent multifocal paragangliomas, SDHB mutation carriers (PGL-4) are more likely to develop malignant disease and possibly extraparaganglial neoplasias, including renal cell and thyroid carcinomas. Appropriate and timely clinical screening is recommended in all patients with PGL-1 and PGL-4.	Univ Freiburg, Med Klin, Dept Hypertens & Nephrol, D-79106 Freiburg, Germany; Univ Freiburg, Dept Neuroradiol, D-79106 Freiburg, Germany; Univ Freiburg, Dept Diagnost Radiol, D-79106 Freiburg, Germany; Univ Freiburg, Dept Nucl Med, D-79106 Freiburg, Germany; Univ Freiburg, Dept Otorhinolaryngol, D-79106 Freiburg, Germany; Inst Cardiol, Dept Hypertens, Warsaw, Poland; Ohio State Univ, Clin Canc Genet Program, Columbus, OH 43210 USA; Ohio State Univ, Human Canc Genet Program, Columbus, OH 43210 USA; Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; Ohio State Univ, Dept Internal Med, Div Human Genet, Columbus, OH 43210 USA; Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; Univ Nancy, Hop Brabois, Dept Endocrinol, Nancy, France; Univ Padua, Dept Endocrinol, Padua, Italy	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Institute of Cardiology - Poland; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; CHU de Nancy; Universite de Lorraine; University of Padua	Neumann, HPH (corresponding author), Univ Freiburg, Med Klin, Dept Hypertens & Nephrol, Hugstetter Str 55, D-79106 Freiburg, Germany.	neumann@med1.ukl.uni-freiburg.de	Opocher, Giuseppe/F-3950-2014	Opocher, Giuseppe/0000-0002-9845-9623; Eng, Charis/0000-0002-3693-5145	NCI NIH HHS [P30CA16058] Funding Source: Medline; NICHD NIH HHS [R01HD39058-02S1, R01HD39058-02] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039058] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282; Badenhop RF, 2001, GENE CHROMOSOME CANC, V31, P255, DOI 10.1002/gcc.1142; Bauters C, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.6.e75; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Baysal BE, 2002, J MED GENET, V39, P178, DOI 10.1136/jmg.39.3.178; Baysal BE, 2002, J MED GENET, V39, P617, DOI 10.1136/jmg.39.9.617; BAYSAL BE, IN PRESS J MED GENET; Cascon A, 2002, EUR J HUM GENET, V10, P457, DOI 10.1038/sj.ejhg.5200829; Eisenhofer G, 1999, NEW ENGL J MED, V340, P1872, DOI 10.1056/NEJM199906173402404; Eng C, 1996, JAMA-J AM MED ASSOC, V276, P1575, DOI 10.1001/jama.276.19.1575; Eng C, 2003, NAT REV CANCER, V3, P193, DOI 10.1038/nrc1013; Gimenez-Roqueplo AP, 2003, CANCER RES, V63, P5615; Gimenez-Roqueplo AP, 2001, AM J HUM GENET, V69, P1186, DOI 10.1086/324413; Gimm O, 2000, CANCER RES, V60, P6822; HEUTINK P, 1992, HUM MOL GENET, V1, P7, DOI 10.1093/hmg/1.1.7; Hoegerle S, 2003, EUR J NUCL MED MOL I, V30, P689, DOI 10.1007/s00259-003-1115-3; Hoegerle S, 2002, RADIOLOGY, V222, P507, DOI 10.1148/radiol.2222010622; Janetschek G, 1998, J UROLOGY, V160, P330, DOI 10.1016/S0022-5347(01)62886-6; Maher ER, 2002, HUM MOL GENET, V11, P2347, DOI 10.1093/hmg/11.20.2347; Milunsky JM, 2001, AM J MED GENET, V100, P311, DOI 10.1002/ajmg.1270; NEUMANN HPH, 1993, NEW ENGL J MED, V329, P1531, DOI 10.1056/NEJM199311183292103; Neumann HPH, 1999, BRIT J SURG, V86, P94, DOI 10.1046/j.1365-2168.1999.00974.x; Neumann HPH, 1999, J CLIN ENDOCR METAB, V84, P2608, DOI 10.1210/jc.84.8.2608; Neumann HPH, 2002, NEW ENGL J MED, V346, P1459, DOI 10.1056/NEJMoa020152; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; Niemann S, 2003, HUM GENET, V113, P92, DOI 10.1007/s00439-003-0938-0; Pacak K, 2001, HYPERTENSION, V38, P6, DOI 10.1161/01.HYP.38.1.6; RICCARDI VM, 1981, NEW ENGL J MED, V305, P1617, DOI 10.1056/NEJM198112313052704; Sawka AM, 2003, J CLIN ENDOCR METAB, V88, P553, DOI 10.1210/jc.2002-021251; Taschner PEM, 2001, GENE CHROMOSOME CANC, V31, P274, DOI 10.1002/gcc.1144; VANDERMEY AGL, 1989, LANCET, V2, P1291; Vanharanta S, 2004, AM J HUM GENET, V74, P153, DOI 10.1086/381054; Walz MK, 2002, WORLD J SURG, V26, P1005, DOI 10.1007/s00268-002-6632-x	33	657	683	2	37	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 25	2004	292	8					943	951		10.1001/jama.292.8.943	http://dx.doi.org/10.1001/jama.292.8.943			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	847WR	15328326	Bronze			2022-12-24	WOS:000223429200019
J	Lewis, T				Lewis, T			10-minute consultation - Using the NO TEARS tool for medication review	BRITISH MEDICAL JOURNAL			English	Article									Carreg Wen Surg, Torfaen NP4 9AF, Wales		Lewis, T (corresponding author), Carreg Wen Surg, Torfaen NP4 9AF, Wales.	Tessa.Lewis@gp-w93015.wales.nhs.uk							0	30	30	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	AUG 21	2004	329	7463					434	434		10.1136/bmj.329.7463.434	http://dx.doi.org/10.1136/bmj.329.7463.434			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	849EA	15321901	Green Published, Bronze, Green Submitted			2022-12-24	WOS:000223520300020
J	Araki, T; Sasaki, Y; Milbrandt, J				Araki, T; Sasaki, Y; Milbrandt, J			Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration	SCIENCE			English	Article							WALLERIAN DEGENERATION; LIFE-SPAN; SACCHAROMYCES-CEREVISIAE; PROTEIN; DEACETYLASE; NEUROPROTECTION; INHIBITORS; LONGEVITY; FAMILY; YEAST	Axonal degeneration is an active program of self-destruction that is observed in many physiological and pathological settings. In Wallerian degeneration slow (wld(s)) mice, Wallerian degeneration in response to axonal injury is delayed because of a mutation that results in overexpression of a chimeric protein (Wld(s)) composed of the ubiquitin assembly protein Ufd2a and the nicotinamide adenine dinucleotide (NAD) biosynthetic enzyme Nmnat1. We demonstrate that increased Nmnat activity is responsible for the axon-sparing activity of the Wlds protein. Furthermore, we demonstrate that SIRT1, a mammalian ortholog of Sir2, is the downstream effector of increased Nmnat activity that leads to axonal protection. These findings suggest that novel therapeutic strategies directed at increasing the supply of NAD and/or Sir2 activation may be effective for treatment of diseases characterized by axonopathy and neurodegeneration.	Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA	Washington University (WUSTL)	Milbrandt, J (corresponding author), Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA.	jmilbrandt@wustl.edu	Araki, Toshiyuki/H-4289-2019	Araki, Toshiyuki/0000-0003-3625-2042; Milbrandt, Jeffrey/0000-0002-5477-7689	NIA NIH HHS [AG13730, AG05681] Funding Source: Medline; NINDS NIH HHS [NS40745] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005681, R01AG013730] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Anderson RM, 2002, J BIOL CHEM, V277, P18881, DOI 10.1074/jbc.M111773200; ARAKI T, UNPUB; Bruzzone S, 2001, FASEB J, V15, P10; Buck SW, 2004, J LEUKOCYTE BIOL, V75, P939, DOI 10.1189/jlb.0903424; BUCKMASTER EA, 1995, EUR J NEUROSCI, V7, P1596, DOI 10.1111/j.1460-9568.1995.tb01155.x; COLEMAN MP, TRENDS NEUROSCI, V25, P532; Conforti L, 2000, P NATL ACAD SCI USA, V97, P11377, DOI 10.1073/pnas.97.21.11377; Gillingwater TH, 2004, J CEREBR BLOOD F MET, V24, P62, DOI 10.1097/01.WCB.0000095798.98378.34; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; LUNN ER, 1989, EUR J NEUROSCI, V1, P27, DOI 10.1111/j.1460-9568.1989.tb00771.x; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Magni G, 2004, CELL MOL LIFE SCI, V61, P19, DOI 10.1007/s00018-003-3161-1; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Sajadi A, 2004, CURR BIOL, V14, P326, DOI 10.1016//j.cub.2004.01.053; Skaper SD, 2003, ANN NY ACAD SCI, V993, P217, DOI 10.1111/j.1749-6632.2003.tb07532.x; SKAPER SD, 2003, ANN NY ACAD SCI, V993, P287; Southan GJ, 2003, CURR MED CHEM, V10, P321, DOI 10.2174/0929867033368376; Szabo C, 1996, P NATL ACAD SCI USA, V93, P1753, DOI 10.1073/pnas.93.5.1753; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Zhou TJ, 2002, J BIOL CHEM, V277, P13148, DOI 10.1074/jbc.M111469200	28	860	917	1	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2004	305	5686					1010	1013		10.1126/science.1098014	http://dx.doi.org/10.1126/science.1098014			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845ND	15310905				2022-12-24	WOS:000223250700050
J	Christopherson, KW; Hangoc, G; Mantel, CR; Broxmeyer, HE				Christopherson, KW; Hangoc, G; Mantel, CR; Broxmeyer, HE			Modulation of hematopoietic stem cell homing and engraftment by CD26	SCIENCE			English	Article							UMBILICAL-CORD BLOOD; MYELOID PROGENITOR CELLS; BONE-MARROW; FACTOR-I; COMPETITIVE REPOPULATION; NOD/SCID MICE; CXCR4; TRANSPLANTATION; MOBILIZATION; ASSAY	Hematopoietic stem cell homing and engraftment are crucial to transplantation efficiency, and clinical engraftment is severely compromised when donor-cell numbers are limiting. The peptidase CD26 (DPPIV/dipeptidylpeptidase IV) removes dipeptides from the amino terminus of proteins. We present evidence that endogenous CD26 expression on donor cells negatively regulates homing and engraftment. By inhibition or deletion of CD26, it was possible to increase greatly the efficiency of transplantation. These results suggest that hematopoietic stem cell engraftment is not absolute, as previously suggested, and indicate that improvement of bone marrow transplant efficiency may be possible in the clinic.	Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; Indiana Univ, Sch Med, Walther Oncol Ctr, Indianapolis, IN 46202 USA; Walther Canc Inst, Indianapolis, IN 46208 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Walther Cancer Institute; Walther Cancer Institute	Broxmeyer, HE (corresponding author), Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.	hbroxmey@iupui.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067384, R01HL056416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007519, R01DK053674] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL67384, R01 HL56416] Funding Source: Medline; NIDDK NIH HHS [T32 DK07519, R01 DK53674] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ara T, 2003, IMMUNITY, V19, P257, DOI 10.1016/S1074-7613(03)00201-2; Benveniste P, 2003, NAT IMMUNOL, V4, P708, DOI 10.1038/ni940; BROXMEYER HE, 1989, P NATL ACAD SCI USA, V86, P3828, DOI 10.1073/pnas.86.10.3828; Broxmeyer HE, 2003, J LEUKOCYTE BIOL, V73, P630, DOI 10.1189/jlb.1002495; Broxmeyer HE, 2002, BLOOD, V100, p609A; Broxmeyer HE, 2003, J IMMUNOL, V170, P421, DOI 10.4049/jimmunol.170.1.421; Broxmeyer HE, 2001, INT J HEMATOL, V74, P9, DOI 10.1007/BF02982544; BROXMEYER HE, 2004, THOMAS HEMATOPOIETIC, P550; Christopherson KW, 2003, EXP HEMATOL, V31, P1126, DOI 10.1016/j.exphem.2003.07.002; Christopherson KW, 2003, BLOOD, V101, P4680, DOI 10.1182/blood-2002-12-3893; Christopherson KW, 2002, J IMMUNOL, V169, P7000, DOI 10.4049/jimmunol.169.12.7000; Ema H, 2004, IMMUNITY, V20, P1, DOI 10.1016/S1074-7613(04)00002-0; GLUCKMAN E, 1989, NEW ENGL J MED, V321, P1174, DOI 10.1056/NEJM198910263211707; Gothot A, 1998, BLOOD, V92, P2641, DOI 10.1182/blood.V92.8.2641.420k36_2641_2649; HARRISON DE, 1993, EXP HEMATOL, V21, P206; HARRISON DE, 1980, BLOOD, V55, P77; Hattori K, 2001, BLOOD, V97, P3354, DOI 10.1182/blood.V97.11.3354; Jaroscak J, 2003, BLOOD, V101, P5061, DOI 10.1182/blood-2001-12-0290; Kim CH, 1998, BLOOD, V91, P100, DOI 10.1182/blood.V91.1.100.100_100_110; Kollet O, 2002, BLOOD, V100, P2778, DOI 10.1182/blood-2002-02-0564; Liles WC, 2003, BLOOD, V102, P2728, DOI 10.1182/blood-2003-02-0663; Matsuzaki Y, 2004, IMMUNITY, V20, P87, DOI 10.1016/S1074-7613(03)00354-6; Mazurier F, 2003, NAT MED, V9, P959, DOI 10.1038/nm886; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Rosenkilde MM, 2004, J BIOL CHEM, V279, P3033, DOI 10.1074/jbc.M309546200; Shpall EJ, 2002, BIOL BLOOD MARROW TR, V8, P368, DOI 10.1053/bbmt.2002.v8.pm12171483; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Wang JF, 2003, BLOOD, V101, P2924, DOI 10.1182/blood-2002-09-2782; Wright DE, 2002, J EXP MED, V195, P1145, DOI 10.1084/jem.20011284; Yahata T, 2003, BLOOD, V101, P2905, DOI 10.1182/blood-2002-07-1995	30	407	432	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2004	305	5686					1000	1003		10.1126/science.1097071	http://dx.doi.org/10.1126/science.1097071			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845ND	15310902				2022-12-24	WOS:000223250700047
J	Lesser, MP; Mazel, CH; Gorbunov, MY; Falkowski, PG				Lesser, MP; Mazel, CH; Gorbunov, MY; Falkowski, PG			Discovery of symbiotic nitrogen-fixing cyanobacteria in corals	SCIENCE			English	Article							FLUORESCENT PROTEINS; MARINE CYANOBACTERIUM; DIVERSITY; FIXATION; BACTERIA; PHOTOSYNTHESIS; PHYCOERYTHRIN; EMISSION; FAMILY; LIGHT	Colonies of the Caribbean coral Montastraea cavernosa exhibit a solar-stimulated orange-red fluorescence that is spectrally similar to a variety of fluorescent proteins expressed by corals. The source of this. uorescence is phycoerythrin in unicellular, nonheterocystis, symbiotic cyanobacteria within the host cells of the coral. The cyanobacteria coexist with the symbiotic dinoflagellates (zooxanthellae) of the coral and express the nitrogen. xing enzyme nitrogenase. The presence of this prokaryotic symbiont in a nitrogen-limited zooxanthellate coral suggests that nitrogen fixation may be an important source of this limiting element for the symbiotic association.	Univ New Hampshire, Dept Zool, Durham, NH 03824 USA; Univ New Hampshire, Ctr Marine Biol, Durham, NH 03824 USA; Phys Sci Inc, Andover, MA 01810 USA; Rutgers State Univ, Inst Marine & Coastal Sci, Environm Biophys & Mol Ecol Program, New Brunswick, NJ 08901 USA; Rutgers State Univ, Dept Geol Sci, Piscataway, NJ USA	University System Of New Hampshire; University of New Hampshire; University System Of New Hampshire; University of New Hampshire; Physical Sciences Inc.; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Lesser, MP (corresponding author), Univ New Hampshire, Dept Zool, Durham, NH 03824 USA.	mpl@cisunix.unh.edu						ADAMS DG, 2001, ECOLOGY CYANOBACTERI, P523; Berman-Frank I, 2001, SCIENCE, V294, P1534, DOI 10.1126/science.1064082; Dove SG, 2001, CORAL REEFS, V19, P197, DOI 10.1007/PL00006956; Dubinsky Z., 1994, Pacific Science, V48, P313; DUCKLOW HW, 1990, CORAL REEFS, P265; FALKOWSKI PG, 1993, BIOSCIENCE, V43, P606, DOI 10.2307/1312147; Gilmore AM, 2003, PHOTOCHEM PHOTOBIOL, V77, P515, DOI 10.1562/0031-8655(2003)077<0515:STROTE>2.0.CO;2; GLAZER AN, 1982, BIOCHEM SYST ECOL, V10, P203, DOI 10.1016/0305-1978(82)90031-X; Heikal AA, 2000, P NATL ACAD SCI USA, V97, P11996, DOI 10.1073/pnas.97.22.11996; Kelmanson IV, 2003, MOL BIOL EVOL, V20, P1125, DOI 10.1093/molbev/msg130; Knowlton N, 2003, AM NAT, V162, pS51, DOI 10.1086/378684; KUHL M, 1995, MAR ECOL PROG SER, V117, P159, DOI 10.3354/meps117159; Labas YA, 2002, P NATL ACAD SCI USA, V99, P4256, DOI 10.1073/pnas.062552299; Lesser MP, 1997, CORAL REEFS, V16, P187, DOI 10.1007/s003380050073; Litvaitis MK, 2002, HYDROBIOLOGIA, V468, P135, DOI 10.1023/A:1015262621848; Lokstein H, 1999, BBA-BIOENERGETICS, V1410, P97, DOI 10.1016/S0005-2728(98)00172-8; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Mazel CH, 2003, LIMNOL OCEANOGR, V48, P402, DOI 10.4319/lo.2003.48.1_part_2.0402; MAZEL CH, 1995, MAR ECOL PROG SER, V120, P185, DOI 10.3354/meps120185; Muscatine L, 1990, CORAL REEFS, P75; Nubel U, 1997, APPL ENVIRON MICROB, V63, P3327; Rohwer F, 2001, CORAL REEFS, V20, P85; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Schonhuber W, 1999, APPL ENVIRON MICROB, V65, P1259; SHASHAR N, 1994, MAR ECOL PROG SER, V111, P259, DOI 10.3354/meps111259; Veron J. E. N., 1995, CORALS SPACE TIME; WIEBE WJ, 1975, SCIENCE, V188, P257, DOI 10.1126/science.188.4185.257; WYMAN M, 1985, SCIENCE, V230, P818, DOI 10.1126/science.230.4727.818	28	330	344	11	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2004	305	5686					997	1000		10.1126/science.1099128	http://dx.doi.org/10.1126/science.1099128			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845ND	15310901				2022-12-24	WOS:000223250700046
J	Hernando, E; Nahle, Z; Juan, G; Diaz-Rodriguez, E; Alaminos, M; Hemann, M; Michel, L; Mittal, V; Gerald, W; Benezra, R; Lowe, SW; Cordon-Cardo, C				Hernando, E; Nahle, Z; Juan, G; Diaz-Rodriguez, E; Alaminos, M; Hemann, M; Michel, L; Mittal, V; Gerald, W; Benezra, R; Lowe, SW; Cordon-Cardo, C			Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control	NATURE			English	Article							SISTER-CHROMATID SEPARATION; SPINDLE CHECKPOINT; CHROMOSOME INSTABILITY; MAMMALIAN-CELLS; BLADDER-CANCER; GENES; MAD2; E2F; DISRUPTION; PROTEINS	Advanced human cancers are invariably aneuploid, in that they harbour cells with abnormal chromosome numbers(1,2). However, the molecular defects underlying this trait, and whether they are a cause or a consequence of the malignant phenotype, are not clear. Mutations that disable the retinoblastoma (Rb) pathway are also common in human cancers(1). These mutations promote tumour development by deregulating the E2F family of transcription factors leading to uncontrolled cell cycle progression(3). We show that the mitotic checkpoint protein Mad2 is a direct E2F target and, as a consequence, is aberrantly expressed in cells with Rb pathway defects. Concordantly, Mad2 is overexpressed in several tumour types, where it correlates with high E2F activity and poor patient prognosis. Generation of Rb pathway lesions in normal and transformed cells produces aberrant Mad2 expression and mitotic defects leading to aneuploidy, such that elevated Mad2 contributes directly to these defects. These results demonstrate how chromosome instability can arise as a by-product of defects in cell cycle control that compromise the accuracy of mitosis, and suggest a new model to explain the frequent appearance of aneuploidy in human cancer.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA	Cold Spring Harbor Laboratory; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Lowe, SW (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	lowe@cshl.edu	Díaz-Rodriguez, Elena/I-4784-2015; ALAMINOS, MIGUEL/N-9960-2016	Díaz-Rodriguez, Elena/0000-0002-6240-6327; ALAMINOS, MIGUEL/0000-0003-4876-2672; Hernando, Eva/0000-0003-1023-0312	NCI NIH HHS [P30 CA008748] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alaminos M, 2003, CANCER RES, V63, P4538; Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Arber N, 1997, CANCER RES, V57, P1569; Cahill DP, 1999, GENOMICS, V58, P181, DOI 10.1006/geno.1999.5831; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; DALBAGNI G, 1993, LANCET, V342, P469, DOI 10.1016/0140-6736(93)91595-D; Darzynkiewicz Z, 1996, CYTOMETRY, V25, P1; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hernando E, 2001, INT J CANCER, V95, P223, DOI 10.1002/1097-0215(20010720)95:4<223::AID-IJC1038>3.0.CO;2-L; Jallepalli PV, 2001, NAT REV CANCER, V1, P109, DOI 10.1038/35101065; Kalitsis P, 2000, GENE DEV, V14, P2277, DOI 10.1101/gad.827500; Lanni JS, 1998, MOL CELL BIOL, V18, P1055, DOI 10.1128/MCB.18.2.1055; Lentini L, 2002, NEOPLASIA, V4, P380, DOI 10.1038/sj.neo.7900256; Michel L, 2004, P NATL ACAD SCI USA, V101, P4459, DOI 10.1073/pnas.0306069101; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Sanchez-Carbayo M, 2002, CANCER RES, V62, P6973; Schuldiner O, 2001, ONCOGENE, V20, P4984, DOI 10.1038/sj.onc.1204459; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wassmann K, 1998, P NATL ACAD SCI USA, V95, P11193, DOI 10.1073/pnas.95.19.11193; Yu HT, 2002, CURR OPIN CELL BIOL, V14, P706, DOI 10.1016/S0955-0674(02)00382-4; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418	30	432	450	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2004	430	7001					797	802		10.1038/nature02820	http://dx.doi.org/10.1038/nature02820			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306814	Bronze			2022-12-24	WOS:000223233600046
J	Greeley, R; Squyres, SW; Arvidson, RE; Bartlett, P; Bell, JF; Blaney, D; Cabrol, NA; Farmer, J; Farrand, B; Golombek, MP; Gorevan, SP; Grant, JA; Haldemann, AFC; Herkenhoff, KE; Johnson, J; Landis, G; Madsen, MB; McLennan, SM; Moersch, J; Rice, JW; Richter, L; Ruff, S; Sullivan, RJ; Thompson, SD; Wang, A; Weitz, CM; Whelley, P				Greeley, R; Squyres, SW; Arvidson, RE; Bartlett, P; Bell, JF; Blaney, D; Cabrol, NA; Farmer, J; Farrand, B; Golombek, MP; Gorevan, SP; Grant, JA; Haldemann, AFC; Herkenhoff, KE; Johnson, J; Landis, G; Madsen, MB; McLennan, SM; Moersch, J; Rice, JW; Richter, L; Ruff, S; Sullivan, RJ; Thompson, SD; Wang, A; Weitz, CM; Whelley, P		Athena Sci Team	Wind-related processes detected by the Spirit rover at Gusev Crater, Mars	SCIENCE			English	Article							ROCKS		Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; Cornell Univ, Dept Astron, Ithaca, NY USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63031 USA; Honeybee Robot, New York, NY 10012 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; Univ Colorado, Space Sci Inst, Boulder, CO 80301 USA; Smithsonian Inst, Natl Air & Space Museum, Ctr Earth & Planetary Studies, Washington, DC 20560 USA; US Geol Survey, Flagstaff, AZ 86001 USA; Univ Copenhagen, Niels Bohr Inst Astron Phys & Geophys, Ctr Planetary Sci, DK-2100 Copenhagen, Denmark; Univ Copenhagen, Orsted Lab, DK-2100 Copenhagen, Denmark; SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; Deutsch Zentrum Luft & Raumfart, German Aerosp Ctr, Inst Space Simulat, D-51170 Cologne, Germany; NASA, Washington, DC 20546 USA	Arizona State University; Arizona State University-Tempe; Cornell University; Washington University (WUSTL); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Colorado System; University of Colorado Boulder; Smithsonian Institution; United States Department of the Interior; United States Geological Survey; University of Copenhagen; Niels Bohr Institute; University of Copenhagen; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Tennessee System; University of Tennessee Knoxville; Helmholtz Association; German Aerospace Centre (DLR); National Aeronautics & Space Administration (NASA)	Greeley, R (corresponding author), Arizona State Univ, Dept Geol Sci, Box 871404, Tempe, AZ 85287 USA.	Greeley@asu.edu	Haldemann, Albert F C/I-9224-2012; Madsen, Morten Bo/D-2082-2011; Farmer, Jack D/B-9343-2019; Whelley, Patrick/B-9560-2012; Moersch, Jeffrey E/F-7189-2010	Haldemann, Albert F C/0000-0003-3741-8841; Madsen, Morten Bo/0000-0001-8909-5111; Whelley, Patrick/0000-0003-3266-9772; Moersch, Jeffrey E/0000-0003-3433-9419; McLennan, Scott/0000-0003-4259-7178				Arvidson RE, 2004, SCIENCE, V305, P821, DOI 10.1126/science.1099922; Bandfield JL, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002290; Bell JF, 2004, SCIENCE, V305, P800, DOI 10.1126/science.1100175; Bell JF, 2002, ICARUS, V158, P56, DOI 10.1006/icar.2002.6865; Bridges NT, 2004, PLANET SPACE SCI, V52, P199, DOI 10.1016/j.pss.2003.08.026; Bridges NT, 1999, J GEOPHYS RES-PLANET, V104, P8595, DOI 10.1029/98JE02550; Christensen PR, 2004, SCIENCE, V305, P837, DOI 10.1126/science.1100564; Crisp JA, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002038; Golombek MP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002035; Golombek MP, 2000, J GEOPHYS RES-PLANET, V105, P1841, DOI 10.1029/1999JE001043; GOLOMBEK MP, 2004, LUNAR PLANET SCI, V35; Gorevan SP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002061; Grant JA, 2004, SCIENCE, V305, P807, DOI 10.1126/science.1099849; Greeley R, 1999, J GEOPHYS RES-PLANET, V104, P8573, DOI 10.1029/98JE02553; GREELEY R, 1987, GEOPHYS RES LETT, V14, P925, DOI 10.1029/GL014i009p00925; Greeley R, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002491; GREELEY R, 1982, J GEOPHYS RES, V87, P9, DOI 10.1029/JB087iB12p10009; GREELEY R, 1979, J GEOPHYS RES, V84, P6248, DOI 10.1029/JB084iB11p06248; Greeley R., 1985, WIND GEOLOGICAL PROC, DOI 10.1017/CBO9780511573071; Greeley R., 1992, MARS, P730; Herkenhoff KE, 2004, SCIENCE, V305, P824, DOI 10.1126/science.1100015; Herkenhoff KE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002076; McSween HY, 2004, SCIENCE, V305, P842, DOI 10.1126/science.3050842; Mellon MT, 2000, ICARUS, V148, P437, DOI 10.1006/icar.2000.6503; Pollack J. B., 1977, Journal of Geophysical Research, V82, P4479, DOI 10.1029/JS082i028p04479; Rafkin SCR, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002027; RAUPACH MR, 1992, BOUND-LAY METEOROL, V60, P375, DOI 10.1007/BF00155203; RAUPACH MR, 1993, J GEOPHYS RES-ATMOS, V98, P3023, DOI 10.1029/92JD01922; SHARP RP, 1963, J GEOL, V71, P617, DOI 10.1086/626936; Smith PH, 1997, SCIENCE, V278, P1758, DOI 10.1126/science.278.5344.1758; Squyres SW, 2004, SCIENCE, V305, P794, DOI 10.1126/science.3050794; TOIGO D, 2003, J GEOPHYS RES, V108, DOI DOI 10.1029/2003JE002064; Tomasko MG, 1999, J GEOPHYS RES-PLANET, V104, P8987, DOI 10.1029/1998JE900016	33	85	86	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					810	+		10.1126/science.1100108	http://dx.doi.org/10.1126/science.1100108			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297660				2022-12-24	WOS:000223104900034
J	Kilner, RM; Madden, JR; Hauber, ME				Kilner, RM; Madden, JR; Hauber, ME			Brood parasitic cowbird nestlings use host young to procure resources	SCIENCE			English	Article							PARENT-OFFSPRING CONFLICT; SIBLING COMPETITION; MODELS; SELFISH; CHICKS; COST; NEST	Young brood parasites that tolerate the company of host offspring challenge the existing evolutionary view of family life. In theory, all parasitic nestlings should be ruthlessly self-interested and should kill host offspring soon after hatching. Yet many species allow host young to live, even though they are rivals for host resources. Here we show that the tolerance of host nestlings by the parasitic brown-headed cowbird Molothrus ater is adaptive. Host young procure the cowbird a higher provisioning rate, so it grows more rapidly. The cowbird's unexpected altruism toward host offspring simply promotes its selfish interests in exploiting host parents.	Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; Univ Calif Berkeley, Museum Vertebrate Zool, Dept Integrat Biol, Berkeley, CA 94720 USA	University of Cambridge; University of Auckland; University of California System; University of California Berkeley	Kilner, RM (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	rmk1002@hermes.cam.ac.uk	Kilner, Rebecca/B-2867-2012	Kilner, Rebecca/0000-0003-1159-0758				Davies N.B., 2000, CUCKOOS COWBIRDS OTH; Dearborn DC, 1996, CONDOR, V98, P645, DOI 10.2307/1369581; Dearborn DC, 1998, BEHAV ECOL SOCIOBIOL, V43, P259, DOI 10.1007/s002650050490; FORBES LS, 1993, AM NAT, V142, P82, DOI 10.1086/285530; Gebhardt-Henrich S., 1998, AVIAN GROWTH DEV, P324; GODFRAY HCJ, 1995, NATURE, V376, P133, DOI 10.1038/376133a0; GUSTAFSSON L, 1988, NATURE, V335, P813, DOI 10.1038/335813a0; Haig D, 1996, J EVOLUTION BIOL, V9, P357, DOI 10.1046/j.1420-9101.1996.9030357.x; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hauber Mark E., 2004, Etologia, V10, P1; Hauber ME, 2003, BEHAV ECOL, V14, P227, DOI 10.1093/beheco/14.2.227; Hosoi SA, 2000, ANIM BEHAV, V59, P823, DOI 10.1006/anbe.1999.1370; Johnstone RA, 1999, P NATL ACAD SCI USA, V96, P12644, DOI 10.1073/pnas.96.22.12644; Kilner RM, 2003, ANIM BEHAV, V66, P569, DOI 10.1006/anbe.2003.2204; Kilpatrick AM, 2002, CAN J ZOOL, V80, P145, DOI 10.1139/Z01-217; Lichtenstein G, 1998, P ROY SOC B-BIOL SCI, V265, P249, DOI 10.1098/rspb.1998.0289; Lotem A, 1998, TRENDS ECOL EVOL, V13, P342, DOI 10.1016/S0169-5347(98)01401-3; MACNAIR MR, 1979, ANIM BEHAV, V27, P1202, DOI 10.1016/0003-3472(79)90067-8; MAY RM, 1985, AM NAT, V126, P475, DOI 10.1086/284433; Maynard Smith J., 1991, Animal Behaviour, V42, P1034; PARKER GA, 1989, AM NAT, V133, P846, DOI 10.1086/284956; PARKER GA, 1979, ANIM BEHAV, V27, P1210, DOI 10.1016/0003-3472(79)90068-X; Payne RB, 2001, ANIM BEHAV, V62, P473, DOI 10.1006/anbe.2001.1773; Reeve HK, 1999, MG BEH ECOL, P3; Rodriguez-Girones MA, 1999, P ROY SOC B-BIOL SCI, V266, P2399, DOI 10.1098/rspb.1999.0937; ROTHSTEIN SI, 1975, CONDOR, V77, P250, DOI 10.2307/1366221; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; TRIVERS RL, 1974, AM ZOOL, V14, P249; Wilson DS, 2002, EVOLUTION OF BEGGING: COMPETITION, COOPERATION AND COMMUNICATION, P43, DOI 10.1007/0-306-47660-6_3; [No title captured]	30	133	143	0	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					877	879		10.1126/science.1098487	http://dx.doi.org/10.1126/science.1098487			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297677				2022-12-24	WOS:000223104900053
J	Morris, RV; Klingelhofer, G; Bernhardt, B; Schroder, C; Rodionov, DS; de Souza, PA; Yen, A; Gellert, R; Evlanov, EN; Foh, J; Kankeleit, E; Gutlich, P; Ming, DW; Renz, F; Wdowiak, T; Squyres, SW; Arvidson, RE				Morris, RV; Klingelhofer, G; Bernhardt, B; Schroder, C; Rodionov, DS; de Souza, PA; Yen, A; Gellert, R; Evlanov, EN; Foh, J; Kankeleit, E; Gutlich, P; Ming, DW; Renz, F; Wdowiak, T; Squyres, SW; Arvidson, RE			Mineralogy at Gusev crater from the Mossbauer spectrometer on the Spirit rover	SCIENCE			English	Article							ROCKS; MARS; SOILS; SPECTROSCOPY; HEMATITE	Mossbauer spectra measured on Mars by the Spirit rover during the primary mission are characterized by two ferrous iron doublets ( olivine and probably pyroxene) and a ferric iron doublet ( tentatively associated to nanophase ferric iron oxide). Two sextets resulting from nonstoichiometric magnetite are also present, except for a coating on the rock Mazatzal, where a hematite-like sextet is present. Greater proportions of ferric-bearing phases are associated with undisturbed soils and rock surfaces as compared to fresh rock surfaces exposed by grinding. The ubiquitous presence of olivine in soil suggests that physical rather than chemical weathering processes currently dominate at Gusev crater.	NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; Johannes Gutenberg Univ Mainz, Inst Anorgan & Analyt Chem, D-55128 Mainz, Germany; IKI, Space Res Inst, Moscow, Russia; CVRD Grp, Vitoria, Brazil; CALTECH, Jet Prop Lab, Pasadena, CA USA; Max Planck Inst Chem, D-55128 Mainz, Germany; Tech Univ Darmstadt, Darmstadt, Germany; Univ Alabama Birmingham, Birmingham, AL USA; Cornell Univ, Ithaca, NY USA; Washington Univ, St Louis, MO USA	National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Johannes Gutenberg University of Mainz; Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Max Planck Society; Technical University of Darmstadt; University of Alabama System; University of Alabama Birmingham; Cornell University; Washington University (WUSTL)	Morris, RV (corresponding author), NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA.	richard.v.morris@nasa.gov	de Souza, Paulo/P-7294-2019; de Souza, Paulo/W-2993-2019; de Souza, Paulo A/B-8961-2008; Schröder, Christian/B-3870-2009	de Souza, Paulo/0000-0002-0091-8925; de Souza, Paulo A/0000-0002-0091-8925; Schröder, Christian/0000-0002-7935-6039; Renz, Franz/0000-0003-1494-1242				Arvidson RE, 2004, SCIENCE, V305, P821, DOI 10.1126/science.1099922; BANDFIELD JL, 2002, J GEOPHYS RES, V107, P1626; Bell JF, 2004, SCIENCE, V305, P800, DOI 10.1126/science.1100175; Bertelsen P, 2004, SCIENCE, V305, P827, DOI 10.1126/science.1100112; Bishop J.L., 1996, SPEC PUBL GEOCHEM SO, V5, P337; BURNS RG, 1989, ACS SYM SER, V415, P262; BURNS RG, 1993, REMOTE GEOCHEMICAL A, P539; Christensen PR, 2004, SCIENCE, V305, P837, DOI 10.1126/science.1100564; Cornell RM, 2003, IRON OXIDES STRUCTUR, DOI [10.1002/3527602097.ins, DOI 10.1002/]; DANIELS JM, 1969, J PHYS CHEM SOLIDS, V30, P1561, DOI 10.1016/0022-3697(69)90217-0; de Souza PA, 1999, LAB ROBOTICS AUTOMAT, V11, P3, DOI 10.1002/(SICI)1098-2728(1999)11:1<3::AID-LRA2>3.0.CO;2-F; DEGRAVE E, 1991, PHYS CHEM MINER, V18, P337, DOI 10.1007/BF00200191; Dyar MD, 2003, METEORIT PLANET SCI, V38, P1733, DOI 10.1111/j.1945-5100.2003.tb00012.x; Gellert R, 2004, SCIENCE, V305, P829, DOI 10.1126/science.1099913; Herkenhoff KE, 2004, SCIENCE, V305, P824, DOI 10.1126/science.1100015; Hoefen TM, 2003, SCIENCE, V302, P627, DOI 10.1126/science.1089647; Klingelhofer G, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002138; MCCAMMON C, 1995, AGU REFERENCE SHELF, V2, P332; McSween HY, 2004, SCIENCE, V305, P842, DOI 10.1126/science.3050842; MCSWEEN HY, 1994, METEORITICS, V29, P757, DOI 10.1111/j.1945-5100.1994.tb01092.x; MENZIES ON, 2001, LUNAR PLANET SCI, V32; MORRIS RV, 1995, J GEOPHYS RES-PLANET, V100, P5319, DOI 10.1029/94JE01500; Morris RV, 2000, J GEOPHYS RES-PLANET, V105, P1757, DOI 10.1029/1999JE001059; MORRIS RV, 1989, J GEOPHYS RES-SOLID, V94, P2760, DOI 10.1029/JB094iB03p02760; MYNENI SCB, 2000, REV MINERALOGY GEOCH, V40; SCHAEFER MW, 1983, NATURE, V303, P325, DOI 10.1038/303325a0; Squyres SW, 2004, SCIENCE, V305, P794, DOI 10.1126/science.3050794; Squyres SW, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002121; Stevens J. G., 1998, MOSSBAUER MINERAL HD; VIEIRA VWA, 1986, PHYS SCRIPTA, V33, P180, DOI 10.1088/0031-8949/33/2/016	30	206	209	3	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					833	836		10.1126/science.1100020	http://dx.doi.org/10.1126/science.1100020			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297666				2022-12-24	WOS:000223104900039
J	Rios, RM; Sanchis, A; Tassin, AM; Fedriani, C; Bornens, M				Rios, RM; Sanchis, A; Tassin, AM; Fedriani, C; Bornens, M			GMAP-210 recruits gamma-tubulin complexes to cis-Golgi membranes and is required for Golgi ribbon formation	CELL			English	Article							MAMMALIAN-CELLS; MICROTUBULE DYNAMICS; INTERMEDIATE COMPARTMENT; PROTEIN COMPLEX; APPARATUS; CYCLE; OVEREXPRESSION; MITOCHONDRIA; CENTROSOME; CHAIN	Mammalian cells concentrate Golgi membranes around the centrosome in a microtubule-dependent manner. The mechanisms involved in generating a single Golgi ribbon in the periphery of the centrosome remain unknown. Here we show that GMAP-210, a cis-Golgi microtubule binding protein, recruits gamma-tubulin-containing complexes to Golgi membranes even in conditions where microtubule polymerization is prevented and independently of Golgi apparatus localization within the cell. Under overexpression conditions, very short microtubules, or tubulin oligomers, are stabilized on Golgi membranes. GMAP-210 depletion by RNA interference results in extensive fragmentation of the Golgi apparatus, supporting a role for GMAP-210 in Golgi ribbon formation. Targeting of GMAP-210 or its C terminus to mitochondria induces the recruitment of gamma-tubulin to their surface and redistribution of mitochondria to a pericentrosomal location. All our experiments suggest that GMAP-210 displays microtubule anchoring and membrane fusion activities, thus contributing to the assembly and maintenance of the Golgi ribbon around the centrosome.	Univ Sevilla, Fac Biol, Dept Microbiol, E-41080 Seville, Spain; CNRS, UMR 144, Inst Curie, Sect Rech, F-75248 Paris 05, France	University of Sevilla; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite	Rios, RM (corresponding author), Univ Sevilla, Fac Biol, Dept Microbiol, Apdo 1095, E-41080 Seville, Spain.	rmrios@us.es	rios, rosa m/G-5742-2015	rios, rosa m/0000-0001-5778-6946				Abal M, 2002, J CELL BIOL, V159, P731, DOI 10.1083/jcb.200207076; Akhmanova A, 2001, CELL, V104, P923, DOI 10.1016/S0092-8674(01)00288-4; Altan-Bonnet N, 2003, P NATL ACAD SCI USA, V100, P13314, DOI 10.1073/pnas.2234055100; Barr FA, 1998, EMBO J, V17, P3258, DOI 10.1093/emboj/17.12.3258; Barr FA, 2003, CURR OPIN CELL BIOL, V15, P405, DOI 10.1016/S0955-0674(03)00054-1; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Chabin-Brion K, 2001, MOL BIOL CELL, V12, P2047, DOI 10.1091/mbc.12.7.2047; Colanzi A, 2003, CURR OPIN CELL BIOL, V15, P462, DOI 10.1016/S0955-0674(03)00067-X; De Vos K, 2000, J CELL BIOL, V149, P1207, DOI 10.1083/jcb.149.6.1207; Diao A, 2003, J CELL BIOL, V160, P201, DOI 10.1083/jcb.200207045; Dictenberg JB, 1998, J CELL BIOL, V141, P163, DOI 10.1083/jcb.141.1.163; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Grissom PM, 2002, MOL BIOL CELL, V13, P817, DOI 10.1091/mbc.01-08-0402; Harada A, 1998, J CELL BIOL, V141, P51, DOI 10.1083/jcb.141.1.51; Infante C, 1999, J CELL BIOL, V145, P83, DOI 10.1083/jcb.145.1.83; JASMIN BJ, 1989, P NATL ACAD SCI USA, V86, P7218, DOI 10.1073/pnas.86.18.7218; Khodjakov A, 1999, J CELL BIOL, V146, P585, DOI 10.1083/jcb.146.3.585; KREIS TE, 1987, EMBO J, V6, P2597, DOI 10.1002/j.1460-2075.1987.tb02550.x; Lippincott-Schwartz J, 2000, HISTOCHEM CELL BIOL, V114, P93; Llanos R, 1999, BIOCHEMISTRY-US, V38, P15712, DOI 10.1021/bi990895w; Maag RS, 2003, CURR OPIN CELL BIOL, V15, P456, DOI 10.1016/S0955-0674(03)00075-9; Marra P, 2001, NAT CELL BIOL, V3, P1101, DOI 10.1038/ncb1201-1101; Marsh BJ, 2001, P NATL ACAD SCI USA, V98, P2399, DOI 10.1073/pnas.051631998; Moudjou M, 1996, J CELL SCI, V109, P875; Pernet-Gallay K, 2002, TRAFFIC, V3, P822, DOI 10.1034/j.1600-0854.2002.31107.x; PISTOR S, 1994, EMBO J, V13, P758, DOI 10.1002/j.1460-2075.1994.tb06318.x; Prigozhina NL, 2004, MOL BIOL CELL, V15, P1374, DOI 10.1091/mbc.E03-06-0405; Rios RM, 2003, CURR OPIN CELL BIOL, V15, P60, DOI 10.1016/S0955-0674(02)00013-3; RIOS RM, 1994, J CELL BIOL, V125, P997, DOI 10.1083/jcb.125.5.997; RODIONOV VI, 1993, J CELL BIOL, V123, P1811, DOI 10.1083/jcb.123.6.1811; Saoudi Y, 1998, J CELL BIOL, V142, P1519, DOI 10.1083/jcb.142.6.1519; Satoh A, 2003, TRAFFIC, V4, P153, DOI 10.1034/j.1600-0854.2003.00103.x; Short B, 2001, J CELL BIOL, V155, P877, DOI 10.1083/jcb.200108079; Sutterlin C, 2002, CELL, V109, P359, DOI 10.1016/S0092-8674(02)00720-1; Takahashi M, 2002, MOL BIOL CELL, V13, P3235, DOI 10.1091/mbc.E02-02-0112; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Tassin AM, 1998, J CELL BIOL, V141, P689, DOI 10.1083/jcb.141.3.689; Terada Y, 2003, J CELL BIOL, V162, P757, DOI 10.1083/jcb.200305048; Thyberg J, 1999, EXP CELL RES, V246, P263, DOI 10.1006/excr.1998.4326; Usui T, 2003, EMBO J, V22, P4779, DOI 10.1093/emboj/cdg459; Xu Y, 2002, J CELL BIOL, V158, P293, DOI 10.1083/jcb.200202058; Yoshimura S, 2001, J CELL SCI, V114, P4105	44	182	189	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	AUG 6	2004	118	3					323	335						13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846XP	15294158				2022-12-24	WOS:000223353100009
J	Squyres, SW; Arvidson, RE; Bell, JF; Bruckner, J; Cabrol, NA; Calvin, W; Carr, MH; Christensen, PR; Clark, BC; Crumpler, L; Des Marais, DJ; d'Uston, C; Economou, T; Farmer, J; Farrand, W; Folkner, W; Golombek, M; Gorevan, S; Grant, JA; Greeley, R; Grotzinger, J; Haskin, L; Herkenhoff, KE; Hviid, S; Johnson, J; Klingelhofer, G; Knoll, A; Landis, G; Lemmon, M; Li, R; Madsen, MB; Malin, MC; McLennan, SM; McSween, HY; Ming, DW; Moersch, J; Morris, RV; Parker, T; Rice, JW; Richter, L; Rieder, R; Sims, M; Smith, M; Smith, P; Soderblom, LA; Sullivan, R; Wanke, H; Wdowiak, T; Wolff, M; Yen, A				Squyres, SW; Arvidson, RE; Bell, JF; Bruckner, J; Cabrol, NA; Calvin, W; Carr, MH; Christensen, PR; Clark, BC; Crumpler, L; Des Marais, DJ; d'Uston, C; Economou, T; Farmer, J; Farrand, W; Folkner, W; Golombek, M; Gorevan, S; Grant, JA; Greeley, R; Grotzinger, J; Haskin, L; Herkenhoff, KE; Hviid, S; Johnson, J; Klingelhofer, G; Knoll, A; Landis, G; Lemmon, M; Li, R; Madsen, MB; Malin, MC; McLennan, SM; McSween, HY; Ming, DW; Moersch, J; Morris, RV; Parker, T; Rice, JW; Richter, L; Rieder, R; Sims, M; Smith, M; Smith, P; Soderblom, LA; Sullivan, R; Wanke, H; Wdowiak, T; Wolff, M; Yen, A			The Spirit Rover's Athena Science Investigation at Gusev Crater, Mars	SCIENCE			English	Article							MAGNETIC-PROPERTIES EXPERIMENTS; MOSSBAUER SPECTROMETER; LANDING SITES; ROCKS; MISSION; SOILS	The Mars Exploration Rover Spirit and its Athena science payload have been used to investigate a landing site in Gusev crater. Gusev is hypothesized to be the site of a former lake, but no clear evidence for lacustrine sedimentation has been found to date. Instead, the dominant lithology is basalt, and the dominant geologic processes are impact events and eolian transport. Many rocks exhibit coatings and other characteristics that may be evidence for minor aqueous alteration. Any lacustrine sediments that may exist at this location within Gusev apparently have been buried by lavas that have undergone subsequent impact disruption.	Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; Max Planck Inst Chem, Abt Kosmochem, D-55128 Mainz, Germany; NASA, Ames SETI Inst, Moffett Field, CA 94035 USA; Univ Nevada, Dept Geol Sci, Reno, NV 89557 USA; US Geol Survey, Menlo Pk, CA 94025 USA; Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; Lockheed Martin Corp, Littleton, CO 80127 USA; New Mexico Museum Nat Hist & Sci, Albuquerque, NM 87104 USA; NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; Ctr Etud Spatiale Rayonnements, F-31028 Toulouse 4, France; Univ Chicago, Enrico Fermi Inst, Chicago, IL 60637 USA; Space Sci Inst, Boulder, CO 80301 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Honeybee Robot, New York, NY 10012 USA; Smithsonian Inst, Ctr Earth & Planetary Studies, Washington, DC 20560 USA; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; US Geol Survey, Flagstaff, AZ 86001 USA; Max Planck Inst Aeron, D-37191 Katlenburg Lindau, Germany; Johannes Gutenberg Univ Mainz, D-55099 Mainz, Germany; Harvard Univ, Bot Museum, Cambridge, MA 02138 USA; NASA, Glenn Res Ctr, Cleveland, OH 44135 USA; Texas A&M Univ, Dept Atmospher Sci, College Stn, TX 77843 USA; Ohio State Univ, Dept Civil & Environm Engn & Geodet Sci, Columbus, OH 43210 USA; Niels Bohr Inst, DK-2100 Copenhagen 0, Denmark; Malin Space Sci Syst, San Diego, CA 92191 USA; SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; Deutsch Zentrum Luft & Raumfahrt, Inst Raumsimulat, D-51170 Cologne, Germany; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; Univ Alabama Birmingham, Dept Phys, Birmingham, AL 35294 USA; Space Sci Inst, Martinez, GA 30907 USA	Cornell University; Washington University (WUSTL); Max Planck Society; National Aeronautics & Space Administration (NASA); Nevada System of Higher Education (NSHE); University of Nevada Reno; United States Department of the Interior; United States Geological Survey; Arizona State University; Arizona State University-Tempe; Lockheed Martin; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of Chicago; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Smithsonian Institution; Massachusetts Institute of Technology (MIT); United States Department of the Interior; United States Geological Survey; Max Planck Society; Johannes Gutenberg University of Mainz; Harvard University; National Aeronautics & Space Administration (NASA); NASA Glenn Research Center; Texas A&M University System; Texas A&M University College Station; University System of Ohio; Ohio State University; University of Copenhagen; Niels Bohr Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Tennessee System; University of Tennessee Knoxville; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Helmholtz Association; German Aerospace Centre (DLR); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Arizona; University of Alabama System; University of Alabama Birmingham	Squyres, SW (corresponding author), Cornell Univ, Dept Astron, Ithaca, NY 14853 USA.	squyres@astro.cornell.edu	Lemmon, Mark/X-2333-2019; Moersch, Jeffrey E/F-7189-2010; Smith, Michael/C-8875-2012; Sullivan, Robert/AAR-8193-2020; Farmer, Jack D/B-9343-2019; Madsen, Morten Bo/D-2082-2011; Lemmon, Mark T/E-9983-2010	Lemmon, Mark/0000-0002-4504-5136; Moersch, Jeffrey E/0000-0003-3433-9419; Madsen, Morten Bo/0000-0001-8909-5111; Lemmon, Mark T/0000-0002-4504-5136; McLennan, Scott/0000-0003-4259-7178				Arvidson RE, 2004, SCIENCE, V305, P821, DOI 10.1126/science.1099922; Bell JF, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002070; Bell JF, 2004, SCIENCE, V305, P800, DOI 10.1126/science.1100175; Bertelsen P, 2004, SCIENCE, V305, P827, DOI 10.1126/science.1100112; Bruckner J, 2003, J GEOPHYS RES-PLANET, V108, DOI [10.1029/2003JE002060, 10.1029/2003JE002150]; Cabrol NA, 1996, ICARUS, V123, P269, DOI 10.1006/icar.1996.0157; Cabrol NA, 1998, ICARUS, V132, P362, DOI 10.1006/icar.1998.5903; Cabrol NA, 1998, ICARUS, V133, P98, DOI 10.1006/icar.1998.5914; Christensen PR, 2004, SCIENCE, V305, P837, DOI 10.1126/science.1100564; CHRISTENSEN PR, 1986, ICARUS, V68, P217, DOI 10.1016/0019-1035(86)90020-5; Christensen PR, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002117; Crisp JA, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002038; Gellert R, 2004, SCIENCE, V305, P829, DOI 10.1126/science.1099913; Golombek MP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002074; Gorevan SP, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002061; Grant JA, 2004, SCIENCE, V305, P807, DOI 10.1126/science.1099849; GRANT JA, 1993, J GEOPHYS RES-PLANET, V98, P11025, DOI 10.1029/93JE00121; Greeley R, 1999, J GEOPHYS RES-PLANET, V104, P8573, DOI 10.1029/98JE02553; Greeley R, 2004, SCIENCE, V305, P810, DOI 10.1126/science.1100108; Greeley R, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002006; Herkenhoff KE, 2004, SCIENCE, V305, P824, DOI 10.1126/science.1100015; Herkenhoff KE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002076; Klingelhofer G, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002138; Madsen MB, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002029; Maki JN, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002077; McSween HY, 2004, SCIENCE, V305, P842, DOI 10.1126/science.3050842; Melosh H.L, 1989, IMPACT CRATERING GEO; Milam KA, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002023; Morris RV, 2004, SCIENCE, V305, P833, DOI 10.1126/science.1100020; Rafkin SCR, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002027; Smith MD, 2004, ICARUS, V167, P148, DOI 10.1016/j.icarus.2003.09.010; Squyres SW, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002121	32	299	305	1	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					794	799		10.1126/science.3050794	http://dx.doi.org/10.1126/science.3050794			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297657				2022-12-24	WOS:000223104900031
J	Pochan, DJ; Chen, ZY; Cui, HG; Hales, K; Qi, K; Wooley, KL				Pochan, DJ; Chen, ZY; Cui, HG; Hales, K; Qi, K; Wooley, KL			Toroidal triblock copolymer assemblies	SCIENCE			English	Article							DIBLOCK COPOLYMERS; BLOCK-COPOLYMERS; MULTIPLE MORPHOLOGIES; SHAPED MORPHOLOGY; DILUTE-SOLUTION; DNA COMPLEXES; F-ACTIN; MICELLES; VESICLES; SURFACTANT	A stable phase of toroidal, or ringlike, supramolecular assemblies was formed by combining dilute solution characteristics critical for both bundling of like-charged biopolymers and block copolymer micelle formation. The key to toroid versus classic cylinder micelle formation is the interaction of the negatively charged hydrophilic block of an amphiphilic triblock copolymer with a positively charged divalent organic counterion. This produces a self-attraction of cylindrical micelles that leads to toroid formation, a mechanism akin to the toroidal bundling of semiflexible charged biopolymers such as DNA. The toroids can be kinetically trapped or chemically cross-linked. insight into the mechanism of toroid formation can be gained by observation of intermediate structures kinetically trapped during film casting.	Univ Delaware, Delaware Biotechnol Inst, Newark, DE 19716 USA; Washington Univ, Ctr Mat Innovat, St Louis, MO 63130 USA; Washington Univ, Dept Chem, St Louis, MO 63130 USA	University of Delaware; Washington University (WUSTL); Washington University (WUSTL)	Pochan, DJ (corresponding author), Univ Delaware, Delaware Biotechnol Inst, Newark, DE 19716 USA.		Wooley, Karen L/D-4399-2015; Cui, Honggang/E-8012-2010; Qi, Kai/C-2558-2018; Cui, Honggang/C-6550-2008; Wooley, Karen/AAX-2259-2020	Wooley, Karen L/0000-0003-4086-384X; Qi, Kai/0000-0002-4166-7421; Wooley, Karen/0000-0003-4086-384X				Bermudez H, 2002, MACROMOLECULES, V35, P8203, DOI 10.1021/ma020669l; Bernheim-Groswasser A, 2000, J PHYS CHEM B, V104, P4005, DOI 10.1021/jp994301a; Bloomfield VA, 1997, BIOPOLYMERS, V44, P269, DOI 10.1002/(SICI)1097-0282(1997)44:3<269::AID-BIP6>3.0.CO;2-T; Bottcher C, 1998, J AM CHEM SOC, V120, P12, DOI 10.1021/ja971047w; Cornelissen JJLM, 1998, SCIENCE, V280, P1427, DOI 10.1126/science.280.5368.1427; Dalhaimer P, 2004, J POLYM SCI POL PHYS, V42, P168, DOI 10.1002/polb.10709; Discher BM, 1999, SCIENCE, V284, P1143, DOI 10.1126/science.284.5417.1143; Ewert K, 2004, CURR MED CHEM, V11, P133, DOI 10.2174/0929867043456160; Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187; In M, 1999, J PHYS CHEM B, V103, P7747, DOI 10.1021/jp9919922; Jain S, 2004, MACROMOLECULES, V37, P1511, DOI 10.1021/ma035467j; Jain S, 2003, SCIENCE, V300, P460, DOI 10.1126/science.1082193; Koltover I, 1998, SCIENCE, V281, P78, DOI 10.1126/science.281.5373.78; Prochazka K, 1996, MACROMOLECULES, V29, P6518, DOI 10.1021/ma960630e; Raez J, 2002, J AM CHEM SOC, V124, P10381, DOI 10.1021/ja020349h; Riegel IC, 2002, LANGMUIR, V18, P3358, DOI 10.1021/la015592t; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Tang JX, 1996, J BIOL CHEM, V271, P8556, DOI 10.1074/jbc.271.15.8556; Tang JX, 2001, EUR BIOPHYS J BIOPHY, V30, P477, DOI 10.1007/s002490100178; van der Schoot P, 1999, MACROMOL THEOR SIMUL, V8, P428; Vriezema DM, 2004, MACROMOLECULES, V37, P4736, DOI 10.1021/ma035789n; Vriezema DM, 2003, ANGEW CHEM INT EDIT, V42, P772, DOI 10.1002/anie.200390204; Won YY, 1999, SCIENCE, V283, P960, DOI 10.1126/science.283.5404.960; Wong GCL, 2000, SCIENCE, V288, P2035, DOI 10.1126/science.288.5473.2035; Yu K, 1996, LANGMUIR, V12, P5980, DOI 10.1021/la960894u; ZHANG LF, 1995, SCIENCE, V268, P1728, DOI 10.1126/science.268.5218.1728; Zhang LF, 1997, PHYS REV LETT, V79, P5034, DOI 10.1103/PhysRevLett.79.5034; Zhang LF, 1996, J AM CHEM SOC, V118, P3168, DOI 10.1021/ja953709s; Zhu JT, 2004, LANGMUIR, V20, P3809, DOI 10.1021/la0361565	29	677	685	4	370	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 1	2004	306	5693					94	97		10.1126/science.1102866	http://dx.doi.org/10.1126/science.1102866			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15459386				2022-12-24	WOS:000224304000043
J	Renault, AD; Sigal, YJ; Morris, AJ; Lehmann, R				Renault, AD; Sigal, YJ; Morris, AJ; Lehmann, R			Soma-germ line competition for lipid phosphate uptake regulates germ cell migration and survival	SCIENCE			English	Article							LYSOPHOSPHATIDIC ACID; DROSOPHILA; PLATELETS; RECEPTORS	Lipid phosphates can act as signaling molecules to influence cell division, apoptosis, and migration. wunen and wunen2 encode Drosophila lipid phosphate phosphohydrolases, integral membrane enzymes that dephosphorylate extracellular lipid phosphates. wun and wun2 act redundantly in somatic tissues to repel migrating germ cells, although the mechanism by which germ cells respond is unclear. Here, we report that wun2 also functions in germ cells, enabling them to perceive the wun/wun2-related signal from the soma. Upon Wun2 expression, cultured insect cells dephosphorylate and internalize exogenously supplied lipid phosphate. We propose that Drosophila germ cell migration and survival are controlled by competition for hydrolysis of a lipid phosphate between germ cells and soma.	NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; NYU, Sch Med, Dev Genet Program, New York, NY 10016 USA; NYU, Sch Med, Skirball Inst, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA	Howard Hughes Medical Institute; New York University; New York University; New York University; New York University; University of North Carolina; University of North Carolina Chapel Hill	Lehmann, R (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, 540 1st Ave, New York, NY 10016 USA.	lehmann@saturn.med.nyu.edu	Morris, Andrew/B-7869-2010	Lehmann, Ruth/0000-0002-8454-5651; Renault, Andrew/0000-0003-4313-9726	NICHD NIH HHS [HD421900 RO1] Funding Source: Medline; NIGMS NIH HHS [GM54388] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Burnett C, 2003, EMBO REP, V4, P793, DOI 10.1038/sj.embor.embor900; Chun J, 2002, PHARMACOL REV, V54, P265, DOI 10.1124/pr.54.2.265; EICHHOLTZ T, 1993, BIOCHEM J, V291, P677, DOI 10.1042/bj2910677; Escalante-Alcalde D, 2003, DEVELOPMENT, V130, P4623, DOI 10.1242/dev.00635; Hooks SB, 2001, J BIOL CHEM, V276, P4611, DOI 10.1074/jbc.M007782200; Ishii I, 2002, J BIOL CHEM, V277, P25152, DOI 10.1074/jbc.M200137200; Martinho RG, 2004, CURR BIOL, V14, P159, DOI 10.1016/j.cub.2003.12.036; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Moolenaar WH, 1999, EXP CELL RES, V253, P230, DOI 10.1006/excr.1999.4702; Renault AD, 2002, MECH DEVELOP, V119, pS293, DOI 10.1016/S0925-4773(03)00131-X; Roberts R, 1998, J BIOL CHEM, V273, P22059, DOI 10.1074/jbc.273.34.22059; Santos AC, 2004, CURR BIOL, V14, pR578, DOI 10.1016/j.cub.2004.07.018; Siess W, 2002, BBA-MOL CELL BIOL L, V1582, P204, DOI 10.1016/S1388-1981(02)00173-7; Starz-Gaiano M, 2001, DEVELOPMENT, V128, P983; Van Doren M, 1998, CURR BIOL, V8, P243; Van Doren M, 1998, NATURE, V396, P466, DOI 10.1038/24871; WYLIE CR, COMMUNICATION; YATOMI Y, 1995, BLOOD, V86, P193, DOI 10.1182/blood.V86.1.193.bloodjournal861193; Zhang N, 1997, NATURE, V385, P64, DOI 10.1038/385064a0	19	69	70	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2004	305	5692					1963	1966		10.1126/science.1102421	http://dx.doi.org/10.1126/science.1102421			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857RM	15331773				2022-12-24	WOS:000224136000049
J	Aaby, P				Aaby, P			Being wrong in the right direction?	LANCET			English	Editorial Material									Danish Epidemiol Sci Ctr, Bandim Hlth Project, Bissau, Guinea Bissau	Aarhus University	Aaby, P (corresponding author), Danish Epidemiol Sci Ctr, Bandim Hlth Project, Apartado 861, Bissau, Guinea Bissau.	psb@mail.gtelecom.gw		Aaby, Peter/0000-0001-8331-1389					0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 11	2004	364	9438					984	984		10.1016/S0140-6736(04)17024-4	http://dx.doi.org/10.1016/S0140-6736(04)17024-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853MF	15364191				2022-12-24	WOS:000223831000030
J	Watanabe, KN; Taeb, M; Okusu, H				Watanabe, KN; Taeb, M; Okusu, H			Japanese controversies over transgenic crop regulation	SCIENCE			English	Editorial Material									Univ Tsukuba, Ctr Gene Res, Tsukuba 3058572, Japan; Int Plant Genet Resources Inst, Rome, Italy; United Nations Univ, Inst Adv Studies, Yokohama, Kanagawa 2200012, Japan	University of Tsukuba; Alliance; Bioversity International; United Nations University	Watanabe, KN (corresponding author), Univ Tsukuba, Ctr Gene Res, Tsukuba 3058572, Japan.	nabechan@gene.tsukuba.ac.jp		WATANABE, KAZUO/0000-0003-1499-9989				Barru N., 2003, GLOBAL STATUS COMMER; *DEP ENV FOOD RUR, GEN MOD; *JAP BIOIND ASS, BIOT Q A; Kapuscinski AR, 2003, NAT BIOTECHNOL, V21, P599, DOI 10.1038/nbt0603-599; MENON P, 2002, FRONTLINE, V19; Watanabe K.N., 2004, INTELLECTUAL PROPERT, P187; Watanabe KN, 2004, NAT BIOTECHNOL, V22, P943, DOI 10.1038/nbt0804-943a; Watanabe KN, 2003, NATURE, V421, P689, DOI 10.1038/421689a; 2004, KYOTO SHIMBUN N 0611; 2004, GUIDELINE PLANTING G	10	11	11	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2004	305	5690					1572	1572		10.1126/science.1100734	http://dx.doi.org/10.1126/science.1100734			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	854GV	15361611				2022-12-24	WOS:000223891200027
J	Bai, YF; Han, XG; Wu, JG; Chen, ZZ; Li, LH				Bai, YF; Han, XG; Wu, JG; Chen, ZZ; Li, LH			Ecosystem stability and compensatory effects in the Inner Mongolia grassland	NATURE			English	Article							BIODIVERSITY; DIVERSITY; DYNAMICS; ECOLOGY	Numerous studies have suggested that biodiversity reduces variability in ecosystem productivity through compensatory effects(1-6); that is, a species increases in its abundance in response to the reduction of another in a fluctuating environment(1,7). But this view has been challenged on several grounds(8-10). Because most studies have been based on artificially constructed grasslands with short duration, long-term studies of natural ecosystems are needed. On the basis of a 24-year study of the Inner Mongolia grassland, here we present three key findings. First, that January-July precipitation is the primary climatic factor causing fluctuations in community biomass production; second, that ecosystem stability (conversely related to variability in community biomass production) increases progressively along the hierarchy of organizational levels (that is, from species to functional group to whole community); and finally, that the community-level stability seems to arise from compensatory interactions among major components at both species and functional group levels. From a hierarchical perspective, our results corroborate some previous findings of compensatory effects(1,4,7,11). Undisturbed mature steppe ecosystems seem to culminate with high biodiversity, productivity and ecosystem stability concurrently. Because these relationships are correlational, further studies are necessary to verify the causation among these factors. Our study provides new insights for better management and restoration of the rapidly degrading Inner Mongolia grassland.	Chinese Acad Sci, Inst Bot, Lab Quantitat Vegetat Ecol, Beijing 100093, Peoples R China; Arizona State Univ, Sch Life Sci, Fac Ecol Evolut & Environm Sci, Tempe, AZ 85287 USA	Chinese Academy of Sciences; Institute of Botany, CAS; Arizona State University; Arizona State University-Tempe	Wu, JG (corresponding author), Chinese Acad Sci, Inst Bot, Lab Quantitat Vegetat Ecol, Beijing 100093, Peoples R China.	Jingle.Wu@asu.edu	Wu, Jianguo/G-6267-2010; Han, Xingguo/K-7552-2016; Han, Xingguo/B-3980-2012	Wu, Jianguo/0000-0002-1182-3024; Han, Xingguo/0000-0002-1836-975X; 				Bai Y.F., 1999, ACTA PHYTOECOL SIN, V23, P155; Brown JH, 2001, SCIENCE, V293, P643, DOI 10.1126/science.293.5530.643; Chen S.H., 2001, ROOT SYSTEMS GRASSLA; Chen Z., 2000, TYPICAL STEPPE ECOSY; CHEN ZZ, 1985, RES GRASSLAND ECOSYS, V1, P112; GIVNISH TJ, 1994, NATURE, V371, P113, DOI 10.1038/371113b0; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; Huston M A, 2000, Science, V289, P1255; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; JIANG S, 1985, RES GRASSLAND ECOSYS, V1; Knapp AK, 2001, SCIENCE, V291, P481, DOI 10.1126/science.291.5503.481; Knapp AK, 2002, SCIENCE, V298, P2202, DOI 10.1126/science.1076347; LI B, 1988, RES GRASSLAND ECOSYS, V3, P84; Loreau M, 2000, OIKOS, V91, P3, DOI 10.1034/j.1600-0706.2000.910101.x; Loreau M, 1998, P NATL ACAD SCI USA, V95, P5632, DOI 10.1073/pnas.95.10.5632; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; MCNAUGHTON SJ, 1985, ECOL MONOGR, V55, P259, DOI 10.2307/1942578; MCNAUGHTON SJ, 1977, AM NAT, V111, P515, DOI 10.1086/283181; Naeem S, 1997, NATURE, V390, P507, DOI 10.1038/37348; O'Connor TG, 2001, J ECOL, V89, P850, DOI 10.1046/j.0022-0477.2001.00605.x; Pfisterer AB, 2002, NATURE, V416, P84, DOI 10.1038/416084a; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; TILMAN D, 1994, NATURE, V367, P363, DOI 10.1038/367363a0; Tong C, 2004, J ARID ENVIRON, V59, P133, DOI 10.1016/j.jaridenv.2004.01.004; Wardle DA, 2000, OIKOS, V89, P11, DOI 10.1034/j.1600-0706.2000.890102.x; WU JG, 1994, ECOL MONOGR, V64, P447, DOI 10.2307/2937145; Wu JG, 1995, Q REV BIOL, V70, P439, DOI 10.1086/419172; Wu Jianguo, 1992, P67; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463	30	835	1122	78	972	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 9	2004	431	7005					181	184		10.1038/nature02850	http://dx.doi.org/10.1038/nature02850			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HI	15356630				2022-12-24	WOS:000223746000043
J	Goldenberg, NA; Knapp-Clevenger, R; Manco-Johnson, MJ				Goldenberg, NA; Knapp-Clevenger, R; Manco-Johnson, MJ		Mt States Regional Thrombophilia G	Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	45th Annual Meeting and Exhibition of the American-Society-of-Hematology	DEC 06-09, 2003	San Diego, CA	Amer Soc Hematol			RECURRENT VENOUS THROMBOEMBOLISM; DEEP-VEIN THROMBOSIS; POSTTHROMBOTIC SYNDROME; RISK-FACTORS; THROMBOPHILIA; ANTICOAGULATION; CHILDHOOD; REGISTRY; THERAPY; DISEASE	Background: Elevated levels of plasma factor VIII and D-dimer predict recurrent venous thromboembolism in adults. We sought to determine whether an elevation of factor VIII, D-dimer, or both at diagnosis and persistence of the laboratory abnormality after three to six months of anticoagulant therapy correlate with poor outcomes of thrombosis in children. Methods: We evaluated levels of factor VIII and D-dimer and additional components of an extensive laboratory thrombophilia (i.e., hypercoagulability) panel at the time of diagnosis in 144 children with a radiologically confirmed acute thrombotic event. All patients were treated initially with heparin and then with either warfarin or low-molecular-weight heparin for at least three to six months, according to the current standard of care. Patients were examined at follow-up visits 3, 6, and 12 months after diagnosis and then annually, at which times testing was repeated in children with previously abnormal factor VIII and D-dimer test results and a uniform evaluation for the post-thrombotic syndrome was performed. Results: Among 82 children for whom complete data were available regarding laboratory test results at diagnosis and thrombotic outcomes during follow-up, 67 percent had factor VIII levels above the cutoff value of 150 IU per deciliter, D-dimer levels above 500 ng per milliliter, or both at diagnosis, and at least one of the two laboratory values was persistently elevated in 43 percent of the 75 patients in whom testing was performed after three to six months of anticoagulant therapy. Fifty-one percent of the 82 patients had a poor outcome (i.e., a lack of thrombus resolution, recurrent thrombosis, or the post-thrombotic syndrome) during a median follow-up of 12 months (range, 3 months to 5 years). Elevated levels of factor VIII, D-dimer, or both at diagnosis were highly predictive of a poor outcome (odds ratio, 6.1; P=0.008), as was the persistence of at least one laboratory abnormality at three to six months (odds ratio, 4.7; P=0.002). The combination of a factor VIII level above 150 IU per deciliter and a D-dimer level above 500 ng per milliliter at diagnosis was 91 percent specific for a poor outcome, and after three to six months of standard anticoagulation, the combination was 88 percent specific. Conclusions: Elevated levels of plasma factor VIII, D-dimer, or both at diagnosis and a persistent elevation of at least one of these factors after standard-duration anticoagulant therapy predict a poor outcome in children with thrombosis.	Univ Colorado, Hlth Sci Ctr, Dept Pediat, Sect Hematol Oncol & Bone Marrow Transplantat, Denver, CO 80218 USA; Childrens Hosp, Denver, CO 80218 USA; Mt States Reg Hemophilia & Thrombosis Ctr, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Children's Hospital Colorado	Goldenberg, NA (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Pediat, Sect Hematol Oncol & Bone Marrow Transplantat, 1056 E 19th Ave,B-115, Denver, CO 80218 USA.	neil.goldenberg@uchsc.edu			PHS HHS [M01-R00069] Funding Source: Medline; ODCDC CDC HHS [UR6/CCU820552-01] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); ODCDC CDC HHS		Bick RL, 2003, HEMATOL ONCOL CLIN N, V17, P9, DOI 10.1016/S0889-8588(02)00101-6; Eichinger S, 2003, JAMA-J AM MED ASSOC, V290, P1071, DOI 10.1001/jama.290.8.1071; Kahn SR, 2003, BLOOD, V102, p57A; KOSTER T, 1994, THROMB HAEMOSTASIS, V71, P719; Kraaijenhagen RA, 2000, THROMB HAEMOSTASIS, V83, P5; Kyrle PA, 2000, NEW ENGL J MED, V343, P457, DOI 10.1056/NEJM200008173430702; Male C, 1999, J PEDIATR-US, V134, P199, DOI 10.1016/S0022-3476(99)70416-6; Manco-Johnson MJ, 2003, BLOOD, V102, p553A; Manco-Johnson MJ, 2000, J PEDIATR-US, V136, P446, DOI 10.1016/S0022-3476(00)90006-4; Manco-Johnson MJ, 2002, THROMB HAEMOSTASIS, V88, P155; MANCOJOHNSON MJ, 1995, AM J HEMATOL, V48, P240, DOI 10.1002/ajh.2830480407; MARZINOTTO V, 2001, THROMB HAEMOST S2, V78, pOC962; Mathew P, 2003, BLOOD, V102, p548A; Meijers JCM, 2000, NEW ENGL J MED, V342, P696, DOI 10.1056/NEJM200003093421004; MEISSNER MH, 1993, J VASC SURG, V18, P596, DOI 10.1016/0741-5214(93)90069-X; Monagle P, 2000, PEDIATR RES, V47, P763, DOI 10.1203/00006450-200006000-00013; Monagle P, 2001, CHEST, V119, p344S, DOI 10.1378/chest.119.1_suppl.344S; Nowak-Gottl U, 2001, BLOOD, V97, P858, DOI 10.1182/blood.V97.4.858; Palareti G, 2002, THROMB HAEMOSTASIS, V87, P7; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; Rutherford RB, 2000, J VASC SURG, V31, P1307, DOI 10.1016/S0741-5214(00)90143-5; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; Van Ommen CH, 2003, J THROMB HAEMOST, V1, P2516, DOI 10.1046/j.1538-7836.2003.00465.x; van Ommen CH, 2001, J PEDIATR-US, V139, P676, DOI 10.1067/mpd.2001.118192; Vlieg AV, 2000, BLOOD, V95, P3678; Wong D L, 1988, Pediatr Nurs, V14, P9	26	165	169	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 9	2004	351	11					1081	1088		10.1056/NEJMoa040161	http://dx.doi.org/10.1056/NEJMoa040161			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	852CX	15356305	Bronze			2022-12-24	WOS:000223733900007
J	Hynek, BM				Hynek, BM			Implications for hydrologic processes on Mars from extensive bedrock outcrops throughout Terra Meridiani	NATURE			English	Article								Grey haematite was recently detected in the Terra Meridiani region of Mars(1,2) by the Thermal Emission Spectrometer onboard the Mars Global Surveyor spacecraft. The formation of haematite on Earth often requires liquid water to be present for long periods of time, making this an important target for deciphering the history of water on Mars. The Mars Exploration Rover Opportunity landed in Meridiani early in 2004 and has since discovered light-toned bedrock outcrops rich in chemical and textural signatures of long-term water interaction locally at the landing site(3). Here I use remote sensing data to show that the light-toned outcrops at the landing site are not a local phenomenon. Instead, they are observable throughout the haematite-bearing plains in both visible and thermal infrared remote sensing data. Moreover, the light-toned material outcrops around much of the margin and is mappable for hundreds of kilometres to the north, east and west of the plains. I infer that 3 x 10(5) km(2) of this material is exposed over 20degrees of longitude, indicating the extended presence of surface or near-surface water over a large region of Mars.	Univ Colorado, Atmospher & Space Phys Lab, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Hynek, BM (corresponding author), Univ Colorado, Atmospher & Space Phys Lab, Campus Box 392, Boulder, CO 80309 USA.	brian.hynek@lasp.colorado.edu						Arvidson RE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001982; Christensen PR, 2001, J GEOPHYS RES-PLANET, V106, P23873, DOI 10.1029/2000JE001415; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9623, DOI 10.1029/1999JE001093; CHRISTENSEN PR, 2004, LUNAR PLANET SCI C, V35, P2186; Edgett KS, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL016515; Hynek BM, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002062; Hynek BM, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2002JE001891; HYNEK BM, 2004, LUNAR PLANET SCI C, V35, P1899; JAKOSKY BM, 2004, UNPUB J GEOPHYS RES; Lane MD, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017183; Malin MC, 2000, SCIENCE, V290, P1927, DOI 10.1126/science.290.5498.1927; Malin MC, 2001, J GEOPHYS RES-PLANET, V106, P23429, DOI 10.1029/2000JE001455; Mellon MT, 2000, ICARUS, V148, P437, DOI 10.1006/icar.2000.6503; PALLUCONI FD, 1981, ICARUS, V45, P415, DOI 10.1016/0019-1035(81)90044-0; PUTZIG NE, 2004, LUN PLAN SCI C, V35, P1863; Squyres S. W., 2004, LUNAR PLANET SCI C, VXXXV, P2187; Tanaka KL, 2000, ICARUS, V144, P254, DOI 10.1006/icar.1999.6297	17	72	73	2	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 9	2004	431	7005					156	159		10.1038/nature02902	http://dx.doi.org/10.1038/nature02902			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HI	15356623				2022-12-24	WOS:000223746000036
J	Nichol, G; Kaul, P; Huszti, E; Bridges, JFP				Nichol, G; Kaul, P; Huszti, E; Bridges, JFP			Cost-effectiveness of cardiac resynchronization therapy in patients with symptomatic heart failure	ANNALS OF INTERNAL MEDICINE			English	Article							IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; CONVENIENT APPROXIMATION; SECONDARY PREVENTION; LIFE EXPECTANCY; CLINICAL-TRIALS; CONDUCTION; UNCERTAINTY; MORBIDITY; DEALE	Background: Heart failure is a common, costly, and debilitating illness. Resynchronization of ventricular contraction in patients with heart failure improves ejection fraction. The long-term morbidity and costs associated with such cardiac resynchronization therapy remain unclear. Objective: To assess the incremental cost-effectiveness of cardiac resynchronization therapy. Design: Markov model with Monte Carlo simulation. Future costs and effects were discounted at 3%. Data Sources: Effects data were obtained from a concurrent systematic review. Health-related quality-of-life and cost data were obtained from publicly available data or from surveys. Target Population: Patients with reduced ventricular function and prolonged QRS. Time Horizon: Lifetime. Perspective: U.S. health care system. Interventions: Cardiac resynchronization therapy versus medical therapy. Outcome Measures: Quality-adjusted life-years (QALYs), costs, and incremental cost-effectiveness. Results of Base-Case Analysis: Medical therapy yielded a median of 2.64 (interquartile range, 2.47 to 2.82) discounted QALYs and a median discounted lifetime cost of $34400 (interquartile range, $31100 to $37700). Cardiac resynchronization therapy was associated with a median incremental cost of $107800 (interquartile range, $79800 to $156500) per additional QALY. Results of Sensitivity Analysis: Results were sensitive to changes in several variables, including the relative risk for death or hospitalization. Limitations: These results apply to patients who meet the inclusion criteria of the currently completed trials. Conclusions: The incremental cost per QALY for cardiac resynchronization is similar to that of other commonly used interventions but is sensitive to changes in several key variables. Resynchronization therapy should not be considered in patients with comorbid illness that shortens life expectancy.	Univ Washington, Harborview Prehosp Emergency Care Res & Training, Harborview Med Ctr, Seattle, WA 98104 USA; Univ Ottawa, Ottawa Hlth Res Inst, Ottawa, ON, Canada; Univ Alberta, Edmonton, AB, Canada; Case Western Reserve Univ, Cleveland, OH 44106 USA	Harborview Medical Center; University of Washington; University of Washington Seattle; University of Ottawa; Ottawa Hospital Research Institute; University of Alberta; Case Western Reserve University	Nichol, G (corresponding author), Univ Washington, Harborview Prehosp Emergency Care Res & Training, Harborview Med Ctr, 325 9th Ave,Box 359747, Seattle, WA 98104 USA.	nichol@u.washington.edu	Nichol, Graham/Z-4996-2019	Kaul, Padma/0000-0003-2239-3944				Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168; Abraham WT, 2000, J CARD FAIL, V6, P369, DOI 10.1054/jcaf.2000.20841; Abrams KR, 2000, METHODS METAANALYSIS; *ALB EV BAS PRACT, 2003, SYST REV BIV PAC HEA; Auricchio A, 2002, J AM COLL CARDIOL, V39, P2026, DOI 10.1016/S0735-1097(02)01895-8; BECK JR, 1982, AM J MED, V73, P883, DOI 10.1016/0002-9343(82)90786-0; BECK JR, 1982, AM J MED, V73, P889, DOI 10.1016/0002-9343(82)90787-2; Bigger JT, 1997, NEW ENGL J MED, V337, P1569, DOI 10.1056/NEJM199711273372201; Bridges John F P, 2003, Appl Health Econ Health Policy, V2, P213; Briggs A, 1998, HEALTH ECON, V7, P723, DOI 10.1002/(SICI)1099-1050(199812)7:8<723::AID-HEC392>3.3.CO;2-F; BRIGGS A, 1994, HEALTH ECON, V3, P95, DOI 10.1002/hec.4730030206; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Cazeau S, 2001, NEW ENGL J MED, V344, P873, DOI 10.1056/NEJM200103223441202; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CHRISTENSEN R, 1989, DATA DISTRIBUTIONS S; Connolly SJ, 2000, EUR HEART J, V21, P2071, DOI 10.1053/euhj.2000.2476; CRITCHFIELD GC, 1986, MED DECIS MAKING, V6, P85, DOI 10.1177/0272989X8600600205; Doubilet P, 1985, Med Decis Making, V5, P157, DOI 10.1177/0272989X8500500205; Eichhorn E, 2001, NEW ENGL J MED, V344, P1659; Ezekowitz JA, 2003, ANN INTERN MED, V138, P445, DOI 10.7326/0003-4819-138-6-200303180-00007; *FDA, 2002, P010012 FDA; FEENY D, 1995, PHARMACOECONOMICS, V7, P490, DOI 10.2165/00019053-199507060-00004; FROBERG DG, 1989, J CLIN EPIDEMIOL, V42, P585, DOI 10.1016/0895-4356(89)90155-8; Furlong W, 1990, WORKING PAPER SERIES, V90-9; Garrigue S, 2002, HEART, V87, P529, DOI 10.1136/heart.87.6.529; Gold MR, 1996, COST EFFECTIVENESS H; Gold MR, 1996, COST EFFECTIVENESS H, P425; Hirth RA, 2000, MED DECIS MAKING, V20, P332, DOI 10.1177/0272989X0002000310; Kaul P, 2003, J AM COLL CARDIOL, V41, p535A; Leclercq C, 2002, EUR HEART J, V23, P1780, DOI 10.1053/euhj.2002.3232; Llewellyn-Thomas H. A., 2000, ADAPTATION CHANGING, P109; LlewellynThomas HA, 1996, MED CARE, V34, pDS109; Lloyd-Williams F, 2003, J CLIN EPIDEMIOL, V56, P1157, DOI 10.1016/S0895-4356(03)00205-1; Lothgren M, 2000, HEALTH ECON, V9, P623, DOI 10.1002/1099-1050(200010)9:7<623::AID-HEC539>3.0.CO;2-V; MASON J, 1993, BRIT MED J, V306, P570, DOI 10.1136/bmj.306.6877.570; Masoudi FA, 2003, AM HEART J, V146, P250, DOI 10.1016/S0002-8703(03)00189-3; Massie BM, 1998, LANCET, V352, P29; McAlister FA, 2004, ANN INTERN MED, V141, P381, DOI 10.7326/0003-4819-141-5-200409070-00101; *N AM SOC PAC EL, CPT COD GUID; *NAT HEART LUNG BL, 2002, NHLBI FACT BOOK; Nichol G, 2003, CIRCULATION, V108, P697, DOI 10.1161/01.CIR.0000084545.65645.28; Owens DK, 1997, ANN INTERN MED, V126, P1, DOI 10.7326/0003-4819-126-1-199701010-00001; Pfeffer MA, 2003, LANCET, V362, P759, DOI 10.1016/S0140-6736(03)14282-1; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; PORTER M, 1984, SOC SCI MED, V19, P1197, DOI 10.1016/0277-9536(84)90370-8; Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175; Shamim W, 1999, INT J CARDIOL, V70, P171, DOI 10.1016/S0167-5273(99)00077-7; Sox HC, 1988, MED DECISION MAKING; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; TORRANCE GW, 1995, PHARMACOECONOMICS, V7, P503, DOI 10.2165/00019053-199507060-00005; Uretsky BF, 2000, CIRCULATION, V102, P611, DOI 10.1161/01.CIR.102.6.611; *US DEP HHS, 2001, US DEC LIF TABL 1998; US Department of Labor. Bureau of Labor Statistics, CONS PRIC IND; VANHOUT BA, 1994, HEALTH ECON, V3, P309, DOI 10.1002/hec.4730030505; VANNEUMANN J, 1994, THEORY GAMES EC BEHA; Wilkoff BL, 2002, JAMA-J AM MED ASSOC, V288, P3115; WINER BJ, 1971, LATIN SQUARES RELATE, P685; Xiao HB, 1996, INT J CARDIOL, V53, P163, DOI 10.1016/0167-5273(95)02502-2; Young JB, 2003, JAMA-J AM MED ASSOC, V289, P2685, DOI 10.1001/jama.289.20.2685	59	83	83	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 7	2004	141	5					343	351		10.7326/0003-4819-141-5-200409070-00102	http://dx.doi.org/10.7326/0003-4819-141-5-200409070-00102			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	852CW	15353425				2022-12-24	WOS:000223733800002
J	Foster				Foster			How often are adverse events reported in English hospital statistics?	BMJ-BRITISH MEDICAL JOURNAL			English	Article								About 850 000 medical errors occur in NHS hospitals every year, resulting in 40 000 deaths. In-wl the United Kingdom, the National Patient Safety Agency (NPSA) was created to learn from patient safety incidents occurring in the NHS.(w2) In February 2004, it launched a new patient reporting system, drawing together reports of patient safety errors and systems failures provided by health professionals across England and Wales.(w3) An adverse event can be defined as "an unintended injury caused by medical management rather than a disease process, resulting in death, life threatening illness, disability at the time of discharge, admission to hospital, or prolongation of hospital stay."(w4) A medical or surgical misadventure is an adverse event that might have been avoided if the patient had received ordinary standards of care. We took at four years of hospital episode statistics to examine patterns in the recording of adverse events within this routinely collected source of data and ask whether it could be of use in monitoring this problem.	Univ London Imperial Coll Sci Technol & Med, Dr Foster Unit, London SW7 2AZ, England	Imperial College London	Foster (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dr Foster Unit, London SW7 2AZ, England.		Aylin, Paul/A-1073-2014	Aylin, Paul/0000-0003-4589-1743; Bottle, Alex/0000-0001-9978-2011				Australian Institute for Health and Welfare, 2001, REP ADV EV ROUT COLL; EMSLIE S, 2001, RISK MANAGEMENT NATL; Michel P, 2004, BRIT MED J, V328, P199, DOI 10.1136/bmj.328.7433.199; STEEL K, 1981, NEW ENGL J MED, V304, P638, DOI 10.1056/NEJM198103123041104; Wolff AM, 1996, MED J AUSTRALIA, V164, P458, DOI 10.5694/j.1326-5377.1996.tb122120.x	5	26	26	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 14	2004	329	7462					369	+		10.1136/bmj.329.7462.369	http://dx.doi.org/10.1136/bmj.329.7462.369			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	847YI	15310606	Green Published			2022-12-24	WOS:000223433600013
J	Harper, NS; McAlpine, D				Harper, NS; McAlpine, D			Optimal neural population coding of an auditory spatial cue	NATURE			English	Article							INTERAURAL TIME DIFFERENCE; INFERIOR COLLICULUS; SOUND LOCALIZATION; FISHER INFORMATION; CENTRAL NUCLEUS; BARN OWL; NEURONS; DELAY; DISCRIMINATION; CAT	A sound, depending on the position of its source, can take more time to reach one ear than the other. This interaural ( between the ears) time difference (ITD) provides a major cue for determining the source location(1,2). Many auditory neurons are sensitive to ITDs(3,4), but the means by which such neurons represent ITD is a contentious issue. Recent studies question whether the classical general model ( the Jeffress model(5)) applies across species(6,7). Here we show that ITD coding strategies of different species can be explained by a unifying principle: that the ITDs an animal naturally encounters should be coded with maximal accuracy. Using statistical techniques and a stochastic neural model, we demonstrate that the optimal coding strategy for ITD depends critically on head size and sound frequency. For small head sizes and/or low-frequency sounds, the optimal coding strategy tends towards two distinct sub-populations tuned to ITDs outside the range created by the head. This is consistent with recent observations in small mammals(6,7). For large head sizes and/or high frequencies, the optimal strategy is a homogeneous distribution of ITD tunings within the range created by the head. This is consistent with observations in the barn owl(8-10). For humans, the optimal strategy to code ITDs from an acoustically measured distribution depends on frequency; above 400 Hz a homogeneous distribution is optimal, and below 400 Hz distinct sub-populations are optimal.	UCL, Dept Physiol, London WC1E 6BT, England; UCL, UCL Ear Inst, London WC1E 6BT, England; UCL, CoMPLEX, London WC1E 6BT, England	University of London; University College London; University of London; University College London; University of London; University College London	McAlpine, D (corresponding author), UCL, Dept Physiol, Mortimer St, London WC1E 6BT, England.	d.mcalpine@ucl.ac.uk		Harper, Nicol/0000-0002-7851-4840; McAlpine, David/0000-0001-5467-6725				Bala ADS, 2003, NATURE, V424, P771, DOI 10.1038/nature01835; BERNSTEIN LR, 1985, J ACOUST SOC AM, V78, P514, DOI 10.1121/1.392473; Bethge M, 2002, NEURAL COMPUT, V14, P2317, DOI 10.1162/08997660260293247; Brand A, 2002, NATURE, V417, P543, DOI 10.1038/417543a; Brunel N, 1998, NEURAL COMPUT, V10, P1731, DOI 10.1162/089976698300017115; CARR CE, 1988, P NATL ACAD SCI USA, V85, P8311, DOI 10.1073/pnas.85.21.8311; COLES RB, 1988, J COMP PHYSIOL A, V163, P117, DOI 10.1007/BF00612002; Culling JF, 1998, J ACOUST SOC AM, V103, P3540, DOI 10.1121/1.423061; Dayan P., 2001, THEORETICAL NEUROSCI; DOMNITZ RH, 1977, J ACOUST SOC AM, V61, P1586, DOI 10.1121/1.381472; HENNING GB, 1974, J ACOUST SOC AM, V55, P84, DOI 10.1121/1.1928135; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; Joris PX, 1998, NEURON, V21, P1235, DOI 10.1016/S0896-6273(00)80643-1; Kapfer C, 2002, NAT NEUROSCI, V5, P247, DOI 10.1038/nn810; KUWADA S, 1983, J NEUROPHYSIOL, V50, P981, DOI 10.1152/jn.1983.50.4.981; McAlpine D, 2001, NAT NEUROSCI, V4, P396, DOI 10.1038/86049; Shackleton TM, 2003, J NEUROSCI, V23, P716, DOI 10.1523/JNEUROSCI.23-02-00716.2003; Skottun BC, 2001, P NATL ACAD SCI USA, V98, P14050, DOI 10.1073/pnas.241513998; Strutt J., 1907, PHILOS MAG, V13, P214, DOI [DOI 10.1080/14786440709463595, 10.1080/14786440709463595]; TAKAHASHI T, 1986, J NEUROSCI, V6, P3413; Wagner H, 2002, EUR J NEUROSCI, V15, P1343, DOI 10.1046/j.1460-9568.2002.01970.x; WAGNER H, 1987, J NEUROSCI, V7, P3105; WIGHTMAN FL, 1992, J ACOUST SOC AM, V91, P1648, DOI 10.1121/1.402445; YIN TCT, 1990, J NEUROPHYSIOL, V64, P465, DOI 10.1152/jn.1990.64.2.465	24	210	211	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 5	2004	430	7000					682	686		10.1038/nature02768	http://dx.doi.org/10.1038/nature02768			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843LM	15295602				2022-12-24	WOS:000223085400047
J	Newman, LS; Feinberg, MW; LeWine, HE				Newman, LS; Feinberg, MW; LeWine, HE			A bitter tale	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FOXGLOVE EXTRACT		Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; Harvard Vanguard Med Associates, Dept Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Vanguard Medical Associates	Newman, LS (corresponding author), Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA.	lnewman1@partners.org		Feinberg, Mark/0000-0001-9523-3859				ANTMAN EM, 1990, CIRCULATION, V81, P1744, DOI 10.1161/01.CIR.81.6.1744; Gowda R M, 2003, Heart, V89, pe14, DOI 10.1136/heart.89.4.e14; Hauptman PJ, 1999, CIRCULATION, V99, P1265, DOI 10.1161/01.CIR.99.9.1265; HOFFMAN B F, 1990, P814; KELLY RA, 1992, AM J CARDIOL, V69, pG108, DOI 10.1016/0002-9149(92)91259-7; KWAN T, 1992, CHEST, V102, P949, DOI 10.1378/chest.102.3.949; RICH SA, 1993, ANN EMERG MED, V22, P1904, DOI 10.1016/S0196-0644(05)80420-2; SMITH TW, 1973, NEW ENGL J MED, V289, P1125, DOI 10.1056/NEJM197311222892106; Thierry S, 2000, INTENS CARE MED, V26, P1586, DOI 10.1007/s001340000636; Watson WA, 2003, AM J EMERG MED, V21, P353, DOI 10.1016/S0735-6757(03)00088-3	10	5	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 5	2004	351	6					594	599		10.1056/NEJMcps040238	http://dx.doi.org/10.1056/NEJMcps040238			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843HS	15295053				2022-12-24	WOS:000223069900014
J	Passier, A; Smits-van Herwaarden, A; van Puijenbroek, E				Passier, A; Smits-van Herwaarden, A; van Puijenbroek, E			Photo-onycholysis associated with the use of doxycycline	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Netherlands Pharmacovigilance Ctr Lareb, NL-5327 MH Shertogenbosch, Netherlands		Passier, A (corresponding author), Netherlands Pharmacovigilance Ctr Lareb, Goudsbloemvallei 7, NL-5327 MH Shertogenbosch, Netherlands.	A.Passier@Lareb.nl	van Puijenbroek, Eugene/AAI-3240-2020	Passier, Anneke/0000-0001-5594-6360; van Puijenbroek, Eugene/0000-0002-2236-1398				BRUINSMA W, 2000, GUIDE DRUG ERUPTIONS, P26; CAVENS TR, 1981, CUTIS, V27, P53; FRANK SB, 1971, ARCH DERMATOL, V103, P520, DOI 10.1001/archderm.103.5.520; SHEA CR, 1993, J INVEST DERMATOL, V101, P329, DOI 10.1111/1523-1747.ep12365484; Yong CKK, 2000, PEDIATRICS, V106, part. no., DOI 10.1542/peds.106.1.e13	5	20	20	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 31	2004	329	7460					265	265		10.1136/bmj.329.7460.265	http://dx.doi.org/10.1136/bmj.329.7460.265			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	844BY	15284149	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000223133300017
J	Karhadkar, SS; Bova, GS; Abdallah, N; Dhara, S; Gardner, D; Maitra, A; Isaacs, JT; Berman, DM; Beachy, PA				Karhadkar, SS; Bova, GS; Abdallah, N; Dhara, S; Gardner, D; Maitra, A; Isaacs, JT; Berman, DM; Beachy, PA			Hedgehog signalling in prostate regeneration, neoplasia and metastasis	NATURE			English	Article							INTERMEDIATE FILAMENT PROTEIN; SONIC-HEDGEHOG; STEM-CELLS; SUPPRESSOR GENE; CANCER; GROWTH; INHIBITION; RAT; DIFFERENTIATION; PROLIFERATION	Metastatic cancers adopt certain properties of normal cells in developing or regenerating organs, such as the ability to proliferate and alter tissue organization. We find here that activity of the Hedgehog (Hh) signalling pathway, which has essential roles in developmental patterning(1-6), is required for regeneration of prostate epithelium, and that continuous pathway activation transforms prostate progenitor cells and renders them tumorigenic. Elevated pathway activity furthermore distinguishes metastatic from localized prostate cancer, and pathway manipulation can modulate invasiveness and metastasis. Pathway activity is triggered in response to endogenous expression of Hh ligands, and is dependent upon the expression of Smoothened, an essential Hh response component(1,2,7) that is not expressed in benign prostate epithelial cells. Monitoring and manipulating Hh pathway activity may thus offer significant improvements in diagnosis and treatment of prostate cancers with metastatic potential.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; ARS, USDA, Poisonous Plant Res Lab, Logan, UT 84341 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; United States Department of Agriculture (USDA)	Berman, DM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	dberman@jhmi.edu; pbeachy@jhmi.edu	Karhadkar, Sunil/Y-9235-2019	Karhadkar, Sunil/0000-0001-7943-0203; Bova, George/0000-0003-1639-3104; berman, david/0000-0001-5985-3698				Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; ALBINI A, 1987, CANCER RES, V47, P3239; Bandyopadhyay S, 2003, CANCER RES, V63, P1731; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Berman DM, 2004, DEV BIOL, V267, P387, DOI 10.1016/j.ydbio.2003.11.018; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; DONG JT, 1995, SCIENCE, V268, P884, DOI 10.1126/science.7754374; ENGLISH HF, 1987, PROSTATE, V11, P229, DOI 10.1002/pros.2990110304; Fan L, 2004, ENDOCRINOLOGY, V145, P3961, DOI 10.1210/en.2004-0079; Freestone SH, 2003, DEV BIOL, V264, P352, DOI 10.1016/j.ydbio.2003.08.018; Garraway LA, 2003, PROSTATE, V55, P206, DOI 10.1002/pros.10244; Guang RJ, 2000, CANCER RES, V60, P749; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; ISAACS JT, 1986, PROSTATE, V9, P261, DOI 10.1002/pros.2990090306; KACHINSKY AM, 1994, DEV BIOL, V165, P216, DOI 10.1006/dbio.1994.1248; Lamm MLG, 2002, DEV BIOL, V249, P349, DOI 10.1006/dbio.2002.0774; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Litingtung Y, 1998, NAT GENET, V20, P58, DOI 10.1038/1717; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Meeker AK, 1996, ENDOCRINOLOGY, V137, P5743, DOI 10.1210/en.137.12.5743; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Park HL, 2000, DEVELOPMENT, V127, P1593; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sanchez P, 2004, P NATL ACAD SCI USA, V101, P12561, DOI 10.1073/pnas.0404956101; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493; Zulewski H, 2001, DIABETES, V50, P521, DOI 10.2337/diabetes.50.3.521	32	853	950	1	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 7	2004	431	7009					707	712		10.1038/nature02962	http://dx.doi.org/10.1038/nature02962			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859WS	15361885				2022-12-24	WOS:000224299300045
J	Lu, WG; Yamamoto, V; Ortega, B; Baltimore, D				Lu, WG; Yamamoto, V; Ortega, B; Baltimore, D			Mammalian Ryk is a Wnt coreceptor required for stimulation of neurite outgrowth	CELL			English	Article							DROSOPHILA DERAILED RECEPTOR; NEURONAL PATHWAY SELECTION; TRANSCRIPTION FACTOR LEF-1; NEURAL CREST DEVELOPMENT; BETA-CATENIN; INT-1 PROTOONCOGENE; WNT/BETA-CATENIN; XENOPUS EMBRYOS; GENE LINOTTE; PROTEIN	The Ryk receptor belongs to the atypical receptor tyrosine kinase family. It is a new member of the family of Wnt receptor proteins. However, the molecular mechanisms by which the Ryk receptor functions remain unknown. Here, we report that mammalian Ryk, unlike the Drosophila Ryk homolog Derailed, functions as a coreceptor along with Frizzled for Wnt ligands. Ryk also binds to Dishevelled, through which it activates the canonical Writ pathway, providing a link between Wnt and Dishevelled. Transgenic mice expressing Ryk siRNA exhibit defects in axon guidance, and Ryk is required for neurite outgrowth induced by Wnt-3a and in the activation of T cell factor (TCF) induced by Wnt-1. Thus, Ryk appears to play a crucial role in Wnt-mediated signaling.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Baltimore, D (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	baltimo@caltech.edu			NCI NIH HHS [2R01 CA51462-13] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA051462] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bonkowsky JL, 1999, NATURE, V402, P540, DOI 10.1038/990122; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; CALLAHAN CA, 1995, NATURE, V376, P171, DOI 10.1038/376171a0; Castelo-Branco GA, 2003, P NATL ACAD SCI USA, V100, P12747, DOI 10.1073/pnas.1534900100; Chenn A, 2003, CEREB CORTEX, V13, P599, DOI 10.1093/cercor/13.6.599; DURA JM, 1995, FEBS LETT, V370, P250, DOI 10.1016/0014-5793(95)00847-3; DURA JM, 1993, J NEUROGENET, V9, P1, DOI 10.3109/01677069309167272; Garcia-Castro MI, 2002, SCIENCE, V297, P848, DOI 10.1126/science.1070824; Halford MM, 2001, BIOESSAYS, V23, P34, DOI 10.1002/1521-1878(200101)23:1<34::AID-BIES1005>3.3.CO;2-4; Halford MM, 2000, NAT GENET, V25, P414, DOI 10.1038/78099; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Hari L, 2002, J CELL BIOL, V159, P867, DOI 10.1083/jcb.200209039; HOVENS CM, 1992, P NATL ACAD SCI USA, V89, P11818, DOI 10.1073/pnas.89.24.11818; Hsieh JC, 1999, NATURE, V398, P431, DOI 10.1038/18899; Huber O, 1996, MECH DEVELOP, V59, P3, DOI 10.1016/0925-4773(96)00597-7; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; Ishitani T, 2003, MOL CELL BIOL, V23, P1379, DOI 10.1128/MCB.23.4.1379-1389.2003; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Kamitori K, 1999, DEV BRAIN RES, V114, P149, DOI 10.1016/S0165-3806(99)00033-4; Krylova O, 2002, NEURON, V35, P1043, DOI 10.1016/S0896-6273(02)00860-7; Lee HY, 2004, SCIENCE, V303, P1020, DOI 10.1126/science.1091611; Lewis JL, 2004, DEVELOPMENT, V131, P1299, DOI 10.1242/dev.01007; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lucas FR, 1997, DEV BIOL, V192, P31, DOI 10.1006/dbio.1997.8734; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; MCMAHON AP, 1992, CELL, V69, P581, DOI 10.1016/0092-8674(92)90222-X; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Moreau-Fauvarque C, 1998, MECH DEVELOP, V78, P47, DOI 10.1016/S0925-4773(98)00147-6; Oates AC, 1998, MECH DEVELOP, V78, P165, DOI 10.1016/S0925-4773(98)00167-1; Orford K, 1997, J BIOL CHEM, V272, P24735, DOI 10.1074/jbc.272.40.24735; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Patthy L, 2000, TRENDS BIOCHEM SCI, V25, P12, DOI 10.1016/S0968-0004(99)01504-2; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; PEIFER M, 1994, DEV BIOL, V166, P543, DOI 10.1006/dbio.1994.1336; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Simon AF, 1998, MECH DEVELOP, V76, P45, DOI 10.1016/S0925-4773(98)00104-X; Smit L, 2004, J BIOL CHEM, V279, P17232, DOI 10.1074/jbc.M307801200; STERNBERG PW, 1988, DEV BIOL, V130, P67, DOI 10.1016/0012-1606(88)90414-9; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tanaka M, 1997, P NATL ACAD SCI USA, V94, P4493, DOI 10.1073/pnas.94.9.4493; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; van Es JH, 2003, CURR OPIN GENET DEV, V13, P28, DOI 10.1016/S0959-437X(02)00012-6; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Willert K, 1998, CURR OPIN GENET DEV, V8, P95, DOI 10.1016/S0959-437X(98)80068-3; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; YEE K, 1993, BLOOD, V82, P1335; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443	57	343	368	2	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 1	2004	119	1					97	108		10.1016/j.cell.2004.09.019	http://dx.doi.org/10.1016/j.cell.2004.09.019			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	859UE	15454084	Bronze			2022-12-24	WOS:000224292600012
J	Beachy, PA; Karhadkar, SS; Berman, DM				Beachy, PA; Karhadkar, SS; Berman, DM			Mending and malignancy	NATURE			English	Editorial Material							HEDGEHOG		Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Urol, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Beachy, PA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.		Karhadkar, Sunil/Y-9235-2019	Karhadkar, Sunil/0000-0001-7943-0203; berman, david/0000-0001-5985-3698				Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; KARHADKAR SS, 2004, NATURE          0912, DOI DOI 10.1038/NATURE02962; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Watkins DN, 2003, NATURE, V422, P313, DOI 10.1038/nature01493	6	48	58	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 23	2004	431	7007					402	402		10.1038/431402a	http://dx.doi.org/10.1038/431402a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15385990	Bronze			2022-12-24	WOS:000224000500020
J	Wilkinson, P; Pattenden, S; Armstrong, B; Fletcher, A; Kovats, RS; Mangtani, P; McMichael, AJ				Wilkinson, P; Pattenden, S; Armstrong, B; Fletcher, A; Kovats, RS; Mangtani, P; McMichael, AJ			Vulnerability to winter mortality in elderly people in Britain: population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SEASONAL-VARIATION; TEMPERATURE; DEPRIVATION; ENGLAND; RISK	Objective To examine the determinants of vulnerability to winter mortality in elderly British people. Design Population based cohort study (119389 person years of follow up). Setting 106 general practices from the Medical Research Council trial of assessment and management of older people in Britain. Participants People aged greater than or equal to75 years. Main outcome measures Mortality (10123 deaths) determined by follow up through the Office for National Statistics. Results Month to month variation accounted for 17% of annual all cause mortality, but only 7.8% after adjustment for temperature. The overall winter:non-winter rate ratio was 1.31 (95% confidence interval 1.26 to 1.36). There was little evidence that this ratio varied by geographical region, age, or any of the personal, socioeconomic, or clinical factors examined, with two exceptions: after adjustment for all major covariates the winter:non-winter ratio in women compared with men was 1.11 (1.00 to 1.23), and those with a self reported history of respiratory illness had a winter:non-winter ratio of 1.20 (1.08 to 1.34) times that of people without a history of respiratory illness. There was no evidence that socioeconomic deprivation or self reported financial worries were predictive of winter death. Conclusion Except for female sex and pre-existing respiratory illness, there was little evidence for vulnerability to winter death associated with factors thought to lead to vulnerability. The lack of socioeconomic gradient suggests that policies aimed at relief of fuel poverty may need to be supplemented by additional measures to tackle the burden of excess winter deaths in elderly people.	Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Wilkinson, P (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	paul.wilkinson@lshtm.ac.uk		Mangtani, Punam/0000-0001-7074-2999; Wilkinson, Paul/0000-0001-7456-259X; Kovats, Sari/0000-0002-4823-8099; armstrong, benedict/0000-0003-4407-0409				Armstong B, 2000, EPIDEMIOLOGY, V11, pS113; Aylin P, 2001, INT J EPIDEMIOL, V30, P1100, DOI 10.1093/ije/30.5.1100; Bokenes L, 2000, Int J Circumpolar Health, V59, P216; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Carstairs V, 1995, J EPIDEMIOL COMMUN H, V49, pS3, DOI 10.1136/jech.49.Suppl_2.S3; CARSTAIRS V R M, 1990, Health Bulletin (Edinburgh), V48, P162; Curwen M., 1990, HLTH TRENDS, V22, P169; Fletcher AE, 2002, BMC HEALTH SERV RES, V2, DOI 10.1186/1472-6963-2-21; Goodwin J, 2000, Int J Circumpolar Health, V59, P195; Huber PJ, 1981, ROBUST STAT; Keatinge WR, 1997, LANCET, V349, P1341, DOI 10.1016/S0140-6736(96)12338-2; KEATINGE WR, 1989, INT J BIOMETEOROL, V33, P71, DOI 10.1007/BF01686280; Laake K, 1996, AGE AGEING, V25, P343, DOI 10.1093/ageing/25.5.343; Lawlor DA, 2000, J PUBLIC HEALTH MED, V22, P176, DOI 10.1093/pubmed/22.2.176; MCKEE CM, 1989, EUR J EPIDEMIOL, V5, P178, DOI 10.1007/BF00156826; NEILD PJ, 1994, CLIN SCI, V86, P43, DOI 10.1042/cs0860043; O'Neill M, 2003, EPIDEMIOLOGY, V14, pS101, DOI 10.1097/00001648-200309001-00244; Pattenden S, 2003, J EPIDEMIOL COMMUN H, V57, P628, DOI 10.1136/jech.57.8.628; Schwartz J B, 1996, PDA J Pharm Sci Technol, V50, P197; Shah S, 1999, J EPIDEMIOL COMMUN H, V53, P499, DOI 10.1136/jech.53.8.499; Sheth T, 1999, J AM COLL CARDIOL, V33, P1916, DOI 10.1016/S0735-1097(99)00137-0; Smolander J, 2002, INT J SPORTS MED, V23, P86, DOI 10.1055/s-2002-20137; Stout RW, 1996, AGE AGEING, V25, P256, DOI 10.1093/ageing/25.3.256; van Rossum CTM, 2001, INT J EPIDEMIOL, V30, P1109, DOI 10.1093/ije/30.5.1109; Wilkinson P, 2001, COLD COMFORT SOCIAL; WOODHOUSE PR, 1993, J HYPERTENS, V11, P1267	26	176	180	1	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 18	2004	329	7467					647	651		10.1136/bmj.38167.589907.55	http://dx.doi.org/10.1136/bmj.38167.589907.55			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856JU	15315961	Bronze, Green Published, Green Submitted, Green Accepted			2022-12-24	WOS:000224042300016
J	Blight, SK; Larue, RC; Mahapatra, A; Longstaff, DG; Chang, E; Zhao, G; Kang, PT; Church-Church, KB; Chan, MK; Krzycki, JA				Blight, SK; Larue, RC; Mahapatra, A; Longstaff, DG; Chang, E; Zhao, G; Kang, PT; Church-Church, KB; Chan, MK; Krzycki, JA			Direct charging of tRNA(CUA) with pyrrolysine in vitro and in vivo	NATURE			English	Article							TRANSFER-RNA-SYNTHETASES; AMINOACYL-TRANSFER-RNAS; ESCHERICHIA-COLI; METHANOSARCINA-BARKERI; GENETIC-CODE; CORRINOID PROTEIN; METHYLTRANSFERASE; ACID; MONOMETHYLAMINE; SELENOCYSTEINE	Pyrrolysine is the 22nd amino acid(1-3). An unresolved question has been how this atypical genetically encoded residue is inserted into proteins, because all previously described naturally occurring aminoacyl-tRNA synthetases are specific for one of the 20 universally distributed amino acids. Here we establish that synthetic L-pyrrolysine is attached as a free molecule to tRNA(CUA) by PylS, an archaeal class II aminoacyl-tRNA synthetase. PylS activates pyrrolysine with ATP and ligates pyrrolysine to tRNA(CUA) in vitro in reactions specific for pyrrolysine. The addition of pyrrolysine to Escherichia coli cells expressing pylT (encoding tRNA(CUA)) and pylS results in the translation of UAG in vivo as a sense codon. This is the first example from nature of direct aminoacylation of a tRNA with a non-canonical amino acid and shows that the genetic code of E. coli can be expanded to include UAG-directed pyrrolysine incorporation into proteins.	Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; Ohio State Univ, Dept Chem, Columbus, OH 43210 USA; Ohio State Univ, Dept Biochem, Columbus, OH 43210 USA; Ohio State Univ, Biochem Program, Columbus, OH 43210 USA; Ohio State Univ, CCIC Mass Spectrometry & Proteom Facil, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Krzycki, JA (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12th Ave, Columbus, OH 43210 USA.	krzycki.1@osu.edu	Green, Kari B/H-3541-2011	Larue, Ross/0000-0002-0170-7345				Atkins JF, 2002, SCIENCE, V296, P1409, DOI 10.1126/science.1073339; Burke SA, 1997, J BIOL CHEM, V272, P16570, DOI 10.1074/jbc.272.26.16570; Burke SA, 1998, J BACTERIOL, V180, P3432, DOI 10.1128/JB.180.13.3432-3440.1998; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; COLE FX, 1970, BIOCHEMISTRY-US, V9, P480, DOI 10.1021/bi00805a005; Commans S, 1999, FEMS MICROBIOL REV, V23, P335, DOI 10.1111/j.1574-6976.1999.tb00403.x; Doring V, 2001, SCIENCE, V292, P501, DOI 10.1126/science.1057718; Francklyn C, 2002, RNA, V8, P1363, DOI 10.1017/S1355838202021180; Hao B, 2002, SCIENCE, V296, P1462, DOI 10.1126/science.1069556; HAO B, IN PRESS CHEM BIOL; HO YS, 1987, P NATL ACAD SCI USA, V84, P2185, DOI 10.1073/pnas.84.8.2185; Ibba M, 2004, GENE DEV, V18, P731, DOI 10.1101/gad.1187404; James CM, 2001, J BIOL CHEM, V276, P34252, DOI 10.1074/jbc.M102929200; Jester BC, 2003, P NATL ACAD SCI USA, V100, P14351, DOI 10.1073/pnas.2036253100; Kiick KL, 2001, FEBS LETT, V502, P25, DOI 10.1016/S0014-5793(01)02657-6; LaRiviere FJ, 2001, SCIENCE, V294, P165, DOI 10.1126/science.1064242; Paul L, 1996, J BACTERIOL, V178, P6599, DOI 10.1128/jb.178.22.6599-6607.1996; Paul L, 2000, J BACTERIOL, V182, P2520, DOI 10.1128/JB.182.9.2520-2529.2000; Polycarpo C, 2003, MOL CELL, V12, P287, DOI 10.1016/S1097-2765(03)00280-6; SCHIMMEL PR, 1979, ANNU REV BIOCHEM, V48, P601, DOI 10.1146/annurev.bi.48.070179.003125; Smith MW, 1999, MICROBIOL-SGM, V145, P2891, DOI 10.1099/00221287-145-10-2891; Sowers K. R., 1995, P459; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; Stadtman TC, 1996, ANNU REV BIOCHEM, V65, P83, DOI 10.1146/annurev.bi.65.070196.000503; VARSHNEY U, 1991, J BIOL CHEM, V266, P24712; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0	27	181	196	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2004	431	7006					333	335		10.1038/nature02895	http://dx.doi.org/10.1038/nature02895			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15329732				2022-12-24	WOS:000223864000047
J	Luscombe, NM; Babu, MM; Yu, HY; Snyder, M; Teichmann, SA; Gerstein, M				Luscombe, NM; Babu, MM; Yu, HY; Snyder, M; Teichmann, SA; Gerstein, M			Genomic analysis of regulatory network dynamics reveals large topological changes	NATURE			English	Article							GENE-EXPRESSION; TRANSCRIPTION FACTORS; SMALL-WORLD; PROGRAM; MOTIFS; CELLS	Network analysis has been applied widely, providing a unifying language to describe disparate systems ranging from social interactions to power grids. It has recently been used in molecular biology, but so far the resulting networks have only been analysed statically(1-8). Here we present the dynamics of a biological network on a genomic scale, by integrating transcriptional regulatory information(9-11) and gene-expression data(12-16) for multiple conditions in Saccharomyces cerevisiae. We develop an approach for the statistical analysis of network dynamics, called SANDY, combining well-known global topological measures, local motifs and newly derived statistics. We uncover large changes in underlying network architecture that are unexpected given current viewpoints and random simulations. In response to diverse stimuli, transcription factors alter their interactions to varying degrees, thereby rewiring the network. A few transcription factors serve as permanent hubs, but most act transiently only during certain conditions. By studying sub-network structures, we show that environmental responses facilitate fast signal propagation (for example, with short regulatory cascades), whereas the cell cycle and sporulation direct temporal progression through multiple stages (for example, with highly inter-connected transcription factors). Indeed, to drive the latter processes forward, phase-specific transcription factors interregulate serially, and ubiquitously active transcription factors layer above them in a two-tiered hierarchy. We anticipate that many of the concepts presented here-particularly the large-scale topological changes and hub transience-will apply to other biological networks, including complex sub-systems in higher eukaryotes.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA; MRC, Mol Biol Lab, Div Struct Studies, Cambridge CB2 2QH, England	Yale University; Yale University; Yale University; MRC Laboratory Molecular Biology	Luscombe, NM (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 208114, New Haven, CT 06520 USA.	sandy@bioinfo.mbb.yale.edu	Califano, Andrea/F-7239-2012; Mohan, Babu P./I-7362-2019; 白, 纯歌/V-1853-2017	Snyder, Michael/0000-0003-0784-7987; Teichmann, Sarah/0000-0002-6294-6366				Babu MM, 2003, NUCLEIC ACIDS RES, V31, P1234, DOI 10.1093/nar/gkg210; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Cho RJ, 1998, MOL CELL, V2, P65, DOI 10.1016/S1097-2765(00)80114-8; Christie KR, 2004, NUCLEIC ACIDS RES, V32, pD311, DOI 10.1093/nar/gkh033; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Gasch AP, 2001, MOL BIOL CELL, V12, P2987, DOI 10.1091/mbc.12.10.2987; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Guelzim N, 2002, NAT GENET, V31, P60, DOI 10.1038/ng873; Horak CE, 2002, GENE DEV, V16, P3017, DOI 10.1101/gad.1039602; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Martinez-Antonio A, 2003, CURR OPIN MICROBIOL, V6, P482, DOI 10.1016/j.mib.2003.09.002; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Oltvai ZN, 2002, SCIENCE, V298, P763, DOI 10.1126/science.1078563; Pilpel Y, 2001, NAT GENET, V29, P153, DOI 10.1038/ng724; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Svetlov VV, 1995, YEAST, V11, P1439, DOI 10.1002/yea.320111502; Teichmann SA, 2004, NAT GENET, V36, P492, DOI 10.1038/ng1340; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Wagner A, 2001, P ROY SOC B-BIOL SCI, V268, P1803, DOI 10.1098/rspb.2001.1711; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yu HY, 2004, NUCLEIC ACIDS RES, V32, P328, DOI 10.1093/nar/gkh164; Yu HY, 2004, TRENDS GENET, V20, P227, DOI 10.1016/j.tig.2004.04.008; Zeitlinger J, 2003, CELL, V113, P395, DOI 10.1016/S0092-8674(03)00301-5	28	685	709	2	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2004	431	7006					308	312		10.1038/nature02782	http://dx.doi.org/10.1038/nature02782			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372033				2022-12-24	WOS:000223864000041
J	Schlienger, RG; Kraenzlin, ME; Jick, SS; Meier, CR				Schlienger, RG; Kraenzlin, ME; Jick, SS; Meier, CR			Use of beta-blockers and risk of fractures	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRACTICE RESEARCH DATABASE; OSTEOBLAST-LIKE CELLS; BONE-MINERAL DENSITY; THIAZIDE-DIURETICS; HIP FRACTURE; ADRENERGIC RECEPTORS; CONTROLLED-TRIAL; NERVOUS-SYSTEM; HYDROCHLOROTHIAZIDE; RESORPTION	Context Animal studies suggest that the beta-blocker propranolol increases bone formation, but data on whether use of beta-blockers (with or without concomitant use of thiazide diuretics) is associated with reduced fracture risk in humans are limited. Objective To determine whether use of beta-blockers alone or in combination with thiazides is associated with a decreased risk of fracture in adults. Design, Setting, and Participants Case-control analysis using the UK General Practice Research Database (GPRD). The study included 30601 case patients aged 30 to 79 years with an incident fracture diagnosis between 1993 and 1999 and 120819 controls, matched to cases on age, sex, calendar time, and general practice attended. Main Outcome Measures Odds ratios (ORs) of having a fracture in association with use of beta-blockers or a combination of beta-blockers with thiazides. Results The most frequent fractures were of the hand/lower arm (n=12837 [42.0%]) and of the foot (n=4627 [15.1%]). Compared with patients who did not use either beta-blockers or thiazide diuretics, the OR for current use of beta-blockers only (greater than or equal to3 prescriptions) was 0.77 (95% confidence interval [CI], 0.72-0.83); for current use of thiazides only (greater than or equal to3 prescriptions), 0.80 (95% CI, 0.74-0.86); and for combined current use of beta-blockers and thiazides, 0.71 (95% CI, 0.64-0.79). Data were adjusted for smoking; body mass index; number of practice visits; and use of calcium channel blockers, angiotensin-converting enzyme inhibitors, antipsychotics, antidepressants, statins, antiepileptics, benzodiazepines, corticosteroids, and estrogens. Conclusions Our data suggest that current use of beta-blockers is associated with a reduced risk of fractures, taken alone as well as in combination with thiazide diuretics. Many elderly patients with hypertension who are at risk of developing osteoporosis may potentially benefit from combined therapy with beta-blockers and thiazides.	Univ Basel Hosp, Div Clin Pharmacol & Toxicol, Basel Pharmacoepidemiol Unit, CH-4031 Basel, Switzerland; Univ Basel Hosp, Div Endocrinol Diabet & Clin Nutr, CH-4031 Basel, Switzerland; Univ Basel, Dept Pharmaceut Sci, Inst Clin Pharm, Basel, Switzerland; Boston Univ, Sch Med, Boston Collaborat Drug Surveillance Program, Lexington, MA USA	University of Basel; University of Basel; University of Basel; Boston University	Meier, CR (corresponding author), Univ Basel Hosp, Div Clin Pharmacol & Toxicol, Basel Pharmacoepidemiol Unit, Hebelstr 2, CH-4031 Basel, Switzerland.	Meierch@uhbs.ch		Jick, Susan/0000-0002-2215-1067				Arai M, 2003, BBA-MOL CELL RES, V1640, P137, DOI 10.1016/S0167-4889(03)00042-9; Arnett TR, 1996, BONE, V18, P277, DOI 10.1016/8756-3282(95)00486-6; Aubin R, 1996, KIDNEY INT, V50, P1476, DOI 10.1038/ki.1996.461; Barry ELR, 1997, AM J PHYSIOL-CELL PH, V272, pC109, DOI 10.1152/ajpcell.1997.272.1.C109; Bauer DC, 2004, ARCH INTERN MED, V164, P146, DOI 10.1001/archinte.164.2.146; Cherruau M, 1999, BONE, V25, P545, DOI 10.1016/S8756-3282(99)00211-2; Cherruau M, 2003, J CELL PHYSIOL, V194, P341, DOI 10.1002/jcp.10209; Cock TA, 2003, LANCET, V362, P1572, DOI 10.1016/S0140-6736(03)14747-2; Cumming RG, 2003, CNS DRUGS, V17, P825, DOI 10.2165/00023210-200317110-00004; Ensrud KE, 2003, ARCH INTERN MED, V163, P949, DOI 10.1001/archinte.163.8.949; Feskanich D, 1997, OSTEOPOROSIS INT, V7, P79, DOI 10.1007/BF01623465; HALL TJ, 1994, CALCIFIED TISSUE INT, V55, P266, DOI 10.1007/BF00310404; Herings RMC, 1996, J CLIN EPIDEMIOL, V49, P115, DOI 10.1016/0895-4356(95)00552-8; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Jick H, 1997, EPIDEMIOLOGY, V8, P446, DOI 10.1097/00001648-199707000-00017; Jick SS, 2003, PHARMACOTHERAPY, V23, P686, DOI 10.1592/phco.23.5.686.32205; LaCroix AZ, 2000, ANN INTERN MED, V133, P516, DOI 10.7326/0003-4819-133-7-200010030-00010; LACROIX AZ, 1990, NEW ENGL J MED, V322, P286, DOI 10.1056/NEJM199002013220502; Meier CR, 2000, JAMA-J AM MED ASSOC, V283, P3205, DOI 10.1001/jama.283.24.3205; Meier CR, 2000, ARCH INTERN MED, V160, P349, DOI 10.1001/archinte.160.3.349; MINKOWITZ B, 1991, J ORTHOPAED RES, V9, P869, DOI 10.1002/jor.1100090613; MOORE RE, 1993, BONE MINER, V23, P301, DOI 10.1016/S0169-6009(08)80105-5; Moser M, 1998, JAMA-J AM MED ASSOC, V279, P1813, DOI 10.1001/jama.279.22.1813; Pasco JA, 2004, J BONE MINER RES, V19, P19, DOI 10.1359/JBMR.0301214; Perez-Castrillon JL, 2003, AM J HYPERTENS, V16, P453, DOI 10.1016/S0895-7061(03)00845-8; RAY WA, 1989, LANCET, V1, P687; Reid IR, 2000, AM J MED, V109, P362, DOI 10.1016/S0002-9343(00)00510-6; Rejnmark L, 2003, EUR J CLIN INVEST, V33, P41, DOI 10.1046/j.1365-2362.2003.01103.x; Rodriguez LAG, 1998, BRIT J CLIN PHARMACO, V45, P419; Schoofs MWCJ, 2003, ANN INTERN MED, V139, P476, DOI 10.7326/0003-4819-139-6-200309160-00010; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Togari A, 1997, NEUROSCI LETT, V233, P125, DOI 10.1016/S0304-3940(97)00649-6; Togari A, 2002, MICROSC RES TECHNIQ, V58, P77, DOI 10.1002/jemt.10121; van Staa TP, 2000, RHEUMATOLOGY, V39, P1383, DOI 10.1093/rheumatology/39.12.1383; Walley T, 1997, LANCET, V350, P1097, DOI 10.1016/S0140-6736(97)04248-7; ZAWADA ET, 1987, MINER ELECTROL METAB, V13, P72	36	259	274	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 15	2004	292	11					1326	1332		10.1001/jama.292.11.1326	http://dx.doi.org/10.1001/jama.292.11.1326			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853YL	15367554	Bronze			2022-12-24	WOS:000223866800024
J	Kolbe, JJ; Glor, RE; Schettino, LRG; Lara, AC; Larson, A; Losos, JB				Kolbe, JJ; Glor, RE; Schettino, LRG; Lara, AC; Larson, A; Losos, JB			Genetic variation increases during biological invasion by a Cuban lizard	NATURE			English	Article							POPULATION BIOLOGY; UNITED-STATES; ANOLIS-SAGREI; EVOLUTION; PHENETICS; FLORIDA	A genetic paradox(1,2) exists in invasion biology: how do introduced populations, whose genetic variation has probably been depleted by population bottlenecks, persist and adapt to new conditions? Lessons from conservation genetics show that reduced genetic variation due to genetic drift and founder effects limits the ability of a population to adapt, and small population size increases the risk of extinction(1,3,4). Nonetheless, many introduced species experiencing these same conditions during initial introductions persist, expand their ranges, evolve rapidly and become invasive. To address this issue, we studied the brown anole, a worldwide invasive lizard. Genetic analyses indicate that at least eight introductions have occurred in Florida from across this lizard's native range, blending genetic variation from different geographic source populations and producing populations that contain substantially more, not less, genetic variation than native populations. Moreover, recently introduced brown anole populations around the world originate from Florida, and some have maintained these elevated levels of genetic variation. Here we show that one key to invasion success may be the occurrence of multiple introductions that transform among-population variation in native ranges to within-population variation in introduced areas. Furthermore, these genetically variable populations may be particularly potent sources for introductions elsewhere. The growing problem of invasive species introductions brings considerable economic and biological costs(5,6). If these costs are to be mitigated, a greater understanding of the causes, progression and consequences of biological invasions is needed(7).	Washington Univ, Dept Biol, St Louis, MO 63130 USA; CITMA, Inst Ecol & Sistemat, Havana 10800, Cuba	Washington University (WUSTL)	Kolbe, JJ (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	kolbe@biology.wustl.edu	Glor, Richard/N-4656-2013	Glor, Richard/0000-0002-3359-1631				Allendorf FW, 2003, CONSERV BIOL, V17, P24, DOI 10.1046/j.1523-1739.2003.02365.x; Campbell TS, 2003, BIOL INVASIONS, V5, P193, DOI 10.1023/A:1026172314139; Campbell Todd S., 1996, Herpetological Review, V27, P155; Campbell TS, 2000, ANAL EFFECTS EXOTIC; EHRLICH PR, 1989, BIOL INVASIONS GLOBA, P3125; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Facon B, 2003, MOL ECOL, V12, P3027, DOI 10.1046/j.1365-294X.2003.01972.x; Frankham R, 1998, NATURE, V392, P441, DOI 10.1038/33022; Frankham R, 2010, INTRO CONSERVATION G; Gerber GP, 2000, OECOLOGIA, V124, P599, DOI 10.1007/s004420000414; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huey RB, 2000, SCIENCE, V287, P308, DOI 10.1126/science.287.5451.308; Kolar CS, 2002, SCIENCE, V298, P1233, DOI 10.1126/science.1075753; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; LEE JC, 1992, COPEIA, P942, DOI 10.2307/1446624; LEE JC, 1985, COPEIA, P182, DOI 10.2307/1444808; LOSOS JB, 1993, OECOLOGIA, V95, P525, DOI 10.1007/BF00317437; Macey JR, 1997, J MOL EVOL, V44, P660, DOI 10.1007/PL00006190; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; NOVAK SJ, 1993, HEREDITY, V71, P167, DOI 10.1038/hdy.1993.121; Nylander J.A.A., 2002, MRMODELTEST V1 0B; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Queller DC, 2000, NATURE, V405, P519, DOI 10.1038/35014705; Roderick GK, 2003, NAT REV GENET, V4, P889, DOI 10.1038/nrg1201; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420; WILLIAMS EE, 1969, Q REV BIOL, V44, P345, DOI 10.1086/406245; Williamson M, 1996, BIOL INVASIONS	30	774	817	7	356	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 9	2004	431	7005					177	181		10.1038/nature02807	http://dx.doi.org/10.1038/nature02807			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HI	15356629				2022-12-24	WOS:000223746000042
J	Poulton, SW; Fralick, PW; Canfield, DE				Poulton, SW; Fralick, PW; Canfield, DE			The transition to a sulphidic ocean similar to 1.84 billion years ago	NATURE			English	Article							GUNFLINT FORMATION; PYRITE FORMATION; IRON; EVOLUTION; ANOXIA; MODEL; CHEMISTRY; SULFATE; ONTARIO; ISOTOPE	The Proterozoic aeon (2.5 to 0.54 billion years (Gyr) ago) marks the time between the largely anoxic world of the Archean (>2.5Gyr ago)(1) and the dominantly oxic world of the Phanerozoic (<0.54 Gyr ago). The course of ocean chemistry through the Proterozoic has traditionally been explained by progressive oxygenation of the deep ocean in response to an increase in atmospheric oxygen around 2.3 Gyr ago. This postulated rise in the oxygen content of the ocean is in turn thought to have led to the oxidation of dissolved iron, Fe(II), thus ending the deposition of banded iron formations (BIF) around 1.8 Gyr ago(1,2). An alternative interpretation suggests that the increasing atmospheric oxygen levels enhanced sulphide weathering on land and the flux of sulphate to the oceans. This increased rates of sulphate reduction, resulting in Fe(II) removal in the form of pyrite as the oceans became sulphidic(3). Here we investigate sediments from the similar to 1.8-Gyr-old Animikie group, Canada, which were deposited during the final stages of the main global period of BIF deposition. This allows us to evaluate the two competing hypotheses for the termination of BIF deposition. We use iron-sulphur-carbon (Fe-S-C) systematics to demonstrate continued ocean anoxia after the final global deposition of BIF and show that a transition to sulphidic bottom waters was ultimately responsible for the termination of BIF deposition. Sulphidic conditions may have persisted until a second major rise in oxygen between 0.8 to 0.58 Gyr ago(4,5), possibly reducing global rates of primary production and arresting the pace of algal evolution(6).	Univ So Denmark, Inst Biol, Danish Ctr Earth Syst Sci, DK-5230 Odense M, Denmark; Lakehead Univ, Dept Geol, Thunder Bay, ON P7B 5E1, Canada	University of Southern Denmark; Lakehead University	Poulton, SW (corresponding author), Univ So Denmark, Inst Biol, Danish Ctr Earth Syst Sci, Campusvej 55, DK-5230 Odense M, Denmark.	s.poulton@biology.sdu.dk	Canfield, Don/C-1735-2012	Canfield, Don/0000-0001-7602-8366; Poulton, Simon/0000-0001-7621-189X				Anbar AD, 2002, SCIENCE, V297, P1137, DOI 10.1126/science.1069651; Anderson TF, 2004, AM J SCI, V304, P203, DOI 10.2475/ajs.304.3.203; Arnold GL, 2004, SCIENCE, V304, P87, DOI 10.1126/science.1091785; BERNER RA, 1984, GEOLOGY, V12, P365, DOI 10.1130/0091-7613(1984)12<365:CMFDFF>2.0.CO;2; Brocks JJ, 2004, GEOCHIM COSMOCHIM AC, V68, pA796; Canfield DE, 1999, AM J SCI, V299, P697, DOI 10.2475/ajs.299.7-9.697; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; Canfield DE, 1996, NATURE, V382, P127, DOI 10.1038/382127a0; CARRIGAN WJ, 1991, PRECAMBRIAN RES, V52, P347, DOI 10.1016/0301-9268(91)90088-R; CLOUD P, 1972, AM J SCI, V272, P537, DOI 10.2475/ajs.272.6.537; DERRY LA, 1992, GEOCHIM COSMOCHIM AC, V56, P1317, DOI 10.1016/0016-7037(92)90064-P; DERRY LA, 1990, GEOCHIM COSMOCHIM AC, V54, P2965, DOI 10.1016/0016-7037(90)90114-Z; DREVER JI, 1974, GEOL SOC AM BULL, V85, P1099, DOI 10.1130/0016-7606(1974)85<1099:GMFTOO>2.0.CO;2; Fralick P, 2002, CAN J EARTH SCI, V39, P1085, DOI 10.1139/E02-028; Habicht KS, 2002, SCIENCE, V298, P2372, DOI 10.1126/science.1078265; Holland H.D., 1984, CHEM EVOLUTION ATMOS; KISSIN SA, 2003, LAKE SUPERIOR I P, V49, P43; Lyons TW, 1997, GEOCHIM COSMOCHIM AC, V61, P3367, DOI 10.1016/S0016-7037(97)00174-9; OJAKANGAS RW, 1983, GEOL SOC AM MEM, V160, P49; Passier HF, 1999, NATURE, V397, P146, DOI 10.1038/16441; Poulton SW, 2002, AM J SCI, V302, P774, DOI 10.2475/ajs.302.9.774; POULTON SW, UNPUB CHEM GEOL; Pufahl PK, 2004, SEDIMENTOLOGY, V51, P791, DOI 10.1111/j.1365-3091.2004.00651.x; RAISWELL R, 1985, AM J SCI, V285, P710, DOI 10.2475/ajs.285.8.710; Raiswell R, 1998, AM J SCI, V298, P219, DOI 10.2475/ajs.298.3.219; Raiswell R, 2001, J SEDIMENT RES, V71, P286, DOI 10.1306/070300710286; Schidlowski M., 1983, P149; Shen Y, 2003, NATURE, V423, P632, DOI 10.1038/nature01651; Shen YN, 2002, AM J SCI, V302, P81, DOI 10.2475/ajs.302.2.81; STRAUSS H, 1993, PRECAMBRIAN RES, V63, P225, DOI 10.1016/0301-9268(93)90035-Z	30	335	354	5	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 9	2004	431	7005					173	177		10.1038/nature02912	http://dx.doi.org/10.1038/nature02912			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HI	15356628				2022-12-24	WOS:000223746000041
J	Leung, GM; Rainer, TH; Lau, FL; Wong, IOL; Tong, A; Wong, TW; Kong, JHB; Hedley, AJ; Lam, TH				Leung, GM; Rainer, TH; Lau, FL; Wong, IOL; Tong, A; Wong, TW; Kong, JHB; Hedley, AJ; Lam, TH		Hosp Authority SARS Collaborative	A clinical prediction rule for diagnosing severe acute respiratory syndrome in the emergency department	ANNALS OF INTERNAL MEDICINE			English	Article							HONG-KONG; SARS CORONAVIRUS; LABORATORY TESTS; OUTBREAK; VALIDATION; PNEUMONIA; MORTALITY; INFECTION; DISEASE; MODELS	Background: Accurate, objective models of triage for patients with suspected severe acute respiratory syndrome (SARS) could assess risks and improve decisions about isolation and inpatient treatment. Objective: To develop and validate a clinical prediction rule for identifying patients with SARS in an emergency department setting. Design: Retrospective analysis using a 2-step coefficient-based multivariable logistic regression scoring method with internal validation by bootstrapping. Setting: 2 hospitals in Hong Kong Participants: 1274 consecutive patients from 1 hospital and 1375 consecutive patients from another hospital. Measurements: Points were assigned on the basis of history, physical examination, and simple investigations obtained at presentation. The outcome measure was a final diagnosis of SARS, as confirmed by World Health Organization laboratory criteria. Results: Predictors for SARS on the basis of history (step 1) included previous contact with a patient with SARS and the presence of fever, myalgia, and malaise. Age 65 years and older and younger than 18 years and the presence of sputum, abdominal pain, sore throat, and rhinorrhea were inversely related to having SARS. In step 2, haziness or pneumonic consolidation on chest radiographs and low lymphocyte and platelet counts, in addition to a positive contact history and fever were associated with a higher probability of SARS. A high neutrophil count, the extremes of age, and sputum production were associated with a lower probability of SARS. In the derivation sample, the observed incidence of SARS was 4.4% for those assigned to the low-risk group (in steps 1 or 2); in the high-risk group, incidence of SARS was 21.0% for quartile 1, 39.5% for quartile 2, 61.2% for quartile 3, and 79.7% for quartile 4. This prediction rule achieved an optimism-corrected sensitivity of 0.90, a specificity of 0.62, and an area under the receiver-operating characteristic curve of 0.85. Limitations: The prediction rule may not apply to isolated cases occurring during an interepidemic period. Generalizability of the findings should be confirmed in other SARS-affected countries and should be prospectively validated if SARS returns. Conclusions: our findings suggest that a simple model that uses clinical data at the time of presentation to an emergency department during an acute outbreak predicted the incidence of SARS and provided good diagnostic utility.	Chinese Univ Hong Kong, Prince Wales Hosp, Accid & Emergency Med Acad Unit, Shatin, Hong Kong, Peoples R China; Chinese Univ Hong Kong, United Christian Hosp, Pamela Youde Nethersole E Hosp, Shatin, Hong Kong, Peoples R China; Hong Kong Hosp Author, Shatin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Pamela Youde Nethersole Eastern Hospital; United Christian Hospital	Rainer, TH (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Accid & Emergency Med Acad Unit, Shatin, Hong Kong, Peoples R China.	b875722@mailserv.cuhk.edu.hk	Leung, Gabriel Matthew/C-4336-2009; Rainer, Timothy/I-2591-2013; Wong, Oi Ling/C-4538-2009; Hedley, Anthony/C-4305-2009; Hedley, Anthony J/A-9113-2013; Wong, Tze Wai/K-5344-2013; Lam, Tai Hing/C-4317-2009	Rainer, Timothy/0000-0003-3355-3237; Lam, Tai Hing/0000-0002-2033-9971; Leung, Gabriel/0000-0002-2503-6283				Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1; Efron B, 1998, INTRO BOOTSTRAP; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; Fouchier RAM, 2004, CAN MED ASSOC J, V170, P63; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hon KLE, 2003, LANCET, V361, P1701, DOI 10.1016/S0140-6736(03)13364-8; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Lee DS, 2003, JAMA-J AM MED ASSOC, V290, P2581, DOI 10.1001/jama.290.19.2581; LEE KL, 1995, CIRCULATION, V91, P1659, DOI 10.1161/01.CIR.91.6.1659; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; LEUNG CM, IN PRESS EMERG INFEC; Leung GM, 2003, J EPIDEMIOL COMMUN H, V57, P857, DOI 10.1136/jech.57.11.857; LEUNG GM, IN PRESS SARS 1 PLAG; Ng EKO, 2003, CLIN CHEM, V49, P1976, DOI 10.1373/clinchem.2003.024125; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Poon LLM, 2003, J CLIN VIROL, V28, P233, DOI 10.1016/j.jcv.2003.08.004; Rainer TH, 2004, ANN INTERN MED, V140, P614, DOI 10.7326/0003-4819-140-8-200404200-00008; Rainer TH, 2003, BRIT MED J, V326, P1354, DOI 10.1136/bmj.326.7403.1354; Steyerberg EW, 2001, MED DECIS MAKING, V21, P45, DOI 10.1177/0272989X0102100106; Steyerberg EW, 2003, J CLIN EPIDEMIOL, V56, P441, DOI 10.1016/S0895-4356(03)00047-7; Sullivan LM, 2004, STAT MED, V23, P1631, DOI 10.1002/sim.1742; Tang P, 2004, CAN MED ASSOC J, V170, P47; Tsang KW, 2003, NEW ENGL J MED, V348, P1977, DOI 10.1056/NEJMoa030666; WHO, 2003, US LAB METH SARS DIA; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wong KT, 2003, RADIOLOGY, V228, P395, DOI 10.1148/radiol.2283030541; World Health Organization, 2003, CAS DEF SURV SEV AC	29	33	33	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 7	2004	141	5					333	342		10.7326/0003-4819-141-5-200409070-00106	http://dx.doi.org/10.7326/0003-4819-141-5-200409070-00106			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	852CW	15326019	Green Accepted, Green Submitted			2022-12-24	WOS:000223733800001
J	Kerr, DJ				Kerr, DJ			Two errors	LANCET			English	Editorial Material									Radcliffe Infirm, Dept Clin Pharmacol, Oxford OX2 6HE, England	Radcliffe Infirmary	Kerr, DJ (corresponding author), Radcliffe Infirm, Dept Clin Pharmacol, Oxford OX2 6HE, England.	david.kerr@clinical-pharmacology.oxford.ac.uk							0	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	SEP 4	2004	364	9437					907	907		10.1016/S0140-6736(04)16988-2	http://dx.doi.org/10.1016/S0140-6736(04)16988-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	851KY	15351200				2022-12-24	WOS:000223685200039
J	Chang, CP; Neilson, JR; Bayle, JH; Gestwicki, JE; Kuo, A; Stankunas, K; Graef, IA; Crabtree, GR				Chang, CP; Neilson, JR; Bayle, JH; Gestwicki, JE; Kuo, A; Stankunas, K; Graef, IA; Crabtree, GR			A field of myocardial-endocardial NFAT signaling underlies heart valve morphogenesis	CELL			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTION FACTOR; GROWTH-FACTOR; EMBRYONIC LETHALITY; CARDIAC DEVELOPMENT; CUSHION FORMATION; DNA-BINDING; CALCINEURIN; VEGF; IDENTIFICATION	The delicate leaflets that make up vertebrate heart valves are essential for our moment-to-moment existence. Abnormalities of valve formation are the most common serious human congenital defect. Despite their importance, relatively little is known about valve development. We show that the initiation of heart valve morphogenesis in mice requires calcineurin/NFAT to repress VEGF expression in the myocardium underlying the site of prospective valve formation. This repression of VEGF at E9 is essential for endocardial cells to transform into mesenchymal cells. Later, at Ell, a second wave of calcineurin/NFAT signaling is required in the endocardium, adjacent to the earlier myocardial site of NFAT action, to direct valvular elongation and refinement. Thus, NFAT signaling functions sequentially from myocardium to endocardium within a valvular morphogenetic field to initiate and perpetuate embryonic valve formation. This mechanism also operates in zebrafish, indicating a conserved role for calcineurin/NFAT signaling in vertebrate heart valve morphogenesis.	Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Dev Biol, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Med, Div Cardiovasc, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Crabtree, GR (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.	crabtree@stanford.edu		Neilson, Joel R./0000-0002-3408-608X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL072092] Funding Source: NIH RePORTER; NHLBI NIH HHS [R21 HL72092-01] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Akiyama H, 2004, P NATL ACAD SCI USA, V101, P6502, DOI 10.1073/pnas.0401711101; Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; Brickner ME, 2000, NEW ENGL J MED, V342, P256, DOI 10.1056/NEJM200001273420407; Brown CB, 1999, SCIENCE, V283, P2080, DOI 10.1126/science.283.5410.2080; Camenisch TD, 2002, NAT MED, V8, P850, DOI 10.1038/nm742; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; CARPENTER SJ, 1980, ANAT REC, V197, P221, DOI 10.1002/ar.1091970211; Chang CP, 2003, GENESIS, V36, P7, DOI 10.1002/gene.10186; CHANG CP, 1995, GENE DEV, V9, P663, DOI 10.1101/gad.9.6.663; Chen BB, 2000, NAT GENET, V24, P296, DOI 10.1038/73528; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Dor Y, 2001, DEVELOPMENT, V128, P1531; DURAND DB, 1988, MOL CELL BIOL, V8, P1715, DOI 10.1128/MCB.8.4.1715; DVORAK HF, 1979, J IMMUNOL, V122, P166; EISENBERG LM, 1995, CIRC RES, V77, P1, DOI 10.1161/01.RES.77.1.1; EMMEL EA, 1989, SCIENCE, V246, P1617, DOI 10.1126/science.2595372; Erickson SL, 1997, DEVELOPMENT, V124, P4999; Fedak PWM, 2002, CIRCULATION, V106, P900, DOI 10.1161/01.CIR.0000027905.26586.E8; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; Gitler AD, 2003, NAT GENET, V33, P75, DOI 10.1038/ng1059; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Haigh JJ, 2000, DEVELOPMENT, V127, P1445; HO SN, 1995, J BIOL CHEM, V270, P19898, DOI 10.1074/jbc.270.34.19898; Hurlstone AFL, 2003, NATURE, V425, P633, DOI 10.1038/nature02028; Iwamoto R, 2003, P NATL ACAD SCI USA, V100, P3221, DOI 10.1073/pnas.0537588100; Jackson LF, 2003, EMBO J, V22, P2704, DOI 10.1093/emboj/cdg264; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; Kuo CJ, 2001, P NATL ACAD SCI USA, V98, P4605, DOI 10.1073/pnas.081615298; Lakkis MM, 1998, DEVELOPMENT, V125, P4359; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Miquerol L, 2000, DEVELOPMENT, V127, P3941; Miquerol L, 1999, DEV BIOL, V212, P307, DOI 10.1006/dbio.1999.9355; MJAATVEDT CH, 1989, DEV BIOL, V136, P118, DOI 10.1016/0012-1606(89)90135-8; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Moorman AFM, 1998, CIRC RES, V82, P629, DOI 10.1161/01.RES.82.6.629; Nakajima Y, 2000, ANAT RECORD, V258, P119, DOI 10.1002/(SICI)1097-0185(20000201)258:2<119::AID-AR1>3.0.CO;2-U; Neilson JR, 2004, IMMUNITY, V20, P255, DOI 10.1016/S1074-7613(04)00052-4; Olson EN, 2003, GENE DEV, V17, P1937, DOI 10.1101/gad.1110103; PARR MB, 1986, BIOL REPROD, V34, P393, DOI 10.1095/biolreprod34.2.393; Ramsdell AF, 1998, ACTA ANAT, V162, P1; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Reynolds LP, 2001, BIOL REPROD, V64, P1033, DOI 10.1095/biolreprod64.4.1033; RUNYAN RB, 1983, DEV BIOL, V95, P108, DOI 10.1016/0012-1606(83)90010-6; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; STURM K, 1993, METHOD ENZYMOL, V225, P164; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Wolfe SA, 1997, NATURE, V385, P172, DOI 10.1038/385172a0	56	257	263	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 3	2004	118	5					649	663		10.1016/j.cell.2004.08.010	http://dx.doi.org/10.1016/j.cell.2004.08.010			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852BN	15339668	Bronze			2022-12-24	WOS:000223730300014
J	Matroule, JY; Lam, H; Burnette, DT; Jacobs-Wagner, C				Matroule, JY; Lam, H; Burnette, DT; Jacobs-Wagner, C			Cytokinesis monitoring during development: Rapid pole-to-pole shuttling of a signaling protein by localized kinase and phosphatase in Caulobacter	CELL			English	Article							ASYMMETRIC CELL-DIVISION; RESPONSE REGULATOR; ESCHERICHIA-COLI; DYNAMIC LOCALIZATION; CYCLE REGULATION; CRESCENTUS; DIFFERENTIATION; TRANSDUCTION; DOMAIN; ENVZ	For successful generation of different cell types by asymmetric cell division, cell differentiation should be initiated only after completion of division. Here, we describe a control mechanism by which Caulobacter couples the initiation of a developmental program to the completion of cytokinesis. Genetic evidence indicates that localization of the signaling protein DivK at the flagellated pole prevents premature initiation of development. Photobleaching and FRET experiments show that polar localization of DivK is dynamic with rapid pole-to-pole shuttling of diffusible DivK generated by the localized activities of PleC phosphatase and DivJ kinase at opposite poles. This shuttling is interrupted upon completion of cytokinesis by the segregation of PleC and DivJ to different daughter cells, resulting in disruption of DivK localization at the flagellated pole and subsequent initiation of development in the flagellated progeny. Thus, dynamic polar localization of a diffusible protein provides a control mechanism that monitors cytokinesis to regulate development.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Jacobs-Wagner, C (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, POB 208103, New Haven, CT 06520 USA.	christine.jacobs-wagner@yale.edu		Jacobs-Wagner, Christine/0000-0003-0980-5334	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065835] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM065835] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AIBA H, 1989, J BIOL CHEM, V264, P14090; Aldridge P, 1999, MOL MICROBIOL, V32, P379, DOI 10.1046/j.1365-2958.1999.01358.x; Alley MRK, 2001, MOL MICROBIOL, V40, P1335, DOI 10.1046/j.1365-2958.2001.02476.x; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Doe CQ, 2001, CURR OPIN CELL BIOL, V13, P68, DOI 10.1016/S0955-0674(00)00176-9; Elowitz MB, 1999, J BACTERIOL, V181, P197, DOI 10.1128/JB.181.1.197-203.1999; ELY B, 1991, METHOD ENZYMOL, V204, P372; EVINGER M, 1977, J BACTERIOL, V132, P294, DOI 10.1128/JB.132.1.294-301.1977; HECHT GB, 1995, EMBO J, V14, P3915, DOI 10.1002/j.1460-2075.1995.tb00063.x; Hsing WH, 1998, J BACTERIOL, V180, P4538, DOI 10.1128/JB.180.17.4538-4546.1998; Hsing WH, 1997, J BACTERIOL, V179, P3729, DOI 10.1128/jb.179.11.3729-3735.1997; HUGUENEL ED, 1982, DIFFERENTIATION, V21, P71, DOI 10.1111/j.1432-0436.1982.tb01199.x; Hung DY, 2002, P NATL ACAD SCI USA, V99, P13160, DOI 10.1073/pnas.202495099; Jacobs C, 2001, P NATL ACAD SCI USA, V98, P4095, DOI 10.1073/pnas.051609998; Knoblich JA, 2001, NAT REV MOL CELL BIO, V2, P11, DOI 10.1038/35048085; Lam H, 2003, DEV CELL, V5, P149, DOI 10.1016/S1534-5807(03)00191-6; Laub MT, 2002, P NATL ACAD SCI USA, V99, P4632, DOI 10.1073/pnas.062065699; Losick R, 1999, GENE DEV, V13, P377, DOI 10.1101/gad.13.4.377; Lu BW, 2000, ANNU REV NEUROSCI, V23, P531, DOI 10.1146/annurev.neuro.23.1.531; Ohta N, 1996, TRENDS MICROBIOL, V4, P326, DOI 10.1016/0966-842X(96)10050-0; Ohta N, 2000, PROKARYOTIC DEVELOPMENT, P341; Ohta N, 2003, J BACTERIOL, V185, P4424, DOI 10.1128/JB.185.15.4424-4431.2003; OSLEY MA, 1977, P NATL ACAD SCI USA, V74, P124, DOI 10.1073/pnas.74.1.124; OSLEY MA, 1977, CELL, V12, P393, DOI 10.1016/0092-8674(77)90115-5; Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504; Roberts RC, 1996, J BACTERIOL, V178, P1829, DOI 10.1128/jb.178.7.1829-1841.1996; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; SOMMER JM, 1989, J BACTERIOL, V171, P392, DOI 10.1128/jb.171.1.392-401.1989; SOMMER JM, 1991, GENETICS, V129, P623; SPRATT BG, 1986, GENE, V41, P337, DOI 10.1016/0378-1119(86)90117-4; TERRANA B, 1976, J BACTERIOL, V128, P456, DOI 10.1128/JB.128.1.456-462.1976; Tomomori C., 2003, HISTIDINE KINASES SI, P11, DOI [10.1016/B978-012372484-7/50003-5, DOI 10.1016/B978-012372484-7/50003-5]; Viollier PH, 2002, EMBO J, V21, P4420, DOI 10.1093/emboj/cdf454; WANG SP, 1993, P NATL ACAD SCI USA, V90, P630, DOI 10.1073/pnas.90.2.630; Wang Y, 2001, MOL MICROBIOL, V40, P347, DOI 10.1046/j.1365-2958.2001.02395.x; Wheeler RT, 1999, MOL CELL, V4, P683, DOI 10.1016/S1097-2765(00)80379-2; Wu JG, 1998, P NATL ACAD SCI USA, V95, P1443, DOI 10.1073/pnas.95.4.1443; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Youvan D. C., 1997, BIOTECHNOLOGY, V3, P1; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	40	109	110	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 3	2004	118	5					579	590		10.1016/j.cell.2004.08.019	http://dx.doi.org/10.1016/j.cell.2004.08.019			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	852BN	15339663	Bronze			2022-12-24	WOS:000223730300009
J	Bourc'his, D; Bestor, TH				Bourc'his, D; Bestor, TH			Meiotic catastrophe and retrotransposon reactivation in male germ cells lacking Dnmt3L	NATURE			English	Article							CYTOSINE METHYLATION; GENE FAMILY; EXPRESSION; IMPRINTS; MICE	Mammalian genomes employ heritable cytosine methylation in the long-term silencing of retrotransposons and genes subject to genomic imprinting and X chromosome inactivation. Little is known of the mechanisms that direct cytosine methylation to specific sequences. Here we show that DNA methyltransferase 3-like (Dnmt3L (ref. 1)) is expressed in testes during a brief perinatal period in the non-dividing precursors of spermatogonial stem cells at a stage where retrotransposons undergo de novo methylation. Deletion of the Dnmt3L gene prevented the de novo methylation of both long-terminal-repeat (LTR) and non-LTR retrotransposons, which were transcribed at high levels in spermatogonia and spermatocytes. Loss of Dnmt3L from early germ cells also caused meiotic failure in spermatocytes, which do not express Dnmt3L. Whereas dispersed repeated sequences were demethylated in mutant germ cells, tandem repeats in pericentric regions were methylated normally. This result indicates that the Dnmt3L protein might have a function in the de novo methylation of dispersed repeated sequences in a premeiotic genome scanning process that occurs in male germ cells at about the time of birth.	Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA	Columbia University	Bestor, TH (corresponding author), Columbia Univ Coll Phys & Surg, Dept Genet & Dev, 701 W 168th St, New York, NY 10032 USA.	thb12@columbia.edu		Bourc'his, Deborah/0000-0001-9499-7291				Aapola U, 2000, GENOMICS, V65, P293, DOI 10.1006/geno.2000.6168; Bestor TH, 2003, TRENDS GENET, V19, P185, DOI 10.1016/S0168-9525(03)00049-0; Bestor TH, 1996, NAT GENET, V12, P363, DOI 10.1038/ng0496-363; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; CAMBARERI EB, 1989, SCIENCE, V244, P1571, DOI 10.1126/science.2544994; Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999; Davis TL, 1999, GENOMICS, V58, P18, DOI 10.1006/geno.1999.5813; DOBSON MJ, 1994, J CELL SCI, V107, P2749; ENDERS GC, 1994, DEV BIOL, V163, P331, DOI 10.1006/dbio.1994.1152; Hata K, 2002, DEVELOPMENT, V129, P1983; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; KUFF EL, 1988, ADV CANCER RES, V51, P183, DOI 10.1016/S0065-230X(08)60223-7; La Salle S, 2004, DEV BIOL, V268, P403, DOI 10.1016/j.ydbio.2003.12.031; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Maloisel L, 1998, GENE DEV, V12, P1381, DOI 10.1101/gad.12.9.1381; Odorisio T, 1998, NAT GENET, V18, P257, DOI 10.1038/ng0398-257; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; PIETRAS DF, 1983, NUCLEIC ACIDS RES, V11, P6965, DOI 10.1093/nar/11.20.6965; PONZETTOZIMMERMAN C, 1984, NUCLEIC ACIDS RES, V12, P2807, DOI 10.1093/nar/12.6.2807; SANFORD J, 1984, NUCLEIC ACIDS RES, V12, P2822; Ueda T, 2000, GENES CELLS, V5, P649, DOI 10.1046/j.1365-2443.2000.00351.x; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	25	820	842	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 2	2004	431	7004					96	99		10.1038/nature02886	http://dx.doi.org/10.1038/nature02886			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850VC	15318244				2022-12-24	WOS:000223641500049
J	Portenoy, RK				Portenoy, RK			Appropriate use of opioids for persistent non-cancer pain	LANCET			English	Editorial Material									Beth Israel Med Ctr, Dept Pain Med & Palliat Care, New York, NY 10003 USA	Harvard University; Beth Israel Deaconess Medical Center	Portenoy, RK (corresponding author), Beth Israel Med Ctr, Dept Pain Med & Palliat Care, New York, NY 10003 USA.	Rportenoy@chpnet.org						American Academy of Pain Medicine and American Pain Society, US OP TREATM CHRON P; [Anonymous], 2000, ACH BAL NAT OP CONTR; Chou R, 2003, J PAIN SYMPTOM MANAG, V26, P1026, DOI 10.1016/j.jpainsymman.2003.03.003; Portenoy RK, 1997, COMPREHENSIVE TXB SU, P563; Rosenblum A, 2003, JAMA-J AM MED ASSOC, V289, P2370, DOI 10.1001/jama.289.18.2370; *ROYAL COLL AN ROY, 2004, REC APPR US OP PERS; Zacny J, 2003, DRUG ALCOHOL DEPEN, V69, P215, DOI 10.1016/S0376-8716(03)00003-6; ZENZ M, 1992, J PAIN SYMPTOM MANAG, V7, P69, DOI 10.1016/0885-3924(92)90116-Y	8	26	27	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 28	2004	364	9436					739	740		10.1016/S0140-6736(04)16951-1	http://dx.doi.org/10.1016/S0140-6736(04)16951-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	849VO	15337386				2022-12-24	WOS:000223569600007
J	Schulz, R; Belle, SH; Czaja, SJ; McGinnis, KA; Stevens, A; Zhang, S				Schulz, R; Belle, SH; Czaja, SJ; McGinnis, KA; Stevens, A; Zhang, S			Long-term care placement of dementia patients and caregiver health and well-being	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NURSING-HOME PLACEMENT; ALZHEIMERS-DISEASE; FAMILY CAREGIVERS; OLDER-PEOPLE; INSTITUTIONALIZATION; BURDEN; REACH; PREDICTORS; PROJECT; TIME	Context Placing a relative with dementia into a long-term care facility is common among caregivers. Placement transition and factors that affect caregiver health and well-being after placement of the patient are not well described. Objective To assess the impact of placing a relative with dementia in a long-term care facility on caregivers' health and well-being. Design, Setting, and Participants Prospective study from 1996 to 2000 of the placement transition in a sample of 1222 caregiver-patient dyads recruited from 6 US sites. A total of 180 patients were placed in a long-term care facility during the 18-month follow-up period. Data collected before and after placement were analyzed to identify factors associated with placement, the nature of contact between caregivers and their institutionalized relatives after placement, and the relation of both of these factors to health outcomes among dementia caregivers. Main Outcome Measures Caregiver depression (symptoms on the Center for Epidemiological Studies-Depression [CES-D] scale; range, 0-60) and anxiety (State Trait Inventory; range, 10-40) and use of prescription medications for depression and anxiety. Results Caregivers who institutionalized their relative reported depressive symptoms and anxiety to be as high as they were while in-home caregivers. Overall CES-D scores for depression did not change from before to after placement (median [IQR], 15.0 [8-24.5] and 15.0 [7.7-28]; P=.64). Overall anxiety scores on the State Trait Inventory also did not change significantly (median [IQR], 22.0 (19-27] before vs 21.1 [18-27] after; P=.21). These effects were most pronounced among caregivers who were married to the patient (P=.02 for depression), visited more frequently (P=.01 for depression and P<.001 for anxiety), and were less satisfied with the help they received from others (P=.003 for depression and P<.001 for anxiety). The use of antidepressants did not change significantly before (21.1%) to after (17.9%) placement (P=.16). The use of anxiolytics before to after placement increased from 14.6% to 19% (P=.02), and nearly half of caregivers (48.3%) were at risk for clinical depression following placement of their relative. Conclusions The transition to institutional care is particularly difficult for spouses, almost half of whom visit the patient daily and continue to provide help with physical care during their visits. Clinical interventions that better prepare the caregiver for a placement transition and treat their depression and anxiety following placement may be of great benefit to these individuals.	Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Univ Ctr Social & Urban Res, Pittsburgh, PA 15260 USA; Univ Miami, Dept Psychiat & Behav Sci, Miami, FL 33152 USA; Univ Miami, Ctr Aging, Miami, FL 33152 USA; Univ Alabama Birmingham, Div Gerontol & Geriatr Med, Birmingham, AL USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Miami; University of Miami; University of Alabama System; University of Alabama Birmingham	Schulz, R (corresponding author), Univ Pittsburgh, Sch Med, Dept Psychiat, 121 Univ Pl,6th Floor, Pittsburgh, PA 15260 USA.	schulz@pitt.edu			NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P60MD000207] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL065112] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH052247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [U01NR004261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG013305] Funding Source: NIH RePORTER; NHLBI NIH HHS [P50 HL65112] Funding Source: Medline; NIA NIH HHS [UO1-AG13305] Funding Source: Medline; NIMHD NIH HHS [P60 MD000207] Funding Source: Medline; NIMH NIH HHS [P30 MH52247] Funding Source: Medline; NINR NIH HHS [U01-NR04261] Funding Source: Medline	NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		BOWKER AH, 1948, J AM STAT ASSOC, V43, P572, DOI 10.2307/2280710; COLLINS C, 1994, NURS RES, V43, P221; COX DR, 1972, J R STAT SOC B, V34, P187; Dellasega C, 1991, J Community Health Nurs, V8, P197, DOI 10.1207/s15327655jchn0804_2; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gitlin LN, 2003, PSYCHOL AGING, V18, P361, DOI 10.1037/0882-7974.18.3.361; GRAFSTROM M, 1995, ALZ DIS ASSOC DIS, V9, P78, DOI 10.1097/00002093-199509020-00004; Hebert R, 2001, J GERONTOL A-BIOL, V56, pM693, DOI 10.1093/gerona/56.11.M693; Heyman A, 1997, NEUROLOGY, V48, P1304, DOI 10.1212/WNL.48.5.1304; Kaplan L, 1999, FAM PROCESS, V38, P85, DOI 10.1111/j.1545-5300.1999.00085.x; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Keefe J, 2000, FAM RELAT, V49, P235, DOI 10.1111/j.1741-3729.2000.00235.x; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Levesque L., 2000, AM OURNAL ALZHEIMERS, V15, P229; Magaziner J, 2000, GERONTOLOGIST, V40, P663, DOI 10.1093/geront/40.6.663; McDowell I, 2002, GERONTOLOGIST, V42, P643; MONTGOMERY RJV, 1994, J GERONTOL, V49, pS62, DOI 10.1093/geronj/49.2.S62; Pot AM, 2001, INT J GERIATR PSYCH, V16, P273, DOI 10.1002/gps.331; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; ROTHENHAEUSLER HB, 1997, Z GERONTOPSYCHOL PSY, V10, P61; Schulz R, 2001, JAMA-J AM MED ASSOC, V285, P3123, DOI 10.1001/jama.285.24.3123; Schulz R, 2003, NEW ENGL J MED, V349, P1936, DOI 10.1056/NEJMsa035373; Schulz R, 1997, ANN BEHAV MED, V19, P110, DOI 10.1007/BF02883327; Schulz R, 2002, GERONTOLOGIST, V42, P589, DOI 10.1093/geront/42.5.589; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; Smith GE, 2000, J AM GERIATR SOC, V48, P519, DOI 10.1111/j.1532-5415.2000.tb04998.x; Spielberger C., 1970, MANUAL STATE TRAIT I; Stevens A, 2004, J AGING HEALTH, V16, P375, DOI 10.1177/0898264304264206; STEVENS AB, IN PRESS AGING MENT; Tarlow BJ, 2004, RES AGING, V26, P429, DOI 10.1177/0164027504264493; TERI L, 1992, PSYCHOL AGING, V7, P622, DOI 10.1037/0882-7974.7.4.622; Tornatore JB, 2002, GERONTOLOGIST, V42, P497, DOI 10.1093/geront/42.4.497; Whitlatch CJ, 2001, GERONTOLOGIST, V41, P462, DOI 10.1093/geront/41.4.462; Wisniewski SR, 2003, PSYCHOL AGING, V18, P375, DOI 10.1037/0882-7974.18.3.375; Yaffe K, 2002, JAMA-J AM MED ASSOC, V287, P2090, DOI 10.1001/jama.287.16.2090; Yamamoto-Mitani N, 2002, J GERONTOL B-PSYCHOL, V57, pS234, DOI 10.1093/geronb/57.4.S234; ZARIT SH, 1992, GERONTOLOGIST, V32, P665, DOI 10.1093/geront/32.5.665	37	228	234	1	34	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 25	2004	292	8					961	967		10.1001/jama.292.8.961	http://dx.doi.org/10.1001/jama.292.8.961			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	847WR	15328328				2022-12-24	WOS:000223429200021
J	Alonso, PD; Milner, AC; Ketcham, RA; Cookson, MJ; Rowe, TB				Alonso, PD; Milner, AC; Ketcham, RA; Cookson, MJ; Rowe, TB			The avian nature of the brain and inner ear of Archaeopteryx	NATURE			English	Article							EVOLUTION; ORIGIN; SIZE	Archaeopteryx, the earliest known flying bird (avialan) from the Late Jurassic period, exhibits many shared primitive characters with more basal coelurosaurian dinosaurs ( the clade including all theropods more bird- like than Allosaurus)(1), such as teeth, a long bony tail and pinnate feathers(2). However, Archaeopteryx possessed asymmetrical flight feathers on its wings and tail, together with a wing feather arrangement shared with modern birds. This suggests some degree of powered flight capability(3) but, until now, little was understood about the extent to which its brain and special senses were adapted for flight. We investigated this problem by computed tomography scanning and three-dimensional reconstruction of the braincase of the London specimen of Archaeopteryx. Here we show the reconstruction of the braincase from which we derived endocasts of the brain and inner ear. These suggest that Archaeopteryx closely resembled modern birds in the dominance of the sense of vision and in the possession of expanded auditory and spatial sensory perception in the ear. We conclude that Archaeopteryx had acquired the derived neurological and structural adaptations necessary for flight. An enlarged forebrain suggests that it had also developed enhanced somatosensory integration with these special senses demanded by a lifestyle involving flying ability(4).	Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England; Univ Complutense Madrid, Dept Paleontol, E-28040 Madrid, Spain; Univ Texas, High Resolut Xray CT Facil, Austin, TX 78712 USA; Univ Texas, Dept Geol Sci, Austin, TX 78712 USA; Univ Hertfordshire, Hatfield AL10 9AB, Herts, England	Natural History Museum London; Complutense University of Madrid; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Hertfordshire	Milner, AC (corresponding author), Nat Hist Museum, Dept Palaeontol, Cromwell Rd, London SW7 5BD, England.	A.Milner@nhm.ac.uk	Domínguez Alonso, Patricio/C-2679-2013; Ketcham, Richard/B-5431-2011	Ketcham, Richard/0000-0002-2748-0409				BROCHU CA, 2003, MEMOIR SOC VERTEBRAT, V7, P1, DOI DOI 10.2307/3889334; Dominguez P, 2002, NATURE, V417, P841, DOI 10.1038/nature00805; DUBBELDAM JL, 1998, CENTRAL NERVOUS SYST, V3, P1525; Elzanowski A., 1991, Journal of Vertebrate Paleontology, V11, P90; Elzanowski A, 1996, J VERTEBR PALEONTOL, V16, P81, DOI 10.1080/02724634.1996.10011286; Elzanowski Andrzej, 2002, P129; Franzosa J.W., 2004, THESIS U TEXAS; Gleich O, 2000, SPR HDB AUD, V13, P70; Gray A.A., 1908, LABYRINTH ANIMALS IN, VII; Hopson J.A., 1979, P39; HOPSON JA, 1977, ANNU REV ECOL SYST, V8, P429, DOI 10.1146/annurev.es.08.110177.002241; Iwaniuk AN, 2002, CAN J ZOOL, V80, P16, DOI 10.1139/Z01-204; JERISON HJ, 1968, NATURE, V219, P1381, DOI 10.1038/2191381a0; Jerison HJ., 1973, EVOLUTION BRAIN INTE; Ji Q, 2001, NATURE, V410, P1084, DOI 10.1038/35074079; Ketcham RA, 2001, COMPUT GEOSCI-UK, V27, P381, DOI 10.1016/S0098-3004(00)00116-3; OSTROM JH, 1976, BIOL J LINN SOC, V8, P91, DOI 10.1111/j.1095-8312.1976.tb00244.x; Padian K, 1998, BIOL REV, V73, P1, DOI 10.1111/j.1469-185X.1997.tb00024.x; PALTEL R, 1979, BIOL REPTILIA, V9, P147; PEARSON R, 1972, AVIAN BRAIN; Shimizu Toru, 2001, P135; STARCK D, 1979, BIOL REPTILIA, V9, P1; Walker A., 1985, P123; Wever E.., 1978, REPTILE EAR ITS STRU; WHETSTONE K N, 1983, Journal of Vertebrate Paleontology, V2, P439; Whybrow P.J., 1982, Neues Jahrbuch fuer Geologie und Palaeontologie Monatshefte, V1982, P184; Witmer L.M., 1997, ENCY DINOSAURS, P151; Witmer LM, 2003, NATURE, V425, P950, DOI 10.1038/nature02048; WITMER LM, 1990, ZOOL J LINN SOC-LOND, V100, P327, DOI 10.1111/j.1096-3642.1990.tb01865.x	29	141	149	0	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2004	430	7000					666	669		10.1038/nature02706	http://dx.doi.org/10.1038/nature02706			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843LM	15295597	Green Published			2022-12-24	WOS:000223085400042
J	Newsome, TP; Scaplehorn, N; Way, M				Newsome, TP; Scaplehorn, N; Way, M			Src mediates a switch from microtubule- to actin-based motility of vaccinia virus	SCIENCE			English	Article							INTRACELLULAR ENVELOPED VIRIONS; FUNCTIONAL-ANALYSIS; N-WASP; MOVEMENT; PROTEIN; TRANSPORT; DOMAINS; A33R	The cascade of events that leads to vaccinia-induced actin polymerization requires Src-dependent tyrosine phosphorylation of the viral membrane protein A36R. We found that a localized outside-in signaling cascade induced by the viral membrane protein B5R is required to potently activate Src and induce A36R phosphorylation at the plasma membrane. In addition, Src-mediated phosphorylation of A36R regulated the ability of virus particles to recruit and release conventional kinesin. Thus, Src activity regulates the transition between cytoplasmic microtubule transport and actin-based motility at the plasma membrane.	Canc Res UK, London Res Inst, Lincolns Inn Fields Labs, Cell Motil Lab, London WC2A 3PX, England	Cancer Research UK	Way, M (corresponding author), Canc Res UK, London Res Inst, Lincolns Inn Fields Labs, Cell Motil Lab, Room 529,44 Lincolns Inn Fields, London WC2A 3PX, England.	michael.way@cancer.org.uk	Newsome, Timothy P/AAB-4033-2019	Newsome, Timothy P/0000-0002-2193-596X; Scaplehorn, Niki/0000-0001-9451-8748; Way, Michael/0000-0001-7207-2722				Cudmore S, 1996, J CELL SCI, V109, P1739; CUDMORE S, 1995, NATURE, V378, P636, DOI 10.1038/378636a0; Frischknecht F, 1999, NATURE, V401, P926, DOI 10.1038/44860; Frishknecht F, 2001, TRENDS CELL BIOL, V11, P30, DOI 10.1016/S0962-8924(00)01871-7; Geada MM, 2001, J GEN VIROL, V82, P2747, DOI 10.1099/0022-1317-82-11-2747; Herrera E, 1998, J VIROL, V72, P294, DOI 10.1128/JVI.72.1.294-302.1998; Hollinshead M, 2001, J CELL BIOL, V154, P389, DOI 10.1083/jcb.200104124; Karcher RL, 2002, TRENDS CELL BIOL, V12, P21, DOI 10.1016/S0962-8924(01)02184-5; Katz E, 2003, J VIROL, V77, P12266, DOI 10.1128/JVI.77.22.12266-12275.2003; Mathew E, 1998, J VIROL, V72, P2429, DOI 10.1128/JVI.72.3.2429-2438.1998; Moreau V, 2000, NAT CELL BIOL, V2, P441, DOI 10.1038/35017080; Rietdorf J, 2001, NAT CELL BIOL, V3, P992, DOI 10.1038/ncb1101-992; Scaplehorn N, 2002, CURR BIOL, V12, P740, DOI 10.1016/S0960-9822(02)00812-6; Smith GA, 2002, ANNU REV CELL DEV BI, V18, P135, DOI 10.1146/annurev.cellbio.18.012502.105920; Smith GL, 2002, J GEN VIROL, V83, P2915, DOI 10.1099/0022-1317-83-12-2915; Snapper SB, 2001, NAT CELL BIOL, V3, P897, DOI 10.1038/ncb1001-897; Sodeik B, 2000, TRENDS MICROBIOL, V8, P465, DOI 10.1016/S0966-842X(00)01824-2; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; van Eijl H, 2000, VIROLOGY, V271, P26, DOI 10.1006/viro.2000.0260; Ward BM, 2004, J VIROL, V78, P2486, DOI 10.1128/JVI.78.5.2486-2493.2004; Ward BM, 2003, J VIROL, V77, P4113, DOI 10.1128/JVI.77.7.4113-4126.2003; Ward BM, 2001, J VIROL, V75, P11651, DOI 10.1128/JVI.75.23.11651-11663.2001; Ward BM, 2001, J VIROL, V75, P4802, DOI 10.1128/JVI.75.10.4802-4813.2001; Zettl M, 2002, CURR BIOL, V12, P1617, DOI 10.1016/S0960-9822(02)01112-0	24	124	131	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	2004	306	5693					124	129		10.1126/science.1101509	http://dx.doi.org/10.1126/science.1101509			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	859YJ	15297625				2022-12-24	WOS:000224304000052
J	Huq, E; Al-Sady, B; Hudson, M; Kim, CH; Apel, M; Quail, PH				Huq, E; Al-Sady, B; Hudson, M; Kim, CH; Apel, M; Quail, PH			PHYTOCHROME-INTERACTING FACTOR 1 is a critical bHLH regulator of chlorophyll biosynthesis	SCIENCE			English	Article							SIGNAL-TRANSDUCTION; TRANSCRIPTION FACTOR; NEGATIVE REGULATOR; LIGHT; ARABIDOPSIS; PIF3; PROTEIN; PROMOTER; PLANTS	Photosynthetic organisms must achieve a delicate balance between the light energy absorbed by chlorophyll and their capacity to channel that energy into productive photochemical reactions. Release of excess absorbed energy in the cell can cause lethal photooxidative damage. We identified a basic helix-toop-helix (bHLH) transcription factor, designated PHYTOCHROME-INTERACTING FACTOR 1 (PIF1), that negatively regulates chlorophyll biosynthesis. pif1 mutant seedlings accumulate excess free protochlorophyllide when grown in the dark, with consequent lethal bleaching upon exposure to light. PIF1 interacts specifically with the photoactivated conformer of phytochromes A and B, suggesting a signaling pathway by which chlorophyll biosynthetic rates are tightly controlled during the critical initial emergence of seedlings from subterranean darkness into sunlight.	Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; Univ Texas, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA; Univ Texas, Inst Mol Biol, Austin, TX 78712 USA; ARS, USDA, Ctr Plant Gene Express, Albany, CA 94710 USA; ETH, Inst Plant Sci, CH-8092 Zurich, Switzerland	University of California System; University of California Berkeley; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; United States Department of Agriculture (USDA); Swiss Federal Institutes of Technology Domain; ETH Zurich	Quail, PH (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	quait@nature.berkeley.edu	Hudson, Matthew E/A-4438-2008; Kim, Chanhong/G-5506-2012; Kim, Chanhong/AAL-4930-2021	Hudson, Matthew E/0000-0002-4737-0936; Kim, Chanhong/0000-0003-4133-9070; Al-Sady, Bassem/0000-0002-8996-7941; Huq, Enamul/0000-0001-7692-5139	NIGMS NIH HHS [GM47475] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047475] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bauer D, 2004, PLANT CELL, V16, P1433, DOI 10.1105/tpc.021568; Fairchild CD, 2000, GENE DEV, V14, P2377; Halliday KJ, 1999, P NATL ACAD SCI USA, V96, P5832, DOI 10.1073/pnas.96.10.5832; Huq E, 2002, EMBO J, V21, P2441, DOI 10.1093/emboj/21.10.2441; HUQ E, UNPUB; INSKEEP WP, 1985, PLANT PHYSIOL, V77, P483, DOI 10.1104/pp.77.2.483; Kim JY, 2003, PLANT CELL, V15, P2399, DOI 10.1105/tpc.014498; Kircher S, 2002, PLANT CELL, V14, P1541, DOI 10.1105/tpc.001156; Martinez-Garcia JF, 2000, SCIENCE, V288, P859, DOI 10.1126/science.288.5467.859; Meskauskiene R, 2001, P NATL ACAD SCI USA, V98, P12826, DOI 10.1073/pnas.221252798; MONTE E, UNPUB; Nagy F, 2002, ANNU REV PLANT BIOL, V53, P329, DOI 10.1146/annurev.arplant.53.100301.135302; Neff MM, 2000, GENE DEV, V14, P257; Ni M, 1998, CELL, V95, P657, DOI 10.1016/S0092-8674(00)81636-0; Ni M, 1999, NATURE, V400, P781, DOI 10.1038/23500; op den Camp RGL, 2003, PLANT CELL, V15, P2320, DOI 10.1105/tpc.014662; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; Quail PH, 2000, SEMIN CELL DEV BIOL, V11, P457, DOI 10.1006/scdb.2000.0199; Reinbothe S, 1996, CELL, V86, P703, DOI 10.1016/S0092-8674(00)80144-0; Salter MG, 2003, NATURE, V426, P680, DOI 10.1038/nature02174; WANG H, 2004, ARABIDOPSIS BOOK; Zhu YX, 2000, P NATL ACAD SCI USA, V97, P13419, DOI 10.1073/pnas.230433797	22	352	396	4	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2004	305	5692					1937	1941		10.1126/science.1099728	http://dx.doi.org/10.1126/science.1099728			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857RM	15448264				2022-12-24	WOS:000224136000040
J	Wilson, JF				Wilson, JF			Frailty - and its dangerous effects - Might be preventable	ANNALS OF INTERNAL MEDICINE			English	Article							SERUM INTERLEUKIN-6; FUNCTIONAL DECLINE; GERIATRIC SYNDROME; PROGRAM					jenwilson@acponline.org	Wilson, Jennifer/Q-3623-2019	Wilson, Jennifer/0000-0003-4025-3136				Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gill TM, 2002, NEW ENGL J MED, V347, P1068, DOI 10.1056/NEJMoa020423; Gill TM, 2004, ARCH PHYS MED REHAB, V85, P1043, DOI 10.1016/j.apmr.2003.10.021; Keysor JJ, 2001, J GERONTOL A-BIOL, V56, pM412, DOI 10.1093/gerona/56.7.M412; Leng S, 2002, J AM GERIATR SOC, V50, P1268, DOI 10.1046/j.1532-5415.2002.50315.x; Leng SX, 2004, AGING CLIN EXP RES, V16, P153; LIPSITZ LA, 2004, SCI AGING KNWOLEDGE, DOI DOI 10.1126/SAGEKE.2004.16PE16; Morley JE, 2002, J GERONTOL A-BIOL, V57, pM698, DOI 10.1093/gerona/57.11.M698; Studenski S, 2003, J AM GERIATR SOC, V51, P314, DOI 10.1046/j.1532-5415.2003.51104.x; Walston J, 2002, ARCH INTERN MED, V162, P2333, DOI 10.1001/archinte.162.20.2333; WALSTON J, SCI AGING KNOWLEDGE, DOI DOI 10.1126/SAGEKE.4.PE4	11	37	40	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 21	2004	141	6					489	492		10.7326/0003-4819-141-6-200409210-00035	http://dx.doi.org/10.7326/0003-4819-141-6-200409210-00035			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	856TM	15381535				2022-12-24	WOS:000224067900026
J	Aitken, CM; Jones, DM; Larter, SR				Aitken, CM; Jones, DM; Larter, SR			Anaerobic hydrocarbon biodegradation in deep subsurface oil reservoirs	NATURE			English	Article							PETROLEUM RESERVOIRS; AROMATIC-HYDROCARBONS; CRUDE-OIL; IN-SITU; DEGRADATION; NAPHTHALENE; MICROBIOLOGY; METABOLITES; OXIDATION; BACTERIA	Biodegradation of crude oil in subsurface petroleum reservoirs is an important alteration process with major economic consequences(1). Aerobic degradation of petroleum hydrocarbons at the surface is well documented(2) and it has long been thought that the flow of oxygen- and nutrient-bearing meteoric waters into reservoirs was necessary for in-reservoir petroleum biodegradation(3). The occurrence of biodegraded oils in reservoirs where aerobic conditions are unlikely(4), together with the identification of several anaerobic microorganisms in oil fields(5) and the discovery of anaerobic hydrocarbon biodegradation mechanisms(6,7), suggests that anaerobic degradation processes could also be responsible. The extent of anaerobic hydrocarbon degradation processes in the world's deep petroleum reservoirs, however, remains strongly contested. Moreover, no organism has yet been isolated that has been shown to degrade hydrocarbons under the conditions found in deep petroleum reservoirs(8). Here we report the isolation of metabolites indicative of anaerobic hydrocarbon degradation from a large fraction of 77 degraded oil samples from both marine and lacustrine sources from around the world, including the volumetrically important Canadian tar sands. Our results therefore suggest that anaerobic hydrocarbon degradation is a common process in biodegraded subsurface oil reservoirs.	Univ Newcastle Upon Tyne, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Calgary, Dept Geol & Geophys, Calgary, AB T2N 1N4, Canada	Newcastle University - UK; University of Calgary	Jones, DM (corresponding author), Univ Newcastle Upon Tyne, Sch Civil Engn & Geosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	martin.jones@ncl.ac.uk		Larter, Stephen/0000-0001-7195-1477				Aitken C.M., 2004, THESIS U NEWCASTLE U; Annweiler E, 2002, APPL ENVIRON MICROB, V68, P852, DOI 10.1128/AEM.68.2.852-858.2002; ATLAS RM, 1992, ADV MICROB ECOL, V12, P287; Bastin ES, 1926, SCIENCE, V63, P21, DOI 10.1126/science.63.1618.21; BENNETT PC, 1993, APPL GEOCHEM, V8, P529, DOI 10.1016/0883-2927(93)90012-6; Boll M, 2002, CURR OPIN CHEM BIOL, V6, P604, DOI 10.1016/S1367-5931(02)00375-7; Connan J., 1986, ADV PETROLEUM GEOCHE, V1, P299, DOI DOI 10.1016/B978-0-12-032001-1.50011-0; Elshahed MS, 2001, ENVIRON SCI TECHNOL, V35, P682, DOI 10.1021/es001571u; EVANS CR, 1971, CHEM GEOL, V8, P147, DOI 10.1016/0009-2541(71)90002-7; Gieg LM, 2002, ENVIRON SCI TECHNOL, V36, P3755, DOI 10.1021/es0205333; Head IM, 2003, NATURE, V426, P344, DOI 10.1038/nature02134; HORSTAD I, 1992, ORG GEOCHEM, V19, P107, DOI 10.1016/0146-6380(92)90030-2; Jones DM, 2001, ANAL CHEM, V73, P703, DOI 10.1021/ac000621a; Kartsev A.A., 1959, GEOCHEMICAL METHODS, P287, DOI [10.1525/9780520346079, DOI 10.1525/9780520346079]; Larter S, 2003, ORG GEOCHEM, V34, P601, DOI 10.1016/S0146-6380(02)00240-1; LHARIDON S, 1995, NATURE, V377, P223, DOI 10.1038/377223a0; MAGOT M, 1994, RECHERCHE, V25, P936; Magot M, 2000, ANTON LEEUW INT J G, V77, P103, DOI 10.1023/A:1002434330514; Palmer S.E., 1993, ORG GEOCHEM, P511, DOI 10.1007/978-1-4615-2890-6_23; Peters K.E., 1993, BIOMARKER GUIDE; Phelps CD, 2002, ENVIRON MICROBIOL, V4, P532, DOI 10.1046/j.1462-2920.2002.00330.x; Rios-Hernandez LA, 2003, APPL ENVIRON MICROB, V69, P434, DOI 10.1128/AEM.69.1.434-443.2003; Roling WFM, 2003, RES MICROBIOL, V154, P321, DOI 10.1016/S0923-2508(03)00086-X; RUETER P, 1994, NATURE, V372, P455, DOI 10.1038/372455a0; Seewald JS, 2003, NATURE, V426, P327, DOI 10.1038/nature02132; Van Der LINDEN A. C, 1965, ADVANCE ENZYMOLADVANCES IN ENZYMOLOGY AND RELATED SUBJECTS OF BIOCHEMISTRY, V27, P469; WATSON JS, 1999, THESIS U NEWCASTLE U; Widdel F, 2001, CURR OPIN BIOTECH, V12, P259, DOI 10.1016/S0958-1669(00)00209-3; Zengler K, 1999, NATURE, V401, P266, DOI 10.1038/45777; Zhang XM, 2000, BIODEGRADATION, V11, P117, DOI 10.1023/A:1011128109670	30	274	297	7	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2004	431	7006					291	294		10.1038/nature02922	http://dx.doi.org/10.1038/nature02922			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372028				2022-12-24	WOS:000223864000036
J	Bacci, A; Huguenard, JR; Prince, DA				Bacci, A; Huguenard, JR; Prince, DA			Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids	NATURE			English	Article							ENDOGENOUS CANNABINOIDS; VISUAL-CORTEX; PYRAMIDAL NEURONS; CELLS; SYNAPSES; SUPPRESSION; ANANDAMIDE; RECORDINGS; CHANNELS; NETWORKS	Neocortical GABA-containing interneurons form complex functional networks responsible for feedforward and feedback inhibition and for the generation of cortical oscillations associated with several behavioural functions(1,2). We previously reported that fast-spiking (FS), but not low-threshold-spiking (LTS), neocortical interneurons from rats generate a fast and precise self-inhibition mediated by inhibitory autaptic transmission(3). Here we show that LTS cells possess a different form of self-inhibition. LTS, but not FS, interneurons undergo a prominent hyperpolarization mediated by an increased K+-channel conductance. This self-induced inhibition lasts for many minutes, is dependent on an increase in intracellular [Ca2+] and is blocked by the cannabinoid receptor antagonist AM251, indicating that it is mediated by the autocrine release of endogenous cannabinoids. Endocannabinoid-mediated slow self-inhibition represents a powerful and long-lasting mechanism that alters the intrinsic excitability of LTS neurons, which selectively target the major site of excitatory connections onto pyramidal neurons; that is, their dendrites(4-7). Thus, modulation of LTS networks after their sustained firing will lead to long-lasting changes of glutamate-mediated synaptic strength in pyramidal neurons, with consequences during normal and pathophysiological cortical network activities.	Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA	Stanford University	Prince, DA (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	daprince@stanford.edu	Huguenard, John/I-5016-2012; Huguenard, John/K-6429-2019	Huguenard, John/0000-0002-6950-1191; Huguenard, John/0000-0002-6950-1191; Bacci, Alberto/0000-0002-3355-5892				Bacci A, 2003, J NEUROSCI, V23, P9664; Bacci A, 2003, J NEUROSCI, V23, P859; Beierlein M, 2000, NAT NEUROSCI, V3, P904, DOI 10.1038/78809; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; Cravatt BF, 2001, P NATL ACAD SCI USA, V98, P9371, DOI 10.1073/pnas.161191698; Diana MA, 2003, J NEUROSCI, V23, P5906; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; Freund TF, 2003, TRENDS NEUROSCI, V26, P489, DOI 10.1016/S0166-2236(03)00227-3; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Grenier F, 2003, J NEUROPHYSIOL, V89, P841, DOI 10.1152/jn.00420.2002; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Kreitzer AC, 2002, NEURON, V34, P787, DOI 10.1016/S0896-6273(02)00695-5; Losonczy A, 2004, P NATL ACAD SCI USA, V101, P1362, DOI 10.1073/pnas.0304752101; MACKIE K, 1995, J NEUROSCI, V15, P6552; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Pouzat C, 1999, J NEUROSCI, V19, P1675; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Tamas G, 1997, J PHYSIOL-LONDON, V500, P715, DOI 10.1113/jphysiol.1997.sp022054; Tamas G, 1998, J NEUROSCI, V18, P4255; Thomson AM, 1997, CEREB CORTEX, V7, P510, DOI 10.1093/cercor/7.6.510; Trettel J, 2004, J PHYSIOL-LONDON, V556, P95, DOI 10.1113/jphysiol.2003.058198; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Wischmeyer E, 1998, J BIOL CHEM, V273, P34063, DOI 10.1074/jbc.273.51.34063; Xiang ZX, 2002, J NEUROPHYSIOL, V88, P740, DOI 10.1152/jn.2002.88.2.740; Yamada M, 1998, PHARMACOL REV, V50, P723	30	213	218	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2004	431	7006					312	316		10.1038/nature02913	http://dx.doi.org/10.1038/nature02913			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372034				2022-12-24	WOS:000223864000042
J	Vetsch, M; Puorger, C; Spirig, T; Grauschopf, U; Weber-Ban, EU; Glockshuber, R				Vetsch, M; Puorger, C; Spirig, T; Grauschopf, U; Weber-Ban, EU; Glockshuber, R			Pilus chaperones represent a new type of protein-folding catalyst	NATURE			English	Article							DRIVES FIBER FORMATION; ESCHERICHIA-COLI; OUTER-MEMBRANE; BIOGENESIS; FIMC; PAPD; MECHANISM; SUBUNITS; BACTERIA; PATHWAY	Adhesive type 1 pili from uropathogenic Escherichia coli strains have a crucial role during infection by mediating the attachment to and potentially the invasion of host tissue. These filamentous, highly oligomeric protein complexes are assembled by the 'chaperone-usher' pathway(1), in which the individual pilus subunits fold in the bacterial periplasm and form stoichiometric complexes with a periplasmic chaperone molecule that is essential for pilus assembly(2-4). The chaperone subsequently delivers the subunits to an assembly platform (usher) in the outer membrane, which mediates subunit assembly and translocation to the cell surface(5-8). Here we show that the periplasmic type 1 pilus chaperone FimC binds non-native pilus subunits and accelerates folding of the subunit FimG by 100-fold. Moreover, we find that the FimC FimG complex is formed quantitatively and very rapidly when folding of FimG is initiated in the presence of both FimC and the assembly-competent subunit FimF, even though the FimC-FimG complex is thermodynamically less stable than the FimF-FimG complex. FimC thus represents a previously unknown type of protein-folding catalyst, and simultaneously acts as a kinetic trap preventing spontaneous subunit assembly in the periplasm.	ETH Honggerberg, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Glockshuber, R (corresponding author), ETH Honggerberg, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland.	rudi@mol.biol.ethz.ch		Spirig, Thomas/0000-0001-8936-238X; Weber-Ban, Eilika/0000-0002-5773-9274				BAKER D, 1992, NATURE, V356, P263, DOI 10.1038/356263a0; BALBACH J, 2000, FRONTIERS MOL BIOL; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; Choudhury D, 1999, SCIENCE, V285, P1061, DOI 10.1126/science.285.5430.1061; DODSON KW, 1993, P NATL ACAD SCI USA, V90, P3670, DOI 10.1073/pnas.90.8.3670; EDER J, 1995, MOL MICROBIOL, V16, P609, DOI 10.1111/j.1365-2958.1995.tb02423.x; Frand AR, 2000, TRENDS CELL BIOL, V10, P203, DOI 10.1016/S0962-8924(00)01745-1; Hahn E, 2002, J MOL BIOL, V323, P845, DOI 10.1016/S0022-2836(02)01005-7; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hermanns U, 2000, BIOCHEMISTRY-US, V39, P11564, DOI 10.1021/bi000549a; JACOBDUBUISSON F, 1994, J BIOL CHEM, V269, P12447; Jones CH, 1997, EMBO J, V16, P6394, DOI 10.1093/emboj/16.21.6394; JONES CH, 1993, P NATL ACAD SCI USA, V90, P8397, DOI 10.1073/pnas.90.18.8397; KLEMM P, 1990, MOL GEN GENET, V220, P334; KUEHN MJ, 1991, P NATL ACAD SCI USA, V88, P10586, DOI 10.1073/pnas.88.23.10586; LINDBERG F, 1989, J BACTERIOL, V171, P6052, DOI 10.1128/jb.171.11.6052-6058.1989; Nishlyama M, 2003, J MOL BIOL, V330, P513, DOI 10.1016/S0022-2836(03)00591-6; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Sauer FG, 2000, CURR OPIN STRUC BIOL, V10, P548, DOI 10.1016/S0959-440X(00)00129-9; Sauer FG, 2002, CELL, V111, P543, DOI 10.1016/S0092-8674(02)01050-4; Sauer FG, 1999, SCIENCE, V285, P1058, DOI 10.1126/science.285.5430.1058; Saulino ET, 2000, P NATL ACAD SCI USA, V97, P9240, DOI 10.1073/pnas.160070497; Schiene-Fischer C, 2002, NAT STRUCT BIOL, V9, P419, DOI 10.1038/nsb804; SCHMID FX, 1983, BIOCHEMISTRY-US, V22, P4690, DOI 10.1021/bi00289a013; Thanassi DG, 1998, P NATL ACAD SCI USA, V95, P3146, DOI 10.1073/pnas.95.6.3146; Vetsch M, 2002, J MOL BIOL, V322, P827, DOI 10.1016/S0022-2836(02)00845-8; Zavialov AV, 2003, CELL, V113, P587, DOI 10.1016/S0092-8674(03)00351-9; Zavialov AV, 2002, MOL MICROBIOL, V45, P983, DOI 10.1046/j.1365-2958.2002.03066.x	28	90	95	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 16	2004	431	7006					329	332		10.1038/nature02891	http://dx.doi.org/10.1038/nature02891			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	853XJ	15372038				2022-12-24	WOS:000223864000046
J	Khademi, S; O'Connell, J; Remis, J; Robles-Colmenares, Y; Miericke, LJW; Stroud, RM				Khademi, S; O'Connell, J; Remis, J; Robles-Colmenares, Y; Miericke, LJW; Stroud, RM			Mechanism of ammonia transport by Amt/MEP/Rh: Structure of AmtB at 1.3.5 angstrom	SCIENCE			English	Article							SIGNAL-TRANSDUCTION PROTEIN; ESCHERICHIA-COLI; PHYLOGENETIC CHARACTERIZATION; CORYNEBACTERIUM-GLUTAMICUM; SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; GREEN-ALGA; FAMILY; GLNK; NH4+	The first structure of an ammonia channel from the Amt/MEP/Rh protein superfamily, determined to 1.35 angstrom resolution, shows it to be a channel that spans the membrane 11 times. Two structurally similar halves span the membrane with opposite polarity. Structures with and without ammonia or methyl ammonia show a vestibule that recruits NH4+/NH3, a binding site for NH4+, and a 20 angstrom-long hydrophobic channel that lowers the NH4+ pK(a) to below 6 and conducts NH3. Favorable interactions for NH3 are seen within the channel and use conserved histidines. Reconstitution of AmtB into vesicles shows that AmtB conducts uncharged NH3.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Stroud, RM (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, S412C Genentech Hall,600 16th St, San Francisco, CA 94143 USA.	stroud@msg.ucsf.edu	Stroud, Rhonda/GQZ-0151-2022	Stroud, Rhonda/0000-0001-5242-8015	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024485, R37GM024485] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM24485] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Atkinson MR, 1998, MOL MICROBIOL, V29, P431, DOI 10.1046/j.1365-2958.1998.00932.x; Blakey D, 2002, BIOCHEM J, V364, P527, DOI 10.1042/BJ20011761; BROACH J, 1976, J BACTERIOL, V128, P86, DOI 10.1128/JB.128.1.86-98.1976; Coutts G, 2002, EMBO J, V21, P536, DOI 10.1093/emboj/21.4.536; DEREWENDA ZS, 1995, J MOL BIOL, V252, P248, DOI 10.1006/jmbi.1995.0492; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; HACKETTE SL, 1970, J BIOL CHEM, V245, P4241; Javelle A, 2004, J BIOL CHEM, V279, P8530, DOI 10.1074/jbc.M312399200; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; KHADEMI S, UNPUB; KNEPPER MA, 1989, PHYSIOL REV, V69, P179, DOI 10.1152/physrev.1989.69.1.179; Ludewig U, 2002, J BIOL CHEM, V277, P13548, DOI 10.1074/jbc.M200739200; LUDEWIG U, IN PRESS J PHYSL LON; MARINI AM, 1994, EMBO J, V13, P3456, DOI 10.1002/j.1460-2075.1994.tb06651.x; Marini AM, 1997, TRENDS BIOCHEM SCI, V22, P460, DOI 10.1016/S0968-0004(97)01132-8; Marini AM, 2000, NAT GENET, V26, P341, DOI 10.1038/81656; Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282; Meier-Wagner J, 2001, MICROBIOL-UK, V147, P135, DOI 10.1099/00221287-147-1-135; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Park JH, 1996, J MEMBRANE BIOL, V153, P171, DOI 10.1007/s002329900120; PRIVER NA, 1993, BIOCHEMISTRY-US, V32, P2459, DOI 10.1021/bi00061a002; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Saier MH, 1999, BBA-REV BIOMEMBRANES, V1422, P1, DOI 10.1016/S0304-4157(98)00023-9; Siewe RM, 1996, J BIOL CHEM, V271, P5398, DOI 10.1074/jbc.271.10.5398; Sohlenkamp C, 2002, PLANT PHYSIOL, V130, P1788, DOI 10.1104/pp.008599; Soupene E, 2004, P NATL ACAD SCI USA, V101, P7787, DOI 10.1073/pnas.0401809101; Soupene E, 1998, P NATL ACAD SCI USA, V95, P7030, DOI 10.1073/pnas.95.12.7030; Soupene E, 2002, P NATL ACAD SCI USA, V99, P7769, DOI 10.1073/pnas.112225599; Soupene E, 2002, J BACTERIOL, V184, P3396, DOI 10.1128/JB.184.12.3396-3400.2002; Soupene E, 2002, P NATL ACAD SCI USA, V99, P3926, DOI 10.1073/pnas.062043799; Tate R, 1998, MOL PLANT MICROBE IN, V11, P188, DOI 10.1094/MPMI.1998.11.3.188; Thomas GH, 2000, MOL MICROBIOL, V37, P331, DOI 10.1046/j.1365-2958.2000.01994.x; WANG MY, 1993, PLANT PHYSIOL, V103, P1259, DOI 10.1104/pp.103.4.1463; Westhoff CM, 2004, J BIOL CHEM, V279, P17443, DOI 10.1074/jbc.M311853200; Westhoff CM, 2002, J BIOL CHEM, V277, P12499, DOI 10.1074/jbc.C200060200	36	516	528	7	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2004	305	5690					1587	1594		10.1126/science.1101952	http://dx.doi.org/10.1126/science.1101952			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	854GV	15361618				2022-12-24	WOS:000223891200035
J	Li, SR; Zhou, DY; Lu, MM; Morrisey, EE				Li, SR; Zhou, DY; Lu, MM; Morrisey, EE			Advanced cardiac morphogenesis does not require heart tube fusion	SCIENCE			English	Article							VENTRAL MORPHOGENESIS; TRANSCRIPTION FACTOR; ZEBRAFISH; CELLS; ASYMMETRY; ENDODERM; GATA4; MESP1; GENES; MICE	The bilateral cardiac mesoderm migrates from the lateral region of the embryo to the ventral midline, where it fuses to form the primitive heart tube. It is generally accepted that migration and fusion are essential for subsequent stages of cardiac morphogenesis. We present evidence that, in Foxp4 mutant embryonic mice, each bilateral heart-forming region is capable of developing into a highly differentiated four-chambered mammalian heart in the absence of midline fusion. These data demonstrate that left-right chamber specification, cardiac looping, septation, cardiac myocyte differentiation, and endocardial cushion formation are preprogrammed in the precardiac mesoderm and do not require midline positional identity or heart tube fusion.	Univ Penn, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Morrisey, EE (corresponding author), Univ Penn, Dept Med, Philadelphia, PA 19104 USA.	emorrise@mail.med.upenn.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071589] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL71589] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alexander J, 1999, DEV BIOL, V215, P343, DOI 10.1006/dbio.1999.9441; Bisgrove BW, 2000, DEVELOPMENT, V127, P3567; Bisgrove BW, 2001, AM J MED GENET, V101, P315, DOI 10.1002/ajmg.1180; Brand T, 2003, DEV BIOL, V258, P1, DOI 10.1016/S0012-1606(03)00112-X; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Gitler AD, 2004, DEV CELL, V7, P107, DOI 10.1016/j.devcel.2004.06.002; Kramer R, 1996, P NATL ACAD SCI USA, V93, P4833, DOI 10.1073/pnas.93.10.4833; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; Li S., UNPUB; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Lu MM, 2002, MECH DEVELOP, V119, pS197, DOI 10.1016/S0925-4773(03)00116-3; Molkentin JD, 1997, GENE DEV, V11, P1061, DOI 10.1101/gad.11.8.1061; Reiter JF, 1999, GENE DEV, V13, P2983, DOI 10.1101/gad.13.22.2983; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Saga Y, 1999, DEVELOPMENT, V126, P3437; Saga Y, 1998, MECH DEVELOP, V75, P53, DOI 10.1016/S0925-4773(98)00077-X; Sedmera D, 2000, ANAT RECORD, V258, P319, DOI 10.1002/(SICI)1097-0185(20000401)258:4<319::AID-AR1>3.0.CO;2-O; Shu WG, 2001, J BIOL CHEM, V276, P27488, DOI 10.1074/jbc.M100636200; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Tanaka M, 1999, DEVELOPMENT, V126, P1269; Thomas T, 1998, DEV BIOL, V196, P228, DOI 10.1006/dbio.1998.8849; Van Der Zwaag B, 2002, DEV DYNAM, V225, P336, DOI 10.1002/dvdy.10159; Yelon D, 1999, SEMIN CELL DEV BIOL, V10, P93, DOI 10.1006/scdb.1998.0278	23	73	76	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2004	305	5690					1619	1622		10.1126/science.1098674	http://dx.doi.org/10.1126/science.1098674			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	854GV	15361625				2022-12-24	WOS:000223891200043
J	Um, SH; Frigerio, F; Watanabe, M; Picard, F; Joaquin, M; Sticker, M; Fumagalli, S; Allegrini, PR; Kozma, SC; Auwerx, J; Thomas, G				Um, SH; Frigerio, F; Watanabe, M; Picard, F; Joaquin, M; Sticker, M; Fumagalli, S; Allegrini, PR; Kozma, SC; Auwerx, J; Thomas, G			Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity	NATURE			English	Article							SKELETAL-MUSCLE; RECEPTOR SUBSTRATE-1; AMINO-ACID; CELL SIZE; RESISTANCE; PHOSPHORYLATION; KINASE; GENES; ACTIVATION; GLUCOSE	Elucidating the signalling mechanisms by which obesity leads to impaired insulin action is critical in the development of therapeutic strategies for the treatment of diabetes(1). Recently, mice deficient for S6 Kinase 1 (S6K1), an effector of the mammalian target of rapamycin (mTOR) that acts to integrate nutrient and insulin signals(2), were shown to be hypoinsulinaemic, glucose intolerant and have reduced beta-cell mass(3). However, S6K1-deficient mice maintain normal glucose levels during fasting, suggesting hypersensitivity to insulin(3), raising the question of their metabolic fate as a function of age and diet. Here, we report that S6K1-deficient mice are protected against obesity owing to enhanced beta-oxidation. However on a high fat diet, levels of glucose and free fatty acids still rise in S6K1-deficient mice, resulting in insulin receptor desensitization. Nevertheless, S6K1-deficient mice remain sensitive to insulin owing to the apparent loss of a negative feedback loop from S6K1 to insulin receptor substrate 1 (IRS1), which blunts S307 and S636/S639 phosphorylation; sites involved in insulin resistance(4,5). Moreover, wild-type mice on a high fat diet as well as K/K A(y) and ob/ob (also known as Lep/Lep) mice-two genetic models of obesity-have markedly elevated S6K1 activity and, unlike S6K1-deficient mice, increased phosphorylation of IRS1 S307 and S636/S639. Thus under conditions of nutrient satiation S6K1 negatively regulates insulin signalling.	Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; Genopole Strasbourg, Inst Clin Souris, F-67404 Illkirch Graffenstaden, France; Novartis Pharma AG, CH-4057 Basel, Switzerland	Friedrich Miescher Institute for Biomedical Research; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Novartis	Thomas, G (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	gthomas@fmi.ch	Joaquin, Manel/O-6533-2019; Thomas, George/K-9235-2014; Joaquin, Manel/E-2216-2015; FUMAGALLI, Stefano/C-2914-2019; Auwerx, Johan/ABE-9307-2021	Joaquin, Manel/0000-0001-8973-5916; Thomas, George/0000-0003-3518-8149; Joaquin, Manel/0000-0001-8973-5916; Auwerx, Johan/0000-0002-5065-5393; Fumagalli, Stefano/0000-0001-5832-8680				Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Bouzakri K, 2003, DIABETES, V52, P1319, DOI 10.2337/diabetes.52.6.1319; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Doty FD, 1999, J MAGN RESON, V138, P144, DOI 10.1006/jmre.1998.1703; Dressel U, 2003, MOL ENDOCRINOL, V17, P2477, DOI 10.1210/me.2003-0151; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Greiwe JS, 2001, AM J PHYSIOL-ENDOC M, V281, pE466, DOI 10.1152/ajpendo.2001.281.3.E466; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; IWATSUKA H, 1970, ENDOCRINOL JAPON, V17, P23; Jiang GQ, 2002, FRONT BIOSCI-LANDMRK, V7, pD904; Kahn BB, 1998, CELL, V92, P593, DOI 10.1016/S0092-8674(00)81125-3; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Le Marchand-Brustel Y, 2003, BIOCHEM SOC T, V31, P1152; Luquet S, 2003, FASEB J, V17, P2299, DOI 10.1096/fj.03-0269fje; Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003; MARETTE A, 1991, INT J OBESITY, V15, P823; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Patti ME, 1999, ANN NY ACAD SCI, V892, P187, DOI 10.1111/j.1749-6632.1999.tb07796.x; Patti ME, 1998, J CLIN INVEST, V101, P1519, DOI 10.1172/JCI1326; Pende M, 2000, NATURE, V408, P994, DOI 10.1038/35050135; Picard F, 2002, CELL, V111, P931, DOI 10.1016/S0092-8674(02)01169-8; Proietto J, 1999, MOL CELL ENDOCRINOL, V151, P143, DOI 10.1016/S0303-7207(99)00050-7; Radimerski T, 2002, GENE DEV, V16, P2627, DOI 10.1101/gad.239102; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Tanaka T, 2003, P NATL ACAD SCI USA, V100, P15924, DOI 10.1073/pnas.0306981100; Tremblay F, 2001, J BIOL CHEM, V276, P38052; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zick Y, 2001, TRENDS CELL BIOL, V11, P437, DOI 10.1016/S0962-8924(01)02129-8	30	1308	1371	0	87	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 9	2004	431	7005					200	205		10.1038/nature02866	http://dx.doi.org/10.1038/nature02866			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852HI	15306821				2022-12-24	WOS:000223746000048
J	Stott, L; Cannariato, K; Thunell, R; Haug, GH; Koutavas, A; Lund, S				Stott, L; Cannariato, K; Thunell, R; Haug, GH; Koutavas, A; Lund, S			Decline of surface temperature and salinity in the western tropical Pacific Ocean in the Holocene epoch	NATURE			English	Article							EL-NINO; EQUATORIAL PACIFIC; SEA-LEVEL; CLIMATE; VARIABILITY; BALANCE	In the present-day climate, surface water salinities are low in the western tropical Pacific Ocean and increase towards the eastern part of the basin(1). The salinity of surface waters in the tropical Pacific Ocean is thought to be controlled by a combination of atmospheric convection, precipitation, evaporation and ocean dynamics(2), and on interannual timescales significant variability is associated with the El Nino/Southern Oscillation cycles. However, little is known about the variability of the coupled ocean atmosphere system on timescales of centuries to millennia. Here we combine oxygen isotope and Mg/Ca data from foraminifers retrieved from three sediment cores in the western tropical Pacific Ocean to reconstruct Holocene sea surface temperatures and salinities in the region. We find a decrease in sea surface temperatures of similar to0.5 degreesC over the past 10,000 yr, whereas sea surface salinities decreased by similar to1.5 practical salinity units. Our data imply either that the Pacific basin as a whole has become progressively less salty or that the present salinity gradient along the Equator has developed relatively recently.	Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA; Univ S Carolina, Dept Geol Sci, Columbia, SC 29205 USA; Geoforschungszentrum Potsdam, D-14473 Potsdam, Germany; MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	University of Southern California; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; Massachusetts Institute of Technology (MIT)	Stott, L (corresponding author), Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA.	stott@usc.edu						Aggarwal PK, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019911; Clement AC, 1999, PALEOCEANOGRAPHY, V14, P441, DOI 10.1029/1999PA900013; Cronin MF, 1998, J GEOPHYS RES-OCEANS, V103, P27567, DOI 10.1029/98JC02605; deMenocal P, 2000, SCIENCE, V288, P2198, DOI 10.1126/science.288.5474.2198; FAIRBANKS RG, 1989, NATURE, V342, P637, DOI 10.1038/342637a0; Fairbanks RG, 1997, CORAL REEFS, V16, pS93, DOI 10.1007/s003380050245; Gagan MK, 1998, SCIENCE, V279, P1014, DOI 10.1126/science.279.5353.1014; Haug GH, 2001, SCIENCE, V293, P1304, DOI 10.1126/science.1059725; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; Levitus S., 1994, WORLD OCEAN ATLAS 19, V3; Liu ZY, 2000, GEOPHYS RES LETT, V27, P2265, DOI 10.1029/2000GL011452; McPhaden MJ, 1999, SCIENCE, V283, P950, DOI 10.1126/science.283.5404.950; Morimoto M, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013521; Nurnberg D, 1996, GEOCHIM COSMOCHIM AC, V60, P803, DOI 10.1016/0016-7037(95)00446-7; Oppo DW, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2001GC000260; PRELL WL, 1986, NATURE, V323, P526, DOI 10.1038/323526a0; Schmittner A, 2000, GEOPHYS RES LETT, V27, P1163, DOI 10.1029/1999GL011048; Sun DZ, 1998, GEOPHYS RES LETT, V25, P2659, DOI 10.1029/98GL01813; Waelbroeck C, 2002, QUATERNARY SCI REV, V21, P295, DOI 10.1016/S0277-3791(01)00101-9	19	349	387	5	125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 2	2004	431	7004					56	59		10.1038/nature02903	http://dx.doi.org/10.1038/nature02903			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	850VC	15343330	Green Published, Green Submitted			2022-12-24	WOS:000223641500039
J	Klausner, R; Alonso, P				Klausner, R; Alonso, P			An attack on all fronts	NATURE			English	Article							PLACEBO-CONTROLLED TRIAL; GLOBAL FUND; MALARIA		Bill & Melinda Gates Fdn, Global Hlth Program, Seattle, WA 98102 USA; Ctr Invest Saude Manhica, Manhica, Mozambique; Univ Barcelona, IDIBAPS, Hosp Clin, Ctr Int Hlth, E-08007 Barcelona, Spain	Bill & Melinda Gates Foundation; Centro de Investigacao em Saude de Manhica; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Klausner, R (corresponding author), Bill & Melinda Gates Fdn, Global Hlth Program, Seattle, WA 98102 USA.		Alonso, Pedro L/AAZ-3645-2020	Alonso, Pedro L/0000-0003-3292-3443				Adjuik M, 2004, LANCET, V363, P9, DOI 10.1016/S0140-6736(03)15162-8; [Anonymous], 2004, COCHRANE DB SYST REV; [Anonymous], 2003, AFR MAL REP 2003; Attaran A, 2004, LANCET, V363, P237, DOI 10.1016/S0140-6736(03)15330-5; BOYD MARK F., 1939, AMER JOUR TROP MED, V19, P1; Butler D, 2004, NATURE, V429, P588, DOI 10.1038/429588a; Schellenberg D, 2001, LANCET, V357, P1471, DOI 10.1016/S0140-6736(00)04643-2; Shulman CE, 1999, LANCET, V353, P632, DOI 10.1016/S0140-6736(98)07318-8	8	13	16	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 19	2004	430	7002					930	931		10.1038/430930a	http://dx.doi.org/10.1038/430930a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318232	Bronze			2022-12-24	WOS:000223369800055
J	Stramer, SL; Glynn, SA; Kleinman, SH; Strong, DM; Caglioti, S; Wright, DJ; Dodd, RY; Busch, MP				Stramer, SL; Glynn, SA; Kleinman, SH; Strong, DM; Caglioti, S; Wright, DJ; Dodd, RY; Busch, MP		Natl Heart Lung Blood Inst Nucleic	Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-C; UNITED-STATES; COST-EFFECTIVENESS; RNA; RISK; NAT; TRANSMISSION; TRANSFUSION; SAFETY	BACKGROUND Testing of blood donors for human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV) RNA by means of nucleic acid amplification was introduced in the United States as an investigational screening test in mid-1999 to identify donations made during the window period before seroconversion. METHODS We analyzed all antibody-nonreactive donations that were confirmed to be positive for HIV-1 and HCV RNA on nucleic acid - amplification testing of "minipools" ( pools of 16 to 24 donations) by the main blood-collection programs in the United States during the first three years of nucleic acid screening. RESULTS Among 37,164,054 units screened, 12 were confirmed to be positive for HIV-1 RNA or 1 in 3.1 million donations - only 2 of which were detected by HIV-1 p24 antigen testing. For HCV, of 39,721,404 units screened, 170 were confirmed to be positive for HCV RNA, or 1 in 230,000 donations ( or 1 in 270,000 on the basis of 139 donations confirmed to be positive for HCV RNA with the use of a more sensitive HCV-antibody test). The respective rates of positive HCV and HIV-1 nucleic acid - amplification tests were 3.3 and 4.1 times as high among first-time donors as among donors who gave blood repeatedly. Follow-up studies of 67 HCV RNA - positive donors demonstrated that seroconversion occurred a median of 35 days after the index donation, followed by a low rate of resolution of viremia; three cases of long-term immunologically silent HCV infection were documented. CONCLUSIONS Minipool nucleic acid - amplification testing has helped prevent the transmission of approximately 5 HIV-1 infections and 56 HCV infections annually and has reduced the residual risk of transfusion-transmitted HIV-1 and HCV to approximately 1 in 2 million blood units.	Amer Red Cross, Natl Testing & Reference Labs, Gaithersburg, MD 20877 USA; Amer Red Cross, Rockville, MD USA; WESTAT Corp, Rockville, MD 20850 USA; Univ British Columbia, Victoria, BC, Canada; Puget Sound Blood Ctr, Seattle, WA 98104 USA; Blood Syst Lab, Tempe, AZ USA; Blood Syst Res Inst, Blood Ctr Pacific, San Francisco, CA USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	American Red Cross; American Red Cross; Westat; University of British Columbia; Puget Sound Blood Center; Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco	Stramer, SL (corresponding author), Amer Red Cross, Natl Testing & Reference Labs, 9315 Gaither Rd, Gaithersburg, MD 20877 USA.	stramers@usa.redcross.org	Abrams, William R/A-5782-2008		NHLBI NIH HHS [N01-HB-97082, N01-HB-97081, N01-HB-97080, N01-HB-97078, N01-HB-47114, N01-HB-97079, N01-HB-97077] Funding Source: Medline; DIVISION OF BLOOD DISEASES AND RESOURCES [N01HB097080, N01HB097077, N01HB097078, N01HB047114, N01HB097082, N01HB097079, N01HB097081] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF BLOOD DISEASES AND RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alter Miriam J, 2003, MMWR Recomm Rep, V52, P1; Beld M, 1999, BLOOD, V94, P1183, DOI 10.1182/blood.V94.4.1183.416k15_1183_1191; Busch MP, 2000, TRANSFUSION, V40, P1157, DOI 10.1046/j.1537-2995.2000.40101157.x; Busch MP, 2003, JAMA-J AM MED ASSOC, V289, P959, DOI 10.1001/jama.289.8.959; Busch MP, 1998, INFUSIONSTHERAPIE, V25, P194; Busch MP, 2001, TRANSFUS CLIN BIOL, V8, P200, DOI 10.1016/S1246-7820(01)00125-2; Busch MP, 2001, BLOOD SAFETY IN THE NEW MILLENNIUM, P33; Chamberland ME, 2002, CLIN INFECT DIS, V34, P797, DOI 10.1086/338787; Delwart EL, 2004, VOX SANG, V86, P171, DOI 10.1111/j.0042-9007.2004.00416.x; Dodd RY, 2002, TRANSFUSION, V42, P975, DOI 10.1046/j.1537-2995.2002.00174.x; Dodd RY, 2003, NEW ENGL J MED, V349, P1205, DOI 10.1056/NEJMp038138; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Galel SA, 2002, TRANSFUSION, V42, P1507, DOI 10.1046/j.1537-2995.2002.00236.x; Giachetti C, 2002, J CLIN MICROBIOL, V40, P2408, DOI 10.1128/JCM.40.7.2408-2419.2002; Grant PR, 2002, TRANSFUSION MED, V12, P229, DOI 10.1046/j.1365-3148.2002.00382.x; Jackson BR, 2003, TRANSFUSION, V43, P721, DOI 10.1046/j.1537-2995.2003.00392.x; Janssen RS, 1999, JAMA-J AM MED ASSOC, V281, P1893; LEHMANN EL, 1959, TESTING STATISTICAL, P140; MAPLE PAC, 1994, J MED VIROL, V44, P43, DOI 10.1002/jmv.1890440109; Marshall DA, 2004, VOX SANG, V86, P28, DOI 10.1111/j.0042-9007.2004.00379.x; McCullough J, 2000, TRANSFUSION, V40, P143; *NAT BLOOD DAT RES, 2003, 2002 NAT BLOOD COLL; Notari EP, 2001, TRANSFUSION, V41, P751, DOI 10.1046/j.1537-2995.2001.41060751.x; Orland JR, 2001, HEPATOLOGY, V33, P321, DOI 10.1053/jhep.2001.22112; Orton SL, 2004, TRANSFUSION, V44, P275, DOI 10.1111/j.1537-2995.2004.00623.x; Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969; Peoples BG, 2000, TRANSFUSION, V40, P1280, DOI 10.1046/j.1537-2995.2000.40101280.x; PRATT JW, 1981, CONCEPTS NONPARAMETR, P41; Schmidt WN, 1997, J INFECT DIS, V176, P27, DOI 10.1086/514033; Schreiber GB, 1996, NEW ENGL J MED, V334, P1685, DOI 10.1056/NEJM199606273342601; Schreiber GB, 2002, TRANSFUSION, V42, P414, DOI 10.1046/j.1525-1438.2002.00084.x; Stramer SL, 2000, TRANSFUSION, V40, P1165, DOI 10.1046/j.1537-2995.2000.40101165.x; Stramer SL, 2001, TRANSFUSION, V41, P1079; Stramer SL, 1999, TRANSFUSION, V39, p2S; Tobler LH, 1997, CLIN CHEM, V43, P1487; Tobler LH, 2003, TRANSFUSION, V43, P1452, DOI 10.1046/j.1537-2995.2003.00521.x; 2004, MMWR MORB MORTAL WKL, V53, P281	37	368	402	0	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 19	2004	351	8					760	768		10.1056/NEJMoa040085	http://dx.doi.org/10.1056/NEJMoa040085			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	847CY	15317889				2022-12-24	WOS:000223367900008
J	Little, MP; Blettner, M; Boice, JD; Bridges, BA; Cardis, E; Charles, MW; de Vathaire, F; Doll, R; Fujimoto, K; Goodhead, D; Grosche, B; Hall, P; Heidenreich, WF; Jacob, P; Moolgovkar, SH; Muirhead, CR; Niwa, O; Paretzke, HG; Richardson, RB; Samet, JM; Sasaki, Y; Shore, RE; Straume, T; Wakeford, R				Little, MP; Blettner, M; Boice, JD; Bridges, BA; Cardis, E; Charles, MW; de Vathaire, F; Doll, R; Fujimoto, K; Goodhead, D; Grosche, B; Hall, P; Heidenreich, WF; Jacob, P; Moolgovkar, SH; Muirhead, CR; Niwa, O; Paretzke, HG; Richardson, RB; Samet, JM; Sasaki, Y; Shore, RE; Straume, T; Wakeford, R			Potential funding crisis for the Radiation Effects Research Foundation	LANCET			English	Editorial Material							ATOMIC-BOMB SURVIVORS; NONCANCER DISEASE INCIDENCE; CANCER		Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England	Imperial College London	Little, MP (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England.	mark.little@imperial.ac.uk	Cardis, Elisabeth/C-3904-2017; de Vathaire, Florent/L-2983-2016; Wakeford, Richard/I-1978-2019	Cardis, Elisabeth/0000-0003-0999-6839; Wakeford, Richard/0000-0002-2934-0987; Shore, Roy/0000-0002-6842-2248; Muirhead, Colin/0000-0001-5394-1267; Little, Mark/0000-0003-0980-7567; de Vathaire, Florent/0000-0002-8374-9281; Grosche, Bernd/0000-0003-2024-3555				Adelstein SJ, 2004, RADIAT RES, V161, P621, DOI 10.1667/0033-7587(2004)161[0621:ASMADM]2.0.CO;2; CULLINGS HM, 2003, RERF UPDATE, V14, P17; HYUBER T, 2003, RADIAT ENVIRON BIOPH, V42, P27; ICRP, 1991, ANN ICRP, V21, P1; Malakoff D, 2004, SCIENCE, V304, P33; Pierce DA, 2000, RADIAT RES, V154, P178, DOI 10.1667/0033-7587(2000)154[0178:RRCRAL]2.0.CO;2; Preston DL, 2003, RADIAT RES, V160, P381, DOI 10.1667/RR3049; Preston DL, 1994, RADIAT RES, V137, P68; ROESSLER G, 2003, HLTH PHYS NEWS, V31, P4; Straume T, 2003, NATURE, V424, P539, DOI 10.1038/nature01815; THOMPSON DE, 1994, RAD RES S, V137, P17; United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), 2000, SOURC EFF ION RAD, VII; *US NAT AC SCI, 1990, HLTH EFF EXP LOW LEV; WONG FL, 1993, RADIAT RES, V135, P418, DOI 10.2307/3578884; Yamada M, 2004, RADIAT RES, V161, P622, DOI 10.1667/RR3183; 2004, JAPAN TIMES     0403	16	3	3	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	AUG 14	2004	364	9434					557	558		10.1016/S0140-6736(04)16861-X	http://dx.doi.org/10.1016/S0140-6736(04)16861-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845WD	15313337				2022-12-24	WOS:000223275100003
J	Nummela, S; Thewissen, JGM; Bajpai, S; Hussain, ST; Kumar, K				Nummela, S; Thewissen, JGM; Bajpai, S; Hussain, ST; Kumar, K			Eocene evolution of whale hearing	NATURE			English	Article							CETACEA; ORIGIN	The origin of whales ( order Cetacea) is one of the best-documented examples of macroevolutionary change in vertebrates(1-3). As the earliest whales became obligately marine, all of their organ systems adapted to the new environment. The fossil record indicates that this evolutionary transition took less than 15 million years, and that different organ systems followed different evolutionary trajectories. Here we document the evolutionary changes that took place in the sound transmission mechanism of the outer and middle ear in early whales. Sound transmission mechanisms change early on in whale evolution and pass through a stage ( in pakicetids) in which hearing in both air and water is unsophisticated. This intermediate stage is soon abandoned and is replaced ( in remingtonocetids and protocetids) by a sound transmission mechanism similar to that in modern toothed whales. The mechanism of these fossil whales lacks sophistication, and still retains some of the key elements that land mammals use to hear airborne sound.	Northeastern Ohio Univ Coll Med & Pharm, Coll Med, Dept Anat, Rootstown, OH 44272 USA; Indian Inst Technol, Dept Earth Sci, Roorkee 427667, Uttaranchel, India; Howard Univ, Coll Med, Dept Anat, Washington, DC 20059 USA; Wadia Inst Himalayan Geol, Dehra Dun 248001, Uttar Pradesh, India	Northeast Ohio Medical University (NEOMED); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee; Howard University; Department of Science & Technology (India); Wadia Institute of Himalayan Geology (WIHG)	Thewissen, JGM (corresponding author), Northeastern Ohio Univ Coll Med & Pharm, Coll Med, Dept Anat, Rootstown, OH 44272 USA.	thewisse@neoucom.edu	Bajpai, Sunil/E-8416-2010; KUMAR, Kishor/H-7232-2013	KUMAR, Kishor/0000-0003-0875-9735; Thewissen, J. G. M./0000-0002-0973-4137				BERTA A, 1994, SCIENCE, V263, P180, DOI 10.1126/science.263.5144.180; Brill RL, 2001, J ACOUST SOC AM, V109, P1717, DOI 10.1121/1.1356704; FLEISCHER G, 1976, J PALEONTOL, V50, P133; Fleischer G., 1978, Advances in Anatomy Embryology and Cell Biology, V55, P1; Fordyce RE., 2001, SECONDARY ADAPTATION, P169; Gingerich PD, 2003, PALEOBIOLOGY, V29, P429, DOI 10.1666/0094-8373(2003)029<0429:LTIEWE>2.0.CO;2; GINGERICH PD, 1983, SCIENCE, V220, P403, DOI 10.1126/science.220.4595.403; Hemila S, 2001, HEARING RES, V151, P221, DOI 10.1016/S0378-5955(00)00232-X; Hemila S, 1999, HEARING RES, V133, P82, DOI 10.1016/S0378-5955(99)00055-6; HEMILA S, 1995, HEARING RES, V85, P31, DOI 10.1016/0378-5955(95)00031-X; KETTEN DR, 1992, EVOLUTIONARY BIOLOGY OF HEARING, P717; Lancaster W.C., 1990, Journal of Vertebrate Paleontology, V10, P117; Lombard R. Eric, 1993, P241; Luo Z., 1999, U MICHIGAN PAPERS PA, V31, P1; Luo ZX, 1998, ADV VERT PALEOBIOL, P269; Mason MJ, 2001, J ZOOL, V255, P467; Moller A. R., 1974, HDB SENSORY PHYSL AU, VV, P491; Norris K. S., 1964, P317; Nummela S, 1999, HEARING RES, V133, P61, DOI 10.1016/S0378-5955(99)00053-2; Nummela S, 1999, HEARING RES, V133, P71, DOI 10.1016/S0378-5955(99)00054-4; NUMMELA S, 1995, HEARING RES, V85, P18, DOI 10.1016/0378-5955(95)00030-8; OELSCHLAGER HA, 1990, NATO ADV SCI I A-LIF, V196, P137; Spoor F, 2002, NATURE, V417, P163, DOI 10.1038/417163a; Thewissen JGM, 2002, ANNU REV ECOL SYST, V33, P73, DOI 10.1146/annurev.ecolsys.33.020602.095426; THEWISSEN JGM, 1993, NATURE, V361, P444, DOI 10.1038/361444a0; Thewissen JGM, 1996, NATURE, V381, P379, DOI 10.1038/381379b0; Tonndorf J., 1968, ARCH OTOLARYNGOL, V87, P49; Uhen MD, 1998, ADV VERT PALEOBIOL, P29; Wagner GP, 2000, EVOL BIOL, V31, P155; Wyss AR, 1987, AM MUS NAT HIST NOVI, V2871, P1	30	66	70	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 12	2004	430	7001					776	778		10.1038/nature02720	http://dx.doi.org/10.1038/nature02720			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	845HS	15306808				2022-12-24	WOS:000223233600040
J	Hoppe, T; Cassata, G; Barral, JM; Springer, W; Hutagalung, AH; Epstein, HF; Baumeister, R				Hoppe, T; Cassata, G; Barral, JM; Springer, W; Hutagalung, AH; Epstein, HF; Baumeister, R			Regulation of the myosin-directed chaperone UNC-45 by a novel E3/E4-multiubiquitylation complex in C. elegans	CELL			English	Article							E3 UBIQUITIN LIGASE; CAENORHABDITIS-ELEGANS; QUALITY-CONTROL; DOMAIN PROTEIN; HEAVY-CHAIN; CHIP; GENE; IDENTIFICATION; FAMILY	The organization of the motor protein myosin into motile cellular structures requires precise temporal and spatial control. Caenorhabditis elegans UNC-45 facilitates this by functioning both as a chaperone and as a Hsp90 cochaperone for myosin during thick filament assembly. Consequently, mutations in C. elegans unc45 result in paralyzed animals with severe myofibril disorganization in striated body wall muscles. Here, we report a new E3/E4 complex, formed by CHN-1, the C. elegans ortholog of CHIP (carboxyl terminus of Hsc70-interacting protein), and UFD-2, an enzyme known to have ubiquitin conjugating E4 activity in yeast, as necessary and sufficient to multiubiquitylate UNC-45 in vitro. The phenotype of unc-45 temperature-sensitive animals is partially suppressed by chn-1 loss of function, while UNC-45 overexpression in worms deficient for chn-1 results in severely disorganized muscle cells. These results identify CHN-1 and UFD-2 as a functional E3/E4 complex and UNC-45 as its physiologically relevant substrate.	Univ Munich, Adolph Butenandt Inst, Dept Mol Neurogenet, D-80336 Munich, Germany; Univ Freiburg, Dept Bioinformat & Mol Genet, D-79104 Freiburg, Germany; Univ Hamburg, Ctr Mol Neurobiol, D-20251 Hamburg, Germany; Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of Munich; University of Freiburg; University of Hamburg; Baylor College of Medicine; Baylor College of Medicine	Baumeister, R (corresponding author), Univ Munich, Adolph Butenandt Inst, Dept Mol Neurogenet, Schillerstr 44, D-80336 Munich, Germany.	baumeister@celegans.de	Hutagalung, Alex/AAH-5795-2021; Hoppe, Thorsten/AAC-7880-2020	Hoppe, Thorsten/0000-0002-4734-9352; Springer, Wolfdieter/0000-0002-1178-3149				Alberti S, 2002, J BIOL CHEM, V277, P45920, DOI 10.1074/jbc.M204196200; Ao WY, 2000, J CELL BIOL, V148, P375, DOI 10.1083/jcb.148.2.375; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Barral JM, 1998, J CELL BIOL, V143, P1215, DOI 10.1083/jcb.143.5.1215; Barral JM, 1999, BIOESSAYS, V21, P813, DOI 10.1002/(SICI)1521-1878(199910)21:10<813::AID-BIES3>3.0.CO;2-0; Barral JM, 2002, SCIENCE, V295, P669, DOI 10.1126/science.1066648; BRENNER S, 1974, GENETICS, V77, P71; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Cyr DM, 2002, TRENDS BIOCHEM SCI, V27, P368, DOI 10.1016/S0968-0004(02)02125-4; Dai Q, 2003, EMBO J, V22, P5446, DOI 10.1093/emboj/cdg529; Demand J, 2001, CURR BIOL, V11, P1569, DOI 10.1016/S0960-9822(01)00487-0; DeRenzo C, 2003, NATURE, V424, P685, DOI 10.1038/nature01887; EPSTEIN HF, 1974, NATURE, V250, P579, DOI 10.1038/250579a0; EPSTEIN HF, 1974, J MOL BIOL, V90, P291, DOI 10.1016/0022-2836(74)90374-X; Etheridge L, 2002, DEV DYNAM, V224, P457, DOI 10.1002/dvdy.10123; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Hutagalung AH, 2002, J CELL SCI, V115, P3983, DOI 10.1242/jcs.00107; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Jones D, 2002, GENOME BIOL, V3; Kaneko C, 2003, BIOCHEM BIOPH RES CO, V300, P297, DOI 10.1016/S0006-291X(02)02834-6; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Mahoney JA, 2002, BIOCHEM J, V361, P587, DOI 10.1042/0264-6021:3610587; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Murata S, 2003, INT J BIOCHEM CELL B, V35, P572, DOI 10.1016/S1357-2725(02)00394-1; Nikolay R, 2004, J BIOL CHEM, V279, P2673, DOI 10.1074/jbc.M311112200; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Price MG, 2002, J CELL SCI, V115, P4013, DOI 10.1242/jcs.00108; Venolia L, 1999, CELL MOTIL CYTOSKEL, V42, P163, DOI 10.1002/(SICI)1097-0169(1999)42:3&lt;163::AID-CM1&gt;3.0.CO;2-E; VENOLIA L, 1990, GENETICS, V126, P345; Waterston R., 1988, NEMATODE C ELEGANS, P281; Wong KCY, 2000, J CELL SCI, V113, P2421; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899	35	113	118	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 6	2004	118	3					337	349		10.1016/j.cell.2004.07.014	http://dx.doi.org/10.1016/j.cell.2004.07.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	846XP	15294159	Bronze			2022-12-24	WOS:000223353100010
J	Spiegel, PB; Salama, P; Maloney, S; van der Veen, A				Spiegel, PB; Salama, P; Maloney, S; van der Veen, A			Quality of malnutrition assessment surveys conducted during famine in Ethiopia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NUTRITIONAL-STATUS; DISPLACED PERSONS; PUBLIC-HEALTH; MORTALITY; MORBIDITY; REFUGEE; CAMPS	Context During 1999 and 2000, approximately 10 million people were affected by famine in Ethiopia. Results of nutrition assessments and surveys conducted by humanitarian organizations were used by donors and government agencies to determine needs for food aid and to make other decisions on geographic allocation of limited resources; however, accurate results might have been hampered by methodological errors. Objectives To identify common methodological errors in nutrition assessments and surveys and to provide practical recommendations for improvement. Design and Setting Nutrition assessments and surveys (n=125) conducted by 14 nongovernmental organizations (NGOs) in 54 woredas (districts) in Ethiopia from May 1, 1999, through July 31, 2000. Surveys were ranked as valid and precise according to 5 criteria: use of population proportional to size sampling, sample size, number of clusters, number of children per cluster, and use of weight-for-height index. Main Outcome Measures Number and proportion of surveys that used standard, internationally accepted methods and reported valid and precise results. Results Fifty-eight of the 125 surveys (46%) were not intended to be standard 30 X 30 cluster surveys. Of the remaining 67 surveys, 6 (9%) met predetermined criteria for validity and precision. All 67 used the anthropometric index of weight-for-height, with 58 (87%) reporting z scores. Fifty-four (81%) used nonrandom sampling without consideration of population size and 6 (9%) had sample sizes of fewer than 500 persons. Conclusions Major methodological errors were identified among 30 X 30 cluster surveys designed to measure acute malnutrition prevalence in Ethiopia during the famine of 1999-2000. Donor agencies and NGOs should be educated about the need for improved quality of nutrition assessments and their essential role in directing allocation of scarce food resources.	Ctr Dis Control & Prevent, Natl Ctr Environm Hlth, Div Emergency & Environm Hlth Serv, Int Emergency & Refugee Hlth Branch, Atlanta, GA USA; Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA USA; WHO, Off Reg Humanitarian Emergency Coordinator, Addis Ababa, Ethiopia	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; World Health Organization	Spiegel, PB (corresponding author), UNHCR, Case Postale 2500, CH-1211 Geneva, Switzerland.	spiegel@unhcr.ch	Spiegel, Paul/AAL-3238-2021	Spiegel, Paul/0000-0002-6158-6661				[Anonymous], 1992, MMWR Recomm Rep, V41, P1; [Anonymous], 1997, REF HLTH APPR EM SIT; BENNETT S, 1991, World Health Statistics Quarterly, V44, P98; BINKIN N, 1992, DISASTERS, V16, P97, DOI 10.1111/j.1467-7717.1992.tb00383.x; BOSS LP, 1994, JAMA-J AM MED ASSOC, V272, P371, DOI 10.1001/jama.272.5.371; Brogan Donna, 1994, Annals of Epidemiology, V4, P302, DOI 10.1016/1047-2797(94)90086-8; Cochran W. G., 1977, SAMPLING TECHNIQUES; DEGOYET CD, 1979, MANAGEMENT NUTR EMER; *EV BAS WORK GROUP, CLIN EP GLOSS; Garfield R, 2000, NUTR REV, V58, P269, DOI 10.1111/j.1753-4887.2000.tb01880.x; HENDERSON RH, 1982, B WORLD HEALTH ORGAN, V60, P253; KATZ J, 1995, AM J CLIN NUTR, V61, P155, DOI 10.1093/ajcn/61.1.155; LEMESHOW S, 1985, INT J EPIDEMIOL, V14, P473, DOI 10.1093/ije/14.3.473; LINDTJORN B, 1990, BMJ-BRIT MED J, V301, P1123, DOI 10.1136/bmj.301.6761.1123; MERCER A, 1992, DISASTERS, V16, P28, DOI 10.1111/j.1467-7717.1992.tb00373.x; *MSF, 1995, NUTR GUID; MURRAY MJ, 1976, LANCET, V1, P1283; *OG WELF SOC, 1999, WORLD FOOD PROGR SUM; Salama P, 2001, JAMA-J AM MED ASSOC, V286, P563, DOI 10.1001/jama.286.5.563; SEAMAN J, 1978, INT J EPIDEMIOL, V7, P31, DOI 10.1093/ije/7.1.31; Spiegel PB, 2001, DISASTERS, V25, P172, DOI 10.1111/1467-7717.00169; SULLIVAN K, 1995, ANN M SOC EP RES JUN; TOOLE M J, 1989, Bulletin of the World Health Organization, V67, P381; TOOLE MJ, 1990, JAMA-J AM MED ASSOC, V263, P3296, DOI 10.1001/jama.263.24.3296; TOOLE MJ, 1993, JAMA-J AM MED ASSOC, V270, P600, DOI 10.1001/jama.270.5.600; TOOLE MJ, 1995, INFECT DIS CLIN N AM, V9, P353; *TRANS GOV ETH REL, 1995, GUID NUTR STAT DAT F; *UNICEF, 2000, SIT REP ETH; *USAID, 2000, US AG INT DEV COMB T; World Health Organization, 2000, MAN NUTR MAJ EM	30	44	44	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 4	2004	292	5					613	618		10.1001/jama.292.5.613	http://dx.doi.org/10.1001/jama.292.5.613			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	843AE	15292087	Bronze			2022-12-24	WOS:000223045500019
J	Lin, JD; Wu, PH; Tarr, PT; Lindenberg, KS; St-Pierre, J; Zhang, CY; Mootha, VK; Jager, S; Vianna, CR; Reznick, RM; Cui, LB; Manieri, M; Donovan, MX; Wu, ZD; Cooper, MP; Fan, MC; Rohas, LM; Zavacki, AM; Cinti, S; Shulman, GI; Lowell, BB; Krainc, D; Spiegelman, BM				Lin, JD; Wu, PH; Tarr, PT; Lindenberg, KS; St-Pierre, J; Zhang, CY; Mootha, VK; Jager, S; Vianna, CR; Reznick, RM; Cui, LB; Manieri, M; Donovan, MX; Wu, ZD; Cooper, MP; Fan, MC; Rohas, LM; Zavacki, AM; Cinti, S; Shulman, GI; Lowell, BB; Krainc, D; Spiegelman, BM			Defects in adaptive energy metabolism with CNS-Linked hyperactivity in PGC-1 alpha null mice	CELL			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE GTP; CONTROLLING MITOCHONDRIAL BIOGENESIS; TRANSCRIPTIONAL COACTIVATOR PGC-1; INSULIN-RESISTANCE; HEPATIC GLUCONEOGENESIS; UNCOUPLING PROTEIN; GLUCOSE-PRODUCTION; BINDING-PROTEIN; TRANSGENIC MICE; CDNA CLONING	PGC-1alpha is a coactivator of nuclear receptors and other transcription factors that regulates several metabolic processes, including mitochondrial biogenesis and respiration, hepatic gluconeogenesis, and muscle fiber-type switching. We show here that, while hepatocytes lacking PGC-1alpha are defective in the program of hormone-stimulated gluconeogenesis, the mice have constitutively activated gluconeogenic gene expression that is completely insensitive to normal feeding controls. C/EBPbeta is elevated in the livers of these mice and activates the gluconeogenic genes in a PGC-1alpha-independent manner. Despite having reduced mitochondrial function, PGC-1alpha null mice are paradoxically lean and resistant to diet-induced obesity. This is largely due to a profound hyperactivity displayed by the null animals and is associated with lesions in the striatal region of the brain that controls movement. These data illustrate a central role for PGC-1alpha in the control of energy metabolism but also reveal novel systemic compensatory mechanisms and pathogenic effects of impaired energy homeostasis.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med,Mass Gen Inst Neurodegenerat, Dept Neurol, Charlestown, MA 02129 USA; Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; MIT, Ctr Genome Res, Whitehead Inst, Cambridge, MA 02139 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Internal Med, New Haven, CT 06520 USA; Univ Ancona, Fac Med, Inst Normal Human Morphol, I-60020 Ancona, Italy; Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Dept Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Thyroid Sect, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Yale University; Marche Polytechnic University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Spiegelman, BM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA.	bruce_spiegelman@dfci.harvard.edu	vianna, claudia/I-4991-2012; Shulman, Gerald I./P-7176-2019; St-Pierre, Julie/AGB-3651-2022; Wu, Pei-Hsuan/AAL-1704-2020	Shulman, Gerald I./0000-0003-1529-5668; St-Pierre, Julie/0000-0002-2815-7099; Wu, Pei-Hsuan/0000-0002-6690-0744; Jager, Sibylle/0000-0001-8102-7149; Fan, Melina/0000-0002-6196-8408; CINTI, Saverio/0000-0003-0362-5017; Wu, Zhidan/0000-0001-7289-9420	NIDDK NIH HHS [R01 DK040936, DK61562, DK40936, DK065584, DK54477] Funding Source: Medline; NINDS NIH HHS [NS045242, NS002174] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061562, R01DK040936, R56DK054477, R01DK054477, K01DK065584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS045242] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aoki T T, 1981, Prog Clin Biol Res, V67, P161; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; BOUILLAUD F, 1985, P NATL ACAD SCI USA, V82, P445, DOI 10.1073/pnas.82.2.445; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Croniger C, 1998, J BIOL CHEM, V273, P31629, DOI 10.1074/jbc.273.48.31629; Fan M, 2004, GENE DEV, V18, P278, DOI 10.1101/gad.1152204; Ginsberg HN, 2000, J CLIN INVEST, V106, P453, DOI 10.1172/JCI10762; Goto M, 2000, BIOCHEM BIOPH RES CO, V274, P350, DOI 10.1006/bbrc.2000.3134; GRONINGER C, 1997, J BIOL CHEM, V272, P26306; Hanson RW, 1997, ANNU REV BIOCHEM, V66, P581, DOI 10.1146/annurev.biochem.66.1.581; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; JACOBSSON A, 1985, J BIOL CHEM, V260, P6250; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kirpichnikov D, 2002, ANN INTERN MED, V137, P25, DOI 10.7326/0003-4819-137-1-200207020-00009; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; Lieberman LS, 2003, ANNU REV NUTR, V23, P345, DOI 10.1146/annurev.nutr.23.011702.073212; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2003, J BIOL CHEM, V278, P30843, DOI 10.1074/jbc.M303643200; Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200; Liu S, 1999, J CLIN INVEST, V103, P207, DOI 10.1172/JCI4243; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Miyake K, 2002, J CLIN INVEST, V110, P1483, DOI 10.1172/JCI200215880; Moller DE, 2001, NATURE, V414, P821, DOI 10.1038/414821a; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nordlie RC, 1999, ANNU REV NUTR, V19, P379, DOI 10.1146/annurev.nutr.19.1.379; PARK EA, 1993, J BIOL CHEM, V268, P613; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Roesler WJ, 2001, ANNU REV NUTR, V21, P141, DOI 10.1146/annurev.nutr.21.1.141; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Schon EA, 2003, J CLIN INVEST, V111, P303, DOI 10.1172/JCI200317741; Shin DJ, 2003, J BIOL CHEM, V278, P50047, DOI 10.1074/jbc.M309736200; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; Tritos NA, 2003, BRAIN RES, V961, P255, DOI 10.1016/S0006-8993(02)03961-6; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	46	940	979	3	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 1	2004	119	1					121	+		10.1016/j.cell.2004.09.013	http://dx.doi.org/10.1016/j.cell.2004.09.013			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	859UE	15454086	Green Published, Bronze			2022-12-24	WOS:000224292600014
J	Park, M; Penick, EC; Edwards, JG; Kauer, JA; Ehlers, MD				Park, M; Penick, EC; Edwards, JG; Kauer, JA; Ehlers, MD			Recycling endosomes supply AMPA receptors for LTP	SCIENCE			English	Article							CULTURED HIPPOCAMPAL-NEURONS; LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; PLASMA-MEMBRANE; SILENT SYNAPSES; ACTIVATION; INSERTION; CELLS; RAB6; TRANSMISSION	Long-term potentiation (LTP) of synaptic strength, the most established cellular model of information storage in the brain, is expressed by an increase in the number of postsynaptic AMPA receptors. However, the source of AMPA receptors mobilized during LTP is unknown. We report that AMPA receptors are transported from recycling endosomes to the plasma membrane for LTP. Stimuli that triggered LTP promoted not only AMPA receptor insertion but also generalized recycling of cargo and membrane from endocytic compartments. Thus, recycling endosomes supply AMPA receptors for LTP and provide a mechanistic link between synaptic potentiation and membrane remodeling during synapse modification.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Neuroproteom Lab, Durham, NC 27710 USA; Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA	Duke University; Duke University; Duke University; Duke University; Duke University; Brown University	Ehlers, MD (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Box 3209, Durham, NC 27710 USA.	ehlers@neuro.duke.edu		Kauer, Julie/0000-0002-3362-1642	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011289] Funding Source: NIH RePORTER; NIDA NIH HHS [DA11289] Funding Source: Medline; NIMH NIH HHS [MH64748] Funding Source: Medline; NINDS NIH HHS [NS39402] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Karcher RL, 2001, SCIENCE, V293, P1317, DOI 10.1126/science.1061086; KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1; Khvotchev MV, 2003, J NEUROSCI, V23, P10531; Knight DE, 2002, TRAFFIC, V3, P298, DOI 10.1034/j.1600-0854.2002.030407.x; Lee SH, 2004, NEURON, V43, P221, DOI 10.1016/j.neuron.2004.06.015; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Nizak C, 2003, SCIENCE, V300, P984, DOI 10.1126/science.1083911; Passafaro M, 1999, NAT NEUROSCI, V2, P1063, DOI 10.1038/15990; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Pickard L, 2001, NEUROPHARMACOLOGY, V41, P700, DOI 10.1016/S0028-3908(01)00127-7; Prekeris R, 1998, J CELL BIOL, V143, P957, DOI 10.1083/jcb.143.4.957; Rosenberg M, 2001, J NEUROSCI, V21, P5036, DOI 10.1523/JNEUROSCI.21-14-05036.2001; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Short B, 2002, CURR BIOL, V12, P1792, DOI 10.1016/S0960-9822(02)01221-6; Steiner P, 2002, J CELL BIOL, V157, P1197, DOI 10.1083/jcb.200202022; Sun W, 2003, J CELL BIOL, V162, P125, DOI 10.1083/jcb.200302083; White J, 1999, J CELL BIOL, V147, P743, DOI 10.1083/jcb.147.4.743; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	30	545	558	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 24	2004	305	5692					1972	1975		10.1126/science.1102026	http://dx.doi.org/10.1126/science.1102026			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	857RM	15448273				2022-12-24	WOS:000224136000052
J	Fairen, AG; Fernandez-Remolar, D; Dohm, JM; Baker, VR; Amils, R				Fairen, AG; Fernandez-Remolar, D; Dohm, JM; Baker, VR; Amils, R			Inhibition of carbonate synthesis in acidic oceans on early Mars	NATURE			English	Article							IMPACT EROSION; IRON; MINERALS	Several lines of evidence have recently reinforced the hypothesis that an ocean existed on early Mars(1-7). Carbonates are accordingly expected to have formed from oceanic sedimentation of carbon dioxide from the ancient martian atmosphere(7,8). But spectral imaging of the martian surface has revealed the presence of only a small amount of carbonate, widely distributed in the martian dust(9). Here we examine the feasibility of carbonate synthesis in ancient martian oceans using aqueous equilibrium calculations. We show that partial pressures of atmospheric carbon dioxide in the range 0.8-4 bar, in the presence of up to 13.5 mM sulphate and 0.8 mM iron in sea water(8), result in an acidic oceanic environment with a pH of less than 6.2. This precludes the formation of siderite, usually expected to be the first major carbonate mineral to precipitate(8). We conclude that extensive interaction between an atmosphere dominated by carbon dioxide and a lasting sulphate- and iron-enriched acidic ocean on early Mars is a plausible explanation for the observed absence of carbonates.	Univ Autonoma Madrid, Ctr Biol Mol, CSIC, E-28049 Madrid, Spain; CSIC, INTA, Ctr Astrobiol, Madrid 28850, Spain; Univ Arizona, Dept Hydrol & Water Resources, Tucson, AZ 85721 USA; Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); University of Arizona; University of Arizona	Fairen, AG (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol, CSIC, E-28049 Madrid, Spain.	agfairen@cbm.uam.es	FernÃndez-Remolar, David/AAG-8643-2020; Dohm, James/A-3831-2014; Amils, Ricardo/X-2706-2019	FernÃndez-Remolar, David/0000-0003-2409-7444; 				Baker VR, 2001, NATURE, V412, P228, DOI 10.1038/35084172; Bandfield JL, 2003, SCIENCE, V301, P1084, DOI 10.1126/science.1088054; Barley ME, 1997, NATURE, V385, P55, DOI 10.1038/385055a0; BHATTACHARYYA A, 1983, MODERN CARBONATE ENV; Brain DA, 1998, J GEOPHYS RES-PLANET, V103, P22689, DOI 10.1029/98JE02074; Bruland K. W., 1983, CHEM OCEANOGR, V8, P157, DOI 10.1016/b978-0-12-588608-6.50009-2.; BURNS RG, 1987, J GEOPHYS RES-SOLID, V92, pE570, DOI 10.1029/JB092iB04p0E570; CARR MH, 2003, J GEOPHYS RES-PLANET, V108, DOI [DOI 10.1029/2002JE001963, 10.1029/2002je001963]; Catling DC, 1999, J GEOPHYS RES-PLANET, V104, P16453, DOI 10.1029/1998JE001020; CLARK BC, 1999, 5 MARS C LUN PLAN I; Clifford SM, 2001, ICARUS, V154, P40, DOI 10.1006/icar.2001.6671; Craddock RA, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001505; Dohm JM, 2001, J GEOPHYS RES-PLANET, V106, P32943, DOI 10.1029/2000JE001468; Fairen AG, 2003, ICARUS, V165, P53, DOI 10.1016/S0019-1035(03)00144-1; Fernandez-Remolar D, 2004, PLANET SPACE SCI, V52, P239, DOI 10.1016/j.pss.2003.08.027; Forget F, 1997, SCIENCE, V278, P1273, DOI 10.1126/science.278.5341.1273; Head JW, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2000JE001445; HOLLAND HD, 1973, ECON GEOL, V68, P1169, DOI 10.2113/gsecongeo.68.7.1169; HUGUENIN RL, 1974, J GEOPHYS RES, V79, P3895, DOI 10.1029/JB079i026p03895; JOHNSON JW, 1991, SUPCRT92 SOFTWARE PA; Kirkland LE, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002105; Malin MC, 2003, SCIENCE, V302, P1931, DOI 10.1126/science.1090544; MELOSH HJ, 1989, NATURE, V338, P487, DOI 10.1038/338487a0; Moore JM, 2004, NATURE, V428, P711, DOI 10.1038/428711a; Mukhin LM, 1996, NATURE, V379, P141, DOI 10.1038/379141a0; Phillips RJ, 2001, SCIENCE, V291, P2587, DOI 10.1126/science.1058701; Russell MJ, 1997, J GEOL SOC LONDON, V154, P377, DOI 10.1144/gsjgs.154.3.0377; SCHAEFER MW, 1993, GEOCHIM COSMOCHIM AC, V57, P4619, DOI 10.1016/0016-7037(93)90187-2; SQUYRES SW, 1994, SCIENCE, V265, P744, DOI 10.1126/science.265.5173.744; Zuber MT, 2001, NATURE, V412, P220, DOI 10.1038/35084163	30	137	145	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 23	2004	431	7007					423	426		10.1038/nature02911	http://dx.doi.org/10.1038/nature02911			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	855UN	15386004				2022-12-24	WOS:000224000500032
J	Stanfield, RL; Dooley, H; Flajnik, MF; Wilson, IA				Stanfield, RL; Dooley, H; Flajnik, MF; Wilson, IA			Crystal structure of a shark single-domain antibody V region in complex with lysozyme	SCIENCE			English	Article							ANTIGEN RECEPTOR; SOMATIC DIVERSIFICATION; VARIABLE DOMAIN; LOOP STRUCTURES; LIGHT-CHAINS; IMMUNOGLOBULINS; VERTEBRATE; EVOLUTION; FRAGMENT; REARRANGEMENT	Cartilaginous fish are the phylogenetically oldest living organisms known to possess components of the vertebrate adaptive immune system. Key to their immune response are heavy-chain, homodimeric immunoglobulins called new antigen receptors (IgNARs), in which the variable (V) domains recognize antigens with only a single immunoglobulin domain, akin to camelid heavy-chain V domains. The 1.45 angstrom resolution crystal structure of the type I IgNAR V domain in complex with hen egg-white lysozyme (HEL) reveals a minimal antigen-binding domain that contains only two of the three conventional complementarity-determining regions but still binds HEL with nanomolar affinity by means of a binding interface comparable in size to conventional antibodies.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; Natl Aquarium, Baltimore, MD 21202 USA	Scripps Research Institute; Scripps Research Institute; University System of Maryland; University of Maryland Baltimore	Wilson, IA (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wilson@scripps.edu	Stanfield, Robyn/AAH-3190-2019; Dooley, Helen/N-9872-2018	Dooley, Helen/0000-0002-2570-574X; Flajnik, Martin Francis/0000-0002-2792-5084; stanfield, robyn/0000-0001-9521-9184	NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR006603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM038273, R01GM038273] Funding Source: NIH RePORTER; NCRR NIH HHS [RR06603] Funding Source: Medline; NIGMS NIH HHS [GM38273] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; DAVIES J, 1994, FEBS LETT, V339, P285, DOI 10.1016/0014-5793(94)80432-X; Decanniere K, 1999, STRUCTURE, V7, P361, DOI 10.1016/S0969-2126(99)80049-5; Decanniere K, 2001, J MOL BIOL, V313, P473, DOI 10.1006/jmbi.2001.5075; Decanniere K, 2000, J MOL BIOL, V300, P83, DOI 10.1006/jmbi.2000.3839; Desmyter A, 1996, NAT STRUCT BIOL, V3, P803, DOI 10.1038/nsb0996-803; Desmyter A, 2002, J BIOL CHEM, V277, P23645, DOI 10.1074/jbc.M202327200; Desmyter A, 2001, J BIOL CHEM, V276, P26285, DOI 10.1074/jbc.M102107200; Diaz M, 2002, IMMUNOGENETICS, V54, P501, DOI 10.1007/s00251-002-0479-z; Diaz M, 1998, IMMUNOL REV, V162, P13, DOI 10.1111/j.1600-065X.1998.tb01425.x; Dooley H, 2003, MOL IMMUNOL, V40, P25, DOI 10.1016/S0161-5890(03)00084-1; Dumoulin M, 2003, NATURE, V424, P783, DOI 10.1038/nature01870; FLAJNIK MJ, UNPUB; GREENBERG AS, 1995, NATURE, V374, P168, DOI 10.1038/374168a0; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; HINDS KR, 1986, NATURE, V320, P546, DOI 10.1038/320546a0; KOKUBU F, 1988, EMBO J, V7, P3413, DOI 10.1002/j.1460-2075.1988.tb03215.x; Lee SS, 2000, J EXP MED, V191, P1637, DOI 10.1084/jem.191.10.1637; Loris R, 2003, J BIOL CHEM, V278, P28252, DOI 10.1074/jbc.M302336200; MUYLDERMANS S, 1994, PROTEIN ENG, V7, P1129, DOI 10.1093/protein/7.9.1129; Nuttall SD, 2002, FEBS LETT, V516, P80, DOI 10.1016/S0014-5793(02)02506-1; Nuttall SD, 2001, MOL IMMUNOL, V38, P313, DOI 10.1016/S0161-5890(01)00057-8; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Richards MH, 2000, MOL BIOL EVOL, V17, P146, DOI 10.1093/oxfordjournals.molbev.a026227; Roux KH, 1998, P NATL ACAD SCI USA, V95, P11804, DOI 10.1073/pnas.95.20.11804; Spinelli S, 1996, NAT STRUCT BIOL, V3, P752, DOI 10.1038/nsb0996-752; Spinelli S, 2000, BIOCHEMISTRY-US, V39, P1217, DOI 10.1021/bi991830w; Spinelli S, 2001, J MOL BIOL, V311, P123, DOI 10.1006/jmbi.2001.4856; Streltsov VA, 2004, P NATL ACAD SCI USA, V101, P12444, DOI 10.1073/pnas.0403509101; Vranken W, 2002, BIOCHEMISTRY-US, V41, P8570, DOI 10.1021/bi012169a	30	201	239	3	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 17	2004	305	5691					1770	1773		10.1126/science.1101148	http://dx.doi.org/10.1126/science.1101148			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	856IS	15319492				2022-12-24	WOS:000224039500040
J	Rando, TA				Rando, TA			Artificial sweeteners - Enhancing glycosylation to treat muscular dystrophies	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Stanford Univ, Dept Neurol & Neurol Sci, Palo Alto, CA 94304 USA; Vet Affairs Palo Alto Hlth Care Syst, Neurol Serv, Palo Alto, CA USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Rando, TA (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Palo Alto, CA 94304 USA.							BARRESI R, 2004, NAT MED, V117, P953; Engvall E, 2003, FASEB J, V17, P1579, DOI 10.1096/fj.02-1215rev; Muntoni F, 2004, CURR OPIN NEUROL, V17, P205, DOI 10.1097/00019052-200404000-00020; Nguyen HH, 2002, P NATL ACAD SCI USA, V99, P5616, DOI 10.1073/pnas.082613599; Rando TA, 2001, MUSCLE NERVE, V24, P1575, DOI 10.1002/mus.1192	5	4	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 16	2004	351	12					1254	1256		10.1056/NEJMcibr042066	http://dx.doi.org/10.1056/NEJMcibr042066			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	853WS	15371584				2022-12-24	WOS:000223861300017
J	Weinstein, AR; Sesso, HD; Lee, IM; Cook, NR; Manson, JE; Buring, JE; Gaziano, JM				Weinstein, AR; Sesso, HD; Lee, IM; Cook, NR; Manson, JE; Buring, JE; Gaziano, JM			Relationship of physical activity vs body mass index with type 2 diabetes in women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK-FACTOR; LIFE-STYLE; MELLITUS; EXERCISE; PREVENTION; OBESITY; DISEASE; WEIGHT; HEALTH; DIET	Context Physical inactivity and body mass index (BMI) are established independent risk factors in the development of type 2 diabetes; however, their comparative importance and joint relationship with diabetes are unclear. Objective To examine the relative contributions and joint association of physical activity and BMI with diabetes. Design, Setting, and Participants Prospective cohort study of 37878 women free of cardiovascular disease, cancer, and diabetes with 6.9 years of mean follow-up. Weight, height, and recreational activities were reported at study entry. Normal weight was defined as a BMI of less than 25; overweight, 25 to less than 30; and obese, 30 or higher. Active was defined as expending more than 1000 kcal on recreational activities per week. Main Outcome Measure Incident type 2 diabetes, defined as anew self-reported diagnosis of diabetes. Results During the follow-up, 1361 cases of incident diabetes occurred. Individually, BMI and physical Activity were significant predictors of incident diabetes. Compared with normal-weight individuals, the multivariate-adjusted hazard ratio (HR) was 3.22 (95% confidence interval [CI], 2.69-3.87) for overweight individuals and 9.09 (95% CI, 7.62-10.8) for obese individuals. For overall activity (kilocalories expended per week), compared with the least active first quartile, the multivariate-adjusted HRs were 0.91 (95% CI, 0.79-1.06) for the second quartile, 0.86 (95% CI, 0.74-1.01) for the third, and 0.82 (95% CI, 0.70-0.97) for the fourth (P for trend=.01). In the combined analyses, overweight and obese participants, whether active or inactive, had significantly elevated risks, compared with normal-weight active individuals. The multivariate-adjusted HRS were 1.15 (95% CI, 0.83-1.59) for normal-weight inactive, 3.68 (95% CI, 2.63-5.15) for overweight active, 4.16 (95% CI, 3.05-5.66) for overweight inactive, 11.5 (95% CI, 8.34-15.9) for obese active, and 11.8 (95% CI, 8.75-16.0) for obese inactive participants. Conclusions Although BMI and physical inactivity are independent predictors of incident diabetes, the magnitude of the association with BMI was greater than with physical activity in combined analyses. These findings underscore the critical importance of adiposity as a determinant of diabetes.	Brigham & Womens Hosp, Dept Med, Div Prevent Med, Boston VA Healthcare Syst, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System	Weinstein, AR (corresponding author), Womens Hlth Ctr Hlth Care Associates, Beth Israel Deaconess Med Ctr, 330 Brookline Ave,Atrium Suite, Boston, MA 02115 USA.	aweinste@bidmc.harvard.edu	Lee, I-Min/ABD-5409-2021		NCI NIH HHS [CA-4799] Funding Source: Medline; NHLBI NIH HHS [HL-65727, HL-43851] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R03HL065727, R01HL043851] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Blumenthal JA, 2000, ARCH INTERN MED, V160, P1947, DOI 10.1001/archinte.160.13.1947; Boden G, 2001, ENDOCRIN METAB CLIN, V30, P801, DOI 10.1016/S0889-8529(05)70216-4; Buring JE, 1992, J MYOCARDIAL ISCHEMI, V4, P30; Buring JE, 1992, J MYOCARDIAL ISCHEMI, V4, P27; COLDITZ GA, 1990, AM J EPIDEMIOL, V132, P501, DOI 10.1093/oxfordjournals.aje.a115686; Folsom AR, 2000, AM J PUBLIC HEALTH, V90, P134, DOI 10.2105/AJPH.90.1.134; Gavin JR, 1997, DIABETES CARE, V20, P1183; Goodyear LJ, 1998, ANNU REV MED, V49, P235, DOI 10.1146/annurev.med.49.1.235; HELMRICH SP, 1991, NEW ENGL J MED, V325, P147, DOI 10.1056/NEJM199107183250302; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Hu FB, 1999, JAMA-J AM MED ASSOC, V282, P1433, DOI 10.1001/jama.282.15.1433; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lee IM, 1996, RES Q EXERCISE SPORT, V67, P206, DOI 10.1080/02701367.1996.10607944; Lee IM, 2001, JAMA-J AM MED ASSOC, V285, P1447, DOI 10.1001/jama.285.11.1447; MANSON JE, 1991, LANCET, V338, P774, DOI 10.1016/0140-6736(91)90664-B; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; PAOLISSO G, 1995, DIABETOLOGIA, V38, P1213, DOI 10.1007/BF00422371; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Rexrode KM, 2000, J WOMEN HEALTH GEN-B, V9, P19, DOI 10.1089/152460900318911; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; Willet W., 1998, NUTR EPIDEMIOLOGY, P74, DOI DOI 10.1093/ACPROF:OSO/9780195122978.001.0001; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; World Health Organization Expert Committee on Physical Status, 1995, US INT ANTHR REP WHO	27	244	254	2	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 8	2004	292	10					1188	1194		10.1001/jama.292.10.1188	http://dx.doi.org/10.1001/jama.292.10.1188			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	851ZA	15353531	Bronze			2022-12-24	WOS:000223723800018
J	Doherty, RB				Doherty, RB			Assessing the new medicare prescription drug law	ANNALS OF INTERNAL MEDICINE			English	Article								The Medicare Modernization Act (MMA) is the product of a political compromise to attract moderate Republicans and enough Democrats without losing Republican conservatives. The compromise offered more private health plans to beneficiaries while maintaining and improving traditional Medicare's benefits. This compromise did not settle the debate over the legislation, which is a major issue in the 2004 elections. Voters poorly understand the law because of its complexity. In this paper, I explain how the policy decisions made by the U.S. Congress have contributed to the law's complexity and controversy. I examine the new private health plan options that will be offered to beneficiaries, improvements made to traditional Medicare, and the impact of introducing income-based determinations into Medicare. I also discuss the impact of the drug benefit on beneficiaries in different income and assets categories and Congress's decision to prohibit the federal government from directly negotiating prices with drug manufacturers. I conclude by assessing the major claims made by critics and proponents. Both might be more circumspect in their assessments of the law's impact, since it is impossible to predict how a law of such complexity, with so many human variables, will work out in the end. The MMA is a worthwhile but imperfect effort to extend drug coverage to seniors who are most in need. It deserves neither condemnation nor indiscriminate praise but instead a commitment to help it succeed.	Amer Coll Physicians, Customer Serv, Philadelphia, PA 19106 USA	American College of Physicians	Doherty, RB (corresponding author), Amer Coll Physicians, Customer Serv, 190 N Independence Mall W, Philadelphia, PA 19106 USA.							*AARP, MED CHANG COULD AFF; Altman DE, 2004, NEW ENGL J MED, V350, P9, DOI 10.1056/NEJMp038224; BALL RM, 1997, MED PREPARING CHALLE; BUSH GW, 2003, REMARKS PRESIDENT SI; Holtz-Eakin D, 2004, COMMUNICATION   0123; *KAIS FAM FDN, 2004, MARCH APR 2004 KAIS; KENNEDY EM, 2003, DINGELL ANNOUNCE THE; 2003, ANG SEN CONTR EUPH W; 2004, PRESCR DRUG COV MED	9	25	25	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 7	2004	141	5					391	395		10.7326/0003-4819-141-5-200409070-00100	http://dx.doi.org/10.7326/0003-4819-141-5-200409070-00100			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	852CW	15353431				2022-12-24	WOS:000223733800008
J	Gardner, A; West, SA				Gardner, A; West, SA			Spite among siblings	SCIENCE			English	Editorial Material							POLYEMBRYONIC WASP; COMPETITION		Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JT, Midlothian, Scotland	University of Edinburgh	Gardner, A (corresponding author), Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JT, Midlothian, Scotland.	andy.gardner@ed.ac.uk	West, Stuart A/M-3608-2014; Gardner, Andy/K-5353-2013	West, Stuart A/0000-0003-2152-3153; Gardner, Andy/0000-0002-1304-3734				Donnell DM, 2004, P NATL ACAD SCI USA, V101, P10095, DOI 10.1073/pnas.0403625101; Frank S. A., 1998, FDN SOCIAL EVOLUTION, DOI DOI 10.1515/9780691206820; Gardner A, 2004, J EVOLUTION BIOL, V17, P1195, DOI 10.1111/j.1420-9101.2004.00775.x; Giron D, 2004, NATURE, V430, P676, DOI 10.1038/nature02721; GIRON D, 2004, P R SOC B S     0617, DOI DOI 10.1098/RSB1.2004.0205; Grafen A., 1985, Oxford Surveys in Evolutionary Biology, V2, P28; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; HAMILTON WD, 1970, NATURE, V228, P1218, DOI 10.1038/2281218a0	9	23	24	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 3	2004	305	5689					1413	1414		10.1126/science.1103635	http://dx.doi.org/10.1126/science.1103635			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	852NK	15353789				2022-12-24	WOS:000223761900032
J	Sordella, R; Bell, DW; Haber, DA; Settleman, J				Sordella, R; Bell, DW; Haber, DA; Settleman, J			Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways	SCIENCE			English	Article							GROWTH-FACTOR RECEPTOR; CELL-CYCLE PROGRESSION; RAS/RAF/MEK/ERK PATHWAY; TYROSINE KINASE; INHIBITOR; ZD1839; TRIAL	Gefitinib (Iressa, AstraZeneca Pharmaceuticals) is a tyrosine kinase inhibitor that targets the epidermal growth factor receptor (EGFR) and induces dramatic clinical responses in nonsmall. cell lung cancers (NSCLCs) with activating mutations within the EGFR kinase domain. We report that these mutant EGFRS selectively activate Akt and signal transduction and activator of transcription (STAT) signaling pathways, which promote cell survival, but have no effect on extracellular signal-regulated kinase signaling which induces proliferation. NSCLC cells expressing mutant EGFRs underwent extensive apoptosis after small interfering RNA-mediated knockdown of the mutant EGFR or treatment with pharmacological inhibitors of Akt and STAT signaling and were relatively resistant to apoptosis induced by conventional chemotherapeutic drugs. Thus, mutant EGFRs selectively transduce survival signals on which NSCLCs become dependent, inhibition of those signals by gefitinib may contribute to the drug's efficacy.	Massachusetts Gen Hosp, Ctr Canc, Ctr Mol Therapeut, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University	Settleman, J (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Ctr Mol Therapeut, Bldg 149,13th St, Charlestown, MA 02129 USA.	settleman@helix.mgh.harvard.edu			PHS HHS [P01 95281] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ahonen TJ, 2003, J BIOL CHEM, V278, P27287, DOI 10.1074/jbc.M304307200; Baselga J, 2002, J CLIN ONCOL, V20, P4292, DOI 10.1200/JCO.2002.03.100; Calo V, 2003, J CELL PHYSIOL, V197, P157, DOI 10.1002/jcp.10364; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; Chang FM, 2003, INT J ONCOL, V22, P469; EARP HS, 1995, BREAST CANCER RES TR, V35, P115, DOI 10.1007/BF00694752; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Giaccone G, 2004, J CLIN ONCOL, V22, P777, DOI 10.1200/JCO.2004.08.001; Grant S, 2002, FRONT BIOSCI-LANDMRK, V7, pD376, DOI 10.2741/grant; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kindler T, 2003, LEUKEMIA, V17, P999, DOI 10.1038/sj.leu.2402940; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Paner GP, 2003, ANTICANCER RES, V23, P2253; SORDELLA R, UNPUB; Wakeling AE, 2002, CANCER RES, V62, P5749; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096	19	1353	1450	5	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 20	2004	305	5687					1163	1167		10.1126/science.1101637	http://dx.doi.org/10.1126/science.1101637			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	849RD	15284455				2022-12-24	WOS:000223557400051
J	Carucci, D				Carucci, D			Know thine enemy	NATURE			English	Article							PLASMODIUM-FALCIPARUM; LIFE-CYCLE; PROTEINS; INVASION; SEQUENCE; GENOME		Fdn Natl Inst Hlth, Bethesda, MD USA	National Institutes of Health (NIH) - USA	Carucci, D (corresponding author), Fdn Natl Inst Hlth, Bethesda, MD USA.							BORDECH Z, 2003, PLOS BIOL, V1, pE5; Cowman AF, 2002, SCIENCE, V298, P126, DOI 10.1126/science.1078169; Doolan DL, 2003, J EXP BIOL, V206, P3789, DOI 10.1242/jeb.00615; Doolan DL, 2003, P NATL ACAD SCI USA, V100, P9952, DOI 10.1073/pnas.1633254100; Duraisingh MT, 2003, EMBO J, V22, P1047, DOI 10.1093/emboj/cdg096; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Volkman SK, 2002, SCIENCE, V298, P216, DOI 10.1126/science.1075642	10	5	5	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2004	430	7002					944	945		10.1038/430944a	http://dx.doi.org/10.1038/430944a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318241	Bronze			2022-12-24	WOS:000223369800064
J	Hoffman, S				Hoffman, S			Save the children	NATURE			English	Article							CIRCUMSPOROZOITE PROTEIN VACCINE; PLASMODIUM; MALARIA; GENOMICS; EFFICACY		Sanaria, Rockville, MD USA	Sanaria Inc.	Hoffman, S (corresponding author), Sanaria, Rockville, MD USA.							Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Hoffman SL, 2002, NATURE, V415, P702, DOI 10.1038/415702a; Kester KE, 2001, J INFECT DIS, V183, P640, DOI 10.1086/318534; Long CA, 2002, SCIENCE, V297, P345, DOI 10.1126/science.1074484; Luke TC, 2003, J EXP BIOL, V206, P3803, DOI 10.1242/jeb.00644; McConkey SJ, 2003, NAT MED, V9, P729, DOI 10.1038/nm881; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202	8	11	16	0	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 19	2004	430	7002					940	941		10.1038/430940a	http://dx.doi.org/10.1038/430940a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318239				2022-12-24	WOS:000223369800062
J	Ridley, R; Toure, Y				Ridley, R; Toure, Y			Winning the drugs war	NATURE			English	Article							DISCOVERY		UNICEF UNDP World Bank WHO Special Programme Res, New York, NY 10017 USA	UNICEF	Ridley, R (corresponding author), UNICEF UNDP World Bank WHO Special Programme Res, New York, NY 10017 USA.							Adjuik M, 2004, LANCET, V363, P9, DOI 10.1016/S0140-6736(03)15162-8; Alloueche A, 2004, LANCET, V363, P1843, DOI 10.1016/S0140-6736(04)16350-2; [Anonymous], 2004, SCAL HOM BAS MAN MAL; [Anonymous], 2003, AFR MAL REP 2003; Fidock DA, 2004, NAT REV DRUG DISCOV, V3, P509, DOI 10.1038/nrd1416; Lang T, 2003, LANCET INFECT DIS, V3, P162, DOI 10.1016/S1473-3099(03)00547-4; *MMV, 2004, MED MAL VENT ANN REP; Nwaka S, 2003, NAT REV DRUG DISCOV, V2, P919, DOI 10.1038/nrd1230; Ridley RG, 2002, NATURE, V415, P686, DOI 10.1038/415686a; Vennerstrom JL, 2004, NATURE, V430, P900, DOI 10.1038/nature02779	10	14	14	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 19	2004	430	7002					942	943		10.1038/430942a	http://dx.doi.org/10.1038/430942a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	847DA	15318240				2022-12-24	WOS:000223369800063
J	Golden, DBK; Kagey-Sobotka, A; Norman, PS; Hamilton, RG; Lichtenstein, LM				Golden, DBK; Kagey-Sobotka, A; Norman, PS; Hamilton, RG; Lichtenstein, LM			Outcomes of allergy to insect stings in children, with and without venom immunotherapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LARGE LOCAL REACTIONS; QUALITY-OF-LIFE; NATURAL-HISTORY; DISCONTINUATION	Background: Children are thought to "outgrow'' the allergy to insect stings, but there are no reports documenting the natural history of this reaction. We studied the outcome of allergic reactions to insect stings in childhood 10 to 20 years afterward in patients who had not received venom immunotherapy and in those who had been treated. Methods: Between 1978 and 1985, we diagnosed allergic reaction to insect stings in 1033 children, of whom 356 received venom immunotherapy. We conducted a survey of these patients by telephone and mail between January 1997 and January 2000, to determine the outcome of stings that occurred in the period from 1987 through 1999. Results: Of the 1033 patients, 512 patients (50 percent) responded, with a mean follow-up period of 18 years, a mean duration of venom immunotherapy of 3.5 years in treated patients, and an incidence of stings of 43 percent. Systemic reactions occurred less frequently in patients who had received venom immunotherapy (2 of 64 patients, or 3 percent) than in untreated patients (19 of 111 patients, or 17 percent; P=0.007). Patients with a history of moderate-to-severe reactions had a higher rate of reaction if they had not been treated (7 of 22 patients, or 32 percent) than if they had received venom immunotherapy (2 of 43 patients, or 5 percent; P=0.007). In patients who had been treated and who had a history of mild (cutaneous) systemic reaction (i.e., one with only cutaneous manifestations), none of the 21 subjects who received stings had a systemic reaction. Conclusions: A clinically important number of children do not outgrow allergic reactions to insect stings. Venom immunotherapy in children leads to a significantly lower risk of systemic reaction to stings even 10 to 20 years after treatment is stopped, and this prolonged benefit is greater than the benefit seen in adults.	Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins Medicine	Golden, DBK (corresponding author), Johns Hopkins Asthma & Allergy Ctr, 5501 Hopkins Bayview Blvd, Baltimore, MD 21224 USA.	dgolden1@jhmi.edu			NIAID NIH HHS [AI08270] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI008270, R37AI008270] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BARNARD JH, 1973, J ALLERGY CLIN IMMUN, V52, P259, DOI 10.1016/0091-6749(73)90044-4; Elberink JNGO, 2002, J ALLERGY CLIN IMMUN, V109, P162, DOI 10.1067/mai.2002.120552; Elberink JNGO, 2002, J ALLERGY CLIN IMMUN, V110, P174, DOI 10.1067/mai.2002.125827; Golden DBK, 2000, J ALLERGY CLIN IMMUN, V105, P385, DOI 10.1016/S0091-6749(00)90092-7; Golden DBK, 2001, J ALLERGY CLIN IMMUN, V107, P925, DOI 10.1067/mai.2001.115095; Graft DF, 1998, J ALLERGY CLIN IMMUN, V101, P573, DOI 10.1016/S0091-6749(98)70161-7; GRAFT DF, 1984, J PEDIATR-US, V104, P664, DOI 10.1016/S0022-3476(84)80940-3; HUNT KJ, 1978, NEW ENGL J MED, V299, P157, DOI 10.1056/NEJM197807272990401; Lerch E, 1998, J ALLERGY CLIN IMMUN, V101, P606, DOI 10.1016/S0091-6749(98)70167-8; LICHTENSTEIN LM, 1974, NEW ENGL J MED, V290, P1223, DOI 10.1056/NEJM197405302902204; Light WC, 2001, J ALLERGY CLIN IMMUN, V107, P925, DOI 10.1067/mai.2001.114985; MAURIELLO PM, 1984, J ALLERGY CLIN IMMUN, V74, P494, DOI 10.1016/0091-6749(84)90384-1; SCHUBERTH KC, 1988, J ALLERGY CLIN IMMUN, V81, P200, DOI 10.1016/0091-6749(88)90364-8; SCHUBERTH KC, 1982, J PEDIATR-US, V100, P546, DOI 10.1016/S0022-3476(82)80750-6; SETTIPANE GA, 1970, ACTA ALLERGOL, V25, P286, DOI 10.1111/j.1398-9995.1970.tb01264.x; VALENTINE MD, 1990, NEW ENGL J MED, V323, P1601, DOI 10.1056/NEJM199012063232305	16	176	185	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 12	2004	351	7					668	674		10.1056/NEJMoa022952	http://dx.doi.org/10.1056/NEJMoa022952			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845FZ	15306668				2022-12-24	WOS:000223225500009
J	Christensen, PR; Ruff, SW; Fergason, RL; Knudson, AT; Anwar, S; Arvidson, RE; Bandfield, JL; Blaney, DL; Budney, C; Calvin, WM; Glotch, TD; Golombek, MP; Gorelick, N; Graff, TG; Hamilton, VE; Hayes, A; Johnson, JR; McSween, HY; Mehall, GL; Mehall, LK; Moersch, JE; Morris, RV; Rogers, AD; Smith, MD; Squyres, SW; Wolff, MJ; Wyatt, MB				Christensen, PR; Ruff, SW; Fergason, RL; Knudson, AT; Anwar, S; Arvidson, RE; Bandfield, JL; Blaney, DL; Budney, C; Calvin, WM; Glotch, TD; Golombek, MP; Gorelick, N; Graff, TG; Hamilton, VE; Hayes, A; Johnson, JR; McSween, HY; Mehall, GL; Mehall, LK; Moersch, JE; Morris, RV; Rogers, AD; Smith, MD; Squyres, SW; Wolff, MJ; Wyatt, MB			Initial results from the Mini-TES experiment in Gusev crater from the Spirit rover	SCIENCE			English	Article							THERMAL EMISSION-SPECTROSCOPY; ROCKS; TERRESTRIAL	The Miniature Thermal Emission Spectrometer (Mini-TES) on Spirit has studied the mineralogy and thermophysical properties at Gusev crater. Undisturbed soil spectra show evidence for minor carbonates and bound water. Rocks are olivine-rich basalts with varying degrees of dust and other coatings. Dark-toned soils observed on disturbed surfaces may be derived from rocks and have derived mineralogy (+/- 5 to 10%) of 45% pyroxene (20% Ca-rich pyroxene and 25% pigeonite), 40% sodic to intermediate plagioclase, and 15% olivine (forsterite 45% +/- 5 to 10). Two spectrally distinct coatings are observed on rocks, a possible indicator of the interaction of water, rock, and airfall dust. Diurnal temperature data indicate particle sizes from 40 to 80 mum in hollows to similar to0.5 to 3 mm in soils.	Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Univ Nevada, Dept Geol Sci, Reno, NV 89557 USA; Univ Hawaii, Inst Geophys & Planetol, Honolulu, HI 96822 USA; Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; US Geol Survey, Flagstaff, AZ 86001 USA; Univ Tennessee, Dept Earth & Planetary Sci, Knoxville, TN 37996 USA; NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; Space Sci Inst, Martinez, GA 30907 USA	Arizona State University; Arizona State University-Tempe; Washington University (WUSTL); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Nevada System of Higher Education (NSHE); University of Nevada Reno; University of Hawaii System; Cornell University; United States Department of the Interior; United States Geological Survey; University of Tennessee System; University of Tennessee Knoxville; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Christensen, PR (corresponding author), Arizona State Univ, Dept Geol Sci, Tempe, AZ 85287 USA.	phil.christensen@asu.edu	Moersch, Jeffrey E/F-7189-2010; Rogers, A. Deanne/ABE-8469-2021; Blaney, Diana/M-1756-2019; Hayes, Alexander G/P-2024-2014; Johnson, Jeffrey R/F-3972-2015; Smith, Michael/C-8875-2012; Rogers, Deanne/I-9737-2016; Glotch, Timothy/B-6829-2008	Moersch, Jeffrey E/0000-0003-3433-9419; Rogers, A. Deanne/0000-0002-4671-2551; Blaney, Diana/0000-0002-4267-7939; Hayes, Alexander G/0000-0001-6397-2630; Johnson, Jeffrey R/0000-0002-5586-4901; Rogers, Deanne/0000-0002-4671-2551; Bandfield, Joshua/0000-0003-3571-3716; Gorelick, Noel/0000-0002-5548-2436				Arvidson RE, 2004, SCIENCE, V305, P821, DOI 10.1126/science.1099922; Bandfield JL, 2000, SCIENCE, V287, P1626, DOI 10.1126/science.287.5458.1626; Bandfield JL, 2003, SCIENCE, V301, P1084, DOI 10.1126/science.1088054; Bell JF, 2004, SCIENCE, V305, P800, DOI 10.1126/science.1100175; Bishop JL, 2004, ICARUS, V169, P311, DOI 10.1016/j.icarus.2003.12.025; CHRISTENSEN PR, 1986, ICARUS, V68, P217, DOI 10.1016/0019-1035(86)90020-5; Christensen PR, 2000, J GEOPHYS RES-PLANET, V105, P9735, DOI 10.1029/1998JE000624; CHRISTENSEN PR, 1993, J GEOPHYS RES-SOL EA, V98, P19819, DOI 10.1029/93JB00135; Christensen PR, 2001, J GEOPHYS RES-PLANET, V106, P23823, DOI 10.1029/2000JE001370; CHRISTENSEN PR, 2003, J GEOPHYS RES, V198; CICCOLLELA SM, 2003, P LUNAR PLANET SCI, V34, P1836; Feely KC, 1999, J GEOPHYS RES-PLANET, V104, P24195, DOI 10.1029/1999JE001034; Grant JA, 2004, SCIENCE, V305, P807, DOI 10.1126/science.1099849; Hamilton VE, 2001, J GEOPHYS RES-PLANET, V106, P14733, DOI 10.1029/2000JE001353; Herkenhoff KE, 2004, SCIENCE, V305, P824, DOI 10.1126/science.1100015; Kieffer H. H., 1977, Journal of Geophysical Research, V82, P4249, DOI 10.1029/JS082i028p04249; KIEFFER HH, 1973, J GEOPHYS RES, V78, P4291, DOI 10.1029/JB078i020p04291; LANE MD, 2004, P LUNAR PLANET SCI, V35; McSween HY, 2004, SCIENCE, V305, P842, DOI 10.1126/science.3050842; Mellon MT, 2000, ICARUS, V148, P437, DOI 10.1006/icar.2000.6503; Presley MA, 1997, J GEOPHYS RES-PLANET, V102, P6551, DOI 10.1029/96JE03303; Ramsey MS, 1998, J GEOPHYS RES-SOL EA, V103, P577, DOI 10.1029/97JB02784; Ruff SW, 2004, ICARUS, V168, P131, DOI 10.1016/j.icarus.2003.11.003; Smith M.R., UNPUB; Squyres SW, 2004, SCIENCE, V305, P794, DOI 10.1126/science.3050794; Wyatt MB, 2001, J GEOPHYS RES-PLANET, V106, P14711, DOI 10.1029/2000JE001356	26	139	141	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2004	305	5685					837	842		10.1126/science.1100564	http://dx.doi.org/10.1126/science.1100564			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	843RT	15297667				2022-12-24	WOS:000223104900040
J	Fine, PVA; Mesones, I; Coley, PD				Fine, PVA; Mesones, I; Coley, PD			Herbivores promote habitat specialization by trees in amazonian forests	SCIENCE			English	Article							RAIN-FOREST; RECRUITMENT; VEGETATION; DIVERSITY; PATTERNS; STRESS; SHRUB	In an edaphically heterogeneous area in the Peruvian Amazon, clay soils and nutrient-poor white sands each harbor distinctive plant communities. To determine whether a trade-off between growth and antiherbivore defense enforces habitat specialization on these two soil types, we conducted a reciprocal transplant study of seedlings of 20 species from six genera of phylogenetically independent pairs of edaphic specialist trees and manipulated the presence of herbivores. Clay specialist species grew significantly faster than white-sand specialists in both soil types when protected from herbivores. However, when unprotected, white-sand specialists dominated in white-sand forests and clay specialists dominated in clay forests. Therefore, habitat specialization in this system results from an interaction of herbivore pressure with soil type.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; Field Museum Nat Hist, Environm Program, Chicago, IL 60605 USA; Field Museum Nat Hist, Conservat Program, Chicago, IL 60605 USA; Field Museum Nat Hist, Dept Bot, Chicago, IL 60605 USA; Univ Nacl Amazonia Peruana, Dept Forestry, Iquitos, Peru	Utah System of Higher Education; University of Utah; Field Museum of Natural History (Chicago); Field Museum of Natural History (Chicago); Field Museum of Natural History (Chicago); Universidad Nacional de la Amazonia Peruana	Fine, PVA (corresponding author), Univ Utah, Dept Biol, 257 S 1400 East, Salt Lake City, UT 84112 USA.	fine@biology.utah.edu		Fine, Paul/0000-0002-0550-5628				CHASE MW, 1993, ANN MO BOT GARD, V80, P528, DOI 10.2307/2399846; Clark DB, 1999, ECOLOGY, V80, P2662, DOI 10.1890/0012-9658(1999)080[2662:EFATLS]2.0.CO;2; Cobb NS, 1997, OECOLOGIA, V109, P389, DOI 10.1007/s004420050098; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Coomes DA, 1996, VEGETATIO, V122, P167, DOI 10.1007/BF00044699; DeWalt SJ, 2004, ECOLOGY, V85, P471, DOI 10.1890/02-0728; Endler J.A., 1977, Monographs in Population Biology, pi; FINE PVA, UNPUB; GARCIAVILLACORT.R, 2002, FOLIA AMAZONICA, V14, P11; Gentry A.H., 1986, CONSERVATION BIOL SC, P153; GENTRY AH, 1988, ANN MO BOT GARD, V75, P1, DOI 10.2307/2399464; Harley CDG, 2003, ECOLOGY, V84, P1477, DOI 10.1890/0012-9658(2003)084[1477:ASAHIT]2.0.CO;2; Harper J. L., 1977, Population biology of plants.; JANZEN D H, 1974, Biotropica, V6, P69, DOI 10.2307/2989823; Jorgensen P.M., 1999, CATALOGUE VASCULAR P; King RT, 2003, BIOTROPICA, V35, P462, DOI 10.1111/j.1744-7429.2003.tb00603.x; Louda S. M., 1990, Perspectives on plant competition., P413; Louda SM, 1996, J ECOL, V84, P229, DOI 10.2307/2261358; LOUDA SM, 1983, ECOLOGY, V64, P511, DOI 10.2307/1939971; LOUDA SM, 1982, ECOL MONOGR, V52, P25, DOI 10.2307/2937343; Mark AF, 2001, AUSTRAL ECOL, V26, P423, DOI 10.1046/j.1442-9993.2001.01127.x; MCKEY D, 1978, SCIENCE, V202, P61; Medina E., 1989, Mineral nutrients in tropical forest and savanna ecosystems., P217; Moran JA, 2000, BIOTROPICA, V32, P2, DOI 10.1111/j.1744-7429.2000.tb00442.x; Moritz C, 2000, ANNU REV ECOL SYST, V31, P533, DOI 10.1146/annurev.ecolsys.31.1.533; Ogden R, 2002, P NATL ACAD SCI USA, V99, P13612, DOI 10.1073/pnas.212248499; Olff H, 1998, TRENDS ECOL EVOL, V13, P261, DOI 10.1016/S0169-5347(98)01364-0; PARKER MA, 1981, ECOLOGY, V62, P1390, DOI 10.2307/1937302; Proctor John, 1999, Botanical Journal of Scotland, V51, P1; Ruokolainen K, 1997, J TROP ECOL, V13, P243, DOI 10.1017/S0266467400010439; Ruokolainen K., 1998, GEOECOLOGIA DESARROL, P253; Sollins P, 1998, ECOLOGY, V79, P23, DOI 10.1890/0012-9658(1998)079[0023:FISCIT]2.0.CO;2; TUOMISTO H, 1995, SCIENCE, V269, P63, DOI 10.1126/science.269.5220.63; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; Vasquez R, 1997, FLORULA RESERVAS BIO; YOUNG KR, 1989, BRITTONIA, V41, P388, DOI 10.2307/2807552	38	393	409	5	177	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 30	2004	305	5684					663	665		10.1126/science.1098982	http://dx.doi.org/10.1126/science.1098982			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	842GQ	15286371				2022-12-24	WOS:000222992100046
J	Gnos, E; Hofmann, BA; Al-Kathiri, A; Lorenzetti, S; Eugster, O; Whitehouse, MJ; Villa, IM; Jull, AJT; Eikenberg, J; Spettel, B; Krahenbuhl, U; Franchi, IA; Greenwood, RC				Gnos, E; Hofmann, BA; Al-Kathiri, A; Lorenzetti, S; Eugster, O; Whitehouse, MJ; Villa, IM; Jull, AJT; Eikenberg, J; Spettel, B; Krahenbuhl, U; Franchi, IA; Greenwood, RC			Pinpointing the source of a lunar meteorite: Implications for the evolution of the moon	SCIENCE			English	Article							PROCELLARUM KREEP TERRANE; IMPACT-MELT BRECCIAS; ABSOLUTE AGES; SURFACE	The lunar meteorite Sayh al Uhaymir 169 consists of an impact melt breccia extremely enriched with potassium, rare earth elements, and phosphorus [thorium, 32.7 parts per million (ppm); uranium, 8.6 ppm; potassium oxide, 0.54 weight percent], and adherent regolith. The isotope systematics of the meteorite record four lunar impact events at 3909 +/- 13 million years ago (Ma), similar to 2800 Ma, similar to 200 Ma, and < 0.34 Ma, and collision with Earth sometime after 9.7 &PLUSMN; 1.3 thousand years ago. With these data, we can link the impact-melt breccia to Imbrium and pinpoint the source region of the meteorite to the Lalande impact crater.	Univ Bern, Inst Geol, CH-3012 Bern, Switzerland; Nat Hist Museum Burgergemeinde Bern, CH-3005 Bern, Switzerland; Univ Bern, Inst Phys, Abt Weltraumforsch & Planetol, CH-3012 Bern, Switzerland; Swedish Museum Nat Hist, Lab Isotope Geol, SE-10405 Stockholm, Sweden; Univ Arizona, Natl Sci Fdn, Arizona Accelerator Mass Spectrometry Lab, Tucson, AZ 85721 USA; Paul Scherrer Inst, CH-5232 Villigen, Switzerland; Max Planck Inst Chem, Abt Kosmochem, D-55020 Mainz, Germany; Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland; Open Univ, Planetary & Space Sci Res Inst, Milton Keynes MK7 6AA, Bucks, England	University of Bern; University of Bern; Swedish Museum of Natural History; National Science Foundation (NSF); University of Arizona; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Max Planck Society; University of Bern; Open University - UK	Gnos, E (corresponding author), Univ Bern, Inst Geol, Baltzerstr 1, CH-3012 Bern, Switzerland.	gnos@geo.unibe.ch	Gnos, Edwin/AAI-7477-2020; Whitehouse, Martin J/E-1425-2013; Lorenzetti, Silvio Rene/B-1188-2009	Gnos, Edwin/0000-0003-0940-8435; Whitehouse, Martin J/0000-0003-2227-577X; Lorenzetti, Silvio Rene/0000-0002-8339-8960; Greenwood, Richard/0000-0002-5544-8027; Hofmann, Beda/0000-0003-2738-8466				BALDWIN RB, 1985, ICARUS, V61, P63, DOI 10.1016/0019-1035(85)90156-3; BALDWIN RB, 1987, ICARUS, V71, P19, DOI 10.1016/0019-1035(87)90159-X; Cohen BA, 2000, SCIENCE, V290, P1754, DOI 10.1126/science.290.5497.1754; Dalrymple GB, 1996, J GEOPHYS RES-PLANET, V101, P26069, DOI 10.1029/96JE02806; ELPHIC RC, 2002, J GEOPHYS RES, V107, pE4; EUGSTER O, 1995, GEOCHIM COSMOCHIM AC, V59, P177, DOI 10.1016/0016-7037(94)00327-I; Feldman M., 2001, NATL IDENTITIES, V3, P5; Haskin LA, 2000, J GEOPHYS RES-PLANET, V105, P20403, DOI 10.1029/1999JE001128; Heiken G., 1991, LUNAR SOURCE BOOK US; HOHENBERG CM, 1978, P LUNAR PLANET SCI C, V9, P2311; Jolliff BL, 2000, J GEOPHYS RES-PLANET, V105, P4197, DOI 10.1029/1999JE001103; Jolliff BL, 1998, INT GEOL REV, V40, P916, DOI 10.1080/00206819809465245; Korotev RL, 2000, J GEOPHYS RES-PLANET, V105, P4317, DOI 10.1029/1999JE001063; Lawrence DJ, 1999, GEOPHYS RES LETT, V26, P2681, DOI 10.1029/1999GL008361; METZGER AE, 1973, SCIENCE, V179, P800, DOI 10.1126/science.179.4075.800; Min KW, 2000, GEOCHIM COSMOCHIM AC, V64, P73, DOI 10.1016/S0016-7037(99)00204-5; Russell SS, 2003, METEORIT PLANET SCI, V38, pA189, DOI 10.1111/j.1945-5100.2003.tb00328.x; Stoffler D, 2001, SPACE SCI REV, V96, P9, DOI 10.1023/A:1011937020193; TUNIZ C, 1983, GEOPHYS RES LETT, V10, P804, DOI 10.1029/GL010i009p00804; WARREN PH, 1994, ICARUS, V111, P338, DOI 10.1006/icar.1994.1149; Wiechert U, 2001, SCIENCE, V294, P345, DOI 10.1126/science.1063037; Wieczorek MA, 2000, J GEOPHYS RES-PLANET, V105, P20417, DOI 10.1029/1999JE001092; Wilhelms D. E., 1987, US GEOL SURV PROF PA, V1348, P1	23	120	128	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 30	2004	305	5684					657	659		10.1126/science.1099397	http://dx.doi.org/10.1126/science.1099397			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	842GQ	15286369				2022-12-24	WOS:000222992100044
J	Gartner, ZJ; Tse, BN; Grubina, R; Doyon, JB; Snyder, TM; Liu, DR				Gartner, ZJ; Tse, BN; Grubina, R; Doyon, JB; Snyder, TM; Liu, DR			DNA-templated organic synthesis and selection of a library of macrocycles	SCIENCE			English	Article							CARBONIC-ANHYDRASE	The translation of nucleic acid libraries into corresponding synthetic compounds would enable selection and amplification principles to be applied to man-made molecules. We used multistep DNA-templated organic synthesis to translate libraries of DNA sequences, each containing three "codons," into libraries of sequence-programmed synthetic small-molecule macrocycles. The resulting DNA-macrocycle conjugates were subjected to in vitro selections for protein affinity. The identity of a single macrocycle possessing known target protein affinity was inferred through the sequence of the amplified DNA template surviving the selection. This work represents the translation, selection, and amplification of libraries of nucleic acids encoding synthetic small molecules rather than biological macromolecules.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA	Harvard University	Liu, DR (corresponding author), Harvard Univ, Dept Chem & Biol Chem, 12 Oxford St, Cambridge, MA 02138 USA.	drliu@fas.harvard.edu	Liu, David R./HCH-3132-2022	gartner, zev/0000-0001-7803-1219; Snyder, Thomas/0000-0001-7256-7821	NIGMS NIH HHS [R01GM065865, R01 GM065865-02, R01 GM065865-04, R01 GM065865-01A2, R01 GM065865-03, R01 GM065865] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Calderone CT, 2002, ANGEW CHEM INT EDIT, V41, P4104, DOI 10.1002/1521-3773(20021104)41:21<4104::AID-ANIE4104>3.0.CO;2-O; Doyon JB, 2003, J AM CHEM SOC, V125, P12372, DOI 10.1021/ja036065u; Gartner ZJ, 2003, ANGEW CHEM INT EDIT, V42, P1370, DOI 10.1002/anie.200390351; Gartner ZJ, 2002, ANGEW CHEM INT EDIT, V41, P1796, DOI 10.1002/1521-3773(20020517)41:10<1796::AID-ANIE1796>3.0.CO;2-Z; Gartner ZJ, 2002, J AM CHEM SOC, V124, P10304, DOI 10.1021/ja027307d; Gartner ZJ, 2001, J AM CHEM SOC, V123, P6961, DOI 10.1021/ja015873n; Halpin DR, 2004, PLOS BIOL, V2, P1022, DOI 10.1371/journal.pbio.0020174; JAIN A, 1994, J MED CHEM, V37, P2100, DOI 10.1021/jm00039a023; Joyce GF, 2004, ANNU REV BIOCHEM, V73, P791, DOI 10.1146/annurev.biochem.73.011303.073717; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Li C., 1997, ORGANIC REACTIONS AQ; Lin HN, 2002, ANGEW CHEM INT EDIT, V41, P4403; MARYANOFF BE, 1989, CHEM REV, V89, P863, DOI 10.1021/cr00094a007; Taylor SV, 2001, ANGEW CHEM INT EDIT, V40, P3310, DOI 10.1002/1521-3773(20010917)40:18<3310::AID-ANIE3310>3.0.CO;2-P; Tripp BC, 2001, J BIOL CHEM, V276, P48615, DOI 10.1074/jbc.R100045200; Wilson DS, 1999, ANNU REV BIOCHEM, V68, P611, DOI 10.1146/annurev.biochem.68.1.611; WOODWARD RB, 1981, J AM CHEM SOC, V103, P3210, DOI 10.1021/ja00401a049	17	367	407	4	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 10	2004	305	5690					1601	1605		10.1126/science.1102629	http://dx.doi.org/10.1126/science.1102629			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	854GV	15319493	Green Accepted			2022-12-24	WOS:000223891200038
